<SEC-DOCUMENT>0001213900-24-026942.txt : 20240328
<SEC-HEADER>0001213900-24-026942.hdr.sgml : 20240328
<ACCEPTANCE-DATETIME>20240328092116
ACCESSION NUMBER:		0001213900-24-026942
CONFORMED SUBMISSION TYPE:	20-F
PUBLIC DOCUMENT COUNT:		85
CONFORMED PERIOD OF REPORT:	20231231
FILED AS OF DATE:		20240328
DATE AS OF CHANGE:		20240328

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Arbe Robotics Ltd.
		CENTRAL INDEX KEY:			0001861841
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-COMPUTER INTEGRATED SYSTEMS DESIGN [7373]
		ORGANIZATION NAME:           	06 Technology
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			L3
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		20-F
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-40884
		FILM NUMBER:		24793970

	BUSINESS ADDRESS:	
		STREET 1:		107 HA'HASHMONAIM ST
		CITY:			TEL AVIV
		STATE:			L3
		ZIP:			6713321
		BUSINESS PHONE:		972.73.7969804

	MAIL ADDRESS:	
		STREET 1:		107 HA'HASHMONAIM ST
		CITY:			TEL AVIV
		STATE:			L3
		ZIP:			6713321
</SEC-HEADER>
<DOCUMENT>
<TYPE>20-F
<SEQUENCE>1
<FILENAME>ea0202461-20f_arberobo.htm
<DESCRIPTION>ANNUAL REPORT
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<!-- Generated by CompSci Transform (tm) - http://www.compsciresources.com -->
<!-- Created: Thu Mar 28 12:24:36 UTC 2024 -->
<html xmlns:country="http://xbrl.sec.gov/country/2023" xmlns:dtr="http://www.xbrl.org/dtr/type/2022-03-31" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:ecd="http://xbrl.sec.gov/ecd/2023" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2023" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:compsci="http://compsciresources.com" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:us-types="http://fasb.org/us-types/2023" xmlns:srt="http://fasb.org/srt/2023" xmlns:xl="http://www.xbrl.org/2003/XLink" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:us-gaap="http://fasb.org/us-gaap/2023" xmlns:arbe="http://www.arberobotics.com/20231231" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns="http://www.w3.org/1999/xhtml">
<head>
     <title> </title>

<meta content="text/html" http-equiv="Content-Type"/>
</head>
<body><div style="font: 10pt Times New Roman, Times, Serif"><div>

</div><p style="margin: 0"></p><div>

</div><!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="font-size: 1pt; border-top: Black 2pt solid; border-bottom: Black 1pt solid">&#160;</div></div><!-- Field: /Rule-Page --><div>

</div><p style="text-align: center; margin-top: 0; margin-bottom: 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>UNITED STATES</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>SECURITIES AND EXCHANGE COMMISSION</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>WASHINGTON, D.C. 20549</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>FORM <ix:nonNumeric contextRef="c0" name="dei:DocumentType" id="ixv-26117">20-F</ix:nonNumeric></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><ix:nonNumeric contextRef="c0" format="ixt:fixed-false" name="dei:DocumentRegistrationStatement" id="ixv-32"><span style="font-family: Times New Roman, Times, Serif">&#9744;</span></ix:nonNumeric>
<b>REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>OR</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><ix:nonNumeric contextRef="c0" format="ixt:fixed-true" name="dei:DocumentAnnualReport" id="ixv-45"><span style="font-family: Times New Roman, Times, Serif">&#9746;</span></ix:nonNumeric>
<b>ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>For the fiscal year ended <ix:nonNumeric contextRef="c0" format="ixt:date-monthname-day-year-en" name="dei:DocumentPeriodEndDate" id="ixv-26118"><ix:nonNumeric contextRef="c0" format="ixt:date-monthname-day-en" name="dei:CurrentFiscalYearEndDate" id="ixv-26119">December 31</ix:nonNumeric>, <ix:nonNumeric contextRef="c0" name="dei:DocumentFiscalYearFocus" id="ixv-26120">2023</ix:nonNumeric></ix:nonNumeric></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>OR</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><ix:nonNumeric contextRef="c0" format="ixt:fixed-false" name="dei:DocumentTransitionReport" id="ixv-62"><span style="font-family: Times New Roman, Times, Serif">&#9744;</span></ix:nonNumeric>&#160;<b>TRANSITION
REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>For the transition period from _________ to
_____________.</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>OR</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><ix:nonNumeric contextRef="c0" format="ixt:fixed-false" name="dei:DocumentShellCompanyReport" id="ixv-79"><span style="font-family: Times New Roman, Times, Serif">&#9744;</span></ix:nonNumeric>&#160;<b>SHELL
COMPANY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Date of event requiring this shell company report:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Commission file number: <ix:nonNumeric contextRef="c0" name="dei:EntityFileNumber" id="ixv-26121">001-40884</ix:nonNumeric></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><ix:nonNumeric contextRef="c0" name="dei:EntityRegistrantName" id="ixv-26122">Arbe Robotics Ltd.</ix:nonNumeric> </b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Exact name of Registrant as Specified in its Charter)</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><ix:nonNumeric contextRef="c0" format="ixt-sec:edgarprovcountryen" name="dei:EntityIncorporationStateCountryCode" id="ixv-101"><b>Israel</b></ix:nonNumeric></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Jurisdiction of Incorporation or Organization)</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><ix:nonNumeric contextRef="c0" name="dei:EntityAddressAddressLine1" id="ixv-26123">107 HaHashmonaim St</ix:nonNumeric>., <ix:nonNumeric contextRef="c0" name="dei:EntityAddressCityOrTown" id="ixv-26124">Tel Aviv-Yafo</ix:nonNumeric>, <ix:nonNumeric contextRef="c0" format="ixt-sec:countrynameen" name="dei:EntityAddressCountry" id="ixv-26125">Israel</ix:nonNumeric></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Address of Principal Executive Offices)</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><ix:nonNumeric contextRef="c1" name="dei:ContactPersonnelName" id="ixv-26126">Kobi Marenko</ix:nonNumeric>, Chief Executive Officer</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><ix:nonNumeric contextRef="c1" name="dei:EntityAddressAddressLine1" id="ixv-26127">107 HaHashmonaim St</ix:nonNumeric>., <ix:nonNumeric contextRef="c1" name="dei:EntityAddressCityOrTown" id="ixv-26128">Tel Aviv-Yafo</ix:nonNumeric>, <ix:nonNumeric contextRef="c1" format="ixt-sec:countrynameen" name="dei:EntityAddressCountry" id="ixv-26129">Israel</ix:nonNumeric></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Tel: +<ix:nonNumeric contextRef="c1" name="dei:CityAreaCode" id="ixv-26130">972</ix:nonNumeric>-<ix:nonNumeric contextRef="c1" name="dei:LocalPhoneNumber" id="ixv-26131">73-7969804</ix:nonNumeric>, ext. 200</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Email: <ix:nonNumeric contextRef="c1" name="dei:ContactPersonnelEmailAddress" id="ixv-26132">kobi.m@arberobotics.com</ix:nonNumeric></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Name, Telephone, E-mail and/or Facsimile Number
and Address of Company Contact Person)</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Securities registered or to be registered pursuant
to Section 12(b) of the Act:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr> <td style="vertical-align: bottom; width: 32%; border-bottom: black 1.5pt solid; text-align: center"><span style="font-size: 10pt"><b>Title of Each Class</b></span></td> <td style="vertical-align: top; width: 2%">&#160;</td> <td style="vertical-align: bottom; width: 32%; border-bottom: black 1.5pt solid; text-align: center"><span style="font-size: 10pt"><b>Trading Symbol(s)</b></span></td> <td style="vertical-align: top; width: 2%">&#160;</td> <td style="vertical-align: top; width: 32%; border-bottom: black 1.5pt solid; text-align: center"><span style="font-size: 10pt"><b>Name of Each Exchange On Which Registered</b></span></td></tr> <tr style="vertical-align: top; background-color: rgb(204,238,255)"> <td style="text-align: center"><ix:nonNumeric contextRef="c2" name="dei:Security12bTitle" id="ixv-150"><span style="font-size: 10pt"><b>Ordinary shares, par value NIS 0.000216 per share</b></span></ix:nonNumeric></td> <td>&#160;</td> <td> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><ix:nonNumeric contextRef="c2" name="dei:TradingSymbol" id="ixv-156"><b>ARBE</b></ix:nonNumeric></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p></td> <td>&#160;</td> <td> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>The <ix:nonNumeric contextRef="c2" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName" id="ixv-26133">Nasdaq</ix:nonNumeric> Stock Market LLC</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p></td></tr>
<tr style="vertical-align: top; background-color: White"> <td style="text-align: center"><ix:nonNumeric contextRef="c3" name="dei:Security12bTitle" id="ixv-166"><span style="font-size: 10pt"><b>Warrants</b></span></ix:nonNumeric></td> <td style="text-align: center">&#160;</td> <td style="text-align: center"><ix:nonNumeric contextRef="c3" name="dei:TradingSymbol" id="ixv-171"><span style="font-size: 10pt"><b>ARBEW</b></span></ix:nonNumeric></td> <td style="text-align: center">&#160;</td> <td style="text-align: center"><span style="font-size: 10pt"><b>The <ix:nonNumeric contextRef="c3" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName" id="ixv-26134">Nasdaq</ix:nonNumeric> Stock Market LLC</b></span></td></tr> </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Securities registered or to be registered pursuant
to Section 12(g) of the Act:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="text-decoration:underline">None</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Title of Class)</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Securities for which there is a reporting obligation
pursuant to Section 15(d) of the Act:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="text-decoration:underline">None</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Title of Class)</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The number of the issuer&#8217;s ordinary shares as of March 1, 2024
was <ix:nonFraction contextRef="c4" decimals="INF" format="ixt:num-dot-decimal" name="dei:EntityCommonStockSharesOutstanding" scale="0" unitRef="shares" id="ixv-26135">78,221,557</ix:nonFraction> ordinary shares.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Indicate by check mark if the registrant is a
well-known seasoned issuer, as defined in Rule 405 of the Securities Act.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Yes&#160;<span style="font-family: Times New Roman, Times, Serif">&#9744;</span>&#160;<ix:nonNumeric contextRef="c0" name="dei:EntityWellKnownSeasonedIssuer" id="ixv-26136">No</ix:nonNumeric>&#160;<span style="font-family: Times New Roman, Times, Serif">&#9746;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><!-- Field: Page; Sequence: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="margin: 0pt">&#160;</p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If this report is an annual or transition report,
indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or 15(d) of the Securities Exchange Act
of 1934.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Yes&#160;<span style="font-family: Times New Roman, Times, Serif">&#9744;</span>&#160;<ix:nonNumeric contextRef="c0" name="dei:EntityVoluntaryFilers" id="ixv-26137">No</ix:nonNumeric>&#160;<span style="font-family: Times New Roman, Times, Serif">&#9746;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Indicate by check mark whether the registrant
(1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months
(or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements
for the past 90 days.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><ix:nonNumeric contextRef="c0" name="dei:EntityCurrentReportingStatus" id="ixv-26138">Yes</ix:nonNumeric>&#160;<span style="font-family: Times New Roman, Times, Serif">&#9746;</span>&#160;No&#160;<span style="font-family: Times New Roman, Times, Serif">&#9744;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="background-color: white">Indicate
by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted&#160;pursuant to
Rule 405 of Regulation S-T (&#167; 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant
was required to submit such files).</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><ix:nonNumeric contextRef="c0" name="dei:EntityInteractiveDataCurrent" id="ixv-26139">Yes</ix:nonNumeric>&#160;<span style="font-family: Times New Roman, Times, Serif">&#9746;</span>&#160;No&#160;<span style="font-family: Times New Roman, Times, Serif">&#9744;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Indicate by check mark whether the registrant
is a large accelerated filer, an accelerated filer, a non-accelerated filer or an emerging growth company. See definition of &#8220;large
accelerated filer,&#8221; &#8220;accelerated filer&#8221; and &#8220;emerging growth company&#8221; in Rule 12b-2 of the Exchange Act.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Large accelerated filer&#160;<span style="font-family: Times New Roman, Times, Serif">&#9744;</span>&#160;&#160;&#160;&#160;&#160;&#160;&#160;Accelerated
filer&#160;<span style="font-family: Times New Roman, Times, Serif">&#9744;</span>&#160;&#160;&#160;&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="c0" format="ixt-sec:entityfilercategoryen" name="dei:EntityFilerCategory" id="ixv-26140">Non-accelerated
filer</ix:nonNumeric>&#160;<span style="font-family: Times New Roman, Times, Serif">&#9746;</span>&#160;&#160;&#160;&#160;&#160;&#160;&#160;Emerging growth
company&#160;<ix:nonNumeric contextRef="c0" format="ixt:fixed-true" name="dei:EntityEmergingGrowthCompany" id="ixv-268"><span style="font-family: Times New Roman, Times, Serif">&#9746;</span></ix:nonNumeric></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If an emerging growth company that prepares its
financial statements in accordance with U.S. GAAP, indicate by check mark if the registrant has elected not to use the extended transition
period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. <ix:nonNumeric contextRef="c0" format="ixt:fixed-false" name="dei:EntityExTransitionPeriod" id="ixv-274"><span style="font-family: Times New Roman, Times, Serif">&#9744;</span></ix:nonNumeric></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.25in"><span style="font-size: 10pt">&#8224;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">The term &#8220;new or revised financial accounting standard&#8221; refers to any update issued by the Financial Accounting Standards Board to its Accounting Standards Codification after April 5, 2012.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Indicate by check mark whether the registrant
has filed a report on and attestation to its management&#8217;s assessment of the effectiveness of its internal control over financial
reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or
issued its audit report. <ix:nonNumeric contextRef="c0" format="ixt:fixed-false" name="dei:IcfrAuditorAttestationFlag" id="ixv-289"><span style="font-family: Times New Roman, Times, Serif">&#9744;</span></ix:nonNumeric></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If securities are registered pursuant to Section
12(b) of the Act, indicate by check mark whether the financial statements of the registrant included in the filing reflect the correction
of an error to previously issued financial statements.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Indicate by check mark whether any of those error
corrections are restatements that required a recovery analysis of incentive based compensation received by any of the registrant&#8217;s
executive officers during the relevant recovery period pursuant to &#167;240.10D-1(b) <ix:nonNumeric contextRef="c0" format="ixt:fixed-false" name="dei:DocumentFinStmtErrorCorrectionFlag" id="ixv-299"><span style="font-family: Times New Roman, Times, Serif">&#9744;</span></ix:nonNumeric></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Indicate by check mark which basis of accounting
the registrant has used to prepare the financial statements included in this filing</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 15%; padding-right: 0.5pt; padding-left: 0.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9746;</span><span style="font-size: 10pt">&#160;<ix:nonNumeric contextRef="c0" name="dei:DocumentAccountingStandard" id="ixv-26141">U.S. GAAP</ix:nonNumeric>&#160;</span></td> <td style="width: 65%; padding-right: 0.5pt; padding-left: 0.5pt; text-align: center"><span style="font-size: 10pt">&#160; International Financial Reporting Standards as issued by the International<br/> Accounting Standards Board&#160;<span style="font-family: Times New Roman, Times, Serif">&#9744;</span>&#160;</span></td> <td style="width: 20%; padding-right: 0.5pt; padding-left: 0.5pt"> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Other&#160;<span style="font-family: Times New Roman, Times, Serif">&#9744;</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p></td></tr> </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If &#8220;Other&#8221; has been checked in response
to the previous question, indicate by check mark which financial statement item the registrant has elected to follow: Item 17&#160;<span style="font-family: Times New Roman, Times, Serif">&#9744;</span>&#160;Item
18&#160;<span style="font-family: Times New Roman, Times, Serif">&#9744;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If this is an annual report, indicate by check
mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes <span style="font-family: Times New Roman, Times, Serif">&#9744;</span>
No <ix:nonNumeric contextRef="c0" format="ixt:fixed-false" name="dei:EntityShellCompany" id="ixv-332"><span style="font-family: Times New Roman, Times, Serif">&#9746;</span></ix:nonNumeric></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="font-size: 1pt; border-top: Black 1pt solid; border-bottom: Black 2pt solid">&#160;</div></div><!-- Field: /Rule-Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><!-- Field: Page; Sequence: 2 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="margin: 0pt">&#160;</p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>ARBE ROBOTICS LTD. </b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>FORM 20-F ANNUAL REPORT </b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>TABLE OF CONTENTS</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td style="vertical-align: top; width: 10%; padding-right: 0.5pt; padding-left: 0.5pt">&#160;</td>
    <td style="vertical-align: top; width: 81%; padding-right: 0.5pt; padding-left: 0.5pt">&#160;</td>
    <td style="vertical-align: bottom; width: 9%; border-bottom: black 1.5pt solid; padding-right: 0.5pt; padding-left: 0.5pt; text-align: center"><span style="font-size: 10pt"><b>Page</b></span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td colspan="3" style="padding-right: 0.5pt; padding-left: 0.5pt; text-align: center"><a href="#a_001"><span style="font-size: 10pt">PART I</span></a></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: top; padding-right: 0.5pt; padding-left: 0.5pt">&#160;</td>
    <td style="vertical-align: top; padding-right: 0.5pt; padding-left: 0.5pt">&#160;</td>
    <td style="vertical-align: bottom; padding-right: 0.5pt; padding-left: 0.5pt; text-align: center">&#160;</td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: top; padding-right: 0.5pt; padding-left: 0.5pt"><span style="font-size: 10pt">Item 1.</span></td>
    <td style="vertical-align: top; padding-right: 0.5pt; padding-left: 0.5pt"><a href="#a_002"><span style="font-size: 10pt">Identity of Directors, Senior Management and Advisers&#160;</span></a></td>
    <td style="vertical-align: bottom; padding-right: 0.5pt; padding-left: 0.5pt; text-align: center">3</td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: top; padding-right: 0.5pt; padding-left: 0.5pt"><span style="font-size: 10pt">Item 2.</span></td>
    <td style="vertical-align: top; padding-right: 0.5pt; padding-left: 0.5pt"><a href="#a_003"><span style="font-size: 10pt">Offer Statistics and Expected Timetable</span></a></td>
    <td style="vertical-align: bottom; padding-right: 0.5pt; padding-left: 0.5pt; text-align: center">3</td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: top; padding-right: 0.5pt; padding-left: 0.5pt"><span style="font-size: 10pt">Item 3.</span></td>
    <td style="vertical-align: top; padding-right: 0.5pt; padding-left: 0.5pt"><a href="#a_004"><span style="font-size: 10pt">Key Information</span></a></td>
    <td style="vertical-align: bottom; padding-right: 0.5pt; padding-left: 0.5pt; text-align: center">3</td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: top; padding-right: 0.5pt; padding-left: 0.5pt"><span style="font-size: 10pt">Item 4.</span></td>
    <td style="vertical-align: top; padding-right: 0.5pt; padding-left: 0.5pt"><a href="#a_005"><span style="font-size: 10pt">Information on the Company</span></a></td>
    <td style="vertical-align: bottom; padding-right: 0.5pt; padding-left: 0.5pt; text-align: center">37</td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: top; padding-right: 0.5pt; padding-left: 0.5pt"><span style="font-size: 10pt">Item 4A.</span></td>
    <td style="vertical-align: top; padding-right: 0.5pt; padding-left: 0.5pt"><a href="#a_006"><span style="font-size: 10pt">Unresolved Staff Comments</span></a></td>
    <td style="vertical-align: bottom; padding-right: 0.5pt; padding-left: 0.5pt; text-align: center">55</td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: top; padding-right: 0.5pt; padding-left: 0.5pt"><span style="font-size: 10pt">Item 5.</span></td>
    <td style="vertical-align: top; padding-right: 0.5pt; padding-left: 0.5pt"><a href="#a_007"><span style="font-size: 10pt">Operating And Financial Review And Prospects</span></a></td>
    <td style="vertical-align: bottom; padding-right: 0.5pt; padding-left: 0.5pt; text-align: center">55</td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: top; padding-right: 0.5pt; padding-left: 0.5pt"><span style="font-size: 10pt">Item 6.</span></td>
    <td style="vertical-align: top; padding-right: 0.5pt; padding-left: 0.5pt"><a href="#a_008"><span style="font-size: 10pt">Directors, Senior Management and Employees</span></a></td>
    <td style="vertical-align: bottom; padding-right: 0.5pt; padding-left: 0.5pt; text-align: center">65</td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: top; padding-right: 0.5pt; padding-left: 0.5pt"><span style="font-size: 10pt">Item 7.</span></td>
    <td style="vertical-align: top; padding-right: 0.5pt; padding-left: 0.5pt"><a href="#a_009"><span style="font-size: 10pt">Major Shareholders and Related Party Transactions</span></a></td>
    <td style="vertical-align: bottom; padding-right: 0.5pt; padding-left: 0.5pt; text-align: center">88</td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: top; padding-right: 0.5pt; padding-left: 0.5pt"><span style="font-size: 10pt">Item 8.</span></td>
    <td style="vertical-align: top; padding-right: 0.5pt; padding-left: 0.5pt"><a href="#a_010"><span style="font-size: 10pt">Financial Information</span></a></td>
    <td style="vertical-align: bottom; padding-right: 0.5pt; padding-left: 0.5pt; text-align: center">89</td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: top; padding-right: 0.5pt; padding-left: 0.5pt"><span style="font-size: 10pt">Item 9.</span></td>
    <td style="vertical-align: top; padding-right: 0.5pt; padding-left: 0.5pt"><a href="#a_011"><span style="font-size: 10pt">The Offer and Listing</span></a></td>
    <td style="vertical-align: bottom; padding-right: 0.5pt; padding-left: 0.5pt; text-align: center">90</td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: top; padding-right: 0.5pt; padding-left: 0.5pt"><span style="font-size: 10pt">Item 10.</span></td>
    <td style="vertical-align: top; padding-right: 0.5pt; padding-left: 0.5pt"><a href="#a_012"><span style="font-size: 10pt">Additional Information</span></a></td>
    <td style="vertical-align: bottom; padding-right: 0.5pt; padding-left: 0.5pt; text-align: center">90</td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: top; padding-right: 0.5pt; padding-left: 0.5pt"><span style="font-size: 10pt">Item 11.</span></td>
    <td style="vertical-align: top; padding-right: 0.5pt; padding-left: 0.5pt"><a href="#a_013"><span style="font-size: 10pt">Quantitative and Qualitative Disclosures About Market Risk</span></a></td>
    <td style="vertical-align: bottom; padding-right: 0.5pt; padding-left: 0.5pt; text-align: center">115</td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: top; padding-right: 0.5pt; padding-left: 0.5pt"><span style="font-size: 10pt">Item 12.</span></td>
    <td style="vertical-align: top; padding-right: 0.5pt; padding-left: 0.5pt"><a href="#a_014"><span style="font-size: 10pt">Description of Securities Other than Equity Securities</span></a></td>
    <td style="vertical-align: bottom; padding-right: 0.5pt; padding-left: 0.5pt; text-align: center">115</td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: top; padding-right: 0.5pt; padding-left: 0.5pt">&#160;</td>
    <td style="vertical-align: top; padding-right: 0.5pt; padding-left: 0.5pt">&#160;</td>
    <td style="vertical-align: bottom; padding-right: 0.5pt; padding-left: 0.5pt; text-align: center">&#160;</td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td colspan="3" style="padding-right: 0.5pt; padding-left: 0.5pt; text-align: center"><a href="#a_015"><span style="font-size: 10pt">PART II</span></a></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: top; padding-right: 0.5pt; padding-left: 0.5pt">&#160;</td>
    <td style="vertical-align: top; padding-right: 0.5pt; padding-left: 0.5pt">&#160;</td>
    <td style="vertical-align: bottom; padding-right: 0.5pt; padding-left: 0.5pt; text-align: center">&#160;</td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: top; padding-right: 0.5pt; padding-left: 0.5pt"><span style="font-size: 10pt">Item 13.</span></td>
    <td style="vertical-align: top; padding-right: 0.5pt; padding-left: 0.5pt"><a href="#a_016"><span style="font-size: 10pt">Defaults, Dividend Arrearages and Delinquencies</span></a></td>
    <td style="vertical-align: bottom; padding-right: 0.5pt; padding-left: 0.5pt; text-align: center">119</td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: top; padding-right: 0.5pt; padding-left: 0.5pt"><span style="font-size: 10pt">Item 14.</span></td>
    <td style="vertical-align: top; padding-right: 0.5pt; padding-left: 0.5pt"><a href="#a_017"><span style="font-size: 10pt">Material Modifications to the Rights of Security Holders and Use Of Proceeds</span></a></td>
    <td style="vertical-align: bottom; padding-right: 0.5pt; padding-left: 0.5pt; text-align: center">119</td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: top; padding-right: 0.5pt; padding-left: 0.5pt"><span style="font-size: 10pt">Item 15.</span></td>
    <td style="vertical-align: top; padding-right: 0.5pt; padding-left: 0.5pt"><a href="#a_018"><span style="font-size: 10pt">Controls and Procedures</span></a></td>
    <td style="vertical-align: bottom; padding-right: 0.5pt; padding-left: 0.5pt; text-align: center">119</td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: top; padding-right: 0.5pt; padding-left: 0.5pt"><span style="font-size: 10pt">Item 16.</span></td>
    <td style="vertical-align: top; padding-right: 0.5pt; padding-left: 0.5pt"><a href="#a_019"><span style="font-size: 10pt">[Reserved]</span></a></td>
    <td style="vertical-align: bottom; padding-right: 0.5pt; padding-left: 0.5pt; text-align: center">120</td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: top; padding-right: 0.5pt; padding-left: 0.5pt"><span style="font-size: 10pt">Item 16A.</span></td>
    <td style="vertical-align: top; padding-right: 0.5pt; padding-left: 0.5pt"><a href="#a_020"><span style="font-size: 10pt">Audit Committee Financial Expert</span></a></td>
    <td style="vertical-align: bottom; padding-right: 0.5pt; padding-left: 0.5pt; text-align: center">120</td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: top; padding-right: 0.5pt; padding-left: 0.5pt"><span style="font-size: 10pt">Item 16B.</span></td>
    <td style="vertical-align: top; padding-right: 0.5pt; padding-left: 0.5pt"><a href="#a_021"><span style="font-size: 10pt">Code of Ethics</span></a></td>
    <td style="vertical-align: bottom; padding-right: 0.5pt; padding-left: 0.5pt; text-align: center">120</td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: top; padding-right: 0.5pt; padding-left: 0.5pt"><span style="font-size: 10pt">Item 16C.</span></td>
    <td style="vertical-align: top; padding-right: 0.5pt; padding-left: 0.5pt"><a href="#a_022"><span style="font-size: 10pt">Principal Accountant Fees and Services</span></a></td>
    <td style="vertical-align: bottom; padding-right: 0.5pt; padding-left: 0.5pt; text-align: center">120</td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: top; padding-right: 0.5pt; padding-left: 0.5pt"><span style="font-size: 10pt">Item 16D.</span></td>
    <td style="vertical-align: top; padding-right: 0.5pt; padding-left: 0.5pt"><a href="#a_023"><span style="font-size: 10pt">Exemptions from the Listing Standards for Audit Committees</span></a></td>
    <td style="vertical-align: bottom; padding-right: 0.5pt; padding-left: 0.5pt; text-align: center">121</td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: top; padding-right: 0.5pt; padding-left: 0.5pt"><span style="font-size: 10pt">Item 16E.</span></td>
    <td style="vertical-align: top; padding-right: 0.5pt; padding-left: 0.5pt"><a href="#a_024"><span style="font-size: 10pt">Purchases of Equity Securities by the Issuer and Affiliated Purchasers</span></a></td>
    <td style="vertical-align: bottom; padding-right: 0.5pt; padding-left: 0.5pt; text-align: center">121</td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: top; padding-right: 0.5pt; padding-left: 0.5pt"><span style="font-size: 10pt">Item 16F.</span></td>
    <td style="vertical-align: top; padding-right: 0.5pt; padding-left: 0.5pt"><a href="#a_025"><span style="font-size: 10pt">Change in Registrant&#8217;s Certifying Accountant</span></a></td>
    <td style="vertical-align: bottom; padding-right: 0.5pt; padding-left: 0.5pt; text-align: center">121</td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: top; padding-right: 0.5pt; padding-left: 0.5pt"><span style="font-size: 10pt">Item 16G.</span></td>
    <td style="vertical-align: top; padding-right: 0.5pt; padding-left: 0.5pt"><a href="#a_026"><span style="font-size: 10pt">Corporate Governance</span></a></td>
    <td style="vertical-align: bottom; padding-right: 0.5pt; padding-left: 0.5pt; text-align: center">121</td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: top; padding-right: 0.5pt; padding-left: 0.5pt"><span style="font-size: 10pt">Item 16H.</span></td>
    <td style="vertical-align: top; padding-right: 0.5pt; padding-left: 0.5pt"><a href="#a_027"><span style="font-size: 10pt">Mine Safety Disclosure</span></a></td>
    <td style="vertical-align: bottom; padding-right: 0.5pt; padding-left: 0.5pt; text-align: center">121</td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: top; padding-right: 0.5pt; padding-left: 0.5pt"><span style="font-size: 10pt">Item 16I. </span></td>
    <td style="vertical-align: top; padding-right: 0.5pt; padding-left: 0.5pt"><a href="#a_028"><span style="font-size: 10pt">Disclosure Regarding Foreign Jurisdictions that Prevent Inspections</span></a></td>
    <td style="vertical-align: bottom; padding-right: 0.5pt; padding-left: 0.5pt; text-align: center">121</td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: top; padding-right: 0.5pt; padding-left: 0.5pt"><span style="font-size: 10pt">Item 16J.</span></td>
    <td style="vertical-align: top; padding-right: 0.5pt; padding-left: 0.5pt"><a href="#a_029"><span style="font-size: 10pt">Insider trading policies</span></a></td>
    <td style="vertical-align: bottom; padding-right: 0.5pt; padding-left: 0.5pt; text-align: center">121</td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: top; padding-right: 0.5pt; padding-left: 0.5pt"><span style="font-size: 10pt">Item 16K</span></td>
    <td style="vertical-align: top; padding-right: 0.5pt; padding-left: 0.5pt"><a href="#a_030"><span style="font-size: 10pt">Cybersecurity</span></a></td>
    <td style="vertical-align: bottom; padding-right: 0.5pt; padding-left: 0.5pt; text-align: center">122</td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: top; padding-right: 0.5pt; padding-left: 0.5pt">&#160;</td>
    <td style="vertical-align: top; padding-right: 0.5pt; padding-left: 0.5pt">&#160;</td>
    <td style="vertical-align: bottom; padding-right: 0.5pt; padding-left: 0.5pt; text-align: center">&#160;</td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td colspan="3" style="padding-right: 0.5pt; padding-left: 0.5pt; text-align: center"><a href="#a_031"><span style="font-size: 10pt">PART III</span></a></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: top; padding-right: 0.5pt; padding-left: 0.5pt">&#160;</td>
    <td style="vertical-align: top; padding-right: 0.5pt; padding-left: 0.5pt">&#160;</td>
    <td style="vertical-align: bottom; padding-right: 0.5pt; padding-left: 0.5pt; text-align: center">&#160;</td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: top; padding-right: 0.5pt; padding-left: 0.5pt"><span style="font-size: 10pt">Item 17.</span></td>
    <td style="vertical-align: top; padding-right: 0.5pt; padding-left: 0.5pt"><a href="#a_032"><span style="font-size: 10pt">Financial Statements</span></a></td>
    <td style="vertical-align: bottom; padding-right: 0.5pt; padding-left: 0.5pt; text-align: center">123</td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: top; padding-right: 0.5pt; padding-left: 0.5pt"><span style="font-size: 10pt">Item 18.</span></td>
    <td style="vertical-align: top; padding-right: 0.5pt; padding-left: 0.5pt"><a href="#a_033"><span style="font-size: 10pt">Financial Statements</span></a></td>
    <td style="vertical-align: bottom; padding-right: 0.5pt; padding-left: 0.5pt; text-align: center">123</td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: top; padding-right: 0.5pt; padding-left: 0.5pt"><span style="font-size: 10pt">Item 19.</span></td>
    <td style="vertical-align: top; padding-right: 0.5pt; padding-left: 0.5pt"><a href="#a_034"><span style="font-size: 10pt">Exhibits</span></a></td>
    <td style="text-align: center; vertical-align: bottom; padding-right: 0.5pt; padding-left: 0.5pt">123</td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p><div>

</div><!-- Field: Page; Sequence: 3; Options: NewSection --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->i<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><div><a id="a_001"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>PART I</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>CERTAIN INFORMATION</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Unless otherwise indicated or the context otherwise
requires, all references in this annual report to the terms &#8220;Arbe,&#8221; the Company,&#8221; &#8220;us,&#8221; &#8220;we&#8221;
and words of like import refer to Arbe Robotics Ltd., together with its subsidiaries.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Industry and Market Data</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In this annual report, we present industry data,
information and statistics regarding the markets in which we compete as well as publicly available information, industry and general publications
and research and studies conducted by third parties. This information is supplemented where necessary with our own internal estimates,
taking into account publicly available information about other industry participants and our management&#8217;s judgment where information
is not publicly available. This information appears in &#8220;<i>Summary of the Annual report,</i>&#8221; &#8220;Item 5. Operating and
Financial Review and Prospects&#8221; &#8220;<i>Item 4. Information on the Company</i>&#8221; and other sections of this annual report.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Industry publications, research, studies and forecasts
generally state that the information they contain has been obtained from sources believed to be reliable, but that the accuracy and completeness
of such information is not guaranteed. Forecasts and other forward-looking&#160;information obtained from these sources are subject to
the same qualifications and uncertainties as the other forward-looking&#160;statements in this annual report. These forecasts and forward-looking&#160;information
are subject to uncertainty and risk due to a variety of factors, including those described under &#8220;<i>Risk Factors</i>&#8221; in
Section D under Item 3 of this annual report. These and other factors could cause results to differ materially from those expressed in
any forecasts or estimates.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Trademarks, Trade Names and Service Marks</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We own or have rights to trademarks, trade names
and service marks that it uses in connection with the operation of its business. In addition, our names, logos and website names and addresses
are their trademarks or service marks. Other trademarks, trade names and service marks appearing in this annual report are the property
of their respective owners. Solely for convenience, in some cases, the trademarks, trade names and service marks referred to in this annual
report are listed without the applicable &#8220;&#169;,&#8221; &#8220;<sup>SM</sup>&#8221; and&#160;&#8220;<sup>TM&#8221;</sup> symbols,
but they will assert, to the fullest extent under applicable law, their rights to these trademarks, trade names and service marks.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">This annual report contains &#8220;forward-looking
statements&#8221; that are subject to risks and uncertainties. Statements that are not historical facts, including statements about us
and the transactions contemplated by the Business Combination Agreement, and our perspectives and expectations, are forward-looking statements.
Such statements include, but are not limited to, statements regarding possible or anticipated future results of our business, financial
condition, results of operations, liquidity, plans and objectives. The words &#8220;expect,&#8221; &#8220;believe,&#8221; &#8220;estimate,&#8221;
&#8220;intend,&#8221; &#8220;plan,&#8221; &#8220;anticipate,&#8221; &#8220;project,&#8221; &#8220;may,&#8221; &#8220;will,&#8221; &#8220;could,&#8221;
&#8220;should,&#8221; &#8220;potential&#8221; and similar words or expressions indicate forward-looking statements. These forward-looking
statements are not guarantees of future performance and are subject to various risks and uncertainties, assumptions (including assumptions
about general economic, market, industry and operational factors), known or unknown, which could cause the actual results to vary materially
from those indicated or anticipated.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The statements contained in this annual report
regarding the following matters are forward-looking&#160;by their nature:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">Our projection of revenue and other operating results;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">Our expectation that we will be engaging with Tier 1 automotive suppliers and OEMs which would be building the radars based on our chipset solution, eliminating expenses associated with system completion, requirement for undertaking significant capital expenditures associated with developing mass production manufacturing and the expenses of operating any such manufacturing capability;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><!-- Field: Page; Sequence: 4; Options: NewSection --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">Our expectation that radars are crucial to the automotive industry and will be deployed in nearly all new vehicles as a long range, cost-effective sensor with the fewest environmental limitations;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">Our belief that our radar chipset heralds a breakthrough in radar technology that will enable Tier 1 manufacturers and OEMs to replace the current radars with an advanced solution that meets the safety requirements of Euro New Car Assessment Program (&#8220;Euro-NCAP&#8221;) and the United States National Highway Traffic Safety Administration (&#8220;NHTSA&#8221;) for autonomous vehicles at all levels of autonomous driving;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">Our belief that a fully autonomous vehicle is seen as a potential solution for reducing the number of traffic accidents (due to the elimination of the &#8220;human element&#8221; from the equation), and as an incentive to create innovative autonomous vehicle-sharing services that will lead to the public foregoing the purchase of private vehicles, to reduce the problem of traffic congestion, and to significantly reduce fuel consumption and air pollution;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">Our belief that automakers will choose to integrate advanced driver assistance systems (ADAS L2+/L3) based on several technologies simultaneously (imaging radar, camera and optionally LiDAR), and that it is likely that this trend of integrating technologies into vehicles will continue in the coming&#160;years;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">Our belief that our 4D imaging radar technology holds significant advantages for a fusion with camera over alternative technologies such as LiDAR laser systems and over current-generation radar technologies that are on the market presently or have been announced for development;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">Our belief that our ground-breaking technology that contains an advanced processor, consumes relatively low amounts of energy and can scan a vehicle&#8217;s environment at an exceptionally high resolution in real-time, and identify objects and distinguish between them with great long-range accuracy and a wide field of view, differentiates us and will enable us to successfully compete and develop and maintain a leadership position in its target markets;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">Our expectation that our marketing strategy, primarily targeted at Tier 1 manufacturers, will foster cooperation with Tier 1 suppliers to integrate our radar chipsets into their radar systems to be sold to OEMs and that the Tier 1 suppliers that use our radar chipsets will be successful in marketing the systems to automakers;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">Our belief that our engagement of Global Foundries for the manufacturing and supply chain management will provide us with a more secure path in production for quality control and reliability for automotive requirements;</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">Our belief that as automakers seek to develop hands off/eyes off driving, imaging radar will become a critical ingredient and that our radar chipset will meet this need;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">Our belief that certain operational or registration requirements for some autonomous functions will be removed as state regulators gain better experience with the technology;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">Our expectation that awareness among automakers and vehicle owners of the importance and benefits of installing ADAS and partial autonomous driving L2+/L3 (even in the absence of binding regulation) has increased, and that it is likely that in the future, the vast majority of new vehicles will be equipped with these systems;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">Our belief that our radar chipset solution will make it possible to enable the launch of an autonomous vehicle and will be the primary sensor for autonomous driving in the retail market in tandem with a camera;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">Our belief that our existing infrastructure positions us to capitalize on regulatory changes pertaining to required installation of traffic accident prevention systems in general, and radar systems in particular, which is expected to increase the demand for the technology and products that we are developing;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>


</div><!-- Field: Page; Sequence: 5 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">Our belief that an increased demand for autonomous vehicles and the transition to mass production of Level 2+ and higher autonomous vehicles, requiring advanced systems for automatically integrating vehicles in traffic and preventing traffic accidents, is expected to increase the demand for products in our field of activity in the time frame we anticipate; and</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">Our belief that a requirement on the part of insurance companies to install radar systems as a condition for issuing insurance policies is expected to increase the demand for our products.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The preceding list is not intended to be an exhaustive
list of all of our forward-looking&#160;statements. The forward-looking&#160;statements are based on our beliefs, assumptions and expectations
of future performance, taking into account the information currently available to us. These statements are only predictions based upon
our current expectations and projections about future events. There are important factors that could cause our actual results, levels
of activity, performance or achievements to differ materially from the results, levels of activity, performance or achievements expressed
or implied by the forward-looking&#160;statements. In particular, you should consider the risks described under &#8220;Risk Factors&#8221;
in Section D under Item 3 of this annual report.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">You should not rely upon forward-looking&#160;statements
as predictions of future events. Although we believe that the expectations reflected in the forward-looking&#160;statements are reasonable,
we cannot guarantee that future results, levels of activity, performance and events and circumstances reflected in the forward-looking&#160;statements
will be achieved or will occur. Except as required by law, we undertake no obligation to update publicly any forward-looking&#160;statements
for any reason after the date of this annual report, to confirm these statements to actual results or to changes in our expectations.</p><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><div><a id="a_002"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>ITEM 1. IDENTITY OF DIRECTORS, SENIOR MANAGEMENT AND ADVISERS</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Not Applicable.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p><div>

</div><div><a id="a_003"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>ITEM 2. OFFER STATISTICS AND EXPECTED TIMETABLE</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Not Applicable.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><div><a id="a_004"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>ITEM 3. KEY INFORMATION </b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0px">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">A.</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">[Reserved]</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0px">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">B.</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">Capitalization and indebtedness. Not Applicable</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0px">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">C.</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">Reasons for the offer and use of proceeds. Not Applicable.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0px">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">D.</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">Risk Factors</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>An investment in our ordinary shares involves
significant risks. You should carefully consider all of the information in this annual report, including the risks and uncertainties described
below, before making an investment in our ordinary shares. Any of the following risks could have a material adverse effect on our business,
financial condition and results of operations. In any such case, the market price of our ordinary shares could decline, and you may lose
all or part of your investment.</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>The risks set out below are not exhaustive
and do not comprise all of the risks associated with an investment in us. Additional risks and uncertainties not currently known to us
or which we currently deem immaterial may also have a material adverse effect on our business, financial condition, results of operations,
prospects and/or our share price.</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Risks Related to Our Business and Industry</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>We are a research and development company
with a history of losses and we expect to incur significant expenses and losses as we continue the development of our radar technology.
</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We incurred a net loss of approximately $43.5
million on revenues of approximately $1.5 million for the year ended December 31, 2023, a net loss of approximately $40.5 million on revenues
of approximately $3.5 million for year ended December 31, 2022 and a net loss of approximately $58.1&#160;million on revenues of approximately
$2.2 million for the year ended December&#160;31, 2021. No assurance can be made that we can or will become profitable. We are primarily
a research and development company and we are continuing to incur research and development expenses as we work on the development of our
4D imaging radar technology. We plan the transition to production of our radar chip for sale to customers during 2024 or early 2025, although
we can give no assurance that this timetable will be met. Most of our revenue to date has been generated from sales of chipsets and prototype
radar systems and professional services. Until such time as we begin material commercial deliveries of our products, we will likely continue
to generate losses. Even if we are able to begin making material commercial deliveries of our products, we can give no assurance that
we will be successful in the commercial sale of our products.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 6 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We anticipate that our losses may continue to
be significant as we:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">Shift our research and development from production intent to production ready chipset;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">expand our production capabilities or outsources such production;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">expand our design, development, installation and servicing capabilities;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">produce chips for inventory and incur storage charges;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">incur costs in providing support and assistance to our initial commercial customers to Tier 1 suppliers as they integrate our product in their product that they market to automotive companies and to our automotive company customers as they introduce our radar in their vehicles</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">incur sales and marketing activities costs and develop our distribution infrastructure; and.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">incur general and administration costs as we progress with our product development and continue to incur significant expenses in research and development as well as costs related to our status as a publicly traded corporation</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We will incur the expenses from these efforts
before we receive sufficient revenues to cover our incremental expenses with respect thereto, and therefore our losses in future periods
may be significant. In addition, we may find that these efforts are more expensive than we currently anticipate or that these efforts
may not result in revenues, which would further increase our losses.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Our limited operating history and evolving
business model makes evaluating our business and future prospects difficult and may increase the risk of your investment.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We have focused primarily on developing our 4D
imaging radar technology products since 2017 and did not generate any revenue until&#160;2020. Our relatively limited operating history
and modest level of revenue to date make it difficult to evaluate our future prospects and the risks and challenges we may encounter.
Further, because we have limited historical financial data and operate in a rapidly evolving market, any predictions about our future
revenue and expenses may not be as accurate as they would be if we had a history of sales in commercial quantities or if we operated in
a more predictable market rather than a market that is itself a developing market that is developing at a slower rate than we had anticipated.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In late 2023 we broadened our focus to seek contracts
with Tier 1 suppliers and OEMs for orders in commercial quantity in addition to sales of radars for testing purposes. If this strategy
is not successful, and we do not generate orders for commercial quantities of our products, we may incur increased losses. In this connection,
as both our business and the market for ADAS vehicles develops, our operations may undergo other changes that result is a material change
in our business and the direction of our business. Any such modifications could result in increased losses (as pivoting the business may
be costly) and future results may differ materially from those presented herein.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>


</div><!-- Field: Page; Sequence: 7 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Any change in our business model may make the
results of our operations to date less useful in evaluating our business and prospects.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If we fail to address the risks and difficulties
that we face, including those described elsewhere in this &#8220;Risk Factors&#8221; section, our business, financial condition and results
of operations could be impaired. We have encountered in the past, and will encounter in the future, risks and uncertainties frequently
experienced by growing companies with limited operating histories in rapidly changing industries. If our assumptions regarding these risks
and uncertainties, which we use to plan and operate our business, are incorrect or change, or if we do not address these risks successfully,
the results of our operations could differ materially from our expectations and our business, financial condition and results of operations
could be adversely affected.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>We expect to continue to invest substantially
in research and development to develop and commercialize new products, and these investments could significantly increase our losses and
may not generate significant revenue for us.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our future growth depends on maintaining our technological
leadership in order to introduce new products that achieve market acceptance and penetrate new markets.&#8239;Our research and development
expenses were approximately $34.1 million in 2023, $36.7 million for 2022 and approximately $28.6&#160;million for 2021. We expect that
our research and development expenses are likely to continue to be significant in the future as we seek to expand our research and development
effort to meet the anticipated market need. Because we expense our research and development activities, as we increase these expenses
it will adversely affect the results of our operations. In addition, our research and development program may not produce successful results,
and even if it does successfully produce new products, those products may not achieve market acceptance, create additional revenue or
become profitable. Because the market for our products is both leading edge technology in an evolving industry, we can only be successful
if we can offer leading edge technology. Our failure to offer leading edge technology can materially impair our ability to operate profitably.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Agreements with customers may not generate
the anticipated revenue as we are subject to the risks of cancellation or postponement of contracts or unsuccessful implementation.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Prospective customers of our products generally
must make significant commitments of resources to test and validate our products and confirm that they can integrate our products with
other technologies before including our products in any particular system, product or model. The development cycles of our products with
new customers vary widely depending on the application, market, customer and the complexity of the product. In the automotive market,
for example, this development cycle can be over several&#160;years. As a result of these lengthy development cycles, we spend significant
time and resources to have our products selected by potential customers for a particular use. If we fail to secure such relationships,
we may not have an opportunity to supply our products within a sector with such a long lead time for a period of several&#160;years. Further,
we are subject to the risk that customers that order products, which are subject to the customer&#8217;s ability to integrate the product
with its other systems, may cancel or postpone orders if the customer is not satisfied that our product and service meet the customer&#8217;s
requirements.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>The development cycle of products using
our technology as well as the market for our products that are under development can be impacted by various factors which cannot be predicted,
including international conflicts, climate and weather conditions, global economic conditions and customer trends.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The development process for our products as well
as the timing of our sales and the market for our products can be affected by various factors, many of which are unpredictable. These
factors include such conditions as international conflicts, climate and weather conditions, significant natural disasters such as the
outbreak of a pandemic, such as COVID-19, or other catastrophic events. In recent months the following conditions have affected or may
affect various aspects of our business.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -18pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">The effects of the attack by Hamas on October 7, 2023 and the war between Israel and Hamas which is continuing as of the date of this report and is discussed below under the Risk Factor &#8220;Risks Related to our Incorporation and Location in Israel -- Conditions in Israel could materially and adversely affect our business.&#8221;</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  </table><div>

</div><!-- Field: Page; Sequence: 8 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">The effects of the February 24, 2022 invasion by the Russian Federation of Ukraine, which is ongoing and is discussed below.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -18pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">Extreme weather conditions that may adversely affect manufacturing facilities of our suppliers and/or customers, and cause material delays in our supply chain or to our forecasted orders.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -18pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">The effects of any other military conflicts and cybersecurity actions; and</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -18pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">Any other conditions which may affect the automotive industry generally and the ability of automotive companies in their evaluation and purchase of our products or our ability and the ability of our customers and potential customers to evaluate our product or order our product.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Any factors which affect the ability or willingness
of customers and potential customers to test our products or purchase our products could materially impair our ability to develop our
business, We cannot predict the extent that any of the foregoing will impact our business nor what other factors which we do not presently
contemplate may impact our business; however, any of these factors, as well as other factors not presently contemplated, may have a material
adverse effect upon our business.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>We may need to raise additional funds
in the future in order to execute our business plan and these funds may not be available to us when it needs them. If we cannot raise
additional funds when we need them, our business, prospects, financial condition and operating results could be negatively affected.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We are presently primarily a research and development
company, as we are continuing to spend significantly more in research and development than we are generating in revenue. Although our
working capital at December 31, 2023 was approximately $41.2 million, we may nonetheless require additional capital in order to fund our
growth strategy and to respond to technological advancements, competitive dynamics or technologies, customer demands, business opportunities,
challenges, acquisitions or unforeseen circumstances, and we intend to seek funding through equity, debt or convertible debt financing.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We may not be able to timely secure such debt
or equity financing on favorable terms, or at all. If we raise additional funds through the issuance of equity or convertible debt or
other equity-linked securities, our shareholders could experience significant dilution. In addition, any debt financing we may obtain
in the future, whether in the form of a credit facility, convertible debt could involve restrictive covenants relating to our capital
raising activities and other financial and operational matters, which may make it more difficult for us to obtain additional capital and
to pursue business opportunities, including potential acquisitions. If we are unable to obtain adequate financing or financing on terms
satisfactory to us when we require it, our ability to continue to grow or support its business and to respond to business challenges could
be significantly limited. In addition, because our decision to issue debt or equity in the future will depend on market conditions and
other factors beyond our control, we cannot predict or estimate the amount, timing, nature or success of our future capital raising efforts.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>If market adoption of our products does
not develop, or develops more slowly than we expect, our business will be adversely affected.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">While our products can be applied for uses in
different markets, many of our products are still relatively new in the market and it is possible that other technologies and devices,
based on new or existing technology or a combination of technologies, will achieve acceptance or leadership as compared to our existing
or future product lines. Even if our products are used, we cannot guarantee that our products will be designed into or included in subsequent
generations of such commercialized technology. In addition, we expect that widescale use of our products may lag behind these initial
applications significantly. The speed of market growth for our products is difficult if not impossible to predict. In addition, to the
extent that a market for our products develops successfully, we expect that there will be increasing competition from alternative providers
and other modalities. If we are not successful in commercializing our products in a timely manner, or not as successful as we expect,
or if other modalities gain acceptance by our potential customers, regulators
and safety organizations or other market participants, our business, results of operations and financial condition will be materially
and adversely affected.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>


</div><!-- Field: Page; Sequence: 9 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>We may not be able to accurately estimate
the supply and demand of our products, which could result in a variety of inefficiencies in our business and hinder our ability to generate
revenue. If we fail to accurately predict our manufacturing requirements, we could incur additional costs or experience delays.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">It is difficult to predict our future revenues
and budget for our expenses, and we may have limited insight into trends that may emerge and affect our business. We expect that we will
be required to provide forecasts of our demand to our potential customers several&#160;months prior to the scheduled delivery date. Currently,
because it is a developing market, there is little historical basis for making judgments on the demand for our products or our ability
to develop, produce, and deliver products, or our profitability in the future. If we overestimate our requirements, we or our potential
suppliers may have excess inventory, which indirectly would increase our costs. If we underestimate our requirements, we or our potential
suppliers may have inadequate inventory, which could interrupt the manufacturing of our products and result in delays in shipments, which
is likely to affect revenue and customer relations. In addition, lead times for materials and components that our potential suppliers
order may vary significantly and depend on factors such as the specific supplier, contract terms and demand for each component at a given
time. If we fail to order sufficient quantities of product components in a timely manner, the delivery of products to our potential customer
base could be delayed, which would harm our business, financial condition and operating results.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>We target many customers that are large
companies with substantial negotiating power, exacting product standards and potentially competitive internal solutions. If we are unable
to sell our products to these customers, our prospects and results of operations will be adversely affected.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Many of our customers and potential customers
are large, multinational companies with substantial negotiating power relative to us and, in some instances, may have internal solutions
that are competitive with our products. These large, multinational companies also have significant resources, which may allow them to
acquire or develop competitive technologies either independently or in partnership with others. Accordingly, even after investing significant
resources to develop a product, we may not secure a design win or may not be able to commercialize a product on profitable terms. Because
our products are a key aspect of the safety of vehicles that use our products and must comply with international standards, our products
will be held to a stringent safety test before they are included in a vehicle. If our products are not selected by these large companies
or if these companies develop or acquire competitive technology or negotiate terms that are disadvantageous to us, it will have an adverse
effect on our business.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Our principal customers include Tier-1 suppliers
with a view to including our chipset as part of a radar system that they market to the automobile industry and which compete with other
Tier 1 suppliers in marketing to the automotive industry. </i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Many of our customers and potential customers
are either large, multinational Tier-1 companies which market radar systems that include our chipset in the systems they market to the
automotive industry, including OEMs, or large multinational automobile companies. Thus, we are dependent upon the ability of our Tier
1 suppliers to market their systems to the automotive industry. To the extent our product is part of a radar that is offered by such Tier-1
supplier, we depend on the ability of the Tier-1 supplier to successfully market and sell its product (which includes our product) to
the OEM&#8217;s, many times following a bid process conducted by the OEM. Accordingly, even after investing significant resources to develop
a product, we largely rely on our Tier-1 customers&#8217; efforts to secure a design win in order to be able to commercialize our product
on profitable terms. Because our products are a component on a complete radar product offered by our Tier-1 customer to the OEM, if the
radar products are not selected by these large OEM companies or if these OEM companies develop or acquire competitive technology or negotiate
terms that are disadvantageous to us, it will have an adverse effect on our business. We also market directly to automobile manufacturers
and seek to include our radar system in their automobiles. To the extent that we are not successful in marketing to the automotive industry
our business will be materially impaired.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 10 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>We continue to work with other companies,
including our sole supplier and our Tier 1 companies to develop our business, and these initiatives may prove more costly than we currently
anticipate, and we may not succeed in generating sufficient revenue to operate profitability.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We continue to make investments and implement
initiatives designed to grow our business, including:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">investing in research and development;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">working with Tier 1 suppliers to develop a radar
    product based on our chipsets with a view to the Tier 1 marking this product to the automotive and related markets;</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">expanding our sales and marketing efforts to attract new customers in new industries;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">investing in new applications and markets for our products;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">further enhancing our manufacturing processes and relationships; and</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">incurring in legal, accounting, and other administrative functions necessary to support our operations as a public company.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">These initiatives may prove more expensive than
we currently anticipate, and we may not succeed in increasing our revenue, if at all, in an amount sufficient to offset these higher expenses
and to achieve and maintain profitability. The market opportunities we are pursuing are being developed, and it may be years before the
markets we expect to serve generate significant demand for our products at scale, if at all.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In addition, our revenue may be adversely affected
for a number of reasons, including the development and/or market acceptance and timing of market introduction of new technology that competes
with our products, changes by other market participants with respect to their acceptance or implementation of our technology, failure
of our customers to commercialize autonomous systems that include our products, our inability to effectively manage our inventory or manufacture
products at scale, our failure to enter new markets or to attract new customers or expand orders from existing customers or due to increasing
competition. Furthermore, it is difficult to predict the size and growth rate of our target markets, customer demand for our products,
commercialization timelines, developments in autonomous sensing and related technology, the entry of competitive products, or the success
of existing competitive products and services. Accordingly, we do not expect to achieve profitability over the near term. If our revenue
does not grow over the long term, our ability to achieve and maintain profitability may be adversely affected, and the value of our business
may significantly decrease.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>The markets in which we compete are characterized
by rapid technological change, which requires us to continue to develop new products and product innovations and could adversely affect
market adoption of our products.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">While we intend to invest substantial amounts
in research and development, continuing technological changes in our technology and competitive technologies could adversely affect adoption
of our products. Our future success will depend upon our ability to develop and introduce a variety of new capabilities and innovations
to our existing product offerings, as well as to introduce a variety of new product offerings to address the changing needs of the markets
in which we offer our products. Delays in delivering new products that meet customer requirements could damage our relationships with
customers and lead them to seek alternative sources of supply.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If we are unable to develop products or system
configurations that meet customer requirements, including pricing, on a timely basis or that remain competitive with other technological
alternatives, our products could lose market share, our revenue will decline, it may experience operating losses and our business and
prospects will be adversely affected.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Certain of our development and supply arrangements
could be terminated or may not materialize into long-term contracts.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We have arrangements with Tier 1 suppliers and
other companies for the development of products or for the incorporation of our products in a customer&#8217;s products. Some of these
arrangements are evidenced by memorandums of understandings and early-stage agreements that are used for design and development purposes
but that will require renegotiation at later stages of development or replacement by production or master agreements that have yet to be implemented under separately negotiated
statements of work, each of which could be terminated or may not materialize into next-stage contracts or long-term contract arrangements.
If these arrangements are terminated or if we are unable to enter into next-stage contracts or long-term operational contracts, our business,
prospects, financial condition and operating results may be materially adversely affected.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>


</div><!-- Field: Page; Sequence: 11 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>We will be subject to risks associated with
our agreements with Tier 1s and other companies.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If we are successful in entering into definitive
agreements with potential suppliers, including Tier 1s, these arrangements will subject us to risks, including risks associated with non-performance
by the third party and sharing proprietary information, any of which may materially and adversely affect our business and prospects. Because
of our limited ability to monitor or control the actions of these third parties, to the extent any of these strategic third parties suffer
negative publicity or harm to their reputation from events relating to their business, we may also suffer negative publicity or harm to
our reputation by virtue of our association with any such third party. In addition, a third party may have different priorities than we
have with the effect that the supplier may not give our products the priority that we consider important, which could impair our ability
to generate revenue.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>We may experience difficulties in managing
our growth and expanding our operations.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We expect to experience significant growth in
the scope and nature of our operations. Our ability to manage our operations and future growth will require us to continue to improve
our operational, financial and management controls, compliance programs and reporting systems. We are currently in the process of strengthening
our compliance programs, including those related to export controls, privacy and cybersecurity and anti-corruption and financial controls.
We may not be able to implement improvements in an efficient or timely manner and may discover deficiencies in existing controls, programs,
systems and procedures, which could have an adverse effect on our business, reputation and financial results.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Continued pricing pressures may result in
lower than anticipated margins or losses, which may adversely affect our business.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Cost-cutting initiatives adopted by our Tier-1
customers and automobile and other automotive customers as well as the effects of competition may result in increased downward pressure
on pricing. We expect that as our industry develops and competition grows, our agreements with existing customers may require step-downs
in pricing over the term of the agreements or, if commercialized, over the periods of production, and we may not be able to negotiate
price reductions from our suppliers. In addition, our existing or future customers may reserve the right to terminate their supply contracts
for convenience, which enhances their ability to obtain price reductions. Certain large customers may possess significant leverage over
their suppliers, including us, because the market is highly competitive. Accordingly, we expect to be subject to substantial continuing
pressure from our existing and prospective customers to reduce the price of our products. It is possible that pricing pressures beyond
our expectations could intensify as automotive OEMs pursue restructuring, consolidation and cost-cutting initiatives. If we are unable
to generate sufficient production cost savings in the future to offset price reductions, our gross margin and profitability would be adversely
affected. Further, to the extent that the specifications of our chips result in prices which are not competitive, our sales and gross
margin may be impaired and we may not be able to operate profitably.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Adverse conditions within our industry or
the global economy more generally could have adverse effects on our results of operations</i></b>.</p><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our business is directly affected by and significantly
dependent on business cycles and other factors affecting the global automobile industry and the global economy generally. Production and
sales within our industry are cyclical and depend on general economic conditions and other factors, including consumer spending and preferences,
the timing by automobile manufacturers as to the introduction autonomous features that require our technology, changes in interest rates
and credit availability, consumer confidence, fuel costs, fuel availability, environmental impact, governmental incentives and regulatory
requirements and political volatility. In addition, production and sales can be affected by our customers&#8217; ability to continue operating
in response to challenging economic conditions, regulatory requirements and other factors. Any significant adverse change in any of these
factors may result in a reduction in automotive sales and production by
our customers and could have a material adverse effect on our business, results of operations and financial condition.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>


</div><!-- Field: Page; Sequence: 12 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Use of our products for markets other than
the automotive market may not develop or may develop much more slowly than we anticipate, which would adversely affect our business and
prospects.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We are investing in and pursuing market opportunities
in various sectors and industries in addition to the automobile industry, such as autonomous delivery vehicles or robotaxies, delivery
robots, autonomous trucks, agriculture, infrastructure and traffic systems. We believe that our ability to increase our revenue will depend
in part on our ability to identify potential new markets and develop products and implements a marketing plan aimed at these new markets
as they emerge. Each new market presents distinct risks and, in many cases, requires us to address the particular requirements of that
market.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Addressing these requirements can be time-consuming
and costly. The market for our existing products and technology outside of our core customer base is relatively new, rapidly developing
and unproven in many markets or industries. Many of the participants in the markets for our core technology outside of our existing target
industries are still in testing and developing and may not succeed in commercializing some of our products. We cannot be certain that
our products will be sold into these markets, or any market outside of where we currently operate, at scale. Adoption of our products
outside of the automotive industry will depend on numerous factors, including: whether the technological capabilities of similar products
meet users&#8217; current or anticipated needs, whether the benefits of designing products such as our products into larger systems outweigh
the costs, complexity and time needed to deploy such technology or replace or modify existing systems that may have used other modalities,
whether users in other applications can move beyond the testing and development phases and proceed to commercializing systems supported
by our technology and whether developers of products such as our products can keep pace with rapid technological change in certain developing
markets and the global response to supply chain delays. If technology developed by us does not achieve commercial success outside of the
automotive industry, or if the market develops at a pace slower than we expect, our business, results of operation and financial condition
may be materially and adversely affected.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>We may be subject to the effects of inflationary
pressures, which may impair our gross margins and our ability to operate profitably.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Although we do not believe that our business was
adversely affected by inflation prior to 2023, we have been experiencing cost increases, including increased labor costs, as a result
of the recent inflationary pressures, combined with supply line delays and recent shortages of semiconductors. The effects of the war
in Israel, the Russian invasion of Ukraine, which exacerbated the already existing inflationary pressures and supply line delays and shortages,
may impair our margin and our ability to operate profitable. To the extent that inflation, along with supply line delays and semiconductor
shortages, we may incur increased costs in our components as well as from our contract manufacturers, and we may not be able to pass on
any costs we may incur to our customers. To the extent that we are unable to pass on costs, our gross margin may be significantly eroded
which may result in increased losses during our developmental phase and may impair our ability to operate profitable when we are in full
production mode. We cannot assure you that these factors will not impair our ability to generate a profit from our operations.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>If we seek to expand our business through
acquisition, we may not be successful in identifying acquisition targets or integrating their businesses with our existing business.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">From time to time, we may undertake acquisitions
to add new products and technologies, acquire talent, gain new sales channels or enter into new markets or sales territories. To date,
we have no experience either with acquisitions or the integration of acquired technology and personnel.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">There are significant risks associated with any
acquisition program, including, but not limited to, the following:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">We may incur significant expenses and devote significant management time to the acquisition and we may be unable to consummate the acquisition on acceptable terms.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>


</div><!-- Field: Page; Sequence: 13 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">If we identify an acquisition, we may face competition from other companies in the industry or from financial buyers seeking to make the acquisition.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">The integration of any acquisition with our existing business may be difficult and, if we are not able to integrate the business successfully, it may not only be unable to operate the business profitably, but management may be unable to devote the necessary time to the development of our existing business;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">The key employees who operated the acquired business successfully prior to the acquisition may not be happy working for us and may resign, thus leaving the business without the necessary continuity of management.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">Even if the business is successful, our senior executive officers may need to devote significant time to the acquired business, which may distract them from their other management activities.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">If the business does not operate as we expect, we may incur an impairment charge based on the value of the assets acquired.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">We may have difficulty maintaining the necessary quality control over the acquired business and our products and services.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">To the extent that an acquired company operates at a loss prior to our acquisition, we may not be able to develop profitable operations following the acquisition.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">Problems and claims relating to the acquired business that were not disclosed at the time of the acquisition may result in increased costs and may impair our ability to operate the acquired company.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">The acquired company may have liabilities or obligations that were not disclosed to us, or the acquired assets, including intellectual property assets, may not have the value we anticipated.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">Any indemnification obligations of the seller under the purchase agreement may be inadequate to compensate us for any loss, damage or expense that we may sustain, including undisclosed claims or liabilities.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">To the extent that the acquired company is dependent upon our management to maintain relationships with existing customers, we may have difficulty in retaining the business of these customers if there is a change in management.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">Government agencies may seek damages after we makes the acquisition for conduct that occurred prior to the acquisition and we may not have adequate recourse against the seller.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">We may require significant capital both to acquire and to operate the business, and the capital requirements of the business may be greater than we anticipated, and our failure to obtain capital on reasonable terms may impair the value of the acquisition and may impair our continuing operations.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">The acquired company may be impacted by unanticipated events, such as a pandemic such as the COVID-19 pandemic, the effect of climate changes, terrorist or other disruptive activities in Israel, social unrest or other factors over which we may have no control.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If any of these risks occur, our business, financial
condition and prospects may be impaired.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 14 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>The complexity of our products could result
in unforeseen delays or expenses from undetected defects, errors or bugs in hardware or software which could reduce the market adoption
of our products, damage our reputation with current or prospective customers, expose us to product liability, recalls, warranties and
other claims and adversely affect its operating costs.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our products are being designed to be, among other
things, compatible with autonomous control. Autonomous driving technologies are subject to risks and there have been accidents and fatalities
associated with such technologies as well as breakdowns of the systems. The safety of such technologies depends in part on user interaction
and users, as well as other drivers on the roadways, may not be accustomed to using or adapting to such technologies. To the extent accidents
associated with our products that are used with autonomous controls occur, we could be subject to liability, negative publicity, government
scrutiny and further regulation. Any of the foregoing could materially and adversely affect our results of operations, financial condition
and growth prospects.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our products are technologically complex and require
high standards to manufacture. We have experienced in the past and will likely also experience in the future defects, errors or bugs at
various stages of development and manufacturing. We may be unable to timely release new products, manufacture existing products, correct
problems that have arisen or correct such problems to our customers&#8217; satisfaction. Additionally, undetected errors and defects,
especially as new products are introduced or as new versions are released, could result in serious injury, including fatalities, to the
end users of technology incorporating our products, or those in the surrounding area, our customers never being able to commercialize
technology incorporating our products, litigation against us, negative publicity and other consequences. These risks are particularly
prevalent in the highly competitive markets in which we operate. Some errors or defects in our products may only be discovered after they
have been tested, commercialized and deployed by customers. In certain instances, we may provide our customers with a time-limited warranty
for our products. If such errors or defects occur within the respective warranty period, we may incur significant additional development
costs and product recall, repair or replacement costs. These problems may also result in claims against us by our customers or by third
parties. Our reputation or brand may be damaged as a result of these problems and customers may be reluctant to buy our products, which
could adversely affect our ability to retain existing customers and attract new customers and could adversely affect our financial results.</p><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In addition, we could face material legal claims
for breach of contract, product liability, tort or breach of warranty as a result of these problems. Defending a lawsuit, regardless of
its merit, could be costly and may divert management&#8217;s attention and adversely affect the market&#8217;s perception of us and our
products. In addition, our business liability insurance coverage could prove inadequate with respect to a claim and future coverage may
be unavailable on acceptable terms or at all. These product-related issues could result in claims against us and our business could be
adversely affected.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We will be affected by these problems regardless
of whether the defective product or component was manufactured or assembled by us or by a supplier or contract manufacturer, and we may
not have adequate recourse against the supplier or contract manufacturer, and we may not be able to obtain sufficient product liability
insurance to protect it against such loss or expense, including the cost of litigation.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Legislation or government regulations may
be adopted which may affect our products and liability.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Autonomous driving technology is subject to considerable
regulatory uncertainty as the law evolves to catch up with the rapidly evolving nature of the technology itself, all of which are beyond
our control. Our products also may not achieve the requisite level of autonomous compatibility required for certification and rollout
to consumers or satisfy changing regulatory requirements which could require us and the Tier 1 suppliers that develop and market products
based on our chipset to redesign, modify or update our or their products. Further, accidents, particularly accidents that involve a large
number of deaths, even if our products are not involved, may result in industry-wide reevaluation of the technologies used, with the effect
that there is a slowdown as automobile manufacturers cease making purchase during the reevaluation process, which may result in suppliers
other than us becoming a preferred supplier.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The industry may become subject to increased legislation
and regulation. Such legislation may be triggered by a perceived safety concern, or it may result from a public reaction to accidents
caused by automobiles, drones or other autonomous vehicles. The potential market for our products is international, and each country or
region may impose different regulations. These regulations may relate the technical requirement and standards for end products or the
components and may impose liability on the manufacturer or the seller of the product, which liability may be strict liability, for damage
resulting from the autonomous vehicle. Further, the legislation or regulations in different countries may impose different standards,
which may be conflicting. Any legislation or regulations that impose standards or impose liability are likely to increase
our manufacturing costs as well as the cost of compliance and product liability insurance.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>


</div><!-- Field: Page; Sequence: 15 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>We operate in a highly competitive market
against a large number of both established competitors and new market entrants, and some market participants have substantially greater
resources than we have.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The markets for sensing technology applicable
to autonomous solutions across numerous industries are highly competitive. Our future success will depend on our ability to maintain our
ability to develop and protect from in a timely manner and to stay ahead of existing and new competitors and to satisfy the market that
is technology is leading edge technology. A large number of companies offer radar-based and LiDAR-based technologies in competition with
us. Some of these companies are better capitalized and better known than we. Our competitors compete with us directly by offering similar
products and indirectly by attempting to solve some of the same challenges with different technology. We face competition from other market
participants, some of which have significantly greater resources than we have. Our competitors may commercialize&#160;new technology which
may achieve market adoption or stronger brand recognition as compared to our products. Even in emerging markets, we face substantial competition
from numerous competitors seeking to prove the value of their technology. Additionally, increased competition may result in pricing pressure
and reduced margins and may impede our ability to increase the sales of our products or cause it to lose market share, any of which will
adversely affect our business, results of operations and financial condition.</p><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">

</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Fluctuation of the results of our earnings
on a quarterly and annual basis, could cause the share price of the our ordinary shares to fluctuate or decline.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We are currently a research and development company,
and the results of our operations to date have primarily reflected our research and development expenses. Commencing 2020 through 2023,
we had modest revenue from sales of our products and services, primarily to customers making purchases for their own evaluation projects.
In the future, sales in any given quarter can fluctuate based on the timing and success of our customers&#8217; development projects and
marketing programs. Accordingly, the results of any one quarter should not be relied upon as an indication of future performance. Our
quarterly financial results may fluctuate as a result of a variety of factors, many of which are outside of our control and may not fully
reflect the underlying performance of our business. These fluctuations could adversely affect our ability to meet our expectations or
those of securities analysts or investors. If we do not meet these expectations for any period, the value of our business and our securities
could decline significantly. Factors that may cause these quarterly fluctuations include, without limitation, those listed below:</p><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">

</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">The timing and magnitude of orders and shipments of our products in any quarter;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">Pricing changes we may adopt to drive market adoption or in response to competitive pressure;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">The effect of supply line problems affecting us and our suppliers or customers;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">The effect of inflation;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">The timing of the completion of our application engineering services;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">Our ability to retain our existing customers and attract new customers;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">Our ability to develop, introduce, manufacture, and ship products in a timely manner that meet customer requirements;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">Disruption in our sales channels or termination of our relationships with important channel partners;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">Delays in customers; purchasing cycles or deferments of customers; purchases in anticipation of new products or updates from us or our competitors;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">Fluctuations in demand pressures for our products;</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  </table><div>

</div><!-- Field: Page; Sequence: 16 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">The mix of products sold in any quarter;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">The duration of, and responses of governments and industry to any worldwide or regional health crisis;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">Events and conditions affecting Israel-based businesses;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">The timing and rate of broader market adoption of autonomous systems, both generally and those utilizing our smart vision solutions across automotive and other market sectors;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">Market acceptance of our core products and further technological advancements by us, our competitors, and other market participants;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">The ability of our customers to commercialize systems that incorporate our products;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">Any change in the competitive dynamics of our markets, including the consolidation of competitors, regulatory developments, and new market entrants;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">Our ability to effectively manage our inventory;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">Changes in the source, cost, availability, and regulations pertaining to the materials we use;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">Adverse litigation, judgments, settlements, or other litigation-related costs, or claims that may give rise to such costs;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">Adverse publicity, litigation, and governmental investigations affecting autonomous vehicles, regardless of whether our products are involved;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">The war with Hamas, any other conflicts which may involve Israel and the effects of the Russian invasion of Ukraine; and</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">General economic, industry, and market conditions, including trade disputes.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Changes in tax laws or exposure to additional
income tax liabilities could affect our future profitability.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Factors that could materially affect our future
effective tax rates include but are not limited to:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">New income or other tax laws or regulations could be enacted at any time, which could adversely affect our business operations and financial performance. Further, existing tax laws and regulations could be interpreted, modified, or applied adversely to us. </span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"><tr style="vertical-align: top">
<td style="width: 18pt"/><td style="width: 18pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Actual
                                            or perceived political instability in Israel or any negative changes in the political environment
                                            may, individually or in aggregate, adversely affect the Israeli economy and, in turn, may
                                            result in major changes in Israeli tax laws, regulations and tax policies.</span></td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">Changes in accounting and tax standards or practices;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">Eligibility for beneficial treatment under Israeli tax laws;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">Changes in the composition of operating income by tax jurisdiction;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">Our operating results before taxes; and</span></td></tr>
  </table><div>

</div><p style="margin-top: 0; margin-bottom: 0">&#160;</p><div>

</div><p style="margin-top: 0; margin-bottom: 0"></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">Our ability to use our accumulated tax losses to offset future income.</span></td></tr>
  </table><div>
</div><p style="margin-top: 0; margin-bottom: 0">&#160;</p><div>

</div><!-- Field: Page; Sequence: 17 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 100%">
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We may be subject to regular review and audit
    by Israeli and other foreign tax authorities. Although we believe our tax estimates are reasonable, the authorities in these jurisdictions
    could review our tax returns and impose additional taxes, interest, linkage and penalties, and the authorities could claim that various
    withholding requirements apply to us or our subsidiaries or assert that benefits of tax treaties are not available to us or our subsidiaries,
    any of which could materially affect our income tax provision, net income, or cash flows in the period or periods for which such determination
    and settlement is made. Our determinations are not binding on any taxing authorities, and accordingly the final determination in an audit
    or other proceeding may be materially different than the treatment reflected in our tax provisions, accruals and returns. An assessment
    of additional taxes because of an audit could have a material adverse effect on our business, financial condition, results of operations
    and cash flows.</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">There can be no assurance that our effective tax
rate will not increase over time as a result of changes in corporate income tax rates or other changes in the tax laws in the jurisdictions
in which we operate. Any changes in tax laws could have an adverse impact on our financial results. Corporate tax reform, base-erosion
efforts and tax transparency continue to be high priorities in many tax jurisdictions where we have business operations. As a result,
policies regarding corporate income and other taxes in numerous jurisdictions are under heightened scrutiny, and tax reform legislation
is being proposed or enacted in a number of jurisdictions.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The tax benefits that may be available to us require
that we continue to meet various conditions and may be terminated or reduced in the future, which could increase our costs and taxes.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Changes in our product mix may impact our
financial performance.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our financial performance can be affected by the
mix of products we sell during a given period. If our sales include more lower-gross margin products than higher gross margin products,
our results of operations and financial condition may be adversely affected. There can be no guarantees that we will be able to successfully
alter our product mix so that we are selling more of our high-gross margin products. In addition, our earnings forecasts and guidance
are expected to include assumptions about product sales mixes. If actual results vary from this projected product mix of sales, our results
of operations and financial condition could be adversely affected.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>We are highly dependent on the services
of our co-founders, who are our senior executive officers.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We are highly dependent on our co-founders,&#160;Kobi
Marenko and Noam Arkind, who have acted as our Chief Executive Officer and Chief Technology Officer, respectively, since inception, and
as such, are deeply involved in all aspects of our business, including product development. The loss of either of them would adversely
affect our business because it could be more difficult for us to, among other things, compete with other market participants, manage our
research and development activities, and retain existing customers or cultivate new ones. Negative public perception of, or negative news
related to, Mr. Marenko or Mr. Arkind may adversely affect our brand, relationship with customers, or standing in the industry.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Our business depends on our ability to attract
and retain highly skilled personnel and senior management. Failure to effectively retain, attract and motivate key employees could impair
our ability to operate profitably.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Competition for highly skilled personnel is
often intense, especially in Israel, where our principal office is located, and we may incur significant costs to attract them. We
may face challenges in attracting or retaining qualified personnel to fulfill our current or future needs. The highly competitive
environment for highly skilled personnel can result in higher compensation packages for employees. We have, from time to time,
experienced, and we expect to continue to experience, difficulty in hiring and retaining highly skilled employees with appropriate
qualifications. In addition, job candidates and existing employees often consider the value of the equity awards they receive in
connection with their employment. If the perceived value of our equity or equity awards declines, it may adversely affect our
ability to retain highly skilled employees. Our stock price may affect their decision as to whether to accept an offer of employment
from us. Our success will depend in part on the attraction, retention, and motivation of executive personnel critical to our
business and operations. If we fail to attract new personnel or fail to retain and motivate our current personnel, we could face
disruptions in our operations, strategic relationships, key information, expertise, or&#160;know-how,&#160;and unanticipated
recruitment and onboarding costs, and our business and future growth prospects could be adversely affected. We cannot give assurance that
we will be able to hire all the required personnel when we require them.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>


</div><!-- Field: Page; Sequence: 18 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>We face numerous risks associated with commercial
production.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We do not have manufacturing facilities, and we
rely on third parties for the manufacture of our products. We cannot be sure that our manufacturer, GlobalFoundries, or other companies
with which we may develop a strategic alliance will be able to develop efficient, automated, cost-efficient production capabilities and
processes and reliable sources of component supply that will enable us to meet the quality, price, engineering, design and production
standards, as well as the production volumes, required to successfully mass market our products. GlobalFoundries is a major semiconductor
manufacturer in the automotive industry, among other industries. Even if we and our supplier and strategic alliances are successful in
developing our initial production and further high volume production capability and processes and reliably sourcing our component supply,
we do not know whether we will be able to do so in a manner that avoids significant delays and cost overruns, including as a result of
factors beyond our control such as problems with potential suppliers and strategic partners, force majeure events, or in time to meet
our product commercialization schedules or to satisfy the requirements of our potential customer base. Any failure to develop such production
processes and capabilities within our projected costs and timelines could have a material adverse effect on our business, prospects, financial
condition, and operating results.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>We rely on third-party suppliers, and because
key components in our products come from limited or sole sources of supply, we are susceptible to supply shortages, long lead times for
components, and supply changes, any of which could disrupt our supply chain and delay deliveries of our products to customers.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-size: 10pt">The components that
go into the manufacture of our solutions are sourced from third-party suppliers. Some of the key components used to manufacture our products
come from limited or single</span>-<span style="font-size: 10pt">source suppliers. We are therefore subject to the risk of shortages and
long lead times in the supply of these components, as well as the risk that our suppliers will discontinue or modify components used in
our products. We purchase semiconductor chips that are an integral part of our products from GlobalFoundries. To the extent that our Tier
1 suppliers modify their products, it may be necessary for us to make modifications to the chipset that we sell to the Tier 1 supplier,
and we would need to work with GlobalFoundries, to develop and produce a modified product to meet the Tier 1 supplier&#8217;s cost and
timing requirements. If GlobalFoundries fails to deliver or delays the delivery of the semiconductor products or is otherwise unable to
meet our quality and delivery requirements, we may be required to seek an alternative source of supply. Although alternate chip manufacturers
are available, any change in suppliers would necessitate a change in the design of the semiconductor, a process that could take up to
two&#160;years, which would result in a loss of sales and a delay in the development and marketing of our products, which could materially
and adversely affect our results of operation, financial position, and prospects. Further, we, like other companies in the automotive
industry, are affected by an industry-wide semiconductor shortage, which results, in part, from the effects of the COVID-19 pandemic and
the Russian invasion to Ukraine.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Reliance on third-party manufacturers reduces
our control over the manufacturing process, including our ability to finalize changes through validation, reduced control over quality,
product costs, and product supply and timing. We may experience delays in shipments or issues concerning product quality from our third-party
manufacturers. If GlobalFoundries experiences interruptions, delays, or disruptions in supplying our products, including by natural disasters,
other health epidemics and outbreaks, work stoppages, capacity constraints, the effects of the war between Israel and Hamas, or other
international conflicts, our ability to ship products to distributors and customers would be delayed. In addition, unfavorable economic
conditions could result in financial distress among third-party manufacturers upon which we rely, thereby increasing the risk of disruption
of supplies necessary to fulfill our production requirements and meet customer demands. These delays or product quality issues could have
an immediate and material adverse effect on our ability to fulfill orders and could have a negative effect on our operating results. In
addition, such delays or issues with product quality could adversely affect our reputation and our relationship with Tier 1 suppliers
and OEMs. If GlobalFoundries or any other third-party manufacturers experience financial, operational, manufacturing capacity, or other
difficulties, or experience shortages in required components, or if they are otherwise unable or unwilling to continue to manufacture
our products in required volumes or at all, our supply may be disrupted, we may be required to seek alternate manufacturers, and we may
be required to re-design our products. It would be time-consuming, and costly and impracticable to begin to use new manufacturers and designs, and such changes could
cause significant interruptions in supply, have an adverse effect on our ability to meet our scheduled product deliveries, and subsequently
lead to the loss of sales. While we take measures to protect our trade secrets, the use of <span style="font-size: 10pt">a third-party
manufacturer may also risk disclosure of our innovative and proprietary manufacturing methodologies, which could adversely affect our
business. In addition, increased component costs could result in lower gross margins. Even where we are able to pass increased component
costs along to our customers, there may be a lapse of time before we are able to do so, such that we must absorb the increased cost. If
we are unable to buy these components in quantities sufficient to meet our requirements on a timely basis, we will not be able to deliver
products to our customers, which may result in such customers using competitive products instead of our products.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>


</div><!-- Field: Page; Sequence: 19 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Our sales and operations in international
markets expose us to operational, financial and regulatory risks.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Sales to international customers, <span style="text-decoration:underline">i.e.</span>,&#160;customers
located outside of Israel, accounted for almost all of our sales to date. International operations are subject to a number of other risks,
including:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">Exchange rate fluctuations;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">Political and economic instability, international terrorism, and anti-American and anti-Israel sentiment, particularly in emerging markets;</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-size: 10pt">&#9679;</span></td>
    <td><span style="font-size: 10pt">Reaction to any conflicts involving Israel, including its war with Hamas, including any official or unofficial boycotts of Israeli companies;</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-size: 10pt">&#9679;</span></td>
    <td>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The effects of the Russian invasion of Ukraine as it may affect suppliers
    and customers in Europe;</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">Global or regional health crises;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">Potential for violations of anti-corruption laws and regulations, such as those related to bribery or fraud;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">Preference for locally branded products, and laws and business practices favoring local competition;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">Increased difficulty in managing inventory;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">Less effective protection of intellectual property;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">Stringent regulation of our products or systems incorporating our products;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">Difficulties and costs of staffing and managing foreign operations;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">Import and export laws and the impact of tariffs; and</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 24px; font-size: 10pt"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="font-size: 10pt; text-align: justify"><span style="font-size: 10pt">Changes in local tax and customs duty laws or changes in the enforcement, application, or interpretation of such laws.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The occurrence of any of these risks could negatively
affect our international business and, consequently, our business, operating results, and financial condition.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Our business is subject to the risks of
earthquakes, fires, floods, and other natural catastrophic events, global pandemics, and interruptions by&#160;man-made&#160;problems
such as network security breaches, computer viruses, or terrorism. Material disruptions of our business or information systems resulting
from these events could adversely affect our operating results.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">A significant natural disaster, such as an earthquake,
fire, flood, or significant power outage, or other similar events, such as infectious disease outbreaks or pandemic events, could have
an adverse effect on our business and operating results. Despite the implementation of network security measures, our networks and our
products may also be vulnerable to computer viruses,&#160;break-ins,&#160;and similar disruptions from unauthorized tampering with our
solutions, and we have been subject to cybersecurity breaches
that were not material and did not result in access to our technical or other confidential information. <span style="font-size: 10pt">In
addition, natural disasters, acts of terrorism, or war could cause disruptions in our remaining manufacturing operations, our or our customers&#8217;
businesses, our suppliers&#8217; businesses, or the economy as a whole. We also rely on information technology systems to communicate
among our workforce and with third parties. Any disruption to our communications, whether caused by a natural disaster or by man-made
problems such as power disruptions, ransomware attacks, or other cybersecurity breaches, could adversely affect our business. To the extent
that any such disruptions result in delays or cancellations of orders or impede our suppliers&#8217; ability to timely deliver product
components or the deployment of our products, our business, operating results, and financial condition would be adversely affected.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 20 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Our business is sensitive to conditions
affecting the automotive industry, the duration and economic, governmental, and social impact of which are difficult to predict and may
significantly harm our business, prospects, financial condition, and operating results.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Adverse conditions affecting one or more automotive
manufacturers or the automotive industry in general could have a material adverse effect on our business, prospects, financial condition,
and operating results. Our business may be negatively affected by challenges to the larger automotive ecosystem. In addition, factors,
including the effects of climate change, government regulations, and the ability of suppliers to obtain rare earth elements, as well as
other conditions that cannot be presently identified, can continue to affect the automotive industry. To the extent that radar systems
in vehicles are software-based, with manufacturers or software suppliers having the ability to modify or update software remotely, there
is a risk of security breaches that may affect the safety of the vehicle.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Increasing attention to, and evolving expectations
regarding, environmental, social and sustainability matters may impact our business and reputation.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Evolving and increased expectations regarding
environmental, social and sustainability initiatives and disclosures may result in increased costs, enhanced compliance disclosure obligations,
or other impacts to our business, financial condition, or results of operations. Moreover, our environmental, social and sustainability
initiatives may be costly and may not have the desired effect, or we may ultimately be unable to complete certain initiatives or targets,
either on the timelines initially announced or at all, due to technological, legal, cost, or other constraints, which may be within or
outside of our control. Moreover, actions or statements that we may take based on expectations, assumptions, or third-party information
that we currently believe to be reasonable may subsequently be determined to be erroneous or be subject to misinterpretation. If we fail
to, or are perceived to fail to, comply with or advance certain environmental, social or sustainability initiatives, we may be subject
to various adverse impacts, including reputational damage, activism and potential stakeholder engagement and/or litigation. Additionally,
many of our customers, suppliers and others with which we have business relationships may be subject to similar expectations, which may
augment or create additional risks, including risks that may not be known to us.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Risks Related to our Intellectual Property</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>We may not be able to adequately protect
or enforce our intellectual property rights or prevent unauthorized parties from copying or reverse engineering our solutions. Our efforts
to protect and enforce our intellectual property rights and prevent third parties from violating our rights may be costly.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The success of our products and our business
depends in part on our ability to obtain patents and other intellectual property rights and maintain adequate legal protection for our
products in the United&#160;States, Europe, and other international jurisdictions. We rely on a combination of patent, copyright, service
mark, trademark, and trade secret laws, as well as confidentiality procedures and contractual restrictions, to establish and protect
our proprietary rights, all of which provide only limited protection. We cannot assure you that any patents will be issued with respect
to our currently pending patent applications or that any trademarks will be registered with respect to our currently pending applications
in a manner that gives us adequate defensive protection or competitive advantages, if at all, or that any patents issued to us or any
trademarks registered by them will not be challenged, invalidated, or circumvented. We have filed for patents and trademarks in Israel,
the United&#160;States, Europe, and China. Not all patent applications have resulted in patents, and we cannot assure you that patents
will be granted. Further, patent protection may not be available in all countries in which we operate or in which we seek to enforce
our intellectual property rights, and it may be difficult to enforce our patent rights. Our currently issued patents and trademarks and
any patents and trademarks that may be issued or registered, as applicable, in the future with respect to pending or future applications
may not provide sufficiently broad protection or may not prove to be enforceable in actions against alleged infringers. We cannot be
certain that the steps we have taken will prevent unauthorized use of our technology or the reverse engineering of our technology. Moreover,
others may independently develop technologies that are competitive with us or infringe on our intellectual property.</p><div>

</div><!-- Field: Page; Sequence: 21 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Protecting against the unauthorized use of our
intellectual property, products, and other proprietary rights is expensive and difficult, particularly internationally. We intend to enforce
the intellectual property portfolio we have developed. Unauthorized parties may attempt to copy or reverse engineer our solutions or certain
aspects of our solutions that we consider proprietary. Litigation may be necessary in the future to enforce or defend our intellectual
property rights, to prevent unauthorized parties from copying or reverse engineering our solutions, to determine the validity and scope
of the proprietary rights of others, or to block the importation of infringing products into countries where we have patent protection.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Effective patent, trademark, service mark, copyright,
and trade secret protection may not be available in every country in which our products are available, and competitors based in other
countries may sell infringing products in one or more markets. An inability to adequately protect and enforce our intellectual property
and other proprietary rights, or an inability to prevent authorized parties from copying or reverse engineering our smart vision solutions
or certain aspects of our solutions that we consider proprietary, could seriously adversely affect our business, operating results, financial
condition, and prospects.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>In addition to patented technology, we rely
on our unpatented proprietary technology, trade secrets, processes, and&#160;know-how.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We rely on proprietary information (such as trade
secrets,&#160;know-how,&#160;and confidential information) to protect intellectual property that may not be patentable or subject to copyright,
trademark, trade dress, or service mark protection, or that we believe is best protected by means that do not require public disclosure.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We generally seek to protect our proprietary information
by entering into confidentiality agreements, consulting services, or employment agreements that contain&#160;non-disclosure&#160;and&#160;non-use&#160;provisions
with our employees, consultants, contractors, and third parties. However, we may fail to enter into the necessary agreements, and even
if entered into, these agreements may be breached or may otherwise fail to prevent disclosure, third-party infringement, or misappropriation
of our proprietary information, may be limited as to their terms, and may not provide an adequate remedy in the event of unauthorized
disclosure or use of proprietary information. We have limited control over the protection of trade secrets used by our current or future
manufacturing partners and suppliers and could lose future trade secret protection if any unauthorized disclosure of such information
occurs. In addition, our proprietary information may otherwise become known or be independently developed by our competitors or other
third parties. To the extent that our employees, consultants, contractors, advisors, and other third parties use intellectual property
owned by others in their work for us, disputes may arise as to the rights to related or resulting&#160;know-how&#160;and inventions. Costly
and time-consuming litigation could be necessary to enforce and determine the scope of our proprietary rights, and failure to obtain or
maintain protection for our proprietary information could adversely affect our competitive business position. Furthermore, laws regarding
trade secret rights in certain markets where we operate may afford little or no protection to our trade secrets.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We also rely on physical and electronic security
measures to protect our proprietary information, but we cannot provide assurance that these security measures will not be breached or
provide adequate protection for our property. There is a risk that third parties may obtain and improperly utilize our proprietary information
to our competitive disadvantage. We may not be able to detect or prevent the unauthorized use of such information or take appropriate
and timely steps to enforce our intellectual property rights or to protect us against cybersecurity invasions that either lock our computers
so we cannot access our information or discloses our confidential information to others or to the general public. As an Israeli company,
we may be subject to attempts at cybersecurity breaches by persons or countries who seek to attach anything Israeli, and we have seen
increased attempts to do so.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>


</div><!-- Field: Page; Sequence: 22 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Third-party claims that we are infringing
intellectual property, whether successful or not, could subject it to costly and time-consuming litigation or expensive licenses, and
our business could be adversely affected.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Although we hold patents related to our products,
a number of companies, both within and outside of the industry in which we operate, hold other patents covering various aspects of our
products. In addition to these patents, participants in this industry typically also protect their technology, especially embedded software,
through copyrights and trade secrets. As a result, there is frequent litigation based on allegations of infringement, misappropriation,
or other violations of intellectual property rights. In the future, we may receive inquiries from other intellectual property holders
and may become subject to claims that it infringes on their intellectual property rights, particularly as we expand our presence in the
market. In addition, parties may claim that the names and branding of our products infringe on their trademark rights in certain countries
or territories. If such a claim were to prevail, we may have to change the names and branding of our products in the affected territories,
and we could incur other costs.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We currently have a number of agreements in effect
pursuant to which we have agreed to defend, indemnify, and hold harmless our customers, suppliers, and partners from damages and costs
that may arise from the infringement by our products of third-party patents or other intellectual property rights. The scope of these
indemnity obligations varies, but may, in some instances, include indemnification for damages and expenses, including attorneys&#8217;
fees. Our insurance may not cover all intellectual property infringement claims. A claim that our products infringe on a third party&#8217;s
intellectual property rights, even if untrue, could adversely affect our relationships with our customers, deter future customers from
purchasing our products, and expose us to costly litigation and settlement expenses. Even if we are not a party to any litigation between
a customer and a third party relating to infringement by our products, an adverse outcome in any such litigation could make it more difficult
for us to defend our products against intellectual property infringement claims in any subsequent litigation in which it is a named party.
Any of these results could adversely affect our brand and operating results.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our defense of intellectual property rights claims
brought against us or our customers, suppliers, and channel partners, with or without merit, could be time-consuming, expensive to litigate
or settle, divert management resources and attention, and force us to acquire intellectual property rights and licenses, which may involve
substantial royalty or other payments and may not be available on acceptable terms or at all. Further, a party making such a claim, if
successful, could secure a judgment that requires us to pay substantial damages or obtain an injunction which will prohibit us from selling
our products. An adverse determination also could invalidate our intellectual property rights, adversely affect our ability to offer our
products to our customers, and may require that we procure or develop substitute products that do not infringe, which could require significant
effort and expense. Any of these events could adversely affect our business, operating results, financial condition, and prospects.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Legal and Regulatory Risks Related to our Business</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>We are subject to, and must remain in compliance
with, numerous laws and governmental regulations concerning the manufacturing, use, distribution, and sale of our products. Some of our
customers also require that we comply with their own unique requirements relating to these matters.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our products contain electronic components, and
such components may contain materials that are subject to government regulation in the locations where we develop, manufacture, and assemble
our products, as well as the locations where we sell our products. Among other things, certain applicable laws and regulations require
or may in the future require the submission of annual reports to certain governmental agencies certifying that such products comply with
applicable performance standards, the maintenance of manufacturing, testing, and distribution records, and the reporting of certain product
defects to such regulatory agencies or consumers. Because our products are to be included in automobiles throughout the world, our radars
will need to comply with the applicable standards, laws or regulations in every country in which cars with our radar are sold, including
the United States, the European Union, Great Britain, China and Japan. If our products fail to comply with applicable regulations, we
and/or our products could be subjected to a variety of enforcement actions or sanctions, such as product recalls, repairs or replacements,
warning letters, untitled letters, safety alerts, injunctions, import alerts, administrative product detentions or seizures, or civil
penalties. The occurrence of any of the foregoing could harm our business, results of operations, and financial condition.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Since we operate on a global basis, we must continually
monitor applicable laws and regulations and engage in an ongoing compliance process to take necessary steps so that we and our suppliers
are in compliance with all existing laws and regulations. If there is unanticipated or onerous new legislation or regulation that significantly
impacts our use of various components or requires more expensive components, such legislation or regulation could materially adversely
affect our business, results of operations, and financial condition.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>


</div><!-- Field: Page; Sequence: 23 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Since our products are used for autonomous driving
applications, they are subject to complicated and rapidly evolving laws and regulatory schemes that vary from jurisdiction to jurisdiction
at the state, federal, and international levels, including requirements related to safety, data privacy<i>,</i> artificial intelligence,
security, cybersecurity, and product liability, among other areas. These are rapidly evolving areas in which new or changed requirements
could impose limitations on the use of our products. If we fail to adhere to these new laws and regulations or fail to continually monitor
emerging developments, it may be subject to litigation, loss of customers, or negative publicity, and our business, results of operations,
and financial condition will be adversely affected. We are unable to predict how any future changes will impact it or if such impacts
will be material to our business.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>The evolution of the regulatory framework
for autonomous vehicles and their related components is outside of our control.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our business is subject to a patchwork of regulations
from local, state and federal authorities. U.S. federal regulations include those imposed by the U.S. Department of Transportation and
the NHTSA. In 2023, the NHTSA promulgated the &#8220;Occupant Protection for Vehicles with Automated Driving Systems&#8221; final rule
to update several Federal Motor Vehicle Safety Standards (&#8220;FMVSS&#8221;) to account for vehicles that are equipped with ADAS and
do not have traditional manual controls associated with human drivers. The NHTSA also proposed rules to update FMVSS for crash avoidance,
safety messaging and passengerless vehicles as well as jointly proposed a rule with the Federal Motor Carrier Safety Administration regarding
AEB test devices for heavy vehicles.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Certain states have legal restrictions on self-driving&#160;vehicles,
and many other states are considering them. This patchwork increases the difficulty of maintaining legal compliance. In Europe, certain
vehicle safety regulations apply to self-driving&#160;braking and steering systems, and certain treaties also restrict the legality of
certain higher levels of self-driving&#160;vehicles. Self-driving&#160;laws and regulations are expected to continue to evolve in numerous
jurisdictions in the U.S.&#160;and foreign countries and may restrict autonomous driving features that we may deploy.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Our business may be adversely affected by
changes in automotive safety regulations or concerns that drive further regulation of the automobile safety market.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Government vehicle safety regulations are an important
factor for our business. Historically, these regulations have imposed ever-more stringent safety regulations for vehicles. These safety
regulations often require, or customers demand, that vehicles have more safety features per vehicle and more advanced safety products.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;<b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">While we believe increasing automotive safety
standards will present a market opportunity for our products, government safety regulations are subject to change based on a number of
factors that are not within our control, including new scientific or technological data, adverse publicity regarding industry recalls
and safety risks of autonomous driving, accidents involving our products, domestic and foreign political developments or considerations,
and litigation relating to our products and our competitors&#8217; products. Changes in government regulations, as well as changes or
evolutions in court doctrines in interpreting those regulations, especially in the autonomous driving industry, could adversely affect
our business. If government priorities shift and we are unable to adapt to changing regulations or to court interpretations of those regulations,
our business may be materially and adversely affected.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Federal and local regulators impose more stringent
compliance and reporting requirements in response to product recalls and safety issues in the automotive industry. As the vehicles that
use our products go into production, we may become subject to stringent requirements, including a duty to report, strict timing requirements,
and safety defects with our products. Such rules and regulations may impose potentially significant civil penalties for violations, including
the failure to comply with such reporting actions. If we cannot rapidly address any safety concerns or defects with our products, our
business, results of operations, and financial condition may be adversely affected.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 24 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The U.S.&#160;Department of Transportation
has issued regulations that require manufacturers of certain autonomous vehicles to provide documentation covering specific topics
to regulators, such as how automated systems detect objects on the road, how information is displayed to drivers, what cybersecurity
measures are in place, and the methods used to test the design and validation of autonomous driving systems. As cars that carry our
sensors go into production, the obligations of complying with safety regulations could increase, and it could require increased
resources and adversely affect our business.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Failures, or perceived failures, to comply
with privacy, data protection, and information security requirements in the variety of jurisdictions in which we operate may adversely
impact our business, and such legal requirements are evolving, uncertain and may require improvements in, or changes to, our policies
and operations.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our current and potential future operations and
sales are subject to laws and regulations addressing privacy and the collection, use, storage, disclosure, transfer, and protection of
a variety of types of data. For example, the European Commission has adopted the General Data Protection Regulation and California has
enacted the California Consumer Privacy Act&#160;of&#160;2018, both of which provide for potentially material penalties for&#160;non-compliance.&#160;These
regulations may, among other things, impose data security requirements, disclosure requirements, and restrictions on data collection,
use, and sharing that may impact our operations and the development of our business. While, generally, we do not have access to, collect,
store, process, or share information collected by our products unless our customers choose to proactively provide such information to
us, our products may evolve both to address potential customer requirements or to add new features and functionality. Therefore, the full
impact of these privacy regimes on our business is rapidly evolving across jurisdictions and remains uncertain at this time.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We may also be affected by cyberattacks and other
means of gaining unauthorized access to our products, systems, and data. For instance, cyber criminals or insiders may target us or third
parties with whom we have business relationships in an effort to harm them, their proper use, or the data stored in them, resulting in
direct and indirect damages, including disruption, interruption, or severance of operations, ransomware, leaks and data loss, theft of
property, espionage, harm to reputation, harm to public trust, and rehabilitation expenses. We work to prevent and reduce exposure to
the risk of cyber-attacks with strategies including the use of information security systems, assimilation of a culture of data security
(including training for managers and employees), refinement and adjustment of procedures, internal control programs, and auditing and
support with the assistance of experts in the field. During 2023, we suffered a cybersecurity breach that did not have any material effect
upon our business. We cannot assure that we will not suffer in the future from cybersecurity attacks that may have a material adverse
effect upon our business and our ability to conduct research and development or to market and sell our products.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our operations are rich in technology and computing
and may be exposed to risks related to the stability of the information systems, their compatibility with the scope of our operations,
information security, technical failures, overload of system servers, and the like. An impairment of the stability of computer systems
and an inability on the part of us to return its systems to normal operation within a reasonable timeframe, or a lack of technological
ability to meet commitments or the expectations of potential customers and strategic partners, may damage our reputation and harm our
business outcomes.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We are assessing the continually evolving privacy
and data security regimes and measures that we believe are appropriate in response. Since these data security regimes are evolving, uncertain,
and complex, especially for a global business like ours, we may need to update or enhance our compliance measures as our products, markets,
and customer demands further develop, and these updates or enhancements may require implementation costs. The compliance measures we do
adopt may prove ineffective. Any failure, or perceived failure, by us to comply with current and future regulatory or customer-driven
privacy, data protection, and information security requirements, or to prevent or mitigate security breaches, cyberattacks, or improper
access to, use of, or disclosure of data, or any security issues or cyberattacks affecting us, could result in significant liability,
costs (including the costs of mitigation and recovery), and a material loss of revenue resulting from the adverse impact on our reputation
and brand, loss of proprietary information and data, disruption to our business and relationships, and diminished ability to retain or
attract customers and business partners. Such events may result in governmental enforcement actions and prosecutions, private litigation,
fines and penalties, or adverse publicity, and could cause customers and business partners to lose trust in us, which could have an adverse
effect on our reputation and business.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>


</div><!-- Field: Page; Sequence: 25 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>We may be exposed to liabilities under
the U.S.&#160;Foreign Corrupt Practices Act and other U.S.&#160;and foreign anti-corruption, anti-money laundering, export control, sanctions,
and other trade laws and regulations, and any determination that we violated these laws could have a material adverse effect on our business.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We are subject to export control and import laws
and regulations, including the U.S.&#160;Export Administration Regulations, U.S.&#160;Customs regulations, and various economic and trade
sanctions regulations administered by the U.S.&#160;Treasury Department&#8217;s Office of Foreign Assets Control. We are also subject
to the U.S.&#160;Foreign Corrupt Practices Act&#160;of&#160;1977, as amended (the &#8220;FCPA&#8221;), the U.S.&#160;domestic bribery
statute contained in 18 U.S.C. &#167; 201, the U.S.&#160;Travel Act, the&#160;USA&#160;PATRIOT Act, the United&#160;Kingdom Bribery Act&#160;2010,
the Proceeds of Crime Act&#160;2002, and possibly other anti-bribery and anti-money laundering laws in countries outside of the United&#160;States
in which we conduct our activities. Compliance with these laws has been the subject of increasing focus and activity by regulatory authorities,
both in the United&#160;States and elsewhere, in recent&#160;years. Anti-corruption laws are interpreted broadly and prohibit companies,
their employees, and third-party intermediaries from authorizing, promising, offering, providing, soliciting, or accepting, directly or
indirectly, improper payments or benefits to or from any person, whether in the public or private sector. Our activities outside the United&#160;States
may create the risk of unauthorized payments or offers of payments by employees, consultants, sales agents, or distributors, even though
they may not always be subject to our control. It is our policy to implement safeguards to discourage these practices by our employees,
consultants, sales agents, and distributors. However, our existing safeguards and any future improvements may prove to be less than effective,
and our employees, consultants, sales agents, or distributors may engage in conduct for which we might be held responsible, even if it
does not explicitly authorize such activities. Should our export activity be subject to security oversight, this may have a material effect
on our activity. Further, our business may be affected by sanctions that may be imposed on customers or suppliers who trade with sanctioned
countries and/or companies in violation of United States or European restrictions.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Noncompliance with anti-corruption, anti-money
laundering, export control, sanctions, and other trade laws could subject us to whistleblower complaints, investigations, sanctions, settlements,
prosecution, other enforcement actions, disgorgement of profits, significant fines, damages, other civil and criminal penalties or injunctions,
suspension and/or debarment from contracting with certain persons, the loss of export privileges, reputational harm, adverse media coverage,
and other collateral consequences. If any subpoenas or investigations are launched, or governmental or other sanctions are imposed, or
if we do not prevail in any possible civil or criminal litigation, our business, results of operations, and financial condition could
be materially harmed. Responding to any action will likely result in a materially significant diversion of management&#8217;s attention
and resources, significant defense and compliance costs, and other professional fees. In addition, the U.S.&#160;government may seek to
hold us liable for successor liability for FCPA violations committed by companies in which we invest or that we may acquire. As a general
matter, enforcement actions and sanctions could harm our business, results of operations, and financial condition.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Regulations related to conflict minerals
may cause us to incur additional expenses and could limit the supply and increase the costs of certain metals used in the manufacturing
of our products.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We are subject to the requirements under the&#160;Dodd-Frank
Wall Street Reform and Consumer Protection Act&#160;of 2010, or the&#160;Dodd-Frank Act, that will require us to determine, disclose,
and report whether our products contain conflict minerals. The implementation of these requirements could adversely affect the sourcing,
availability, and pricing of the materials used in the manufacture of components used in our products. In addition, we will incur additional
costs to comply with the disclosure requirements, including costs related to conducting diligence procedures to determine the sources
of conflict minerals that may be used in or necessary to the production of our products and, if applicable, potential changes to products,
processes, or sources of supply as a consequence of such verification activities. It is also possible that our reputation may be adversely
affected if we determine that certain of our products contain minerals not determined to be conflict minerals or if we are unable to alter
our products, processes, or sources of supply to avoid the use of such materials.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>


</div><!-- Field: Page; Sequence: 26 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>We may become involved in legal and regulatory
proceedings and commercial or contractual disputes, which could have an adverse effect on our profitability and consolidated financial
position.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We may be, from time to time, involved in
litigation, regulatory proceedings, and commercial or contractual disputes that may be significant. These matters may include,
without limitation, disputes with our potential suppliers and strategic partners and our potential customer base, intellectual
property claims, stockholder litigation, government investigations, class&#160;action lawsuits, personal injury claims,
environmental issues, customs and VAT disputes, and employment and tax issues. In addition, we could face in the future a variety of
labor and employment claims against <span style="font-size: 10pt">us, which could include but are not limited to general
discrimination, wage and hour, privacy, pension (including, for US employees, ERISA), or disability claims. In such matters,
government agencies or private parties may seek to recover from us very large, indeterminate amounts in penalties or monetary
damages (including, in some cases, treble or punitive damages) or seek to limit our operations in some way. These types of lawsuits
could require significant management time and attention or could involve substantial legal liability, adverse regulatory outcomes,
and/or substantial expenses to defend. Often, these cases raise complex factual and legal issues and create risks and uncertainties.
No assurances can be given that any proceedings and claims will not have a material adverse impact on our operating results and
consolidated financial position or that our established reserves or our available insurance will mitigate this impact.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>The results of our operations may be affected
by changes in currency exchange rates.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our results of operations and cash flows are subject
to fluctuations due to changes in foreign currency exchange rates. Currently, most of our revenue is generated in U.S. dollars, while
our expenses are generally denominated in the currencies of the jurisdictions in which we conduct our operations, primarily the Israeli
Shekel, the U.S. dollar and, to some extent, the euro. We have not generated significant revenue to date, and we do not believe that foreign
currency exchange rates have not had, or currently have, a material effect on our business. However, we cannot give any assurance that
changes in foreign currency exchange rates will not have a material impact on us.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Our cash and cash equivalents could be adversely
affected if the financial institutions in which we hold our cash and cash equivalents fail.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We regularly maintain cash balances at third-party
financial institutions in the United States and in Israel. Maintaining any significant portion of our cash in financial institutions is
subject to adverse conditions in the financial or credit markets, which could impact access to our invested cash or cash equivalents and
adversely impact our operating liquidity and financial performance. We are diversifying our investments for cash designated for our long-term
activities into short-term deposits and money market funds and also considering spreading our cash and cash equivalents among several
financial institutions in order to reduce the risks associated with maintaining all of our cash and cash equivalents at one financial
institution. Notwithstanding these efforts, the failure of one or more of the financial institutions in which our cash and cash equivalents
are held could result in our inability to obtain or a significant delay in obtaining the return of our funds from any of those financial
institutions or any other adverse condition suffered by any of those financial institutions, could impact access to our invested cash
or cash equivalents and could adversely impact our operating liquidity and financial performance. Part of our cash was held in Silicon
Valley Bank (&#8220;SVB&#8221;), and, following the restructure of SVB, we transferred substantially all the cash from SVB to other financial
institutions.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Risks Related to our Ordinary Shares</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Market conditions may adversely affect the
liquidity and price of our securities.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The price of our securities may fluctuate significantly.
An active trading market for our securities may not be sustained. In addition, the price of our securities can vary due to general economic
conditions and forecasts, our general business condition, and the release of our financial reports. Additionally, if our securities become
delisted from Nasdaq and are quoted on the OTC Markets (an inter-dealer automated quotation system for equity securities that is not
a national securities exchange), the liquidity and price of our securities may be more limited than if we were quoted or listed on the
NYSE, Nasdaq, or another national securities exchange, in which event you may be unable to sell your securities unless a market can be
established or sustained.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>


</div><!-- Field: Page; Sequence: 27 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Our internal controls over financial reporting
may not be effective, and our independent registered public accounting firm may not be able to certify as to their effectiveness, which
could have a significant and adverse effect on our business and reputation.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The&#160;Sarbanes-Oxley Act&#160;requires,
among other things, that we maintain effective disclosure controls and procedures and internal control over financial reporting. We
are continuing to develop and refine our disclosure controls, internal control over financial reporting, and other procedures that
are designed to ensure that information required to be disclosed by us in the reports that we file with the SEC is recorded,
processed, summarized, and reported within the time periods specified in SEC rules and forms, and that information required to be
disclosed in reports under the&#160;Exchange&#160;Act&#160;is accumulated and communicated to our principal executive and financial
officers. If we are not able to protect our computer system, including our financial records and client and personnel information,
against cybersecurity attacks, including ransomware attacks, we may not be able to maintain effective disclosure controls or
internal controls over financial reporting.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our current controls and any new controls that
we develop may become inadequate because of changes in conditions in our business. Further, weaknesses in our internal controls may be
discovered in the future. Any failure to develop or maintain effective controls, or any difficulties encountered in their implementation
or improvement, could adversely affect our operating results, or cause us to fail to meet our reporting obligations and may result in
a restatement of our financial statements for prior periods. Any failure to implement and maintain effective internal controls could also
adversely affect the results of operations. Ineffective disclosure controls and procedures and internal control over financial reporting
could also cause investors to lose confidence in our reported financial and other information.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In order to maintain and improve the effectiveness
of our disclosure controls and procedures and internal control over financial reporting, we have expended and are continuing to expend
significant resources, including accounting-related costs, and provide significant management oversight. Any failure to maintain the adequacy
of our internal controls, or consequent inability to produce accurate financial statements on a timely basis, could increase our operating
costs and materially and adversely affect our ability to operate our business. In the event that our internal controls are perceived as
inadequate or that we are unable to produce timely or accurate financial statements, investors may lose confidence in our operating results,
and the stock price of our ordinary shares could decline. In addition, if we are unable to continue to meet these requirements, we may
not be able to maintain listings on Nasdaq.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our independent registered public accounting firm
is not required to attest to the effectiveness of our internal controls over financial reporting and will not be required to attest to
such effectiveness as long as we continue to be a non-accelerated filer. At such time as our independent registered public accounting
firm is required to attest to the effectiveness of our internal controls, such firm may issue a report that our internal controls are
not effective if it is not satisfied with the level at which our controls are documented, designed, or operating. Any failure to maintain
effective disclosure controls and internal control over financial reporting could have a material and adverse effect on our business and
operating results.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>We face risks related to the ongoing Russian
invasion of Ukraine and any other conflicts that may arise on a global or regional scale which could adversely affect our business and
results of operations. </b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On February 24, 2022, the Russian Federation launched
an invasion of Ukraine that has had an immediate impact on the global economy resulting in higher energy prices and higher prices for
certain raw materials and goods and services which in turn is contributing to higher inflation in the United States and other countries
across the globe with significant disruption to financial markets and supply and distribution chains for certain raw materials and goods
and services on an unprecedented scale, including the effects of fuel shortages in Europe. The Russian Federation could resort to cyberattacks
and other action that impact businesses across the United States, the European Union, Israel and other nations across the globe including
those without any direct business ties to the Russian Federation or Ukraine. Although we do not have any business in Russia or Ukraine,
the effects of the invasion could affect the European economy, which may affect European automobile companies.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Other conflicts with a global impact that may
arise from time to time, including conflicts in the Middle East, could have a material adverse effect on our business, results of operations,
and/or financial condition.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Risks Related to our Incorporation and Location
in Israel</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Conditions in Israel could materially and
adversely affect our business.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="background-color: white"><b><i>The
war in Israel and other</i></b></span><b><i> conditions in Israel could materially and adversely affect our business.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We are an Israeli corporation, and many of our
employees, including certain management members, operate from our offices in Tel Aviv-Yafo, Israel. In addition, the majority of our officers
and directors are residents of Israel.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>


</div><!-- Field: Page; Sequence: 28 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Accordingly, political, economic, and military
conditions in Israel and the surrounding region may directly affect our business and operations.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In recent&#160;years, Israel has been engaged
in sporadic armed conflicts with Hamas and other Islamist terrorist groups that control the Gaza Strip and with Hezbollah, an&#160;Islamist
terrorist group that controls large portions of Lebanon; and with Iranian-backed military forces in Syria and elsewhere.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On October 7, 2023, following a large-scale attack
led by the Hamas organization from the Gaza Strip on <span style="background-color: white">civilian and military targets in </span>Israel,
the Israeli government declared a war against Hamas. <span style="background-color: white">In addition, Hezbollah has also launched attacks
against Israeli military sites and troops and against Israeli towns in northern Israel. In response to these attacks, the Israel Defense
Force (&#8220;IDF&#8221;) has carried out a number of targeted strikes on sites belonging to Hezbollah in southern Lebanon. Further, Israel
faces threats from more distant neighbors, in particular, Iran which threatened to attack Israel.&#160; The Iran-backed Houthi movement,
which controls parts of Yemen and launched a number of attacks on marine vessels traversing the Red Sea</span>. <span style="background-color: white">The
Red Sea is a vital maritime route for international trade traveling to and from Israel and much of the world.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="background-color: white">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As of the date of this annual report, this conflict
is still ongoing and is causing political and economic instability in the Middle East, and the long-term effects of the war on Israeli
tech companies remain uncertain. It is hard to predict how long the war will last. All these factors may have a negative impact on us
and our activities. We are examining and evaluating the wars&#8217; effects on our activities and considering different measures to face
them and withstand these risks. The risks we may face include, but are not limited to:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">As a result of work stoppages, damages to infrastructure,
and delays in the supply chain caused by the war, our business activities in Israel may suffer disruptions and may slow down.</td>
</tr><tr style="vertical-align: top; text-align: justify">
<td>&#160;</td><td style="text-align: left">&#160;</td><td style="text-align: justify">&#160;</td></tr>
     </table><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">The war may lead to a decrease in demand for the products
and services of Israeli companies. Negative media coverage surrounding the conflict can damage the image of our company.</td>
</tr><tr style="vertical-align: top; text-align: justify">
<td>&#160;</td><td style="text-align: left">&#160;</td><td style="text-align: justify">&#160;</td></tr>
     </table><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">Further, in the past, the State of Israel and Israeli companies
have been subjected to economic boycotts. More countries may impose restrictions on doing business with Israel and Israeli companies
if hostilities on Israel continue or increase. The war may lead to an increase in input costs, such as labor, raw materials, and energy.</td>
</tr><tr style="vertical-align: top; text-align: justify">
<td>&#160;</td><td style="text-align: left">&#160;</td><td style="text-align: justify">&#160;</td></tr>
     </table><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">The war has a negative affect on the Israeli economy as a
whole.</td>
</tr><tr style="vertical-align: top; text-align: justify">
<td>&#160;</td><td style="text-align: left">&#160;</td><td style="text-align: justify">&#160;</td></tr>
     </table><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">The war may lead to a decrease in the share price of our
ordinary shares as a result of investors' fear of the geopolitical risks.</td>
</tr><tr style="vertical-align: top; text-align: justify">
<td>&#160;</td><td style="text-align: left">&#160;</td><td style="text-align: justify">&#160;</td></tr>
     </table><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify"><span>Since October 7, 2023,
the IDF has called up more than 350,000 of its reserve forces to serve. A number of our employees are currently subject to military service
in the IDF and many of them have been called to serve. Such disruption could affect our business, prospects, financial condition, and
results of operations. Future&#160;call-ups may impact</span> our workforce availability and project timelines as well.</td>
</tr><tr style="vertical-align: top; text-align: justify">
<td>&#160;</td><td style="text-align: left">&#160;</td><td style="text-align: justify">&#160;</td></tr>
     <tr style="vertical-align: top; text-align: justify">
<td>&#160;</td><td style="text-align: left">&#160;</td><td style="text-align: justify">&#160;</td></tr>
     </table><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">The heightened tensions in the area increased the risk of
cyberattacks against our company.</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 14.4pt"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 14.4pt"></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 14.4pt"></p><div>


</div><!-- Field: Page; Sequence: 29 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our commercial insurance does not cover losses
that may occur as a result of events associated with war and terrorism. Although the Israeli government currently covers the reinstatement
value of direct damage that is caused by terrorist attacks or acts of war, we cannot assure you that this government coverage will be
maintained or that it will sufficiently cover our potential damages. Any losses or damages incurred by us could have a material adverse
effect on our business. Any armed conflicts or political instability in the region would likely negatively affect business conditions
and could harm our results of operations.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Israeli government has been pursuing changes
to Israel&#8217;s judicial system, which in turn may affect the checks and balances between the authorities in Israel. In response to
the foregoing developments, individuals, organizations and institutions, both within and outside of Israel, have voiced concerns that
the proposed changes may negatively impact the business and economic environment in Israel, all of which may affect our business. Actual
or perceived political instability in Israel or any negative changes in the political environment may, individually or in aggregate adversely
affect the Israeli economy and, in turn, our business, financial condition, results of operations, and prospects.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>We may become subject to claims for remuneration
or royalties for assigned service invention rights by our employees, which could result in litigation and adversely affect our business.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">A significant portion of our intellectual property
has been developed by our employees in the course of their employment with us. Under the Israeli Patent Law,&#160;5727-1967, or the &#8220;Patent
Law&#8221;, inventions conceived by an employee in the course of and as a result of his or her employment with a company are regarded
as &#8220;service inventions,&#8221; which belong to the employer, unless there is a specific agreement between the employee and employer
giving the employee service invention rights. The Patents Law also provides that if there is no such agreement between an employer and
an employee, the Israeli Compensation and Royalties Committee (the &#8220;Committee&#8221;), a body constituted under the Patent Law,
will determine whether the employee is entitled to remuneration for his or her inventions. Case law clarifies that the right to receive
consideration for &#8220;service inventions&#8221; can be waived by the employee and that, in certain circumstances, such waiver does
not necessarily have to be explicit. The Committee will examine, on a case-by-case basis, the general contractual framework between the
parties using the interpretation rules of the general Israeli contract laws. Further, the Committee has not yet determined one specific
formula for calculating this remuneration but rather uses the criteria specified in the Patents Law.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Although we generally enter into assignment-of-invention
agreements with our employees pursuant to which such individuals assign to it all rights to any inventions created in the scope of their
employment or engagement with us, we may face claims demanding remuneration in consideration for assigned inventions. As a consequence
of such claims, we could be required to pay additional
remuneration or royalties to our current and/or former employees, or be forced to litigate such claims, which could negatively affect
our business.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>


</div><!-- Field: Page; Sequence: 30 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>The potential tax benefits that may be available
to us require us to meet various conditions and may not be available to us, which could increase our costs and taxes.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We may be eligible for certain tax benefits provided to &#8220;Preferred
Technology Enterprises&#8221; under the Israeli Law for the Encouragement of Capital Investments, 5719-1959, referred to as the Investment
Law. We have not yet applied for these benefits. In order to receive and remain eligible for the tax benefits for the Preferred Technology
Enterprises tax benefits, we must continue to meet certain conditions stipulated in the Investment Law and its regulations. If these tax
benefits are reduced, cancelled or discontinued, our Israeli taxable income from would be subject to regular Israeli corporate tax rates.
The standard corporate tax rate for Israeli companies has been 23% since 2018. Additionally, if we increase our activities outside of
Israel through acquisitions, for example, our expanded activities might not be eligible for inclusion in future Israeli tax benefit programs.
See &#8220;<i>Certain Material Israeli Tax Considerations</i>.&#8221;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>The terms of grants received from the Israeli
government require us to satisfy specified conditions in order to transfer the manufacture of products based on know-how funded by the
Israel Innovation Authority outside of Israel or to transfer outside of Israel the know-how itself.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Under the Israeli Encouragement of Research, Development,
and Technological Innovation in Industry Law,&#160;5744-1984, or the Innovation Law, research, and development programs that meet specified
criteria and may be approved by a committee of the Israel Innovation Authority of the Israeli Ministry of Economy and Industry, or IIA,
are eligible for grants from the IIA.&#160;The grant amounts are determined by the research committee and are typically a percentage of
the project&#8217;s expenditures. Under most programs, the grantee is required to pay royalties to the State of Israel from the sale of
products developed under the program.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our research and development efforts in relation
to our product have been partially financed through royalty-bearing and non-royalty bearing grants from the IIA in the total amount of
approximately $3.8&#160;million through December 31, 2023.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Under the terms and conditions of the IIA grants
provided to us and pursuant to applicable laws, we are required to pay royalties from sales of products and services that incorporate
know-how developed with the IIA-funded, royalty-bearing grants. Such royalties are due up to an amount equal to 100% of the IIA grants
received, linked to the U.S.&#160;dollar, plus interest on the unpaid amount received based on the 12-month Secured Overnight Financing
Rate, known as SOFR, from the year the grant was approved. If we will manufacture IIA-funded products outside of Israel and generate sales,
the ceiling may increase based on the percentage of production that is outside of Israel, up to a maximum of 300% of the IIA grants, linked
to the dollar and bearing interest as detailed above.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt"><i>&#160;</i></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 24px; font-size: 10pt"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="font-size: 10pt; text-align: justify"><span style="font-size: 10pt"><i>Local Manufacturing Obligation.</i> Under the regulations promulgated under the Innovation Law and the guidelines issued by the IIA, the manufacturing of products that incorporate know-how developed with the IIA-funded outside of Israel by us or by another entity may be subject to certain approvals and\or limitations, and if we fail to obtain the required approval, we may be subject to fines and/or an acceleration of our royalty obligation.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt"><i>&#160;</i></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 24px; font-size: 10pt"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="font-size: 10pt; text-align: justify"><span style="font-size: 10pt"><i>Know-How transfer limitation</i></span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 72pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 48px">&#160;</td>
    <td style="width: 24px; font-size: 10pt"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="font-size: 10pt; text-align: justify"><span style="font-size: 10pt">The Innovation Law restricts the ability to transfer know-how funded by the IIA outside of Israel. Transfer of IIA-funded know-how outside of Israel requires prior approval of the IIA and may be subject to additional payments to the IIA, calculated according to formulae provided under the Innovation Law. If we wish to transfer IIA-funded know-how, the terms for approval will be determined according to the nature of the transaction and the consideration paid to us in connection with such a transfer.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 72pt; text-align: justify; text-indent: -24pt">&#160;</p><div>


</div><!-- Field: Page; Sequence: 31 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 48px">&#160;</td>
    <td style="width: 24px; font-size: 10pt"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="font-size: 10pt; text-align: justify"><span style="font-size: 10pt">Approval of transfer the of IIA-funded know-how to another Israeli company may be granted only if the recipient abides by the provisions of the Innovation Law and related regulations, including the restrictions on the transfer of know-how and manufacturing rights outside of Israel.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 24px; font-size: 10pt"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="font-size: 10pt; text-align: justify"><span style="font-size: 10pt"><i>Change of Control.</i> Any non-Israeli citizen, resident, or entity that, among other things, (i)&#160;becomes a holder of 5% or more of our share capital or voting rights, (ii)&#160;is entitled to appoint one or more of our directors or the chief executive officer, or (iii)&#160;serves as one of our directors or as our chief executive officer, is required to notify the IIA and undertake to comply with the Innovation Law and the rules and regulations thereunder as applicable to the grant programs of the IIA, including the restrictions on transfer described above.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Approval to manufacture products outside of Israel
or consent to the transfer of IIA-funded know-how, if requested, is within the discretion of the IIA.&#160;Furthermore, the IIA may impose
certain conditions on any arrangement under which it permits us to transfer IIA-funded know-how or manufacturing out of Israel.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The consideration available to our shareholders
in a future transaction involving the transfer outside of Israel of know-how developed with IIA funding (such as a merger or similar transaction)
may be reduced by any amounts that we are required to pay to the IIA.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Our Restated Articles contain a forum selection
clause for substantially all disputes between us and our shareholders under the Israeli Companies Law and the Israeli Securities Law,
which could limit our shareholders&#8217; ability to bring claims and proceedings against us, our directors, officers, and other employees.
Enforcement of a U.S.&#160;judgment against us or our officers and directors in Israel or the United&#160;States, or assertion of a U.S.&#160;securities
law claim in Israel or serving process on our officers and directors, may also be difficult.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Under our Restated Articles, the competent courts
of Tel Aviv, Israel, will be the exclusive forum for (i)&#160;any derivative action or proceeding brought on our behalf, (ii)&#160;any
action asserting a claim of breach of fiduciary duty owed by any director, officer, or other employee to us or our shareholders, or (iii)&#160;any
action asserting a claim arising pursuant to any provision of the Israeli Companies Law or the Israeli Securities Law,&#160;1968-5728
(the &#8220;Israeli Securities Law&#8221;). This exclusive forum provision is intended to apply to claims arising under Israeli law and
would not apply to claims brought pursuant to the Securities Act or the Exchange&#160;Act. Our Restated Articles also provide that, unless
we consent in writing to the selection of an alternative forum and the Company consents in writing to the selection of an alternative
forum, the federal district courts of the United States of America will be the exclusive forum for the resolution of any complaint asserting
a cause of action arising under the Securities Act, including all causes of action asserted against any defendant to such a complaint.
This provision does not affect any other claim for which federal district courts in the United States would have exclusive jurisdiction
and expressly does not apply to causes of action arising under the Securities Exchange Act. Such exclusive forum provision in the Restated
Articles will not relieve us of our duties to comply with federal securities laws and the rules and regulations thereunder, and our shareholders
will not be deemed to have waived their compliance with these laws, rules, and regulations. This exclusive forum provision may limit a
shareholder&#8217;s ability to bring a claim in a judicial forum of its choosing for disputes with us, our directors, officers, or other
employees, which may discourage lawsuits against us, our directors, officers, and employees. Investors cannot waive compliance with the
federal securities laws and the rules and regulations thereunder, including the provisions of the Securities Act that provide that state
and federal courts in the United States both have jurisdiction over claims based on the Securities Act. A United States court may not
enforce the provision in our Restated Articles that provides for exclusive jurisdiction of the federal district courts in actions under
the Securities Act.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Another obstacle to the assertion of claims against
us or our directors or officers is the fact that most of them are not residents of the United&#160;States, and most of their and our assets
are located outside the United&#160;States. Service of process upon us or our non-U.S.&#160;resident directors and officers and enforcement
of judgments obtained in the United&#160;States against us or our non-U.S.&#160;directors and executive officers may therefore be difficult
to effect within the United&#160;States. It may be difficult to assert claims under U.S.&#160;securities laws in original actions instituted
in Israel or obtain a judgment based on the civil liability provisions of U.S.&#160;federal securities laws. Israeli courts may refuse
to hear a claim based on a violation of U.S.&#160;securities laws against us or our non-U.S.&#160;officers and directors because Israel
may not be the most appropriate forum to bring such a claim. In addition, even if an Israeli court agrees to hear a claim, it may determine
that Israeli law and not U.S.&#160;law are applicable to the claim. If U.S.&#160;law is found to be applicable, the content of applicable
U.S.&#160;law must be proven as a fact, which can be a time-consuming and costly process. Certain matters of procedure will also
be governed by Israeli law. There is little binding case law in Israel addressing these matters.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>


</div><!-- Field: Page; Sequence: 32 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->29<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Additionally, the acceptance of foreign judgment
in Israel is mainly regulated in the Foreign Judgment Enforcement Law, 5718-1958, pursuant to which Israeli courts might not enforce judgments
obtained in the United&#160;States against us or our non-U.S.&#160;directors and executive officers, which may make it difficult to collect
on judgments rendered against us or our non-U.S.&#160;officers and directors. An Israeli court will not enforce a non-Israeli judgment
if it was given in a state whose laws do not provide for the enforcement of judgments of Israeli courts (subject to exceptional cases),
if our enforcement is likely to prejudice the sovereignty or security of the State of Israel, if it was obtained by fraud or in the absence
of due process, if it is at variance with another valid judgment that was given in the same matter between the same parties, or if a suit
in the same matter between the same parties was pending before a court or tribunal in Israel at the time the foreign action was brought.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>The rights and responsibilities of our shareholders
will be governed by Israeli law, which may differ in some respects from the rights and responsibilities of shareholders of U.S.&#160;corporations.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Because we are incorporated under Israeli law,
the rights and responsibilities of our shareholders are governed by our Restated Articles and the Israeli Companies Law, with minor exceptions
pertaining to U.S. securities laws. These rights and responsibilities differ in some respects from the rights and responsibilities of
shareholders in typical U.S.&#160;corporations. In particular, pursuant to the Israeli Companies Law, each shareholder of an Israeli company
has to act in good faith in exercising such shareholder&#8217;s rights and fulfilling such shareholder&#8217;s obligations toward the
company and other shareholders and to refrain from abusing such shareholder&#8217;s power in the company, including, among other things,
in voting at the general meeting of shareholders and class meetings on amendments to a company&#8217;s articles of association, increases
in a company&#8217;s authorized share capital, mergers, and transactions requiring shareholders&#8217; approval under the Israeli Companies
Law. In addition, a controlling shareholder of an Israeli company or a shareholder who knows that it possesses the power to determine
the outcome of a shareholder vote, who has the power to appoint or prevent the appointment of a director or officer in the company, or
who has other powers toward the company, has a duty to act in fairness towards the company. Moreover, a shareholder also has a general
duty to refrain from discriminating against other shareholders. These provisions may be interpreted to impose additional obligations and
liabilities on our shareholders that are not typically imposed on shareholders of U.S.&#160;corporations.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Provisions of Israeli law and our Restated
Articles may delay, prevent, or make undesirable an acquisition of all or a significant portion of our shares or assets.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Certain provisions of Israeli law and our Restated
Articles could have the effect of delaying or preventing a change in control, may make it more difficult for a third party to acquire
us or our shareholders to elect different individuals to our board of directors, even if doing so would be beneficial to our shareholders,
and may limit the price that investors may be willing to pay in the future for our ordinary shares. Among other things:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 24px; font-size: 10pt"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="font-size: 10pt; text-align: justify"><span style="font-size: 10pt">Israeli Companies Law regulates acquisitions and requires that a tender offer be effected when certain thresholds of percentage ownership of voting power in a company are exceeded (subject to certain conditions);</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 24px; font-size: 10pt"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="font-size: 10pt; text-align: justify"><span style="font-size: 10pt">The Israeli Companies Law requires special approvals for certain transactions involving directors, officers, or significant shareholders and regulates other matters that may be relevant to these types of transactions;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 24px; font-size: 10pt"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="font-size: 10pt; text-align: justify"><span style="font-size: 10pt">The Israeli Companies Law does not provide for shareholder action by written consent for public companies, thereby requiring all shareholder actions to be taken at a general meeting of shareholders;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 24px; font-size: 10pt"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="font-size: 10pt; text-align: justify"><span style="font-size: 10pt">Our Restated Articles divide our directors into three classes, each of which is elected for a three-year term once every three&#160;years;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 24px; font-size: 10pt"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="font-size: 10pt; text-align: justify"><span style="font-size: 10pt">Our Restated Articles provide that certain articles
can be amended or changed only by the majority of at least sixty percent (60%) of the total voting power of the shareholders. </span></td></tr>
  </table><div>

</div><p style="margin-top: 0; margin-bottom: 0">&#160;</p><div>

</div><!-- Field: Page; Sequence: 33 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->30<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 24px; text-align: left"><span style="font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-size: 10pt">Our Restated Articles do not
permit a director to be removed except by a vote of a majority of the voting power of the shareholders represented at a general meeting
in person or by proxy and voting thereon, as one class, and disregarding abstentions from the count of the voting power of the shareholders
present and voting; and</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 24px; font-size: 10pt"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="font-size: 10pt; text-align: justify"><span style="font-size: 10pt">Our Restated Articles provide that director vacancies may be filled by our board of directors.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Further, Israeli tax considerations may make potential
transactions undesirable to us or to some of our shareholders, especially whose country of residence does not have a tax treaty with Israel
granting tax relief to such shareholders from Israeli tax. For example, Israeli tax law does not recognize tax-free share exchanges to
the same extent as U.S.&#160;tax law. With respect to mergers, Israeli tax law allows for tax deferral in certain circumstances but makes
the deferral contingent on the fulfillment of numerous conditions, including a restrictive period of two&#160;years from the date of the
transaction during which certain sales and dispositions of shares of the participating companies are restricted. Moreover, with respect
to certain share swap transactions, the tax deferral is limited in time, and when such time expires, the tax becomes payable even if the
shares have not been disposed of. See the section titled &#8220;<i>Material Israeli Tax Considerations&#160;&#8212;&#160;Taxation of Our
Shareholders</i>.&#8221;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our board of directors has sole discretion as
to whether to pay dividends. If our board of directors decides to pay dividends, the form, frequency, and amount will depend upon our
future, operations and earnings, capital requirements and surplus, general financial condition, contractual restrictions, and other factors
that our directors may deem relevant. The Israeli Companies Law imposes restrictions on our ability to declare and pay dividends. See
the section titled &#8220;<i>Item 10.B Additional Information&#8212;Dividend and Liquidation Rights&#8221;</i> for additional information.
Payment of dividends may also be subject to Israeli withholding taxes. See the section titled &#8220;<i>Material Israeli Tax Considerations</i>&#8221;
for additional information.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>We are subject to the Israeli Privacy Protection
Law and its regulations</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We are subject to the Israeli Privacy Protection
Law,&#160;5741-1981, and the regulations promulgated thereunder and guidelines issued by the Israeli Privacy Protection Authority with
respect to the manner in which personal data is processed, maintained, transferred, disclosed, accessed, and secured. In this respect,
the privacy regulations governing information security may require us to adjust certain data protection and data security practices, information
security measures, certain organizational procedures, applicable positions, and other technical and organizational measures. Failure to
comply with the Israeli privacy laws may expose us to administrative fines, civil claims (including class&#160;actions), and, in certain
cases, criminal liability.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>As a foreign private issuer, under Nasdaq
rules, we are permitted to adopt certain home country practices in relation to corporate governance matters that differ significantly
from Nasdaq corporate governance listing standards, which, if we follow such practices, may afford our shareholders less protection than
they would enjoy if we complied with the Nasdaq corporate governance standards.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As a foreign private issuer, we are generally
subject to the Nasdaq corporate governance listing standards. However, Nasdaq rules permit a foreign private issuer like us to follow
the corporate governance practices of our home country, which is Israel, in lieu of Nasdaq corporate governance requirements relating
to independent directors and the formation and composition of board committees, with respect to the disclosure of third-party director
and nominee compensation and the requirement to distribute annual and interim reports. These corporate governance practices in Israel
may differ significantly from Nasdaq corporate governance listing standards. Currently, we do not plan to rely on the home country practice
exemption with respect to our corporate governance, other than the quorum requirements. Our Restated Articles provide that two shareholders
holding 25% of the voting shares constitute a quorum, as contrasted with the Nasdaq requirement of a minimum of one-third of a company&#8217;s
outstanding voting securities. If we choose to take advantage of other home country practices in the future, our shareholders may be afforded
less protection than they otherwise would enjoy under Nasdaq corporate governance listing standards applicable to U.S.&#160;domestic issuers.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>


</div><!-- Field: Page; Sequence: 34 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->31<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i><b><i>Risks Related to our ordinary shares.</i></b></i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>We may issue additional ordinary shares
or other securities without shareholder approval, which would dilute existing ownership interests and may depress the market price of
our ordinary shares.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We may issue additional ordinary shares or other
securities (including convertible securities) in the future in connection with, among other things, our equity incentive plan without
shareholder approval, although we require shareholder approval for the creation of a class or series of preferred shares. The creation
of a class or series of preferred shares required shareholder approval. Our issuance of additional ordinary shares would have the following
effects:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 24px; font-size: 10pt"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="font-size: 10pt; text-align: justify"><span style="font-size: 10pt">Our existing shareholders&#8217; proportionate ownership interest may decrease;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 24px; font-size: 10pt"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="font-size: 10pt; text-align: justify"><span style="font-size: 10pt">The amount of cash available per share, including for the payment of dividends in the future, may decrease;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 24px; font-size: 10pt"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="font-size: 10pt; text-align: justify"><span style="font-size: 10pt">The relative voting strength of each previously outstanding ordinary share may be diminished; and</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 24px; font-size: 10pt"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="font-size: 10pt; text-align: justify"><span style="font-size: 10pt">The market price of our ordinary shares may decline.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Any such issuance may be dilutive to our shareholders
or may cause the stock price to decrease.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Because our executive officers and directors
and their affiliate beneficially own or control approximately 35% of our ordinary shares, they may be able to control any action requiring
shareholder approval.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our executive officers and directors and their
affiliates beneficially own or control the voting rights with respect to approximately 35% of our ordinary shares. They will have the
power to control any action for which shareholder approval is required or sought by us, particularly since our Restated Articles provide
that a quorum for action by shareholders at a meeting called by the board of directors is two shareholders holding at least 25%.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Because we have a classified board of directors,
it may be more difficult for a third party to obtain control of us.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our Restated Articles provide for a classified
board of directors, with each class of directors being elected for a term of three&#160;years. As a result, the shareholders will vote
for only one-third of the board each year. A classified board of directors may make it more difficult for a third party to gain control
of us, which may affect the opportunity of our shareholders to receive any potential benefit that could be available from a third party
seeking to obtain control over us.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>The private warrants that we issued in exchange
for private warrants are accounted for as liabilities, and the changes in value of these warrants could have a material effect on our
financial results.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The warrants that we issued in the merger (the
&#8220;Merger&#8221;) pursuant to which our wholly-owned subsidiary, Autobot MergerSub, Inc. was merged with an into Industrial Tech Acquisitions
Inc. (&#8220;ITAC&#8221;), a special purpose acquisition corporation, generally known as a SPAC, pursuant to which ITAC became our wholly-owned
subsidiary, and we issued ordinary shares and warrants to the holders of ITAC&#8217; common stock and warrants, in exchange for ITAC&#8217;s
private warrants are treated as liabilities. As a result of the Merger, the 3,112,080 private warrants held by the members of the ITAC
former sponsor are treated as liabilities. E. Scott Crist, one of our directors, holds 2,303,031 of these warrants. The Accounting Standards
Codification 815, Derivatives and Hedging (&#8220;ASC&#160;815&#8221;) provides for the remeasurement of the fair value of such derivatives
at each balance sheet date, with a resulting non-cash gain or loss related to the change in the fair value being recognized in earnings
in the statements of operations. As a result of the recurring fair value measurement, as long as the warrants are outstanding, our financial
statements and results of operations may fluctuate quarterly based on factors that are outside of our control. Due to the recurring fair
value measurement, we will recognize non-cash gains or losses on the private warrants each reporting period based on the change in the
derivative liability, and the amount of such gains or losses could be material. Further, the gain or loss on the derivative liability,
which will not be related to our operations, could result in our reporting a loss in a period in which our operations are profitable and
net income in a period in which we have a significant loss from operations. Since the amount of the warrant liability reflects the market
price of our ordinary shares, to the extent that the market price of our ordinary shares increases from period to period, we are likely
to recognize a financial expense, and to the extent that the market price
of our ordinary shares declines from period to period, we would recognize financial income.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>


</div><!-- Field: Page; Sequence: 35 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->32<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Any projections, forecasts, or guidance
that we may issue may not be an indication of the actual results of the transaction or our future results.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">From time to time, we issue guidance as to our
estimated results. Any such guidance is prepared based on numerous variables and assumptions that are inherently uncertain and may be
beyond our control. Furthermore, they may exclude, among other things, certain material items such as transaction-related expenses, and
they may include a non-GAAP measure. Any such forecasts are subject to the risks, including those described in these risk factors, and
should not be relied upon as an indicator of future results.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Sales of our ordinary shares by our legacy shareholders and PIPE investors
may adversely affect the market price of our ordinary shares.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In addition to the ordinary shares we issued to
the former stockholders of ITAC in connection with the Merger with ITAC and ordinary shares which we sold pursuant to a registration statement,
our shareholders who were shareholders prior to our Merger with ITAC, who are our legacy shareholders, and our shareholders who purchased
ordinary shares in a PIPE offering contemporaneously with the closing of the Merger with ITAC, who own a significant percentage of our
ordinary shares, may sell their ordinary shares either pursuant to Rule 144 or pursuant to a registration statement, subject to certain
limitations with respect to shares held by our officers, directors, and other affiliates. In addition, we may raise funds through the
issuance of ordinary shares and convertible debt securities. The sale of such ordinary shares may adversely affect the market price of
our ordinary shares.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>The market price of our securities may be
volatile, subject to wide fluctuations.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Fluctuations in the price of our securities could
contribute to the loss of all or part of your investment. Because our ordinary shares are publicly traded, the trading price of our securities
could be volatile and subject to wide fluctuations in response to various factors, some of which are beyond our control. Any of the factors
listed below could have a material adverse effect on your investment in our securities, and our securities may trade at prices significantly
below the price you paid for them. In such circumstances, the trading price of our securities may not recover and may experience a further
decline.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Factors affecting the trading price of our securities
may include:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 24px; font-size: 10pt"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="font-size: 10pt; text-align: justify"><span style="font-size: 10pt">actual or anticipated fluctuations in our quarterly financial results or the quarterly financial results of companies perceived to be similar to them;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 24px; font-size: 10pt"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="font-size: 10pt; text-align: justify"><span style="font-size: 10pt">changes in the market&#8217;s expectations about our operating results;</span></td></tr>
  <tr style="vertical-align: top">
    <td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="font-size: 10pt; text-align: justify"><span style="font-size: 10pt">public sales by us of our stock in negotiated transactions to investors who may immediately sell the shares;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 24px; font-size: 10pt"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="font-size: 10pt; text-align: justify"><span style="font-size: 10pt">success of competitors;</span></td></tr>
  <tr style="vertical-align: top">
    <td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="font-size: 10pt; text-align: justify"><span style="font-size: 10pt">the market&#8217;s attitude toward Israel and Israeli technology companies;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 24px; font-size: 10pt"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="font-size: 10pt; text-align: justify"><span style="font-size: 10pt">our operating results failing to meet the expectations of securities analysts or investors in a particular period;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 24px; font-size: 10pt"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="font-size: 10pt; text-align: justify"><span style="font-size: 10pt">changes in financial estimates and recommendations by securities analysts concerning us or the market or potential market for driverless cars and other vehicles;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 24px; font-size: 10pt"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="font-size: 10pt; text-align: justify"><span style="font-size: 10pt">operating and share price performance of other companies that investors deem comparable to us;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 24px; font-size: 10pt"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="font-size: 10pt; text-align: justify"><span style="font-size: 10pt">the market&#8217;s perception of our ability to develop and market our products;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 24px; font-size: 10pt"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="font-size: 10pt; text-align: justify"><span style="font-size: 10pt">the market&#8217;s perception as to our ability to develop and maintain any perceived technological advantage it may have;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 24px; font-size: 10pt"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="font-size: 10pt; text-align: justify"><span style="font-size: 10pt">actions by social media users to seek to increase activity in our securities;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>



</div><!-- Field: Page; Sequence: 36 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->33<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 24px; font-size: 10pt"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="font-size: 10pt; text-align: justify"><span style="font-size: 10pt">Changes or anticipated changes in laws and regulations affecting our business;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 24px; font-size: 10pt"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="font-size: 10pt; text-align: justify"><span style="font-size: 10pt">our ability to meet compliance requirements, including compliance with the Nasdaq continued listing requirements;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 24px; font-size: 10pt"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="font-size: 10pt; text-align: justify"><span style="font-size: 10pt">commencement of, or involvement in, litigation involving us or the automotive industry in general;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 24px; font-size: 10pt"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="font-size: 10pt; text-align: justify"><span style="font-size: 10pt">changes in our capital structure, such as future issuances of securities or the incurrence of additional debt;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 24px; font-size: 10pt"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="font-size: 10pt; text-align: justify"><span style="font-size: 10pt">the volume of our ordinary shares available for public sale;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 24px; font-size: 10pt"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="font-size: 10pt; text-align: justify"><span style="font-size: 10pt">changes in trading patterns resulting from social media action not related to the results of our business;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 24px; font-size: 10pt"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="font-size: 10pt; text-align: justify"><span style="font-size: 10pt">any major change in our board or management;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 24px; font-size: 10pt"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="font-size: 10pt; text-align: justify"><span style="font-size: 10pt">sales of substantial amounts of our ordinary shares by our directors, executive officers, or significant shareholders, or the perception that such sales could occur;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 24px; font-size: 10pt"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="font-size: 10pt; text-align: justify"><span style="font-size: 10pt">general economic and political conditions such as recessions, interest rates, international currency fluctuations, and acts of war or terrorism; and</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 24px; font-size: 10pt"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="font-size: 10pt; text-align: justify"><span style="font-size: 10pt">all of the risks described in these Risk Factors.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Broad market and industry factors may materially
harm the market price of our securities, irrespective of our operating performance. Global stock markets in general and Nasdaq in particular
have experienced price and volume fluctuations that have often been unrelated or disproportionate to the operating performance of the
particular companies affected. The trading prices and valuations of these stocks and our securities are not predictable. A loss of investor
confidence in the market for retail stocks or the stocks of other companies that investors perceive to be similar to us could depress
our share price regardless of our business, prospects, financial conditions, or results of operations. A decline in the market price of
our securities could also adversely affect our ability to issue additional securities and our ability to obtain additional financing in
the future.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Our Articles and Israeli law could prevent
a takeover that shareholders could consider favorable and could also reduce the market price of our ordinary shares.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Certain provisions of Israeli law and our Restated
Articles could have the effect of delaying or preventing a change in control and may make it more difficult for a third party to acquire
us or for our shareholders to elect different individuals to our board of directors, even if doing so would be beneficial to our shareholders,
and may limit the price that investors may be willing to pay in the future for our ordinary shares. For example, Israeli corporate law
regulates mergers, requires that a tender offer be effected when certain thresholds of percentage ownership of voting power in a company
are exceeded (subject to certain conditions), and establishes a high ownership threshold to squeeze out minority shareholders in a full
tender offer. Further, Israeli tax considerations may make potential transactions undesirable to us or to some of our shareholders, especially
whose country of residence does not have a tax treaty with Israel granting tax relief to such shareholders from Israeli tax. See the section
titled &#8220;<i>Material Israeli Tax Considerations&#160;&#8212;&#160;Taxation of Our Shareholders</i>.&#8221;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>We do not intend to pay dividends in the
foreseeable future. Accordingly, you may not receive any return on investment unless you sell your ordinary shares for a price greater
than the price you paid for your ordinary shares or, if you purchased ITAC common stock prior to the Merger with ITAC, the price you paid
for your ITAC common stock.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We currently intend to retain all available funds
and any future earnings for use in the operation of our business and do not anticipate paying any dividends on our ordinary shares in
the foreseeable future. Consequently, you may be unable to realize a gain on your investment only if you are able to sell such shares
at a price that is greater than your purchase price, which may never occur.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>


</div><!-- Field: Page; Sequence: 37 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->34<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our board of directors has broad discretion about
whether to pay dividends. If our board of directors decides to pay dividends, the form, frequency, and amount will depend upon our future,
operations and earnings, capital requirements and surplus, general financial condition, contractual restrictions, and other factors that
our directors may deem relevant. The Companies Law imposes restrictions on our ability to declare and pay dividends.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>If securities or industry analysts do not
publish or cease publishing research or reports about us, our business, or our market, or if they change their recommendations regarding
our ordinary shares adversely, then the price and trading volume of our ordinary shares could decline.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The trading market for our ordinary shares is
influenced by the research and reports that industry or financial analysts publish about us or our business. We do not control these analysts
or the content and opinions included in their reports. As a young public company, we may be slow to attract research coverage, and the
analysts who publish information about our ordinary shares will have had relatively little experience with us, which could affect their
ability to accurately forecast our results and make it more likely that we fail to meet their estimates. In the event we obtain industry
or financial analyst coverage, if any of the analysts who cover us issue an inaccurate or unfavorable opinion regarding it, our share
price will likely decline. In addition, the share prices of many companies in the technology industry have declined significantly after
those companies failed to meet, or significantly exceed, the financial guidance publicly announced by the companies or the expectations
of analysts. If our financial results fail to meet, or significantly exceed, our announced guidance or the expectations of analysts or
public investors, analysts could downgrade our ordinary shares or publish unfavorable research about it. If one or more of these analysts
cease coverage of us or fail to publish reports on it regularly, our visibility in the financial markets could decrease, which in turn
could cause our share price or trading volume to decline.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>The IRS may not agree that we should be
treated as a non-U.S.&#160;corporation for U.S.&#160;federal income tax purposes.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Although we are incorporated and tax residents
in Israel, the IRS may assert that we should be treated as a U.S.&#160;corporation for U.S.&#160;federal income tax purposes pursuant
to Section&#160;7874 of the Code. For U.S.&#160;federal income tax purposes, a corporation is generally considered a U.S.&#160;&#8220;domestic&#8221;
corporation if it is created or organized in or under the laws of the U.S., any state thereof, or the District of Columbia. Because we
are not so created or organized (but are instead incorporated only in Israel), we would generally be classified as a foreign corporation
(that is, a corporation other than a U.S.&#160;&#8220;domestic&#8221; corporation) under these rules. Section&#160;7874 of the Code provides
an exception under which a corporation created or organized under foreign law may, in certain circumstances, be treated as a U.S.&#160;corporation
for U.S.&#160;federal income tax purposes.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As more fully described in Item 10.E in the section titled &#8220;<i>Certain
Material U.S.&#160;Federal Income Tax Considerations&#160;&#8212;&#160;U.S.&#160;Federal Income Tax Treatment&#8212;&#160;Tax Residence
of Arbe for U.S.&#160;Federal Income Tax Purposes</i>,&#8221; based on the terms of the Merger, the rules for determining share ownership
under Code Section&#160;7874, and the Treasury regulations promulgated under Code Section&#160;7874 (the &#8220;Section&#160;7874 Regulations&#8221;),
and certain factual assumptions, we are not currently expected to be treated as a U.S.&#160;corporation for U.S.&#160;federal income tax
purposes under Code Section&#160;7874. However, the application of Section&#160;7874 of the Code is complex, is subject to detailed regulations
(the application of which is uncertain in various respects and would be impacted by changes in such U.S.&#160;tax laws and regulations
with possible retroactive effect) and is subject to certain factual uncertainties. Accordingly, there can be no assurance that the IRS
will not challenge our status as a foreign corporation under Code Section&#160;7874 or that such a challenge would not be sustained by
a court.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If the IRS were to successfully challenge under
Code Section&#160;7874 our status as a foreign corporation for U.S.&#160;federal income tax purposes, we and certain of our shareholders
could be subject to significant adverse tax consequences, including a higher effective corporate income tax rate on us and future withholding
taxes on certain of our shareholders, depending on the application of any income tax treaty that might apply to reduce such withholding
taxes. In particular, holders of our ordinary shares and/or warrants would be treated as holders of stock and warrants of a U.S.&#160;corporation.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>


</div><!-- Field: Page; Sequence: 38 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->35<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">See Item 10.E, &#8220;<i>Certain Material U.S.&#160;Federal
Income Tax Considerations&#160;&#8212;&#160;U.S.&#160;Federal Income Tax Treatment of Arbe&#160;&#8212;&#160;Tax Residence of Arbe for
U.S.&#160;Federal Income Tax Purposes,</i>&#8221; for a more detailed discussion of the application of Code Section&#160;7874 to the Merger.
Investors should consult their own advisors regarding the application of Code Section&#160;7874 to the Merger.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>U.S.&#160;Holders of our ordinary shares
and/or warrants may suffer adverse tax consequences if we are treated as a passive foreign investment company.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">A non-U.S.&#160;corporation generally will be
treated as a &#8220;passive foreign investment company,&#8221; or a PFIC, for U.S.&#160;federal income tax purposes, in any taxable year
if either (1)&#160;at least 75% of its gross income for such year is passive income (such as interest, dividends, rents, and royalties
(other than rents or royalties derived from the active conduct of a trade or business) and gains from the disposition of assets giving
rise to passive income) or (2)&#160;at least 50% of the value of its assets (based on an average of the quarterly values of the assets)
during such year is attributable to assets that produce or are held for the production of passive income. Although based on the current
and anticipated composition of the income, assets, and operations of us and our subsidiaries, we do not believe we will be treated as
a PFIC for U.S.&#160;federal income tax purposes for its current taxable year and do not expect to become one for U.S.&#160;federal income
tax purposes in the near future. This is a factual determination that depends on, among other things, the composition of our income and
assets and the market value of its shares and assets, including the composition of income and assets and the market value of shares and
assets of our subsidiaries, from time to time. Accordingly, a complete determination can only be made annually after the close of each
taxable year. Thus, no assurance can be given as to whether we will be a PFIC in 2023 or for any future taxable year. In addition, our
U.S.&#160;counsel does not express any opinion with respect to our PFIC status for 2023 or future taxable&#160;years.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If we are a PFIC for any taxable year, a U.S.&#160;Holder
of our ordinary shares and/or warrants may be subject to adverse tax consequences and may incur certain information reporting obligations.
Under the PFIC rules, unless such U.S.&#160;Holder makes an election available under the Code (which election could itself have adverse
consequences for such U.S.&#160;Holder), such U.S.&#160;Holder may be subject to U.S.&#160;federal income tax at the then prevailing maximum
rates on ordinary income and possibly an &#8220;interest&#8221; charge, in respect of &#8220;excess distributions&#8221; and upon any
gain from the disposition of our ordinary shares and/or warrants, as if the excess distribution or gain had been recognized ratably over
such U.S.&#160;Holder&#8217;s holding period of our ordinary shares and/or warrants. Certain elections, including a qualified electing
fund election (a QEF election or a mark-to-market election, that may be available to U.S.&#160;Holders of our ordinary shares to mitigate
some of the adverse tax consequences resulting from PFIC treatment, however, are not available with respect to our warrants. Additionally,
there can be no assurance that we will have timely knowledge of our status as a PFIC in the future or that we will timely provide information
that would be required in order for a U.S.&#160;Holder to make a QEF election. For a further discussion, see Item 10.E, &#8220;<i>Certain
Material U.S.&#160;Federal Income Tax Considerations&#160;&#8212;&#160;U.S.&#160;Holders&#160;&#8212;&#160;U.S.&#160;Federal Income Tax
Consequences of the Ownership and Disposition of ordinary shares and Warrants to U.S.&#160;Holders&#160;&#8212;&#160;Passive Foreign Investment
Company Rules</i>.&#8221; U.S.&#160;Holders of our ordinary shares and/or warrants are strongly encouraged to consult their own advisors
regarding the potential application of these rules to us and the ownership of our ordinary shares and/or warrants.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>We are subject to the Israeli Privacy Protection
Law and its regulations</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We are subject to the Israeli Privacy Protection
Law,&#160;5741-1981, and the regulations promulgated thereunder and guidelines issued by the Israeli Privacy Protection Authority with
respect to the manner in which personal data is processed, maintained, transferred, disclosed, accessed, and secured. In this respect,
the privacy regulations governing information security may require us to adjust certain data protection and data security practices, information
security measures, certain organizational procedures, applicable positions, and other technical and organizational measures. Failure to
comply with the Israeli privacy laws may expose us to administrative fines, civil claims (including class&#160;actions), and, in certain
cases, criminal liability.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>


</div><!-- Field: Page; Sequence: 39 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->36<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Risks Related to our Ordinary Shares</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>We may issue additional ordinary shares
or other securities without shareholder approval, which would dilute existing ownership interests and may depress the market price of
our ordinary shares.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We may issue additional ordinary shares or other
securities in the future in connection with, among other things, our equity incentive plan without shareholder approval, although we require
shareholder approval for the creation of a class or series of preferred shares and for the adoption of a new equity incentive plan. The
creation of a class or series of preferred shares required shareholder approval. Our issuance of additional ordinary shares would have
the following effects:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 24px; font-size: 10pt"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="font-size: 10pt; text-align: justify"><span style="font-size: 10pt">Our existing shareholders&#8217; proportionate ownership interest may decrease;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 24px; font-size: 10pt"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="font-size: 10pt; text-align: justify"><span style="font-size: 10pt">the amount of cash available per share, including for the payment of dividends in the future, may decrease;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 24px; font-size: 10pt"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="font-size: 10pt; text-align: justify"><span style="font-size: 10pt">the relative voting strength of each previously outstanding ordinary share may be diminished; and</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 24px; font-size: 10pt"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="font-size: 10pt; text-align: justify"><span style="font-size: 10pt">the market price of our ordinary shares may decline.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Any such issuance may be dilutive to our shareholders
or may cause the stock price to decrease.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;&#160;</i></b></p><div>

</div><div><a id="a_005"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>ITEM 4. INFORMATION ON THE COMPANY</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>A. History and Development of the Company</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Our Organization</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our corporate name is Arbe Robotics Ltd. We are
an Israeli corporation founded on November&#160;4, 2015. The mailing address for our principal executive office is 107 HaHashmonaim St.
Tel Aviv-Yafo, Israel. Our telephone number is +972-73-7969804, ext. 200.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As an Israeli corporation, we are organized pursuant
to and subject to the provisions of the Israeli Companies Law, 5759-1999, as amended and the regulations promulgated thereunder (collectively
the &#8220;Israeli Companies Law&#8221;).</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We have three wholly-owned subsidiaries, two in
the United States -- Arbe Robotics US Inc. and Autobot HoldCo. Inc., both Delaware corporations, and one, Shanghai Arbe Technologies Co.,
Ltd., organized under the laws of the People&#8217;s Republic of China.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Our Status as a Foreign Private Issuer under
the Exchange&#160;Act</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We are a &#8220;foreign private issuer&#8221;
under SEC rules. Consequently, for so long as we continue to meet such qualification, we will be subject to the reporting requirements
under the Exchange&#160;Act applicable to foreign private issuers. We are required to file our annual report for each year with the SEC
by April 30 of the following year. In addition, we will furnish reports on Form&#160;6-K&#160;to the SEC regarding certain information
that is distributed or required to be distributed by us to our shareholders.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Based on such foreign private issuer status, under
existing rules and regulations, we will not be required to file periodic reports and financial statements with the SEC as frequently or
as promptly as a U.S.&#160;company whose securities are registered under the Exchange&#160;Act. We will also not be required to comply
with Regulation&#160;FD, which addresses certain restrictions on the selective disclosure of material information. In addition, among
other matters, our officers, directors and principal shareholders are exempt from the reporting and &#8220;short-swing&#8221; profit recovery
provisions of Section&#160;16 of the Exchange&#160;Act and the rules under the Exchange&#160;Act with respect to their purchases and sales
of ordinary shares.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Despite our initial exemption due to our foreign
private issuer status, we nevertheless currently expect to issue interim quarterly financial information publicly and to furnish it to
the SEC on Form&#160;6-K.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>


</div><!-- Field: Page; Sequence: 40 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->37<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Our Status as an Emerging Growth Company</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We are an &#8220;emerging growth company,&#8221;
as defined in Section&#160;2(a)&#160;of the Securities Act, as modified by the JOBS Act. As such, we will be eligible to take advantage
of certain exemptions from various reporting requirements that are applicable to other public companies that are not &#8220;emerging growth
companies&#8221; including, but not limited to, not being required to comply with the auditor attestation requirements of Section&#160;404
of the Sarbanes-Oxley&#160;Act, reduced disclosure obligations regarding executive compensation in their periodic reports and proxy statements,
and exemptions from the requirements of holding a non-binding&#160;advisory vote on executive compensation and shareholder approval of
any golden parachute payments not previously approved. We are a non-accelerated filer, which is a company that has either a public float
of less the $75&#160;million or a public float from $75&#160;million to less than $700&#160;million and annual revenues of less than $100&#160;million.
As long as we remain either an emerging growth company or a non-accelerated filer, we will be exempt from the auditor attestation requirement.
If some investors find our securities less attractive as a result, there may be a less active trading market for our securities and the
prices of our securities may be more volatile.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Further, Section&#160;102(b)(1)&#160;of the JOBS
Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies
(that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered
under the Exchange&#160;Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that
a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging&#160;growth
companies but any such election to opt out is irrevocable. We have elected not to opt out of such extended transition period, which means
that when a standard is issued or revised and it has different application dates for public or private companies, we, as an emerging growth
company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison
of our financial statements with certain other public companies difficult or impossible because of the potential differences in accounting
standards used.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We will remain an emerging growth company until
the earlier of: (i)&#160;the last&#160;day of the fiscal year (a)&#160;following the fifth anniversary of the closing of our initial public
offering, (b)&#160;in which our total annual gross revenue of at least $1.235&#160;billion, or (c)&#160;in which we are deemed to be a
large accelerated filer, which means the market value of our ordinary shares that is held by non-affiliates&#160;exceeds $700&#160;million
as of the last business&#160;day of our most recently completed second fiscal quarter; and (ii)&#160;the date on which we have issued
more than $1.00&#160;billion in non-convertible&#160;debt securities during the prior three-year&#160;period. References to &#8220;emerging
growth company&#8221; in this proxy statement/annual report have the meaning associated with that term in the JOBS Act.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Functional and Reporting Currency</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">A substantial portion of our activity, including
transactions with customers, as well as equity transactions and cash investments, are incurred in U.S.&#160;dollars. Our management believes
that the U.S.&#160;dollar is the currency of the primary economic environment in which we operate. Thus, our functional and reporting
currency is the U.S.&#160;dollar.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Where to get Additional Information</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The SEC maintains an Internet site that contains
reports, proxy and information statements, and other information regarding issuers that file electronically with the SEC. We are subject
to the information requirements of the Exchange Act and will file annual and other reports, including this annual report, and other information
with the SEC. You can read our SEC filings, over the Internet at the SEC&#8217;s website at www.sec.gov. These documents, and other information
concerning us, is available on our website at https://arberobotics.com/. Information contained on, or that can be accessed through, our
website or any other website is expressly not incorporated by reference into and is not a part of this annual report.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>


</div><!-- Field: Page; Sequence: 41 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->38<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>B. Business Overview</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We are a provider of 4D imaging radar
solutions, and we are leading a radar revolution, enabling safe driver-assist systems today while paving the way for fully
autonomous driving in the future. We are a Tier 2 supplier, empowering Tier-1 companies, which are companies that supply parts or
systems directly to OEMs (car manufacturers), autonomous ground vehicles, commercial and industrial vehicles, and a wide array of
safety applications with next-generation sensing based on our proprietary chipset and perception algorithms. While the role of
automotive radars in the traditional perception paradigm was limited to &#8220;legacy ADAS features&#8221;, such as Adaptive Cruise
Control (ACC) and Automatic Emergency Braking (AEB), the introduction of our imaging radar with its a high channel count delivers an
order of magnitude better native resolution than existing radar solutions profoundly changes this paradigm, making the radar a key
player in the overall driving solution including hands-free and eyes-off <span style="font-size: 10pt">features. We believe that our
imaging radar is essential for Level 2+ and higher levels of autonomy.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We provide long-range high resolution in 4D -
the distance, the angular measurement of objects, both horizontally and vertically, and their relative speed. This is designed to enable
the vehicle to determine the exact location and shape of objects. For example, it could determine whether a stationary object in front
of a vehicle is a manhole cover you can drive over or a guardrail you need to avoid. Our 4D imaging radar is the world&#8217;s first radar
to separate, track, and identify objects in any weather or lighting condition in 2K pixels, ultra-high resolution in both azimuth and
elevation, delivering an image that we believe is 100 times more detailed than any commercial radar on the market. We achieve this capability
with our proprietary radio frequency chipset with the highest channel count in the industry, and a groundbreaking radar processor chip,
the first dedicated processor designed specifically for the performance and power saving requirements of the automotive industry.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Through our state-of-the-art analysis of the vehicle&#8217;s surroundings,
we believe that our cutting-edge radar chipset incorporates the first radar technology detailed enough to enhance the OEM&#8217;s perception
algorithms, elevating L2+ and higher applications from nice-to-have comfort solutions to must-have safety features. The data captured
by our perception radar, based on our chipset technology, has the fidelity, richness and resolution to leverage artificial intelligence
to identify, classify and track objects in 360&#176; to create a full free space map around the vehicle, as well as an analysis of the
evolving hazards sensed by the radars.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Our Radar Systems</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We are a semiconductor company developing advanced
radar solutions, which are mainly intended to be used in Advanced Driver Assistance Systems (&#8220;ADAS&#8221;) and autonomous vehicles&#8217;
(&#8220;AV&#8221;) sensor suites as well as a wide array of safety applications with advanced sensing and paradigm changing perception.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The target market for our chipsets are automotive
module manufacturers called Tier 1 automotive suppliers, and automotive manufacturers (OEMs) worldwide. Additionally, alongside these
potential customers, there is a large target market for robotized vehicles and transportation applications such as last-mile delivery
robots, robot taxis and shuttles, heavy machinery, trucks, construction, busses and trains.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our chipset solution includes three types of chips:
transmitter (Tx), receiver (Rx) and processor, which together are referred to as our &#8220;radar chipset&#8221; or the &#8220;chipset.&#8221;
We believe our radar chipset solution is a first of its kind, capable of high-resolution sensing &#8220;in four dimensions&#8221; generating
tens of thousands of detections per frame with a point cloud density that is unparalleled by any other radar solution on the market. The
chipset distinguishes itself through its improved ability to support multi-channel processing&#160;-&#160;up to 2,304 virtual channels,
through a combination of up to two transmitters (24 channels each) and up to four receivers (12 channels each). By comparison, other current-generation
radar systems presently utilize 12 virtual channels, while the newest, best in class systems available in the market by our competitors
are utilizing 256 virtual channels at best.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our solution addresses the core issues that have
caused the recent autonomous vehicle and autopilot accidents such as detection of stationary objects, identifying vulnerable road users,
operation at poor lighting conditions and eliminating false alarms at low latency with no range, Doppler, and angular ambiguities. Unlike
the vast majority of the radars on the market, our radar technology is designed to address all driving scenarios and use cases, which
we believe makes it a mandatory technology for any vehicles program targeting advanced ADAS features (L2), supervised autonomous driving
features (L2+) and up to unsupervised autonomous driving (L3 &amp; L4).</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We are a Tier-2 semiconductor company, developing
advanced radar technology and solutions &#8211; multi-channel Radio Frequency Integrated Circuit (RF IC) for transmission and reception
and a dedicated radar processing IC that includes specialized Radar Processing Unit (&#8216;RPU&#8217;) and additional general-purpose
processing/control cores. We do not have our own manufacturing facilities. We rely on GlobalFoundries for manufacturing our products.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>


</div><!-- Field: Page; Sequence: 42 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->39<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Based on our advanced technology, our radar chipset solution is capable
of sensing the vehicle environment, at long ranges and with a wide field of view, at a rate of up to 30 frames per second, allowing it
to generate a reliable ultra-high-definition image, under all weather and lighting conditions, with great precision, while minimizing
the likelihood of false alarms. Information about the environment is &#8216;sensed&#8217; by the Tx and Rx elements of the chipset, at
the 77 &#8211; 81 GHz RF band. The data is then processed at the Radar Processor, by an advanced proprietary algorithms into a 4D image&#160;&#8212;&#160;range,
radial (on line-of-sight) velocity, azimuth and elevation&#160;&#8212;&#160;at ultra-high resolution with high fidelity and low latency,
which is an input to the perception algorithm, sensor fusion and to the vehicle control, to allow emergency braking in any conditions,
to enable safe adaptive cruise control, lane-change assist, and up to advanced automated and autonomous driving features, scaling up with
the industry&#8217;s evolution toward hands-free, eyes-off and full autonomous driving.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We designed two radar development platforms:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 24px; font-size: 10pt"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="font-size: 10pt; text-align: justify"><span style="font-size: 10pt">The Phoenix Perception Radar, with its 2K ultra-high resolution, enables what we believe is an unmatched level of safety, and enriches perception algorithms for advanced capabilities including Free Space Mapping, object tracking, and Simultaneous Localization and Mapping (SLAM) at a cost that we believe is comparable in cost, size, power and heat with currently available radars that provide less than 200 channels. No matter the speed, elevation, range, or surrounding weather and lighting conditions, Phoenix differentiates true threats from false alarms to ensure a safe road ahead for drivers, pedestrians, and other vulnerable road users. We believe it is the industry&#8217;s first perception radar.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 18pt; text-align: justify">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 24px; font-size: 10pt">&#160;</td>
    <td style="width: 24px; font-size: 10pt"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="font-size: 10pt; text-align: justify"><span style="font-size: 10pt">Designed primarily for corner and back installation, Lynx &#8211; (4D imaging Radar) complements Phoenix Perception Radar to deliver a 360&#176; view around the vehicle. Lynx offers a full set of benefits at an affordable price &#8211; true long-range performance, high resolution, small form factor, and a very wide field of view. It effortlessly outperforms the current industry 3X4 corner radars and even the leading 12*16 long-range radars on the market, providing perception and superior imaging that are critical for true safety and autonomous driving.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 18pt; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As of the date of this annual report, we are working
with four Tier-1s who are building production radars based on our chipset, including Magna, Weifu, Hirain, and Sensrad, which are currently
developing a total of seven different radar products. Radars that are based on our chipset were submitted to nine RFIs/RFQs that are currently
active with OEM, robotaxis, delivery robots, and autonomous trucks projects. We have been selected for five &#8220;imaging radar - based
perception&#8221; projects, of which two are top five global OEMs which are progressing towards a selection in 2024. Our solution was
also selected to provide perception radars for autonomous trucks and AGVs across ports in China. Our solution is constantly evaluated
in field trials, including&#160;day and night performance, in variable weather and lighting conditions. The trials, thus far, have revealed
what we believe is superior and promising performance: Our radar chipset solution senses its environment according to its spec, with the
highest native resolution available in the market, and therefore enables an accurate and separate identification of all objects in the
environment at their actual position distinguishing between vehicles, vulnerable road users (pedestrians, animals, cyclists, motorcyclists)
and objects and obstacles along the way. Based on the sensing of the environment created by the chipset at any given moment, the radar
system can alert the vehicle central computer unit, allowing the driver assistance system to take control of the car, and activate safety
applications such as emergency braking and lane control assist, or to activate autonomous control functions to avoid the danger.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We are currently focusing, and primarily devoting
our resources, to the use of our radar chip solution in the automotive industry. However, the technology is also integrated into other
fields, and we are collaborating with other companies to generate business in non-automotive markets, such as autonomous ground vehicles
and delivery robots, heavy machinery and intelligent traffic systems.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our radar chipset solution is designed to integrate
into the radar systems of next-generation ADAS in autonomous vehicles of all levels of autonomous driving, thanks in part to its ability
to accurately scan an increased range of detection (of more than 350 meters) in a wide field of view, while optimizing costs and power-consumption,
without its functionality being impaired by interference from other radar systems in the environment. The system maintains efficacy under
conditions of low signal-to-noise ratio (&#8220;SNR&#8221;) and in multi-object scenarios (conditions under which alternative technologies struggle to provide
effective solutions)&#160;&#8212; both in respect of false positives (error category&#160;I) and false negatives (error category&#160;II).</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We believe that our chipset solves some of the
challenges faced by current-generation radar systems, by providing a system that enables:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 24px; font-size: 10pt"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="font-size: 10pt; text-align: justify"><span style="font-size: 10pt">Increased resolution and improved capability to differentiate between adjacent objects;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 24px; font-size: 10pt"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="font-size: 10pt; text-align: justify"><span style="font-size: 10pt">Enhanced detection of stationary objects;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 24px; font-size: 10pt"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="font-size: 10pt; text-align: justify"><span style="font-size: 10pt">Generation of a high-resolution radar image of all the objects in the scene;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 24px; font-size: 10pt"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="font-size: 10pt; text-align: justify"><span style="font-size: 10pt">Compliance with the European NCAP and the NHTSA for installation in Level 2 and higher autonomous vehicles;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 24px; font-size: 10pt"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="font-size: 10pt; text-align: justify"><span style="font-size: 10pt">Reduction of false alarms;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 24px; font-size: 10pt"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="font-size: 10pt; text-align: justify"><span style="font-size: 10pt">Ability to process the huge volumes of data generated when imaging the environment in four dimensions, at high update rate in real-time;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 24px; font-size: 10pt"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="font-size: 10pt; text-align: justify"><span style="font-size: 10pt">Reducing mutual interference between radars that operate in the environment simultaneously;</span></td></tr>
  <tr style="vertical-align: top">
    <td style="font-size: 10pt; text-align: justify">&#160;</td>
    <td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="font-size: 10pt; text-align: justify">&#160;</td>
    <td style="font-size: 10pt"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="font-size: 10pt; text-align: justify"><span style="font-size: 10pt">Reduced energy consumption; and</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 24px; font-size: 10pt"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="font-size: 10pt; text-align: justify"><span style="font-size: 10pt">Maintain competitive retail radar costs.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>


</div><!-- Field: Page; Sequence: 43 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->40<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our technology is the first to create a high-fidelity,
high-resolution radar image, that facilitates tracking, and SLAM and real-time decision-making. Our radar chipset heralds a breakthrough
in radar technology that will enable Tier 1 manufacturers and OEMs to replace the current radars with an advanced solution that meets
the current safety requirements of Euro-NCAP and NHTSA for autonomous vehicles at all levels of autonomous driving.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Although our radar systems can identify images,
each auto maker has its own computer system that instructs the vehicle how to respond to the images identified by our radar. If the computer
system does not address the response to the image generated, the automobile may not operate as planned.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following chart<sup>1 </sup>shows the number
of radar sensors, cameras and LiDAR units in vehicles with different levels of autonomy. As the level of autonomy increases, the number
of radar sensors and cameras increases. LiDAR units are not expected to be included in any vehicle with an autonomy level less than 3.
The number of radar sensors is a function of the autonomy level of the vehicle.&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><img alt="" src="image_008.jpg"/></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Recognizing the different levels of innovation
and autonomy and the need to standardize the approaches across the spectrum of possibilities for the sake of safety, the Society of Automotive
Engineers (SAE) has developed and defined six levels of automation for autonomous vehicles: Level 0 through Level 5. These levels have
been adopted by the U.S.&#160;Department of Transportation. These levels are:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24pt; text-align: justify">Level 0 &#8212;&#160;No Automation: A
vehicle that is fully controlled by a driver.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24pt; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24pt; text-align: justify">Level 1 &#8212;&#160;Driver Assistance:
A vehicle controlled by the driver, featuring minimal autonomous control components, designed to assist the driver. For example: a button
that when pressed, keeps the vehicle at a constant speed, parking assistance or staying inside a lane.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24pt; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24pt; text-align: justify">Level 2 &#8212;&#160;Partial Automation:
A vehicle that includes integrated automation systems, where the driver is still required to control and monitor the environment at all
times. For example: A system capable of detecting lanes and driving independently (cruise control) but alerts the driver to emergencies
(driver involvement is required to operate the steering wheel and brakes). The industry refers to a level that was not originally recognized
by the SAE, Level 2+, which adds in surround perception and AI to improve the safety and convenience of human-driven vehicles. While the
driver is still responsible for the car, the platform can perform automated maneuvers for a more seamless driving experience&#160;&#8212;&#160;such
as making highway entrances and exits, lane changes and merges.</p><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24pt; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24pt; text-align: justify">Level 3 &#8212;&#160;Conditional Automation:
Requires the presence of a driver behind the wheel, but the driver is not required to monitor the environment. The driver must be prepared
to seize control of the vehicle at any given time upon receipt of an alert. For example: The driver can press the control button and be
relieved of the need to monitor the route (and can attend to other matters during this time), but the driver&#8217;s presence and alertness
are still essential. At this level, the vehicle can be used as an autonomous vehicle only when road and weather conditions allow it.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24pt; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24pt; text-align: justify">Level 4 &#8212;&#160;High Automation:
The vehicle is capable of performing all driving functions under certain conditions. The driver has the option of taking over control
of the vehicle.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24pt; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24pt; text-align: justify">Level 5 &#8212;&#160;Full Automation:
The vehicle is capable of performing all driving functions under all conditions.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Pictured below is our Production Intent System
(&#8220;B Sample&#8221; in automotive terminology), and below the picture is an infographic of the specifications.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p><div>

</div><!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 25%"><div style="font-size: 1pt; border-top: Black 1.5pt solid">&#160;</div></div><!-- Field: /Rule-Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"/><td style="width: 0.25in; text-align: left"><span style="font-size: 10pt"><sup>1</sup></span></td><td style="text-align: justify"><span style="font-size: 10pt">NXP Automotive Radar Teach In,
August 26, 2020</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><p style="margin: 0pt 0; font-size: 10pt"></p><div>

</div><!-- Field: Page; Sequence: 44 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->41<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="margin: 0pt 0; font-size: 10pt">&#160;</p><div>

</div><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt"><img alt="" src="image_002.jpg"/></p><div>

</div><p style="margin: 0pt 0; font-size: 10pt">&#160;</p><div>

</div><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt"><img alt="" src="image_003.jpg"/></p><div>

</div><p style="margin: 0pt 0; font-size: 10pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The dimensions of radar systems based on our radar
chipset, and the projected affordable price point are expected to facilitate its integration into mass production.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We estimate that we will be able to offer our
radar chipset solution in commercial quantities in 2024; however, such schedule is based on our completing the chipset development and
making our product suitable as a commercial product. We can give no assurance that we will be able to sell the radar chipset solution
in commercial quantities or that our manufacturer will have the facilities available to manufacture the chipsets in such quantities.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Market Outlook</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The automotive industry is increasingly harnessing
sophisticated technologies in its aim to develop and enhance safety and introduce autonomous driving vehicles. Today, the leading technologies
are based primarily on cameras, high resolution radar sensors, and in some cases Lidar sensors, combined with data processing based on
complex algorithms. The various technologies differ from each other in their features and performance in different conditions and scenarios.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Significant investment and rapid growth in this
industry are being driven by the need to increase road safety. Given the stakes involved in commercializing autonomous driving features,
the technologies and products needed for truly safe driver assist solutions require long development and validation cycles and must ensure
safety prior to commercial deployment.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In the last decade, the world&#8217;s leading
car manufacturers have begun to incorporate advanced automation systems in vehicles, aiming to assist the driver and even control certain
driving functions. The vision for the future is that within several&#160;years, the technology would enable production of autonomous vehicles
that support driverless vehicles, including development of unmanned shuttle services (robotaxis) that would complement traditional public
transport services. The vision of a fully autonomous vehicle (driverless) is seen as a potential solution for reducing the number of traffic
accidents (due to the elimination of the &#8220;human element&#8221; from the equation), and as an incentive to create innovative autonomous
vehicle-sharing services that will lead to the public foregoing the purchase of private vehicles, to reduce the problem of traffic congestion,
and to potentially significantly reduce fuel consumption and air pollution.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 45 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->42<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">According to a forecast by Evercore ISI<sup>2</sup>,
a decrease in sales of vehicles of Level 1 and Level 2 automation is expected. A growth trend is expected in the sales volumes of Level
2+, L2++, Level 3, Level 4 and Level 5 vehicles. Starting 2028 over 30% of new vehicles will offer hand free driving (L2++ and higher).</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><img alt="" src="image_004.jpg"/></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">* Source: Evercore ISI, Global Automotive Report,
May 2023.</p><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">

</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Driver assistance systems include advanced automation
functions (based on camera and radar) designed to reduce the risk of traffic accidents, alert the driver to obstacles on the road, and
even take control of the vehicle under certain conditions. The ADAS category includes the following systems, among others:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-size: 10pt">(a)</span></td><td style="text-align: justify"><span style="font-size: 10pt"><span style="text-decoration:underline">Distance maintenance system</span>&#160;&#8212;&#160;designed
to warn of a collision with a vehicle ahead or behind, by alerting the driver of imminent danger and flagging the need to take preventive
action. This type of system may be an effective tool to compensate for the driver&#8217;s lack of concentration or distraction while
driving.</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt"></p><div>

</div><!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 25%"><div style="font-size: 1pt; border-top: Black 1.5pt solid">&#160;</div></div><!-- Field: /Rule-Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt"></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 2%; padding-right: 0.5pt; padding-left: 0.5pt; font-size: 10pt"><span style="font-size: 10pt"><sup>2</sup></span></td>
    <td style="width: 98%; padding-right: 0.5pt; padding-left: 0.5pt; font-size: 10pt; text-align: justify"><span style="font-size: 10pt"><i>https://www.electronicproducts. com/automotive-radar-and-lidar-sensors-one-masterpiece-and-another-in-the-making/#</i></span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt"></p><div>

</div><!-- Field: Page; Sequence: 46 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->43<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-size: 10pt">(b)</span></td><td style="text-align: justify"><span style="font-size: 10pt">&#8239;<span style="text-decoration:underline">Lane departure control
system</span>&#160;&#8212;&#160;designed to alert the driver when veering off a lane without signaling.</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-size: 10pt">(c)</span></td><td style="text-align: justify"><span style="font-size: 10pt"><span style="text-decoration:underline">Autonomous braking system</span>&#160;&#8212;&#160;designed
to operate the brake system autonomously, or increase their power when identifying risk of harm to road users (pedestrians, cyclists,
vehicles, etc.).</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In recent&#160;years, automakers have been installing
ADAS such as those mentioned above as standard features in many vehicle models, and these systems have also been installed electively
by vehicle owners. In many cases, automakers choose to integrate ADAS based on several technologies simultaneously (radar and cameras),
and we believe that it is likely that this trend of integrating technologies into vehicles will continue in the coming&#160;years.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Alongside development and production of current-generation
ADAS, there has been accelerated development of advanced technology of next-generation systems, designed to support autonomous driving,
in preparation for manufacture of Level 2+ and higher autonomy. The currently deployed radar technology holds a central position in the
ADAS category. This type of technology is installed in adaptive cruise control (ACC) systems, blind spot detection (BSD) systems, forward
collision warning (FCW) systems, and intelligent park assist systems, among others.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">According to the IDTechEx Research<sup>3</sup>
forecast, total radar-system sales for Level 2 or higher autonomous vehicles is expected to grow from 55&#160;million units in 2019 to
223&#160;million units in 2030 and 400&#160;million units in 2040. More specifically, by 2025, sales of Level 1 and Level 2 vehicle radar
systems are expected to grow, whereas in the following&#160;years, Level 3, Level 4, and Level 5 vehicle radar systems are expected to
grow and gradually take over most of the market.</p><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">

</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Growth Strategies</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our growth strategies include the following:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-size: 10pt"><i>Extending engagements with
OEMs and Driving Stack providers:</i> While we keep focus on the well-established production path with our Tier 1 customers, we are extending
our focus to better fit the age-of-autonomy: Working directly with OEM&#8217;s feature owners, perception teams and driving stack providers
(NVIDIA and others) to enhance the mutual understanding for the need for an imaging radar and how it is to be used for advanced ADAS
and higher level of autonomy. We will extend the work through collaborative field tests, radar datasets, perception and fusion early
integrations with perception radars, feature benchmarking and development of innovative algorithms that maximizes the benefits of such
a radar to these partners, providing them with what we believe is an invaluable competitive edge.</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-size: 10pt"><i>Capitalize
                                            on The L2++/L3 becoming the new competition Frontier: </i>The ADAS/L2 features are becoming
                                            commoditized across OEMs and as such, becoming also extremely cost-sensitive. We will continue
                                            to extend our focus of the more advanced L2+ (supervised) and L3/L4 (unsupervised) features,
                                            which are becoming the leading, competitive features of all key OEMs. These features require
                                            advanced systems, and specifically, imaging radar, for automatically integrating vehicles
                                            in traffic, preventing traffic accidents and eventually bring hands-off and potentially eyes-off
                                            driving features to the masses. Such features are expected to dramatically increase the demand
                                            for products in our field of activity, to achieve the required level of performance and safety.</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-size: 10pt"><i>Capitalize on Regulatory
Changes. </i>We believe that our existing infrastructure positions us well to capitalize on regulatory changes pertaining to required
installation of traffic accident prevention systems in general, and radar systems in particular, which is expected to increase the demand
for the technology and products that we are developing.</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 24px; font-size: 10pt"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="font-size: 10pt; text-align: justify"><span style="font-size: 10pt"><i>Capitalize on Economic Incentives. </i>To the extent that insurance companies require that radars be installed on vehicles as a condition for issuing insurance policies is expected to increase the demand for our products. Other private parties may also impose requirements for radar systems, which would similarly heighten demand for our products.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt"></p><div>

</div><!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 25%"><div style="font-size: 1pt; border-top: Black 1.5pt solid">&#160;</div></div><!-- Field: /Rule-Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt"></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <td style="font-size: 10pt; width: 2%"><span style="font-size: 10pt"><sup>3</sup></span></td>
    <td style="font-size: 10pt; text-align: justify; width: 98%"><span style="font-size: 10pt">IDTechEx Research &#8211; May 2020</span></td></tr>
</table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt"></p><div>

</div><!-- Field: Page; Sequence: 47 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->44<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 24px; font-size: 10pt"><span style="font-size: 10pt"><i>&#9679;</i></span></td>
    <td style="font-size: 10pt; text-align: justify"><span style="font-size: 10pt"><i>Expand Product Applications. </i>Our activities are presently mainly focused on chipsets for vehicle radars systems. However, the technology developed by us (originally intended to facilitate drone monitoring and control) may also be used for other non-automotive target markets (to be understood in this context to mean all markets that are not mass-produced cars) which we are approaching, such as autonomous ground vehicles, robots; agricultural tools; automation for industry and factories; smart traffic systems; train junctions; heavy transportation and heavy machinery. In the future, we intend to consider developing new products based on its technology such as consumer electronics and Internet of Things (IoT); biotech and medical fields.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Sales and Marketing</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In light of the proven ability of technological
systems to reduce the risk of traffic accidents, authorities, organizations and governments around the world have established regulations
that require the installation of ADAS in certain vehicles and operation of autonomous driving features. For instance, in 2018, the NHTSA
required the installation of a rear-view system in private vehicles, and in 2015 the Israeli government approved incentives for vehicle
owners to install life-saving safety systems (including a lane departure warning, frontal distance monitoring and pedestrian identification).
According to a market study published in August&#160;2019<sup>4</sup>, the global ADAS market was estimated at $39&#160;billion in 2018
and is expected to grow to around $190&#160;billion by 2026, at an annual growth rate of around 21%. Another market study, published by
Markets and Markets<sup>5</sup>, estimates the global ADAS market in 2020 at $27&#160;billion, projecting it to grow to around $65.1 billion
by 2030, at a compound annual growth rate of approximately 12%. Despite discrepancies in the estimated scope of the market (due to varying
research methodologies), it appears that there is unanimity among the research bodies that the ADAS market is expected to grow in the
coming&#160;years, due in part to mandatory safety regulations, increased demand for Advanced Driver Assistance Systems, and continued
development of (partially or fully) autonomous vehicles.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The European New Car Assessment Program, otherwise
referred to as NCAP, rates vehicles by safety features. The rating system has been successful at influencing consumers to make vehicle
purchases based on how high the NCAP rating is, making safety a priority for consumers. The mission of NCAP is &#8220;Vision Zero&#8221;
to eventually have zero accidents or fatalities on the road, with this vision, automotive technology companies and automakers are looking
for technologies that will enable them to develop more safety features that can predict and prevent car accidents before they happen.
Vision Zero will require that all vehicles shift from passively protecting individuals to actively protecting them&#160;&#8212;&#160;both
in the vehicle as well as outside the car.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our marketing strategy is primarily targeted at
Tier 1 manufacturers, with the aim of fostering cooperation with the Tier 1 manufacturers to integrate our radar chipsets into the radar
systems that Tier 1 manufacturers will sell to OEMs.&#160;Our sales and marketing team continues to focus on expanding its relationships
with OEMs and Tier-1 suppliers and seeks to leverage its existing relationships to expand its market to other industries. We are considered
a Tier-2 Automotive supplier because we sell our product to Tier-1 companies that then integrate our product into the overall system supplied
to the OEMs.&#160;Our business model of being a Tier-2 supplier that subcontracts its manufacturing, together with its market leadership,
results in an advantageous cost structure that requires minimal sales and marketing expenses with respect to OEMs. We are taking marketing
steps intended to position us as a leading company in research and development of chip technology for next-generation imaging radar systems
in autonomous vehicles. Marketing is directed by the chief marketing officer who works from our headquarters in Israel, and by the chief
business officer who works in the United&#160;States, and the vice president of sales.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The marketing strategies employed include participation
in industry conferences, public relations publications, issuing newsletters and proactive inquiries to potential customers. We leverage
a variety of channels to reach prospects which include organic and paid social media activity, joint events, webinars and media and analyst
relations.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 25%"><div style="font-size: 1pt; border-top: Black 1.5pt solid">&#160;</div></div><!-- Field: /Rule-Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="font-size: 10pt; width: 2%"><span style="font-size: 10pt"><sup>4</sup></span></td>
    <td style="font-size: 10pt; text-align: justify; width: 98%"><span style="font-size: 10pt">&#8239;by Allied Market Research &#8211; https://www.alliedmarketresearch.com/ADAS-market</span></td></tr>
  <tr style="vertical-align: top">
    <td style="font-size: 10pt"><span style="font-size: 10pt"><sup>5</sup></span></td>
    <td style="font-size: 10pt; text-align: justify"><span style="font-size: 10pt">&#8239;https://www.marketsandmarkets.com/Market-Reports/driver-assistance-systems-market-1201.html</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt"></p><div>

</div><!-- Field: Page; Sequence: 48 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->45<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As part of our marketing program, our radar solution
is available on the open NVIDIA platform. NVIDIA is a scalable, software-defined, end-to-end AI platform for the transportation industry
and companies around the world, including auto- and truck makers, Tier 1 automotive suppliers, robotaxis, sensor and mapping companies
and autonomous vehicle startups are developing on NVIDIA.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Material Agreements</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We are party to certain agreements that we believe
are important to our business. Some of these agreements are memoranda of understanding, with a definitive agreement to be negotiated in
the future. We can give no assurance that these memoranda of understanding will develop into agreement or will generate significant, if
any, revenue for us. Further, our ability to generate revenue from any of these agreements is dependent upon our ability to develop and
deliver products that meet the customer&#8217;s requirement, as to which no assurance can be given.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Strategic Agreements</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our business development strategy is based primarily
on cooperation with Tier 1 automotive manufacturers to integrate our radar chipset into the radar systems manufactured by the Tier 1 manufacturers,
which will ultimately be sold by the Tier 1 manufacturers to the OEMs.&#160;We are party to strategic agreements with Tier 1 automotive
manufacturers, as follows:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="text-decoration:underline">Magna</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As of October 2022, we were chosen by Veoneer
(one of the top five automotive radar suppliers) as the radar chip set solution for their next generation radar (Gen 5). On October 6,
2022, Veoneer signed a memorandum of understanding with us establishing a technical collaboration and business alliance relating to its
plans to co-develop radars for automotive-grade safety and advanced driver assistance systems based on our chipsets. Veoneer (Magna) is
already sampling its next generation for the imaging radar to OEMs. Veoneer selected our chipset solution for its next generation radars,
including a long-range, high-resolution radar with 48x48 RF channels and a 360&#176; surround radar with 24x12 RF channels. During 2022
multiple Request for Quotation (RFQ) or Request for Information (RFI) were submitted based on our chipsets in the United States, Europe
and China. During 2023, Magna International Inc. completed the acquisition of Veoneer Active Safety from SSW Partners.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="text-decoration:underline">Weifu</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On January&#160;8, 2020, we entered into an agreement
with Weifu High-Technology Group Co., Ltd (hereinafter: &#8220;Weifu&#8221;), a Tier 1 automotive manufacturer in China pursuant to which
Weifu agreed to develop and manufacture vehicle radar systems based on our radar chips. The agreement with Weifu included, inter alia,
a commitment by Weifu to pay us for chipset costs, support in development, system design and documentation. On December&#160;18, 2020,
we and Weifu expanded the joint project and agreed to increase the scope of the project for an additional fee. The agreement also stipulated
the price that Weifu will pay to buy the chips during the mass production phase. Weifu is in the process of developing radar systems based
on our radar chips, and has begun performing demonstrations to OEMs in China, using a sample provided by us. Weifu announced it reached
a road pilot phase of our chipset based radar systems. On July 18, 2023, we entered into a technical services agreement with Weifu for
services and support to be provided by us to Weifu during a period of 12 months for $1,000,000. On July 28, 2023, Weifu issued an $11.6
million preliminary order for our radar chipsets, for its estimated requirements in 2024 and 2025.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="text-decoration:underline">Hirain</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On March 1, 2020, we entered a memorandum of
understanding with Hirain Technologies, a Tier 1 automotive manufacturer in China, pursuant to which Hirain will develop and
manufacture radar systems for vehicles based on our radar chips, backed by funding from a bi-national Israel-China research
foundation (Beijing). On August 19, 2020, a distribution agreement was signed between the parties, granting Hirain the right to sell
our demo systems to its customers in China. Effective March 1, 2021, we and Hirain entered into an agreement under which Hirain will
develop and manufacture automotive radar systems based on our radar chipset. The agreement with Hirain included, inter alia, a
commitment by Hirain to pay us for chipset costs, support in development, system design and documentation. During the fourth quarter
of 2022, Hirain issued a preliminary order for 340,000 radar chipsets, in order to secure capacity for its anticipated production
ramp-up. In January 2024, Hirain announced that it will begin its imaging radars by the end of 2024, following a significant of the
successful development of a high-performance B-sample (a production intent system design). Hirain is currently positioned to embark
on a rigorous data collection phase, with plans to cover 1 million kilometers using a vehicle fleet equipped with Hirain&#8217;s
LRR610 Imaging Radars, powered by our chipset. This development initiative is designed to optimize the fusion and perception system,
which enables key automotive safety and comfort features.&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 49 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->46<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="text-decoration:underline">Ordering samples (proof of concept)&#160;-&#160;OEMs</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As of December 31, 2023, we had received orders
from OEMs, Tier 1 manufacturers and other companies who seek to take advantage of the market opportunity to purchase from us our i samples,
which are systems for the purpose of testing capabilities and development. The agreements grant the right of use to the recipients of
the samples while safeguarding our intellectual property and limiting our liability. The volume of revenue for selling samples is not
significant. In October 2021, we were chosen by a European OEM to participate in its artificial intelligence-based technologies for environment
perception (radar sensors) innovation project. The revenue from this project is not significant. In 2023, we were chosen by two European
OEM for perception projects and by a Japanese OEM for a perception project. The revenue from these projects is not significant.</p><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">

</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">These
                                            selections were further extended to expected participation as a short listing in RFQ for
                                            high volume serial production in the second quarter of 2024. Although our primary focus is
                                            on seeking orders for commercial production, we believe these agreements with OEMs and Tier
                                            1 manufacturers represent an important part of our marketing effort directed at the OEMs
                                            and Tier 1 suppliers.</p><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">

</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="text-decoration:underline">Chips for non-retail automotive radar systems</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Sensrad</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On October&#160;16, 2020, we entered into an agreement
with Qamcom Research&#160;&amp; Technology AB (&#8220;Qamcom&#8221;), which set out principles of cooperation between the parties for
the development of radar systems based on our radar chips, for non-automotive target markets, such as delivery robots, agricultural tools,
smart traffic lights, train junctions, and other markets.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On January 11, 2021, we entered into a strategic
agreement with Qamcom under which Qamcom will develop and manufacture imaging radars based on our chipset to be used in the non-automotive
market. The agreement with Qamcom included, inter alia, a commitment by Qamcom to pay us for the chipset cost and portion of the module
hardware cost, for the receipt of support in development, system design and documentation.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">During 2023, Sensrad was incorporated as a spin-off
venture from Qamcom Group&#8217;s radar division to offer a unique imaging radar sensor based on the latest software and hardware technology,
including our radar chipset. Sensrad is co-owned by Gapwaves, which is considered a technical powerhouse within antenna and radar technology
industry.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">During January 2023, Sensrad announced significant
customer orders for radar systems leveraging our chipset. The recent orders from global companies underscore the market&#8217;s recognition
of the transformative impact of our radar chipset technology, integrated into Sensrad&#8217;s Hugin Imaging Radar systems.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">KargoBot</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On April 28, 2023, we and Weifu announced a strategic
cooperation with DIDI Global&#8217;s KargoBot, an autonomous truck company, for developing and marketing safe L4 autonomous trucks with
4D Imaging Radars based on our proprietary chipset. We and Weifu continue to accelerate the implementation on the platform fleets.</p><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">

</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Other Evaluations</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our radar is also being evaluated by other leading
Tier-1s and we are engaged in discussions with OEMs that did not approve our releasing their names.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 50 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->47<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Manufacturing</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On June&#160;27, 2022, we entered into a manufacturing
agreement with GlobalFoundries Singapore Pte. Ltd. (&#8220;GlobalFoundries&#8221;) for the manufacture of our semiconductor products,
as well as other services, including pre-production, quality assurance, assembly, testing and supply-chain management. The initial term
of the agreement is five years. The agreement includes customary terms for semiconductor manufacturing agreements, such as product recalls,
warranty and business continuity.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We depend on GlobalFoundries to manufacture our
semiconductor products. This agreement helps us secure the production of our semiconductor products and GlobalFoundries is committed to
supply our binding forecasts.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We leverage GlobalFoundries capabilities as a
silicon manufacturer and chipset supply chain management in turn-key work model to better secure production capacity to meet our customers&#8217;
fulfillment and quality and reliability automotive requirements.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Research and Development</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We were founded as a research and development
company, developing microchips for miniature radar systems for companies operating drone fleets, with the aim of providing a technological
solution that would enable the drone to detect at high speeds and improved resolution various obstacles, using little electrical power.
Once drone technology was developed, we decided to change the focus of our strategy and research and development to the field of chips
for radar systems for autonomous vehicles.</p><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">

</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our research and development activities are conducted
in Israel. We have received Israel Innovation Authority (&#8220;IIA&#8221;) grant approval for certain approved programs. We received
grants from IIA and the European Community that, as of March 1, 2024, amount to approximately $3.8&#160;million, based on the exchange
rate when the grants were received. We are obligated to pay royalties to the IIA, amounting to 4% of the sales of the products and other
related revenues generated from such projects. The maximum aggregate royalties paid generally cannot exceed 100% of the grants received,
plus annual interest generally equal to 12-months SOFR applicable to dollar deposits, as published on the first business day of each calendar
year. The obligation to pay these royalties is contingent on sales of the products.</p><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">

</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our principal operating expenses are research
and development expenses, which were approximately $34.1 million, $36.7 million and $28.6 million for the years ended December 31, 2023,
2022 and 2021, respectively. Our research and development efforts are focused on enhancing and developing the 4D imaging radar chipset
solution and the accompanying software. The increase in research and development expenses reflects the ramp up in our operations, including
hiring and starting work toward our full production plan.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Intellectual Property </b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our intellectual property is a crucial part of
our business. Our IP rights are protected by a combination of patents, trade secret protection, confidentiality agreements, and other
contractual agreements with employees and third parties. We have applied for patent protection in several jurisdictions including Israel,
United&#160;States, Europe, and China and have been granted patents in both Israel, the United States and the PRC. Unpatented trade secrets
are also an important aspect of our business.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We filed patent applications for 18 unique
patent families covering a wide range of fields related to our products features and aspects including radar signal processing,
radar Tx/Rx integrated circuit design, radar coexistence and mutual&#160;interface mitigation techniques, package design, antenna
design, post-processing methods and algorithms, and system design. We filed these applications, including utility and provisional
applications, in jurisdictions that we believe are the main automotive markets and development centers around the world, principally
the United&#160;States, the European Union and China. Twenty patents, covering eleven different inventions, have been granted in the
United States, Israel and China, with patents generally having a term of 20&#160;years from their filing date. Among the patents
granted are patents covering methods for mitigation of mutual interference between automotive radars including frequency hopping
multiband chirp techniques, a radome for automotive radar patch antennas, RFIC packaging techniques including low loss transmission
lines, a radar-based system for real-time simultaneous localization and mapping, known as SLAM, a MIMO radar array antenna, and a
method for separating targets and clutter from noise.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 51 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->48<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Competition</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The market for competitive automotive sensing
solutions that enable autonomous driving is an emerging market with many potential applications in the development stage. As a result,
we face competition from a range of companies (from large corporations to start-ups) seeking to have their products incorporated into
these developing applications and it may take a period of time for its primary competitors to emerge.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The ADAS market is formed of Tier 1 manufacturers
which manufacture radar systems, as well as companies that develop and manufacture software and hardware such as chips and sensors for
the radar systems, which are called Tier 2 suppliers. We are a Tier 2 supplier, which has its products manufactured by a third-party manufacturer.
As a Tier 2 supplier, we supply imaging radar chipset to Tier 1 manufacturers who are building imaging radar systems and to OEMs.</p><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">

</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We believe that the following strengths differentiate
us and will enable us to successfully compete and maintain our leadership position in our target markets.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-size: 10pt"><i>Technology. </i>We believe
that our 4D imaging radar technology brings the fundamental leap required to achieve true radar imaging capabilities to the level that
it can be used as a primary sensor for perception in tandem with cameras and optionally LiDAR. Our technology addresses the key challenges
in the automotive radar domain while maintaining competitive size, power and cost for the Level 2+, Level 3 and Level 4 mass market,
for high-density, high-resolution RF front-end, through cutting-edge algorithms to effectively utilize the radar and the powerful radar
processing unit required to run the radar. We believe our technology will bring safety and autonomy to the mass market in all weather
and all lighting conditions with redundancy at an attractive cost.</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-size: 10pt"><i>Cost and Energy Efficient
High-Performance Radar Solutions. </i>Tier-1 manufacturers and automakers are extremely sensitive to the cost of any component in the
vehicle, and especially to relatively highly priced individual components such as radar sensors. They demand competitive prices and put
significant weight on this parameter when deciding on vendors. We expect that our products will be competitively priced as a result of
mass production. We believe that our products will be competitively prices will offer better performance.</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-size: 10pt"><i>Global Coverage and Large
Ecosystem. </i>Our products are marketed worldwide and amenable to implementation globally.</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-size: 10pt"><i>Significant Validation from
Leading Companies in the industry. </i>Our progress has garnered the attention of major companies in the industry.</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-size: 10pt"><i>&#9679;</i></span></td><td style="text-align: justify"><span style="font-size: 10pt"><i>Automotive grade development
and production. </i>Vehicle components, particularly parts of the autonomous vehicle driving technology system, are required to have
a high functional safety grade. Achieving compliance with functional safety standards is a time-consuming and labor-intensive process
that requires significant cooperation with automotive grade industry participants, such as Tier-1 suppliers and automobile manufacturers.
Since 2018, we have worked closely with leading Tier-1 suppliers such as Veoneer, Valeo, Hirain and Weifu, to develop a radar solution
that meets these rigorous requirements. This process has included continuous and extensive product-safety auditing. As a result of our
close work with these Tier&#160;1 automotive suppliers, we have developed rigorous safety and quality expertise. We believe that this
experience provides us with a competitive advantage in marketing against companies that have not worked with Tier 1 automotive suppliers
in the development of their product.</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt"></p><div>

</div><!-- Field: Page; Sequence: 52 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->49<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 24px; font-size: 10pt"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="font-size: 10pt; text-align: justify"><span style="font-size: 10pt"><i>Relationships with multiple Tier-1 suppliers enable market penetration. </i>OEMs design their future models and vehicles several&#160;years in advance and often then freeze the design in order to produce and deliver the vehicles on time. Therefore, designs for mass-production of reliable Level 2+ to Level 3 and Level 4 consumer car programs where imaging and perception radars are required, is expected in&#160;2025-2028 are being decided in&#160;2024. Radar solutions that will be candidates for inclusion in these programs must go through the process of automotive-grade manufacturing and audit by the OEMs and Tier-1 suppliers. We believe that our experience working with Tier 1 automotive suppliers and OEMs places us in a better position to market to the next generation of autonomous vehicles.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our chipset has the highest channel count in the
industry, which provides the highest resolutions, true 4-dimensional view of the vehicle&#8217;s environment, including separation in
high resolution in elevation, an industry first. In addition, our dedicated radar processor chip, which was designed specifically for
the automotive industry sets it apart from competition, providing not only fast time to market, but more importantly the ability to reduce
power consumption, and overall solution cost.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following chart compares the performance of
radar chipset, to our chipset:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><img alt="" src="image_005.jpg"/></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">While Texas Instruments and NXP offer a low-resolution
radar chip of 4Rx * 4Tx, capable of scaling up to 16Rx * 16 Tx without a dedicated processor for current generation radars, other companies
are targeting the imaging radar space with high resolution radar chipsets.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 53 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->50<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="text-decoration:underline">Mobileye</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">After previously announcing the development of
a 2,304 virtual channels radar (48x48 Rx*Tx), Mobileye has announced that it updated its channel count to 1,536 virtual channels (32x48),
which we believe gives up some image quality resolution and decreases the throughput and required processing power. We believe that on
the one hand MobilEye&#8217;s decision to develop a 4D imaging radar is significant to the automotive market in acknowledging Mobileye&#8217;s
view of the imaging radar&#8217;s key role in the overall perception solution, while on the other hand we believe that our excess channel
count indicates that our solution has a higher angular native resolution with lower native false alarms and an efficient handling of high
throughput and processing. Mobileye has stated that its radar system is planned to complete production in 2025, which we believe places
Mobileye two&#160;years behind us. We believe that Mobileye plans to play some of the roles of the Tier 1 automotive supplier, and compete
with our customers, who are leading automotive radar Tier 1s, with&#160;years of experience in this space. We believe, based on the specification
Mobileye published, that our current chipset has better performance, price and power and that using our radar chipset solution would better
meet the needs of the developing autonomous vehicle market.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We believe that our technology offers advanced
radar performance at an affordable price. The illustration below provides a comparison of the leading radar systems channel count and
prices.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">

</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-size: 10pt"><img alt="" src="image_006.jpg"/>&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="text-decoration:underline">*Source: Arbe&#8217;s assessment of competitive
landscape</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="text-decoration:underline">Current Generation ADAS Radars</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Traditional commercial radar systems have
5-degree (or worse) resolution. Due to their low azimuth resolution and lack of elevation resolution, traditional radars, that were
originally designed for controlling emergency braking and adaptive cruise control, are limited to detecting moving vehicles and
discarding all detections of the stationary environment and cannot address free space mapping that requires high elevation
resolution. Traditional radars have a high level of false alarms that trigger reports of phantom objects and false positives. For
this reason, the detection threshold, is raised which results in decreased radar sensitivity and may lead to accidents. We have
revolutionized radar by addressing these core issues that have caused recent driverless vehicle and autopilot accidents by detecting
stationary objects, identifying vulnerable road users, and eliminating false alarms without radar ambiguities.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 54 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->51<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="text-decoration:underline">Ambarella for short range radar</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">During 2021, Ambarella acquired Oculii, which
was established in 2013, and offers a software solution which is implemented on top of traditional 4Rx * 3Tx radar chips, with the aim
to improve the elevation and azimuth resolution and to expand the field of view. This approach will also lead to a denser point cloud,
which in turn would allow more advanced signal processing. However, this software solution is not applicable to autonomy level beyond
level 2, in complex driving features and with higher levels of autonomy.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="text-decoration:underline">Continental ARS 540</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Continental system is based on four Texas
Instrument 3Rx * 4Tx chips, cascaded to achieve a 16*12 array, as well as the Xilinx FPGA (field-programmable gate array) board, and not
a radar processor on a chip like our solution. FPGA is not designed for large scale automotive solutions, and therefore has many drawbacks
- it is expensive, the continental system costs in the range of $200 in high volumes, it requires high power consumption, has heat dissipation
issues, and supports fewer frames per second and very low number of detections per frame. The platform may have ambiguity issues increasing
the false alarm rate as well as filtering out real detection.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Environmental, Social and Governance (ESG)</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As an auto-tech company, we have developed what
we believe is a revolutionary radar that will enable truly safe driver-assist systems that can save lives on the road. Our mission is
to strengthen and enhance the safety of vehicle users and others in the industry who can apply the technology to their service.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our Environmental, Social and Governance (ESG)
practices are guided by our social mission of saving lives and securing people&#8217;s safety on the road. Notably, the social element
in ESG is reflected in the essence of our product as we created a system that assists with the prevention of injuries and fatalities while
driving. As part of our community involvement. we encourage our employees to participate in in volunteering initiatives in the local community.
As part of our spirit, we strengthen diversity and equality through equal pay and affirmative action towards recruiting and advancing
qualified women.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We conduct our business activities based on a
firm commitment to ethical values and corporate governance best practices. Our policy is to follow leading ESG principles in relation
to our supply chain, including, evaluating, and engaging responsible suppliers. Our suppliers must operate in compliance with all applicable
national and international laws and regulations, as well as implementing the principles of the Responsible Business Alliance (RBA) Code
of Conduct. We are working with GlobalFoundries, a company that we believe values, supports and leads best ESG practices.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We believe in the importance of promoting and
adopting practices that support ESG implementation within our activities. During 2023, we identified significant ESG topics relevant across
all company activities. We will continue to advance our commitment to ESG practices across our operations, as well as monitor the development
of regulatory requirements.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Regulations</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The automotive industry is subject to high standards
of safety and quality. The integration of Advanced Driver Assistance Systems may stem from binding regulatory directives or from initiative
on part of the car manufacturers (driven, inter alia, by the wish to obtain a higher safety rating or to accommodate demand from vehicle
consumers). Our products will need to meet quality and safety control standards, regional and international ISO standards and dedicated
standards pertaining to ADAS.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 55 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->52<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Autonomous vehicles are subject to emerging regulatory
frameworks at the federal and state levels that are in a rapid state of change. In general, at both the federal and state level, the U.S.&#160;has
provided a positive and relatively permissive legal environment to allow the safe testing and development of autonomous functionality.
We do not anticipate any near-term federal standards that would impede the foreseeable deployments of our radar technology. Some states,
however, particularly California and New&#160;York, still enforce certain operational or registration requirements for certain autonomous
functions. For example, California has been regulating autonomous vehicles in some fashion since 2012 through various restrictions and
appears poised to continue to do so, as in December 2022, California introduced new legislation that would prohibit full self-driving
marketing claims. California state lawmakers are also considering bills that would prohibit autonomous trucks and self-driving vehicles
weighing more than 10,001 without human drivers behind the wheel. It is possible that restrictions at the state level in the U.S. will
ease or be removed as the data and experience supporting the safety of autonomous functionality continues to grow, but we cannot predict
when or whether that might happen. However, we believe such hurdles will be removed as state regulators gain better experience with the
technology. U.S.&#160;federal regulations, however, remain largely permissive of deployments of higher levels of safe and responsible
autonomous functionality.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In 2015, the NHTSA announced a plan to update
the criteria for 5-star safety ratings, to encourage automakers to use technology to prevent traffic accidents. In 2016, the NHTSA added
automated braking systems to the list of technologies required to achieve a 5-star safety ratings. The technologies currently recommended
by the NHTSA include: forward collision warning, lane departure warning, rear view video system, and automatic emergency breaking.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In 2023, the NHTSA promulgated the &#8220;Occupant
Protection for Vehicles with Automated Driving Systems&#8221; final rule to update several FMVSS to account for vehicles that are equipped
with ADAS and do not have traditional manual controls associated with human drivers. The NHTSA also proposed rules to update FMVSS for
crash avoidance, safety messaging and passengerless vehicles and jointly proposed a rule with the Federal Motor Carrier Safety Administration
regarding AEB test devices for heavy vehicles.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Foreign markets such as the China and the EU also
continue to develop their respective standards to define deployment requirements for higher levels of autonomy. In China, for example,
the government has undertaken numerous efforts to promote autonomous vehicle development, including its February&#160;2020 release of
the Strategies for Innovation and Development of Autonomous Vehicles by China&#8217;s National Development and Reform Commission and ten
other agencies. This initiative sets forth an ambitious plan to create a systematic framework for technical innovation, industrial ecology,
infrastructure, regulations and standards, product regulation and network security in the autonomous vehicles market by 2025, and from
2035 to 2050, to fully establish an ecosystem for autonomous vehicles. Much of the emerging regulatory and legislative activity around
autonomous vehicles in the EU has been focused on data privacy and security, given the volume and types of data collected, stored and
transmitted by autonomous vehicles. A key part of Europe&#8217;s emerging autonomous vehicles strategy is the creation of a common European
mobility data space, to be further developed in the EU&#8217;s &#8220;Smart and Sustainable Transport Strategy.&#8221; Given the intense
work in these areas, we expect a workable path forward in the near-term in these markets.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The automotive industry in Japan puts all automotive
and telecommunications technologies through a rigorous certification process prior to commercial evaluation in the region. In February
2022, we obtained the Japanese Telecommunication and Radio certification for radar samples based on our mass production RF chipset.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Like all companies operating in similar industries,
we are subject to environmental regulation, including water use; air emissions; use of recycled materials; energy sources; the storage,
handling, treatment, transportation and disposal of hazardous materials; and the remediation of environmental contamination. Compliance
with these rules may include the need to obtain permits and licenses and to allow inspections of our facilities and products.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Overall, the autonomous vehicles regulatory landscape
is still evolving rapidly. We may become subject to additional regulatory schemes and requirements as the development of federal, state
and foreign legal frameworks around autonomous vehicles continues to develop and change.</p><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">

</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 56 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->53<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In recent&#160;years, governments, authorities
and organizations around the world have sought to tackle the problem of traffic accidents, through, among other methods, regulation
and legislation that encourage, and even require, installation of ADAS in vehicles. Such trends are gaining momentum and are being promoted
by the NHTSA and Euro-NCAP, among others, who institute standards for safety ratings for new vehicles, and provide the highest rating
(5 stars) where advanced technology for the prevention of traffic accidents is installed. A similar trend applies to the Chinese car safety
assessment program CNCAP which incorporates &#8220;Active Safety&#8221; criteria into its 5-star rating. In Israel, for instance, in 2015,
the government approved the Ministry of Transport&#8217;s plan to provide a financial incentive for private vehicle owners to install
lifesaving safety systems, and to establish that buses and trucks would be required to install a system for identifying pedestrians as
a condition for renewing the vehicle&#8217;s license.</p><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><img alt="" src="image_007.jpg"/></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Source: Yole, Driving Radar Resolution, February&#160;2023.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">It should be noted that in addition to the regulatory
trends, awareness among automakers and vehicle owners of the importance and benefits of installing ADAS (even in the absence of binding
regulation) has increased, and it is likely that in the future, the vast majority of new vehicles will be equipped with such systems.
This trend is expected to accelerate due to various factors, including improvements that have enabled price reduction.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Regulation or standardization may stipulate that
automakers or vehicle-owners install ADAS in general, and radar systems in particular, which could facilitate our penetration into potential
target markets.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Similarly, internal regulation adopted by OEMs
voluntarily, or regulation by insurance companies requiring ADAS as a prerequisite for an insurance policy may also benefit our operations
and business outcomes.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As an Israeli company, we are subject to laws
and regulations applicable to all companies, including export controls, privacy, cybersecurity, anti-corruption, labor relations and workplace
laws and regulations.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Legal Proceedings</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We are not currently a party to any legal proceedings.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>C. Organizational Structure</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We have three wholly-owned subsidiaries, two in
the United States -- Arbe Robotics US Inc. and Autobot HoldCo. Inc., both Delaware corporations, and one, Shanghai Arbe Technologies Co.,
Ltd., organized under the laws of the People&#8217;s Republic of China.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>D. Property, plants and equipment.</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We do not have any material tangible fixed assets.
We do not own any real estate. We rent offices from third parties, extending over an area of approximately 2,000 square meters located
in 105 and 107 HaHashmonaim Street in Tel Aviv. We pay monthly rent of approximately $37,600. The offices serve for both our R&amp;D activities
and our corporate headquarters.</p><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">

</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 57 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->54<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><div><a id="a_006"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>ITEM 4A. UNRESOLVED STAFF COMMENTS</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Not Applicable</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p><div>

</div><div><a id="a_007"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>ITEM 5. OPERATING AND FINANCIAL REVIEW AND PROSPECTS </b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following discussion and analysis of our financial
condition and results of operations should be read in conjunction with our audited financial statements as of December 31, 2023 and 2022
and for the&#160;years ended December&#160;31, 2023, 2022 and 2021 and notes to those statements included elsewhere in this annual report.
Some of the information contained in this discussion and analysis or set forth elsewhere in this annual report, including information
with respect to our plans and strategy for our business, includes forward-looking statements that involve risks and uncertainties. As
a result of many factors, including those factors set forth in the &#8220;Cautionary Note&#160;Concerning Forward-Looking Statements&#8221;
and &#8220;Risk Factors&#8221; in Section D under Item 3 of this annual report, our actual results could differ materially from the results
described in or implied by the forward-looking statements contained in the following discussion and analysis.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Overview </b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We are driving a radar revolution, paving the
way for an autonomous future, utilizing an outstanding, truly safe, commercially viable, 4D Imaging solution. As a global leader in radar
technology, we enable safe roads today paving the way to full autonomy for passenger cars, autonomous trucks, delivery robots, robotaxies,
commercial vehicles, and empowering a wide array of safety applications with advanced sensing and paradigm-changing perception.</p><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">

</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Founded in 2015 by Chief Executive Officer Kobi
Marenko, Chief Technology Officer Dr. Noam Arkind, and former Chief Operations Officer Oz Fixman, our breakthrough technology has transformed
radar as a sensor for ADAS (advanced driver assistance systems) and autonomous vehicles from the chip-level up, with technological breakthroughs
across all core components. As a result, we have created what we believe is the leading imaging radar sensor, the only radar capable of
enhancing perception algorithm that meets the demanding performance, safety, and cost requirements for Level 2+ through Level 5 autonomous
vehicles, bypassing the traditional limitations of legacy radar technology- low resolution, inability to sense stationary objects, high
false alarm rate, lack of resolution, to name a few. Integrating the advanced hardware with our custom AI stack enables support for advanced
perception capabilities at mass market prices, with top performance in all environments, weather and lighting.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our 4D imaging radar, delivering an image that
we believe is 100 times more detailed than any commercial radar on the market, sets a new standard for safety in the industry, and is
designed to enable accurate and reliable sensing in some of the most challenging use cases that autonomous vehicles can encounter on a
regular basis &#8211; such as providing free space mapping in a tunnel, detecting a tire on the road ahead in heavy rain, tracking pedestrians
in the dark. This is achieved by the development of a chipset with the highest channel count in the industry, proprietary radar processing
algorithms, and our industry first radar-based perception applications.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our advanced semiconductors technology has made
us one of the leading providers for the world&#8217;s top OEMs. With 136 employees, as of March 1, 2024, we have scaled to over 39 evaluation
projects and were have been advised that we are on the short list with nine OEMs, robotaxis, delivery robots, and autonomous trucks projects.
We have been selected for evaluation by five &#8220;Imaging Radar - based perception&#8221; projects, out of them, two are top five global
OEM which are progressing towards selection in 2024.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Revenue for the ADAS/AD radar industry is expected
to have an estimated total addressable market opportunity of approximately $13.5 billion in 2028<sup>6</sup>. Our model to capture this
opportunity is to work directly with top established Tier 1 automotive suppliers in order to power their next generation radars. Correspondingly,
we have established relationships with four Tier-1 suppliers who are building production radars based on our chipset, including Magna,
Weifu, Hirain, and Sensrad. GlobalFoundries, our chip manufacturer which is responsible for chip production and supply chain management,
has advised us that it will have the capacity necessary to meet our anticipated commitments for 2024 and 2025.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 25%"><div style="font-size: 1pt; border-top: Black 1.5pt solid">&#160;</div></div><!-- Field: /Rule-Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0px">&#160;</td>
    <td style="width: 24px; font-size: 10pt"><span style="font-size: 10pt"><sup>6</sup></span></td>
    <td style="font-size: 10pt; text-align: justify"><span style="font-size: 10pt">Yole Group, Driving Radar Resolution, September&#160;2023.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 58 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->55<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Key Factors Affecting our Operating Results</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We believe that our future performance and success
depends to a substantial extent on the following factors, each of which is in turn subject to significant risks and challenges, including
those discussed below and in the section of this annual report in Item 3 under &#8220;Risk Factors.&#8221;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In our industry, staying ahead hinges on delivering
cutting-edge technology at competitive prices. Success requires us to consistently offer the latest advancements, which is why we channel
our research and development towards maintaining our technological edge. Our ability to thrive is closely tied to the worldwide demand
for ADAS.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Although we believe that widespread adoption of
4D imaging radar across applications for safety and autonomy is approaching and that we are well-positioned in both automotive and non-automotive
markets to take advantage of this opportunity, mass production passenger vehicles OEMs are just beginning to develop level 2+ and autonomous
systems that will rely on incorporating imaging radar technology. We expect the rate of actual adoption and commercialization of radar-based
solutions by automotive OEMs and their suppliers will impact our results of operations, including revenue and gross margins for the foreseeable
future. Government regulations relating to ADAS and autonomous driving solutions are also key factors in the development of the market.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We also intend to target markets beyond mass production
passenger vehicles, including vehicle applications like trucks, shuttles, automated ground delivery vehicles, and industrial verticals
like industrial robots, security systems, ground protection, drones, traffic monitoring. Our solution has the potential to be a primary
sensor candidate for many autonomous and semi-autonomous applications and next generation perception platforms. As a result, we believe
that we could operate in some of those markets in parallel with the automotive market.&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As a Tier 2 supplier of advanced technology to
Tier 1 automotive suppliers and OEMs, our results of operations will be impacted by the level of demand for our product from Tier 1 automotive
suppliers and OEMs which base their radars based on our chipset solution.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We are competing for talent in a highly competitive
environment, which results in higher compensation packages to employees. We cannot give assurance that we will be able to hire all required
positions when they are required or to retain those that we hire.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>



</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our radar system is being evaluated by eleven
of the top-15 global automakers by sales, reflecting the significant commercial interest in imaging radar. We anticipate that these programs
will make their decisions with respect to their radar technology commencing in 2024. We also have a preliminary orders from Hirain, the
leading Chinese ADAS Tier 1 supplier, for the first months of production, moving us into the mass production phase. The order consists
of 340,000 radar chipsets that will be supplied to Hirain&#8217;s customers throughout China, and a preliminary order from Weifu, a high-technology
ghasroup, a prominent tier 1 supplier in the Chinese automotive market, for a $11.6 million. Because of the preliminary nature of the
order, it is not included in our backlog.</p><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In order to achieve profitability, we need to
generate orders and binding commitments from our current evaluation projects. Delays in the autonomy programs of the OEMs to which we
provide our chipset, currently or in the future, could adversely affect our ability to meet our revenue targets and achieve profitability
in the time frame we anticipate.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 59 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->56<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Since OEMs rely on Tier 1 automotive suppliers
for components such as radar-based product, if a leading Tier1 supplier goes into production with an imaging radar that is based on our
chips the chances of an OEM basing its radar on our technology is likely to increase. We believe that the fact that Tier-1 suppliers already
have radar production lines that they need to upgrade for imaging radar, reduces dramatically the risk and the cost in taking our technology
to the mainstream.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As with other companies engaged in ADAS, our business
is dependent upon regulations relating to autonomous driving solutions. Although we believe that our systems comply with applicable regulations,
any new regulations may have the effect of preferring one technology over other technologies, Since the nature and scope of future regulations
may be affected by conditions and events, we cannot predict the nature of any future regulations and their effect on our business,</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><b><i>Market Trends and Uncertainties </i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><b>&#160;</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We estimate the total addressable market for Advanced
Drive Assistance Systems, known as ADAS, and autonomous driving technology, will grow to approximately $65.1 billion or more in 2030<sup>7</sup>
and we believe that this growth will result in a demand for our imaging radar chips. As automotive OEMs have shifted their focus from
Level 4/5 autonomy to Level 2+, we believe we have the opportunity, with our first to market 4D imaging radar, to capture a significant
share of the lucrative market. We believe that we are positioned as the leading company with deeply integrated hardware and software products
that currently meet the OEM specification requirements for safe Level 2+ to Level 5 autonomy, which constitutes a significant portion
of the market.</p><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">

</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We believe that we have multiple levers for sustained
growth and market opportunities in addition to the automotive industry, with a core strategy to focus on attractive markets with significant
growth and profitability potential. Specifically, the markets of focus include passenger cars, commercial trucks, and robotaxi fleets.
Each such market is potentially a significant global opportunity, and these markets have historically been underserved by inferior technology
or not served at all.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our most immediate market focus is on passenger
and commercial vehicle safety on highways and ADAS applications. We believe there is significant room for improvement with regard to standard
ADAS and crash avoidance. ADAS volumes are primarily driven by the Chinese, European and North American markets which have increasingly
stringent safety regulations and consumer preference for safety. We are well positioned to capitalize on the increased ADAS demand in
response to these increased safety regulations. Although increasing automotive performance requirements may generate higher demand, we
may not be able to take advantage of demand if we are unable to anticipate regulatory and industry changes and adapt quickly enough to
meet new regulatory standards or requirements. Market acceptance of active safety technology depends upon many factors.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Adverse economic conditions may also result in
a higher rate of losses on accounts receivables that we accrue in the future due to credit defaults. As a result, a downturn in the worldwide
economy could have a material adverse effect on our business, results of operations, and/or financial condition.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>War with Hamas, Terrorism and Related Conflicts
</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On October 7, 2023, Hamas terrorists infiltrated
Israel&#8217;s southern border from the Gaza Strip and conducted a series of attacks on civilian and military targets. Hamas also launched
extensive rocket attacks on Israel&#8217;s civilian population and industrial centers along Israel&#8217;s border with the Gaza Strip
and in the Central District of Israel. Following the attack, Israel&#8217;s government declared war against Hamas and a military campaign
against the organization as Hamas. In addition, Hezbollah has attacked military and civilian targets in northern Israel, to which Israel
has responded. How long the current conflict in Gaza becomes is unknown at this time and any continued clash among Israel, Hamas or Hezbollah
or other countries in the region may escalate in the future into a greater regional conflict. To date, our operations and financial results
have not been affected in any material affect, and we are considering different measures to seek to address this conflict risks. These
risks are disclosed in greater detail in &#8220;Risk Factors &#8211; Risks Related to our Incorporation and Location in Israel -- Conditions
in Israel could materially and adversely affect our business.&#8221;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 60 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->57<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Global Demand </b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our business is related to global automotive sales
and automotive vehicle production by our Tier-1 customers and their OEM customers and engagements. Economic conditions in North America,
Europe and Asia can have a large impact on the production volume of new vehicles, and, accordingly, have an impact on our revenue. OEM
customers&#8217; production can vary from period to period due to global demand, market conditions and competitive conditions. We expect
to continue to seek to capitalize on our strong and collaborative relationships with OEMs and Tier 1s to expand our presence in key markets
and capture the long-term growth opportunities in those markets.&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>ADAS and Autonomous Driving Regulation&#8239;&#8239;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Demand for our solutions is influenced by the
impact of regulation and the ratings systems deployed by the various NCAPs, particularly the Euro NCAP and the U.S. NCAP, administered
by the National Highway Traffic Safety Administration. As these NCAPs demand more ADAS applications such as automatic emergency braking,
we believe that OEMs will increasingly include ADAS as a standard feature in their models to maintain or to achieve the highest safety
ratings. In many countries, these safety assessments have created a &#8220;market for safety&#8221; as car manufacturers seek to demonstrate
that their models satisfy the NCAPs&#8217; highest ratings. We expect national NCAPs to continue to add specific ADAS applications to
their evaluation items over the next several&#8239;years, led by the Euro NCAP. In recent&#8239;years, as regulatory requirements and
NCAP ratings have increased, OEMs have also begun to highlight their safety features as a competitive advantage. As additional regulations
are implemented around the world, we expect this to lead to increased global adoption of ADAS, and we believe that we are well positioned
to benefit from such increasing safety regulations globally, particularly due to the verifiable nature of our current and future solutions.&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Fully autonomous vehicles are still nascent, and
regulation of autonomous driving is evolving globally on both a local and national level. We believe that regulatory bodies will demand
that AV functionality undergo certain validation and audit requirements before autonomous driving is permitted. The potential impact of
regulatory requirements and initiatives on the timing for widespread adoption of fully or even partially autonomous driving and on the
cost of developing and introducing autonomous driving solutions is uncertain. Notwithstanding the uncertainties, we see a clear trend
of adopting partial autonomous driving features, operated in specific scenarios, under specific conditions and in different level of supervision
radars that are based on our chipset can help develop such features and make them available on private vehicle and in high level of safety
at a very affordable cost.</p><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#8239;&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We cannot provide any assurance how any such regulations
will impact us and the extent of such impact, particularly if autonomous driving is prohibited in certain areas.&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 2%; padding-right: 0.5pt; padding-left: 0.5pt; font-size: 10pt"><span style="font-size: 10pt"><sup>7</sup></span></td>
    <td style="width: 98%; padding-right: 0.5pt; padding-left: 0.5pt; font-size: 10pt; text-align: justify"><span style="font-size: 10pt">https://www.marketsandmarkets.com/Market-Reports/driver-assistance-systems-market-1201.html</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Effect of the Russian Invasion in Ukraine</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On February 24, 2022, the Russian Federation launched
an invasion of Ukraine that has had an immediate impact on the global economy resulting in higher energy prices and higher prices for
certain raw materials and goods and services which in turn is contributing to higher inflation in the United States and other countries
across the globe with significant disruption to financial markets and supply and distribution chains for certain raw materials and goods
and services on an unprecedented scale, including the effects of fuel shortages in Europe. The Russian Federation could resort to cyberattacks
and other action that impact businesses across the United States, the European Union, Israel and other nations across the globe including
those without any direct business ties to the Russian Federation or Ukraine. Although we do not have any business in Russia or Ukraine,
the effects of the invasion could affect the European economy, which may affect European automobile companies.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 61 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->58<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Reliance on Supplier</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Since we rely on GlobalFoundries for our manufacturing,
to the extent that any of the factors described above affect GlobalFoundries, including its ability to obtain the semiconductors necessary
for our product, our ability to deliver any products that are ordered from us will be impaired, which may impact our ability to obtain
orders for our products.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Public company expenses</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 20pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As a public company, we will be implementing additional
procedures and processes for the purpose of addressing the standards and requirements applicable to public companies. Specifically, we
expect our accounting, legal and personnel-related expenses to increase as we establish more comprehensive compliance and governance functions
and hire additional personnel to support such functions, maintain and review internal controls over financial reporting in accordance
with the Sarbanes-Oxley Act, and prepare and distribute periodic reports in accordance with SEC rules.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Results of Operations</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Years Ended December 31, 2023, 2022 and 2021</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="10" style="text-align: center; font-weight: bold; border-bottom: Black 1.5pt solid">Year&#160;Ended December&#160;31,</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; border-bottom: Black 1.5pt solid">(dollars in thousands)</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="text-align: center; font-weight: bold; border-bottom: Black 1.5pt solid">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="text-align: center; font-weight: bold; border-bottom: Black 1.5pt solid">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="text-align: center; font-weight: bold; border-bottom: Black 1.5pt solid">2021</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-indent: -9pt; padding-left: 9pt">Revenues</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">1,470</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">3,517</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">2,249</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1.5pt; text-indent: -9pt; padding-left: 9pt">Cost of Revenues</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">1,508</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">1,283</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">1,440</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -9pt; padding-left: 9pt">Gross Profit (Loss)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(38</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,234</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">809</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; text-indent: -9pt; padding-left: 9pt">Operating Expenses:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -9pt; padding-left: 0.25in">Research and Development</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">34,082</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">36,731</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">28,564</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; text-indent: -9pt; padding-left: 0.25in">Sales and Marketing</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">5,194</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">4,621</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,814</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt; text-indent: -9pt; padding-left: 0.25in">General and Administrative</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">7,571</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">8,613</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">3,709</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt; text-indent: -9pt; padding-left: 9pt">Total Operating Expenses</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">46,847</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">49,965</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">34,087</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -9pt; padding-left: 9pt">Operating Loss</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(46,885</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(47,731</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(33,278</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt; text-indent: -9pt; padding-left: 9pt">Financial Expenses (Income), net</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(3,385</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(7,237</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">24,814</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 4pt; text-indent: -9pt; padding-left: 9pt">Net Loss</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">(43,500</td><td style="padding-bottom: 4pt; text-align: left">)</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">(40,494</td><td style="padding-bottom: 4pt; text-align: left">)</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">(58,092</td><td style="padding-bottom: 4pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -9pt; padding-left: 9pt">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 4pt; text-indent: -9pt; padding-left: 9pt">Basic loss per share attributable to Ordinary Shareholders</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">(0.60</td><td style="padding-bottom: 4pt; text-align: left">)</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">(0.64</td><td style="padding-bottom: 4pt; text-align: left">)</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">(2.64</td><td style="padding-bottom: 4pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 4pt; text-indent: -9pt; padding-left: 9pt">Weighted-average number of shares used in computing basic loss per share attributable to Ordinary Shareholders</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">72,021,520</td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">68,489,983</td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">22,027,292</td><td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -9pt; padding-left: 9pt">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 4pt; text-indent: -9pt; padding-left: 9pt">Diluted loss per share attributable to Ordinary Shareholders</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">(0.71</td><td style="padding-bottom: 4pt; text-align: left">)</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">(0.80</td><td style="padding-bottom: 4pt; text-align: left">)</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">(2.64</td><td style="padding-bottom: 4pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 4pt; text-indent: -9pt; padding-left: 9pt">Weighted-average number of shares used in computing diluted loss per share attributable to Ordinary Shareholders</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">62,390,302</td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">60,960,641</td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">22,027,292</td><td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  </table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 62 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->59<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Revenue</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following table sets forth our revenue for
the years ended December&#160;31, 2023, 2022 and 2021 by geographic region (dollars in thousands):</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt; padding-left: 0.125in; text-indent: -0.125in; font-weight: bold; text-align: center">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Year&#160;Ended December&#160;31, 2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Year&#160;Ended<br/> December&#160;31, 2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Year&#160;Ended<br/> December&#160;31, 2021</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt; padding-left: 0.125in; text-indent: -0.125in; font-weight: bold; text-align: center">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Revenue</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>% of</b></p> <p style="text-align: center; margin-top: 0pt; font: 10pt Times New Roman, Times, Serif; margin-bottom: 0pt"><b>Revenue</b></p></td><td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Revenue</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>% of</b></p> <p style="text-align: center; margin-top: 0pt; font: 10pt Times New Roman, Times, Serif; margin-bottom: 0pt"><b>Revenue</b></p></td><td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Revenue</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>% of</b></p> <p style="text-align: center; margin-top: 0pt; font: 10pt Times New Roman, Times, Serif; margin-bottom: 0pt"><b>Revenue</b></p></td><td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">Revenue by Geography:</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; width: 28%">China</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">639</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">43.5</td><td style="width: 1%; text-align: left">%</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">1,476</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">42.0</td><td style="width: 1%; text-align: left">%</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">702</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">31.2</td><td style="width: 1%; text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">Hong Kong</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">266</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">18.1</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">35</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1.6</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in">Sweden</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">247</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">16.8</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,276</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">36.3</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">928</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">41.2</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in">USA</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">148</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">10.1</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">135</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3.8</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">63</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2.8</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in">Germany</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">81</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">5.5</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">284</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">8.1</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">351</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">15.6</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in">Israel</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">50</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3.4</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">25</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">0.7</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">34</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1.5</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in">Italy</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">124</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3.5</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in">Switzerland</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">197</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">5.6</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">53</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2.4</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 1.5pt">Other</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">39</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">2.6</td><td style="padding-bottom: 1.5pt; text-align: left">%</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">83</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">3.7</td><td style="padding-bottom: 1.5pt; text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; padding-bottom: 4pt">Total revenue</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">1,470</td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">100</td><td style="padding-bottom: 4pt; text-align: left">%</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">3,517</td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">100</td><td style="padding-bottom: 4pt; text-align: left">%</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">2,249</td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">100</td><td style="padding-bottom: 4pt; text-align: left">%</td></tr>
  </table><div>



</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The reduction in revenue in 2023 compared to 2022
was mainly due to reduction in chipsets sales and to lower extent due to reduction in professional services, as we shifted our focus to
chips for production. The increase in revenue in 2022 compared to 2021 was primarily driven by sales of chipsets.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 27pt; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Cost of Revenue</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Cost of revenue includes the manufacturing cost
of radar sensors and chipsets, which primarily consists of components cost, assembly costs and personnel-related costs directly associated
with our customer support personnel and an allocated portion of facility, IT costs and depreciation. Once we are operating on a production
basis, we expect cost of revenue to increase as we increase our revenue, however, we expect the cost per unit to decrease over time as
we shift from the manufacturing of prototype full radar system to production of chipsets sales in response to orders for commercial quantities.
The fixed cost components (most notably labor cost) will also drive margin improvement upon revenue increase due to leveraging economy
of scale notwithstanding increased labor costs.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Cost of revenue for 2023 was approximately $1.5
million, resulting in a gross loss of approximately $0.04 million. Cost of revenue for 2022 was approximately $1.3 million, resulting
in a gross profit of approximately $2.2 million. Cost of revenue for 2021 was approximately $1.4&#160;million, resulting in a gross profit
of $0.8 million.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Gross Margin</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Gross margin for 2023 was negative margin of 2.6%
compared to 63.5% gross margin in 2022 and to 36.0% in 2021. The negative gross margin in 2023 primarily resulted from reduced revenue
and fixed costs. The improvement in gross margin for 2022 compared to 2021 was primarily related to economy of scale, revenue mix and
lower cost per unit as we progress toward commercial production.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Operating Expenses</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Research and Development Expenses</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our research and development efforts are focused
on enhancing and developing the 4D imaging radar chipset solution and the accompanying software.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 27pt; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 27pt; background-color: white"></p><div>

</div><!-- Field: Page; Sequence: 63 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->60<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 27pt; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Research and development expenses include:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-size: 10pt">Personnel-related expenses,
including salaries, benefits, and share-based compensation expense for personnel in research and engineering functions;</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-size: 10pt">Expenses related to materials,
software licenses, supplies and third-party services;</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-size: 10pt">Prototype expenses;</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-size: 10pt">Operation costs related to
develop manufacturing processes;</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-size: 10pt">Allocated portion of facility
and IT costs and depreciation; and</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-size: 10pt">Participation grants received
from the Israel Innovation Authority (&#8220;IIA&#8221;) and the European Union &#8220;Ecsel&#8221; program (Electronic Components and
Systems for European Leadership), which reduced our research and development expense in 2023, 2022 and 2021.</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our principal operating expenses is research and
development, which was approximately $34.1 million in 2023, $36.7 million in 2022 and $28.6 million in 2021. The reduction of $2.6 million
in 2023 compared to 2022 was mainly due to reduction in subcontractors cost and in cost of materials purchased, as we progress towards
production items and to a lesser extent, the reduction related to favorable foreign exchange rate impact, partially offset by increase
in share-based compensation to employees.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The increase in 2022 from 2021 was primarily as
a result of a $8.3 million increase in labor costs including share-based compensation costs, driven mainly by increased headcount and
higher value of equity awards offset by foreign exchange impact, as our expenses are incurred in NIS and our financial statements are
in US dollars.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Research and development expenses in 2024 will
include mainly activities relating to product enhancement and new products as well as the development of the next generation radar system.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Sales and Marketing Expenses</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Sales and marketing expenses were approximately
$5.2 million in 2023 compared to $4.6 million in 2022 and $1.8 million in 2021. The increase of $0.6&#160;million in 2023 was primarily
attributed to an increase in employee share-based compensation, partially offset by favorable foreign exchange rate impact. The increase
of 2.8 million in 2022 was primarily attributed to labor cost, which included share-based compensation, and to a lesser extent an increase
in travel and conferences cost.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Labor cost related expenses consist of salaries
and benefits. Marketing expenses include the cost of sales commissions, marketing programs, trade shows, consulting services, promotional
materials, demonstration equipment and an allocated portion of facility, IT costs and depreciation. We expect that our sales and marketing
expenses will increase in absolute dollars over time as we hire additional sales and marketing personnel to support our customers, Tier-1
supplier relationships, and OEM relationships, as we will also increase our marketing activities and penetration and grow our domestic
and international footprint.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>General and Administrative Expenses</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">General and administrative expenses, which were
approximately $7.6&#160;million in 2023, approximately $8.6&#160;million in 2022 and approximately $3.7&#160;million in 2021, consist
of personnel-related expenses for corporate, executive, finance, and other administrative functions, expenses for outside professional
services, including legal, audit, accounting services and other costs related to our status as a publicly traded company as well as expenses
for facilities, depreciation, and travel. Personnel-related expenses consist of salaries, benefits, foreign exchange rate impact and employee
share-based compensation. The decrease of $1.1 million in 2023 was primarily related to a reduction in our directors and officers (D&amp;O)
insurance. The increase of approximately $4.9 million in 2022 was primarily caused by an increase in labor cost and employee share-based
compensation costs of approximately $2 million and an increase of $2.3 million which was attributed to additional legal, accounting, and
general overhead costs resulting from our status as a public company, most notably directors and officers (D&amp;O) insurance.</p><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><!-- Field: Page; Sequence: 64 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->61<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Financial Expenses, Net</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Financial income, net of $3.4&#160;million in
2023, was primarily related to deposit interest, favorable foreign exchange rate revaluations and to a lesser extent, warrants revaluation
income. Financial income, net of $7.2&#160;million in 2022, was primarily related to revaluations of warrants issued to shareholders partially
offset by loan interest and exchange rate impact. Financial expenses, net of $24.8&#160;million in 2021, were primarily related to $6.3
million revaluations of warrants issued to shareholders and $17.9 million revaluation of convertible loan.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">To the extent that our financial expenses is based
on a change in warrant liability, as our stock price increases the warrant liability increases with a result that we incur a financing
charge as a result of an increased liability, and as our stock price decreases, we incur financing income which has a positive effect
in the results of our operations as a result of a decreased liability.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Liquidity and Capital Resources</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Prior to the Merger with ITAC, we historically
funded our operations primarily from private placements of our equity securities as well as loans, including convertible loans. As a result
of the Merger, we received total gross proceeds of approximately $118.3 million out of which transaction costs were approximately $16.7
million. The total gross proceeds include the $100 million from the sale of 10,000,000 ordinary shares to PIPE investors at $10.00 per
share and $18.3 million, representing the funds remaining in ITAC&#8217;s trust account after payment to the redeeming ITAC stockholders.
As of December 31, 2023, we had cash and cash equivalents totaling $28.6 million and bank deposits totaling $15.4 million, with no debt.
Cash equivalents and bank deposits are invested in accordance with our investment policy. Prior to the Merger, our principal sources of
liquidity was approximately $70&#160;million of net proceeds received through private placements, invested as an advance on account of
issuance of convertible preferred shares (which share were converted into ordinary shares immediately prior to the Merger) or exercise
of warrants.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">During June 2023, we raised $23.0 million from
Special Situations Funds, a family of funds focused primarily on growth oriented small public companies with a concentration on the technology
and life sciences industries, pursuant to which we issued a total of 11,794,873 Ordinary Shares at a purchase price of $1.95 per share.
Existing investors also joined this round. The aggregate net proceeds received by the Company from the offering were $22.5 million&#160;net
of underwriting discounts and other offering costs.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Selected Balance Sheet Information (dollars in
thousands).</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">December 31.</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: justify">Current assets</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">47,436</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">58,756</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">Working capital</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">41,225</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">48,327</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify">Accumulated deficit</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(203,640</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(160,140</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">Shareholders&#8217; equity</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">42,093</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">48,753</td><td style="text-align: left">&#160;</td></tr>
  </table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As of December 31, 2023, we had cash and cash
equivalents totaling $28.6 million and bank deposits totaling $15.4 million. We use our funds primarily for our operating activities.
Cash and cash equivalents are invested in accordance with our investment policy. As of December 31, 2023 and 2022, we had no debt.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Cash Flow Summary</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following table summarizes our cash flows
for the years ended December 31, 2023, 2022 and 2021 (in thousands):</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="10" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Years Ended December&#160;31,</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2021</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-align: left">Net cash used in operating activities</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">(33,513</td><td style="width: 1%; text-align: left">)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">(40,362</td><td style="width: 1%; text-align: left">)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">(26,416</td><td style="width: 1%; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Net cash used in investing activities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(15,251</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(1,318</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(684</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Net cash provided by (used in) financing activities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">23,199</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(4,941</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">125,082</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Net (decrease) increase in cash and cash equivalents and restricted cash</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(25,612</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(45,432</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">97,982</td><td style="text-align: left">&#160;</td></tr>
  </table><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>



</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><!-- Field: Page; Sequence: 65 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->62<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Operating Activities</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">During the year ended December 31, 2023, operating
activities used approximately $33.5&#160;million in cash. The primary factors affecting operating cash flows during this period were
net loss of approximately $43.5&#160;million, impacted by non-cash charges of approximately $13.4&#160;million consisting of $13.6 million
of share-based compensation and depreciation of approximately $0.6&#160;million offset by warrants revaluation of approximately $0.8
million. Additionally, our working capital has decreased by approximately $3.4&#160;million.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">During the year ended December 31, 2022, operating
activities used approximately $40.4&#160;million in cash. The primary factors affecting operating cash flows during this period were
net loss of approximately $40.5&#160;million, impacted by non-cash charges of approximately $1.5&#160;million consisting of $8.1 million
revaluations of warrants, share-based compensation of approximately $9.1&#160;million as well as depreciation of approximately $0.5&#160;million.
Additionally, our working capital has decreased by approximately $1.4&#160;million.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">During the year ended December 31, 2021, operating
activities used approximately $26.4&#160;million in cash. The primary factors affecting operating cash flows during this period were
net loss of approximately $58.1&#160;million, impacted by non-cash charges of approximately $27.1&#160;million consisting of $24.5 million
revaluations of warrants and convertible loan, share-based compensation of approximately $2.3&#160;million as well as depreciation of
approximately $0.3&#160;million. Additionally, our working capital has increased by approximately $4.5&#160;million.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Investing Activities</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">During the year ended December 31, 2023, cash
used in investing activities was approximately $15.3 million, which was primarily from cash used to short-term deposits consist of approximately
$15.0 million and purchase from cash used to equipment and leasehold improvements of approximately $0.3.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">During the year ended December 31, 2022, cash
used in investing activities was approximately $1.3&#160;million, which was primarily from cash used to purchase equipment and leasehold
improvements of approximately $0.9&#160;million and a short-term deposit of approximately $0.4&#160;million.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">During the year ended December 31, 2021, cash
used in investing activities was approximately $0.7&#160;million, which was primarily from cash used to purchase equipment and leasehold
improvements of approximately $0.8&#160;million, partially offset by the withdrawals from short term deposit of approximately $0.1&#160;million.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Financing Activities</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">During the year ended December 31, 2023, cash
provided by financing activities was approximately $23.2&#160;million, consisting primarily of proceeds from issuance of ordinary shares
of approximately $22.5&#160;million and issuance and exercise of options of approximately $0.7 million.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">During the year ended December 31, 2022, cash
used in financing activities was approximately $4.9&#160;million, consisting primarily of repayment of short-term loan of approximately
$5.2&#160;million, partially offset by issuance and exercise of options of approximately $0.3 million.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">During the year ended December 31, 2021, cash
provided by financing activities was approximately $125.1&#160;million, consisting primarily of net proceeds from Merger with ITAC, which
is accounted for as a recapitalization, and net proceeds from the PIPE financing of approximately $98.6&#160;million, proceeds from exercise
of warrants of approximately $12.9&#160;million, proceeds from a convertible loan of approximately $11.3&#160;million and proceeds from
short term loan of approximately $4.7&#160;million as well as from issuance and exercise of options of approximately $0.2 million, partially
offset by repayment of long-term loan of approximately $2.6&#160;million.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 66 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->63<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Funding Requirements</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>




</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We expect our 2024 expenses to be in line with
or slightly greater than the 2023 level. Our production build-up efforts have stabilized, and we have progressed toward productization,
alongside with our efforts to streamline our expenses and to emphasize resources to support our next step target from proof-of-concept
phase to the production and commercialization stage. We continue to expand our research and development activities, and we expect to
incur commercialization expenses related to product sales, marketing, manufacturing and distribution. Our costs and our revenue can be
impacted by the conditions described in the &#8216;Overview under Market Trends and Uncertainties&#8217; as well as the factors described
in Risk Factors, which would affect our requirement for additional funding.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We also expect to incur additional losses before
we receive incremental revenues to offset the losses. We anticipate that we will shift toward profitable operations in the coming years.
We anticipate the current cash balance together with our revenues will enable us to continue until we are cash flow positive from operations.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our losses will be driven by:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-size: 10pt">expand production capabilities
to bring our chipset to automotive grade production;</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-size: 10pt">expand our design, development,
installation and servicing capabilities;</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">

</p><p style="margin-top: 0; margin-bottom: 0">&#160;&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">significant
investment in research and development;</span></td>
</tr></table><div>

</div><p style="margin-top: 0; margin-bottom: 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">increase
our sales and marketing activities and develop our distribution infrastructure; and</span></td>
</tr></table><div>

</div><p style="margin-top: 0; margin-bottom: 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-size: 10pt">increase our general and administrative
expenses to support the growth and public company infrastructure.</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In addition, we may find that these efforts are
more expensive than we currently anticipate or that these efforts may not result in revenues, which would further increase our losses.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We are considering the issuance of debt securities
for working capital in anticipation of our proposed production ramp up in 2025.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">See Item 11 with respect to Quantitative and
Qualitative Disclosures about Market Risk</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Critical Accounting Estimates</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We prepare our consolidated financial statements
in accordance with GAAP. The preparation of these consolidated financial statements requires us to make estimates, assumptions and judgments
that can significantly impact the amounts we report as assets, liabilities, revenue, costs and expenses and the related disclosures.
We base our estimates on historical experience and other assumptions that we believe are reasonable under the circumstances. Our actual
results could differ significantly from these estimates under different assumptions and conditions. We believe that the accounting policies
discussed below are critical to understanding our historical and future performance as these policies involve a greater degree of judgment
and complexity.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><i>Share-Based Compensation</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We recognize the cost of share-based awards granted
to employees and directors based on the estimated grant-date fair value of the awards. We elected to recognize share-based compensation
costs on a straight-line method for awards. Forfeitures are accounted for as they occur.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The fair value of each option award is estimated
on the grant date using the Black-Scholes option pricing model. The application of the Black-Scholes model utilizes significant assumptions,
including volatility. Significant judgment is required in determining the expected volatility of our ordinary share. Due to the limited
history of trading of our Ordinary Shares, we determined expected volatility based on a peer group of publicly traded companies. Increases
(decreases) in the assumptions result in a directionally similar impact to the fair value of the option award.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 67 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->64<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Warrant liabilities</i></p><div>




</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Warrants recorded as liabilities are recorded
at their fair value and remeasured on each reporting date with changes in estimated fair value of ordinary share warrant liability in
the consolidated statement of operations.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In evaluating warrants liabilities, we, with
the assistance of third-party valuations, utilize the Black-Scholes valuation model to estimate the fair value of these warrants at each
reporting date. The application of the Black-Scholes model utilizes significant assumptions, including volatility. Significant judgment
is required in determining the expected volatility of our ordinary share. Due to the limited history of trading of our Ordinary Shares,
we determined expected volatility based on a peer group of publicly traded companies. Increases (decreases) in the assumptions result
in a directionally similar impact to the fair value of the ordinary share warrant liability.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><b>Emerging Growth Company Status</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Section 102(b)(1) of the Jumpstart Our Business
Startups Act of 2012 (&#8220;JOBS Act&#8221;) exempts emerging growth companies from being required to comply with new or revised financial
accounting standards until private companies are required to comply with the new or revised financial accounting standards. The JOBS
Act provides that a company can choose not to take advantage of the extended transition period and comply with the requirements that
apply to non-emerging growth companies, and any such election to not take advantage of the extended transition period is irrevocable.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;We are an &#8220;emerging growth company&#8221;
as defined in Section 2(a) of the Securities Act, and have elected to take advantage of the benefits of the extended transition period
for new or revised financial accounting standards. Following the consummation of the Business Combination, our Post-Combination Company
will remain an emerging growth company until the earliest of (i) the last day of the fiscal year in which the market value of our ordinary
shares that held by non-affiliates exceeds $700 million as of the end of that year&#8217;s second fiscal quarter, (ii) the last day of
the fiscal year in which we achieve total annual gross revenue of $1.235 billion or more during such fiscal year (as indexed for inflation),
(iii) the date on which we issue more than $1 billion in non-convertible debt in the prior three-year period or (iv) December 31, 2025.
We expect to continue to take advantage of the benefits of the extended transition period, although we may decide to early adopt such
new or revised accounting standards to the extent permitted by such standards. This may make it difficult or impossible to compare our
financial results with the financial results of another public company that is either not an emerging growth company or is an emerging
growth company that has chosen not to take advantage of the extended transition period exemptions because of the potential differences
in accounting standards used.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><b>Recent Accounting Pronouncements</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">See Note 2 of Notes to Consolidated Financial Statements for information
related to recent accounting pronouncements.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p><div>

</div><div><a id="a_008"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>ITEM 6. DIRECTORS, SENIOR MANAGEMENT AND EMPLOYEES</b>&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>A. Directors and Senior Management</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following table provides information about
our directors and our senior management. Our senior management consists of our chief executive officer and those current executive officers
who have responsibility for a major segment of our business (<i>&#8220;<b>Senior Management</b>&#8221;)</i>.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: black 1.5pt solid; width: 30%"><span style="font-size: 10pt"><b>Name</b></span></td>
    <td style="width: 1%">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; width: 8%; text-align: center"><span style="font-size: 10pt"><b>Age</b></span></td>
    <td style="width: 1%">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; width: 60%; text-align: center"><span style="font-size: 10pt"><b>Position(s)</b></span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-size: 10pt">Yair Shamir</span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">78</span></td>
    <td>&#160;</td>
    <td><span style="font-size: 10pt">Director and Chairman of the Board</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td><span style="font-size: 10pt">Ehud Levy</span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">58</span></td>
    <td>&#160;</td>
    <td><span style="font-size: 10pt">Director</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-size: 10pt">Boaz Schwartz, PhD</span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">61</span></td>
    <td>&#160;</td>
    <td><span style="font-size: 10pt">Director</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td><span style="font-size: 10pt">E.&#160;Scott Crist</span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">58</span></td>
    <td>&#160;</td>
    <td><span style="font-size: 10pt">Director</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-size: 10pt">Thilo Koslowski</span></td>
    <td>&#160;</td>
    <td style="text-align: center"/>
    <td>&#160;</td>
    <td><span style="font-size: 10pt">Director</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td><span style="font-size: 10pt">Alexander Hitzinger</span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">52</span></td>
    <td>&#160;</td>
    <td><span style="font-size: 10pt">Director</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-size: 10pt">Yonina Eldar, PhD</span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">51</span></td>
    <td>&#160;</td>
    <td><span style="font-size: 10pt">Director</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td><span style="font-size: 10pt">Kobi Marenko</span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">51</span></td>
    <td>&#160;</td>
    <td><span style="font-size: 10pt">Chief Executive Officer and Director (co-founder)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-size: 10pt">Noam Arkind, PhD</span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">37</span></td>
    <td>&#160;</td>
    <td><span style="font-size: 10pt">Chief Technology Officer and Director (co-founder)</span></td></tr>

<tr style="vertical-align: bottom; background-color: White">
    <td><span style="font-size: 10pt">Karine Pinto-Flomenboim</span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">46</span></td>
    <td>&#160;</td>
    <td><span style="font-size: 10pt">Chief Financial Officer</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-size: 10pt">Ram Machness</span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">51</span></td>
    <td>&#160;</td>
    <td><span style="font-size: 10pt">Chief Business Officer</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td><span style="font-size: 10pt">Shlomit Hacohen</span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">50</span></td>
    <td>&#160;</td>
    <td><span style="font-size: 10pt">Chief Marketing Officer</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-size: 10pt">Shay Naeh</span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">54</span></td>
    <td>&#160;</td>
    <td><span style="font-size: 10pt">Vice President Operations</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>Nadav Snir</td>
    <td>&#160;</td>
    <td style="text-align: center">43</td>
    <td>&#160;</td>
    <td>Vice President IC</td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 68 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->65<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Directors</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Yair Shamir, Chairman of the Board</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Mr.&#160;Shamir was appointed as a director on
December&#160;9, 2019, and he has served as Chairman of the Board since December 16, 2021. Mr.&#160;Shamir is co-founding and managing
partner of Catalyst Investments. Mr.&#160;Shamir was elected as a member of the 19<sup>th</sup> Knesset (Israeli Parliament) and served
as Minister of Agriculture and Rural Development for the Government of Israel from 2013 until&#160;2015. Mr.&#160;Shamir serves as chairman
of the Shalem College, a research and educational institute in Jerusalem. Mr.&#160;Shamir has formerly served as chairman of the National
Road Safety Authority and of four government companies: Metropolitan Mass Transit System (NTA), Israel Aerospace Industries (IAI), EL-AL
Israel Airways and the National Roads Company.&#160; Mr.&#160;Shamir has served as a member of numerous company boards within Catalyst&#8217;s
investment portfolio. From 2003 to-2007, Mr.&#160;Shamir was the Chairman of Shamir Optical Industry Ltd (NASDAQ:&#160;SHMR). From&#160;1997-2006,
Mr.&#160;Shamir served as the CEO and Chairman of VCON Telecommunications Ltd. From&#160;2005-2013, he served as a board member of DSP
Group Corporation (NASDAQ:&#160;DSPG). Mr.&#160;Shamir was the CEO of Elite Food Industries, Ltd. between the&#160;years of 1994 and
1995. From 1995 to 1997, Mr.&#160;Shamir served as Executive Vice President of the Challenge Fund L.P.&#160;Prior to this he was Executive
VP of Scitex Corporation and General Manager of Scitex Israel from 1988 until&#160;1993.&#160;Mr.&#160;Shamir was the Chairman of Gvahim
from 2006 to 2013. He was also a Board Member of Mikveh Israel from 2010 until&#160;2013. Mr.&#160;Shamir was also a member of the Board
of Governors of the Technion University and sat on the executive committee of the Beer Sheva University from 1990 until&#160;2013. Mr.&#160;Shamir
served in the Israeli Air Force as a pilot and engineer from&#160;1965-1988. During his term in the Air Force, Mr.&#160;Shamir attained
the rank of colonel and served as head of the electronics department, the highest professional electronics position within the Israeli
Air Force. Mr.&#160;Shamir holds a B.Sc. in Electronics Engineering from the Technion, Israel Institute of Technology.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Ehud Levy, Director</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Mr.&#160;Levy was appointed as a director on
March&#160;29, 2016. Mr.&#160;Levy is the Managing General Partner of Canaan Partners Israel, and a Venture Partner with Lenovo Capital
heading its investment opportunities in Israel. Mr. Levy is also an active private investor in tech companies operating as a partner
with a leading investment team, Kaedan Capital. Prior to these activities, Mr.&#160;Levy was a Managing Partner at Vertex VC for seven&#160;years.
Among other successful investments, Mr.&#160;Levy identified Waze as a bright star from the start, leading the first investment round
in the company and serving on its board of directors until its acquisition by Google for over $1 billion. Previously, Mr.&#160;Levy co-founded
and served as Chairman and CEO of Ki-Bi Mobile Technologies, a mass-market device specialist for mobile content distribution and led
the business from concept to commercial success, an IPO in London and eventual acquisition. Earlier, Mr.&#160;Levy served as COO and
CFO of Telegate, a telecommunications company, where he was responsible for a restructuring plan leading to the successful acquisition
of the company for over US$400 million. Prior to Telegate, Mr.&#160;Levy was an investment banker in New&#160;York and Tel Aviv, served
on the board of directors of several technology companies. Mr.&#160;Levy holds a BSc in Computer Engineering (with honors) from the Technion
in Israel, and an MBA from Columbia Business School, New&#160;York.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Boaz Schwartz PhD, Director</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Dr.&#160;Schwartz was appointed as a director
on October 7, 2021, upon closing of the Merger. Dr. Schwartz is a seasoned finance professional and a tech investor. Dr.&#160;Schwartz
has founded and managed Deutsche Bank Israel for 24&#160;years and until December&#160;2020. Following his retirement from Deutsche Bank,
Dr. Schwartz became an active tech investor in both early and late-stage companies. He has a wide portfolio of investments in Fintech,
Autotech and other technology related ventures. Dr.&#160;Schwartz is an active investor and works closely with his investee companies
helping on both strategy and finance related matters. Dr.&#160;Schwartz has developed Deutsche Bank Israel to become one of the leading
global investment banks operating in Israel with very strong corporate finance advisory franchise, the leading project finance bank in
Israel, the top foreign bank on TASE, and a leading trader in the Israeli fixed income and forex. Dr.&#160;Schwartz is a senior advisor
to Vitruvian Partners in Israel; a board member and chairman of the finance committee&#160;of IDC Herzliya&#160;&#8212;&#160;the only
private university in Israel&#160;;board member of iArgento Ltd&#160;&#8212;&#160;a traded venture capital fund; Covercy Ltd&#160;&#8212;&#160;a
real estate investment management SaaS platform and Foretellix Ltd. - a verification and validation automation tool for autonomous vehicles;
a board observer of Addionics Ltd. - an enabling battery technology for automotive industry and Trieye - a leading HD SWIR imaging and
3D camera developer;&#160;and the vice-Chairman of Zabar Solar Ltd.&#160;&#8212;&#160;a leading green energy developer and operator.
Dr.&#160;Schwartz is also a long time member of the Israeli chapter of the YPO.&#160;Dr.&#160;Schwartz earned a PhD in Finance from the
University of Chicago; MBA with Distinction from the Wharton School at the University of Pennsylvania; MSc and BSc in Electrical Engineering
from the University of Tel Aviv.&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><!-- Field: Page; Sequence: 69 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->66<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>E.&#160;Scott Crist, Director</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Mr.&#160;Crist was appointed as a director on
October 7, 2021, upon closing of the Merger. Mr. Crist is managing partner for Texas Ventures as well as CEO of Osperity, a leader in
AI-driven computer vision for the industrial sector. Mr.&#160;Crist has an extensive background as an entrepreneur and venture capitalist
and was the former CEO of Infrastructure Networks and founder/CEO of Telscape International (NASDAQ), a telecommunications company focused
on certain emerging markets around the world. Prior to that, he served as President and CEO for Matrix Telecom, which Inc. Magazine once
ranked 7<sup>th</sup> on its list of the 500 fastest growing private companies in the US.&#160;Previously, Mr.&#160;Crist worked for
Trammell Crow Group, IBM and Booz-Allen Hamilton. Mr.&#160;Crist has a Master of Business Administration from the Kellogg School at Northwestern
University and a Bachelor of Science in Electrical Engineering from NC State University. Mr.&#160;Crist is also an Entrepreneur of the
Year recipient from NASDAQ/Ernst&#160;&amp; Young. In addition, Mr.&#160;Crist is chairman of the VA-Gov Housing fund, the nation&#8217;s
largest lender for the Veteran Administration&#8217;s Homeless Shelter Program.&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Thilo Koslowski, Director </i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Mr. Koslowski was appointed
as a director on February 21, 2022. Mr. Koslowski is a board advisor and an executive strategic consultant to various companies and startups
in the technology, automotive and digital business markets and to venture capital firms. Mr. Koslowski has an extensive background in
the fields of autonomous cars, smart-mobility and digital customer experience. From 2016 to 2020, Mr. Koslowski was the founder and CEO
of Porsche Digital, a wholly owned subsidiary of Porsche AG, serving as the technology and digital unit of Porsche AG. From 1999-2016,
Mr. Koslowski was VP and practice leader at Gartner, Inc, a leading technological research and advisory firm, where he established Gartner&#8217;s
global automotive advisory-services. Mr. Koslowski is a board member, observer and investor in international startups. In addition, as
part of Mr. Koslowski&#8217;s years at Porsche Digital, he was the co-founder and board member of APX, Europe&#8217;s leading early-stage
joint venture capital, backed by both Axel Springer and Porsche.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Alexander Hitzinger, Director </i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><i>&#160;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Mr. Hitzinger was appointed
as a director on May 2, 2022. Mr. Hitzinger led the self- driving development, was a member of the management board of Volkswagen Commercial
Vehicles from January 2019 to June 2020 and from June 2020 to February 2022 served as chief executive officer of Artemis GmbH, where he
was the chief architect of the revolutionary vehicle concept for next generation autonomous mobility for their flagship-product Audi Landjet.
Prior to his role at VW Group, from April 2016 to January 2019, Mr. Hitzinger held the position of head of product design for autonomous
transportation at Apple, where he was responsible for building and leading the automotive team at the company. He was also the technical
director and chief engineer for the Porsche 919, which was the winner of 24 hours of Le Mans and the World Endurance Championship for
three consecutive years. Mr. Hitzinger also serves as a Board Member and Advisor to multiple technology companies in the United States
and Israel, such as Arbe Robotics, Electra Vehicles, Tau Motors and Foretellix. Mr. Hitzinger holds a Bachelor in Mechanical Engineering
and a Masters in Business Administration.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Yonina Eldar PhD, Director</i></b></p><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Prof. Eldar was appointed as a director on November
7, 2023. Prof. Eldar, is a professor in the Department of Mathematics and Computer Science, Weizmann Institute of Science, Rehovot, Israel,
where she holds the Dorothy and Patrick Gorman Professorial Chair and heads the Center for Biomedical Engineering. Prof. Eldar was previously
a professor in the Department of Electrical Engineering at the Technion, where she held the Edwards Chair in Engineering. Prof. Eldar
is also a visiting professor at MIT, a visiting scientist at the Broad Institute, a visiting research collaborator at Princeton, an adjunct
professor at Northeastern University and Duke University, an advisory professor of Fudan University, a distinguished visiting professor
of Tsinghua University, and was a visiting professor at Stanford. Prof. Eldar is a member of the Israel Academy of Sciences and Humanities
(elected 2017) and of the Academia Europaea (elected 2023), an IEEE Fellow, a EURASIP Fellow, a Fellow of the Asia-Pacific Artificial
Intelligence Association, and a Fellow of the 8400 Health Network. Prof. Eldar is author of the book &#8220;Sampling Theory: Beyond Bandlimited
Systems&#8221; and co-author of eight other books in the areas of convex optimization, compressed sensing, radar, communications, imaging,
information theory and machine learning. Prof. Eldar received her B.Sc. degree in physics and B.Sc. degree in Electrical Engineering
from Tel-Aviv University, and her Ph.D. in electrical engineering and computer science from the Massachusetts Institute of Technology.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 70 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->67<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Senior Management</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Kobi Marenko<i>, </i>Chief Executive Officer,
Co-Founder and Director</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Mr. Marenko has served as a director and our Chief
Executive Officer since inception on November 4, 2015. Jacob Marinka, who is also known as Kobi Marenko, is an entrepreneur with over
20&#160;years of experience in leading technology and media startups from seed stage to acquisition. Prior to founding us, from 2012 to
2014, Mr.&#160;Marenko was the founder and President of Taptica, a mobile DSP listed on the London Stock Exchange (LON: TRMR). Prior to
this experience, from 2004-2012, Mr. Marenko was the founder and CEO of Logia, a mobile content platform acquired by Digital Turbine (NASDAQ:
APPS). For over 20 years, Mr. Marenko was leading tech and media startups from seed to acquisition. Mr.&#160;Marenko holds a BA in Philosophy
from Tel Aviv University.</p><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Noam Arkind PhD, Chief Technology Officer,
Co-Founder and Director</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Dr. Arkind has served as a director and our Chief
Technology Officer since inception on November 4, 2015. Dr.&#160;Arkind has over 10&#160;years of experience in R&amp;D and holds a Ph.D.
in Applied Mathematics from the Robotics Lab at Weizmann Institute of Science. Prior to founding us, from 2013 to 2015, Dr.&#160;Arkind
led the algorithm development at Taptica and the Space IL control system. Dr.&#160;Arkind holds a B.Sc. in Applied Mathematics from Bar
Ilan University, a M.Sc. and PhD in Mathematics and Computer Science from the Weizmann Institute of Science.</p><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Karine Pinto-Flomenboim, Chief Financial Officer
</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Ms.&#160;Pinto-Flomenboim has served as our Chief
Financial Officer since November 8, 2021. Ms.&#160;Pinto-Flomenboim has more than 20 years of financial experience, having worked with
multinational publicly traded companies. Prior to joining us, from 2019 to 2021, Ms.&#160;Pinto-Flomenboim served as the Chief Financial
Officer of TIBA, a leading manufacturer of parking access and revenue control systems, where she led the company&#8217;s exit for $135M
and navigated the company through a reorganization, M&amp;A and COVID-19. Prior to this experience, from 2011 to 2018, Ms. Pinto-Flomenboim
held the position of director of business controlling and head of corporate FP&amp;A at Caesarstone Ltd. (Nasdaq: CSTE), a global publicly
traded company that invented and pioneered quartz surfaces. From 2003 to 2011, Ms. Pinto-Flomenboim held the position of head of FP&amp;A
at the process diagnostic and control (PDC) division of Applied Materials, Inc. (Nasdaq: AMAT). From 2000 to 2003 Ms.&#160;Pinto-Flomenboim
served at various financial positions at Intel Fab 8 (Nasdaq: INTC). Ms. Pinto-Flomenboim holds a master&#8217;s in economics from the
Hebrew University of Jerusalem, graduated from The National Investor Relations Institute (NIRI), and is an active member of the Israeli
CFO Forum.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Ram Machness, Chief Business Officer</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Mr. Machness has served as our Chief Business
Officer since April 30, 2018. Since July 2023, Mr. Machness has also served as head of our radar group. Mr.&#160;Machness has over 30&#160;years
of experience in embedded systems and the semiconductor industry. Prior to joining us from 2007 to 2018, Mr.&#160;Machness managed the
business development, customer engagement and product marketing at TI (Nasdaq: TXN), a Global American based technology company that designs
and manufactures semiconductors. Prior to this experience, from 2003-2007, Mr.&#160;Machness served in various consulting position in
companies such DSP Group (Nasdaq: DSPG), a global leader in wireless communications and voice processing chipsets and algorithms for a
wide range of smart-enabled devices, and Microsoft (Nasdaq: MSFT), A multinational technology corporation which produces computer software,
consumer electronics, personal computers, and related services. His professional experience also includes roles in system engineering
and R&amp;D management. Mr.&#160;Machness holds a B.A in Computer Science from The Open University and an MBA Tel Aviv University.</p><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 71 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->68<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Shlomit Hacohen, Chief Marketing Officer</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Ms.&#160;Hacohen has served as our Chief Marketing
Officer since November 27, 2017. Ms.&#160;Hacohen is a seasoned marketer with over 20&#160;years of experience in developing marketing
strategies, launching products, and building brand awareness. Prior to joining us, from 2015 to 2017, Ms.&#160;Hacohen was CMO and executive
marketer in organizations such as DEEP, Collabrium, Viaccess Orca, Comverse (Nasdaq: CMVT), and Check Point (Nasdaq: CHKP). Ms.&#160;Hacohen
holds a BA in Management and Sociology from Tel Aviv University and an MBA from the Technion.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Shay Naeh, Vice President Operations</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Mr. Naeh has served as our Vice President Operations
since December 6, 2020. Mr.&#160;Naeh has over 23&#160;years of experience in semiconductors design, program management, quality, and
operations with automotive Tier 1s and OEMs.&#160;Prior to joining us, from 1998 to 2020, Mr.&#160;Naeh worked with Texas Instruments
(Nasdaq: TXN) and Valens (NYSE: VLN). Mr.&#160;Naeh holds a B.Sc. in Electrical Engineering and an MBA both from the Tel Aviv University.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Nadav Snir, Vice President IC</b></p><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Mr. Snir has served as our Vice President IC since
February 2023. As Vice President IC, Mr. Snir leads our IC Research and Development group. From July 2018, Mr. Snir led our RFIC R&amp;D
team. Prior to joining us, Mr. Snir worked as an RFIC Design Engineer at DSP Group and at ELIPSE RFIC Array Devices. Mr. Snir received
an MBA degree from the Technion, and a B.Sc. in Electrical and Computer Engineering from Ben Gurion University.</p><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Director Independence</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As an Israeli company, we are subject to various
corporate governance requirements under the Israeli Companies Law. Pursuant to regulations promulgated under the Israeli Companies Law,
companies with shares traded on certain U.S.&#160;stock exchanges, including Nasdaq, may, subject to certain conditions, opt out from
the Israeli Companies Law requirements to appoint external directors and related Israeli Companies Law rules concerning the composition
of the audit committee, compensation committee and nominating committee of the board of directors (other than the gender diversification
rule under the Israeli Companies Law, which requires the appointment of a director from the other gender if at the time a director is
appointed all members of the board of directors are of the same gender). In accordance with these regulations, we have elected to opt
out of those requirements of the Israeli Companies Law. These exemptions will continue to be available to us so long as: (i)&#160;we
do not have a &#8220;controlling shareholder&#8221; as defined under the Israeli Companies Law, (ii)&#160;our shares are traded on certain
U.S.&#160;stock exchanges, including Nasdaq, and (iii)&#160;we comply with the director independence requirements and the audit committee,
compensation committee and nominating committee composition requirements under U.S.&#160;laws (including applicable Nasdaq rules) applicable
to U.S.&#160;domestic issuers.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">With respect to certain matters (including various
related party transactions), a controlling shareholder is deemed to include a shareholder that holds 25% or more of the voting rights
in a public company if no other shareholder holds more than 50% of the voting rights in the company, but excludes a shareholder whose
power derives solely from his or her position as a director of the company or from any other position with the company.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We comply with Nasdaq rule&#160;5605(b)(1), which
requires that the board of directors be comprised of a majority of independent directors, although as long as we are a foreign private
issuer, we may elect to follow Israeli law in lieu of certain Nasdaq requirements, including the independent director requirement. A&#160;majority
of our board of directors composed of directors who are &#8220;independent&#8221; as defined by the rules of Nasdaq, and all of the non-executive
directors qualify as &#8220;independent&#8221; under these standards. The board of directors established categorical standards to assist
it in making its determination of director independence. We use the definition of &#8220;independence&#8221; of Nasdaq to make this determination.
Nasdaq Listing Rule&#160;5605(a)(2)&#160;provides that an &#8220;independent director&#8221; is a person other than an officer or employee
or any other individual having a relationship which, in the opinion of the Board, would interfere with the exercise of independent judgment
in carrying out the responsibilities of a director, and includes specific relationships that would disqualify a director from being independent,
including being an employee during the past three years.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 72 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->69<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p><div>




</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The board of directors will assess on a regular
basis, at least annually, which members are independent, and the Nomination and Corporate Governance Committee will assess the independence
of each nominee for director as part of its duties in designating nominations for the board of director&#8217;s nominees for director.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As a foreign private issuer, we are permitted
to comply with Israeli corporate governance practices instead of the Nasdaq corporate governance rules,&#160;provided&#160;that, we disclose
which requirements we are not following and the equivalent Israeli requirement. We rely on this &#8220;home country practice exemption&#8221;
with respect to the quorum requirement for shareholder meetings and with respect to the Nasdaq requirement of obtaining stockholder approval
for the certain issuance of more than 20% of our common shares. As permitted under the Israeli Companies Law, pursuant to our Restated
Articles, the quorum required for an ordinary meeting of shareholders consist of at least two shareholders present in person, by proxy
or by other voting instrument in accordance with the Israeli Companies Law, who hold at least 25% of the voting power of its shares (and
in an adjourned meeting, with some exceptions, any number of shareholders). Israeli law has no requirement for obtaining shareholder
approval for the issuance of equity securities and, accordingly, our board has the authority to issue ordinary shares without obtaining
shareholder approval under circumstances where shareholder approval is required under the Nasdaq corporate governance regulations. Although
we comply with the rules generally applicable to U.S.&#160;domestic companies listed on Nasdaq, we may in the future decide to use the
foreign private issuer exemption with respect to some or all of the other corporate governance rules. To the extent that we elect to
take advantage of the exceptions permitted to foreign private issuers, we must disclose those exceptions and describe the relevant Israeli
law provisions.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;<b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>6. B. Compensation&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Required Approvals under the Israeli Companies
Law</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Under the Israeli Companies Law, terms of office
and employment of executive officers and directors, are generally subject to the approval of the compensation committee and the board
of directors and must generally be consistent with the Company&#8217;s Compensation Policy, which is mandated by the Israeli Companies
Law.</p><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Directors</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Under the Israeli Companies Law, the compensation
of a public company&#8217;s directors generally requires the approval of its compensation committee, the subsequent approval of its board
of directors and, unless exempted under regulations promulgated under the Israeli Companies Law, the approval of its shareholders at
a general meeting. If the compensation is inconsistent with the Company&#8217;s compensation policy, the shareholder approval will require
the Compensation Majority.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The term &#8220;Compensation Majority&#8221; refers
to an approval requirement under the Israeli Companies Law, pursuant to which, certain compensation arrangements are subject to a simple
majority vote of the shares present and voting at a shareholders meeting, in person or by proxy, and voting thereon, provided that either:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -26.7pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-size: 10pt">such
                                            majority includes at least a majority of the shares held by disinterested shareholders who
                                            vote at the general meeting, with disinterested shareholders being defined as shareholders
                                            who are not controlling shareholders and do not have a personal interest in such compensation
                                            policy; or</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 49.65pt; text-align: justify; text-indent: -1cm">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-size: 10pt">the
                                            total number of shares of&#160;the disinterested shareholders who vote against the policy,
                                            does not exceed 2% of the company&#8217;s aggregate voting rights.</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Executive Officers (Other than the Chief Executive
Officer)</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Israeli Companies Law requires that the compensation
of a public company&#8217;s executive officers (other than the chief executive officer) shall be approved by the compensation committee,
and the subsequent approval of its board of directors. If such compensation arrangement is inconsistent with the company&#8217;s stated
compensation policy, then shareholder approval by the vote of a Compensation Majority is also required. However, if the shareholders
of the company do not approve a compensation arrangement with an executive officer that is inconsistent with the company&#8217;s stated
compensation policy, the compensation committee and board of directors may override the shareholders&#8217; decision if each of the compensation
committee and the board of directors provide detailed reasons for their decision.&#160; Our Compensation Policy enables our chief executive
officer to approve immaterial changes in the terms of employment of an executive officer (provided that the changes of the terms of employment
are in accordance with our Compensation Policy) and allows us to exculpate, indemnify and insure its executive officers and directors
subject to certain limitations as set forth therein.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 73 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->70<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Chief Executive Officer</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Under the Israeli Companies Law, the compensation
of a public company&#8217;s chief executive officer is required to be approved by the compensation committee, the subsequent approval
of its board of directors and, unless exempted under regulations promulgated under the Israeli Companies Law, the approval of its shareholders
at a general meeting, by a vote of a Compensation Majority, whether or not consistent with the Compensation Policy.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">However, if the shareholders do not approve the
compensation arrangement with the chief executive officer, then the compensation committee and board of directors may override the shareholders&#8217;
decision, based on detailed reasons for their decision.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>CEO and Director Nominees</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Shareholder approval may not be required for
the compensation terms of a candidate for the chief executive officer position or a director nominee, for the period commencing on the
appointment and until the upcoming shareholders meeting, if the board of directors and the compensation committee have approved such
terms and have determined that the compensation arrangement is consistent with our Compensation Policy, and that the proposed compensation
terms are generally under the same circumstances and are not materially different than the predecessor of such candidate.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In addition, in certain circumstances, the compensation
committee may waive the need in shareholder approval requirement with regard to the approval of the engagement terms of a candidate for
the chief executive officer position (or a director nominee who is not an executive director) if they determine that the compensation
arrangement is consistent with the company&#8217;s Compensation Policy, that the chief executive officer (or the director nominee) did
not have any affiliation or prior business relationship with the company or a controlling shareholder of the company, and that such engagement
terms would be detrimental to the company&#8217;s ability to engage the chief executive officer candidate.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Aggregate Compensation of Executive Officers and Directors </b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">For the years ended December 31, 2023 and 2022,
we paid an aggregate of $5.0 million and $4.53 million, respectively, in cash and benefits in-kind, including equity compensation,
to or accrued on behalf of all of our directors and members of Senior Management for their services in all capacities during 2023 and
2022, and directors&#8217; fees. These amounts include amounts set aside or accruals for pension, severance, retirement or similar benefits
or expenses, in the amounts of approximately $274,000 and $411,000, for the years ended December 31, 2023 and 2022, respectively, but
does not include reimbursement of business travel, relocation, professional and business association dues and expenses, and other benefit
costs commonly reimbursed or paid by companies in Israel which are not treated as compensation. In addition, we incurred $2,640,000 and
$2,244,000 of share-based compensation expense related to equity awards made by us to our Senior Management and directors for the years
ended December 31, 2023 and 2022, respectively. For the year ended December 31, 2022, the aggregate compensation for all or our directors
and Senior Management includes $1,052,000 for individuals who served in such capacities during 2022 but are no longer employed by us.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As of December 31, 2023, (i) options to purchase
2,266,173 ordinary shares, and (ii) 541,681 restricted stock units granted to our current Senior Management and directors were outstanding
under our equity incentive plans at a weighted-average exercise price of $4.81 per share.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Equity-based compensation granted to Senior Management
generally vests over a period of four years, commencing one year after the date of grant, with quarterly vesting thereafter, however,
equity-based compensation granted in 2023 as an additional award, vests one-year after the date of grant. For directors, equity-based
compensation generally vests over a period of three years with a quarterly vesting.</p><div>



</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 74 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->71<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Individual Compensation of Covered </b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">The table below sets
forth the compensation paid to our chief executive office, our chief technology officer and our five most highly compensated &#8216;office
holders&#8217; (as defined by the Israeli Companies Law) during or with respect to the year ended December&#160;31, 2023, and as recorded
in the financial statements for such period. We refer to those five individuals for whom disclosure is provided herein as our &#8220;Covered
Executives.&#8221;</p><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">The term &#8220;compensation&#8221;
for purposes of this section regarding the Covered Executives refers to the term &#8220;Terms of Office and Employment&#8221; as defined
under the Israeli Companies Law, which includes amounts accrued or paid in connection with salary cost, consultancy fees, bonuses, equity-based
compensation, retirement or termination payments, benefits and perquisites such as car, phone and social benefits and any undertaking
to provide such compensation. Each of the Covered Executives was covered by our directors and officers liability insurance policy and
was entitled to indemnification and exculpation in accordance with applicable law and our articles of association.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><i>&#160;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><i>Summary Compensation Table: </i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td colspan="21" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-size: 10pt"><b>Information
    Regarding the Covered Executive<sup>(1)</sup></b></span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; border-bottom: Black 1.5pt solid"><span style="font-size: 10pt"><b>Name and Principal Position<sup>(2)</sup></b></span></td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-size: 10pt"><b>Salary<sup>(3)</sup></b></span></td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Bonus<sup>(4)</sup></td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="white-space: nowrap; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-size: 10pt"><b>Equity-Based<br/>
    Compensation<sup>(5)</sup></b></span></td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>All
Other<br/>
Compensation&#160;<sup>(6)</sup></b></p></td><td style="padding-bottom: 1.5pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Total</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 40%; text-align: left; text-indent: -9pt; padding-left: 9pt">Kobi Marenko, Chief Executive Officer</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">314,615</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">&#160;</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">167,016</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">14,516</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">496,147</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; text-indent: -9pt; padding-left: 9pt">Noam Arkind PhD, Chief Technology Officer</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">317,023</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">166,933</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">6,176</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">490,132</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -9pt; padding-left: 9pt">Ram Machness, Chief Business Officer</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">263,967</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">25,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">616,948</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">23,130</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">929,045</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; text-indent: -9pt; padding-left: 9pt">Gonen Barkan, Chief Radar Officer</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">261,952</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">560,495</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">31,855</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">854,302</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -9pt; padding-left: 9pt">Karine Pinto-Flomenboim, Chief Financial Officer</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">233,008</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">521,599</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3,033</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">757,640</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; text-indent: -9pt; padding-left: 9pt">Ben Rathaus, PhD, Vice President AI and Perception</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">240,446</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">401,016</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3,033</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">644,495</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -9pt; padding-left: 9pt">Shlomit Hacohen, Chief Marketing Officer</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">201,266</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">412,654</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3,033</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">616,953</td><td style="text-align: left">&#160;</td></tr>
  </table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white; text-indent: 0.5in">&#160;</p><div>

</div><!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 25%"><div style="font-size: 1pt; border-top: Black 1.5pt solid">&#160;</div></div><!-- Field: /Rule-Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white; text-indent: 0.5in"></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"/><td style="width: 0.25in; text-align: left"><span style="font-size: 10pt">(1)</span></td><td style="text-align: justify"><span style="font-size: 10pt">All
                                            amounts reported in the table are in terms of our cost as reflected in our consolidated financial
                                            statements for the year ended December&#160;31, 2023, plus compensation paid to such Covered
                                            Executives in 2024 in respect of services provided during 2023.</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"/><td style="width: 0.25in; text-align: left"><span style="font-size: 10pt">(2)</span></td><td style="text-align: justify"><span style="font-size: 10pt">All
                                            Covered Executive listed in the table are full-time employees.</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.7pt; text-align: justify; text-indent: -17.85pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in; text-align: left"><span style="font-size: 10pt">(3)</span></td><td style="text-align: justify"><span style="font-size: 10pt">Salary
                                            includes the Covered Executive&#8217;s gross salary plus payment of social benefits made
                                            by us on behalf of such Covered Executive. Such benefits may include, to the extent applicable
                                            to the Covered Executive, payments, contributions and/or allocations for savings funds (such
                                            as managers&#8217; life insurance policy), education funds (referred to in Hebrew as &#8220;keren
                                            hishtalmut&#8221;), pension, severance, risk insurances (such as life, or work disability
                                            insurance), payments for social security and tax gross-up payments, vacation, and benefits,
                                            convalescence or recreation pay and other benefits and perquisites consistent with our policies.</span></td>
</tr><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left">&#160;</td><td style="text-align: justify">&#160;</td></tr>
     <tr style="vertical-align: top; text-align: justify">
<td style="text-align: left">(4)</td><td style="text-align: justify"><p style="margin: 0pt 0">We did not pay bonuses to our Covered Executives in 2023, except that
we paid Mr. Machness a bonus for assuming the additional duties as head of our radar group.</p></td></tr>
     </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.7pt; text-align: justify; text-indent: -17.85pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"/><td style="width: 0.25in; text-align: left"><span style="font-size: 10pt">(5)</span></td><td style="text-align: justify">Equity-based compensation represents the financial expense reflected in our consolidated financial statements
for the year ended December&#160;31, 2023, with respect to equity-based compensation vested during 2023. Assumptions and key variables
used in the calculation of such amounts are described in Note <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">9
of Notes to Consolidated Financial Statements, which are included in this annual report. The amounts reported in this column do not represent
the number of shares and options held by the office holders. See Item 6E of this annual report for information regarding the equity holding
of our chief executive officer, chief technology officer and all officers and directors as a group.</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.7pt; text-align: justify; text-indent: -17.85pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"/><td style="width: 0.25in; text-align: left"><span style="font-size: 10pt">(6)</span></td><td style="text-align: justify"><p style="margin: 0pt 0; font: 10pt Times New Roman, Times, Serif">All other compensation represents mainly leased vehicles and other
incidental monetary benefits.</p></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 75 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->72<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Non-Employee Director Remuneration </i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>




</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The current composition of our Board of Directors
includes three directors who do not occupy executive positions with us (Mr. Shamir, Mr. Levy and Mr. Crist, hereinafter &#8220;<b>Non-Executive
Directors</b>&#8221;), four directors who we consider to be industry experts (Dr. Schwartz, Mr. Koslowski, Mr. Hitzinger, and Prof. Eldar
hereinafter &#8220;<b>Industry Expert Directors</b>&#8221;), and two directors who are executive officers (Mr. Marenko and Dr. Arkind,
hereinafter &#8220;<b>Executive Directors</b>&#8221;).</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Consistent with our Compensation Policy for directors
and officers, our Compensation Committee, Board and the shareholders, have approved that the Non-Executive Directors shall receive an
annual fee of $30,000 plus applicable value added tax as remuneration for their service on the Board, and that Industry Expert Directors
shall receive an annual fee of $100,000, other than Prof. Eldar who is a full time professor and researcher at the Weizmann Institute
of Science and receives $50,000, plus applicable value added tax as remuneration for their service on the Board.&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Prof. Eldar was appointed to our Board on a vacancy
basis on November 7, 2023, and her annual compensation will be brought for the shareholder approval at the 2024 annual general meeting,
pursuant to the circumstances described under &#8220;<i>CEO and Director Nominees</i>&#8221; above.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In addition, our Compensation Committee, Board
and the shareholders have approved, consistent with our Compensation Policy, the grant to our Non-Executive and Industry Expert Directors
equity-based compensation, that generally vests over a period of three years with a quarterly vesting, for a term of ten years (subject
to early expiration in the event of termination of services and as described in our 2021 Plan) as follows:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; text-align: justify"><b>Name of Director</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><b>Amount of Options</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><b>Exercise Price</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: center"><b>Fully Vested</b></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 33%; text-align: justify">Dr. Boaz Schwartz</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 15%; text-align: right">81,589</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 15%; text-align: right">8.00</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 30%; text-align: center">October 2024</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">40,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">2.873</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">August 2026</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">Mr. Thilo Koslowski</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">80,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">8.00</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">March 2025</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">40,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">2.873</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">August 2026</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify">Mr. Alexander Hitzinger</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">80,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">6.04</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">May 2025</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">40,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">2.873</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">August 2026</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">Prof. Yonina Eldar*</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">80,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">2.074</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">November 2026</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify">Mr. Yair Shamir</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">80,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">2.873</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">August 2026<i>&#160;&#160;</i></span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">Mr. Ehud Levy</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">80,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">2.873</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">August 2026<i>&#160;&#160;</i></span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify">Mr. Scott Crist</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">80,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">2.873</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">August 2026<i>&#160;&#160;</i></span></td></tr>
  </table><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"/><td style="width: 0.25in; text-align: left">*</td><td style="text-align: justify">The grant of Prof. Edlar&#8217;s options will be brought for
the shareholder approval at the 2024 annual general meeting.</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We also reimburse our Industry Expert Directors
for travel expenses up to an amount of 9,000 Euros a year for their services and for participating in Board meetings in Israel to the
extent incurred.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>CEO and CTO Annual Bonus Plan</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In August 2023 our shareholders approved, following
the approvals of the Compensation Committee and the Board, a framework annual cash bonus plan to each of Mr. Marenko, our Chief Executive
Officer, and Dr. Arkind, our Chief Technology Officer, based on performance-based measurable criteria for each calendar year as of the
year ended December 31, 2023 and onwards, until the year ended December 31, 2025 (&#8220;<b>Bonus Plan</b>&#8221;). The proposed Bonus
Plan is intended to incentivize those officers by closely aligning their personal economic interest with our performance and share price
appreciation.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Pursuant to the Bonus Plan, the target bonus
in the event of 100% achievement of the target goals is three (3) monthly salaries, while for overachievement performance of 120% and
above, the officer may be eligible for an additional one (1) monthly salary, totaling four (4) monthly salaries. Our Compensation Committee
and the Board may set during the first quarter of the year per each, the performance targets for each calendar year, while performance
targets will be comprised of 70% measurable criteria and up to 30% of non-measurable criteria.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 76 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->73<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In special circumstances (e.g., regulatory
changes, significant changes in the business environment, a significant organizational change, merger and acquisition events, or
other similar events etc.), our Compensation Committee and the Board may make adjustments to the objectives, and in such special
circumstances, to modify the objectives and/or their relative weights or the amount of bonus payouts (including decreasing such
amounts to zero), in connection with the applicable bonus period<span style="font-size: 10pt">.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As the Company has not determined yet any specific
measurable criteria, the Bonus Plan was not applicable for the year ended on December 31, 2023.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Compensation Policy under the Israeli Companies
Law</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i><span style="text-decoration:underline">Required approvals</span></i>. In general,
under the Israeli Companies Law, a public company must have a compensation policy approved by the board of directors after receiving
and considering the recommendations of the compensation committee. In addition, a compensation policy must be approved at least once
every three&#160;years by the board of directors, upon recommendation of its compensation committee, and thereafter, approval of the
vote of shareholders by a Compensation Majority.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In the event that the shareholders fail to approve
the compensation policy in a duly convened general meeting by the Compensation Majority, the board of directors may nevertheless override
that decision, provided that the compensation committee and then the board of directors decide, on the basis of detailed reasons and
after further review of the compensation policy, that approval of the compensation policy is for the benefit of the company despite the
failure of the shareholders to approve the policy.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If a company that adopts a compensation policy
in advance of its initial public offering (or in our case, prior to the Business Combination) and describes the policy in its prospectus
for such offering, then that compensation policy will be deemed validly adopted in accordance with the Israeli Companies Law and will
remain in effect for term of five&#160;years from the date such company becomes a public company. Our Compensation Policy for Executive
Officers and Directors (the &#8220;<b>Compensation Policy</b>&#8221;) is filed as an exhibit to this annual report.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i><span style="text-decoration:underline">Objectives</span></i>. The compensation policy
must serve as the basis for decisions concerning the financial terms of employment or engagement of Office Holders, including exculpation,
insurance, indemnification or any monetary payment or obligation of payment in respect of employment or engagement. The compensation
policy must relate to certain factors, including advancement of the company&#8217;s objectives, business plan and long-term strategy,
and creation of appropriate incentives for Office Holders. It must also consider, among other things, the company&#8217;s risk management,
size, and the nature of its operations.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our Compensation Policy, which became effective
immediately after the consummation of the Merger, is designed to promote retention and motivation of directors and executive officers,
incentivize superior individual excellence, align the interests of our directors and executive officers with our long-term performance
and provide a risk management tool. To that end, a portion of an executive officer compensation package is targeted to reflect the short
and long-term goals, as well as the executive officer&#8217;s individual performance. On the other hand, our Compensation Policy includes
measures, such as limits on the value of cash bonuses and equity-based compensation, limitations on the ratio between the variable and
the total compensation of an executive officer and minimum vesting periods for equity-based compensation.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i><span style="text-decoration:underline">Compensation features</span></i>. The Compensation
Policy also addresses our executive officers&#8217; individual characteristics (such as their respective positions, education, scope
of responsibilities and contribution to the attainment of its goals) as the basis for compensation variation among its executive officers
and considers the internal ratios between compensation of its executive officers and directors and other employees. Pursuant to our Compensation
Policy, the compensation that may be granted to an executive officer may include: base salary, annual bonuses and other cash bonuses
(such as a signing bonus and special bonuses with respect to any special achievement), equity-based compensation, benefits and retirement
and termination of service arrangements.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i><span style="text-decoration:underline">Fair market value</span></i>. In order to
calculate the caps set forth in the Compensation Policy, the determination of the fair market value of equity-based awards at the time
of grant, are prorated into each vesting year of the award, according to acceptable valuation and accounting practices; so that, the
cap will be applicable to the value of the award at each vesting year.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 77 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->74<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p><div>




</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i><span style="text-decoration:underline">Cash bonuses</span></i>. An annual cash bonus
may be awarded to executive officers upon the attainment of&#160;pre-set&#160;periodic objectives and individual targets. The annual
cash bonus that may be granted to our executive officers other than the chief executive officer will be based on performance objectives
and a discretionary evaluation of the executive officer&#8217;s overall performance by the chief executive officer and subject to minimum
thresholds. Furthermore, our chief executive officer will be entitled to recommend performance objectives, and such performance objectives
will be approved by the Compensation Committee and by our board of directors. All cash bonuses are limited to a maximum amount linked
to the executive officer&#8217;s base salary. In addition, the total variable compensation components (annual bonus and equity-based
compensation) may not exceed 85% of each executive officer&#8217;s total compensation package with respect to any calendar year. See
&#8220;<i>CEO and CTO Annual Bonus Plan</i>&#8221;.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i><span style="text-decoration:underline">Performance measures</span></i>. The measurable
performance objectives of our chief executive officer will be determined annually by our Compensation Committee (and, if required by
law, by our board of directors) and will include the weight to be assigned to each achievement in the overall evaluation. A less significant
portion of the chief executive officer&#8217;s annual cash bonus may be based on a discretionary evaluation of the chief executive officer&#8217;s
overall performance by the Compensation Committee and the board of directors based on quantitative and qualitative criteria.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i><span style="text-decoration:underline">Equity-based compensation</span></i>. The
equity-based compensation under the Compensation Policy for our Office Holders is designed in a manner consistent with the underlying
objectives in determining the base salary and the annual cash bonus. Primary objectives include enhancing the alignment between the executive
officers&#8217; interests and our long-term interests and those of its shareholders and strengthening the retention and the motivation
of executive officers in the long term. Our Compensation Policy provides for executive officer compensation in the form of share options
or other equity-based awards, such as restricted shares and restricted share units, in accordance with its share incentive plan then
in place. Generally, all equity-based incentives granted to executive officers will be subject to vesting periods in order to promote
long-term retention of the awarded executive officers. Equity-based compensation will be granted from time to time and be individually
determined and awarded according to the performance, educational background, prior business experience, qualifications, role and the
personal responsibilities of the executive officer.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i><span style="text-decoration:underline">Director remuneration</span></i>. The Compensation
Policy also provides for compensation to the members of our board of directors either (i)&#160;in accordance with the amounts provided
in the Companies Regulations (Rules Regarding the Compensation and Expenses of an External Director)&#160;5760-2000, as amended by the
Companies Regulations (Relief for Public Companies Traded in Stock Exchange Outside of Israel)&#160;5760-2000, as such regulations may
be amended from time to time, or (ii)&#160;in accordance with the amounts determined in the Compensation Policy.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our Compensation Policy, which was approved by
its our board of directors and shareholders, became effective upon the closing of the Business Combination, and is filed as an exhibit
to this annual report.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Clawback policy</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our Compensation Policy contains a compensation
recovery provision which allows us under certain conditions to recover bonuses paid in excess due to an accounting restatement.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In December 2023, in accordance with the Nasdaq
requirements that we maintain a clawback policy that meets these requirements, our Board of Directors adopted a clawback policy covering
our executive officers. An &#8220;executive officer&#8221; is our chief executive officer, president, principal financial officer, principal
accounting officer (or if there is no such accounting officer, the controller), any vice-president in charge of a significant principal
business unit, division, or function (such as sales, administration, or finance), any other officer who performs a policy-making function,
or any other person who performs similar policy-making functions for us. The executive officers named in Item 6.A are part of our executive
officers for the purpose of the clawback policy.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The clawback policy relates to
incentive-based compensation, which is any compensation that is granted, earned or vested based wholly or in part upon the
attainment of a financial reporting measure. The clawback policy covers the recovery of incentive-based compensation from an
executive officer only in the event that we are required to prepare an accounting restatement due to the material noncompliance of
our financial reporting requirement under the United States securities laws, including any required accounting restatement to
correct an error in previously issued financial statements that is material to the previously issued financial statements, or that
would result in a material misstatement if the error were corrected in the current period or left uncorrected in the current period.
Questions as to &#8220;materiality&#8221; will be made by the Compensation Committee in coordination with the Audit Committee.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 78 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->75<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The incentive-based compensation subject to recovery
is the incentive-based compensation received during the three completed fiscal years immediately preceding the date that we are required
to prepare an accounting restatement as described above, provided that the person served as an executive officer at any time during the
performance period applicable to the incentive-based compensation in question provided that the clawback policy shall only apply if the
incentive-based compensation is received while we have a class of securities listed on Nasdaq.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our clawback policy is available on our website.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Employment Agreements </b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We have entered into employment agreements with
each of our executive officers. Under these agreements, each of our executive officers is employed for unlimited period. We may terminate
employment for cause, at any time, without advance notice or remuneration, for certain acts of the executive officer, such as a conviction
or plea of guilty to a felony or any crime involving moral turpitude, negligent or dishonest acts to our detriment, or misconduct or
a failure to perform agreed duties. We may also terminate an executive officer&#8217;s employment without cause upon an advance written
notice of one or two months. In such case of termination by us, we will provide severance payments to the executive officer as expressly
required by applicable law of the jurisdiction where the executive officer is based. The executive officer may resign at any time with
the same advance written notice.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Each executive officer has agreed to hold, both
during and after the termination or expiration of his or her employment agreement, in confidence and not to use, except as required in
the performance of his or her duties in connection with the employment or pursuant to applicable law, any of our confidential information
or trade secrets, any confidential information or trade secrets of our clients or prospective clients, or the confidential or proprietary
information of any third party received by us and for which we have confidential obligations. The executive officers have also agreed
to disclose to us all inventions, designs and trade secrets which they conceive, develop or reduce to practice during the executive officer&#8217;s
employment with us and to assign all right, title and interest in them to us, and assist us in obtaining and enforcing patents, copyrights
and other legal rights for these inventions, designs and trade secrets.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In addition, each executive officer has agreed
to be bound by non-competition and non-solicitation restrictions during the term of his or her employment and typically for one year
following the last date of employment. Specifically, each executive officer has agreed not to (i) approach our suppliers, clients, customers
or contacts or other persons or entities introduced to the executive officer in his or her capacity as a representative of us for the
purpose of doing business with such persons or entities that will harm our business relationships with these persons or entities; (ii)
assume employment with or provide services to any of our competitors, or engage, whether as principal, partner, licensor or otherwise,
with any of our competitors, without our express consent; or (iii) seek directly or indirectly, to solicit the services of any of our
employees who is employed by us on or after the date of the executive officer&#8217;s termination, or in the year preceding such termination,
without our express consent.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Insurance, Indemnification and Release
</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In November 2023, our Compensation Committee
and Board approved the purchase of an insurance coverage in respect of the liability of Office Holders currently in office and any additional
or others which may be appointed from time to time in the future, for up to $10&#160;million in coverage, consistent with the Company&#8217;s
Compensation Policy as originally approved by the shareholders under the Israeli Companies Law.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We have also entered into indemnification
agreements with each of our Office Holders<i>. </i>Under these agreements, we agree to indemnify our directors and executive
officers against certain liabilities and expenses incurred by such persons in connection with claims made by reason of their being a
director or officer of our company. The maximum indemnification amount set forth in such agreements is limited to the greater of
(i)&#160;25% of our shareholders&#8217; equity on a consolidated basis, based on the most recent financial statements made publicly
available before the date on which the indemnity payment is made; and (ii) $25&#160;million. The maximum amount set forth in such
agreements is in addition to any amount paid (if paid) under insurance&#160;and/or&#160;by a third-party&#160;pursuant to an
indemnification arrangement.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 79 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->76<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our board of directors has approved the indemnification of Mr. Marenko
to cover any guarantees and personal undertakings he may be providing on our behalf and for our benefit, with respect to contractual obligations
provided by us to third parties, such as landlords and lessors, limited to the face value of such guarantee, based on the indemnity terms
provided to all of our executive officers.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Equity Incentive Plans </b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>2016 Incentive Share Option Plan </i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our 2016 Incentive Share Option Plan (the &#8220;2016
Plan&#8221;) was adopted by our board of directors on September&#160;25, 2016. The 2016 Plan provides for the grant of options to our
employees, directors, Office Holders, service providers and consultants.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Authorized Shares. </i>As of December 31,
2023, there were 2,047,116 ordinary shares subject to options under the 2016 plan and 302,912 ordinary shares reserved and available
for issuance under the 2016 Plan. The 2016 Plan provides that ordinary shares subject to options granted under the 2016 Plan that expire
or become un-exercisable without having been exercised will become available again for future grants under the 2021 Plan.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Administration. </i>Our board of directors
had authorized the compensation committee to serve as administrator (the &#8220;<b>Administrator</b>&#8221;) of the 2016 Plan. Under
the 2016 Plan, the administrator has the full power and authority, subject to applicable law, to, among other things: (i)&#160;designate
participants in the 2016 Plan; (ii)&#160;determine the terms and provisions of the respective option agreements, including, but not limited
to, the number of options to be granted to each optionee, the number of shares to be covered by each option, provisions concerning the
time and the extent to which the option may be exercised and the nature and duration of restriction as to the transferability and to
amend, cancel, suspend, convert or substitute such option agreements, as necessary; (iii)&#160;determine the Fair Market Value of the
shares covered by each option; (iv)&#160;make an election as to the type of Section&#160;102 approved option; (v)&#160;designate the
type of options; (vi)&#160;interpret the provisions and supervise the administration of the 2016 Plan; (vii)&#160;accelerate the right
of an optionee to exercise in whole or in part, any previously granted option; (viii)&#160;determine the exercise price of the option;
(ix)&#160;prescribe, amend and rescind rules and regulation relating to the 2016 Plan; (x)&#160;extend the period of the 2016 Plan; and
(xi)&#160;make all other determinations deemed necessary or advisable for the administration of the 2016 Plan, including, without limitation,
to adjust the terms of the 2016 Plan or any option agreement so as to reflect (a)&#160;changes in applicable law and (b)&#160;the laws
of other jurisdictions within which we wish to grant options.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Eligibility.</i> The 2016 Plan provides for
granting Options under the Israeli tax regime, including in compliance with Section&#160;102 (&#8220;Section&#160;102&#8221;) of the
Israeli Income Tax Ordinance (New Version),&#160;5721-1961 (the &#8220;Ordinance&#8221;), and Section&#160;3(i)&#160;of the Ordinance.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Section&#160;102 of the Ordinance allows employees,
directors and officers who are not &#8220;controlling shareholders&#8221; (as used under the Ordinance) and are considered Israeli residents
to receive favorable tax treatment for compensation in the form of shares or options under certain terms and conditions. Our non-employee
service providers and controlling shareholders who are considered Israeli residents may only be granted options under section 3(i)&#160;of
the Ordinance, which does not provide for similar tax benefits. Section&#160;102 includes two alternatives for tax treatment involving
the issuance of options or shares to a trustee for the benefit of the grantees and also includes an additional alternative for the issuance
of options or shares directly to the grantee. Section&#160;102(b)(2)&#160;of the Ordinance, which provides the most favorable tax treatment
for the grantee, permits the issuance to a trustee under the &#8220;capital gain track.&#8221;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Grant.</i> Options granted pursuant to the
2016 Plan are evidenced by (i)&#160;a resolution of our board of directors and/or a written option agreement with the optionee, in such
form as the Administrator has from time to time approved and (ii)&#160;any all other documents required by us, whether before or after
the grant of the options (including, without limitation, any customary documents and undertaking towards the trustee, if applicable,
and/or the tax authorities.</p><div>




</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 80 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->77<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Each option agreement states, among other matters,
the number of shares to which the option relates, the type of option granted thereunder, the vesting dates, the exercise price per share,
the expiration date and such other terms and conditions as the Administrator in its discretion may prescribe, provided that they are
consistent with the 2016 Plan. In case of a conflict between the provisions of the 2016 Plan and an option agreement, the provisions
of the 2016 Plan will prevail, unless otherwise specifically stated in the option agreement.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Each granted option will expire no later than
seven&#160;years from the date of the grant thereof, unless a shorter term of expiration is otherwise designated by the administrator.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Awards. </i>The 2016 Plan provides for the
grant of options to purchase ordinary shares pursuant to the 2016 Plan.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Exercise. </i>An option under the 2016 Plan
may be exercised by providing us with a written notice of exercise and full payment of the exercise price for such shares, in such form
and method as may be determined by the administrator and, when applicable, by the trustee in accordance with the requirements of Section&#160;102,
the Ordinance and any other applicable law.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Transferability. </i>Other than by will, the
laws of descent and distribution or as otherwise provided under the 2016 Plan, neither the options nor any right in connection with such
options are assignable or transferable.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Termination of Employment.</i> In the event
of termination of an optionee&#8217;s employment or service with us or any of our affiliates, all unvested and exercisable awards held
by such optionee as of the date of termination will expire, unless extended as specified below.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In the event of an optionee&#8217;s termination
of employment or service, on the termination date, the unvested portion of the optionee&#8217;s option will cease to vest and such unvested
options will expire and will not become exercisable. In the event of termination of employment or service of an optionee, vested options
as of the termination date will expire.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Notwithstanding any of the foregoing, and unless
otherwise stated in the optionee&#8217;s option agreement, an option may be exercised after the termination of employment for an additional
period of time, but only with respect to the options that had vested at the time of such termination of employment, if: (i)&#160;termination
is without cause (as defined in the 2016 Plan), by us or by the optionee, or retirement at the retirement age as defined in the applicable
law, in which event any vested options as of the termination date may be exercised within 60&#160;days after the date of such termination
of employment, but in no event subsequent to the expiration date of such option. After such 60-day period, all such unexercised awards
will terminate, and the shares covered by such awards will again be available for issuance or (ii)&#160;termination is the result of
death or disability of the optionee, in which event any vested options as of termination date may be exercised within a period of twelve
(12)&#160;months after the date of such termination, but in any event no later than the expiration date of such option; or (iii)&#160;at
any time the administrator may authorize, in its sole and absolute discretion and without such act constituting a precedent in respect
of any other optionee, an extension of the terms of all or part of the vested options beyond the date of such termination for a period
not to exceed the period during which the options by their terms would otherwise have expired.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Adjustments. </i>In the event of any merger,
reorganization, consolidation, recapitalization, share dividend, share split, share distribution, spin off, combination or reclassification
of our ordinary shares or any other change in corporate structure affecting the number of the ordinary shares, an adjustment in the number
of ordinary shares to be covered by the 2016 Plan, or the exercise price, will be made by the administrator, in its sole direction, consistent
with its determinations under the 2016 Plan.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In the event of a transaction involving us,
the unexercised options then outstanding under the 2016 Plan or a portion thereof may be, subject to the approval of the board of
directors and the successor company, assumed or substituted for an appropriate number of options or shares or other securities of
the successor company (or a parent or subsidiary of the successor company). In the event of such assumption and/or substitution of
options, appropriate adjustments will be made to the exercise price so as to reflect such action and all other terms and conditions
of the option agreement will remain unchanged, including, but not limited to, the vesting schedule, unless otherwise determined by
the Administrator, which determination will be in its sole discretion and final. In any such transaction, if the successor company
(or parent or subsidiary of the successor company) does not agree to assume or substitute the options, the board will have full
power and authority to determine that (i)&#160;the vesting dates will be accelerated so that any unvested option or any portion
thereof will be immediately vested upon the occurrence of the transaction; or (ii)&#160;any unvested options will be cancelled or
cashed out in connection with the transaction. Notwithstanding anything to the contrary in the 2016 Plan and subject to the above,
if, in a transaction, the successor company (or parent or subsidiary of the successor company) does not agree to assume or
substitute the options, unless determined otherwise by the board, all unexercised options and all unvested options will expire as of
the date of the transaction.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 81 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->78<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Following the adoption of the 2021 Equity Incentive
Plan (the &#8220;2021 Plan&#8221;), we will not grant any awards pursuant to the 2016 Plan although previously granted options under
the 2016 Plan will remain outstanding and governed by the 2016 Plan. Any remaining ordinary shares reserved and available for issuance
under the 2016 Plan can be awarded under the 2021 Plan.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>2021 Equity Incentive Plan </b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On October 7, 2021, we adopted the 2021 Plan,
under which we may grant equity-based incentive awards to attract, motivate and retain the talent for which it competes. The maximum
number of shares that may be issued pursuant to the 2021 Plan is the sum of (a) 4,079,427 ordinary shares plus (and without the need
to further amend the Plan) (b) on January 1 of each calendar year beginning on January 1, 2022 and ending on and including January 1,
2031, a number of ordinary shares equal to the lesser of: (i) 5% of the total number of ordinary shares outstanding on December 31 of
the immediately preceding calendar year, and (ii) an amount determined by the Board, if so determined prior to the January 1 of the calendar
year in which the increase will occur. In addition, any remaining ordinary shares reserved and available for issuance under the 2016
Plan can be issued pursuant to the 2021 Plan. As of December 31, 2023, there were 7,253,183 ordinary shares subject to options under
the 2021 plan and 308,334 ordinary shares reserved and available for issuance under the 2021 Plan. Following the increase in the size
of the reserved and available option pool on December 26, 2023, by an additional 3,655,415 ordinary shares, there were a total of 4,266,661
ordinary shares reserved and available for issuance under the 2021 Plan.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Administration.</i> Our board of directors
had authorized the compensation committee of our board of directors, to administer the 2021 Plan. Under the 2021 Plan, the administrator
has the authority, subject to applicable law, to interpret the terms of the 2021 Plan and any award agreements or awards granted thereunder,
designate recipients of awards, determine and amend the terms of awards, including the exercise price of an option award, the fair market
value of an ordinary share, the time and vesting schedule applicable to an award or the method of payment for an award, accelerate or
amend the vesting schedule applicable to an award, prescribe the forms of agreement for use under the 2021 Plan and take all other actions
and make all other determinations necessary for the administration of the 2021 Plan.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The administrator also has the authority to amend
and rescind rules and regulations relating to the 2021 Plan or terminate the 2021 Plan at any time before the date of expiration of its
ten-year term.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Eligibility.</i> The 2021 Plan provides for
granting awards under various tax regimes, including, without limitation, for awards granted to our Israeli employees or service providers,
in compliance with Section&#160;102 of the Ordinance or Section&#160;3(i)&#160;of the Ordinance and for awards granted to non-Israeli
employees or service providers.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Section&#160;102 of the Ordinance allows employees,
directors and officers who are not &#8220;controlling shareholders&#8221; (as used under the Ordinance) and are considered Israeli residents
to receive favorable tax treatment for compensation in the form of shares or options. Our non-employee service providers and controlling
shareholders may only be granted options under section 3(i)&#160;of the Ordinance, which does not provide for similar tax benefits.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Grant.</i> All awards granted pursuant to
the 2021 Plan will be granted pursuant to a resolution of our Compensation Committee (and the Board, if it necessary under the Israeli
Companies Law) and an award agreement, in a form approved, from time to time, by the administrator. The award agreement will set forth
the terms and conditions of the award, including the type of award, number of shares subject to such award, vesting schedule and conditions
(including performance goals or measures) and the exercise price, if applicable. Certain awards under the 2021 Plan may constitute or
provide for a deferral of compensation, subject to Section&#160;409A of the Code, which may impose additional requirements on the terms
and conditions of such awards.</p><div>




</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 82 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->79<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Awards.</i> The 2021 Plan provides for the
grant of stock options (including incentive stock options and nonqualified stock options), ordinary shares, restricted shares, restricted
share units and other share-based awards.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Exercise.</i> An award under the 2021 Plan
may be exercised by providing us with a written or electronic notice of exercise and full payment of the exercise price for such shares
underlying the award, if applicable, in such form and method as may be determined by the administrator and permitted by applicable law.
An award may not be exercised for a fraction of a share. With regard to tax withholding, exercise price and purchase price obligations
arising in connection with awards under the 2021 Plan, the administrator may, in its discretion, accept cash, provide for net withholding
of shares in a cashless exercise mechanism or, if the issuance of the shares is subject to an effective registration statement under
the Securities Act, direct a securities broker to sell shares and deliver all or a part of the proceeds to us.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Transferability.</i> Other than by will, the
laws of descent and distribution or as otherwise provided under the 2021 Plan, neither the options nor any right in connection with such
options are assignable or transferable.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Termination of Employment. </i>In the event
of termination of a grantee&#8217;s employment or service with us or any of our affiliates, all vested and exercisable awards held by
such grantee as of the date of termination may be exercised within three&#160;months after such date of termination, unless otherwise
determined by the Compensation Committee. After such period, all such unexercised awards will terminate and the shares covered by such
awards will again be available for issuance under the 2021 Plan.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In the event of termination of a grantee&#8217;s
employment or service with us or any of its affiliates due to such grantee&#8217;s death, permanent disability or retirement, all vested
and exercisable awards held by such grantee as of the date of termination may be exercised by the grantee or the grantee&#8217;s legal
guardian, estate, or by a person who acquired the right to exercise the award by bequest or inheritance, as applicable, within twelve&#160;months
after such date of termination, unless otherwise provided by the administrator. Any awards which are unvested as of the date of such
termination or which are vested but not then exercised within such date, will terminate and the shares covered by such awards will again
be available for issuance under the 2021 Plan.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Notwithstanding any of the foregoing, if a grantee&#8217;s
employment or services with us or any of its affiliates is terminated for &#8220;cause&#8221; (as defined in the 2021 Plan), all outstanding
awards held by such grantee (whether vested or unvested) will terminate on the date of such termination (and in certain circumstances
defined in the 2021 Plan, within 12&#160;months thereafter), and the shares covered by such awards shall again be available for issuance
under the 2021 Plan .</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Transactions.</i> In the event of a recapitalization
event, as defined in the 2021 Plan, including share split, reverse share split, share dividend, combination or reclassification of our
shares, or any other increase or decrease in the number of issued shares effected without receipt of consideration by us, the administrator
in its sole discretion will make an appropriate adjustment in the number of shares related to each outstanding award and to the number
of shares reserved for issuance under the 2021 Plan, to the class&#160;and kind of shares subject to the 2021 Plan, as well as the exercise
price per share of each outstanding award, as applicable, the terms and conditions concerning vesting and exercisability and the term
and duration of outstanding awards, or any other terms that the administrator adjusts in its discretion, or the type or class of security,
asset or right underlying the award (which need not be only that of us, and may be that of the surviving corporation or any affiliate
thereof or such other acquiring party or entity party to any of the above transactions); provided that any fractional shares resulting
from such adjustment will be rounded down to the nearest whole share unless otherwise determined by the administrator.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In the event of a merger or consolidation of
us, or a sale of all, or substantially all, of the our shares or assets or other transaction having a similar effect on us, or a
change of control event (including an acquisition of 50% or more of the share capital) or change in the composition of the board of
directors, or liquidation or dissolution, a structural change, as defined in the 2021 Plan, or such other transaction or
circumstances that the board of directors determines to be a relevant transaction, then without the consent of the grantee, the
administrator may but is not required to (i)&#160;cause any outstanding award to be assumed or substituted by such successor
corporation, or (ii)&#160;regardless of whether or not the successor corporation assumes or substitutes the award (a)&#160;provide
the grantee with the option to exercise the award as to all or part of the shares, and may provide for an acceleration of vesting of
unvested awards, or (b)&#160;cancel the award and pay in cash, shares of us, the acquirer or other corporation which is a party to
such transaction or other property as determined by the administrator as fair in the circumstances. Notwithstanding the foregoing,
in the event of a Merger/Sale the administrator may upon such event amend, modify or terminate the terms of any award as it shall
deem, in good faith, appropriate.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 83 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->80<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>C. Board Practices </b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Terms of Directors and Officers </b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">According to our Restated Articles, our directors
are generally appointed by our shareholders. Our board is classified into three classes as follows:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -18pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-size: 10pt">Class I directors, who serve
until the annual general meeting to be held in 2025. Mr. Ehud Levy, Dr. Noam Arkind and Mr. Alexander Hitzinger are our Class I directors.</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -18pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-size: 10pt">Class II directors, who serve
until the annual general meeting in 2026. Dr. Boaz Schwartz, Thilo Koslowski and Prof. Yonina Eldar are our Class II directors.</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -18pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-size: 10pt">Class III directors, who serve
until the annual general meeting in 2024. Mr. Yair Shamir, Mr. Kobi Marenko and Mr. Scott Crist are our Class III directors.</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">At each annual general meeting, the shareholders
will vote for the election of the directors of the class whose term expires at such annual general meeting, and such directors shall
be elected to hold office until the third annual general meeting next succeeding his/her election and until his/her respective successor
shall have been elected and qualified until such earlier time as such director&#8217;s office is vacated.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our officers are appointed by our Chief Executive
Officer and serve according to the direction of the Board.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 36pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Committees of the Board of Directors </b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The board of directors has the following standing
committees: an Audit Committee, a Compensation Committee and a Nominating&#160;and Corporate Governance Committee. Each of the committees
of the board of directors has the composition and responsibilities described below.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Audit Committee</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our Audit Committee consists of three independent
directors, each of whom is financially literate and one of whom is an audit committee financial expert. A member of the Audit Committee
may not, other than his or her capacity as a director or member of the Audit Committee, accept any consulting, advisory or other compensatory
fee from the us; shall not have participated in the preparation of our financial statements or any current subsidiary at any time during
the past three years; or our affiliate or a member of the immediate family of an affiliate.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Audit Committee is responsible, among its
other duties and responsibilities, for overseeing our accounting and financial reporting processes, audits of financial statements, qualifications
and independence of the independent registered public accounting firm, the effectiveness of internal control over financial reporting
and the performance of the internal audit function and independent registered public accounting firm. The Audit Committee reviews and
assess the qualitative aspects of our financial reporting, processes to manage business and financial risks, and compliance with significant
applicable legal, ethical and regulatory requirements and is directly responsible for the appointment, compensation, retention and oversight
of the independent registered public accounting firm. In addition, the Audit Committee is responsible for the following additional matters
pursuant to the Israeli Companies Law:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-size: 10pt">recommending to the board of
directors the retention and termination of the internal auditor, and the internal auditor&#8217;s engagement fees and terms, in accordance
with the Israeli Companies Law as well as approving the yearly or periodic work plan proposed by the internal auditor;</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-size: 10pt">reviewing with the general
counsel and/or external counsel, as deemed necessary, legal and regulatory matters that could have a material impact on the financial
statements;</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt"></p><div>

</div><!-- Field: Page; Sequence: 84 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->81<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-size: 10pt">identifying irregularities
in the company&#8217;s business administration, including by consulting with the internal auditor or with the independent auditor, and
suggesting corrective measures to the board of directors;</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-size: 10pt">reviewing policies and procedures
with respect to transactions (other than transactions related to the compensation or terms of services) between the company and officers
and directors, or affiliates of officers or directors, or transactions that are not in the ordinary course of our business and deciding
whether to approve such acts and transactions if so required under the Israeli Companies Law; and</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-size: 10pt">establishing procedures for
the handling of employees&#8217; complaints as to the management of our business and the protection to be provided to such employees.</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Audit Committee has the authority, with the assistance of management,
to advise the Board and any other Board committee if the clawback provisions of our clawback policy are triggered based upon a financial
statement restatement or other financial statement change.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Audit Committee also has the responsibility
to implement and oversee our cybersecurity and information security policies and periodically review the policies and manage potential
cybersecurity incidents.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The charter of the Audit Committee is available
on our website.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The members of the Audit Committee are Dr. Boaz
Schwartz, Mr. Ehud Levy and Mr. Thilo Koslowski. Each member is an independent director and &#8220;financially literate&#8221; under
the Nasdaq rules, and Dr. Boaz Schwartz is an &#8220;audit committee financial expert.&#8221;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Compensation Committee</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Under Nasdaq corporate governance rules, we are
required to maintain a compensation committee consisting of at least two independent directors. The Compensation Committee is responsible,
among its other duties and responsibilities, for reviewing and approving all forms of compensation to be provided to, and employment
agreements with, our executive officers and directors, establishing the general compensation policies of us and our subsidiaries and
reviewing, approving and overseeing the administration of our employee benefits plans and reviewing our Compensation Policy.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Compensation Committee has the authority
to retain compensation consultants, outside counsel and other advisers.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Compensation Committee is also responsible
for the following pursuant to the Israeli Companies Law:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.7pt; text-align: justify; text-indent: -17.85pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-size: 10pt">recommending to the board of
directors with respect to the approval of the compensation policy for &#8220;Office Holders&#8221; (a term used under the Israeli Companies
Law, which essentially means directors and executive officers, and also includes some officers who are not listed as Senior Management);</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.7pt; text-align: justify; text-indent: -17.85pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-size: 10pt">Generally, once every three&#160;years,
reviewing and approving any extensions to the Compensation Policy;</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.7pt; text-align: justify; text-indent: -17.85pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-size: 10pt">reviewing the implementation
of the compensation policy and periodically recommending to the board of directors with respect to any amendments or updates of the compensation
plan;</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.7pt; text-align: justify; text-indent: -17.85pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-size: 10pt">resolving whether or not to
approve arrangements with respect to the terms of office and employment of Office Holders;</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-size: 10pt">exempting,
under certain circumstances, from the requirement of approval by the general meeting of shareholders, transactions with our chief executive
officer; and,</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 85 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->82<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Compensation Committee shall have, with the
assistance of management, the authority and responsibility to, either by itself or in coordination with the Audit Committee, make any
determinations and take or authorize the taking of any action contemplated by our clawback policy.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The charter of the Compensation Committee is
available on our website.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The members of the Compensation Committee are
Mr. Scott Crist, Dr. Boaz Schwartz and Yair Shamir. Each member of the Compensation Committee is an independent director.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Nominating and Governance Committee</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our Nominating and Governance Committee is responsible,
among other things, for:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-size: 10pt">overseeing and assisting its
board in reviewing and recommending nominees for election as directors, including determining whether a nominee for election as a director
is an independent director;</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-size: 10pt">assessing the performance of
the members of the board; and</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-size: 10pt">establishing and maintaining
effective corporate governance policies and practices, including, but not limited to, developing and recommending to the board a set
of corporate governance guidelines applicable to us.</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The charter for the Nominating and Governance
Committee is available on our website.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The members of the Nominating and Governance
Committee are Mr. Ehud Levy, Mr. Yair Shamir and Mr. Alexander Hitzinger. Each member of the Nominating and Governance Committee is independent
under the Nasdaq standards.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Diversity</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Nasdaq rules provide that each company listed
on Nasdaq must have or explain why it does not have at least two members of its board of directors including (i) at least one diverse
director who self identifies as female and (ii) at least one diverse director who self-identifies as an underrepresented minority or
LGBTQ+. For foreign issuers &#8220;diverse&#8221; means an individual who self-identifies as one or more of the following: female, LGBTQ+,
or an underrepresented individual based on national, racial, ethnic, indigenous, cultural, religious or linguistic identity in the country
of the company&#8217;s principal executive offices. For a smaller reporting company, the second diverse director can be female, LGBTQ+
or an underrepresented minority. We will be required to have two female directors or provide an explanation why we do not by December
31,2026.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In addition, Nasdaq rules require us to provide
a board diversity matrix in the from provided by Nasdaq, which we provide on our website.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Under Israeli law, if, at the time of a director
is appointed all members of the board are of the same gender, then the appointed director must be of the other gender. Since we have
a female member of our board, we satisfy the diversity requirement under Israeli law.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Chairperson of the Board </i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our Articles provide that the chairperson of
the board is appointed by the members of the board of directors and serves as chairperson of the board throughout his or her term as
a director, unless resolved otherwise by the board of directors. Under the Companies Law, if the chief executive officer (or any relative
thereof, or subordinate employee) will be nominated to serve as the chairperson of the board of directors, and this will be subject to
a shareholder approval in a special disinterested majority vote.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 86 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->83<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Internal Auditor</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>




</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Under the Israeli Companies Law, the board of
directors of a public company must appoint an internal auditor based on the recommendation of the audit committee. The role of the internal
auditor is, among other things, to examine whether a company&#8217;s actions comply with applicable law and orderly business procedure.
Under the Israeli Companies Law, the internal auditor cannot be an interested party or an Office Holder or a relative of an interested
party or an Office Holder, nor may the internal auditor be the company&#8217;s independent auditor or its representative. An &#8220;interested
party&#8221; is defined in the Israeli Companies Law as: (i)&#160;a holder of 5% or more of the issued share capital or voting power
in a company, (ii)&#160;any person or entity who has the right to designate one or more directors or to designate the chief executive
officer of the company, or (iii)&#160;any person who serves as a director or as a chief executive officer of the company.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On February 28, 2022, the Board, following the
recommendation of our Audit Committee, appointed Ms. Dana Gottesman as our internal auditor. Ms. Gottesman is a partner at BDO Israel
Consulting Group.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Director Independence</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our board of directors reviewed the materiality
of any relationship that each of our proposed directors has with us, either directly or indirectly. Based on this review, the board determined
that Mr. Yair Shamir, Mr. Ehud Levy, Prof. Yonina Eldar, Dr. Boaz Schwartz, Mr. Thilo Koslowski, Mr. Alexander Hitzinger and Mr. Scott
Crist are &#8220;independent directors&#8221; as defined by Nasdaq.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>External Directors</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">See the section entitled &#8220;Election and
Removal of Directors&#8221; in Item 10.B</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Family Relationships </b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">There is no family relationship among any of
our directors or executive officers.&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Involvement in Certain Legal Proceedings</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">No executive officer or director of ours has been involved in the
last ten years in any of the following:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 36pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">Any bankruptcy petition filed by or against any business or property
    of such person, or of which such person was a general partner or executive officer either at the time of the bankruptcy or within
    two years prior to that time;</span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">Any conviction in a criminal proceeding or being subject to a pending
    criminal proceeding (excluding traffic violations and other minor offenses);</span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">Being subject to any order, judgment, or decree, not subsequently reversed,
    suspended or vacated, of any court of competent jurisdiction, permanently or temporarily enjoining, barring, suspending or otherwise
    limiting his involvement in any type of business, securities or banking activities;</span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">Being found by a court of competent jurisdiction (in a civil action),
    the SEC or the Commodity Futures Trading Commission to have violated a federal or state securities or commodities law, and the judgment
    has not been reversed, suspended, or vacated;</span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">Being the subject of or a party to any judicial or administrative order,
    judgment, decree or finding, not subsequently reversed, suspended or vacated relating to an alleged violation of any federal or state
    securities or commodities law or regulation, or any law or regulation respecting financial institutions or insurance companies, including,
    but not limited to, a temporary or permanent injunction, order of disgorgement or restitution, civil money penalty or temporary or
    permanent cease-and-desist order, or removal or prohibition order, or any law or regulation prohibiting mail, fraud, wire fraud or
    fraud in connection with any business entity; or</span></td></tr>
  </table><div>

</div><p style="margin-top: 0; margin-bottom: 0">&#160;</p><div>

</div><p style="margin-top: 0; margin-bottom: 0"></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 20pt"/><td style="width: 20pt; text-align: left"><span style="font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-size: 10pt">Being the subject of or a party
to any sanction or order, not subsequently reversed, suspended or vacated, of any self-regulatory organization (as defined in Section
3(a)(26) of the Exchange Act, any registered entity (as defined in Section 1(a)(29) of the Commodity Exchange Act), or any equivalent
exchange, association, entity or organization that has disciplinary authority over its members or persons associated with a member.</span></td>
</tr></table><div>
</div><p style="margin-top: 0; margin-bottom: 0">&#160;</p><div>

</div><p style="margin-top: 0; margin-bottom: 0"></p><div>

</div><!-- Field: Page; Sequence: 87 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->84<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="margin-top: 0; margin-bottom: 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>D. Employees </b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As of December 31, 2023, we had 137 employees
and consultants, of which four individuals provide services to us through consulting agreements. 131 of our workforce were based in Israel,
one in the United States, one in China, one in Thailand, one in United Kingdom and two in Germany. The following table sets forth a breakdown
of our global workforce by category of activity as of December 31, 2023:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">As of December&#160;31,</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; border-bottom: Black 1.5pt solid">Category of Activity</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: left; padding-left: 0.5pt">Research and development &amp; operations</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">114</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">114</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 0.5pt">Sales and marketing</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">10</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">13</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 0.5pt">General &amp; Administrative</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">13</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">14</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; padding-bottom: 4pt; padding-left: 0.5pt">Total</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">137</td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">141</td><td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  </table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our global workforce decreased by four employees from December 31,
2022, to December 31, 2023. This decrease was primarily attributed to a decrease in the sales and marketing department, and, to a lesser
extent, in General and Administrative.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As of March 1, 2024, our global workforce remains
relatively flat and decreased to 136 employees. None of our employees are represented by a labor union, and we consider our employee relations
to be <span style="background-color: white">satisfactory</span>. To date, we have not experienced any work stoppages.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>E. Share Ownership</b>.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Holders of our ordinary shares are entitled to
vote together as a single class on all matters submitted to shareholders for approval. No holder of ordinary shares has different voting
rights from any other holders of ordinary shares. We are not aware of any arrangement that may, at a subsequent date, result in a change
of control of our company.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following table sets forth information regarding
the beneficial ownership of ordinary shares on March 1, 2024, by</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 20pt"/><td style="width: 20pt; text-align: left"><span style="font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-size: 10pt">each person known by us to be the
beneficial owner of more than 5% of the outstanding ordinary shares;</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 20pt"/><td style="width: 20pt; text-align: left"><span style="font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-size: 10pt">each of our directors, chief executive
officer, chief financial officer and other members of Senior Management; and</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 20pt"/><td style="width: 20pt; text-align: left"><span style="font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-size: 10pt">all of our Senior Management and
directors as a group.</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Unless otherwise indicated, we believe that all
persons named in the table below have sole voting and investment power with respect to all shares beneficially owned by them. Except as
otherwise noted herein, the number and percentage of ordinary shares beneficially owned is determined in accordance with Rule&#160;13d-3&#160;of
the Exchange&#160;Act, and the information is not necessarily indicative of beneficial ownership for any other purpose. Under such rule,
beneficial ownership includes any ordinary shares as to which the holder has sole or shared voting power or investment power and also
any ordinary shares which the holder has the right to acquire within 60&#160;days of March 1, 2024 through the exercise of any option,
warrant, convertible security or other right. As of March 1, 2024, there were 78,221,557 ordinary shares outstanding.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>


</div><!-- Field: Page; Sequence: 88 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->85<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; border-bottom: Black 1.5pt solid"><span style="font-size: 10pt"><b>Name and Address of Beneficial Owner<sup>(1)</sup></b></span></td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Number of <br/> Ordinary <br/> Shares <br/> Beneficially <br/> Owned</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Percentage</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; font-style: italic">Directors and Senior Management:</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; padding-left: 0.5pt"><span style="font-size: 10pt">Kobi Marenko<sup>(2)</sup></span></td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">3,929,072</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">5.01</td><td style="width: 1%; text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.5pt"><span style="font-size: 10pt">Noam Arkind<sup>(3)</sup></span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3,026,003</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3.86</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.5pt"><span style="font-size: 10pt">Karine Pinto-Flomenboim<sup>(4)</sup></span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">188,027</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-size: 10pt">*</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.5pt"><span style="font-size: 10pt">Ehud Levy<sup>(5)</sup></span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">9,049,762</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">11.57</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.5pt"><span style="font-size: 10pt">Yair Shamir<sup>(6)</sup></span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">7,334,262</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">9.37</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.5pt"><span style="font-size: 10pt">Boaz Schwartz<sup>(7)</sup></span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">373,276</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-size: 10pt">*</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.5pt"><span style="font-size: 10pt">E.&#160;Scott Crist<sup>(8)</sup></span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3,620,546</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">4.5</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.5pt"><span style="font-size: 10pt">Thilo Koslowski<sup>(9)</sup></span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">59,999</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-size: 10pt">*</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.5pt"><span style="font-size: 10pt">Alexander Hitzinger<sup>(10)</sup></span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">118,109</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-size: 10pt">*</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 0.5pt"><span style="font-size: 10pt">Prof. Yonina Eldar<sup>(9)</sup></span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">6,666</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><p style="margin: 0pt 0">*</p></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.5pt">All directors and Senior Management as a group</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">28,790,998</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">34.95</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.5pt">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; font-style: italic; text-align: left; padding-left: 0.5pt">Five Percent Holders:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 0.5pt"><span style="font-size: 10pt">Canaan Partners Israel (CPI) (Cayman) L.P.<sup>(11)</sup></span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">9,049,762</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">11.57</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.5pt"><span style="font-size: 10pt">AWM Investment Company, Inc. <sup>(12)</sup></span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">7,713,175</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">9.86</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 0.5pt"><span style="font-size: 10pt">CEL Catalyst Mobility Ltd. and Catalyst IV Fund L.P <sup>(13)</sup></span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">7,334,262</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">9.37</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.5pt"><span style="font-size: 10pt">iAngels Technologies LP&#160;&#8211;&#160;Series&#160;Arbe Robotics Ltd. Advanced Investment<sup>(14)</sup></span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">4,981,089</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">6.37</td><td style="text-align: left">%</td></tr>
  </table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left"></p><div>

</div><!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 25%"><div style="font-size: 1pt; border-top: Black 1.5pt solid">&#160;</div></div><!-- Field: /Rule-Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left"></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"/><td style="width: 0.25in; text-align: left"><span style="font-size: 10pt">*</span></td><td style="text-align: justify"><span style="font-size: 10pt">Less than 1%</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"/><td style="width: 0.25in; text-align: left"><span style="font-size: 10pt">(1)</span></td><td style="text-align: justify"><span style="font-size: 10pt">Unless otherwise noted, the address
for each named beneficial owner who is a director or senior management is c/o Arbe Robotics Ltd., HaHashmonaim St. 107, Tel Aviv-Yafo,
Israel.</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"/><td style="width: 0.25in; text-align: left"><span style="font-size: 10pt">(2)</span></td><td style="text-align: justify"><span style="font-size: 10pt">Consists of 2,849,482 ordinary shares held directly by
                                                                                                                     Mr.&#160;Marenko, 177,076 ordinary shares subject to options and 902,514 ordinary shares held by Inter &#8212; Development of
                                                                                                                     Content in Internet Company Ltd. (&#8220;Inter&#8221;), which is owned by Mr.&#160;Marenko, who has the right to vote and dispose of
                                                                                                                     shares owned by Inter.</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"/><td style="width: 0.25in; text-align: left"><span style="font-size: 10pt">(3)</span></td><td style="text-align: justify"><span style="font-size: 10pt">Consists of 2,849,482 ordinary
shares held directly by Mr.&#160;Arkind and 176,521 ordinary shares subject to options.</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24pt; text-align: justify; text-indent: -24pt">&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 24px; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4)</span></td>
    <td style="text-align: justify; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Consists of ordinary shares subject to options and restricted stock units.</span></td></tr>
  </table><div>

</div><p style="margin-top: 0; margin-bottom: 0">&#160;</p><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24pt; text-align: justify; text-indent: -24pt">
</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"/><td style="width: 0.25in; text-align: left"><span style="font-size: 10pt">(5)</span></td><td style="text-align: justify"><span style="font-size: 10pt">Consists of (i) 9,036,429 ordinary
shares identified in footnote (10) below, and (ii) 13,333 ordinary shares subject to options granted to Mr. Levy. Mr.&#160;Levy is affiliated
with Canaan Partners Israel (CPI) (Cayman) L.P and may be deemed to have beneficial ownership with respect to these shares. Mr.&#160;Levy
disclaims beneficial interest in the shares owned by Canaan Partners except to the extent of his pecuniary interest therein.</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"/><td style="width: 0.25in; text-align: left"><span style="font-size: 10pt">(6)</span></td><td style="text-align: justify"><span style="font-size: 10pt">Consists of (i) 7,320,929 ordinary
shares identified in footnote (12) below, and (ii) 13,333 ordinary shares subject to options granted to Mr. Shamir. &#160;Mr.&#160;Shamir
is affiliated with CEL Catalyst Mobility Ltd. but disclaims any beneficial ownership of the reported shares except to the extent of any
pecuniary interest such member may have therein, directly or indirectly.</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"/><td style="width: 0.25in; text-align: left"><span style="font-size: 10pt">(7)</span></td><td style="text-align: justify"><span style="font-size: 10pt">Consist of: (i) 298,619 ordinary
shares held by Geneva Insurance Group (Barbados) Inc. in respect of Separate Account&#160;2020-418-VUL (the &#8220;Account&#8221;), which
account is held for the benefit of a trust (the &#8220;Master Trust&#8221;), of which Mr.&#160;Schwartz, alongside others, is an indirect
beneficiary, and (ii) 74,657 ordinary shares subject to options. Accordingly, Mr.&#160;Schwarz may be deemed to have an indirect beneficial
ownership interest with respect to the shares. Furthermore, Mr.&#160;Schwartz is one of three members of the Investment Committee of
the Master Trust, which holds the Account. The Investment Committee operates by majority, and Mr.&#160;Schwartz does not have any independent
control of the Investment Committee and may only act with the vote of one or more of the other members of the Investment Committee.</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"/><td style="width: 0.25in; text-align: left"><span style="font-size: 10pt">(8)</span></td><td style="text-align: justify"><span style="font-size: 10pt">Consists of (i) 964,182 ordinary
shares owned by Mr. Crist, (ii) 340,000 ordinary shares held by Texas Ventures Mgmt, LLC (&#8220;Texas Ventures&#8221;), (iii) 2,303,031
ordinary shares issuable upon exercise of private warrants owned by Mr. Crist and (iv) 13,333 ordinary shares subject to options granted
to Mr. Crist.&#160;&#160;Mr. Crist is chief executive officer and majority owner of Texas Ventures and has the right to vote and dispose
of securities held by Texas Ventures. Mr. Crist disclaims any beneficial ownership of the shares held by Texas Ventures other than to
the extent of any pecuniary interest he may have therein, directly or indirectly.</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><!-- Field: Page; Sequence: 89 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->86<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"/><td style="width: 0.25in; text-align: left"><span style="font-size: 10pt">(9)</span></td><td style="text-align: justify"><span style="font-size: 10pt">Consist of ordinary shares subject
to options.</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"/><td style="width: 0.25in; text-align: left"><span style="font-size: 10pt">(10)</span></td><td style="text-align: justify"><span style="font-size: 10pt">Consists of (i) 64,777 ordinary
shares and (ii) 53,332 ordinary shares subject to options.</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"/><td style="width: 0.25in; text-align: left"><span style="font-size: 10pt">(11)</span></td><td style="text-align: justify">Canaan Partners Israel (CPI) GP L.P. (&#8220;CPI General Partner&#8221;)
is the general partner of Canaan Partners Israel (CPI) (Cayman) L.P.&#160;CPI General Partner has the power to direct Canaan Partners
Israel (CPI) (Cayman) L.P. to vote and dispose of the shares by decision of its managing partner Mr.&#160;Ehud Levy. The business address
of the foregoing person is c/o Canaan Partners Israel (CPI) (Cayman) L.P, 12/11 Rav Ashi St. Tel Aviv, Israel.</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"/><td style="width: 0.25in; text-align: left"><span style="font-size: 10pt">(12)</span></td><td style="text-align: justify">Consists of: (i) 3,727,920 shares held by Special Situations
Fund III QP, L.P. (ii) 1,118,789 shares held by Special Situations Cayman Fund, L.P. (iii) 688,178 shares held by Special Situations
Private Equity Fund, L.P. (iv) 337,741 shares held by Special Situations Technology Fund, L.P. and (v) 1,840,547 shares held by Special
Situations Technology Fund II, L.P. AWM Investment Company, Inc., a Delaware corporation (&#8220;AWM&#8221;), is the investment adviser
to Special Situations Cayman Fund, L.P., a Cayman Islands Limited Partnership (&#8220;SSF CAYMAN&#8221;), Special Situations Fund III
QP, L.P., a Delaware limited partnership (&#8220;SSFQP&#8221;), Special Situations Private Equity Fund, L.P., a Delaware limited partnership
(&#8220;SSPE&#8221;), Special Situations Technology Fund, L.P., a Delaware limited partnership (&#8220;SSF TECH&#8221;) and Special Situations
Technology Fund II, L.P., a Delaware limited partnership (&#8220;SSF TECH II&#8221;). Mr. David M. Greenhouse (&#8220;Greenhouse&#8221;)
and Mr. Adam C. Stettner (&#8220;Stettner&#8221;) are limited partners of MGP Advisers Limited Partnership, a Delaware limited partnership,
the general partner of SSFQP. Greenhouse and Stettner are members of, SSCayman, L.L.C., a Delaware limited liability company, the general
partner of SSF CAYMAN,&#160;MG Advisers, L.L.C., a New York limited liability company, the general partner of SSPE and SST Advisers,
L.L.C., a Delaware limited liability company, the general partner of SSF TECH and SSF TECH II. Greenhouse and Stettner are also the controlling
principals of AWM and have the power to direct, vote and dispose of the shares The business address for AMW is c/o Special Situations
Funds, 527 Madison Avenue, Suite 2600, New York, NY 10022.</td>
</tr></table><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">(13)</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">Consists of: (i) 5,423,493 ordinary shares issued to CEL Catalyst Mobility Ltd. (ii) 1,897,436 ordinary shares issued to CATALYST IV FUND L.P. and (iii) 13,333 ordinary shares subject to options granted to Mr. Shamir. CEL Catalyst Mobility Ltd. is held by CEL Catalyst China Israel Fund L.P and Catalyst CEL Fund L.P.&#160;The directors of CEL Catalyst Mobility Ltd. are Yair Shamir and Shengyan Fan who have the power to direct it to vote and dispose of the shares and each such director has shared voting and investment power over the shares. Each director disclaims any beneficial ownership of the reported shares other than to the extent of any pecuniary interest such member may have therein, directly or indirectly. The business address of each of the foregoing persons is c/o Catalyst Investment (Israel)&#160;III Ltd., 28 Haarbaa St., Tel Aviv 6473925, Israel.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">(14)</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">Consists of shares held by iAngels Technologies LP&#160;&#8212;&#160;Series&#160;Arbe Robotics Ltd. Advanced Investment. iAngels Crowd Ltd. (&#8220;iAngels General Partner&#8221;) is the general partner of iAngels Technologies LP&#160;&#8212;&#160;Series&#160;Arbe Robotics Ltd. Advanced Investment. iAngels General Partner has the power to direct iAngels Technologies LP&#160;&#8212;&#160;Series&#160;Arbe Robotics Ltd. Advanced Investment to vote and dispose of the shares by decision of its Investment Committee. The Investment Committee is comprised of Mrs.&#160;Mor Assia, Mrs.&#160;Shelly Hod Moyal and Mr.&#160;David Assia, and each member of the Investment Committee has shared voting and investment power over the shares. Each member of the Investment Committee disclaims any beneficial ownership of the reported shares other than to the extent of any pecuniary interest such member may have therein, directly or indirectly. The business address of each of the foregoing persons is c/o iAngels Technologies LP&#160;&#8212;&#160;Series&#160;Arbe Robotics Ltd. Advanced Investment, 18 Rotschild St., Tel Aviv, Israel.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24pt; text-align: justify; text-indent: -24pt"></p><div>

</div><!-- Field: Page; Sequence: 90 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->87<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><div><a id="a_009"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>ITEM 7. MAJOR SHAREHOLDERS AND RELATED PARTY TRANSACTIONS</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 36pt"><b>&#160;</b></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.25in"><span style="font-size: 10pt"><b>A.</b></span></td>
    <td style="text-align: justify"><span style="font-size: 10pt"><b>Major Shareholders</b></span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">See Section E, &#8220;Share Ownership,&#8221; under Item 6 for information
as to our major shareholders.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 36pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.25in"><span style="font-size: 10pt"><b>B.</b></span></td>
    <td style="text-align: justify"><span style="font-size: 10pt"><b>Related Party Transactions</b></span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">This section refers to related-party transactions
with respect to our directors and executive officers, which are unusual and not in the ordinary course of business of the Company and
does not include compensation or indemnification of Senior Management, which is disclosed above in <i>Item 6.B. Compensation</i>.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.25in"><span style="font-size: 10pt">1.</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">Kobi Marenko, our CEO, has a non-controlling interest in Taya Ventures L.P, which is a minority shareholder.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.25in"><span style="font-size: 10pt">2.</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">Inter, a company owned by Kobi Marenko, purchased 50,167 ordinary shares in October 2022 for $501,670 as part of our PIPE offering.&#160;&#160;The purchase was made on the same terms as other investors in the PIPE offering, which involved the sale of 10,000,000 ordinary shares at $10.00 per share contemporaneously with the Merger with ITAC.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.25in"><span style="font-size: 10pt">3.</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">We and certain investor shareholders (the &#8220;<b>Investor Shareholders</b>&#8221;) are parties to an investor rights agreement, as amended, which grants the Investor Shareholders certain registration rights with respect to their ordinary shares, which agreement includes standard covenants and indemnification provisions. In the event that we wish to provide additional registration rights, we may be required to obtain the approval of the holders of majority of the ordinary shares held by the Investor Shareholders for as long they, as a group, continue to hold such majority upon completion of a Merger. Such approval is not required if the proposed transaction is approved by the majority of our independent directors (currently, a majority of our board of directors are independent directors). This investor rights agreement will continue and survive for a period of five&#160;years after the closing of the Merger, or earlier upon the consummation of any consolidation or merger of the Company with or into a third party as described under the agreement.</span></td></tr>
</table><div>

</div><p style="margin: 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 20pt; text-align: left"><span style="font-size: 10pt">4.</span></td><td style="text-align: justify"><span style="font-size: 10pt">During June 2023, we raised $23.0
million from Special Situations Funds, a family of funds focused primarily on growth oriented small public companies with a concentration
on the technology and life sciences industries, pursuant to which the Company issued a total of 11,794,873 Ordinary Shares with a purchase
price of $1.95 per share. Existing investors participated in this offering.&#160;&#160;The aggregate net proceeds received by the Company
from the offering were $22.5 million&#160;net of issuance costs.&#160;&#160;Two of the investors in the financing are affiliates of two
of our directors.&#160;&#160;Catalyst Investments, and Geneva Insurance Group, invested $5.3 million and $250,000, respectively.&#160;&#160;Mr.
Yair Shamir, chairman and a director is co-founder and managing partner of Catalyst Investments, and Mr. Boaz Scwartz, a director, is
a beneficiary of a master trust held by Geneva Insurance Group (Barbados) Inc. and Mr. Schwartz is one of three members of the investment
committee of the master trust.</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">For a description of the approvals required under
Israeli law for related-party transactions, disclosure of personal interest and transactions with controlling shareholders, see under
&#8220;Item 10.B.&#8212;Conflict of Interest.&#8221;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">For a description of the approvals required under
Israeli law for compensation arrangements of officers and directors, see &#8220;Item 6.B.-&#160;Compensation of Directors and Executive
Officers.&#8221;</p><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Fiduciary Duties of Directors and Executive
Officers</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Israeli Companies Law provides for fiduciary
duties that Office Holders owe to a company. An &#8216;Office Holder&#8217; is defined under the Israeli Companies Law as a general manager,
chief business manager, deputy general manager, vice general manager, any other person assuming the responsibilities of any of these positions
regardless of such person&#8217;s title, a director and any other manager directly subordinate to the general manager. Each person listed
in the table under the section A of Item 6 as Senior Management is an Office Holders under the Israeli Companies Law. However, there are
certain additional persons who are not listed in the above table who may meet the definition of an Officer Holder but who are not part
of our Senior Management as defined in our organizational structure.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 91 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->88<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">An Office Holder&#8217;s fiduciary duties consist
of a duty of care and a duty of loyalty. The duty of care requires an Office Holders to act with a reasonable level of care and generally
requires to obtain:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 20pt"/><td style="width: 20pt; text-align: left"><span style="font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-size: 10pt">information on the appropriateness
of a given action submitted for his or her approval or performed by virtue of his or her position; and</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 20pt"/><td style="width: 20pt; text-align: left"><span style="font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-size: 10pt">all other important information
pertaining to these actions.</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The duty of loyalty requires an Office Holder
to act in good faith and in the best interests of a company and generally includes the following duties:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 20pt"/><td style="width: 20pt; text-align: left"><span style="font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-size: 10pt">refrain from any conflict of interest
between the performance of his or her duties in the company and his performance of duties with respect to another position or his or
her personal affairs;</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 20pt"/><td style="width: 20pt; text-align: left"><span style="font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-size: 10pt">refrain from any activity that
is competitive with the business of the company;</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 20pt"/><td style="width: 20pt; text-align: left"><span style="font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-size: 10pt">refrain from exploiting any business
opportunity of the company in order to receive a personal gain for himself or herself or others; and</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 20pt"/><td style="width: 20pt; text-align: left"><span style="font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-size: 10pt">disclose to the company any information
or documents relating to the company&#8217;s affairs which the Office Holders received as a result of his or her position as Office Holders.</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Shareholder Duties</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Pursuant to the Israeli Companies Law, a shareholder
has a duty to act in good faith and in a customary manner toward the company and other shareholders and to refrain from abusing his or
her power with respect to the company, including, among other things, in voting at a general meeting and at shareholder class meetings
with respect to the following matters:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 20pt"/><td style="width: 20pt; text-align: left"><span style="font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-size: 10pt">an amendment to a company&#8217;s
articles of association;</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 20pt"/><td style="width: 20pt; text-align: left"><span style="font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-size: 10pt">an increase of a company&#8217;s
authorized share capital;</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 20pt"/><td style="width: 20pt; text-align: left"><span style="font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-size: 10pt">a merger; or</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 20pt"/><td style="width: 20pt; text-align: left"><span style="font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-size: 10pt">interested party transactions that
require shareholder approval.</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In addition, a shareholder has a general duty
to refrain from discriminating against other shareholders.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">A controlling shareholder also has a duty of fairness
toward the company. For the definition of a &#8216;controlling shareholder&#8221; see above at Item 6.B &#8211; &#8220;Director Independence.&#8221;
The Israeli Companies Law does not define the substance of this duty of fairness, except to state that the remedies generally available
upon a breach of the fiduciary duty will also apply in the event of a breach of the duty of fairness.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>C. Interests of Experts and Counsel</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Not applicable.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><div><a id="a_010"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>ITEM 8. FINANCIAL INFORMATION</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 36pt"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>A. Consolidated Statements and Other Financial Information</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our consolidated financial statements begin on
page F-1.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 36pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Legal Proceedings</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 36pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">See &#8220;Legal Proceeding&#8221; under Section
B of &#8220;Item 4. Information on the Company&#8221;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt">&#160;</p><div>


</div><!-- Field: Page; Sequence: 92 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->89<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Dividends</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We have never declared or paid any dividend on
our ordinary shares and we do not anticipate paying any dividends on our ordinary shares in the future. We currently intend to retain
all future earnings to finance our operations and to expand our business.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 36pt"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>No Significant Changes</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Except as disclosed elsewhere in this annual report,&#160;no
other significant changes to our financial condition have occurred since the date of the annual financial statements contained herein.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: -70pt">&#160;</p><div>

</div><div><a id="a_011"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>ITEM 9. THE OFFER AND LISTING</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 36pt"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>A. Offer and Listing Details</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our ordinary shares, par value NIS0.000216 per
share, and warrants are listed for trading on the Nasdaq Capital Market under the symbols &#8220;ARBE&#8221; and &#8220;ARBEW,&#8221;
respectively.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our ordinary shares and warrants are issued in
book entry form.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The transfer agent for our ordinary shares and
warrant agent for our warrants is Continental Stock Transfer &amp; Trust Company, 1 State Street, 30th Floor, New York, New York 10004,
telephone: (212) 509-4000.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our publicly traded ordinary shares and warrants
are not subject to any transfer restrictions.&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">See &#8220;Description or Warrants&#8221; in Section
B under Item 12.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>B. Plan of Distribution</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Not Applicable.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>C. Markets</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our ordinary shares and warrants are currently
traded on the Nasdaq Capital Market.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 36pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>D. Selling Shareholders</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Not Applicable.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 36pt"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>E. Dilution</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Not Applicable.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 36pt"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>F. Expenses of the Issuer</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 36pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">Not Applicable.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 36pt">&#160;</p><div>

</div><div><a id="a_012"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>ITEM 10. ADDITIONAL INFORMATION</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 36pt"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>A. Share Capital</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Not Applicable.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt"></p><div>

</div><!-- Field: Page; Sequence: 93 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->90<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>B. Memorandum and Articles of Association</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We are an Israeli corporation and our affairs
are governed by our Restated Articles of Association (the &#8220;Restated Articles&#8221;) and the Israeli Companies Law. The following
are summaries of material provisions of our Restated Articles and the Israeli Companies Law insofar as they relate to the material terms
of our ordinary shares. This description does not purport to be complete and is qualified in its entirety by reference to the full text
of our Restated Articles, which is filed as an exhibit to this Form 20-F, and by the Israeli Companies Law.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>General</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">This section summarizes the material rights of
the holders of ordinary shares under Israeli Companies Law, and the material provisions of the Restated Articles.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Authorized Capital</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The authorized share capital consists of&#160;130,000,000
ordinary shares, par value NIS 0.000216. As of March 1, 2024, we had 78,221,557 ordinary shares outstanding.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">All of the outstanding ordinary shares are validly
issued, fully paid and&#160;non-assessable.&#160;The ordinary shares are not redeemable and do not entitle their holders to pre-emptive
rights. Our Restated Articles and the Israeli Companies Law do not restrict in any way the ownership or voting of ordinary shares by non-residents
or persons who are not citizens of Israel, except with respect to subjects of nations which are in a state of war with Israel. All ordinary
shares have identical rights.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Subject to the rights of holders of shares with
special rights (if such shares are issued in the future), holders of paid up ordinary shares are entitled to participate in the payment
of dividends and, in the event of a winding-up of Arbe, in the distribution of assets available for distribution, in proportion to their
respective shareholdings and in respect of which such dividend is being paid or such distribution is being made, without considering any
premium those holders might have paid in excess of that par value.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Shares with preferential rights relating, among
other things, to dividends, voting and repayment of share capital can be created by adoption of a resolution of the shareholders at a
general meeting of shareholders at which a quorum is present, by a simple majority of the voting power represented at the meeting in person
or by proxy and voting thereon. We can effect a share distribution or share dividend with board approval. A stock split (as well as other
changes to our authorized capital, including an increase to the authorized capital) requires shareholder approval, consisting of the majority
of the shareholders present with the required quorum. Modification or abrogation of the rights of any class of shares by the Company requires
shareholder approval of all shares acting as one class, without any required separate resolution of any class of shares.</p><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">An increase in the authorized share capital, the
creation of a new class of shares, an increase in the authorized share capital of a class of shares, or the issuance of additional shares
thereof out of the authorized and unissued share capital, shall not be deemed, for purposes hereof, to modify or derogate or cancel the
rights attached to previously issued shares of such class or of any other class, and any such change must be approved by the shareholders.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Any transaction that has the effect of reducing
the share capital, such as the declaration and payment of dividends in the absence of sufficient retained earnings or profits, requires
the approval of both the board of directors and an Israeli court.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Election and Removal of Directors</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Pursuant to our Restated Articles, directors will
be appointed by a simple majority vote of holders of the voting shares, participating and voting at an annual general meeting of the shareholders.
Our ordinary shares are currently our only voting shares.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Under the Israeli Companies Law, an Israeli public
company is required to appoint at least two natural persons as &#8220;external directors,&#8221; unless the company elects to opt out
of the requirement to maintain such regime. Appointments of external directors are to be for a term of three years and may be extended
for additional three-year terms, subject to certain conditions as provided under the Israeli Companies Law and regulations promulgated
thereunder.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>


</div><!-- Field: Page; Sequence: 94 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->91<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our directors are divided into three classes,
with one class being elected each year at the Company&#8217;s annual general meeting of shareholders for a term of approximately three
years, until the third annual general meeting following such election or&#160;re-election&#160;or generally, until they are removed by
a vote of a majority of the voting power of the shareholders represented at the general meeting in person or by proxy and voting thereon,
as one class, and disregarding abstentions from the count of the voting power of the shareholders present and voting. The term of office
of each class directors currently serving on our board shall expire at the annual general meeting for 2025 for Class I directors, 2026
for Class II directors and 2024 for Class III directors. Any change in our Restated Articles to amend the provisions relating to a classified
board requires the approval of the holders of 60% of the ordinary shares outstanding on the applicable record date.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Under our Restated Articles, a director shall
vacate his or her office if that director dies; is declared bankrupt; is declared to be legally incompetent; resigns such office by notice
in writing given to the Company; is not&#160;re-elected&#160;by the shareholders upon expiration of his or her term at the relevant annual
general meeting of shareholders, or otherwise as provided in the Israeli Companies Law.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In addition, our Restated Articles allow our board
of directors to fill vacancies on the board of directors or to appoint new directors up to the maximum number of directors permitted under
our Restated Articles (which is currently nine members). Such directors serve for a term of office equal to the remaining period of the
term of office of the directors(s)&#160;whose office(s)&#160;have been vacated or in the case of new directors, for a term of office according
to the class to which such director was assigned upon appointment.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Under our Restated Articles, the board of directors
must consist of not less than three but no more than&#160;nine directors, including &#8220;external directors&#8221; if appointed (as
defined by the Israeli Companies Law). We presently have nine directors. We have opted out of the external director regime, and we maintain
the current regime, which is based on our board or directors consisting of a majority of independent directors, using the Nasdaq definition
of independent director. For further information, see &#8220;Item 6 &#8211; Management.&#8221;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Dividends and Liquidation</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We may declare a dividend to be paid to the holders
of the ordinary shares in proportion to their respective shareholdings. Under the Israeli Companies Law, dividend distributions are determined
by the board of directors and do not require the approval of the shareholders of a company unless the company&#8217;s articles of association
provide otherwise. Our Restated Articles do not require shareholder approval of a dividend distribution and provide that dividend distributions
may be determined by the board of directors; provided that any declaration of a dividend in the absence of sufficient retained earnings
or profits, requires the approval of both the board of directors and an Israeli court. In certain circumstances provided by regulations
promulgated under the Israeli Companies Law, our Board may also approve distributions in the absence of sufficient retained earnings or
profits, without the approval of the Israeli court, subject to complying with certain conditions as provided therein.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Pursuant to the Israeli Companies Law, dividends
may be distributed only out of&#160;earnings or earnings generated over the two&#160;years preceding the distribution, according to the
company&#8217;s most recently reviewed or audited financial statements, provided that the end of the period to which the financial statements
relate is not more than six&#160;months prior to the date of the distribution. If a company does not meet such criteria, then it may distribute
dividends only with court approval. In each case, we would only be permitted to distribute a dividend if the board of directors and the
court, if applicable, determines that there is no reasonable concern that distribution of the dividend will prevent us from being able
to meet our existing and foreseeable obligations as they become due.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In the event of liquidation, after satisfaction
of liabilities to our creditors, our assets will be distributed to the holders of the ordinary shares in proportion to their shareholdings.
This right, as well as the right to receive dividends, may be affected by the grant of preferential dividend or distribution rights to
holders of a class of shares with preferential rights which may be authorized in the future.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Shareholder Meetings</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Under Israeli Companies law, we are required to
hold an annual general meeting of our shareholders once every calendar year (an &#8220;annual meeting&#8221;) and no later than 15&#160;months
after the date of the previous annual general meeting. All meetings other than the annual general meeting of shareholders are referred
to in our Restated Articles as special meetings (&#8220;special meetings,&#8221; and, together with the annual meeting, &#8220;general
meetings&#8221;).</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 95 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->92<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In addition, the Israeli Companies Law provides
that the board of directors is required to convene a special meeting upon the written request of (i)&#160;any two or more of our directors
or&#160;one-quarter&#160;or more of the members of our board of directors or (ii)&#160;one or more shareholders holding, in the aggregate,
either (a)&#160;10% or more of our issued and outstanding shares and 1% or more of our outstanding voting power or (b)&#160;10% or more
of our outstanding voting power.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Subject to the provisions of the Israeli Companies
Law and regulations promulgated thereunder, shareholders entitled to participate and vote at general meetings are the shareholders of
record on a date to be decided by the board of directors, which may generally be between four and sixty&#160;days prior to the date of
the meeting, pursuant to recently amended regulations governing relief to Israeli public companies traded abroad.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Furthermore, the Israeli Companies Law requires
that resolutions regarding the following matters must be passed at a general meeting of shareholders:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 20pt"/><td style="width: 20pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">amendments
                                            to the articles of association;</span></td>
</tr></table><div>

</div><p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 20pt"/><td style="width: 20pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">appointment
                                            or termination of auditors;</span></td>
</tr></table><div>

</div><p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 20pt"/><td style="width: 20pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">appointment
                                            of external directors (to the extent required);</span></td>
</tr></table><div>

</div><p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 20pt"/><td style="width: 20pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">approval
                                            of certain related party transactions as required by law;</span></td>
</tr></table><div>

</div><p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 20pt"/><td style="width: 20pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">increases
                                            or reductions of authorized share capital and the creation of preferred shares.</span></td>
</tr></table><div>

</div><p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 20pt"/><td style="width: 20pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">a
                                            merger; and</span></td>
</tr></table><div>

</div><p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 20pt"/><td style="width: 20pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">resolutions
                                            required for the management of the company, in which at such time the board of directors
                                            is unable to resolve or perform its duties.</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Israeli Companies Law and regulations promulgated
thereunder require that a notice of any annual general meeting or special meeting be provided to shareholders at least 21&#160;days prior
to the meeting and if the agenda of the meeting includes the appointment or removal of directors, the approval of transactions with Office
Holders or interested or related parties, an approval of a merger, approval of compensation policy or approval of compromise or settlement
between the company to its creditors or shareholders, notice must be provided at least 35&#160;days prior to the meeting. Under the Israeli
Companies Law and our Restated Articles, shareholders are permitted act by way of written consent in lieu of a meeting.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Quorum</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Pursuant to the Restated Articles, holders of
ordinary shares have one vote for each ordinary share held on all matters submitted to a vote before the shareholders at a general meeting.
The quorum required for our general meetings consists of at least two shareholders present in person or by proxy and holding shares representing,
in the aggregate, at least 25% of our voting power. A meeting adjourned for lack of a quorum will be adjourned either to (i)&#160;to the
same day in the next week, at the same time and place, or (ii)&#160;to such&#160;day and at such time and place as indicated in the notice
of such meeting, or (iii)&#160;to such&#160;day and at such time and place as the chairperson of the meeting shall determine (which may
be earlier or later than the date pursuant to clause (i)&#160;above). At the adjourned meeting, one or more shareholders, present in person
or by proxy shall constitute a quorum.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Voting Requirements</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our Restated Articles provide that all shareholder
resolutions require a simple majority vote, unless otherwise required by the Israeli Companies Law or by our Restated Articles.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Shareholders may vote, in person or by proxy,
the number of voting shares that they own on the record date for the applicable general meeting.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our Restated Articles also provide that the removal
of any director from office requires a vote of a majority of the votes cast at a general meeting if a quorum is present. Any amendment
of the provisions relating to our classified board requires the vote of 60% of the total voting power of the shareholders. A resolution
for the voluntary winding up, or an approval of a scheme of arrangement or reorganization, pursuant to Section&#160;350 of the Israeli
Companies Law requires the approval of holders of at least 75% of the voting rights represented at the meeting and voting on the resolution
provided that a quorum is present.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 96 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->93<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Under the Israeli Companies Law, each of (i)&#160;the
approval of an extraordinary transaction with a controlling shareholder; (ii)&#160;the terms of employment or other engagement of the
controlling shareholder of the company or such controlling shareholder&#8217;s relative (even if such terms are not extraordinary) or
(iii) the approval of certain compensation-related matters of officers and directors &#8211; generally require a special disinterested
majority approval.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">With respect to required approvals with respect
to compensation-related matters see also under &#8220;<i>Item 6.B Board Practices&#160;&#8212;&#160;Committees of the Board of Directors&#160;&#8212;&#160;Compensation
Committee</i>&#8221; and &#8220;&#8212;&#160;<i>Compensation Policy under the Israeli Companies Law</i>.&#8221;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Disclosure of Personal Interests of an Office
Holder and Approval of Certain Transactions</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Israeli Companies Law requires that an Office
Holder promptly disclose to the board of directors any personal interest that he or she may have and all related material information
known to him or her concerning any existing or proposed transaction with the company. Under the Israeli Companies Law, a &#8216;personal
interest&#8217; includes an interest of any person in an act or transaction of the company, excluding a personal interest arising solely
from holding shares in the company, but including the personal interest (i) of his/her immediate family, spouses, siblings, parents, grandparents,
descendants, spouse&#8217;s descendants, siblings or parents or the spouse of any of such persons, or; (ii) of an entity in which such
person or a relative of such person is a 5% or greater shareholder, director or general manager or in which he or she has the right to
appoint at least one director or the general manager. In addition, under the Israeli Companies Law, in case of a person voting by proxy,
&#8220;personal interest&#8221; includes the personal interest of either the proxy holder or the shareholder granting the proxy, whether
the proxy holder has discretion to vote or not.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If an Office Holder has a personal interest in
a non-extraordinary transaction, meaning any transaction that is in the ordinary course of business, on market terms and that is not likely
to have a material impact on the company&#8217;s profitability, assets or liabilities, approval by the board of directors is required
for the transaction, unless the company&#8217;s articles of association provide for a different method of approval.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If an Office Holder has a personal interest in
any transaction (i) that is not in the ordinary course of business, (ii) not on market terms or (iii) that is likely to have a material
impact on the company&#8217;s profitability, assets or liabilities (each, an &#8216;extraordinary transaction&#8217;), then an approval
is first required by the company&#8217;s audit committee and subsequently by the board of directors.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">A director and any other Office Holder who has
a personal interest in a transaction which is being considered by the board of directors or the audit committee, may not be present at
such a meeting or vote on that matter. However, if a majority of the directors (whether of the audit committee or of the board of directors)
has a personal interest in the matter, then it is allowed for those directors to participate, deliberate and vote in such meeting, provided
however, that, a shareholder approval is also required to approve such transaction.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Certain disclosures and approval requirements
apply under Israeli law to certain transactions with controlling shareholders, certain transactions in which a controlling shareholder
has a personal interest and certain arrangements regarding the terms of service or employment of a controlling shareholder. For these
purposes, a controlling shareholder is any shareholder can direct the company&#8217;s actions, including any shareholder holding 25% or
more of the voting rights provided that no other shareholder owns more than 50% of the voting rights in the company. Two or more shareholders
with a personal interest in the approval of the same transaction are deemed to be one shareholder for the purpose of computing such threshold.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Israeli law requires that on certain
related-party transactions, including matters requiring Compensation Majority, each shareholder voting thereon is required to state
whether the shareholder is a Controlling&#160;Shareholder and/or if the shareholder has any personal interest in the matter in the
proposed resolution.&#160;If any shareholder casting a vote in connection hereto does not explicitly indicate on the proxy card the
foregoing, then the shareholder&#8217;s vote on the applicable item will not be counted. Pursuant to recently amended regulations, a
shareholder may be regarded as not having any personal interest unless the shareholder expressly notifies the company, which
notification may be through its proxy card or by another method.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 97 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->94<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">For a description of the approvals required under
Israeli law for compensation arrangements of officers and directors, see &#8220;Item 6 &#8212;&#160;Compensation of Directors and Executive
Officers.&#8221;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Access to Corporate Records</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Under the Israeli Companies Law, all shareholders
generally have the right to review minutes of the general meetings, the shareholders register, the material shareholders register (which,
according to the Israeli Companies Law, is a register of holders of 5% or more of a company&#8217;s voting shares), the articles of association,
the financial statements, and any document that a company is required by law to file publicly with the Israeli Companies Registrar and
other documents as provided in the Israeli Companies Law. Any shareholder who specifies the purpose of its request may request to review
any document in our possession that relates to any action or transaction with a related party which requires shareholder approval under
the Israeli Companies Law. We may deny a request to review a document if we determine that the request was not made in good faith, that
the document contains a commercial secret or a patent or that the document&#8217;s disclosure may otherwise impair the interests of the
company.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Limitations on Liability and Indemnification
of Officers and Directors -- Exemption, Insurance and Indemnification of Directors and Officers</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i><span style="text-decoration:underline">Exemption.</span></i>&#160;Under the Israeli
Companies Law, a company may not exempt an Office Holder from liability for a breach of the duty of loyalty or from liability arising
out of a prohibited distribution to shareholders. Our Articles of Association allow us to exempt in advance, an Office Holder from liability
towards the company, in whole or in part, for damages caused to the company as a result of a breach of duty of care that is not a breach
of the duty of loyalty or liability arising out of a prohibited distribution to shareholders.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i><span style="text-decoration:underline">Indemnification.</span></i>&#160;Under the
Israeli Companies Law, a company may indemnify an Office Holder in respect of the following liabilities and expenses incurred by him or
her for acts performed by him or her as an Office Holder, either in advance of an event or following an event, provided a provision authorizing
such indemnification is contained in its articles of association:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 20pt"/><td style="width: 20pt; text-align: left"><span style="font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-size: 10pt">a financial liability imposed on
him or her in favor of another person pursuant to a judgment, including a settlement or arbitrator&#8217;s award approved by a court.
However, if an undertaking to indemnify an Office Holder with respect to such liability is provided in advance, then such an undertaking
must be limited to events which, in the opinion of the board of directors, can be foreseen based on the company&#8217;s activities when
the undertaking to indemnify was given, and to an amount or according to criteria determined by the board of directors as reasonable
under the circumstances.&#160;&#160;Such undertaking shall detail the abovementioned events and amount or criteria;</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 20pt"/><td style="width: 20pt; text-align: left"><span style="font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-size: 10pt">reasonable litigation expenses,
including attorneys&#8217; fees, incurred by the Office Holder in connection with a monetary sanction or as a result of an investigation
or proceeding instituted against him or her by an authority authorized to conduct such investigation or proceeding,&#160;<i>provided</i>&#160;that
(i)&#160;no indictment was filed against such Office Holder as a result of such investigation or proceeding; and (ii)&#160;no financial
liability, such as a criminal penalty, was imposed upon him or her in lieu of criminal proceedings or, if such financial liability was
imposed, it was imposed with respect to an offense that does not require proof of criminal intent; and</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 20pt"/><td style="width: 20pt; text-align: left"><span style="font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-size: 10pt">reasonable litigation expenses,
including attorneys&#8217; fees, incurred by the Office Holder or imposed by a court in proceedings instituted against him or her by
the company, on its behalf or by a&#160;third-party&#160;or in connection with criminal proceedings in which the Office Holder was acquitted
or as a result of a conviction for an offense that does not require proof of criminal intent.</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>


</div><!-- Field: Page; Sequence: 98 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->95<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We provide our directors and other Office Holders
with the maximum indemnity permitted by the Israeli Companies Law.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i><span style="text-decoration:underline">D&amp;O Insurance</span>.&#160;</i>Under the
Israeli Companies Law, a company may insure an Office Holder against the following liabilities incurred for acts performed as an Office
Holder if and to the extent provided in the company&#8217;s articles of association:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 20pt"/><td style="width: 20pt; text-align: left"><span style="font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-size: 10pt">a breach of the duty of loyalty,
provided that the Office Holder acted in good faith and had reasonable grounds to assume that the act that resulted in such breach would
not prejudice the interests of the company;</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 20pt"/><td style="width: 20pt; text-align: left"><span style="font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-size: 10pt">a breach of duty of care to the
company or to any other person;</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 20pt"/><td style="width: 20pt; text-align: left"><span style="font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-size: 10pt">a financial liability imposed on
such Office Holder in respect to his or her capacity as an Office Holder in favor of any other person; and</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 20pt"/><td style="width: 20pt; text-align: left"><span style="font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-size: 10pt">any other event, occurrence, matter
or circumstances under any law with respect to which the company may, or will be able to, insure an Office Holder, and to the extent
such law requires the inclusion of a provision permitting such insurance in the articles of association, then such provision is deemed
to be included and incorporated by reference (including, without limitation, in accordance with section&#160;56h(b)(1)&#160;of the Securities
Law, if and to the extent applicable, Section&#160;50P of the Competition Law).</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i><span style="text-decoration:underline">Limitations on Exemption, Insurance, and
Indemnification.</span></i>&#160;Under the Israeli Companies Law, a company may not indemnify, exculpate, or insure an Office Holder against
any of the following:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 20pt"/><td style="width: 20pt; text-align: left"><span style="font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-size: 10pt">a breach of the duty of loyalty,
except to the extent that the Office Holder acted in good faith and had a reasonable basis to believe that the act would not prejudice
the company;</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 20pt"/><td style="width: 20pt; text-align: left"><span style="font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-size: 10pt">a breach of the duty of care committed
intentionally or recklessly, excluding a breach arising out of the negligent conduct of the Office Holder;</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 20pt"/><td style="width: 20pt; text-align: left"><span style="font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-size: 10pt">an act or omission committed with
intent to derive illegal personal benefit; or</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 20pt"/><td style="width: 20pt; text-align: left"><span style="font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-size: 10pt">a fine or forfeiture levied against
the Office Holder.</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i><span style="text-decoration:underline">Required Approvals.</span></i>&#160;Under the
Israeli Companies Law, exculpation, indemnification and insurance of Office Holders must be approved by the compensation committee and
the board of directors and, with respect to directors and the CEO, also by the general meeting of the shareholders. Under certain circumstances
set forth in the Israel Companies Law, shareholder approval may be exempted, subject to our meeting the conditions provided thereunder.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our Restated Articles permit us to exempt, indemnify
and insure our Office Holders to the extent permitted by law and the Restated Articles. The Office Holders are currently covered by a
directors and officers&#8217; liability insurance policy.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We have entered into indemnification, insurance
and exculpation agreements with each of our directors and certain executive officers, undertaking to indemnify, insure and exculpate them
to the fullest extent permitted by law.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In so far as indemnification for liabilities
arising under the Securities Act&#160;of&#160;1933 may be permitted to directors, officers and controlling persons of the company,
we have been advised that in the opinion of the Securities and Exchange Commission such indemnification is against public policy as
expressed in the Securities Act&#160;of&#160;1933 and is, therefore, unenforceable. In the event that a claim for indemnification
against such liabilities (other than the payment by the company of expenses incurred or paid by a director, officer or controlling
person of the company in the successful defense of any action, suit or proceeding) is asserted by such director, officer or
controlling person in connection with the securities being registered, the registrant will, unless in the opinion of its counsel the
matter has been settled by controlling precedent, submit to a court of appropriate jurisdiction the question whether such
indemnification by it is against public policy as expressed in the Securities Act and will be governed by the final adjudication of
such issue.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 99 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->96<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">There is no pending litigation or proceeding against
any of our Office Holders as to which indemnification is being sought, nor are we aware of any pending or threatened litigation that may
result in claims for indemnification by any Office Holder.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Exclusive Jurisdiction of Certain Actions</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our Restated Articles provide that unless we consent
in writing to the selection of an alternative forum, the federal district courts of the United&#160;States of America shall be the exclusive
forum for the resolution of any complaint asserting a cause of action arising under the Securities Act. Since the Securities Act provide
for both federal and state court jurisdiction, a state court in the United States may be reluctant to enforce the exclusive jurisdiction
provisions to the extent that they are deemed to preclude state court jurisdiction for claims arising under the Securities Act.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our Restated Articles provide that unless we consent
in writing to the selection of an alternative forum, the competent courts in Tel Aviv, Israel will be the exclusive forum for (i)&#160;any
derivative action or proceeding brought on behalf of us, (ii)&#160;any action asserting a claim of breach of a duty owed by any director,
officer or other of our employees to us or our shareholders, or (iii)&#160;any action asserting a claim arising pursuant to any provision
of the Israeli Companies Law or the Israeli Securities Law, 5728-1968 or otherwise arising from the holding of our ordinary shares.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Transfer Agent and Warrant Agent</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The transfer agent for our ordinary shares and
the warrant agent for our warrants is Continental Stock Transfer&#160;&amp; Trust Company, 1 State Street, 30<sup>th</sup>&#160;Floor,
New&#160;York, New&#160;York 10004, telephone: (212)&#160;509-4000.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Anti-Takeover&#160;Provisions</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Acquisitions under Israeli Law</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt"><i>(a)</i></span></td>
    <td style="text-align: justify"><span style="font-size: 10pt"><i>Full Tender Offer</i></span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">A person wishing to acquire shares of a public
Israeli company and who could as a result hold over 90% of the target company&#8217;s voting rights or the target company&#8217;s issued
and outstanding share capital (or of a class thereof), is required by the Israeli Companies Law to make a tender offer to all of the company&#8217;s
shareholders for the purchase of all of the issued and outstanding shares of the company (or the applicable class). If (a)&#160;the shareholders
who do not accept the offer hold less than 5% of the issued and outstanding share capital of the company (or the applicable class) and
the shareholders who accept the offer constitute a majority of the offerees that do not have a personal interest in the acceptance of
the tender offer or (b)&#160;the shareholders who do not accept the tender offer hold less than 2% of the issued and outstanding share
capital of the company (or of the applicable class), all of the shares that the acquirer offered to purchase will be transferred to the
acquirer by operation of law . A shareholder who had its shares transferred may petition the court within six&#160;months from the date
of acceptance of the full tender offer, regardless of whether such shareholder agreed to the offer, to determine whether the tender offer
was for less than fair value and whether the fair value should be paid as determined by the court. However, an offeror may provide in
the offer that a shareholder who accepted the offer will not be entitled to appraisal rights as described in the preceding sentence if
the offeror and the company disclosed the information required by law in connection with the tender offer. If the full tender offer was
not accepted in accordance with any of the above alternatives, the acquirer may not acquire shares of the company that will increase its
holdings to more than 90% of the company&#8217;s issued and outstanding share capital (or of the applicable class) from shareholders who
accepted the tender offer.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 100 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->97<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt"><i>(b)</i></span></td>
    <td style="text-align: justify"><span style="font-size: 10pt"><i>Special Tender Offer</i></span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Israeli Companies Law provides that an
acquisition of shares of an Israeli public company must be made by means of a special tender offer if, because of the acquisition,
the purchaser would become a holder of 25% or more of the voting rights in the company. This rule does not apply if there is already
another holder of 25% or more of the voting rights in the company. Similarly, the Israeli Companies Law provides that an acquisition
of shares in an Israeli public company must be made by means of a tender offer if as a result of the acquisition the purchaser would
become a holder of more than 45% of the voting rights in the company, if there is no other shareholder of the company who holds more
than 45% of the voting rights in the company. These requirements do not apply if the acquisition (i)&#160;occurs in the context of a
private placement by the company that received shareholder approval, (ii)&#160;was from a shareholder holding 25% or more of the
voting rights in the company and resulted in the acquirer becoming a holder of 25% or more of the voting rights in the company, or
(iii)&#160;was from a holder of more than 45% of the voting rights in the company and resulted in the acquirer becoming a holder of
more than 45% of the voting rights in the company. A special tender offer may be consummated and is deemed to be accepted only if
(i)&#160;at least 5% of the voting power attached to the company&#8217;s outstanding shares will be acquired by the offeror and
(ii)&#160;the number of shares tendered in the offer exceeds the number of shares whose holders objected to the offer (excluding
controlling shareholders, holders of 25% or more of the voting rights in the company and any person having a personal interest in
the acceptance of the tender offer).</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In the event that a special tender offer is made,
the company&#8217;s board of directors is required to express its opinion on the advisability of the offer and may abstain from expressing
any opinion if it is unable to do so,&#160;<i>provided</i>&#160;that it gives the reasons for its abstention. An Office Holder in a company
who, in his or her capacity as an Office Holder, performs an action for the purpose of causing failure of an existing or foreseeable special
tender offer or is to impair the chances of its acceptance, will personally be liable for the damages to the purchaser and shareholders,
unless such Office Holder acted in good faith and had reasonable grounds to believe he or she was acting for the benefit of the company.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If a special tender offer is accepted, then shareholders
who did not respond to or that had objected to the offer may accept the offer within four&#160;days of the last&#160;day set for the acceptance
of the offer.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In the event that a special tender offer is accepted,
the purchaser or any person or entity controlling it or under common control with the purchaser or such controlling person or entity may
not make a subsequent tender offer for the purchase of shares of the target company and may not enter into a merger with the target company
for a period of one year from the date of the offer, unless the purchaser or such person or entity undertook to effect such an offer or
merger in the initial special tender offer.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt"><i>(c)</i></span></td>
    <td style="text-align: justify"><span style="font-size: 10pt"><i>Mergers</i></span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Israeli Companies Law permits merger transactions
if approved by (i) the board of directors of each of the merging companies and, (ii) unless certain conditions described under the Israeli
Companies Law are met, a majority of the shareholders of each of the merging companies voted on the matter, provided that a proper quorum
was present. The board of directors of a merging company is required, pursuant to the Israeli Companies Law, to discuss and determine
whether in its opinion there is a reasonable concern that as a result of a proposed merger, the surviving company will not be able to
satisfy its obligations to its creditors, such determination taking into account the financial status of the merging companies. If the
board of directors determines that such a concern exists, it may not approve a proposed merger. Following the approval of the board of
directors of each of the merging companies, the boards of directors of the merging companies must jointly prepare a merger proposal to
submit to the Israeli Registrar of Companies.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">For the purposes of the shareholder vote,
unless a court rules otherwise, if one of the merging companies (or any person who holds 25% or more of the outstanding shares or
the right to appoint 25% or more of the directors of one of the merging companies) holds shares in the other merging company, the
merger will not be deemed approved if a majority of the shares voted at the shareholders meeting by shareholders other than the
other party to the merger, or by any person who holds 25% or more of the outstanding shares or the right to appoint 25% or more of
the directors of the other party, vote against the merger. In addition, if the&#160;non-surviving&#160;entity of the merger has more
than one class of shares, the merger must be approved by each class of shareholders. If the transaction would have been approved but
for the separate approval of each class or the exclusion of the votes of certain shareholders as provided above, a court may still
approve the merger upon the request of holders of at least 25% of the voting rights of the company, if the court holds that the
merger is fair and reasonable, taking into account the value of the parties to the merger and the consideration offered to the
shareholders. If a merger is with a company&#8217;s controlling shareholder or if the controlling shareholder has a personal
interest in the merger, the merger is instead subject to the same special majority approval that governs all extraordinary
transactions with controlling shareholders.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 101 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->98<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Under the Israeli Companies Law, each merging
company must inform its secured creditors of the proposed merger plan. Upon the request of a creditor of either party to the proposed
merger, the court may delay or prevent the merger if it concludes that there is a reasonable concern that, because of the merger, the
surviving company will be unable to satisfy the obligations of any of the parties to the merger. The court also may give further instructions
to secure the rights of the creditors.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In addition, a merger may not be completed unless
at least 50&#160;days have passed from the date that a merger proposal was filed with the Israeli Registrar of Companies, and 30&#160;days
have passed since obtaining the approval of the shareholders of both merging companies.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Anti-Takeover Measures</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Israeli Companies Law allows us to create
and issue shares with different rights from those attached to its ordinary shares, including shares providing certain preferred rights
such as voting, distributing, pre-emptive rights or other matters. No preferred shares are currently authorized under our Restated Articles.
In the future, if we authorize, create, and issue a specific class of preferred shares, such class of shares, depending on the specific
rights that may be attached to it, may have the ability to frustrate or prevent a takeover or otherwise prevent our shareholders from
realizing a potential premium over the market value of their ordinary shares. The authorization and designation of a class of preferred
shares will require an approval by the shareholders at a general meeting. The convening of the meeting, the shareholders entitled to participate,
and the majority vote required to be obtained at such a meeting will be subject to the requirements set forth in the Israeli Companies
Law as described above in&#160;<i>&#8220;&#8212;&#160;Voting Rights&#8221;</i>.&#160;In addition, as disclosed under&#160;<i>&#8220;&#8212;&#160;Election
of Directors&#8221;</i>&#160;we have a classified board structure, which limits the ability of any investor or potential investor or group
of investors or potential investors to gain immediate control of our board of directors.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>C. Material Contracts</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On June 27, 2022, we entered into a manufacturing
agreement with GlobalFoundries Singapore Pte. Ltd. (&#8220;GlobalFoundries&#8221;) for the manufacturing of our semiconductor products,
as well as other services, including pre-production, quality assurance, assembly, testing and supply-chain management. The initial term
of the agreement is five years. The agreement includes other customary terms for semiconductor manufacturing agreements, such as product
recalls, warranty and business continuity. We depend on GlobalFoundries to manufacture our semiconductor products. As of the date of this
annual report, we have not engaged GlobalFoundries to manufacture products in commercial quantities.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>D. Exchange Controls</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Generally, Israeli residents may freely deal in
foreign currency and foreign assets, and non-residents may freely deal in Israeli currency and Israeli assets. There are currently no
Israeli currency control restrictions on remittances of dividends on the ordinary shares or the proceeds from the sale of the shares provided
that all taxes were paid or withheld. Non-residents of Israel may freely hold and trade our securities. Neither our Restated Article nor
Israeli laws restrict in any way the ownership or voting of ordinary shares by non-residents, except those restrictions that may exist
with respect to citizens of countries which are in a state of war with Israel.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>10.E. Taxation </b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following summary of the material
Israeli and U.S. tax consequences of an investment in our ordinary shares is based upon laws and relevant interpretations thereof in
effect as of the date hereof, all of which are subject to change, possibly with retroactive effect. This summary is not intended to
be, nor should it be construed as, legal or tax advice and is not exhaustive of all possible tax considerations. This summary also
does not deal with all possible tax consequences relating to an investment in our ordinary shares, such as the tax consequences
under state, local, non-U.S. and non-Israeli tax laws. Investors should consult their own tax advisors with respect to the tax
consequences of the acquisition, ownership and disposition of our ordinary shares.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt">&#160;<b>&#160;</b></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"><tr style="vertical-align: top">
<td style="width: 18pt"/><td style="width: 36pt"><b>I.</b></td><td><b>Material Israeli Income Tax Considerations</b></td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following description is not intended to constitute
a complete analysis of all tax consequences relating to the acquisition, ownership, and disposition of our ordinary shares. You should
consult your own tax advisor concerning the tax consequences of your situation, as well as any tax consequences that may arise under the
laws of any state, local, foreign or other taxing jurisdiction.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 102 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->99<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Summary of material Israeli Income tax considerations</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following is a summary of certain material
Israeli income tax laws applicable to us. This section also contains a discussion of certain material Israeli income tax consequences
concerning the ownership and disposition of ordinary shares purchased by investors. This summary does not discuss all the aspects of Israeli
tax law that may be relevant to a particular investor in light of his or her personal investment circumstances or to some types of investors
subject to special treatment under Israeli law. Examples of such investors include residents of Israel or traders in securities who are
subject to special tax regimes not covered in this discussion. To the extent that the discussion is based on tax legislation that has
not yet been subject to judicial or administrative interpretation, we cannot assure you that the appropriate tax authorities or the courts
will accept the views expressed in this discussion. The discussion below is not intended, and should not be construed, as legal or professional
tax advice and is not exhaustive of all possible tax considerations. The discussion is subject to change, including due to amendments
under Israeli law or changes to the applicable judicial or administrative interpretations of Israeli law, which change could affect the
tax consequences described below, possibly with a retroactive effect.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>THEREFORE, YOU ARE URGED TO CONSULT YOUR OWN
TAX ADVISORS AS TO THE ISRAELI OR OTHER TAX CONSEQUENCES OF THE PURCHASE, OWNERSHIP AND DISPOSITION OF OUR ORDINARY SHARES, INCLUDING,
IN PARTICULAR, THE EFFECT OF ANY FOREIGN, STATE OR LOCAL TAXES.</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>General corporate tax structure in Israel</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Israeli companies are generally subject to corporate
tax at a flat rate. In December&#160;2016, the Israeli Parliament approved the Economic Efficiency Law (Legislative Amendments for Applying
the Economic Policy for the 2017 and 2018 Budget&#160;Years) which reduced the corporate income tax rate from 25% to 24% effective from
January&#160;1, 2017, and to 23% effective from January&#160;1, 2018, and thereafter. However, the effective tax rate payable by a company
that derives income from an Approved Enterprise, a Preferred Enterprise, a Benefited Enterprise or a Technological Enterprise (as discussed
below) may be considerably less. Capital gains derived by an Israeli company are generally subject to corporate tax rate.</p><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Law for the Encouragement of Industry (Taxes),&#160;5729-1969</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Law for the Encouragement of Industry (Taxes),&#160;5729-1969,
generally referred to as the Industry Encouragement Law, provides several tax benefits for &#8220;Industrial Companies.&#8221; We may
qualify as an Industrial Company within the meaning of the Industry Encouragement Law.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Industry Encouragement Law defines an &#8220;Industrial
Company&#8221; as an Israeli resident-company, of which 90% or more of its income in any tax year, other than income from certain government
loans, capital gains, interest and dividends, is derived from an &#8220;Industrial Enterprise&#8221; owned by it and located in Israel
or in the &#8220;Area&#8221;, in accordance with the definition under section 3A of the Israeli Income Tax Ordinance New Version 5721-1961,
or the Ordinance. An &#8220;Industrial Enterprise&#8221; is defined as an enterprise whose principal activity in a given tax year is industrial
production.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Following are the main tax benefits available
to Industrial Companies:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 20pt"/><td style="width: 20pt; text-align: left"><span style="font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-size: 10pt">Amortization of the cost of purchased
patent, rights to use a patent and know-how, which are used for the development or advancement of the Industrial Enterprise, over an
eight-year period, commencing on the year in which such rights were first exercised;</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 20pt"/><td style="width: 20pt; text-align: left"><span style="font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-size: 10pt">Under limited conditions, an election
to file consolidated tax returns with controlled Israeli Industrial Companies; and</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 20pt"/><td style="width: 20pt; text-align: left"><span style="font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-size: 10pt">Expenses related to a public offering
are deductible in equal amounts over three&#160;years commencing on the year of the offering.</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 103 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->100<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Eligibility for benefits under the Industry Encouragement
Law is not contingent upon approval of any governmental authority.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Tax benefits and grants for research and development</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Israeli tax law allows, under certain conditions,
a tax deduction for expenditures related to research and development, including capital expenditures, for the year in which such expenditures
are incurred. Expenditures are deemed related to scientific research and development projects, if:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 20pt"/><td style="width: 20pt; text-align: left"><span style="font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-size: 10pt">The expenditures are approved by
the relevant Israeli government ministry, determined by the field of research;</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 20pt"/><td style="width: 20pt; text-align: left"><span style="font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-size: 10pt">The research and development must
be for the promotion of the company; and</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 20pt"/><td style="width: 20pt; text-align: left"><span style="font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-size: 10pt">The research and development are
carried out by or on behalf of the company seeking such tax deduction.</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The amount of such deductible expenses is reduced
by the sum of any funds received through government grants for the finance of such scientific research and development projects. No deduction
under these research and development deduction rules is allowed if such deduction is related to an expense invested in an asset depreciable
under the general depreciation rules of the Ordinance. Expenditures that are unqualified under the conditions above are deductible in
equal amounts over three&#160;years.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">From time to time, we may apply to the Israel
Innovation Authority for approval to allow a tax deduction for all or most of research and development expenses during the year incurred.
There can be no assurance that such application will be accepted. If we will not be able to deduct research and development expenses during
the year of the payment, we may be able to deduct research and development expenses in equal amounts over a period of three&#160;years
commencing in the year of the payment of such expenses.</p><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Law for the Encouragement of Capital Investments,&#160;5719-1959</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Law for the Encouragement of Capital Investments,&#160;5719-1959,
generally referred to as the Investment Law, provides certain incentives for capital investments in production facilities (or other eligible
assets). Generally, an investment program that is implemented in accordance with the provisions of the Investment Law, referred to as
an Approved Enterprise, a Beneficiary Enterprise, a Preferred Enterprise, a Preferred Technological Enterprise, or a Special Preferred
Technological Enterprise, is entitled to benefits as discussed below. These benefits may include cash grants from the Israeli government
and tax benefits, based upon, among other things, the geographic location of the facility in which the investment is made in Israel. In
order to qualify for these incentives, we are required to comply with the requirements of the Investment Law.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Investment Law was significantly amended
effective as of April&#160;1, 2005 (the &#8220;<span style="text-decoration:underline">2005 Amendment</span>&#8221;), as of January&#160;1, 2011 (the &#8220;<span style="text-decoration:underline">2011
Amendment</span>&#8221;) and as of January&#160;1, 2017 (the &#8220;<span style="text-decoration:underline">2017 Amendment</span>&#8221;). Pursuant to the 2005 Amendment, tax
benefits granted in accordance with the provisions of the Investment Law prior to its revision by the 2005 Amendment remain in
force, but any benefits granted subsequently are subject to the provisions of the amended Investment Law. Similarly, the 2011
Amendment introduced new benefits to replace those granted in accordance with the provisions of the Investment Law in effect prior
to the 2011 Amendment. However, companies entitled to benefits under the Investment Law as in effect prior to January&#160;1, 2011,
were entitled to choose to continue and enjoy such benefits, provided that certain conditions are met, or instead elect,
irrevocably, to forego such benefits and have the benefits of the 2011 Amendment apply. The 2017 Amendment introduces new benefits
for Technological Enterprises, alongside the existing tax benefits.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 104 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->101<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Tax benefits under the 2011 Amendment</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The 2011 Amendment canceled the availability of
the benefits granted to Industrial Companies under the Investment Law prior to 2011 and, instead, introduced new benefits for income generated
by a &#8220;Preferred Company&#8221; through its &#8220;Preferred Enterprise&#8221; (as such terms are defined in the Investment Law)
as of January&#160;1, 2011. The definition of a Preferred Company includes a company incorporated in Israel that is not fully owned by
a governmental entity, and that has, among other things, Preferred Enterprise status and is controlled and managed from Israel. Pursuant
to the 2011 Amendment, a Preferred Company is entitled to a reduced corporate tax rate of 15% with respect to its income derived by its
Preferred Enterprise in 2011 and 2012, unless the Preferred Enterprise is located in a specified development zone, in which case the rate
will be 10%. Under the 2011 Amendment, such corporate tax rate was reduced from 15% and 10%, respectively, to 12.5% and 7%, respectively,
in 2013, 16% and 9% respectively, in 2014, 2015 and 2016, and 16% and 7.5%, respectively, in 2017 and thereafter. Income derived by a
Preferred Company from a &#8220;Special Preferred Enterprise&#8221; (as such term is defined under the Investment Law) would be entitled,
subject to certain conditions and during a benefits period of 10&#160;years, to further reduced tax rates of 8%, or 5% if the Special
Preferred Enterprise is located in a certain development zone.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Dividends distributed from income which is attributed
to a &#8220;Preferred Enterprise&#8221; will be subject to tax at the following rates: (i)&#160;Israeli resident corporations&#160;&#8212;&#160;0%
(although, if such dividends are subsequently distributed to individuals or a non-Israeli company the below rates detailed in sub sections
(ii)&#160;and (iii)&#160;shall apply) (ii)&#160;Israeli resident individuals&#160;&#8212;&#160;20% (iii)&#160;Non-Israeli residents (both
individuals and corporations)&#160;&#8212;&#160;20%, or a reduced tax rate as determined under the provisions of any applicable double
tax treaty, when relevant.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The withholding tax rate applicable to distribution
of dividend from such income to non-Israeli residents is 25% (or 30% if distributed to a &#8220;Substantial Shareholder&#8221; at the
time of the sale or at any time during the preceding twelve&#160;months period, as defined below), which may be reduced by applying in
advance for a withholding tax certificate from the Israel Tax Authority (the &#8220;ITA&#8221;). A &#8220;Substantial Shareholder&#8221;
is generally a person who alone or together with such person&#8217;s relative or another person who collaborates with such person on a
permanent basis, holds, directly or indirectly, at least 10% of any of the &#8220;Means of Control&#8221; of the corporation. &#8220;Means
of control&#8221; generally include the right to vote, receive profits, nominate a director or an executive officer, receive assets upon
liquidation, or instructs a person who holds any of the aforesaid rights how to act, regardless of the source of such right.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The 2011 Amendment also provided transitional
provisions to address companies already enjoying existing tax benefits under the Investment Law. These transitional provisions provide,
among other things, that unless an irrevocable request is made to apply the provisions of the Investment Law as amended in 2011 with respect
to income to be derived as of January&#160;1, 2011, a Beneficiary Enterprise can elect to continue to benefit from the benefits provided
to it before the 2011 Amendment came into effect, provided that certain conditions are met.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>New tax benefits under the 2017 Amendment
that became effective on January&#160;1, 2017</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The 2017 Amendment was enacted as part of the
Economic Efficiency Law that was published on December&#160;29, 2016 and is effective as of January&#160;1, 2017. The 2017 Amendment provides
new tax benefits for two types of &#8220;Technological Enterprises,&#8221; as described below, and is in addition to the other existing
tax beneficial programs under the Investment Law.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The 2017 Amendment provides that a Preferred Company
satisfying certain conditions will qualify as having a &#8220;Preferred Technological Enterprise&#8221; and will thereby enjoy a reduced
corporate tax rate of 12% on income that qualifies as &#8220;Preferred Technological Income&#8221;, as defined under the Investment Law.
The corporate tax rate is further reduced to 7.5% with respect to a Preferred Technological Enterprise located in &#8220;Development Zone
A&#8221;. In addition, a Preferred Technological Company will enjoy a reduced corporate tax rate of 12% on capital gains derived from
the sale of certain &#8220;Benefitted Intangible Assets&#8221; (as defined under the Investment Law) to a related foreign company if the
Benefitted Intangible Assets were acquired from a foreign company on or after January&#160;1, 2017, for at least NIS 200&#160;million,
and the sale receives a prior approval from the Israel Innovation Authority.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>


</div><!-- Field: Page; Sequence: 105 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->102<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The 2017 Amendment further provides that a Preferred
Company satisfying certain conditions (including group consolidated revenues of at least NIS 10&#160;billion) will qualify as a &#8220;Special
Preferred Technological Enterprise&#8221; and will thereby enjoy a reduced corporate tax rate of 6% on &#8220;Preferred Technological
Income&#8221; regardless of the company&#8217;s geographic location within Israel. In addition, a Special Preferred Technological Enterprise
will enjoy a reduced corporate tax rate of 6% on capital gains derived from the sale of certain &#8220;Benefitted Intangible Assets&#8221;
to a related foreign company if the Benefitted Intangible Assets were either developed by the Special Preferred Enterprise or acquired
from a foreign company on or after January&#160;1, 2017, and the sale received a prior approval from the Israel Innovation Authority.
A Special Preferred Technological Enterprise that acquires Benefitted Intangible Assets from a foreign company for more than NIS 500&#160;million
will be eligible for these benefits for at least ten&#160;years, subject to certain approvals as specified in the Investment Law.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Dividends distributed by a Preferred Technological
Enterprise or a Special Preferred Technological Enterprise, paid out of Preferred Technological Income, are generally subject to tax at
the rate of 20% or a lower rate as may be provided in an applicable tax treaty.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The withholding tax rate applicable to distribution
of dividend from such income to non-Israeli residents is 25% (or 30% if distributed to a &#8220;Substantial Shareholder&#8221; at the
time of the sale or at any time during the preceding twelve&#160;months period), which may be reduced by applying in advance for a withholding
tax certificate from the Israel Tax Authority. In addition, if such dividends are distributed to a foreign company that holds solely or
together with other foreign companies 90% or more in the Israeli company, and other conditions are met, the withholding tax rate will
be 4% (subject to the receipt of a valid certificate from the Israel Tax Authority allowing for a reduced tax rate in advance). However,
if such dividends are paid to an Israeli company, no tax is required to be withheld.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We believe that we may be eligible to the tax
benefits under the 2017 Amendment. This will be further examined when relevant.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Taxation of our shareholders</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Capital Gains Tax on Sales of our ordinary
shares</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Israeli law generally imposes a capital gains
tax on the sale of any capital assets by Israeli residents, as defined for Israeli tax purposes, and on the sale of capital assets by
non-Israeli resident, if such assets (i) are located in Israel, (ii) are shares or rights to shares in an Israeli resident company, or
(iii) represent, directly or indirectly, rights to assets located in Israel, unless a specific exemption is available or unless a tax
treaty between Israel and the shareholder&#8217;s country of residence provides otherwise. The Ordinance distinguishes between real gain
and inflationary surplus. The inflationary surplus is a portion of the total capital gain equivalent to the increase of the relevant asset&#8217;s
purchase price attributable to an increase in the Israeli consumer price index, or, in certain circumstances, a foreign currency exchange
rate, between the date of purchase and the date of sale. Inflationary surplus is currently not subject to tax in Israel under certain
conditions. The real gain is the excess of the total capital gain over the inflationary surplus.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Capital gains taxes applicable to non-Israeli
resident shareholders</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">A non-Israeli resident that derives capital gains
from the sale of shares in an Israeli resident company that were purchased after the company was listed for trading on a stock exchange
outside of Israel, will be exempt from Israeli tax if, among other conditions, the shares were not held through a &#8220;permanent establishment&#8221;
that the non-resident maintains in Israel. However, non-Israeli corporations will not be entitled to the foregoing exemption if Israeli
residents, whether directly or indirectly: (i)&#160;have a controlling interest of more than 25% in such non-Israeli corporation or (ii)&#160;are
the beneficiaries of, or are entitled to, 25% or more of the revenues or profits of such non-Israeli corporation. In addition, such an
exemption is not applicable to a person whose gains from selling or otherwise disposing of the shares are deemed to be business income.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">If not exempt, a
non-Israeli resident corporate shareholder will generally be subject to tax on capital gain at the ordinary corporate tax rate (23%
in 2024), or at the rate of 25%, if generated by an individual, or 30%, if generated by an individual who is a &#8220;Substantial
Shareholder&#8221;, at the time of sale or at any time during the preceding 12-month period (or if the shareholder claims a
deduction for interest and linkage differences expenses in connection with the purchase and holding of such shares). However,
withholding tax rates may be higher than the above tax rates, and therefore in order to be eligible for the capital gains rates
mentioned, the taxpayer will need to perform certain administrative procedures with the ITA and obtain a tax certificate from the
ITA. Individual and corporate shareholders dealing in securities in Israel are taxed at the tax rates applicable to business income
(a corporate tax rate for a corporation (23% in 202<span style="font-size: 10pt">4) and a marginal tax rate of up to 47% for an
individual (assuming the activity does rise to a level of business) in 2024, excluding Surtax as discussed below), unless contrary
provisions in a relevant tax treaty apply. </span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"></p><div>

</div><!-- Field: Page; Sequence: 106 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->103<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Additionally, a sale of securities by a non-Israeli
resident may be exempt from Israeli capital gains tax under the provisions of an applicable tax treaty. For example, under the Convention
Between the Government of the United&#160;States of America and the Government of the State of Israel with respect to Taxes on Income,
as amended (the &#8220;United&#160;States Israel Tax Treaty&#8221;), the sale, exchange or other disposition of shares by a shareholder
who is a United&#160;States resident (for purposes of the treaty) holding the shares as a capital asset and is entitled to claim the benefits
afforded to such a resident by the U.S.&#160;Israel Tax Treaty (a &#8220;U.S.&#160;Resident&#8221;) is generally exempt from Israeli capital
gains tax unless:&#160;(i)&#160;the capital gain arising from such sale, exchange or disposition is attributed to real estate located
in Israel; (ii)&#160;the capital gain arising from such sale, exchange or disposition is attributed to royalties; (iii)&#160;the capital
gain arising from such sale, exchange or disposition is attributed to a permanent establishment in Israel, under certain terms; (iv)&#160;such
U.S.&#160;Resident holds, directly or indirectly, shares representing 10% or more of the voting power during any part of the 12 month
period preceding the disposition, subject to certain conditions; or (v)&#160;such U.S.&#160;Resident is an individual and was present
in Israel for 183&#160;days or more during the relevant taxable year. In any such case, the sale, exchange or disposition of such shares
by the U.S.&#160;Resident would be subject to tax in Israel (unless exempt under the Israeli domestic law as described above). Under the
United&#160;States Israel Tax Treaty, the gain may be treated as foreign source income for United&#160;States foreign tax credit purposes,
upon an election by the U.S.&#160;Resident, and such U.S.&#160;Resident may be permitted to claim a credit for such taxes against the
United&#160;States federal income tax imposed on such sale, subject to the limitations under the United&#160;States federal income tax
laws applicable to foreign tax credits. The United&#160;States Israel Tax Treaty does not provide such credit against any United&#160;States
state or local taxes.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Regardless of whether shareholders may be liable
for Israeli tax on the sale of our ordinary shares, the payment of the consideration may be subject to withholding tax at Israel. Shareholders
may be required to demonstrate that they are exempt from tax on their capital gains in order to avoid tax withholding at the time of sale
(i.e., provide certificate of residency and other relevant documentation to the ITA in order to obtain a withholding tax exemption from
the ITA)<i>. </i>Specifically, in transactions involving a sale of all of the shares of an Israeli resident company, in the form of a
merger or otherwise, the ITA may require shareholders who are not liable for Israeli tax to sign declarations in forms specified by the
ITA or obtain a specific exemption from the ITA to confirm their status as non-Israeli resident, and, in the absence of such declarations
or exemptions, may require the purchaser of the shares to withhold taxes at source.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Capital gains taxes applicable to Israeli
resident shareholders</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Generally, an Israeli resident corporation that
derives capital gains from the sale of shares in an Israeli resident company that were purchased after the company was listed for trading
on a stock exchange outside of Israel will generally be subject to tax on the real capital gains generated on such sale at the corporate
tax rate (currently of 23%).</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">An Israeli resident individual will generally
be subject to capital gain tax at the rate of 25%. However, if the individual shareholder claims deduction of interest expenditures or
is a &#8220;Substantial Shareholder&#8221; at the time of the sale or at any time during the preceding twelve&#160;months period, such
gain will be taxed at the rate of 30%. Individual holders dealing in securities in Israel for whom the income from the sale of securities
is considered &#8220;business income&#8221; as defined under section 2(1)&#160;of the Ordinance are taxed at the marginal tax rates applicable
to business income (up to 47% in 2024 plus 3% Surtax, when applicable).</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Certain Israeli institutions who are exempt from
tax under section 9(2)&#160;or section 129C(a)(1)&#160;of the Ordinance (such as exempt trust funds and pension funds) may be exempt from
capital gains tax from the sale of the shares.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Taxation of Israeli shareholders on receipt
of dividends</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">An Israeli resident individual is generally subject
to Israeli income tax on the receipt of dividends paid on our ordinary shares at the rate of 25%, plus 3% Surtax, when applicable. With
respect to a person who is a &#8220;Substantial Shareholder&#8221; at the time of receiving the dividend or on any time during the preceding
twelve&#160;months, the applicable tax rate is 30%, plus 3% Surtax, when applicable. Such dividends are generally subject to Israeli withholding
tax at a rate of 25% if the shares are registered with a nominee company (whether the recipient is a substantial shareholder or not).</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 107 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->104<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If the recipient of the dividend is an Israeli
resident corporation such dividend income will be exempt from tax provided the income from which such dividend is distributed was derived
or accrued within Israel and was received directly or indirectly from another corporation that is subject to Israeli corporate tax.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">An exempt trust fund, pension fund or other entity
that is exempt from tax under section 9(2)&#160;or section 129C(a)(1)&#160;of the Ordinance is exempt from tax on dividend.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Dividend distribution by a Preferred Technology
Enterprise or a Special Preferred Technology Enterprise is subject to beneficial withholding tax rates. For a further discussion, see
&#8220;Certain Material Israeli Tax Considerations&#160;&#8212;&#160;Law for the Encouragement of Capital Investments,&#160;5719-1959&#160;&#8212;&#160;New
tax benefits under the 2017 Amendment that became effective on January&#160;1, 2017.&#8221;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Taxation of non-Israeli shareholders on
receipt of dividends</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Non-Israeli residents (either individuals or corporations)
are generally subject to Israeli income tax on the receipt of dividends paid on our ordinary shares at the rate of 25%, which tax will
be withheld, unless relief is provided in a treaty between Israel and the shareholder&#8217;s country of residence. With respect to a
person who is a &#8220;Substantial Shareholder&#8221; at the time of receiving the dividend or on any time during the preceding twelve&#160;months,
the applicable tax rate is 30%. Such dividends are generally subject to Israeli withholding tax at a rate of 25% if the shares are registered
with a nominee company (whether the recipient is a Substantial Shareholder or not), unless a reduced rate is provided under an applicable
tax treaty (subject to the receipt in advance of a valid certificate from the Israel Tax Authority allowing for a reduced tax rate). For
example, under the United&#160;States Israel Tax Treaty, the maximum rate of tax that may be withheld in Israel on dividends paid to a
holder of our ordinary shares who is a U.S.&#160;Resident is 25%. However, the maximum rate of withholding tax on dividends, not generated
by a Preferred Enterprise, Approved Enterprise or Beneficial Enterprise, that are paid to a United&#160;States corporation holding 10%
or more of the outstanding voting capital throughout the tax year in which the dividend is distributed as well as during the previous
tax year, is 12.5%, provided that not more than 25% of the gross income for such preceding year consists of certain types of dividends
and interest. Notwithstanding the foregoing, dividends distributed from income attributed to an Approved Enterprise, Benefited Enterprise
or Preferred Enterprise are not entitled to such reduced rate under the tax treaty but are subject to a withholding tax rate of 15% for
a shareholder that is a U.S.&#160;corporation, provided that the conditions related to the outstanding voting rights and the gross income
for the previous year (as set forth in the previous sentences) are met. If the dividend is attributable partly to income derived from
an Approved Enterprise, Benefited Enterprise or Preferred Enterprise, and partly to other sources of income, the withholding rate will
be a blended rate reflecting the relative portions of the two types of income. We cannot assure you that we will designate the profits
that we may distribute in a way that will reduce shareholders&#8217; tax liability. Application for the reduced tax rate requires appropriate
documentation to be presented and specific instruction received from the Israeli Tax Authorities to be followed. To the extent tax is
withheld at source at the maximum rates (see above), a qualified tax treaty recipient will be required to comply with certain administrative
procedures with the Israeli Tax Authorities in order to receive a refund of the excess tax withheld.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">A foreign resident receiving dividend income from
an Israeli company, from which the full tax was withheld, will generally be exempt from filing a tax return in Israel, provided that (i)
such income was not generated from business conducted in Israel by the foreign resident, (ii) the foreign resident has no other taxable
sources of income in Israel with respect to which a tax return is required to be filed and (iii) the foreign resident is not liable to
Surtax (see below) in accordance with section 121B of the Ordinance.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Dividend distribution by a Preferred Technology
Enterprise or a Special Preferred Technology Enterprise is subject to beneficial withholding tax rates. For a further discussion, see
&#8220;Certain Material Israeli Tax Considerations&#160;&#8212;&#160;Law for the Encouragement of Capital Investments,&#160;5719-1959&#160;&#8212;&#160;New
tax benefits under the 2017 Amendment that became effective on January&#160;1, 2017.&#8221;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 108 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->105<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Surtax</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Subject to the provisions of an applicable tax
treaty, individuals who are subject to tax in Israel are also subject to an additional tax at a rate of 3% on their annual income (including,
but not limited to, dividends, interest and capital gain) exceeding NIS 721,560 for 2024. This amount is linked to the annual change in
the Israeli consumer price index.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Estate and Gift Tax</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Currently, Israel does not impose estate tax and
gifts are generally exempt from tax.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>THE ISRAELI TAX DISCUSSION SET FORTH ABOVE
IS INCLUDED FOR GENERAL INFORMATION ONLY AND MAY NOT BE APPLICABLE TO YOU DEPENDING UPON YOUR PARTICULAR SITUATION.&#160;YOU ARE URGED
TO CONSULT YOUR OWN TAX ADVISOR WITH RESPECT TO THE TAX CONSEQUENCES TO YOU OF THE OWNERSHIP AND DISPOSITION OF ORDINARY SHARES AND WARRANTS,
AS APPLICABLE, INCLUDING THE TAX CONSEQUENCES UNDER ISRAELI TAX LAW AND OTHER NON-ISRAELI TAX LAWS AND TAX TREATIES AND THE POSSIBLE EFFECTS
OF CHANGES IN ISRAELI&#160;OR OTHER TAX LAWS.</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 36pt"><b>II. Certain Material U.S.&#160;Federal
Income Tax Considerations</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following discussion summarizes the material
U.S.&#160;federal income tax consequences to U.S.&#160;Holders and Non-U.S.&#160;Holders (as defined below) of the ownership and disposition
of ordinary shares and warrants. This discussion applies only to the ordinary shares and warrants, as the case may be, that are held as
&#8220;capital assets&#8221; within the meaning of Section&#160;1221 of the U.S.&#160;Internal Revenue Code of 1986, as amended (the &#8220;Code&#8221;)
(generally, property held for investment).</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following does not purport to be a complete
analysis of all potential tax effects arising in connection with the ownership and disposition of ordinary shares and warrants. The effects
of other U.S.&#160;federal tax laws, such as estate and gift tax laws, and any applicable state, local, or non-U.S.&#160;tax laws are
not discussed. This discussion is based on the Code, Treasury regulations promulgated thereunder, judicial decisions, and published rulings
and administrative pronouncements of the U.S.&#160;Internal Revenue Service (the &#8220;IRS&#8221;), in each case in effect as of the
date hereof. These authorities may change or be subject to differing interpretations. Any such change or differing interpretation may
be applied retroactively in a manner that could adversely affect the tax consequences discussed below. We have not sought and will not
seek any rulings from the IRS regarding the matters discussed below. There can be no assurance the IRS will not take or a court will not
sustain a contrary position regarding the tax consequences discussed below.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">This discussion does not address all U.S.&#160;federal
income tax consequences relevant to a holder&#8217;s particular circumstances, including the impact of the Medicare contribution tax on
net investment income and the alternative minimum tax. In addition, it does not address consequences relevant to holders subject to special
rules, including, without limitation:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 20pt"/><td style="width: 20pt; text-align: left"><span style="font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-size: 10pt">banks, insurance companies, and
certain other financial institutions;</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 20pt"/><td style="width: 20pt; text-align: left"><span style="font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-size: 10pt">regulated investment companies
and real estate investment trusts;</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 20pt"/><td style="width: 20pt; text-align: left"><span style="font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-size: 10pt">brokers, dealers, or traders in
securities;</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 20pt"/><td style="width: 20pt; text-align: left"><span style="font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-size: 10pt">traders in securities that elect
to mark to market;</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 20pt"/><td style="width: 20pt; text-align: left"><span style="font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-size: 10pt">tax-exempt&#160;organizations or
governmental organizations;</span></td>
</tr></table><div>

</div><!-- Field: Page; Sequence: 109 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->106<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">U.S.&#160;expatriates and former citizens or long-term&#160;residents of the U.S.;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">persons holding ordinary shares and/or warrants, as the case may be, as part of a hedge, straddle, constructive sale, or other risk reduction strategy or as part of a conversion transaction or other integrated or similar transaction;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">persons subject to special tax accounting rules as a result of any item of gross income with respect to ordinary shares and/or warrants, as the case may be, being taken into account in an applicable financial statement;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">persons that actually or constructively own 5% or more (by vote or value) of the outstanding ordinary shares;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">founders, sponsors, officers or directors of ITAC or holders of private placement warrants;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">&#8220;controlled foreign corporations,&#8221; &#8220;passive foreign investment companies,&#8221; and corporations that accumulate earnings to avoid U.S.&#160;federal income tax (and their shareholders);</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">S corporations, partnerships, or other entities or arrangements treated as partnerships or other flow-through&#160;entities for U.S.&#160;federal income tax purposes (and investors therein);</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">U.S.&#160;Holders having a functional currency other than the U.S.&#160;dollar;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">persons who hold or received ordinary shares and/or warrants, as the case may be, pursuant to the exercise of any employee stock option or otherwise as compensation; and</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">tax-qualified&#160;retirement plans.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If an entity or arrangement treated as a partnership
for U.S.&#160;federal income tax purposes holds ordinary shares and/or warrants, the tax treatment of an owner of such entity will depend
on the status of the owner or participant in the arrangement, the activities of the entity or arrangement, and certain determinations
made at the owner or participant level. Accordingly, entities or arrangements treated as partnerships for U.S.&#160;federal income tax
purposes and the partners in such partnerships should consult their tax advisors regarding the U.S.&#160;federal income tax consequences
to them.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">For purposes of this discussion, a &#8220;U.S.&#160;Holder&#8221;
is any beneficial owner of ordinary shares and/or warrants, as the case may be, that is for U.S.&#160;federal income tax purposes:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">an individual who is a citizen or resident of the U.S.;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">a corporation (or other entity taxable as a corporation) created or organized in, or under the laws of, the U.S., any state thereof, or the District of Columbia;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">an estate, the income of which is subject to U.S.&#160;federal income tax regardless of its source; or</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">a trust that (1)&#160;is subject to the primary supervision of a U.S.&#160;court and the control of one or more &#8220;United&#160;States persons&#8221; (within the meaning of Section&#160;7701(a)(30)&#160;of the Code) or (2)&#160;has a valid election in effect to be treated as a United&#160;States person for U.S.&#160;federal income tax purposes.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>THE U.S.&#160;FEDERAL INCOME TAX
TREATMENT OF THE OWNERSHIP AND DISPOSITION OF ORDINARY SHARES AND/OR WARRANTS TO ANY PARTICULAR HOLDER WILL DEPEND ON THE
HOLDER&#8217;S PARTICULAR TAX CIRCUMSTANCES.&#160;YOU ARE URGED TO CONSULT YOUR TAX ADVISOR REGARDING THE U.S.&#160;FEDERAL, STATE,
LOCAL, AND NON-U.S.&#160;INCOME AND OTHER TAX CONSEQUENCES TO YOU, IN LIGHT OF YOUR PARTICULAR INVESTMENT OR TAX CIRCUMSTANCES, OF
THE OWNERSHIP AND DISPOSITION OF ORDINARY SHARES AND/OR WARRANTS.</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 110 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->107<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>U.S. Federal Income Tax Treatment of Arbe</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Tax Residence of Arbe for U.S.&#160;Federal
Income Tax Purposes</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Although we are incorporated and tax resident
in Israel, the IRS may assert that we should be treated as a U.S.&#160;corporation for U.S.&#160;federal income tax purposes pursuant
to Section&#160;7874 of the Code. For U.S.&#160;federal income tax purposes, a corporation is generally considered a U.S.&#160;&#8220;domestic&#8221;
corporation if it is created or organized in or under the laws of the U.S., any state thereof, or the District of Columbia. Because we
are not so created or organized (but is instead incorporated only in Israel), it would generally be classified as a foreign corporation
(that is, a corporation other than a U.S.&#160;&#8220;domestic&#8221; corporation) under these rules. Section&#160;7874 of the Code provides
an exception under which a corporation created or organized only under foreign law may, in certain circumstances, be treated as a U.S.&#160;corporation
for U.S.&#160;federal income tax purposes. The Section&#160;7874 rules are complex and require analysis of all relevant facts, and there
is limited guidance and significant uncertainties as to their application.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Under Code Section&#160;7874, a corporation created
or organized outside the U.S.&#160;(i.e., a foreign corporation) will nevertheless be treated as a U.S.&#160;corporation for U.S.&#160;federal
income tax purposes when (i)&#160;the foreign corporation directly or indirectly acquires substantially all of the assets held directly
or indirectly by a U.S.&#160;corporation (including the indirect acquisition of assets of the U.S.&#160;corporation by acquiring the outstanding
shares of the U.S.&#160;corporation), (ii)&#160;the shareholders of the acquired U.S.&#160;corporation hold, by vote or value, at least
80% of the shares of the foreign acquiring corporation after the acquisition by reason of holding shares in the U.S.&#160;acquired corporation
(the &#8220;Section&#160;7874 Percentage&#8221;), and (iii)&#160;the foreign corporation&#8217;s &#8220;expanded affiliated group&#8221;
does not have substantial business activities in the foreign corporation&#8217;s country of creation or organization relative to such
expanded affiliated group&#8217;s worldwide activities (the &#8220;Substantial Business Activities Exception&#8221;). In order to satisfy
the Substantial Business Activities Exception, at least 25% of the employees (by headcount and compensation), real and tangible assets,
and gross income of the foreign acquiring corporation&#8217;s &#8220;expanded affiliated group&#8221; must be based, incurred, located,
and derived, respectively, in the country in which the foreign acquiring corporation is created or organized. The Section&#160;7874 Regulations
further provide for a number of special rules that aggregate multiple acquisitions of U.S.&#160;corporations for purposes of Code Section&#160;7874
that are made as part of a plan or made over a 36-month&#160;period, making it more likely that Code Section&#160;7874 will apply to a
foreign acquiring corporation.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We indirectly acquired substantially all of the
assets of ITAC through the Merger. Based upon the terms of the Merger, the rules for determining share ownership under Code Section&#160;7874
and the Section&#160;7874 Regulations, and certain factual assumptions, we currently expect that the Section&#160;7874 Percentage of ITAC
stockholders in us should be less than 80% after the Merger. Accordingly, we are not expected to be treated as a U.S.&#160;corporation
for U.S.&#160;federal income tax purposes under Section&#160;7874 of the Code. The calculation of the Section&#160;7874 Percentage is
complex, is subject to detailed regulations (the application of which is uncertain in various respects and could be impacted by changes
in U.S.&#160;tax laws and regulations with possible retroactive effect) and is subject to certain factual uncertainties.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The remainder of this discussion assumes that
we will not be treated as a U.S.&#160;corporation for U.S.&#160;federal income tax purposes under Section&#160;7874 of the Code.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>U.S.&#160;Federal Income Tax Consequences
of the Ownership and Disposition of ordinary shares and warrants to U.S.&#160;Holders</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Distributions on ordinary shares</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If we make distributions of cash or property
on the ordinary shares, such distributions will be treated first as a dividend to the extent of our current and accumulated earnings
and profits (as determined for U.S.&#160;federal income tax purposes), and then as a tax-free&#160;return of capital to the extent
of the U.S.&#160;Holder&#8217;s tax basis, with any excess treated as gain from the sale or exchange of the shares. The amount of
any such distribution will include any amounts withheld by us (or another applicable withholding agent). If we do not provide
calculations of its earnings and profits under U.S.&#160;federal income tax principles, a U.S.&#160;Holder should expect all cash
distributions to be reported as dividends for U.S.&#160;federal income tax purposes. Any dividend will not be eligible for the
dividends received deduction allowed to corporations in respect of dividends received from U.S.&#160;corporations.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 111 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->108<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Subject to the discussions above under &#8220;&#8212;&#160;<i>Utilization
of ITAC&#8217;s Tax Attributes and Certain Other Adverse Tax Consequences to Arbe and Arbe&#8217;s Shareholders</i>&#8221; and below under
&#8220;&#8212;&#160;<i>Passive Foreign Investment Company Rules</i>,&#8221; dividends received by certain non-corporate&#160;U.S.&#160;Holders
(including individuals) may be &#8220;qualified dividend income,&#8221; which is taxed at the lower applicable capital gains rate, provided
that:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">either (a)&#160;the shares are readily tradable on an established securities market in the U.S.&#160;or (b)&#160;we are eligible for the benefits of a qualifying income tax treaty with the U.S.&#160;that includes an exchange of information program;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">we are neither a PFIC (as discussed below under below under &#8220;&#8212;&#160;Passive Foreign Investment Company Rules&#8221;) nor treated as such with respect to the U.S.&#160;Holder for our taxable year in which the dividend is paid or the preceding taxable year;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">the U.S.&#160;Holder satisfies certain holding period requirements;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">the U.S.&#160;Holder is not under an obligation to make related payments with respect to positions in substantially similar or related property; and</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">the taxpayer does not take the dividends into account as investment income under Code Section&#160;163(d)(4)(B).</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">There can be no assurances that we will be eligible
for benefits of an applicable comprehensive income tax treaty between the U.S.&#160;and Israel. In addition, there also can be no assurance
that ordinary shares will be considered &#8220;readily tradable&#8221; on an established securities market in accordance with applicable
legal authorities. Furthermore, we will not constitute a qualified foreign corporation for purposes of these rules if it is a PFIC for
the taxable year in which it pays a dividend or for the preceding taxable year. See &#8220;&#8212;&#160;<i>Passive Foreign Investment
Company Rules.</i>&#8221; U.S.&#160;Holders should consult their tax advisors regarding the availability of the lower rate for dividends
paid with respect to ordinary shares.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The amount of any dividend distribution paid in
foreign currency will be the U.S.&#160;dollar amount calculated by reference to the applicable exchange rate in effect on the date of
actual or constructive receipt, regardless of whether the payment is in fact converted into U.S.&#160;dollars at that time. A U.S.&#160;Holder
may have foreign currency gain or loss if the dividend is converted into U.S.&#160;dollars after the date of receipt.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Subject to certain exceptions, dividends on ordinary
shares will constitute foreign source income for foreign tax credit limitation purposes. If the dividends are qualified dividend income
(as discussed above), the amount of the dividend taken into account for purposes of calculating the foreign tax credit limitation will
be limited to the gross amount of the dividend, multiplied by a fraction, the numerator of which is the reduced rate applicable to qualified
dividend income and the denominator of which is the highest rate of tax normally applicable to dividends. The limitation on foreign taxes
eligible for credit is calculated separately with respect to specific classes of income. For this purpose, dividends distributed by us
with respect to the ordinary shares generally will constitute &#8220;passive category income&#8221; but could, in the case of certain
U.S.&#160;Holders, constitute &#8220;general category income&#8221;. The rules governing foreign tax credits are complex and U.S.&#160;Holders
are urged to consult their tax advisors regarding the creditability of foreign taxes in their particular circumstances. In lieu of claiming
a foreign tax credit, a U.S.&#160;Holder may, in certain circumstances, deduct foreign taxes in computing the holder&#8217;s taxable income,
subject to generally applicable limitations under U.S.&#160;law. Generally, an election to deduct foreign taxes instead of claiming foreign
tax credits applies to all foreign taxes paid or accrued in the taxable year.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Sale, Exchange, Redemption or Other Taxable
Disposition of ordinary shares and warrants</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Subject to the discussion below under &#8220;&#8212;&#160;<i>Passive
Foreign Investment Company Rules</i>,&#8221; a U.S.&#160;Holder generally will recognize gain or loss on any sale, exchange, redemption
or other taxable disposition of ordinary shares or warrants in an amount equal to the difference between (i)&#160;the amount realized
on the disposition and (ii)&#160;such U.S.&#160;Holder&#8217;s adjusted tax basis in such shares and/or warrants. Any gain or loss recognized
by a U.S.&#160;Holder on a taxable disposition of ordinary shares or warrants generally will be capital gain or loss. A non-corporate&#160;U.S.&#160;Holder,
including an individual, who has held the ordinary shares and/or warrants for more than one year generally will be eligible for reduced
tax rates for such long-term&#160;capital gains. The deductibility of capital losses is subject to limitations.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 112 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->109<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Any such gain or loss recognized generally will
be treated as U.S.&#160;source income or loss. Accordingly, in the event any Israeli tax (including withholding tax)&#160;is imposed upon
such sale or other disposition, a U.S.&#160;Holder may not be able to utilize foreign tax credits unless such holder has foreign source
income or gain in the same category from other sources. Moreover, there are special rules under the income tax treaty between the U.S.&#160;and
Israel (the &#8220;<i>Treaty</i>&#8221;), which may impact a U.S.&#160;Holder&#8217;s ability to claim a foreign tax credit. U.S.&#160;Holders
are urged to consult their tax advisor regarding the ability to claim a foreign tax credit and the application of the Treaty to such U.S.&#160;Holder&#8217;s
particular circumstances.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Exercise, Lapse, or Redemption of warrants</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Subject to the PFIC rules discussed below, a U.S.&#160;Holder
generally will not recognize gain or loss upon the acquisition of an ordinary share on the exercise of the warrants for cash. A U.S.&#160;Holder&#8217;s
tax basis in an ordinary shares received upon exercise of the warrants generally should be an amount equal to the sum of the U.S.&#160;Holder&#8217;s
tax basis in the warrants exchanged therefor (assuming the Merger is not a taxable transaction) and the exercise price. The U.S.&#160;Holder&#8217;s
holding period for an ordinary share received upon exercise of the warrants will begin on the date following the date of exercise (or
possibly the date of exercise) of the warrants and will not include the period during which the U.S.&#160;Holder held the warrants. If
the warrants are allowed to lapse unexercised, a U.S.&#160;Holder generally will recognize a capital loss equal to such holder&#8217;s
tax basis in the warrants.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The tax consequences of a cashless exercise of
the warrants are not clear under current tax law. Subject to the PFIC rules discussed below, a cashless exercise may be tax-deferred,
either because the exercise is not a gain realization event or because the exercise is treated as a recapitalization for U.S.&#160;federal
income tax purposes. In either tax-deferred&#160;situation, a U.S.&#160;Holder&#8217;s basis in the ordinary shares received generally
would equal the U.S.&#160;Holder&#8217;s basis in the warrants exercised therefor. If the cashless exercise is not treated as a gain realization
event, a U.S.&#160;Holder&#8217;s holding period in the ordinary shares would be treated as commencing on the date following the date
of exercise (or possibly the date of exercise) of the warrants and will not include the period during which the U.S.&#160;Holder held
the warrants. If the cashless exercise were treated as a recapitalization, the holding period of the ordinary shares would include the
holding period of the warrants exercised therefor.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">It is also possible that a cashless exercise of
the warrants could be treated in part as a taxable exchange in which gain or loss would be recognized in the manner set forth above under
&#8220;&#8212;&#160;<i>Sale, Exchange, Redemption or Other Taxable Disposition of ordinary shares and warrants</i>.&#8221; In such event,
a U.S.&#160;Holder could be deemed to have surrendered warrants equal to the number of ordinary shares having an aggregate fair market
value equal to the exercise price for the total number of warrants to be exercised. Subject to the PFIC rules discussed below, the U.S.&#160;Holder
would recognize capital gain or loss with respect to the warrants deemed surrendered in an amount generally equal to the difference between
(i)&#160;the fair market value of the ordinary shares that would have been received in a regular exercise of the warrants deemed surrendered,
net of the aggregate exercise price of such warrants and (ii)&#160;the U.S.&#160;Holder&#8217;s tax basis in such warrants. In this case,
a U.S.&#160;Holder&#8217;s aggregate tax basis in the ordinary shares received would equal the sum of (i)&#160;U.S.&#160;Holder&#8217;s
tax basis in the warrants deemed exercised and (ii)&#160;the aggregate exercise price of such warrants. A U.S.&#160;Holder&#8217;s holding
period for the ordinary shares received in such case generally would commence on the date following the date of exercise (or possibly
the date of exercise) of the warrants and will not include the period during which the U.S.&#160;Holder held the warrants.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Due to the absence of authority on the
U.S.&#160;federal income tax treatment of a cashless exercise of warrants, including when a U.S.&#160;Holder&#8217;s holding period
would commence with respect to the ordinary share received, there can be no assurance regarding which, if any, of the alternative
tax consequences and holding periods described above would be adopted by the IRS or a court of law. Accordingly, U.S.&#160;Holders
should consult their tax advisors regarding the tax consequences of a cashless exercise of warrants.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Subject to the PFIC rules described below, if
we redeem warrants for cash pursuant to the redemption provisions of the Warrant Agreement or if we purchase warrants in an open market
transaction, such redemption or purchase generally will be treated as a taxable disposition to the U.S.&#160;Holder, taxed as described
above under &#8220;&#8212;&#160;<i>Sale, Exchange, Redemption or Other Taxable Disposition of ordinary shares and warrants</i>.&#8221;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 113 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->110<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Possible Constructive Distributions</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The terms of each warrant provide for an adjustment
to the number of ordinary shares for which the warrants may be exercised or to the exercise price of the warrants in certain events, as
discussed in the section of this registration statement captioned &#8220;Description of warrants.&#8221; An adjustment which has the effect
of preventing dilution generally is not taxable. A U.S.&#160;Holder of the warrants would, however, be treated as receiving a constructive
distribution from us if, for example, the adjustment increases the holder&#8217;s proportionate interest in our assets or earnings and
profits (for instance, through an increase in the number of ordinary shares that would be obtained upon exercise of such warrant) as a
result of a distribution of cash or other property such as other securities to the holders of the ordinary shares which is taxable to
the U.S.&#160;Holders of such shares as described under &#8220;&#8212;&#160;<i>Distributions on ordinary shares</i>&#8221; above. Such
constructive distribution would be subject to tax as described under that section in the same manner as if the U.S.&#160;Holder of such
warrants received a cash distribution from us equal to the fair market value of such increase in interest.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Passive Foreign Investment Company Rules</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The treatment of U.S.&#160;Holders of the ordinary
shares and warrants could be materially different from that described above, if we are treated as a &#8220;passive foreign investment
company,&#8221; or PFIC, for U.S.&#160;federal income tax purposes. An entity treated as a foreign corporation for U.S.&#160;federal income
tax purposes generally will be a PFIC for U.S.&#160;federal income tax purposes for any taxable year if either:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">at least 75% of its gross income for such year is passive income (such as interest, dividends, rents and royalties (other than rents or royalties derived from the active conduct of a trade or business) and gains from the disposition of assets giving rise to passive income); or</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">at least 50% of the value of its assets (based on an average of the quarterly values of the assets) during such year is attributable to assets that produce passive income or are held for the production of passive income.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">For this purpose, we will be treated as owning
our proportionate share of the assets and earning its proportionate share of the income of any other entity treated as a corporation for
U.S.&#160;federal income tax purposes in which we own, directly or indirectly, 25% or more (by value) of the stock.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Whether we are treated as a PFIC is determined
on an annual basis. Although based on the current and anticipated composition of the income, assets and operations of us and our subsidiaries,
we do not believe we will be treated as a PFIC for U.S.&#160;federal income tax purposes for our current taxable year, and do not expect
to become one for U.S.&#160;federal income tax purposes in the near future, this is a factual determination that depends on, among other
things, the composition of our income and assets, and the market value of our shares and assets, including the composition of income and
assets and the market value of shares and assets of its subsidiaries, from time to time, and thus the determination can only be made annually
after the close of each taxable year. Thus, no assurance can be given as to whether we will be a PFIC in 2023 or for any future taxable
year. In addition, our U.S.&#160;counsel expresses no opinion with respect to our PFIC status for 2023 or future taxable&#160;years.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Under the PFIC rules, if we were considered
a PFIC at any time that a U.S.&#160;Holder owns ordinary shares or warrants, we would generally continue to be treated as a PFIC
with respect to such holder in a particular year unless (i)&#160;we has ceased to be a PFIC and (ii)&#160;(a)&#160;the
U.S.&#160;Holder has made a valid &#8220;QEF election&#8221; (as described below) for the first taxable year in which the holder
owned such holder&#8217;s ordinary shares in which we were a PFIC, (b)&#160;a valid mark-to-market&#160;election (as described
below) is in effect for the particular year, or (c)&#160;the U.S.&#160;Holder has made a &#8220;deemed sale&#8221; election under
the PFIC rules. If such a &#8220;deemed sale&#8221; election is made, a U.S.&#160;Holder will be deemed to have sold its ordinary
shares at their fair market value on the last&#160;day of the last taxable year in which we are classified as a PFIC, and any gain
from such deemed sale would be subject to the consequences described below. After the &#8220;deemed sale&#8221; election, the
ordinary shares with respect to which the &#8220;deemed sale&#8221; election was made will not be treated as shares in a PFIC unless
we subsequently become a PFIC.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 114 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->111<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">For each taxable year that we are treated as a
PFIC with respect to a U.S.&#160;Holder&#8217;s ordinary shares or warrants, the U.S.&#160;Holder will be subject to special tax rules
with respect to any &#8220;excess distribution&#8221; (as defined below) received and any gain realized from a sale or disposition (including
a pledge of ordinary shares and under proposed regulations transfers of warrants and certain transfers of ordinary shares that would otherwise
qualify as nonrecognition transactions for U.S.&#160;federal income tax purposes) of its ordinary shares or warrants (collectively the
&#8220;<i>excess distribution rules</i>&#8221;), unless, with respect to the ordinary shares, the U.S.&#160;Holder makes a valid QEF or
mark-to-market&#160;election as discussed below. Generally, distributions received by a U.S.&#160;Holder in a taxable year that are greater
than 125% of the average annual distributions received by such U.S.&#160;Holder during the shorter of the three preceding taxable&#160;years
or the portion of such U.S.&#160;Holder&#8217;s holding period for the ordinary shares or warrants that preceded the taxable year of the
distribution will be treated as excess distributions. Under these special tax rules:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">the excess distribution or gain will be allocated ratably over the U.S.&#160;Holder&#8217;s holding period for the ordinary shares or warrants;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">the amount allocated to the U.S.&#160;Holder&#8217;s taxable year in which the U.S.&#160;Holder recognized the gain or received the excess distribution or to the period in the U.S.&#160;Holder&#8217;s holding period before the first&#160;day of our first taxable year in which we are a PFIC, will be treated as ordinary income; and</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">the amount allocated to each other taxable year (or portions thereof) of the U.S.&#160;Holder and included in such holder&#8217;s holding period will be subject to the highest tax rate in effect for individuals or corporations, as applicable, for each such year without regard to the U.S.&#160;Holder&#8217;s other items of income and loss for such year; and</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">the interest charge generally applicable to underpayments of tax will be imposed on the U.S.&#160;Holder with respect to the resulting tax attributable to each such year.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Under the excess distribution rules, the tax liability
for amounts allocated to taxable&#160;years prior to the year of disposition or excess distribution cannot be offset by any net operating
losses, and gains (but not losses) realized on the sale of the ordinary shares or warrants cannot be treated as capital gains, even though
the U.S.&#160;Holder holds the ordinary shares or warrants as capital assets.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Certain of the PFIC rules may impact U.S.&#160;Holders
with respect to equity interests in subsidiaries and other entities which we may hold, directly or indirectly, that are PFICs (collectively,
&#8220;Lower-Tier&#160;PFICs&#8221;). There can be no assurance, however, that we do not own, or will not in the future acquire, an interest
in a subsidiary or other entity that is or would be treated as a Lower-Tier&#160;PFIC.&#160;U.S.&#160;Holders should consult their tax
advisors regarding the application of the PFIC rules to any of our subsidiaries.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If we are a PFIC, a U.S.&#160;Holder of our shares
may avoid taxation under the excess distribution rules described above in respect to the ordinary shares by making a timely and valid
&#8220;qualified electing fund&#8221; (&#8220;QEF&#8221;) election (if eligible to do so). However, a U.S.&#160;Holder may make a QEF
election with respect to its ordinary shares only if we provide U.S.&#160;Holders on an annual basis with certain financial information
specified under applicable U.S.&#160;Treasury regulations, including the information provided in a PFIC Annual Information Statement.
There can be no assurance, however, that we will have timely knowledge of its status as a PFIC in the future or that we will timely provide
such information for such&#160;years. The failure to provide such information on an annual basis could prevent a U.S.&#160;Holder from
making a QEF election or result in the invalidation or termination of a U.S.&#160;Holder&#8217;s prior QEF election.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">A U.S.&#160;Holder that makes a QEF election
with respect to its ordinary shares would generally be required to include in income for each year that we are treated as a PFIC the
U.S.&#160;Holder&#8217;s pro rata share of our ordinary earnings for the year (which would be subject to tax as ordinary income) and
net capital gains for the year (which would be subject to tax at the rates applicable to long-term&#160;capital gains), without
regard to the amount of any distributions made in respect of the ordinary shares. Any net deficits or net capital losses of us for a
taxable year, however, would not be passed through and included on the tax return of the U.S.&#160;Holder. A
U.S.&#160;Holder&#8217;s basis in the ordinary shares would be increased by the amount of income inclusions under the QEF rules.
Dividends actually paid on the ordinary shares generally would not be subject to U.S.&#160;federal income tax to the extent of prior
income inclusions and would reduce the U.S.&#160;Holder&#8217;s basis in the ordinary shares by a corresponding amount. If we own
any interests in a Lower-Tier&#160;PFIC, a U.S.&#160;Holder generally must make a separate QEF election for each
Lower-Tier&#160;PFIC, subject to our providing the relevant tax information for each Lower-Tier&#160;PFIC on an annual basis. There
can be no assurance that we will have timely knowledge of the status of any such Lower-Tier&#160;PFIC.&#160;In addition, we may not
hold a controlling interest in any such Lower-Tier&#160;PFIC and thus there can be no assurance that we will be able to cause the
Lower-Tier&#160;PFIC to provide such required information.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 115 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->112<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If a U.S.&#160;Holder does not make a QEF election
effective from the first taxable year of a U.S.&#160;Holder&#8217;s holding period for the ordinary shares in which we are a PFIC (or
a mark-to-market&#160;election, as discussed below), then the U.S.&#160;Holder generally will remain subject to the excess distribution
rules. A U.S.&#160;Holder that first makes a QEF election in a later year may avoid the continued application of the excess distribution
rules to its ordinary shares by making a &#8220;deemed sale&#8221; election. In that case, the U.S.&#160;Holder will be deemed to have
sold the ordinary shares at their fair market value on the first&#160;day of the taxable year in which the QEF election becomes effective,
and any gain from such deemed sale would be subject to the excess distribution rules described above. As a result of the &#8220;deemed
sale&#8221; election, the U.S.&#160;Holder will have additional basis (to the extent of any gain recognized on the deemed sale) and, solely
for purposes of the PFIC rules, a new holding period in the ordinary shares.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">It is not entirely clear how various aspects of
the PFIC rules apply to the warrants. However, a U.S.&#160;Holder may not make a QEF election with respect to its warrants. As a result,
if a U.S.&#160;Holder sells or otherwise disposes of such warrants (other than upon exercise of such warrants) and we were a PFIC at any
time during the U.S.&#160;Holder&#8217;s holding period of such warrants, any gain recognized generally will be treated as an excess distribution,
taxed as described above.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If a U.S.&#160;Holder that exercises such warrants
properly makes and maintains a QEF election with respect to the newly acquired ordinary shares (or has previously made a QEF election
with respect to the ordinary shares), the QEF election will apply to the newly acquired ordinary shares. Notwithstanding such QEF election,
the rules relating to &#8220;excess distributions&#8221; discussed above, adjusted to take into account the current income inclusions
resulting from the QEF election, will continue to apply with respect to such newly acquired ordinary shares (which under proposed regulations
will be deemed to have a holding period for purposes of the PFIC rules that includes the period the U.S.&#160;Holder held the warrants),
unless the U.S.&#160;Holder makes a &#8220;deemed sale&#8221; election under the PFIC rules. U.S.&#160;Holders are urged to consult their
tax advisors as to the application of the rules governing &#8220;deemed sale&#8221; elections to their particular circumstances.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The QEF election is made on a shareholder-by-shareholder&#160;basis
and, once made, can be revoked only with the consent of the IRS.&#160;A U.S.&#160;Holder that is eligible to make a QEF election with
respect to its ordinary shares generally may do so by providing the appropriate information to the IRS in the U.S.&#160;Holder&#8217;s
timely filed tax return for the year in which the election becomes effective. Retroactive QEF elections generally may be made only by
filing a protective statement with such return and if certain other conditions are met or with the consent of the IRS.&#160;U.S.&#160;Holders
should consult their tax advisors regarding the availability and tax consequences of a retroactive QEF election under their particular
circumstances.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">U.S.&#160;Holders should consult their tax advisors
as to the availability and desirability of a QEF election.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Alternatively, if we are a PFIC and ordinary
shares constitute &#8220;marketable stock&#8221; (as defined below), a U.S.&#160;Holder may make a mark-to-market&#160;election for such
holder&#8217;s ordinary shares with respect to such shares for the first taxable year in which it holds (or is deemed to hold) ordinary
shares and each subsequent taxable year to elect out of the excess distribution rules discussed above. If a U.S.&#160;Holder makes a
mark-to-market&#160;election with respect to its ordinary shares, such U.S.&#160;Holder generally will include in income for each year
that we are treated as a PFIC with respect to such ordinary shares an amount equal to the excess, if any, of the fair market value of
the ordinary shares as of the close of the U.S.&#160;Holder&#8217;s taxable year over the adjusted basis in the ordinary shares. A U.S.&#160;Holder
will be allowed a deduction for the excess, if any, of the adjusted basis of the ordinary shares over their fair market value as of the
close of the taxable year. However, deductions will be allowed only to the extent of any net mark-to-market&#160;gains on the ordinary
shares included in the U.S.&#160;Holder&#8217;s income for prior taxable&#160;years. Amounts included in income under a mark-to-market&#160;election,
as well as gain on the actual sale or other disposition of the ordinary shares, will be treated as ordinary income. Ordinary loss treatment
will also apply to the deductible portion of any mark-to-market&#160;loss on the ordinary shares, as well as to any loss realized on
the actual sale or disposition of the ordinary shares, to the extent the amount of such loss does not exceed the net mark-to-market&#160;gains
for such ordinary shares previously included in income. A U.S.&#160;Holder&#8217;s basis in the ordinary shares will be adjusted to reflect
any mark-to-market&#160;gain or loss. If a U.S.&#160;Holder makes a mark-to-market&#160;election, any distributions we make would generally
be subject to the rules discussed above under &#8220;<i>&#8212;&#160;Distributions on ordinary shares</i>,&#8221; except the lower rates
applicable to qualified dividend income would not apply. Currently, U.S.&#160;Holders of warrants will not be able to make a mark-to-market&#160;election
with respect to their warrants.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 116 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->113<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The mark-to-market&#160;election is available
only for &#8220;marketable stock,&#8221; which is stock that is regularly traded on a qualified exchange or other market, as defined in
applicable U.S.&#160;Treasury regulations. The ordinary shares, which listed on Nasdaq, are expected to qualify as marketable stock for
purposes of the PFIC rules, but there can be no assurance that ordinary shares will be &#8220;regularly traded&#8221; for purposes of
these rules. If made, a mark-to-market&#160;election would be effective for the taxable year for which the election was made and for all
subsequent taxable&#160;years unless ordinary shares cease to qualify as &#8220;marketable stock&#8221; for purposes of the PFIC rules
or the IRS consents to the revocation of the election. Because a mark-to-market&#160;election cannot be made for equity interests in any
Lower-Tier&#160;PFICs, a U.S.&#160;Holder that does not make the applicable QEF elections generally will continue to be subject to the
excess distribution rules with respect to its indirect interest in any Lower-Tier&#160;PFICs as described above, even if a mark-to-market&#160;election
is made for ordinary shares.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If a U.S.&#160;Holder does not make a mark-to-market&#160;election
(or a QEF election, as discussed above) effective from the first taxable year of a U.S.&#160;Holder&#8217;s holding period for the ordinary
shares in which we are a PFIC, then the U.S.&#160;Holder generally will remain subject to the excess distribution rules. A U.S.&#160;Holder
that first makes a mark-to-market&#160;election with respect to the ordinary shares in a later year will continue to be subject to the
excess distribution rules during the taxable year for which the mark-to-market&#160;election becomes effective, including with respect
to any mark-to-market&#160;gain recognized at the end of that year. In subsequent&#160;years for which a valid mark-to-mark&#160;election
remains in effect, the excess distribution rules generally will not apply. A U.S.&#160;Holder that is eligible to make a mark-to-market&#160;with
respect to such holder&#8217;s ordinary shares may do so by providing the appropriate information on IRS Form&#160;8621 and timely filing
that form with the U.S.&#160;Holder&#8217;s tax return for the year in which the election becomes effective.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">U.S.&#160;Holders should consult their tax advisors
as to the availability and desirability of a mark-to-market&#160;election, as well as the impact of such election on interests in any
Lower-Tier&#160;PFICs.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">A U.S.&#160;Holder of a PFIC may be required to
file an IRS Form&#160;8621 on an annual basis and to provide such other information as may be required by the U.S.&#160;Treasury Department.
Failure to do so, if required, will extend the statute of limitations applicable to such U.S.&#160;Holder until such required information
is furnished to the IRS.&#160;U.S.&#160;Holders should consult their tax advisors regarding any reporting requirements that may apply
to them if we are a PFIC.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The rules dealing with PFICs and with the QEF,
&#8220;deemed sale,&#8221; and mark-to-market&#160;elections are very complex and are affected by various factors in addition to those
described above. U.S.&#160;Holders are strongly encouraged to consult their tax advisors regarding the application of the PFIC rules to
their particular circumstances.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>THE U.S.&#160;FEDERAL INCOME TAX DISCUSSION
SET FORTH ABOVE IS INCLUDED FOR GENERAL INFORMATION ONLY AND MAY NOT BE APPLICABLE TO YOU DEPENDING UPON YOUR PARTICULAR SITUATION.&#160;YOU
ARE URGED TO CONSULT YOUR OWN TAX ADVISOR WITH RESPECT TO THE TAX CONSEQUENCES TO YOU OF THE OWNERSHIP AND DISPOSITION OF ORDINARY SHARES
AND WARRANTS, AS APPLICABLE, INCLUDING THE TAX CONSEQUENCES UNDER STATE, LOCAL, FOREIGN AND OTHER TAX LAWS AND TAX TREATIES AND THE POSSIBLE
EFFECTS OF CHANGES IN U.S.&#160;OR OTHER TAX LAWS.</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>10.F. Dividends and Paying Agents</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Not Applicable.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 36pt"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>10.G. Statement by Experts</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 36pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Not Applicable.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>10.H. Documents on Display</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We are subject to the informational requirements
of the Securities Exchange Act of 1934, as amended, and will file reports, registration statements and other information with the SEC.
Our reports, registration statements and other information can be inspected on the SEC&#8217;s website at www.sec.gov and such information
can also be inspected and copies ordered at the public reference facilities maintained by the SEC at the following location: 100 F Street
NE, Washington, D.C. 20549. You may also visit our website at https://arberobotics.com. Information contained on, or that can be accessed
through, our website or any other website is expressly not incorporated by reference into and is not a part of this annual report.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 36pt"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>I. Subsidiary Information</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Not Applicable.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 117 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->114<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><div><a id="a_013"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>ITEM 11. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK
</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We are exposed to various market risks, which
may result in potential losses arising from adverse changes in market rates, such as interest rates, foreign exchange rates and inflation
and supply line factors. The effect of inflation and supply line factors and interest rates are described in Item 5. Operating and Financial
Review and Prospects.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Interest Rate Risk</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b>&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As of December 31, 2023, we had $28.6 million
in cash and cash equivalents and $15.4 million in short term bank deposits, which consisted of funds held in interest-bearing checking
accounts and no debt. Our primary exposure to interest rate sensitivity affects the interest income we receive and is affected by changes
in the general level of Bank of Israel and the United States Fed Funds rate, affects bank interest rates. Due to the short-term nature
and the low-risk profile of our interest-bearing accounts, an immediate change in interest rates would not have a material effect on the
fair market value of our cash and cash equivalents and short-term restricted bank deposits or on our financial position or results of
operations.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Foreign Currency Exchange Risk</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our results of operations and cash flows are subject
to fluctuations due to changes in foreign currency exchange rates. Currently most of our revenue is generated in US Dollar while our expenses
are generally denominated in the currencies of the jurisdictions in which we conduct our operations, primarily Israeli Shekel, US Dollar
and Euro to some extent. We have not generated significant revenue to date and we do not believe that foreign currency exchange rates
have not had, or currently have, a material effect on our business, but we cannot give any assurance that changes in foreign currency
exchange rates will not have a material impact on us.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><div><a id="a_014"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>ITEM 12. DESCRIPTION OF SECURITIES OTHER THAN
EQUITY SECURITIES</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>A. Debt Securities</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Not applicable.&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>B. Warrants and Rights&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Description of Warrants</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Each of our warrants entitles the holder thereof
to purchase one ordinary share at a price of $11.50 per share, subject to adjustment as discussed below, at any time commencing December&#160;11,
2021. The Warrants will expire October 7. 2026, which is five&#160;years after the effective time of the Merger, at 5:00&#160;p.m., New&#160;York
City time, or earlier upon redemption or liquidation.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We will not be obligated to deliver any ordinary
shares pursuant to the exercise of a warrant and will have no obligation to settle such warrant exercise unless a registration statement
under the Securities Act with respect to the ordinary shares underlying the warrants is then effective and a prospectus relating thereto
is current, subject to our satisfying our obligations described below with respect to registration. No warrant will be exercisable and
we will not be obligated to issue ordinary shares unless the ordinary shares issuable upon such warrant exercise have been registered,
qualified or deemed to be exempt under the securities laws of the state of residence of the registered holder of the warrants. In the
event that the conditions in the two immediately preceding sentences are not satisfied with respect to a warrant, the holder of such warrant
will not be entitled to exercise such warrant and such warrant may have no value and expire worthless. In no event will we be required
to net cash settle any warrant.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 118 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->115<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The issuance of the warrants was registered pursuant
to a registration statement on Form F-4 relating to the issuance of our ordinary shares and warrants to the holders of ITAC&#8217;s common
stock and warrants pursuant to the Merger with ITAC. We are required to maintain a current prospectus relating to those ordinary shares
until the warrants expire or are redeemed, as specified in the warrant agreement. If a registration statement covering the ordinary shares
issuable upon exercise of the warrants is not effective, warrant holders may, until such time as there is an effective registration statement
and during any period when we will have failed to maintain an effective registration statement, exercise warrants on a &#8220;cashless
basis&#8221; in accordance with Section&#160;3(a)(9)&#160;of the Securities Act or another exemption. Notwithstanding the above, if the
ordinary shares at the time of any exercise of a warrant are not listed on a national securities exchange such that it satisfies the definition
of a &#8220;covered security&#8221; under Section&#160;18(b)(1)&#160;of the Securities Act, we may, at our option, require holders of
public warrants who exercise their warrants to do so on a &#8220;cashless basis&#8221; in accordance with Section&#160;3(a)(9)&#160;of
the Securities Act and, in the event we so elect, we will not be required to file or maintain in effect a registration statement, and
in the event we do not so elect, we will use our best efforts to register or qualify the shares under applicable blue sky laws to the
extent an exemption is not available.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We may call the warrants for redemption (excluding
the private warrants as described below):</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">in whole and not in part;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">at a price of $0.01 per warrant;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">upon not less than 30&#160;days&#8217; prior written notice of redemption (the &#8220;30-day&#160;redemption period&#8221;) to each warrant holder; and</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">if, and only if, the reported last sale price of the ordinary shares
equals or exceeds $18.00 per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like) for
any 20&#160;trading days within a 30-trading&#160;day period ending three&#160;business days before we send the notice of redemption
to the warrant holders.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If and when the warrants become redeemable by
us, we may not exercise our redemption right if the issuance of the ordinary shares upon exercise of the warrants is not exempt from registration
or qualification under applicable state blue sky laws or we are unable to effect such registration or qualification. We will use our best
efforts to register or qualify such ordinary shares under the blue sky laws of the state of residence in those states in which the ITAC
warrants were offered by ITAC in its IPO.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The last of the redemption criterion discussed
above is designed to prevent a redemption call unless there is at the time of the call a significant premium to the warrant exercise price.
If the foregoing conditions are satisfied and we issue a notice of redemption of the warrants, each warrant holder will be entitled to
exercise its warrant prior to the scheduled redemption date. However, the price of our ordinary shares may fall below the $18.00 redemption
trigger price (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like) as well as the $11.50 warrant
exercise price after the redemption notice is issued.</p><div>


</div><!-- Field: Page; Sequence: 119 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->116<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If we call the warrants for redemption as described
above, we will have the option to require any holder that wishes to exercise its warrant to do so on a &#8220;cashless basis.&#8221; In
determining whether to require all holders to exercise their warrants on a &#8220;cashless basis,&#8221; our \management will consider,
among other factors, our cash position, the number of warrants that are outstanding and the dilutive effect on our shareholders of issuing
the maximum number of ordinary shares issuable upon the exercise of the warrants. If our management takes advantage of this option, all
holders of warrants would pay the exercise price by surrendering their warrants for that number of our ordinary shares equal to the quotient
obtained by dividing (x)&#160;the product of the number of ordinary shares underlying the warrants, multiplied by the difference between
the exercise price of the warrants and the &#8220;fair market value&#8221; (defined below) by (y)&#160;the fair market value. The &#8220;fair
market value&#8221; shall mean the average reported last sale price of our ordinary shares for the 10&#160;trading days ending on the
third&#160;trading day prior to the date on which the notice of redemption is sent to the holders of warrants. If our management takes
advantage of this option, the notice of redemption will contain the information necessary to calculate the number of ordinary shares to
be received upon exercise of the warrants, including the &#8220;fair market value&#8221; in such case. Requiring a cashless exercise in
this manner will reduce the number of shares to be issued and thereby lessen the dilutive effect of a warrant redemption. If we call the
warrants for redemption and our management does not take advantage of this option, the ITAC Sponsor and its permitted transferees would
still be entitled to exercise their warrants issued in respect of their private ITAC warrants for cash or on a cashless basis using the
same formula described above that other warrant holders would have been required to use had all warrant holders been required to exercise
their warrants on a cashless basis, as described in more detail below.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">A holder of a warrant may notify us in writing
in the event it elects to be subject to a requirement that such holder will not have the right to exercise such warrant, to the extent
that after giving effect to such exercise, such person (together with such person&#8217;s affiliates), to the warrant agent&#8217;s actual
knowledge, would beneficially own in excess of 4.9% or 9.8% (or such other amount as a holder may specify) of the ordinary shares outstanding
immediately after giving effect to such exercise.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If the number of outstanding ordinary shares is increased by a stock
dividend payable in ordinary shares, or by a split-up&#160;of shares of ordinary shares or other similar event, then, on the effective
date of such stock dividend, split-up&#160;or similar event, the number of ordinary shares issuable on exercise of each warrant will be
increased in proportion to such increase in the outstanding ordinary shares. A rights offering to holders of ordinary shares entitling
holders to purchase ordinary shares at a price less than the fair market value will be deemed a stock dividend of a number of ordinary
shares equal to the product of (i)&#160;the number of ordinary shares actually sold in such rights offering (or issuable under any other
equity securities sold in such rights offering that are convertible into or exercisable for ordinary shares) and (ii)&#160;one (1)&#160;minus
the quotient of (x)&#160;the price per ordinary share paid in such rights offering divided by (y)&#160;the fair market value. For these
purposes (i)&#160;if the rights offering is for securities convertible into or exercisable for ordinary shares, in determining the price
payable for ordinary shares, there will be taken into account any consideration received for such rights, as well as any additional amount
payable upon exercise or conversion and (ii)&#160;fair market value means the volume weighted average price of our ordinary shares as
reported during the ten (10)&#160;trading day period ending on the&#160;trading day prior to the first date on which our ordinary shares
trade on the applicable exchange or in the applicable market, regular way, without the right to receive such rights.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In addition, if we, at any time while the warrants
are outstanding and unexpired, pay a dividend or make a distribution in cash, securities or other assets to the holders of ordinary shares
on account of such ordinary shares (or other shares into which the warrants are convertible), other than (a)&#160;as described above,
(b)&#160;certain ordinary cash dividends, then the warrant exercise price will be decreased, effective immediately after the effective
date of such event, by the amount of cash and/or the fair market value of any securities or other assets paid on each ordinary share in
respect of such event.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If the number of outstanding ordinary shares is decreased by a consolidation,
combination, reverse stock split or reclassification of ordinary shares or other similar event, then, on the effective date of such consolidation,
combination, reverse stock split, reclassification or similar event, the number of our ordinary shares issuable on exercise of each warrant
will be decreased in proportion to such decrease in outstanding shares.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Whenever the number of ordinary shares purchasable
upon the exercise of the warrants is adjusted, as described above, the warrant exercise price will be adjusted by multiplying the warrant
exercise price immediately prior to such adjustment by a fraction (x)&#160;the numerator of which will be the number of ordinary shares
purchasable upon the exercise of the warrants immediately prior to such adjustment, and (y)&#160;the denominator of which will be the
number of ordinary shares so purchasable immediately thereafter.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 120 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->117<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In case of any reclassification or reorganization
of the outstanding ordinary shares (other than those described above or that solely affects the par value of such ordinary shares), or
in the case of any merger or consolidation of us with or into another corporation (other than a consolidation or merger in which we are
the continuing corporation and that does not result in any reclassification or reorganization of our outstanding ordinary shares), or
in the case of any sale or conveyance to another corporation or entity of the assets or other property of us as an entirety or substantially
as an entirety in connection with which we are dissolved, the holders of the warrants will thereafter have the right to purchase and receive,
upon the basis and upon the terms and conditions specified in the warrants and in lieu of the ordinary shares immediately theretofore
purchasable and receivable upon the exercise of the rights represented thereby, the kind and amount of shares of stock or other securities
or property (including cash) receivable upon such reclassification, reorganization, merger or consolidation, or upon a dissolution following
any such sale or transfer, that the holder of the warrants would have received if such holder had exercised their warrants immediately
prior to such event. If less than 70% of the consideration receivable by the holders of ordinary shares in such a transaction is payable
in the form of ordinary shares in the successor entity that is listed for trading on a national securities exchange or is quoted in an
established over-the-counter&#160;market, or is to be so listed for trading or quoted immediately following such event, and if the registered
holder of the warrant properly exercises the warrant within thirty&#160;days following public disclosure of such transaction, the warrant
exercise price will be reduced as specified in the warrant agreement based on the Black-Scholes&#160;value (as defined in the warrant
agreement) of the warrant. The purpose of such exercise price reduction is to provide additional value to holders of the warrants when
an extraordinary transaction occurs during the exercise period of the warrants pursuant to which the holders of the warrants otherwise
do not receive the full potential value of the warrants in order to determine and realize the option value component of the warrant. This
formula is to compensate the warrant holder for the loss of the option value portion of the warrant due to the requirement that the warrant
holder exercise the warrant within 30&#160;days of the event. The Black-Scholes&#160;model is an accepted pricing model for estimating
fair market value where no quoted market price for an instrument is available.</p><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The warrants were issued in registered form under
a warrant agreement between Continental Stock Transfer&#160;&amp; Trust Company, as warrant agent, and us, which reflects an assumption
and amendment to the warrant agreement between Continental Stock Transfer&#160;&amp; Trust Company and ITAC and provides that we assume
the obligations of ITAC under the warrant agreement. You should review a copy of the warrant assumption and amendment agreement, which
is filed as an exhibit to this annual report, for a complete description of the terms and conditions applicable to our warrants. The warrant
agreement provides that the terms of the warrants may be amended without the consent of any holder to cure any ambiguity or correct any
defective provision, but requires the approval by the holders of a majority of the then outstanding public warrants to make any change
in the warrants.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The warrants may be exercised upon surrender of
the warrant certificate on or prior to the expiration date at the offices of the warrant agent, with the exercise form on the reverse
side of the warrant certificate completed and executed as indicated, accompanied by full payment of the exercise price (or on a cashless
basis, if applicable), by certified or official bank check payable to us, for the number of warrants being exercised. The warrant holders
do not have the rights or privileges of holders of ordinary shares and any voting rights until they exercise their warrants and receive
ordinary shares. After the issuance of ordinary shares upon exercise of the warrants, each holder will be entitled to one (1)&#160;vote
for each ordinary share held of record on all matters to be voted on by shareholders.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The warrants issued to the holders of the ITAC
private warrants will not be redeemable by us so long as they are held by the Sponsor, the underwriters of ITAC&#8217;s IPO or their permitted
transferees. The Sponsor, the underwriters and their permitted transferees, have the option to exercise the private placement warrants
on a cashless basis. Except as described below, the warrants issued in respect of ITAC private warrants have terms and provisions that
are identical to those of the warrants issued to holders of the ITAC public warrants, including as to exercise price, exercisability and
exercise period. If the warrants issued in respect of the ITAC private warrants are held by holders other than the sponsor, the underwriters
or their permitted transferees, such warrants will be redeemable by us and exercisable by the holders on the same basis as the warrants
issued in respect of the ITAC public warrants.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If holders of the private placement warrants elect
to exercise them on a cashless basis, they would pay the exercise price by surrendering their warrants for that number of ordinary shares
equal to the quotient obtained by dividing (x)&#160;the product of the number of ordinary shares underlying the warrants, multiplied by
the difference between the exercise price of the warrants and the &#8220;fair market value&#8221; (defined below) by (y)&#160;the fair
market value. The &#8220;fair market value&#8221; shall mean the average reported last sale price of our ordinary shares for the 10&#160;trading
days ending on the third&#160;trading day prior to the date on which the notice of warrant exercise is sent to the warrant agent.</p><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In addition, we have granted certain registration
rights to the holders of our private warrant that are held by the former holders of the ITAC&#8217;s private placement warrants.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>C. Other Securities</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Not Applicable</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>D. American Depository Shares</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Not Applicable</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><!-- Field: Page; Sequence: 121 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->118<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><div><a id="a_015"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>PART II</b></p><div>

</div><p style="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p><div>

</div><div><a id="a_016"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>ITEM 13. DEFAULTS, DIVIDEND ARREARAGES AND DELINQUENCIES</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Not Applicable.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><div><a id="a_017"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>ITEM 14. MATERIAL MODIFICATIONS TO THE RIGHTS OF SECURITY HOLDERS
AND USE OF PROCEEDS</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Not Applicable</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><div><a id="a_018"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><b>ITEM 15. CONTROLS AND PROCEDURES</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><b>Evaluation of Disclosure Controls and Procedures</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We maintain disclosure controls and procedures
(as that term is defined in Rules&#160;13a-15(e)&#160;and&#160;15d-15(e)&#160;under the Securities Exchange Act of 1934, as amended (&#8220;Exchange
Act&#8221;)) that are designed to ensure that information required to be disclosed in the Company&#8217;s reports under the Exchange Act
is recorded, processed, summarized and reported within the time periods specified in the SEC&#8217;s rules and forms and that such information
is accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer, as appropriate,
to allow timely decisions regarding required disclosures. Any controls and procedures, no matter how well designed and operated, can provide
only reasonable assurance of achieving the desired control objectives. Our management, with the participation of our Chief Executive Officer
and Chief Financial Officer, has evaluated the effectiveness of the design and operation of our disclosure controls and procedures as
of December&#160;31,&#160;2023 Based upon that evaluation, our Chief Executive Officer and Chief Financial Officer concluded that, as
of December&#160;31, 2023, our disclosure controls and procedures were effective to accomplish their objectives at the reasonable assurance
level.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Management&#8217;s Report on Internal Control
over Financial Reporting</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our management, under the supervision of our Chief
Executive Officer and Chief Financial Officer, is responsible for establishing and maintaining adequate internal control over our financial
reporting as defined in Rules 13a-15(f) and 15d-15(f) of the Exchange Act. Internal control over financial reporting is designed to provide
reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes
in accordance with generally accepted accounting principles.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Because of its inherent limitations, internal
control over financial reporting may not prevent or detect misstatements. Therefore, even those systems determined to be effective can
provide only reasonable assurances with respect to financial statement preparation and presentation. Also, projections of any evaluation
of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that
the degree of compliance with the policies or procedures may decline.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our management, including our Chief Executive
Officer and Chief Financial Officer, conducted an evaluation, pursuant to Rule 13a-15(c) promulgated under the Exchange Act, of the effectiveness,
as of the end of the period covered by this annual report, of its internal control over financial reporting based on the framework in
Internal Control&#8212;Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission (2013). Based
on the results of this evaluation, our management concluded that as of December 31, 2023, our internal control over financial reporting
was effective.</p><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"></p><div>

</div><!-- Field: Page; Sequence: 122 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->119<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><b>Attestation Report
of the Registered Public Accounting Firm</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">As an &#8220;emerging
growth company,&#8221; as defined in the JOBS Act, we may take advantage of certain temporary exemptions from various reporting requirements,
including, but not limited to, not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley
Act (and the SEC rules and regulations thereunder). When these exemptions cease to apply, we expect to incur additional expenses and devote
increased management effort toward ensuring compliance with them.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt; background-color: white"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><b>Changes in Internal
Control over Financial Reporting</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">There were no changes in our internal controls
over financial reporting (as such term is defined in Rules&#160;13a-15(f)&#160;and&#160;15d-15(f)&#160;under the Securities Exchange Act)
that occurred during the period covered by this annual report that have materially affected, or are reasonably likely to materially affect,
our internal control over financial reporting.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><div><a id="a_019"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>ITEM 16. [RESERVED]</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><div><a id="a_020"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>ITEM 16A. AUDIT COMMITTEE FINANCIAL EXPERT</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our board of directors has determined that Dr.
Boaz Schwartz is an &#8220;audit committee financial expert.&#8221;</p><div>

</div><p style="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p><div>

</div><div><a id="a_021"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>ITEM 16B. CODE OF ETHICS</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We have adopted a Code of Ethics that applies
to our principal executive and financial officers, and that also applies to all of our employees. The Code of Ethics is publicly available
on our website at www.arberobotics.com and is filed as an exhibit to this annual report. We will disclose on our website any amendment
to, or waiver from, a provision of our Code of Ethics and Conduct that applies to our directors or executive officers to the extent required
under the rules of the SEC.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 36pt">&#160;</p><div>

</div><div><a id="a_022"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>ITEM &#160;16C. PRINCIPAL ACCOUNTANT FEES AND SERVICES</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 36pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Somekh Chaikin, a member
firm of KPMG International, located in Tel Aviv, Israel (PCAOB ID <ix:nonNumeric contextRef="c0" name="dei:AuditorFirmId" id="ixv-26142">1057</ix:nonNumeric>), has served as our independent registered public accounting firm
since 2021. The following are Somekh Chaikin&#8217;s fees for 2023 and 2022:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Year ended December 31,</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: left">Audit fees (1)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">170,000</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">200,950</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">Tax fees (2)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">22,500</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">12,500</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 4pt">Total</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">192,500</td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">213,450</td><td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  </table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white; text-indent: 0.5in"></p><div>

</div><!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 25%"><div style="font-size: 1pt; border-top: Black 1.5pt solid">&#160;</div></div><!-- Field: /Rule-Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white; text-indent: 0.5in"></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"/><td style="width: 0.25in; text-align: left"><span style="font-size: 10pt">(1)</span></td><td style="text-align: justify"><span style="font-size: 10pt">&#8220;Audit fees&#8221; include
fees for services performed by our independent public accounting firm in connection with the audit of our annual consolidated financial
statements for 2023 and 2022, certain procedures regarding our annual report submitted on Form 20-F, our quarterly financial results
submitted on Form 6-K, and consultation concerning financial accounting and reporting standards. Audit fees for 2022 also include services
in connection with our F-3 filings with the SEC.</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"/><td style="width: 0.25in; text-align: left"><span style="font-size: 10pt">(2)</span></td><td style="text-align: justify"><span style="font-size: 10pt">&#8220;Tax fees&#8221; include
fees for professional services rendered and performed during the period by our independent registered public accounting firm for tax
compliance and tax advice and tax planning services on actual or contemplated transactions.</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"></p><div>

</div><!-- Field: Page; Sequence: 123 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->120<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><b>Audit Committee&#8217;s
Pre-Approval Policies and Procedures</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Our Audit Committee has
adopted a pre-approval policy for the engagement of our independent accountant to perform certain audit and non-audit services. Pursuant
to this policy, which is designed to assure that such engagements do not impair the independence of our auditors, the audit committee
pre-approves a maximum amount for certain potential services and approval is provided prior to any service performed by the independent
accountant. Prior to any engagement of&#160;the independent accountant by the Company or its subsidiaries to render audit or non-audit
services, a detailed description of the particular service to be performed as well as the fee structure are pre-approved by the Company&#8217;s
audit committee.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 36pt">&#160;</p><div>

</div><div><a id="a_023"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>ITEM 16D. EXEMPTIONS FROM THE LISTING STANDARDS FOR AUDIT COMMITTEES</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Not Applicable.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><div><a id="a_024"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>ITEM 16E. PURCHASES OF EQUITY SECURITIES BY THE ISSUER AND AFFILIATED
PURCHASERS</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">None.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt">&#160;</p><div>

</div><div><a id="a_025"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>ITEM 16F. CHANGE IN REGISTRANT&#8217;S CERTIFYING ACCOUNTANT</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">None.</p><div>

</div><p style="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p><div>

</div><div><a id="a_026"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>ITEM 16G. CORPORATE GOVERNANCE</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our ordinary shares are listed on the Nasdaq Capital
Market. As such, we are subject to corporate governance requirements imposed by Nasdaq. Under Nasdaq rules, foreign private issuers, such
as us, may, in general, follow their home country corporate governance practices in lieu of some of the Nasdaq corporate governance requirements.
A Nasdaq-listed foreign private issuer is required to provide a general summary of the significant differences either on the company website
or in its annual report. Currently, we do not plan to rely on the home country practice exemption with respect to its corporate governance
other than (i) the quorum requirements and (ii) the home country exception from the Nasdaq requirement for obtaining shareholder approval
for certain issuances of more than 20% of our common shares. Our Restated Articles provide that two shareholders holding 25% of the voting
shares constitutes a quorum, as contrasted with the Nasdaq requirement of one-third of a company&#8217;s outstanding voting securities.
Israeli law has no requirement for obtaining shareholder approval for the issuance of more than 20% of our common shares, and, accordingly,
we are able to issue more our common shares without shareholder approval, including issuances which would otherwise require shareholder
approval under the Nasdaq regulations. This exception does not apply to increases in our authorized capital stock or the issuance of preferred
shares both of which requires shareholder approval under Israeli law.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt">&#160;</p><div>

</div><div><a id="a_027"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>ITEM 16H. MINE SAFETY DISCLOSURE</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Not applicable.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt"><b>&#160;</b>&#160;</p><div>

</div><div><a id="a_028"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>ITEM 16I. DISCLOSURE REGARDING FOREIGN JURISDICTIONS
THAT PREVENT INSPECTIONS</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Not applicable</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><div><a id="a_029"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>ITEM 16J. INSIDER TRADING POLICIES</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p><div>

</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">We have an <ix:nonNumeric contextRef="c81" format="ixt:fixed-false" name="ecd:NonRule10b51ArrTrmntdFlag" id="ixv-26143"><ix:nonNumeric contextRef="c81" format="ixt:fixed-false" name="ecd:Rule10b51ArrTrmntdFlag" id="ixv-26144"><ix:nonNumeric contextRef="c81" format="ixt:fixed-false" name="ecd:NonRule10b51ArrAdoptedFlag" id="ixv-26145"><ix:nonNumeric contextRef="c81" format="ixt:fixed-false" name="ecd:Rule10b51ArrAdoptedFlag" id="ixv-26146">insider</ix:nonNumeric></ix:nonNumeric></ix:nonNumeric></ix:nonNumeric> tradition policy governing the purchase, sale, and
other dispositions of the registrant&#8217;s securities by directors, senior management, and employees. Our insider trading policy is
filed as an exhibit to this Form 20-F.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><!-- Field: Page; Sequence: 124 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->121<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p><div>

</div><div><a id="a_030"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>ITEM 16K. CYBERSECURITY</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="text-decoration:underline">Risk Management</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We face significant and persistent cybersecurity
risks due to the need to protect our business, including our intellectual property and intellectual property of others that is licensed
for our use, our confidential information and information concerning our personnel and others with whom we conduct business. As other
technology companies we occasionally face threats from actors who seek to disrupt our business as well as others who are engaging in malicious
activities for profit, to make a political point or for no particular reason other than creating disruption. Disclose of certain information
as a result of a cybersecurity breach may result is a breach of privacy laws. The substantial level of harm that could occur to us and
our suppliers and customers were we to suffer impacts of a material cybersecurity incident; and our use of third-party products, services
and components requires us to maintain robust governance and oversight of these risks and to implement mechanisms, technologies and processes
designed to help us assess, identify, and eliminate these risks.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">While we have not, as of the date of this Form
20-F, experienced a cybersecurity threat or incident that resulted in a material adverse impact to our business or operations, we cannot
assure you that we will not experience such an incident in the future. While we did suffer a cybersecurity incident in 2023 which did
not result in any material adverse impact to our business, we did not experience any disclosure of our proprietary information, and following
such incident we took additional steps to protect ourselves from cybersecurity incidents. Any cybersecurity incidents, whether or not
successful, could result in our incurring additional costs related to, for example, rebuilding our internal systems, implementing additional
threat protection measures, responding to regulatory inquiries or actions, paying damages or making payments to obtain access to our computer
systems, or taking other remedial steps with respect to third parties, as well as incurring significant reputational harm. We have seen
an increase in cyberattack volume, frequency, and sophistication. We seek to detect and investigate unauthorized attempts and attacks
against our network, products, and services, and to prevent their occurrence and recurrence where practicable through changes or updates
to our internal processes and tools and changes or updates to our products and services; however, we remain potentially vulnerable to
known or unknown threats. In some instances, we, our suppliers, our customers, and the users of our products and services can be unaware
of a threat or incident or its magnitude and effects. Further, there are increasing regulation requirements regarding responses to cybersecurity
incidents, including reporting to regulators, which could subject us to additional liability and reputational harm.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="text-decoration:underline">Governance</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We aim to incorporate industry best practices
throughout our cybersecurity program. Our cybersecurity strategy focuses on implementing effective and efficient controls, technologies,
and other processes to assess, identify, and manage material cybersecurity risks.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our cybersecurity program is designed to be aligned
with applicable industry standards, and we have engaged outside sources to assist in this effort. We have processes in place to assess,
identify, manage, and address material cybersecurity threats and incidents. We have ISO 27001:2013 certification, which is an early standard
for information security management. Steps taken by us include, among other things: an audit which was conducted by the company&#8217;s
internal auditor during 2023 of the cybersecurity measures and practices of the Company, the engagement with professional service providers
(such as a chief information security officer (&#8220;CISO&#8221;) and security operations center services), security awareness training
for employees; mechanisms to detect and monitor unusual network activity; and containment and incident response tools.</p><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We monitor issues that are internally discovered
or externally reported that may affect our products and have processes to assess those issues for potential cybersecurity impact or risk.
We also have a process in place to manage cybersecurity risks associated with third-party service providers. We are in the process of
implementing technical and organizational security measures to follow our information security program.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Under our cybersecurity governance framework,
the Audit Committee, in its charter, is empowered to implement and oversee our cybersecurity and information security policies and periodically
review their compliance and mitigate potential cybersecurity threats.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our CISO, who is a third party engaged by us,
leads the strategy, engineering, and operations of cybersecurity of the Company and is responsible for handling the risk management by
assessment, analysis, reporting, managing the cyber protection following the relevant requirements, the work with the information security
team, implementing information security awareness among the employees, and updating the company&#8217;s policies. Our CISO provides annual
analysis and updates to the management on our cybersecurity and information security policies and programs, as well as ad hoc updates
on information security and cybersecurity matters.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-size: 10pt">&#160;</span></p><div>


</div><!-- Field: Page; Sequence: 125 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->122<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><div><a id="a_031"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>PART III</b></p><div>

</div><p style="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p><div>

</div><div><a id="a_032"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>ITEM 17. FINANCIAL STATEMENTS</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Not applicable.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><div><a id="a_033"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>ITEM 18. FINANCIAL STATEMENTS</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">See Index to Financial Statements on Page F-1</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt">&#160;</p><div>

</div><div><a id="a_034"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>ITEM 19. EXHIBITS </b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 9%; border-bottom: black 1.5pt solid; padding-right: 0.5pt; padding-left: 0.5pt"><span style="font-size: 10pt"><b>Exhibit&#160;No.</b></span></td>
    <td style="width: 1%; padding-right: 0.5pt; padding-left: 0.5pt">&#160;</td>
    <td style="width: 90%; border-bottom: black 1.5pt solid; padding-right: 0.5pt; padding-left: 0.5pt; text-align: center"><span style="font-size: 10pt"><b>Description</b></span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="padding-right: 0.5pt; padding-left: 0.5pt; text-align: justify"><span style="font-size: 10pt">1.1</span></td>
    <td style="padding-right: 0.5pt; padding-left: 0.5pt">&#160;</td>
    <td style="padding-right: 0.5pt; padding-left: 0.5pt; text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/1861841/000121390021054688/ea149261ex3-1_arberobotics.htm"><span style="font-size: 10pt">Amended and Restated Articles of Association of Arbe <sup>(1)</sup></span></a></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-right: 0.5pt; padding-left: 0.5pt; text-align: justify"><span style="font-size: 10pt">2.1</span></td>
    <td style="padding-right: 0.5pt; padding-left: 0.5pt">&#160;</td>
    <td style="padding-right: 0.5pt; padding-left: 0.5pt; text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/1861841/000121390022016391/f20f2021ex2-1_arberobotics.htm"><span style="font-size: 10pt">Description of Securities<sup>(5)</sup></span></a></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="padding-right: 0.5pt; padding-left: 0.5pt; text-align: justify"><span style="font-size: 10pt">4.1</span></td>
    <td style="padding-right: 0.5pt; padding-left: 0.5pt">&#160;</td>
    <td style="padding-right: 0.5pt; padding-left: 0.5pt; text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/1861841/000121390021033361/ff42021ex4-4_arberobotics.htm"><span style="font-size: 10pt">Warrant Agreement dated September&#160;8, 2020, between Continental Stock Transfer&#160;&amp; Trust Company, LLC and ITAC<sup>(3)</sup></span></a></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-right: 0.5pt; padding-left: 0.5pt; text-align: justify"><span style="font-size: 10pt">4.2</span></td>
    <td style="padding-right: 0.5pt; padding-left: 0.5pt">&#160;</td>
    <td style="padding-right: 0.5pt; padding-left: 0.5pt; text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/1861841/000121390021054688/ea149261ex4-1_arberobotics.htm"><span style="font-size: 10pt">Amendment No. 1 to Warrant Agreement among Continental Stock Transfer&#160;&amp; Trust Company, LLC, ITAC and Arbe<sup>(1)</sup></span></a></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="padding-right: 0.5pt; padding-left: 0.5pt; text-align: justify"><span style="font-size: 10pt">4.3</span></td>
    <td style="padding-right: 0.5pt; padding-left: 0.5pt">&#160;</td>
    <td style="padding-right: 0.5pt; padding-left: 0.5pt; text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/1861841/000121390021033361/ff42021ex10-3_arberobotics.htm"><span style="font-size: 10pt">Registration Rights Agreement dated September&#160;8, 2020&#160;among ITAC, Industrial Tech Partners LLC and the holders signatory thereto<sup>(3)</sup></span></a></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-right: 0.5pt; padding-left: 0.5pt; text-align: justify"><span style="font-size: 10pt">4.4*</span></td>
    <td style="padding-right: 0.5pt; padding-left: 0.5pt">&#160;</td>
    <td style="padding-right: 0.5pt; padding-left: 0.5pt; text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/1861841/000121390021033361/ff42021ex10-9_arberobotics.htm"><span style="font-size: 10pt">2016 Incentive Share Option Plan of Arbe<sup>(3)</sup></span></a></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="padding-right: 0.5pt; padding-left: 0.5pt; text-align: justify"><span style="font-size: 10pt">4.5*</span></td>
    <td style="padding-right: 0.5pt; padding-left: 0.5pt">&#160;</td>
    <td style="padding-right: 0.5pt; padding-left: 0.5pt; text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/1861841/000121390021055243/ff12021a1ex10-9_arberobotics.htm"><span style="font-size: 10pt">2021 Share Incentive Plan of Arbe<sup>(4)</sup></span></a></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-right: 0.5pt; padding-left: 0.5pt; text-align: justify"><span style="font-size: 10pt">4.6</span></td>
    <td style="padding-right: 0.5pt; padding-left: 0.5pt">&#160;</td>
    <td style="padding-right: 0.5pt; padding-left: 0.5pt; text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/1861841/000121390021043224/ff42021a2ex10-11_arberobo.htm"><span style="font-size: 10pt">Form of Director and Officer Indemnification Agreement for Arbe<sup>(3)</sup></span></a></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="padding-right: 0.5pt; padding-left: 0.5pt; text-align: justify"><span style="font-size: 10pt">4.7</span></td>
    <td style="padding-right: 0.5pt; padding-left: 0.5pt">&#160;</td>
    <td style="padding-right: 0.5pt; padding-left: 0.5pt; text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/1861841/000121390021043224/ff42021a2ex10-12_arberobo.htm"><span style="font-size: 10pt">Compensation Policy of Arbe for Officers and Directors<sup>(3)</sup></span></a></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-right: 0.5pt; padding-left: 0.5pt; text-align: justify"><span style="font-size: 10pt">4.8</span></td>
    <td style="padding-right: 0.5pt; padding-left: 0.5pt">&#160;</td>
    <td style="padding-right: 0.5pt; padding-left: 0.5pt; text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/1861841/000121390021048275/ff42021a4ex10-13_arberobo.htm"><span style="font-size: 10pt">Third Amended and Restated Investor Rights Agreement<sup>(4)</sup></span></a></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="padding-right: 0.5pt; padding-left: 0.5pt; text-align: justify"><span style="font-size: 10pt">8.1</span></td>
    <td style="padding-right: 0.5pt; padding-left: 0.5pt">&#160;</td>
    <td style="padding-right: 0.5pt; padding-left: 0.5pt; text-align: justify"><a href="ea020246101ex8-1_arberobo.htm"><span style="font-size: 10pt">List of Subsidiaries of Arbe<sup>(6)</sup></span></a></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-right: 0.5pt; padding-left: 0.5pt; text-align: justify"><span style="font-size: 10pt">11.1</span></td>
    <td style="padding-right: 0.5pt; padding-left: 0.5pt">&#160;</td>
    <td style="padding-right: 0.5pt; padding-left: 0.5pt; text-align: justify"><a href="https://www.sec.gov/Archives/edgar/data/1861841/000121390022016391/f20f2021ex11-1_arberobotics.htm"><span style="font-size: 10pt">Code of Ethics of Arbe<sup>(5)</sup></span></a></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="padding-right: 0.5pt; padding-left: 0.5pt; text-align: justify"><span style="font-size: 10pt">12.1</span></td>
    <td style="padding-right: 0.5pt; padding-left: 0.5pt">&#160;</td>
    <td style="padding-right: 0.5pt; padding-left: 0.5pt; text-align: justify"><a href="ea020246101ex12-1_arberobo.htm"><span style="font-size: 10pt">Certification of Principal Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002<sup>(6)</sup></span></a></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-right: 0.5pt; padding-left: 0.5pt; text-align: justify"><span style="font-size: 10pt">12.2</span></td>
    <td style="padding-right: 0.5pt; padding-left: 0.5pt">&#160;</td>
    <td style="padding-right: 0.5pt; padding-left: 0.5pt; text-align: justify"><a href="ea020246101ex12-2_arberobo.htm"><span style="font-size: 10pt">Certification of Principal Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002<sup>(6)</sup></span></a></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="padding-right: 0.5pt; padding-left: 0.5pt; text-align: justify"><span style="font-size: 10pt">13.1</span></td>
    <td style="padding-right: 0.5pt; padding-left: 0.5pt">&#160;</td>
    <td style="padding-right: 0.5pt; padding-left: 0.5pt; text-align: justify"><a href="ea020246101ex13-1_arberobo.htm"><span style="font-size: 10pt">Section 1350 Certification of the Chief Executive Officer and Chief Financial Officer<sup>(6)</sup></span></a></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-right: 0.5pt; padding-left: 0.5pt; text-align: justify"><span style="font-size: 10pt">19.1</span></td>
    <td style="padding-right: 0.5pt; padding-left: 0.5pt">&#160;</td>
    <td style="padding-right: 0.5pt; padding-left: 0.5pt; text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/1861841/000121390023022143/f20f2022ex19-1_arberobotics.htm"><span style="font-size: 10pt">Insider trading policy<sup>(2)</sup></span></a></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="padding-right: 0.5pt; padding-left: 0.5pt; text-align: justify"><span style="font-size: 10pt">23.1</span></td>
    <td style="padding-right: 0.5pt; padding-left: 0.5pt">&#160;</td>
    <td style="padding-right: 0.5pt; padding-left: 0.5pt; text-align: justify"><a href="ea020246101ex23-1_arberobo.htm"><span style="font-size: 10pt">Consent of Somekh Chaikin Member Firm of KPMG International<sup>(6)</sup></span></a></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-right: 0.5pt; padding-left: 0.5pt; text-align: justify">97.1</td>
    <td style="padding-right: 0.5pt; padding-left: 0.5pt">&#160;</td>
    <td style="padding-right: 0.5pt; padding-left: 0.5pt; text-align: justify"><a href="ea020246101ex97-1_arberobo.htm">Clawback Policy<sup>(6)</sup></a></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-size: 10pt">101.INS</span></td>
    <td>&#160;</td>
    <td><span style="font-size: 10pt">Inline XBRL Instance Document.</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td><span style="font-size: 10pt">101.SCH</span></td>
    <td>&#160;</td>
    <td><span style="font-size: 10pt">Inline XBRL Taxonomy Extension Schema Document.</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-size: 10pt">101.CAL</span></td>
    <td>&#160;</td>
    <td><span style="font-size: 10pt">Inline XBRL Taxonomy Extension Calculation Linkbase Document.</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td><span style="font-size: 10pt">101.DEF</span></td>
    <td>&#160;</td>
    <td><span style="font-size: 10pt">Inline XBRL Taxonomy Definition Linkbase Document.</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-size: 10pt">101.LAB</span></td>
    <td>&#160;</td>
    <td><span style="font-size: 10pt">Inline XBRL Taxonomy Extension Label Linkbase Document</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td><span style="font-size: 10pt">101.PRE</span></td>
    <td>&#160;</td>
    <td><span style="font-size: 10pt">Inline XBRL Taxonomy Extension Presentation Linkbase Document</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-size: 10pt">104</span></td>
    <td>&#160;</td>
    <td><span style="font-size: 10pt">Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"/><td style="width: 0.25in; text-align: left"><span style="font-size: 10pt">*</span></td><td style="text-align: justify"><span style="font-size: 10pt">Indicates a management contract
or compensation plan.</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"/><td style="width: 0.25in; text-align: left"><span style="font-size: 10pt">(1)</span></td><td style="text-align: justify"><span style="font-size: 10pt">Filed as an exhibit to the Report
on Form 6-K, filed by Arbe with the SEC on October 27, 2021, and incorporated herein by reference.</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"/><td style="width: 0.25in; text-align: left"><span style="font-size: 10pt">(2)</span></td><td style="text-align: justify"><span style="font-size: 10pt">Previously filed.</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"/><td style="width: 0.25in; text-align: left"><span style="font-size: 10pt">(3)</span></td><td style="text-align: justify"><span style="font-size: 10pt">Filed as an exhibit to the Registration
Statement on Form F-4, File No.&#160;333-257250, filed by the Company with the SEC, and incorporated herein by reference.</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"/><td style="width: 0.25in; text-align: left"><span style="font-size: 10pt">(4)</span></td><td style="text-align: justify"><span style="font-size: 10pt">Filed as an exhibit to the Registration
Statement on Form F-1, File No. 333-259757, filed by the Company with the SEC, and incorporated herein by reference.</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"/><td style="width: 0.25in; text-align: left"><span style="font-size: 10pt">(5)</span></td><td style="text-align: justify"><span style="font-size: 10pt">Filed as an exhibit to the Company&#8217;s
Form 20-F for the year ended December 31, 2021, filed by the Company with the SEC on March 31, 2022, and incorporated herein by reference.</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"/><td style="width: 0.25in; text-align: left"><span style="font-size: 10pt">(6)</span></td><td style="text-align: justify"><span style="font-size: 10pt">Filed herewith.</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24pt; text-align: justify; text-indent: -24pt">&#160;</p><div>


</div><!-- Field: Page; Sequence: 126 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->123<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>SIGNATURE</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The registrant hereby certifies that it meets
all of the requirements for filing on Form 20-F and that it has duly caused and authorized the undersigned to sign this annual report
on its behalf.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="padding-right: 0.5pt; padding-left: 0.5pt"><span style="font-size: 10pt">March 28, 2024</span></td>
    <td colspan="2" style="padding-right: 0.5pt; padding-left: 0.5pt"><span style="font-size: 10pt">ARBE ROBOTICS LTD</span></td></tr>
  <tr style="vertical-align: top">
    <td style="width: 60%; padding-right: 0.5pt; padding-left: 0.5pt">&#160;</td>
    <td style="width: 3%; padding-right: 0.5pt; padding-left: 0.5pt">&#160;</td>
    <td style="width: 37%; padding-right: 0.5pt; padding-left: 0.5pt">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="padding-right: 0.5pt; padding-left: 0.5pt">&#160;</td>
    <td style="padding-right: 0.5pt; padding-left: 0.5pt"><span style="font-size: 10pt">By: </span></td>
    <td style="border-bottom: black 1.5pt solid; padding-right: 0.5pt; padding-left: 0.5pt"><span style="font-size: 10pt">/s/ Jacob (Kobi) Marinka</span></td></tr>
  <tr style="vertical-align: top">
    <td style="padding-right: 0.5pt; padding-left: 0.5pt">&#160;</td>
    <td style="padding-right: 0.5pt; padding-left: 0.5pt">&#160;</td>
    <td style="padding-right: 0.5pt; padding-left: 0.5pt"><span style="font-size: 10pt">Jacob (Kobi) Marinka</span></td></tr>
  <tr style="vertical-align: top">
    <td style="padding-right: 0.5pt; padding-left: 0.5pt">&#160;</td>
    <td style="padding-right: 0.5pt; padding-left: 0.5pt">&#160;</td>
    <td style="padding-right: 0.5pt; padding-left: 0.5pt"><span style="font-size: 10pt">Chief Executive Officer</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><!-- Field: Page; Sequence: 127 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->124<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif">ARBE
ROBOTICS LTD. AND SUBSIDIARIES</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><b>INDEX
TO CONSOLIDATED FINANCIAL STATEMENTS </b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="padding-bottom: 1.5pt; width: 91%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Page</b></span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="text-align: justify"><a href="#f_007"><span style="font-family: Times New Roman, Times, Serif"><span style="font-size: 10pt">Report
    of Independent Registered Public Accounting Firm</span></span></a></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-2</span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="text-align: justify"><a href="#F_002"><span style="font-family: Times New Roman, Times, Serif"><span style="font-size: 10pt">Consolidated
    Balance Sheets</span></span></a></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-3</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><a href="#F_003"><span style="font-size: 10pt">Consolidated
    Statements of Operations</span></a></span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-5</span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><a href="#F_004"><span style="font-size: 10pt">Consolidated
    Statements of Changes in Redeemable Convertible Preferred Shares and Shareholders&#8217; Equity (Deficiency)</span></a></span></td>
    <td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-6</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><a href="#F_005"><span style="font-size: 10pt">Consolidated
    Statements of Cash Flows</span></a></span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-7</span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><a href="#F_006"><span style="font-size: 10pt">Notes
    to the Consolidated Financial Statements</span></a></span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-8</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 128; Options: NewSection --><div>
    </div><div style="border-bottom: Black 1.5pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>




</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;<img alt="" src="fin_001.jpg"/></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.6in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Somekh
Chaikin</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">KPMG
Millennium Tower</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">17
Ha&#8217;arba&#8217;a Street, PO Box 609</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Tel
Aviv 61006, Israel</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">+972
3 684 8000</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></p><div>

</div><div><a id="f_007"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif"><b>Report
of Independent Registered Public Accounting Firm</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif">To
the Shareholders and Board of Directors<br/>
Arbe Robotics Ltd.:</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><i>Opinion
on the Consolidated Financial Statements</i></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">We
have audited the accompanying consolidated balance sheets of Arbe Robotics Ltd. and its subsidiaries, (hereinafter: &#8220;the Company&#8221;)
as of December 31, 2023 and 2022, the related consolidated statements of operations, changes in redeemable convertible preferred shares
and shareholders&#8217; equity (deficiency) and cash flows for each of the years in the three-year period ended December 31, 2023, and
the related notes (collectively, &#8220;the consolidated financial statements&#8221;). In our opinion, the consolidated financial statements
present fairly, in all material respects, the financial position of the Company as of December 31, 2023 and 2022, and the results of
its operations and its cash flows for each of the years in the three-year period ended December 31, 2023, in conformity with U.S generally
accepted accounting principles.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><i>Basis
for Opinion </i></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">These
consolidated financial statements are the responsibility of the Company&#8217;s management. Our responsibility is to express an opinion on
these consolidated financial statements based on our audits. We are a public accounting firm registered with the Public Company Accounting
Oversight Board (United States) (PCAOB) and are required to be independent with respect to the Company in accordance with the U.S. federal
securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB. We conducted our audits
in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance
about whether the consolidated financial statements are free of material misstatement, whether due to error or fraud. The Company is
not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. As part of our audits,
we are required to obtain an understanding of internal control over financial reporting but not for the purpose of expressing an opinion
on the effectiveness of the Company&#8217;s internal control over financial reporting. Accordingly, we express no such opinion.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Our
audits included performing procedures to assess the risks of material misstatement of the consolidated financial statements, whether
due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence
regarding the amounts and disclosures in the consolidated financial statements. Our audits also included evaluating the accounting principles
used and significant estimates made by management, as well as evaluating the overall presentation of the consolidated financial statements.
We believe that our audits provide a reasonable basis for our opinion.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><ix:nonNumeric contextRef="c0" name="dei:AuditorName" id="ixv-12309"><span style="font-family: Times New Roman, Times, Serif">Somekh
Chaikin</span></ix:nonNumeric></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Member
Firm of KPMG International</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">We
have served as the Company&#8217;s auditor since 2021</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><ix:nonNumeric contextRef="c0" name="dei:AuditorLocation" id="ixv-12319"><span style="font-family: Times New Roman, Times, Serif">Tel
Aviv, Israel</span></ix:nonNumeric></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">March
27, 2024</span></p><div>



</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"></p><div>


</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-align: center; text-indent: -56.7pt"></p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-align: center; text-indent: -56.7pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-align: center; text-indent: -56.7pt"></p><div>

</div><!-- Field: Page; Sequence: 129 --><div>
    </div><div style="border-bottom: Black 1.5pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-align: center; text-indent: -56.7pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><div><a id="f_002"></a></div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-align: center; text-indent: -56.7pt"><span style="font-family: Times New Roman, Times, Serif">ARBE
ROBOTICS LTD. AND SUBSIDIARIES</span></p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-align: center; text-indent: -56.7pt"><span style="font-family: Times New Roman, Times, Serif">CONSOLIDATED
BALANCE SHEETS</span></p><div>

</div><!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="border-top: Black 1.5pt solid; font-size: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></div></div><!-- Field: /Rule-Page --><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-align: center; text-indent: -56.7pt"></p><div>



</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b>U.S.
dollars in thousands (except share and per share data)</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">December
    31,</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2023</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2022</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-left: 0.125in; text-align: center"><span style="font-family: Times New Roman, Times, Serif">ASSETS</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">CURRENT
    ASSETS:</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.25in; width: 76%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Cash
    and cash equivalents</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="3" unitRef="usd" id="ixv-26147">28,587</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c6" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="3" unitRef="usd" id="ixv-26148">54,171</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -0.125in; padding-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Restricted
    cash</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RestrictedCashCurrent" scale="3" unitRef="usd" id="ixv-26149">163</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c6" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RestrictedCashCurrent" scale="3" unitRef="usd" id="ixv-26150">144</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Short
    term bank deposits</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ShortTermInvestments" scale="3" unitRef="usd" id="ixv-26151">15,402</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c6" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ShortTermInvestments" scale="3" unitRef="usd" id="ixv-26152">400</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -0.125in; padding-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Trade
    receivable</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AccountsReceivableNetCurrent" scale="3" unitRef="usd" id="ixv-26153">1,258</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c6" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AccountsReceivableNetCurrent" scale="3" unitRef="usd" id="ixv-26154">2,202</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.25in; text-align: justify; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Prepaid
    expenses and other receivables</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" scale="3" unitRef="usd" id="ixv-26155">2,026</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c6" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" scale="3" unitRef="usd" id="ixv-26156">1,839</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: justify; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Total
    current assets</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AssetsCurrent" scale="3" unitRef="usd" id="ixv-26157">47,436</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c6" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AssetsCurrent" scale="3" unitRef="usd" id="ixv-26158">58,756</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">NON-CURRENT
    ASSETS:</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Operating
    lease right-of-use assets</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="3" unitRef="usd" id="ixv-26159">1,740</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c6" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="3" unitRef="usd" id="ixv-26160">465</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -0.125in; padding-left: 0.25in; text-align: justify; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Property
    and equipment, net</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PropertyPlantAndEquipmentNet" scale="3" unitRef="usd" id="ixv-26161">1,309</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c6" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PropertyPlantAndEquipmentNet" scale="3" unitRef="usd" id="ixv-26162">1,609</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Total
    non-current assets</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AssetsNoncurrent" scale="3" unitRef="usd" id="ixv-26163">3,049</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c6" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AssetsNoncurrent" scale="3" unitRef="usd" id="ixv-26164">2,074</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold; text-align: justify; padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">Total
    assets</span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:Assets" scale="3" unitRef="usd" id="ixv-26165">50,485</ix:nonFraction></span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c6" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:Assets" scale="3" unitRef="usd" id="ixv-26166">60,830</ix:nonFraction></span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table><div>





</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 130 --><div>
    </div><div style="border-bottom: Black 1.5pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><div><a id="f_002-0"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><b>ARBE
ROBOTICS LTD. AND SUBSIDIARIES</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><b>CONSOLIDATED
BALANCE SHEETS</b></span></p><div>

</div><!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="border-top: Black 1.5pt solid; font-size: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></div></div><!-- Field: /Rule-Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b>U.S.
dollars in thousands (except share and per share data)</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">December
    31,</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2023</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2022</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: center"><span style="font-family: Times New Roman, Times, Serif">LIABILITIES
    AND SHAREHOLDERS&#8217; EQUITY</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">CURRENT
    LIABILITIES:</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.25in; width: 76%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Trade
    payables</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AccountsPayableTradeCurrent" scale="3" unitRef="usd" id="ixv-26167">1,149</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c6" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AccountsPayableTradeCurrent" scale="3" unitRef="usd" id="ixv-26168">1,244</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -0.125in; padding-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Operating
    lease liabilities</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OperatingLeaseLiabilityCurrent" scale="3" unitRef="usd" id="ixv-26169">436</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c6" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OperatingLeaseLiabilityCurrent" scale="3" unitRef="usd" id="ixv-26170">364</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Employees
    and payroll accruals</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" scale="3" unitRef="usd" id="ixv-26171">2,916</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c6" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" scale="3" unitRef="usd" id="ixv-26172">2,861</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -0.125in; padding-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Deferred
    revenue</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-0; font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c6" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DeferredRevenueCurrent" scale="3" unitRef="usd" id="ixv-26173">351</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.25in; text-align: justify; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Accrued
    expenses and other payables</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AccountsPayableAndOtherAccruedLiabilitiesCurrent" scale="3" unitRef="usd" id="ixv-26174">1,710</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c6" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AccountsPayableAndOtherAccruedLiabilitiesCurrent" scale="3" unitRef="usd" id="ixv-26175">5,609</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: justify; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Total
    current liabilities</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:LiabilitiesCurrent" scale="3" unitRef="usd" id="ixv-26176">6,211</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c6" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:LiabilitiesCurrent" scale="3" unitRef="usd" id="ixv-26177">10,429</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">LONG-TERM
    LIABILITIES:</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -0.125in; padding-left: 0.25in; font-style: italic; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-style: normal; font-weight: normal">Operating
    lease liabilities</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OperatingLeaseLiabilityNoncurrent" scale="3" unitRef="usd" id="ixv-26178">1,306</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c6" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OperatingLeaseLiabilityNoncurrent" scale="3" unitRef="usd" id="ixv-26179">17</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.25in; text-align: justify; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Warrant
    liabilities</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:WarrantsAndRightsOutstanding" scale="3" unitRef="usd" id="ixv-26180">875</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c6" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:WarrantsAndRightsOutstanding" scale="3" unitRef="usd" id="ixv-26181">1,631</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.25in; text-indent: -0.125in; text-align: justify; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Total
    long-term liabilities</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:LiabilitiesNoncurrent" scale="3" unitRef="usd" id="ixv-26182">2,181</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c6" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:LiabilitiesNoncurrent" scale="3" unitRef="usd" id="ixv-26183">1,648</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">SHAREHOLDERS&#8217;
    EQUITY:</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Ordinary Shares, NIS&#160;<ix:nonFraction contextRef="c5" decimals="6" format="ixt:num-dot-decimal" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" unitRef="ilsPershares" id="ixv-26184"><ix:nonFraction contextRef="c6" decimals="6" format="ixt:num-dot-decimal" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" unitRef="ilsPershares" id="ixv-26185">0.000216</ix:nonFraction></ix:nonFraction> par value; <ix:nonFraction contextRef="c5" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:CommonStockSharesAuthorized" scale="0" unitRef="shares" id="ixv-26186"><ix:nonFraction contextRef="c6" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:CommonStockSharesAuthorized" scale="0" unitRef="shares" id="ixv-26187">130,000,000</ix:nonFraction></ix:nonFraction> authorized shares as of December 31, 2023 and 2022; <ix:nonFraction contextRef="c5" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:CommonStockSharesOutstanding" scale="0" unitRef="shares" id="ixv-26188">77,925,095</ix:nonFraction> and <ix:nonFraction contextRef="c6" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:CommonStockSharesOutstanding" scale="0" unitRef="shares" id="ixv-26189">64,160,890</ix:nonFraction> outstanding shares at December 31, 2023 and 2022, respectively</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-1; font-family: Times New Roman, Times, Serif; font-size: 10pt">*)</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-2; font-family: Times New Roman, Times, Serif; font-size: 10pt">*)</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Additional
    paid-in capital</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AdditionalPaidInCapitalCommonStock" scale="3" unitRef="usd" id="ixv-26190">245,733</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c6" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AdditionalPaidInCapitalCommonStock" scale="3" unitRef="usd" id="ixv-26191">208,893</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Accumulated
    deficit</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RetainedEarningsAccumulatedDeficit" scale="3" sign="-" unitRef="usd" id="ixv-26192">203,640</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction contextRef="c6" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RetainedEarningsAccumulatedDeficit" scale="3" sign="-" unitRef="usd" id="ixv-26193">160,140</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -0.125in; padding-left: 0.25in; text-align: justify; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Total
    shareholders&#8217; equity</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" unitRef="usd" id="ixv-26194">42,093</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c6" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" unitRef="usd" id="ixv-26195">48,753</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.25in; text-indent: -0.125in; font-weight: bold; text-align: justify; padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">Total
    liabilities and shareholders&#8217; equity</span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:LiabilitiesAndStockholdersEquity" scale="3" unitRef="usd" id="ixv-26196">50,485</ix:nonFraction></span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c6" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:LiabilitiesAndStockholdersEquity" scale="3" unitRef="usd" id="ixv-26197">60,830</ix:nonFraction></span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">*)</span></td><td style="text-align: justify"><ix:footnote id="ix_0_footnote" xml:lang="en-US"><span style="font-family: Times New Roman, Times, Serif">Represents less than $1.</span></ix:footnote></td>
</tr></table><div>



</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 28.35pt; text-align: justify; text-indent: -28.35pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif">The
accompanying notes are an integral part of these consolidated financial statements.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"></p><div>

</div><!-- Field: Page; Sequence: 131 --><div>
    </div><div style="border-bottom: Black 1.5pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></p><div>

</div><div style="border-bottom: Black 1.5pt solid; padding: 0in 0in 1pt"><a id="F_003"></a><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><b>ARBE
ROBOTICS LTD. AND SUBSIDIARIES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><b>CONSOLIDATED
STATEMENTS OF OPERATIONS</b></span></p>

</div><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b>U.S.
dollars in thousands (except share and per share data)</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="10" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Year
    ended December 31,</span></td><td style="padding-bottom: 2.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2023</span></td><td style="padding-bottom: 2.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2022</span></td><td style="padding-bottom: 2.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2021</span></td><td style="padding-bottom: 2.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; width: 64%; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Revenues</span></td><td style="width: 1%; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:Revenues" scale="3" unitRef="usd" id="ixv-26198">1,470</ix:nonFraction></span></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 1%; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c7" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:Revenues" scale="3" unitRef="usd" id="ixv-26199">3,517</ix:nonFraction></span></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 1%; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c8" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:Revenues" scale="3" unitRef="usd" id="ixv-26200">2,249</ix:nonFraction></span></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Costs
    of revenues</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CostOfRevenue" scale="3" unitRef="usd" id="ixv-26201">1,508</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c7" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CostOfRevenue" scale="3" unitRef="usd" id="ixv-26202">1,283</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c8" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CostOfRevenue" scale="3" unitRef="usd" id="ixv-26203">1,440</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Gross
    profit (loss)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:GrossProfit" scale="3" sign="-" unitRef="usd" id="ixv-26204">38</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c7" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:GrossProfit" scale="3" unitRef="usd" id="ixv-26205">2,234</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c8" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:GrossProfit" scale="3" unitRef="usd" id="ixv-26206">809</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Operating
    expenses:</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Research
    and development, net</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ResearchAndDevelopmentExpense" scale="3" unitRef="usd" id="ixv-26207">34,082</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c7" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ResearchAndDevelopmentExpense" scale="3" unitRef="usd" id="ixv-26208">36,731</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c8" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ResearchAndDevelopmentExpense" scale="3" unitRef="usd" id="ixv-26209">28,564</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Sales
    and marketing</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:SellingAndMarketingExpense" scale="3" unitRef="usd" id="ixv-26210">5,194</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c7" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:SellingAndMarketingExpense" scale="3" unitRef="usd" id="ixv-26211">4,621</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c8" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:SellingAndMarketingExpense" scale="3" unitRef="usd" id="ixv-26212">1,814</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">General
    and administrative</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:GeneralAndAdministrativeExpense" scale="3" unitRef="usd" id="ixv-26213">7,571</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c7" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:GeneralAndAdministrativeExpense" scale="3" unitRef="usd" id="ixv-26214">8,613</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c8" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:GeneralAndAdministrativeExpense" scale="3" unitRef="usd" id="ixv-26215">3,709</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Total
    operating expenses</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OperatingExpenses" scale="3" unitRef="usd" id="ixv-26216">46,847</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c7" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OperatingExpenses" scale="3" unitRef="usd" id="ixv-26217">49,965</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c8" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OperatingExpenses" scale="3" unitRef="usd" id="ixv-26218">34,087</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Operating
    loss</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OperatingIncomeLoss" scale="3" sign="-" unitRef="usd" id="ixv-26219">46,885</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction contextRef="c7" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OperatingIncomeLoss" scale="3" sign="-" unitRef="usd" id="ixv-26220">47,731</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction contextRef="c8" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OperatingIncomeLoss" scale="3" sign="-" unitRef="usd" id="ixv-26221">33,278</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Financial
    expense (income), net</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NonoperatingIncomeExpense" scale="3" unitRef="usd" id="ixv-26222">3,385</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction contextRef="c7" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NonoperatingIncomeExpense" scale="3" unitRef="usd" id="ixv-26223">7,237</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c8" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NonoperatingIncomeExpense" scale="3" sign="-" unitRef="usd" id="ixv-26224">24,814</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">Net
    loss</span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="3" sign="-" unitRef="usd" id="ixv-26225">43,500</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction contextRef="c7" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="3" sign="-" unitRef="usd" id="ixv-26226">40,494</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction contextRef="c8" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="3" sign="-" unitRef="usd" id="ixv-26227">58,092</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">Basic
    loss per share attributable to Ordinary Shareholders</span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction contextRef="c0" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:EarningsPerShareBasic" scale="0" sign="-" unitRef="usdPershares" id="ixv-26228">0.60</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction contextRef="c7" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:EarningsPerShareBasic" scale="0" sign="-" unitRef="usdPershares" id="ixv-26229">0.64</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction contextRef="c8" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:EarningsPerShareBasic" scale="0" sign="-" unitRef="usdPershares" id="ixv-26230">2.64</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">Weighted-average
    number of shares used in computing basic loss per share attributable to Ordinary Shareholders</span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="0" unitRef="shares" id="ixv-26231">72,021,520</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c7" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="0" unitRef="shares" id="ixv-26232">68,489,983</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c8" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="0" unitRef="shares" id="ixv-26233">22,027,292</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">Diluted
    loss per share attributable to Ordinary Shareholders</span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction contextRef="c0" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:EarningsPerShareDiluted" scale="0" sign="-" unitRef="usdPershares" id="ixv-26234">0.71</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction contextRef="c7" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:EarningsPerShareDiluted" scale="0" sign="-" unitRef="usdPershares" id="ixv-26235">0.80</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction contextRef="c8" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:EarningsPerShareDiluted" scale="0" sign="-" unitRef="usdPershares" id="ixv-26236">2.64</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; padding-bottom: 4pt">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt; text-align: right">&#160;</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt; text-align: right">&#160;</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt; text-align: right">&#160;</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">Weighted-average
    number of shares used in computing diluted loss per share attributable to Ordinary Shareholders</span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="0" unitRef="shares" id="ixv-26237">62,390,302</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c7" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="0" unitRef="shares" id="ixv-26238">60,960,641</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c8" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="0" unitRef="shares" id="ixv-26239">22,027,292</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">The
accompanying notes are an integral part of these consolidated financial statements.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 132 --><div>
    </div><div style="border-bottom: Black 1.5pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;<b>&#160;</b></span></p><div>

</div><div style="border-bottom: Black 1.5pt solid; padding: 0in 0in 1pt"><a id="F_004"></a><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-align: center; text-indent: -56.7pt"><span style="font-family: Times New Roman, Times, Serif">ARBE
ROBOTICS LTD. AND SUBSIDIARIES</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-align: center; text-indent: -56.7pt"><span style="font-family: Times New Roman, Times, Serif">CONSOLIDATED
STATEMENTS OF CHANGES IN REDEEMABLE CONVERTIBLE PREFERRED SHARES AND SHAREHOLDERS&#8217; EQUITY (DEFICIENCY)</span></p>

</div><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b>U.S.
dollars in thousands (except share data)</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 28.35pt; text-align: justify; text-indent: -28.35pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 28.35pt; text-align: justify; text-indent: -28.35pt"></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt; padding-left: 0.125in; text-indent: -0.125in; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td colspan="50" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">Redeemable
    convertible preferred Shares</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td colspan="14" style="padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="padding-bottom: 1.5pt; text-align: right; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-left: 0.125in; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">Seed</span></td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">Series
    A</span></td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">Series
    A-1</span></td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">Series
    B</span></td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">Series
    B-1</span></td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">Series
    B-2</span></td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">Total</span></td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="border-left: Black 1.5pt solid; text-align: center; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">Ordinary
    Shares</span></td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">Additional<br/>
    paid-in</span></td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">Accumulated</span></td><td style="text-align: center; padding-bottom: 2.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="padding-bottom: 1.5pt; vertical-align: bottom; font-weight: bold; text-align: center"><p style="text-align: center; margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">Total</span></p>
                                                                                <p style="text-align: center; margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt"><b>Shareholders&#8217;<br/>
                                            equity<br/></b></span></p></td>
    <td style="padding-bottom: 2.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-left: 0.125in; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt"><b>&#160;</b></span></td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt"><b>&#160;</b></span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt"><b>Number</b></span></td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt"><b>&#160;</b></span></td>
    <td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt"><b>&#160;</b></span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt"><b>Amount</b></span></td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt"><b>&#160;</b></span></td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt"><b>&#160;</b></span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt"><b>Number</b></span></td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt"><b>&#160;</b></span></td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt"><b>&#160;</b></span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt"><b>Amount</b></span></td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt"><b>&#160;</b></span></td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt"><b>&#160;</b></span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt"><b>Number</b></span></td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt"><b>&#160;</b></span></td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt"><b>&#160;</b></span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt"><b>Amount</b></span></td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt"><b>&#160;</b></span></td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt"><b>&#160;</b></span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt"><b>Number</b></span></td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt"><b>&#160;</b></span></td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt"><b>&#160;</b></span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt"><b>Amount</b></span></td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt"><b>&#160;</b></span></td>
    <td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt"><b>&#160;</b></span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt"><b>Number</b></span></td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt"><b>&#160;</b></span></td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt"><b>&#160;</b></span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt"><b>Amount</b></span></td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt"><b>&#160;</b></span></td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt"><b>&#160;</b></span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt"><b>Number</b></span></td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt"><b>&#160;</b></span></td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt"><b>&#160;</b></span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt"><b>Amount</b></span></td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt"><b>&#160;</b></span></td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt"><b>&#160;</b></span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt"><b>Amount</b></span></td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt"><b>&#160;</b></span></td><td style="border-left: Black 1.5pt solid; text-align: center; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt"><b>&#160;</b></span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt"><b>Number</b></span></td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt"><b>&#160;</b></span></td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt"><b>&#160;</b></span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt"><b>Amount</b></span></td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt"><b>&#160;</b></span></td><td style="text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt"><b>&#160;</b></span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt"><b>capital</b></span></td><td style="text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt"><b>&#160;</b></span></td><td style="text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt"><b>&#160;</b></span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt"><b>deficit</b></span></td><td style="text-align: center; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt"><b>&#160;</b></span></td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt"><b>&#160;</b></span></td>
    <td style="border-bottom: Black 1.5pt solid; vertical-align: bottom; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">(deficiency)</span></td>
    <td style="padding-bottom: 2.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt"><b>&#160;</b></span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="border-left: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="text-align: right; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; width: 21.6%"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">Balance
    at December 31, 2020</span></td><td style="width: 0.2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="width: 0.2%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="width: 4%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt"><ix:nonFraction contextRef="c9" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:SharesOutstanding" scale="0" unitRef="shares" id="ixv-26240">5,540,254</ix:nonFraction></span></td><td style="width: 0.2%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="width: 0.2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="width: 0.2%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="width: 4%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt"><ix:nonFraction contextRef="c9" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" unitRef="usd" id="ixv-26241">650</ix:nonFraction></span></td><td style="width: 0.2%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="width: 0.2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="width: 0.2%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="width: 4%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt"><ix:nonFraction contextRef="c10" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:SharesOutstanding" scale="0" unitRef="shares" id="ixv-26242">7,780,937</ix:nonFraction></span></td><td style="width: 0.2%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="width: 0.2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="width: 0.2%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="width: 4%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt"><ix:nonFraction contextRef="c10" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" unitRef="usd" id="ixv-26243">9,394</ix:nonFraction></span></td><td style="width: 0.2%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="width: 0.2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="width: 0.2%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="width: 4%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt"><ix:nonFraction contextRef="c11" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:SharesOutstanding" scale="0" unitRef="shares" id="ixv-26244">5,460,043</ix:nonFraction></span></td><td style="width: 0.2%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="width: 0.2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="width: 0.2%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="width: 4%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt"><ix:nonFraction contextRef="c11" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" unitRef="usd" id="ixv-26245">2,500</ix:nonFraction></span></td><td style="width: 0.2%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="width: 0.2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="width: 0.2%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="width: 4%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt"><ix:nonFraction contextRef="c12" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:SharesOutstanding" scale="0" unitRef="shares" id="ixv-26246">10,863,143</ix:nonFraction></span></td><td style="width: 0.2%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="width: 0.2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="width: 0.2%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="width: 4%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt"><ix:nonFraction contextRef="c12" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" unitRef="usd" id="ixv-26247">32,159</ix:nonFraction></span></td><td style="width: 0.2%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="width: 0.2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="width: 0.2%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="width: 4%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt"><ix:nonFraction contextRef="c13" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:SharesOutstanding" scale="0" unitRef="shares" id="ixv-26248">4,144,887</ix:nonFraction></span></td><td style="width: 0.2%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="width: 0.2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="width: 0.2%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="width: 4%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt"><ix:nonFraction contextRef="c13" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" unitRef="usd" id="ixv-26249">10,447</ix:nonFraction></span></td><td style="width: 0.2%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="width: 0.2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="width: 0.2%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="width: 4%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt"><ix:nonFraction contextRef="c14" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:SharesOutstanding" scale="0" unitRef="shares" id="ixv-26250">71,977</ix:nonFraction></span></td><td style="width: 0.2%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="width: 0.2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="width: 0.2%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="width: 4%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt"><ix:nonFraction contextRef="c14" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" unitRef="usd" id="ixv-26251">290</ix:nonFraction></span></td><td style="width: 0.2%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="width: 0.2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="width: 0.2%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="width: 4%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt"><ix:nonFraction contextRef="c15" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" unitRef="usd" id="ixv-26252">55,440</ix:nonFraction></span></td><td style="width: 0.2%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="border-left: Black 1.5pt solid; width: 0.2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="width: 0.2%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="width: 4%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt"><ix:nonFraction contextRef="c16" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:SharesOutstanding" scale="0" unitRef="shares" id="ixv-26253">9,272,428</ix:nonFraction></span></td><td style="width: 0.2%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="width: 0.2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="width: 0.2%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="width: 4%; text-align: right"><span style="-sec-ix-hidden: hidden-fact-3; font-family: Times New Roman, Times, Serif; font-size: 7pt">*)</span></td><td style="width: 0.2%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="width: 0.2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="width: 0.2%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="width: 4%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt"><ix:nonFraction contextRef="c17" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" unitRef="usd" id="ixv-26254">1,397</ix:nonFraction></span></td><td style="width: 0.2%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="width: 0.2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="width: 0.2%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="width: 4%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">(<ix:nonFraction contextRef="c18" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" sign="-" unitRef="usd" id="ixv-26255">61,554</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; width: 0.2%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">)</span></td><td style="width: 0.2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">(<ix:nonFraction contextRef="c19" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" sign="-" unitRef="usd" id="ixv-26256">60,157</ix:nonFraction></span></td>
    <td style="padding-bottom: 1.5pt"><span style="font-size: 7pt">)<span style="font-family: Times New Roman, Times, Serif">&#160;</span></span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="border-left: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="text-align: right; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">Exercise
    of warrants</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-4; font-family: Times New Roman, Times, Serif; font-size: 7pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-5; font-family: Times New Roman, Times, Serif; font-size: 7pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-6; font-family: Times New Roman, Times, Serif; font-size: 7pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-7; font-family: Times New Roman, Times, Serif; font-size: 7pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-8; font-family: Times New Roman, Times, Serif; font-size: 7pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt"><ix:nonFraction contextRef="c25" decimals="INF" format="ixt:num-dot-decimal" name="arbe:StockIssuedDuringPeriodSharesExerciseOfWarrants" scale="0" unitRef="shares" id="ixv-26257">1,194,886</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt"><ix:nonFraction contextRef="c25" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants" scale="3" unitRef="usd" id="ixv-26258">8,027</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt"><ix:nonFraction contextRef="c26" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants" scale="3" unitRef="usd" id="ixv-26259">8,027</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="border-left: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-9; font-family: Times New Roman, Times, Serif; font-size: 7pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-10; font-family: Times New Roman, Times, Serif; font-size: 7pt">-</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="background-color: rgb(204,238,255); text-align: right; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">Conversion
    of preferred shares into ordinary shares</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">(<ix:nonFraction contextRef="c20" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" scale="0" sign="-" unitRef="shares" id="ixv-26260">5,540,254</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">)</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">(<ix:nonFraction contextRef="c20" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" scale="3" sign="-" unitRef="usd" id="ixv-26261">650</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">(<ix:nonFraction contextRef="c21" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" scale="0" sign="-" unitRef="shares" id="ixv-26262">7,780,937</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">(<ix:nonFraction contextRef="c21" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" scale="3" sign="-" unitRef="usd" id="ixv-26263">9,394</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">(<ix:nonFraction contextRef="c22" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" scale="0" sign="-" unitRef="shares" id="ixv-26264">5,460,043</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">(<ix:nonFraction contextRef="c22" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" scale="3" sign="-" unitRef="usd" id="ixv-26265">2,500</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">(<ix:nonFraction contextRef="c23" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" scale="0" sign="-" unitRef="shares" id="ixv-26266">10,863,143</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">(<ix:nonFraction contextRef="c23" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" scale="3" sign="-" unitRef="usd" id="ixv-26267">32,159</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">)</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">(<ix:nonFraction contextRef="c24" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" scale="0" sign="-" unitRef="shares" id="ixv-26268">4,144,887</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">(<ix:nonFraction contextRef="c24" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" scale="3" sign="-" unitRef="usd" id="ixv-26269">10,447</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">(<ix:nonFraction contextRef="c25" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" scale="0" sign="-" unitRef="shares" id="ixv-26270">1,266,863</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">(<ix:nonFraction contextRef="c25" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" scale="3" sign="-" unitRef="usd" id="ixv-26271">8,317</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">(<ix:nonFraction contextRef="c26" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" scale="3" sign="-" unitRef="usd" id="ixv-26272">63,467</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">)</span></td><td style="border-left: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt"><ix:nonFraction contextRef="c27" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" scale="0" unitRef="shares" id="ixv-26273">35,056,127</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-11; font-family: Times New Roman, Times, Serif; font-size: 7pt">*)</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt"><ix:nonFraction contextRef="c29" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" scale="3" unitRef="usd" id="ixv-26274">63,467</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-12; font-family: Times New Roman, Times, Serif; font-size: 7pt">-</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt"><ix:nonFraction contextRef="c8" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" scale="3" unitRef="usd" id="ixv-26275">63,467</ix:nonFraction></span></td>
    <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">Conversion
    of convertible loan to ordinary shares</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-13; font-family: Times New Roman, Times, Serif; font-size: 7pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-14; font-family: Times New Roman, Times, Serif; font-size: 7pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-15; font-family: Times New Roman, Times, Serif; font-size: 7pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-16; font-family: Times New Roman, Times, Serif; font-size: 7pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-17; font-family: Times New Roman, Times, Serif; font-size: 7pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-18; font-family: Times New Roman, Times, Serif; font-size: 7pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-19; font-family: Times New Roman, Times, Serif; font-size: 7pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="border-left: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt"><ix:nonFraction contextRef="c27" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodSharesConversionOfUnits" scale="0" unitRef="shares" id="ixv-26276">3,205,020</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-20; font-family: Times New Roman, Times, Serif; font-size: 7pt">*)</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt"><ix:nonFraction contextRef="c29" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodValueConversionOfUnits" scale="3" unitRef="usd" id="ixv-26277">30,844</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-21; font-family: Times New Roman, Times, Serif; font-size: 7pt">-</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt"><ix:nonFraction contextRef="c8" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodValueConversionOfUnits" scale="3" unitRef="usd" id="ixv-26278">30,844</ix:nonFraction></span></td>
    <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">Issuance
    of ordinary shares, net of issuance costs</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-22; font-family: Times New Roman, Times, Serif; font-size: 7pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-23; font-family: Times New Roman, Times, Serif; font-size: 7pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-24; font-family: Times New Roman, Times, Serif; font-size: 7pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-25; font-family: Times New Roman, Times, Serif; font-size: 7pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-26; font-family: Times New Roman, Times, Serif; font-size: 7pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-27; font-family: Times New Roman, Times, Serif; font-size: 7pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-28; font-family: Times New Roman, Times, Serif; font-size: 7pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="border-left: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt"><ix:nonFraction contextRef="c27" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" scale="0" unitRef="shares" id="ixv-26279">13,866,887</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-29; font-family: Times New Roman, Times, Serif; font-size: 7pt">*)</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt"><ix:nonFraction contextRef="c29" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="3" unitRef="usd" id="ixv-26280">91,990</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-30; font-family: Times New Roman, Times, Serif; font-size: 7pt">-</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt"><ix:nonFraction contextRef="c8" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="3" unitRef="usd" id="ixv-26281">91,990</ix:nonFraction></span></td>
    <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">Exercise
    of warrants</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-31; font-family: Times New Roman, Times, Serif; font-size: 7pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-32; font-family: Times New Roman, Times, Serif; font-size: 7pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-33; font-family: Times New Roman, Times, Serif; font-size: 7pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="border-left: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt"><ix:nonFraction contextRef="c27" decimals="INF" format="ixt:num-dot-decimal" name="arbe:StockIssuedDuringPeriodSharesExerciseOfWarrants" scale="0" unitRef="shares" id="ixv-26282">872,614</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-34; font-family: Times New Roman, Times, Serif; font-size: 7pt">*)</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt"><ix:nonFraction contextRef="c29" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants" scale="3" unitRef="usd" id="ixv-26283">9,222</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-35; font-family: Times New Roman, Times, Serif; font-size: 7pt">-</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt"><ix:nonFraction contextRef="c8" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants" scale="3" unitRef="usd" id="ixv-26284">9,222</ix:nonFraction></span></td>
    <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">Stock-based
    compensation</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-36; font-family: Times New Roman, Times, Serif; font-size: 7pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-37; font-family: Times New Roman, Times, Serif; font-size: 7pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-38; font-family: Times New Roman, Times, Serif; font-size: 7pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-39; font-family: Times New Roman, Times, Serif; font-size: 7pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-40; font-family: Times New Roman, Times, Serif; font-size: 7pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-41; font-family: Times New Roman, Times, Serif; font-size: 7pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-42; font-family: Times New Roman, Times, Serif; font-size: 7pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="border-left: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-43; font-family: Times New Roman, Times, Serif; font-size: 7pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt"><ix:nonFraction contextRef="c29" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" scale="3" unitRef="usd" id="ixv-26285">2,211</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-44; font-family: Times New Roman, Times, Serif; font-size: 7pt">-</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt"><ix:nonFraction contextRef="c8" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" scale="3" unitRef="usd" id="ixv-26286">2,211</ix:nonFraction></span></td>
    <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">Stock-based
    compensation to service providers</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-45; font-family: Times New Roman, Times, Serif; font-size: 7pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-46; font-family: Times New Roman, Times, Serif; font-size: 7pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-47; font-family: Times New Roman, Times, Serif; font-size: 7pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-48; font-family: Times New Roman, Times, Serif; font-size: 7pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-49; font-family: Times New Roman, Times, Serif; font-size: 7pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-50; font-family: Times New Roman, Times, Serif; font-size: 7pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-51; font-family: Times New Roman, Times, Serif; font-size: 7pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="border-left: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-52; font-family: Times New Roman, Times, Serif; font-size: 7pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt"><ix:nonFraction contextRef="c29" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodValueIssuedForServices" scale="3" unitRef="usd" id="ixv-26287">115</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-53; font-family: Times New Roman, Times, Serif; font-size: 7pt">-</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt"><ix:nonFraction contextRef="c8" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodValueIssuedForServices" scale="3" unitRef="usd" id="ixv-26288">115</ix:nonFraction></span></td>
    <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">Exercise
    of options</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-54; font-family: Times New Roman, Times, Serif; font-size: 7pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-55; font-family: Times New Roman, Times, Serif; font-size: 7pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-56; font-family: Times New Roman, Times, Serif; font-size: 7pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-57; font-family: Times New Roman, Times, Serif; font-size: 7pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-58; font-family: Times New Roman, Times, Serif; font-size: 7pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-59; font-family: Times New Roman, Times, Serif; font-size: 7pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="border-left: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt"><ix:nonFraction contextRef="c27" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="0" unitRef="shares" id="ixv-26289">743,780</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-60; font-family: Times New Roman, Times, Serif; font-size: 7pt">*)</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt"><ix:nonFraction contextRef="c29" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" unitRef="usd" id="ixv-26290">223</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-61; font-family: Times New Roman, Times, Serif; font-size: 7pt">-</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt"><ix:nonFraction contextRef="c8" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" unitRef="usd" id="ixv-26291">223</ix:nonFraction></span></td>
    <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">Net
    loss</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-62; font-family: Times New Roman, Times, Serif; font-size: 7pt">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-63; font-family: Times New Roman, Times, Serif; font-size: 7pt">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-64; font-family: Times New Roman, Times, Serif; font-size: 7pt">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-65; font-family: Times New Roman, Times, Serif; font-size: 7pt">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-66; font-family: Times New Roman, Times, Serif; font-size: 7pt">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-67; font-family: Times New Roman, Times, Serif; font-size: 7pt">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-68; font-family: Times New Roman, Times, Serif; font-size: 7pt">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="border-left: Black 1.5pt solid; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-69; font-family: Times New Roman, Times, Serif; font-size: 7pt">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-70; font-family: Times New Roman, Times, Serif; font-size: 7pt">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">(<ix:nonFraction contextRef="c28" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="3" sign="-" unitRef="usd" id="ixv-26292">58,092</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">(<ix:nonFraction contextRef="c8" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="3" sign="-" unitRef="usd" id="ixv-26293">58,092</ix:nonFraction></span></td>
    <td style="padding-bottom: 1.5pt"><span style="font-size: 7pt">)<span style="font-family: Times New Roman, Times, Serif">&#160;</span></span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="border-left: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="text-align: right; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">Balance
    at December 31, 2021</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-71; font-family: Times New Roman, Times, Serif; font-size: 7pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-72; font-family: Times New Roman, Times, Serif; font-size: 7pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-73; font-family: Times New Roman, Times, Serif; font-size: 7pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-74; font-family: Times New Roman, Times, Serif; font-size: 7pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-75; font-family: Times New Roman, Times, Serif; font-size: 7pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-76; font-family: Times New Roman, Times, Serif; font-size: 7pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-77; font-family: Times New Roman, Times, Serif; font-size: 7pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-78; font-family: Times New Roman, Times, Serif; font-size: 7pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-79; font-family: Times New Roman, Times, Serif; font-size: 7pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-80; font-family: Times New Roman, Times, Serif; font-size: 7pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-81; font-family: Times New Roman, Times, Serif; font-size: 7pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-82; font-family: Times New Roman, Times, Serif; font-size: 7pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-83; font-family: Times New Roman, Times, Serif; font-size: 7pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="border-left: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt"><ix:nonFraction contextRef="c37" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:SharesOutstanding" scale="0" unitRef="shares" id="ixv-26294">63,016,856</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-84; font-family: Times New Roman, Times, Serif; font-size: 7pt">*)</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt"><ix:nonFraction contextRef="c38" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" unitRef="usd" id="ixv-26295">199,469</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">(<ix:nonFraction contextRef="c39" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" sign="-" unitRef="usd" id="ixv-26296">119,646</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt"><ix:nonFraction contextRef="c40" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" unitRef="usd" id="ixv-26297">79,823</ix:nonFraction></span></td>
    <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="border-left: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="text-align: right; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">Stock-based
    compensation</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-85; font-family: Times New Roman, Times, Serif; font-size: 7pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-86; font-family: Times New Roman, Times, Serif; font-size: 7pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-87; font-family: Times New Roman, Times, Serif; font-size: 7pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-88; font-family: Times New Roman, Times, Serif; font-size: 7pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-89; font-family: Times New Roman, Times, Serif; font-size: 7pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-90; font-family: Times New Roman, Times, Serif; font-size: 7pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-91; font-family: Times New Roman, Times, Serif; font-size: 7pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="border-left: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="font-weight: bold; text-align: right"><span style="-sec-ix-hidden: hidden-fact-92; font-family: Times New Roman, Times, Serif; font-size: 7pt">-</span></td><td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt"><ix:nonFraction contextRef="c49" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" scale="3" unitRef="usd" id="ixv-26298">8,793</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="font-weight: bold; text-align: right"><span style="-sec-ix-hidden: hidden-fact-93; font-family: Times New Roman, Times, Serif; font-size: 7pt">-</span></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt"><ix:nonFraction contextRef="c7" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" scale="3" unitRef="usd" id="ixv-26299">8,793</ix:nonFraction></span></td>
    <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">Stock-based
    compensation to service providers</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-94"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></div></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-95"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></div></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-96"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></div></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-97"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></div></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-98"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></div></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-99"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></div></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-100; font-family: Times New Roman, Times, Serif; font-size: 7pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="border-left: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-101; font-family: Times New Roman, Times, Serif; font-size: 7pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt"><ix:nonFraction contextRef="c49" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodValueIssuedForServices" scale="3" unitRef="usd" id="ixv-26300">354</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="font-weight: bold; text-align: right"><span style="-sec-ix-hidden: hidden-fact-102; font-family: Times New Roman, Times, Serif; font-size: 7pt">-</span></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt"><ix:nonFraction contextRef="c7" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodValueIssuedForServices" scale="3" unitRef="usd" id="ixv-26301">354</ix:nonFraction></span></td>
    <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">Exercise
    of options and vested RSUs</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-103; font-family: Times New Roman, Times, Serif; font-size: 7pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-104; font-family: Times New Roman, Times, Serif; font-size: 7pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-105; font-family: Times New Roman, Times, Serif; font-size: 7pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-106; font-family: Times New Roman, Times, Serif; font-size: 7pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-107; font-family: Times New Roman, Times, Serif; font-size: 7pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="border-left: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt"><ix:nonFraction contextRef="c48" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="0" unitRef="shares" id="ixv-26302">1,144,034</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-108; font-family: Times New Roman, Times, Serif; font-size: 7pt">*)</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt"><ix:nonFraction contextRef="c49" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" unitRef="usd" id="ixv-26303">277</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="font-weight: bold; text-align: right"><span style="-sec-ix-hidden: hidden-fact-109; font-family: Times New Roman, Times, Serif; font-size: 7pt">-</span></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt"><ix:nonFraction contextRef="c7" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" unitRef="usd" id="ixv-26304">277</ix:nonFraction></span></td>
    <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">Net
    loss</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-110; font-family: Times New Roman, Times, Serif; font-size: 7pt">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-111; font-family: Times New Roman, Times, Serif; font-size: 7pt">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-112; font-family: Times New Roman, Times, Serif; font-size: 7pt">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-113; font-family: Times New Roman, Times, Serif; font-size: 7pt">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-114; font-family: Times New Roman, Times, Serif; font-size: 7pt">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-115; font-family: Times New Roman, Times, Serif; font-size: 7pt">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-116; font-family: Times New Roman, Times, Serif; font-size: 7pt">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="border-left: Black 1.5pt solid; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-117; font-family: Times New Roman, Times, Serif; font-size: 7pt">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-118; font-family: Times New Roman, Times, Serif; font-size: 7pt">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">(<ix:nonFraction contextRef="c50" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="3" sign="-" unitRef="usd" id="ixv-26305">40,494</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">)</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; vertical-align: bottom; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">(<ix:nonFraction contextRef="c7" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="3" sign="-" unitRef="usd" id="ixv-26306">40,494</ix:nonFraction></span></td>
    <td style="padding-bottom: 1.5pt"><span style="font-size: 7pt">)<span style="font-family: Times New Roman, Times, Serif">&#160;</span></span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="border-left: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="background-color: rgb(204,238,255); text-align: right; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">Balance
    at December 31, 2022</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-119; font-family: Times New Roman, Times, Serif; font-size: 7pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-120; font-family: Times New Roman, Times, Serif; font-size: 7pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-121; font-family: Times New Roman, Times, Serif; font-size: 7pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-122; font-family: Times New Roman, Times, Serif; font-size: 7pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-123; font-family: Times New Roman, Times, Serif; font-size: 7pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-124; font-family: Times New Roman, Times, Serif; font-size: 7pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-125; font-family: Times New Roman, Times, Serif; font-size: 7pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-126; font-family: Times New Roman, Times, Serif; font-size: 7pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-127; font-family: Times New Roman, Times, Serif; font-size: 7pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-128; font-family: Times New Roman, Times, Serif; font-size: 7pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-129; font-family: Times New Roman, Times, Serif; font-size: 7pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-130; font-family: Times New Roman, Times, Serif; font-size: 7pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-131; font-family: Times New Roman, Times, Serif; font-size: 7pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="border-left: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt"><ix:nonFraction contextRef="c58" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:SharesOutstanding" scale="0" unitRef="shares" id="ixv-26307">64,160,890</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-132; font-family: Times New Roman, Times, Serif; font-size: 7pt">*)</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt"><ix:nonFraction contextRef="c59" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" unitRef="usd" id="ixv-26308">208,893</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">(<ix:nonFraction contextRef="c60" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" sign="-" unitRef="usd" id="ixv-26309">160,140</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt"><ix:nonFraction contextRef="c6" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" unitRef="usd" id="ixv-26310">48,753</ix:nonFraction></span></td>
    <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="border-left: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="background-color: rgb(204,238,255); text-align: right; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">Issuance
    of ordinary shares, net of issuance costs</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-133"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></div></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-134"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></div></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-135"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></div></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-136"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></div></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-137"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></div></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="border-left: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt"><ix:nonFraction contextRef="c66" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" scale="0" unitRef="shares" id="ixv-26311">11,794,873</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-138"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></div></td><td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt"><ix:nonFraction contextRef="c67" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="3" unitRef="usd" id="ixv-26312">22,496</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-139; font-family: Times New Roman, Times, Serif; font-size: 7pt">-</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="3" unitRef="usd" id="ixv-26313">22,496</ix:nonFraction></span></td>
    <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#1500;Stock-based
    compensation</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-140; font-family: Times New Roman, Times, Serif; font-size: 7pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-141; font-family: Times New Roman, Times, Serif; font-size: 7pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-142; font-family: Times New Roman, Times, Serif; font-size: 7pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-143; font-family: Times New Roman, Times, Serif; font-size: 7pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-144; font-family: Times New Roman, Times, Serif; font-size: 7pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="border-left: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="font-weight: bold; text-align: right"><span style="-sec-ix-hidden: hidden-fact-145; font-family: Times New Roman, Times, Serif; font-size: 7pt">-</span></td><td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt"><ix:nonFraction contextRef="c67" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" scale="3" unitRef="usd" id="ixv-26314">13,012</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-146; font-family: Times New Roman, Times, Serif; font-size: 7pt">-</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" scale="3" unitRef="usd" id="ixv-26315">13,012</ix:nonFraction></span></td>
    <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">Stock-based
    compensation to service providers</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-147; font-family: Times New Roman, Times, Serif; font-size: 7pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-148; font-family: Times New Roman, Times, Serif; font-size: 7pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-149; font-family: Times New Roman, Times, Serif; font-size: 7pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-150; font-family: Times New Roman, Times, Serif; font-size: 7pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-151; font-family: Times New Roman, Times, Serif; font-size: 7pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="border-left: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-152; font-family: Times New Roman, Times, Serif; font-size: 7pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt"><ix:nonFraction contextRef="c67" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodValueIssuedForServices" scale="3" unitRef="usd" id="ixv-26316">629</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-153; font-family: Times New Roman, Times, Serif; font-size: 7pt">-</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodValueIssuedForServices" scale="3" unitRef="usd" id="ixv-26317">629</ix:nonFraction></span></td>
    <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">Exercise
    of options and vested RSUs</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-154; font-family: Times New Roman, Times, Serif; font-size: 7pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-155; font-family: Times New Roman, Times, Serif; font-size: 7pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-156; font-family: Times New Roman, Times, Serif; font-size: 7pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="font-weight: bold; text-align: right"><span style="-sec-ix-hidden: hidden-fact-157; font-family: Times New Roman, Times, Serif; font-size: 7pt">-</span></td><td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-158; font-family: Times New Roman, Times, Serif; font-size: 7pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-159; font-family: Times New Roman, Times, Serif; font-size: 7pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-160; font-family: Times New Roman, Times, Serif; font-size: 7pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="border-left: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt"><ix:nonFraction contextRef="c66" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="0" unitRef="shares" id="ixv-26318">1,969,332</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-161; font-family: Times New Roman, Times, Serif; font-size: 7pt">*)</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt"><ix:nonFraction contextRef="c67" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" unitRef="usd" id="ixv-26319">703</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-162; font-family: Times New Roman, Times, Serif; font-size: 7pt">-</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" unitRef="usd" id="ixv-26320">703</ix:nonFraction></span></td>
    <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">Net
    loss</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-163; font-family: Times New Roman, Times, Serif; font-size: 7pt">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-164; font-family: Times New Roman, Times, Serif; font-size: 7pt">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-165; font-family: Times New Roman, Times, Serif; font-size: 7pt">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-166; font-family: Times New Roman, Times, Serif; font-size: 7pt">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-167; font-family: Times New Roman, Times, Serif; font-size: 7pt">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-168; font-family: Times New Roman, Times, Serif; font-size: 7pt">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-169; font-family: Times New Roman, Times, Serif; font-size: 7pt">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="border-left: Black 1.5pt solid; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-170; font-family: Times New Roman, Times, Serif; font-size: 7pt">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-171; font-family: Times New Roman, Times, Serif; font-size: 7pt">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">(<ix:nonFraction contextRef="c68" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="3" sign="-" unitRef="usd" id="ixv-26321">43,500</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">(<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="3" sign="-" unitRef="usd" id="ixv-26322">43,500</ix:nonFraction></span></td>
    <td style="padding-bottom: 1.5pt"><span style="font-size: 7pt">)<span style="font-family: Times New Roman, Times, Serif">&#160;</span></span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">Balance
    at December 31, 2023</span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="-sec-ix-hidden: hidden-fact-172; font-family: Times New Roman, Times, Serif; font-size: 7pt">-</span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">$</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="-sec-ix-hidden: hidden-fact-173; font-family: Times New Roman, Times, Serif; font-size: 7pt">-</span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="-sec-ix-hidden: hidden-fact-174; font-family: Times New Roman, Times, Serif; font-size: 7pt">-</span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">$</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="-sec-ix-hidden: hidden-fact-175; font-family: Times New Roman, Times, Serif; font-size: 7pt">-</span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="-sec-ix-hidden: hidden-fact-176; font-family: Times New Roman, Times, Serif; font-size: 7pt">-</span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">$</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="-sec-ix-hidden: hidden-fact-177; font-family: Times New Roman, Times, Serif; font-size: 7pt">-</span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="-sec-ix-hidden: hidden-fact-178; font-family: Times New Roman, Times, Serif; font-size: 7pt">-</span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">$</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="-sec-ix-hidden: hidden-fact-179; font-family: Times New Roman, Times, Serif; font-size: 7pt">-</span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="-sec-ix-hidden: hidden-fact-180; font-family: Times New Roman, Times, Serif; font-size: 7pt">-</span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">$</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="-sec-ix-hidden: hidden-fact-181; font-family: Times New Roman, Times, Serif; font-size: 7pt">-</span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="-sec-ix-hidden: hidden-fact-182; font-family: Times New Roman, Times, Serif; font-size: 7pt">-</span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">$</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="-sec-ix-hidden: hidden-fact-183; font-family: Times New Roman, Times, Serif; font-size: 7pt">-</span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">$</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="-sec-ix-hidden: hidden-fact-184; font-family: Times New Roman, Times, Serif; font-size: 7pt">-</span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="border-left: Black 1.5pt solid; padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt"><ix:nonFraction contextRef="c78" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:SharesOutstanding" scale="0" unitRef="shares" id="ixv-26323">77,925,095</ix:nonFraction></span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="-sec-ix-hidden: hidden-fact-185; font-family: Times New Roman, Times, Serif; font-size: 7pt">*)</span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">$</span></td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt"><ix:nonFraction contextRef="c79" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" unitRef="usd" id="ixv-26324">245,733</ix:nonFraction></span></td><td style="padding-bottom: 4pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">$</span></td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">(<ix:nonFraction contextRef="c80" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" sign="-" unitRef="usd" id="ixv-26325">203,640</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">)</span></td><td style="text-align: left; font-weight: bold; padding-bottom: 3pt; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span><span style="font-size: 7pt">$</span></td>
    <td style="border-bottom: Black 4pt double; vertical-align: bottom; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt"><ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" unitRef="usd" id="ixv-26326">42,093</ix:nonFraction></span></td>
    <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 28.35pt; text-align: justify; text-indent: -28.35pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">*)</span></td><td style="text-align: justify"><ix:footnote id="ix_1_footnote" xml:lang="en-US"><span style="font-family: Times New Roman, Times, Serif">Represents less than $1.</span></ix:footnote></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24pt; text-align: justify; text-indent: -24pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">The
accompanying notes are an integral part of these consolidated financial statements.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 133 --><div>
    </div><div style="border-bottom: Black 1.5pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>




</div><div style="border-bottom: Black 1.5pt solid; padding: 0in 0in 1pt"><a id="F_005"></a><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-align: center; text-indent: -56.7pt"><span style="font-family: Times New Roman, Times, Serif">ARBE
ROBOTICS LTD. AND SUBSIDIARIES</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-align: center; text-indent: -56.7pt"><span style="font-family: Times New Roman, Times, Serif">CONSOLIDATED
STATEMENTS OF CASH FLOWS</span></p>

</div><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b>U.S.
dollars in thousands</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="10" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2.85pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><b>Year
ended&#160;December 31,</b></span></p></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2023</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2022</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2021</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><span style="text-decoration:underline">Cash flows from
    operating activities:</span></span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-align: justify; text-indent: -0.125in; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif">Net
    loss</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="3" sign="-" unitRef="usd" id="ixv-26327">43,500</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction contextRef="c7" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="3" sign="-" unitRef="usd" id="ixv-26328">40,494</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction contextRef="c8" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="3" sign="-" unitRef="usd" id="ixv-26329">58,092</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; text-indent: -0.125in; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify; text-indent: -0.125in; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif">Adjustments
    to reconcile net loss to net cash used in operating activities:</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; text-indent: -0.125in; padding-left: 0.125in">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify; text-indent: -0.125in; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif">Depreciation</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:Depreciation" scale="3" unitRef="usd" id="ixv-26330">557</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c7" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:Depreciation" scale="3" unitRef="usd" id="ixv-26331">481</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c8" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:Depreciation" scale="3" unitRef="usd" id="ixv-26332">342</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; text-indent: -0.125in; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif">Stock-based
    compensation</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensation" scale="3" unitRef="usd" id="ixv-26333">13,012</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c7" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensation" scale="3" unitRef="usd" id="ixv-26334">8,793</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c8" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensation" scale="3" unitRef="usd" id="ixv-26335">2,211</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify; text-indent: -0.125in; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif">Stock<span style="font-size: 10pt">-</span>based
    compensation to service providers</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IssuanceOfStockAndWarrantsForServicesOrClaims" scale="3" unitRef="usd" id="ixv-26336">629</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c7" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IssuanceOfStockAndWarrantsForServicesOrClaims" scale="3" unitRef="usd" id="ixv-26337">354</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c8" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IssuanceOfStockAndWarrantsForServicesOrClaims" scale="3" unitRef="usd" id="ixv-26338">115</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; text-indent: -0.125in; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif">Revaluation
    of warrants and accretion</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AdjustmentOfWarrantsGrantedForServices" scale="3" sign="-" unitRef="usd" id="ixv-26339">756</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction contextRef="c7" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AdjustmentOfWarrantsGrantedForServices" scale="3" sign="-" unitRef="usd" id="ixv-26340">8,122</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c8" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AdjustmentOfWarrantsGrantedForServices" scale="3" unitRef="usd" id="ixv-26341">6,599</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify; text-indent: -0.125in; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif">Revaluation
    of convertible loan</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-186; font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-187; font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c8" decimals="-3" format="ixt:num-dot-decimal" name="arbe:RevaluationOfConvertibleLoan" scale="3" unitRef="usd" id="ixv-26342">17,866</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; text-indent: -0.125in; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify; text-indent: -0.125in; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif">Change
    in operating assets and liabilities:</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; text-indent: -0.125in; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif">Trade
    receivable</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInAccountsReceivable" scale="3" sign="-" unitRef="usd" id="ixv-26343">694</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction contextRef="c7" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInAccountsReceivable" scale="3" unitRef="usd" id="ixv-26344">2,015</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction contextRef="c8" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInAccountsReceivable" scale="3" unitRef="usd" id="ixv-26345">50</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify; text-indent: -0.125in; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif">Prepaid
    expenses and other receivables</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" scale="3" unitRef="usd" id="ixv-26346">187</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c7" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" scale="3" sign="-" unitRef="usd" id="ixv-26347">1,219</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction contextRef="c8" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" scale="3" unitRef="usd" id="ixv-26348">2,228</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; text-indent: -0.125in; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif">Operating
    lease ROU assets and liabilities, net</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInOperatingLeaseLiability" scale="3" unitRef="usd" id="ixv-26349">86</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction contextRef="c7" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInOperatingLeaseLiability" scale="3" sign="-" unitRef="usd" id="ixv-26350">84</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-188; font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify; text-indent: -0.125in; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif">Trade
    payables</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInAccountsPayableTrade" scale="3" sign="-" unitRef="usd" id="ixv-26351">103</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction contextRef="c7" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInAccountsPayableTrade" scale="3" sign="-" unitRef="usd" id="ixv-26352">769</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c8" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInAccountsPayableTrade" scale="3" unitRef="usd" id="ixv-26353">458</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; text-indent: -0.125in; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif">Employees
    and payroll accruals</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities" scale="3" unitRef="usd" id="ixv-26354">55</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction contextRef="c7" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities" scale="3" sign="-" unitRef="usd" id="ixv-26355">234</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c8" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities" scale="3" unitRef="usd" id="ixv-26356">1,557</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify; text-indent: -0.125in; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif">Deferred
    revenue</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInDeferredRevenue" scale="3" sign="-" unitRef="usd" id="ixv-26357">101</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction contextRef="c7" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInDeferredRevenue" scale="3" sign="-" unitRef="usd" id="ixv-26358">375</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c8" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInDeferredRevenue" scale="3" unitRef="usd" id="ixv-26359">445</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-bottom: 1.5pt; text-indent: -0.125in; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif">Accrued
    expenses and other payables</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities" scale="3" sign="-" unitRef="usd" id="ixv-26360">3,899</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c7" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities" scale="3" unitRef="usd" id="ixv-26361">884</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c8" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities" scale="3" unitRef="usd" id="ixv-26362">4,361</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify; text-indent: -0.125in; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-bottom: 1.5pt; text-indent: -0.125in; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif">Net
    cash used in operating activities</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="3" sign="-" unitRef="usd" id="ixv-26363">33,513</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction contextRef="c7" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="3" sign="-" unitRef="usd" id="ixv-26364">40,362</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction contextRef="c8" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="3" sign="-" unitRef="usd" id="ixv-26365">26,416</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify; text-indent: -0.125in; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-decoration: underline; text-align: justify; text-indent: -0.125in; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif">Cash
    flows from investing activities:</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify; text-indent: -0.125in; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif">Change
    in bank deposits</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PaymentsForProceedsFromInvestments" scale="3" unitRef="usd" id="ixv-26366">15,002</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction contextRef="c7" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PaymentsForProceedsFromInvestments" scale="3" unitRef="usd" id="ixv-26367">400</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c8" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PaymentsForProceedsFromInvestments" scale="3" sign="-" unitRef="usd" id="ixv-26368">100</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-bottom: 1.5pt; text-indent: -0.125in; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif">Purchase
    of property and equipment</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="3" unitRef="usd" id="ixv-26369">249</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction contextRef="c7" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="3" unitRef="usd" id="ixv-26370">918</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction contextRef="c8" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="3" unitRef="usd" id="ixv-26371">784</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify; text-indent: -0.125in; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-bottom: 1.5pt; text-indent: -0.125in; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif">Net
    cash used in investing activities</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="3" sign="-" unitRef="usd" id="ixv-26372">15,251</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction contextRef="c7" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="3" sign="-" unitRef="usd" id="ixv-26373">1,318</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction contextRef="c8" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="3" sign="-" unitRef="usd" id="ixv-26374">684</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify; text-indent: -0.125in; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-decoration: underline; text-align: justify; text-indent: -0.125in; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif">Cash
    flows from financing activities:</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify; text-indent: -0.125in; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif">Proceeds
    from short-term loan</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-189; font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-190; font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c8" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ProceedsFromShortTermDebt" scale="3" unitRef="usd" id="ixv-26375">4,715</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; text-indent: -0.125in; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif">Repayment
    of long-term loan</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-191; font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-192; font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction contextRef="c8" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RepaymentsOfLongTermDebt" scale="3" unitRef="usd" id="ixv-26376">2,639</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify; text-indent: -0.125in; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif">Proceeds
    from recapitalization and PIPE offering, net of issuance costs</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-193; font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-194; font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c8" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ProceedsFromIssuanceInitialPublicOffering" scale="3" unitRef="usd" id="ixv-26377">98,587</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; text-indent: -0.125in; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif">Repayment
    of short-term loan</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-195; font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction contextRef="c7" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RepaymentsOfShortTermDebt" scale="3" unitRef="usd" id="ixv-26378">5,218</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-196; font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify; text-indent: -0.125in; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif">Proceeds
    from issuance of ordinary shares, net of issuance costs</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ProceedsFromIssuanceOfCommonStock" scale="3" unitRef="usd" id="ixv-26379">22,496</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-197; font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-198; font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; text-indent: -0.125in; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif">Proceeds
    from exercise of warrants</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-199; font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-200; font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c8" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ProceedsFromWarrantExercises" scale="3" unitRef="usd" id="ixv-26380">12,859</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify; text-indent: -0.125in; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif">Proceeds
    from exercise of options</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ProceedsFromStockOptionsExercised" scale="3" unitRef="usd" id="ixv-26381">703</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c7" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ProceedsFromStockOptionsExercised" scale="3" unitRef="usd" id="ixv-26382">277</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c8" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ProceedsFromStockOptionsExercised" scale="3" unitRef="usd" id="ixv-26383">223</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-bottom: 1.5pt; text-indent: -0.125in; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif">Proceeds
    from convertible loan</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-201; font-family: Times New Roman, Times, Serif">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-202; font-family: Times New Roman, Times, Serif">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c8" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ProceedsFromConvertibleDebt" scale="3" unitRef="usd" id="ixv-26384">11,337</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify; text-indent: -0.125in; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-bottom: 1.5pt; text-indent: -0.125in; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif">Net
    cash provided by (used in) financing activities</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="3" unitRef="usd" id="ixv-26385">23,199</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction contextRef="c7" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="3" sign="-" unitRef="usd" id="ixv-26386">4,941</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c8" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="3" unitRef="usd" id="ixv-26387">125,082</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify; text-indent: -0.125in; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; text-indent: -0.125in; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif">Effect
    of exchange rate fluctuations on cash and cash equivalent</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" sign="-" unitRef="usd" id="ixv-26388">47</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction contextRef="c7" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" unitRef="usd" id="ixv-26389">1,189</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-203; font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify; text-indent: -0.125in; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; text-indent: -0.125in; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif">Increase
    (decrease) in cash, cash equivalents and restricted cash</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" scale="3" sign="-" unitRef="usd" id="ixv-26390">25,612</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction contextRef="c7" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" scale="3" sign="-" unitRef="usd" id="ixv-26391">45,432</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c8" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" scale="3" unitRef="usd" id="ixv-26392">97,982</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify; padding-bottom: 1.5pt; text-indent: -0.125in; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif">Cash,
    cash equivalents and restricted cash at the beginning of the year</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c6" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" unitRef="usd" id="ixv-26393">54,315</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c40" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" unitRef="usd" id="ixv-26394">100,936</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c19" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" unitRef="usd" id="ixv-26395">2,954</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; text-indent: -0.125in; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify; padding-bottom: 4pt; text-indent: -0.125in; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif">Cash,
    cash equivalents and restricted cash at the end of the year</span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" unitRef="usd" id="ixv-26396">28,750</ix:nonFraction></span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c6" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" unitRef="usd" id="ixv-26397">54,315</ix:nonFraction></span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c40" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" unitRef="usd" id="ixv-26398">100,936</ix:nonFraction></span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; text-indent: -0.125in; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: justify; text-indent: -0.125in; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif">Supplemental
    non-cash disclosure:</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-bottom: 4pt; text-indent: -0.125in; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif">Exercise
    of warrants into convertible preferred shares</span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="-sec-ix-hidden: hidden-fact-204; font-family: Times New Roman, Times, Serif">-</span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="-sec-ix-hidden: hidden-fact-205; font-family: Times New Roman, Times, Serif">-</span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c8" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ConversionOfStockAmountConverted1" scale="3" unitRef="usd" id="ixv-26399">4,389</ix:nonFraction></span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify; padding-bottom: 4pt; text-indent: -0.125in; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif">Issuance
    of private warrants</span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="-sec-ix-hidden: hidden-fact-206; font-family: Times New Roman, Times, Serif">-</span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="-sec-ix-hidden: hidden-fact-207; font-family: Times New Roman, Times, Serif">-</span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c8" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockIssued1" scale="3" unitRef="usd" id="ixv-26400">6,598</ix:nonFraction></span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-bottom: 4pt; text-indent: -0.125in; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif">Conversion
    of convertible loan into ordinary shares upon the recapitalization</span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="-sec-ix-hidden: hidden-fact-208; font-family: Times New Roman, Times, Serif">-</span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="-sec-ix-hidden: hidden-fact-209; font-family: Times New Roman, Times, Serif">-</span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c8" decimals="-3" format="ixt:num-dot-decimal" name="arbe:ConversionOfConvertibleLoanIntoOrdinarySharesUponTheRecapitalization" scale="3" unitRef="usd" id="ixv-26401">30,844</ix:nonFraction></span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify; padding-bottom: 4pt; text-indent: -0.125in; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif">Conversion
of preferred shares into ordinary shares upon the recapitalization</span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="-sec-ix-hidden: hidden-fact-210; font-family: Times New Roman, Times, Serif">-</span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="-sec-ix-hidden: hidden-fact-211; font-family: Times New Roman, Times, Serif">-</span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c8" decimals="-3" format="ixt:num-dot-decimal" name="arbe:ConversionOfPreferredSharesIntoOrdinarySharesUponTheRecapitalization" scale="3" unitRef="usd" id="ixv-26402">63,467</ix:nonFraction></span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-bottom: 4pt; text-indent: -0.125in; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif">Lease
    liabilities arising from obtaining right-of-use assets</span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" scale="3" unitRef="usd" id="ixv-26403">1,713</ix:nonFraction></span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c7" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" scale="3" unitRef="usd" id="ixv-26404">797</ix:nonFraction></span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="-sec-ix-hidden: hidden-fact-212; font-family: Times New Roman, Times, Serif">-</span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify; padding-bottom: 4pt; text-indent: -0.125in; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif">Purchase
    of property and equipment</span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1" scale="3" unitRef="usd" id="ixv-26405">8</ix:nonFraction></span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c7" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1" scale="3" unitRef="usd" id="ixv-26406">7</ix:nonFraction></span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c8" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1" scale="3" unitRef="usd" id="ixv-26407">340</ix:nonFraction></span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table><div>






</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b>U.S.
dollars in thousands</b></span></p><div>




</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Supplemental disclosure
    of cash flows activities:</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-align: justify; padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">Interest
    paid</span></td><td style="width: 1%; padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 4pt double; width: 9%; text-align: right"><span style="-sec-ix-hidden: hidden-fact-213; font-family: Times New Roman, Times, Serif">-</span></td><td style="width: 1%; padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 1%; padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 4pt double; width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c7" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:InterestPaidNet" scale="3" unitRef="usd" id="ixv-26408">250</ix:nonFraction></span></td><td style="width: 1%; padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 1%; padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 4pt double; width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c8" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:InterestPaidNet" scale="3" unitRef="usd" id="ixv-26409">209</ix:nonFraction></span></td><td style="width: 1%; padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">*)</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Represents
                                            less than $1.</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">The
accompanying notes are an integral part of these consolidated financial statements.</span></p><div>




</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-transform: uppercase; text-align: justify; text-indent: -56.7pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-transform: uppercase; text-align: justify; text-indent: -56.7pt"></p><div>

</div><!-- Field: Page; Sequence: 134 --><div>
    </div><div style="border-bottom: Black 1.5pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-transform: uppercase; text-align: justify; text-indent: -56.7pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><div><a id="F_006"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><b>ARBE
ROBOTICS LTD. AND SUBSIDIARIES</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif"><b>NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p><div>

</div><!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="border-top: Black 1.5pt solid; font-size: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></div></div><!-- Field: /Rule-Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-transform: uppercase; text-align: justify; text-indent: -56.7pt"><span style="font-family: Times New Roman, Times, Serif; text-transform: none">U.S.
dollars in thousands (except share and per share data)</span></p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-transform: uppercase; text-align: justify; text-indent: -56.7pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><ix:nonNumeric contextRef="c0" continuedAt="_NatureOfOperations-c0_cont_1" escape="true" name="us-gaap:NatureOfOperations" id="ixv-20056"><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-transform: uppercase; text-align: justify; text-indent: -56.7pt"><span style="font-family: Times New Roman, Times, Serif">Note
1:- General</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 84.45pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">a.</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Arbe
                                            Robotics Ltd. (the &#8220;Company&#8221;) was founded and registered on November 4, 2015 and
                                            commenced its activities in January 2016. The Company, a global leader in Perception Radar
                                            solutions, is spearheading a radar revolution, enabling truly safe driver-assist systems
                                            today while paving the way to full autonomous-driving. The Company&#8217;s radar technology
                                            is a critical sensor for L2+ and higher autonomy. The Company is empowering automakers, Tier
                                            1 suppliers, autonomous ground vehicles, commercial and industrial vehicles, and a wide array
                                            of safety applications with advanced sensing and paradigm changing perception. The Company&#8217;s
                                            Ordinary Shares and Warrants are listed on the Nasdaq Capital Market under the symbols &#8220;ARBE&#8221;
                                            and &#8220;ARBEW,&#8221; respectively.</span></td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 84.45pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">b.</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">On
                                            October 26, 2017, the Company established a Delaware subsidiary, Arbe Robotics US Inc. Arbe
                                            Robotics US Inc is engaged mainly in the Company&#8217;s sales and will operate as the Company&#8217;s
                                            distributor in the U.S.</span></td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">On
February 5, 2024, the Company established a Chinese subsidiary, Shanghai Arbe Technologies Co., Ltd (&#8220;Arbe China&#8221;). Arbe
China was formed to assist mainly in providing customer support in the China region.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 84.45pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">c.</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">On
                                            October 7, 2021, the Company consummated the merger (the &#8220;Merger&#8221;) pursuant to
                                            which the Company&#8217;s wholly-owned subsidiary, Autobot MergerSub, Inc. (&#8220;Merger
                                            Sub&#8221;) was merged with an into Industrial Tech Acquisitions Inc. (&#8220;ITAC&#8221;)
                                            pursuant to which ITAC became a wholly-owned&#160;subsidiary of the Company, and the Company
                                            issued ordinary shares and warrants to the holders of ITAC common stock and warrants, respectively.
                                            In connection with the Merger, the name of ITAC was changed to Autobot HoldCo, Inc.</span></td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 84.45pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">In
connection with the Merger, and immediately prior to the closing of the Merger, the Company effected a recapitalization (the &#8220;Recapitalization&#8221;),
which was approved by the Company&#8217;s directors and shareholders. As part of the Recapitalization, (i) all warrants (other than certain
outstanding warrants) were exercised, (ii) all outstanding preferred shares, including preferred shares issued upon exercise of warrants,
were converted into ordinary shares and (iii) the ordinary shares that were outstanding after the exercise and conversion pursuant to
clauses (i) and (ii) became and were converted into a total of <ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:CommonStockOtherSharesOutstanding" scale="0" unitRef="shares" id="ixv-26410">48,268,611</ix:nonFraction> ordinary shares. The Recapitalization resulted in a 46.25783-for-one
stock split and a change in the par value of the ordinary shares from NIS <ix:nonFraction contextRef="c82" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:SharesIssuedPricePerShare" scale="0" unitRef="ilsPershares" id="ixv-26411">0.01</ix:nonFraction> per share to NIS <ix:nonFraction contextRef="c83" decimals="6" format="ixt:num-dot-decimal" name="us-gaap:SharesIssuedPricePerShare" scale="0" unitRef="ilsPershares" id="ixv-26412">0.000216</ix:nonFraction> per share. The stock split was
based on a valuation of the Ordinary Shares of $<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PaymentsOfOrdinaryDividends" scale="3" unitRef="usd" id="ixv-26413">525,000</ix:nonFraction> after the Recapitalization, with each Ordinary Share being valued at $<ix:nonFraction contextRef="c5" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:SharesIssuedPricePerShare" scale="0" unitRef="usdPershares" id="ixv-26414">10.00</ix:nonFraction>.
As part of the Recapitalization, the number of Ordinary Shares issuable upon exercise of outstanding options and warrants was multiplied
by the stock split ratio, which is the conversion ratio, and the exercise price of such options and warrants was divided by the conversion
ratio. Fractional shares were rounded to the closest integral number of Ordinary Shares, with a half-share being rounded to the next
higher number of Ordinary Shares. As a result, all Ordinary Shares, preferred shares, options to purchase ordinary shares, warrants to
purchase preferred shares, exercise price and net loss per share amounts in these financial statements were adjusted retroactively for
the year ended December 31, 2021, as if the stock split and change in par value had been in effect at January 1, 2021.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 84.45pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p></ix:nonNumeric><div>

</div><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 84.45pt; text-align: justify; text-indent: 0in"></p><div>

</div><!-- Field: Page; Sequence: 135 --><div>
    </div><div style="border-bottom: Black 1.5pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-transform: uppercase; text-align: justify; text-indent: -56.7pt"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><b>ARBE
ROBOTICS LTD. AND SUBSIDIARIES</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif"><b>NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p><div>

</div><!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="border-top: Black 1.5pt solid; font-size: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></div></div><!-- Field: /Rule-Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-transform: uppercase; text-align: justify; text-indent: -56.7pt"><span style="font-family: Times New Roman, Times, Serif; text-transform: none">U.S.
dollars in thousands (except share and per share data)</span></p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-transform: uppercase; text-align: justify; text-indent: -56.7pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>



</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-transform: uppercase; text-align: justify; text-indent: -56.7pt"><span style="font-family: Times New Roman, Times, Serif">Note
1:- &#160;&#160;General (<span style="text-transform: none">Cont</span>.)</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 84.45pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><ix:continuation id="_NatureOfOperations-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">Pursuant
to the Merger, Arbe issued to ITAC securityholders (a) <ix:nonFraction contextRef="c84" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:CommonStockOtherSharesOutstanding" scale="0" unitRef="shares" id="ixv-26415">3,866,842</ix:nonFraction> Ordinary Shares to the holders of ITAC common stock and (b) <ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:ClassOfWarrantOrRightOutstanding" scale="0" unitRef="shares" id="ixv-26416">10,735,680</ix:nonFraction>
Arbe warrants to the holders of ITAC warrants, of which <ix:nonFraction contextRef="c85" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:ClassOfWarrantOrRightOutstanding" scale="0" unitRef="shares" id="ixv-26417">7,623,600</ix:nonFraction> warrants are public warrants and <ix:nonFraction contextRef="c86" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:ClassOfWarrantOrRightOutstanding" scale="0" unitRef="shares" id="ixv-26418">3,112,080</ix:nonFraction> warrants are private warrants.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 84.45pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">Total
gross proceeds resulted from the Merger and the related PIPE financing were approximately $<ix:nonFraction contextRef="c87" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ProceedsFromIssuanceInitialPublicOffering" scale="3" unitRef="usd" id="ixv-26419">118,288</ix:nonFraction>, of which total transaction costs
amounted to approximately $<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:SaleOfStockConsiderationReceivedOnTransaction" scale="3" unitRef="usd" id="ixv-26420">16,707</ix:nonFraction>. The total gross proceeds include the $<ix:nonFraction contextRef="c88" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ProceedsFromIssuanceInitialPublicOffering" scale="3" unitRef="usd" id="ixv-26421">100,000</ix:nonFraction> from the sale of <ix:nonFraction contextRef="c87" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" scale="0" unitRef="shares" id="ixv-26422">10,000,000</ix:nonFraction> Ordinary Shares to the PIPE
investors at $<ix:nonFraction contextRef="c89" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:SharesIssuedPricePerShare" scale="0" unitRef="usdPershares" id="ixv-26423">10.00</ix:nonFraction> per share.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 84.45pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">d.</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">The
                                            Company depends on one supplier for the development and productization of its products. If
                                            this supplier fails to deliver or delays the delivery of the necessary products, the Company
                                            will be required to seek alternative sources of supply. A change in supplier could result
                                            in manufacturing delays and increased costs, which could result in a possible loss of sales
                                            which would adversely affect the Company&#8217;s business, prospects, results of operations
                                            and financial position.</span></td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 84.45pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">e.</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">As
                                            the Company operates internationally and substantially all of its revenue is derived from
                                            sales outside of Israel, the business is affected by inflation, supply chain issues and economic
                                            conditions in countries in which the Company is seeking to conduct business, security and
                                            cybersecurity issues, fiscal and monetary policies, interest rates and regulations affection
                                            the automobile industry, the timing by the automobile and other industries on the introduction
                                            of unmanned automobiles and other unmanned devices, safety concerns and well as the effect
                                            of regional conflicts and steps taken by governments with respect to parties to such conflicts.&#160;
                                            As an Israeli company, the Company is also subject to the effect on Israel and the Israeli
                                            economy of the present war with Hamas as well as any other regional conflicts which may develop
                                            and the relationship between Israel and other countries, including the United States, China
                                            and the European Union.</span></td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 84.45pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.5in; text-align: justify; font-size: 10pt">&#160;</td>
    <td style="width: 0.25in; text-align: justify; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">f.</span></td>
    <td style="text-align: justify; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company has incurred losses from operations since its inception and has negative cash flow from operating activities. Management's plans with regard to these matters include continued development and marketing of its products as well as seeking additional financing arrangements.</span></td></tr>
  </table></ix:continuation><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 84.45pt; text-align: justify; text-indent: 0in">&#160;</p><div>

</div><ix:nonNumeric contextRef="c0" continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_1" escape="true" name="us-gaap:SignificantAccountingPoliciesTextBlock" id="ixv-20178"><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-transform: uppercase; text-align: justify; text-indent: -56.7pt"><span style="font-family: Times New Roman, Times, Serif">Note
2:-&#160;&#160; Significant Accounting Policies</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<ix:nonNumeric contextRef="c0" continuedAt="_BasisOfAccountingPolicyPolicyTextBlock-c0_cont_1" escape="true" name="us-gaap:BasisOfAccountingPolicyPolicyTextBlock" id="ixv-20183"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"><tr style="vertical-align: top">
<td style="width: 57.9pt"/><td style="width: 27.15pt"><span style="font-family: Times New Roman, Times, Serif">a.</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Basis of presentation:</span></td></tr></table></ix:nonNumeric>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<ix:continuation continuedAt="_BasisOfAccountingPolicyPolicyTextBlock-c0_cont_2" id="_BasisOfAccountingPolicyPolicyTextBlock-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 84.45pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">The
consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States
of America (US GAAP). The significant accounting policies followed in the preparation of the financial statements applied on a consistent
basis for all years presented in these financial statements.</span></p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 84.45pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<ix:continuation id="_BasisOfAccountingPolicyPolicyTextBlock-c0_cont_2"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">The
consolidated financial statements include the accounts of the Company&#8217;s wholly owned subsidiaries. All intercompany balances and
transactions have been eliminated in consolidation.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p></ix:continuation></ix:nonNumeric><div>




</div><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"></p><div>

</div><!-- Field: Page; Sequence: 136 --><div>
    </div><div style="border-bottom: Black 1.5pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-transform: uppercase; text-align: justify; text-indent: -56.7pt"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><b>ARBE
ROBOTICS LTD. AND SUBSIDIARIES</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif"><b>NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p><div>

</div><!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="border-top: Black 1.5pt solid; font-size: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></div></div><!-- Field: /Rule-Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-transform: uppercase; text-align: justify; text-indent: -56.7pt"><span style="font-family: Times New Roman, Times, Serif; text-transform: none">U.S.
dollars in thousands (except share and per share data)</span></p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-transform: uppercase; text-align: justify; text-indent: -56.7pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>


</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-transform: uppercase; text-align: justify; text-indent: -56.7pt"><span style="font-family: Times New Roman, Times, Serif">note
2:- &#160;&#160;Significant Accounting Policies (<span style="text-transform: none">Cont</span>.)</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_2" id="_SignificantAccountingPoliciesTextBlock-c0_cont_1"><ix:nonNumeric contextRef="c0" continuedAt="_UseOfEstimates-c0_cont_1" escape="true" name="us-gaap:UseOfEstimates" id="ixv-20248"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">b.</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Use of estimates:</span></td>
</tr></table></ix:nonNumeric>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<ix:continuation continuedAt="_UseOfEstimates-c0_cont_2" id="_UseOfEstimates-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">The
preparation of consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect
the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial
statements and the reported amounts of revenues and expenses during the reporting periods. Significant items subject to such estimates
and assumptions including fair value of warrants, share-based compensation and the underlying fair value of the Company&#8217;s Ordinary
Shares issued prior to the Merger.</span></p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<ix:continuation id="_UseOfEstimates-c0_cont_2"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">The
Company bases these estimates on historical and anticipated results, trends and various other assumptions that it believes are reasonable
under the circumstances, including assumptions as to future events. Actual results could differ from those estimates.</span></p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<ix:nonNumeric contextRef="c0" continuedAt="_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock-c0_cont_1" escape="true" name="us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" id="ixv-20268"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">c.</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Consolidated financial statements in U.S. dollars:</span></td>
</tr></table></ix:nonNumeric>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<ix:continuation continuedAt="_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock-c0_cont_2" id="_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">A
substantial portion the Company&#8217;s activity including transactions with customers, as well as equity transactions and cash investments,
are incurred in U.S. dollars. The Company&#8217;s management believes that the U.S. dollar is the currency of the primary economic environment
in which the Company operates. Thus, the functional and reporting currency of the Company is the U.S. dollar.</span></p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<ix:continuation continuedAt="_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock-c0_cont_3" id="_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock-c0_cont_2"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">A
subsidiary&#8217;s functional currency is the currency of the primary economic environment in which the subsidiary operates; normally,
that is the currency of the environment in which a subsidiary primarily generates and expends cash. In making the determination of the
appropriate functional currency for a subsidiary, the Company considers cash flow indicators, local market indicators, financing indicators
and the subsidiary&#8217;s relationship with both the parent company and other subsidiaries. The Company has determined the functional
currency of its U.S. subsidiaries to be the U.S. Dollar.</span></p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<ix:continuation continuedAt="_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock-c0_cont_4" id="_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock-c0_cont_3"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">Monetary
accounts maintained in currencies other than the U.S. dollar are remeasured into U.S. dollars in accordance with Statement of the Accounting
Standard Codification (&#8220;ASC&#8221;) No. 830 &#8220;Foreign Currency Matters&#8221; (&#8220;ASC No. 830&#8221;). All transaction
gains and losses of the remeasured monetary balance sheet items are reflected in the statements of operations as financial income or
expenses as appropriate.</span></p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<ix:continuation id="_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock-c0_cont_4"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">Transactions
in foreign currency are translated into dollars in accordance with the principles set forth in ASC Subtopic 830-20, <i>Foreign Currency
Transaction</i>. Monetary assets and liabilities denominated in foreign currencies of the reporting date are translated to the functional
currency at the closing rate at the end of the reporting period. Non-monetary assets and liabilities denominated in foreign currency
are translated using the exchange rate at the date of the transaction. Gains and losses from remeasurement of assets and liabilities
denominated in currencies other than the respective functional currencies are included in the consolidated statements of operations.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p></ix:continuation></ix:continuation><div>




</div><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"></p><div>

</div><!-- Field: Page; Sequence: 137 --><div>
    </div><div style="border-bottom: Black 1.5pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-transform: uppercase; text-align: justify; text-indent: -56.7pt"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><b>ARBE
ROBOTICS LTD. AND SUBSIDIARIES</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif"><b>NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p><div>

</div><!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="border-top: Black 1.5pt solid; font-size: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></div></div><!-- Field: /Rule-Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-transform: uppercase; text-align: justify; text-indent: -56.7pt"><span style="font-family: Times New Roman, Times, Serif; text-transform: none">U.S.
dollars in thousands (except share and per share data)</span></p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-transform: uppercase; text-align: justify; text-indent: -56.7pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>


</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-transform: uppercase; text-align: justify; text-indent: -56.7pt"><span style="font-family: Times New Roman, Times, Serif">note
2:- &#160;&#160;Significant Accounting Policies (<span style="text-transform: none">Cont</span>.)</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 113.4pt; text-align: justify; text-indent: -28.35pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_3" id="_SignificantAccountingPoliciesTextBlock-c0_cont_2"><ix:nonNumeric contextRef="c0" continuedAt="_ConcentrationRiskCreditRisk-c0_cont_1" escape="true" name="us-gaap:ConcentrationRiskCreditRisk" id="ixv-20344"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">d.</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Concentration of credit risk:</span></td>
</tr></table></ix:nonNumeric>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<ix:continuation continuedAt="_ConcentrationRiskCreditRisk-c0_cont_2" id="_ConcentrationRiskCreditRisk-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">Most
of the Company&#8217;s cash and cash equivalents, restricted cash and short-term deposits were deposited with Israeli banks and were
comprised mainly of cash deposits and short-term deposits.</span></p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<ix:continuation id="_ConcentrationRiskCreditRisk-c0_cont_2"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">The
Company&#8217;s trade receivables are derived from customers located globally. The Company mitigates its credit risks by performing credit
evaluations of its customers&#8217; financial conditions and requires customer advance payments in certain circumstances. The Company
generally does not require collateral.</span></p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<ix:nonNumeric contextRef="c0" continuedAt="_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy-c0_cont_1" escape="true" name="us-gaap:CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" id="ixv-20364"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">e.</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Cash and cash equivalents and restricted cash:</span></td>
</tr></table></ix:nonNumeric>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<ix:continuation continuedAt="_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy-c0_cont_2" id="_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">The
Company considers all highly liquid short-term deposits with original maturities of three months or less from the purchase date to be
cash equivalents. Cash equivalents consist primarily of amounts invested in short-term deposits.</span></p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<ix:continuation id="_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy-c0_cont_2"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">Restricted
cash consists of deposits at a financial institution that serves as collateral for a credit card agreement and lease agreements.</span></p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<ix:nonNumeric contextRef="c0" continuedAt="arbe_ShortTermDepositsPolicyPolicyTextBlock-c0_cont_1" escape="true" name="arbe:ShortTermDepositsPolicyPolicyTextBlock" id="ixv-20384"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">f.</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Short term deposits:</span></td>
</tr></table></ix:nonNumeric>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: -28.35pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<ix:continuation id="arbe_ShortTermDepositsPolicyPolicyTextBlock-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">Short-term
deposits are bank deposits with an original maturity of more than three months and less than one year from the date of acquisition. The
deposits are presented according to their terms of deposit. As of December 31, 2023, these bank deposit bearing annual interest rates
in the range of&#160;<ix:nonFraction contextRef="c90" decimals="2" format="ixt:num-dot-decimal" name="srt:DemandDepositLiabilitiesInterestBearingAverageRatePaid" scale="-2" unitRef="pure" id="ixv-26424">4</ix:nonFraction>%-<ix:nonFraction contextRef="c91" decimals="2" format="ixt:num-dot-decimal" name="srt:DemandDepositLiabilitiesInterestBearingAverageRatePaid" scale="-2" unitRef="pure" id="ixv-26425">6</ix:nonFraction>%,</span></p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: -28.35pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<ix:nonNumeric contextRef="c0" continuedAt="_FairValueOfFinancialInstrumentsPolicy-c0_cont_1" escape="true" name="us-gaap:FairValueOfFinancialInstrumentsPolicy" id="ixv-20399"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">g.</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Fair value of financial instruments:</span></td>
</tr></table></ix:nonNumeric>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<ix:continuation continuedAt="_FairValueOfFinancialInstrumentsPolicy-c0_cont_2" id="_FairValueOfFinancialInstrumentsPolicy-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">The
estimated fair value of financial instruments has been determined by the Company using available market information and valuation methodologies.
Considerable judgment is required in estimating fair values. Accordingly, the estimates may not be indicative of the amounts the Company
could realize in a current market exchange. The following methods and assumptions were used by the Company in estimating the fair value
of their financial instruments:</span></p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<ix:continuation continuedAt="_FairValueOfFinancialInstrumentsPolicy-c0_cont_3" id="_FairValueOfFinancialInstrumentsPolicy-c0_cont_2"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">The
carrying values of cash and cash equivalents, short-term deposits, restricted cash, trade receivables, other current assets, trade payables,
employees and payroll accruals, accrued expenses and other current liabilities approximate their fair values due to the short-term maturities
of these instruments.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p></ix:continuation></ix:continuation><div>

</div><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 103.05pt; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 138 --><div>
    </div><div style="border-bottom: Black 1.5pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 103.05pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-transform: uppercase; text-align: justify; text-indent: -56.7pt"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><b>ARBE
ROBOTICS LTD. AND SUBSIDIARIES</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif"><b>NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p><div>

</div><!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="border-top: Black 1.5pt solid; font-size: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></div></div><!-- Field: /Rule-Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-transform: uppercase; text-align: justify; text-indent: -56.7pt"><span style="font-family: Times New Roman, Times, Serif; text-transform: none">U.S.
dollars in thousands (except share and per share data)</span></p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-transform: uppercase; text-align: justify; text-indent: -56.7pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>


</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">note
2:-&#160;&#160; Significant Accounting Policies (<span style="text-transform: none">Cont</span>.)</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 103.05pt; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify"></p><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_4" id="_SignificantAccountingPoliciesTextBlock-c0_cont_3"><ix:continuation continuedAt="_FairValueOfFinancialInstrumentsPolicy-c0_cont_4" id="_FairValueOfFinancialInstrumentsPolicy-c0_cont_3"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">The
Company applies ASC No. 820, &#8220;Fair Value Measurements and Disclosures&#8221; (&#8220;ASC No. 820&#8221;), with respect to fair
value measurements of all financial assets and liabilities. In accordance with ASC No.&#160;820, the Company measures its short-term
deposits and warrant liability at fair value. Short-term deposits are classified within Level&#160;1 because these assets are valued
using quoted market prices. Fair value represents the amount that would be received to sell an asset or paid to transfer a liability
in an orderly transaction between market participants. As such, fair value is a market-based measurement that should be determined based
on assumptions that market participants would use in pricing an asset or a liability. A three-tier fair value hierarchy is established
as a basis for considering such assumptions and for inputs used in the valuation methodologies in measuring fair value:</span></p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 103.05pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<ix:continuation continuedAt="_FairValueOfFinancialInstrumentsPolicy-c0_cont_5" id="_FairValueOfFinancialInstrumentsPolicy-c0_cont_4"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.75in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Level
                                            1&#8212;Observable inputs that reflect quoted prices (unadjusted) for identical assets or
                                            liabilities in active markets.</span></td>
</tr></table></ix:continuation>

<p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<ix:continuation continuedAt="_FairValueOfFinancialInstrumentsPolicy-c0_cont_6" id="_FairValueOfFinancialInstrumentsPolicy-c0_cont_5"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.75in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Level
                                            2&#8212;Include other inputs that are directly or indirectly observable in the marketplace.</span></td>
</tr></table></ix:continuation>

<p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<ix:continuation continuedAt="_FairValueOfFinancialInstrumentsPolicy-c0_cont_7" id="_FairValueOfFinancialInstrumentsPolicy-c0_cont_6"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.75in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Level
                                            3&#8212;Unobservable inputs which are supported by little or no market activity.</span></td>
</tr></table></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 103.05pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<ix:continuation continuedAt="_FairValueOfFinancialInstrumentsPolicy-c0_cont_8" id="_FairValueOfFinancialInstrumentsPolicy-c0_cont_7"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">The
fair value hierarchy also requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when
measuring fair value.</span></p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<ix:continuation continuedAt="_FairValueOfFinancialInstrumentsPolicy-c0_cont_9" id="_FairValueOfFinancialInstrumentsPolicy-c0_cont_8"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">Pursuant
to the Merger, the Company (i) assumed a derivative warrant liability related to Company&#8217;s warrants that were issued to the holders of
private placement warrants that had been issued by ITAC in connection with its initial public offering, and (ii) issued equity instrument
in connection with warrants that had been issued as part of ITAC&#8217;s initial public offering and pursuant to the Merger became warrants
to purchase the Company&#8217;s Ordinary Shares. The fair value of the Company&#8217;s public warrants is measured based on the market
price of such warrants and are considered a Level 1 fair value measurement. The Company utilizes a Black-Scholes option pricing model
to estimate the fair value of the private placement warrants which are considered a Level 3 fair value measurement.</span></p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<ix:continuation id="_FairValueOfFinancialInstrumentsPolicy-c0_cont_9"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">The
Company&#8217;s private warrants are measured at each reporting period, with changes in fair value recognized in the statement of operations.
See Note 8.</span></p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<ix:nonNumeric contextRef="c0" continuedAt="_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy-c0_cont_1" escape="true" name="us-gaap:ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy" id="ixv-20512"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">h.</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Trade Receivables</span></td>
</tr></table></ix:nonNumeric>

<p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<ix:continuation continuedAt="_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy-c0_cont_2" id="_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">Trade
receivables are recorded at the invoiced amount and do not bear interest. Trade receivables are periodically assessed for allowance for
doubtful accounts, which is the Company&#8217;s best estimate of the amount of credit losses with respect to its existing trade receivable.</span></p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<ix:continuation continuedAt="_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy-c0_cont_3" id="_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy-c0_cont_2"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">The
Company&#8217;s accounts receivables accounting policy from January 1, 2023, following the adoption of the new current expected credit
losses (&#8220;CECL&#8221;) standard:</span></p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<ix:continuation continuedAt="_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy-c0_cont_4" id="_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy-c0_cont_3"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">The
Company estimates CECL on trade receivables at inception for estimated losses resulting from the inability of the Company&#8217;s customers
to make required payments, based on estimated current expected credit losses. The allowance represents the current estimate of lifetime
expected credit losses over the remaining duration of existing accounts receivable considering historical information, current market
conditions and reasonable and supportable forecasts when appropriate. The estimate is a result of the Company&#8217;s ongoing evaluation
of collectability, customer creditworthiness, historical levels of credit losses, and future expectations.</span></p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<ix:continuation id="_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy-c0_cont_4"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">The
allowance for credit losses was not material for the years ended December 31, 2023, 2022 and 2021.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p></ix:continuation></ix:continuation><div>




</div><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"></p><div>

</div><!-- Field: Page; Sequence: 139 --><div>
    </div><div style="border-bottom: Black 1.5pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-transform: uppercase; text-align: justify; text-indent: -56.7pt"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><b>ARBE
ROBOTICS LTD. AND SUBSIDIARIES</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif"><b>NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p><div>

</div><!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="border-top: Black 1.5pt solid; font-size: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></div></div><!-- Field: /Rule-Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-transform: uppercase; text-align: justify; text-indent: -56.7pt"><span style="font-family: Times New Roman, Times, Serif; text-transform: none">U.S.
dollars in thousands (except share and per share data)</span></p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-transform: uppercase; text-align: justify; text-indent: -56.7pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>


</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">note
2:- &#160;&#160;Significant Accounting Policies (<span style="text-transform: none">Cont</span>.)</span></p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_5" id="_SignificantAccountingPoliciesTextBlock-c0_cont_4"><ix:nonNumeric contextRef="c0" continuedAt="_PropertyPlantAndEquipmentPolicyTextBlock-c0_cont_1" escape="true" name="us-gaap:PropertyPlantAndEquipmentPolicyTextBlock" id="ixv-20587"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">i.</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Property and equipment:</span></td>
</tr></table></ix:nonNumeric>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<ix:continuation continuedAt="_PropertyPlantAndEquipmentPolicyTextBlock-c0_cont_2" id="_PropertyPlantAndEquipmentPolicyTextBlock-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">Property
and equipment are recorded at cost and depreciated over their estimated useful lives using the straight-line method. Upon retirement
or sale, the cost of assets disposed of and the related accumulated depreciation are removed from the accounts and any resulting gain
or loss is included in income. Repair and maintenance costs are expensed as incurred.</span></p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<ix:continuation continuedAt="_PropertyPlantAndEquipmentPolicyTextBlock-c0_cont_3" id="_PropertyPlantAndEquipmentPolicyTextBlock-c0_cont_2"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"><ix:nonNumeric contextRef="c0" continuedAt="arbe_PropertyPlantAndEquipmentUsefulLifeTableTextBlock-c0_cont_1" escape="true" name="arbe:PropertyPlantAndEquipmentUsefulLifeTableTextBlock" id="ixv-20604"><span style="font-family: Times New Roman, Times, Serif">Depreciation
is calculated using the straight-line method over the estimated useful lives of the assets, at the following annual rates:</span></ix:nonNumeric></p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<ix:continuation continuedAt="arbe_PropertyPlantAndEquipmentUsefulLifeTableTextBlock-c0_cont_2" id="arbe_PropertyPlantAndEquipmentUsefulLifeTableTextBlock-c0_cont_1"><ix:continuation continuedAt="_PropertyPlantAndEquipmentPolicyTextBlock-c0_cont_4" id="_PropertyPlantAndEquipmentPolicyTextBlock-c0_cont_3"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Computers and peripheral equipment</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c92" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:PropertyPlantAndEquipmentSalvageValuePercentage" scale="-2" unitRef="pure" id="ixv-26426">15</ix:nonFraction>-<ix:nonFraction contextRef="c93" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:PropertyPlantAndEquipmentSalvageValuePercentage" scale="-2" unitRef="pure" id="ixv-26427">33</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Office furniture and equipment</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c94" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:PropertyPlantAndEquipmentSalvageValuePercentage" scale="-2" unitRef="pure" id="ixv-26428">7</ix:nonFraction>-<ix:nonFraction contextRef="c95" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:PropertyPlantAndEquipmentSalvageValuePercentage" scale="-2" unitRef="pure" id="ixv-26429">15</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 88%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Vehicles</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 9%; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c96" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:PropertyPlantAndEquipmentSalvageValuePercentage" scale="-2" unitRef="pure" id="ixv-26430">15</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Leasehold improvement</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: center"><span style="-sec-ix-hidden: hidden-fact-214; font-family: Times New Roman, Times, Serif">(*)</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table></ix:continuation></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 113.4pt; text-align: justify; text-indent: -28.35pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<ix:continuation id="arbe_PropertyPlantAndEquipmentUsefulLifeTableTextBlock-c0_cont_2"><ix:continuation id="_PropertyPlantAndEquipmentPolicyTextBlock-c0_cont_4"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.75in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">(*)</span></td><td style="text-align: justify"><ix:footnote id="ix_2_footnote" xml:lang="en-US"><span style="font-family: Times New Roman, Times, Serif">Leasehold improvements are amortized using the straight-line method over the shorter of the lease term or the estimated useful life of the improvements.</span></ix:footnote></td>
</tr></table></ix:continuation></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<ix:nonNumeric contextRef="c0" continuedAt="_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock-c0_cont_1" escape="true" name="us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" id="ixv-20678"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">j.</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Impairment of long-lived assets:</span></td>
</tr></table></ix:nonNumeric>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<ix:continuation id="_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">Long-lived
assets are reviewed for impairment in accordance with ASC 360, &#8220;Property, Plant and Equipment&#8221; a (&#8220;ASC 360&#8221;),
whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Impairment exists when
the carrying value of the asset exceeds the aggregate undiscounted cash flows expected to be generated by the asset. The impairment to
be recognized is measured by the amount by which the carrying amount of the assets exceeds their fair value. During the years ended December
31, 2023, 2022 and 2021, no impairment losses were identified.</span></p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<ix:nonNumeric contextRef="c0" continuedAt="_PostemploymentBenefitPlansPolicy-c0_cont_1" escape="true" name="us-gaap:PostemploymentBenefitPlansPolicy" id="ixv-20693"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">k.</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Accrued post-employment benefit:</span></td>
</tr></table></ix:nonNumeric>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<ix:continuation continuedAt="_PostemploymentBenefitPlansPolicy-c0_cont_2" id="_PostemploymentBenefitPlansPolicy-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in">The employees of Arbe Ltd. are included under section 14 of the Israeli
Severance Compensation Act, 1963 (&#8220;Section 14&#8221;). Pursuant to Section 14, the Company&#8217;s Israeli employees are entitled
to monthly deposits, at a rate of&#160;<ix:nonFraction contextRef="c0" decimals="4" format="ixt:num-dot-decimal" name="arbe:SeverancePercentageOfMonthlySalary" scale="-2" unitRef="pure" id="ixv-26431">8.33</ix:nonFraction>% of their monthly salary, deposited on their behalf to their chosen insurance funds. By making
the payments in accordance with Section 14, the Company is released from any future severance payments in respect of those employees.
The obligation to make the monthly deposits is expensed as incurred. The deposits pursuant to Section 14 are not recorded as an asset
in the consolidated balance sheet, and there is no liability recorded as the Company does not have a future obligation to make any additional
payments. Severance costs amounted to approximately $<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:SeveranceCosts1" scale="3" unitRef="usd" id="ixv-26432">1,166</ix:nonFraction>, $<ix:nonFraction contextRef="c7" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:SeveranceCosts1" scale="3" unitRef="usd" id="ixv-26433">1,240</ix:nonFraction> and $<ix:nonFraction contextRef="c8" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:SeveranceCosts1" scale="3" unitRef="usd" id="ixv-26434">826</ix:nonFraction> for the years ended December 31, 2023, 2022 and 2021, respectively.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<ix:continuation id="_PostemploymentBenefitPlansPolicy-c0_cont_2"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">One
of the Company&#8217;s U.S. Subsidiaries has a 401(k) defined contribution plan covering one employee in the U.S. The expenses recorded
by the U.S. subsidiaries for matching contributions for the years ended December 31, 2023, 2022 and 2021 were immaterial.</span></p><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-transform: uppercase; text-align: justify; text-indent: -56.7pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p></ix:continuation></ix:continuation><div>

</div><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-transform: uppercase; text-align: justify; text-indent: -56.7pt"></p><div>

</div><!-- Field: Page; Sequence: 140 --><div>
    </div><div style="border-bottom: Black 1.5pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-transform: uppercase; text-align: justify; text-indent: -56.7pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-transform: uppercase; text-align: justify; text-indent: -56.7pt"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><b>ARBE
ROBOTICS LTD. AND SUBSIDIARIES</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif"><b>NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p><div>

</div><!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="border-top: Black 1.5pt solid; font-size: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></div></div><!-- Field: /Rule-Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-transform: uppercase; text-align: justify; text-indent: -56.7pt"><span style="font-family: Times New Roman, Times, Serif; text-transform: none">U.S.
dollars in thousands (except share and per share data)</span></p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-transform: uppercase; text-align: justify; text-indent: -56.7pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>


</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-transform: uppercase; text-align: justify; text-indent: -56.7pt"><span style="font-family: Times New Roman, Times, Serif">note
2:-&#160;&#160; Significant Accounting Policies (<span style="text-transform: none">Cont</span>.)</span></p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-transform: uppercase; text-align: justify; text-indent: -56.7pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_6" id="_SignificantAccountingPoliciesTextBlock-c0_cont_5"><ix:nonNumeric contextRef="c0" continuedAt="_ShareBasedCompensationOptionAndIncentivePlansPolicy-c0_cont_1" escape="true" name="us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy" id="ixv-20757"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">l.</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Stock-based compensation:</span></td>
</tr></table></ix:nonNumeric>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<ix:continuation continuedAt="_ShareBasedCompensationOptionAndIncentivePlansPolicy-c0_cont_2" id="_ShareBasedCompensationOptionAndIncentivePlansPolicy-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">The
Company accounts for stock-based compensation in accordance with ASC 718, &#8220;Compensation - Stock Compensation&#8221;, which requires
the measurement and recognition of compensation expense based on estimated fair values for all share-based payment awards made to employees,
nonemployees and directors. ASC 718 requires companies to estimate the fair value of equity-based payment awards on the date of grant
using an option-pricing model. The value of the portion of the award that is ultimately expected to vest is recognized as an expense
in the Company&#8217;s statements of operations over the applicable service periods.</span></p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<ix:continuation id="_ShareBasedCompensationOptionAndIncentivePlansPolicy-c0_cont_2"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">The
Company measures its share-based payment awards made to employees, directors, and non-employee service providers based on estimated fair
values. The fair value of each option award is estimated on the grant date using the Black-Scholes option pricing model which requires
several assumptions, of which the most significant are the expected share price volatility and the expected option term. The Company
recognizes forfeitures of equity-based awards as they occur. For graded vesting awards, the Company recognizes compensation expenses
based on the straight-line method over the applicable service period.</span></p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<ix:nonNumeric contextRef="c0" continuedAt="_EarningsPerSharePolicyTextBlock-c0_cont_1" escape="true" name="us-gaap:EarningsPerSharePolicyTextBlock" id="ixv-20777"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">m.</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Net loss per share attributable to ordinary shareholders:</span></td>
</tr></table></ix:nonNumeric>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<ix:continuation continuedAt="_EarningsPerSharePolicyTextBlock-c0_cont_2" id="_EarningsPerSharePolicyTextBlock-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">The
Company computes net loss per share using the two-class method required for participating securities. The two-class method requires income
available to ordinary shareholders for the period to be allocated between ordinary shares and participating securities based upon their
respective rights to receive dividends as if all income for the period had been distributed. The Company considered its convertible preferred
shares, which were outstanding through October 7, 2021, the date of the closing of the Merger, to be participating securities as the
holders of the convertible preferred shares would be entitled to dividends that would be distributed to the holders of ordinary shares,
equal to the higher of their original issue price pro-rata basis assuming conversion of all convertible preferred shares into ordinary
shares and that there are no preferences to any holders of any shares. These participating securities do not contractually require the
holders of such shares to participate in the Company&#8217;s losses. As such, net loss for the periods presented was not allocated to
the Company&#8217;s participating securities.</span></p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<ix:continuation id="_EarningsPerSharePolicyTextBlock-c0_cont_2"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">The
Company&#8217;s basic net loss per share is calculated by dividing net loss attributable to ordinary shareholders by the weighted-average
number of ordinary shares outstanding for the period, without consideration of potentially dilutive securities. The diluted net loss
per share is calculated by giving effect to all potentially dilutive securities outstanding for the period using the treasury share method
or the if-converted method based on the nature of such securities. Diluted net loss per share is the same as basic net loss per share
in periods when the effects of potentially dilutive shares of ordinary shares are anti-dilutive. See Note 10.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p></ix:continuation></ix:continuation><div>

</div><div>




</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"></p><div>

</div><!-- Field: Page; Sequence: 141 --><div>
    </div><div style="border-bottom: Black 1.5pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-transform: uppercase; text-align: justify; text-indent: -56.7pt"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><b>ARBE
ROBOTICS LTD. AND SUBSIDIARIES</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif"><b>NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p><div>

</div><!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="border-top: Black 1.5pt solid; font-size: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></div></div><!-- Field: /Rule-Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-transform: uppercase; text-align: justify; text-indent: -56.7pt"><span style="font-family: Times New Roman, Times, Serif; text-transform: none">U.S.
dollars in thousands (except share and per share data)</span></p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-transform: uppercase; text-align: justify; text-indent: -56.7pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>


</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-transform: uppercase; text-align: justify; text-indent: -56.7pt"><span style="font-family: Times New Roman, Times, Serif">note
2:- &#160;&#160;Significant Accounting Policies (<span style="text-transform: none">Cont</span>.)</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_7" id="_SignificantAccountingPoliciesTextBlock-c0_cont_6"><ix:nonNumeric contextRef="c0" continuedAt="_ComprehensiveIncomePolicyPolicyTextBlock-c0_cont_1" escape="true" name="us-gaap:ComprehensiveIncomePolicyPolicyTextBlock" id="ixv-20842"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">n.</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Other Comprehensive loss:</span></td>
</tr></table></ix:nonNumeric>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<ix:continuation id="_ComprehensiveIncomePolicyPolicyTextBlock-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">The
Company has no components of comprehensive loss other than net loss. Thus, comprehensive loss is the same as net loss for the periods
presented.</span></p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 74.7pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<ix:nonNumeric contextRef="c0" continuedAt="_RevenueRecognitionPolicyTextBlock-c0_cont_1" escape="true" name="us-gaap:RevenueRecognitionPolicyTextBlock" id="ixv-20858"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">p.</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Revenue recognition:</span></td>
</tr></table></ix:nonNumeric>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<ix:continuation continuedAt="_RevenueRecognitionPolicyTextBlock-c0_cont_2" id="_RevenueRecognitionPolicyTextBlock-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">The
Company follows the provisions of ASC Topic 606, Revenue from Contracts with Customers (&#8220;ASC 606&#8221;), which apply to all contracts
with customers. Under Topic 606, revenues are recognized when control of the promised goods or services is transferred to the customers,
in an amount that reflects the consideration that the Company expects to receive in exchange for those goods or services. To determine
the appropriate revenue recognition for arrangements that an entity determines are within the scope of Topic 606, the entity performs
the following five steps:</span></p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<ix:continuation continuedAt="_RevenueRecognitionPolicyTextBlock-c0_cont_3" id="_RevenueRecognitionPolicyTextBlock-c0_cont_2"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.75in"/><td style="width: 0.25in; text-align: left"/><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Identify
                                            the contract(s) with a customer;</span></td>
</tr></table></ix:continuation>

<p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<ix:continuation continuedAt="_RevenueRecognitionPolicyTextBlock-c0_cont_4" id="_RevenueRecognitionPolicyTextBlock-c0_cont_3"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.75in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Identify
                                            the performance obligations in the contract;</span></td>
</tr></table></ix:continuation>

<p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<ix:continuation continuedAt="_RevenueRecognitionPolicyTextBlock-c0_cont_5" id="_RevenueRecognitionPolicyTextBlock-c0_cont_4"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.75in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Determine
                                            the transaction price;</span></td>
</tr></table></ix:continuation>

<p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<ix:continuation continuedAt="_RevenueRecognitionPolicyTextBlock-c0_cont_6" id="_RevenueRecognitionPolicyTextBlock-c0_cont_5"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.75in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Allocate
                                            the transaction price to the performance obligations in the contract; and</span></td>
</tr></table></ix:continuation>

<p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<ix:continuation continuedAt="_RevenueRecognitionPolicyTextBlock-c0_cont_7" id="_RevenueRecognitionPolicyTextBlock-c0_cont_6"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.75in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Recognize
                                            revenue when (or as) the entity satisfies a performance obligation.</span></td>
</tr></table></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<ix:continuation continuedAt="_RevenueRecognitionPolicyTextBlock-c0_cont_8" id="_RevenueRecognitionPolicyTextBlock-c0_cont_7"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">At
contract inception, once the contract is determined to be within the scope of Topic 606, the Company assesses the goods or services promised
within the contract and determines the performance obligations and assesses whether each promised good or service is distinct. The Company
evaluates each performance obligation to determine if it is satisfied at a point in time or over time. See Note 3.</span></p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><i>&#160;</i></span></p>

<ix:continuation continuedAt="_RevenueRecognitionPolicyTextBlock-c0_cont_9" id="_RevenueRecognitionPolicyTextBlock-c0_cont_8"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif"><i>Nature
of Products and Services</i></span></p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><i>&#160;</i></span></p>

<ix:continuation continuedAt="_RevenueRecognitionPolicyTextBlock-c0_cont_10" id="_RevenueRecognitionPolicyTextBlock-c0_cont_9"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">The
Company derives its revenues mainly from sales of chipsets and prototype radar systems to be installed onto automotive vehicles and professional
services. Revenue from chipsets and prototype radar systems is recognized at the point in time when the control of the goods is transferred
to the customer, generally upon delivery, and the Company has no remaining performance obligations.</span></p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><i>&#160;</i></span></p>

<ix:continuation continuedAt="_RevenueRecognitionPolicyTextBlock-c0_cont_11" id="_RevenueRecognitionPolicyTextBlock-c0_cont_10"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif"><i>Right
of Return</i></span></p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<ix:continuation continuedAt="_RevenueRecognitionPolicyTextBlock-c0_cont_12" id="_RevenueRecognitionPolicyTextBlock-c0_cont_11"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">The
Company&#8217;s general terms and conditions for its contracts do not contain a right of return that allows the customer to return products
and receive a credit. Therefore, the Company does not estimate returns and generally recognizes revenue at contract price upon product
delivery.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p></ix:continuation></ix:continuation><div>

</div><div>




</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"></p><div>

</div><!-- Field: Page; Sequence: 142 --><div>
    </div><div style="border-bottom: Black 1.5pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-transform: uppercase; text-align: justify; text-indent: -56.7pt"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><b>ARBE
ROBOTICS LTD. AND SUBSIDIARIES</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif"><b>NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p><div>

</div><!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="border-top: Black 1.5pt solid; font-size: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></div></div><!-- Field: /Rule-Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-transform: uppercase; text-align: justify; text-indent: -56.7pt"><span style="font-family: Times New Roman, Times, Serif; text-transform: none">U.S.
dollars in thousands (except share and per share data)</span></p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-transform: uppercase; text-align: justify; text-indent: -56.7pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>


</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-transform: uppercase; text-align: justify; text-indent: -56.7pt"><span style="font-family: Times New Roman, Times, Serif">note
2:- &#160;&#160;Significant Accounting Policies (<span style="text-transform: none">Cont</span>.)</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><i>&#160;</i></span></p><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_8" id="_SignificantAccountingPoliciesTextBlock-c0_cont_7"><ix:continuation continuedAt="_RevenueRecognitionPolicyTextBlock-c0_cont_13" id="_RevenueRecognitionPolicyTextBlock-c0_cont_12"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif"><i>Deferred
Revenue</i></span></p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<ix:continuation id="_RevenueRecognitionPolicyTextBlock-c0_cont_13"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">Deferred
revenues, which represent a contract liability, where the Company has an obligation to transfer goods or services to the customer for
which it received consideration from the customer.</span></p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<ix:nonNumeric contextRef="c0" continuedAt="_CostOfSalesPolicyTextBlock-c0_cont_1" escape="true" name="us-gaap:CostOfSalesPolicyTextBlock" id="ixv-21009"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">q.</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Cost of revenues:</span></td>
</tr></table></ix:nonNumeric>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<ix:continuation id="_CostOfSalesPolicyTextBlock-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">Cost
of revenue includes the manufacturing cost of radar sensors and chipsets, which primarily consists of components cost, assembly costs
and personnel-related costs directly associated with our customer support personnel.</span></p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<ix:nonNumeric contextRef="c0" continuedAt="_ResearchAndDevelopmentExpensePolicy-c0_cont_1" escape="true" name="us-gaap:ResearchAndDevelopmentExpensePolicy" id="ixv-21024"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">r.</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Research and development expenses, net:</span></td>
</tr></table></ix:nonNumeric>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<ix:continuation id="_ResearchAndDevelopmentExpensePolicy-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">Research
and development costs, net of grants received, are charged to the consolidated statement of operations as incurred.</span></p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<ix:nonNumeric contextRef="c0" continuedAt="_IncomeTaxPolicyTextBlock-c0_cont_1" escape="true" name="us-gaap:IncomeTaxPolicyTextBlock" id="ixv-21039"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">s.</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Income taxes:</span></td>
</tr></table></ix:nonNumeric>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<ix:continuation continuedAt="_IncomeTaxPolicyTextBlock-c0_cont_2" id="_IncomeTaxPolicyTextBlock-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">The
Company accounts for income taxes in accordance with ASC 740, &#8220;Income Taxes&#8221;. This standard prescribes the use of the asset
and liability method whereby deferred tax asset and liability account balances are determined based on differences between the financial
statement carrying amount and the tax bases of assets and liabilities and are measured using the enacted tax rates and laws that will
be in effect when the differences are expected to reverse. The Company provides a valuation allowance, if necessary, to reduce deferred
tax assets to the amount that is more likely than not to be realized.</span></p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<ix:continuation id="_IncomeTaxPolicyTextBlock-c0_cont_2"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">The
Company recognizes the tax benefit from a tax position only if it is more likely than not that the tax position will be sustained on
examination by the taxing authorities, based on the technical merits of the position. A tax position that meets the more-likely-than-not
recognition threshold is measured at the largest amount that is greater than <ix:nonFraction contextRef="c0" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" unitRef="pure" id="ixv-26435">50</ix:nonFraction> percent likely of being realized upon settlement with
the taxing authority using the facts, circumstances, and information available at the reporting date.</span></p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<ix:nonNumeric contextRef="c0" continuedAt="_ContingentLiabilityReserveEstimatePolicy-c0_cont_1" escape="true" name="us-gaap:ContingentLiabilityReserveEstimatePolicy" id="ixv-21059"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">t.</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Contingent Liabilities</span></td>
</tr></table></ix:nonNumeric>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 84.45pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<ix:continuation id="_ContingentLiabilityReserveEstimatePolicy-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">The
Company accounts for its contingent liabilities in accordance with ASC No.&#160;450, &#8220;Contingencies.&#8221; A provision is recorded
when it is both probable that a liability has been incurred and the amount of the loss can be reasonably estimated. With respect to legal
matters, provisions are reviewed and adjusted to reflect the impact of negotiations, estimated settlements, legal rulings, advice of
legal counsel and other information and events pertaining to a particular matter. As of December&#160;31, 2023 and 2022, the Company
is not a party to any litigation that could have a material adverse effect on the Company&#8217;s business, financial position, results
of operations or cash flows.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p></ix:continuation></ix:continuation><div>




</div><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"></p><div>

</div><!-- Field: Page; Sequence: 143 --><div>
    </div><div style="border-bottom: Black 1.5pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-transform: uppercase; text-align: justify; text-indent: -56.7pt"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><b>ARBE
ROBOTICS LTD. AND SUBSIDIARIES</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif"><b>NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p><div>

</div><!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="border-top: Black 1.5pt solid; font-size: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></div></div><!-- Field: /Rule-Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-transform: uppercase; text-align: justify; text-indent: -56.7pt"><span style="font-family: Times New Roman, Times, Serif; text-transform: none">U.S.
dollars in thousands (except share and per share data)</span></p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-transform: uppercase; text-align: justify; text-indent: -56.7pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>


</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-transform: uppercase; text-align: justify; text-indent: -56.7pt"><span style="font-family: Times New Roman, Times, Serif">note
2:- &#160;&#160;Significant Accounting Policies (<span style="text-transform: none">Cont</span>.)</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 84.45pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><ix:continuation id="_SignificantAccountingPoliciesTextBlock-c0_cont_8"><ix:nonNumeric contextRef="c0" continuedAt="_LesseeLeasesPolicyTextBlock-c0_cont_1" escape="true" name="us-gaap:LesseeLeasesPolicyTextBlock" id="ixv-21119"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">u.</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Leases:</span></td>
</tr></table></ix:nonNumeric>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<ix:continuation continuedAt="_LesseeLeasesPolicyTextBlock-c0_cont_2" id="_LesseeLeasesPolicyTextBlock-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">On
January 1, 2022, the Company adopted Accounting Standards Update No. 2016-02, Leases (Topic 842) (ASU 2016-02) relating to the accounting
treatment of lease obligations, using the modified retrospective method.</span></p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<ix:continuation continuedAt="_LesseeLeasesPolicyTextBlock-c0_cont_3" id="_LesseeLeasesPolicyTextBlock-c0_cont_2"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">The
Company elected the package of practical expedients permitted under the transition guidance. The Company also elected not to recognize
a lease liability and a right-of-use (&#8220;ROU&#8221;) asset on the balance sheet for leases with a term of twelve months or less.
The Company recognizes the associated lease payments in the consolidated statements of income on a straight-line basis over the lease
term.</span></p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<ix:continuation continuedAt="_LesseeLeasesPolicyTextBlock-c0_cont_4" id="_LesseeLeasesPolicyTextBlock-c0_cont_3"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">Under
Topic 842, the Company determines if an arrangement is a lease at inception. ROU assets and liabilities are recognized at the commencement
date based on the present value of remaining lease payments over the lease term. For this purpose, the Company considers fixed and determinable
payments at the time of commencement. As most of the Company leases do not provide an implicit rate, the Company uses its incremental
borrowing rate based on the information available at the commencement date in determining the present value of lease payments. The incremental
borrowing rate is estimated to approximate the interest rate on a collateralized basis with similar terms and payments. The ROU asset
is recorded net of any lease incentives received. The lease terms may include options to extend or terminate the lease when it is reasonably
certain that the Company will exercise such options.</span></p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<ix:continuation id="_LesseeLeasesPolicyTextBlock-c0_cont_4"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">Payments
under the Company&#8217;s lease agreements are primarily fixed, however, certain lease agreements contain variable costs such as common
area maintenance, real estate taxes, and insurance are not included in the lease liability and are recognized as they are incurred. See
Note 6.</span></p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<ix:nonNumeric contextRef="c0" continuedAt="_NewAccountingPronouncementsPolicyPolicyTextBlock-c0_cont_1" escape="true" name="us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock" id="ixv-21149"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">v.</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Impact of recently issued accounting standard:</span></td>
</tr></table></ix:nonNumeric>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<ix:continuation id="_NewAccountingPronouncementsPolicyPolicyTextBlock-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">In
June 2016, the FASB issued ASU No. 2016-13, Financial Instruments&#8212;Credit Losses (&#8220;ASC 326&#8221;): Measurement of Credit
Losses on Financial Instruments to introduce a new model for recognizing credit losses on financial instruments based on estimated current
expected credit losses, or CECL. Under the new standard, an entity is required to estimate CECL on trade receivables at inception, based
on historical information, current conditions, and reasonable and supportable forecasts. The guidance is effective for the Company for
annual periods beginning after December 15, 2022, including interim periods within those fiscal years. Early application is permitted.
The Company adopted ASC 326 on January 1, 2023, and there was no material impact on the Company&#8217;s consolidated balance sheet and
the consolidated statements of operations upon adoption.</span></p></ix:continuation></ix:continuation><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 28.35pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 28.35pt; text-align: justify; text-indent: 0in"></p><div>

</div><!-- Field: Page; Sequence: 144 --><div>
    </div><div style="border-bottom: Black 1.5pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 28.35pt; text-align: justify; text-indent: 0in"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"></p><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-transform: uppercase; text-align: justify; text-indent: -56.7pt"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><b>ARBE
ROBOTICS LTD. AND SUBSIDIARIES</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif"><b>NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p><div>

</div><!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="border-top: Black 1.5pt solid; font-size: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></div></div><!-- Field: /Rule-Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-transform: uppercase; text-align: justify; text-indent: -56.7pt"><span style="font-family: Times New Roman, Times, Serif; text-transform: none">U.S.
dollars in thousands (except share and per share data)</span></p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-transform: uppercase; text-align: justify; text-indent: -56.7pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>


</div><ix:nonNumeric contextRef="c0" escape="true" name="us-gaap:RevenueFromContractWithCustomerTextBlock" id="ixv-21205"><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">NOTE
3:- &#160;&#160;REVENUE</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif"><i>Disaggregation
of Revenues</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"><ix:nonNumeric contextRef="c0" continuedAt="_DisaggregationOfRevenueTableTextBlock-c0_cont_1" escape="true" name="us-gaap:DisaggregationOfRevenueTableTextBlock" id="ixv-21216"><span style="font-family: Times New Roman, Times, Serif">Revenue
disaggregated by geography for the years ended December 31, 2023, 2022 and 2021, based on the billing address of the Company&#8217;s
customers, consists of the following:</span></ix:nonNumeric></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<ix:continuation id="_DisaggregationOfRevenueTableTextBlock-c0_cont_1"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="22" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><b>Year
                                            ended</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><b>December
                                            31,</b></span></p></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2023</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2022</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2021</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Revenue</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">%
    of Revenue</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Revenue</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">%
    of Revenue</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Revenue</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">%
    of Revenue</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Revenue by geography:</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 28%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">China</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c98" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" unitRef="usd" id="ixv-26436">639</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c99" decimals="3" format="ixt:num-dot-decimal" name="us-gaap:RevenueRemainingPerformanceObligationPercentage" scale="-2" unitRef="pure" id="ixv-26437">43.5</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c100" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" unitRef="usd" id="ixv-26438">1,476</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c101" decimals="3" format="ixt:num-dot-decimal" name="us-gaap:RevenueRemainingPerformanceObligationPercentage" scale="-2" unitRef="pure" id="ixv-26439">42.0</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c102" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" unitRef="usd" id="ixv-26440">702</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c103" decimals="3" format="ixt:num-dot-decimal" name="us-gaap:RevenueRemainingPerformanceObligationPercentage" scale="-2" unitRef="pure" id="ixv-26441">31.2</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Hong Kong</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c104" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" unitRef="usd" id="ixv-26442">266</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c105" decimals="3" format="ixt:num-dot-decimal" name="us-gaap:RevenueRemainingPerformanceObligationPercentage" scale="-2" unitRef="pure" id="ixv-26443">18.1</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-215; font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-216; font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c108" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" unitRef="usd" id="ixv-26444">35</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c109" decimals="3" format="ixt:num-dot-decimal" name="us-gaap:RevenueRemainingPerformanceObligationPercentage" scale="-2" unitRef="pure" id="ixv-26445">1.6</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Sweden</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c110" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" unitRef="usd" id="ixv-26446">247</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c111" decimals="3" format="ixt:num-dot-decimal" name="us-gaap:RevenueRemainingPerformanceObligationPercentage" scale="-2" unitRef="pure" id="ixv-26447">16.8</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c112" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" unitRef="usd" id="ixv-26448">1,276</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c113" decimals="3" format="ixt:num-dot-decimal" name="us-gaap:RevenueRemainingPerformanceObligationPercentage" scale="-2" unitRef="pure" id="ixv-26449">36.3</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c114" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" unitRef="usd" id="ixv-26450">928</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c115" decimals="3" format="ixt:num-dot-decimal" name="us-gaap:RevenueRemainingPerformanceObligationPercentage" scale="-2" unitRef="pure" id="ixv-26451">41.2</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">USA</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c116" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" unitRef="usd" id="ixv-26452">148</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c117" decimals="3" format="ixt:num-dot-decimal" name="us-gaap:RevenueRemainingPerformanceObligationPercentage" scale="-2" unitRef="pure" id="ixv-26453">10.1</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c118" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" unitRef="usd" id="ixv-26454">135</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c119" decimals="3" format="ixt:num-dot-decimal" name="us-gaap:RevenueRemainingPerformanceObligationPercentage" scale="-2" unitRef="pure" id="ixv-26455">3.8</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c120" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" unitRef="usd" id="ixv-26456">63</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c121" decimals="3" format="ixt:num-dot-decimal" name="us-gaap:RevenueRemainingPerformanceObligationPercentage" scale="-2" unitRef="pure" id="ixv-26457">2.8</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Germany</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c122" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" unitRef="usd" id="ixv-26458">81</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c123" decimals="3" format="ixt:num-dot-decimal" name="us-gaap:RevenueRemainingPerformanceObligationPercentage" scale="-2" unitRef="pure" id="ixv-26459">5.5</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c124" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" unitRef="usd" id="ixv-26460">284</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c125" decimals="3" format="ixt:num-dot-decimal" name="us-gaap:RevenueRemainingPerformanceObligationPercentage" scale="-2" unitRef="pure" id="ixv-26461">8.1</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c126" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" unitRef="usd" id="ixv-26462">351</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c127" decimals="3" format="ixt:num-dot-decimal" name="us-gaap:RevenueRemainingPerformanceObligationPercentage" scale="-2" unitRef="pure" id="ixv-26463">15.6</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Israel</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c128" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" unitRef="usd" id="ixv-26464">50</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c129" decimals="3" format="ixt:num-dot-decimal" name="us-gaap:RevenueRemainingPerformanceObligationPercentage" scale="-2" unitRef="pure" id="ixv-26465">3.4</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c130" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" unitRef="usd" id="ixv-26466">25</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c131" decimals="3" format="ixt:num-dot-decimal" name="us-gaap:RevenueRemainingPerformanceObligationPercentage" scale="-2" unitRef="pure" id="ixv-26467">0.7</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c132" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" unitRef="usd" id="ixv-26468">34</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c133" decimals="3" format="ixt:num-dot-decimal" name="us-gaap:RevenueRemainingPerformanceObligationPercentage" scale="-2" unitRef="pure" id="ixv-26469">1.5</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Italy</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-217; font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-218; font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c136" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" unitRef="usd" id="ixv-26470">124</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c137" decimals="3" format="ixt:num-dot-decimal" name="us-gaap:RevenueRemainingPerformanceObligationPercentage" scale="-2" unitRef="pure" id="ixv-26471">3.5</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-219; font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-220; font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Switzerland</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-221; font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-222; font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c142" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" unitRef="usd" id="ixv-26472">197</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c143" decimals="3" format="ixt:num-dot-decimal" name="us-gaap:RevenueRemainingPerformanceObligationPercentage" scale="-2" unitRef="pure" id="ixv-26473">5.6</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c144" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" unitRef="usd" id="ixv-26474">53</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c145" decimals="3" format="ixt:num-dot-decimal" name="us-gaap:RevenueRemainingPerformanceObligationPercentage" scale="-2" unitRef="pure" id="ixv-26475">2.4</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Other</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c146" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" unitRef="usd" id="ixv-26476">39</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c147" decimals="3" format="ixt:num-dot-decimal" name="us-gaap:RevenueRemainingPerformanceObligationPercentage" scale="-2" unitRef="pure" id="ixv-26477">2.6</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-223; font-family: Times New Roman, Times, Serif">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-224; font-family: Times New Roman, Times, Serif">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c150" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" unitRef="usd" id="ixv-26478">83</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c151" decimals="3" format="ixt:num-dot-decimal" name="us-gaap:RevenueRemainingPerformanceObligationPercentage" scale="-2" unitRef="pure" id="ixv-26479">3.7</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">Total revenue</span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" unitRef="usd" id="ixv-26480">1,470</ix:nonFraction></span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c5" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:RevenueRemainingPerformanceObligationPercentage" scale="-2" unitRef="pure" id="ixv-26481">100</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c7" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" unitRef="usd" id="ixv-26482">3,517</ix:nonFraction></span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c6" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:RevenueRemainingPerformanceObligationPercentage" scale="-2" unitRef="pure" id="ixv-26483">100</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c8" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" unitRef="usd" id="ixv-26484">2,249</ix:nonFraction></span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c40" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:RevenueRemainingPerformanceObligationPercentage" scale="-2" unitRef="pure" id="ixv-26485">100</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td></tr>
  </table></ix:continuation>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif"><i>Contract
Liabilities</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 85.05pt 0pt 0; text-align: justify; text-indent: -28.35pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">Contract
liabilities consist of deferred revenue and customer advanced payments. Deferred revenue includes billings in excess of revenue recognized
related to product sales and is recognized as revenue when the Company performs under the contract. Customer advanced payments represent
required customer payments in advance of product shipments according to customer&#8217;s payment term. Customer advance payments are
recognized as revenue when control of the performance obligation is transferred to the customer.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">Contract
liabilities presented as deferred revenue amounted to $<ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DeferredRevenue" scale="3" unitRef="usd" id="ixv-26486">0</ix:nonFraction> and $<ix:nonFraction contextRef="c6" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DeferredRevenue" scale="3" unitRef="usd" id="ixv-26487">351</ix:nonFraction> as of December 31, 2023 and 2022, respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif"><i>Remaining
Performance Obligation</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">The
Company&#8217;s remaining performance obligations are comprised of product and services revenue not yet performed. As of December&#160;31,
2023 and 2022 the aggregate amount of the transaction price allocated to remaining performance obligations was $<ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueRemainingPerformanceObligation" scale="3" unitRef="usd" id="ixv-26488">977</ix:nonFraction> and $<ix:nonFraction contextRef="c6" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueRemainingPerformanceObligation" scale="3" unitRef="usd" id="ixv-26489">232</ix:nonFraction>, respectively.
The Company expects to recognize 2023 remaining performance obligations as revenue during 2024.</span></p></ix:nonNumeric><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: 0in"></p><div>

</div><!-- Field: Page; Sequence: 145 --><div>
    </div><div style="border-bottom: Black 1.5pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-transform: uppercase; text-align: justify; text-indent: -56.7pt"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><b>ARBE
ROBOTICS LTD. AND SUBSIDIARIES</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif"><b>NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p><div>

</div><!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="border-top: Black 1.5pt solid; font-size: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></div></div><!-- Field: /Rule-Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-transform: uppercase; text-align: justify; text-indent: -56.7pt"><span style="font-family: Times New Roman, Times, Serif; text-transform: none">U.S.
dollars in thousands (except share and per share data)</span></p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-transform: uppercase; text-align: justify; text-indent: -56.7pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>


</div><ix:nonNumeric contextRef="c0" escape="true" name="us-gaap:OtherCurrentAssetsTextBlock" id="ixv-21906"><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-align: justify; text-indent: -56.7pt"><span style="font-family: Times New Roman, Times, Serif">NOTE
4:-&#160;&#160; PREPAID EXPENSES AND OTHER RECEIVABLES</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-align: justify; text-indent: -56.7pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<ix:nonNumeric contextRef="c0" escape="true" name="us-gaap:DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock" id="ixv-21911"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">December
    31,</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2023</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2022</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Government authorities</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="arbe:GovernmentAuthorities" scale="3" unitRef="usd" id="ixv-26490">385</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c6" decimals="-3" format="ixt:num-dot-decimal" name="arbe:GovernmentAuthorities" scale="3" unitRef="usd" id="ixv-26491">280</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Deposits</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DepositAssets" scale="3" unitRef="usd" id="ixv-26492">69</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c6" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DepositAssets" scale="3" unitRef="usd" id="ixv-26493">85</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Grants receivable</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:GrantsReceivableCurrent" scale="3" unitRef="usd" id="ixv-26494">310</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c6" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:GrantsReceivableCurrent" scale="3" unitRef="usd" id="ixv-26495">319</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Prepaid expenses
    and other</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PrepaidExpenseAndOtherAssets" scale="3" unitRef="usd" id="ixv-26496">1,262</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c6" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PrepaidExpenseAndOtherAssets" scale="3" unitRef="usd" id="ixv-26497">1,155</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify; padding-bottom: 4pt; padding-left: 0.5in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PrepaidExpenseAndOtherAssetsNoncurrent" scale="3" unitRef="usd" id="ixv-26498">2,026</ix:nonFraction></span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c6" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PrepaidExpenseAndOtherAssetsNoncurrent" scale="3" unitRef="usd" id="ixv-26499">1,839</ix:nonFraction></span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table></ix:nonNumeric></ix:nonNumeric><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-transform: uppercase; text-align: justify; text-indent: -56.7pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><ix:nonNumeric contextRef="c0" escape="true" name="us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock" id="ixv-22051"><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-transform: uppercase; text-align: justify; text-indent: -56.7pt"><span style="font-family: Times New Roman, Times, Serif">Note
5:- Property and Equipment</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-transform: uppercase; text-align: justify; text-indent: -56.7pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<ix:nonNumeric contextRef="c0" escape="true" name="us-gaap:PropertyPlantAndEquipmentTextBlock" id="ixv-22056"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">December
    31,</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2023</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2022</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Cost:</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.25in; width: 76%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Computers
    and peripheral equipment</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c152" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" unitRef="usd" id="ixv-26500">2,448</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c153" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" unitRef="usd" id="ixv-26501">2,350</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Leasehold
    improvement</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c97" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" unitRef="usd" id="ixv-26502">582</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c154" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" unitRef="usd" id="ixv-26503">438</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Office
    furniture and equipment</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c155" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" unitRef="usd" id="ixv-26504">133</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c156" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" unitRef="usd" id="ixv-26505">128</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Vehicles</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c96" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" unitRef="usd" id="ixv-26506">149</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c157" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" unitRef="usd" id="ixv-26507">139</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" unitRef="usd" id="ixv-26508">3,312</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c6" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" unitRef="usd" id="ixv-26509">3,055</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Accumulated
    depreciation</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" scale="3" unitRef="usd" id="ixv-26510">2,003</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c6" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" scale="3" unitRef="usd" id="ixv-26511">1,446</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">Property
    and equipment, net</span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PropertyPlantAndEquipmentNet" scale="3" unitRef="usd" id="ixv-26512">1,309</ix:nonFraction></span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c6" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PropertyPlantAndEquipmentNet" scale="3" unitRef="usd" id="ixv-26513">1,609</ix:nonFraction></span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table></ix:nonNumeric>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: -28.35pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">Depreciation
expense for the years ended December 31, 2023, 2022 and 2021 was $<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:Depreciation" scale="3" unitRef="usd" id="ixv-26514">557</ix:nonFraction>, $<ix:nonFraction contextRef="c7" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:Depreciation" scale="3" unitRef="usd" id="ixv-26515">481</ix:nonFraction> and $<ix:nonFraction contextRef="c8" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:Depreciation" scale="3" unitRef="usd" id="ixv-26516">342</ix:nonFraction>, respectively.</span></p></ix:nonNumeric><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-transform: uppercase; text-align: justify; text-indent: -56.7pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-transform: uppercase; text-align: justify; text-indent: -56.7pt"></p><div>

</div><!-- Field: Page; Sequence: 146 --><div>
    </div><div style="border-bottom: Black 1.5pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-transform: uppercase; text-align: justify; text-indent: -56.7pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-transform: uppercase; text-align: justify; text-indent: -56.7pt"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><b>ARBE
ROBOTICS LTD. AND SUBSIDIARIES</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif"><b>NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p><div>

</div><!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="border-top: Black 1.5pt solid; font-size: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></div></div><!-- Field: /Rule-Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-transform: uppercase; text-align: justify; text-indent: -56.7pt"><span style="font-family: Times New Roman, Times, Serif; text-transform: none">U.S.
dollars in thousands (except share and per share data)</span></p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-transform: uppercase; text-align: justify; text-indent: -56.7pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>


</div><ix:nonNumeric contextRef="c0" escape="true" name="us-gaap:LesseeOperatingLeasesTextBlock" id="ixv-22311"><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-transform: uppercase; text-align: justify; text-indent: -56.7pt"><span style="font-family: Times New Roman, Times, Serif">Note
6:-&#160;&#160; LEASES</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-transform: uppercase; text-align: justify; text-indent: -56.7pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-weight: normal; text-transform: none">The
Company has five non-cancelable operating lease agreements for certain office spaces in Israel. The leases have original lease periods
expiring until 2027, some of which may include options to extend the leases for up to three additional years. The Company does not assume
renewals in its determination of the lease term unless the renewals are considered as reasonably certain to exercise.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-transform: uppercase; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-weight: normal; text-transform: none">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"><ix:nonNumeric contextRef="c0" continuedAt="_OperatingLeaseLeaseIncomeTableTextBlock-c0_cont_1" escape="true" name="us-gaap:OperatingLeaseLeaseIncomeTableTextBlock" id="ixv-22321"><span style="font-family: Times New Roman, Times, Serif; font-weight: normal; text-transform: none">Supplemental
cash flow information related to leases was as follows:</span></ix:nonNumeric></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-transform: uppercase; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-weight: normal; text-transform: none">&#160;</span></p>

<ix:continuation id="_OperatingLeaseLeaseIncomeTableTextBlock-c0_cont_1"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-align: justify"><span style="text-decoration: none; font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><b>Year
                                            ended</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2.85pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><b>December
                                            31,</b></span></p></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: justify"><span style="text-decoration: none; font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2023</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2022</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-decoration: none; width: 76%; text-align: justify"><span style="text-decoration: none; font-family: Times New Roman, Times, Serif">Cash
    payments and expenses related to operating leases</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OperatingLeasePayments" scale="3" unitRef="usd" id="ixv-26517">451</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction contextRef="c7" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OperatingLeasePayments" scale="3" unitRef="usd" id="ixv-26518">370</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-decoration: none; text-align: justify"><span style="text-decoration: none; font-family: Times New Roman, Times, Serif">Operating
    lease right-of-use assets and liabilities, net</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="arbe:OperatingLeaseRightofuseAssetsAndLiabilitiesNet" scale="3" sign="-" unitRef="usd" id="ixv-26519">2</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction contextRef="c7" decimals="-3" format="ixt:num-dot-decimal" name="arbe:OperatingLeaseRightofuseAssetsAndLiabilitiesNet" scale="3" unitRef="usd" id="ixv-26520">84</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  </table></ix:continuation>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-transform: uppercase; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-weight: normal; text-transform: none">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"><ix:nonNumeric contextRef="c0" continuedAt="_LesseeOperatingLeaseLiabilityMaturityTableTextBlock-c0_cont_1" escape="true" name="us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock" id="ixv-22397"><span style="font-family: Times New Roman, Times, Serif; font-weight: normal; text-transform: none">Maturities
of lease liabilities as of December 31, 2023, were as follows:</span></ix:nonNumeric></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-transform: uppercase; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-weight: normal; text-transform: none">&#160;</span></p>

<ix:continuation id="_LesseeOperatingLeaseLiabilityMaturityTableTextBlock-c0_cont_1"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 88%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">2024</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" scale="3" unitRef="usd" id="ixv-26521">443</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">2025</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" scale="3" unitRef="usd" id="ixv-26522">393</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">2026</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree" scale="3" unitRef="usd" id="ixv-26523">356</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">2027 and after</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour" scale="3" unitRef="usd" id="ixv-26524">1,033</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Total lease payments</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue" scale="3" unitRef="usd" id="ixv-26525">2,225</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Less imputed interest</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" scale="3" unitRef="usd" id="ixv-26526">483</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Total lease liabilities</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OperatingLeaseLiability" scale="3" unitRef="usd" id="ixv-26527">1,742</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table></ix:continuation>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-transform: uppercase; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-weight: normal; text-transform: none">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"><ix:nonNumeric contextRef="c0" continuedAt="_LeaseCostTableTextBlock-c0_cont_1" escape="true" name="us-gaap:LeaseCostTableTextBlock" id="ixv-22483"><span style="font-family: Times New Roman, Times, Serif; font-weight: normal; text-transform: none">Supplemental
balance sheet information related to operating leases were as follows:</span></ix:nonNumeric></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-transform: uppercase; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-weight: normal; text-transform: none">&#160;</span></p>

<ix:continuation id="_LeaseCostTableTextBlock-c0_cont_1"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="white-space: nowrap; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">December&#160;31,</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">December&#160;31,</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2023</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><b>202<span style="font-size: 10pt">2</span></b></span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Operating lease right-of-use assets</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="white-space: nowrap; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="white-space: nowrap; width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="3" unitRef="usd" id="ixv-26528">1,740</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c6" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="3" unitRef="usd" id="ixv-26529">465</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Current maturities of operating leases</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="white-space: nowrap; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="white-space: nowrap; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OperatingLeaseLiabilityCurrent" scale="3" unitRef="usd" id="ixv-26530">436</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c6" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OperatingLeaseLiabilityCurrent" scale="3" unitRef="usd" id="ixv-26531">364</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Long-term operating lease liabilities</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="white-space: nowrap; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="white-space: nowrap; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OperatingLeaseLiabilityNoncurrent" scale="3" unitRef="usd" id="ixv-26532">1,306</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c6" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OperatingLeaseLiabilityNoncurrent" scale="3" unitRef="usd" id="ixv-26533">17</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Weighted average remaining lease term (in years)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="white-space: nowrap; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="white-space: nowrap; text-align: right"><ix:nonNumeric contextRef="c5" format="ixt-sec:duryear" name="us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1" id="ixv-22586"><span style="font-family: Times New Roman, Times, Serif">5.5</span></ix:nonNumeric></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><ix:nonNumeric contextRef="c6" format="ixt-sec:duryear" name="us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1" id="ixv-22595"><span style="font-family: Times New Roman, Times, Serif">1.1</span></ix:nonNumeric></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Weighted average discount rate</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="white-space: nowrap; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="white-space: nowrap; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c5" decimals="3" format="ixt:num-dot-decimal" name="us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent" scale="-2" unitRef="pure" id="ixv-26534">9.4</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c6" decimals="3" format="ixt:num-dot-decimal" name="us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent" scale="-2" unitRef="pure" id="ixv-26535">5.8</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td></tr>
  </table></ix:continuation></ix:nonNumeric><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-transform: uppercase; text-align: justify; text-indent: -56.7pt"><span style="font-family: Times New Roman, Times, Serif; font-weight: normal; text-transform: none">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-transform: uppercase; text-align: justify; text-indent: -56.7pt"></p><div>

</div><!-- Field: Page; Sequence: 147 --><div>
    </div><div style="border-bottom: Black 1.5pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-transform: uppercase; text-align: justify; text-indent: -56.7pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-transform: uppercase; text-align: justify; text-indent: -56.7pt"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><b>ARBE
ROBOTICS LTD. AND SUBSIDIARIES</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif"><b>NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p><div>

</div><!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="border-top: Black 1.5pt solid; font-size: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></div></div><!-- Field: /Rule-Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-transform: uppercase; text-align: justify; text-indent: -56.7pt"><span style="font-family: Times New Roman, Times, Serif; text-transform: none">U.S.
dollars in thousands (except share and per share data)</span></p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-transform: uppercase; text-align: justify; text-indent: -56.7pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>


</div><ix:nonNumeric contextRef="c0" escape="true" name="us-gaap:CommitmentsAndContingenciesDisclosureTextBlock" id="ixv-22657"><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-transform: uppercase; text-align: justify; text-indent: -56.7pt"><span style="font-family: Times New Roman, Times, Serif">Note
7:- &#160;&#160;COMMITMENTS AND CONTINGENT LIABILITIES</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">The
Company participated in programs sponsored mainly by the Israeli Innovation Authority (&#8220;IIA&#8221;), an Israeli government agency,
for the support of its research and development activities. Through December 31, 2023, the Company had obtained grants aggregating to
$<ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:GrantsReceivable" scale="3" unitRef="usd" id="ixv-26536">3,846</ix:nonFraction> for certain of its research and development projects. The Company is obligated to pay royalties to the IIA, amounting to <ix:nonFraction contextRef="c0" decimals="2" format="ixt:num-dot-decimal" name="arbe:RoyaltyPercentage" scale="-2" unitRef="pure" id="ixv-26537">4</ix:nonFraction>% of
the sales of the products and other related revenues generated from such projects. The maximum aggregate royalties paid generally cannot
exceed <ix:nonFraction contextRef="c0" decimals="2" format="ixt:num-dot-decimal" name="arbe:GrantsReceived" scale="-2" unitRef="pure" id="ixv-26538">100</ix:nonFraction>% of the grants received, plus annual interest generally equal to 12-months SOFR applicable to dollar deposits, as published
on the first business day of each calendar year. The obligation to pay these royalties is contingent on sales of the products and in
the absence of such sales, no payment is required.&#160;</span></p></ix:nonNumeric><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 84.45pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><ix:nonNumeric contextRef="c0" escape="true" name="us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" id="ixv-22668"><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-transform: uppercase; text-align: justify; text-indent: -56.7pt"><span style="font-family: Times New Roman, Times, Serif">Note
8:- &#160;&#160;warrants liabilities</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">The
Company issued in 2019 warrants to purchase a number of convertible Series B-1 convertible preferred shares, for an aggregate exercise
price of $<ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AdditionalCollateralAggregateFairValue" scale="3" unitRef="usd" id="ixv-26539">550</ix:nonFraction>. As a result of the Merger and the related Recapitalization, the warrants became convertible into the Company&#8217;s ordinary
shares. The Company classified the warrants as freestanding and treated as liability pursuant to ASC 480 and remeasured every reporting
period with any change to fair value recorded within financial expenses in the statements of operations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">As
a result of the Merger, the Company assumed a derivative warrant liability related to <ix:nonFraction contextRef="c158" decimals="0" format="ixt:num-dot-decimal" name="arbe:DerivativeWarrantLiabilityShares" scale="0" unitRef="shares" id="ixv-26540">3,112,080</ix:nonFraction> private placement warrants assumed by
the Company pursuant to the terms of the Merger.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">The
Company utilizes a Black-Scholes option pricing model to estimate the fair value of the private placement warrants and the convertible
warrants (hereinafter: the &#8220;warrants&#8221;) and are considered a Level 3 fair value measurement. Black-Scholes option pricing
model takes into consideration certain parameters in computation of the fair value of the warrants which the significant parameter is
expected volatility. The Company computed a sensitivity analysis of the fair value to changes of the expected volatility. The volatility
impact of +/-<ix:nonFraction contextRef="c0" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate" scale="-2" unitRef="pure" id="ixv-26541">5</ix:nonFraction>% on the warrants&#8217; fair value is approximately $<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:FairValueAdjustmentOfWarrants" scale="3" unitRef="usd" id="ixv-26542">180</ix:nonFraction>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">The
warrants are measured at each reporting period, with changes in fair value recognized in the statement of operations. During 2023, 2022
and 2021, the Company recognized ($<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ProceedsFromIssuanceOfWarrants" scale="3" unitRef="usd" id="ixv-26543">756</ix:nonFraction>), ($<ix:nonFraction contextRef="c7" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ProceedsFromIssuanceOfWarrants" scale="3" unitRef="usd" id="ixv-26544">8,425</ix:nonFraction>) and $<ix:nonFraction contextRef="c8" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ProceedsFromIssuanceOfWarrants" scale="3" unitRef="usd" id="ixv-26545">3,083</ix:nonFraction>, respectively, with respect with those warrants as a finance expenses (income).</span></p></ix:nonNumeric><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-weight: normal; text-transform: none">&#160;</span></p><div>

</div><!-- Field: Page; Sequence: 148 --><div>
    </div><div style="border-bottom: Black 1.5pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-transform: uppercase; text-align: justify"></p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-transform: uppercase; text-align: justify; text-indent: -56.7pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-transform: uppercase; text-align: justify; text-indent: -56.7pt"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><b>ARBE
ROBOTICS LTD. AND SUBSIDIARIES</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif"><b>NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p><div>

</div><!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="border-top: Black 1.5pt solid; font-size: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></div></div><!-- Field: /Rule-Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-transform: uppercase; text-align: justify; text-indent: -56.7pt"><span style="font-family: Times New Roman, Times, Serif; text-transform: none">U.S.
dollars in thousands (except share and per share data)</span></p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-transform: uppercase; text-align: justify; text-indent: -56.7pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>


</div><ix:nonNumeric contextRef="c0" continuedAt="_StockholdersEquityNoteDisclosureTextBlock-c0_cont_1" escape="true" name="us-gaap:StockholdersEquityNoteDisclosureTextBlock" id="ixv-22726"><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-transform: uppercase; text-align: justify; text-indent: -56.7pt"><span style="font-family: Times New Roman, Times, Serif">Note
9:- &#160;&#160;Shareholders&#8217; equity</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">a.</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">In connection with the Merger, the Company adopted its restated articles, pursuant to which the Company&#8217;s authorized capital consisted of <ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:CommonStockSharesAuthorized" scale="0" unitRef="shares" id="ixv-26546">130,000,000</ix:nonFraction> Ordinary Shares, with a par value of NIS <ix:nonFraction contextRef="c5" decimals="6" format="ixt:num-dot-decimal" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" unitRef="ilsPershares" id="ixv-26547">0.000216</ix:nonFraction> per share and <ix:nonNumeric contextRef="c0" name="us-gaap:StockholdersEquityReverseStockSplit" id="ixv-26548">the Company effected a 1:46.25783 stock split</ix:nonNumeric>.</span></td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: -28.35pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.75in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">b.</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">During June 2023, the Company raised $<ix:nonFraction contextRef="c159" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:CommonUnitIssuanceValue" scale="0" unitRef="usd" id="ixv-26549">23,000</ix:nonFraction> with Special Situations Funds, pursuant to which the Company issued a total of <ix:nonFraction contextRef="c159" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:CommonUnitIssued" scale="0" unitRef="shares" id="ixv-26550">11,794,873</ix:nonFraction> Ordinary Shares with a purchase price of $<ix:nonFraction contextRef="c159" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:SharePrice" scale="0" unitRef="usdPershares" id="ixv-26551">1.95</ix:nonFraction> per share. Existing investors, including two affiliates of Arbe&#8217;s directors also participated in this offering. The aggregate net proceeds received by the Company from the offering were $<ix:nonFraction contextRef="c160" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:ProceedsFromIssuanceOfCommonStock" scale="0" unitRef="usd" id="ixv-26552">22,496</ix:nonFraction>&#160;net of issuance costs.</span></td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.75in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">c.</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Share
                                            option and RSU&#8217;s:</span></td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: -28.35pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">During
2016, the Company adopted the 2016 Share Incentive Plan (the &#8220;2016 Plan&#8221;) which provides the Company with the ability to grant
its employees, directors and service providers options to purchase Ordinary Shares of the Company, at a purchase price as determined
by the Board of Directors at the date of grant. Pursuant to the 2016 Plan, <ix:nonFraction contextRef="c161" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" scale="0" unitRef="shares" id="ixv-26553">3,384,454</ix:nonFraction> Ordinary Shares were reserved for issuance. Each
option granted under the Plan expires no later than <ix:nonNumeric contextRef="c0" format="ixt-sec:durwordsen" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" id="ixv-26554">seven years</ix:nonNumeric> from the date of grant or 60 days after termination of engagement. The
vesting period of the share options is generally <ix:nonNumeric contextRef="c162" format="ixt-sec:durwordsen" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" id="ixv-26555">four years</ix:nonNumeric>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">In
August 2021, the Board of the Company approved and in September 2021 the shareholders approved, the Arbe Robotics Ltd. 2021 Equity Incentive
Plan (the &#8220;2021 Plan&#8221;) which became effective on October 7, 2021. The 2021 Plan covers (a) <ix:nonFraction contextRef="c163" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" scale="0" unitRef="shares" id="ixv-26556">4,079,427</ix:nonFraction> ordinary shares plus
(b) and without the need to further amend the Plan on January 1 of each calendar year beginning on January 1, 2022 and ending on and
including January 1, 2031, a number of Shares equal to the lesser of: <ix:nonNumeric contextRef="c164" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardTermsOfAward" id="ixv-26557">(i) 5% of the total number of ordinary shares outstanding on December
31 of the immediately preceding calendar year, and (ii) an amount determined by the Board, if so determined prior to the January 1 of
the calendar year in which the increase will occur</ix:nonNumeric>.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p></ix:nonNumeric><div>

</div><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: 0in"></p><div>

</div><!-- Field: Page; Sequence: 149 --><div>
    </div><div style="border-bottom: Black 1.5pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-transform: uppercase; text-align: justify; text-indent: -56.7pt"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><b>ARBE
ROBOTICS LTD. AND SUBSIDIARIES</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif"><b>NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p><div>

</div><!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="border-top: Black 1.5pt solid; font-size: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></div></div><!-- Field: /Rule-Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-transform: uppercase; text-align: justify; text-indent: -56.7pt"><span style="font-family: Times New Roman, Times, Serif; text-transform: none">U.S.
dollars in thousands (except share and per share data)</span></p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-transform: uppercase; text-align: justify; text-indent: -56.7pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>


</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-transform: uppercase; text-align: justify; text-indent: -56.7pt"><span style="font-family: Times New Roman, Times, Serif">Note
9:- &#160;&#160;Shareholders&#8217; equity (<span style="text-transform: none">Cont</span>.)</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><ix:continuation continuedAt="_StockholdersEquityNoteDisclosureTextBlock-c0_cont_2" id="_StockholdersEquityNoteDisclosureTextBlock-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">Upon
the adoption of the 2021 Plan, the Company will no longer grant any awards under the 2016 Plan, although previously granted options under
the 2016 Plan will remain outstanding and governed by the 2016 Plan and awards available for grant under the 2016 Plan which had not
been issued or which expired unexercised may be issued pursuant to the 2021 Plan. <ix:nonNumeric contextRef="c164" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRights" id="ixv-26558">The vesting period of the awards is generally <ix:nonNumeric contextRef="c164" format="ixt-sec:durwordsen" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" id="ixv-26559">four
years</ix:nonNumeric>. Generally, under the terms of the Plans, unless determined otherwise,&#160;25% of an award granted becomes exercisable on the
first anniversary of the date of grant and&#160;6.25% becomes exercisable once every quarter during the subsequent&#160;three years.</ix:nonNumeric></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">Share
option and RSU&#8217;s plans:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: -28.35pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"><ix:nonNumeric contextRef="c0" continuedAt="_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock-c0_cont_1" escape="true" name="us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" id="ixv-22820"><span style="font-family: Times New Roman, Times, Serif">A
summary of the stock option activity under the Company&#8217;s equity plans during the years ended December 31, 2023, 2022 and 2021 is
as follows:</span></ix:nonNumeric></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<ix:continuation id="_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock-c0_cont_1"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><b>Outstanding</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2.85pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><b>share
                                            options</b></span></p></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Weighted-average
    exercise<br/>
 price ($)</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Weighted
    average remaining contractual<br/>
 life (years)</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Aggregate
    intrinsic value ($ in thousands)</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Options:</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 52%; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Outstanding
    as of December&#160;31, 2020</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c19" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" scale="0" unitRef="shares" id="ixv-26560">3,768,034</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c19" decimals="3" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" unitRef="usdPershares" id="ixv-26561">0.767</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 9%; text-align: right"><ix:nonNumeric contextRef="c165" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" id="ixv-22925"><span style="font-family: Times New Roman, Times, Serif">4.626</span></ix:nonNumeric></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c19" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" scale="3" unitRef="usd" id="ixv-26562">119,146</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Granted</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c8" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" scale="0" unitRef="shares" id="ixv-26563">1,966,916</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c8" decimals="3" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" scale="0" unitRef="usdPershares" id="ixv-26564">7.250</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Forfeited</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction contextRef="c8" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" scale="0" unitRef="shares" id="ixv-26565">117,863</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c8" decimals="3" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" scale="0" unitRef="usdPershares" id="ixv-26566">0.972</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Exercised</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction contextRef="c8" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised" scale="0" unitRef="shares" id="ixv-26567">155,750</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c8" decimals="3" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" scale="0" unitRef="usdPershares" id="ixv-26568">0.602</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Outstanding
    as of December&#160;31, 2021</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c40" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" scale="0" unitRef="shares" id="ixv-26569">5,461,337</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c40" decimals="3" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" unitRef="usdPershares" id="ixv-26570">3.102</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt; text-align: right"><ix:nonNumeric contextRef="c8" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" id="ixv-23102"><span style="font-family: Times New Roman, Times, Serif">5.363</span></ix:nonNumeric></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c40" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" scale="3" unitRef="usd" id="ixv-26571">16,713,971</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Granted</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c7" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" scale="0" unitRef="shares" id="ixv-26572">1,630,142</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c7" decimals="3" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" scale="0" unitRef="usdPershares" id="ixv-26573">6.833</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Forfeited</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction contextRef="c7" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" scale="0" unitRef="shares" id="ixv-26574">468,814</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c7" decimals="3" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" scale="0" unitRef="usdPershares" id="ixv-26575">5.557</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Exercised</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction contextRef="c7" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised" scale="0" unitRef="shares" id="ixv-26576">570,451</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c7" decimals="3" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" scale="0" unitRef="usdPershares" id="ixv-26577">0.482</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Outstanding as of December&#160;31,
    2022</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c6" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" scale="0" unitRef="shares" id="ixv-26578">6,052,214</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c6" decimals="3" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" unitRef="usdPershares" id="ixv-26579">4.166</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><ix:nonNumeric contextRef="c7" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" id="ixv-23279"><span style="font-family: Times New Roman, Times, Serif">5.570</span></ix:nonNumeric></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c6" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" scale="3" unitRef="usd" id="ixv-26580">7,761,705</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Granted</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c0" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" scale="0" unitRef="shares" id="ixv-26581">430,874</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c0" decimals="3" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" scale="0" unitRef="usdPershares" id="ixv-26582">2.728</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Forfeited</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction contextRef="c0" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" scale="0" unitRef="shares" id="ixv-26583">351,671</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c0" decimals="3" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" scale="0" unitRef="usdPershares" id="ixv-26584">7.767</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Exercised</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction contextRef="c0" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised" scale="0" unitRef="shares" id="ixv-26585">1,074,162</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c0" decimals="3" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" scale="0" unitRef="usdPershares" id="ixv-26586">0.654</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 4pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 11.35pt; text-align: left; text-indent: -8.5pt"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif"><b>Outstanding
                                            as of December&#160;31, 2023 </b></span></p></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c5" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" scale="0" unitRef="shares" id="ixv-26587">5,057,255</ix:nonFraction></span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c5" decimals="3" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" unitRef="usdPershares" id="ixv-26588">4.543</ix:nonFraction></span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonNumeric contextRef="c0" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" id="ixv-23460"><span style="font-family: Times New Roman, Times, Serif">5.662</span></ix:nonNumeric></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" scale="3" unitRef="usd" id="ixv-26589">2,352,517</ix:nonFraction></span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">Exercisable as of December&#160;31,
    2023</span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c5" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" scale="0" unitRef="shares" id="ixv-26590">3,210,191</ix:nonFraction></span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c5" decimals="3" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" scale="0" unitRef="usdPershares" id="ixv-26591">3.643</ix:nonFraction></span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonNumeric contextRef="c0" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" id="ixv-23531"><span style="font-family: Times New Roman, Times, Serif">4.403</span></ix:nonNumeric></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" scale="3" unitRef="usd" id="ixv-26592">2,277,303</ix:nonFraction></span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">Options available for
    future grants</span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c5" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" scale="0" unitRef="shares" id="ixv-26593">611,246</ix:nonFraction></span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: -28.35pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p></ix:continuation></ix:continuation><div>

</div><!-- Field: Page; Sequence: 150 --><div>
    </div><div style="border-bottom: Black 1.5pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: -28.35pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-transform: uppercase; text-align: justify; text-indent: -56.7pt"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><b>ARBE
ROBOTICS LTD. AND SUBSIDIARIES</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif"><b>NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p><div>

</div><!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="border-top: Black 1.5pt solid; font-size: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></div></div><!-- Field: /Rule-Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-transform: uppercase; text-align: justify; text-indent: -56.7pt"><span style="font-family: Times New Roman, Times, Serif; text-transform: none">U.S.
dollars in thousands (except share and per share data)</span></p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-transform: uppercase; text-align: justify; text-indent: -56.7pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>


</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-transform: uppercase; text-align: justify; text-indent: -56.7pt"><span style="font-family: Times New Roman, Times, Serif">Note
9:-&#160;&#160; Shareholders&#8217; equity (<span style="text-transform: none">Cont</span>.)</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><ix:continuation continuedAt="_StockholdersEquityNoteDisclosureTextBlock-c0_cont_3" id="_StockholdersEquityNoteDisclosureTextBlock-c0_cont_2"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"><ix:nonNumeric contextRef="c0" continuedAt="_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock-c0_cont_1" escape="true" name="us-gaap:ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock" id="ixv-23660"><span style="font-family: Times New Roman, Times, Serif">A
summary of the Company&#8217;s RSUs activity during the years ended December 31, 2023, 2022 and 2021 is as follows:</span></ix:nonNumeric></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 84.95pt; text-align: left; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-transform: uppercase; text-align: justify; text-indent: -56.7pt"></p>

<ix:continuation id="_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock-c0_cont_1"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Numbers
    of RSUs</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">RSUs:</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; text-align: left">&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"><b>Outstanding as of January 1, 2021</b></span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-225; font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 88%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Granted</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c167" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted" scale="0" unitRef="shares" id="ixv-26594">1,968,794</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Forfeited</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-226; font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Vested</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-227; font-family: Times New Roman, Times, Serif">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Outstanding as of December&#160;31,
    2021</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c168" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" scale="0" unitRef="shares" id="ixv-26595">1,968,794</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Granted</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c169" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted" scale="0" unitRef="shares" id="ixv-26596">1,619,898</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Forfeited</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction contextRef="c169" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures" scale="0" unitRef="shares" id="ixv-26597">417,025</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Vested</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction contextRef="c169" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsPeriodIncreaseDecrease" scale="0" unitRef="shares" id="ixv-26598">573,583</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Outstanding as of December&#160;31,
    2022</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c170" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" scale="0" unitRef="shares" id="ixv-26599">2,598,084</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Granted</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c171" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted" scale="0" unitRef="shares" id="ixv-26600">2,908,983</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Forfeited</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction contextRef="c171" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures" scale="0" unitRef="shares" id="ixv-26601">370,067</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Vested</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction contextRef="c171" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsPeriodIncreaseDecrease" scale="0" unitRef="shares" id="ixv-26602">895,170</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 4pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Outstanding as of December&#160;31,
    2023</span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c172" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" scale="0" unitRef="shares" id="ixv-26603">4,241,830</ix:nonFraction></span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table></ix:continuation>
<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-transform: uppercase; text-align: justify; text-indent: -56.7pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">Fair
value factors:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: -28.35pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"><ix:nonNumeric contextRef="c0" continuedAt="_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock-c0_cont_1" escape="true" name="us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" id="ixv-23871"><span style="font-family: Times New Roman, Times, Serif">The
following table sets forth the parameters used in computation of the options compensation to employees and service providers:</span></ix:nonNumeric></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<ix:continuation id="_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock-c0_cont_1"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="10" style="border-bottom: Black 1.5pt solid; white-space: nowrap; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><b>Year
                                            ended </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><b>December
                                            31</b></span></p></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2023</span></td><td style="white-space: nowrap; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2022</span></td><td style="white-space: nowrap; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2021</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="white-space: nowrap; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="white-space: nowrap; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="white-space: nowrap; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Expected term, in years</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="white-space: nowrap; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="white-space: nowrap; width: 9%; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><ix:nonNumeric contextRef="c0" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" id="ixv-26604">5.82</ix:nonNumeric></span></td><td style="white-space: nowrap; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="white-space: nowrap; width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="white-space: nowrap; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="white-space: nowrap; width: 9%; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><ix:nonNumeric contextRef="c173" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" id="ixv-26605">4.41</ix:nonNumeric>-<ix:nonNumeric contextRef="c174" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" id="ixv-26606">6.11</ix:nonNumeric></span></td><td style="white-space: nowrap; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="white-space: nowrap; width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="white-space: nowrap; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="white-space: nowrap; width: 9%; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><ix:nonNumeric contextRef="c175" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" id="ixv-26607">4.61</ix:nonNumeric>-<ix:nonNumeric contextRef="c176" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" id="ixv-26608">6.11</ix:nonNumeric></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Expected volatility</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="white-space: nowrap; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="white-space: nowrap; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c90" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" scale="-2" unitRef="pure" id="ixv-26609">47</ix:nonFraction>%-<ix:nonFraction contextRef="c91" decimals="4" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" scale="-2" unitRef="pure" id="ixv-26610">51.75</ix:nonFraction>%</span></td><td style="white-space: nowrap; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="white-space: nowrap; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="white-space: nowrap; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c173" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" scale="-2" unitRef="pure" id="ixv-26611">47</ix:nonFraction>%-<ix:nonFraction contextRef="c174" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" scale="-2" unitRef="pure" id="ixv-26612">48</ix:nonFraction>%</span></td><td style="white-space: nowrap; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="white-space: nowrap; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="white-space: nowrap; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c175" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" scale="-2" unitRef="pure" id="ixv-26613">42</ix:nonFraction>%-<ix:nonFraction contextRef="c176" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" scale="-2" unitRef="pure" id="ixv-26614">46</ix:nonFraction>%</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Risk-free interest rate</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="white-space: nowrap; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="white-space: nowrap; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c90" decimals="4" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" unitRef="pure" id="ixv-26615">4.15</ix:nonFraction>%-<ix:nonFraction contextRef="c91" decimals="4" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" unitRef="pure" id="ixv-26616">4.55</ix:nonFraction>%</span></td><td style="white-space: nowrap; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="white-space: nowrap; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="white-space: nowrap; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c173" decimals="4" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" unitRef="pure" id="ixv-26617">1.74</ix:nonFraction>%-<ix:nonFraction contextRef="c174" decimals="4" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" unitRef="pure" id="ixv-26618">3.96</ix:nonFraction>%</span></td><td style="white-space: nowrap; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="white-space: nowrap; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="white-space: nowrap; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c175" decimals="4" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" unitRef="pure" id="ixv-26619">0.49</ix:nonFraction>%-<ix:nonFraction contextRef="c176" decimals="4" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" unitRef="pure" id="ixv-26620">1.28</ix:nonFraction>%</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Expected dividend yield</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="white-space: nowrap; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="white-space: nowrap; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c0" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" scale="-2" unitRef="pure" id="ixv-26621">0</ix:nonFraction></span>%</td><td style="white-space: nowrap; text-align: left"/><td style="white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="white-space: nowrap; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="white-space: nowrap; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c7" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" scale="-2" unitRef="pure" id="ixv-26622">0</ix:nonFraction></span>%</td><td style="white-space: nowrap; text-align: left"/><td style="white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="white-space: nowrap; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="white-space: nowrap; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c8" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" scale="-2" unitRef="pure" id="ixv-26623">0</ix:nonFraction></span>%</td><td style="text-align: left"/></tr>
  </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 84.45pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif"><i>&#160;</i></span></p></ix:continuation></ix:continuation><div>


</div><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 84.45pt; text-align: justify; text-indent: 0in"></p><div>

</div><!-- Field: Page; Sequence: 151 --><div>
    </div><div style="border-bottom: Black 1.5pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 84.45pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif"><i>&#160;</i></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 84.45pt; text-align: justify; text-indent: 0in"></p><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-transform: uppercase; text-align: justify; text-indent: -56.7pt"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><b>ARBE
ROBOTICS LTD. AND SUBSIDIARIES</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif"><b>NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p><div>

</div><!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="border-top: Black 1.5pt solid; font-size: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></div></div><!-- Field: /Rule-Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-transform: uppercase; text-align: justify; text-indent: -56.7pt"><span style="font-family: Times New Roman, Times, Serif; text-transform: none">U.S.
dollars in thousands (except share and per share data)</span></p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-transform: uppercase; text-align: justify; text-indent: -56.7pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>


</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-transform: uppercase; text-align: justify; text-indent: -56.7pt"><span style="font-family: Times New Roman, Times, Serif">Note
9:- &#160;&#160;Shareholders&#8217; equity (<span style="text-transform: none">Cont</span>.)</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 84.45pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif"><i>&#160;</i></span></p><div>

</div><ix:continuation continuedAt="_StockholdersEquityNoteDisclosureTextBlock-c0_cont_4" id="_StockholdersEquityNoteDisclosureTextBlock-c0_cont_3"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif"><i>Fair
value:</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 84.45pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">Prior
to the Merger, which resulted in the Company becoming a public entity, in determining the fair value for share options granted, the board
of directors considered the fair value of the ordinary shares as of each grant date. The fair value of the ordinary shares underlying
the share options was determined by the board of directors at each award grant date based upon a variety of factors, including the results
obtained from independent third-party valuations, the Company&#8217;s financial position and historical financial performance, the status
of technological developments within the Company&#8217;s products, the composition and ability of the current management team, an evaluation
or benchmark of the Company&#8217;s competition, the current business climate in the marketplace, the illiquid nature of the ordinary
shares, arm&#8217;s length sales of the Company&#8217;s capital stock, the effect of the rights and preferences of the Company&#8217;s preferred
shareholders, and the prospects of a liquidity event, among others. Subsequent to the Company becoming a public entity, the fair value
of the Ordinary Shares is the market price of the Ordinary Shares on the date of grant.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 84.45pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif"><i>Expected
volatility:</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 84.45pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">As
the Company was privately owned until October 2021, there is not sufficient historical volatility for the expected term of the stock
options. Therefore, the Company uses an average historical share price volatility based on an analysis of reported data for a peer group
of comparable publicly traded companies which were selected based upon industry similarities.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 84.45pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif"><i>Expected
term (years):</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 84.45pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">Expected
term represents the period that the Company&#8217;s option grants are expected to be outstanding. There is not sufficient historical
share exercise data to calculate the expected term of the stock options. Therefore, the Company elected to utilize the simplified method
to value option grants. Under this approach, the weighted-average expected life is presumed to be the average of the shortest vesting
term and the contractual term of the option.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 84.45pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif"><i>Risk-free
interest rate:</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 84.45pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">The
Company determined the risk-free interest rate by using a weighted-average equivalent to the expected term based on the U.S. Treasury
yield curve in effect as of the date of grant.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 84.45pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif"><i>Expected
dividend yield:</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 84.45pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">The
Company does not anticipate paying any dividends in the foreseeable future. Thus, the Company used <ix:nonFraction contextRef="c0" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodExpectedDividendRate" scale="-2" unitRef="pure" id="ixv-26624">0</ix:nonFraction>% as its expected dividend yield.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 84.45pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p></ix:continuation><div>

</div><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 84.45pt; text-align: justify; text-indent: 0in"></p><div>

</div><!-- Field: Page; Sequence: 152 --><div>
    </div><div style="border-bottom: Black 1.5pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 84.45pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-transform: uppercase; text-align: justify; text-indent: -56.7pt"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><b>ARBE
ROBOTICS LTD. AND SUBSIDIARIES</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif"><b>NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p><div>

</div><!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="border-top: Black 1.5pt solid; font-size: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></div></div><!-- Field: /Rule-Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-transform: uppercase; text-align: justify; text-indent: -56.7pt"><span style="font-family: Times New Roman, Times, Serif; text-transform: none">U.S.
dollars in thousands (except share and per share data)</span></p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-transform: uppercase; text-align: justify; text-indent: -56.7pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>


</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-transform: uppercase; text-align: justify; text-indent: -56.7pt"><span style="font-family: Times New Roman, Times, Serif">Note
9:- &#160;&#160;Shareholders&#8217; equity (<span style="text-transform: none">Cont</span>.)</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: -28.35pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><ix:continuation id="_StockholdersEquityNoteDisclosureTextBlock-c0_cont_4"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"><ix:nonNumeric contextRef="c0" continuedAt="_ScheduleOfShareBasedCompensationActivityTableTextBlock-c0_cont_1" escape="true" name="us-gaap:ScheduleOfShareBasedCompensationActivityTableTextBlock" id="ixv-24186"><span style="font-family: Times New Roman, Times, Serif; background-color: white">The
following table presents stock-based compensation expense to employees included in the Company&#8217;s consolidated statements of operations:</span></ix:nonNumeric></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: -28.35pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<ix:continuation id="_ScheduleOfShareBasedCompensationActivityTableTextBlock-c0_cont_1"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="10" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><b>Year
                                            ended </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><b>December
                                            31,</b></span></p></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2023</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2022</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2021</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Research and development</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c177" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensation" scale="3" unitRef="usd" id="ixv-26625">8,721</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c178" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensation" scale="3" unitRef="usd" id="ixv-26626">5,726</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c179" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensation" scale="3" unitRef="usd" id="ixv-26627">1,518</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Sales and marketing</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c180" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensation" scale="3" unitRef="usd" id="ixv-26628">2,229</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c181" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensation" scale="3" unitRef="usd" id="ixv-26629">1,403</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c182" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensation" scale="3" unitRef="usd" id="ixv-26630">217</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">General and administrative</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c183" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensation" scale="3" unitRef="usd" id="ixv-26631">1,786</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c184" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensation" scale="3" unitRef="usd" id="ixv-26632">1,537</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c185" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensation" scale="3" unitRef="usd" id="ixv-26633">419</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Cost of revenues</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c186" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensation" scale="3" unitRef="usd" id="ixv-26634">276</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c187" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensation" scale="3" unitRef="usd" id="ixv-26635">127</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c188" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensation" scale="3" unitRef="usd" id="ixv-26636">57</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">Total stock-based compensation
    expense</span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensation" scale="3" unitRef="usd" id="ixv-26637">13,012</ix:nonFraction></span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c7" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensation" scale="3" unitRef="usd" id="ixv-26638">8,793</ix:nonFraction></span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c8" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensation" scale="3" unitRef="usd" id="ixv-26639">2,211</ix:nonFraction></span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table></ix:continuation>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 84.45pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; background-color: white">Share
based compensation expenses are not deductible for income tax purposes, and therefore the Company did not recognize any tax benefits
related to the share-based compensation for the years ended December&#160;31, 2023, 2022 and 2021.</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-transform: uppercase; text-align: justify; text-indent: -56.7pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-weight: normal">The
Company adopted ASU 2018-07 and accordingly measured at the grant dates of each of the above stock-based compensation issued to service
providers their fair value using Black and Scholes model, which requires inputs such as exercise price, estimated ordinary share price,
expected dividend yield, estimated ordinary share price volatility and risk-free interest rate. During 2023, 2022 and 2021, the Company
recognized the total fair value of the stock-based compensation of development related service providers in the amounts of $<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" unitRef="usd" id="ixv-26640">629</ix:nonFraction>, $<ix:nonFraction contextRef="c7" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" unitRef="usd" id="ixv-26641">354</ix:nonFraction>
and $<ix:nonFraction contextRef="c8" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" unitRef="usd" id="ixv-26642">115</ix:nonFraction>, respectively.</span></p></ix:continuation><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"></p><div>

</div><!-- Field: Page; Sequence: 153 --><div>
    </div><div style="border-bottom: Black 1.5pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-transform: uppercase; text-align: justify; text-indent: -56.7pt"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><b>ARBE
ROBOTICS LTD. AND SUBSIDIARIES</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif"><b>NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p><div>

</div><!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="border-top: Black 1.5pt solid; font-size: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></div></div><!-- Field: /Rule-Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-transform: uppercase; text-align: justify; text-indent: -56.7pt"><span style="font-family: Times New Roman, Times, Serif; text-transform: none">U.S.
dollars in thousands (except share and per share data)</span></p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-transform: uppercase; text-align: justify; text-indent: -56.7pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>


</div><ix:nonNumeric contextRef="c0" escape="true" name="us-gaap:EarningsPerShareTextBlock" id="ixv-24430"><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">NOTE
10:- &#160;&#160;NET LOSS PER SHARE ATTRIBUTIBLE TO ORDINARY SHARHOLDERS</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-align: justify; text-indent: -56.7pt"><span style="font-family: Times New Roman, Times, Serif; font-weight: normal">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-weight: normal; background-color: white"><ix:nonNumeric contextRef="c0" continuedAt="_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock-c0_cont_1" escape="true" name="us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" id="ixv-26643">The
following table sets forth the computation of basic and diluted net loss per share attributable to ordinary shareholders for the periods
presented:</ix:nonNumeric> </span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-align: justify; text-indent: -56.7pt"><span style="font-family: Times New Roman, Times, Serif; font-weight: normal">&#160;</span></p>

<ix:continuation continuedAt="_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock-c0_cont_2" id="_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock-c0_cont_1"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="10" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><b>Year
                                            ended </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><b>December
                                            31,</b></span></p></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2023</span></td><td style="padding-bottom: 2.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2022</span></td><td style="padding-bottom: 2.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2021</span></td><td style="padding-bottom: 2.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"><b><span style="text-decoration:underline">Basic</span></b></span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="padding-bottom: 1.5pt; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="padding-bottom: 1.5pt; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="padding-bottom: 1.5pt; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: left"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: left"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: left; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif"><b>Numerator:</b></span></p></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Net loss</span></td><td style="width: 1%; padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 4pt double; width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLossAttributableToNonredeemableNoncontrollingInterest" scale="3" sign="-" unitRef="usd" id="ixv-26644">43,500</ix:nonFraction></span></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="width: 1%; padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 4pt double; width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction contextRef="c7" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLossAttributableToNonredeemableNoncontrollingInterest" scale="3" sign="-" unitRef="usd" id="ixv-26645">40,494</ix:nonFraction></span></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="width: 1%; padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 4pt double; width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction contextRef="c8" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLossAttributableToNonredeemableNoncontrollingInterest" scale="3" sign="-" unitRef="usd" id="ixv-26646">58,092</ix:nonFraction></span></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: left; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: left; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif"><b>Denominator:</b></span></p></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Weighted-average
    shares used in computing loss per share attributable to ordinary shareholders, basic</span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c0" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment" scale="0" unitRef="shares" id="ixv-26647">72,021,520</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c7" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment" scale="0" unitRef="shares" id="ixv-26648">63,489,983</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c8" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment" scale="0" unitRef="shares" id="ixv-26649">22,027,292</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Loss per share attributable to ordinary shareholders,
    basic</span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction contextRef="c0" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:EarningsPerShareBasic" scale="0" sign="-" unitRef="usdPershares" id="ixv-26650">0.60</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction contextRef="c7" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:EarningsPerShareBasic" scale="0" sign="-" unitRef="usdPershares" id="ixv-26651">0.64</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction contextRef="c8" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:EarningsPerShareBasic" scale="0" sign="-" unitRef="usdPershares" id="ixv-26652">2.64</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"><b><span style="text-decoration:underline">Diluted</span></b></span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>

<tr style="vertical-align: bottom">
    <td style="text-align: left"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 11.35pt; text-align: left; text-indent: -8.5pt"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif"><b>Numerator:</b></span></p></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Adjusted Net loss*</span></td><td style="width: 1%; padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 4pt double; width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" id="ix_0_fact" name="us-gaap:TemporaryEquityAccretionToRedemptionValueAdjustment" scale="3" sign="-" unitRef="usd">44,256</ix:nonFraction></span></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="width: 1%; padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 4pt double; width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction contextRef="c7" decimals="-3" format="ixt:num-dot-decimal" id="ix_1_fact" name="us-gaap:TemporaryEquityAccretionToRedemptionValueAdjustment" scale="3" sign="-" unitRef="usd">48,919</ix:nonFraction></span></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="width: 1%; padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 4pt double; width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction contextRef="c8" decimals="-3" format="ixt:num-dot-decimal" id="ix_2_fact" name="us-gaap:TemporaryEquityAccretionToRedemptionValueAdjustment" scale="3" sign="-" unitRef="usd">58,092</ix:nonFraction></span></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 11.35pt; text-align: left; text-indent: -8.5pt"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif"><b>Denominator:</b></span></p></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Weighted-average
    shares used in computing loss per share attributable to ordinary shareholders, diluted</span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c0" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="0" unitRef="shares" id="ixv-26656">62,390,302</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c7" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="0" unitRef="shares" id="ixv-26657">60,960,641</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c8" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="0" unitRef="shares" id="ixv-26658">22,027,292</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Loss per share attributable to ordinary shareholders,
    diluted*</span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction contextRef="c0" decimals="2" format="ixt:num-dot-decimal" id="ix_3_fact" name="us-gaap:EarningsPerShareDiluted" scale="0" sign="-" unitRef="usdPershares">0.71</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction contextRef="c7" decimals="2" format="ixt:num-dot-decimal" id="ix_4_fact" name="us-gaap:EarningsPerShareDiluted" scale="0" sign="-" unitRef="usdPershares">0.80</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction contextRef="c8" decimals="2" format="ixt:num-dot-decimal" id="ix_5_fact" name="us-gaap:EarningsPerShareDiluted" scale="0" sign="-" unitRef="usdPershares">2.64</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  </table></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-align: justify; text-indent: -56.7pt"><span style="font-family: Times New Roman, Times, Serif; font-weight: normal">&#160;</span></p>

<ix:continuation continuedAt="_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock-c0_cont_3" id="_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock-c0_cont_2"><table cellpadding="0" cellspacing="0" style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">*</span></td><td style="text-align: justify"><ix:footnote id="ix_3_footnote" xml:lang="en-US"><span style="font-family: Times New Roman, Times, Serif; font-weight: normal">Loss per share attributable to ordinary shareholders, diluted, was adjusted and take into consideration warrants liabilities revaluations as part of our net loss for 2023 and 2022.</span></ix:footnote></td>
</tr></table></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-align: justify; text-indent: -56.7pt"><span style="font-family: Times New Roman, Times, Serif; font-weight: normal">&#160;</span></p>

<ix:continuation id="_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock-c0_cont_3"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><b>Year
                                            ended </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2.85pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><b>December
                                            31,</b></span></p></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2023</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2022</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Net loss</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLossAttributableToNonredeemableNoncontrollingInterest" scale="3" sign="-" unitRef="usd" id="ixv-26662">43,500</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction contextRef="c7" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLossAttributableToNonredeemableNoncontrollingInterest" scale="3" sign="-" unitRef="usd" id="ixv-26663">40,494</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Revaluation of warrants</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ProceedsFromIssuanceOfWarrants" scale="3" unitRef="usd" id="ixv-26664">756</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction contextRef="c7" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ProceedsFromIssuanceOfWarrants" scale="3" unitRef="usd" id="ixv-26665">8,425</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">Adjusted Net loss</span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:TemporaryEquityAccretionToRedemptionValueAdjustment" scale="3" sign="-" unitRef="usd" id="ixv-26666">44,256</ix:nonFraction></span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction contextRef="c7" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:TemporaryEquityAccretionToRedemptionValueAdjustment" scale="3" sign="-" unitRef="usd" id="ixv-26667">48,919</ix:nonFraction></span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  </table></ix:continuation>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-align: justify; text-indent: -56.7pt"><span style="font-family: Times New Roman, Times, Serif; font-weight: normal">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"><ix:nonNumeric contextRef="c0" continuedAt="_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock-c0_cont_1" escape="true" name="us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" id="ixv-24921"><span style="font-family: Times New Roman, Times, Serif; font-weight: normal">The
potential Ordinary Shares that were excluded from the computation of diluted net loss per share attributable to ordinary shareholders
for the years ended December 31, 2023, 2022 and 2021 because including them would have been anti-dilutive are as follows:</span></ix:nonNumeric></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-align: justify; text-indent: -56.7pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<ix:continuation id="_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock-c0_cont_1"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="10" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><b>Year
                                            ended </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><b>December
                                            31,</b></span></p></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2023</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2022</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2021</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Convertible preferred shares</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 9%; text-align: right"><span style="-sec-ix-hidden: hidden-fact-228; font-family: Times New Roman, Times, Serif">-</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 9%; text-align: right"><span style="-sec-ix-hidden: hidden-fact-229; font-family: Times New Roman, Times, Serif">-</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c191" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="0" unitRef="shares" id="ixv-26668">26,499,069</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Outstanding share options</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c192" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="0" unitRef="shares" id="ixv-26669">9,299,085</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c193" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="0" unitRef="shares" id="ixv-26670">8,650,298</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c194" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="0" unitRef="shares" id="ixv-26671">1,362,786</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">Total</span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="0" unitRef="shares" id="ixv-26672">9,299,085</ix:nonFraction></span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c7" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="0" unitRef="shares" id="ixv-26673">8,650,298</ix:nonFraction></span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c8" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="0" unitRef="shares" id="ixv-26674">27,861,855</ix:nonFraction></span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table></ix:continuation></ix:nonNumeric><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-align: justify; text-indent: -56.7pt"><span style="font-family: Times New Roman, Times, Serif; font-weight: normal">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-align: justify; text-indent: -56.7pt"></p><div>

</div><!-- Field: Page; Sequence: 154 --><div>
    </div><div style="border-bottom: Black 1.5pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-align: justify; text-indent: -56.7pt"><span style="font-family: Times New Roman, Times, Serif; font-weight: normal">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-align: justify; text-indent: -56.7pt"></p><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-transform: uppercase; text-align: justify; text-indent: -56.7pt"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><b>ARBE
ROBOTICS LTD. AND SUBSIDIARIES</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif"><b>NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p><div>

</div><!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="border-top: Black 1.5pt solid; font-size: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></div></div><!-- Field: /Rule-Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-transform: uppercase; text-align: justify; text-indent: -56.7pt"><span style="font-family: Times New Roman, Times, Serif; text-transform: none">U.S.
dollars in thousands (except share and per share data)</span></p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-transform: uppercase; text-align: justify; text-indent: -56.7pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>


</div><ix:nonNumeric contextRef="c0" continuedAt="_IncomeTaxDisclosureTextBlock-c0_cont_1" escape="true" name="us-gaap:IncomeTaxDisclosureTextBlock" id="ixv-25104"><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">NOTE
11:- &#160;&#160;TAXES ON INCOME</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 84.45pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">a.</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">General:</span></td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 84.45pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif"><i>Israeli
tax rate:</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: -28.35pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">The
Corporate tax rate in Israel relevant to the Company in 2021, 2022 and 2023 - <ix:nonFraction contextRef="c128" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" scale="-2" unitRef="pure" id="ixv-26675"><ix:nonFraction contextRef="c130" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" scale="-2" unitRef="pure" id="ixv-26676"><ix:nonFraction contextRef="c132" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" scale="-2" unitRef="pure" id="ixv-26677">23</ix:nonFraction></ix:nonFraction></ix:nonFraction>%.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif"><i>United
States:</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">The
Company&#8217;s subsidiaries are separately taxed under the U.S. tax laws at a corporate rate of <ix:nonFraction contextRef="c116" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" scale="-2" unitRef="pure" id="ixv-26678">21</ix:nonFraction>%.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 84.45pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">b.</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Loss
                                            before income taxes:</span></td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: -28.35pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"><ix:nonNumeric contextRef="c0" continuedAt="_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock-c0_cont_1" escape="true" name="us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" id="ixv-25146"><span style="font-family: Times New Roman, Times, Serif">The
following are the domestic (i.e. Israeli) and foreign components of the Company&#8217;s loss before income taxes:</span></ix:nonNumeric></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: -28.35pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<ix:continuation id="_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock-c0_cont_1"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="10" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2.85pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><b>Year
                                            ended </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2.85pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><b>December
                                            31,</b></span></p></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2023</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2022</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2021</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Domestic</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" scale="3" unitRef="usd" id="ixv-26679">43,500</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction contextRef="c7" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" scale="3" unitRef="usd" id="ixv-26680">40,494</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction contextRef="c8" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" scale="3" unitRef="usd" id="ixv-26681">58,092</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Foreign</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-230; font-family: Times New Roman, Times, Serif">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-231; font-family: Times New Roman, Times, Serif">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-232; font-family: Times New Roman, Times, Serif">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">Total</span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="3" unitRef="usd" id="ixv-26682">43,500</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction contextRef="c7" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="3" unitRef="usd" id="ixv-26683">40,494</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction contextRef="c8" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="3" unitRef="usd" id="ixv-26684">58,092</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  </table></ix:continuation>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 84.45pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">c.</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Taxes
                                            on income:</span></td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: -28.35pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"><ix:nonNumeric contextRef="c0" continuedAt="_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock-c0_cont_1" escape="true" name="us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" id="ixv-25301"><span style="font-family: Times New Roman, Times, Serif">The
reconciliation of the income tax benefit that would result from applying the Israeli statutory tax rate to the Company&#8217;s reported
income tax (benefit) is as follows:</span></ix:nonNumeric></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: -28.35pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<ix:continuation continuedAt="_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock-c0_cont_2" id="_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock-c0_cont_1"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="10" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2.85pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><b>Year
                                            ended </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2.85pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><b>December
                                            31,</b></span></p></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2023</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2022</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2021</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; width: 64%; text-align: left; padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">Loss
    before income taxes, as reported in the consolidated statements of operations</span></td><td style="width: 1%; padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 4pt double; width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="3" unitRef="usd" id="ixv-26685">43,500</ix:nonFraction></span></td><td style="width: 1%; padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 1%; padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 4pt double; width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c7" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="3" unitRef="usd" id="ixv-26686">40,494</ix:nonFraction></span></td><td style="width: 1%; padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 1%; padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 4pt double; width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c8" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="3" unitRef="usd" id="ixv-26687">58,092</ix:nonFraction></span></td><td style="width: 1%; padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">Statutory
    tax rate</span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c0" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" scale="-2" unitRef="pure" id="ixv-26688">23</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c7" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" scale="-2" unitRef="pure" id="ixv-26689">23</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c8" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" scale="-2" unitRef="pure" id="ixv-26690">23</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Income
    tax benefit at statutory tax rate</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" scale="3" sign="-" unitRef="usd" id="ixv-26691">10,005</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction contextRef="c7" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" scale="3" sign="-" unitRef="usd" id="ixv-26692">9,314</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction contextRef="c8" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" scale="3" sign="-" unitRef="usd" id="ixv-26693">13,361</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Effect
    of Non-deductible expenses</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncomeTaxReconciliationNondeductibleExpense" scale="3" unitRef="usd" id="ixv-26694">3,063</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c7" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncomeTaxReconciliationNondeductibleExpense" scale="3" unitRef="usd" id="ixv-26695">475</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c8" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncomeTaxReconciliationNondeductibleExpense" scale="3" unitRef="usd" id="ixv-26696">6,129</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Remeasurement
    of deferred taxes from currency exchange*</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-233; font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c7" decimals="-3" format="ixt:num-dot-decimal" id="ix_6_fact" name="us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential" scale="3" unitRef="usd">3,517</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c8" decimals="-3" format="ixt:num-dot-decimal" id="ix_7_fact" name="us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential" scale="3" unitRef="usd">209</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Change
    in valuation allowance</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" scale="3" unitRef="usd" id="ixv-26699">7,508</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c7" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" scale="3" unitRef="usd" id="ixv-26700">5,322</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c8" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" scale="3" unitRef="usd" id="ixv-26701">7,023</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Other</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncomeTaxReconciliationOtherAdjustments" scale="3" sign="-" unitRef="usd" id="ixv-26702">566</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-234; font-family: Times New Roman, Times, Serif">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-235; font-family: Times New Roman, Times, Serif">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">Reported
    income taxes benefit</span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="-sec-ix-hidden: hidden-fact-236; font-family: Times New Roman, Times, Serif">-</span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="-sec-ix-hidden: hidden-fact-237; font-family: Times New Roman, Times, Serif">-</span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="-sec-ix-hidden: hidden-fact-238; font-family: Times New Roman, Times, Serif">-</span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table></ix:continuation>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<ix:continuation id="_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock-c0_cont_2"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif"><b>*</b></span></td><td style="text-align: justify"><ix:footnote id="ix_4_footnote" xml:lang="en-US"><span style="font-family: Times New Roman, Times, Serif">The
income Tax Regulations (rules regarding ledger management of foreign invested companies and certain partnerships and the determination
of their taxable income), 1986 allow Foreign Invested Companies (i.e., foreign holding percentage of more than <ix:nonFraction contextRef="c0" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" scale="-2" unitRef="pure" id="ixv-26703">25</ix:nonFraction>%) to report for tax
purposes in US dollars. The Company implemented these regulations on January 1, 2023.</span></ix:footnote></td>
</tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p></ix:continuation></ix:nonNumeric><div>

</div><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"></p><div>

</div><!-- Field: Page; Sequence: 155 --><div>
    </div><div style="border-bottom: Black 1.5pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-transform: uppercase; text-align: justify; text-indent: -56.7pt"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><b>ARBE
ROBOTICS LTD. AND SUBSIDIARIES</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif"><b>NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p><div>

</div><!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="border-top: Black 1.5pt solid; font-size: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></div></div><!-- Field: /Rule-Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-transform: uppercase; text-align: justify; text-indent: -56.7pt"><span style="font-family: Times New Roman, Times, Serif; text-transform: none">U.S.
dollars in thousands (except share and per share data)</span></p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-transform: uppercase; text-align: justify; text-indent: -56.7pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-transform: uppercase; text-align: justify; text-indent: -56.7pt"><span style="font-family: Times New Roman, Times, Serif">Note
11:- &#160;&#160;TAXES ON INCOME (<span style="text-transform: none">Cont</span>.)</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 84.45pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><ix:continuation id="_IncomeTaxDisclosureTextBlock-c0_cont_1"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">d.</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Net
                                            operating loss carryforward:</span></td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; background-color: white">As
of December&#160;31, 2023, the Company had a net operating loss carryforward for Israeli tax purposes of approximately $<ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OperatingLossCarryforwards" scale="3" unitRef="usd" id="ixv-26704">121,880</ix:nonFraction>. These
net operating loss carryforwards can be carried forward and offset against taxable income indefinitely.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">e.</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Deferred
                                            tax assets and liabilities:</span></td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 84.45pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">Deferred
tax assets and liabilities are recognized for the tax effects of temporary differences between the carrying amounts of assets and liabilities
for financial reporting purposes and the amounts used for income tax purposes and for carryforwards.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 84.45pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"><ix:nonNumeric contextRef="c0" continuedAt="_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock-c0_cont_1" escape="true" name="us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" id="ixv-25671"><span style="font-family: Times New Roman, Times, Serif">The
principal components of the Company&#8217;s deferred tax assets are as follows:</span></ix:nonNumeric></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 84.45pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<ix:continuation id="_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock-c0_cont_1"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">December
    31</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2023</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2022</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Deferred tax assets:</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; width: 76%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Net operating loss carry forwards</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwards" scale="3" unitRef="usd" id="ixv-26705">28,032</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c6" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwards" scale="3" unitRef="usd" id="ixv-26706">21,991</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Research and development</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DeferredTaxAssetsInProcessResearchAndDevelopment" scale="3" unitRef="usd" id="ixv-26707">6,252</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c6" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DeferredTaxAssetsInProcessResearchAndDevelopment" scale="3" unitRef="usd" id="ixv-26708">4,834</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Employees and payroll accrual</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" scale="3" unitRef="usd" id="ixv-26709">299</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c6" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" scale="3" unitRef="usd" id="ixv-26710">272</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Property and equipment</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DeferredTaxAssetsPropertyPlantAndEquipment" scale="3" unitRef="usd" id="ixv-26711">79</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c6" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DeferredTaxAssetsPropertyPlantAndEquipment" scale="3" unitRef="usd" id="ixv-26712">57</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Total deferred tax assets</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DeferredTaxAssetsGross" scale="3" unitRef="usd" id="ixv-26713">34,662</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c6" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DeferredTaxAssetsGross" scale="3" unitRef="usd" id="ixv-26714">27,154</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Valuation allowance</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DeferredTaxAssetsValuationAllowance" scale="3" unitRef="usd" id="ixv-26715">34,662</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction contextRef="c6" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DeferredTaxAssetsValuationAllowance" scale="3" unitRef="usd" id="ixv-26716">27,154</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">Deferred
    tax assets, net of valuation allowance</span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="-sec-ix-hidden: hidden-fact-239; font-family: Times New Roman, Times, Serif">-</span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="-sec-ix-hidden: hidden-fact-240; font-family: Times New Roman, Times, Serif">-</span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 84.45pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">Based
on the available evidence, management believes that it is more likely than not that certain of its deferred tax assets relating to net
operating loss carryforwards and other temporary differences in Israel will not be realized and accordingly, a valuation allowance has
been provided.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: -28.35pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">f.</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Tax
                                            assessments:</span></td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: -28.35pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">The
Israeli entity&#8217;s&#8217; income tax assessments are considered final through 2018<span style="font-size: 10pt; background-color: white">.</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">g.</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Unrecognized
                                            Tax Benefits:</span></td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: -28.35pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; background-color: white">As
of December&#160;31, 2023, 2022 and 2021, the Company did not have any unrecognized tax benefits and does not expect that the amount
of unrecognized tax benefits will change significantly within the next 12 months. The Company&#8217;s accounting policy is to accrue
interest and penalties related to an underpayment of income taxes as a component of income tax expense.</span></p></ix:continuation><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></p><div>




</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"></p><div>

</div><!-- Field: Page; Sequence: 156 --><div>
    </div><div style="border-bottom: Black 1.5pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->29<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"></p><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-transform: uppercase; text-align: justify; text-indent: -56.7pt"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><b>ARBE
ROBOTICS LTD. AND SUBSIDIARIES</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif"><b>NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p><div>

</div><!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="border-top: Black 1.5pt solid; font-size: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></div></div><!-- Field: /Rule-Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-transform: uppercase; text-align: justify; text-indent: -56.7pt"><span style="font-family: Times New Roman, Times, Serif; text-transform: none">U.S.
dollars in thousands (except share and per share data)</span></p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-transform: uppercase; text-align: justify; text-indent: -56.7pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>


</div><ix:nonNumeric contextRef="c0" escape="true" name="us-gaap:SegmentReportingDisclosureTextBlock" id="ixv-25960"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif"><b>NOTE
12:- &#160;&#160;SEGMENT INFORMATION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; background-color: white">The
Company operates in one operating and reportable segment. Operating segments are defined as components of an enterprise about which separate
financial information is evaluated regularly by the chief operating decision maker, who is the Company&#8217;s chief executive officer
(&#8220;<b>CEO</b>&#8221;), in deciding how to allocate resources and assessing performance. The Company&#8217;s chief operating decision
maker allocates resources and assesses performance based upon discrete financial information at the consolidated level. </span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 28.35pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"><ix:nonNumeric contextRef="c0" continuedAt="_LongLivedAssetsByGeographicAreasTableTextBlock-c0_cont_1" escape="true" name="us-gaap:LongLivedAssetsByGeographicAreasTableTextBlock" id="ixv-25973"><span style="font-family: Times New Roman, Times, Serif; background-color: white">Revenue
by geographical region can be found in the revenue recognition disclosures in Note 3 The following table presents the Company&#8217;s
property and equipment, net of depreciation, by geographic region:</span></ix:nonNumeric></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 28.35pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<ix:continuation id="_LongLivedAssetsByGeographicAreasTableTextBlock-c0_cont_1"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">December
    31,</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><b>202<span style="font-size: 10pt">3</span></b></span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><b>202<span style="font-size: 10pt">2</span></b></span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Israel</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c129" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PropertyPlantAndEquipmentNet" scale="3" unitRef="usd" id="ixv-26717">1,309</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c131" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PropertyPlantAndEquipmentNet" scale="3" unitRef="usd" id="ixv-26718">1,609</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">United States</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-241; font-family: Times New Roman, Times, Serif">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-242; font-family: Times New Roman, Times, Serif">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">Total property and equipment,
    net:</span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PropertyPlantAndEquipmentNet" scale="3" unitRef="usd" id="ixv-26719">1,309</ix:nonFraction></span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c6" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PropertyPlantAndEquipmentNet" scale="3" unitRef="usd" id="ixv-26720">1,609</ix:nonFraction></span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table></ix:continuation>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 28.35pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; background-color: white">*)</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; background-color: white">Represents
less than $1</span></td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 28.35pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif"><b>Major
Customers:</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">During
the year ended December 31, 2023, the Company had three customers that accounted for <ix:nonFraction contextRef="c195" decimals="3" format="ixt:num-dot-decimal" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" unitRef="pure" id="ixv-26721">38.9</ix:nonFraction>%, <ix:nonFraction contextRef="c196" decimals="3" format="ixt:num-dot-decimal" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" unitRef="pure" id="ixv-26722">18.1</ix:nonFraction>% and <ix:nonFraction contextRef="c197" decimals="3" format="ixt:num-dot-decimal" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" unitRef="pure" id="ixv-26723">12.7</ix:nonFraction>%, respectively, of revenues.
During the year ended December 31, 2022, the Company had three customers that accounted for <ix:nonFraction contextRef="c198" decimals="3" format="ixt:num-dot-decimal" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" unitRef="pure" id="ixv-26724">33.4</ix:nonFraction>%, <ix:nonFraction contextRef="c199" decimals="3" format="ixt:num-dot-decimal" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" unitRef="pure" id="ixv-26725">19.4</ix:nonFraction>% and <ix:nonFraction contextRef="c200" decimals="3" format="ixt:num-dot-decimal" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" unitRef="pure" id="ixv-26726">18.9</ix:nonFraction>%, respectively, of
revenues. During the year ended December 31, 2021, the Company had three customers that accounted for <ix:nonFraction contextRef="c201" decimals="3" format="ixt:num-dot-decimal" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" unitRef="pure" id="ixv-26727">41.1</ix:nonFraction>%, <ix:nonFraction contextRef="c202" decimals="3" format="ixt:num-dot-decimal" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" unitRef="pure" id="ixv-26728">31.2</ix:nonFraction>% and <ix:nonFraction contextRef="c203" decimals="3" format="ixt:num-dot-decimal" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" unitRef="pure" id="ixv-26729">15.6</ix:nonFraction>%, respectively,
of revenues.</span></p></ix:nonNumeric><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif">F-30</span></p><div>

</div><!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="border-top: Black 1.5pt solid; font-size: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></div></div><!-- Field: /Rule-Page --><div>




</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><div style="display: none"><ix:header>
<ix:hidden>
<ix:nonFraction contextRef="c5" id="hidden-fact-0" name="us-gaap:DeferredRevenueCurrent" unitRef="usd" xsi:nil="true"/>
<ix:nonFraction contextRef="c5" id="hidden-fact-1" name="us-gaap:CommonStockValue" unitRef="usd" xsi:nil="true"/>
<ix:nonFraction contextRef="c6" id="hidden-fact-2" name="us-gaap:CommonStockValue" unitRef="usd" xsi:nil="true"/>
<ix:nonFraction contextRef="c16" id="hidden-fact-3" name="us-gaap:StockholdersEquity" unitRef="usd" xsi:nil="true"/>
<ix:nonFraction contextRef="c20" id="hidden-fact-4" name="us-gaap:StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants" unitRef="usd" xsi:nil="true"/>
<ix:nonFraction contextRef="c21" id="hidden-fact-5" name="us-gaap:StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants" unitRef="usd" xsi:nil="true"/>
<ix:nonFraction contextRef="c22" id="hidden-fact-6" name="us-gaap:StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants" unitRef="usd" xsi:nil="true"/>
<ix:nonFraction contextRef="c23" id="hidden-fact-7" name="us-gaap:StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants" unitRef="usd" xsi:nil="true"/>
<ix:nonFraction contextRef="c24" id="hidden-fact-8" name="us-gaap:StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants" unitRef="usd" xsi:nil="true"/>
<ix:nonFraction contextRef="c27" id="hidden-fact-9" name="us-gaap:StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants" unitRef="usd" xsi:nil="true"/>
<ix:nonFraction contextRef="c28" id="hidden-fact-10" name="us-gaap:StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants" unitRef="usd" xsi:nil="true"/>
<ix:nonFraction contextRef="c27" id="hidden-fact-11" name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" unitRef="usd" xsi:nil="true"/>
<ix:nonFraction contextRef="c28" id="hidden-fact-12" name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" unitRef="usd" xsi:nil="true"/>
<ix:nonFraction contextRef="c20" id="hidden-fact-13" name="us-gaap:StockIssuedDuringPeriodValueConversionOfUnits" unitRef="usd" xsi:nil="true"/>
<ix:nonFraction contextRef="c21" id="hidden-fact-14" name="us-gaap:StockIssuedDuringPeriodValueConversionOfUnits" unitRef="usd" xsi:nil="true"/>
<ix:nonFraction contextRef="c22" id="hidden-fact-15" name="us-gaap:StockIssuedDuringPeriodValueConversionOfUnits" unitRef="usd" xsi:nil="true"/>
<ix:nonFraction contextRef="c23" id="hidden-fact-16" name="us-gaap:StockIssuedDuringPeriodValueConversionOfUnits" unitRef="usd" xsi:nil="true"/>
<ix:nonFraction contextRef="c24" id="hidden-fact-17" name="us-gaap:StockIssuedDuringPeriodValueConversionOfUnits" unitRef="usd" xsi:nil="true"/>
<ix:nonFraction contextRef="c25" id="hidden-fact-18" name="us-gaap:StockIssuedDuringPeriodValueConversionOfUnits" unitRef="usd" xsi:nil="true"/>
<ix:nonFraction contextRef="c26" id="hidden-fact-19" name="us-gaap:StockIssuedDuringPeriodValueConversionOfUnits" unitRef="usd" xsi:nil="true"/>
<ix:nonFraction contextRef="c27" id="hidden-fact-20" name="us-gaap:StockIssuedDuringPeriodValueConversionOfUnits" unitRef="usd" xsi:nil="true"/>
<ix:nonFraction contextRef="c28" id="hidden-fact-21" name="us-gaap:StockIssuedDuringPeriodValueConversionOfUnits" unitRef="usd" xsi:nil="true"/>
<ix:nonFraction contextRef="c20" id="hidden-fact-22" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" unitRef="usd" xsi:nil="true"/>
<ix:nonFraction contextRef="c21" id="hidden-fact-23" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" unitRef="usd" xsi:nil="true"/>
<ix:nonFraction contextRef="c22" id="hidden-fact-24" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" unitRef="usd" xsi:nil="true"/>
<ix:nonFraction contextRef="c23" id="hidden-fact-25" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" unitRef="usd" xsi:nil="true"/>
<ix:nonFraction contextRef="c24" id="hidden-fact-26" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" unitRef="usd" xsi:nil="true"/>
<ix:nonFraction contextRef="c25" id="hidden-fact-27" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" unitRef="usd" xsi:nil="true"/>
<ix:nonFraction contextRef="c26" id="hidden-fact-28" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" unitRef="usd" xsi:nil="true"/>
<ix:nonFraction contextRef="c27" id="hidden-fact-29" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" unitRef="usd" xsi:nil="true"/>
<ix:nonFraction contextRef="c28" id="hidden-fact-30" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" unitRef="usd" xsi:nil="true"/>
<ix:nonFraction contextRef="c20" id="hidden-fact-31" name="us-gaap:StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants" unitRef="usd" xsi:nil="true"/>
<ix:nonFraction contextRef="c21" id="hidden-fact-32" name="us-gaap:StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants" unitRef="usd" xsi:nil="true"/>
<ix:nonFraction contextRef="c22" id="hidden-fact-33" name="us-gaap:StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants" unitRef="usd" xsi:nil="true"/>
<ix:nonFraction contextRef="c27" id="hidden-fact-34" name="us-gaap:StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants" unitRef="usd" xsi:nil="true"/>
<ix:nonFraction contextRef="c28" id="hidden-fact-35" name="us-gaap:StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants" unitRef="usd" xsi:nil="true"/>
<ix:nonFraction contextRef="c20" id="hidden-fact-36" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" unitRef="usd" xsi:nil="true"/>
<ix:nonFraction contextRef="c21" id="hidden-fact-37" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" unitRef="usd" xsi:nil="true"/>
<ix:nonFraction contextRef="c22" id="hidden-fact-38" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" unitRef="usd" xsi:nil="true"/>
<ix:nonFraction contextRef="c23" id="hidden-fact-39" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" unitRef="usd" xsi:nil="true"/>
<ix:nonFraction contextRef="c24" id="hidden-fact-40" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" unitRef="usd" xsi:nil="true"/>
<ix:nonFraction contextRef="c25" id="hidden-fact-41" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" unitRef="usd" xsi:nil="true"/>
<ix:nonFraction contextRef="c26" id="hidden-fact-42" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" unitRef="usd" xsi:nil="true"/>
<ix:nonFraction contextRef="c27" id="hidden-fact-43" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" unitRef="usd" xsi:nil="true"/>
<ix:nonFraction contextRef="c28" id="hidden-fact-44" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" unitRef="usd" xsi:nil="true"/>
<ix:nonFraction contextRef="c20" id="hidden-fact-45" name="us-gaap:StockIssuedDuringPeriodValueIssuedForServices" unitRef="usd" xsi:nil="true"/>
<ix:nonFraction contextRef="c21" id="hidden-fact-46" name="us-gaap:StockIssuedDuringPeriodValueIssuedForServices" unitRef="usd" xsi:nil="true"/>
<ix:nonFraction contextRef="c22" id="hidden-fact-47" name="us-gaap:StockIssuedDuringPeriodValueIssuedForServices" unitRef="usd" xsi:nil="true"/>
<ix:nonFraction contextRef="c23" id="hidden-fact-48" name="us-gaap:StockIssuedDuringPeriodValueIssuedForServices" unitRef="usd" xsi:nil="true"/>
<ix:nonFraction contextRef="c24" id="hidden-fact-49" name="us-gaap:StockIssuedDuringPeriodValueIssuedForServices" unitRef="usd" xsi:nil="true"/>
<ix:nonFraction contextRef="c25" id="hidden-fact-50" name="us-gaap:StockIssuedDuringPeriodValueIssuedForServices" unitRef="usd" xsi:nil="true"/>
<ix:nonFraction contextRef="c26" id="hidden-fact-51" name="us-gaap:StockIssuedDuringPeriodValueIssuedForServices" unitRef="usd" xsi:nil="true"/>
<ix:nonFraction contextRef="c27" id="hidden-fact-52" name="us-gaap:StockIssuedDuringPeriodValueIssuedForServices" unitRef="usd" xsi:nil="true"/>
<ix:nonFraction contextRef="c28" id="hidden-fact-53" name="us-gaap:StockIssuedDuringPeriodValueIssuedForServices" unitRef="usd" xsi:nil="true"/>
<ix:nonFraction contextRef="c20" id="hidden-fact-54" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" unitRef="usd" xsi:nil="true"/>
<ix:nonFraction contextRef="c21" id="hidden-fact-55" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" unitRef="usd" xsi:nil="true"/>
<ix:nonFraction contextRef="c22" id="hidden-fact-56" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" unitRef="usd" xsi:nil="true"/>
<ix:nonFraction contextRef="c24" id="hidden-fact-57" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" unitRef="usd" xsi:nil="true"/>
<ix:nonFraction contextRef="c25" id="hidden-fact-58" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" unitRef="usd" xsi:nil="true"/>
<ix:nonFraction contextRef="c26" id="hidden-fact-59" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" unitRef="usd" xsi:nil="true"/>
<ix:nonFraction contextRef="c27" id="hidden-fact-60" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" unitRef="usd" xsi:nil="true"/>
<ix:nonFraction contextRef="c28" id="hidden-fact-61" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" unitRef="usd" xsi:nil="true"/>
<ix:nonFraction contextRef="c20" id="hidden-fact-62" name="us-gaap:NetIncomeLoss" unitRef="usd" xsi:nil="true"/>
<ix:nonFraction contextRef="c21" id="hidden-fact-63" name="us-gaap:NetIncomeLoss" unitRef="usd" xsi:nil="true"/>
<ix:nonFraction contextRef="c22" id="hidden-fact-64" name="us-gaap:NetIncomeLoss" unitRef="usd" xsi:nil="true"/>
<ix:nonFraction contextRef="c23" id="hidden-fact-65" name="us-gaap:NetIncomeLoss" unitRef="usd" xsi:nil="true"/>
<ix:nonFraction contextRef="c24" id="hidden-fact-66" name="us-gaap:NetIncomeLoss" unitRef="usd" xsi:nil="true"/>
<ix:nonFraction contextRef="c25" id="hidden-fact-67" name="us-gaap:NetIncomeLoss" unitRef="usd" xsi:nil="true"/>
<ix:nonFraction contextRef="c26" id="hidden-fact-68" name="us-gaap:NetIncomeLoss" unitRef="usd" xsi:nil="true"/>
<ix:nonFraction contextRef="c27" id="hidden-fact-69" name="us-gaap:NetIncomeLoss" unitRef="usd" xsi:nil="true"/>
<ix:nonFraction contextRef="c29" id="hidden-fact-70" name="us-gaap:NetIncomeLoss" unitRef="usd" xsi:nil="true"/>
<ix:nonFraction contextRef="c30" id="hidden-fact-71" name="us-gaap:SharesOutstanding" unitRef="shares" xsi:nil="true"/>
<ix:nonFraction contextRef="c30" id="hidden-fact-72" name="us-gaap:StockholdersEquity" unitRef="usd" xsi:nil="true"/>
<ix:nonFraction contextRef="c31" id="hidden-fact-73" name="us-gaap:SharesOutstanding" unitRef="shares" xsi:nil="true"/>
<ix:nonFraction contextRef="c31" id="hidden-fact-74" name="us-gaap:StockholdersEquity" unitRef="usd" xsi:nil="true"/>
<ix:nonFraction contextRef="c32" id="hidden-fact-75" name="us-gaap:SharesOutstanding" unitRef="shares" xsi:nil="true"/>
<ix:nonFraction contextRef="c32" id="hidden-fact-76" name="us-gaap:StockholdersEquity" unitRef="usd" xsi:nil="true"/>
<ix:nonFraction contextRef="c33" id="hidden-fact-77" name="us-gaap:SharesOutstanding" unitRef="shares" xsi:nil="true"/>
<ix:nonFraction contextRef="c33" id="hidden-fact-78" name="us-gaap:StockholdersEquity" unitRef="usd" xsi:nil="true"/>
<ix:nonFraction contextRef="c34" id="hidden-fact-79" name="us-gaap:SharesOutstanding" unitRef="shares" xsi:nil="true"/>
<ix:nonFraction contextRef="c34" id="hidden-fact-80" name="us-gaap:StockholdersEquity" unitRef="usd" xsi:nil="true"/>
<ix:nonFraction contextRef="c35" id="hidden-fact-81" name="us-gaap:SharesOutstanding" unitRef="shares" xsi:nil="true"/>
<ix:nonFraction contextRef="c35" id="hidden-fact-82" name="us-gaap:StockholdersEquity" unitRef="usd" xsi:nil="true"/>
<ix:nonFraction contextRef="c36" id="hidden-fact-83" name="us-gaap:StockholdersEquity" unitRef="usd" xsi:nil="true"/>
<ix:nonFraction contextRef="c37" id="hidden-fact-84" name="us-gaap:StockholdersEquity" unitRef="usd" xsi:nil="true"/>
<ix:nonFraction contextRef="c41" id="hidden-fact-85" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" unitRef="usd" xsi:nil="true"/>
<ix:nonFraction contextRef="c42" id="hidden-fact-86" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" unitRef="usd" xsi:nil="true"/>
<ix:nonFraction contextRef="c43" id="hidden-fact-87" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" unitRef="usd" xsi:nil="true"/>
<ix:nonFraction contextRef="c44" id="hidden-fact-88" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" unitRef="usd" xsi:nil="true"/>
<ix:nonFraction contextRef="c45" id="hidden-fact-89" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" unitRef="usd" xsi:nil="true"/>
<ix:nonFraction contextRef="c46" id="hidden-fact-90" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" unitRef="usd" xsi:nil="true"/>
<ix:nonFraction contextRef="c47" id="hidden-fact-91" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" unitRef="usd" xsi:nil="true"/>
<ix:nonFraction contextRef="c48" id="hidden-fact-92" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" unitRef="usd" xsi:nil="true"/>
<ix:nonFraction contextRef="c50" id="hidden-fact-93" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" unitRef="usd" xsi:nil="true"/>
<ix:nonFraction contextRef="c41" id="hidden-fact-94" name="us-gaap:StockIssuedDuringPeriodValueIssuedForServices" unitRef="usd" xsi:nil="true"/>
<ix:nonFraction contextRef="c42" id="hidden-fact-95" name="us-gaap:StockIssuedDuringPeriodValueIssuedForServices" unitRef="usd" xsi:nil="true"/>
<ix:nonFraction contextRef="c43" id="hidden-fact-96" name="us-gaap:StockIssuedDuringPeriodValueIssuedForServices" unitRef="usd" xsi:nil="true"/>
<ix:nonFraction contextRef="c44" id="hidden-fact-97" name="us-gaap:StockIssuedDuringPeriodValueIssuedForServices" unitRef="usd" xsi:nil="true"/>
<ix:nonFraction contextRef="c45" id="hidden-fact-98" name="us-gaap:StockIssuedDuringPeriodValueIssuedForServices" unitRef="usd" xsi:nil="true"/>
<ix:nonFraction contextRef="c46" id="hidden-fact-99" name="us-gaap:StockIssuedDuringPeriodValueIssuedForServices" unitRef="usd" xsi:nil="true"/>
<ix:nonFraction contextRef="c47" id="hidden-fact-100" name="us-gaap:StockIssuedDuringPeriodValueIssuedForServices" unitRef="usd" xsi:nil="true"/>
<ix:nonFraction contextRef="c48" id="hidden-fact-101" name="us-gaap:StockIssuedDuringPeriodValueIssuedForServices" unitRef="usd" xsi:nil="true"/>
<ix:nonFraction contextRef="c50" id="hidden-fact-102" name="us-gaap:StockIssuedDuringPeriodValueIssuedForServices" unitRef="usd" xsi:nil="true"/>
<ix:nonFraction contextRef="c41" id="hidden-fact-103" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" unitRef="usd" xsi:nil="true"/>
<ix:nonFraction contextRef="c42" id="hidden-fact-104" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" unitRef="usd" xsi:nil="true"/>
<ix:nonFraction contextRef="c43" id="hidden-fact-105" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" unitRef="usd" xsi:nil="true"/>
<ix:nonFraction contextRef="c46" id="hidden-fact-106" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" unitRef="usd" xsi:nil="true"/>
<ix:nonFraction contextRef="c47" id="hidden-fact-107" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" unitRef="usd" xsi:nil="true"/>
<ix:nonFraction contextRef="c48" id="hidden-fact-108" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" unitRef="usd" xsi:nil="true"/>
<ix:nonFraction contextRef="c50" id="hidden-fact-109" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" unitRef="usd" xsi:nil="true"/>
<ix:nonFraction contextRef="c41" id="hidden-fact-110" name="us-gaap:NetIncomeLoss" unitRef="usd" xsi:nil="true"/>
<ix:nonFraction contextRef="c42" id="hidden-fact-111" name="us-gaap:NetIncomeLoss" unitRef="usd" xsi:nil="true"/>
<ix:nonFraction contextRef="c43" id="hidden-fact-112" name="us-gaap:NetIncomeLoss" unitRef="usd" xsi:nil="true"/>
<ix:nonFraction contextRef="c44" id="hidden-fact-113" name="us-gaap:NetIncomeLoss" unitRef="usd" xsi:nil="true"/>
<ix:nonFraction contextRef="c45" id="hidden-fact-114" name="us-gaap:NetIncomeLoss" unitRef="usd" xsi:nil="true"/>
<ix:nonFraction contextRef="c46" id="hidden-fact-115" name="us-gaap:NetIncomeLoss" unitRef="usd" xsi:nil="true"/>
<ix:nonFraction contextRef="c47" id="hidden-fact-116" name="us-gaap:NetIncomeLoss" unitRef="usd" xsi:nil="true"/>
<ix:nonFraction contextRef="c48" id="hidden-fact-117" name="us-gaap:NetIncomeLoss" unitRef="usd" xsi:nil="true"/>
<ix:nonFraction contextRef="c49" id="hidden-fact-118" name="us-gaap:NetIncomeLoss" unitRef="usd" xsi:nil="true"/>
<ix:nonFraction contextRef="c51" id="hidden-fact-119" name="us-gaap:SharesOutstanding" unitRef="shares" xsi:nil="true"/>
<ix:nonFraction contextRef="c51" id="hidden-fact-120" name="us-gaap:StockholdersEquity" unitRef="usd" xsi:nil="true"/>
<ix:nonFraction contextRef="c52" id="hidden-fact-121" name="us-gaap:SharesOutstanding" unitRef="shares" xsi:nil="true"/>
<ix:nonFraction contextRef="c52" id="hidden-fact-122" name="us-gaap:StockholdersEquity" unitRef="usd" xsi:nil="true"/>
<ix:nonFraction contextRef="c53" id="hidden-fact-123" name="us-gaap:SharesOutstanding" unitRef="shares" xsi:nil="true"/>
<ix:nonFraction contextRef="c53" id="hidden-fact-124" name="us-gaap:StockholdersEquity" unitRef="usd" xsi:nil="true"/>
<ix:nonFraction contextRef="c54" id="hidden-fact-125" name="us-gaap:SharesOutstanding" unitRef="shares" xsi:nil="true"/>
<ix:nonFraction contextRef="c54" id="hidden-fact-126" name="us-gaap:StockholdersEquity" unitRef="usd" xsi:nil="true"/>
<ix:nonFraction contextRef="c55" id="hidden-fact-127" name="us-gaap:SharesOutstanding" unitRef="shares" xsi:nil="true"/>
<ix:nonFraction contextRef="c55" id="hidden-fact-128" name="us-gaap:StockholdersEquity" unitRef="usd" xsi:nil="true"/>
<ix:nonFraction contextRef="c56" id="hidden-fact-129" name="us-gaap:SharesOutstanding" unitRef="shares" xsi:nil="true"/>
<ix:nonFraction contextRef="c56" id="hidden-fact-130" name="us-gaap:StockholdersEquity" unitRef="usd" xsi:nil="true"/>
<ix:nonFraction contextRef="c57" id="hidden-fact-131" name="us-gaap:StockholdersEquity" unitRef="usd" xsi:nil="true"/>
<ix:nonFraction contextRef="c58" id="hidden-fact-132" name="us-gaap:StockholdersEquity" unitRef="usd" xsi:nil="true"/>
<ix:nonFraction contextRef="c61" id="hidden-fact-133" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" unitRef="usd" xsi:nil="true"/>
<ix:nonFraction contextRef="c62" id="hidden-fact-134" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" unitRef="usd" xsi:nil="true"/>
<ix:nonFraction contextRef="c63" id="hidden-fact-135" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" unitRef="usd" xsi:nil="true"/>
<ix:nonFraction contextRef="c64" id="hidden-fact-136" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" unitRef="usd" xsi:nil="true"/>
<ix:nonFraction contextRef="c65" id="hidden-fact-137" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" unitRef="usd" xsi:nil="true"/>
<ix:nonFraction contextRef="c66" id="hidden-fact-138" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" unitRef="usd" xsi:nil="true"/>
<ix:nonFraction contextRef="c68" id="hidden-fact-139" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" unitRef="usd" xsi:nil="true"/>
<ix:nonFraction contextRef="c61" id="hidden-fact-140" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" unitRef="usd" xsi:nil="true"/>
<ix:nonFraction contextRef="c62" id="hidden-fact-141" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" unitRef="usd" xsi:nil="true"/>
<ix:nonFraction contextRef="c63" id="hidden-fact-142" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" unitRef="usd" xsi:nil="true"/>
<ix:nonFraction contextRef="c65" id="hidden-fact-143" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" unitRef="usd" xsi:nil="true"/>
<ix:nonFraction contextRef="c69" id="hidden-fact-144" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" unitRef="usd" xsi:nil="true"/>
<ix:nonFraction contextRef="c66" id="hidden-fact-145" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" unitRef="usd" xsi:nil="true"/>
<ix:nonFraction contextRef="c68" id="hidden-fact-146" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" unitRef="usd" xsi:nil="true"/>
<ix:nonFraction contextRef="c61" id="hidden-fact-147" name="us-gaap:StockIssuedDuringPeriodValueIssuedForServices" unitRef="usd" xsi:nil="true"/>
<ix:nonFraction contextRef="c62" id="hidden-fact-148" name="us-gaap:StockIssuedDuringPeriodValueIssuedForServices" unitRef="usd" xsi:nil="true"/>
<ix:nonFraction contextRef="c63" id="hidden-fact-149" name="us-gaap:StockIssuedDuringPeriodValueIssuedForServices" unitRef="usd" xsi:nil="true"/>
<ix:nonFraction contextRef="c65" id="hidden-fact-150" name="us-gaap:StockIssuedDuringPeriodValueIssuedForServices" unitRef="usd" xsi:nil="true"/>
<ix:nonFraction contextRef="c69" id="hidden-fact-151" name="us-gaap:StockIssuedDuringPeriodValueIssuedForServices" unitRef="usd" xsi:nil="true"/>
<ix:nonFraction contextRef="c66" id="hidden-fact-152" name="us-gaap:StockIssuedDuringPeriodValueIssuedForServices" unitRef="usd" xsi:nil="true"/>
<ix:nonFraction contextRef="c68" id="hidden-fact-153" name="us-gaap:StockIssuedDuringPeriodValueIssuedForServices" unitRef="usd" xsi:nil="true"/>
<ix:nonFraction contextRef="c61" id="hidden-fact-154" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" unitRef="usd" xsi:nil="true"/>
<ix:nonFraction contextRef="c62" id="hidden-fact-155" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" unitRef="usd" xsi:nil="true"/>
<ix:nonFraction contextRef="c63" id="hidden-fact-156" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" unitRef="usd" xsi:nil="true"/>
<ix:nonFraction contextRef="c70" id="hidden-fact-157" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" unitRef="usd" xsi:nil="true"/>
<ix:nonFraction contextRef="c64" id="hidden-fact-158" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" unitRef="usd" xsi:nil="true"/>
<ix:nonFraction contextRef="c65" id="hidden-fact-159" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" unitRef="usd" xsi:nil="true"/>
<ix:nonFraction contextRef="c69" id="hidden-fact-160" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" unitRef="usd" xsi:nil="true"/>
<ix:nonFraction contextRef="c66" id="hidden-fact-161" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" unitRef="usd" xsi:nil="true"/>
<ix:nonFraction contextRef="c68" id="hidden-fact-162" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" unitRef="usd" xsi:nil="true"/>
<ix:nonFraction contextRef="c61" id="hidden-fact-163" name="us-gaap:NetIncomeLoss" unitRef="usd" xsi:nil="true"/>
<ix:nonFraction contextRef="c62" id="hidden-fact-164" name="us-gaap:NetIncomeLoss" unitRef="usd" xsi:nil="true"/>
<ix:nonFraction contextRef="c63" id="hidden-fact-165" name="us-gaap:NetIncomeLoss" unitRef="usd" xsi:nil="true"/>
<ix:nonFraction contextRef="c70" id="hidden-fact-166" name="us-gaap:NetIncomeLoss" unitRef="usd" xsi:nil="true"/>
<ix:nonFraction contextRef="c64" id="hidden-fact-167" name="us-gaap:NetIncomeLoss" unitRef="usd" xsi:nil="true"/>
<ix:nonFraction contextRef="c65" id="hidden-fact-168" name="us-gaap:NetIncomeLoss" unitRef="usd" xsi:nil="true"/>
<ix:nonFraction contextRef="c69" id="hidden-fact-169" name="us-gaap:NetIncomeLoss" unitRef="usd" xsi:nil="true"/>
<ix:nonFraction contextRef="c66" id="hidden-fact-170" name="us-gaap:NetIncomeLoss" unitRef="usd" xsi:nil="true"/>
<ix:nonFraction contextRef="c67" id="hidden-fact-171" name="us-gaap:NetIncomeLoss" unitRef="usd" xsi:nil="true"/>
<ix:nonFraction contextRef="c71" id="hidden-fact-172" name="us-gaap:SharesOutstanding" unitRef="shares" xsi:nil="true"/>
<ix:nonFraction contextRef="c71" id="hidden-fact-173" name="us-gaap:StockholdersEquity" unitRef="usd" xsi:nil="true"/>
<ix:nonFraction contextRef="c72" id="hidden-fact-174" name="us-gaap:SharesOutstanding" unitRef="shares" xsi:nil="true"/>
<ix:nonFraction contextRef="c72" id="hidden-fact-175" name="us-gaap:StockholdersEquity" unitRef="usd" xsi:nil="true"/>
<ix:nonFraction contextRef="c73" id="hidden-fact-176" name="us-gaap:SharesOutstanding" unitRef="shares" xsi:nil="true"/>
<ix:nonFraction contextRef="c73" id="hidden-fact-177" name="us-gaap:StockholdersEquity" unitRef="usd" xsi:nil="true"/>
<ix:nonFraction contextRef="c74" id="hidden-fact-178" name="us-gaap:SharesOutstanding" unitRef="shares" xsi:nil="true"/>
<ix:nonFraction contextRef="c74" id="hidden-fact-179" name="us-gaap:StockholdersEquity" unitRef="usd" xsi:nil="true"/>
<ix:nonFraction contextRef="c75" id="hidden-fact-180" name="us-gaap:SharesOutstanding" unitRef="shares" xsi:nil="true"/>
<ix:nonFraction contextRef="c75" id="hidden-fact-181" name="us-gaap:StockholdersEquity" unitRef="usd" xsi:nil="true"/>
<ix:nonFraction contextRef="c76" id="hidden-fact-182" name="us-gaap:SharesOutstanding" unitRef="shares" xsi:nil="true"/>
<ix:nonFraction contextRef="c76" id="hidden-fact-183" name="us-gaap:StockholdersEquity" unitRef="usd" xsi:nil="true"/>
<ix:nonFraction contextRef="c77" id="hidden-fact-184" name="us-gaap:StockholdersEquity" unitRef="usd" xsi:nil="true"/>
<ix:nonFraction contextRef="c78" id="hidden-fact-185" name="us-gaap:StockholdersEquity" unitRef="usd" xsi:nil="true"/>
<ix:nonFraction contextRef="c0" id="hidden-fact-186" name="arbe:RevaluationOfConvertibleLoan" unitRef="usd" xsi:nil="true"/>
<ix:nonFraction contextRef="c7" id="hidden-fact-187" name="arbe:RevaluationOfConvertibleLoan" unitRef="usd" xsi:nil="true"/>
<ix:nonFraction contextRef="c8" id="hidden-fact-188" name="us-gaap:IncreaseDecreaseInOperatingLeaseLiability" unitRef="usd" xsi:nil="true"/>
<ix:nonFraction contextRef="c0" id="hidden-fact-189" name="us-gaap:ProceedsFromShortTermDebt" unitRef="usd" xsi:nil="true"/>
<ix:nonFraction contextRef="c7" id="hidden-fact-190" name="us-gaap:ProceedsFromShortTermDebt" unitRef="usd" xsi:nil="true"/>
<ix:nonFraction contextRef="c0" id="hidden-fact-191" name="us-gaap:RepaymentsOfLongTermDebt" unitRef="usd" xsi:nil="true"/>
<ix:nonFraction contextRef="c7" id="hidden-fact-192" name="us-gaap:RepaymentsOfLongTermDebt" unitRef="usd" xsi:nil="true"/>
<ix:nonFraction contextRef="c0" id="hidden-fact-193" name="us-gaap:ProceedsFromIssuanceInitialPublicOffering" unitRef="usd" xsi:nil="true"/>
<ix:nonFraction contextRef="c7" id="hidden-fact-194" name="us-gaap:ProceedsFromIssuanceInitialPublicOffering" unitRef="usd" xsi:nil="true"/>
<ix:nonFraction contextRef="c0" id="hidden-fact-195" name="us-gaap:RepaymentsOfShortTermDebt" unitRef="usd" xsi:nil="true"/>
<ix:nonFraction contextRef="c8" id="hidden-fact-196" name="us-gaap:RepaymentsOfShortTermDebt" unitRef="usd" xsi:nil="true"/>
<ix:nonFraction contextRef="c7" id="hidden-fact-197" name="us-gaap:ProceedsFromIssuanceOfCommonStock" unitRef="usd" xsi:nil="true"/>
<ix:nonFraction contextRef="c8" id="hidden-fact-198" name="us-gaap:ProceedsFromIssuanceOfCommonStock" unitRef="usd" xsi:nil="true"/>
<ix:nonFraction contextRef="c0" id="hidden-fact-199" name="us-gaap:ProceedsFromWarrantExercises" unitRef="usd" xsi:nil="true"/>
<ix:nonFraction contextRef="c7" id="hidden-fact-200" name="us-gaap:ProceedsFromWarrantExercises" unitRef="usd" xsi:nil="true"/>
<ix:nonFraction contextRef="c0" id="hidden-fact-201" name="us-gaap:ProceedsFromConvertibleDebt" unitRef="usd" xsi:nil="true"/>
<ix:nonFraction contextRef="c7" id="hidden-fact-202" name="us-gaap:ProceedsFromConvertibleDebt" unitRef="usd" xsi:nil="true"/>
<ix:nonFraction contextRef="c8" id="hidden-fact-203" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" unitRef="usd" xsi:nil="true"/>
<ix:nonFraction contextRef="c0" id="hidden-fact-204" name="us-gaap:ConversionOfStockAmountConverted1" unitRef="usd" xsi:nil="true"/>
<ix:nonFraction contextRef="c7" id="hidden-fact-205" name="us-gaap:ConversionOfStockAmountConverted1" unitRef="usd" xsi:nil="true"/>
<ix:nonFraction contextRef="c0" id="hidden-fact-206" name="us-gaap:StockIssued1" unitRef="usd" xsi:nil="true"/>
<ix:nonFraction contextRef="c7" id="hidden-fact-207" name="us-gaap:StockIssued1" unitRef="usd" xsi:nil="true"/>
<ix:nonFraction contextRef="c0" id="hidden-fact-208" name="arbe:ConversionOfConvertibleLoanIntoOrdinarySharesUponTheRecapitalization" unitRef="usd" xsi:nil="true"/>
<ix:nonFraction contextRef="c7" id="hidden-fact-209" name="arbe:ConversionOfConvertibleLoanIntoOrdinarySharesUponTheRecapitalization" unitRef="usd" xsi:nil="true"/>
<ix:nonFraction contextRef="c0" id="hidden-fact-210" name="arbe:ConversionOfPreferredSharesIntoOrdinarySharesUponTheRecapitalization" unitRef="usd" xsi:nil="true"/>
<ix:nonFraction contextRef="c7" id="hidden-fact-211" name="arbe:ConversionOfPreferredSharesIntoOrdinarySharesUponTheRecapitalization" unitRef="usd" xsi:nil="true"/>
<ix:nonFraction contextRef="c8" id="hidden-fact-212" name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" unitRef="usd" xsi:nil="true"/>
<ix:nonFraction contextRef="c0" id="hidden-fact-213" name="us-gaap:InterestPaidNet" unitRef="usd" xsi:nil="true"/>
<ix:nonFraction contextRef="c97" id="hidden-fact-214" name="us-gaap:PropertyPlantAndEquipmentSalvageValuePercentage" unitRef="pure" xsi:nil="true"/>
<ix:nonFraction contextRef="c106" id="hidden-fact-215" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" unitRef="usd" xsi:nil="true"/>
<ix:nonFraction contextRef="c107" id="hidden-fact-216" name="us-gaap:RevenueRemainingPerformanceObligationPercentage" unitRef="pure" xsi:nil="true"/>
<ix:nonFraction contextRef="c134" id="hidden-fact-217" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" unitRef="usd" xsi:nil="true"/>
<ix:nonFraction contextRef="c135" id="hidden-fact-218" name="us-gaap:RevenueRemainingPerformanceObligationPercentage" unitRef="pure" xsi:nil="true"/>
<ix:nonFraction contextRef="c138" id="hidden-fact-219" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" unitRef="usd" xsi:nil="true"/>
<ix:nonFraction contextRef="c139" id="hidden-fact-220" name="us-gaap:RevenueRemainingPerformanceObligationPercentage" unitRef="pure" xsi:nil="true"/>
<ix:nonFraction contextRef="c140" id="hidden-fact-221" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" unitRef="usd" xsi:nil="true"/>
<ix:nonFraction contextRef="c141" id="hidden-fact-222" name="us-gaap:RevenueRemainingPerformanceObligationPercentage" unitRef="pure" xsi:nil="true"/>
<ix:nonFraction contextRef="c148" id="hidden-fact-223" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" unitRef="usd" xsi:nil="true"/>
<ix:nonFraction contextRef="c149" id="hidden-fact-224" name="us-gaap:RevenueRemainingPerformanceObligationPercentage" unitRef="pure" xsi:nil="true"/>
<ix:nonFraction contextRef="c166" id="hidden-fact-225" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" unitRef="shares" xsi:nil="true"/>
<ix:nonFraction contextRef="c167" id="hidden-fact-226" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures" unitRef="shares" xsi:nil="true"/>
<ix:nonFraction contextRef="c167" id="hidden-fact-227" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsPeriodIncreaseDecrease" unitRef="shares" xsi:nil="true"/>
<ix:nonFraction contextRef="c189" id="hidden-fact-228" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" unitRef="shares" xsi:nil="true"/>
<ix:nonFraction contextRef="c190" id="hidden-fact-229" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" unitRef="shares" xsi:nil="true"/>
<ix:nonFraction contextRef="c0" id="hidden-fact-230" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" unitRef="usd" xsi:nil="true"/>
<ix:nonFraction contextRef="c7" id="hidden-fact-231" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" unitRef="usd" xsi:nil="true"/>
<ix:nonFraction contextRef="c8" id="hidden-fact-232" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" unitRef="usd" xsi:nil="true"/>
<ix:nonFraction contextRef="c0" id="hidden-fact-233" name="us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential" unitRef="usd" xsi:nil="true"/>
<ix:nonFraction contextRef="c7" id="hidden-fact-234" name="us-gaap:IncomeTaxReconciliationOtherAdjustments" unitRef="usd" xsi:nil="true"/>
<ix:nonFraction contextRef="c8" id="hidden-fact-235" name="us-gaap:IncomeTaxReconciliationOtherAdjustments" unitRef="usd" xsi:nil="true"/>
<ix:nonFraction contextRef="c0" id="hidden-fact-236" name="us-gaap:IncomeTaxExpenseBenefit" unitRef="usd" xsi:nil="true"/>
<ix:nonFraction contextRef="c7" id="hidden-fact-237" name="us-gaap:IncomeTaxExpenseBenefit" unitRef="usd" xsi:nil="true"/>
<ix:nonFraction contextRef="c8" id="hidden-fact-238" name="us-gaap:IncomeTaxExpenseBenefit" unitRef="usd" xsi:nil="true"/>
<ix:nonFraction contextRef="c5" id="hidden-fact-239" name="us-gaap:DeferredTaxAssetsLiabilitiesNet" unitRef="usd" xsi:nil="true"/>
<ix:nonFraction contextRef="c6" id="hidden-fact-240" name="us-gaap:DeferredTaxAssetsLiabilitiesNet" unitRef="usd" xsi:nil="true"/>
<ix:nonFraction contextRef="c117" id="hidden-fact-241" name="us-gaap:PropertyPlantAndEquipmentNet" unitRef="usd" xsi:nil="true"/>
<ix:nonFraction contextRef="c119" id="hidden-fact-242" name="us-gaap:PropertyPlantAndEquipmentNet" unitRef="usd" xsi:nil="true"/>
<ix:nonNumeric contextRef="c0" name="dei:AmendmentFlag" id="ixv-26975">false</ix:nonNumeric>
<ix:nonNumeric contextRef="c0" name="dei:DocumentFiscalPeriodFocus" id="ixv-26976">FY</ix:nonNumeric>
<ix:nonNumeric contextRef="c0" name="dei:EntityAddressPostalZipCode" id="ixv-26977">6329302</ix:nonNumeric>
<ix:nonNumeric contextRef="c1" name="dei:EntityAddressPostalZipCode" id="ixv-26978">6329302</ix:nonNumeric>
<ix:nonNumeric contextRef="c0" name="dei:EntityCentralIndexKey" id="ixv-26979">0001861841</ix:nonNumeric>
</ix:hidden>
<ix:references><link:schemaRef xlink:href="arbe-20231231.xsd" xlink:type="simple"/></ix:references>
<ix:resources><ix:relationship fromRefs="hidden-fact-1 hidden-fact-2" toRefs="ix_0_footnote"/>
<ix:relationship fromRefs="hidden-fact-3 hidden-fact-11 hidden-fact-20 hidden-fact-29 hidden-fact-34 hidden-fact-60 hidden-fact-84 hidden-fact-108 hidden-fact-132 hidden-fact-161 hidden-fact-185" toRefs="ix_1_footnote"/>
<ix:relationship fromRefs="hidden-fact-214" toRefs="ix_2_footnote"/>
<ix:relationship fromRefs="ix_0_fact ix_1_fact ix_2_fact ix_3_fact ix_4_fact ix_5_fact" toRefs="ix_3_footnote"/>
<ix:relationship fromRefs="hidden-fact-233 ix_6_fact ix_7_fact" toRefs="ix_4_footnote"/>
<xbrli:context id="c0">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-01-01</xbrli:startDate>
    <xbrli:endDate>2023-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c1">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="dei:EntityAddressesAddressTypeAxis">dei:BusinessContactMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-01-01</xbrli:startDate>
    <xbrli:endDate>2023-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c2">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">arbe:OrdinarySharesParValueNIS0000216PerShareMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-01-01</xbrli:startDate>
    <xbrli:endDate>2023-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c3">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">arbe:WarrantsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-01-01</xbrli:startDate>
    <xbrli:endDate>2023-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c4">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-03-01</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c5">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c6">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c7">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c8">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-01-01</xbrli:startDate>
    <xbrli:endDate>2021-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c9">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">arbe:SeedMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2020-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c10">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2020-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c11">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">arbe:SeriesA1PreferredStockMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2020-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c12">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2020-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c13">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">arbe:SeriesB1PreferredStockMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2020-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c14">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">arbe:SeriesB2PreferredStockMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2020-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c15">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2020-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c16">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2020-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c17">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2020-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c18">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2020-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c19">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2020-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c20">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">arbe:SeedMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-01-01</xbrli:startDate>
    <xbrli:endDate>2021-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c21">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-01-01</xbrli:startDate>
    <xbrli:endDate>2021-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c22">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">arbe:SeriesA1PreferredStockMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-01-01</xbrli:startDate>
    <xbrli:endDate>2021-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c23">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-01-01</xbrli:startDate>
    <xbrli:endDate>2021-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c24">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">arbe:SeriesB1PreferredStockMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-01-01</xbrli:startDate>
    <xbrli:endDate>2021-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c25">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">arbe:SeriesB2PreferredStockMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-01-01</xbrli:startDate>
    <xbrli:endDate>2021-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c26">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-01-01</xbrli:startDate>
    <xbrli:endDate>2021-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c27">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-01-01</xbrli:startDate>
    <xbrli:endDate>2021-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c28">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-01-01</xbrli:startDate>
    <xbrli:endDate>2021-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c29">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-01-01</xbrli:startDate>
    <xbrli:endDate>2021-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c30">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">arbe:SeedMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2021-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c31">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2021-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c32">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">arbe:SeriesA1PreferredStockMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2021-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c33">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2021-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c34">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">arbe:SeriesB1PreferredStockMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2021-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c35">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">arbe:SeriesB2PreferredStockMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2021-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c36">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2021-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c37">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2021-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c38">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2021-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c39">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2021-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c40">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2021-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c41">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">arbe:SeedMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c42">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c43">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">arbe:SeriesA1PreferredStockMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c44">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c45">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">arbe:SeriesB1PreferredStockMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c46">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">arbe:SeriesB2PreferredStockMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c47">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c48">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c49">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c50">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c51">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">arbe:SeedMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c52">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c53">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">arbe:SeriesA1PreferredStockMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c54">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c55">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">arbe:SeriesB1PreferredStockMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c56">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">arbe:SeriesB2PreferredStockMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c57">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c58">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c59">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c60">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c61">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">arbe:SeedMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-01-01</xbrli:startDate>
    <xbrli:endDate>2023-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c62">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-01-01</xbrli:startDate>
    <xbrli:endDate>2023-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c63">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">arbe:SeriesA1PreferredStockMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-01-01</xbrli:startDate>
    <xbrli:endDate>2023-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c64">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">arbe:SeriesB1PreferredStockMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-01-01</xbrli:startDate>
    <xbrli:endDate>2023-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c65">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">arbe:SeriesB2PreferredStockMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-01-01</xbrli:startDate>
    <xbrli:endDate>2023-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c66">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-01-01</xbrli:startDate>
    <xbrli:endDate>2023-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c67">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-01-01</xbrli:startDate>
    <xbrli:endDate>2023-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c68">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-01-01</xbrli:startDate>
    <xbrli:endDate>2023-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c69">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-01-01</xbrli:startDate>
    <xbrli:endDate>2023-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c70">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-01-01</xbrli:startDate>
    <xbrli:endDate>2023-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c71">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">arbe:SeedMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c72">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c73">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">arbe:SeriesA1PreferredStockMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c74">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c75">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">arbe:SeriesB1PreferredStockMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c76">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">arbe:SeriesB2PreferredStockMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c77">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c78">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c79">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c80">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c81">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-10-01</xbrli:startDate>
    <xbrli:endDate>2023-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c82">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c83">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c84">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">arbe:ArbeRoboticsLtdMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c85">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">arbe:PublicWarrantsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c86">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">arbe:PrivateWarrantsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c87">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">arbe:PIPEMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-01-01</xbrli:startDate>
    <xbrli:endDate>2023-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c88">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-01-01</xbrli:startDate>
    <xbrli:endDate>2023-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c89">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">arbe:PIPEMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c90">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-01-01</xbrli:startDate>
    <xbrli:endDate>2023-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c91">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
<!-- [WMV5][XcpuxYn59dz7vgYynUDuwG7r97K2jUTysl7vcz0lJt/tSeJz73kx1cLt0ZFF2SK/vxBCY0vdSrZEr5dnmkj55Vn3PE+1u+YOtkjz23BDixtN+DSa6ODpxKHuuFDR2EFRAYrDV15EdRUTOp8hTdByKJ//xoC7ECC663wnKueQq7LbhDBxlm0Wi1xZdy33k9DRJYjt/rCQI8A6bBdr5ony7RknOIsPU1pWTweSc4Wp+IQVoYO/x93rSQOoZayYDA6QKphrWds//8G7qNePkBp+rg==] CSR-->
  <xbrli:period>
    <xbrli:startDate>2023-01-01</xbrli:startDate>
    <xbrli:endDate>2023-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c92">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c93">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c94">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:OfficeEquipmentMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c95">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:OfficeEquipmentMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c96">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:VehiclesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c97">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c98">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CN</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-01-01</xbrli:startDate>
    <xbrli:endDate>2023-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c99">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CN</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c100">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CN</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c101">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CN</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c102">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CN</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-01-01</xbrli:startDate>
    <xbrli:endDate>2021-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c103">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CN</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2021-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c104">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:HK</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-01-01</xbrli:startDate>
    <xbrli:endDate>2023-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c105">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:HK</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c106">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:HK</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c107">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:HK</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c108">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:HK</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-01-01</xbrli:startDate>
    <xbrli:endDate>2021-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c109">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:HK</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2021-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c110">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:SE</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-01-01</xbrli:startDate>
    <xbrli:endDate>2023-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c111">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:SE</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c112">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:SE</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c113">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:SE</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c114">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:SE</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-01-01</xbrli:startDate>
    <xbrli:endDate>2021-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c115">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:SE</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2021-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c116">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-01-01</xbrli:startDate>
    <xbrli:endDate>2023-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c117">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c118">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c119">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c120">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-01-01</xbrli:startDate>
    <xbrli:endDate>2021-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c121">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2021-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c122">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:DE</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-01-01</xbrli:startDate>
    <xbrli:endDate>2023-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c123">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:DE</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c124">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:DE</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c125">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:DE</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c126">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:DE</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-01-01</xbrli:startDate>
    <xbrli:endDate>2021-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c127">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:DE</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2021-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c128">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:IL</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-01-01</xbrli:startDate>
    <xbrli:endDate>2023-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c129">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:IL</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c130">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:IL</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c131">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:IL</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c132">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:IL</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-01-01</xbrli:startDate>
    <xbrli:endDate>2021-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c133">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:IL</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2021-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c134">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:IT</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-01-01</xbrli:startDate>
    <xbrli:endDate>2023-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c135">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:IT</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c136">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:IT</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c137">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:IT</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c138">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:IT</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-01-01</xbrli:startDate>
    <xbrli:endDate>2021-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c139">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:IT</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2021-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c140">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CH</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-01-01</xbrli:startDate>
    <xbrli:endDate>2023-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c141">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CH</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c142">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CH</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c143">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CH</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c144">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CH</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-01-01</xbrli:startDate>
    <xbrli:endDate>2021-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c145">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CH</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2021-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c146">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">arbe:OtherGeographicalMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-01-01</xbrli:startDate>
    <xbrli:endDate>2023-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c147">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">arbe:OtherGeographicalMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c148">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">arbe:OtherGeographicalMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c149">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">arbe:OtherGeographicalMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c150">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">arbe:OtherGeographicalMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-01-01</xbrli:startDate>
    <xbrli:endDate>2021-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c151">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">arbe:OtherGeographicalMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2021-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c152">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c153">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c154">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c155">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:OfficeEquipmentMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c156">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:OfficeEquipmentMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c157">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:VehiclesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c158">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-01-01</xbrli:startDate>
    <xbrli:endDate>2023-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c159">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c160">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-06-01</xbrli:startDate>
    <xbrli:endDate>2023-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c161">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">arbe:TwoThousandSixteenIncentivePlanMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2016-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c162">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">arbe:PlanOneMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-01-01</xbrli:startDate>
    <xbrli:endDate>2023-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c163">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">arbe:TwoThousandTwentyOneEquityIncentivePlanMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c164">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">arbe:TwoThousandTwentyOneEquityIncentivePlanMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-01-01</xbrli:startDate>
    <xbrli:endDate>2023-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c165">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2020-12-31</xbrli:startDate>
    <xbrli:endDate>2020-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c166">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2020-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c167">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-01-01</xbrli:startDate>
    <xbrli:endDate>2021-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c168">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2021-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c169">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c170">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c171">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-01-01</xbrli:startDate>
    <xbrli:endDate>2023-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c172">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c173">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c174">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c175">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-01-01</xbrli:startDate>
    <xbrli:endDate>2021-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c176">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-01-01</xbrli:startDate>
    <xbrli:endDate>2021-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c177">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-01-01</xbrli:startDate>
    <xbrli:endDate>2023-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c178">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c179">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-01-01</xbrli:startDate>
    <xbrli:endDate>2021-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c180">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingAndMarketingExpenseMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-01-01</xbrli:startDate>
    <xbrli:endDate>2023-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c181">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingAndMarketingExpenseMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c182">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingAndMarketingExpenseMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-01-01</xbrli:startDate>
    <xbrli:endDate>2021-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c183">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-01-01</xbrli:startDate>
    <xbrli:endDate>2023-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c184">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c185">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-01-01</xbrli:startDate>
    <xbrli:endDate>2021-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c186">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-01-01</xbrli:startDate>
    <xbrli:endDate>2023-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c187">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c188">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-01-01</xbrli:startDate>
    <xbrli:endDate>2021-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c189">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:ConvertiblePreferredStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-01-01</xbrli:startDate>
    <xbrli:endDate>2023-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c190">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:ConvertiblePreferredStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c191">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:ConvertiblePreferredStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-01-01</xbrli:startDate>
    <xbrli:endDate>2021-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c192">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">arbe:OutstandingShareOptionsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-01-01</xbrli:startDate>
    <xbrli:endDate>2023-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c193">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">arbe:OutstandingShareOptionsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c194">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">arbe:OutstandingShareOptionsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-01-01</xbrli:startDate>
    <xbrli:endDate>2021-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c195">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">arbe:Customer1Member</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-01-01</xbrli:startDate>
    <xbrli:endDate>2023-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c196">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">arbe:Customer2Member</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-01-01</xbrli:startDate>
    <xbrli:endDate>2023-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c197">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">arbe:Customer3Member</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-01-01</xbrli:startDate>
    <xbrli:endDate>2023-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c198">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">arbe:Customer1Member</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c199">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">arbe:Customer2Member</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c200">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">arbe:Customer3Member</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c201">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">arbe:Customer1Member</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-01-01</xbrli:startDate>
    <xbrli:endDate>2021-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c202">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">arbe:Customer2Member</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-01-01</xbrli:startDate>
    <xbrli:endDate>2021-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c203">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">arbe:Customer3Member</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-01-01</xbrli:startDate>
    <xbrli:endDate>2021-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:unit id="shares">
  <xbrli:measure>xbrli:shares</xbrli:measure>
</xbrli:unit><xbrli:unit id="usd">
  <xbrli:measure>iso4217:USD</xbrli:measure>
</xbrli:unit><xbrli:unit id="ilsPershares">
  <xbrli:divide>
    <xbrli:unitNumerator>
      <xbrli:measure>iso4217:ILS</xbrli:measure>
    </xbrli:unitNumerator>
    <xbrli:unitDenominator>
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unitDenominator>
  </xbrli:divide>
</xbrli:unit><xbrli:unit id="usdPershares">
  <xbrli:divide>
    <xbrli:unitNumerator>
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unitNumerator>
    <xbrli:unitDenominator>
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unitDenominator>
  </xbrli:divide>
</xbrli:unit><xbrli:unit id="pure">
  <xbrli:measure>xbrli:pure</xbrli:measure>
</xbrli:unit></ix:resources></ix:header>

</div></div></body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-8.1
<SEQUENCE>2
<FILENAME>ea020246101ex8-1_arberobo.htm
<DESCRIPTION>LIST OF SUBSIDIARIES OF ARBE
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Exhibit 8.1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>LIST OF SUBSIDIARIES OF ARBE ROBOTICS LTD.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: Black 1.5pt solid; width: 49%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name of Subsidiary</FONT></TD>
    <TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; width: 49%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Jurisdiction of Incorporation</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Arbe Robotics US, Inc</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Delaware (USA)</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Autobot HoldCo, Inc</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Delaware (USA)</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shanghai Arbe Technologies Co., Ltd</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">People&rsquo;s Republic of China</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-12.1
<SEQUENCE>3
<FILENAME>ea020246101ex12-1_arberobo.htm
<DESCRIPTION>CERTIFICATION
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Exhibit 12.1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER
PURSUANT TO</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>EXCHANGE ACT RULE 13A-14(A)/15D-14(A)</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>AS ADOPTED PURSUANT TO SECTION 302</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>OF THE SARBANES-OXLEY ACT OF 2002</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">I, Jacob Marinka (AKA Kobi Marenko), certify that:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 24px; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.</FONT></TD>
    <TD STYLE="text-align: justify; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">I have reviewed this annual report on Form 20-F of Arbe Robotics Ltd.;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 24px; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.</FONT></TD>
    <TD STYLE="text-align: justify; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 24px; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.</FONT></TD>
    <TD STYLE="text-align: justify; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 24px; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.</FONT></TD>
    <TD STYLE="text-align: justify; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The registrant&rsquo;s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f) for the company and have:</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 24px">&nbsp;</TD>
    <TD STYLE="width: 24px; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD>
    <TD STYLE="text-align: justify; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 24px">&nbsp;</TD>
    <TD STYLE="width: 24px; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD>
    <TD STYLE="text-align: justify; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 24px">&nbsp;</TD>
    <TD STYLE="width: 24px; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT></TD>
    <TD STYLE="text-align: justify; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Evaluated the effectiveness of the registrant&rsquo;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 24px">&nbsp;</TD>
    <TD STYLE="width: 24px; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)</FONT></TD>
    <TD STYLE="text-align: justify; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Disclosed in this report any change in the registrant&rsquo;s internal control over financial reporting that occurred during the period covered by the annual report that has materially affected, or is reasonably likely to materially affect, the registrant&rsquo;s internal control over financial reporting; and</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 24px; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.</FONT></TD>
    <TD STYLE="text-align: justify; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The registrant&rsquo;s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&rsquo;s auditors and the audit committee of the registrant&rsquo;s board of directors (or persons performing the equivalent functions):</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 24px">&nbsp;</TD>
    <TD STYLE="width: 24px; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD>
    <TD STYLE="text-align: justify; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&rsquo;s ability to record, process, summarize and report financial information; and</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 24px">&nbsp;</TD>
    <TD STYLE="width: 24px; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD>
    <TD STYLE="text-align: justify; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&rsquo;s internal control over financial reporting.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR>
    <TD STYLE="vertical-align: top; width: 60%; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date:&nbsp;March
    28, 2024</FONT></TD>
    <TD STYLE="width: 40%; border-bottom: black 1.5pt solid; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ Jacob (Kobi) Marinka &nbsp;</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Jacob (Kobi) Marinka </FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top; font-size: 10pt">&nbsp;</TD>
    <TD>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Chief Executive Officer<BR>
(Principal Executive Officer)</P></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-12.2
<SEQUENCE>4
<FILENAME>ea020246101ex12-2_arberobo.htm
<DESCRIPTION>CERTIFICATION
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Exhibit 12.2</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER
PURSUANT TO</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>EXCHANGE ACT RULE 13A-14(A)/15D-14(A)</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>AS ADOPTED PURSUANT TO SECTION 302</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>OF THE SARBANES-OXLEY ACT OF 2002</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">I, Karine Pinto-Flomenboim, certify that:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 24px; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.</FONT></TD>
    <TD STYLE="text-align: justify; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">I have reviewed this annual report on Form 20-F of Arbe Robotics Ltd.;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 24px; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.</FONT></TD>
    <TD STYLE="text-align: justify; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 24px; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.</FONT></TD>
    <TD STYLE="text-align: justify; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 24px; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.</FONT></TD>
    <TD STYLE="text-align: justify; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The registrant&rsquo;s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f) for the company and have:</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 24px">&nbsp;</TD>
    <TD STYLE="width: 24px; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD>
    <TD STYLE="text-align: justify; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 24px">&nbsp;</TD>
    <TD STYLE="width: 24px; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD>
    <TD STYLE="text-align: justify; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 24px">&nbsp;</TD>
    <TD STYLE="width: 24px; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT></TD>
    <TD STYLE="text-align: justify; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Evaluated the effectiveness of the registrant&rsquo;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 24px">&nbsp;</TD>
    <TD STYLE="width: 24px; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)</FONT></TD>
    <TD STYLE="text-align: justify; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Disclosed in this report any change in the registrant&rsquo;s internal control over financial reporting that occurred during the period covered by the annual report that has materially affected, or is reasonably likely to materially affect, the registrant&rsquo;s internal control over financial reporting; and</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 24px; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.</FONT></TD>
    <TD STYLE="text-align: justify; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The registrant&rsquo;s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&rsquo;s auditors and the audit committee of the registrant&rsquo;s board of directors (or persons performing the equivalent functions):</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 24px">&nbsp;</TD>
    <TD STYLE="width: 24px; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD>
    <TD STYLE="text-align: justify; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&rsquo;s ability to record, process, summarize and report financial information; and</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 24px">&nbsp;</TD>
    <TD STYLE="width: 24px; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD>
    <TD STYLE="text-align: justify; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&rsquo;s internal control over financial reporting.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR>
    <TD STYLE="vertical-align: top; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date:
    March 28, 2024</FONT></TD>
    <TD STYLE="border-bottom: black 1.5pt solid; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ Karine Pinto-Flomenboim</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Karine Pinto-Flomenboim</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top; width: 60%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 40%">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Chief Financial Officer<BR>
(Principal Accounting Officer)</P></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"></P>


</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-13.1
<SEQUENCE>5
<FILENAME>ea020246101ex13-1_arberobo.htm
<DESCRIPTION>CERTIFICATION
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Exhibit 13.1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>CERTIFICATION PURSUANT TO 18 U.S.C. SECTION&nbsp;1350,<BR>
AS ADOPTED PURSUANT TO SECTION&nbsp;906 OF THE SARBANES-OXLEY ACT OF&nbsp;2002</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt">In connection with the
Annual Report of Arbe Robotics Ltd. (the &ldquo;Registrant&rdquo;) on Form&nbsp;20-F for the year ended December 31, 2023, as filed
with the Securities and Exchange Commission on the date hereof (the &ldquo;Report&rdquo;), the undersigned certifies pursuant to 18
U.S.C. 1350, as adopted pursuant to Section&nbsp;906 of the Sarbanes-Oxley Act of 2002, that:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px">&nbsp;</TD>
    <TD STYLE="width: 24px; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.</FONT></TD>
    <TD STYLE="text-align: justify; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Report, fully complies with the requirements of Section&nbsp;13(a) or Section&nbsp;15(d) of the Securities Exchange Act of 1934, as amended; and</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px">&nbsp;</TD>
    <TD STYLE="width: 24px; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.</FONT></TD>
    <TD STYLE="text-align: justify; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Registrant.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Date: March 28, 2024</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 36pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR>
    <TD STYLE="vertical-align: top; width: 60%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid; width: 40%; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ Jacob (Kobi) Marinka</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Jacob (Kobi) Marinka</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top; font-size: 10pt">&nbsp;</TD>
    <TD>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Chief Executive Officer<BR>
(Principal Executive Officer)</P></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 36pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR>
    <TD STYLE="vertical-align: top; width: 60%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid; width: 40%; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ Karine Pinto-Flomenboim</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Karine Pinto-Flomenboim</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top; font-size: 10pt">&nbsp;</TD>
    <TD>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Chief Financial Officer<BR>
(Principal Accounting Officer)</P></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.1
<SEQUENCE>6
<FILENAME>ea020246101ex23-1_arberobo.htm
<DESCRIPTION>CONSENT OF SOMEKH CHAIKIN MEMBER FIRM OF KPMG INTERNATIONAL
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: right"><B>Exhibit 23.1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: center"><B>Consent of Independent Registered Public
Accounting Firm</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt"><FONT STYLE="font-size: 10pt">We consent to the incorporation
by reference in the registration statement on Form F-3, File No. 333-269235 and the registration statement on Form S-8, File No. 333-269230
of our report dated March 27, 2024, with respect to the consolidated financial statements of </FONT>Arbe Robotics Ltd <FONT STYLE="font-size: 10pt">.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt">Somekh Chaikin</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt">Member Firm of KPMG International</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt">Tel Aviv, Israel</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt">March 28, 2024</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-97.1
<SEQUENCE>7
<FILENAME>ea020246101ex97-1_arberobo.htm
<DESCRIPTION>CLAWBACK POLICY
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: right">Exhibit 97.1</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 102.3pt 0pt 101.5pt; text-align: center">&nbsp;&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 102.3pt 0pt 101.5pt; text-align: center">ARBE ROBOTICS LTD.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 102.4pt 0pt 101.5pt; text-align: center"><B>EXECUTIVE COMPENSATION CLAWBACK
POLICY</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 102.15pt 0pt 101.5pt; text-align: center">Adopted as of December
1, 2023</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">The Board of
Directors (the &ldquo;<B>Board</B>&rdquo;) of Arbe Robotics Ltd. (the &ldquo;<B>Company</B>&rdquo;) has adopted the following executive
compensation clawback policy (this &ldquo;<B>Policy</B>&rdquo;). This Policy shall supplement any other clawback or compensation recovery
policy or policies adopted by the Company or included in any agreement between the Company, or any subsidiary of the Company, and a person
covered by this Policy. If any such other policy or agreement provides that a greater amount of compensation shall be subject to clawback,
such other policy or agreement shall apply to the amount in excess of the amount subject to clawback under this Policy.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">This Policy
shall be interpreted to comply with Securities and Exchange Commission (&ldquo;<B>SEC</B>&rdquo;) Rule 10D-1 and Listing Rule 5608 (the
&ldquo;<B>Listing Rule</B>&rdquo;) of The Nasdaq Stock Market, LLC (&ldquo;<B>Nasdaq</B>&rdquo;), as may be amended or supplemented and
interpreted from time to time by Nasdaq. To the extent this Policy is in any manner deemed inconsistent with the Listing Rule, this Policy
shall be treated as having been amended to be compliant with the Listing Rule.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><B>1.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;
</FONT><U>Definitions</U></B>. Unless the context otherwise requires, the following definitions apply for purposes of this Policy:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.75in">(a)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;
</FONT><B><U>Executive Officer</U></B>. An executive officer is the Company&rsquo;s chief executive officer, president, principal financial
officer, principal accounting officer (or if there is no such accounting officer, the controller), any vice-president of the Company in
charge of a principal business unit, division, or function (such as sales, administration, or finance), any other officer who performs
a policy-making function, or any other person who performs similar policy-making functions for the Company. Executive officers of the
Company&rsquo;s subsidiaries are deemed executive officers of the Company if they perform such policy making functions for the Company.
Policy-making function is not intended to include policy-making functions that are not significant. Identification of an executive officer
for purposes of the Listing Rule would include at a minimum executive officers identified in the Listing Rule.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.75in">(b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;
</FONT><B><U>Financial Reporting Measures</U></B>. Financial reporting measures are measures that are determined and presented in accordance
with the accounting principles used in preparing the Company&rsquo;s financial statements, and any measures that are derived wholly or
in part from such measures. Stock price and total shareholder return are also financial reporting measures. A financial reporting measure
need not be presented within the financial statements or included in a filing with the SEC and may be such financial measures as may be
determined by the Board or the Compensation Committee thereof (the &ldquo;<B>Compensation Committee</B>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.75in">(c)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;
</FONT><B><U>Incentive-Based Compensation</U></B>. Incentive-based compensation is any compensation that is granted, earned or vested
based wholly or in part upon the attainment of a financial reporting measure.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.75in">(d)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;
</FONT><B><U>Received</U></B>. Incentive-based compensation is deemed &ldquo;received&rdquo; in the Company&rsquo;s fiscal period during
which the financial reporting measure specified in the incentive-based compensation award is attained, even if the payment or grant of
the incentive-based compensation occurs after the end of that period.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.75in">&nbsp;</P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><B>2.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;
</FONT><U>Application of this Policy</U></B>. The recovery of Incentive-Based Compensation from an Executive Officer as provided for in
this Policy shall apply only in the event that the Company is required to prepare an accounting restatement due to the material noncompliance
of the Company with any financial reporting requirement under the United States securities laws, including any required accounting restatement
to correct an error in previously issued financial statements that is material to the previously issued financial statements, or that
would result in a material misstatement if the error were corrected in the current period or left uncorrected in the current period. Questions
as to &ldquo;materiality&rdquo; will be made by the Compensation Committee in coordination with the Audit Committee.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"> <B>3.</B> <B><U>Recovery Period</U></B>.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.75in">(a)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;
</FONT>The Incentive-Based Compensation subject to recovery is the Incentive-Based Compensation Received during the three (3) completed
fiscal years immediately preceding the date that the Company is required to prepare an accounting restatement as described in Section
2 above, provided that the person served as an Executive Officer at any time during the performance period applicable to the Incentive-Based
Compensation in question. The date that the Company is required to prepare an accounting restatement shall be determined pursuant to the
Listing Rule.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.75in">(b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;
</FONT>Notwithstanding the foregoing, this Policy shall only apply if the Incentive-Based Compensation is Received (i) while the Company
has a class of securities listed on Nasdaq and (ii) on or after October 2, 2023.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.75in">(c)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;
</FONT>The provisions of the Listing Rule shall apply with respect to Incentive-Based Compensation received during a transition period
arising due to a change in the Company&rsquo;s fiscal year.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><B>4.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;
</FONT><U>Erroneously Awarded Compensation</U></B>. The amount of Incentive-Based Compensation subject to recovery from the applicable
Executive Officers under this Policy (&ldquo;<B>Erroneously Awarded Compensation</B>&rdquo;) shall be equal to the amount of Incentive-Based
Compensation Received that exceeds the amount of Incentive Based-Compensation that otherwise would have been Received had it been determined
based on the restated amounts and shall be computed without regard to any taxes paid. For Incentive-Based Compensation based on stock
price or total shareholder return, where the amount of Erroneously Awarded Compensation is not subject to mathematical recalculation directly
from the information in an accounting restatement: (a) the amount shall be based on a reasonable estimate by the Company&rsquo;s Chief
Financial Officer (or principal accounting officer, if the office of Chief Financial Officer is not then filled) of the effect of the
accounting restatement on the stock price or total shareholder return upon which the Incentive-Based Compensation was received, which
estimate shall be subject to the review and approval of the Compensation Committee; and (b) the Company must maintain reasonable documentation
of the determination of that reasonable estimate and provide such documentation to Nasdaq if requested. Notwithstanding the foregoing,
if the proposed Incentive-Based Compensation recovery would affect compensation paid to the Company&rsquo;s Chief Financial Officer, the
determination shall be made by the Compensation Committee.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><B>5.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;
</FONT><U>Timing of Recovery</U></B>. The Company shall recover any Erroneously Awarded Compensation reasonably promptly, except to the
extent that the conditions of paragraphs (a), (b), or (c) below apply. The Compensation Committee shall determine the repayment schedule
for each amount of Erroneously Awarded Compensation in a manner that complies with this &ldquo;reasonably promptly&rdquo; requirement.
Such determination shall be consistent with any applicable legal guidance by the SEC, Nasdaq, judicial opinion, or otherwise. The determination
of &ldquo;reasonably promptly&rdquo; may vary from case to case and the Compensation Committee is authorized to adopt additional rules
or policies to further describe what repayment schedules satisfy this requirement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.75in">(a)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;
</FONT>Erroneously Awarded Compensation need not be recovered if the direct expense paid to a third party to assist in enforcing (or making
determinations in connection with the enforcement of) this Policy would exceed the amount to be recovered and the Compensation Committee
has made a determination that recovery would be impracticable. Before concluding that it would be impracticable to recover any amount
of Erroneously Awarded Compensation based on expense of enforcement, the Company shall (i) make a reasonable attempt to recover such Erroneously
Awarded Compensation, (ii) document such reasonable attempt or attempts to recover, and (iii) provide appropriate documentation to the
Compensation Committee or Nasdaq, if requested.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.75in">(b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;
</FONT>Erroneously Awarded Compensation need not be recovered if recovery would violate the laws of Israel where that law was adopted
prior to November 28, 2022. Before concluding that it would be impracticable to recover any amount of Erroneously Awarded Compensation
based on a violation of the laws of Israel, the Company shall obtain an opinion of Israeli counsel, in form and substance that would be
reasonably acceptable to Nasdaq, that recovery would result in such a violation and shall provide such opinion to Nasdaq, if requested.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.75in">(c)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;
</FONT>Erroneously Awarded Compensation need not be recovered if recovery would likely cause an otherwise tax-qualified retirement plan
under the United States Internal Revenue Code, under which benefits are broadly available to employees of the Company, to fail to meet
the requirements of Sections 401(a)(13) or 411(a) of the United States Internal Revenue Code and the regulations thereunder (as such provision
may be amended, modified or supplemented).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><B>6.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;
</FONT><U>Compensation Committee Decisions</U></B>. Decisions of the Compensation Committee with respect to this Policy shall be final,
conclusive and binding on all Executive Officers subject to this Policy.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><B>7.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;
</FONT><U>No Indemnification</U></B>. Notwithstanding anything to the contrary in any other policy of the Company or any agreement between
the Company and an Executive Officer, no Executive Officer shall be indemnified by the Company against the loss arising from the recovery
of any Erroneously Awarded Compensation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><B>8.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;
</FONT><U>Agreement to Policy by Executive Officers</U></B>. The Company shall take reasonable steps to inform Executive Officers of this
Policy and obtain their express agreement to this Policy, which steps may constitute the inclusion of this Policy as an attachment to
any award that is accepted by an Executive Officer. This Policy shall be deemed to apply to each employment or grant agreement between
the Company or any of its subsidiaries and any Executive Officer subject to this Policy.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 102.35pt 0pt 101.5pt; text-align: center"># # #</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 102.35pt 0pt 101.5pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 102.35pt 0pt 101.5pt; text-align: center"></P>

<!-- Field: Page; Sequence: 3; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 102.35pt 0pt 101.5pt; text-align: center">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>8
<FILENAME>fin_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 fin_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1"  U &P# 2(  A$! Q$!_\0
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3 4444 %%%% !1110 4444 ?_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>9
<FILENAME>image_002.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_002.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" $: 9L# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#SU9L[7YWC
M&.>W3\JH:[:,ERET%&R=06([-W%:11=A)R2.05&/Q%+/;K>:=)"&)D'SIQCD
M#I^5?2SAS1L>=&24DSDV/S4!J:YPW(Q5BQLI;^?RHB@(Y)=L<5YO-[UD=?F2
M*WR@;<FG#OG S4]W82Z?/Y<V"I^XP/# =Q5?(.1P16_J&YK6($<1Q(<-SUJ]
M\RO\I![&J=N46!%QR1GI5I&.PX'%>C2^%(X:F]R8X*9.3V!KF]1D,EXY].*V
MY&$<+9Z=>M<](V\ECU)K'$RT433#QU;+.E8^U')P2.U=$ 6 &,\>O6L'1U)F
M<@ ]*Z G<00P!'Z4\/\ "37^(,;P$# [C@^PJCK,!DTY9@%S"Q&/8U>9_F)(
MY'7'>G((YT:&09212H!'Y?K6TX\T6C&$N629R0;@8J5(@R_,/O$?E4;*T;O$
MP^9"5J:)LL P.U,#%>;Y'HO8Z2R,+HT!RJ2)M&#PN.1^H[U1)='965@RG!!]
M:F@+$ @@.% 53Z^OY4NJY2Z$N %F7=P>XX/ZUU0E9'-:[*-[,1"0?O&LYFVJ
M"H&3[5-<2EV )X'%5\]<CCM6%27,[F\(\JL6=,7-\O;@\@9 KHU. 3CA0>0>
MM<[I0_T@G<"1V'7\JWXAP2,8(X'8UU8=>Z<U?XB0LN%*@DGD^@-29V[6W[2>
MG'3V--5<+R1M^E D7@JIR.#70<QA:P@AOO,[2*&!'0GO6=-)BV))(WG -:_B
M&$&RAE3DHY!P>F:PI2=HC'11CD5YU;231Z%)\T$6-%C\S4HP2<=CC(KK?(!4
M.H4!AM"],XZ?2N4T=72YW*1^/2NM&>#@$CE?XL@]O_KUIADN5F-:_,9?B",R
M6MM<9+[2R%L=.XSZ=:R-/S]H'&?0$UU-S MQI]U$&4>8F]>?[O-<SIH(G)!P
M?>B<;5$5"5Z;.B9AN5@YW>A_E2YV,V6QGD9Y JJC@9R%)]A4JN3A<# /YBNT
MXRZ#\O4<="?Y5D>(X?-TY7R24;('I6FA5EV\ENV:9=H)8)%/(9>/8_UJ)QYH
MM%0?+),Y. ;8AGHHSR>IJ)WR#E,N>I%2R 1@Q@G(Y/'>H6R1CJ1W!KS7V/2W
M%6)FD^4Y(P=I_B]LUV]G$88%RH)V<J#G:?KWKD=*B+WR*C%74[AD9!Q79(H9
M?DVC(Y XXKIP\=V<N(>R'JLRR ] W3)R#6?J.X7.XJ!E1UYR1Q6E@ DGY1P>
M*H:H@^SPOC<V2I;//K75<YEJ[%5925 )'R\$5865#C@GIALUGAAT]*E20)ER
M!P,U5TP<;%&^B$5Y,P(RY^4BJY("#GGWHED,T[/CEC1\H&3G-<#=V['H1325
MR,B3)P>#VJ!V>2ZBC1L!#V-2O*88BY&3T7G'XTW2H3)<[AR>O/<UC+5V&SL=
M*0Q67#EER 2W0_X5>X&25X[@?XU!9@_8F SD$$K_ '3[U*JE@2< @]J[XJRL
M>?-ZE&^/D1(Y(VJ#R>2#7+7%P;F=F?OT]JZ#7W9=/0#/W\8QTKG%(/7@^]95
MI._*=-"*MS#T3)^;M3B@S]_'MBEQC#8SZTC ;C6-C<U%(1. =R@XP>U.5S&Z
MG!7G(YJ./(55/)/0D8Y]Z4G &\C)./H/;UKM3.1HY_7+;[-J#%5Q'*/,3\>O
MZTNDB4,3&!E^,-_$!VK5UB$WFELR89[?YQ@8(7N*R[11B)=H/ X;C<:\JM3Y
M:S['5"5X&_>QO?:9*)%4O$ R'!!('7ZFN:!4-G ]O>NMLO*D5 S;P04*[CT/
M7'I_]:N6N(3;W+P,/FC<KBMYK1,*;W1J6Q4Q#/3L":L*W& QQBL^-]H.X_,O
M48Z5860!,G@=16\)V1$X7"^FV6I7G+<"L<G:O6K=](654)/'-4S@]JPJRYI&
ME./*C1T4#>S')Y Q[5O$$LH.-H['O6)HJ;1(^[Y<\BMQ05C ?E2/R/J*ZL.O
M<.6O\0WD,6 8 <$=Q3R6C R6RI]?\XII#;/O9 R1D8/6H]S')7CC:0:Z# RM
M7MQ'J"2H<QS#?TZ'O52Q.^1LC(9LXK2UAU&G%>K!\*3UQWK,LF!D&1^N*\ZJ
MK5+'=3?- WH2J84D,!QENOTI]U 6TYF#[_)8-CVJ&-2\97.,\@X[=?QJS;E3
M)*LK Q,-C9'')P>G2M%>QGL[G,%M\QR>">?I22+CG@#H*+E#;7<L)Y*,5_*F
M8+#J,FN<ZC2T?"2F09W#L1Q6T'##:-I .<>U8VD@_,<Y'=:T]PP3BN^A\!Q5
MOB++''RL""#@^_I3SR"!U'0FHM^]<X SQUJ574D@ECTR.N*V.8IZA*J64@E5
M7)&1@=#U%<PY9RS,#N/;&*V-8N!)*D2@G!YP.3Z50CTV]F!"P2$'N1@?K7G8
MB:YCT*$;1+.BQ9D Q(,YSM'!KI\B,E=JLO3T&>P/J.*R-*TV6S&ZX"@GJN[.
M?Q]:T7E3 SCCJ!WI4L12A'5D5*4Y2T1+$ZKG>@&X\A1G/8C^5<TMLUI>7$/F
M?/&V!W&*VFNL-D9)( .3FJ\EP2Q;C)ZG')K*IC8-^ZC2G1E&]V(LC,NX]6]N
ME/23!!/3KBJ<TLO42$$4R&ZY*L,./3O6U''1F^62L93P[2NC;5P7PC;EZ9J#
M4+I;:T)!(;MGK443*#C.WCD_TK+U.X>XD2)#G;P![UVU9\L;F-.'-*W0CLUC
M687%P/,3/0\Y/T]JU=:MM/NM+%_!&(+E/EE1?NN.@QCC/?WK(AD47"JAS''U
M)]:VKV")]"N8HF8&-A*P'(Z]/;K7#'6+.MOWD4M C+3-() CJ."W''>NFC.5
M/RD$?=QTK"T"+_1WD !R< UL%B=@5@!^M==)6@CEK.\V2 YPXXY[U3UA6^PE
MON;6#$#T/%7E;"@\ YQR.!4-_'YUA,BNRAE(^:KELS*#M)'.QL?EYS]*;<RY
MBV X)/(%5H9.<'[N*-VYV<D9KEYWRV._D5[A]UAQST%*H<YSR!Z4U\YR3]*B
MNIB(@B\,W))'2LF[%E::3SIF)&P 8'^-:^BQ$<O\W/IFL93N(&.?;O74:/"_
MEJ 64XRN!CCUI4E>1%1VB;L39@<\EL8^F/2D;=ECQD]3CK348B5E*C&S.%/!
M /7/KS1N7:#R/4"O1//92UE=^GN,$KD'GJ*YT+@8/-=-J8)L) O3&0,]*YH'
M.>>E<]5:G70?NB\E>.*<!(0#L6D&-N<X"\DU UVP8@!O\_C6=TC;7H:B!AR<
MJ3][CJ?6@G@$#!S@^YH*?,-[')Z'N#2'<9.%7IUKIV1S[LF1@LA#9.%((Q^A
MK"B)>]+*,@L!TS@9K0N9@;=PISQ@8XK.M/\ C[&1[$$<'CIFN/$RO9&M.-C<
MB7<=Q 211U7G'X]ZI>(( )8+M,;91AR/[P_^MBKOER;FE!V$#C#KG\/RS2W<
M7VW39+?.90-Z CJ5'.#[@T[>[8$[2N<^L^UCDY]SUJ?S=Z@9)/UK+W'/K4B.
M-XQG%9*9O8GG(+]20.*B(.>:<QR!T]:;QFAE&OI&"A&WCD9S6R5W194QXQP/
M3_\ 76-I840-D#GJ>X^E:@8JA7 Z=<5Z%#X3@K?$.WC)_P!H[A@YI@)7=T].
MG6@.?E9@!BFR,%RQP #SCM6US*QDZQ*7:-.,J,FJ]DI:3 &3U&>]12LUU=.Z
MAVR>-H)-:6GZ7J3R K92[3U8C;7DSFG-MG>HVC8THR&*@$D =2/\*> V"CX0
M@_>QU/\ 6KJZ-?28+B.'Y>H/(-6/[%7&)KIS_N#%:/$THK<S]E-G->(K5Q/'
M>!!LD4*Y X+BL< RD! 2Y[*#7HC:?9M&$DC$BY!P_(R.,T](XHAB*)$'HJXK
MDJ8F+=XHWA!I69RFGV-R;90()%/N,#]:TDTZX:/#;4YSRV:V&<FHB2:7UVHE
M:.@G1BW=E(6(3[TQ/LHQ4@CB0G SZY-2M[&HCP36,L35EO(:I06R$RJ9V1JO
MN !43R,3R33FJ)B*P;;-4-=B>M0-4K5"QYS2 8W6HV(IS'VJ)C0,8_2J4WJI
M(9>E6V.1CO5:8=: )H+T&)G8X8#I[U1<E%DF;^(D+ZU6F#*Q9.#U(H>99XE9
M1M"\$9[]Z[XXASCRO=&#@HNZ+NEK(QW8' Y&.3_]>NI2$W%G,D:J97@( QUX
M]?QKGM'C!!!4M'G)*]1CT'>NGLE<3Q2!)-F0" F"H/J/:NR@O=.>H]3/T?$5
MHJ%,L.N*U%R0?E(R<@'I4 A6V=XF8R[21N[5*SE=@+X]!Z9KNBK)(Y).\FQX
M(1L8(P/KD4H97&[<5 &!G&.>QJ-&;;\X) P0>X)_I3NSEL'((.!S[TQ')/'Y
M&Y6&&W$D#^51J0Q(V\-5[5E:/4'Q@JP#9]>*H9$A&WKV%<,E9V/2B[JX*K*C
M,Q&U1GGJ3[51D+L2\GS$G.<U8NI"LGEY+*OID<U68^@PIZY-8R92'PIYC*A.
M"3P".*[33H'2&/!"MC&X'K^/^>U<A8([W(\KYV7D(>21]*[>VA157:JJF!E!
M_$..GO6^'74YZ[TL6%:1) 73>I&,CH1T-0%AGYN!G@YJRI=2,-M Z@=^_K5&
M0E9&QG:6R >PKM1QL+D!H' [YX)ZBN:Z''<GBND#Y R,, 0#7.,IB=BS<Y('
M>L:RV.B@]T1S,  B_C[T+OVC&?S%,92Q&.6)[T_$@X &/I7*=9?.UQD'<%XY
MZ4,^UR<%O?O005W*QXZ\#%-#[?E!.1U/K75<YDBIJ$Q$"*1@L<D9JG;;C,JC
M=\QYQV&.O_ZZL7K!KG.00%Q\O:H+,[I\MG PQQG@5PUM9&ZT1M0L6B93QGK@
M@[0>/PJ>(A+N-GR%!!7C SZ\>U19&S[I9%P&R?R^G6K]GI5[JL96RA=D5L-(
MHP./4^U:W45=LRLV[(X_5[466IS1+C83NCP<_*>156'J>*]&OO EQJ:0/<S)
M!,@VLR_-N7T^M2VOP]TRW7]_<3S9ZX.T?I7#*I%5&T]#KBGRZGG>,\9Q]:='
M%+.0L4+N?]A2<UZS;^'-$M /*L(V([O\Q_6KRB.)<11H@_V5Q2>(71%<IYWI
MFB:D\(_T*1#_ +7RYK:3PU>.%WO'&HY()S74-(3WJ(MD=:/KE1*RT,W1BW=F
M,GAR$?ZVX8_[BXJPNCZ<G6#>?]LYJ\2>U,)]ZQEB*LMY%JG!;(9'%!",0P1Q
MC_97%.,A/M333:Q+!B<5$WOUIS&F$\T ,-,/%.8X]*C8@T -)S4;4YOYTP\T
M ,;Z5$W-/./2F,: (F-1-4CBHF)S0 QJB)I[5&>0>>*!$3\5$Q.[^52D]*A<
M<\&D,C8]:C?!!]:<QJ,M@?6@13F7&1BJ( 2;.<!JU94RO//%9TR#G(QFJ3MJ
M#U.AT6$/$PR H(#9&0*Z!E099'$?)^8<\#'OS7)^']0CCN5MIW*'/[N4'&WV
M/K77*LD;[LJ3GDEN-WMCGTXKVL+)3@<%96D-GD#73O@&-P'^7D]!TJ'<KJ0"
M0P&!D5+?_/%"^""1M^Z!Q_DU2#[$.[DCCKSBO0CL<K+<>'&W[H'3%2(Y QEF
M(XST_&JL4HVKTZXP!Q4ZL &8# /KZ4",;7D</&Y],<GFLK*Q0LY/+\+ZXK?U
M6 2V>3R4([YQ7,22M)(05X^Z !TKBK:2N=]%WA89MS\S9P>F*1P0-I.1Z4X9
M4@KC)XX-1LO/RCCN37,S8T]$A8WJ,CJ&'//I['L:[3#JOS* ,DA<X./7':N=
M\/6ZY\P#:PR,]0>.A'I@5T2I_!'@[L''?-=M"-HG%7=Y";@ 86&6Y^Z#C\_6
MJ%XRI>. QP<$ C':M#S248RM\IX_^O6=JA_?QL6)<IC/7.#70MSG(YKGRH6+
MIT&1]:PII"\F0,@\DD\"I[N<R%8EY51SGUJJ2)%VL%/'0US59W=D=E&'*KL&
M/0J0".,]C3>6YV=?>@/M/).['1AG I,Y]#[YK W+C-E<(<<]<4D9?:H=E+;?
MO#UJ.5QY8QD8&[ [TUGVQNX Z8&*T<M2$BK,#+*2#U))('.*73R/M!RI.!G(
M.,<BHBY [YQTJ2Q#"YRA7/0@CJ/2N66Z+9I:C="VTZ62-%+#Y"-HPN?6NE\"
M>*VG@6PF(7'RG''/8_C7):O&@TURIX:0#Y3U/O6%IE\^FZBDH)VYPV/2N?%M
M\Z15%:'T#)N/M4!&*BT:_34M-CE!!8##58D!!XKC-B$^HZ5"U2M434 ,)]*8
M<4X\?6F,: $)J)NO:G'TIC&@!"?>FD]J0GFFF@ S3#3CG%-[4"&'ZU&>E/:H
MF- Q&Z8J,D?C2]328H 8QJ)LYS4I'K4;<T 0GI@&HG-3,/:HF!H$1-WXYJ(^
MG-3$8J)ASCUI 1-@9X.:A<'O4QYQZ5$W?'2@"!A[U$X^M3,>:B<=Z (2^1[5
M6F0,"14[$]JC(RO/% &;(IX(X(.0178>']9^WVXM+C!EBZ#'5<<GZ]*YB2/'
MUJ!))+:X6>%BCH>"*WH5G2E=;&<X*:LST.<)+9.!SY9#K@]5)_\ KBLT."XR
M3Z8S5O2;^'4[*241DOL*R =<X_SS6<!T&,CUKZ"$U**://<;-IEI)=I!9L@D
MX]:F61B?E4\#DYXJCO&#QS0UR+>%I3R0.!ZUIS(CD9!K5^@(@BX8CYV_I6)P
M?NY/-/DD8S-(SY)YYJ-6^4E<5YTY\TKGH0@HJPHQV&!GUJ[IFE3:E,R1ND87
MJ[YX_+FJB@NRJ% +' .,\UK6MQ)#=1V]NQ10.JCECU)J+I;A)M+0W[729-.*
M>8X5G7&4;<CKZ_\ Z\&KNU\?-@$# %('5[>*8\."P95'!X'8TS8H =-Y4#*Y
M/W37?3^%6//G>^HYWVX1L;MOY_C69K<BQP(<X<,5'N/6M(1KNDW?,'.2"1\Q
M]:SM<3=8D^6=\3\'T!JI:1=@IVYD<XV'+.,Y[TOF*W!QD#/3K3 YSRV6_2@E
M<G!7.,$$=:XKGHCY,;0!^9J(R1G^!OSIQ(;JOXYI/(Q_&*3U <THP!R/3!Z>
MU,E.8>#G/\)]:AW$J 0,XX [^].<X$8/&WDBDV%AAW+P1U'&*FL,-*X=BIQR
M.U0;FSPY%3VFQ)?E^^HZ^OM4=4)CM5).GJQ(;]YU';ZUS\JY&?2NO-B=1$\+
M#&8SL.>-XZ?X?C6%-IS1Z1#?;6&Z4Q/DC&>W';H1^%<F*3YC2GL=7\.]>$$H
MLYG^4\#)[5Z=,OZU\[6UP]E=I*AP5.:]V\/ZHFKZ/%*&S(H :N1&A8?BH6%6
M).IJNP]Z8$;$YJ%C4K=:B)R* &DXXIC')I3P:830 A-,)'2E)]*830 I/>F$
MX-'6D]J &DTPBGD>])M]* (\8Z4A[XZT_'IS36P:!$; D9%1$9[5.TA6-B%!
M'<8ZBH5QC(8%.H/J*!D3?I4;<U*[J'V9!;^[W_*E4(L;,>6R  >U %5EXXY]
M:B9<CWQ4KAVF58N58?0D_3TJ%EV,%9@6/84@(2!]1WIC =*G91U.*B<8!XR:
M!%9E)!.?R%1,,_X598<<@U"X/&.* *S+E:A.!GW]ZM.!QG!]JK,._2F!&XR2
M1_.JCJ>M6S]#S4+@ =.M( TZ^FTJ[6YB)VD_.H/45O37,<TK30O\DA#J1[]<
MUSC#(/2DMIV@DVL<(3^5=F'KN'NO8RG33=SHPV0I/7MBJE_*K%4/"CGZFDCE
M_=&7G':J,DC.&);..V*]"4_=L9QAK<1G#] <TI2/HJD'\Z8N000=I Z&IK='
MD=4')<]1V'<UD:$L02&V:51M=OE7.3]35G21YEVK'H>"".*K7,R%U$2J@48
M (P?<GN:T-)3 W-N SPY/&?2LXVE(SEL=3%\UG.BJH*X9<Y.1G^=- 5Y"0"5
M& .H&?:ELF<N0J_>4X/][CIGZBHF/ /3D9)ZD_YXKTZ6UCBGN/R[A6:+*G!
M/./QJM?GS-+N%W(<*2..0>M3H=I W,.P ')YIDV&@F! ;(. 1UR*T:NB%HT<
M?V'(-&1R6Q@G J%R02WIZ5(C@KD(=OKGH:\ZYZ@'"]N,>M1[A_ 7V]L5,H+R
M #: .3]*G6Y1%"HA"CI\JT[";,K*Y7'?KDT\X8GG%0*,NOH*F5MKY&,_2L8N
MY8Y>I(Y('Y4^%F%P-JY_SV]Z3((XZGGIBDB8";)^F<TWT(9NZ6Y:=W/!/O\
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M,BM)_P ]#PP/U[4V5&8Y@).SC>PX/'?ZTPV:*PV2S(H_@WY7]:G>5BBJ3PO
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MLYJZB1F$!48 ]1@_*> 3VK6-%7N]S-SZ&4MC!"@PQ5&Y&X9*^E8^KV#V-P"
M?+D&Y"?U%=20FYQ&N'"_<(PNT\?GFJ&KV'VC3MZKAX%+  ]5[_XU%:C>#LMA
MPG9ZG**-[ =S5ANFT=J;"NQ-QZGI0[$GBO,6B.DC)H'44E6;&QFO[E885RQ[
M^E))R=D#=M61@\T\<]:OW^A7FFQF60!XU(4LIR :H*1TK5PE!VDA)IZH>.*Z
M[3HT%E;%PN"/E+-]T^U<@.:["U7$"QJ(W5E&X=B2.*ZL-N8U=BVK<@8/F,,?
M*<#CK^M!,:HKH&;Y,8SR?48J*,E(X\#+?=R>2!ZG_/:A2H8C^$-@D'/MW^M=
M]SFL/<H2DAV -U<#[I]J"6VX8@$D+\R\^@]C3F;<2 ,KC()X^HIK.AW<';\K
M Y].G3WJ@$+A(2%/S#J!TIC 2Q&+# RJ4;IW[?2D&\1C=@\<;3[]Z:Q!7<2V
M3T*YZ5-[[E6.'9=CE6ZKP15JPMQ-/N<9C0;F]_:I-8A*:O*J-NW8*D#KFKQ!
MM;>.W5@6ZGCVS7ETZ7ON^R.MRT]22>19U S@H?E7IQFJCL&X).0<<CK0H)0'
M'[S/R\]:21 I.T, .H/7-=C9"0W+>9A,[O3M5^!(V1'E79(O) ;&X=OI6;&,
MRKPPY["MR,OO+J(R2""-N.#U44HZDR'+$4Q.I*K[D<9QP#_6M"&/?#<1O@2%
M"$.,;@/6J/V:-]VQU+ JP4GKCK_A4L%T$O@&5AM)9BQZ\<8-;;&>Y5. I=6W
M*0!QWX[BGB0.% !4#T7H?\BH+C;;WK1?,&5MI.<XIC3F'))&>BXXYH4K%V);
MJZ\A0-S!WXXZBLA1N;)!8=" >:'<N[,[98\Y [T@5BI[8/)%<\YN3*2LB0,.
M1GC'>EW*#D@,Q/3I^-1CN2V6'OC-'S='!^O4BHN [=NSMP,\<TT8QT/YT,I)
MP P'3!.*10H4<$_C2N,V($QGB/E?EXYST(]ZE"$1D\L<C\?P[5%NVQJ/XN).
M1GCOFI45P3O/\.?EZ+[>M=\;;&3-2P:*YM7L;E2(I5V?0^M<9?6KV-[+;2#E
M#@'U'8UTUO,%D+<E^U-\2VB7UFNI0H0\1V2CV]:RQ%/GA=;K\A4Y<L[=&<H,
MXH_*C- Z]:\LZQPJ1"!V_"HP:D'RG.>![5K AE2?_6$#K49/K3Y3F4D8'/;M
M4;>M<[W-%L/BC\R54'KFM%@,XQ@ U6L%X>3'/0<58.?0>E=5&-HW,Y/4<AV.
M'4XQS]*L2:I+MQ$@0>IY-5<$ C\,5&>G6M9;"%EFEF_UDC-^/%3V48()W(N
M3D_2JM:6FYROS$ DJ>,_A4P5Y!+8TX%0Q+N.!M&2&S@'M5@94EBN2HS@#V[5
M"D2N2\B*_'S[ASGM3A(SJHP,LV#NZ8&<UWK1&#',P;,N0$P<,#]X&I4+$N?,
M!)^\>A^GM4!!D7G:N,@?W3WSBI"X6/\ TB95=F"G<3DD],U5R01G.Y]R%"?F
M&>@]_7GC-)N3:V_&PIA\C)QC]<42M]G0N(_,$7(X!QDCTZ^M(S*%,6T#OMSP
M<^E+R Y*[B-M.\!_@. 1W'8U6)&:U]>AV2PW )8.NUCCH1V^M8W7G%>+5CRS
M:.V+NK@/O#C\*Z*U9;"#;RDC<MZBLG3+47-R6<?NHAN?G%6;B1GD)SUZ@UK0
M7*G,SJ:NQTUG>1WMHUJY#HZ%6)!S7(7$#6MU+ X^9&P:U+"1H'251QGH:D\2
MP$7<-R$91-&"2>A-=%;WZ?,]T13]V5NYCP;C/&%QDL,9]:[" AXUVKE^!M7&
M5X__ %UREB/],B. 0#G!KJ8648920,X+8^N*G#H*H^.7<QVR!L/C##MWH4+W
M9L[L D#IGC([_7VJ,/D*,<Y^7C)-$K*B%BFW:<XY/?\ ^O77<QL2-_$VQ2,X
MVAN_7..QS43MO)'.0?3GZ4]ONA200QSSVJO(Y "@%5SDC&<'O[T/0$2;\,5\
MQB1R,\?4>M,=\CKM_P ]?I488/N9V  Z_+@CVIN]</O4( "6Y&/_ -=),NPR
M[6 /!*Z NH*Y4#(^OK6?NWS.RQD\\<XIL\ZSR%N5]_:D3*GY"!W)STJ&TWH:
M)6#:&QN)SGC':DDD9I"6;=@XX'6E8 #Y3G/IW]ZC;@AL@^U2RBS#L# ,K].<
M<G%78U5"I1]J]"-QZY]?I5"+ C=ED(9>Q';US6G&N8D*G=U;?QGD]JN.K,Y$
M@):7",-R L#G.1Z9J/S&4!R02J\<G&3Z?X4_8BL)C&P<<<G]#WYJ,6Y=$5E
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,C53&/E'Y52U$S__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>10
<FILENAME>image_003.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_003.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" #< :\# 2(  A$! Q$!_\0
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M.J,54?1=O')#!!%+.]S+%#'')<R+&DEQ(B*KSR)"D<2O*P,CK%&D:LQ"(J@
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M?X8T;P[#((UV(TZZ59VIN) I(,LYDE<EB[L68GOJ*Q.@**** "BBB@ HHHH
M*P/$GA?0/%VG+I/B33+?5]-6[MK[[%=[VMVNK.3S;666)75)Q#+B58IUDA,B
MHSQL44C?HJZ56I1J0JT:DZ56G)3IU:4Y4ZE.2O:4)P<9PDKNTHRBU=V:N95Z
M%#%4:N'Q-&EB,/6@Z=:A7IPK4:M.5N:%6E4C.G4A+EC>$X2B[*\7:Q\Z?L[6
M&E>&=)\6> ?[/M=-\6>"O$MQIGB/R8O(GUS3Y5,W@_Q1*N$%PNJ^&C96_P!M
M";IKG3[J*5VE@;'T77COQ$^'FM:EK&G?$+X=:E9:#\2M"M'T]'U*.:3P[XR\
M/O+]HF\)^+8;;%P;)I\W.E:M:AM0T*^9KBW6:&6XMI>7M_VCO#>@L-.^+^A>
M(?@_KL7[N=O$FGW=_P"#[R13M>;0O'6DVUSH&HV3'!C:ZFTV]56 N+&!PRCZ
M7'83$\05ZF;9<IX_$XOEJYCE].?M<QPN,Y(1Q$Z6%E-XC%Y?7G!U\+6PD,5]
M6A5G@\10P[PU&=7XO*,;A.$<+1X=SCV>5X/+W/#Y-FU2FJ&49AEKJU9X2G7Q
ML*2PF S?"TJL<)C\-F$\%]=J8>GF6#Q6+6.Q-/#_ $2JJHPJA1DG"@ 9)))P
M.,DDD^I))Y-5KZ^L],LKS4M1NH++3]/M;B^OKVZD2&VM+.TA>>YNKB9RJ106
M\$;RRR.0D<:,S$ $UX#J'[5_[/\ 9*%L_B/I7B6_D ^S:+X-MM3\8:[>NQPD
M5II/AVRU&\ED=OE4&)5SU8#FO/-:\/?$K]J.6#2/&/AO6?A'^SRL\-SK7A37
M)8[7XH?&.*WF$L6B>(["QGF3P#X GDC4ZQHT]W/XH\26ZBQO4T?3KBY@GY:/
M#^-IN-;-Z5?)<OB^:MB<?0GAZ\X1=Y4L!@L1[#%8_%U$G3HTZ.']A&I*,\5B
M\-AZ=6;]J?$67U[T<GQ&'SO'2]VG0R[$4\70ISEI&IC\;A7B,)@<-"ZG5G6Q
M/MY0BX8;"8BO.E%:O[*"7GBRR^*GQZOH+BVB^//Q"G\2^$H;R,PW0^&?A;2K
M+P9\/;F:)@)(AK&D:/+XB@B?E;;6H7P#(U?6U06MK;65M;V5G;P6EG:00VMI
M:VT206UM;6\:Q06]O!$JQPP0Q(D<44:JD<:JB*%  GK@S/&K,,=B,7&E["E4
ME"&'H<W/]7PF'HT<+@Z#G:/.Z.%PV'A.?+'VE3VU11BJBC'T\!A7@L'0PTJG
MM:D(RE6K<O+[;$UJE7$8FLH7ER*KB*]:<8<TG"G[*#E)P<I%%%%<!V!1110
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MVB] TC_A3>JZI^T)INH_$JXOO#<'@[P/;>(O%NAZ5^T[>Q^/=9@^)]UXEO\
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MH6I?$SXL^(=/?X2?'A;+7?!]FVC:O=>'O[43QA>VXF\0:/<3,-.O+UKV3[(
M?U=V%_8ZK8V6J:7>VFI:;J5I;W^G:C87,-Y8W]C>0I<6E[97=N\EO=6EU;R1
MSV]S!))#/#(DL3LC*QMUX+^RO\,/$/P2_9C_ &=?@SXMO[#5/%/PE^!GPG^&
MGB/4M*>XETN_USP+X$T'PQJMWILEVD=U)83WNES26;W$<<[6[1M*B.64>]4
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M*/2/#]M\-O$.MZ'IFN1R^(M4GU^ RZA86UK#IRB] /VH\)?\%9_V*O'7BSX
MZ7X9^+'AB?P!^T;\$O&GQP\#?&C6O%?@_P *?#:PTGP5XA\$>&[OP=XGOO%'
MB#2-5T+X@W]]X[TW[+X4N]+74;;['J$&I1V5U"D$GZ40S0W,,5Q;S17%O<11
MS03PR)+#-#*@DBFBEC+))%(C*\<B,R.C!E)!!K^1SX5_\$+OBYXC_9Q_9_\
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M?XRVNHZ#X3UG7=*M/!OC[P]<^)[OPO8Z_P#:M;TN]T8"2_T*2['F-]+^,?\
M@A'\,/$G[4/[5O[2WA_]H7XM?#2^_:.^!7CKX9>$/#/PZAT_PU!\ /B3\5O
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MGI-EX(\.>+]1EEN9=2CM+V6WNK:[2']]*_F>^+__  0.\?\ [4GQ4_:$\?\
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M5XR\):1XOO;O6]'U[Q7I>@6MSI>BM-J5LGWA_P $\OVC/VC_ -HWPQ\3-?\
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MX:UKXK66A>*?!?BJXT?Q,FH^'-9OK#39- >+5(@#]WZ*_#SXA?MS?M%_#/X
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MIUG'JUW:Q;?*MKG4DA6\GMX]J^7#+,\:;5VJ,#&M110 4444 %%%% !1110
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MTND5&=XT_/W_ (5[K?@C5OBK^PQJ>K:UXE\#^(/A=J?QG_8^\1:M=W>J^+/
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M?%.^L/ GC:[^(/ACP/?>+Q-X&TWQ/=?VJ1?1Z(-.1CY#:S?M"INL@SOO9PS
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M?'[]EK]G7X':9^U7X]N/C1^S59^#/V0]<^(WPH\4^%_V4O"5NWPG^,/P9O\
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MW_<K((_EK>FFAMH9;BXEC@MX(I)IYYG6*&&&)2\LLLCE4CCC16=W=@J*"S$
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L7Q+UZYN/$/Q$\;7\[PVTMU?>*O&.J:SK5S<RV\$LSWF]X8B?+7Z5HHH _]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>11
<FILENAME>image_004.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_004.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" %Z ><# 2(  A$! Q$!_\0
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MI[*MY>V]NSC*B60+GZ9JM_PDFA_]!BP_\"%_QH U**R_^$DT/_H,6'_@0O\
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M$+_C1_PDFA_]!BP_\"%_QH U**R_^$DT/_H,6'_@0O\ C1_PDFA_]!BP_P#
MA?\ &@#4HK+_ .$DT/\ Z#%A_P"!"_XT?\))H?\ T&+#_P "%_QH U**R5\4
M:"SL@UFQRN,_OU_QIW_"2:'_ -!BP_\  A?\: -2BLO_ (230_\ H,6'_@0O
M^-'_  DFA_\ 08L/_ A?\: -2BLO_A)-#_Z#%A_X$+_C1_PDFA_]!BP_\"%_
MQH U**R_^$DT/_H,6'_@0O\ C1_PDFA_]!BP_P# A?\ &@#4HK+_ .$DT/\
MZ#%A_P"!"_XT?\))H?\ T&+#_P "%_QH U**R_\ A)-#_P"@Q8?^!"_XT?\
M"2:'_P!!BP_\"%_QH U**R_^$DT/_H,6'_@0O^-'_"2:'_T&+#_P(7_&@#4H
MK+_X230_^@Q8?^!"_P"-'_"2:'_T&+#_ ,"%_P : -2BLO\ X230_P#H,6'_
M ($+_C1_PDFA_P#08L/_  (7_&@#4HK+_P"$DT/_ *#%A_X$+_C1_P ))H?_
M $&+#_P(7_&@#4KGM+UZ:]NY(99[$217$T;P)N\S9&2-P&3[=N]7?^$DT/\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MH****@H**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **HZEK6F:.L;:E?V]H)20AF<+N(ZXS6?_
M ,)MX7_Z#^G_ /?]:I0D]4A.26[-ZBL'_A-O"_\ T']/_P"_ZT?\)MX7_P"@
M_I__ '_6GR2[,7-'N;U%8/\ PFWA?_H/Z?\ ]_UH_P"$V\+_ /0?T_\ [_K1
MR2[,.:/<WJ*P?^$V\+_]!_3_ /O^M'_";>%_^@_I_P#W_6CDEV8<T>YO45@_
M\)MX7_Z#^G_]_P!:/^$V\+_]!_3_ /O^M')+LPYH]S>HK!_X3;PO_P!!_3_^
M_P"M'_";>%_^@_I__?\ 6CDEV8<T>YO45@_\)MX7_P"@_I__ '_6C_A-O"__
M $']/_[_ *T<DNS#FCW-ZBL'_A-O"_\ T']/_P"_ZT?\)MX7_P"@_I__ '_6
MCDEV8<T>YM"W@%PUP(8Q.RA&D"C<5'0$]<57FTG3;D.)]/M)0[^8X>%6W-C&
MXY')QQFLW_A-O"__ $']/_[_ *T?\)MX7_Z#^G_]_P!:.2?9_B'-'N:BZ;8I
M;);+96X@1@ZQ")=JL#D$#& <U-);PRRQ2R0QO)$28W902A/!P>U8O_";>%_^
M@_I__?\ 6C_A-O"__0?T_P#[_K1R3[/\0YH]S5@TZQM9WGM[*WBFD^_)'$JL
MWU(&34OV>'[3]I\F/S]NSS=HW;<YQGKC/:L7_A-O"_\ T']/_P"_ZT?\)MX7
M_P"@_I__ '_6CDGV8<T>Y/J?AVQU2:VED01M#=)<L41?WS*" 'XY&#27_ANP
MOETZ,1K!!8W'GI#$BA&."-I&,8^8U#_PFWA?_H/Z?_W_ %H_X3;PO_T']/\
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M<WJ*P?\ A-O"_P#T']/_ ._ZT?\ ";>%_P#H/Z?_ -_UHY)=F'-'N;U%8/\
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M.6/8P_\ A#/#/_0!T[_P'7_"C_A#/#/_ $ =._\  =?\*W**.>7<.6/8P_\
MA#/#/_0!T[_P'7_"C_A#/#/_ $ =._\  =?\*W**.>7<.6/8P_\ A#/#/_0!
MT[_P'7_"C_A#/#/_ $ =._\  =?\*W**.>7<.6/8P_\ A#/#/_0!T[_P'7_"
MC_A#/#/_ $ =._\  =?\*W**.>7<.6/8P_\ A#/#/_0!T[_P'7_"C_A#/#/_
M $ =._\  =?\*W**.>7<.6/8P_\ A#/#/_0!T[_P'7_"C_A#/#/_ $ =._\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MX3KT&.GS8YV?#&KZI<7\NGZI#*9$B#)/MPK '&?NCD\\\=.@KJJ*=P"BBBD
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MBBB@ HHHH **H:UJ#:5I%Q?+&)&B (0G&>0/ZUS%CXSU3449[?282@8(6:?
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M0/LR&8H0"!M7GG^76DA\/V$V(VNIK>X*[PDI7!';D<9/'';WJIXO_P"1KO\
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M #D 9Z5ECQ)HY$1-\BB8$H7!7('?D=/3U[5<L]0M-0C#VDZ3*55\KZ'I_(T
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M6-+9^II/=%X=1]:Z77_^0<O_ %T']:Y&RU"TU %K2=90N,E0>.3Z_0UUVO\
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MY&*[FZ_Y%P?]<D_I7-5E2V?J:3W1GV6B6-AJ$M[;1E)9AAP#A3SGH*[77O\
MD'I_UT']:YH=1]:Z77_^0<O_ %T']:)_%$([,\T?PM+<7AEGDMHXV9MZ6^Y<
M@\=QU]3W[YZ5M>$]+N=)N4AGO/M*M.K1DK@J.X)[_P" JY5G3_\ D(V__705
M;22=B4[LU/$?6W_X%_2L*MWQ'UM_^!?TK"J:7P(<_B-#1/\ D*1_1OY5+X@_
MX_T_ZYC^9J+1/^0I']&_E4OB#_C_ $_ZYC^9I/\ B_(?V#*K8\._\?4W^X/Y
MUCUL>'?^/J;_ '!_.JJ_ R8?$C%\67K6,\\R/&CF157S$9@21TXZ?7H*Y63Q
M%K$"&9["*:$2,K>0K$KS[D9P.ON:[G521JL^"1R/Y"J>X^IIQ6B![F[X:8/;
M2N 0&*G##!''>L:Z_P"/N?\ ZZ-_.MOP[_J9_P#>'\JY76KR2VU6&*)XPTUP
MRE7C8AAGGYAPOX]:B/\ $D4_A1:KH]+!.A2 =2'KS@ZWJT%Q:?:-/#V\^T.T
M"$LAW$'()Z9QBO2=(_Y [?5Z*K]V_F$5JTSR8:-J./\ CU?\Q_C1_8VH_P#/
MJ_YC_&NT'2BO7_M"IV1\W_8.'_F?X?Y&B\;P_#=HY%VNMF00>U>65ZYJ?_(C
M7/\ UZFO(ZTRM\T9O^\<.?P4)THKI&WX@>E>[6G_ !Y0?]<U_E7A)Z5[M:?\
M>4'_ %S7^589SM#YG3PU\53Y?J34445\\?8G$?$C_D'V/_75OY5YU7HOQ(_Y
M!]C_ -=6_E7G5?6Y9_NR^?YGY[GO^^R]%^1M>$?^1JT__?/_ *":]BKQWPC_
M ,C5I_\ OG_T$U[%7E9O_&CZ?J>]PY_NTO\ %^B"BBBO'/I#R?QW_P C5/\
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M']:XT:E'D?NWZ^HKL/$+JFFH68*/,')/L:<IQ<HV8E%I.YSE6=/_ .0C;_\
M7052\^'_ )ZI_P!]59TZ:(ZE; 2(29!@ UK*2L]2$G<V/$?6W_X%_2L*KWC-
MW0V>UF7._H?I7*^=+_SU?_OJN>%91C:QK*G=W.LT3_D*1_1OY5+X@_X_T_ZY
MC^9K&\,2R-KT(9V(VMP3[5=\57<D&J1J@7!B!Y'N:/:KGYF'(^6Q6K8\._\
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M 3&3]:F=92C:PXTVG<P=:_Y#=[_UU-4:O:U_R&[W_KJ:HUSFIVW@S_D&3_\
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MGVUQ!-%&ZF'[J^8=I/."1W(W-CZUJUP>G^.;V[ALU%E$;F>5H0KOY8/S@*_
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M&@'03:QIL&WS;^V7<5 'F#)W?=_/M3SJ5B$9FO+=0I ;=(!M)&0#GH<5R_\
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M(7F0;2 2V>3LY/K]P?F?6D!;'B+1S$THU"$HL@B9L\!O\/?I3TU_2I&D5+^
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M)&<=/J: +3>)M&106U"(90/CG.,D=.O4'CKP?2G-XCT=2X.HP91UC/S?Q'.
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MN_O.%_L;XB_]#7IW_@"/\*/[&^(O_0UZ=_X C_"NZHH]J^R^Y![-=W]YPO\
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?E/2HKZ#2[>+4[E+F]5,331IM5V]0.U%7**S;N:'_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>12
<FILENAME>image_005.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_005.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" $R G # 2(  A$! Q$!_\0
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M7^0>RA_3?^9Y_P#\*M\._P#/O)_WU3Y/A5X<6.-A!)EAD_-7>[!4\R#R8/\
M=J76G=:_@O\ (:HPMM^+_P SSC_A5OAW_GWD_P"^J/\ A5OAW_GWD_[ZKT#8
M*-@JO;3[_@O\A>RA_3?^9Y__ ,*M\._\^\G_ 'U1_P *M\._\^\G_?5>@;!0
M4 &3TH]M/O\ @O\ (/90_IO_ #//_P#A5OAW_GWD_P"^J/\ A5OAW_GWD_[Z
MKOP$;[K*>,\'-+L%'MI]_P %_D'LH?TW_F>?_P#"K?#O_/O)_P!]4?\ "K?#
MO_/O)_WU7H&P&C8,XH]M/O\ @O\ (/90_IO_ #//_P#A5OAW_GWD_P"^J/\
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M(>)"0SAL@$=?RH^W)Y@C^T#<5# 9['H:?M?(.09@^A_*C!]#^52QW:RJ6CN
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MZ\TDVC7S2$12J5#KY+&5@85#Y( [Y''-=IUFIIVFFPM9+=I#,CNS % N%/;
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MTF^E5&*MO0./FN"VYF0C=CH!DCB@9T77IWHK 33-2>9%DF=8]_[YEF/[U<\
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MJZL621H@0J%9+DR<$8=Q[YP0/KTKKA!0BHKH=4(J,;(T[JTD^T+/!-%!B(Q
M/'N49((/4>G2H8='A46TMR_FS0LS^;TWELY)Y]ZSY-+U:1MN\[<,)&>X)$AW
M @A?X?ER*BN-(U>2!8@22 0[?:2%<<;0%_AQCK5%&T-)MH[>\@B+1FZW%R#D
MC(QQ55]$F9'"W,,;2H8Y-D&!MR#P,]>.M5)=+U9G:2.0HA.!&9RSA,\+O^O/
M7VK>M4ECLX4G??,J .WJV.33 RG\.1&'8LH5@BJ&"8Y$A?GGOG!H3PY$MLT9
ME!=BIW[>0!G(&3T.:VZ*!&$-"=+FV(D#)N'G[5VAD5% 7'NR*:W:** )8_\
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M?W7_ #J*B@"7,']U_P Z,P?W7_.HJ* )<P?W7_.C,']U_P ZBHH ES!_=?\
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MJQKNCW,GB#6&TNS(D\RP8&V5=X12_F< @C@CN,UWNDV TO2+6Q4J?)C"EE&
MQ[G\:Y'5M"U>\\5WT]FUU9I,]J8[R$C V*^=PSRN2H(/7-:4:?)&S.3,<6L5
M7YXJR22];:7U[D36VN6NK6E[;V6J36"1JES;,Y#22@,4=06.%!P&&><CTJE-
MI_C&.WGM9OMLKK-]KADB)>.0NO,3$,K *W3' SWJ:RT?Q-_:=HU^ES)YC$7:
MB9A"B[G),;AP1U7Y2I[<BJL_ASQ*=+TY;07J7*VUR;CS+I_]9N'EX.[[VWIV
M]:V/./2K3SC96YN$V3F)?,0-NVM@9&>_/>IL5YZ;#Q!/I4]FUMJ:2FXGG$QF
M )B>,A%!#?>!(XZ BL^[T7QF8W69[R=DM%MXV@EP&V3+AR-P^=D#$_E0!ZE@
MT8/I7GL^B^(Y9)9].EO(%$<,36]PY59D\QBY7YF*.!C'/(XI;OP_J:0ZH;8Z
MHC?V@#;;96E#PA!P5+CY=V>A!H ]!I)^1']*I:-]K&BV0OXEBNQ"HEC5RP5O
MJ>M79_NQ_2FMQ,\G.LQR>/KHW]H;N&60VHC"[F1<X&T5M:UX>TOP9I-W>I;R
M7DETWEPB1<K"I'0G^O>EU;2[W0M?GU[3+%;P3*25 RT3_P!X#N#6%I>K^)+E
MKVTFLI[]+S.Z.9"%5CWR>@]O:O,:Y6XR6MW;3^K_ *'U\?WT(U*+2@E'F7-:
M]NGE;Y7.@^']S->^&KJT>0CR7,<;_P!T,,_I6O\ V=="&-5M+>+RPBNL4I4S
MJ,Y&1T&<'GFDT#0CH?A]K0,&N9 SR,O]\CH/I1'!<RWNGS&TFC:-5$KOCD!2
M",YXY[=Z]"C%QII2W/F\?4IU,5.=/9L2RT>\1$-U,7<2+D&4L/+_ (E]Z>^E
MW*:/):6_RR>>77;*0&7.1_\ J]JVZ*V.(YZ31]0G8++*,;\R/YI/F+D$ #MM
M]:2;2M8DV.;S+Y*G:Y 7& K_ %P#D>]=%10!E7EM=F:\:&VAG$PC*&5P K*,
M<C]:6TTN2"2"074\:I!Y9B!4@'.<YQ6I10!E&PN+?0S9+-)<R/A"[XX!//X8
MS6J % 51A0,#Z444 2Q_ZJ7Z#^=>8>,]8>V\96PEB$UO:(K"%NC%NI^M>GQ_
MZJ7Z#^=<?XGT*:34[77+.U6ZFM\"6W;^,#H1[BN;$QE*'N]T>KE56E3KWJK1
MIKMJUWZ7VOYB3>&=%T^&7Q2+6X>+R1*EEY?W'/?'^<5D_#S4I)]4U*#:$@D'
MGK&OW4.<<?G5"#Q)XG/B"2Y:UNI!(/+:T,;;=G8 =C[UUGA+0'TL75]=0I#<
MW;9\E.D29SMKEI>_43@K)7OI_7W'JXJ]##3CB)<TI)<NM[:[6\OYNI8.B326
M:6CI:;(\#S0#OD <'GTR!SUYID^AW;.PBECV;U,3,[ PJ'R0/7(XK7LX;JWL
M_+N+K[3/EB)60+U)P"!Z<"LF+2M0%C?PSO"\EQ(CAP20QR-Q(/;VKTCY8<N@
M,#$AE4Q"(!TW-\TFTC=^>#^%0_V#?FXWR7@?."6+'+<#Y<8[8R.:L:1I,UK=
M>?<B/*KM "@\Y.=I_A'M34T^^GEA%RTXVR[I9!,,-][&T=1P10!=TBSFL;:2
M*9T8F0L-K$X&!U/K6A7+B#65NC$YE,CPLZF.0* XV ,W'/?BM;2XKZ*2Y^V,
MS L"C,X.>N<#L.E,1I444=\=Z "G1_ZU/J*;3H_]:GU% '+>,6B;4;"&[9UM
M&=F<KZ]*J0^#X;>\DN[ZZ3^R(E\T2;N7'I_GK71:_I,>LVSPE@LBL6C?K@_X
M5Q-]H7B66R33MKR6T3955<;37EUZ;51R<;]O\GY'#6A:;<HW[?Y/R+6E:^VJ
M>-($M8_)L51TCC ZKCJ?R%=;K%])8:>TD(5IW8)$K*2"Q]0.<5C>%/"S:-ON
MKME:[==H5>0@^OK74=P>XZ>U=F'C-0]_=G114E&\]V89\1J4'EP;F*+)\S8
M1L ,?0;B1^%0-XBE$K'RXRL;,KB-]RMCN&]*Z'8F"-B\C!XZB@1QJ,"- /0*
M*Z#8P/\ A(I1=O&4M2L2MOQ/P^,?=/<\]*=9^(7FNH;=[8DNP5FZ'DG! ] !
MS6YY,6 /*CP.GRCBE\M-P;8NX=#CD4 8AUV:)YEDCMR8Y91_K-N51@,#/5CG
MI4;>(Y#=0JL4(2;(4/)@H=V!YG]VM\QQL<F-"<YY4=?6D,49+$QH2WWOE'/U
MH RK#73>3Q0&W"R2,VW:^Y2BDAF!]B!^=;%1+;1+<"=4 <)Y8QT"YST^M2T
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M/,B_YX_^/4 145+YD7_/'_QZCS(O^>/_ (]0!%14OF1?\\?_ !ZCS(O^>/\
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MS(O^>/\ X]3$145+YD7_ #Q_\>H\R+_GC_X]0!%14OF1?\\?_'J/,B_YX_\
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M JP]N.:YZE>-/1ZGI87+JN)7,FDM=W:]M[>G5GI]%<]H&NW-U>3:5JD:1:E
MH8^6?ED7U'O6IJ=[)911-$BNTDFP!@3V)[<]JVA-35T<=:C*C/DE_P !KNO(
MNT5D+KC>7EK&42#=N7>HX4?,?P_6F?\ "0HT]MMMW^S3LRK*2,L00O3MR>]4
M8FU166=:5GF6"V>3R21(VY0%/..O7.*@A\0%X]SVK;A&LLBJP_=H0#G/?KVH
M VZ*H66J+>RA!!)&&0O&S$'>H.">.G:K] !1110 5++_ *N+_=J*EO9XK6R%
MQ,P6*.,LS'L!28TF]$)17G&K^)O$<]B-4L4%MIC,0I50S8[%O3-7-)\2ZU81
M6D^O1JUE=-M28@*Z9Z$CN*YEBH.5M?4]:64UE3Y^:+>UKZW6Z]?([NBBBNH\
M@**** "BBB@ HHHH **** 'K_JI/PIE/7_52?A6;JVJP:19F>;+,3A$'5C4R
MDHIM["DU%79?HK@F\;:B9-RPVZIG[I!/ZYKK-(U0ZC IE@:";;NV-W'J*QIX
MFG4=HF-.O"H[1-&BBBN@W"BBB@ HHHH **** "N>\=?\B1JG_7-?_0UKH:Y[
MQU_R)&J?]<U_]#6LJW\.7H_R.[+O]\I?XH_FCJ:**XKQAXDG2_30]*O1:3(G
MVG4+[ (LX!SWXW'L*TA!S=D<4I**NSM2 000"#U![UPOB?X6:+KY,UKG3KHG
M):)<HWU7_"N377O$=NUK--XDO%#L;MXIHT_<V2GAI,#[S]E'K70M\0-3$]E,
M8M*6UN 9Y8A,S26UN.K2$<!L=!ZG%=4:-6F[P9SRJ4YJTT6]6\!W=S96>FZ=
M>6]OIUG&$BC=6)+?Q,<=R:KW_P .[Z3PU;Z-8:C;P(7\V\D=&S/)VZ?PCL*S
M(/BGJEW?QK%8V45LY:4^<6!CMQSO9@<9QV]:TK+XAWE_JEG9_9K*T%TQG)N9
M"##;=F;G[[=AZ5JWB8I+MKT,N7#R;??0@MOAE?:?X7N].L=3MH[^^;;<W3(W
M^I'\"]QD]:E\#_"\>%]7;4K^ZAO)T7%N(T($9/5N>_I5CQ!\0GM-=;2M&@AN
MFA4&>9\LJL>B* >31)XWUBQ\00:1>Z09;A[0S[+6-BTC'[JJ"> .Y/O4-XB4
M7?KKYEJ-&+5EL=[17F/_  L?69+L6$6G6AO(_EN"NYU60GB-0#R0.I]:]!LO
M[2:.W>]-N'*$S)$IP&[8S7+.E*'Q'1&I&6Q=J.[4O %'5D(%24D_W8_I6:+>
MQYWI#6%S#)H6JJ('#GRIP,%7]ZJ^)/$5O%:?V%HGR64?$TPZRGOSZ5UNK>&;
M+59?.):&<]73^+ZBL^S\!Z=;W2SSRR7 4Y$9 "Y]_6O.>'K+W4EZ^1YWLJJ]
MU6]?(N^$[1HO"MM#.I D5F*GLK'_  J%K'6(((1#-(TC,_F-N&<@X3/MM'YD
MUT8    P!T HKTH1Y8J/8[HKE21F:=%J 2[2YD<,6_=2/AOT':H+F.^M-(LX
M6GEFG-Q&DC185F4DY )K:HJAG-FW\0%N)7'RGR_F'RC#8#>K?=YJ>6WU9!,D
M,D[28_=R-(NS;@<$8^]G=S]*W:* .91=9^U&$O<;Q%OC^=<(2Y +^O IT5CJ
MD"(H$Y0*5?9(/,8Y<@@GMRM=)10,R;"WU*.:*2ZG9RS.)5W#:%Q\N!]:UJ**
M!$L?^JE^@_G7$ZS/!9>+?,O[<2VLT*IDC.T="17;1_ZJ7Z#^=9>K:1;:O;B*
M<%67E)%ZK6%>G*</=W1E6@Y1]W='/3-HW@Z![Z"5;V]N 3:(?X%/<_XU1\"S
M75_KNH7MP[.6B =CTR3P/TJ:3X?-+("VH*%'&1&<X_.NJTK2;71[,6UJIQG+
M,>KGU-<M&C4YTVN5+H84Z<W)-JR70DL[K[;9FX6WEMV)8;9TPV02,D>G&:S;
M#6FO+^QMVC0"6 M(Q4@E]H;"^W-:EO?6UY:&ZMI5FA&X;EZ$KP1^E9UIK]A+
M&C&,Q;4RFU=P"X!X(''88]<"O1.TJ0Z]>3R+&D*DM+LR(^1]_H">>%'/N:T+
M[5&M7F1(%9HH@S.SA>2#C /7I3EU'3O,7;&1(O4>0=T0SU;CY1R?S-1/JVD3
M2+(ZB20'8A,))P<]..G!H @.O20B)9;4)*RKF,.,$MMP=W;K5BWUP3WT=JUO
ML9B5+>8"-P)&!CKTIL][I-TFUXV?:^-JPDEMO/3'( %6K%]/NOWMI#&1#^[6
M01;0/93CI]*0%ZBBBF(*='_K4^HIM.C_ -:GU% ' ?$^WGEN=.:-2R%GC ']
M\D8KH-*U"WTO3K#2=4U*$ZP\3"*1E#>5GH"?\YQ6IJVFVVJVTUI=INB<YXX*
MGL0>QKA[CX;3RW1D75]RD_>E0E_SS7#4ISC4<X*]SZ##XC#UL/'#UY\G+?I>
M]]M?S74H^&K"_MOB$8[MC)-&'>63.=P(X/XY%>CW=Q#;^2TRLQ:3:FU<D-CK
M[<9YJEHF@VVB1/L=Y[B7!EGE.6?_ .M6E)%'*4+J&*'<N>QQBML/2=.%F<.8
MXM8FLI+9)+:U[=;=/)&.=3T>]'E^1]H.XNL8BW$]27 ].#43W^BLR3BQ#I.=
MK3^3QR,GGZ8S_P#6K0&B6"KA867G@B1@1QC .>!R>*3^Q+%$Q%%L*J0@+$JI
M*[<XSCI70><022:;;_9I(;!9 96AC\J($@@$G'KT-.MFT>[\J.&WB8@DHOE<
MC '/MVJR-*M?L5M:LK%+<#RR&(8'&,Y'?D_G2VVFP6MW)/$H7=&L2J/X5']>
M>M %'^U/)D=!IH6:%6+ 2#Y4QN;GUZ<4Z?7)(7V_87;=M*8;)VDX!( )&>HJ
MPNBV"Q>7Y3[-Q;!D;J>O.>_>GC2;-3*51P9&#L1(PY'0CGB@"S;S+<6\<RD$
M.H88.14E,BB2")(HU"H@PH'84^@05E>,XI9O"%VD();R<D#N >:U:DF :&,$
M @J00>]3./,G'N:T:GLJD:G9I_<SSOP1,-&T.[U#5[I%TJ482V9=Y=O4#^E4
M?B!'<7MY;:C!=+<Z=.H6W$? C/IBMC5OA['=29L+YK>'<6$$@+(I/7;Z5;T+
MP1#I<L4UY=-=O"=T4>,1H?7'K7G>PJ./LFM.]_Z^X^G6.PL*CQBG>3O[O+TM
MHO)]Y7U.DLD>.PMXY3F18E5OJ ,U/117IK0^4D[ML****!!1110 4444 %%%
M% #U_P!5)^%<AXHD@CUK3VOHV>SVG('KGD_RKKU_U4GX5FZOI,.KV?D2DJRG
M*..JFL*\'.#4=S*M%RA9;F N@:5H[OK-[=I-IJ@/;QCDR$] ?6LS0]:N];\;
MQW!&R((X6)>B)C_]5%WX*U>9$A%S$T49)3,AP,^W:ND\.>&H=!B=V<2W4@P\
MF, #T%<5*E-R5H\J6K.:G"3DDH\JW9L7$7GVTL(8H74J&4X(/K6&ZZSY'GLM
MPDTH;,<!4E6  3.>-IP2<>HKH:*]0[CF$C\0Q2(L8P"=WS8*Y.<[OTQ6OI7V
MS;+]J\[;\NSS]N_./F^[QC/2M"B@ HHHH **** "N>\=?\B1JG_7-?\ T-:Z
M&N>\=?\ (D:I_P!<U_\ 0UK*M_#EZ/\ ([LN_P!\I?XH_FCK/*;U'YU6?2;.
M0S%[.V8SX,V44^9CIN]?QJ:BJO8Y"%M*M',I>TMF,RA9,HIW@= ?4"HTT+38
MXI(DTZR6.3&]%A4!L=,\<U:HHYGW%9%5-!TR-'1--LE208=1"H##T/'-$VAZ
M=<R>9/IUE*^ -SQ*3@=.U6JS]0U>#3I(XW5G9N2%_A'K4RJ<BYI,3Y4M28Z'
MIK3B<Z=9&8$-YAA7=GUSBK LH1=&Z$,(N"NTRX&\CTSUQ0CK)&KH0589!]J=
M5<S?4=D5AHFG"Y%R-/LQ.&W>:(EW9]<XZU<\MO4?G3**&V]PM8?Y3>H_.DFB
M9@F,<#UIM-G^[']*%N#$^SOZK_WU1]G?U7_OJHJ*LDE^SOZK_P!]4?9W]5_[
MZJ*B@"7[._JO_?5'V=_5?^^JBHH E^SOZK_WU1]G?U7_ +ZJ*B@"7[._JO\
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MJT\<0/&@D^S1IY<;#(;=U_$UA7J^SA<]#+\)]:K<G9-]KVZ7Z7[FFGQ+MFN
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MEQ;&5I2B2'>&F'*\<GWZ\=/I74;G045AG1;DWEQ=+,T;R7.0(_E)C)7.6[\
MX':F"UU8.-QF*!OWRB89EY/W#_#QB@#?ZT'@9/ KG(+36[>Q6V3(<NK"0R@[
M!SD'CD_XTKZ=?R.LBK,"$V 2S[L'<A)/J.&H&=%16#%8ZI)*@FFF2+'[[$W+
MOSRN.B].*V+03+9PBX.9@BB0^K8YH$35++_JHO\ =J*J/B6:2W\.321$AO*Q
MD=LG%3.7+%R["D^6+9E7_C&SM)VB@B:X93@L#A<_UJ?2?$]IJDODE'@F/0-R
M#^-<TOA:6]M+2XTJ07"2827)P8V]3[4:_>V7AVS&D::RRWW!N;C^Z?0>_P#*
MO-CB*RES3^'^MCA56JGS3T7];'H-%0V<C36-O*_WWB5F^I%35ZB=SO"BBB@
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M!JEO$\\/V&>T-PER"3DAL8 %7KCQ'H]KY?FW\0$D8E4C)&P]&)'0>YKG-/\
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M $-:RK?PY>C_ ".[+O\ ?*7^*/YHZWS%_P">8H\Q?^>8J.HVGA1MKS1JWH6
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M_G4+NL:%W8*JC)9C@"D,G\Y/^>*T><G_ #Q6L5?$FBO-Y*ZI;&3.,;_Z]*U
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M'P[(UTQ>6T)1F/5EQD9]\5M_VC^_MD^SOY=QC;(6'4J6QCOP.36/X,T.32]
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MG=:987K![JS@F8?Q.@)_.E?5]*9V(U?3\$Y_X^D_QIO]K:5_T%M._P# I/\
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6[>QHHK*M_#EZ,[<O_P!\I?XH_FC_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>13
<FILENAME>image_006.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_006.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" &M G # 2(  A$! Q$!_\0
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M;OW8SQQU]ZJZ7C_A;FO=,C3[?^9KG=7TZZU:\^(ME9(9+AUM66->K[5#%?Q
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M_P#CPH\]O^>?_CPHLP)J*A\]O^>?_CPH\]O^>?\ X\*+,"5E#*58 @]0:
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M_CPHLQ$U%0^>W_//_P >%'GM_P \S_WT*+,9-14/GM_SS_\ 'A1Y[?\ //\
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M&G]IA_O_ *4UKF'*_/W]#Z5S\^IQ6V/M%S;P9Z>:ZKG\S4!UZQRO_$SL>O\
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M_P#?Y/\ &G[)A[1'1^?%_?\ TI#/%M/S]O2N>_MJS_Z"%G_W^3_&@ZS:8/\
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MJ^J:WIMW(#8K;W)BMRHV0&/)0H/X<8Q^=:>T:;36V_X;?>9\B=FGOM^/^1Q
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M!U%%% !1110 4444 %%%% !1110 4T??;\*=31]]OPH =1110 4444 %%%%
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MRH\M/[B_E3]I(.1%'[%_L'\Z/L7^P?SJ]Y:?W%_*CRT_N+^5'M)!R(H_8O\
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M:OXU8JM&JK,N !UJS4/<:"BBBD,CF^X/]X5%4L_W!_O"HJJ(F%%%%4(****
M"BBB@ HHHH **** "FI]Q?I3J:G^K7Z4 .HHHH **** "BBB@ HHHH ****
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M444 %%%% !1110 4U/\ 5K]*=34^XOTH =1110 4444 %%%% !1110 4444
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M'&RC\ 0*[RN"^%UVVHZ-?:AY;1Q7.HRO"I_YYA45?R"X_"N]KY'&7]O*^_\
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M '5_[Z_^M1E_[J_]]?\ UJ=10 W+_P!U?^^O_K49?^ZO_?7_ -:G44 -R_\
M=7_OK_ZU(2^T_*O3U_\ K4^D/0_2@!JE]B_*O0=__K4N7_NK_P!]?_6I5^Z/
MI2T -R_]U?\ OK_ZU&7_ +J_]]?_ %J=10 W+_W5_P"^O_K49?\ NK_WU_\
M6IU% #<O_=7_ +Z_^M1E_P"ZO_?7_P!:G44 -R_]U?\ OK_ZU&7_ +J_]]?_
M %J=10 W+_W5_P"^O_K49?\ NK_WU_\ 6IU% #%+Y?Y5_.G#S#P%7_OK_P"M
M0OWGIXX0_6D S=)C&!C_ 'O_ *U07EI%J%E-97EO'-;3*4DC<Y#"KB_=XQ[B
MF@XX YS33L[H#S:3X,>&WD9DEU"-2<A%N%(7VY7--_X4KX=_Y^=2_P"_Z_\
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MBB@ HHHH **** "BBB@ I#]T_2EI#T/TH %^Z/I2TB_='TI: "BBB@ HHHH
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M\^\R2X(W,2<G )P!5/Q5KOAC4/$.C)J&JV%SI<$DHN+?S@P67&$+J.H&&'/
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M^\/SI"R[3\R]/6@!5^Z/I2TU67:OS+T]:7<O]X?G0 M%)N7^\/SHW+_>'YT
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M)O3^^O\ WT* %VK_ '1^5&U?[H_*@$,,J01Z@Y%+0 FU?[H_*C:O]T?E2T4
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M44 %%%% !1110 4444 %%%% !2'[I^E+2'H?I0 +]U?I2TB_='TI: "BBB@
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MS_['ZTB;]@QMQCWH ?13?G_V/UH^?_8_6@!U%-^?_8_6CY_]C]: '44WY_\
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M?_8_6@!U%-^?_8_6CY_]C]: '44WY_\ 8_6CY_\ 8_6@!U%-^?\ V/UH^?\
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M\)';'G;]DE]<?>3\*N5:V$%%%% !1110 4444 %(W5?K2TUNJ_7^E #J***
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M]C6;I.G:G!<//JFHBZ9%\J%8UV+M_OL.[GC/8=J:>@FM33F^X/\ >%15+/\
M<'^\*BHB-A1115""BBB@ HHHH **** "BBB@ IJ?<7Z4ZFI_JU^E #J*** "
MBBB@ HHHH **** *P'_$\A.!C[,XSC_:7OC^OX5I5FSP2FXBN;=D6:,%,..&
M4D9!].F?K2>=JV!^[LLXY^=_\*J4>:UF2G:YIU@ZIX8LM4N8YKF%G:,;5*R;
M<KG.&XY%6S-JW.V.QZ'&7?WQV_W?UI#/JV7"QV.1G;EW_P!K&>/]S_Q[VIP<
MZ<N:$K/U(JPIU8\E2-UYHT((O*CV\9]N@]A4E99FUC^&.PZ]W?ID^WIC]:3S
MM9W#]W8;<C/SOGJ/;TS^E9\K-;H2Y7_BI;9L=+249V_[2=]O_LP^AZB[5&VM
M;E[[[=?& SK%Y2+"O"@X+<D9Y(^F .,U>I@%%%% !1110 4444 %(W5?K_2E
MIK=5^O\ 2@!U%%% !1110 4444 ,E_U9R<#(W$>F>:\VT/Q!XZNOB+=Z;JND
M"'0D,@#_ &?:D2#.QED_B)XXYZ]J],I@B08^7@<@9X'X4P,F_P!1U&RD67[/
M;_9!+#" ['S9BY )7' QGH0<X/2J6F^))[F\?[5):1P!YE"+#*'/EEN Y^0G
M"Y(%7;O1KRYUN/4%U7;'$ (K=[976/\ O$'(^8],GH.E2'1I)+J,W.H2W%I%
M*TT5NZ#(8@C!?J0-QP/U.*-!%30M?EU6YC60VOESP>?$L:NK*,CC+<2#GDKT
M/US3KJ^GCOM7NU26:/3;=4BMHR?WCLN]F([\;0/3FK%EHK6MS:R37KW$=G&T
M5JAC"[%.!\Q'WC@ =J5]/N!J5^T4KQV]] NZ6-@'AE4;01GKE<?BOO1H!DP^
M(M1/AQM2 TZ?9=)'OAD9D=&D"'CJK#(Z]:L+XBF.NBQ_T,DW;6QM@S>>J@9\
MP]L8YQCH>N>*+;PM_H%U%<WIDGNI(W>6.$(,))YB_+W)S@D_TJR-!<3HIO<V
M27AO%A\D;]Y8M@OGIN/IG'&<4] U(K+5KN^:R-U#"EEJ8D6$Q,PDCPI(W'H2
M5!/&,'UJ[H4\\VF;+ES)/;RR6TDA_C*,5#?4@ U7M-#:PFAE^U27,-DLAL[4
MHJ["P(P6[X!(&<8![U;T>SEL=-2.X96N9'>:<KT\QV+-CV&<?A2=@+]%%4I=
M9TJ"<P3:I8QS!_+,;W"!MW'RX)SGD<>](9=HJ@-<T@R0QC5K R3@&%?M*9D!
M.!M&><GTIO\ ;^B[F7^V-.W*XC8?:DR&/\)YZ\'CVH T:*H/KNCQRR1/JU@D
MD3;9$:Y0%#G&",\'/%7\C&<\=<T %%5[6^L[[?\ 8[NWN/+.'\F57VGT.#Q3
M4U*PDG\B.^M7FSM\M9E+9],9ZT 61]YOK_2EIJ_>;Z_TIU !1110 4444 %%
M%% !1110 4444 *G^M7\:L573_6I^-6*A[C04444AD<WW!_O"HJEG^X/]X5%
M51$PHHHJA!1110 4444 %%%% !1110 4U/N+]*=34_U:_2@!U%%% !1110 4
M444 %%%% !1110 4@^^WX4M-'WV_"@!U%%% !1110 4444 %%%% !1110 4C
M=5^M+36ZK]?Z4 .HHHH **** "BBB@ HILC%5&,9)QD]![UQ_A[XCZ!XFUFX
MTO3+BY>XA5G!FB"I,JGYBA_QQ1J!>\2>.M$\*-(NJ/< 1Q+*[10EU0,Q503Z
MD@X'H":HW_Q.\/:9IWVZZ74(XC<+; &U.XR-&)  ,Y^ZP_$XKF_B?IE]XI\5
M^&]!@TR\;2ENEGU&[2V8Q^B@L!@X7=]-U)XOTJ\\1_%GP]:'2KM- TLFYGN!
M;-Y4DH&[&0,-PB+^8J;L9UUSX_T>UUX:&\&H-J7V7[48$MBS*FTMS@\' Z>O
M%0R_$GP_'=:=:,+[S]1M/MEN@MSDQ88Y//'"D\]J\ZTK2=6U+QCK/B35-'UJ
M*XU#488;2W%NZ VZN"WFL1\L>U4SZX(YK.\2:7XFUKQ#XOU^UT358G6!+#3(
MQ:,I>%F".5!'38&X'/[SZT78'M_AOQ%IOBK18M5TF9Y;5R4RZ%6##@@@U%%X
MKTR?Q=/X8C,[:G!#YT@\H[%3 (.[ISN%)X5LX]$\%Z; ; 6?DVJM-;PQG(?&
M7PH))).3W/-<-X(_M"PG\7>,M6T;4EU&_N_+M[,VK^:8A]P 8SCD GMMIB.X
MU'Q?H^E^)].\.W,LO]I:@,PQI'N&.?O'MT-;M>,Q>']:D^.^D7UW8W$MI:0L
M9;]()!$\K*['YB,#E@..!@"O6=6O#I^F75V(GE\B&28QI]Y]JD[1[FA 7>AK
MQ2WT[3_$OQ\-I:I&^G:'%)<3G(;S;ASEF)[G<ZCVV =JZWX:>.KGQMI]_<7%
MA':/:3(F868I(K9XY_B&.?J*Z.*Y\.V,MW)!;VL$T4HMYO*M-LC.PR% "Y;(
MYXSFFXN]@3/(-)N=*'Q'\0>(XUA&B>#].^RV2Y!!9054 ]R6\S!]2*B^'%K9
M0Z6+_P 0W%DT.H^=K%S"0#,3"P*,W]R/.X@\9+ =*]@SX7BL59;&R\BY8CRH
M['+.4ZYC"YRO.<CBI;F'0;;1YM233K&6V>!?]7;H?.7C8O3D$[<#Z4N5A<^;
MK5QK4<,FIG8OB_6B9I(R/-CAC?MG@ N_/^X*^D==U.T\(>#[N]R$@T^TQ"K-
M]XJN$7GJ2<"HC<:#IEQ86=W:Z?:7IPR1QPC; [#LP7"Y(P#QG%6KN^T:\G.G
MW@AN&$FW9+ 9$\P#.W)!7?CMUHLPN>).^J>$O@38OIY9-4\37NZ:XCX*K)G
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M/OM^%.IH^^WX4 .HHHH **** "BBB@ HHHH **** "FMU7Z_TIU-;JOU_I0
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MF#1++[1,DLKL2L4,2[FD8*6P/P!)/8"JB^*+:73K6Y@M+N6:YD,4=J(]LF\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** ..^(DABT[1Y%A><IJUN1$F-S\G@9XR?>HX;:^U?Q?IVK#1)=)M[&*82
M23E!).77 3"$_*.N2:Z#7-%76X[%&G:'[+>1W0(7.XH3\OMG/6M0C*D>HJKZ
M$<MV>;Z'+K;_  [O/$5YKEU-<-I\_D1C 6/!;#GC)?Y>M7X[W4M>U#2=%CU*
M>SB&E1WUW<0X$LS-@!0Q' SDDBMJT\+I:>"6\-"[9D-O)!]H* 'YL\XSVS45
MUX4;9IMSI^I26>HZ?;"V6Y$8=98P!E70\$9&>O!JKH5G8IWTNL>#M"UJ^EU
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(@ HHHH __]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>14
<FILENAME>image_007.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_007.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" #K 9\# 2(  A$! Q$!_\0
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MQ-3"8FG:=-8K+\%BJ;56CB<)0KT:D'Z91117GF(4444 %%%% !1110 4444
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M:=.A2PE'][B:E6%"G[]2)^5W_#,7[1?_ $,?P7_\2=\#?_0B4?\ #,?[1?\
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M?U_2)O!?BN*>VMK/2=%N=.N([XZI]C=9WFF5HA$LB&,$LP;BOU$_X45\%?\
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M?\*S^../3_A4GBO_ .1:/^%ZZ;_T3/XX_P#AI?%?_P BU[C11[2A_P! S_\
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M9$FN&SQMA1SGC&:B77M#>5H%UG26F2_72GA74;-I4U-AN73FC$Q=;]E!*V9
MN"!D1XI\LM^65K7ORRM:[5[VM:Z:OM=-7NFDKKNOO7^9JT5&LT+RRPI+$\T(
M0S1+(K2Q"4$QF6,$M&) I*%@-X!*Y -24AA1110 445G_P!KZ5]OETO^T]/_
M +3@M_M<^G?;;;[?#:X4_:9;/S?M$=OAE/G/&(\,OS<BFDW>R;LKNR;LN[LG
M9:K5V6NX7L:%%95KKVAWPMFLM9TF\6]CN);,VNHV=P+N*T8K=26QAF<3QVS
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MBCA\5AL74HX2JI1HT\9-X6"H?6FL-4O.E.=&<Z56/D'_  2P\;^$;S]F[0?
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MO5W;;N?H!O3^\O\ WT/\:-Z?WE_[Z'^-?G__ ,.M/V#_ /HA$?\ X<GXO_\
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M GH"2![CK7Y^?\.LOV$?^B'/_P"'/^,7_P \"@_\$LOV$C_S1"4?3XH?&/\
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M5U']G'XKZ#JFM:[HO[/?A+Q_J>C^(_&7C^RO_&'C?PU=ZW\5_"WB#X;/X/\
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M#'23=VOLZJ'(I23_ $5HK\ZO^'4G[#/_ $2GQ'_X>7XU_P#SPJ/^'4G[#/\
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MYT\1)4YUJLZ:_M*K&T)5:DH+E4[1M&45RK2-K=#^0+_AYS_P4:_Z/C_::_\
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M^I:JGBBRU&7XB?%;P^/^$S\$>%='TO4H[K0K_2+NZU""VN;F>VY3Q_\ %?\
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M!O+BTV]MU6WN[!%%K<6Z)!+$\2J@OC_@V-_9,%S:7@_:=_;1^UV$<$-C=?\
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MOGLFHQYIQC)2DKW@FL\SB4H14\,W*R;>68Q1BVDVG*7*ERZIMVBY)I.WO/\
MI!_XB@/^"8F0-_[162 0/^%.+D@\ @?\)5D@D@ C@YIZ?\'/G_!,B7S!$/VC
MI#%$\\HC^#)D\J"/F2:79XH/EPH""\K[8TR-S#-?R\>&/"=SH_@G7_!>O_\
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MHHI %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%?S-_\
M!T+\2?B-\,OV1OV>=5^&OQ \;?#S5-1_:7M=-U#4_ WBG6_"FH7^G?\ "JOB
M/=G3[R]T.]L;FYLC=6UO<FUED:$SP0S%/,B1E_B*_P"&L?VJO^CF_P!H/_P\
MOQ#_ /FAK]$X;\/<5Q)E<,TI9IAL)"=?$4/8U<-B*LT\/.$'+GIU(Q:ESII6
MNK.Y\UFG$M'*\7+"3PE6K*-.G4YX5:<8M5(N25I1;35K/6SZ'^NS17^1-_PU
MC^U5_P!'-_M!_P#AY?B'_P#-#1_PUC^U5_T<W^T'_P"'E^(?_P T->]_Q!_'
M?]#W!?\ A%C/_EIYW^NN&_Z ,1_X.H__ ")_KLT5_D3?\-8_M5?]'-_M!_\
MAY?B'_\ -#1_PUC^U5_T<W^T'_X>7XA__-#1_P 0?QW_ $/<%_X18S_Y:'^N
MN&_Z ,1_X.H__(G^NS17^1-_PUC^U5_T<W^T'_X>7XA__-#1_P -8_M5?]'-
M_M!_^'E^(?\ \T-'_$'\=_T/<%_X18S_ .6A_KKAO^@#$?\ @ZC_ /(G^NS1
M7^1-_P -8_M5?]'-_M!_^'E^(?\ \T-'_#6/[57_ $<W^T'_ .'E^(?_ ,T-
M'_$'\=_T/<%_X18S_P"6A_KKAO\ H Q'_@ZC_P#(G^NS17^1*?VLOVJ0"3^T
MW^T&  23_P +E^(? ')/_(PU^G/PI^'_ ,<_%7AGX7^*/&G[>7QUL&USP%X_
M\:?%+PQHG[2&J)KG@1[?P??^-OA+ISP6NK^+O$%@?%NF:7>6?B<:AX/O;W1-
M7-GI]G:7$E]#CEQ?A96P4(U,1G^$C&;E&*AEV/J2DXP<VE&%1M:62;<4YRA"
M_-)(WH\6T\1)QI9?7;BDY<V(P\4DWRK645?6[:5VHIRM9,_TH:*_S&-9?X[:
MAH_PHG\%?MB?M-V-U\0?C+IOPOU_6_&7QY\;1:-X/A\2^)-9TGP[>)H5Q9>%
M-;\16*Z3I]OK-_XLT>]GTL/]KT[4M'\.7OV6!NSTSX9?M'3> ;GXDW__  42
M^.!T233O&]UX>T/2_'WCB]\7:Y<^%=3TR+1Q=:*OQ-:XT#2?$^BWTNKG4[^.
M2ZTB. XTK4X4FFCYY>&O)&,I\0X2'/.5.,7EF8N3G&?LVK0E-)N6W-)>ZG-\
ML+-Z+BB[:66UG:*DVL5AK<KCS7U46]-[)Z^[K+1?Z6E%?YJ/B+X5_M+VWC[6
MO"/AS_@H3\:-6?P_)JFJ^(=(L/B1\2M?\0:7X:D\8>(O"OAB#PR;/Q?86OQ'
M\3WG_"/W&I:OI^EQ:%%I^DK+J@9H5$-<YX7^&/[7NMVOQ>NM=_X*&^,? Z_"
MCXPZS\&W@\4_&_XCZ=?Z_K?A^32X[Z_ATJX\4PZM807TVM:?::';/974M]?+
M>V=T^GRP1?:$O#>#AS_ZRX)+EI2:>6YFI)5I<E+W%&4WSRVM%JRYN;EU'_K.
M[\O]EXAN\UIB<):\%S3]YR4=%O=IWTM<_P!-&BO\T&Q^&'[5NE7&EQ>.?V]?
MBY:7<$YM_&^DZ+\9?'EQ9^%+ZV\1#P1K>@MXU7Q9>>'[OQ3X=\6317%WHL41
M%_X1MK_7K6\C:)+1K'A;X8_M2)X:MM>^(7[='Q]TC6+[Q2FBZ3X,T[XH^.K>
M74M!\WXD6,WB[4?$MYXUN(_#6C"[\!VUW87$VA:I;ZC::]8P>?:RS0SN/PW@
MDW_K)@I*Z2Y<MS%\[ES6Y%=<R2BY.6D%!QFY<LXN27$[;M_9F(6C;OB<,K)6
M^+>SN[);N2<;7B[?Z6U%?YF^L?#/]J?P]#"-;_X*+?$ZPOM2GU;P[H&GS_$3
MXN1S:OXXT*RN[V]M"&\5;K+P%?BTDC\._$*9#::VRS+#I,4MM/$GYW?\-8_M
M5@LK?M-?M!AE9D8#XS?$,@,C%6P?^$AY&0<'N,'O75A_"JMBU)X?B'!5%"W,
M_P"S\PBO>NE9SE!25XM-QO9Z.S,JO%U.C95<NQ$7*]E]8PTGI:]U'FMNFKVN
MM4?Z[-%?Y$W_  UC^U5_T<W^T'_X>7XA_P#S0T?\-8_M5?\ 1S?[0?\ X>7X
MA_\ S0UT_P#$'\=_T/<%_P"$6,_^6F/^NN&_Z ,1_P"#J/\ \B?Z[-%?Y$W_
M  UC^U5_T<W^T'_X>7XA_P#S0T?\-8_M5?\ 1S?[0?\ X>7XA_\ S0T?\0?Q
MW_0]P7_A%C/_ ):'^NN&_P"@#$?^#J/_ ,B?Z[-%?Y$W_#6/[57_ $<W^T'_
M .'E^(?_ ,T-'_#6/[57_1S?[0?_ (>7XA__ #0T?\0?QW_0]P7_ (18S_Y:
M'^NN&_Z ,1_X.H__ ")_KLT5_D3?\-8_M5?]'-_M!_\ AY?B'_\ -#1_PUC^
MU5_T<W^T'_X>7XA__-#1_P 0?QW_ $/<%_X18S_Y:'^NN&_Z ,1_X.H__(G^
MF/\ \%:QI9_X)K_MF_VZ-4.@_P#"CO%!U\:&;4:W_8(-J=;.C&^#6(U8:6+L
MZ;]M!L_MH@^U?N/,-7O^"8!_8R/[&7PE_P"&$?[+_P"%$?V4/(\KRAXN_P"$
MM\J >*/^%G@_Z>/B3]O&/$W]I?O1*(!8?\24:8!_F)Z_^TE^T9XJT75/#7BC
MX_\ QL\2^'-;LY-/UK0-?^*GCC5]%U>PF*F6QU/2[_7+BRO[24JIDMKJ&6%]
MHW(<"OM7_@E3_P %!_VB?V#_ -HSPV_P9T;Q!\5?"/Q7\1:'X6\??L[Z6;J\
M;XG27US'8Z?<^$;&)9AIWQ(TU93_ &%J\,(BN85?3=:WZ4[O;].+\,L?AN'<
M7AJ6;0Q&)HXN694\/'VF%P.(A3PGLJD*ZKSY8XF$:<YX;$3FJ,(NI2J>S53V
MT<J/%>&JYE1JRP<J=*=%8651\M6O3<JRG&5-TXW=*3DE5IQBYR:C./,X\C_U
M&Z:_W3^'\Q5#1[Z;5-(TO4[G3;W1KC4=.L;Z?2-2$ U'2IKNVBN)=-U 6LUS
M;"]L7D:UNA;W$\ GBD\F:6/:[7W^Z?P_F*_%&K-I[IM/U3:>UUNNC:[-JS?W
M8ZBO-?BUXIU3P?X(U'6M&,*:BDUI;6\T\:S) ;F8(\PB8%)'5 P17!3<P9@0
M,'XFU7]HGXBZ)I>HZSJ?BN&VT[2K*XO[VX?2=) CM[6)I9",VJJ78+LC4E0T
MC(N1NR/=RSA[&YK0>(P\\/"FJLJ*56=13E.*@W:,*4]/?BE=IM[*RN>;C,TP
M^"J*E5C5E)P4VX1BXJ+;2NY3CK[K>BT74_2.BOQEF_X**&'SG7Q'XIN;>W/A
MA9[NT^'OVFVBD\5:.^O6<+RP:?(GFZ;IT4[:\%+)HTUM<)>.B()6[/5/VVM8
MT6YMH-5\87=G;W_B:]\(:7JA\,6%QINJZ[IEGJ%_JEOI\UG:W,D]OI]KI=[+
M<WAA2WV1AX7E5U)]5\#9PK7GA-;V]^O=VU>GL+[:VM>UW:RN<G^L.!_EK_\
M@-/_ .6'ZST5^;.C_M'>/]?TZWU;1O&%MJ&F7?F&UOK?2---O<K%*\+2V[O9
M)YT!=&\J>,-#,@$D,DD;*Y^R_@MXPUGQKX..IZ])#-J%MJMYI[7$,*6XN(H$
M@DCDDBC B64><R,8E1&"J=H8MGS,RX<QV5X=XG$5,-.FJL*4E2G4<XRJ<RC>
M,Z4-+Q:=G=::6VZL)FN'QE7V-.-6,W"4TYQBHM1LVKQG+6S36EGW/6Z*^+_B
MA\9_'6B>.-<T/1;^UT[3])F@M(HQ8VMS),S6EO<R3RRW,4C[V><J$0A%5%P"
M2QK@E^._Q1=E1=>@+,P51_9.F<DG '_'MZFNBAPGF5>A1KQJ8.,:U*G5C&=6
MIS*-2"G'FY:,DGRRBVDW:]KW3,JF=82G4G3<:[=.<H-J$;-P;B[7FG:Z=KI7
MM<_0VBOR&M_V_$O]/U[5=*\>)K.G>&4U%]:O-'\/Z;J,-G_9NKW&AS(QMHW/
MFS:C:S1VL+!)IX@DXC$;J:]3T#]I7Q]XFT32_$.C^)(Y]+UFS2^L)9=$TZ"5
M[>1F53)!);;XG#(P:-_F4CFNB7!6;PUE4P<=;>]4K+6U[:T+WMK:RTU,UQ!@
MGM&N^ND8/K;_ )^=]#])J*_/O3_CY\2H[ZS:XU:TNX!<P":UETRQCCGB:15>
M-I((8Y4W*2 \;JRG!&<8/Z!(VY$8C&Y5;'ID XKQLTR?%92Z*Q,J,U751P=&
M<I+]VXJ2DI0@T_?BUHT^]T=^#Q]'&JI[)5$Z;CS*<4OBO9JTI)_"T]FAU%%?
M/?QT^)'B3P+_ &!:^'7M;:74_MLUS=7%O'=.$MO)1(8HY08E#-*S2.59SM4*
M5&[=R8'!5LPQ5/"8?D56KSN+J2Y8)0@YR<I*,GI&+T46VVDEVVQ&(IX:C.M4
MYN2%KJ*YI-RDHI)775]6DD?0E%?F+XP_; \0> 1HA\5^+]*TIO$>HW&DZ)')
MHUB\NH:C;:;=ZM+;0QK%G<+*QN'#MMC,@CA+B25 <'PS^V_K7BS6['P[I>M7
M<&JZEI\FI64.J>$K&RCGAALXM2E@659+A5O$TV>'4# P53:2*PE,H:%?I%P5
MG#CSJ6#<;-\WM:MK+=W^KZVZVO;J>7_;^!3M:O?MR1OKM_R\Z].Y^K%%?(/P
ME^,OC3Q)XTL- UZXLKZQU*"[ ,=E#:36TUO";A)8WMPH<,$:-XY%8$,&4JR\
M_7U>!F66XC*\0L/B73<Y4XU8RI3<X.$G**U<8--.#33CV:;3/2PN+I8RFZM'
MG45-P:G'EDI))[)R35I)II_B%%%%>>=)^?/_  4:_9!_9H_;%^$/A7PA^T[H
M7B[Q%X9\%^.[?QEX5TSP;XMO_!VH2^+&T+6O#\;76HZ?EY;!-)UG4S-!*K('
M\N95:2-!7XH?\.2/^"6__1&/C'_XD#XJ_P#D"OZ)OVFO^1+T?_L8[?\ ](;Z
MOAZOU7A&>)IY-#V>.S&C"6)Q35*AC\3AZ,&ITTW&E1E"*E-^].3YI2E;5))'
MQV=^S>.?-A\--^QI7G4P]*I.6DK7G44G:*TBE9)=[W/RZ_X<D?\ !+?_ *(Q
M\8__ !('Q5_\@56M?^"*O_!*F_EO+>P^$WQ6OKC3IEMM1M[+]HWQ#=SZ=<N@
MD2VU"&WM9);*X>,B1(+I(I6C(=4*D&OU/!P01V(/Y5\#_&KPE\ M$\1:Y?\
MC3Q9\8/">H?Z0=5U+PEJNJ&SF;QC%%;P1QPPV%U:-%!<:G%):V"D06UP)YYX
M)8Y[E;CZRC/%U9.+S/.4[)KDS+'U&]4G=*O%VUZ-N]M+'C3=.*NL+@7WOA<-
M'[G[-GE\O_!$O_@EG  9_@Y\7X WW3/^T+XGA#85F.TRV2ACM5FP"3M5FZ*Q
M&78_\$:/^"2^J2I!I?PX^(NJ3RV[W<4&F?M-ZOJ$\MI'*8)+N.&SCFDDM8YP
M8'N45H4F_=,XD^6O9]"G_9Z\5:-:> ]'\7_$[7([+Q%X[U^37KF]:#5],\3^
M'M*DTK4-6O)[B&*74)M#L],NK7P_:2:;=Z&PU&=[Z&5FB2W[KX(^"_A8_B+P
M_KO@KQ+\1M4N/"OA6.RTT>)+/0K'1]5TQ[%]'W_:-*T6R_M2]TBVNX;>[2UN
MULX[IK2YE2[N@;BM9+%0C-RS/.TXW:3Q^8137V7*^(;CS/36[6^JVE3IMI+"
MX!I]L-AF_.W[O6R?Z'SI_P .2/\ @EO_ -$8^,?_ (D#XJ_^0*5?^")'_!+7
M<-_P8^,NS(W;/V@?%);;WV@V(!..@) SWK]1**Y?;XS_ *&6;?\ AUQ__P M
M-+4O^@7!?^$>'_\ D#Y4\,?\&X?_  2G\5Z#IGB'3?!?QJ6SU.W$\23?&GQ4
MLT3!VBEAE RN^&:.2-BI9&*[D)4@G>_XAHO^"6O_ $)GQE_\/5XK_P *_:7X
M'?\ )+O"O_7O>_\ ISO*]8K\MQW$W$F'QN+H4^(,Y]G1Q->E#FQ]9ODIU9QC
M=V5VHI)NRO:_4^QP^5974H4:DLNP7-.E3G*V'@ES2A&3LNBNWH?@%_Q#1?\
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M **3&[7_ .1CCMO_  G#ZSPY_P!"NC_X34/_ )8>!_\ $-%_P2U_Z$SXR_\
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MK27,.FI;^.]2CM[N6TTF\UV>..^N?"L%B'72-/O+]5>Y4RP0DQ!V>-6D\/\
M_!R3XW\1Q7-_H/\ P38\)7NGZ;?Z;I^I:P?'&IP:)H]_JMR;72[?6]8O?"<.
MDZ0][=J;> :I=6R/,/+)!XJ*F%X@::?#DZ;A9R<<SR>#2E>,5)/&-)-Q:CIS
M2DFDI-6*C/+T[_VG"2>U\+CFM+-M?N%JDU?HDULG<_L4^"<,L'PP\*)-&\3M
M:7,@5U*L8Y=0NY(GP<';)&RNA_B5@PX(->J5_%LG_!U3\7X8BD7[!FGI!;62
MW?[KQ]XC%O%IR[D2[5H_!WE+I^(V6*Y0_9F5#Y<A45D?\1:'Q _Z,O\ "O\
MX=C4_P#YF*_/L3P#Q?BL3B,0LIC'V]>K6Y5C\!+D]K4G-1NL3K92M>RO9M+M
M]/2XBR6C2I4GC&_9TX0N\/B%S<D8QO9T^MKVN[71_61^T\#_ ,(GX?..!X@
M)[ FPNL GH,X./7!KXG5]K!E;#*0RD'!!!R"#Z@\BOY_M4_X.N?%NMVC6.K_
M +$'@K4K-V5VMKSXHW\\6]#E'"2>%F"NI^ZZX89.#R:YC_B*%/\ T8!\-_\
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MIF!:R*8]4,CR7<\4?XU_\10I_P"C /AO_P"')O?_ )EJ/^(H4_\ 1@'PW_\
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MR_\ !V=X^151/V+?":(JA55?BOJ2JJJ,*JJ/"X 4      # XI?^(M#X@?\
M1E_A7_P[&I__ #,5^>5O#WC"K6JU?[(4?:U:M3E^O8%\OM*E2I:_UA7MSVO;
M6U^I]1#B3)80A#Z[?DA"%_85U?EC&-[>SZ\M_F?VP45_$_\ \1:'Q _Z,O\
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M_P":*O\ 2DHH_P"(K\3?\^<I_P#".K_\UA_J?E7\^,_\'0_^4G^:W_Q#P?\
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)G\/YBG44 ?_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>15
<FILENAME>image_008.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_008.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" $M G # 2(  A$! Q$!_\0
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MC,>"-%U32KG2=(NK#1]2\:7MGJ>M6.L:W=0>&-,T.X\/S7=VS:E(;?\ 3?\
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M:HTE*$E2I*5-35.2ITU*FJEG-0DJ:<%-I<Z@XJ=ES*04445P&@4444 %%%%
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M>KE.3[)?Z"G[ '_)D/[*/_9!/AE_ZBVG5]>U\A?L ?\ )D/[*/\ V03X9?\
MJ+:=7U[7_,%XE?\ )R/$3_LON./_ %L>*C_?'@7_ )(?@K_LCN$__68X>"BB
MBOBCZH**** "BBB@#\>_^"XGB;]KK0OV';K1?V-/$#^"_B)\2_BY\+_A-XI\
M?6=W<Z=K7@;P!\1=9F\-ZEKNB:I8J]_HMU+KUYX<T:[US3HY=0TG2]5OKRT6
M&1/MEKP/_!%;X/\ Q]^ WPNU'P!^T!^T'\9?CAXRO?"?A?Q#K]C\3O&"^/=
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MX>CTKQ)>:;9VULUYJFA3RZ;>2SO"BN7EG@,[B0[O-=V/.*^NXV\(./.'N'>
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MKY_H*VNKO?:SV;71[:?=N?05%-4DCGGDXXQP#CI^%.JAA1110 4444 %%%%
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M*=6-7^NVOY@_^"BNJ?\ !2/XX?\ !6'X':+_ ,$V;;X9^5^Q[X(\->"OC_\
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M^&'C[QS^SEXF?X4>--(U#Q_J&H>(/',/CSPSI$]AX>M]7U6*W-O-X@>#1GT
M0:M'J9WN@_JMU*_M=)L+_4[^1XK+3+2YOKR6&WN;R2.VM(FFG>*TL8;F\NG6
M-&*6]I;SW,S82&&21E4\>34XT</B(*5*36+Q#E[)R<(WFW&*<J-%M1BE%6I\
MJ<)*+DDI2JK)U/9RY*D.:"M"K%0J)IR7O052KRWY>9>^VXRA)\KDXQMT5Y]\
M,/B-IGQ7\'V/CK0]!\8:!H.L7%Z-#B\<^&[_ ,'Z]JFFVEU):PZXWAG6$@UW
M2-/U-HGFTV#7;'3-6DM=D]SIMIYJ(?0:]>,E**E%WBU=-;-=]4OR1DTT[/=;
MA1113$(W0_0_RK[2\/\ _("T7_L%:?\ ^DD5?%K=#]#_ "K[2\/_ /("T7_L
M%:?_ .DD5?#\<_[KEW_837_]1X'I9;\5;_##_P!*D:]%%%?FYZP4444 %%%%
M 'QA^U+_ ,$]/V,?VTYM*OOVF?V>_ 'Q4UK0K5K'1O$NLZ?):>*--L#(TW]G
MV_B'2Y[+5OL!E=Y!9RW;VR/(S1Q*7<GX^3_@@'_P20C "_L<>!WXQE]9\7L<
M#L2VOG/_ .KVK]D*/\_Y_P _RI\]6,;0G**5VHW=K]][*^^B6^K$UY?E^J_K
MIJD?YQ__  5(_8S_ &=?@'_P6Y_8P_9J_96^&&C_  Y\(ZMJ?[.>H>(O"N@S
MZC>0S^(-7^)UW?ZCJ<IU&[O9Q,_ANTM&EC\U8_+MPZHI+$_Z-RJ$544!550J
MJ.@"@!0/8 8K^4_]M[]D7Q9X:_X+C_!?]N&T_8R_:O\ VCOAOX2\$>$?%GB#
MQ]\'-7\'ZII?AWXD>'[76O"_A?0;#P'XAO-(EUK1M)TI+;5-=M[;5+.Z^W:C
M'=PS,(I%;^I7PUK4WB'P]HFO3Z)K/AR76=,L=2DT#Q#;P6FO:,][;I.VFZS:
MV]S=V]MJ5D7\B]@AN[B.*='1)I NX]&(J1G&A&,^?DI^\W%JU2;YIK7>S2]Y
M:-ZID4^;WW*+B^9QC=Q=X1^%KEV3NW9V:;=T;M%>.?#GXJZS\0O%OQ#T.3X4
M?$/P/X=\"ZC9Z-IWC'QWI]GHEGX^U&6.66_NO!FEQW=YJ%[X=TY!!%_;U\+%
M+R[E>"VLV2!IV]CKF- HHHH **** "BBB@ HHHH **** /YXO^#H;Q/=^'O^
M"3/Q$L+:1HX_&'Q:^$'A6^4$@2V<FOW.O-$V",J;C0;=R#D909%+_P &P_AN
M*T_X)%_#*/4+6"YMO$GQ2^-.MM;W,*3P7%O=^-)[>+S(95:-U9;%2592N1GG
MK7VI_P %0?@E?_M;? GQ=^S1JO[+6M?&WPYKAT#Q'H?B5?&FC>'-%T#Q=I4\
M[V6K);+XBT779]1T:":\B@C<-ILLU]'),D\<3(/IO]B3]EOX>?L:_LR?"W]G
M_P"&.@ZAX9\,^$=#CNYM%U/6)=?O+'Q%KY&L^)XGU69G:Y0:[>7WE%7>)(]J
M0NT2H:^AQ>45L%P]EV9UL7E;69X[$4Z& H9E@\5FE.CA\-2K?7<9@L-6KU<!
MA:LZKPM#Z[]7Q-7$4JJ6&5*,:T_ P>>T,=G^99-1P6;1GE6#PU?$YCB,KQF$
MRBK6Q.)K4%@<#C\51H4LPQ=&G26*Q'U'ZSA:6&K46\4ZTIT:=3XM_L#?L2_'
MFY-]\8OV4?@#\0]0,:1'4_$GPN\(WFJF.,L44ZH-+CU A-QV_P"DY P <  >
MO?!CX"_!7]G3P=%\/?@/\*_ ?PA\$17<U^/#'P^\,Z5X7T>2_N JSW]Q::5;
M6R75],J(LMY<^;<NJ(K2E44#UJBO <I-6<I-=G)M?<VU^![UEO97[V5_R"BB
MBI&%%%% !1110 4444 %%?!'[;__  4#^&O["T7P]E^(?@[QGXL7XBSZ[!I8
M\(KI+&R;08;*:Y-[_:E]9<3+?1B'R/,.5<N%&"?@+_B(,_9I_P"B._&C_OUX
M3_\ E[7[5PE]'3QOX\R# \4\'^&_$&?\/9F\2L!FN!>5?5L4\'B:N#Q*I_6<
M[P=;]SBJ-6C/GP]/WX/EYHVD_P MXD\;/"GA#.,7P_Q+QQDV3YU@50>+R[%K
M,/;T%B:%/$T'/V&58FE^]H5:=6/+6G[LE?E=XK]]**_ O_B(,_9I_P"B._&C
M_OUX3_\ E[1_Q$&?LT_]$=^-'_?KPG_\O:^D_P")1?I*?]&?XJ^_(_\ Z)#P
MO^)DO O_ *.9P[]V;?\ SC/WTHK\"_\ B(,_9I_Z([\:/^_7A/\ ^7M'_$09
M^S3_ -$=^-'_ 'Z\)_\ R]H_XE%^DI_T9_BK[\C_ /HD#_B9+P+_ .CF<._=
MFW_SC/WTHK\"_P#B(,_9I_Z([\:/^_7A/_Y>T?\ $09^S3_T1WXT?]^O"?\
M\O:/^)1?I*?]&?XJ^_(__HD#_B9+P+_Z.9P[]V;?_.,_?2BOP+_XB#/V:?\
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MQSCDV"Q\:?LYYUC\;3CA<OEAZM187&TU1QOU7&0K8>I5;H5:T/ZSZ^4/B/\
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MMA_:VJV]A<744=]<:7I/GVQU*^MK,SW%O9_:(%GDB6-YHU8L/ZI?V&_VN_\
M@GSXN^-_[,7@3]DSQ+-_9GP^^$/Q T?Q5_PE^AS^#O$NC6LD%NTNM^-]0UV2
M'3KFYUK7IY;T0:9J5_MN-1=;:".WA*)_:?[1VAP/'%<(XC!XC'T_$:I@L53S
MC"Y50PU7 U^$X1B\LK\4593A4PV(IYA]9HY).FJN*KX!XR-6G' T<-67\J?0
MAJ<2RI\1T<71P$^#J>*PU3*Z^8UJ]/'4>(I.2QU'A^G&,H8BC4P?L*N:QFX4
M*6,6&E"<L55KTCTW]O3]J2;]EKXP6?PVT"U^+FK64W@VR\4SW5I\?/%>CPW
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MI1C*/I4?QG^,,7BR;QXGQ6^(R^.+G3H](N?&(\9^(!XFN-*B6-8M,FUK[?\
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MGPWMKBST?Q/H=Y:W%W#'9NFIW,&F7]UJ,,,=Y-<+?Q'[1=X:-E^>OBK]I/\
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M/,U7KK#4*>&H*:P^;X6C^ZH4J=*/+0A[L5?FE>3_  "_XA[/V</^BX_''\O
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M\V\@V>A6#7L5HEZ 6N]1+6\&X038ZCQ#\$/!UMK/B;P7X;\9:O=^//"WAO\
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M+J"?4VFG>WM[*1W5/.MG1L_6_P!G6\70?"6K>%_$'AC5[[7? %YXRET.37;
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MN]/M1::TOB.P\/O#?K=(YO;?[1=F 164D4HE,<QD,"O72>,/C;?>,8M-ANM
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M*_X5]$?LEQH/VD/A$0B CQ-+@A0"/^)-JO0XR*^>J^B/V3/^3D/A'_V,TO\
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M5TTW1[9M3TR[93FE_=^__@_>!^ZW_"2:9_?F_P"_)_QH_P"$DTS^_-_WY/\
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M)KFAI%N*E9R/V7_B$_AA[S_XAUP):-O^:1X>UO;_ *EFF_7LSZ@_X4S\"?\
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MNRC_ .@<_>ZW_9B_9+NPS6GPYTBZ5" [6VKZ].$)&0&,6N.%)'(!P2.E6/\
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M+"S\026C:E8F%[.#4WMF']CZ?DQ-;J8B-V0=AQN#9YS7@']F>,?^?#Q5_P"
MVL__ !%?G6-XHRG"8S%83_4[ U?JV)KX?VBHX>*J>QJSI\ZC_9DK*?)S)<TK
M7MS/=_P9Q7X_>&W#/%'$G#<?HM\)9A'A_/LXR2./AEN44H8V.59CB\ L7"E'
M@&O&G'$K#*M&G&O64%4455J)*<OW1_X9A_9,_P"B<Z1_X-]>_P#EY1_PS#^R
M9_T3G2/_  ;Z]_\ +ROPN_LSQC_SX>*O_ ;6?_B*/[,\8_\ /AXJ_P# ;6?_
M (BN7_7#*O\ HB\%_P""L/\ _.L\#_B9GPW_ .D4.%?_  ARG_Z7A^Z/_#,/
M[)G_ $3G2/\ P;Z]_P#+RC_AF']DS_HG.D?^#?7O_EY7X7?V9XQ_Y\/%7_@-
MK/\ \12-IGC':W^@>*CP>/LVL^G^Y1_KAE7_ $1>"_\ !6'_ /G6#^DSX;I-
M_P#$J'"NB;_W'*>B?_5O#]V%_99_948!E^&-@RGD,NH>(V4CU!&LD$>X-*/V
M5OV5CP/A?8D^@O\ Q)_\N:F^!:3Q_!SX:I=+,EPGA'2EG2Y$BSK((CN699?W
M@D!^\'^;/6O"_P!MSQ5\2/"WPY\%/\/_ !)#X(L-:^)-GH_Q#\=7-UJVG6?A
M+P:?"7B[4+>_OM6T+2-=U?2;2_\ %]AX7T:2]L=-E=GU".SDEMX;N2=/TK#9
M;E&(H8>O_8V60]O0HUN1X'"MP]M2IU>1OV$;N/M.6_*KN-[*]E_?V1>&_A9G
M61Y+G+\+> \(\XR?*LU>$EPEP]4EA7F>6X#,'AI5'E%)SEAWC70E-TJ3FZ3D
MZ=-R<(^W?\,K_LK?]$OL?_ _Q)_\N:/^&5_V5O\ HE]C_P"!_B3_ .7-2_ C
MQ#X@\6_!7X6>)O%=GK-AXEUKP3HU[K=MXAC2+6_M_E-!)=:DD=K8J)M22%-3
MC)L;.5[:\@DGM+>=I(4]7K7^R,H_Z%&5_P#A!A?_ )2>I_Q"3PK_ .C:\ _^
M(?P]_P#.L\C_ .&5_P!E;_HE]C_X'^)/_ES72>#_ -GC]G;PIXGT;Q'X4^']
MII7B/2;LW.D:C'>:[(]I=&":$R*ESJDT#$PRRIB6)UPQ.,X([BM+1_\ D*6/
M_78_^BWJH95E4)PG#*\MA.$XRA.&!PT9PE&2E&49*BG&49)2C)---)III&^&
M\+?#/!XC#XS">'G ^%Q>$KT<3A<5A^%,AHXC#8G#U(5J&(H5J>6PJ4:U"M3I
MU:56G*-2G4IPG"491BUW.IZ5'J?DB25XA"7("!3N+@#G=TQCM67_ ,(K;?\
M/U/_ -\Q_P"%2>(KVZLQ:&VF:(R-*'VA3N"JI&=RGH3VKF5UG56(5;N4LQ
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M*BZU:L[4H*4XPBY^Y4T<YPBO<EK);;K[>'A2Q!!$K*1R"MO "#Z@@ C\*?\
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M /\ $U^K?\1^\6_^BRK?^&K(?_G6?&_\0TX)_P"A%#_PKS'_ .;#^:_]D/\
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M0E5PN)C&-:G&I4I.2A4A4BE.GRSC:=.#]UJ]K/1L_E)_XAZ_'O\ T<MX<_\
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M_P#XFC^V=+_Y_(O_ !__ .)K]P_XF9\5/^@[A_\ \1W!_P#S:?GW_$).#O\
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M^;?_ !-'+'^;\@/.?L]Q_P \)O\ OT__ ,31]GN/^>$W_?I__B:]&_MK2O\
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MX)&"1G;C(!%'+'^;\@/./L]Q_P \)O\ OT__ ,36CI$$ZZG9,T,JJ)B2QC<
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M(/\ X&Z;_P#(%?VH?\,8_LU_]$"^!7_AJ/!O_P IZ/\ AC']FO\ Z(%\"O\
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M -]24?\ "4WG_/O;_P#?4E<QD>H_,49'J/S%'-+N_P"OD!T__"4WG_/O;_\
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M$EO/^>%O^<G^-<YD>H_,49'J/S%?4\D>WXLY>2/;\6='_P )+>?\\+?\Y/\
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M9?\ /K!_W[7_  JW119=E]R_R J?8++_ )]8/^_:_P"%'V"R_P"?6#_OVO\
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M ,I#ZEB?^??_ )-'_,\':PLL'_18.A_Y9KZ?2OM+P_867]A:+_HL'_(*T_\
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MU_PH^P67_/K!_P!^U_PJW119=E]R_P @*GV"R_Y]8/\ OVO^%'V"R_Y]8/\
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M)OAY\1?A]XG\6:II][X8NI[:2TFNKK0S%IFN:,CB$I%;E9FN"U=1??'KX/\
M[0W@WXW?&/PU\%/ T6B?LD^,_"'Q$\"V/C;5-.^&/AKQ;J_Q'^'+)XFUKXRZ
M?=Z)=6RR^'K;5]4MQ8)%JM[K%]8V1L9+FXN+96]\^ O[:/P7^,/C[X0_#_QG
M\%)/!'QH\8_ ^Q^+LIN? KZAH_A6RTC[>=.TBS\4SZ!#,+6#0HI]7T74HVAT
M^S@O8M&$L&KW!LV]/,.&> <BP&:9GA/HS9O7J9/'-Z7%>7XOC^&:8_A6'^K^
M3<2851H5\1-U5AN'LUHX_,,YIX'%2RK%9A'+J6 Q&8T5B*?#@L]XPS;&8# 8
MGQURVE#,I9=4X?QF&X.E@,'Q!/\ MG-,CQ'-5I4H*FZ^<X"IA,%ED\70684,
M$\;4Q='!5)4:GAEA_P %AAK?AFWU7PY^S?KNO:VJ^.]5U+2-.^)/A6XTJV\+
M>"_ &E_$N;4K3Q3#:RZ7>ZS%X:U)H-:\,JL>H:1K-JUC*[F:-EV_C=_P4B^)
M?@/]I'X$^ / G@3P]XA^'GQ9^&_PM^(+Z=JUEK,'BV:T^(#:]?:C9VGB>VOT
M\,:-JFB^']'>_P!-T[5;.X;Q#J$,NEV+F:6,CI/ W_!13]C[Q-KNC>#M'^"V
MN^']-UO7--L?#FHZM\/?!6C>'=4T_P")NOZKX03Q39B+4)!;:-XCFT:Z769K
MR"TO+JT"17]M-GRZY6#_ (*<_L_:GXBUN[U#]G?Q#-X,T+P9X"OO GB-/#/@
M_4/$'BCQ%J7Q U3P+X3\(Z+I$EVBZ=:0^(-/NAX>U)]0BLK*6WO9=EDODR3<
ME+@'!4,YQ%3"?1,XCIX;#9/Q$JV5YUQI2Q<L0\]P^&RW(L31EBLXITOK^09I
M*6+PN&RZNL:J4<SABIQ6!JXK!=%3B_%5LKH0Q'TB<DGB*V9Y+[/,,KX8GAXT
MO[)KU\=F]"I&AEDZGU/.,O2PU>OC:+POM'@)8>+>+IT,5QZ?\%HM)U'0=<O-
M-^!EQ;ZF9?#4'A=[[XF>%&T)4\5Q>);^RG\;ZVD45CX+O['2] Q>>']6FCU)
MM=N(]#W13R12MG_#O_@L?=WFG_#[1?%WP@75?$^K^%M&O?%6N:9XGTOPU:R:
M_JW@GQ)X_#>&O!>H-J6OZAX7ATC1(M-F\10W,]C#K4TEM(XV*']:T_\ X*)_
ML/ZA/8V:_!;68/!WB@>$[SQCXNF^$GA0^%/#.L^(]2\2PZ3I_CN.*:2[DUBV
M\2^'M:M ]M8:LG]H![VTN)4E,[8;?\%,OV,+B'2[NP_9Y\::KKT/VK3]'T&T
M^$W@F7Q%;^!+3P9J7CRP\3Z>&U(6]OX2O/"$&JZG%90WL=W:Q?:H9].C>5ED
M]#_43AZI0Q.#H_0YX^@ZM:=>%>KQU3=?"2^HU,#AZ53%U<UI>PI4,31Q.,QF
M$K5*,8.>!S/%<D,PR^E4X_\ 6W.H5:.)J_27X.E[.E"C*E#A*:HXB/UN&+K5
M(X:G@)^VJ5</5H8;#8FE"I*2CB\#A^:>#QE2'Z3?LV_%WQ%\=_@]X1^*_B+X
M<:C\+7\:V%MKFB^&-6UO3->OI/#>HV=I>Z-K4MYI0%M$FL6US]KM[1PMS;VS
M1"Z2.9FC3W:ORVM?^"JO[-VA>%GUF\\#_%7P1X0T&_L=!>36?!FF:'9Z7:ZO
M\.Y_B%\.9(;&VUB:.#3_ (@Z%9MIW@Z"$*TVJ&WT^6&V\P,O<_$W_@I%\)OA
M5K_@3PKX@\ _%6[\2>,O!?@#QM?Z9I>A:5*W@>S^)^K1Z+X+TSQ=+=ZU9BVU
M?4]0=[>:VTZ/44L9D\NYE1B=O\XYUX->)F,XAQ<<L\+L]R3#9IC\\KY-D<:E
M#%QP6 RV,,?B,#3Q^+SRM+%RR?+,9EGUW$U\9*<JV*I-WJX[!827[9E?B;P+
MALFPSQW'V4YK7P&$RFCF>:RA5PSQ6,QTI8.CBIX/#932CAEF>/PV.^JT*6&4
M(TZ%1+]WA,5B(_HA17YB^&_^"F7@X?L^^&?C=X^^%GCO0]0\8?&/QU\'O#7@
M#PRNE>)-=U;4_ ][KPU#4X9YM0TNPM[2VTSP_J$VH)>7,$L-]:S6ELEU$T-P
M_P!V_!CXJ^'_ (X_"GP!\7_"EMJ-IX;^(OAC3/%>B6VKPQ6^IP:=JL(GMH[Z
M&&6>**Y5"/,2.:5%;@.PYKY#B?PWXWX.PM7'<2</8O+<OHY]C^&'F,JN"Q&
MJY[EE.%7'9?A\3A,=B8XB>'A-.5:E2>%FXU84L55J4:U.E]'D/&_"O$U>GA,
MDSG#8[&5,HP>??4HPQ5'&4\IQ\Y0PF,K4,1A*$J,:THV5*I4^L14J<JE"G"K
M2G4]-HHHKX@^J"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ K\7O^"I?_  2^U#]L
M6XT7XO\ P>U31="^-?AK1AX?U+2M?D:RT+X@^'K:66XTVUGU2&*5M*\0:3+/
M/%8:A<Q2V=U92BQO&MEMK:=/VAHK[OPV\2.+?"?B_+>-^"<PCE^>9:J]).O0
MAB\#CL%BZ<:6.RW,L%4E"GC,!C*48PK493ISC.G1Q&'K8?$X>C6C\CQQP/PY
MXB\-X[A3BK!2QN4X]TJDE2JRPV*PN*PTW4PN.P.*A&4\-C,+4<I4JL8SBXSJ
MT:U*M0K5:4OXI_AU_P $3/VZO&?BRPT+QIX5\-?##PS%<);WWC#7_&OAWQ#;
M6&FB4M/)I&B^&=3U74KZ;#O):V4D6FP2S-F>XMPSN/Z:-4^%W[.G[&/[$T7P
MM\9>$;KQU\$?!VEZ!X<\5:1<:1I^LZCXQU#Q7XKTNPN=;U33[FZT^SGN+[Q/
MJ\.JW!-W&=-MHT6T=Q8VZ'[PKRKXU_!_PK\>?AQKGPN\:R:G'X;\07&B7%^V
MD72V5^6T'7=-\06:17+13!$DO=+MTN!Y9,ENTL8*E]P_;/$3Z4_'?C=GG!&&
M\2L9A\DX*X=XCR[-\7E7 6&QN35U5I58PQ6=4L4\RQ6:5LZPN$=7^R:D,;0A
ME]:K5JX.G#$U9XI?EG!/T?>$/"C*N*J_ N%K9IQ3G>2XW+L/F'%]?"YG2=.I
M3<J&5U*'U'#X"EE>(Q"IO,82PM:6-IPA3Q4YT*<<._A?0=8_X)4Z+IWBK2/#
MU]^S_8:7IMVWASQ5:6$C+9QS:=?W7CL6MR4S'<6D6J^&+O68+RW::QFU+1YX
M8+F6Z@:"K5IX[_X)6V&M^ /%D&L?LWQ:WIE]_P (;X"UJYM["26VO/%D)U\:
M;;3WML\3"ZC\3&\%U?AX=,?6!%]ILI9Q%4$O_!)/]DRX\.>+/"UW:^/[W2_$
MU_X5DL%O/&$\\W@SP_X/US6?$&D^#?",IM0=/\,MJ'B/Q +VUN?MMU=6NJS6
MTEWY<<6U1_P23_9'33/"NEPZ5XRM8O"GCOQ+XV@FL_$@MY]5A\4:M8ZQ=^$=
M986+I=^%;*XTO3H-*LXXX+RPL[;[-#?!)9,]4^(? VM+$3K^,7TDZL\37JT:
MTW1PLI8C!XC)*E*O5Q$ZG$[JUI5\6X997PU1U%/ RJIU*V$C3E/*.2^*].-&
M-+PT\#J<:%*E4I053$)4<31S6%2E3HQAD*ITXT<,I8^C6@H..+5.T*6(<U%4
MT[_@E;:?#OQ3KT.F?L^P_#SX<^,]:\,^([Z#3@EEX?\ 'GB>2"RU31XA% +V
M3Q%>'1+=+:#2TN+RSATV*73?LT%NLB^F>"?BA_P3]^&GB#Q#XL\">+/@OX6\
M0_$!_#UEXC\0Z1/##<^(DUSPU?\ C;0?MNHA'1['4?#MAJ.O_:O-CL9A;7%Q
M>S&]5JL:A_P3\^!%[\%(?@A;OXOT;1=-^*>M_&7P]XHT/6XM-\9^&_'NN:QK
M>K3:II>L16+1.EK%XAU31[2WO[2]2/1YQ:'<T44J<Q_P["_91.L>'=2;PQKL
MEGX=^"=W\"H]#EUZ>32]4\,W6GZII2Z_JZF'[1>>-K33]8OK:Q\2^?'<VB2(
M($145:\&KQ#X2YGALSP^=>)_C[BJ&)S'.:4<'6J8;,J./R>C2R#%Y35QT,=G
MKPU3%9MFL,UKXK#UJ=2E@*F6Y7+$+$RE2QZ]:GDWB)@*^ K97P%X/X>M0P66
M5'B:4*^!JX/,JE3.,/F%/"2PF4*O##Y=E\LNI8>O2G"IBX8[,(T/8I3P;\YT
M?6?^"2,FD^"[C2KS]G&?2-4\5^)?%O@QY%6>W/BKPRMM>^*;^V%ZCFQFL4EL
M]0U.RO!;VEPCVNH/:SJ89ZXSXK_M/?\ !,73=!\=ZPW@OPQ\9-%^,=_>:]\4
MKGX?^$-/UP:OKWP^T:SUJPN?%#:O?Z#/;ZTFFWR3Z)<6>))";AY)X2[/)[7X
M'_X)=_LP>!M/MM-M[/Q?KT"^#OBCX*U"7Q'KL&H7>K:;\6;+1=-\07ES<)IM
MN8-6T^PT#3K?0;^R6VET[9)+^^EE=CR$?_!)+]FXZ-J.CW_B?XO:S_:KWCWN
MIZOXRM[S59A=^%=.\&B,W0TB(>3::'I=E;V<?E_N?)4DN.*^IP7%'@)'-ZF*
MS/Q1^D7FF$PF-H/"K$XW%86OC<+/,ZN/J5?K&6YU/'8#$8+$8#)LRIVJ<V)S
M*G1Q<8TZN'DZ'@8G(?%UY;##X#@'P5P&(Q&%K+$>PPM#$4L+B(Y?#!PI^PQN
M5PPF,HXJCB\SP$[PM0P%2KAVYTZZ5;T#Q7J7_!.KP99^,_@]XTM/@[X8C\6^
M#/"/Q$^(/PUU#31"UWX2\-Z7:+X5UKQ#HUA#/!'!H>EVUN\&"'AMK62^=7AB
MEN:Z_P ,?'[]A/X;ZAX;\!>$O'?PA\/:MI<-U\-O"FDZ7'"VHQ6,20>)KKPG
MH^H+9S3RZ3YFIVU^]G#?2:8VH7<41S?,(AQW[0'[(_P=T_5OB#^U7J-KXEUW
MQIX,_9^\:>%4\+WOB&>'P+KVD:?X U?15@\0:+:012ZDL^ER26\T-Q=O:B8I
M>PP17<4<H\B_9N_X)T? Z]^ W['>L:O?^,)-?^%FB:;\1;?4M#UJ70(_%'B/
MQA-9>,-2E\2Q1F]O+NW%_P#8[-8(M3A633;&.SE+12,H^?IT_"G,>#:.=9_X
MA^,U>A7QN'P&9X#FHXW!/C+$<'9]F6,E2H8S,JU3%8'#4LJX1R5YC7OB\7E^
M:U%.;IY%+#S]F<_$'!<35<LRC@SPRI5:6%K8O XRU7"XI<,T>)<GP6&C4JX7
M TH8?%UYYAQ)FBP5)_5\-C,NIN,5/-E6C6\ ^*_^"2?CS0M.NM,T/X(^'Q\?
M=1U:.'PWXIT./PYK?BV]\*^*[VXN)+K29R1:I%XDM+FZTJ8R6T-W.3!8-(YD
MM5Z?0O$W_!)GQRWA_P"'.BWO[.>MR:O86_PK\.^&?LT8EGT_5-:FU^P\-6<=
MW!%)#!-XA::[TRX,D2PZN[P6%W%=OY)Z,?\ !*W]E]O$/@_Q#.?B'>/X*NO$
M3Z5IMYXN:YTR;2]=\2:GXNMO#]]!+8,\VC^'O$&L7][H<,<L-Q"LJV]S<W4,
M:(.HM/\ @F_^S[96?ARS@?Q>H\,:5\&](L+C^UK,74D'P0\8W?C;PG/=3KIJ
MO+=W>KWDD6NS@JVHV216Y$>P/7J9CQ=X-U)SJX#Q9^D>I5'B,3A:6(S&<X97
MBX?6<-EMZ];.Y8K,50R[#9'A*U>/U'$RAA:L*56%)8:CA?/P7#GB93A"GB_#
MOP2:A[&AB*E'!1A+'X:2H5\=:C2RI8?!.MCJ^;XBE1E];H1EB*4ITY5'B*M?
M#U'Q7_P3-\)Z]XK\ :E>_ K0M<^%\.D3^+/#$UB+/_A'$^#DQN-)%Y9BU2SG
MF\'3:T]RL$0NK@?;Y[F>.X5YI!Y3X$^)/_!,2&Y\6I:^%O@?X(\+Z1\0WT3P
MMXKCFT9K/XA:_P#$GP+)'X@U'1+/2'FUFRL7\/:G?:%?'6+:UL+>PEEFM?L]
MC<I*_"?#O]@?X/\ [1?Q)_;+\4_%#6/&VH/>?M%?&'PUI6BZ5K?]EZ!H"^(M
M$\(QW^OV&G>1<K)XG-HK6(U2:0PFU8*;$2(LE?57BK_@FY\ /$_C74/B#%J'
MQ"\*>*]1\0:+K3:IX+\3Q^'7MK+2_!^F>"+SPS:0VNG-;0>']>T72+,ZM;+!
M]I:]5[JUNK9G93V8['^$?#U6MD6<>*/CO6S3$91D6(S7$87&8F>7X#.,5DN0
M9]B*>&IPSJC5S2E5KYYB<&\7C*%=8/#4YRH8?&XO$+&8?FPN#\1\XA2S7+>
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%$4(!_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>16
<FILENAME>arbe-20231231.xsd
<DESCRIPTION>XBRL SCHEMA FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!-- Generated by CompSci Transform (tm) - http://www.compsciresources.com -->
<!-- Created: Thu Mar 28 12:24:34 UTC 2024 -->
<xs:schema elementFormDefault="qualified" xmlns:srt-types="http://fasb.org/srt-types/2023" targetNamespace="http://www.arberobotics.com/20231231" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:us-types="http://fasb.org/us-types/2023" xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:arbe="http://www.arberobotics.com/20231231" xmlns:dtr="http://www.xbrl.org/dtr/type/2022-03-31" xmlns:xbrli="http://www.xbrl.org/2003/instance">
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xlink:type="simple" xlink:href="arbe-20231231_lab.xml" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef"/>
      <link:linkbaseRef xlink:type="simple" xlink:href="arbe-20231231_pre.xml" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef"/>
      <link:linkbaseRef xlink:type="simple" xlink:href="arbe-20231231_def.xml" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef"/>
      <link:linkbaseRef xlink:type="simple" xlink:href="arbe-20231231_cal.xml" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef"/>
      <link:roleType roleURI="http://www.arberobotics.com/role/ConsolidatedBalanceSheet" id="arbe_r_ConsolidatedBalanceSheet">
        <link:definition>995301 - Statement - Consolidated Balance Sheets</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.arberobotics.com/role/ConsolidatedBalanceSheet_Parentheticals" id="arbe_r_ConsolidatedBalanceSheet_Parentheticals">
        <link:definition>995302 - Statement - Consolidated Balance Sheets (Parentheticals)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.arberobotics.com/role/ConsolidatedIncomeStatement" id="arbe_r_ConsolidatedIncomeStatement">
        <link:definition>995303 - Statement - Consolidated Statements of Operations</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.arberobotics.com/role/ShareholdersEquityType2or3" id="arbe_r_ShareholdersEquityType2or3">
        <link:definition>995304 - Statement - Consolidated Statements of Changes in Redeemable Convertible Preferred Shares and Shareholders&#8217; Equity (Deficiency)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.arberobotics.com/role/ConsolidatedCashFlow" id="arbe_r_ConsolidatedCashFlow">
        <link:definition>995305 - Statement - Consolidated Statements of Cash Flows</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.arberobotics.com/role/General" id="arbe_r_General">
        <link:definition>995306 - Disclosure - General</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.arberobotics.com/role/SignificantAccountingPolicies" id="arbe_r_SignificantAccountingPolicies">
        <link:definition>995307 - Disclosure - Significant Accounting Policies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.arberobotics.com/role/Revenue" id="arbe_r_Revenue">
        <link:definition>995308 - Disclosure - Revenue</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.arberobotics.com/role/PrepaidExpensesandOtherReceivables" id="arbe_r_PrepaidExpensesandOtherReceivables">
        <link:definition>995309 - Disclosure - Prepaid Expenses and Other Receivables</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.arberobotics.com/role/PropertyandEquipment" id="arbe_r_PropertyandEquipment">
        <link:definition>995310 - Disclosure - Property and Equipment</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.arberobotics.com/role/Leases" id="arbe_r_Leases">
        <link:definition>995311 - Disclosure - Leases</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.arberobotics.com/role/CommitmentsandContingentLiabilities" id="arbe_r_CommitmentsandContingentLiabilities">
        <link:definition>995312 - Disclosure - Commitments and Contingent Liabilities</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.arberobotics.com/role/WarrantsLiabilities" id="arbe_r_WarrantsLiabilities">
        <link:definition>995313 - Disclosure - Warrants Liabilities</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.arberobotics.com/role/ShareholdersEquity" id="arbe_r_ShareholdersEquity">
        <link:definition>995314 - Disclosure - Shareholders&#8217; Equity</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.arberobotics.com/role/NetLossPerShareAttributibletoOrdinarySharholders" id="arbe_r_NetLossPerShareAttributibletoOrdinarySharholders">
        <link:definition>995315 - Disclosure - Net Loss Per Share Attributible to Ordinary Sharholders</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.arberobotics.com/role/TaxesonIncome" id="arbe_r_TaxesonIncome">
        <link:definition>995316 - Disclosure - Taxes on Income</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.arberobotics.com/role/SegmentInformation" id="arbe_r_SegmentInformation">
        <link:definition>995317 - Disclosure - Segment Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.arberobotics.com/role/AccountingPoliciesByPolicy" id="arbe_r_AccountingPoliciesByPolicy">
        <link:definition>996000 - Disclosure - Accounting Policies, by Policy (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.arberobotics.com/role/SignificantAccountingPoliciesTables" id="arbe_r_SignificantAccountingPoliciesTables">
        <link:definition>996001 - Disclosure - Significant Accounting Policies (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.arberobotics.com/role/RevenueTables" id="arbe_r_RevenueTables">
        <link:definition>996002 - Disclosure - Revenue (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.arberobotics.com/role/PrepaidExpensesandOtherReceivablesTables" id="arbe_r_PrepaidExpensesandOtherReceivablesTables">
        <link:definition>996003 - Disclosure - Prepaid Expenses and Other Receivables (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.arberobotics.com/role/PropertyandEquipmentTables" id="arbe_r_PropertyandEquipmentTables">
        <link:definition>996004 - Disclosure - Property and Equipment (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.arberobotics.com/role/LeasesTables" id="arbe_r_LeasesTables">
        <link:definition>996005 - Disclosure - Leases (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.arberobotics.com/role/ShareholdersEquityTables" id="arbe_r_ShareholdersEquityTables">
        <link:definition>996006 - Disclosure - Shareholders&#8217; Equity (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.arberobotics.com/role/NetLossPerShareAttributibletoOrdinarySharholdersTables" id="arbe_r_NetLossPerShareAttributibletoOrdinarySharholdersTables">
        <link:definition>996007 - Disclosure - Net Loss Per Share Attributible to Ordinary Sharholders (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.arberobotics.com/role/TaxesonIncomeTables" id="arbe_r_TaxesonIncomeTables">
        <link:definition>996008 - Disclosure - Taxes on Income (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.arberobotics.com/role/SegmentInformationTables" id="arbe_r_SegmentInformationTables">
        <link:definition>996009 - Disclosure - Segment Information (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.arberobotics.com/role/GeneralDetails" id="arbe_r_GeneralDetails">
        <link:definition>996010 - Disclosure - General (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.arberobotics.com/role/SignificantAccountingPoliciesDetails" id="arbe_r_SignificantAccountingPoliciesDetails">
        <link:definition>996011 - Disclosure - Significant Accounting Policies (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.arberobotics.com/role/ScheduleoftheStraightLineMethodOvertheEstimatedUsefulLivesoftheAssetsTable" id="arbe_r_ScheduleoftheStraightLineMethodOvertheEstimatedUsefulLivesoftheAssetsTable">
        <link:definition>996012 - Disclosure - Significant Accounting Policies (Details) - Schedule of the Straight-Line Method Over the Estimated Useful Lives of the Assets</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.arberobotics.com/role/RevenueDetails" id="arbe_r_RevenueDetails">
        <link:definition>996013 - Disclosure - Revenue (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.arberobotics.com/role/ScheduleofRevenueDisaggregatedbyGeographyTable" id="arbe_r_ScheduleofRevenueDisaggregatedbyGeographyTable">
        <link:definition>996014 - Disclosure - Revenue (Details) - Schedule of Revenue Disaggregated by Geography</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.arberobotics.com/role/ScheduleofPrepaidExpensesandOtherReceivablesTable" id="arbe_r_ScheduleofPrepaidExpensesandOtherReceivablesTable">
        <link:definition>996015 - Disclosure - Prepaid Expenses and Other Receivables (Details) - Schedule of Prepaid Expenses and Other Receivables</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.arberobotics.com/role/PropertyandEquipmentDetails" id="arbe_r_PropertyandEquipmentDetails">
        <link:definition>996016 - Disclosure - Property and Equipment (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.arberobotics.com/role/ScheduleofPropertyandEquipmentTable" id="arbe_r_ScheduleofPropertyandEquipmentTable">
        <link:definition>996017 - Disclosure - Property and Equipment (Details) - Schedule of Property and Equipment</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.arberobotics.com/role/ScheduleofSupplementalCashFlowInformationRelatedtoLeasesTable" id="arbe_r_ScheduleofSupplementalCashFlowInformationRelatedtoLeasesTable">
        <link:definition>996018 - Disclosure - Leases (Details) - Schedule of Supplemental Cash Flow Information Related to Leases</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.arberobotics.com/role/ScheduleofMaturitiesofLeaseLiabilitiesTable" id="arbe_r_ScheduleofMaturitiesofLeaseLiabilitiesTable">
        <link:definition>996019 - Disclosure - Leases (Details) - Schedule of Maturities of Lease Liabilities</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.arberobotics.com/role/ScheduleofSupplementalBalanceSheetInformationRelatedtoOperatingLeasesTable" id="arbe_r_ScheduleofSupplementalBalanceSheetInformationRelatedtoOperatingLeasesTable">
        <link:definition>996020 - Disclosure - Leases (Details) - Schedule of Supplemental Balance Sheet Information Related to Operating Leases</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
<!-- [WMV5][XcpuxYn59dz7vgYynUDuwG7r97K2jUTysl7vcz0lJt/tSeJz73kx1cLt0ZFF2SK/vxBCY0vdSrZEr5dnmkj55Vn3PE+1u+YOtkjz23BDixtN+DSa6ODpxKHuuFDR2EFRAYrDV15EdRUTOp8hTdByKJ//xoC7ECC663wnKueQq7LbhDBxlm0Wi1xZdy33k9DRJYjt/rCQI8A6bBdr5ony7RknOIsPU1pWTweSc4Wp+IQVoYO/x93rSQOoZayYDA6QITB4v3Q+v8XqtQAZ/+ASkw==] CSR-->
      <link:roleType roleURI="http://www.arberobotics.com/role/CommitmentsandContingentLiabilitiesDetails" id="arbe_r_CommitmentsandContingentLiabilitiesDetails">
        <link:definition>996021 - Disclosure - Commitments and Contingent Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.arberobotics.com/role/WarrantsLiabilitiesDetails" id="arbe_r_WarrantsLiabilitiesDetails">
        <link:definition>996022 - Disclosure - Warrants Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.arberobotics.com/role/ShareholdersEquityDetails" id="arbe_r_ShareholdersEquityDetails">
        <link:definition>996023 - Disclosure - Shareholders&#8217; Equity (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.arberobotics.com/role/ScheduleofStockOptionActivityTable" id="arbe_r_ScheduleofStockOptionActivityTable">
        <link:definition>996024 - Disclosure - Shareholders&#8217; Equity (Details) - Schedule of Stock Option Activity</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.arberobotics.com/role/ScheduleofRSUsActivityTable" id="arbe_r_ScheduleofRSUsActivityTable">
        <link:definition>996025 - Disclosure - Shareholders&#8217; Equity (Details) - Schedule of RSUs Activity</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.arberobotics.com/role/ScheduleofCompensationtoEmployeesTable" id="arbe_r_ScheduleofCompensationtoEmployeesTable">
        <link:definition>996026 - Disclosure - Shareholders&#8217; Equity (Details) - Schedule of Compensation to Employees</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.arberobotics.com/role/ScheduleofShareBasedCompensationExpenseTable" id="arbe_r_ScheduleofShareBasedCompensationExpenseTable">
        <link:definition>996027 - Disclosure - Shareholders&#8217; Equity (Details) - Schedule of Share Based Compensation Expense</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.arberobotics.com/role/ScheduleofSetsForththeComputationofBasicandDilutedNetLossPerShareAttributableTable" id="arbe_r_ScheduleofSetsForththeComputationofBasicandDilutedNetLossPerShareAttributableTable">
        <link:definition>996028 - Disclosure - Net Loss Per Share Attributible to Ordinary Sharholders (Details) - Schedule of Sets Forth the Computation of Basic and Diluted Net Loss Per Share Attributable</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.arberobotics.com/role/ScheduleofOrdinarySharesthatwereExcludedfromtheComputationofDilutedNetLossPerShareTable" id="arbe_r_ScheduleofOrdinarySharesthatwereExcludedfromtheComputationofDilutedNetLossPerShareTable">
        <link:definition>996029 - Disclosure - Net Loss Per Share Attributible to Ordinary Sharholders (Details) - Schedule of Ordinary Shares that were Excluded from the Computation of Diluted Net Loss Per Share</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.arberobotics.com/role/TaxesonIncomeDetails" id="arbe_r_TaxesonIncomeDetails">
        <link:definition>996030 - Disclosure - Taxes on Income (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.arberobotics.com/role/ScheduleofCompanysLossBeforeIncomeTaxesTable" id="arbe_r_ScheduleofCompanysLossBeforeIncomeTaxesTable">
        <link:definition>996031 - Disclosure - Taxes on Income  (Details) - Schedule of Company&#8217;s Loss Before Income Taxes</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.arberobotics.com/role/ScheduleofReconciliationIncomeTaxBenefitTable" id="arbe_r_ScheduleofReconciliationIncomeTaxBenefitTable">
        <link:definition>996032 - Disclosure - Taxes on Income  (Details) - Schedule of Reconciliation Income Tax Benefit</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.arberobotics.com/role/ScheduleofDeferredTaxAssetsTable" id="arbe_r_ScheduleofDeferredTaxAssetsTable">
        <link:definition>996033 - Disclosure - Taxes on Income  (Details) - Schedule of Deferred Tax Assets</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.arberobotics.com/role/SegmentInformationDetails" id="arbe_r_SegmentInformationDetails">
        <link:definition>996034 - Disclosure - Segment Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.arberobotics.com/role/ScheduleofPropertyandEquipmentNetofDepreciationbyGeographicRegionTable" id="arbe_r_ScheduleofPropertyandEquipmentNetofDepreciationbyGeographicRegionTable">
        <link:definition>996035 - Disclosure - Segment Information (Details) - Schedule of Property and Equipment, Net of Depreciation, by Geographic Region</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.arberobotics.com/role/DocumentAndEntityInformation" id="DocumentAndEntityInformation">
        <link:definition>000 - Document - Document And Entity Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://fasb.org/us-types/2023" schemaLocation="https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/2022-03-31" schemaLocation="https://www.xbrl.org/dtr/type/2022-03-31/types.xsd"/>
  <xs:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd"/>
  <xs:import namespace="http://fasb.org/srt-types/2023" schemaLocation="https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/sic/2023" schemaLocation="https://xbrl.sec.gov/sic/2023/sic-2023.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/ecd-sub/2023" schemaLocation="https://xbrl.sec.gov/ecd/2023/ecd-sub-2023.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei-sub/2023" schemaLocation="https://xbrl.sec.gov/dei/2023/dei-sub-2023.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/ecd/2023" schemaLocation="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/ecd-sub/2023" schemaLocation="https://xbrl.sec.gov/ecd/2023/ecd-sub-2023.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei-sub/2023" schemaLocation="https://xbrl.sec.gov/dei/2023/dei-sub-2023.xsd"/>
  <xs:element name="ScheduleOfTheStraightLineMethodOverTheEstimatedUsefulLivesOfTheAssetsAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="arbe_ScheduleOfTheStraightLineMethodOverTheEstimatedUsefulLivesOfTheAssetsAbstract"/>
  <xs:element name="ScheduleOfRevenueDisaggregatedByGeographyAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="arbe_ScheduleOfRevenueDisaggregatedByGeographyAbstract"/>
  <xs:element name="ScheduleOfPrepaidExpensesAndOtherReceivablesAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="arbe_ScheduleOfPrepaidExpensesAndOtherReceivablesAbstract"/>
  <xs:element name="ScheduleOfPropertyAndEquipmentAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="arbe_ScheduleOfPropertyAndEquipmentAbstract"/>
  <xs:element name="ScheduleOfSupplementalCashFlowInformationRelatedToLeasesAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="arbe_ScheduleOfSupplementalCashFlowInformationRelatedToLeasesAbstract"/>
  <xs:element name="ScheduleOfMaturitiesOfLeaseLiabilitiesAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="arbe_ScheduleOfMaturitiesOfLeaseLiabilitiesAbstract"/>
  <xs:element name="ScheduleOfSupplementalBalanceSheetInformationRelatedToOperatingLeasesAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="arbe_ScheduleOfSupplementalBalanceSheetInformationRelatedToOperatingLeasesAbstract"/>
  <xs:element name="ScheduleOfStockOptionActivityAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="arbe_ScheduleOfStockOptionActivityAbstract"/>
  <xs:element name="ScheduleOfRsusActivityAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="arbe_ScheduleOfRsusActivityAbstract"/>
  <xs:element name="ScheduleOfCompensationToEmployeesAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="arbe_ScheduleOfCompensationToEmployeesAbstract"/>
  <xs:element name="ScheduleOfShareBasedCompensationExpenseAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="arbe_ScheduleOfShareBasedCompensationExpenseAbstract"/>
  <xs:element name="ScheduleOfSetsForthTheComputationOfBasicAndDilutedNetLossPerShareAttributableAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="arbe_ScheduleOfSetsForthTheComputationOfBasicAndDilutedNetLossPerShareAttributableAbstract"/>
  <xs:element name="ScheduleOfOrdinarySharesThatWereExcludedFromTheComputationOfDilutedNetLossPerShareAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="arbe_ScheduleOfOrdinarySharesThatWereExcludedFromTheComputationOfDilutedNetLossPerShareAbstract"/>
  <xs:element name="ScheduleOfDeferredTaxAssetsAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="arbe_ScheduleOfDeferredTaxAssetsAbstract"/>
  <xs:element name="ScheduleOfPropertyAndEquipmentNetOfDepreciationByGeographicRegionAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="arbe_ScheduleOfPropertyAndEquipmentNetOfDepreciationByGeographicRegionAbstract"/>
  <xs:element name="UnlabeledAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="arbe_UnlabeledAbstract"/>
  <xs:element name="UnlabeledAbstract0" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="arbe_UnlabeledAbstract0"/>
  <xs:element name="UnlabeledAbstract1" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="arbe_UnlabeledAbstract1"/>
  <xs:element name="UnlabeledAbstract2" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="arbe_UnlabeledAbstract2"/>
  <xs:element name="UnlabeledAbstract3" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="arbe_UnlabeledAbstract3"/>
  <xs:element name="UnlabeledAbstract4" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="arbe_UnlabeledAbstract4"/>
  <xs:element name="UnlabeledAbstract5" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="arbe_UnlabeledAbstract5"/>
  <xs:element name="UnlabeledAbstract6" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="arbe_UnlabeledAbstract6"/>
  <xs:element name="UnlabeledAbstract7" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="arbe_UnlabeledAbstract7"/>
  <xs:element name="UnlabeledAbstract8" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="arbe_UnlabeledAbstract8"/>
  <xs:element name="UnlabeledAbstract9" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="arbe_UnlabeledAbstract9"/>
  <xs:element name="UnlabeledAbstract10" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="arbe_UnlabeledAbstract10"/>
  <xs:element name="UnlabeledAbstract11" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="arbe_UnlabeledAbstract11"/>
  <xs:element name="UnlabeledAbstract12" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="arbe_UnlabeledAbstract12"/>
  <xs:element name="UnlabeledAbstract13" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="arbe_UnlabeledAbstract13"/>
  <xs:element name="UnlabeledAbstract14" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="arbe_UnlabeledAbstract14"/>
  <xs:element name="UnlabeledAbstract15" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="arbe_UnlabeledAbstract15"/>
  <xs:element name="UnlabeledAbstract16" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="arbe_UnlabeledAbstract16"/>
  <xs:element name="UnlabeledAbstract17" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="arbe_UnlabeledAbstract17"/>
  <xs:element name="UnlabeledAbstract18" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="arbe_UnlabeledAbstract18"/>
  <xs:element name="UnlabeledAbstract19" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="arbe_UnlabeledAbstract19"/>
  <xs:element name="UnlabeledAbstract20" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="arbe_UnlabeledAbstract20"/>
  <xs:element name="UnlabeledAbstract21" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="arbe_UnlabeledAbstract21"/>
  <xs:element name="UnlabeledAbstract22" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="arbe_UnlabeledAbstract22"/>
  <xs:element name="UnlabeledAbstract23" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="arbe_UnlabeledAbstract23"/>
  <xs:element name="UnlabeledAbstract24" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="arbe_UnlabeledAbstract24"/>
  <xs:element name="UnlabeledAbstract25" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="arbe_UnlabeledAbstract25"/>
  <xs:element name="UnlabeledAbstract26" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="arbe_UnlabeledAbstract26"/>
  <xs:element name="UnlabeledAbstract27" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="arbe_UnlabeledAbstract27"/>
  <xs:element name="UnlabeledAbstract28" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="arbe_UnlabeledAbstract28"/>
  <xs:element name="UnlabeledAbstract29" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="arbe_UnlabeledAbstract29"/>
  <xs:element name="UnlabeledAbstract30" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="arbe_UnlabeledAbstract30"/>
  <xs:element name="UnlabeledAbstract31" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="arbe_UnlabeledAbstract31"/>
  <xs:element name="UnlabeledAbstract32" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="arbe_UnlabeledAbstract32"/>
  <xs:element name="UnlabeledAbstract33" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="arbe_UnlabeledAbstract33"/>
  <xs:element name="UnlabeledAbstract34" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="arbe_UnlabeledAbstract34"/>
  <xs:element name="UnlabeledAbstract35" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="arbe_UnlabeledAbstract35"/>
  <xs:element name="UnlabeledAbstract36" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="arbe_UnlabeledAbstract36"/>
  <xs:element name="UnlabeledAbstract37" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="arbe_UnlabeledAbstract37"/>
  <xs:element name="RevenueByGeographyAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="arbe_RevenueByGeographyAbstract"/>
  <xs:element name="CostAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="arbe_CostAbstract"/>
  <xs:element name="UnlabeledAbstract38" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="arbe_UnlabeledAbstract38"/>
  <xs:element name="UnlabeledAbstract39" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="arbe_UnlabeledAbstract39"/>
  <xs:element name="OptionsAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="arbe_OptionsAbstract"/>
  <xs:element name="UnlabeledAbstract40" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="arbe_UnlabeledAbstract40"/>
  <xs:element name="UnlabeledAbstract41" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="arbe_UnlabeledAbstract41"/>
  <xs:element name="UnlabeledAbstract42" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="arbe_UnlabeledAbstract42"/>
  <xs:element name="UnlabeledAbstract43" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="arbe_UnlabeledAbstract43"/>
  <xs:element name="UnlabeledAbstract44" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="arbe_UnlabeledAbstract44"/>
  <xs:element name="UnlabeledAbstract45" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="arbe_UnlabeledAbstract45"/>
  <xs:element name="UnlabeledAbstract46" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="arbe_UnlabeledAbstract46"/>
  <xs:element name="UnlabeledAbstract47" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="arbe_UnlabeledAbstract47"/>
  <xs:element name="RsusAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="arbe_RsusAbstract"/>
  <xs:element name="UnlabeledAbstract48" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="arbe_UnlabeledAbstract48"/>
  <xs:element name="UnlabeledAbstract49" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="arbe_UnlabeledAbstract49"/>
  <xs:element name="UnlabeledAbstract50" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="arbe_UnlabeledAbstract50"/>
  <xs:element name="UnlabeledAbstract51" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="arbe_UnlabeledAbstract51"/>
  <xs:element name="UnlabeledAbstract52" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="arbe_UnlabeledAbstract52"/>
  <xs:element name="UnlabeledAbstract53" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="arbe_UnlabeledAbstract53"/>
  <xs:element name="BasicAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="arbe_BasicAbstract"/>
  <xs:element name="NumeratorAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="arbe_NumeratorAbstract"/>
  <xs:element name="DenominatorAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="arbe_DenominatorAbstract"/>
  <xs:element name="NumeratorAbstract0" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="arbe_NumeratorAbstract0"/>
  <xs:element name="DenominatorAbstract0" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="arbe_DenominatorAbstract0"/>
  <xs:element name="UnlabeledAbstract54" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="arbe_UnlabeledAbstract54"/>
  <xs:element name="DeferredTaxAssetsAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="arbe_DeferredTaxAssetsAbstract"/>
  <xs:element name="UnlabeledAbstract55" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="arbe_UnlabeledAbstract55"/>
  <xs:element name="UnlabeledAbstract56" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="arbe_UnlabeledAbstract56"/>
  <xs:element name="StockIssuedDuringPeriodSharesExerciseOfWarrants" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="arbe_StockIssuedDuringPeriodSharesExerciseOfWarrants"/>
  <xs:element name="RevaluationOfConvertibleLoan" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="arbe_RevaluationOfConvertibleLoan"/>
  <xs:element name="ConversionOfConvertibleLoanIntoOrdinarySharesUponTheRecapitalization" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="arbe_ConversionOfConvertibleLoanIntoOrdinarySharesUponTheRecapitalization"/>
  <xs:element name="ConversionOfPreferredSharesIntoOrdinarySharesUponTheRecapitalization" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="arbe_ConversionOfPreferredSharesIntoOrdinarySharesUponTheRecapitalization"/>
  <xs:element name="ShortTermDepositsPolicyPolicyTextBlock" type="dtr:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="arbe_ShortTermDepositsPolicyPolicyTextBlock"/>
  <xs:element name="PropertyPlantAndEquipmentUsefulLifeTableTextBlock" type="dtr:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="arbe_PropertyPlantAndEquipmentUsefulLifeTableTextBlock"/>
  <xs:element name="SignificantAccountingPoliciesDetailsScheduleoftheStraightLineMethodOvertheEstimatedUsefulLivesoftheAssetsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="arbe_SignificantAccountingPoliciesDetailsScheduleoftheStraightLineMethodOvertheEstimatedUsefulLivesoftheAssetsTable"/>
  <xs:element name="SignificantAccountingPoliciesDetailsScheduleoftheStraightLineMethodOvertheEstimatedUsefulLivesoftheAssetsLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="arbe_SignificantAccountingPoliciesDetailsScheduleoftheStraightLineMethodOvertheEstimatedUsefulLivesoftheAssetsLineItems"/>
  <xs:element name="GovernmentAuthorities" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="arbe_GovernmentAuthorities"/>
  <xs:element name="OperatingLeaseRightofuseAssetsAndLiabilitiesNet" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="arbe_OperatingLeaseRightofuseAssetsAndLiabilitiesNet"/>
  <xs:element name="ShareholdersEquityDetailsScheduleofRSUsActivityTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="arbe_ShareholdersEquityDetailsScheduleofRSUsActivityTable"/>
  <xs:element name="ShareholdersEquityDetailsScheduleofRSUsActivityLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="arbe_ShareholdersEquityDetailsScheduleofRSUsActivityLineItems"/>
  <xs:element name="ShareholdersEquityDetailsScheduleofCompensationtoEmployeesTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="arbe_ShareholdersEquityDetailsScheduleofCompensationtoEmployeesTable"/>
  <xs:element name="ShareholdersEquityDetailsScheduleofCompensationtoEmployeesLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="arbe_ShareholdersEquityDetailsScheduleofCompensationtoEmployeesLineItems"/>
  <xs:element name="ShareholdersEquityDetailsScheduleofShareBasedCompensationExpenseTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="arbe_ShareholdersEquityDetailsScheduleofShareBasedCompensationExpenseTable"/>
  <xs:element name="ShareholdersEquityDetailsScheduleofShareBasedCompensationExpenseLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="arbe_ShareholdersEquityDetailsScheduleofShareBasedCompensationExpenseLineItems"/>
  <xs:element name="SegmentInformationDetailsScheduleofPropertyandEquipmentNetofDepreciationbyGeographicRegionTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="arbe_SegmentInformationDetailsScheduleofPropertyandEquipmentNetofDepreciationbyGeographicRegionTable"/>
  <xs:element name="SegmentInformationDetailsScheduleofPropertyandEquipmentNetofDepreciationbyGeographicRegionLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="arbe_SegmentInformationDetailsScheduleofPropertyandEquipmentNetofDepreciationbyGeographicRegionLineItems"/>
  <xs:element name="GeneralDetailsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="arbe_GeneralDetailsTable"/>
  <xs:element name="GeneralDetailsLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="arbe_GeneralDetailsLineItems"/>
  <xs:element name="SignificantAccountingPoliciesDetailsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="arbe_SignificantAccountingPoliciesDetailsTable"/>
  <xs:element name="SignificantAccountingPoliciesDetailsLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="arbe_SignificantAccountingPoliciesDetailsLineItems"/>
  <xs:element name="SeverancePercentageOfMonthlySalary" type="dtr:percentItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="arbe_SeverancePercentageOfMonthlySalary"/>
  <xs:element name="RoyaltyPercentage" type="dtr:percentItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="arbe_RoyaltyPercentage"/>
  <xs:element name="GrantsReceived" type="dtr:percentItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="arbe_GrantsReceived"/>
  <xs:element name="WarrantsLiabilitiesDetailsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="arbe_WarrantsLiabilitiesDetailsTable"/>
  <xs:element name="WarrantsLiabilitiesDetailsLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="arbe_WarrantsLiabilitiesDetailsLineItems"/>
  <xs:element name="DerivativeWarrantLiabilityShares" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="arbe_DerivativeWarrantLiabilityShares"/>
  <xs:element name="ShareholdersEquityDetailsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="arbe_ShareholdersEquityDetailsTable"/>
  <xs:element name="ShareholdersEquityDetailsLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="arbe_ShareholdersEquityDetailsLineItems"/>
  <xs:element name="TaxesonIncomeDetailsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="arbe_TaxesonIncomeDetailsTable"/>
  <xs:element name="TaxesonIncomeDetailsLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="arbe_TaxesonIncomeDetailsLineItems"/>
  <xs:element name="SegmentInformationDetailsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="arbe_SegmentInformationDetailsTable"/>
  <xs:element name="ArbeRoboticsLtdMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="arbe_ArbeRoboticsLtdMember"/>
  <xs:element name="Customer1Member" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="arbe_Customer1Member"/>
  <xs:element name="Customer2Member" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="arbe_Customer2Member"/>
  <xs:element name="Customer3Member" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="arbe_Customer3Member"/>
  <xs:element name="OrdinarySharesParValueNIS0000216PerShareMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="arbe_OrdinarySharesParValueNIS0000216PerShareMember"/>
  <xs:element name="OtherGeographicalMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="arbe_OtherGeographicalMember"/>
  <xs:element name="OutstandingShareOptionsMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="arbe_OutstandingShareOptionsMember"/>
  <xs:element name="PIPEMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="arbe_PIPEMember"/>
  <xs:element name="PlanOneMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="arbe_PlanOneMember"/>
  <xs:element name="PrivateWarrantsMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="arbe_PrivateWarrantsMember"/>
  <xs:element name="PublicWarrantsMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="arbe_PublicWarrantsMember"/>
  <xs:element name="SeedMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="arbe_SeedMember"/>
  <xs:element name="SeriesA1PreferredStockMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="arbe_SeriesA1PreferredStockMember"/>
  <xs:element name="SeriesB1PreferredStockMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="arbe_SeriesB1PreferredStockMember"/>
  <xs:element name="SeriesB2PreferredStockMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="arbe_SeriesB2PreferredStockMember"/>
  <xs:element name="TwoThousandSixteenIncentivePlanMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="arbe_TwoThousandSixteenIncentivePlanMember"/>
  <xs:element name="TwoThousandTwentyOneEquityIncentivePlanMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="arbe_TwoThousandTwentyOneEquityIncentivePlanMember"/>
  <xs:element name="WarrantsMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="arbe_WarrantsMember"/>
  <xs:element name="ScheduleOfCompanysLossBeforeIncomeTaxesAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="arbe_ScheduleOfCompanysLossBeforeIncomeTaxesAbstract"/>
  <xs:element name="ScheduleOfReconciliationIncomeTaxBenefitAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="arbe_ScheduleOfReconciliationIncomeTaxBenefitAbstract"/>
  <xs:element name="DocumentAndEntityInformationAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="arbe_DocumentAndEntityInformationAbstract"/>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>17
<FILENAME>arbe-20231231_cal.xml
<DESCRIPTION>XBRL CALCULATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!-- Generated by CompSci Transform (tm) - http://www.compsciresources.com -->
<!-- Created: Thu Mar 28 12:24:34 UTC 2024 -->
<linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <roleRef xlink:type="simple" xlink:href="arbe-20231231.xsd#arbe_r_ConsolidatedBalanceSheet" roleURI="http://www.arberobotics.com/role/ConsolidatedBalanceSheet"/>
  <roleRef xlink:type="simple" xlink:href="arbe-20231231.xsd#arbe_r_ConsolidatedIncomeStatement" roleURI="http://www.arberobotics.com/role/ConsolidatedIncomeStatement"/>
  <roleRef xlink:type="simple" xlink:href="arbe-20231231.xsd#arbe_r_ConsolidatedCashFlow" roleURI="http://www.arberobotics.com/role/ConsolidatedCashFlow"/>
  <roleRef xlink:type="simple" xlink:href="arbe-20231231.xsd#arbe_r_ScheduleofPrepaidExpensesandOtherReceivablesTable" roleURI="http://www.arberobotics.com/role/ScheduleofPrepaidExpensesandOtherReceivablesTable"/>
  <roleRef xlink:type="simple" xlink:href="arbe-20231231.xsd#arbe_r_ScheduleofPropertyandEquipmentTable" roleURI="http://www.arberobotics.com/role/ScheduleofPropertyandEquipmentTable"/>
  <roleRef xlink:type="simple" xlink:href="arbe-20231231.xsd#arbe_r_ScheduleofMaturitiesofLeaseLiabilitiesTable" roleURI="http://www.arberobotics.com/role/ScheduleofMaturitiesofLeaseLiabilitiesTable"/>
  <roleRef xlink:type="simple" xlink:href="arbe-20231231.xsd#arbe_r_ScheduleofCompanysLossBeforeIncomeTaxesTable" roleURI="http://www.arberobotics.com/role/ScheduleofCompanysLossBeforeIncomeTaxesTable"/>
  <roleRef xlink:type="simple" xlink:href="arbe-20231231.xsd#arbe_r_ScheduleofReconciliationIncomeTaxBenefitTable" roleURI="http://www.arberobotics.com/role/ScheduleofReconciliationIncomeTaxBenefitTable"/>
  <roleRef xlink:type="simple" xlink:href="arbe-20231231.xsd#arbe_r_ScheduleofDeferredTaxAssetsTable" roleURI="http://www.arberobotics.com/role/ScheduleofDeferredTaxAssetsTable"/>
  <calculationLink xlink:type="extended" xlink:role="http://www.arberobotics.com/role/ConsolidatedBalanceSheet">
    <loc xlink:type="locator" xlink:label="us-gaap_AssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsCurrent"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RestrictedCashCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedCashCurrent"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_RestrictedCashCurrent" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShortTermInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShortTermInvestments"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_ShortTermInvestments" order="3" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccountsReceivableNetCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_AccountsReceivableNetCurrent" order="4" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" order="5" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AssetsNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsNoncurrent"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AssetsNoncurrent" xlink:to="us-gaap_OperatingLeaseRightOfUseAsset" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentNet" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AssetsNoncurrent" xlink:to="us-gaap_PropertyPlantAndEquipmentNet" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Assets" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Assets"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Assets" xlink:to="us-gaap_AssetsCurrent" order="1" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Assets" xlink:to="us-gaap_AssetsNoncurrent" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesCurrent"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccountsPayableTradeCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsPayableTradeCurrent"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_AccountsPayableTradeCurrent" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_OperatingLeaseLiabilityCurrent" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_EmployeeRelatedLiabilitiesCurrent" order="3" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredRevenueCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredRevenueCurrent"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_DeferredRevenueCurrent" order="4" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent" order="5" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LiabilitiesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesNoncurrent"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesNoncurrent" xlink:to="us-gaap_OperatingLeaseLiabilityNoncurrent" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WarrantsAndRightsOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WarrantsAndRightsOutstanding"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesNoncurrent" xlink:to="us-gaap_WarrantsAndRightsOutstanding" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquity"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockValue"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_CommonStockValue" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AdditionalPaidInCapitalCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_AdditionalPaidInCapitalCommonStock" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit" order="3" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_LiabilitiesCurrent" order="1" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_LiabilitiesNoncurrent" order="2" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_StockholdersEquity" order="3" weight="1"/>
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://www.arberobotics.com/role/ConsolidatedIncomeStatement">
    <loc xlink:type="locator" xlink:label="us-gaap_GrossProfit" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GrossProfit"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Revenues" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Revenues"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_GrossProfit" xlink:to="us-gaap_Revenues" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CostOfRevenue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CostOfRevenue"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_GrossProfit" xlink:to="us-gaap_CostOfRevenue" order="2" weight="-1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingExpenses" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingExpenses"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ResearchAndDevelopmentExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OperatingExpenses" xlink:to="us-gaap_ResearchAndDevelopmentExpense" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SellingAndMarketingExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SellingAndMarketingExpense"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OperatingExpenses" xlink:to="us-gaap_SellingAndMarketingExpense" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_GeneralAndAdministrativeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OperatingExpenses" xlink:to="us-gaap_GeneralAndAdministrativeExpense" order="3" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingIncomeLoss"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="us-gaap_GrossProfit" order="1" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="us-gaap_OperatingExpenses" order="2" weight="-1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_OperatingIncomeLoss" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NonoperatingIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_NonoperatingIncomeExpense" order="2" weight="1"/>
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://www.arberobotics.com/role/ConsolidatedCashFlow">
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_NetIncomeLoss" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Depreciation" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Depreciation"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_Depreciation" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensation"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_ShareBasedCompensation" order="3" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims" order="4" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AdjustmentOfWarrantsGrantedForServices" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdjustmentOfWarrantsGrantedForServices"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_AdjustmentOfWarrantsGrantedForServices" order="5" weight="1"/>
    <loc xlink:type="locator" xlink:label="arbe_RevaluationOfConvertibleLoan" xlink:href="arbe-20231231.xsd#arbe_RevaluationOfConvertibleLoan"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="arbe_RevaluationOfConvertibleLoan" order="6" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOperatingLeaseLiability"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_IncreaseDecreaseInOperatingLeaseLiability" order="7" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayableTrade" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccountsPayableTrade"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayableTrade" order="8" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities" order="9" weight="1"/>
<!-- [WMV5][XcpuxYn59dz7vgYynUDuwG7r97K2jUTysl7vcz0lJt/tSeJz73kx1cLt0ZFF2SK/vxBCY0vdSrZEr5dnmkj55Vn3PE+1u+YOtkjz23BDixtN+DSa6ODpxKHuuFDR2EFRAYrDV15EdRUTOp8hTdByKJ//xoC7ECC663wnKueQq7LbhDBxlm0Wi1xZdy33k9DRJYjt/rCQI8A6bBdr5ony7RknOIsPU1pWTweSc4Wp+IQVoYO/x93rSQOoZayYDA6QnhrnoImw/QPyT3Kwfw6V9Q==] CSR-->
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInDeferredRevenue"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_IncreaseDecreaseInDeferredRevenue" order="10" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities" order="11" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_IncreaseDecreaseInAccountsReceivable" order="12" weight="-1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" order="13" weight="-1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PaymentsForProceedsFromInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsForProceedsFromInvestments"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_PaymentsForProceedsFromInvestments" order="1" weight="-1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" order="2" weight="-1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromShortTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromShortTermDebt"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_ProceedsFromShortTermDebt" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceInitialPublicOffering" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromIssuanceInitialPublicOffering"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_ProceedsFromIssuanceInitialPublicOffering" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_ProceedsFromIssuanceOfCommonStock" order="3" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromWarrantExercises" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromWarrantExercises"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_ProceedsFromWarrantExercises" order="4" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_ProceedsFromStockOptionsExercised" order="5" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromConvertibleDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromConvertibleDebt"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_ProceedsFromConvertibleDebt" order="6" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RepaymentsOfLongTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RepaymentsOfLongTermDebt"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_RepaymentsOfLongTermDebt" order="7" weight="-1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RepaymentsOfShortTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RepaymentsOfShortTermDebt"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_RepaymentsOfShortTermDebt" order="8" weight="-1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities" order="1" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities" order="2" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities" order="3" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" order="4" weight="1"/>
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://www.arberobotics.com/role/ScheduleofPrepaidExpensesandOtherReceivablesTable">
    <loc xlink:type="locator" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PrepaidExpenseAndOtherAssetsNoncurrent"/>
    <loc xlink:type="locator" xlink:label="arbe_GovernmentAuthorities" xlink:href="arbe-20231231.xsd#arbe_GovernmentAuthorities"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_PrepaidExpenseAndOtherAssetsNoncurrent" xlink:to="arbe_GovernmentAuthorities" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DepositAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DepositAssets"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_PrepaidExpenseAndOtherAssetsNoncurrent" xlink:to="us-gaap_DepositAssets" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_GrantsReceivableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GrantsReceivableCurrent"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_PrepaidExpenseAndOtherAssetsNoncurrent" xlink:to="us-gaap_GrantsReceivableCurrent" order="3" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PrepaidExpenseAndOtherAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PrepaidExpenseAndOtherAssets"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_PrepaidExpenseAndOtherAssetsNoncurrent" xlink:to="us-gaap_PrepaidExpenseAndOtherAssets" order="4" weight="1"/>
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://www.arberobotics.com/role/ScheduleofPropertyandEquipmentTable">
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentNet" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentGross" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_PropertyPlantAndEquipmentNet" xlink:to="us-gaap_PropertyPlantAndEquipmentGross" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_PropertyPlantAndEquipmentNet" xlink:to="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" order="2" weight="-1"/>
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://www.arberobotics.com/role/ScheduleofMaturitiesofLeaseLiabilitiesTable">
    <loc xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" order="3" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" order="4" weight="1"/>
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://www.arberobotics.com/role/ScheduleofCompanysLossBeforeIncomeTaxesTable">
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" order="2" weight="1"/>
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://www.arberobotics.com/role/ScheduleofReconciliationIncomeTaxBenefitTable">
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxReconciliationNondeductibleExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxReconciliationNondeductibleExpense"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="us-gaap_IncomeTaxReconciliationNondeductibleExpense" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential" order="3" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" order="4" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxReconciliationOtherAdjustments" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxReconciliationOtherAdjustments"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="us-gaap_IncomeTaxReconciliationOtherAdjustments" order="5" weight="1"/>
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://www.arberobotics.com/role/ScheduleofDeferredTaxAssetsTable">
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsGross" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsGross" xlink:to="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsGross" xlink:to="us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsGross" xlink:to="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" order="3" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsGross" xlink:to="us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment" order="4" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:to="us-gaap_DeferredTaxAssetsGross" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:to="us-gaap_DeferredTaxAssetsValuationAllowance" order="2" weight="-1"/>
  </calculationLink>
</linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>18
<FILENAME>arbe-20231231_def.xml
<DESCRIPTION>XBRL DEFINITION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!-- Generated by CompSci Transform (tm) - http://www.compsciresources.com -->
<!-- Created: Thu Mar 28 12:24:34 UTC 2024 -->
<linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:xbrldt="http://xbrl.org/2005/xbrldt">
  <roleRef xlink:type="simple" xlink:href="arbe-20231231.xsd#arbe_r_ConsolidatedBalanceSheet" roleURI="http://www.arberobotics.com/role/ConsolidatedBalanceSheet"/>
  <roleRef xlink:type="simple" xlink:href="arbe-20231231.xsd#arbe_r_ConsolidatedBalanceSheet_Parentheticals" roleURI="http://www.arberobotics.com/role/ConsolidatedBalanceSheet_Parentheticals"/>
  <roleRef xlink:type="simple" xlink:href="arbe-20231231.xsd#arbe_r_ConsolidatedIncomeStatement" roleURI="http://www.arberobotics.com/role/ConsolidatedIncomeStatement"/>
  <roleRef xlink:type="simple" xlink:href="arbe-20231231.xsd#arbe_r_ShareholdersEquityType2or3" roleURI="http://www.arberobotics.com/role/ShareholdersEquityType2or3"/>
  <roleRef xlink:type="simple" xlink:href="arbe-20231231.xsd#arbe_r_ConsolidatedCashFlow" roleURI="http://www.arberobotics.com/role/ConsolidatedCashFlow"/>
  <roleRef xlink:type="simple" xlink:href="arbe-20231231.xsd#arbe_r_General" roleURI="http://www.arberobotics.com/role/General"/>
  <roleRef xlink:type="simple" xlink:href="arbe-20231231.xsd#arbe_r_SignificantAccountingPolicies" roleURI="http://www.arberobotics.com/role/SignificantAccountingPolicies"/>
  <roleRef xlink:type="simple" xlink:href="arbe-20231231.xsd#arbe_r_Revenue" roleURI="http://www.arberobotics.com/role/Revenue"/>
  <roleRef xlink:type="simple" xlink:href="arbe-20231231.xsd#arbe_r_PrepaidExpensesandOtherReceivables" roleURI="http://www.arberobotics.com/role/PrepaidExpensesandOtherReceivables"/>
  <roleRef xlink:type="simple" xlink:href="arbe-20231231.xsd#arbe_r_PropertyandEquipment" roleURI="http://www.arberobotics.com/role/PropertyandEquipment"/>
  <roleRef xlink:type="simple" xlink:href="arbe-20231231.xsd#arbe_r_Leases" roleURI="http://www.arberobotics.com/role/Leases"/>
  <roleRef xlink:type="simple" xlink:href="arbe-20231231.xsd#arbe_r_CommitmentsandContingentLiabilities" roleURI="http://www.arberobotics.com/role/CommitmentsandContingentLiabilities"/>
  <roleRef xlink:type="simple" xlink:href="arbe-20231231.xsd#arbe_r_WarrantsLiabilities" roleURI="http://www.arberobotics.com/role/WarrantsLiabilities"/>
  <roleRef xlink:type="simple" xlink:href="arbe-20231231.xsd#arbe_r_ShareholdersEquity" roleURI="http://www.arberobotics.com/role/ShareholdersEquity"/>
  <roleRef xlink:type="simple" xlink:href="arbe-20231231.xsd#arbe_r_NetLossPerShareAttributibletoOrdinarySharholders" roleURI="http://www.arberobotics.com/role/NetLossPerShareAttributibletoOrdinarySharholders"/>
  <roleRef xlink:type="simple" xlink:href="arbe-20231231.xsd#arbe_r_TaxesonIncome" roleURI="http://www.arberobotics.com/role/TaxesonIncome"/>
  <roleRef xlink:type="simple" xlink:href="arbe-20231231.xsd#arbe_r_SegmentInformation" roleURI="http://www.arberobotics.com/role/SegmentInformation"/>
  <roleRef xlink:type="simple" xlink:href="arbe-20231231.xsd#arbe_r_AccountingPoliciesByPolicy" roleURI="http://www.arberobotics.com/role/AccountingPoliciesByPolicy"/>
  <roleRef xlink:type="simple" xlink:href="arbe-20231231.xsd#arbe_r_SignificantAccountingPoliciesTables" roleURI="http://www.arberobotics.com/role/SignificantAccountingPoliciesTables"/>
  <roleRef xlink:type="simple" xlink:href="arbe-20231231.xsd#arbe_r_RevenueTables" roleURI="http://www.arberobotics.com/role/RevenueTables"/>
  <roleRef xlink:type="simple" xlink:href="arbe-20231231.xsd#arbe_r_PrepaidExpensesandOtherReceivablesTables" roleURI="http://www.arberobotics.com/role/PrepaidExpensesandOtherReceivablesTables"/>
  <roleRef xlink:type="simple" xlink:href="arbe-20231231.xsd#arbe_r_PropertyandEquipmentTables" roleURI="http://www.arberobotics.com/role/PropertyandEquipmentTables"/>
  <roleRef xlink:type="simple" xlink:href="arbe-20231231.xsd#arbe_r_LeasesTables" roleURI="http://www.arberobotics.com/role/LeasesTables"/>
  <roleRef xlink:type="simple" xlink:href="arbe-20231231.xsd#arbe_r_ShareholdersEquityTables" roleURI="http://www.arberobotics.com/role/ShareholdersEquityTables"/>
  <roleRef xlink:type="simple" xlink:href="arbe-20231231.xsd#arbe_r_NetLossPerShareAttributibletoOrdinarySharholdersTables" roleURI="http://www.arberobotics.com/role/NetLossPerShareAttributibletoOrdinarySharholdersTables"/>
  <roleRef xlink:type="simple" xlink:href="arbe-20231231.xsd#arbe_r_TaxesonIncomeTables" roleURI="http://www.arberobotics.com/role/TaxesonIncomeTables"/>
  <roleRef xlink:type="simple" xlink:href="arbe-20231231.xsd#arbe_r_SegmentInformationTables" roleURI="http://www.arberobotics.com/role/SegmentInformationTables"/>
  <roleRef xlink:type="simple" xlink:href="arbe-20231231.xsd#arbe_r_ScheduleoftheStraightLineMethodOvertheEstimatedUsefulLivesoftheAssetsTable" roleURI="http://www.arberobotics.com/role/ScheduleoftheStraightLineMethodOvertheEstimatedUsefulLivesoftheAssetsTable"/>
  <roleRef xlink:type="simple" xlink:href="arbe-20231231.xsd#arbe_r_ScheduleofRevenueDisaggregatedbyGeographyTable" roleURI="http://www.arberobotics.com/role/ScheduleofRevenueDisaggregatedbyGeographyTable"/>
  <roleRef xlink:type="simple" xlink:href="arbe-20231231.xsd#arbe_r_ScheduleofPrepaidExpensesandOtherReceivablesTable" roleURI="http://www.arberobotics.com/role/ScheduleofPrepaidExpensesandOtherReceivablesTable"/>
  <roleRef xlink:type="simple" xlink:href="arbe-20231231.xsd#arbe_r_ScheduleofPropertyandEquipmentTable" roleURI="http://www.arberobotics.com/role/ScheduleofPropertyandEquipmentTable"/>
  <roleRef xlink:type="simple" xlink:href="arbe-20231231.xsd#arbe_r_ScheduleofSupplementalCashFlowInformationRelatedtoLeasesTable" roleURI="http://www.arberobotics.com/role/ScheduleofSupplementalCashFlowInformationRelatedtoLeasesTable"/>
  <roleRef xlink:type="simple" xlink:href="arbe-20231231.xsd#arbe_r_ScheduleofMaturitiesofLeaseLiabilitiesTable" roleURI="http://www.arberobotics.com/role/ScheduleofMaturitiesofLeaseLiabilitiesTable"/>
  <roleRef xlink:type="simple" xlink:href="arbe-20231231.xsd#arbe_r_ScheduleofSupplementalBalanceSheetInformationRelatedtoOperatingLeasesTable" roleURI="http://www.arberobotics.com/role/ScheduleofSupplementalBalanceSheetInformationRelatedtoOperatingLeasesTable"/>
  <roleRef xlink:type="simple" xlink:href="arbe-20231231.xsd#arbe_r_ScheduleofStockOptionActivityTable" roleURI="http://www.arberobotics.com/role/ScheduleofStockOptionActivityTable"/>
  <roleRef xlink:type="simple" xlink:href="arbe-20231231.xsd#arbe_r_ScheduleofRSUsActivityTable" roleURI="http://www.arberobotics.com/role/ScheduleofRSUsActivityTable"/>
  <roleRef xlink:type="simple" xlink:href="arbe-20231231.xsd#arbe_r_ScheduleofCompensationtoEmployeesTable" roleURI="http://www.arberobotics.com/role/ScheduleofCompensationtoEmployeesTable"/>
  <roleRef xlink:type="simple" xlink:href="arbe-20231231.xsd#arbe_r_ScheduleofShareBasedCompensationExpenseTable" roleURI="http://www.arberobotics.com/role/ScheduleofShareBasedCompensationExpenseTable"/>
  <roleRef xlink:type="simple" xlink:href="arbe-20231231.xsd#arbe_r_ScheduleofSetsForththeComputationofBasicandDilutedNetLossPerShareAttributableTable" roleURI="http://www.arberobotics.com/role/ScheduleofSetsForththeComputationofBasicandDilutedNetLossPerShareAttributableTable"/>
  <roleRef xlink:type="simple" xlink:href="arbe-20231231.xsd#arbe_r_ScheduleofOrdinarySharesthatwereExcludedfromtheComputationofDilutedNetLossPerShareTable" roleURI="http://www.arberobotics.com/role/ScheduleofOrdinarySharesthatwereExcludedfromtheComputationofDilutedNetLossPerShareTable"/>
  <roleRef xlink:type="simple" xlink:href="arbe-20231231.xsd#arbe_r_ScheduleofCompanysLossBeforeIncomeTaxesTable" roleURI="http://www.arberobotics.com/role/ScheduleofCompanysLossBeforeIncomeTaxesTable"/>
  <roleRef xlink:type="simple" xlink:href="arbe-20231231.xsd#arbe_r_ScheduleofReconciliationIncomeTaxBenefitTable" roleURI="http://www.arberobotics.com/role/ScheduleofReconciliationIncomeTaxBenefitTable"/>
  <roleRef xlink:type="simple" xlink:href="arbe-20231231.xsd#arbe_r_ScheduleofDeferredTaxAssetsTable" roleURI="http://www.arberobotics.com/role/ScheduleofDeferredTaxAssetsTable"/>
  <roleRef xlink:type="simple" xlink:href="arbe-20231231.xsd#arbe_r_ScheduleofPropertyandEquipmentNetofDepreciationbyGeographicRegionTable" roleURI="http://www.arberobotics.com/role/ScheduleofPropertyandEquipmentNetofDepreciationbyGeographicRegionTable"/>
  <roleRef xlink:type="simple" xlink:href="arbe-20231231.xsd#arbe_r_GeneralDetails" roleURI="http://www.arberobotics.com/role/GeneralDetails"/>
  <roleRef xlink:type="simple" xlink:href="arbe-20231231.xsd#arbe_r_SignificantAccountingPoliciesDetails" roleURI="http://www.arberobotics.com/role/SignificantAccountingPoliciesDetails"/>
  <roleRef xlink:type="simple" xlink:href="arbe-20231231.xsd#arbe_r_RevenueDetails" roleURI="http://www.arberobotics.com/role/RevenueDetails"/>
  <roleRef xlink:type="simple" xlink:href="arbe-20231231.xsd#arbe_r_PropertyandEquipmentDetails" roleURI="http://www.arberobotics.com/role/PropertyandEquipmentDetails"/>
  <roleRef xlink:type="simple" xlink:href="arbe-20231231.xsd#arbe_r_CommitmentsandContingentLiabilitiesDetails" roleURI="http://www.arberobotics.com/role/CommitmentsandContingentLiabilitiesDetails"/>
  <roleRef xlink:type="simple" xlink:href="arbe-20231231.xsd#arbe_r_WarrantsLiabilitiesDetails" roleURI="http://www.arberobotics.com/role/WarrantsLiabilitiesDetails"/>
  <roleRef xlink:type="simple" xlink:href="arbe-20231231.xsd#arbe_r_ShareholdersEquityDetails" roleURI="http://www.arberobotics.com/role/ShareholdersEquityDetails"/>
  <roleRef xlink:type="simple" xlink:href="arbe-20231231.xsd#arbe_r_TaxesonIncomeDetails" roleURI="http://www.arberobotics.com/role/TaxesonIncomeDetails"/>
  <roleRef xlink:type="simple" xlink:href="arbe-20231231.xsd#arbe_r_SegmentInformationDetails" roleURI="http://www.arberobotics.com/role/SegmentInformationDetails"/>
  <roleRef xlink:type="simple" xlink:href="arbe-20231231.xsd#DocumentAndEntityInformation" roleURI="http://www.arberobotics.com/role/DocumentAndEntityInformation"/>
  <arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default"/>
  <arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain"/>
  <arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension"/>
  <arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member"/>
  <arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" arcroleURI="http://xbrl.org/int/dim/arcrole/all"/>
  <definitionLink xlink:type="extended" xlink:role="http://www.arberobotics.com/role/ConsolidatedBalanceSheet">
    <loc xlink:type="locator" xlink:label="us-gaap_StatementOfFinancialPositionAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AssetsCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsCurrentAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_AssetsCurrentAbstract" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RestrictedCashCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedCashCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_RestrictedCashCurrent" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShortTermInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShortTermInvestments"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_ShortTermInvestments" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccountsReceivableNetCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_AccountsReceivableNetCurrent" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_AssetsCurrent" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AssetsNoncurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsNoncurrentAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_AssetsNoncurrentAbstract" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsNoncurrentAbstract" xlink:to="us-gaap_OperatingLeaseRightOfUseAsset" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentNet" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsNoncurrentAbstract" xlink:to="us-gaap_PropertyPlantAndEquipmentNet" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AssetsNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsNoncurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsNoncurrentAbstract" xlink:to="us-gaap_AssetsNoncurrent" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Assets" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Assets"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsNoncurrentAbstract" xlink:to="us-gaap_Assets" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LiabilitiesCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_LiabilitiesCurrentAbstract" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccountsPayableTradeCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsPayableTradeCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_AccountsPayableTradeCurrent" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_OperatingLeaseLiabilityCurrent" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_EmployeeRelatedLiabilitiesCurrent" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredRevenueCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredRevenueCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_DeferredRevenueCurrent" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_LiabilitiesCurrent" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LiabilitiesNoncurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesNoncurrentAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_LiabilitiesNoncurrentAbstract" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesNoncurrentAbstract" xlink:to="us-gaap_OperatingLeaseLiabilityNoncurrent" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WarrantsAndRightsOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WarrantsAndRightsOutstanding"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesNoncurrentAbstract" xlink:to="us-gaap_WarrantsAndRightsOutstanding" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LiabilitiesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesNoncurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesNoncurrentAbstract" xlink:to="us-gaap_LiabilitiesNoncurrent" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_StockholdersEquityAbstract" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockValue"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_CommonStockValue" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AdditionalPaidInCapitalCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_AdditionalPaidInCapitalCommonStock" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquity"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_StockholdersEquity" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity" order="4" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.arberobotics.com/role/ConsolidatedBalanceSheet_Parentheticals">
    <loc xlink:type="locator" xlink:label="us-gaap_StatementOfFinancialPositionAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_CommonStockSharesAuthorized" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_CommonStockSharesOutstanding" order="2" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.arberobotics.com/role/ConsolidatedIncomeStatement">
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeStatementAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Revenues" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Revenues"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_Revenues" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CostOfRevenue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CostOfRevenue"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_CostOfRevenue" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_GrossProfit" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GrossProfit"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_GrossProfit" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingExpensesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingExpensesAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_OperatingExpensesAbstract" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ResearchAndDevelopmentExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-gaap_ResearchAndDevelopmentExpense" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SellingAndMarketingExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SellingAndMarketingExpense"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-gaap_SellingAndMarketingExpense" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_GeneralAndAdministrativeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-gaap_GeneralAndAdministrativeExpense" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingExpenses" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingExpenses"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_OperatingExpenses" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingIncomeLoss"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_OperatingIncomeLoss" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NonoperatingIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_NonoperatingIncomeExpense" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_NetIncomeLoss" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EarningsPerShareBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareBasic"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_EarningsPerShareBasic" order="8" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" order="9" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EarningsPerShareDiluted" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareDiluted"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_EarningsPerShareDiluted" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" order="11" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.arberobotics.com/role/ShareholdersEquityType2or3">
    <loc xlink:type="locator" xlink:label="us-gaap_StatementLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementClassOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementClassOfStockAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementEquityComponentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementEquityComponentsAxis" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EquityComponentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EquityComponentDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_PreferredStockMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_CommonStockMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AdditionalPaidInCapitalMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_AdditionalPaidInCapitalMember" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RetainedEarningsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_RetainedEarningsMember" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="arbe_SeedMember" xlink:href="arbe-20231231.xsd#arbe_SeedMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="arbe_SeedMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SeriesAPreferredStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SeriesAPreferredStockMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_SeriesAPreferredStockMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="arbe_SeriesA1PreferredStockMember" xlink:href="arbe-20231231.xsd#arbe_SeriesA1PreferredStockMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="arbe_SeriesA1PreferredStockMember" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SeriesBPreferredStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SeriesBPreferredStockMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_SeriesBPreferredStockMember" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="arbe_SeriesB1PreferredStockMember" xlink:href="arbe-20231231.xsd#arbe_SeriesB1PreferredStockMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="arbe_SeriesB1PreferredStockMember" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="arbe_SeriesB2PreferredStockMember" xlink:href="arbe-20231231.xsd#arbe_SeriesB2PreferredStockMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="arbe_SeriesB2PreferredStockMember" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquity"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockholdersEquity" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharesOutstanding"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_SharesOutstanding" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="arbe_StockIssuedDuringPeriodSharesExerciseOfWarrants" xlink:href="arbe-20231231.xsd#arbe_StockIssuedDuringPeriodSharesExerciseOfWarrants"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="arbe_StockIssuedDuringPeriodSharesExerciseOfWarrants" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="arbe_StockIssuedDuringPeriodSharesExerciseOfWarrants" xlink:to="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="arbe_StockIssuedDuringPeriodSharesExerciseOfWarrants" xlink:to="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueConversionOfUnits" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueConversionOfUnits"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="arbe_StockIssuedDuringPeriodSharesExerciseOfWarrants" xlink:to="us-gaap_StockIssuedDuringPeriodValueConversionOfUnits" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="arbe_StockIssuedDuringPeriodSharesExerciseOfWarrants" xlink:to="us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="arbe_StockIssuedDuringPeriodSharesExerciseOfWarrants" xlink:to="us-gaap_StockIssuedDuringPeriodValueNewIssues" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="arbe_StockIssuedDuringPeriodSharesExerciseOfWarrants" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="arbe_StockIssuedDuringPeriodSharesExerciseOfWarrants" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueIssuedForServices" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueIssuedForServices"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="arbe_StockIssuedDuringPeriodSharesExerciseOfWarrants" xlink:to="us-gaap_StockIssuedDuringPeriodValueIssuedForServices" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="arbe_StockIssuedDuringPeriodSharesExerciseOfWarrants" xlink:to="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" order="8" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="arbe_StockIssuedDuringPeriodSharesExerciseOfWarrants" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" order="9" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="arbe_StockIssuedDuringPeriodSharesExerciseOfWarrants" xlink:to="us-gaap_NetIncomeLoss" order="10" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.arberobotics.com/role/ConsolidatedCashFlow">
    <loc xlink:type="locator" xlink:label="us-gaap_StatementOfCashFlowsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_NetIncomeLoss" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Depreciation" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Depreciation"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_Depreciation" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensation"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_ShareBasedCompensation" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AdjustmentOfWarrantsGrantedForServices" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdjustmentOfWarrantsGrantedForServices"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_AdjustmentOfWarrantsGrantedForServices" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="arbe_RevaluationOfConvertibleLoan" xlink:href="arbe-20231231.xsd#arbe_RevaluationOfConvertibleLoan"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="arbe_RevaluationOfConvertibleLoan" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInAccountsReceivable" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOperatingLeaseLiability"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInOperatingLeaseLiability" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayableTrade" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccountsPayableTrade"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayableTrade" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInDeferredRevenue"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInDeferredRevenue" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PaymentsForProceedsFromInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsForProceedsFromInvestments"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_PaymentsForProceedsFromInvestments" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromShortTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromShortTermDebt"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_ProceedsFromShortTermDebt" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RepaymentsOfLongTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RepaymentsOfLongTermDebt"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_RepaymentsOfLongTermDebt" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceInitialPublicOffering" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromIssuanceInitialPublicOffering"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_ProceedsFromIssuanceInitialPublicOffering" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RepaymentsOfShortTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RepaymentsOfShortTermDebt"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_RepaymentsOfShortTermDebt" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_ProceedsFromIssuanceOfCommonStock" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromWarrantExercises" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromWarrantExercises"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_ProceedsFromWarrantExercises" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_ProceedsFromStockOptionsExercised" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromConvertibleDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromConvertibleDebt"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_ProceedsFromConvertibleDebt" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" order="8" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" order="9" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" order="11" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConversionOfStockAmountConverted1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConversionOfStockAmountConverted1"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:to="us-gaap_ConversionOfStockAmountConverted1" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssued1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssued1"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:to="us-gaap_StockIssued1" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="arbe_ConversionOfConvertibleLoanIntoOrdinarySharesUponTheRecapitalization" xlink:href="arbe-20231231.xsd#arbe_ConversionOfConvertibleLoanIntoOrdinarySharesUponTheRecapitalization"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:to="arbe_ConversionOfConvertibleLoanIntoOrdinarySharesUponTheRecapitalization" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="arbe_ConversionOfPreferredSharesIntoOrdinarySharesUponTheRecapitalization" xlink:href="arbe-20231231.xsd#arbe_ConversionOfPreferredSharesIntoOrdinarySharesUponTheRecapitalization"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:to="arbe_ConversionOfPreferredSharesIntoOrdinarySharesUponTheRecapitalization" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:to="us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:to="us-gaap_NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SupplementalCashFlowInformationAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SupplementalCashFlowInformationAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_SupplementalCashFlowInformationAbstract" order="12" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InterestPaidNet" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestPaidNet"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="us-gaap_InterestPaidNet" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.arberobotics.com/role/General">
    <loc xlink:type="locator" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NatureOfOperations" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NatureOfOperations"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="us-gaap_NatureOfOperations" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.arberobotics.com/role/SignificantAccountingPolicies">
    <loc xlink:type="locator" xlink:label="us-gaap_AccountingPoliciesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SignificantAccountingPoliciesTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_SignificantAccountingPoliciesTextBlock" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.arberobotics.com/role/Revenue">
    <loc xlink:type="locator" xlink:label="us-gaap_RevenuesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenuesAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromContractWithCustomerTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RevenuesAbstract" xlink:to="us-gaap_RevenueFromContractWithCustomerTextBlock" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.arberobotics.com/role/PrepaidExpensesandOtherReceivables">
    <loc xlink:type="locator" xlink:label="us-gaap_OtherAssetsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAssetsAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherCurrentAssetsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherCurrentAssetsTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OtherAssetsAbstract" xlink:to="us-gaap_OtherCurrentAssetsTextBlock" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.arberobotics.com/role/PropertyandEquipment">
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentAbstract" xlink:to="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.arberobotics.com/role/Leases">
    <loc xlink:type="locator" xlink:label="us-gaap_LeasesOperatingAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeasesOperatingAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeasesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeasesTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LeasesOperatingAbstract" xlink:to="us-gaap_LesseeOperatingLeasesTextBlock" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.arberobotics.com/role/CommitmentsandContingentLiabilities">
    <loc xlink:type="locator" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.arberobotics.com/role/WarrantsLiabilities">
    <loc xlink:type="locator" xlink:label="us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:to="us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.arberobotics.com/role/ShareholdersEquity">
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquityNoteAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityNoteAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StockholdersEquityNoteAbstract" xlink:to="us-gaap_StockholdersEquityNoteDisclosureTextBlock" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.arberobotics.com/role/NetLossPerShareAttributibletoOrdinarySharholders">
    <loc xlink:type="locator" xlink:label="us-gaap_EarningsPerShareAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EarningsPerShareTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="us-gaap_EarningsPerShareTextBlock" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.arberobotics.com/role/TaxesonIncome">
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_IncomeTaxDisclosureTextBlock" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.arberobotics.com/role/SegmentInformation">
    <loc xlink:type="locator" xlink:label="us-gaap_SegmentReportingInformationRevenueAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentReportingInformationRevenueAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SegmentReportingDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SegmentReportingInformationRevenueAbstract" xlink:to="us-gaap_SegmentReportingDisclosureTextBlock" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.arberobotics.com/role/AccountingPoliciesByPolicy">
    <loc xlink:type="locator" xlink:label="us-gaap_AccountingPoliciesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_BasisOfAccountingPolicyPolicyTextBlock" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_UseOfEstimates" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UseOfEstimates"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_UseOfEstimates" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConcentrationRiskCreditRisk" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskCreditRisk"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ConcentrationRiskCreditRisk" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="arbe_ShortTermDepositsPolicyPolicyTextBlock" xlink:href="arbe-20231231.xsd#arbe_ShortTermDepositsPolicyPolicyTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="arbe_ShortTermDepositsPolicyPolicyTextBlock" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueOfFinancialInstrumentsPolicy"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_FairValueOfFinancialInstrumentsPolicy" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" order="8" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" order="9" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PostemploymentBenefitPlansPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PostemploymentBenefitPlansPolicy"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_PostemploymentBenefitPlansPolicy" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" order="11" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerSharePolicyTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_EarningsPerSharePolicyTextBlock" order="12" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ComprehensiveIncomePolicyPolicyTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" order="13" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RevenueRecognitionPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueRecognitionPolicyTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_RevenueRecognitionPolicyTextBlock" order="14" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CostOfSalesPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CostOfSalesPolicyTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_CostOfSalesPolicyTextBlock" order="15" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ResearchAndDevelopmentExpensePolicy"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ResearchAndDevelopmentExpensePolicy" order="16" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxPolicyTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_IncomeTaxPolicyTextBlock" order="17" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ContingentLiabilityReserveEstimatePolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContingentLiabilityReserveEstimatePolicy"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ContingentLiabilityReserveEstimatePolicy" order="18" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LesseeLeasesPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeLeasesPolicyTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_LesseeLeasesPolicyTextBlock" order="19" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" order="20" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.arberobotics.com/role/SignificantAccountingPoliciesTables">
    <loc xlink:type="locator" xlink:label="us-gaap_AccountingPoliciesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <loc xlink:type="locator" xlink:label="arbe_PropertyPlantAndEquipmentUsefulLifeTableTextBlock" xlink:href="arbe-20231231.xsd#arbe_PropertyPlantAndEquipmentUsefulLifeTableTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="arbe_PropertyPlantAndEquipmentUsefulLifeTableTextBlock" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.arberobotics.com/role/RevenueTables">
    <loc xlink:type="locator" xlink:label="us-gaap_RevenuesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenuesAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RevenuesAbstract" xlink:to="us-gaap_DisaggregationOfRevenueTableTextBlock" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.arberobotics.com/role/PrepaidExpensesandOtherReceivablesTables">
    <loc xlink:type="locator" xlink:label="us-gaap_OtherAssetsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAssetsAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OtherAssetsAbstract" xlink:to="us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.arberobotics.com/role/PropertyandEquipmentTables">
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentAbstract" xlink:to="us-gaap_PropertyPlantAndEquipmentTextBlock" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.arberobotics.com/role/LeasesTables">
    <loc xlink:type="locator" xlink:label="us-gaap_LeasesOperatingAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeasesOperatingAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeaseLeaseIncomeTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLeaseIncomeTableTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LeasesOperatingAbstract" xlink:to="us-gaap_OperatingLeaseLeaseIncomeTableTextBlock" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LeasesOperatingAbstract" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LeaseCostTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeaseCostTableTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LeasesOperatingAbstract" xlink:to="us-gaap_LeaseCostTableTextBlock" order="2" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.arberobotics.com/role/ShareholdersEquityTables">
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquityNoteAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityNoteAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StockholdersEquityNoteAbstract" xlink:to="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StockholdersEquityNoteAbstract" xlink:to="us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StockholdersEquityNoteAbstract" xlink:to="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StockholdersEquityNoteAbstract" xlink:to="us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock" order="3" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.arberobotics.com/role/NetLossPerShareAttributibletoOrdinarySharholdersTables">
    <loc xlink:type="locator" xlink:label="us-gaap_EarningsPerShareAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" order="1" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.arberobotics.com/role/TaxesonIncomeTables">
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" order="2" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.arberobotics.com/role/SegmentInformationTables">
    <loc xlink:type="locator" xlink:label="us-gaap_SegmentReportingInformationRevenueAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentReportingInformationRevenueAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SegmentReportingInformationRevenueAbstract" xlink:to="us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.arberobotics.com/role/ScheduleoftheStraightLineMethodOvertheEstimatedUsefulLivesoftheAssetsTable">
    <loc xlink:type="locator" xlink:label="arbe_SignificantAccountingPoliciesDetailsScheduleoftheStraightLineMethodOvertheEstimatedUsefulLivesoftheAssetsLineItems" xlink:href="arbe-20231231.xsd#arbe_SignificantAccountingPoliciesDetailsScheduleoftheStraightLineMethodOvertheEstimatedUsefulLivesoftheAssetsLineItems"/>
    <loc xlink:type="locator" xlink:label="arbe_SignificantAccountingPoliciesDetailsScheduleoftheStraightLineMethodOvertheEstimatedUsefulLivesoftheAssetsTable" xlink:href="arbe-20231231.xsd#arbe_SignificantAccountingPoliciesDetailsScheduleoftheStraightLineMethodOvertheEstimatedUsefulLivesoftheAssetsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="arbe_SignificantAccountingPoliciesDetailsScheduleoftheStraightLineMethodOvertheEstimatedUsefulLivesoftheAssetsLineItems" xlink:to="arbe_SignificantAccountingPoliciesDetailsScheduleoftheStraightLineMethodOvertheEstimatedUsefulLivesoftheAssetsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="arbe_SignificantAccountingPoliciesDetailsScheduleoftheStraightLineMethodOvertheEstimatedUsefulLivesoftheAssetsTable" xlink:to="us-gaap_PropertyPlantAndEquipmentByTypeAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_PropertyPlantAndEquipmentTypeDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_PropertyPlantAndEquipmentTypeDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_RangeAxis" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="arbe_SignificantAccountingPoliciesDetailsScheduleoftheStraightLineMethodOvertheEstimatedUsefulLivesoftheAssetsTable" xlink:to="srt_RangeAxis" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_RangeMember" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_RangeMember_0" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_MinimumMember" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MinimumMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MinimumMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_MaximumMember" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ComputerEquipmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ComputerEquipmentMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_ComputerEquipmentMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OfficeEquipmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OfficeEquipmentMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_OfficeEquipmentMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_VehiclesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VehiclesMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_VehiclesMember" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LeaseholdImprovementsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeaseholdImprovementsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_LeaseholdImprovementsMember" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentSalvageValuePercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentSalvageValuePercentage"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="arbe_SignificantAccountingPoliciesDetailsScheduleoftheStraightLineMethodOvertheEstimatedUsefulLivesoftheAssetsLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentSalvageValuePercentage" order="1" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.arberobotics.com/role/ScheduleofRevenueDisaggregatedbyGeographyTable">
    <loc xlink:type="locator" xlink:label="us-gaap_DisaggregationOfRevenueLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DisaggregationOfRevenueTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_DisaggregationOfRevenueLineItems" xlink:to="us-gaap_DisaggregationOfRevenueTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_ProductOrServiceAxis" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ProductOrServiceAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_DisaggregationOfRevenueTable" xlink:to="srt_ProductOrServiceAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_ProductsAndServicesDomain" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ProductsAndServicesDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_ProductOrServiceAxis" xlink:to="srt_ProductsAndServicesDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_ProductsAndServicesDomain_0" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ProductsAndServicesDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_ProductOrServiceAxis" xlink:to="srt_ProductsAndServicesDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_StatementGeographicalAxis" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_StatementGeographicalAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_DisaggregationOfRevenueTable" xlink:to="srt_StatementGeographicalAxis" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_SegmentGeographicalDomain" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_SegmentGeographicalDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_StatementGeographicalAxis" xlink:to="srt_SegmentGeographicalDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_SegmentGeographicalDomain_0" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_SegmentGeographicalDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_StatementGeographicalAxis" xlink:to="srt_SegmentGeographicalDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="country_CN" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_CN"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_SegmentGeographicalDomain" xlink:to="country_CN" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="country_HK" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_HK"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_SegmentGeographicalDomain" xlink:to="country_HK" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="country_SE" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_SE"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_SegmentGeographicalDomain" xlink:to="country_SE" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="country_US" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_US"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_SegmentGeographicalDomain" xlink:to="country_US" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="country_DE" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_DE"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_SegmentGeographicalDomain" xlink:to="country_DE" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="country_IL" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_IL"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_SegmentGeographicalDomain" xlink:to="country_IL" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="country_IT" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_IT"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_SegmentGeographicalDomain" xlink:to="country_IT" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="country_CH" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_CH"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_SegmentGeographicalDomain" xlink:to="country_CH" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="arbe_OtherGeographicalMember" xlink:href="arbe-20231231.xsd#arbe_OtherGeographicalMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_ProductsAndServicesDomain" xlink:to="arbe_OtherGeographicalMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="arbe_RevenueByGeographyAbstract" xlink:href="arbe-20231231.xsd#arbe_RevenueByGeographyAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DisaggregationOfRevenueLineItems" xlink:to="arbe_RevenueByGeographyAbstract" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="arbe_RevenueByGeographyAbstract" xlink:to="us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RevenueRemainingPerformanceObligationPercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueRemainingPerformanceObligationPercentage"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="arbe_RevenueByGeographyAbstract" xlink:to="us-gaap_RevenueRemainingPerformanceObligationPercentage" order="1" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.arberobotics.com/role/ScheduleofPrepaidExpensesandOtherReceivablesTable">
    <loc xlink:type="locator" xlink:label="arbe_ScheduleOfPrepaidExpensesAndOtherReceivablesAbstract" xlink:href="arbe-20231231.xsd#arbe_ScheduleOfPrepaidExpensesAndOtherReceivablesAbstract"/>
    <loc xlink:type="locator" xlink:label="arbe_GovernmentAuthorities" xlink:href="arbe-20231231.xsd#arbe_GovernmentAuthorities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="arbe_ScheduleOfPrepaidExpensesAndOtherReceivablesAbstract" xlink:to="arbe_GovernmentAuthorities" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DepositAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DepositAssets"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="arbe_ScheduleOfPrepaidExpensesAndOtherReceivablesAbstract" xlink:to="us-gaap_DepositAssets" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_GrantsReceivableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GrantsReceivableCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="arbe_ScheduleOfPrepaidExpensesAndOtherReceivablesAbstract" xlink:to="us-gaap_GrantsReceivableCurrent" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PrepaidExpenseAndOtherAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PrepaidExpenseAndOtherAssets"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="arbe_ScheduleOfPrepaidExpensesAndOtherReceivablesAbstract" xlink:to="us-gaap_PrepaidExpenseAndOtherAssets" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PrepaidExpenseAndOtherAssetsNoncurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="arbe_ScheduleOfPrepaidExpensesAndOtherReceivablesAbstract" xlink:to="us-gaap_PrepaidExpenseAndOtherAssetsNoncurrent" order="4" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.arberobotics.com/role/ScheduleofPropertyandEquipmentTable">
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="us-gaap_PropertyPlantAndEquipmentByTypeAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_PropertyPlantAndEquipmentTypeDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_PropertyPlantAndEquipmentTypeDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ComputerEquipmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ComputerEquipmentMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_ComputerEquipmentMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LeaseholdImprovementsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeaseholdImprovementsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_LeaseholdImprovementsMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OfficeEquipmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OfficeEquipmentMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_OfficeEquipmentMember" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_VehiclesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VehiclesMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_VehiclesMember" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="arbe_CostAbstract" xlink:href="arbe-20231231.xsd#arbe_CostAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="arbe_CostAbstract" order="1" xbrldt:closed="true"/>
<!-- [WMV5][XcpuxYn59dz7vgYynUDuwG7r97K2jUTysl7vcz0lJt/tSeJz73kx1cLt0ZFF2SK/vxBCY0vdSrZEr5dnmkj55Vn3PE+1u+YOtkjz23BDixtN+DSa6ODpxKHuuFDR2EFRAYrDV15EdRUTOp8hTdByKJ//xoC7ECC663wnKueQq7LbhDBxlm0Wi1xZdy33k9DRJYjt/rCQI8A6bBdr5ony7RknOIsPU1pWTweSc4Wp+IQVoYO/x93rSQOoZayYDA6Q5Bn3zlNyJLD+Vz2vFVjCkw==] CSR-->
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentGross" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="arbe_CostAbstract" xlink:to="us-gaap_PropertyPlantAndEquipmentGross" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentNet" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentNet" order="3" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.arberobotics.com/role/ScheduleofSupplementalCashFlowInformationRelatedtoLeasesTable">
    <loc xlink:type="locator" xlink:label="arbe_ScheduleOfSupplementalCashFlowInformationRelatedToLeasesAbstract" xlink:href="arbe-20231231.xsd#arbe_ScheduleOfSupplementalCashFlowInformationRelatedToLeasesAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeasePayments" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeasePayments"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="arbe_ScheduleOfSupplementalCashFlowInformationRelatedToLeasesAbstract" xlink:to="us-gaap_OperatingLeasePayments" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="arbe_OperatingLeaseRightofuseAssetsAndLiabilitiesNet" xlink:href="arbe-20231231.xsd#arbe_OperatingLeaseRightofuseAssetsAndLiabilitiesNet"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="arbe_ScheduleOfSupplementalCashFlowInformationRelatedToLeasesAbstract" xlink:to="arbe_OperatingLeaseRightofuseAssetsAndLiabilitiesNet" order="1" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.arberobotics.com/role/ScheduleofMaturitiesofLeaseLiabilitiesTable">
    <loc xlink:type="locator" xlink:label="arbe_ScheduleOfMaturitiesOfLeaseLiabilitiesAbstract" xlink:href="arbe-20231231.xsd#arbe_ScheduleOfMaturitiesOfLeaseLiabilitiesAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="arbe_ScheduleOfMaturitiesOfLeaseLiabilitiesAbstract" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="arbe_ScheduleOfMaturitiesOfLeaseLiabilitiesAbstract" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="arbe_ScheduleOfMaturitiesOfLeaseLiabilitiesAbstract" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiability"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:to="us-gaap_OperatingLeaseLiability" order="3" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.arberobotics.com/role/ScheduleofSupplementalBalanceSheetInformationRelatedtoOperatingLeasesTable">
    <loc xlink:type="locator" xlink:label="arbe_ScheduleOfSupplementalBalanceSheetInformationRelatedToOperatingLeasesAbstract" xlink:href="arbe-20231231.xsd#arbe_ScheduleOfSupplementalBalanceSheetInformationRelatedToOperatingLeasesAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="arbe_ScheduleOfSupplementalBalanceSheetInformationRelatedToOperatingLeasesAbstract" xlink:to="us-gaap_OperatingLeaseRightOfUseAsset" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="arbe_ScheduleOfSupplementalBalanceSheetInformationRelatedToOperatingLeasesAbstract" xlink:to="us-gaap_OperatingLeaseLiabilityCurrent" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="arbe_ScheduleOfSupplementalBalanceSheetInformationRelatedToOperatingLeasesAbstract" xlink:to="us-gaap_OperatingLeaseLiabilityNoncurrent" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="arbe_ScheduleOfSupplementalBalanceSheetInformationRelatedToOperatingLeasesAbstract" xlink:to="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="arbe_ScheduleOfSupplementalBalanceSheetInformationRelatedToOperatingLeasesAbstract" xlink:to="us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" order="4" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.arberobotics.com/role/ScheduleofStockOptionActivityTable">
    <loc xlink:type="locator" xlink:label="arbe_ScheduleOfStockOptionActivityAbstract" xlink:href="arbe-20231231.xsd#arbe_ScheduleOfStockOptionActivityAbstract"/>
    <loc xlink:type="locator" xlink:label="arbe_OptionsAbstract" xlink:href="arbe-20231231.xsd#arbe_OptionsAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="arbe_ScheduleOfStockOptionActivityAbstract" xlink:to="arbe_OptionsAbstract" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="arbe_OptionsAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="arbe_OptionsAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="arbe_OptionsAbstract" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="arbe_OptionsAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="arbe_OptionsAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="arbe_OptionsAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="arbe_OptionsAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="arbe_OptionsAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="arbe_OptionsAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised" order="8" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="arbe_OptionsAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" order="9" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.arberobotics.com/role/ScheduleofRSUsActivityTable">
    <loc xlink:type="locator" xlink:label="arbe_ShareholdersEquityDetailsScheduleofRSUsActivityLineItems" xlink:href="arbe-20231231.xsd#arbe_ShareholdersEquityDetailsScheduleofRSUsActivityLineItems"/>
    <loc xlink:type="locator" xlink:label="arbe_ShareholdersEquityDetailsScheduleofRSUsActivityTable" xlink:href="arbe-20231231.xsd#arbe_ShareholdersEquityDetailsScheduleofRSUsActivityTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="arbe_ShareholdersEquityDetailsScheduleofRSUsActivityLineItems" xlink:to="arbe_ShareholdersEquityDetailsScheduleofRSUsActivityTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AwardTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AwardTypeAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="arbe_ShareholdersEquityDetailsScheduleofRSUsActivityTable" xlink:to="us-gaap_AwardTypeAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RestrictedStockUnitsRSUMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_RestrictedStockUnitsRSUMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="arbe_RsusAbstract" xlink:href="arbe-20231231.xsd#arbe_RsusAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="arbe_ShareholdersEquityDetailsScheduleofRSUsActivityLineItems" xlink:to="arbe_RsusAbstract" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="arbe_ShareholdersEquityDetailsScheduleofRSUsActivityLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="arbe_ShareholdersEquityDetailsScheduleofRSUsActivityLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="arbe_ShareholdersEquityDetailsScheduleofRSUsActivityLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsPeriodIncreaseDecrease" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsPeriodIncreaseDecrease"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="arbe_ShareholdersEquityDetailsScheduleofRSUsActivityLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsPeriodIncreaseDecrease" order="5" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.arberobotics.com/role/ScheduleofCompensationtoEmployeesTable">
    <loc xlink:type="locator" xlink:label="arbe_ShareholdersEquityDetailsScheduleofCompensationtoEmployeesLineItems" xlink:href="arbe-20231231.xsd#arbe_ShareholdersEquityDetailsScheduleofCompensationtoEmployeesLineItems"/>
    <loc xlink:type="locator" xlink:label="arbe_ShareholdersEquityDetailsScheduleofCompensationtoEmployeesTable" xlink:href="arbe-20231231.xsd#arbe_ShareholdersEquityDetailsScheduleofCompensationtoEmployeesTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="arbe_ShareholdersEquityDetailsScheduleofCompensationtoEmployeesLineItems" xlink:to="arbe_ShareholdersEquityDetailsScheduleofCompensationtoEmployeesTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_RangeAxis" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="arbe_ShareholdersEquityDetailsScheduleofCompensationtoEmployeesTable" xlink:to="srt_RangeAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_RangeMember" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_RangeMember_0" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_MinimumMember" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MinimumMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MinimumMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_MaximumMember" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="arbe_ShareholdersEquityDetailsScheduleofCompensationtoEmployeesLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="arbe_ShareholdersEquityDetailsScheduleofCompensationtoEmployeesLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="arbe_ShareholdersEquityDetailsScheduleofCompensationtoEmployeesLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="arbe_ShareholdersEquityDetailsScheduleofCompensationtoEmployeesLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" order="4" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.arberobotics.com/role/ScheduleofShareBasedCompensationExpenseTable">
    <loc xlink:type="locator" xlink:label="arbe_ShareholdersEquityDetailsScheduleofShareBasedCompensationExpenseLineItems" xlink:href="arbe-20231231.xsd#arbe_ShareholdersEquityDetailsScheduleofShareBasedCompensationExpenseLineItems"/>
    <loc xlink:type="locator" xlink:label="arbe_ShareholdersEquityDetailsScheduleofShareBasedCompensationExpenseTable" xlink:href="arbe-20231231.xsd#arbe_ShareholdersEquityDetailsScheduleofShareBasedCompensationExpenseTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="arbe_ShareholdersEquityDetailsScheduleofShareBasedCompensationExpenseLineItems" xlink:to="arbe_ShareholdersEquityDetailsScheduleofShareBasedCompensationExpenseTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeStatementLocationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="arbe_ShareholdersEquityDetailsScheduleofShareBasedCompensationExpenseTable" xlink:to="us-gaap_IncomeStatementLocationAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeStatementLocationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_IncomeStatementLocationDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeStatementLocationDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_IncomeStatementLocationDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ResearchAndDevelopmentExpenseMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="us-gaap_ResearchAndDevelopmentExpenseMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SellingAndMarketingExpenseMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SellingAndMarketingExpenseMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="us-gaap_SellingAndMarketingExpenseMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_GeneralAndAdministrativeExpenseMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GeneralAndAdministrativeExpenseMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="us-gaap_GeneralAndAdministrativeExpenseMember" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CostOfSalesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CostOfSalesMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="us-gaap_CostOfSalesMember" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensation"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="arbe_ShareholdersEquityDetailsScheduleofShareBasedCompensationExpenseLineItems" xlink:to="us-gaap_ShareBasedCompensation" order="1" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.arberobotics.com/role/ScheduleofSetsForththeComputationofBasicandDilutedNetLossPerShareAttributableTable">
    <loc xlink:type="locator" xlink:label="arbe_ScheduleOfSetsForthTheComputationOfBasicAndDilutedNetLossPerShareAttributableAbstract" xlink:href="arbe-20231231.xsd#arbe_ScheduleOfSetsForthTheComputationOfBasicAndDilutedNetLossPerShareAttributableAbstract"/>
    <loc xlink:type="locator" xlink:label="arbe_NumeratorAbstract" xlink:href="arbe-20231231.xsd#arbe_NumeratorAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="arbe_ScheduleOfSetsForthTheComputationOfBasicAndDilutedNetLossPerShareAttributableAbstract" xlink:to="arbe_NumeratorAbstract" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetIncomeLossAttributableToNonredeemableNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLossAttributableToNonredeemableNoncontrollingInterest"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="arbe_NumeratorAbstract" xlink:to="us-gaap_NetIncomeLossAttributableToNonredeemableNoncontrollingInterest" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="arbe_DenominatorAbstract" xlink:href="arbe-20231231.xsd#arbe_DenominatorAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="arbe_ScheduleOfSetsForthTheComputationOfBasicAndDilutedNetLossPerShareAttributableAbstract" xlink:to="arbe_DenominatorAbstract" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="arbe_DenominatorAbstract" xlink:to="us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EarningsPerShareBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareBasic"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="arbe_DenominatorAbstract" xlink:to="us-gaap_EarningsPerShareBasic" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="arbe_NumeratorAbstract0" xlink:href="arbe-20231231.xsd#arbe_NumeratorAbstract0"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="arbe_ScheduleOfSetsForthTheComputationOfBasicAndDilutedNetLossPerShareAttributableAbstract" xlink:to="arbe_NumeratorAbstract0" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_TemporaryEquityAccretionToRedemptionValueAdjustment" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TemporaryEquityAccretionToRedemptionValueAdjustment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="arbe_NumeratorAbstract0" xlink:to="us-gaap_TemporaryEquityAccretionToRedemptionValueAdjustment" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="arbe_DenominatorAbstract0" xlink:href="arbe-20231231.xsd#arbe_DenominatorAbstract0"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="arbe_ScheduleOfSetsForthTheComputationOfBasicAndDilutedNetLossPerShareAttributableAbstract" xlink:to="arbe_DenominatorAbstract0" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="arbe_DenominatorAbstract0" xlink:to="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EarningsPerShareDiluted" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareDiluted"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="arbe_DenominatorAbstract0" xlink:to="us-gaap_EarningsPerShareDiluted" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceOfWarrants" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromIssuanceOfWarrants"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="arbe_ScheduleOfSetsForthTheComputationOfBasicAndDilutedNetLossPerShareAttributableAbstract" xlink:to="us-gaap_ProceedsFromIssuanceOfWarrants" order="4" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.arberobotics.com/role/ScheduleofOrdinarySharesthatwereExcludedfromtheComputationofDilutedNetLossPerShareTable">
    <loc xlink:type="locator" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="us-gaap_AntidilutiveSecuritiesNameDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AntidilutiveSecuritiesNameDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="us-gaap_AntidilutiveSecuritiesNameDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConvertiblePreferredStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConvertiblePreferredStockMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="us-gaap_ConvertiblePreferredStockMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="arbe_OutstandingShareOptionsMember" xlink:href="arbe-20231231.xsd#arbe_OutstandingShareOptionsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="arbe_OutstandingShareOptionsMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" order="1" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.arberobotics.com/role/ScheduleofCompanysLossBeforeIncomeTaxesTable">
    <loc xlink:type="locator" xlink:label="arbe_ScheduleOfCompanysLossBeforeIncomeTaxesAbstract" xlink:href="arbe-20231231.xsd#arbe_ScheduleOfCompanysLossBeforeIncomeTaxesAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="arbe_ScheduleOfCompanysLossBeforeIncomeTaxesAbstract" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="arbe_ScheduleOfCompanysLossBeforeIncomeTaxesAbstract" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="arbe_ScheduleOfCompanysLossBeforeIncomeTaxesAbstract" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" order="2" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.arberobotics.com/role/ScheduleofReconciliationIncomeTaxBenefitTable">
    <loc xlink:type="locator" xlink:label="arbe_ScheduleOfReconciliationIncomeTaxBenefitAbstract" xlink:href="arbe-20231231.xsd#arbe_ScheduleOfReconciliationIncomeTaxBenefitAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="arbe_ScheduleOfReconciliationIncomeTaxBenefitAbstract" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="arbe_ScheduleOfReconciliationIncomeTaxBenefitAbstract" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="arbe_ScheduleOfReconciliationIncomeTaxBenefitAbstract" xlink:to="us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxReconciliationNondeductibleExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxReconciliationNondeductibleExpense"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="arbe_ScheduleOfReconciliationIncomeTaxBenefitAbstract" xlink:to="us-gaap_IncomeTaxReconciliationNondeductibleExpense" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="arbe_ScheduleOfReconciliationIncomeTaxBenefitAbstract" xlink:to="us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="arbe_ScheduleOfReconciliationIncomeTaxBenefitAbstract" xlink:to="us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxReconciliationOtherAdjustments" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxReconciliationOtherAdjustments"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="arbe_ScheduleOfReconciliationIncomeTaxBenefitAbstract" xlink:to="us-gaap_IncomeTaxReconciliationOtherAdjustments" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="arbe_ScheduleOfReconciliationIncomeTaxBenefitAbstract" xlink:to="us-gaap_IncomeTaxExpenseBenefit" order="7" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.arberobotics.com/role/ScheduleofDeferredTaxAssetsTable">
    <loc xlink:type="locator" xlink:label="arbe_ScheduleOfDeferredTaxAssetsAbstract" xlink:href="arbe-20231231.xsd#arbe_ScheduleOfDeferredTaxAssetsAbstract"/>
    <loc xlink:type="locator" xlink:label="arbe_DeferredTaxAssetsAbstract" xlink:href="arbe-20231231.xsd#arbe_DeferredTaxAssetsAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="arbe_ScheduleOfDeferredTaxAssetsAbstract" xlink:to="arbe_DeferredTaxAssetsAbstract" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="arbe_DeferredTaxAssetsAbstract" xlink:to="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="arbe_DeferredTaxAssetsAbstract" xlink:to="us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="arbe_DeferredTaxAssetsAbstract" xlink:to="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="arbe_DeferredTaxAssetsAbstract" xlink:to="us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsGross" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="arbe_DeferredTaxAssetsAbstract" xlink:to="us-gaap_DeferredTaxAssetsGross" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="arbe_ScheduleOfDeferredTaxAssetsAbstract" xlink:to="us-gaap_DeferredTaxAssetsValuationAllowance" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="arbe_ScheduleOfDeferredTaxAssetsAbstract" xlink:to="us-gaap_DeferredTaxAssetsLiabilitiesNet" order="2" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.arberobotics.com/role/ScheduleofPropertyandEquipmentNetofDepreciationbyGeographicRegionTable">
    <loc xlink:type="locator" xlink:label="arbe_SegmentInformationDetailsScheduleofPropertyandEquipmentNetofDepreciationbyGeographicRegionLineItems" xlink:href="arbe-20231231.xsd#arbe_SegmentInformationDetailsScheduleofPropertyandEquipmentNetofDepreciationbyGeographicRegionLineItems"/>
    <loc xlink:type="locator" xlink:label="arbe_SegmentInformationDetailsScheduleofPropertyandEquipmentNetofDepreciationbyGeographicRegionTable" xlink:href="arbe-20231231.xsd#arbe_SegmentInformationDetailsScheduleofPropertyandEquipmentNetofDepreciationbyGeographicRegionTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="arbe_SegmentInformationDetailsScheduleofPropertyandEquipmentNetofDepreciationbyGeographicRegionLineItems" xlink:to="arbe_SegmentInformationDetailsScheduleofPropertyandEquipmentNetofDepreciationbyGeographicRegionTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_StatementGeographicalAxis" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_StatementGeographicalAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="arbe_SegmentInformationDetailsScheduleofPropertyandEquipmentNetofDepreciationbyGeographicRegionTable" xlink:to="srt_StatementGeographicalAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_SegmentGeographicalDomain" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_SegmentGeographicalDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_StatementGeographicalAxis" xlink:to="srt_SegmentGeographicalDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_SegmentGeographicalDomain_0" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_SegmentGeographicalDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_StatementGeographicalAxis" xlink:to="srt_SegmentGeographicalDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="country_IL" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_IL"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_SegmentGeographicalDomain" xlink:to="country_IL" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="country_US" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_US"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_SegmentGeographicalDomain" xlink:to="country_US" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentNet" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="arbe_SegmentInformationDetailsScheduleofPropertyandEquipmentNetofDepreciationbyGeographicRegionLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentNet" order="1" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.arberobotics.com/role/GeneralDetails">
    <loc xlink:type="locator" xlink:label="arbe_GeneralDetailsLineItems" xlink:href="arbe-20231231.xsd#arbe_GeneralDetailsLineItems"/>
    <loc xlink:type="locator" xlink:label="arbe_GeneralDetailsTable" xlink:href="arbe-20231231.xsd#arbe_GeneralDetailsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="arbe_GeneralDetailsLineItems" xlink:to="arbe_GeneralDetailsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesAxis" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidatedEntitiesAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="arbe_GeneralDetailsTable" xlink:to="srt_ConsolidatedEntitiesAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesDomain" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidatedEntitiesDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="srt_ConsolidatedEntitiesDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesDomain_0" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidatedEntitiesDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="srt_ConsolidatedEntitiesDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementClassOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementClassOfStockAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="arbe_GeneralDetailsTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_RangeAxis" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="arbe_GeneralDetailsTable" xlink:to="srt_RangeAxis" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_RangeMember" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_RangeMember_0" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsidiarySaleOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="arbe_GeneralDetailsTable" xlink:to="us-gaap_SubsidiarySaleOfStockAxis" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="arbe_ArbeRoboticsLtdMember" xlink:href="arbe-20231231.xsd#arbe_ArbeRoboticsLtdMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_ConsolidatedEntitiesDomain" xlink:to="arbe_ArbeRoboticsLtdMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_MinimumMember" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MinimumMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MinimumMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_MaximumMember" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="arbe_PublicWarrantsMember" xlink:href="arbe-20231231.xsd#arbe_PublicWarrantsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="arbe_PublicWarrantsMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="arbe_PrivateWarrantsMember" xlink:href="arbe-20231231.xsd#arbe_PrivateWarrantsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="arbe_PrivateWarrantsMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="arbe_PIPEMember" xlink:href="arbe-20231231.xsd#arbe_PIPEMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="arbe_PIPEMember" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_CommonStockMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockOtherSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockOtherSharesOutstanding"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="arbe_GeneralDetailsLineItems" xlink:to="us-gaap_CommonStockOtherSharesOutstanding" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharesIssuedPricePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharesIssuedPricePerShare"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="arbe_GeneralDetailsLineItems" xlink:to="us-gaap_SharesIssuedPricePerShare" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PaymentsOfOrdinaryDividends" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsOfOrdinaryDividends"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="arbe_GeneralDetailsLineItems" xlink:to="us-gaap_PaymentsOfOrdinaryDividends" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightOutstanding"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="arbe_GeneralDetailsLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightOutstanding" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceInitialPublicOffering" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromIssuanceInitialPublicOffering"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="arbe_GeneralDetailsLineItems" xlink:to="us-gaap_ProceedsFromIssuanceInitialPublicOffering" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SaleOfStockConsiderationReceivedOnTransaction"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="arbe_GeneralDetailsLineItems" xlink:to="us-gaap_SaleOfStockConsiderationReceivedOnTransaction" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="arbe_GeneralDetailsLineItems" xlink:to="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" order="7" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.arberobotics.com/role/SignificantAccountingPoliciesDetails">
    <loc xlink:type="locator" xlink:label="arbe_SignificantAccountingPoliciesDetailsLineItems" xlink:href="arbe-20231231.xsd#arbe_SignificantAccountingPoliciesDetailsLineItems"/>
    <loc xlink:type="locator" xlink:label="arbe_SignificantAccountingPoliciesDetailsTable" xlink:href="arbe-20231231.xsd#arbe_SignificantAccountingPoliciesDetailsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="arbe_SignificantAccountingPoliciesDetailsLineItems" xlink:to="arbe_SignificantAccountingPoliciesDetailsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_RangeAxis" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="arbe_SignificantAccountingPoliciesDetailsTable" xlink:to="srt_RangeAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_RangeMember" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_RangeMember_0" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_MinimumMember" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MinimumMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MinimumMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_MaximumMember" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_DemandDepositLiabilitiesInterestBearingAverageRatePaid" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_DemandDepositLiabilitiesInterestBearingAverageRatePaid"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="arbe_SignificantAccountingPoliciesDetailsLineItems" xlink:to="srt_DemandDepositLiabilitiesInterestBearingAverageRatePaid" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="arbe_SeverancePercentageOfMonthlySalary" xlink:href="arbe-20231231.xsd#arbe_SeverancePercentageOfMonthlySalary"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="arbe_SignificantAccountingPoliciesDetailsLineItems" xlink:to="arbe_SeverancePercentageOfMonthlySalary" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SeveranceCosts1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SeveranceCosts1"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="arbe_SignificantAccountingPoliciesDetailsLineItems" xlink:to="us-gaap_SeveranceCosts1" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="arbe_SignificantAccountingPoliciesDetailsLineItems" xlink:to="us-gaap_EffectiveIncomeTaxRateContinuingOperations" order="4" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.arberobotics.com/role/RevenueDetails">
    <loc xlink:type="locator" xlink:label="us-gaap_RevenuesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenuesAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredRevenue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredRevenue"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RevenuesAbstract" xlink:to="us-gaap_DeferredRevenue" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RevenueRemainingPerformanceObligation" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueRemainingPerformanceObligation"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RevenuesAbstract" xlink:to="us-gaap_RevenueRemainingPerformanceObligation" order="1" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.arberobotics.com/role/PropertyandEquipmentDetails">
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Depreciation" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Depreciation"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentAbstract" xlink:to="us-gaap_Depreciation" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.arberobotics.com/role/CommitmentsandContingentLiabilitiesDetails">
    <loc xlink:type="locator" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_GrantsReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GrantsReceivable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_GrantsReceivable" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="arbe_RoyaltyPercentage" xlink:href="arbe-20231231.xsd#arbe_RoyaltyPercentage"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="arbe_RoyaltyPercentage" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="arbe_GrantsReceived" xlink:href="arbe-20231231.xsd#arbe_GrantsReceived"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="arbe_GrantsReceived" order="2" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.arberobotics.com/role/WarrantsLiabilitiesDetails">
    <loc xlink:type="locator" xlink:label="arbe_WarrantsLiabilitiesDetailsLineItems" xlink:href="arbe-20231231.xsd#arbe_WarrantsLiabilitiesDetailsLineItems"/>
    <loc xlink:type="locator" xlink:label="arbe_WarrantsLiabilitiesDetailsTable" xlink:href="arbe-20231231.xsd#arbe_WarrantsLiabilitiesDetailsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="arbe_WarrantsLiabilitiesDetailsLineItems" xlink:to="arbe_WarrantsLiabilitiesDetailsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsidiarySaleOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="arbe_WarrantsLiabilitiesDetailsTable" xlink:to="us-gaap_SubsidiarySaleOfStockAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PrivatePlacementMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PrivatePlacementMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="us-gaap_PrivatePlacementMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AdditionalCollateralAggregateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdditionalCollateralAggregateFairValue"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="arbe_WarrantsLiabilitiesDetailsLineItems" xlink:to="us-gaap_AdditionalCollateralAggregateFairValue" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="arbe_DerivativeWarrantLiabilityShares" xlink:href="arbe-20231231.xsd#arbe_DerivativeWarrantLiabilityShares"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="arbe_WarrantsLiabilitiesDetailsLineItems" xlink:to="arbe_DerivativeWarrantLiabilityShares" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="arbe_WarrantsLiabilitiesDetailsLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueAdjustmentOfWarrants" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAdjustmentOfWarrants"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="arbe_WarrantsLiabilitiesDetailsLineItems" xlink:to="us-gaap_FairValueAdjustmentOfWarrants" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceOfWarrants" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromIssuanceOfWarrants"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="arbe_WarrantsLiabilitiesDetailsLineItems" xlink:to="us-gaap_ProceedsFromIssuanceOfWarrants" order="5" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.arberobotics.com/role/ShareholdersEquityDetails">
    <loc xlink:type="locator" xlink:label="arbe_ShareholdersEquityDetailsLineItems" xlink:href="arbe-20231231.xsd#arbe_ShareholdersEquityDetailsLineItems"/>
    <loc xlink:type="locator" xlink:label="arbe_ShareholdersEquityDetailsTable" xlink:href="arbe-20231231.xsd#arbe_ShareholdersEquityDetailsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="arbe_ShareholdersEquityDetailsLineItems" xlink:to="arbe_ShareholdersEquityDetailsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_TitleOfIndividualAxis" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_TitleOfIndividualAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="arbe_ShareholdersEquityDetailsTable" xlink:to="srt_TitleOfIndividualAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_TitleOfIndividualAxis" xlink:to="srt_TitleOfIndividualWithRelationshipToEntityDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_TitleOfIndividualWithRelationshipToEntityDomain_0" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_TitleOfIndividualAxis" xlink:to="srt_TitleOfIndividualWithRelationshipToEntityDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PlanNameAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PlanNameAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="arbe_ShareholdersEquityDetailsTable" xlink:to="us-gaap_PlanNameAxis" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PlanNameDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_PlanNameAxis" xlink:to="us-gaap_PlanNameDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PlanNameDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PlanNameDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_PlanNameAxis" xlink:to="us-gaap_PlanNameDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementEquityComponentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="arbe_ShareholdersEquityDetailsTable" xlink:to="us-gaap_StatementEquityComponentsAxis" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EquityComponentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EquityComponentDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_CommonStockMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="arbe_TwoThousandSixteenIncentivePlanMember" xlink:href="arbe-20231231.xsd#arbe_TwoThousandSixteenIncentivePlanMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PlanNameDomain" xlink:to="arbe_TwoThousandSixteenIncentivePlanMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="arbe_TwoThousandTwentyOneEquityIncentivePlanMember" xlink:href="arbe-20231231.xsd#arbe_TwoThousandTwentyOneEquityIncentivePlanMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PlanNameDomain" xlink:to="arbe_TwoThousandTwentyOneEquityIncentivePlanMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="arbe_PlanOneMember" xlink:href="arbe-20231231.xsd#arbe_PlanOneMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:to="arbe_PlanOneMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="arbe_ShareholdersEquityDetailsLineItems" xlink:to="us-gaap_CommonStockSharesAuthorized" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="arbe_ShareholdersEquityDetailsLineItems" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquityReverseStockSplit" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityReverseStockSplit"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="arbe_ShareholdersEquityDetailsLineItems" xlink:to="us-gaap_StockholdersEquityReverseStockSplit" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonUnitIssuanceValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonUnitIssuanceValue"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="arbe_ShareholdersEquityDetailsLineItems" xlink:to="us-gaap_CommonUnitIssuanceValue" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonUnitIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonUnitIssued"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="arbe_ShareholdersEquityDetailsLineItems" xlink:to="us-gaap_CommonUnitIssued" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharePrice"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="arbe_ShareholdersEquityDetailsLineItems" xlink:to="us-gaap_SharePrice" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="arbe_ShareholdersEquityDetailsLineItems" xlink:to="us-gaap_ProceedsFromIssuanceOfCommonStock" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="arbe_ShareholdersEquityDetailsLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" order="8" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="arbe_ShareholdersEquityDetailsLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" order="9" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="arbe_ShareholdersEquityDetailsLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardTermsOfAward" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardTermsOfAward"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="arbe_ShareholdersEquityDetailsLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardTermsOfAward" order="11" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRights" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRights"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="arbe_ShareholdersEquityDetailsLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRights" order="12" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodExpectedDividendRate" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodExpectedDividendRate"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="arbe_ShareholdersEquityDetailsLineItems" xlink:to="us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodExpectedDividendRate" order="13" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="arbe_ShareholdersEquityDetailsLineItems" xlink:to="us-gaap_AllocatedShareBasedCompensationExpense" order="14" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.arberobotics.com/role/TaxesonIncomeDetails">
    <loc xlink:type="locator" xlink:label="arbe_TaxesonIncomeDetailsLineItems" xlink:href="arbe-20231231.xsd#arbe_TaxesonIncomeDetailsLineItems"/>
    <loc xlink:type="locator" xlink:label="arbe_TaxesonIncomeDetailsTable" xlink:href="arbe-20231231.xsd#arbe_TaxesonIncomeDetailsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="arbe_TaxesonIncomeDetailsLineItems" xlink:to="arbe_TaxesonIncomeDetailsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_StatementGeographicalAxis" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_StatementGeographicalAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="arbe_TaxesonIncomeDetailsTable" xlink:to="srt_StatementGeographicalAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_SegmentGeographicalDomain" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_SegmentGeographicalDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_StatementGeographicalAxis" xlink:to="srt_SegmentGeographicalDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_SegmentGeographicalDomain_0" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_SegmentGeographicalDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_StatementGeographicalAxis" xlink:to="srt_SegmentGeographicalDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="country_IL" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_IL"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_SegmentGeographicalDomain" xlink:to="country_IL" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="country_US" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_US"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_SegmentGeographicalDomain" xlink:to="country_US" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="arbe_TaxesonIncomeDetailsLineItems" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLossCarryforwards" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLossCarryforwards"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="arbe_TaxesonIncomeDetailsLineItems" xlink:to="us-gaap_OperatingLossCarryforwards" order="2" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.arberobotics.com/role/SegmentInformationDetails">
    <loc xlink:type="locator" xlink:label="us-gaap_SegmentReportingInformationLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <loc xlink:type="locator" xlink:label="arbe_SegmentInformationDetailsTable" xlink:href="arbe-20231231.xsd#arbe_SegmentInformationDetailsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_SegmentReportingInformationLineItems" xlink:to="arbe_SegmentInformationDetailsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="arbe_SegmentInformationDetailsTable" xlink:to="us-gaap_ConcentrationRiskByBenchmarkAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConcentrationRiskBenchmarkDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:to="us-gaap_ConcentrationRiskBenchmarkDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConcentrationRiskBenchmarkDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:to="us-gaap_ConcentrationRiskBenchmarkDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConcentrationRiskByTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="arbe_SegmentInformationDetailsTable" xlink:to="us-gaap_ConcentrationRiskByTypeAxis" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConcentrationRiskTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_ConcentrationRiskByTypeAxis" xlink:to="us-gaap_ConcentrationRiskTypeDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConcentrationRiskTypeDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_ConcentrationRiskByTypeAxis" xlink:to="us-gaap_ConcentrationRiskTypeDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_MajorCustomersAxis" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MajorCustomersAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="arbe_SegmentInformationDetailsTable" xlink:to="srt_MajorCustomersAxis" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_NameOfMajorCustomerDomain" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_NameOfMajorCustomerDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_MajorCustomersAxis" xlink:to="srt_NameOfMajorCustomerDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_NameOfMajorCustomerDomain_0" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_NameOfMajorCustomerDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_MajorCustomersAxis" xlink:to="srt_NameOfMajorCustomerDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CustomerConcentrationRiskMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CustomerConcentrationRiskMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ConcentrationRiskTypeDomain" xlink:to="us-gaap_CustomerConcentrationRiskMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="arbe_Customer1Member" xlink:href="arbe-20231231.xsd#arbe_Customer1Member"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_NameOfMajorCustomerDomain" xlink:to="arbe_Customer1Member" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="arbe_Customer2Member" xlink:href="arbe-20231231.xsd#arbe_Customer2Member"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_NameOfMajorCustomerDomain" xlink:to="arbe_Customer2Member" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="arbe_Customer3Member" xlink:href="arbe-20231231.xsd#arbe_Customer3Member"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_NameOfMajorCustomerDomain" xlink:to="arbe_Customer3Member" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SalesRevenueNetMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SalesRevenueNetMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ConcentrationRiskBenchmarkDomain" xlink:to="us-gaap_SalesRevenueNetMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConcentrationRiskPercentage1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SegmentReportingInformationLineItems" xlink:to="us-gaap_ConcentrationRiskPercentage1" order="1" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.arberobotics.com/role/DocumentAndEntityInformation">
    <loc xlink:type="locator" xlink:label="dei_DocumentInformationLineItems" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentInformationLineItems"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentInformationTable" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentInformationTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentInformationTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementClassOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementClassOfStockAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="dei_DocumentInformationTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityAddressesAddressTypeAxis" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressesAddressTypeAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="dei_DocumentInformationTable" xlink:to="dei_EntityAddressesAddressTypeAxis" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_AddressTypeDomain" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AddressTypeDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="dei_EntityAddressesAddressTypeAxis" xlink:to="dei_AddressTypeDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_AddressTypeDomain_0" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AddressTypeDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="dei_EntityAddressesAddressTypeAxis" xlink:to="dei_AddressTypeDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="arbe_OrdinarySharesParValueNIS0000216PerShareMember" xlink:href="arbe-20231231.xsd#arbe_OrdinarySharesParValueNIS0000216PerShareMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="arbe_OrdinarySharesParValueNIS0000216PerShareMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="arbe_WarrantsMember" xlink:href="arbe-20231231.xsd#arbe_WarrantsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="arbe_WarrantsMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_BusinessContactMember" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_BusinessContactMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_AddressTypeDomain" xlink:to="dei_BusinessContactMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityRegistrantName" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_TradingSymbol" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentType" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_CurrentFiscalYearEndDate" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CurrentFiscalYearEndDate"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_CurrentFiscalYearEndDate" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityCommonStockSharesOutstanding" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityCommonStockSharesOutstanding" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_AmendmentFlag" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityCentralIndexKey" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityCurrentReportingStatus" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCurrentReportingStatus"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityCurrentReportingStatus" order="8" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityVoluntaryFilers" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityVoluntaryFilers"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityVoluntaryFilers" order="9" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityFilerCategory" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFilerCategory"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityFilerCategory" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityWellKnownSeasonedIssuer" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityWellKnownSeasonedIssuer"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityWellKnownSeasonedIssuer" order="11" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentPeriodEndDate" order="12" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentFiscalYearFocus" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalYearFocus"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentFiscalYearFocus" order="13" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentFiscalPeriodFocus" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalPeriodFocus"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentFiscalPeriodFocus" order="14" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityEmergingGrowthCompany" order="15" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityShellCompany" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityShellCompany"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityShellCompany" order="16" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityExTransitionPeriod" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityExTransitionPeriod"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityExTransitionPeriod" order="17" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_IcfrAuditorAttestationFlag" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_IcfrAuditorAttestationFlag"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_IcfrAuditorAttestationFlag" order="18" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentRegistrationStatement" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentRegistrationStatement"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentRegistrationStatement" order="19" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentAnnualReport" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAnnualReport"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentAnnualReport" order="20" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentTransitionReport" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentTransitionReport"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentTransitionReport" order="21" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentShellCompanyReport" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentShellCompanyReport"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentShellCompanyReport" order="22" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityFileNumber" order="23" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityIncorporationStateCountryCode" order="24" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressAddressLine1" order="25" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressCityOrTown" order="26" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityAddressCountry" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCountry"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressCountry" order="27" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_ContactPersonnelName" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_ContactPersonnelName"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_ContactPersonnelName" order="28" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_CityAreaCode" order="29" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_LocalPhoneNumber" order="30" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_ContactPersonnelEmailAddress" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_ContactPersonnelEmailAddress"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_ContactPersonnelEmailAddress" order="31" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_Security12bTitle" order="32" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_SecurityExchangeName" order="33" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityInteractiveDataCurrent" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityInteractiveDataCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityInteractiveDataCurrent" order="34" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentFinStmtErrorCorrectionFlag" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFinStmtErrorCorrectionFlag"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentFinStmtErrorCorrectionFlag" order="35" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentAccountingStandard" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAccountingStandard"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentAccountingStandard" order="36" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_AuditorFirmId" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AuditorFirmId"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_AuditorFirmId" order="37" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_AuditorName" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AuditorName"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_AuditorName" order="38" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_AuditorLocation" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AuditorLocation"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_AuditorLocation" order="39" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressPostalZipCode" order="40" xbrldt:closed="true"/>
  </definitionLink>
</linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>19
<FILENAME>arbe-20231231_lab.xml
<DESCRIPTION>XBRL LABEL FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!-- Generated by CompSci Transform (tm) - http://www.compsciresources.com -->
<!-- Created: Thu Mar 28 12:24:34 UTC 2024 -->
<linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel"/>
  <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel"/>
  <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
  <labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
    <loc xlink:type="locator" xlink:label="us-gaap_StatementClassOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementClassOfStockAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementClassOfStockAxis_lbl" xml:lang="en-US">Class of Stock [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_StatementClassOfStockAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsCurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_AssetsCurrent_lbl" xml:lang="en-US">Total current assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_AssetsCurrent_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AssetsNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsNoncurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_AssetsNoncurrent_lbl" xml:lang="en-US">Total non-current assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsNoncurrent" xlink:to="us-gaap_AssetsNoncurrent_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Assets" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Assets"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_Assets_lbl" xml:lang="en-US">Total assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Assets" xlink:to="us-gaap_Assets_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesCurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_LiabilitiesCurrent_lbl" xml:lang="en-US">Total current liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_LiabilitiesCurrent_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LiabilitiesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesNoncurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_LiabilitiesNoncurrent_lbl" xml:lang="en-US">Total long-term liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesNoncurrent" xlink:to="us-gaap_LiabilitiesNoncurrent_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquity"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_StockholdersEquity_lbl" xml:lang="en-US">Total shareholders&#8217; equity</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_StockholdersEquity_lbl0" xml:lang="en-US">Balance</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_StockholdersEquity_lbl1" xml:lang="en-US">Balance</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_lbl1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity_lbl" xml:lang="en-US">Total liabilities and shareholders&#8217; equity</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_GrossProfit" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GrossProfit"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_GrossProfit_lbl" xml:lang="en-US">Gross profit (loss)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GrossProfit" xlink:to="us-gaap_GrossProfit_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingExpenses" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingExpenses"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_OperatingExpenses_lbl" xml:lang="en-US">Total operating expenses</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingExpenses" xlink:to="us-gaap_OperatingExpenses_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingIncomeLoss"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_OperatingIncomeLoss_lbl" xml:lang="en-US">Operating loss</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="us-gaap_OperatingIncomeLoss_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetIncomeLoss_lbl" xml:lang="en-US">Net loss</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_NetIncomeLoss_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_NetIncomeLoss_lbl0" xml:lang="en-US">Net loss</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_NetIncomeLoss_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharesOutstanding"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_SharesOutstanding_lbl" xml:lang="en-US">Balance (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesOutstanding" xlink:to="us-gaap_SharesOutstanding_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_SharesOutstanding_lbl0" xml:lang="en-US">Balance (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesOutstanding" xlink:to="us-gaap_SharesOutstanding_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementEquityComponentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementEquityComponentsAxis_lbl" xml:lang="en-US">Equity Components [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_StatementEquityComponentsAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl" xml:lang="en-US">Net cash used in operating activities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl" xml:lang="en-US">Net cash used in investing activities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl" xml:lang="en-US">Net cash provided by (used in) financing activities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_lbl" xml:lang="en-US">Increase (decrease) in cash, cash equivalents and restricted cash</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl" xml:lang="en-US">Cash, cash equivalents and restricted cash at the beginning of the year</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl0" xml:lang="en-US">Cash, cash equivalents and restricted cash at the end of the year</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_lbl" xml:lang="en-US">General [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccountingPoliciesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountingPoliciesAbstract_lbl" xml:lang="en-US">Significant Accounting Policies [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_AccountingPoliciesAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis_lbl" xml:lang="en-US">Long-Lived Tangible Asset [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_PropertyPlantAndEquipmentByTypeAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="srt_RangeAxis" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_RangeAxis_lbl" xml:lang="en-US">Statistical Measurement [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_RangeAxis" xlink:to="srt_RangeAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RevenuesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenuesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RevenuesAbstract_lbl" xml:lang="en-US">Revenue [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenuesAbstract" xlink:to="us-gaap_RevenuesAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="srt_StatementGeographicalAxis" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_StatementGeographicalAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_StatementGeographicalAxis_lbl" xml:lang="en-US">Geographical [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_StatementGeographicalAxis" xlink:to="srt_StatementGeographicalAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="srt_ProductOrServiceAxis" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ProductOrServiceAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_ProductOrServiceAxis_lbl" xml:lang="en-US">Product and Service [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_ProductOrServiceAxis" xlink:to="srt_ProductOrServiceAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherAssetsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAssetsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherAssetsAbstract_lbl" xml:lang="en-US">Prepaid Expenses and Other Receivables [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherAssetsAbstract" xlink:to="us-gaap_OtherAssetsAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="arbe_ScheduleOfPrepaidExpensesAndOtherReceivablesAbstract" xlink:href="arbe-20231231.xsd#arbe_ScheduleOfPrepaidExpensesAndOtherReceivablesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="arbe_ScheduleOfPrepaidExpensesAndOtherReceivablesAbstract_lbl" xml:lang="en-US">Schedule of Prepaid Expenses and Other Receivables [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_ScheduleOfPrepaidExpensesAndOtherReceivablesAbstract" xlink:to="arbe_ScheduleOfPrepaidExpensesAndOtherReceivablesAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PrepaidExpenseAndOtherAssetsNoncurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsNoncurrent_lbl" xml:lang="en-US">Total</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PrepaidExpenseAndOtherAssetsNoncurrent" xlink:to="us-gaap_PrepaidExpenseAndOtherAssetsNoncurrent_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentAbstract_lbl" xml:lang="en-US">Property and Equipment [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentAbstract" xlink:to="us-gaap_PropertyPlantAndEquipmentAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentNet" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_PropertyPlantAndEquipmentNet_lbl" xml:lang="en-US">Property and equipment, net</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentNet" xlink:to="us-gaap_PropertyPlantAndEquipmentNet_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_PropertyPlantAndEquipmentNet_lbl0" xml:lang="en-US">Property and equipment, net</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentNet" xlink:to="us-gaap_PropertyPlantAndEquipmentNet_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_PropertyPlantAndEquipmentNet_lbl1" xml:lang="en-US">Total property and equipment, net:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentNet" xlink:to="us-gaap_PropertyPlantAndEquipmentNet_lbl1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LeasesOperatingAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeasesOperatingAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LeasesOperatingAbstract_lbl" xml:lang="en-US">Leases [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LeasesOperatingAbstract" xlink:to="us-gaap_LeasesOperatingAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="arbe_ScheduleOfSupplementalCashFlowInformationRelatedToLeasesAbstract" xlink:href="arbe-20231231.xsd#arbe_ScheduleOfSupplementalCashFlowInformationRelatedToLeasesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="arbe_ScheduleOfSupplementalCashFlowInformationRelatedToLeasesAbstract_lbl" xml:lang="en-US">Schedule of Supplemental Cash Flow Information Related to Leases [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_ScheduleOfSupplementalCashFlowInformationRelatedToLeasesAbstract" xlink:to="arbe_ScheduleOfSupplementalCashFlowInformationRelatedToLeasesAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="arbe_ScheduleOfMaturitiesOfLeaseLiabilitiesAbstract" xlink:href="arbe-20231231.xsd#arbe_ScheduleOfMaturitiesOfLeaseLiabilitiesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="arbe_ScheduleOfMaturitiesOfLeaseLiabilitiesAbstract_lbl" xml:lang="en-US">Schedule of Maturities of Lease Liabilities [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_ScheduleOfMaturitiesOfLeaseLiabilitiesAbstract" xlink:to="arbe_ScheduleOfMaturitiesOfLeaseLiabilitiesAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_lbl" xml:lang="en-US">Total lease payments</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_lbl"/>
    <loc xlink:type="locator" xlink:label="arbe_ScheduleOfSupplementalBalanceSheetInformationRelatedToOperatingLeasesAbstract" xlink:href="arbe-20231231.xsd#arbe_ScheduleOfSupplementalBalanceSheetInformationRelatedToOperatingLeasesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="arbe_ScheduleOfSupplementalBalanceSheetInformationRelatedToOperatingLeasesAbstract_lbl" xml:lang="en-US">Schedule of Supplemental Balance Sheet Information Related to Operating Leases [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_ScheduleOfSupplementalBalanceSheetInformationRelatedToOperatingLeasesAbstract" xlink:to="arbe_ScheduleOfSupplementalBalanceSheetInformationRelatedToOperatingLeasesAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract_lbl" xml:lang="en-US">Commitments and Contingent Liabilities [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_lbl" xml:lang="en-US">Warrants Liabilities [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:to="us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquityNoteAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityNoteAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquityNoteAbstract_lbl" xml:lang="en-US">Shareholders&#8217; Equity [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityNoteAbstract" xlink:to="us-gaap_StockholdersEquityNoteAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl" xml:lang="en-US">Outstanding share options ending balance</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl" xml:lang="en-US">Weighted-average exercise price ending balance (in Dollars per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_lbl" xml:lang="en-US">Aggregate intrinsic value ending balance (in Dollars)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_lbl" xml:lang="en-US">Outstanding, Numbers of RSUs, beginning balance</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_lbl0" xml:lang="en-US">Outstanding, Numbers of RSUs, ending balance</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeStatementLocationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeStatementLocationAxis_lbl" xml:lang="en-US">Income Statement Location [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_IncomeStatementLocationAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EarningsPerShareAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerShareAbstract_lbl" xml:lang="en-US">Net Loss Per Share Attributible to Ordinary Sharholders [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="us-gaap_EarningsPerShareAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="arbe_ScheduleOfOrdinarySharesThatWereExcludedFromTheComputationOfDilutedNetLossPerShareAbstract" xlink:href="arbe-20231231.xsd#arbe_ScheduleOfOrdinarySharesThatWereExcludedFromTheComputationOfDilutedNetLossPerShareAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="arbe_ScheduleOfOrdinarySharesThatWereExcludedFromTheComputationOfDilutedNetLossPerShareAbstract_lbl" xml:lang="en-US">Schedule of Ordinary Shares That Were Excluded From the Computation of Diluted Net Loss Per Share [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_ScheduleOfOrdinarySharesThatWereExcludedFromTheComputationOfDilutedNetLossPerShareAbstract" xlink:to="arbe_ScheduleOfOrdinarySharesThatWereExcludedFromTheComputationOfDilutedNetLossPerShareAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_lbl" xml:lang="en-US">Antidilutive Securities [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxDisclosureAbstract_lbl" xml:lang="en-US">Taxes on Income [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_IncomeTaxDisclosureAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="arbe_ScheduleOfCompanysLossBeforeIncomeTaxesAbstract" xlink:href="arbe-20231231.xsd#arbe_ScheduleOfCompanysLossBeforeIncomeTaxesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="arbe_ScheduleOfCompanysLossBeforeIncomeTaxesAbstract_lbl" xml:lang="en-US">Schedule of Company&#8217;s Loss Before Income Taxes [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_ScheduleOfCompanysLossBeforeIncomeTaxesAbstract" xlink:to="arbe_ScheduleOfCompanysLossBeforeIncomeTaxesAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_lbl" xml:lang="en-US">Total</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_lbl0" xml:lang="en-US">Loss before income taxes, as reported in the consolidated statements of operations</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_lbl0"/>
    <loc xlink:type="locator" xlink:label="arbe_ScheduleOfReconciliationIncomeTaxBenefitAbstract" xlink:href="arbe-20231231.xsd#arbe_ScheduleOfReconciliationIncomeTaxBenefitAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="arbe_ScheduleOfReconciliationIncomeTaxBenefitAbstract_lbl" xml:lang="en-US">Schedule of Reconciliation Income Tax Benefit [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_ScheduleOfReconciliationIncomeTaxBenefitAbstract" xlink:to="arbe_ScheduleOfReconciliationIncomeTaxBenefitAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_IncomeTaxExpenseBenefit_lbl" xml:lang="en-US">Reported income taxes benefit</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="us-gaap_IncomeTaxExpenseBenefit_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsGross" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_DeferredTaxAssetsGross_lbl" xml:lang="en-US">Total deferred tax assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsGross" xlink:to="us-gaap_DeferredTaxAssetsGross_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_DeferredTaxAssetsLiabilitiesNet_lbl" xml:lang="en-US">Deferred tax assets, net of valuation allowance</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:to="us-gaap_DeferredTaxAssetsLiabilitiesNet_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SegmentReportingInformationRevenueAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentReportingInformationRevenueAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SegmentReportingInformationRevenueAbstract_lbl" xml:lang="en-US">Segment Information [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SegmentReportingInformationRevenueAbstract" xlink:to="us-gaap_SegmentReportingInformationRevenueAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AssetsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AssetsAbstract_lbl" xml:lang="en-US">ASSETS</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_AssetsAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="arbe_UnlabeledAbstract" xlink:href="arbe-20231231.xsd#arbe_UnlabeledAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="arbe_UnlabeledAbstract_lbl" xml:lang="en-US"></label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_UnlabeledAbstract" xlink:to="arbe_UnlabeledAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AssetsCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsCurrentAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AssetsCurrentAbstract_lbl" xml:lang="en-US">CURRENT ASSETS:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_AssetsCurrentAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl" xml:lang="en-US">Cash and cash equivalents</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RestrictedCashCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedCashCurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_RestrictedCashCurrent_lbl" xml:lang="en-US">Restricted cash</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RestrictedCashCurrent" xlink:to="us-gaap_RestrictedCashCurrent_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShortTermInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShortTermInvestments"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShortTermInvestments_lbl" xml:lang="en-US">Short term bank deposits</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShortTermInvestments" xlink:to="us-gaap_ShortTermInvestments_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccountsReceivableNetCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AccountsReceivableNetCurrent_lbl" xml:lang="en-US">Trade receivable</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsReceivableNetCurrent" xlink:to="us-gaap_AccountsReceivableNetCurrent_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_lbl" xml:lang="en-US">Prepaid expenses and other receivables</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_lbl"/>
    <loc xlink:type="locator" xlink:label="arbe_UnlabeledAbstract0" xlink:href="arbe-20231231.xsd#arbe_UnlabeledAbstract0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="arbe_UnlabeledAbstract0_lbl" xml:lang="en-US"></label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_UnlabeledAbstract0" xlink:to="arbe_UnlabeledAbstract0_lbl"/>
    <loc xlink:type="locator" xlink:label="arbe_UnlabeledAbstract1" xlink:href="arbe-20231231.xsd#arbe_UnlabeledAbstract1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="arbe_UnlabeledAbstract1_lbl" xml:lang="en-US"></label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_UnlabeledAbstract1" xlink:to="arbe_UnlabeledAbstract1_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AssetsNoncurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsNoncurrentAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AssetsNoncurrentAbstract_lbl" xml:lang="en-US">NON-CURRENT ASSETS:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsNoncurrentAbstract" xlink:to="us-gaap_AssetsNoncurrentAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="arbe_UnlabeledAbstract2" xlink:href="arbe-20231231.xsd#arbe_UnlabeledAbstract2"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="arbe_UnlabeledAbstract2_lbl" xml:lang="en-US"></label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_UnlabeledAbstract2" xlink:to="arbe_UnlabeledAbstract2_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset_lbl" xml:lang="en-US">Operating lease right-of-use assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseRightOfUseAsset" xlink:to="us-gaap_OperatingLeaseRightOfUseAsset_lbl"/>
    <loc xlink:type="locator" xlink:label="arbe_UnlabeledAbstract3" xlink:href="arbe-20231231.xsd#arbe_UnlabeledAbstract3"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="arbe_UnlabeledAbstract3_lbl" xml:lang="en-US"></label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_UnlabeledAbstract3" xlink:to="arbe_UnlabeledAbstract3_lbl"/>
    <loc xlink:type="locator" xlink:label="arbe_UnlabeledAbstract4" xlink:href="arbe-20231231.xsd#arbe_UnlabeledAbstract4"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="arbe_UnlabeledAbstract4_lbl" xml:lang="en-US"></label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_UnlabeledAbstract4" xlink:to="arbe_UnlabeledAbstract4_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl" xml:lang="en-US">LIABILITIES AND SHAREHOLDERS&#8217; EQUITY</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="arbe_UnlabeledAbstract5" xlink:href="arbe-20231231.xsd#arbe_UnlabeledAbstract5"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="arbe_UnlabeledAbstract5_lbl" xml:lang="en-US"></label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_UnlabeledAbstract5" xlink:to="arbe_UnlabeledAbstract5_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LiabilitiesCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_LiabilitiesCurrentAbstract_lbl" xml:lang="en-US">CURRENT LIABILITIES:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_LiabilitiesCurrentAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccountsPayableTradeCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsPayableTradeCurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AccountsPayableTradeCurrent_lbl" xml:lang="en-US">Trade payables</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableTradeCurrent" xlink:to="us-gaap_AccountsPayableTradeCurrent_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent_lbl" xml:lang="en-US">Operating lease liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseLiabilityCurrent" xlink:to="us-gaap_OperatingLeaseLiabilityCurrent_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent_lbl0" xml:lang="en-US">Current maturities of operating leases</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseLiabilityCurrent" xlink:to="us-gaap_OperatingLeaseLiabilityCurrent_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_EmployeeRelatedLiabilitiesCurrent_lbl" xml:lang="en-US">Employees and payroll accruals</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:to="us-gaap_EmployeeRelatedLiabilitiesCurrent_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredRevenueCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredRevenueCurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DeferredRevenueCurrent_lbl" xml:lang="en-US">Deferred revenue</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredRevenueCurrent" xlink:to="us-gaap_DeferredRevenueCurrent_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent_lbl" xml:lang="en-US">Accrued expenses and other payables</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent" xlink:to="us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent_lbl"/>
    <loc xlink:type="locator" xlink:label="arbe_UnlabeledAbstract6" xlink:href="arbe-20231231.xsd#arbe_UnlabeledAbstract6"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="arbe_UnlabeledAbstract6_lbl" xml:lang="en-US"></label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_UnlabeledAbstract6" xlink:to="arbe_UnlabeledAbstract6_lbl"/>
    <loc xlink:type="locator" xlink:label="arbe_UnlabeledAbstract7" xlink:href="arbe-20231231.xsd#arbe_UnlabeledAbstract7"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="arbe_UnlabeledAbstract7_lbl" xml:lang="en-US"></label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_UnlabeledAbstract7" xlink:to="arbe_UnlabeledAbstract7_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LiabilitiesNoncurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesNoncurrentAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_LiabilitiesNoncurrentAbstract_lbl" xml:lang="en-US">LONG-TERM LIABILITIES:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesNoncurrentAbstract" xlink:to="us-gaap_LiabilitiesNoncurrentAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent_lbl" xml:lang="en-US">Operating lease liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:to="us-gaap_OperatingLeaseLiabilityNoncurrent_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent_lbl0" xml:lang="en-US">Long-term operating lease liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:to="us-gaap_OperatingLeaseLiabilityNoncurrent_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WarrantsAndRightsOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WarrantsAndRightsOutstanding"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_WarrantsAndRightsOutstanding_lbl" xml:lang="en-US">Warrant liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WarrantsAndRightsOutstanding" xlink:to="us-gaap_WarrantsAndRightsOutstanding_lbl"/>
    <loc xlink:type="locator" xlink:label="arbe_UnlabeledAbstract8" xlink:href="arbe-20231231.xsd#arbe_UnlabeledAbstract8"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="arbe_UnlabeledAbstract8_lbl" xml:lang="en-US"></label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_UnlabeledAbstract8" xlink:to="arbe_UnlabeledAbstract8_lbl"/>
    <loc xlink:type="locator" xlink:label="arbe_UnlabeledAbstract9" xlink:href="arbe-20231231.xsd#arbe_UnlabeledAbstract9"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="arbe_UnlabeledAbstract9_lbl" xml:lang="en-US"></label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_UnlabeledAbstract9" xlink:to="arbe_UnlabeledAbstract9_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_StockholdersEquityAbstract_lbl" xml:lang="en-US">SHAREHOLDERS&#8217; EQUITY:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_StockholdersEquityAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockValue"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CommonStockValue_lbl" xml:lang="en-US">Ordinary Shares, NIS 0.000216 par value; 130,000,000 authorized shares as of December 31, 2023 and 2022; 77,925,095 and 64,160,890 outstanding shares at December 31, 2023 and 2022, respectively</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockValue" xlink:to="us-gaap_CommonStockValue_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare_lbl" xml:lang="en-US">Ordinary shares, par value (in New Shekels per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CommonStockSharesAuthorized_lbl" xml:lang="en-US">Ordinary Shares, shares authorized</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesAuthorized" xlink:to="us-gaap_CommonStockSharesAuthorized_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_CommonStockSharesAuthorized_lbl0" xml:lang="en-US">Ordinary shares, authorized (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesAuthorized" xlink:to="us-gaap_CommonStockSharesAuthorized_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CommonStockSharesOutstanding_lbl" xml:lang="en-US">Ordinary Shares, shares outstanding</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesOutstanding" xlink:to="us-gaap_CommonStockSharesOutstanding_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AdditionalPaidInCapitalCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AdditionalPaidInCapitalCommonStock_lbl" xml:lang="en-US">Additional paid-in capital</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdditionalPaidInCapitalCommonStock" xlink:to="us-gaap_AdditionalPaidInCapitalCommonStock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit_lbl" xml:lang="en-US">Accumulated deficit</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit_lbl"/>
    <loc xlink:type="locator" xlink:label="arbe_UnlabeledAbstract10" xlink:href="arbe-20231231.xsd#arbe_UnlabeledAbstract10"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="arbe_UnlabeledAbstract10_lbl" xml:lang="en-US"></label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_UnlabeledAbstract10" xlink:to="arbe_UnlabeledAbstract10_lbl"/>
    <loc xlink:type="locator" xlink:label="arbe_UnlabeledAbstract11" xlink:href="arbe-20231231.xsd#arbe_UnlabeledAbstract11"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="arbe_UnlabeledAbstract11_lbl" xml:lang="en-US"></label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_UnlabeledAbstract11" xlink:to="arbe_UnlabeledAbstract11_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Revenues" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Revenues"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_Revenues_lbl" xml:lang="en-US">Revenues</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Revenues" xlink:to="us-gaap_Revenues_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CostOfRevenue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CostOfRevenue"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CostOfRevenue_lbl" xml:lang="en-US">Costs of revenues</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CostOfRevenue" xlink:to="us-gaap_CostOfRevenue_lbl"/>
    <loc xlink:type="locator" xlink:label="arbe_UnlabeledAbstract12" xlink:href="arbe-20231231.xsd#arbe_UnlabeledAbstract12"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="arbe_UnlabeledAbstract12_lbl" xml:lang="en-US"></label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_UnlabeledAbstract12" xlink:to="arbe_UnlabeledAbstract12_lbl"/>
    <loc xlink:type="locator" xlink:label="arbe_UnlabeledAbstract13" xlink:href="arbe-20231231.xsd#arbe_UnlabeledAbstract13"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="arbe_UnlabeledAbstract13_lbl" xml:lang="en-US"></label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_UnlabeledAbstract13" xlink:to="arbe_UnlabeledAbstract13_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingExpensesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingExpensesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_OperatingExpensesAbstract_lbl" xml:lang="en-US">Operating expenses:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-gaap_OperatingExpensesAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ResearchAndDevelopmentExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ResearchAndDevelopmentExpense_lbl" xml:lang="en-US">Research and development, net</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchAndDevelopmentExpense" xlink:to="us-gaap_ResearchAndDevelopmentExpense_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SellingAndMarketingExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SellingAndMarketingExpense"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SellingAndMarketingExpense_lbl" xml:lang="en-US">Sales and marketing</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SellingAndMarketingExpense" xlink:to="us-gaap_SellingAndMarketingExpense_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_GeneralAndAdministrativeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_GeneralAndAdministrativeExpense_lbl" xml:lang="en-US">General and administrative</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GeneralAndAdministrativeExpense" xlink:to="us-gaap_GeneralAndAdministrativeExpense_lbl"/>
    <loc xlink:type="locator" xlink:label="arbe_UnlabeledAbstract14" xlink:href="arbe-20231231.xsd#arbe_UnlabeledAbstract14"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="arbe_UnlabeledAbstract14_lbl" xml:lang="en-US"></label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_UnlabeledAbstract14" xlink:to="arbe_UnlabeledAbstract14_lbl"/>
    <loc xlink:type="locator" xlink:label="arbe_UnlabeledAbstract15" xlink:href="arbe-20231231.xsd#arbe_UnlabeledAbstract15"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="arbe_UnlabeledAbstract15_lbl" xml:lang="en-US"></label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_UnlabeledAbstract15" xlink:to="arbe_UnlabeledAbstract15_lbl"/>
    <loc xlink:type="locator" xlink:label="arbe_UnlabeledAbstract16" xlink:href="arbe-20231231.xsd#arbe_UnlabeledAbstract16"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="arbe_UnlabeledAbstract16_lbl" xml:lang="en-US"></label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_UnlabeledAbstract16" xlink:to="arbe_UnlabeledAbstract16_lbl"/>
    <loc xlink:type="locator" xlink:label="arbe_UnlabeledAbstract17" xlink:href="arbe-20231231.xsd#arbe_UnlabeledAbstract17"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="arbe_UnlabeledAbstract17_lbl" xml:lang="en-US"></label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_UnlabeledAbstract17" xlink:to="arbe_UnlabeledAbstract17_lbl"/>
    <loc xlink:type="locator" xlink:label="arbe_UnlabeledAbstract18" xlink:href="arbe-20231231.xsd#arbe_UnlabeledAbstract18"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="arbe_UnlabeledAbstract18_lbl" xml:lang="en-US"></label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_UnlabeledAbstract18" xlink:to="arbe_UnlabeledAbstract18_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EarningsPerShareBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareBasic"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_EarningsPerShareBasic_lbl" xml:lang="en-US">Basic loss per share attributable to Ordinary Shareholders (in Dollars per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareBasic" xlink:to="us-gaap_EarningsPerShareBasic_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_EarningsPerShareBasic_lbl0" xml:lang="en-US">Loss per share attributable to ordinary shareholders, basic (in Dollars per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareBasic" xlink:to="us-gaap_EarningsPerShareBasic_lbl0"/>
    <loc xlink:type="locator" xlink:label="arbe_UnlabeledAbstract19" xlink:href="arbe-20231231.xsd#arbe_UnlabeledAbstract19"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="arbe_UnlabeledAbstract19_lbl" xml:lang="en-US"></label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_UnlabeledAbstract19" xlink:to="arbe_UnlabeledAbstract19_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_lbl" xml:lang="en-US">Weighted-average number of shares used in computing basic loss per share attributable to Ordinary Shareholders (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_lbl"/>
    <loc xlink:type="locator" xlink:label="arbe_UnlabeledAbstract20" xlink:href="arbe-20231231.xsd#arbe_UnlabeledAbstract20"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="arbe_UnlabeledAbstract20_lbl" xml:lang="en-US"></label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_UnlabeledAbstract20" xlink:to="arbe_UnlabeledAbstract20_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EarningsPerShareDiluted" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareDiluted"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_EarningsPerShareDiluted_lbl" xml:lang="en-US">Diluted loss per share attributable to Ordinary Shareholders (in Dollars per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareDiluted" xlink:to="us-gaap_EarningsPerShareDiluted_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_EarningsPerShareDiluted_lbl0" xml:lang="en-US">Loss per share attributable to ordinary shareholders, diluted (in Dollars per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareDiluted" xlink:to="us-gaap_EarningsPerShareDiluted_lbl0"/>
    <loc xlink:type="locator" xlink:label="arbe_UnlabeledAbstract21" xlink:href="arbe-20231231.xsd#arbe_UnlabeledAbstract21"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="arbe_UnlabeledAbstract21_lbl" xml:lang="en-US"></label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_UnlabeledAbstract21" xlink:to="arbe_UnlabeledAbstract21_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_lbl" xml:lang="en-US">Weighted-average number of shares used in computing diluted loss per share attributable to Ordinary Shareholders (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_lbl0" xml:lang="en-US">Weighted-average shares used in computing loss per share attributable to ordinary shareholders, diluted (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_lbl0"/>
    <loc xlink:type="locator" xlink:label="arbe_UnlabeledAbstract22" xlink:href="arbe-20231231.xsd#arbe_UnlabeledAbstract22"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="arbe_UnlabeledAbstract22_lbl" xml:lang="en-US"></label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_UnlabeledAbstract22" xlink:to="arbe_UnlabeledAbstract22_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants_lbl" xml:lang="en-US">Exercise of warrants</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants" xlink:to="us-gaap_StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants_lbl"/>
    <loc xlink:type="locator" xlink:label="arbe_StockIssuedDuringPeriodSharesExerciseOfWarrants" xlink:href="arbe-20231231.xsd#arbe_StockIssuedDuringPeriodSharesExerciseOfWarrants"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="arbe_StockIssuedDuringPeriodSharesExerciseOfWarrants_lbl" xml:lang="en-US">Exercise of warrants (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_StockIssuedDuringPeriodSharesExerciseOfWarrants" xlink:to="arbe_StockIssuedDuringPeriodSharesExerciseOfWarrants_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_lbl" xml:lang="en-US">Conversion of preferred shares into ordinary shares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:to="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_lbl" xml:lang="en-US">Conversion of preferred shares into ordinary shares (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:to="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueConversionOfUnits" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueConversionOfUnits"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodValueConversionOfUnits_lbl" xml:lang="en-US">Conversion of convertible loan to ordinary shares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueConversionOfUnits" xlink:to="us-gaap_StockIssuedDuringPeriodValueConversionOfUnits_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits_lbl" xml:lang="en-US">Conversion of convertible loan to ordinary shares (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits" xlink:to="us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues_lbl" xml:lang="en-US">Issuance of ordinary shares, net of issuance costs</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:to="us-gaap_StockIssuedDuringPeriodValueNewIssues_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues_lbl" xml:lang="en-US">Issuance of ordinary shares, net of issuance costs (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition_lbl" xml:lang="en-US">Stock-based compensation</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueIssuedForServices" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueIssuedForServices"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodValueIssuedForServices_lbl" xml:lang="en-US">Stock-based compensation to service providers</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueIssuedForServices" xlink:to="us-gaap_StockIssuedDuringPeriodValueIssuedForServices_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_lbl" xml:lang="en-US">Exercise of options and vested RSUs</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:to="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl" xml:lang="en-US">Exercise of options and vested RSUs (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl"/>
    <loc xlink:type="locator" xlink:label="arbe_UnlabeledAbstract23" xlink:href="arbe-20231231.xsd#arbe_UnlabeledAbstract23"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="arbe_UnlabeledAbstract23_lbl" xml:lang="en-US"></label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_UnlabeledAbstract23" xlink:to="arbe_UnlabeledAbstract23_lbl"/>
    <loc xlink:type="locator" xlink:label="arbe_UnlabeledAbstract24" xlink:href="arbe-20231231.xsd#arbe_UnlabeledAbstract24"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="arbe_UnlabeledAbstract24_lbl" xml:lang="en-US"></label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_UnlabeledAbstract24" xlink:to="arbe_UnlabeledAbstract24_lbl"/>
    <loc xlink:type="locator" xlink:label="arbe_UnlabeledAbstract25" xlink:href="arbe-20231231.xsd#arbe_UnlabeledAbstract25"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="arbe_UnlabeledAbstract25_lbl" xml:lang="en-US"></label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_UnlabeledAbstract25" xlink:to="arbe_UnlabeledAbstract25_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xml:lang="en-US">Cash flows from operating activities:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="arbe_UnlabeledAbstract26" xlink:href="arbe-20231231.xsd#arbe_UnlabeledAbstract26"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="arbe_UnlabeledAbstract26_lbl" xml:lang="en-US"></label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_UnlabeledAbstract26" xlink:to="arbe_UnlabeledAbstract26_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xml:lang="en-US">Adjustments to reconcile net loss to net cash used in operating activities:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="arbe_UnlabeledAbstract27" xlink:href="arbe-20231231.xsd#arbe_UnlabeledAbstract27"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="arbe_UnlabeledAbstract27_lbl" xml:lang="en-US"></label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_UnlabeledAbstract27" xlink:to="arbe_UnlabeledAbstract27_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Depreciation" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Depreciation"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_Depreciation_lbl" xml:lang="en-US">Depreciation</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Depreciation" xlink:to="us-gaap_Depreciation_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_Depreciation_lbl0" xml:lang="en-US">Depreciation expense</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Depreciation" xlink:to="us-gaap_Depreciation_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensation"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensation_lbl" xml:lang="en-US">Stock-based compensation</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensation" xlink:to="us-gaap_ShareBasedCompensation_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ShareBasedCompensation_lbl0" xml:lang="en-US">Total stock-based compensation expense</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensation" xlink:to="us-gaap_ShareBasedCompensation_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims_lbl" xml:lang="en-US">Stock-based compensation to service providers</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims" xlink:to="us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AdjustmentOfWarrantsGrantedForServices" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdjustmentOfWarrantsGrantedForServices"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AdjustmentOfWarrantsGrantedForServices_lbl" xml:lang="en-US">Revaluation of warrants and accretion</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentOfWarrantsGrantedForServices" xlink:to="us-gaap_AdjustmentOfWarrantsGrantedForServices_lbl"/>
    <loc xlink:type="locator" xlink:label="arbe_RevaluationOfConvertibleLoan" xlink:href="arbe-20231231.xsd#arbe_RevaluationOfConvertibleLoan"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="arbe_RevaluationOfConvertibleLoan_lbl" xml:lang="en-US">Revaluation of convertible loan</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_RevaluationOfConvertibleLoan" xlink:to="arbe_RevaluationOfConvertibleLoan_lbl"/>
    <loc xlink:type="locator" xlink:label="arbe_UnlabeledAbstract28" xlink:href="arbe-20231231.xsd#arbe_UnlabeledAbstract28"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="arbe_UnlabeledAbstract28_lbl" xml:lang="en-US"></label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_UnlabeledAbstract28" xlink:to="arbe_UnlabeledAbstract28_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl" xml:lang="en-US">Change in operating assets and liabilities:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOperatingLeaseLiability"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_IncreaseDecreaseInOperatingLeaseLiability_lbl" xml:lang="en-US">Operating lease ROU assets and liabilities, net</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:to="us-gaap_IncreaseDecreaseInOperatingLeaseLiability_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayableTrade" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccountsPayableTrade"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayableTrade_lbl" xml:lang="en-US">Trade payables</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsPayableTrade" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayableTrade_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities_lbl" xml:lang="en-US">Employees and payroll accruals</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities" xlink:to="us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInDeferredRevenue"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_IncreaseDecreaseInDeferredRevenue_lbl" xml:lang="en-US">Deferred revenue</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:to="us-gaap_IncreaseDecreaseInDeferredRevenue_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities_lbl" xml:lang="en-US">Accrued expenses and other payables</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities" xlink:to="us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities_lbl"/>
    <loc xlink:type="locator" xlink:label="arbe_UnlabeledAbstract29" xlink:href="arbe-20231231.xsd#arbe_UnlabeledAbstract29"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="arbe_UnlabeledAbstract29_lbl" xml:lang="en-US"></label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_UnlabeledAbstract29" xlink:to="arbe_UnlabeledAbstract29_lbl"/>
    <loc xlink:type="locator" xlink:label="arbe_UnlabeledAbstract30" xlink:href="arbe-20231231.xsd#arbe_UnlabeledAbstract30"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="arbe_UnlabeledAbstract30_lbl" xml:lang="en-US"></label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_UnlabeledAbstract30" xlink:to="arbe_UnlabeledAbstract30_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl" xml:lang="en-US">Cash flows from investing activities:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="arbe_UnlabeledAbstract31" xlink:href="arbe-20231231.xsd#arbe_UnlabeledAbstract31"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="arbe_UnlabeledAbstract31_lbl" xml:lang="en-US"></label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_UnlabeledAbstract31" xlink:to="arbe_UnlabeledAbstract31_lbl"/>
    <loc xlink:type="locator" xlink:label="arbe_UnlabeledAbstract32" xlink:href="arbe-20231231.xsd#arbe_UnlabeledAbstract32"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="arbe_UnlabeledAbstract32_lbl" xml:lang="en-US"></label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_UnlabeledAbstract32" xlink:to="arbe_UnlabeledAbstract32_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl" xml:lang="en-US">Cash flows from financing activities:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromShortTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromShortTermDebt"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ProceedsFromShortTermDebt_lbl" xml:lang="en-US">Proceeds from short-term loan</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromShortTermDebt" xlink:to="us-gaap_ProceedsFromShortTermDebt_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceInitialPublicOffering" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromIssuanceInitialPublicOffering"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ProceedsFromIssuanceInitialPublicOffering_lbl" xml:lang="en-US">Proceeds from recapitalization and PIPE offering, net of issuance costs</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceInitialPublicOffering" xlink:to="us-gaap_ProceedsFromIssuanceInitialPublicOffering_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ProceedsFromIssuanceInitialPublicOffering_lbl0" xml:lang="en-US">Total gross proceeds (in Dollars)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceInitialPublicOffering" xlink:to="us-gaap_ProceedsFromIssuanceInitialPublicOffering_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock_lbl" xml:lang="en-US">Proceeds from issuance of ordinary shares, net of issuance costs</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:to="us-gaap_ProceedsFromIssuanceOfCommonStock_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock_lbl0" xml:lang="en-US">Net of issuance costs</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:to="us-gaap_ProceedsFromIssuanceOfCommonStock_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromWarrantExercises" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromWarrantExercises"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ProceedsFromWarrantExercises_lbl" xml:lang="en-US">Proceeds from exercise of warrants</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromWarrantExercises" xlink:to="us-gaap_ProceedsFromWarrantExercises_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ProceedsFromStockOptionsExercised_lbl" xml:lang="en-US">Proceeds from exercise of options</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromStockOptionsExercised" xlink:to="us-gaap_ProceedsFromStockOptionsExercised_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromConvertibleDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromConvertibleDebt"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ProceedsFromConvertibleDebt_lbl" xml:lang="en-US">Proceeds from convertible loan</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromConvertibleDebt" xlink:to="us-gaap_ProceedsFromConvertibleDebt_lbl"/>
    <loc xlink:type="locator" xlink:label="arbe_UnlabeledAbstract33" xlink:href="arbe-20231231.xsd#arbe_UnlabeledAbstract33"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="arbe_UnlabeledAbstract33_lbl" xml:lang="en-US"></label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_UnlabeledAbstract33" xlink:to="arbe_UnlabeledAbstract33_lbl"/>
    <loc xlink:type="locator" xlink:label="arbe_UnlabeledAbstract34" xlink:href="arbe-20231231.xsd#arbe_UnlabeledAbstract34"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="arbe_UnlabeledAbstract34_lbl" xml:lang="en-US"></label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_UnlabeledAbstract34" xlink:to="arbe_UnlabeledAbstract34_lbl"/>
    <loc xlink:type="locator" xlink:label="arbe_UnlabeledAbstract35" xlink:href="arbe-20231231.xsd#arbe_UnlabeledAbstract35"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="arbe_UnlabeledAbstract35_lbl" xml:lang="en-US"></label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_UnlabeledAbstract35" xlink:to="arbe_UnlabeledAbstract35_lbl"/>
    <loc xlink:type="locator" xlink:label="arbe_UnlabeledAbstract36" xlink:href="arbe-20231231.xsd#arbe_UnlabeledAbstract36"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="arbe_UnlabeledAbstract36_lbl" xml:lang="en-US"></label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_UnlabeledAbstract36" xlink:to="arbe_UnlabeledAbstract36_lbl"/>
    <loc xlink:type="locator" xlink:label="arbe_UnlabeledAbstract37" xlink:href="arbe-20231231.xsd#arbe_UnlabeledAbstract37"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="arbe_UnlabeledAbstract37_lbl" xml:lang="en-US"></label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_UnlabeledAbstract37" xlink:to="arbe_UnlabeledAbstract37_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_lbl" xml:lang="en-US">Supplemental non-cash disclosure:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:to="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConversionOfStockAmountConverted1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConversionOfStockAmountConverted1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ConversionOfStockAmountConverted1_lbl" xml:lang="en-US">Exercise of warrants into convertible preferred shares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConversionOfStockAmountConverted1" xlink:to="us-gaap_ConversionOfStockAmountConverted1_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssued1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssued1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_StockIssued1_lbl" xml:lang="en-US">Issuance of private warrants</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssued1" xlink:to="us-gaap_StockIssued1_lbl"/>
    <loc xlink:type="locator" xlink:label="arbe_ConversionOfConvertibleLoanIntoOrdinarySharesUponTheRecapitalization" xlink:href="arbe-20231231.xsd#arbe_ConversionOfConvertibleLoanIntoOrdinarySharesUponTheRecapitalization"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="arbe_ConversionOfConvertibleLoanIntoOrdinarySharesUponTheRecapitalization_lbl" xml:lang="en-US">Conversion of convertible loan into ordinary shares upon the recapitalization</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_ConversionOfConvertibleLoanIntoOrdinarySharesUponTheRecapitalization" xlink:to="arbe_ConversionOfConvertibleLoanIntoOrdinarySharesUponTheRecapitalization_lbl"/>
    <loc xlink:type="locator" xlink:label="arbe_ConversionOfPreferredSharesIntoOrdinarySharesUponTheRecapitalization" xlink:href="arbe-20231231.xsd#arbe_ConversionOfPreferredSharesIntoOrdinarySharesUponTheRecapitalization"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="arbe_ConversionOfPreferredSharesIntoOrdinarySharesUponTheRecapitalization_lbl" xml:lang="en-US">Conversion of preferred shares into ordinary shares upon the recapitalization</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_ConversionOfPreferredSharesIntoOrdinarySharesUponTheRecapitalization" xlink:to="arbe_ConversionOfPreferredSharesIntoOrdinarySharesUponTheRecapitalization_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_lbl" xml:lang="en-US">Lease liabilities arising from obtaining right-of-use assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:to="us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1_lbl" xml:lang="en-US">Purchase of property and equipment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1" xlink:to="us-gaap_NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SupplementalCashFlowInformationAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SupplementalCashFlowInformationAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SupplementalCashFlowInformationAbstract_lbl" xml:lang="en-US">Supplemental disclosure of cash flows activities:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="us-gaap_SupplementalCashFlowInformationAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InterestPaidNet" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestPaidNet"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_InterestPaidNet_lbl" xml:lang="en-US">Interest paid</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestPaidNet" xlink:to="us-gaap_InterestPaidNet_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NonoperatingIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_NonoperatingIncomeExpense_lbl" xml:lang="en-US">Financial expense (income), net</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NonoperatingIncomeExpense" xlink:to="us-gaap_NonoperatingIncomeExpense_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncreaseDecreaseInAccountsReceivable_lbl" xml:lang="en-US">Trade receivable</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:to="us-gaap_IncreaseDecreaseInAccountsReceivable_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_lbl" xml:lang="en-US">Prepaid expenses and other receivables</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:to="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PaymentsForProceedsFromInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsForProceedsFromInvestments"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_PaymentsForProceedsFromInvestments_lbl" xml:lang="en-US">Change in bank deposits</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsForProceedsFromInvestments" xlink:to="us-gaap_PaymentsForProceedsFromInvestments_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_lbl" xml:lang="en-US">Purchase of property and equipment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RepaymentsOfLongTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RepaymentsOfLongTermDebt"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_RepaymentsOfLongTermDebt_lbl" xml:lang="en-US">Repayment of long-term loan</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RepaymentsOfLongTermDebt" xlink:to="us-gaap_RepaymentsOfLongTermDebt_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RepaymentsOfShortTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RepaymentsOfShortTermDebt"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_RepaymentsOfShortTermDebt_lbl" xml:lang="en-US">Repayment of short-term loan</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RepaymentsOfShortTermDebt" xlink:to="us-gaap_RepaymentsOfShortTermDebt_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl" xml:lang="en-US">Effect of exchange rate fluctuations on cash and cash equivalent</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_BusinessContactMember" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_BusinessContactMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_BusinessContactMember_lbl" xml:lang="en-US">Business Contact</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_BusinessContactMember" xlink:to="dei_BusinessContactMember_lbl"/>
    <loc xlink:type="locator" xlink:label="arbe_OrdinarySharesParValueNIS0000216PerShareMember" xlink:href="arbe-20231231.xsd#arbe_OrdinarySharesParValueNIS0000216PerShareMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="arbe_OrdinarySharesParValueNIS0000216PerShareMember_lbl" xml:lang="en-US">Ordinary shares, par value NIS 0.000216 per share</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_OrdinarySharesParValueNIS0000216PerShareMember" xlink:to="arbe_OrdinarySharesParValueNIS0000216PerShareMember_lbl"/>
    <loc xlink:type="locator" xlink:label="arbe_WarrantsMember" xlink:href="arbe-20231231.xsd#arbe_WarrantsMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="arbe_WarrantsMember_lbl" xml:lang="en-US">Warrants</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_WarrantsMember" xlink:to="arbe_WarrantsMember_lbl"/>
    <loc xlink:type="locator" xlink:label="arbe_SeedMember" xlink:href="arbe-20231231.xsd#arbe_SeedMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="arbe_SeedMember_lbl" xml:lang="en-US">Seed</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_SeedMember" xlink:to="arbe_SeedMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_PreferredStockMember_lbl" xml:lang="en-US">Redeemable convertible preferred Shares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockMember" xlink:to="us-gaap_PreferredStockMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SeriesAPreferredStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SeriesAPreferredStockMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SeriesAPreferredStockMember_lbl" xml:lang="en-US">Series A</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SeriesAPreferredStockMember" xlink:to="us-gaap_SeriesAPreferredStockMember_lbl"/>
    <loc xlink:type="locator" xlink:label="arbe_SeriesA1PreferredStockMember" xlink:href="arbe-20231231.xsd#arbe_SeriesA1PreferredStockMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="arbe_SeriesA1PreferredStockMember_lbl" xml:lang="en-US">Series A-1</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_SeriesA1PreferredStockMember" xlink:to="arbe_SeriesA1PreferredStockMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SeriesBPreferredStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SeriesBPreferredStockMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SeriesBPreferredStockMember_lbl" xml:lang="en-US">Series B</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SeriesBPreferredStockMember" xlink:to="us-gaap_SeriesBPreferredStockMember_lbl"/>
    <loc xlink:type="locator" xlink:label="arbe_SeriesB1PreferredStockMember" xlink:href="arbe-20231231.xsd#arbe_SeriesB1PreferredStockMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="arbe_SeriesB1PreferredStockMember_lbl" xml:lang="en-US">Series B-1</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_SeriesB1PreferredStockMember" xlink:to="arbe_SeriesB1PreferredStockMember_lbl"/>
    <loc xlink:type="locator" xlink:label="arbe_SeriesB2PreferredStockMember" xlink:href="arbe-20231231.xsd#arbe_SeriesB2PreferredStockMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="arbe_SeriesB2PreferredStockMember_lbl" xml:lang="en-US">Series B-2</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_SeriesB2PreferredStockMember" xlink:to="arbe_SeriesB2PreferredStockMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CommonStockMember_lbl" xml:lang="en-US">Ordinary Shares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockMember" xlink:to="us-gaap_CommonStockMember_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_CommonStockMember_lbl0" xml:lang="en-US">Ordinary shares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockMember" xlink:to="us-gaap_CommonStockMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:label="us-gaap_CommonStockMember_lbl1" xml:lang="en-US">Common Stock [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockMember" xlink:to="us-gaap_CommonStockMember_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockMember_lbl2" xml:lang="en-US">Ordinary Shares [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockMember" xlink:to="us-gaap_CommonStockMember_lbl2"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AdditionalPaidInCapitalMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AdditionalPaidInCapitalMember_lbl" xml:lang="en-US">Additional paid-in capital</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdditionalPaidInCapitalMember" xlink:to="us-gaap_AdditionalPaidInCapitalMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RetainedEarningsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_RetainedEarningsMember_lbl" xml:lang="en-US">Accumulated deficit</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetainedEarningsMember" xlink:to="us-gaap_RetainedEarningsMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NatureOfOperations" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NatureOfOperations"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_NatureOfOperations_lbl" xml:lang="en-US">GENERAL</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NatureOfOperations" xlink:to="us-gaap_NatureOfOperations_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SignificantAccountingPoliciesTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock_lbl" xml:lang="en-US">SIGNIFICANT ACCOUNTING POLICIES</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SignificantAccountingPoliciesTextBlock" xlink:to="us-gaap_SignificantAccountingPoliciesTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="arbe_PropertyPlantAndEquipmentUsefulLifeTableTextBlock" xlink:href="arbe-20231231.xsd#arbe_PropertyPlantAndEquipmentUsefulLifeTableTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="arbe_PropertyPlantAndEquipmentUsefulLifeTableTextBlock_lbl" xml:lang="en-US">Schedule of the Straight-Line Method Over the Estimated Useful Lives of the Assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_PropertyPlantAndEquipmentUsefulLifeTableTextBlock" xlink:to="arbe_PropertyPlantAndEquipmentUsefulLifeTableTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentSalvageValuePercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentSalvageValuePercentage"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_PropertyPlantAndEquipmentSalvageValuePercentage_lbl" xml:lang="en-US">Property and equipment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentSalvageValuePercentage" xlink:to="us-gaap_PropertyPlantAndEquipmentSalvageValuePercentage_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromContractWithCustomerTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_RevenueFromContractWithCustomerTextBlock_lbl" xml:lang="en-US">REVENUE</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:to="us-gaap_RevenueFromContractWithCustomerTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DisaggregationOfRevenueTableTextBlock_lbl" xml:lang="en-US">Schedule of Revenue Disaggregated by Geography</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:to="us-gaap_DisaggregationOfRevenueTableTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="arbe_RevenueByGeographyAbstract" xlink:href="arbe-20231231.xsd#arbe_RevenueByGeographyAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="arbe_RevenueByGeographyAbstract_lbl" xml:lang="en-US">Revenue by geography:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_RevenueByGeographyAbstract" xlink:to="arbe_RevenueByGeographyAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_lbl" xml:lang="en-US">Revenue</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax" xlink:to="us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RevenueRemainingPerformanceObligationPercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueRemainingPerformanceObligationPercentage"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_RevenueRemainingPerformanceObligationPercentage_lbl" xml:lang="en-US">% of Revenue</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenueRemainingPerformanceObligationPercentage" xlink:to="us-gaap_RevenueRemainingPerformanceObligationPercentage_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherCurrentAssetsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherCurrentAssetsTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_OtherCurrentAssetsTextBlock_lbl" xml:lang="en-US">PREPAID EXPENSES AND OTHER RECEIVABLES</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherCurrentAssetsTextBlock" xlink:to="us-gaap_OtherCurrentAssetsTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock_lbl" xml:lang="en-US">Schedule of Prepaid Expenses and Other Receivables</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock" xlink:to="us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="arbe_GovernmentAuthorities" xlink:href="arbe-20231231.xsd#arbe_GovernmentAuthorities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="arbe_GovernmentAuthorities_lbl" xml:lang="en-US">Government authorities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_GovernmentAuthorities" xlink:to="arbe_GovernmentAuthorities_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DepositAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DepositAssets"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DepositAssets_lbl" xml:lang="en-US">Deposits</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DepositAssets" xlink:to="us-gaap_DepositAssets_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_GrantsReceivableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GrantsReceivableCurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_GrantsReceivableCurrent_lbl" xml:lang="en-US">Grants receivable</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GrantsReceivableCurrent" xlink:to="us-gaap_GrantsReceivableCurrent_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PrepaidExpenseAndOtherAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PrepaidExpenseAndOtherAssets"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_PrepaidExpenseAndOtherAssets_lbl" xml:lang="en-US">Prepaid expenses and other</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PrepaidExpenseAndOtherAssets" xlink:to="us-gaap_PrepaidExpenseAndOtherAssets_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_lbl" xml:lang="en-US">PROPERTY AND EQUIPMENT</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:to="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_PropertyPlantAndEquipmentTextBlock_lbl" xml:lang="en-US">Schedule of Property and Equipment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:to="us-gaap_PropertyPlantAndEquipmentTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="arbe_CostAbstract" xlink:href="arbe-20231231.xsd#arbe_CostAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="arbe_CostAbstract_lbl" xml:lang="en-US">Cost:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_CostAbstract" xlink:to="arbe_CostAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentGross" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_PropertyPlantAndEquipmentGross_lbl" xml:lang="en-US">Property and equipment, gross</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentGross" xlink:to="us-gaap_PropertyPlantAndEquipmentGross_lbl"/>
    <loc xlink:type="locator" xlink:label="arbe_UnlabeledAbstract38" xlink:href="arbe-20231231.xsd#arbe_UnlabeledAbstract38"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="arbe_UnlabeledAbstract38_lbl" xml:lang="en-US"></label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_UnlabeledAbstract38" xlink:to="arbe_UnlabeledAbstract38_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_lbl" xml:lang="en-US">Accumulated depreciation</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:to="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_lbl"/>
    <loc xlink:type="locator" xlink:label="arbe_UnlabeledAbstract39" xlink:href="arbe-20231231.xsd#arbe_UnlabeledAbstract39"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="arbe_UnlabeledAbstract39_lbl" xml:lang="en-US"></label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_UnlabeledAbstract39" xlink:to="arbe_UnlabeledAbstract39_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeasesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeasesTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_LesseeOperatingLeasesTextBlock_lbl" xml:lang="en-US">LEASES</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeasesTextBlock" xlink:to="us-gaap_LesseeOperatingLeasesTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeaseLeaseIncomeTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLeaseIncomeTableTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_OperatingLeaseLeaseIncomeTableTextBlock_lbl" xml:lang="en-US">Schedule of Supplemental Cash Flow Information Related to Leases</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseLeaseIncomeTableTextBlock" xlink:to="us-gaap_OperatingLeaseLeaseIncomeTableTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_lbl" xml:lang="en-US">Schedule of Maturities of Lease Liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_lbl" xml:lang="en-US">2024</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_lbl" xml:lang="en-US">2025</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_lbl" xml:lang="en-US">2026</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_lbl" xml:lang="en-US">2027 and after</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_lbl" xml:lang="en-US">Less imputed interest</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiability"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_OperatingLeaseLiability_lbl" xml:lang="en-US">Total lease liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseLiability" xlink:to="us-gaap_OperatingLeaseLiability_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LeaseCostTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeaseCostTableTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_LeaseCostTableTextBlock_lbl" xml:lang="en-US">Schedule of Supplemental Balance Sheet Information Related to Operating Leases</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LeaseCostTableTextBlock" xlink:to="us-gaap_LeaseCostTableTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_lbl" xml:lang="en-US">Weighted average remaining lease term (in years)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:to="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_lbl" xml:lang="en-US">Weighted average discount rate</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:to="us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl" xml:lang="en-US">COMMITMENTS AND CONTINGENT LIABILITIES</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_lbl" xml:lang="en-US">WARRANTS LIABILITIES</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:to="us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_StockholdersEquityNoteDisclosureTextBlock_lbl" xml:lang="en-US">SHAREHOLDERS&#8217; EQUITY</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:to="us-gaap_StockholdersEquityNoteDisclosureTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_lbl" xml:lang="en-US">Schedule of Stock Option Activity</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:to="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="arbe_OptionsAbstract" xlink:href="arbe-20231231.xsd#arbe_OptionsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="arbe_OptionsAbstract_lbl" xml:lang="en-US">Options:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_OptionsAbstract" xlink:to="arbe_OptionsAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="arbe_UnlabeledAbstract40" xlink:href="arbe-20231231.xsd#arbe_UnlabeledAbstract40"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="arbe_UnlabeledAbstract40_lbl" xml:lang="en-US"></label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_UnlabeledAbstract40" xlink:to="arbe_UnlabeledAbstract40_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_lbl" xml:lang="en-US">Weighted average remaining contractual life (years), ending balance</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_lbl"/>
    <loc xlink:type="locator" xlink:label="arbe_UnlabeledAbstract41" xlink:href="arbe-20231231.xsd#arbe_UnlabeledAbstract41"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="arbe_UnlabeledAbstract41_lbl" xml:lang="en-US"></label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_UnlabeledAbstract41" xlink:to="arbe_UnlabeledAbstract41_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_lbl" xml:lang="en-US">Granted, Outstanding share options</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_lbl" xml:lang="en-US">Granted, Weighted-average exercise price (in Dollars per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_lbl" xml:lang="en-US">Forfeited, Weighted-average exercise price (in Dollars per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_lbl" xml:lang="en-US">Exercised, Weighted-average exercise price (in Dollars per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_lbl"/>
    <loc xlink:type="locator" xlink:label="arbe_UnlabeledAbstract42" xlink:href="arbe-20231231.xsd#arbe_UnlabeledAbstract42"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="arbe_UnlabeledAbstract42_lbl" xml:lang="en-US"></label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_UnlabeledAbstract42" xlink:to="arbe_UnlabeledAbstract42_lbl"/>
    <loc xlink:type="locator" xlink:label="arbe_UnlabeledAbstract43" xlink:href="arbe-20231231.xsd#arbe_UnlabeledAbstract43"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="arbe_UnlabeledAbstract43_lbl" xml:lang="en-US"></label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_UnlabeledAbstract43" xlink:to="arbe_UnlabeledAbstract43_lbl"/>
    <loc xlink:type="locator" xlink:label="arbe_UnlabeledAbstract44" xlink:href="arbe-20231231.xsd#arbe_UnlabeledAbstract44"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="arbe_UnlabeledAbstract44_lbl" xml:lang="en-US"></label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_UnlabeledAbstract44" xlink:to="arbe_UnlabeledAbstract44_lbl"/>
    <loc xlink:type="locator" xlink:label="arbe_UnlabeledAbstract45" xlink:href="arbe-20231231.xsd#arbe_UnlabeledAbstract45"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="arbe_UnlabeledAbstract45_lbl" xml:lang="en-US"></label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_UnlabeledAbstract45" xlink:to="arbe_UnlabeledAbstract45_lbl"/>
    <loc xlink:type="locator" xlink:label="arbe_UnlabeledAbstract46" xlink:href="arbe-20231231.xsd#arbe_UnlabeledAbstract46"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="arbe_UnlabeledAbstract46_lbl" xml:lang="en-US"></label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_UnlabeledAbstract46" xlink:to="arbe_UnlabeledAbstract46_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_lbl" xml:lang="en-US">Exercisable, Outstanding share options</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_lbl" xml:lang="en-US">Exercisable, Weighted-average exercise price (in Dollars per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_lbl" xml:lang="en-US">Exercisable, Weighted average remaining contractual life (years)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_lbl" xml:lang="en-US">Exercisable, Aggregate intrinsic value (in Dollars)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_lbl"/>
    <loc xlink:type="locator" xlink:label="arbe_UnlabeledAbstract47" xlink:href="arbe-20231231.xsd#arbe_UnlabeledAbstract47"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="arbe_UnlabeledAbstract47_lbl" xml:lang="en-US"></label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_UnlabeledAbstract47" xlink:to="arbe_UnlabeledAbstract47_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_lbl" xml:lang="en-US">Options available for future grants, Outstanding share options</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock_lbl" xml:lang="en-US">Schedule of RSUs Activity</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock" xlink:to="us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="arbe_RsusAbstract" xlink:href="arbe-20231231.xsd#arbe_RsusAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="arbe_RsusAbstract_lbl" xml:lang="en-US">RSUs:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_RsusAbstract" xlink:to="arbe_RsusAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="arbe_UnlabeledAbstract48" xlink:href="arbe-20231231.xsd#arbe_UnlabeledAbstract48"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="arbe_UnlabeledAbstract48_lbl" xml:lang="en-US"></label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_UnlabeledAbstract48" xlink:to="arbe_UnlabeledAbstract48_lbl"/>
    <loc xlink:type="locator" xlink:label="arbe_UnlabeledAbstract49" xlink:href="arbe-20231231.xsd#arbe_UnlabeledAbstract49"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="arbe_UnlabeledAbstract49_lbl" xml:lang="en-US"></label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_UnlabeledAbstract49" xlink:to="arbe_UnlabeledAbstract49_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_lbl" xml:lang="en-US">Granted, Numbers of RSUs</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_lbl"/>
    <loc xlink:type="locator" xlink:label="arbe_UnlabeledAbstract50" xlink:href="arbe-20231231.xsd#arbe_UnlabeledAbstract50"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="arbe_UnlabeledAbstract50_lbl" xml:lang="en-US"></label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_UnlabeledAbstract50" xlink:to="arbe_UnlabeledAbstract50_lbl"/>
    <loc xlink:type="locator" xlink:label="arbe_UnlabeledAbstract51" xlink:href="arbe-20231231.xsd#arbe_UnlabeledAbstract51"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="arbe_UnlabeledAbstract51_lbl" xml:lang="en-US"></label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_UnlabeledAbstract51" xlink:to="arbe_UnlabeledAbstract51_lbl"/>
    <loc xlink:type="locator" xlink:label="arbe_UnlabeledAbstract52" xlink:href="arbe-20231231.xsd#arbe_UnlabeledAbstract52"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="arbe_UnlabeledAbstract52_lbl" xml:lang="en-US"></label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_UnlabeledAbstract52" xlink:to="arbe_UnlabeledAbstract52_lbl"/>
    <loc xlink:type="locator" xlink:label="arbe_UnlabeledAbstract53" xlink:href="arbe-20231231.xsd#arbe_UnlabeledAbstract53"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="arbe_UnlabeledAbstract53_lbl" xml:lang="en-US"></label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_UnlabeledAbstract53" xlink:to="arbe_UnlabeledAbstract53_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_lbl" xml:lang="en-US">Schedule of Compensation to Employees</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:to="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_lbl" xml:lang="en-US">Expected term, in years</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_lbl" xml:lang="en-US">Expected volatility</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_lbl" xml:lang="en-US">Risk-free interest rate</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_lbl" xml:lang="en-US">Expected dividend yield</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock_lbl" xml:lang="en-US">Schedule of Share Based Compensation Expense</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock" xlink:to="us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EarningsPerShareTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_EarningsPerShareTextBlock_lbl" xml:lang="en-US">NET LOSS PER SHARE ATTRIBUTIBLE TO ORDINARY SHARHOLDERS</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareTextBlock" xlink:to="us-gaap_EarningsPerShareTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_lbl" xml:lang="en-US">Schedule of Sets Forth the Computation of Basic and Diluted Net Loss Per Share Attributable</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:to="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="arbe_BasicAbstract" xlink:href="arbe-20231231.xsd#arbe_BasicAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="arbe_BasicAbstract_lbl" xml:lang="en-US">Basic</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_BasicAbstract" xlink:to="arbe_BasicAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="arbe_NumeratorAbstract" xlink:href="arbe-20231231.xsd#arbe_NumeratorAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="arbe_NumeratorAbstract_lbl" xml:lang="en-US">Numerator:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_NumeratorAbstract" xlink:to="arbe_NumeratorAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetIncomeLossAttributableToNonredeemableNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLossAttributableToNonredeemableNoncontrollingInterest"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_NetIncomeLossAttributableToNonredeemableNoncontrollingInterest_lbl" xml:lang="en-US">Net loss</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLossAttributableToNonredeemableNoncontrollingInterest" xlink:to="us-gaap_NetIncomeLossAttributableToNonredeemableNoncontrollingInterest_lbl"/>
    <loc xlink:type="locator" xlink:label="arbe_DenominatorAbstract" xlink:href="arbe-20231231.xsd#arbe_DenominatorAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="arbe_DenominatorAbstract_lbl" xml:lang="en-US">Denominator:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_DenominatorAbstract" xlink:to="arbe_DenominatorAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_lbl" xml:lang="en-US">Weighted-average shares used in computing loss per share attributable to ordinary shareholders, basic (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:to="us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EarningsPerShareDilutedAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareDilutedAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_EarningsPerShareDilutedAbstract_lbl" xml:lang="en-US">Diluted</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareDilutedAbstract" xlink:to="us-gaap_EarningsPerShareDilutedAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="arbe_NumeratorAbstract0" xlink:href="arbe-20231231.xsd#arbe_NumeratorAbstract0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="arbe_NumeratorAbstract0_lbl" xml:lang="en-US">Numerator:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_NumeratorAbstract0" xlink:to="arbe_NumeratorAbstract0_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_TemporaryEquityAccretionToRedemptionValueAdjustment" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TemporaryEquityAccretionToRedemptionValueAdjustment"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_TemporaryEquityAccretionToRedemptionValueAdjustment_lbl" xml:lang="en-US">Adjusted Net loss</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TemporaryEquityAccretionToRedemptionValueAdjustment" xlink:to="us-gaap_TemporaryEquityAccretionToRedemptionValueAdjustment_lbl"/>
    <loc xlink:type="locator" xlink:label="arbe_DenominatorAbstract0" xlink:href="arbe-20231231.xsd#arbe_DenominatorAbstract0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="arbe_DenominatorAbstract0_lbl" xml:lang="en-US">Denominator:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_DenominatorAbstract0" xlink:to="arbe_DenominatorAbstract0_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_lbl" xml:lang="en-US">Schedule of Ordinary Shares that were Excluded from the Computation of Diluted Net Loss Per Share</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:to="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_lbl" xml:lang="en-US">Anti-dilutive shares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock_lbl" xml:lang="en-US">TAXES ON INCOME</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxDisclosureTextBlock" xlink:to="us-gaap_IncomeTaxDisclosureTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_lbl" xml:lang="en-US">Schedule of Company&#8217;s Loss Before Income Taxes</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:to="us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_lbl" xml:lang="en-US">Foreign</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_lbl" xml:lang="en-US">Schedule of Reconciliation Income Tax Benefit</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:to="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_lbl" xml:lang="en-US">Statutory tax rate</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_lbl"/>
    <loc xlink:type="locator" xlink:label="arbe_UnlabeledAbstract54" xlink:href="arbe-20231231.xsd#arbe_UnlabeledAbstract54"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="arbe_UnlabeledAbstract54_lbl" xml:lang="en-US"></label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_UnlabeledAbstract54" xlink:to="arbe_UnlabeledAbstract54_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_lbl" xml:lang="en-US">Income tax benefit at statutory tax rate</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:to="us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxReconciliationNondeductibleExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxReconciliationNondeductibleExpense"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_IncomeTaxReconciliationNondeductibleExpense_lbl" xml:lang="en-US">Effect of Non-deductible expenses</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxReconciliationNondeductibleExpense" xlink:to="us-gaap_IncomeTaxReconciliationNondeductibleExpense_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential_lbl" xml:lang="en-US">Remeasurement of deferred taxes from currency exchange</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential" xlink:to="us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_lbl" xml:lang="en-US">Change in valuation allowance</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:to="us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxReconciliationOtherAdjustments" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxReconciliationOtherAdjustments"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_IncomeTaxReconciliationOtherAdjustments_lbl" xml:lang="en-US">Other</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxReconciliationOtherAdjustments" xlink:to="us-gaap_IncomeTaxReconciliationOtherAdjustments_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_lbl" xml:lang="en-US">Schedule of Deferred Tax Assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:to="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="arbe_DeferredTaxAssetsAbstract" xlink:href="arbe-20231231.xsd#arbe_DeferredTaxAssetsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="arbe_DeferredTaxAssetsAbstract_lbl" xml:lang="en-US">Deferred tax assets:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_DeferredTaxAssetsAbstract" xlink:to="arbe_DeferredTaxAssetsAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_lbl" xml:lang="en-US">Net operating loss carry forwards</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:to="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment_lbl" xml:lang="en-US">Research and development</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment" xlink:to="us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_lbl" xml:lang="en-US">Employees and payroll accrual</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:to="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment_lbl" xml:lang="en-US">Property and equipment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment" xlink:to="us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment_lbl"/>
    <loc xlink:type="locator" xlink:label="arbe_UnlabeledAbstract55" xlink:href="arbe-20231231.xsd#arbe_UnlabeledAbstract55"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="arbe_UnlabeledAbstract55_lbl" xml:lang="en-US"></label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_UnlabeledAbstract55" xlink:to="arbe_UnlabeledAbstract55_lbl"/>
    <loc xlink:type="locator" xlink:label="arbe_UnlabeledAbstract56" xlink:href="arbe-20231231.xsd#arbe_UnlabeledAbstract56"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="arbe_UnlabeledAbstract56_lbl" xml:lang="en-US"></label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_UnlabeledAbstract56" xlink:to="arbe_UnlabeledAbstract56_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SegmentReportingDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SegmentReportingDisclosureTextBlock_lbl" xml:lang="en-US">SEGMENT INFORMATION</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SegmentReportingDisclosureTextBlock" xlink:to="us-gaap_SegmentReportingDisclosureTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock_lbl" xml:lang="en-US">Schedule of Property and Equipment, Net of Depreciation, by Geographic Region</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock" xlink:to="us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeasePayments" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeasePayments"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_OperatingLeasePayments_lbl" xml:lang="en-US">Cash payments and expenses related to operating leases</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeasePayments" xlink:to="us-gaap_OperatingLeasePayments_lbl"/>
    <loc xlink:type="locator" xlink:label="arbe_OperatingLeaseRightofuseAssetsAndLiabilitiesNet" xlink:href="arbe-20231231.xsd#arbe_OperatingLeaseRightofuseAssetsAndLiabilitiesNet"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="arbe_OperatingLeaseRightofuseAssetsAndLiabilitiesNet_lbl" xml:lang="en-US">Operating lease right-of-use assets and liabilities, net</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_OperatingLeaseRightofuseAssetsAndLiabilitiesNet" xlink:to="arbe_OperatingLeaseRightofuseAssetsAndLiabilitiesNet_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_lbl" xml:lang="en-US">Forfeited, Outstanding share options</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised_lbl" xml:lang="en-US">Exercised, Outstanding share options</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures_lbl" xml:lang="en-US">Forfeited, Numbers of RSUs</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsPeriodIncreaseDecrease" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsPeriodIncreaseDecrease"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsPeriodIncreaseDecrease_lbl" xml:lang="en-US">Vested, Numbers of RSUs</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsPeriodIncreaseDecrease" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsPeriodIncreaseDecrease_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceOfWarrants" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromIssuanceOfWarrants"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_ProceedsFromIssuanceOfWarrants_lbl" xml:lang="en-US">Revaluation of warrants</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOfWarrants" xlink:to="us-gaap_ProceedsFromIssuanceOfWarrants_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ProceedsFromIssuanceOfWarrants_lbl0" xml:lang="en-US">Warrants</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOfWarrants" xlink:to="us-gaap_ProceedsFromIssuanceOfWarrants_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_lbl" xml:lang="en-US">Domestic</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance_lbl" xml:lang="en-US">Valuation allowance</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsValuationAllowance" xlink:to="us-gaap_DeferredTaxAssetsValuationAllowance_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ComputerEquipmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ComputerEquipmentMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ComputerEquipmentMember_lbl" xml:lang="en-US">Computers and peripheral equipment [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ComputerEquipmentMember" xlink:to="us-gaap_ComputerEquipmentMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OfficeEquipmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OfficeEquipmentMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_OfficeEquipmentMember_lbl" xml:lang="en-US">Office furniture and equipment [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OfficeEquipmentMember" xlink:to="us-gaap_OfficeEquipmentMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_VehiclesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VehiclesMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_VehiclesMember_lbl" xml:lang="en-US">Vehicles [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_VehiclesMember" xlink:to="us-gaap_VehiclesMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LeaseholdImprovementsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeaseholdImprovementsMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_LeaseholdImprovementsMember_lbl" xml:lang="en-US">Leasehold improvement	[Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LeaseholdImprovementsMember" xlink:to="us-gaap_LeaseholdImprovementsMember_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_LeaseholdImprovementsMember_lbl0" xml:lang="en-US">Leasehold improvement [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LeaseholdImprovementsMember" xlink:to="us-gaap_LeaseholdImprovementsMember_lbl0"/>
    <loc xlink:type="locator" xlink:label="srt_MinimumMember" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MinimumMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="srt_MinimumMember_lbl" xml:lang="en-US">Minimum [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_MinimumMember" xlink:to="srt_MinimumMember_lbl"/>
    <loc xlink:type="locator" xlink:label="srt_MaximumMember" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="srt_MaximumMember_lbl" xml:lang="en-US">Maximum [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_MaximumMember" xlink:to="srt_MaximumMember_lbl"/>
    <loc xlink:type="locator" xlink:label="country_CN" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_CN"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="country_CN_lbl" xml:lang="en-US">China [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="country_CN" xlink:to="country_CN_lbl"/>
    <loc xlink:type="locator" xlink:label="country_HK" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_HK"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="country_HK_lbl" xml:lang="en-US">Hong Kong [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="country_HK" xlink:to="country_HK_lbl"/>
    <loc xlink:type="locator" xlink:label="country_SE" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_SE"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="country_SE_lbl" xml:lang="en-US">Sweden [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="country_SE" xlink:to="country_SE_lbl"/>
    <loc xlink:type="locator" xlink:label="country_US" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_US"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="country_US_lbl" xml:lang="en-US">USA [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="country_US" xlink:to="country_US_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="country_US_lbl0" xml:lang="en-US">UNITED STATES [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="country_US" xlink:to="country_US_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:label="country_US_lbl1" xml:lang="en-US">United States [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="country_US" xlink:to="country_US_lbl1"/>
    <loc xlink:type="locator" xlink:label="country_DE" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_DE"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="country_DE_lbl" xml:lang="en-US">Germany [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="country_DE" xlink:to="country_DE_lbl"/>
    <loc xlink:type="locator" xlink:label="country_IL" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_IL"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="country_IL_lbl" xml:lang="en-US">Israel [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="country_IL" xlink:to="country_IL_lbl"/>
    <loc xlink:type="locator" xlink:label="country_IT" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_IT"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="country_IT_lbl" xml:lang="en-US">Italy [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="country_IT" xlink:to="country_IT_lbl"/>
    <loc xlink:type="locator" xlink:label="country_CH" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_CH"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="country_CH_lbl" xml:lang="en-US">Switzerland [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="country_CH" xlink:to="country_CH_lbl"/>
    <loc xlink:type="locator" xlink:label="arbe_OtherGeographicalMember" xlink:href="arbe-20231231.xsd#arbe_OtherGeographicalMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="arbe_OtherGeographicalMember_lbl" xml:lang="en-US">Other [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_OtherGeographicalMember" xlink:to="arbe_OtherGeographicalMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RestrictedStockUnitsRSUMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_RestrictedStockUnitsRSUMember_lbl" xml:lang="en-US">RSUs [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RestrictedStockUnitsRSUMember" xlink:to="us-gaap_RestrictedStockUnitsRSUMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ResearchAndDevelopmentExpenseMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ResearchAndDevelopmentExpenseMember_lbl" xml:lang="en-US">Research and development [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchAndDevelopmentExpenseMember" xlink:to="us-gaap_ResearchAndDevelopmentExpenseMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SellingAndMarketingExpenseMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SellingAndMarketingExpenseMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SellingAndMarketingExpenseMember_lbl" xml:lang="en-US">Sales and marketing [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SellingAndMarketingExpenseMember" xlink:to="us-gaap_SellingAndMarketingExpenseMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_GeneralAndAdministrativeExpenseMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GeneralAndAdministrativeExpenseMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_GeneralAndAdministrativeExpenseMember_lbl" xml:lang="en-US">General and administrative [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GeneralAndAdministrativeExpenseMember" xlink:to="us-gaap_GeneralAndAdministrativeExpenseMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CostOfSalesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CostOfSalesMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CostOfSalesMember_lbl" xml:lang="en-US">Cost of revenues [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CostOfSalesMember" xlink:to="us-gaap_CostOfSalesMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConvertiblePreferredStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConvertiblePreferredStockMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ConvertiblePreferredStockMember_lbl" xml:lang="en-US">Convertible preferred shares [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConvertiblePreferredStockMember" xlink:to="us-gaap_ConvertiblePreferredStockMember_lbl"/>
    <loc xlink:type="locator" xlink:label="arbe_OutstandingShareOptionsMember" xlink:href="arbe-20231231.xsd#arbe_OutstandingShareOptionsMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="arbe_OutstandingShareOptionsMember_lbl" xml:lang="en-US">Outstanding share options [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_OutstandingShareOptionsMember" xlink:to="arbe_OutstandingShareOptionsMember_lbl"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesAxis" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidatedEntitiesAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_ConsolidatedEntitiesAxis_lbl" xml:lang="en-US">Consolidated Entities [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="srt_ConsolidatedEntitiesAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsidiarySaleOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsidiarySaleOfStockAxis_lbl" xml:lang="en-US">Sale of Stock [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SubsidiarySaleOfStockAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PlanNameAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PlanNameAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PlanNameAxis_lbl" xml:lang="en-US">Plan Name [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PlanNameAxis" xlink:to="us-gaap_PlanNameAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="srt_TitleOfIndividualAxis" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_TitleOfIndividualAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_TitleOfIndividualAxis_lbl" xml:lang="en-US">Title of Individual [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_TitleOfIndividualAxis" xlink:to="srt_TitleOfIndividualAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="srt_MajorCustomersAxis" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MajorCustomersAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_MajorCustomersAxis_lbl" xml:lang="en-US">Customer [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_MajorCustomersAxis" xlink:to="srt_MajorCustomersAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConcentrationRiskByBenchmarkAxis_lbl" xml:lang="en-US">Concentration Risk Benchmark [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:to="us-gaap_ConcentrationRiskByBenchmarkAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConcentrationRiskByTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConcentrationRiskByTypeAxis_lbl" xml:lang="en-US">Concentration Risk Type [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskByTypeAxis" xlink:to="us-gaap_ConcentrationRiskByTypeAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockOtherSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockOtherSharesOutstanding"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CommonStockOtherSharesOutstanding_lbl" xml:lang="en-US">Ordinary shares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockOtherSharesOutstanding" xlink:to="us-gaap_CommonStockOtherSharesOutstanding_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharesIssuedPricePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharesIssuedPricePerShare"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SharesIssuedPricePerShare_lbl" xml:lang="en-US">Ordinary shares par value</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesIssuedPricePerShare" xlink:to="us-gaap_SharesIssuedPricePerShare_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PaymentsOfOrdinaryDividends" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsOfOrdinaryDividends"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_PaymentsOfOrdinaryDividends_lbl" xml:lang="en-US">Ordinary shares amount (in Dollars)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsOfOrdinaryDividends" xlink:to="us-gaap_PaymentsOfOrdinaryDividends_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightOutstanding"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ClassOfWarrantOrRightOutstanding_lbl" xml:lang="en-US">Warrants shares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightOutstanding" xlink:to="us-gaap_ClassOfWarrantOrRightOutstanding_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SaleOfStockConsiderationReceivedOnTransaction"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SaleOfStockConsiderationReceivedOnTransaction_lbl" xml:lang="en-US">Transaction costs (in Dollars)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:to="us-gaap_SaleOfStockConsiderationReceivedOnTransaction_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_lbl" xml:lang="en-US">Sale of ordinary shares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:to="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_lbl"/>
    <loc xlink:type="locator" xlink:label="srt_DemandDepositLiabilitiesInterestBearingAverageRatePaid" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_DemandDepositLiabilitiesInterestBearingAverageRatePaid"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="srt_DemandDepositLiabilitiesInterestBearingAverageRatePaid_lbl" xml:lang="en-US">Bank deposit bearing annual interest rate</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_DemandDepositLiabilitiesInterestBearingAverageRatePaid" xlink:to="srt_DemandDepositLiabilitiesInterestBearingAverageRatePaid_lbl"/>
    <loc xlink:type="locator" xlink:label="arbe_SeverancePercentageOfMonthlySalary" xlink:href="arbe-20231231.xsd#arbe_SeverancePercentageOfMonthlySalary"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="arbe_SeverancePercentageOfMonthlySalary_lbl" xml:lang="en-US">Deposits rate</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_SeverancePercentageOfMonthlySalary" xlink:to="arbe_SeverancePercentageOfMonthlySalary_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SeveranceCosts1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SeveranceCosts1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SeveranceCosts1_lbl" xml:lang="en-US">Severance Costs (in Dollars)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SeveranceCosts1" xlink:to="us-gaap_SeveranceCosts1_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_EffectiveIncomeTaxRateContinuingOperations_lbl" xml:lang="en-US">Tax percentage</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="us-gaap_EffectiveIncomeTaxRateContinuingOperations_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredRevenue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredRevenue"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DeferredRevenue_lbl" xml:lang="en-US">Deferred revenue</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredRevenue" xlink:to="us-gaap_DeferredRevenue_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RevenueRemainingPerformanceObligation" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueRemainingPerformanceObligation"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_RevenueRemainingPerformanceObligation_lbl" xml:lang="en-US">Remaining performance obligation</label>
<!-- [WMV5][XcpuxYn59dz7vgYynUDuwG7r97K2jUTysl7vcz0lJt/tSeJz73kx1cLt0ZFF2SK/vxBCY0vdSrZEr5dnmkj55Vn3PE+1u+YOtkjz23BDixtN+DSa6ODpxKHuuFDR2EFRAYrDV15EdRUTOp8hTdByKJ//xoC7ECC663wnKueQq7LbhDBxlm0Wi1xZdy33k9DRJYjt/rCQI8A6bBdr5ony7RknOIsPU1pWTweSc4Wp+IQVoYO/x93rSQOoZayYDA6Qj2ggzXTAovyEI7eNqLe8Cg==] CSR-->
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenueRemainingPerformanceObligation" xlink:to="us-gaap_RevenueRemainingPerformanceObligation_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_GrantsReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GrantsReceivable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_GrantsReceivable_lbl" xml:lang="en-US">Grants value (in Dollars)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GrantsReceivable" xlink:to="us-gaap_GrantsReceivable_lbl"/>
    <loc xlink:type="locator" xlink:label="arbe_RoyaltyPercentage" xlink:href="arbe-20231231.xsd#arbe_RoyaltyPercentage"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="arbe_RoyaltyPercentage_lbl" xml:lang="en-US">Royalty percentage</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_RoyaltyPercentage" xlink:to="arbe_RoyaltyPercentage_lbl"/>
    <loc xlink:type="locator" xlink:label="arbe_GrantsReceived" xlink:href="arbe-20231231.xsd#arbe_GrantsReceived"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="arbe_GrantsReceived_lbl" xml:lang="en-US">Maximum aggregate royalties paid</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_GrantsReceived" xlink:to="arbe_GrantsReceived_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AdditionalCollateralAggregateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdditionalCollateralAggregateFairValue"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AdditionalCollateralAggregateFairValue_lbl" xml:lang="en-US">Aggregate exercise price</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdditionalCollateralAggregateFairValue" xlink:to="us-gaap_AdditionalCollateralAggregateFairValue_lbl"/>
    <loc xlink:type="locator" xlink:label="arbe_DerivativeWarrantLiabilityShares" xlink:href="arbe-20231231.xsd#arbe_DerivativeWarrantLiabilityShares"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="arbe_DerivativeWarrantLiabilityShares_lbl" xml:lang="en-US">Derivative warrant liability shares (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_DerivativeWarrantLiabilityShares" xlink:to="arbe_DerivativeWarrantLiabilityShares_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate_lbl" xml:lang="en-US">Volatility impact rate</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueAdjustmentOfWarrants" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAdjustmentOfWarrants"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_FairValueAdjustmentOfWarrants_lbl" xml:lang="en-US">Fair value of warrants</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueAdjustmentOfWarrants" xlink:to="us-gaap_FairValueAdjustmentOfWarrants_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquityReverseStockSplit" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityReverseStockSplit"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_StockholdersEquityReverseStockSplit_lbl" xml:lang="en-US">Stock split</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityReverseStockSplit" xlink:to="us-gaap_StockholdersEquityReverseStockSplit_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonUnitIssuanceValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonUnitIssuanceValue"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CommonUnitIssuanceValue_lbl" xml:lang="en-US">Ordinary shares issue value</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonUnitIssuanceValue" xlink:to="us-gaap_CommonUnitIssuanceValue_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonUnitIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonUnitIssued"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CommonUnitIssued_lbl" xml:lang="en-US">Ordinary shares issue (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonUnitIssued" xlink:to="us-gaap_CommonUnitIssued_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharePrice"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SharePrice_lbl" xml:lang="en-US">Share Price (in Dollars per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharePrice" xlink:to="us-gaap_SharePrice_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_lbl" xml:lang="en-US">Ordinary shares were reserved for issuance (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_lbl" xml:lang="en-US">Plan expiration period</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_lbl" xml:lang="en-US">Options vested period</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardTermsOfAward" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardTermsOfAward"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardTermsOfAward_lbl" xml:lang="en-US">Share option , description</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardTermsOfAward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardTermsOfAward_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRights" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRights"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRights_lbl" xml:lang="en-US">Vesting period, description</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRights" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRights_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodExpectedDividendRate" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodExpectedDividendRate"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodExpectedDividendRate_lbl" xml:lang="en-US">Expected dividend yield</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodExpectedDividendRate" xlink:to="us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodExpectedDividendRate_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense_lbl" xml:lang="en-US">Stock-based compensation</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AllocatedShareBasedCompensationExpense" xlink:to="us-gaap_AllocatedShareBasedCompensationExpense_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_lbl" xml:lang="en-US">Foreign holding percentage</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLossCarryforwards" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLossCarryforwards"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_OperatingLossCarryforwards_lbl" xml:lang="en-US">Net operating loss carryforward (in Dollars)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLossCarryforwards" xlink:to="us-gaap_OperatingLossCarryforwards_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConcentrationRiskPercentage1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ConcentrationRiskPercentage1_lbl" xml:lang="en-US">Percentage of revenue of customers</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskPercentage1" xlink:to="us-gaap_ConcentrationRiskPercentage1_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_BasisOfAccountingPolicyPolicyTextBlock_lbl" xml:lang="en-US">Basis of presentation</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:to="us-gaap_BasisOfAccountingPolicyPolicyTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_UseOfEstimates" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UseOfEstimates"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_UseOfEstimates_lbl" xml:lang="en-US">Use of estimates</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UseOfEstimates" xlink:to="us-gaap_UseOfEstimates_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_lbl" xml:lang="en-US">Consolidated financial statements in U.S. dollars</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:to="us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConcentrationRiskCreditRisk" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskCreditRisk"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ConcentrationRiskCreditRisk_lbl" xml:lang="en-US">Concentration of credit risk</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskCreditRisk" xlink:to="us-gaap_ConcentrationRiskCreditRisk_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_lbl" xml:lang="en-US">Cash and cash equivalents and restricted cash</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:to="us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_lbl"/>
    <loc xlink:type="locator" xlink:label="arbe_ShortTermDepositsPolicyPolicyTextBlock" xlink:href="arbe-20231231.xsd#arbe_ShortTermDepositsPolicyPolicyTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="arbe_ShortTermDepositsPolicyPolicyTextBlock_lbl" xml:lang="en-US">Short term deposits</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_ShortTermDepositsPolicyPolicyTextBlock" xlink:to="arbe_ShortTermDepositsPolicyPolicyTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueOfFinancialInstrumentsPolicy"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_FairValueOfFinancialInstrumentsPolicy_lbl" xml:lang="en-US">Fair value of financial instruments</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:to="us-gaap_FairValueOfFinancialInstrumentsPolicy_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy_lbl" xml:lang="en-US">Trade Receivables</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy" xlink:to="us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_lbl" xml:lang="en-US">Property and equipment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:to="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_lbl" xml:lang="en-US">Impairment of long-lived assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:to="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PostemploymentBenefitPlansPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PostemploymentBenefitPlansPolicy"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_PostemploymentBenefitPlansPolicy_lbl" xml:lang="en-US">Accrued post-employment benefit</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PostemploymentBenefitPlansPolicy" xlink:to="us-gaap_PostemploymentBenefitPlansPolicy_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_lbl" xml:lang="en-US">Stock-based compensation</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:to="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerSharePolicyTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock_lbl" xml:lang="en-US">Net loss per share attributable to ordinary shareholders</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerSharePolicyTextBlock" xlink:to="us-gaap_EarningsPerSharePolicyTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ComprehensiveIncomePolicyPolicyTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ComprehensiveIncomePolicyPolicyTextBlock_lbl" xml:lang="en-US">Other Comprehensive loss</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" xlink:to="us-gaap_ComprehensiveIncomePolicyPolicyTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RevenueRecognitionPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueRecognitionPolicyTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_RevenueRecognitionPolicyTextBlock_lbl" xml:lang="en-US">Revenue recognition</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenueRecognitionPolicyTextBlock" xlink:to="us-gaap_RevenueRecognitionPolicyTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CostOfSalesPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CostOfSalesPolicyTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CostOfSalesPolicyTextBlock_lbl" xml:lang="en-US">Cost of revenues</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CostOfSalesPolicyTextBlock" xlink:to="us-gaap_CostOfSalesPolicyTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ResearchAndDevelopmentExpensePolicy"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ResearchAndDevelopmentExpensePolicy_lbl" xml:lang="en-US">Research and development expenses, net</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:to="us-gaap_ResearchAndDevelopmentExpensePolicy_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxPolicyTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_IncomeTaxPolicyTextBlock_lbl" xml:lang="en-US">Income taxes</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxPolicyTextBlock" xlink:to="us-gaap_IncomeTaxPolicyTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ContingentLiabilityReserveEstimatePolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContingentLiabilityReserveEstimatePolicy"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ContingentLiabilityReserveEstimatePolicy_lbl" xml:lang="en-US">Contingent Liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ContingentLiabilityReserveEstimatePolicy" xlink:to="us-gaap_ContingentLiabilityReserveEstimatePolicy_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LesseeLeasesPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeLeasesPolicyTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_LesseeLeasesPolicyTextBlock_lbl" xml:lang="en-US">Leases</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeLeasesPolicyTextBlock" xlink:to="us-gaap_LesseeLeasesPolicyTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl" xml:lang="en-US">Impact of recently issued accounting standard</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="arbe_ArbeRoboticsLtdMember" xlink:href="arbe-20231231.xsd#arbe_ArbeRoboticsLtdMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="arbe_ArbeRoboticsLtdMember_lbl" xml:lang="en-US">Arbe Robotics Ltd. [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_ArbeRoboticsLtdMember" xlink:to="arbe_ArbeRoboticsLtdMember_lbl"/>
    <loc xlink:type="locator" xlink:label="arbe_PublicWarrantsMember" xlink:href="arbe-20231231.xsd#arbe_PublicWarrantsMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="arbe_PublicWarrantsMember_lbl" xml:lang="en-US">Public Warrants [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_PublicWarrantsMember" xlink:to="arbe_PublicWarrantsMember_lbl"/>
    <loc xlink:type="locator" xlink:label="arbe_PrivateWarrantsMember" xlink:href="arbe-20231231.xsd#arbe_PrivateWarrantsMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="arbe_PrivateWarrantsMember_lbl" xml:lang="en-US">Private Warrants [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_PrivateWarrantsMember" xlink:to="arbe_PrivateWarrantsMember_lbl"/>
    <loc xlink:type="locator" xlink:label="arbe_PIPEMember" xlink:href="arbe-20231231.xsd#arbe_PIPEMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="arbe_PIPEMember_lbl" xml:lang="en-US">PIPE [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_PIPEMember" xlink:to="arbe_PIPEMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PrivatePlacementMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PrivatePlacementMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_PrivatePlacementMember_lbl" xml:lang="en-US">Private Placement [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PrivatePlacementMember" xlink:to="us-gaap_PrivatePlacementMember_lbl"/>
    <loc xlink:type="locator" xlink:label="arbe_TwoThousandSixteenIncentivePlanMember" xlink:href="arbe-20231231.xsd#arbe_TwoThousandSixteenIncentivePlanMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="arbe_TwoThousandSixteenIncentivePlanMember_lbl" xml:lang="en-US">2016 Share Incentive Plan [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_TwoThousandSixteenIncentivePlanMember" xlink:to="arbe_TwoThousandSixteenIncentivePlanMember_lbl"/>
    <loc xlink:type="locator" xlink:label="arbe_PlanOneMember" xlink:href="arbe-20231231.xsd#arbe_PlanOneMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="arbe_PlanOneMember_lbl" xml:lang="en-US">2016 Plan [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_PlanOneMember" xlink:to="arbe_PlanOneMember_lbl"/>
    <loc xlink:type="locator" xlink:label="arbe_TwoThousandTwentyOneEquityIncentivePlanMember" xlink:href="arbe-20231231.xsd#arbe_TwoThousandTwentyOneEquityIncentivePlanMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="arbe_TwoThousandTwentyOneEquityIncentivePlanMember_lbl" xml:lang="en-US">2021 Plan [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_TwoThousandTwentyOneEquityIncentivePlanMember" xlink:to="arbe_TwoThousandTwentyOneEquityIncentivePlanMember_lbl"/>
    <loc xlink:type="locator" xlink:label="arbe_Customer1Member" xlink:href="arbe-20231231.xsd#arbe_Customer1Member"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="arbe_Customer1Member_lbl" xml:lang="en-US">Customer1 [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_Customer1Member" xlink:to="arbe_Customer1Member_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SalesRevenueNetMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SalesRevenueNetMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SalesRevenueNetMember_lbl" xml:lang="en-US">Revenue Benchmark [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SalesRevenueNetMember" xlink:to="us-gaap_SalesRevenueNetMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CustomerConcentrationRiskMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CustomerConcentrationRiskMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CustomerConcentrationRiskMember_lbl" xml:lang="en-US">Customer Concentration Risk [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CustomerConcentrationRiskMember" xlink:to="us-gaap_CustomerConcentrationRiskMember_lbl"/>
    <loc xlink:type="locator" xlink:label="arbe_Customer2Member" xlink:href="arbe-20231231.xsd#arbe_Customer2Member"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="arbe_Customer2Member_lbl" xml:lang="en-US">Customer2 [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_Customer2Member" xlink:to="arbe_Customer2Member_lbl"/>
    <loc xlink:type="locator" xlink:label="arbe_Customer3Member" xlink:href="arbe-20231231.xsd#arbe_Customer3Member"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="arbe_Customer3Member_lbl" xml:lang="en-US">Customer3 [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_Customer3Member" xlink:to="arbe_Customer3Member_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ClassOfStockDomain_lbl" xml:lang="en-US">Class of Stock [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_ClassOfStockDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EquityComponentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EquityComponentDomain_lbl" xml:lang="en-US">Equity Component [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_EquityComponentDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementTable_lbl" xml:lang="en-US">Statement [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementTable_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementLineItems_lbl" xml:lang="en-US">Statement [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain_lbl" xml:lang="en-US">Long-Lived Tangible Asset [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_PropertyPlantAndEquipmentTypeDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="srt_RangeMember" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_RangeMember_lbl" xml:lang="en-US">Statistical Measurement [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_RangeMember" xlink:to="srt_RangeMember_lbl"/>
    <loc xlink:type="locator" xlink:label="arbe_SignificantAccountingPoliciesDetailsScheduleoftheStraightLineMethodOvertheEstimatedUsefulLivesoftheAssetsTable" xlink:href="arbe-20231231.xsd#arbe_SignificantAccountingPoliciesDetailsScheduleoftheStraightLineMethodOvertheEstimatedUsefulLivesoftheAssetsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="arbe_SignificantAccountingPoliciesDetailsScheduleoftheStraightLineMethodOvertheEstimatedUsefulLivesoftheAssetsTable_lbl" xml:lang="en-US">Significant Accounting Policies (Details) - Schedule of the Straight-Line Method Over the Estimated Useful Lives of the Assets [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_SignificantAccountingPoliciesDetailsScheduleoftheStraightLineMethodOvertheEstimatedUsefulLivesoftheAssetsTable" xlink:to="arbe_SignificantAccountingPoliciesDetailsScheduleoftheStraightLineMethodOvertheEstimatedUsefulLivesoftheAssetsTable_lbl"/>
    <loc xlink:type="locator" xlink:label="arbe_SignificantAccountingPoliciesDetailsScheduleoftheStraightLineMethodOvertheEstimatedUsefulLivesoftheAssetsLineItems" xlink:href="arbe-20231231.xsd#arbe_SignificantAccountingPoliciesDetailsScheduleoftheStraightLineMethodOvertheEstimatedUsefulLivesoftheAssetsLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="arbe_SignificantAccountingPoliciesDetailsScheduleoftheStraightLineMethodOvertheEstimatedUsefulLivesoftheAssetsLineItems_lbl" xml:lang="en-US">Significant Accounting Policies (Details) - Schedule of the Straight-Line Method Over the Estimated Useful Lives of the Assets [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_SignificantAccountingPoliciesDetailsScheduleoftheStraightLineMethodOvertheEstimatedUsefulLivesoftheAssetsLineItems" xlink:to="arbe_SignificantAccountingPoliciesDetailsScheduleoftheStraightLineMethodOvertheEstimatedUsefulLivesoftheAssetsLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="srt_ProductsAndServicesDomain" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ProductsAndServicesDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_ProductsAndServicesDomain_lbl" xml:lang="en-US">Product and Service [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_ProductsAndServicesDomain" xlink:to="srt_ProductsAndServicesDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="srt_SegmentGeographicalDomain" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_SegmentGeographicalDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_SegmentGeographicalDomain_lbl" xml:lang="en-US">Geographical [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_SegmentGeographicalDomain" xlink:to="srt_SegmentGeographicalDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DisaggregationOfRevenueTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DisaggregationOfRevenueTable_lbl" xml:lang="en-US">Disaggregation of Revenue [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisaggregationOfRevenueTable" xlink:to="us-gaap_DisaggregationOfRevenueTable_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DisaggregationOfRevenueLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DisaggregationOfRevenueLineItems_lbl" xml:lang="en-US">Disaggregation of Revenue [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisaggregationOfRevenueLineItems" xlink:to="us-gaap_DisaggregationOfRevenueLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_lbl" xml:lang="en-US">Property, Plant and Equipment [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentLineItems_lbl" xml:lang="en-US">Property, Plant and Equipment [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_lbl" xml:lang="en-US">Award Type [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="arbe_ShareholdersEquityDetailsScheduleofRSUsActivityTable" xlink:href="arbe-20231231.xsd#arbe_ShareholdersEquityDetailsScheduleofRSUsActivityTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="arbe_ShareholdersEquityDetailsScheduleofRSUsActivityTable_lbl" xml:lang="en-US">Shareholders&#8217; Equity (Details) - Schedule of RSUs Activity [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_ShareholdersEquityDetailsScheduleofRSUsActivityTable" xlink:to="arbe_ShareholdersEquityDetailsScheduleofRSUsActivityTable_lbl"/>
    <loc xlink:type="locator" xlink:label="arbe_ShareholdersEquityDetailsScheduleofRSUsActivityLineItems" xlink:href="arbe-20231231.xsd#arbe_ShareholdersEquityDetailsScheduleofRSUsActivityLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="arbe_ShareholdersEquityDetailsScheduleofRSUsActivityLineItems_lbl" xml:lang="en-US">Shareholders&#8217; Equity (Details) - Schedule of RSUs Activity [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_ShareholdersEquityDetailsScheduleofRSUsActivityLineItems" xlink:to="arbe_ShareholdersEquityDetailsScheduleofRSUsActivityLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="arbe_ShareholdersEquityDetailsScheduleofCompensationtoEmployeesTable" xlink:href="arbe-20231231.xsd#arbe_ShareholdersEquityDetailsScheduleofCompensationtoEmployeesTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="arbe_ShareholdersEquityDetailsScheduleofCompensationtoEmployeesTable_lbl" xml:lang="en-US">Shareholders&#8217; Equity (Details) - Schedule of Compensation to Employees [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_ShareholdersEquityDetailsScheduleofCompensationtoEmployeesTable" xlink:to="arbe_ShareholdersEquityDetailsScheduleofCompensationtoEmployeesTable_lbl"/>
    <loc xlink:type="locator" xlink:label="arbe_ShareholdersEquityDetailsScheduleofCompensationtoEmployeesLineItems" xlink:href="arbe-20231231.xsd#arbe_ShareholdersEquityDetailsScheduleofCompensationtoEmployeesLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="arbe_ShareholdersEquityDetailsScheduleofCompensationtoEmployeesLineItems_lbl" xml:lang="en-US">Schedule of Compensation to Employees [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_ShareholdersEquityDetailsScheduleofCompensationtoEmployeesLineItems" xlink:to="arbe_ShareholdersEquityDetailsScheduleofCompensationtoEmployeesLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeStatementLocationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeStatementLocationDomain_lbl" xml:lang="en-US">Income Statement Location [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="us-gaap_IncomeStatementLocationDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="arbe_ShareholdersEquityDetailsScheduleofShareBasedCompensationExpenseTable" xlink:href="arbe-20231231.xsd#arbe_ShareholdersEquityDetailsScheduleofShareBasedCompensationExpenseTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="arbe_ShareholdersEquityDetailsScheduleofShareBasedCompensationExpenseTable_lbl" xml:lang="en-US">Shareholders&#8217; Equity (Details) - Schedule of Share Based Compensation Expense [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_ShareholdersEquityDetailsScheduleofShareBasedCompensationExpenseTable" xlink:to="arbe_ShareholdersEquityDetailsScheduleofShareBasedCompensationExpenseTable_lbl"/>
    <loc xlink:type="locator" xlink:label="arbe_ShareholdersEquityDetailsScheduleofShareBasedCompensationExpenseLineItems" xlink:href="arbe-20231231.xsd#arbe_ShareholdersEquityDetailsScheduleofShareBasedCompensationExpenseLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="arbe_ShareholdersEquityDetailsScheduleofShareBasedCompensationExpenseLineItems_lbl" xml:lang="en-US">Schedule of Share Based Compensation Expense [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_ShareholdersEquityDetailsScheduleofShareBasedCompensationExpenseLineItems" xlink:to="arbe_ShareholdersEquityDetailsScheduleofShareBasedCompensationExpenseLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AntidilutiveSecuritiesNameDomain_lbl" xml:lang="en-US">Antidilutive Securities, Name [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="us-gaap_AntidilutiveSecuritiesNameDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_lbl" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_lbl" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="arbe_SegmentInformationDetailsScheduleofPropertyandEquipmentNetofDepreciationbyGeographicRegionTable" xlink:href="arbe-20231231.xsd#arbe_SegmentInformationDetailsScheduleofPropertyandEquipmentNetofDepreciationbyGeographicRegionTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="arbe_SegmentInformationDetailsScheduleofPropertyandEquipmentNetofDepreciationbyGeographicRegionTable_lbl" xml:lang="en-US">Segment Information (Details) - Schedule of Property and Equipment, Net of Depreciation, by Geographic Region [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_SegmentInformationDetailsScheduleofPropertyandEquipmentNetofDepreciationbyGeographicRegionTable" xlink:to="arbe_SegmentInformationDetailsScheduleofPropertyandEquipmentNetofDepreciationbyGeographicRegionTable_lbl"/>
    <loc xlink:type="locator" xlink:label="arbe_SegmentInformationDetailsScheduleofPropertyandEquipmentNetofDepreciationbyGeographicRegionLineItems" xlink:href="arbe-20231231.xsd#arbe_SegmentInformationDetailsScheduleofPropertyandEquipmentNetofDepreciationbyGeographicRegionLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="arbe_SegmentInformationDetailsScheduleofPropertyandEquipmentNetofDepreciationbyGeographicRegionLineItems_lbl" xml:lang="en-US">Segment Information (Details) - Schedule of Property and Equipment, Net of Depreciation, by Geographic Region [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_SegmentInformationDetailsScheduleofPropertyandEquipmentNetofDepreciationbyGeographicRegionLineItems" xlink:to="arbe_SegmentInformationDetailsScheduleofPropertyandEquipmentNetofDepreciationbyGeographicRegionLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesDomain" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidatedEntitiesDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_ConsolidatedEntitiesDomain_lbl" xml:lang="en-US">Consolidated Entities [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_ConsolidatedEntitiesDomain" xlink:to="srt_ConsolidatedEntitiesDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain_lbl" xml:lang="en-US">Sale of Stock [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="arbe_GeneralDetailsTable" xlink:href="arbe-20231231.xsd#arbe_GeneralDetailsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="arbe_GeneralDetailsTable_lbl" xml:lang="en-US">General (Details) [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_GeneralDetailsTable" xlink:to="arbe_GeneralDetailsTable_lbl"/>
    <loc xlink:type="locator" xlink:label="arbe_GeneralDetailsLineItems" xlink:href="arbe-20231231.xsd#arbe_GeneralDetailsLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="arbe_GeneralDetailsLineItems_lbl" xml:lang="en-US">General [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_GeneralDetailsLineItems" xlink:to="arbe_GeneralDetailsLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="arbe_SignificantAccountingPoliciesDetailsTable" xlink:href="arbe-20231231.xsd#arbe_SignificantAccountingPoliciesDetailsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="arbe_SignificantAccountingPoliciesDetailsTable_lbl" xml:lang="en-US">Significant Accounting Policies (Details) [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_SignificantAccountingPoliciesDetailsTable" xlink:to="arbe_SignificantAccountingPoliciesDetailsTable_lbl"/>
    <loc xlink:type="locator" xlink:label="arbe_SignificantAccountingPoliciesDetailsLineItems" xlink:href="arbe-20231231.xsd#arbe_SignificantAccountingPoliciesDetailsLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="arbe_SignificantAccountingPoliciesDetailsLineItems_lbl" xml:lang="en-US">Significant Accounting Policies (Details) [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_SignificantAccountingPoliciesDetailsLineItems" xlink:to="arbe_SignificantAccountingPoliciesDetailsLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="arbe_WarrantsLiabilitiesDetailsTable" xlink:href="arbe-20231231.xsd#arbe_WarrantsLiabilitiesDetailsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="arbe_WarrantsLiabilitiesDetailsTable_lbl" xml:lang="en-US">Warrants Liabilities (Details) [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_WarrantsLiabilitiesDetailsTable" xlink:to="arbe_WarrantsLiabilitiesDetailsTable_lbl"/>
    <loc xlink:type="locator" xlink:label="arbe_WarrantsLiabilitiesDetailsLineItems" xlink:href="arbe-20231231.xsd#arbe_WarrantsLiabilitiesDetailsLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="arbe_WarrantsLiabilitiesDetailsLineItems_lbl" xml:lang="en-US">Warrants Liabilities [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_WarrantsLiabilitiesDetailsLineItems" xlink:to="arbe_WarrantsLiabilitiesDetailsLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_TitleOfIndividualWithRelationshipToEntityDomain_lbl" xml:lang="en-US">Title of Individual [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:to="srt_TitleOfIndividualWithRelationshipToEntityDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PlanNameDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PlanNameDomain_lbl" xml:lang="en-US">Plan Name [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PlanNameDomain" xlink:to="us-gaap_PlanNameDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="arbe_ShareholdersEquityDetailsTable" xlink:href="arbe-20231231.xsd#arbe_ShareholdersEquityDetailsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="arbe_ShareholdersEquityDetailsTable_lbl" xml:lang="en-US">Shareholders&#8217; Equity (Details) [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_ShareholdersEquityDetailsTable" xlink:to="arbe_ShareholdersEquityDetailsTable_lbl"/>
    <loc xlink:type="locator" xlink:label="arbe_ShareholdersEquityDetailsLineItems" xlink:href="arbe-20231231.xsd#arbe_ShareholdersEquityDetailsLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="arbe_ShareholdersEquityDetailsLineItems_lbl" xml:lang="en-US">Shareholders&#8217; Equity [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_ShareholdersEquityDetailsLineItems" xlink:to="arbe_ShareholdersEquityDetailsLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="arbe_TaxesonIncomeDetailsTable" xlink:href="arbe-20231231.xsd#arbe_TaxesonIncomeDetailsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="arbe_TaxesonIncomeDetailsTable_lbl" xml:lang="en-US">Taxes on Income (Details) [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_TaxesonIncomeDetailsTable" xlink:to="arbe_TaxesonIncomeDetailsTable_lbl"/>
    <loc xlink:type="locator" xlink:label="arbe_TaxesonIncomeDetailsLineItems" xlink:href="arbe-20231231.xsd#arbe_TaxesonIncomeDetailsLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="arbe_TaxesonIncomeDetailsLineItems_lbl" xml:lang="en-US">Taxes on Income [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_TaxesonIncomeDetailsLineItems" xlink:to="arbe_TaxesonIncomeDetailsLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="srt_NameOfMajorCustomerDomain" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_NameOfMajorCustomerDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_NameOfMajorCustomerDomain_lbl" xml:lang="en-US">Customer [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_NameOfMajorCustomerDomain" xlink:to="srt_NameOfMajorCustomerDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConcentrationRiskBenchmarkDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConcentrationRiskBenchmarkDomain_lbl" xml:lang="en-US">Concentration Risk Benchmark [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskBenchmarkDomain" xlink:to="us-gaap_ConcentrationRiskBenchmarkDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConcentrationRiskTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConcentrationRiskTypeDomain_lbl" xml:lang="en-US">Concentration Risk Type [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskTypeDomain" xlink:to="us-gaap_ConcentrationRiskTypeDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="arbe_SegmentInformationDetailsTable" xlink:href="arbe-20231231.xsd#arbe_SegmentInformationDetailsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="arbe_SegmentInformationDetailsTable_lbl" xml:lang="en-US">Segment Information (Details) [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_SegmentInformationDetailsTable" xlink:to="arbe_SegmentInformationDetailsTable_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SegmentReportingInformationLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SegmentReportingInformationLineItems_lbl" xml:lang="en-US">Segment Information [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SegmentReportingInformationLineItems" xlink:to="us-gaap_SegmentReportingInformationLineItems_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="arbe_ConversionOfConvertibleLoanIntoOrdinarySharesUponTheRecapitalization_lbl0" xml:lang="en-US">Conversion of convertible loan into ordinary shares upon the recapitalization.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_ConversionOfConvertibleLoanIntoOrdinarySharesUponTheRecapitalization" xlink:to="arbe_ConversionOfConvertibleLoanIntoOrdinarySharesUponTheRecapitalization_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="arbe_ConversionOfPreferredSharesIntoOrdinarySharesUponTheRecapitalization_lbl0" xml:lang="en-US">Conversion of preferred shares into ordinary shares upon the recapitalization.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_ConversionOfPreferredSharesIntoOrdinarySharesUponTheRecapitalization" xlink:to="arbe_ConversionOfPreferredSharesIntoOrdinarySharesUponTheRecapitalization_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="arbe_DerivativeWarrantLiabilityShares_lbl0" xml:lang="en-US">Derivative warrant liability.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_DerivativeWarrantLiabilityShares" xlink:to="arbe_DerivativeWarrantLiabilityShares_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="arbe_GovernmentAuthorities_lbl0" xml:lang="en-US">Government Authorities means any national, provincial, municipal or local government, administrative or regulatory body or department, court, tribunal, arbitrator or any body that exercises the function of a regulator.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_GovernmentAuthorities" xlink:to="arbe_GovernmentAuthorities_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="arbe_GrantsReceived_lbl0" xml:lang="en-US">Grants received for maximum aggregate royalties.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_GrantsReceived" xlink:to="arbe_GrantsReceived_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="arbe_OperatingLeaseRightofuseAssetsAndLiabilitiesNet_lbl0" xml:lang="en-US">Operating lease right-of-use assets and liabilities net.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_OperatingLeaseRightofuseAssetsAndLiabilitiesNet" xlink:to="arbe_OperatingLeaseRightofuseAssetsAndLiabilitiesNet_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="arbe_PropertyPlantAndEquipmentUsefulLifeTableTextBlock_lbl0" xml:lang="en-US">Tabular disclosure of the useful lives of property, plant and equipment.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_PropertyPlantAndEquipmentUsefulLifeTableTextBlock" xlink:to="arbe_PropertyPlantAndEquipmentUsefulLifeTableTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="arbe_RevaluationOfConvertibleLoan_lbl0" xml:lang="en-US">The cash inflow from the issuance of a long-term debt instrument which can be exchanged for a specified amount of another security, typically the entity&apos;s common stock, at the option of the issuer or the holder.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_RevaluationOfConvertibleLoan" xlink:to="arbe_RevaluationOfConvertibleLoan_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="arbe_RoyaltyPercentage_lbl0" xml:lang="en-US">Percentage of sales that royalties are paid.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_RoyaltyPercentage" xlink:to="arbe_RoyaltyPercentage_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="arbe_SeverancePercentageOfMonthlySalary_lbl0" xml:lang="en-US">Percentage of monthly salary monthly severance rate.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_SeverancePercentageOfMonthlySalary" xlink:to="arbe_SeverancePercentageOfMonthlySalary_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="arbe_ShortTermDepositsPolicyPolicyTextBlock_lbl0" xml:lang="en-US">Policy disclosure of short term deposits.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_ShortTermDepositsPolicyPolicyTextBlock" xlink:to="arbe_ShortTermDepositsPolicyPolicyTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="arbe_StockIssuedDuringPeriodSharesExerciseOfWarrants_lbl0" xml:lang="en-US">The represent the shares of exercise of warrants.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_StockIssuedDuringPeriodSharesExerciseOfWarrants" xlink:to="arbe_StockIssuedDuringPeriodSharesExerciseOfWarrants_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="arbe_DerivativeWarrantLiabilityShares_lbl1" xml:lang="en-US">Derivative Warrant Liability Shares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_DerivativeWarrantLiabilityShares" xlink:to="arbe_DerivativeWarrantLiabilityShares_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SupplementalCashFlowInformationAbstract_lbl0" xml:lang="en-US">Supplemental Cash Flow Information [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="us-gaap_SupplementalCashFlowInformationAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate_lbl0" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Weighted Average Volatility Rate</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent_lbl0" xml:lang="en-US">Accounts Payable and Other Accrued Liabilities, Current</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent" xlink:to="us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ContingentLiabilityReserveEstimatePolicy_lbl0" xml:lang="en-US">Contingent Liability Reserve Estimate, Policy [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ContingentLiabilityReserveEstimatePolicy" xlink:to="us-gaap_ContingentLiabilityReserveEstimatePolicy_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl0" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxReconciliationNondeductibleExpense_lbl0" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Nondeductible Expense, Amount</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxReconciliationNondeductibleExpense" xlink:to="us-gaap_IncomeTaxReconciliationNondeductibleExpense_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="arbe_ConversionOfConvertibleLoanIntoOrdinarySharesUponTheRecapitalization_lbl1" xml:lang="en-US">Conversion Of Convertible Loan Into Ordinary Shares Upon The Recapitalization</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_ConversionOfConvertibleLoanIntoOrdinarySharesUponTheRecapitalization" xlink:to="arbe_ConversionOfConvertibleLoanIntoOrdinarySharesUponTheRecapitalization_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsLiabilitiesNet_lbl0" xml:lang="en-US">Deferred Tax Assets, Net</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:to="us-gaap_DeferredTaxAssetsLiabilitiesNet_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsAbstract_lbl0" xml:lang="en-US">Assets [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_AssetsAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent_lbl1" xml:lang="en-US">Operating Lease, Liability, Noncurrent</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:to="us-gaap_OperatingLeaseLiabilityNoncurrent_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense_lbl0" xml:lang="en-US">Share-Based Payment Arrangement, Expense</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AllocatedShareBasedCompensationExpense" xlink:to="us-gaap_AllocatedShareBasedCompensationExpense_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLossCarryforwards_lbl0" xml:lang="en-US">Operating Loss Carryforwards</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLossCarryforwards" xlink:to="us-gaap_OperatingLossCarryforwards_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesNoncurrentAbstract_lbl0" xml:lang="en-US">Liabilities, Noncurrent [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesNoncurrentAbstract" xlink:to="us-gaap_LiabilitiesNoncurrentAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharesIssuedPricePerShare_lbl0" xml:lang="en-US">Shares Issued, Price Per Share</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesIssuedPricePerShare" xlink:to="us-gaap_SharesIssuedPricePerShare_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RevenueRemainingPerformanceObligationPercentage_lbl0" xml:lang="en-US">Revenue, Remaining Performance Obligation, Percentage</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenueRemainingPerformanceObligationPercentage" xlink:to="us-gaap_RevenueRemainingPerformanceObligationPercentage_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_lbl0" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl0" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SeriesBPreferredStockMember_lbl0" xml:lang="en-US">Series B Preferred Stock [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SeriesBPreferredStockMember" xlink:to="us-gaap_SeriesBPreferredStockMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_lbl0" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Basic</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WarrantsAndRightsOutstanding_lbl0" xml:lang="en-US">Warrants and Rights Outstanding</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WarrantsAndRightsOutstanding" xlink:to="us-gaap_WarrantsAndRightsOutstanding_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="arbe_UnlabeledAbstract38_lbl0" xml:lang="en-US">Unlabeled Abstract38</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_UnlabeledAbstract38" xlink:to="arbe_UnlabeledAbstract38_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="arbe_UnlabeledAbstract39_lbl0" xml:lang="en-US">Unlabeled Abstract39</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_UnlabeledAbstract39" xlink:to="arbe_UnlabeledAbstract39_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InterestPaidNet_lbl0" xml:lang="en-US">Interest Paid, Excluding Capitalized Interest, Operating Activities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestPaidNet" xlink:to="us-gaap_InterestPaidNet_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonUnitIssued_lbl0" xml:lang="en-US">Common Unit, Issued</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonUnitIssued" xlink:to="us-gaap_CommonUnitIssued_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="arbe_PublicWarrantsMember_lbl0" xml:lang="en-US">Public Warrants Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_PublicWarrantsMember" xlink:to="arbe_PublicWarrantsMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsPayableTradeCurrent_lbl0" xml:lang="en-US">Accounts Payable, Trade, Current</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableTradeCurrent" xlink:to="us-gaap_AccountsPayableTradeCurrent_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquityAbstract_lbl0" xml:lang="en-US">Equity, Attributable to Parent [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_StockholdersEquityAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquityNoteDisclosureTextBlock_lbl0" xml:lang="en-US">Equity [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:to="us-gaap_StockholdersEquityNoteDisclosureTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="arbe_UnlabeledAbstract40_lbl0" xml:lang="en-US">Unlabeled Abstract40</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_UnlabeledAbstract40" xlink:to="arbe_UnlabeledAbstract40_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodExpectedDividendRate_lbl0" xml:lang="en-US">Share-Based Goods and Nonemployee Services Transaction, Valuation Method, Expected Dividend Rate</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodExpectedDividendRate" xlink:to="us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodExpectedDividendRate_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="arbe_UnlabeledAbstract43_lbl0" xml:lang="en-US">Unlabeled Abstract43</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_UnlabeledAbstract43" xlink:to="arbe_UnlabeledAbstract43_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="country_US_lbl2" xml:lang="en-US">UNITED STATES</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="country_US" xlink:to="country_US_lbl2"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl0" xml:lang="en-US">Cash and Cash Equivalents, at Carrying Value</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="arbe_UnlabeledAbstract44_lbl0" xml:lang="en-US">Unlabeled Abstract44</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_UnlabeledAbstract44" xlink:to="arbe_UnlabeledAbstract44_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="arbe_UnlabeledAbstract41_lbl0" xml:lang="en-US">Unlabeled Abstract41</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_UnlabeledAbstract41" xlink:to="arbe_UnlabeledAbstract41_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="arbe_UnlabeledAbstract42_lbl0" xml:lang="en-US">Unlabeled Abstract42</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_UnlabeledAbstract42" xlink:to="arbe_UnlabeledAbstract42_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsGross_lbl0" xml:lang="en-US">Deferred Tax Assets, Gross</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsGross" xlink:to="us-gaap_DeferredTaxAssetsGross_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="arbe_UnlabeledAbstract47_lbl0" xml:lang="en-US">Unlabeled Abstract47</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_UnlabeledAbstract47" xlink:to="arbe_UnlabeledAbstract47_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="arbe_UnlabeledAbstract48_lbl0" xml:lang="en-US">Unlabeled Abstract48</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_UnlabeledAbstract48" xlink:to="arbe_UnlabeledAbstract48_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="arbe_UnlabeledAbstract45_lbl0" xml:lang="en-US">Unlabeled Abstract45</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_UnlabeledAbstract45" xlink:to="arbe_UnlabeledAbstract45_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="arbe_UnlabeledAbstract46_lbl0" xml:lang="en-US">Unlabeled Abstract46</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_UnlabeledAbstract46" xlink:to="arbe_UnlabeledAbstract46_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="arbe_UnlabeledAbstract49_lbl0" xml:lang="en-US">Unlabeled Abstract49</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_UnlabeledAbstract49" xlink:to="arbe_UnlabeledAbstract49_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl0" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerShareDiluted_lbl1" xml:lang="en-US">Earnings Per Share, Diluted</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareDiluted" xlink:to="us-gaap_EarningsPerShareDiluted_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues_lbl0" xml:lang="en-US">Stock Issued During Period, Shares, New Issues</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues_lbl0"/>
    <loc xlink:type="locator" xlink:label="arbe_ScheduleOfPropertyAndEquipmentAbstract" xlink:href="arbe-20231231.xsd#arbe_ScheduleOfPropertyAndEquipmentAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="arbe_ScheduleOfPropertyAndEquipmentAbstract_lbl" xml:lang="en-US">Schedule Of Property And Equipment Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_ScheduleOfPropertyAndEquipmentAbstract" xlink:to="arbe_ScheduleOfPropertyAndEquipmentAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RetainedEarningsMember_lbl0" xml:lang="en-US">Retained Earnings [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetainedEarningsMember" xlink:to="us-gaap_RetainedEarningsMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="arbe_UnlabeledAbstract50_lbl0" xml:lang="en-US">Unlabeled Abstract50</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_UnlabeledAbstract50" xlink:to="arbe_UnlabeledAbstract50_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="arbe_UnlabeledAbstract51_lbl0" xml:lang="en-US">Unlabeled Abstract51</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_UnlabeledAbstract51" xlink:to="arbe_UnlabeledAbstract51_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="arbe_UnlabeledAbstract54_lbl0" xml:lang="en-US">Unlabeled Abstract54</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_UnlabeledAbstract54" xlink:to="arbe_UnlabeledAbstract54_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="arbe_UnlabeledAbstract55_lbl0" xml:lang="en-US">Unlabeled Abstract55</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_UnlabeledAbstract55" xlink:to="arbe_UnlabeledAbstract55_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="arbe_UnlabeledAbstract52_lbl0" xml:lang="en-US">Unlabeled Abstract52</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_UnlabeledAbstract52" xlink:to="arbe_UnlabeledAbstract52_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="arbe_UnlabeledAbstract53_lbl0" xml:lang="en-US">Unlabeled Abstract53</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_UnlabeledAbstract53" xlink:to="arbe_UnlabeledAbstract53_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock_lbl0" xml:lang="en-US">Share-Based Payment Arrangement, Restricted Stock Unit, Activity [Table Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock" xlink:to="us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="arbe_UnlabeledAbstract56_lbl0" xml:lang="en-US">Unlabeled Abstract56</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_UnlabeledAbstract56" xlink:to="arbe_UnlabeledAbstract56_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="arbe_UnlabeledAbstract18_lbl0" xml:lang="en-US">Unlabeled Abstract18</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_UnlabeledAbstract18" xlink:to="arbe_UnlabeledAbstract18_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="arbe_UnlabeledAbstract19_lbl0" xml:lang="en-US">Unlabeled Abstract19</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_UnlabeledAbstract19" xlink:to="arbe_UnlabeledAbstract19_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="arbe_UnlabeledAbstract16_lbl0" xml:lang="en-US">Unlabeled Abstract16</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_UnlabeledAbstract16" xlink:to="arbe_UnlabeledAbstract16_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl0" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="arbe_UnlabeledAbstract17_lbl0" xml:lang="en-US">Unlabeled Abstract17</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_UnlabeledAbstract17" xlink:to="arbe_UnlabeledAbstract17_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="arbe_DenominatorAbstract_lbl0" xml:lang="en-US">Denominator Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_DenominatorAbstract" xlink:to="arbe_DenominatorAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="arbe_RevaluationOfConvertibleLoan_lbl1" xml:lang="en-US">Revaluation Of Convertible Loan</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_RevaluationOfConvertibleLoan" xlink:to="arbe_RevaluationOfConvertibleLoan_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayableTrade_lbl0" xml:lang="en-US">Increase (Decrease) in Accounts Payable, Trade</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsPayableTrade" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayableTrade_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DepositAssets_lbl0" xml:lang="en-US">Deposit Assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DepositAssets" xlink:to="us-gaap_DepositAssets_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_MaximumMember_lbl0" xml:lang="en-US">Maximum [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_MaximumMember" xlink:to="srt_MaximumMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="country_SE_lbl0" xml:lang="en-US">SWEDEN</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="country_SE" xlink:to="country_SE_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock_lbl0" xml:lang="en-US">Significant Accounting Policies [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SignificantAccountingPoliciesTextBlock" xlink:to="us-gaap_SignificantAccountingPoliciesTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="arbe_UnlabeledAbstract21_lbl0" xml:lang="en-US">Unlabeled Abstract21</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_UnlabeledAbstract21" xlink:to="arbe_UnlabeledAbstract21_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="arbe_UnlabeledAbstract22_lbl0" xml:lang="en-US">Unlabeled Abstract22</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_UnlabeledAbstract22" xlink:to="arbe_UnlabeledAbstract22_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_lbl0" xml:lang="en-US">Right-of-Use Asset Obtained in Exchange for Operating Lease Liability</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:to="us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="arbe_UnlabeledAbstract20_lbl0" xml:lang="en-US">Unlabeled Abstract20</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_UnlabeledAbstract20" xlink:to="arbe_UnlabeledAbstract20_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_lbl0" xml:lang="en-US">Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-Based Compensation Cost</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:to="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="arbe_UnlabeledAbstract25_lbl0" xml:lang="en-US">Unlabeled Abstract25</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_UnlabeledAbstract25" xlink:to="arbe_UnlabeledAbstract25_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="arbe_DenominatorAbstract0_lbl0" xml:lang="en-US">Denominator Abstract0</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_DenominatorAbstract0" xlink:to="arbe_DenominatorAbstract0_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare_lbl0" xml:lang="en-US">Common Stock, Par or Stated Value Per Share</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="arbe_UnlabeledAbstract26_lbl0" xml:lang="en-US">Unlabeled Abstract26</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_UnlabeledAbstract26" xlink:to="arbe_UnlabeledAbstract26_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="arbe_UnlabeledAbstract23_lbl0" xml:lang="en-US">Unlabeled Abstract23</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_UnlabeledAbstract23" xlink:to="arbe_UnlabeledAbstract23_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential_lbl0" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Amount</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential" xlink:to="us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="arbe_UnlabeledAbstract24_lbl0" xml:lang="en-US">Unlabeled Abstract24</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_UnlabeledAbstract24" xlink:to="arbe_UnlabeledAbstract24_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="arbe_UnlabeledAbstract29_lbl0" xml:lang="en-US">Unlabeled Abstract29</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_UnlabeledAbstract29" xlink:to="arbe_UnlabeledAbstract29_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockSharesOutstanding_lbl0" xml:lang="en-US">Common Stock, Shares, Outstanding</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesOutstanding" xlink:to="us-gaap_CommonStockSharesOutstanding_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="arbe_UnlabeledAbstract27_lbl0" xml:lang="en-US">Unlabeled Abstract27</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_UnlabeledAbstract27" xlink:to="arbe_UnlabeledAbstract27_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_MinimumMember_lbl0" xml:lang="en-US">Minimum [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_MinimumMember" xlink:to="srt_MinimumMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="arbe_UnlabeledAbstract28_lbl0" xml:lang="en-US">Unlabeled Abstract28</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_UnlabeledAbstract28" xlink:to="arbe_UnlabeledAbstract28_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Depreciation_lbl1" xml:lang="en-US">Depreciation</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Depreciation" xlink:to="us-gaap_Depreciation_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_lbl0" xml:lang="en-US">Prepaid Expense and Other Assets, Current</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConcentrationRiskCreditRisk_lbl0" xml:lang="en-US">Concentration Risk, Credit Risk, Policy [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskCreditRisk" xlink:to="us-gaap_ConcentrationRiskCreditRisk_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdditionalPaidInCapitalMember_lbl0" xml:lang="en-US">Additional Paid-in Capital [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdditionalPaidInCapitalMember" xlink:to="us-gaap_AdditionalPaidInCapitalMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="arbe_UnlabeledAbstract32_lbl0" xml:lang="en-US">Unlabeled Abstract32</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_UnlabeledAbstract32" xlink:to="arbe_UnlabeledAbstract32_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ComputerEquipmentMember_lbl0" xml:lang="en-US">Computer Equipment [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ComputerEquipmentMember" xlink:to="us-gaap_ComputerEquipmentMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="arbe_UnlabeledAbstract33_lbl0" xml:lang="en-US">Unlabeled Abstract33</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_UnlabeledAbstract33" xlink:to="arbe_UnlabeledAbstract33_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="arbe_UnlabeledAbstract30_lbl0" xml:lang="en-US">Unlabeled Abstract30</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_UnlabeledAbstract30" xlink:to="arbe_UnlabeledAbstract30_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="arbe_UnlabeledAbstract31_lbl0" xml:lang="en-US">Unlabeled Abstract31</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_UnlabeledAbstract31" xlink:to="arbe_UnlabeledAbstract31_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="arbe_UnlabeledAbstract36_lbl0" xml:lang="en-US">Unlabeled Abstract36</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_UnlabeledAbstract36" xlink:to="arbe_UnlabeledAbstract36_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="arbe_UnlabeledAbstract37_lbl0" xml:lang="en-US">Unlabeled Abstract37</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_UnlabeledAbstract37" xlink:to="arbe_UnlabeledAbstract37_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingExpensesAbstract_lbl0" xml:lang="en-US">Operating Expenses [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-gaap_OperatingExpensesAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="arbe_UnlabeledAbstract34_lbl0" xml:lang="en-US">Unlabeled Abstract34</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_UnlabeledAbstract34" xlink:to="arbe_UnlabeledAbstract34_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_lbl0" xml:lang="en-US">Payments to Acquire Property, Plant, and Equipment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="arbe_UnlabeledAbstract35_lbl0" xml:lang="en-US">Unlabeled Abstract35</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_UnlabeledAbstract35" xlink:to="arbe_UnlabeledAbstract35_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_lbl0" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentNet_lbl2" xml:lang="en-US">Property, Plant and Equipment, Net</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentNet" xlink:to="us-gaap_PropertyPlantAndEquipmentNet_lbl2"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_lbl0" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Intrinsic Value</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="arbe_ShortTermDepositsPolicyPolicyTextBlock_lbl1" xml:lang="en-US">Short Term Deposits Policy Policy Text Block</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_ShortTermDepositsPolicyPolicyTextBlock" xlink:to="arbe_ShortTermDepositsPolicyPolicyTextBlock_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxPolicyTextBlock_lbl0" xml:lang="en-US">Income Tax, Policy [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxPolicyTextBlock" xlink:to="us-gaap_IncomeTaxPolicyTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConversionOfStockAmountConverted1_lbl0" xml:lang="en-US">Conversion of Stock, Amount Converted</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConversionOfStockAmountConverted1" xlink:to="us-gaap_ConversionOfStockAmountConverted1_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants_lbl0" xml:lang="en-US">Stock and Warrants Issued During Period, Value, Preferred Stock and Warrants</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants" xlink:to="us-gaap_StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="arbe_BasicAbstract_lbl0" xml:lang="en-US">Basic Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_BasicAbstract" xlink:to="arbe_BasicAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="arbe_TwoThousandTwentyOneEquityIncentivePlanMember_lbl0" xml:lang="en-US">Two Thousand Twenty One Equity Incentive Plan Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_TwoThousandTwentyOneEquityIncentivePlanMember" xlink:to="arbe_TwoThousandTwentyOneEquityIncentivePlanMember_lbl0"/>
    <loc xlink:type="locator" xlink:label="arbe_ScheduleOfSetsForthTheComputationOfBasicAndDilutedNetLossPerShareAttributableAbstract" xlink:href="arbe-20231231.xsd#arbe_ScheduleOfSetsForthTheComputationOfBasicAndDilutedNetLossPerShareAttributableAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="arbe_ScheduleOfSetsForthTheComputationOfBasicAndDilutedNetLossPerShareAttributableAbstract_lbl" xml:lang="en-US">Schedule Of Sets Forth The Computation Of Basic And Diluted Net Loss Per Share Attributable Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_ScheduleOfSetsForthTheComputationOfBasicAndDilutedNetLossPerShareAttributableAbstract" xlink:to="arbe_ScheduleOfSetsForthTheComputationOfBasicAndDilutedNetLossPerShareAttributableAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_lbl0" xml:lang="en-US">Operating Lease, Weighted Average Discount Rate, Percent</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:to="us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_lbl0" xml:lang="en-US">Revenue from Contract with Customer, Including Assessed Tax</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax" xlink:to="us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_lbl0" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Three</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl0" xml:lang="en-US">Increase (Decrease) in Operating Capital [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit_lbl0" xml:lang="en-US">Retained Earnings (Accumulated Deficit)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_lbl0" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Available for Grant</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonUnitIssuanceValue_lbl0" xml:lang="en-US">Common Unit, Issuance Value</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonUnitIssuanceValue" xlink:to="us-gaap_CommonUnitIssuanceValue_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockMember_lbl0" xml:lang="en-US">Preferred Stock [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockMember" xlink:to="us-gaap_PreferredStockMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_lbl0" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Domestic</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="arbe_UnlabeledAbstract10_lbl0" xml:lang="en-US">Unlabeled Abstract10</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_UnlabeledAbstract10" xlink:to="arbe_UnlabeledAbstract10_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="arbe_UnlabeledAbstract11_lbl0" xml:lang="en-US">Unlabeled Abstract11</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_UnlabeledAbstract11" xlink:to="arbe_UnlabeledAbstract11_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_lbl0" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetIncomeLossAttributableToNonredeemableNoncontrollingInterest_lbl0" xml:lang="en-US">Net Income (Loss) Attributable to Nonredeemable Noncontrolling Interest</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLossAttributableToNonredeemableNoncontrollingInterest" xlink:to="us-gaap_NetIncomeLossAttributableToNonredeemableNoncontrollingInterest_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="arbe_UnlabeledAbstract14_lbl0" xml:lang="en-US">Unlabeled Abstract14</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_UnlabeledAbstract14" xlink:to="arbe_UnlabeledAbstract14_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="arbe_UnlabeledAbstract15_lbl0" xml:lang="en-US">Unlabeled Abstract15</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_UnlabeledAbstract15" xlink:to="arbe_UnlabeledAbstract15_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="arbe_UnlabeledAbstract12_lbl0" xml:lang="en-US">Unlabeled Abstract12</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_UnlabeledAbstract12" xlink:to="arbe_UnlabeledAbstract12_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="arbe_UnlabeledAbstract13_lbl0" xml:lang="en-US">Unlabeled Abstract13</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_UnlabeledAbstract13" xlink:to="arbe_UnlabeledAbstract13_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_DemandDepositLiabilitiesInterestBearingAverageRatePaid_lbl0" xml:lang="en-US">Demand Deposit Liabilities, Interest-Bearing, Average Rate Paid</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_DemandDepositLiabilitiesInterestBearingAverageRatePaid" xlink:to="srt_DemandDepositLiabilitiesInterestBearingAverageRatePaid_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="arbe_ArbeRoboticsLtdMember_lbl0" xml:lang="en-US">Arbe Robotics Ltd Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_ArbeRoboticsLtdMember" xlink:to="arbe_ArbeRoboticsLtdMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="arbe_GrantsReceived_lbl1" xml:lang="en-US">Grants Received</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_GrantsReceived" xlink:to="arbe_GrantsReceived_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_lbl0" xml:lang="en-US">Cash Flow, Noncash Investing and Financing Activities Disclosure [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:to="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RepaymentsOfShortTermDebt_lbl0" xml:lang="en-US">Repayments of Short-Term Debt</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RepaymentsOfShortTermDebt" xlink:to="us-gaap_RepaymentsOfShortTermDebt_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="arbe_SeedMember_lbl0" xml:lang="en-US">Seed Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_SeedMember" xlink:to="arbe_SeedMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseLeaseIncomeTableTextBlock_lbl0" xml:lang="en-US">Operating Lease, Lease Income [Table Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseLeaseIncomeTableTextBlock" xlink:to="us-gaap_OperatingLeaseLeaseIncomeTableTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="arbe_UnlabeledAbstract2_lbl0" xml:lang="en-US">Unlabeled Abstract2</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_UnlabeledAbstract2" xlink:to="arbe_UnlabeledAbstract2_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="arbe_UnlabeledAbstract1_lbl0" xml:lang="en-US">Unlabeled Abstract1</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_UnlabeledAbstract1" xlink:to="arbe_UnlabeledAbstract1_lbl0"/>
    <loc xlink:type="locator" xlink:label="arbe_ScheduleOfRsusActivityAbstract" xlink:href="arbe-20231231.xsd#arbe_ScheduleOfRsusActivityAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="arbe_ScheduleOfRsusActivityAbstract_lbl" xml:lang="en-US">Schedule Of Rsus Activity Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_ScheduleOfRsusActivityAbstract" xlink:to="arbe_ScheduleOfRsusActivityAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="arbe_UnlabeledAbstract4_lbl0" xml:lang="en-US">Unlabeled Abstract4</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_UnlabeledAbstract4" xlink:to="arbe_UnlabeledAbstract4_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="arbe_UnlabeledAbstract3_lbl0" xml:lang="en-US">Unlabeled Abstract3</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_UnlabeledAbstract3" xlink:to="arbe_UnlabeledAbstract3_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="arbe_UnlabeledAbstract0_lbl0" xml:lang="en-US">Unlabeled Abstract0</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_UnlabeledAbstract0" xlink:to="arbe_UnlabeledAbstract0_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="arbe_OrdinarySharesParValueNIS0000216PerShareMember_lbl0" xml:lang="en-US">Ordinary Shares Par Value NIS0000216 Per Share Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_OrdinarySharesParValueNIS0000216PerShareMember" xlink:to="arbe_OrdinarySharesParValueNIS0000216PerShareMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_VehiclesMember_lbl0" xml:lang="en-US">Vehicles [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_VehiclesMember" xlink:to="us-gaap_VehiclesMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="arbe_UnlabeledAbstract9_lbl0" xml:lang="en-US">Unlabeled Abstract9</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_UnlabeledAbstract9" xlink:to="arbe_UnlabeledAbstract9_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OfficeEquipmentMember_lbl0" xml:lang="en-US">Office Equipment [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OfficeEquipmentMember" xlink:to="us-gaap_OfficeEquipmentMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="arbe_UnlabeledAbstract6_lbl0" xml:lang="en-US">Unlabeled Abstract6</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_UnlabeledAbstract6" xlink:to="arbe_UnlabeledAbstract6_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_lbl0" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures and Expirations in Period</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="arbe_UnlabeledAbstract5_lbl0" xml:lang="en-US">Unlabeled Abstract5</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_UnlabeledAbstract5" xlink:to="arbe_UnlabeledAbstract5_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="arbe_UnlabeledAbstract8_lbl0" xml:lang="en-US">Unlabeled Abstract8</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_UnlabeledAbstract8" xlink:to="arbe_UnlabeledAbstract8_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="arbe_UnlabeledAbstract7_lbl0" xml:lang="en-US">Unlabeled Abstract7</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_UnlabeledAbstract7" xlink:to="arbe_UnlabeledAbstract7_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="arbe_PrivateWarrantsMember_lbl0" xml:lang="en-US">Private Warrants Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_PrivateWarrantsMember" xlink:to="arbe_PrivateWarrantsMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims_lbl0" xml:lang="en-US">Issuance of Stock and Warrants for Services or Claims</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims" xlink:to="us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="arbe_OperatingLeaseRightofuseAssetsAndLiabilitiesNet_lbl1" xml:lang="en-US">Operating Lease Rightofuse Assets And Liabilities Net</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_OperatingLeaseRightofuseAssetsAndLiabilitiesNet" xlink:to="arbe_OperatingLeaseRightofuseAssetsAndLiabilitiesNet_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_lbl0" xml:lang="en-US">Schedule of Deferred Tax Assets and Liabilities [Table Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:to="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueAdjustmentOfWarrants_lbl0" xml:lang="en-US">Fair Value Adjustment of Warrants</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueAdjustmentOfWarrants" xlink:to="us-gaap_FairValueAdjustmentOfWarrants_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="arbe_UnlabeledAbstract_lbl0" xml:lang="en-US">Unlabeled Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_UnlabeledAbstract" xlink:to="arbe_UnlabeledAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities_lbl0" xml:lang="en-US">Increase (Decrease) in Other Accounts Payable and Accrued Liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities" xlink:to="us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockSharesAuthorized_lbl1" xml:lang="en-US">Common Stock, Shares Authorized</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesAuthorized" xlink:to="us-gaap_CommonStockSharesAuthorized_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_lbl0" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_lbl0" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Two</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RevenueFromContractWithCustomerTextBlock_lbl0" xml:lang="en-US">Revenue from Contract with Customer [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:to="us-gaap_RevenueFromContractWithCustomerTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquity_lbl2" xml:lang="en-US">Equity, Attributable to Parent</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_lbl2"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_lbl0" xml:lang="en-US">Share-Based Payment Arrangement [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:to="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits_lbl0" xml:lang="en-US">Stock Issued During Period, Shares, Conversion of Units</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits" xlink:to="us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_lbl0" xml:lang="en-US">Share-Based Payment Arrangement, Option, Activity [Table Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:to="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_lbl0" xml:lang="en-US">Property, Plant and Equipment, Policy [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:to="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_lbl0" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_lbl0" xml:lang="en-US">Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:to="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_lbl0" xml:lang="en-US">Sale of Stock, Number of Shares Issued in Transaction</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:to="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SegmentReportingDisclosureTextBlock_lbl0" xml:lang="en-US">Segment Reporting Disclosure [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SegmentReportingDisclosureTextBlock" xlink:to="us-gaap_SegmentReportingDisclosureTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="arbe_Customer1Member_lbl0" xml:lang="en-US">Customer1 Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_Customer1Member" xlink:to="arbe_Customer1Member_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementOfFinancialPositionAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementOfFinancialPositionAbstract_lbl" xml:lang="en-US">Statement of Financial Position [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_StatementOfFinancialPositionAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_lbl0" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SalesRevenueNetMember_lbl0" xml:lang="en-US">Revenue Benchmark [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SalesRevenueNetMember" xlink:to="us-gaap_SalesRevenueNetMember_lbl0"/>
    <loc xlink:type="locator" xlink:label="arbe_ScheduleOfStockOptionActivityAbstract" xlink:href="arbe-20231231.xsd#arbe_ScheduleOfStockOptionActivityAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="arbe_ScheduleOfStockOptionActivityAbstract_lbl" xml:lang="en-US">Schedule Of Stock Option Activity Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_ScheduleOfStockOptionActivityAbstract" xlink:to="arbe_ScheduleOfStockOptionActivityAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="arbe_RoyaltyPercentage_lbl1" xml:lang="en-US">Royalty Percentage</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_RoyaltyPercentage" xlink:to="arbe_RoyaltyPercentage_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment_lbl0" xml:lang="en-US">Deferred Tax Assets, Property, Plant and Equipment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment" xlink:to="us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="arbe_DeferredTaxAssetsAbstract_lbl0" xml:lang="en-US">Deferred Tax Assets Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_DeferredTaxAssetsAbstract" xlink:to="arbe_DeferredTaxAssetsAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LeaseCostTableTextBlock_lbl0" xml:lang="en-US">Lease, Cost [Table Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LeaseCostTableTextBlock" xlink:to="us-gaap_LeaseCostTableTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy_lbl0" xml:lang="en-US">Receivables, Trade and Other Accounts Receivable, Allowance for Doubtful Accounts, Policy [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy" xlink:to="us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_lbl0" xml:lang="en-US">Stock Issued During Period, Shares, Conversion of Convertible Securities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:to="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl0" xml:lang="en-US">New Accounting Pronouncements, Policy [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_lbl0" xml:lang="en-US">Property, Plant and Equipment Disclosure [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:to="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_lbl0" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosure [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:to="us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock_lbl1" xml:lang="en-US">Proceeds from Issuance of Common Stock</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:to="us-gaap_ProceedsFromIssuanceOfCommonStock_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromShortTermDebt_lbl0" xml:lang="en-US">Proceeds from Short-Term Debt</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromShortTermDebt" xlink:to="us-gaap_ProceedsFromShortTermDebt_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SellingAndMarketingExpenseMember_lbl0" xml:lang="en-US">Selling and Marketing Expense [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SellingAndMarketingExpenseMember" xlink:to="us-gaap_SellingAndMarketingExpenseMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_lbl0" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Expiration Period</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_lbl0" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted, Adjustment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:to="us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_lbl0" xml:lang="en-US">Impairment or Disposal of Long-Lived Assets, Policy [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:to="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="arbe_ConversionOfPreferredSharesIntoOrdinarySharesUponTheRecapitalization_lbl1" xml:lang="en-US">Conversion Of Preferred Shares Into Ordinary Shares Upon The Recapitalization</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_ConversionOfPreferredSharesIntoOrdinarySharesUponTheRecapitalization" xlink:to="arbe_ConversionOfPreferredSharesIntoOrdinarySharesUponTheRecapitalization_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_lbl0" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsOfOrdinaryDividends_lbl0" xml:lang="en-US">Payments of Ordinary Dividends</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsOfOrdinaryDividends" xlink:to="us-gaap_PaymentsOfOrdinaryDividends_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensation_lbl1" xml:lang="en-US">Share-Based Payment Arrangement, Noncash Expense</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensation" xlink:to="us-gaap_ShareBasedCompensation_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="arbe_Customer3Member_lbl0" xml:lang="en-US">Customer3 Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_Customer3Member" xlink:to="arbe_Customer3Member_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="arbe_NumeratorAbstract_lbl0" xml:lang="en-US">Numerator Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_NumeratorAbstract" xlink:to="arbe_NumeratorAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SeveranceCosts1_lbl0" xml:lang="en-US">Severance Costs</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SeveranceCosts1" xlink:to="us-gaap_SeveranceCosts1_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_lbl0" xml:lang="en-US">Deferred Tax Assets, Operating Loss Carryforwards</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:to="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_lbl1" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentTextBlock_lbl0" xml:lang="en-US">Property, Plant and Equipment [Table Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:to="us-gaap_PropertyPlantAndEquipmentTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherCurrentAssetsTextBlock_lbl0" xml:lang="en-US">Other Current Assets [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherCurrentAssetsTextBlock" xlink:to="us-gaap_OtherCurrentAssetsTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredRevenue_lbl0" xml:lang="en-US">Deferred Revenue</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredRevenue" xlink:to="us-gaap_DeferredRevenue_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl1" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_lbl0" xml:lang="en-US">Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingExpenses_lbl0" xml:lang="en-US">Operating Expenses</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingExpenses" xlink:to="us-gaap_OperatingExpenses_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ResearchAndDevelopmentExpensePolicy_lbl0" xml:lang="en-US">Research and Development Expense, Policy [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:to="us-gaap_ResearchAndDevelopmentExpensePolicy_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="arbe_TwoThousandSixteenIncentivePlanMember_lbl0" xml:lang="en-US">Two Thousand Sixteen Incentive Plan Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_TwoThousandSixteenIncentivePlanMember" xlink:to="arbe_TwoThousandSixteenIncentivePlanMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PrepaidExpenseAndOtherAssets_lbl0" xml:lang="en-US">Prepaid Expense and Other Assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PrepaidExpenseAndOtherAssets" xlink:to="us-gaap_PrepaidExpenseAndOtherAssets_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance_lbl0" xml:lang="en-US">Deferred Tax Assets, Valuation Allowance</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsValuationAllowance" xlink:to="us-gaap_DeferredTaxAssetsValuationAllowance_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInDeferredRevenue_lbl0" xml:lang="en-US">Increase (Decrease) in Deferred Revenue</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:to="us-gaap_IncreaseDecreaseInDeferredRevenue_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInAccountsReceivable_lbl0" xml:lang="en-US">Increase (Decrease) in Accounts Receivable</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:to="us-gaap_IncreaseDecreaseInAccountsReceivable_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeasePayments_lbl0" xml:lang="en-US">Operating Lease, Payments</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeasePayments" xlink:to="us-gaap_OperatingLeasePayments_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsNoncurrent_lbl0" xml:lang="en-US">Prepaid Expense and Other Assets, Noncurrent</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PrepaidExpenseAndOtherAssetsNoncurrent" xlink:to="us-gaap_PrepaidExpenseAndOtherAssetsNoncurrent_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_lbl0" xml:lang="en-US">Lessee, Operating Lease, Liability, Undiscounted Excess Amount</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerShareBasic_lbl1" xml:lang="en-US">Earnings Per Share, Basic</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareBasic" xlink:to="us-gaap_EarningsPerShareBasic_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ResearchAndDevelopmentExpense_lbl0" xml:lang="en-US">Research and Development Expense</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchAndDevelopmentExpense" xlink:to="us-gaap_ResearchAndDevelopmentExpense_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="arbe_SeriesB1PreferredStockMember_lbl0" xml:lang="en-US">Series B1 Preferred Stock Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_SeriesB1PreferredStockMember" xlink:to="arbe_SeriesB1PreferredStockMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="arbe_PIPEMember_lbl0" xml:lang="en-US">PIPEMember</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_PIPEMember" xlink:to="arbe_PIPEMember_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementOfStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementOfStockholdersEquityAbstract_lbl" xml:lang="en-US">Statement of Stockholders&apos; Equity [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="us-gaap_StatementOfStockholdersEquityAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxReconciliationOtherAdjustments_lbl0" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Other Adjustments, Amount</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxReconciliationOtherAdjustments" xlink:to="us-gaap_IncomeTaxReconciliationOtherAdjustments_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_lbl0" xml:lang="en-US">Schedule of Income before Income Tax, Domestic and Foreign [Table Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:to="us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues_lbl0" xml:lang="en-US">Stock Issued During Period, Value, New Issues</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:to="us-gaap_StockIssuedDuringPeriodValueNewIssues_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ResearchAndDevelopmentExpenseMember_lbl0" xml:lang="en-US">Research and Development Expense [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchAndDevelopmentExpenseMember" xlink:to="us-gaap_ResearchAndDevelopmentExpenseMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SeriesAPreferredStockMember_lbl0" xml:lang="en-US">Series A Preferred Stock [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SeriesAPreferredStockMember" xlink:to="us-gaap_SeriesAPreferredStockMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ComprehensiveIncomePolicyPolicyTextBlock_lbl0" xml:lang="en-US">Comprehensive Income, Policy [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" xlink:to="us-gaap_ComprehensiveIncomePolicyPolicyTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CostOfSalesMember_lbl0" xml:lang="en-US">Cost of Sales [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CostOfSalesMember" xlink:to="us-gaap_CostOfSalesMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_lbl0" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_lbl0" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year One</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockValue_lbl0" xml:lang="en-US">Common Stock, Value, Issued</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockValue" xlink:to="us-gaap_CommonStockValue_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromIssuanceOfWarrants_lbl1" xml:lang="en-US">Proceeds from Issuance of Warrants</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOfWarrants" xlink:to="us-gaap_ProceedsFromIssuanceOfWarrants_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_lbl0" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Four</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="arbe_Customer2Member_lbl0" xml:lang="en-US">Customer2 Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_Customer2Member" xlink:to="arbe_Customer2Member_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl0" xml:lang="en-US">Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Continuing Operations</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesNoncurrent_lbl0" xml:lang="en-US">Liabilities, Noncurrent</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesNoncurrent" xlink:to="us-gaap_LiabilitiesNoncurrent_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised_lbl0" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Exercised</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_lbl0" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="country_DE_lbl0" xml:lang="en-US">GERMANY</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="country_DE" xlink:to="country_DE_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures_lbl0" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Forfeitures</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Assets_lbl0" xml:lang="en-US">Assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Assets" xlink:to="us-gaap_Assets_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromWarrantExercises_lbl0" xml:lang="en-US">Proceeds from Warrant Exercises</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromWarrantExercises" xlink:to="us-gaap_ProceedsFromWarrantExercises_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PostemploymentBenefitPlansPolicy_lbl0" xml:lang="en-US">Postemployment Benefit Plans, Policy [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PostemploymentBenefitPlansPolicy" xlink:to="us-gaap_PostemploymentBenefitPlansPolicy_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TemporaryEquityAccretionToRedemptionValueAdjustment_lbl0" xml:lang="en-US">Temporary Equity, Accretion to Redemption Value, Adjustment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TemporaryEquityAccretionToRedemptionValueAdjustment" xlink:to="us-gaap_TemporaryEquityAccretionToRedemptionValueAdjustment_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConvertiblePreferredStockMember_lbl0" xml:lang="en-US">Convertible Preferred Stock [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConvertiblePreferredStockMember" xlink:to="us-gaap_ConvertiblePreferredStockMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1_lbl0" xml:lang="en-US">Noncash or Part Noncash Acquisition, Fixed Assets Acquired</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1" xlink:to="us-gaap_NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_lbl0" xml:lang="en-US">Cash and Cash Equivalents, Restricted Cash and Cash Equivalents, Policy [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:to="us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BasisOfAccountingPolicyPolicyTextBlock_lbl0" xml:lang="en-US">Basis of Accounting, Policy [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:to="us-gaap_BasisOfAccountingPolicyPolicyTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="arbe_GovernmentAuthorities_lbl1" xml:lang="en-US">Government Authorities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_GovernmentAuthorities" xlink:to="arbe_GovernmentAuthorities_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredRevenueCurrent_lbl0" xml:lang="en-US">Deferred Revenue, Current</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredRevenueCurrent" xlink:to="us-gaap_DeferredRevenueCurrent_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInOperatingLeaseLiability_lbl0" xml:lang="en-US">Increase (Decrease) in Operating Lease Liability</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:to="us-gaap_IncreaseDecreaseInOperatingLeaseLiability_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsPeriodIncreaseDecrease_lbl0" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Period Increase (Decrease)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsPeriodIncreaseDecrease" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsPeriodIncreaseDecrease_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RestrictedCashCurrent_lbl0" xml:lang="en-US">Restricted Cash, Current</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RestrictedCashCurrent" xlink:to="us-gaap_RestrictedCashCurrent_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxExpenseBenefit_lbl0" xml:lang="en-US">Income Tax Expense (Benefit)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="us-gaap_IncomeTaxExpenseBenefit_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_UseOfEstimates_lbl0" xml:lang="en-US">Use of Estimates, Policy [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UseOfEstimates" xlink:to="us-gaap_UseOfEstimates_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="arbe_SeriesA1PreferredStockMember_lbl0" xml:lang="en-US">Series A1 Preferred Stock Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_SeriesA1PreferredStockMember" xlink:to="arbe_SeriesA1PreferredStockMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_lbl0" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Percent</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeStatementAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeStatementAbstract_lbl" xml:lang="en-US">Income Statement [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_IncomeStatementAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="arbe_OutstandingShareOptionsMember_lbl0" xml:lang="en-US">Outstanding Share Options Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_OutstandingShareOptionsMember" xlink:to="arbe_OutstandingShareOptionsMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EffectiveIncomeTaxRateContinuingOperations_lbl0" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Percent</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="us-gaap_EffectiveIncomeTaxRateContinuingOperations_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeOperatingLeasesTextBlock_lbl0" xml:lang="en-US">Lessee, Operating Leases [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeasesTextBlock" xlink:to="us-gaap_LesseeOperatingLeasesTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="arbe_PropertyPlantAndEquipmentUsefulLifeTableTextBlock_lbl1" xml:lang="en-US">Property Plant And Equipment Useful Life Table Text Block</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_PropertyPlantAndEquipmentUsefulLifeTableTextBlock" xlink:to="arbe_PropertyPlantAndEquipmentUsefulLifeTableTextBlock_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RevenueRemainingPerformanceObligation_lbl0" xml:lang="en-US">Revenue, Remaining Performance Obligation, Amount</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenueRemainingPerformanceObligation" xlink:to="us-gaap_RevenueRemainingPerformanceObligation_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="arbe_PlanOneMember_lbl0" xml:lang="en-US">Plan One Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_PlanOneMember" xlink:to="arbe_PlanOneMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="arbe_CostAbstract_lbl0" xml:lang="en-US">Cost Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_CostAbstract" xlink:to="arbe_CostAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RepaymentsOfLongTermDebt_lbl0" xml:lang="en-US">Repayments of Long-Term Debt</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RepaymentsOfLongTermDebt" xlink:to="us-gaap_RepaymentsOfLongTermDebt_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsForProceedsFromInvestments_lbl0" xml:lang="en-US">Payments for (Proceeds from) Investments</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsForProceedsFromInvestments" xlink:to="us-gaap_PaymentsForProceedsFromInvestments_lbl0"/>
    <loc xlink:type="locator" xlink:label="arbe_ScheduleOfRevenueDisaggregatedByGeographyAbstract" xlink:href="arbe-20231231.xsd#arbe_ScheduleOfRevenueDisaggregatedByGeographyAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="arbe_ScheduleOfRevenueDisaggregatedByGeographyAbstract_lbl" xml:lang="en-US">Schedule Of Revenue Disaggregated By Geography Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_ScheduleOfRevenueDisaggregatedByGeographyAbstract" xlink:to="arbe_ScheduleOfRevenueDisaggregatedByGeographyAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment_lbl0" xml:lang="en-US">Deferred Tax Assets, in Process Research and Development</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment" xlink:to="us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_lbl0" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_lbl0"/>
    <loc xlink:type="locator" xlink:label="arbe_ScheduleOfTheStraightLineMethodOverTheEstimatedUsefulLivesOfTheAssetsAbstract" xlink:href="arbe-20231231.xsd#arbe_ScheduleOfTheStraightLineMethodOverTheEstimatedUsefulLivesOfTheAssetsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="arbe_ScheduleOfTheStraightLineMethodOverTheEstimatedUsefulLivesOfTheAssetsAbstract_lbl" xml:lang="en-US">Schedule Of The Straight Line Method Over The Estimated Useful Lives Of The Assets Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_ScheduleOfTheStraightLineMethodOverTheEstimatedUsefulLivesOfTheAssetsAbstract" xlink:to="arbe_ScheduleOfTheStraightLineMethodOverTheEstimatedUsefulLivesOfTheAssetsAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentGross_lbl0" xml:lang="en-US">Property, Plant and Equipment, Gross</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentGross" xlink:to="us-gaap_PropertyPlantAndEquipmentGross_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdjustmentOfWarrantsGrantedForServices_lbl0" xml:lang="en-US">Adjustment of Warrants Granted for Services</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentOfWarrantsGrantedForServices" xlink:to="us-gaap_AdjustmentOfWarrantsGrantedForServices_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="country_CH_lbl0" xml:lang="en-US">SWITZERLAND</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="country_CH" xlink:to="country_CH_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GeneralAndAdministrativeExpenseMember_lbl0" xml:lang="en-US">General and Administrative Expense [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GeneralAndAdministrativeExpenseMember" xlink:to="us-gaap_GeneralAndAdministrativeExpenseMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CostOfSalesPolicyTextBlock_lbl0" xml:lang="en-US">Cost of Goods and Service [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CostOfSalesPolicyTextBlock" xlink:to="us-gaap_CostOfSalesPolicyTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_lbl0" xml:lang="en-US">Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:to="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock_lbl0" xml:lang="en-US">Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Table Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock" xlink:to="us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities_lbl0" xml:lang="en-US">Increase (Decrease) in Employee Related Liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities" xlink:to="us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_lbl0" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="country_CN_lbl0" xml:lang="en-US">CHINA</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="country_CN" xlink:to="country_CN_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SaleOfStockConsiderationReceivedOnTransaction_lbl0" xml:lang="en-US">Sale of Stock, Consideration Received on Transaction</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:to="us-gaap_SaleOfStockConsiderationReceivedOnTransaction_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdditionalPaidInCapitalCommonStock_lbl0" xml:lang="en-US">Additional Paid in Capital, Common Stock</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdditionalPaidInCapitalCommonStock" xlink:to="us-gaap_AdditionalPaidInCapitalCommonStock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="arbe_OtherGeographicalMember_lbl0" xml:lang="en-US">Other Geographical Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_OtherGeographicalMember" xlink:to="arbe_OtherGeographicalMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="arbe_RevenueByGeographyAbstract_lbl0" xml:lang="en-US">Revenue By Geography Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_RevenueByGeographyAbstract" xlink:to="arbe_RevenueByGeographyAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_lbl0" xml:lang="en-US">Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:to="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockOtherSharesOutstanding_lbl0" xml:lang="en-US">Common Stock, Other Shares, Outstanding</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockOtherSharesOutstanding" xlink:to="us-gaap_CommonStockOtherSharesOutstanding_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_lbl0" xml:lang="en-US">Increase (Decrease) in Prepaid Expense and Other Assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:to="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl0" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SellingAndMarketingExpense_lbl0" xml:lang="en-US">Selling and Marketing Expense</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SellingAndMarketingExpense" xlink:to="us-gaap_SellingAndMarketingExpense_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="arbe_SeverancePercentageOfMonthlySalary_lbl1" xml:lang="en-US">Severance Percentage Of Monthly Salary</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_SeverancePercentageOfMonthlySalary" xlink:to="arbe_SeverancePercentageOfMonthlySalary_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl0" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl0" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="arbe_StockIssuedDuringPeriodSharesExerciseOfWarrants_lbl1" xml:lang="en-US">Stock Issued During Period Shares Exercise Of Warrants</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_StockIssuedDuringPeriodSharesExerciseOfWarrants" xlink:to="arbe_StockIssuedDuringPeriodSharesExerciseOfWarrants_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_lbl0" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EmployeeRelatedLiabilitiesCurrent_lbl0" xml:lang="en-US">Employee-related Liabilities, Current</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:to="us-gaap_EmployeeRelatedLiabilitiesCurrent_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="arbe_NumeratorAbstract0_lbl0" xml:lang="en-US">Numerator Abstract0</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_NumeratorAbstract0" xlink:to="arbe_NumeratorAbstract0_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LeaseholdImprovementsMember_lbl1" xml:lang="en-US">Leasehold Improvements [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LeaseholdImprovementsMember" xlink:to="us-gaap_LeaseholdImprovementsMember_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingIncomeLoss_lbl0" xml:lang="en-US">Operating Income (Loss)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="us-gaap_OperatingIncomeLoss_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_lbl0" xml:lang="en-US">Foreign Currency Transactions and Translations Policy [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:to="us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseLiability_lbl0" xml:lang="en-US">Operating Lease, Liability</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseLiability" xlink:to="us-gaap_OperatingLeaseLiability_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_lbl0" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:to="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesCurrentAbstract_lbl0" xml:lang="en-US">Liabilities, Current [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_LiabilitiesCurrentAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerShareDilutedAbstract_lbl0" xml:lang="en-US">Earnings Per Share, Diluted [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareDilutedAbstract" xlink:to="us-gaap_EarningsPerShareDilutedAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodValueIssuedForServices_lbl0" xml:lang="en-US">Stock Issued During Period, Value, Issued for Services</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueIssuedForServices" xlink:to="us-gaap_StockIssuedDuringPeriodValueIssuedForServices_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NonoperatingIncomeExpense_lbl0" xml:lang="en-US">Nonoperating Income (Expense)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NonoperatingIncomeExpense" xlink:to="us-gaap_NonoperatingIncomeExpense_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_lbl0" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromIssuanceInitialPublicOffering_lbl1" xml:lang="en-US">Proceeds from Issuance Initial Public Offering</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceInitialPublicOffering" xlink:to="us-gaap_ProceedsFromIssuanceInitialPublicOffering_lbl1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementOfCashFlowsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementOfCashFlowsAbstract_lbl" xml:lang="en-US">Statement of Cash Flows [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_StatementOfCashFlowsAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="arbe_SeriesB2PreferredStockMember_lbl0" xml:lang="en-US">Series B2 Preferred Stock Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_SeriesB2PreferredStockMember" xlink:to="arbe_SeriesB2PreferredStockMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock_lbl0" xml:lang="en-US">Income Tax Disclosure [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxDisclosureTextBlock" xlink:to="us-gaap_IncomeTaxDisclosureTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_lbl0" xml:lang="en-US">Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:to="us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodValueConversionOfUnits_lbl0" xml:lang="en-US">Stock Issued During Period, Value, Conversion of Units</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueConversionOfUnits" xlink:to="us-gaap_StockIssuedDuringPeriodValueConversionOfUnits_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="arbe_RsusAbstract_lbl0" xml:lang="en-US">Rsus Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_RsusAbstract" xlink:to="arbe_RsusAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharePrice_lbl0" xml:lang="en-US">Share Price</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharePrice" xlink:to="us-gaap_SharePrice_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl0" xml:lang="en-US">Liabilities and Equity [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl0" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_lbl1" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Outstanding, Number</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_lbl0" xml:lang="en-US">Stock Issued During Period, Value, Conversion of Convertible Securities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:to="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdditionalCollateralAggregateFairValue_lbl0" xml:lang="en-US">Additional Collateral, Aggregate Fair Value</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdditionalCollateralAggregateFairValue" xlink:to="us-gaap_AdditionalCollateralAggregateFairValue_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DisaggregationOfRevenueTableTextBlock_lbl0" xml:lang="en-US">Disaggregation of Revenue [Table Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:to="us-gaap_DisaggregationOfRevenueTableTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_lbl0" xml:lang="en-US">Stock Issued During Period, Value, Stock Options Exercised</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:to="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GrantsReceivableCurrent_lbl0" xml:lang="en-US">Grants Receivable, Current</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GrantsReceivableCurrent" xlink:to="us-gaap_GrantsReceivableCurrent_lbl0"/>
    <loc xlink:type="locator" xlink:label="arbe_ScheduleOfShareBasedCompensationExpenseAbstract" xlink:href="arbe-20231231.xsd#arbe_ScheduleOfShareBasedCompensationExpenseAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="arbe_ScheduleOfShareBasedCompensationExpenseAbstract_lbl" xml:lang="en-US">Schedule Of Share Based Compensation Expense Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_ScheduleOfShareBasedCompensationExpenseAbstract" xlink:to="arbe_ScheduleOfShareBasedCompensationExpenseAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="arbe_OptionsAbstract_lbl0" xml:lang="en-US">Options Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_OptionsAbstract" xlink:to="arbe_OptionsAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsCurrentAbstract_lbl0" xml:lang="en-US">Assets, Current [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_AssetsCurrentAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_lbl0" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Authorized</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RevenueRecognitionPolicyTextBlock_lbl0" xml:lang="en-US">Revenue [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenueRecognitionPolicyTextBlock" xlink:to="us-gaap_RevenueRecognitionPolicyTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConcentrationRiskPercentage1_lbl0" xml:lang="en-US">Concentration Risk, Percentage</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskPercentage1" xlink:to="us-gaap_ConcentrationRiskPercentage1_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_lbl0" xml:lang="en-US">Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock_lbl0" xml:lang="en-US">Earnings Per Share, Policy [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerSharePolicyTextBlock" xlink:to="us-gaap_EarningsPerSharePolicyTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_lbl0" xml:lang="en-US">Operating Lease, Weighted Average Remaining Lease Term</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:to="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_lbl0" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Granted</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_lbl0" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:to="us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_lbl0"/>
    <loc xlink:type="locator" xlink:label="arbe_ScheduleOfCompensationToEmployeesAbstract" xlink:href="arbe-20231231.xsd#arbe_ScheduleOfCompensationToEmployeesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="arbe_ScheduleOfCompensationToEmployeesAbstract_lbl" xml:lang="en-US">Schedule Of Compensation To Employees Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_ScheduleOfCompensationToEmployeesAbstract" xlink:to="arbe_ScheduleOfCompensationToEmployeesAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ClassOfWarrantOrRightOutstanding_lbl0" xml:lang="en-US">Class of Warrant or Right, Outstanding</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightOutstanding" xlink:to="us-gaap_ClassOfWarrantOrRightOutstanding_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerShareTextBlock_lbl0" xml:lang="en-US">Earnings Per Share [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareTextBlock" xlink:to="us-gaap_EarningsPerShareTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GrossProfit_lbl0" xml:lang="en-US">Gross Profit</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GrossProfit" xlink:to="us-gaap_GrossProfit_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromStockOptionsExercised_lbl0" xml:lang="en-US">Proceeds from Stock Options Exercised</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromStockOptionsExercised" xlink:to="us-gaap_ProceedsFromStockOptionsExercised_lbl0"/>
    <loc xlink:type="locator" xlink:label="arbe_ScheduleOfDeferredTaxAssetsAbstract" xlink:href="arbe-20231231.xsd#arbe_ScheduleOfDeferredTaxAssetsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="arbe_ScheduleOfDeferredTaxAssetsAbstract_lbl" xml:lang="en-US">Schedule Of Deferred Tax Assets Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_ScheduleOfDeferredTaxAssetsAbstract" xlink:to="arbe_ScheduleOfDeferredTaxAssetsAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Revenues_lbl0" xml:lang="en-US">Revenues</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Revenues" xlink:to="us-gaap_Revenues_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RestrictedStockUnitsRSUMember_lbl0" xml:lang="en-US">Restricted Stock Units (RSUs) [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RestrictedStockUnitsRSUMember" xlink:to="us-gaap_RestrictedStockUnitsRSUMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity_lbl0" xml:lang="en-US">Liabilities and Equity</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShortTermInvestments_lbl0" xml:lang="en-US">Short-Term Investments</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShortTermInvestments" xlink:to="us-gaap_ShortTermInvestments_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GeneralAndAdministrativeExpense_lbl0" xml:lang="en-US">General and Administrative Expense</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GeneralAndAdministrativeExpense" xlink:to="us-gaap_GeneralAndAdministrativeExpense_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesCurrent_lbl0" xml:lang="en-US">Liabilities, Current</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_LiabilitiesCurrent_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsNoncurrentAbstract_lbl0" xml:lang="en-US">Assets, Noncurrent [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsNoncurrentAbstract" xlink:to="us-gaap_AssetsNoncurrentAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock_lbl0" xml:lang="en-US">Long-Lived Assets by Geographic Areas [Table Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock" xlink:to="us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsCurrent_lbl0" xml:lang="en-US">Assets, Current</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_AssetsCurrent_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_lbl0" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_lbl0" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Maturity [Table Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssued1_lbl0" xml:lang="en-US">Stock Issued</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssued1" xlink:to="us-gaap_StockIssued1_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueOfFinancialInstrumentsPolicy_lbl0" xml:lang="en-US">Fair Value of Financial Instruments, Policy [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:to="us-gaap_FairValueOfFinancialInstrumentsPolicy_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_lbl1" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardTermsOfAward_lbl0" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Terms of Award</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardTermsOfAward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardTermsOfAward_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_lbl0" xml:lang="en-US">Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:to="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CostOfRevenue_lbl0" xml:lang="en-US">Cost of Revenue</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CostOfRevenue" xlink:to="us-gaap_CostOfRevenue_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PrivatePlacementMember_lbl0" xml:lang="en-US">Private Placement [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PrivatePlacementMember" xlink:to="us-gaap_PrivatePlacementMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsNoncurrent_lbl0" xml:lang="en-US">Assets, Noncurrent</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsNoncurrent" xlink:to="us-gaap_AssetsNoncurrent_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_lbl0" xml:lang="en-US">Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NatureOfOperations_lbl0" xml:lang="en-US">Nature of Operations [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NatureOfOperations" xlink:to="us-gaap_NatureOfOperations_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsReceivableNetCurrent_lbl0" xml:lang="en-US">Accounts Receivable, after Allowance for Credit Loss, Current</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsReceivableNetCurrent" xlink:to="us-gaap_AccountsReceivableNetCurrent_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromConvertibleDebt_lbl0" xml:lang="en-US">Proceeds from Convertible Debt</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromConvertibleDebt" xlink:to="us-gaap_ProceedsFromConvertibleDebt_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_lbl0" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Foreign</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="arbe_WarrantsMember_lbl0" xml:lang="en-US">Warrants Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_WarrantsMember" xlink:to="arbe_WarrantsMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentSalvageValuePercentage_lbl0" xml:lang="en-US">Property, Plant and Equipment, Salvage Value, Percentage</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentSalvageValuePercentage" xlink:to="us-gaap_PropertyPlantAndEquipmentSalvageValuePercentage_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="country_HK_lbl0" xml:lang="en-US">HONG KONG</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="country_HK" xlink:to="country_HK_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock_lbl0" xml:lang="en-US">Share-Based Payment Arrangement, Activity [Table Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock" xlink:to="us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl0" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition_lbl0" xml:lang="en-US">APIC, Share-Based Payment Arrangement, Option, Increase for Cost Recognition</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset_lbl0" xml:lang="en-US">Operating Lease, Right-of-Use Asset</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseRightOfUseAsset" xlink:to="us-gaap_OperatingLeaseRightOfUseAsset_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquityReverseStockSplit_lbl0" xml:lang="en-US">Stockholders&apos; Equity, Reverse Stock Split</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityReverseStockSplit" xlink:to="us-gaap_StockholdersEquityReverseStockSplit_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharesOutstanding_lbl1" xml:lang="en-US">Shares, Outstanding</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesOutstanding" xlink:to="us-gaap_SharesOutstanding_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_lbl0" xml:lang="en-US">Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="country_IL_lbl0" xml:lang="en-US">ISRAEL</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="country_IL" xlink:to="country_IL_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CustomerConcentrationRiskMember_lbl0" xml:lang="en-US">Customer Concentration Risk [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CustomerConcentrationRiskMember" xlink:to="us-gaap_CustomerConcentrationRiskMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent_lbl1" xml:lang="en-US">Operating Lease, Liability, Current</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseLiabilityCurrent" xlink:to="us-gaap_OperatingLeaseLiabilityCurrent_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="country_IT_lbl0" xml:lang="en-US">ITALY</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="country_IT" xlink:to="country_IT_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GrantsReceivable_lbl0" xml:lang="en-US">Grants Receivable</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GrantsReceivable" xlink:to="us-gaap_GrantsReceivable_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl0" xml:lang="en-US">Commitments and Contingencies Disclosure [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl0" xml:lang="en-US">Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl0"/>
    <loc xlink:type="locator" xlink:label="arbe_ScheduleOfPropertyAndEquipmentNetOfDepreciationByGeographicRegionAbstract" xlink:href="arbe-20231231.xsd#arbe_ScheduleOfPropertyAndEquipmentNetOfDepreciationByGeographicRegionAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="arbe_ScheduleOfPropertyAndEquipmentNetOfDepreciationByGeographicRegionAbstract_lbl" xml:lang="en-US">Schedule Of Property And Equipment Net Of Depreciation By Geographic Region Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_ScheduleOfPropertyAndEquipmentNetOfDepreciationByGeographicRegionAbstract" xlink:to="arbe_ScheduleOfPropertyAndEquipmentNetOfDepreciationByGeographicRegionAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeLeasesPolicyTextBlock_lbl0" xml:lang="en-US">Lessee, Leases [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeLeasesPolicyTextBlock" xlink:to="us-gaap_LesseeLeasesPolicyTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRights_lbl0" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Rights</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRights" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRights_lbl0"/>
  </labelLink>
</linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>20
<FILENAME>arbe-20231231_pre.xml
<DESCRIPTION>XBRL PRESENTATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!-- Generated by CompSci Transform (tm) - http://www.compsciresources.com -->
<!-- Created: Thu Mar 28 12:24:34 UTC 2024 -->
<linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <roleRef xlink:type="simple" xlink:href="arbe-20231231.xsd#arbe_r_ConsolidatedBalanceSheet" roleURI="http://www.arberobotics.com/role/ConsolidatedBalanceSheet"/>
  <roleRef xlink:type="simple" xlink:href="arbe-20231231.xsd#arbe_r_ConsolidatedBalanceSheet_Parentheticals" roleURI="http://www.arberobotics.com/role/ConsolidatedBalanceSheet_Parentheticals"/>
  <roleRef xlink:type="simple" xlink:href="arbe-20231231.xsd#arbe_r_ConsolidatedIncomeStatement" roleURI="http://www.arberobotics.com/role/ConsolidatedIncomeStatement"/>
  <roleRef xlink:type="simple" xlink:href="arbe-20231231.xsd#arbe_r_ShareholdersEquityType2or3" roleURI="http://www.arberobotics.com/role/ShareholdersEquityType2or3"/>
  <roleRef xlink:type="simple" xlink:href="arbe-20231231.xsd#arbe_r_ConsolidatedCashFlow" roleURI="http://www.arberobotics.com/role/ConsolidatedCashFlow"/>
  <roleRef xlink:type="simple" xlink:href="arbe-20231231.xsd#arbe_r_General" roleURI="http://www.arberobotics.com/role/General"/>
  <roleRef xlink:type="simple" xlink:href="arbe-20231231.xsd#arbe_r_SignificantAccountingPolicies" roleURI="http://www.arberobotics.com/role/SignificantAccountingPolicies"/>
  <roleRef xlink:type="simple" xlink:href="arbe-20231231.xsd#arbe_r_Revenue" roleURI="http://www.arberobotics.com/role/Revenue"/>
  <roleRef xlink:type="simple" xlink:href="arbe-20231231.xsd#arbe_r_PrepaidExpensesandOtherReceivables" roleURI="http://www.arberobotics.com/role/PrepaidExpensesandOtherReceivables"/>
  <roleRef xlink:type="simple" xlink:href="arbe-20231231.xsd#arbe_r_PropertyandEquipment" roleURI="http://www.arberobotics.com/role/PropertyandEquipment"/>
  <roleRef xlink:type="simple" xlink:href="arbe-20231231.xsd#arbe_r_Leases" roleURI="http://www.arberobotics.com/role/Leases"/>
  <roleRef xlink:type="simple" xlink:href="arbe-20231231.xsd#arbe_r_CommitmentsandContingentLiabilities" roleURI="http://www.arberobotics.com/role/CommitmentsandContingentLiabilities"/>
  <roleRef xlink:type="simple" xlink:href="arbe-20231231.xsd#arbe_r_WarrantsLiabilities" roleURI="http://www.arberobotics.com/role/WarrantsLiabilities"/>
  <roleRef xlink:type="simple" xlink:href="arbe-20231231.xsd#arbe_r_ShareholdersEquity" roleURI="http://www.arberobotics.com/role/ShareholdersEquity"/>
  <roleRef xlink:type="simple" xlink:href="arbe-20231231.xsd#arbe_r_NetLossPerShareAttributibletoOrdinarySharholders" roleURI="http://www.arberobotics.com/role/NetLossPerShareAttributibletoOrdinarySharholders"/>
  <roleRef xlink:type="simple" xlink:href="arbe-20231231.xsd#arbe_r_TaxesonIncome" roleURI="http://www.arberobotics.com/role/TaxesonIncome"/>
  <roleRef xlink:type="simple" xlink:href="arbe-20231231.xsd#arbe_r_SegmentInformation" roleURI="http://www.arberobotics.com/role/SegmentInformation"/>
  <roleRef xlink:type="simple" xlink:href="arbe-20231231.xsd#arbe_r_AccountingPoliciesByPolicy" roleURI="http://www.arberobotics.com/role/AccountingPoliciesByPolicy"/>
  <roleRef xlink:type="simple" xlink:href="arbe-20231231.xsd#arbe_r_SignificantAccountingPoliciesTables" roleURI="http://www.arberobotics.com/role/SignificantAccountingPoliciesTables"/>
  <roleRef xlink:type="simple" xlink:href="arbe-20231231.xsd#arbe_r_RevenueTables" roleURI="http://www.arberobotics.com/role/RevenueTables"/>
  <roleRef xlink:type="simple" xlink:href="arbe-20231231.xsd#arbe_r_PrepaidExpensesandOtherReceivablesTables" roleURI="http://www.arberobotics.com/role/PrepaidExpensesandOtherReceivablesTables"/>
  <roleRef xlink:type="simple" xlink:href="arbe-20231231.xsd#arbe_r_PropertyandEquipmentTables" roleURI="http://www.arberobotics.com/role/PropertyandEquipmentTables"/>
  <roleRef xlink:type="simple" xlink:href="arbe-20231231.xsd#arbe_r_LeasesTables" roleURI="http://www.arberobotics.com/role/LeasesTables"/>
  <roleRef xlink:type="simple" xlink:href="arbe-20231231.xsd#arbe_r_ShareholdersEquityTables" roleURI="http://www.arberobotics.com/role/ShareholdersEquityTables"/>
  <roleRef xlink:type="simple" xlink:href="arbe-20231231.xsd#arbe_r_NetLossPerShareAttributibletoOrdinarySharholdersTables" roleURI="http://www.arberobotics.com/role/NetLossPerShareAttributibletoOrdinarySharholdersTables"/>
  <roleRef xlink:type="simple" xlink:href="arbe-20231231.xsd#arbe_r_TaxesonIncomeTables" roleURI="http://www.arberobotics.com/role/TaxesonIncomeTables"/>
  <roleRef xlink:type="simple" xlink:href="arbe-20231231.xsd#arbe_r_SegmentInformationTables" roleURI="http://www.arberobotics.com/role/SegmentInformationTables"/>
  <roleRef xlink:type="simple" xlink:href="arbe-20231231.xsd#arbe_r_ScheduleoftheStraightLineMethodOvertheEstimatedUsefulLivesoftheAssetsTable" roleURI="http://www.arberobotics.com/role/ScheduleoftheStraightLineMethodOvertheEstimatedUsefulLivesoftheAssetsTable"/>
  <roleRef xlink:type="simple" xlink:href="arbe-20231231.xsd#arbe_r_ScheduleofRevenueDisaggregatedbyGeographyTable" roleURI="http://www.arberobotics.com/role/ScheduleofRevenueDisaggregatedbyGeographyTable"/>
  <roleRef xlink:type="simple" xlink:href="arbe-20231231.xsd#arbe_r_ScheduleofPrepaidExpensesandOtherReceivablesTable" roleURI="http://www.arberobotics.com/role/ScheduleofPrepaidExpensesandOtherReceivablesTable"/>
  <roleRef xlink:type="simple" xlink:href="arbe-20231231.xsd#arbe_r_ScheduleofPropertyandEquipmentTable" roleURI="http://www.arberobotics.com/role/ScheduleofPropertyandEquipmentTable"/>
  <roleRef xlink:type="simple" xlink:href="arbe-20231231.xsd#arbe_r_ScheduleofSupplementalCashFlowInformationRelatedtoLeasesTable" roleURI="http://www.arberobotics.com/role/ScheduleofSupplementalCashFlowInformationRelatedtoLeasesTable"/>
  <roleRef xlink:type="simple" xlink:href="arbe-20231231.xsd#arbe_r_ScheduleofMaturitiesofLeaseLiabilitiesTable" roleURI="http://www.arberobotics.com/role/ScheduleofMaturitiesofLeaseLiabilitiesTable"/>
  <roleRef xlink:type="simple" xlink:href="arbe-20231231.xsd#arbe_r_ScheduleofSupplementalBalanceSheetInformationRelatedtoOperatingLeasesTable" roleURI="http://www.arberobotics.com/role/ScheduleofSupplementalBalanceSheetInformationRelatedtoOperatingLeasesTable"/>
  <roleRef xlink:type="simple" xlink:href="arbe-20231231.xsd#arbe_r_ScheduleofStockOptionActivityTable" roleURI="http://www.arberobotics.com/role/ScheduleofStockOptionActivityTable"/>
  <roleRef xlink:type="simple" xlink:href="arbe-20231231.xsd#arbe_r_ScheduleofRSUsActivityTable" roleURI="http://www.arberobotics.com/role/ScheduleofRSUsActivityTable"/>
  <roleRef xlink:type="simple" xlink:href="arbe-20231231.xsd#arbe_r_ScheduleofCompensationtoEmployeesTable" roleURI="http://www.arberobotics.com/role/ScheduleofCompensationtoEmployeesTable"/>
  <roleRef xlink:type="simple" xlink:href="arbe-20231231.xsd#arbe_r_ScheduleofShareBasedCompensationExpenseTable" roleURI="http://www.arberobotics.com/role/ScheduleofShareBasedCompensationExpenseTable"/>
  <roleRef xlink:type="simple" xlink:href="arbe-20231231.xsd#arbe_r_ScheduleofSetsForththeComputationofBasicandDilutedNetLossPerShareAttributableTable" roleURI="http://www.arberobotics.com/role/ScheduleofSetsForththeComputationofBasicandDilutedNetLossPerShareAttributableTable"/>
  <roleRef xlink:type="simple" xlink:href="arbe-20231231.xsd#arbe_r_ScheduleofOrdinarySharesthatwereExcludedfromtheComputationofDilutedNetLossPerShareTable" roleURI="http://www.arberobotics.com/role/ScheduleofOrdinarySharesthatwereExcludedfromtheComputationofDilutedNetLossPerShareTable"/>
  <roleRef xlink:type="simple" xlink:href="arbe-20231231.xsd#arbe_r_ScheduleofCompanysLossBeforeIncomeTaxesTable" roleURI="http://www.arberobotics.com/role/ScheduleofCompanysLossBeforeIncomeTaxesTable"/>
  <roleRef xlink:type="simple" xlink:href="arbe-20231231.xsd#arbe_r_ScheduleofReconciliationIncomeTaxBenefitTable" roleURI="http://www.arberobotics.com/role/ScheduleofReconciliationIncomeTaxBenefitTable"/>
  <roleRef xlink:type="simple" xlink:href="arbe-20231231.xsd#arbe_r_ScheduleofDeferredTaxAssetsTable" roleURI="http://www.arberobotics.com/role/ScheduleofDeferredTaxAssetsTable"/>
  <roleRef xlink:type="simple" xlink:href="arbe-20231231.xsd#arbe_r_ScheduleofPropertyandEquipmentNetofDepreciationbyGeographicRegionTable" roleURI="http://www.arberobotics.com/role/ScheduleofPropertyandEquipmentNetofDepreciationbyGeographicRegionTable"/>
  <roleRef xlink:type="simple" xlink:href="arbe-20231231.xsd#arbe_r_GeneralDetails" roleURI="http://www.arberobotics.com/role/GeneralDetails"/>
  <roleRef xlink:type="simple" xlink:href="arbe-20231231.xsd#arbe_r_SignificantAccountingPoliciesDetails" roleURI="http://www.arberobotics.com/role/SignificantAccountingPoliciesDetails"/>
  <roleRef xlink:type="simple" xlink:href="arbe-20231231.xsd#arbe_r_RevenueDetails" roleURI="http://www.arberobotics.com/role/RevenueDetails"/>
  <roleRef xlink:type="simple" xlink:href="arbe-20231231.xsd#arbe_r_PropertyandEquipmentDetails" roleURI="http://www.arberobotics.com/role/PropertyandEquipmentDetails"/>
  <roleRef xlink:type="simple" xlink:href="arbe-20231231.xsd#arbe_r_CommitmentsandContingentLiabilitiesDetails" roleURI="http://www.arberobotics.com/role/CommitmentsandContingentLiabilitiesDetails"/>
  <roleRef xlink:type="simple" xlink:href="arbe-20231231.xsd#arbe_r_WarrantsLiabilitiesDetails" roleURI="http://www.arberobotics.com/role/WarrantsLiabilitiesDetails"/>
  <roleRef xlink:type="simple" xlink:href="arbe-20231231.xsd#arbe_r_ShareholdersEquityDetails" roleURI="http://www.arberobotics.com/role/ShareholdersEquityDetails"/>
  <roleRef xlink:type="simple" xlink:href="arbe-20231231.xsd#arbe_r_TaxesonIncomeDetails" roleURI="http://www.arberobotics.com/role/TaxesonIncomeDetails"/>
  <roleRef xlink:type="simple" xlink:href="arbe-20231231.xsd#arbe_r_SegmentInformationDetails" roleURI="http://www.arberobotics.com/role/SegmentInformationDetails"/>
  <roleRef xlink:type="simple" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#cover" roleURI="http://xbrl.sec.gov/dei/role/document/Cover"/>
  <presentationLink xlink:type="extended" xlink:role="http://www.arberobotics.com/role/ConsolidatedBalanceSheet">
    <loc xlink:type="locator" xlink:label="us-gaap_StatementOfFinancialPositionAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AssetsCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsCurrentAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_AssetsCurrentAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RestrictedCashCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedCashCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_RestrictedCashCurrent" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShortTermInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShortTermInvestments"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_ShortTermInvestments" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccountsReceivableNetCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_AccountsReceivableNetCurrent" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_AssetsCurrent" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AssetsNoncurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsNoncurrentAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_AssetsNoncurrentAbstract" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsNoncurrentAbstract" xlink:to="us-gaap_OperatingLeaseRightOfUseAsset" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentNet" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsNoncurrentAbstract" xlink:to="us-gaap_PropertyPlantAndEquipmentNet" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AssetsNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsNoncurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsNoncurrentAbstract" xlink:to="us-gaap_AssetsNoncurrent" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Assets" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Assets"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsNoncurrentAbstract" xlink:to="us-gaap_Assets" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LiabilitiesCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_LiabilitiesCurrentAbstract" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccountsPayableTradeCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsPayableTradeCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_AccountsPayableTradeCurrent" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_OperatingLeaseLiabilityCurrent" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_EmployeeRelatedLiabilitiesCurrent" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredRevenueCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredRevenueCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_DeferredRevenueCurrent" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_LiabilitiesCurrent" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LiabilitiesNoncurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesNoncurrentAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_LiabilitiesNoncurrentAbstract" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesNoncurrentAbstract" xlink:to="us-gaap_OperatingLeaseLiabilityNoncurrent" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WarrantsAndRightsOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WarrantsAndRightsOutstanding"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesNoncurrentAbstract" xlink:to="us-gaap_WarrantsAndRightsOutstanding" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LiabilitiesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesNoncurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesNoncurrentAbstract" xlink:to="us-gaap_LiabilitiesNoncurrent" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_StockholdersEquityAbstract" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockValue"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_CommonStockValue" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AdditionalPaidInCapitalCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_AdditionalPaidInCapitalCommonStock" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquity"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_StockholdersEquity" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.arberobotics.com/role/ConsolidatedBalanceSheet_Parentheticals">
    <loc xlink:type="locator" xlink:label="us-gaap_StatementOfFinancialPositionAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_CommonStockSharesAuthorized" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_CommonStockSharesOutstanding" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.arberobotics.com/role/ConsolidatedIncomeStatement">
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeStatementAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Revenues" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Revenues"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_Revenues" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CostOfRevenue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CostOfRevenue"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_CostOfRevenue" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_GrossProfit" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GrossProfit"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_GrossProfit" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingExpensesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingExpensesAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_OperatingExpensesAbstract" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ResearchAndDevelopmentExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-gaap_ResearchAndDevelopmentExpense" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SellingAndMarketingExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SellingAndMarketingExpense"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-gaap_SellingAndMarketingExpense" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_GeneralAndAdministrativeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-gaap_GeneralAndAdministrativeExpense" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingExpenses" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingExpenses"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_OperatingExpenses" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingIncomeLoss"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_OperatingIncomeLoss" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NonoperatingIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_NonoperatingIncomeExpense" order="6.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_NetIncomeLoss" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EarningsPerShareBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareBasic"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_EarningsPerShareBasic" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EarningsPerShareDiluted" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareDiluted"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_EarningsPerShareDiluted" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" order="11.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.arberobotics.com/role/ShareholdersEquityType2or3">
    <loc xlink:type="locator" xlink:label="us-gaap_StatementOfStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="us-gaap_StatementTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementClassOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementClassOfStockAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="SeedMember" xlink:href="arbe-20231231.xsd#arbe_SeedMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="SeedMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SeriesAPreferredStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SeriesAPreferredStockMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_SeriesAPreferredStockMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="SeriesA1PreferredStockMember" xlink:href="arbe-20231231.xsd#arbe_SeriesA1PreferredStockMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="SeriesA1PreferredStockMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SeriesBPreferredStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SeriesBPreferredStockMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_SeriesBPreferredStockMember" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="SeriesB1PreferredStockMember" xlink:href="arbe-20231231.xsd#arbe_SeriesB1PreferredStockMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="SeriesB1PreferredStockMember" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="SeriesB2PreferredStockMember" xlink:href="arbe-20231231.xsd#arbe_SeriesB2PreferredStockMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="SeriesB2PreferredStockMember" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="6.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementEquityComponentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementEquityComponentsAxis" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_PreferredStockMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_CommonStockMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AdditionalPaidInCapitalMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_AdditionalPaidInCapitalMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RetainedEarningsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_RetainedEarningsMember" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EquityComponentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" order="4.0"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquity"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockholdersEquity" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharesOutstanding"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_SharesOutstanding" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="StockIssuedDuringPeriodSharesExerciseOfWarrants" xlink:href="arbe-20231231.xsd#arbe_StockIssuedDuringPeriodSharesExerciseOfWarrants"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="StockIssuedDuringPeriodSharesExerciseOfWarrants" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StockIssuedDuringPeriodSharesExerciseOfWarrants" xlink:to="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StockIssuedDuringPeriodSharesExerciseOfWarrants" xlink:to="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueConversionOfUnits" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueConversionOfUnits"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StockIssuedDuringPeriodSharesExerciseOfWarrants" xlink:to="us-gaap_StockIssuedDuringPeriodValueConversionOfUnits" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StockIssuedDuringPeriodSharesExerciseOfWarrants" xlink:to="us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StockIssuedDuringPeriodSharesExerciseOfWarrants" xlink:to="us-gaap_StockIssuedDuringPeriodValueNewIssues" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StockIssuedDuringPeriodSharesExerciseOfWarrants" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StockIssuedDuringPeriodSharesExerciseOfWarrants" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueIssuedForServices" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueIssuedForServices"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StockIssuedDuringPeriodSharesExerciseOfWarrants" xlink:to="us-gaap_StockIssuedDuringPeriodValueIssuedForServices" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StockIssuedDuringPeriodSharesExerciseOfWarrants" xlink:to="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StockIssuedDuringPeriodSharesExerciseOfWarrants" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StockIssuedDuringPeriodSharesExerciseOfWarrants" xlink:to="us-gaap_NetIncomeLoss" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquity_0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquity"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockholdersEquity_0" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharesOutstanding_0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharesOutstanding"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_SharesOutstanding_0" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.arberobotics.com/role/ConsolidatedCashFlow">
    <loc xlink:type="locator" xlink:label="us-gaap_StatementOfCashFlowsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_NetIncomeLoss" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Depreciation" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Depreciation"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_Depreciation" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensation"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_ShareBasedCompensation" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AdjustmentOfWarrantsGrantedForServices" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdjustmentOfWarrantsGrantedForServices"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_AdjustmentOfWarrantsGrantedForServices" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="RevaluationOfConvertibleLoan" xlink:href="arbe-20231231.xsd#arbe_RevaluationOfConvertibleLoan"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="RevaluationOfConvertibleLoan" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInAccountsReceivable" order="0.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" order="1.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOperatingLeaseLiability"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInOperatingLeaseLiability" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayableTrade" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccountsPayableTrade"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayableTrade" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInDeferredRevenue"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInDeferredRevenue" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PaymentsForProceedsFromInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsForProceedsFromInvestments"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_PaymentsForProceedsFromInvestments" order="0.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" order="1.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromShortTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromShortTermDebt"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_ProceedsFromShortTermDebt" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RepaymentsOfLongTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RepaymentsOfLongTermDebt"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_RepaymentsOfLongTermDebt" order="1.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceInitialPublicOffering" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromIssuanceInitialPublicOffering"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_ProceedsFromIssuanceInitialPublicOffering" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RepaymentsOfShortTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RepaymentsOfShortTermDebt"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_RepaymentsOfShortTermDebt" order="3.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_ProceedsFromIssuanceOfCommonStock" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromWarrantExercises" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromWarrantExercises"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_ProceedsFromWarrantExercises" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_ProceedsFromStockOptionsExercised" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromConvertibleDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromConvertibleDebt"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_ProceedsFromConvertibleDebt" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" order="8.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0" order="11.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" order="12.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConversionOfStockAmountConverted1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConversionOfStockAmountConverted1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:to="us-gaap_ConversionOfStockAmountConverted1" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssued1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssued1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:to="us-gaap_StockIssued1" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ConversionOfConvertibleLoanIntoOrdinarySharesUponTheRecapitalization" xlink:href="arbe-20231231.xsd#arbe_ConversionOfConvertibleLoanIntoOrdinarySharesUponTheRecapitalization"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:to="ConversionOfConvertibleLoanIntoOrdinarySharesUponTheRecapitalization" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ConversionOfPreferredSharesIntoOrdinarySharesUponTheRecapitalization" xlink:href="arbe-20231231.xsd#arbe_ConversionOfPreferredSharesIntoOrdinarySharesUponTheRecapitalization"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:to="ConversionOfPreferredSharesIntoOrdinarySharesUponTheRecapitalization" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:to="us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:to="us-gaap_NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SupplementalCashFlowInformationAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SupplementalCashFlowInformationAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_SupplementalCashFlowInformationAbstract" order="13.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InterestPaidNet" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestPaidNet"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="us-gaap_InterestPaidNet" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.arberobotics.com/role/General">
    <loc xlink:type="locator" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NatureOfOperations" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NatureOfOperations"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="us-gaap_NatureOfOperations" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.arberobotics.com/role/SignificantAccountingPolicies">
    <loc xlink:type="locator" xlink:label="us-gaap_AccountingPoliciesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SignificantAccountingPoliciesTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_SignificantAccountingPoliciesTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.arberobotics.com/role/Revenue">
    <loc xlink:type="locator" xlink:label="us-gaap_RevenuesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenuesAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromContractWithCustomerTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RevenuesAbstract" xlink:to="us-gaap_RevenueFromContractWithCustomerTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.arberobotics.com/role/PrepaidExpensesandOtherReceivables">
    <loc xlink:type="locator" xlink:label="us-gaap_OtherAssetsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAssetsAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherCurrentAssetsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherCurrentAssetsTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OtherAssetsAbstract" xlink:to="us-gaap_OtherCurrentAssetsTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.arberobotics.com/role/PropertyandEquipment">
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentAbstract" xlink:to="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.arberobotics.com/role/Leases">
    <loc xlink:type="locator" xlink:label="us-gaap_LeasesOperatingAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeasesOperatingAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeasesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeasesTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LeasesOperatingAbstract" xlink:to="us-gaap_LesseeOperatingLeasesTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.arberobotics.com/role/CommitmentsandContingentLiabilities">
    <loc xlink:type="locator" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.arberobotics.com/role/WarrantsLiabilities">
    <loc xlink:type="locator" xlink:label="us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:to="us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.arberobotics.com/role/ShareholdersEquity">
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquityNoteAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityNoteAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityNoteAbstract" xlink:to="us-gaap_StockholdersEquityNoteDisclosureTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.arberobotics.com/role/NetLossPerShareAttributibletoOrdinarySharholders">
    <loc xlink:type="locator" xlink:label="us-gaap_EarningsPerShareAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EarningsPerShareTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="us-gaap_EarningsPerShareTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.arberobotics.com/role/TaxesonIncome">
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_IncomeTaxDisclosureTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.arberobotics.com/role/SegmentInformation">
    <loc xlink:type="locator" xlink:label="us-gaap_SegmentReportingInformationRevenueAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentReportingInformationRevenueAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SegmentReportingDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SegmentReportingInformationRevenueAbstract" xlink:to="us-gaap_SegmentReportingDisclosureTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.arberobotics.com/role/AccountingPoliciesByPolicy">
    <loc xlink:type="locator" xlink:label="us-gaap_AccountingPoliciesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_BasisOfAccountingPolicyPolicyTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_UseOfEstimates" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UseOfEstimates"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_UseOfEstimates" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConcentrationRiskCreditRisk" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskCreditRisk"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ConcentrationRiskCreditRisk" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ShortTermDepositsPolicyPolicyTextBlock" xlink:href="arbe-20231231.xsd#arbe_ShortTermDepositsPolicyPolicyTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="ShortTermDepositsPolicyPolicyTextBlock" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueOfFinancialInstrumentsPolicy"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_FairValueOfFinancialInstrumentsPolicy" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PostemploymentBenefitPlansPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PostemploymentBenefitPlansPolicy"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_PostemploymentBenefitPlansPolicy" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" order="11.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerSharePolicyTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_EarningsPerSharePolicyTextBlock" order="12.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ComprehensiveIncomePolicyPolicyTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" order="13.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RevenueRecognitionPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueRecognitionPolicyTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_RevenueRecognitionPolicyTextBlock" order="14.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CostOfSalesPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CostOfSalesPolicyTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_CostOfSalesPolicyTextBlock" order="15.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ResearchAndDevelopmentExpensePolicy"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ResearchAndDevelopmentExpensePolicy" order="16.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxPolicyTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_IncomeTaxPolicyTextBlock" order="17.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ContingentLiabilityReserveEstimatePolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContingentLiabilityReserveEstimatePolicy"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ContingentLiabilityReserveEstimatePolicy" order="18.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LesseeLeasesPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeLeasesPolicyTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_LesseeLeasesPolicyTextBlock" order="19.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" order="20.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.arberobotics.com/role/SignificantAccountingPoliciesTables">
    <loc xlink:type="locator" xlink:label="us-gaap_AccountingPoliciesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <loc xlink:type="locator" xlink:label="PropertyPlantAndEquipmentUsefulLifeTableTextBlock" xlink:href="arbe-20231231.xsd#arbe_PropertyPlantAndEquipmentUsefulLifeTableTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="PropertyPlantAndEquipmentUsefulLifeTableTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.arberobotics.com/role/RevenueTables">
    <loc xlink:type="locator" xlink:label="us-gaap_RevenuesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenuesAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RevenuesAbstract" xlink:to="us-gaap_DisaggregationOfRevenueTableTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.arberobotics.com/role/PrepaidExpensesandOtherReceivablesTables">
    <loc xlink:type="locator" xlink:label="us-gaap_OtherAssetsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAssetsAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OtherAssetsAbstract" xlink:to="us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.arberobotics.com/role/PropertyandEquipmentTables">
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentAbstract" xlink:to="us-gaap_PropertyPlantAndEquipmentTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.arberobotics.com/role/LeasesTables">
    <loc xlink:type="locator" xlink:label="us-gaap_LeasesOperatingAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeasesOperatingAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeaseLeaseIncomeTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLeaseIncomeTableTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LeasesOperatingAbstract" xlink:to="us-gaap_OperatingLeaseLeaseIncomeTableTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LeasesOperatingAbstract" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LeaseCostTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeaseCostTableTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LeasesOperatingAbstract" xlink:to="us-gaap_LeaseCostTableTextBlock" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.arberobotics.com/role/ShareholdersEquityTables">
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquityNoteAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityNoteAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityNoteAbstract" xlink:to="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityNoteAbstract" xlink:to="us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityNoteAbstract" xlink:to="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityNoteAbstract" xlink:to="us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.arberobotics.com/role/NetLossPerShareAttributibletoOrdinarySharholdersTables">
    <loc xlink:type="locator" xlink:label="us-gaap_EarningsPerShareAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.arberobotics.com/role/TaxesonIncomeTables">
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.arberobotics.com/role/SegmentInformationTables">
    <loc xlink:type="locator" xlink:label="us-gaap_SegmentReportingInformationRevenueAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentReportingInformationRevenueAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SegmentReportingInformationRevenueAbstract" xlink:to="us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.arberobotics.com/role/ScheduleoftheStraightLineMethodOvertheEstimatedUsefulLivesoftheAssetsTable">
    <loc xlink:type="locator" xlink:label="ScheduleOfTheStraightLineMethodOverTheEstimatedUsefulLivesOfTheAssetsAbstract" xlink:href="arbe-20231231.xsd#arbe_ScheduleOfTheStraightLineMethodOverTheEstimatedUsefulLivesOfTheAssetsAbstract"/>
    <loc xlink:type="locator" xlink:label="SignificantAccountingPoliciesDetailsScheduleoftheStraightLineMethodOvertheEstimatedUsefulLivesoftheAssetsTable" xlink:href="arbe-20231231.xsd#arbe_SignificantAccountingPoliciesDetailsScheduleoftheStraightLineMethodOvertheEstimatedUsefulLivesoftheAssetsTable"/>
    <loc xlink:type="locator" xlink:label="SignificantAccountingPoliciesDetailsScheduleoftheStraightLineMethodOvertheEstimatedUsefulLivesoftheAssetsLineItems" xlink:href="arbe-20231231.xsd#arbe_SignificantAccountingPoliciesDetailsScheduleoftheStraightLineMethodOvertheEstimatedUsefulLivesoftheAssetsLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfTheStraightLineMethodOverTheEstimatedUsefulLivesOfTheAssetsAbstract" xlink:to="SignificantAccountingPoliciesDetailsScheduleoftheStraightLineMethodOvertheEstimatedUsefulLivesoftheAssetsTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SignificantAccountingPoliciesDetailsScheduleoftheStraightLineMethodOvertheEstimatedUsefulLivesoftheAssetsTable" xlink:to="us-gaap_PropertyPlantAndEquipmentByTypeAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ComputerEquipmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ComputerEquipmentMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_ComputerEquipmentMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OfficeEquipmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OfficeEquipmentMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_OfficeEquipmentMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_VehiclesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VehiclesMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_VehiclesMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LeaseholdImprovementsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeaseholdImprovementsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_LeaseholdImprovementsMember" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="srt_RangeAxis" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SignificantAccountingPoliciesDetailsScheduleoftheStraightLineMethodOvertheEstimatedUsefulLivesoftheAssetsTable" xlink:to="srt_RangeAxis" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="srt_RangeMember" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" order="0.0"/>
    <loc xlink:type="locator" xlink:label="srt_MinimumMember" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MinimumMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis" xlink:to="srt_MinimumMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="srt_MaximumMember" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis" xlink:to="srt_MaximumMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SignificantAccountingPoliciesDetailsScheduleoftheStraightLineMethodOvertheEstimatedUsefulLivesoftheAssetsTable" xlink:to="SignificantAccountingPoliciesDetailsScheduleoftheStraightLineMethodOvertheEstimatedUsefulLivesoftheAssetsLineItems" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentSalvageValuePercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentSalvageValuePercentage"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SignificantAccountingPoliciesDetailsScheduleoftheStraightLineMethodOvertheEstimatedUsefulLivesoftheAssetsLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentSalvageValuePercentage" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.arberobotics.com/role/ScheduleofRevenueDisaggregatedbyGeographyTable">
    <loc xlink:type="locator" xlink:label="ScheduleOfRevenueDisaggregatedByGeographyAbstract" xlink:href="arbe-20231231.xsd#arbe_ScheduleOfRevenueDisaggregatedByGeographyAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DisaggregationOfRevenueTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DisaggregationOfRevenueLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfRevenueDisaggregatedByGeographyAbstract" xlink:to="us-gaap_DisaggregationOfRevenueTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="srt_ProductOrServiceAxis" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ProductOrServiceAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisaggregationOfRevenueTable" xlink:to="srt_ProductOrServiceAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="srt_ProductsAndServicesDomain" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ProductsAndServicesDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ProductOrServiceAxis" xlink:to="srt_ProductsAndServicesDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="OtherGeographicalMember" xlink:href="arbe-20231231.xsd#arbe_OtherGeographicalMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ProductOrServiceAxis" xlink:to="OtherGeographicalMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="srt_StatementGeographicalAxis" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_StatementGeographicalAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisaggregationOfRevenueTable" xlink:to="srt_StatementGeographicalAxis" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="srt_SegmentGeographicalDomain" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_SegmentGeographicalDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_StatementGeographicalAxis" xlink:to="srt_SegmentGeographicalDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="country_CN" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_CN"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_StatementGeographicalAxis" xlink:to="country_CN" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="country_HK" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_HK"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_StatementGeographicalAxis" xlink:to="country_HK" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="country_SE" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_SE"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_StatementGeographicalAxis" xlink:to="country_SE" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="country_US" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_US"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_StatementGeographicalAxis" xlink:to="country_US" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="country_DE" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_DE"/>
<!-- [WMV5][XcpuxYn59dz7vgYynUDuwG7r97K2jUTysl7vcz0lJt/tSeJz73kx1cLt0ZFF2SK/vxBCY0vdSrZEr5dnmkj55Vn3PE+1u+YOtkjz23BDixtN+DSa6ODpxKHuuFDR2EFRAYrDV15EdRUTOp8hTdByKJ//xoC7ECC663wnKueQq7LbhDBxlm0Wi1xZdy33k9DRJYjt/rCQI8A6bBdr5ony7RknOIsPU1pWTweSc4Wp+IQVoYO/x93rSQOoZayYDA6Q/CznawVVoNctMWMoMvWcPQ==] CSR-->
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_StatementGeographicalAxis" xlink:to="country_DE" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="country_IL" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_IL"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_StatementGeographicalAxis" xlink:to="country_IL" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="country_IT" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_IT"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_StatementGeographicalAxis" xlink:to="country_IT" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="country_CH" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_CH"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_StatementGeographicalAxis" xlink:to="country_CH" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisaggregationOfRevenueTable" xlink:to="us-gaap_DisaggregationOfRevenueLineItems" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="RevenueByGeographyAbstract" xlink:href="arbe-20231231.xsd#arbe_RevenueByGeographyAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisaggregationOfRevenueLineItems" xlink:to="RevenueByGeographyAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RevenueByGeographyAbstract" xlink:to="us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RevenueRemainingPerformanceObligationPercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueRemainingPerformanceObligationPercentage"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RevenueByGeographyAbstract" xlink:to="us-gaap_RevenueRemainingPerformanceObligationPercentage" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.arberobotics.com/role/ScheduleofPrepaidExpensesandOtherReceivablesTable">
    <loc xlink:type="locator" xlink:label="ScheduleOfPrepaidExpensesAndOtherReceivablesAbstract" xlink:href="arbe-20231231.xsd#arbe_ScheduleOfPrepaidExpensesAndOtherReceivablesAbstract"/>
    <loc xlink:type="locator" xlink:label="GovernmentAuthorities" xlink:href="arbe-20231231.xsd#arbe_GovernmentAuthorities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfPrepaidExpensesAndOtherReceivablesAbstract" xlink:to="GovernmentAuthorities" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DepositAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DepositAssets"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfPrepaidExpensesAndOtherReceivablesAbstract" xlink:to="us-gaap_DepositAssets" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_GrantsReceivableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GrantsReceivableCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfPrepaidExpensesAndOtherReceivablesAbstract" xlink:to="us-gaap_GrantsReceivableCurrent" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PrepaidExpenseAndOtherAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PrepaidExpenseAndOtherAssets"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfPrepaidExpensesAndOtherReceivablesAbstract" xlink:to="us-gaap_PrepaidExpenseAndOtherAssets" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PrepaidExpenseAndOtherAssetsNoncurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfPrepaidExpensesAndOtherReceivablesAbstract" xlink:to="us-gaap_PrepaidExpenseAndOtherAssetsNoncurrent" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.arberobotics.com/role/ScheduleofPropertyandEquipmentTable">
    <loc xlink:type="locator" xlink:label="ScheduleOfPropertyAndEquipmentAbstract" xlink:href="arbe-20231231.xsd#arbe_ScheduleOfPropertyAndEquipmentAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfPropertyAndEquipmentAbstract" xlink:to="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="us-gaap_PropertyPlantAndEquipmentByTypeAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_PropertyPlantAndEquipmentTypeDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ComputerEquipmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ComputerEquipmentMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_ComputerEquipmentMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LeaseholdImprovementsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeaseholdImprovementsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_LeaseholdImprovementsMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OfficeEquipmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OfficeEquipmentMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_OfficeEquipmentMember" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_VehiclesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VehiclesMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_VehiclesMember" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="us-gaap_PropertyPlantAndEquipmentLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="CostAbstract" xlink:href="arbe-20231231.xsd#arbe_CostAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="CostAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentGross" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CostAbstract" xlink:to="us-gaap_PropertyPlantAndEquipmentGross" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentNet" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentNet" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.arberobotics.com/role/ScheduleofSupplementalCashFlowInformationRelatedtoLeasesTable">
    <loc xlink:type="locator" xlink:label="ScheduleOfSupplementalCashFlowInformationRelatedToLeasesAbstract" xlink:href="arbe-20231231.xsd#arbe_ScheduleOfSupplementalCashFlowInformationRelatedToLeasesAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeasePayments" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeasePayments"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfSupplementalCashFlowInformationRelatedToLeasesAbstract" xlink:to="us-gaap_OperatingLeasePayments" order="0.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="OperatingLeaseRightofuseAssetsAndLiabilitiesNet" xlink:href="arbe-20231231.xsd#arbe_OperatingLeaseRightofuseAssetsAndLiabilitiesNet"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfSupplementalCashFlowInformationRelatedToLeasesAbstract" xlink:to="OperatingLeaseRightofuseAssetsAndLiabilitiesNet" order="1.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.arberobotics.com/role/ScheduleofMaturitiesofLeaseLiabilitiesTable">
    <loc xlink:type="locator" xlink:label="ScheduleOfMaturitiesOfLeaseLiabilitiesAbstract" xlink:href="arbe-20231231.xsd#arbe_ScheduleOfMaturitiesOfLeaseLiabilitiesAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfMaturitiesOfLeaseLiabilitiesAbstract" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfMaturitiesOfLeaseLiabilitiesAbstract" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfMaturitiesOfLeaseLiabilitiesAbstract" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiability"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:to="us-gaap_OperatingLeaseLiability" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.arberobotics.com/role/ScheduleofSupplementalBalanceSheetInformationRelatedtoOperatingLeasesTable">
    <loc xlink:type="locator" xlink:label="ScheduleOfSupplementalBalanceSheetInformationRelatedToOperatingLeasesAbstract" xlink:href="arbe-20231231.xsd#arbe_ScheduleOfSupplementalBalanceSheetInformationRelatedToOperatingLeasesAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfSupplementalBalanceSheetInformationRelatedToOperatingLeasesAbstract" xlink:to="us-gaap_OperatingLeaseRightOfUseAsset" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfSupplementalBalanceSheetInformationRelatedToOperatingLeasesAbstract" xlink:to="us-gaap_OperatingLeaseLiabilityCurrent" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfSupplementalBalanceSheetInformationRelatedToOperatingLeasesAbstract" xlink:to="us-gaap_OperatingLeaseLiabilityNoncurrent" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfSupplementalBalanceSheetInformationRelatedToOperatingLeasesAbstract" xlink:to="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfSupplementalBalanceSheetInformationRelatedToOperatingLeasesAbstract" xlink:to="us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.arberobotics.com/role/ScheduleofStockOptionActivityTable">
    <loc xlink:type="locator" xlink:label="ScheduleOfStockOptionActivityAbstract" xlink:href="arbe-20231231.xsd#arbe_ScheduleOfStockOptionActivityAbstract"/>
    <loc xlink:type="locator" xlink:label="OptionsAbstract" xlink:href="arbe-20231231.xsd#arbe_OptionsAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfStockOptionActivityAbstract" xlink:to="OptionsAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OptionsAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OptionsAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OptionsAbstract" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OptionsAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OptionsAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OptionsAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OptionsAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" order="6.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OptionsAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OptionsAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised" order="8.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OptionsAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.arberobotics.com/role/ScheduleofRSUsActivityTable">
    <loc xlink:type="locator" xlink:label="ScheduleOfRsusActivityAbstract" xlink:href="arbe-20231231.xsd#arbe_ScheduleOfRsusActivityAbstract"/>
    <loc xlink:type="locator" xlink:label="ShareholdersEquityDetailsScheduleofRSUsActivityTable" xlink:href="arbe-20231231.xsd#arbe_ShareholdersEquityDetailsScheduleofRSUsActivityTable"/>
    <loc xlink:type="locator" xlink:label="ShareholdersEquityDetailsScheduleofRSUsActivityLineItems" xlink:href="arbe-20231231.xsd#arbe_ShareholdersEquityDetailsScheduleofRSUsActivityLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfRsusActivityAbstract" xlink:to="ShareholdersEquityDetailsScheduleofRSUsActivityTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AwardTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AwardTypeAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareholdersEquityDetailsScheduleofRSUsActivityTable" xlink:to="us-gaap_AwardTypeAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RestrictedStockUnitsRSUMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_RestrictedStockUnitsRSUMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareholdersEquityDetailsScheduleofRSUsActivityTable" xlink:to="ShareholdersEquityDetailsScheduleofRSUsActivityLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="RsusAbstract" xlink:href="arbe-20231231.xsd#arbe_RsusAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareholdersEquityDetailsScheduleofRSUsActivityLineItems" xlink:to="RsusAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareholdersEquityDetailsScheduleofRSUsActivityLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareholdersEquityDetailsScheduleofRSUsActivityLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareholdersEquityDetailsScheduleofRSUsActivityLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures" order="3.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsPeriodIncreaseDecrease" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsPeriodIncreaseDecrease"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareholdersEquityDetailsScheduleofRSUsActivityLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsPeriodIncreaseDecrease" order="4.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareholdersEquityDetailsScheduleofRSUsActivityLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_0" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.arberobotics.com/role/ScheduleofCompensationtoEmployeesTable">
    <loc xlink:type="locator" xlink:label="ScheduleOfCompensationToEmployeesAbstract" xlink:href="arbe-20231231.xsd#arbe_ScheduleOfCompensationToEmployeesAbstract"/>
    <loc xlink:type="locator" xlink:label="ShareholdersEquityDetailsScheduleofCompensationtoEmployeesTable" xlink:href="arbe-20231231.xsd#arbe_ShareholdersEquityDetailsScheduleofCompensationtoEmployeesTable"/>
    <loc xlink:type="locator" xlink:label="ShareholdersEquityDetailsScheduleofCompensationtoEmployeesLineItems" xlink:href="arbe-20231231.xsd#arbe_ShareholdersEquityDetailsScheduleofCompensationtoEmployeesLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfCompensationToEmployeesAbstract" xlink:to="ShareholdersEquityDetailsScheduleofCompensationtoEmployeesTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="srt_RangeAxis" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareholdersEquityDetailsScheduleofCompensationtoEmployeesTable" xlink:to="srt_RangeAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="srt_RangeMember" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" order="0.0"/>
    <loc xlink:type="locator" xlink:label="srt_MinimumMember" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MinimumMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis" xlink:to="srt_MinimumMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="srt_MaximumMember" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis" xlink:to="srt_MaximumMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareholdersEquityDetailsScheduleofCompensationtoEmployeesTable" xlink:to="ShareholdersEquityDetailsScheduleofCompensationtoEmployeesLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareholdersEquityDetailsScheduleofCompensationtoEmployeesLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareholdersEquityDetailsScheduleofCompensationtoEmployeesLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareholdersEquityDetailsScheduleofCompensationtoEmployeesLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareholdersEquityDetailsScheduleofCompensationtoEmployeesLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.arberobotics.com/role/ScheduleofShareBasedCompensationExpenseTable">
    <loc xlink:type="locator" xlink:label="ScheduleOfShareBasedCompensationExpenseAbstract" xlink:href="arbe-20231231.xsd#arbe_ScheduleOfShareBasedCompensationExpenseAbstract"/>
    <loc xlink:type="locator" xlink:label="ShareholdersEquityDetailsScheduleofShareBasedCompensationExpenseTable" xlink:href="arbe-20231231.xsd#arbe_ShareholdersEquityDetailsScheduleofShareBasedCompensationExpenseTable"/>
    <loc xlink:type="locator" xlink:label="ShareholdersEquityDetailsScheduleofShareBasedCompensationExpenseLineItems" xlink:href="arbe-20231231.xsd#arbe_ShareholdersEquityDetailsScheduleofShareBasedCompensationExpenseLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfShareBasedCompensationExpenseAbstract" xlink:to="ShareholdersEquityDetailsScheduleofShareBasedCompensationExpenseTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeStatementLocationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareholdersEquityDetailsScheduleofShareBasedCompensationExpenseTable" xlink:to="us-gaap_IncomeStatementLocationAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeStatementLocationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_IncomeStatementLocationDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ResearchAndDevelopmentExpenseMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_ResearchAndDevelopmentExpenseMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SellingAndMarketingExpenseMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SellingAndMarketingExpenseMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_SellingAndMarketingExpenseMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_GeneralAndAdministrativeExpenseMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GeneralAndAdministrativeExpenseMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_GeneralAndAdministrativeExpenseMember" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CostOfSalesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CostOfSalesMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_CostOfSalesMember" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareholdersEquityDetailsScheduleofShareBasedCompensationExpenseTable" xlink:to="ShareholdersEquityDetailsScheduleofShareBasedCompensationExpenseLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensation"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareholdersEquityDetailsScheduleofShareBasedCompensationExpenseLineItems" xlink:to="us-gaap_ShareBasedCompensation" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.arberobotics.com/role/ScheduleofSetsForththeComputationofBasicandDilutedNetLossPerShareAttributableTable">
    <loc xlink:type="locator" xlink:label="ScheduleOfSetsForthTheComputationOfBasicAndDilutedNetLossPerShareAttributableAbstract" xlink:href="arbe-20231231.xsd#arbe_ScheduleOfSetsForthTheComputationOfBasicAndDilutedNetLossPerShareAttributableAbstract"/>
    <loc xlink:type="locator" xlink:label="NumeratorAbstract" xlink:href="arbe-20231231.xsd#arbe_NumeratorAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfSetsForthTheComputationOfBasicAndDilutedNetLossPerShareAttributableAbstract" xlink:to="NumeratorAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetIncomeLossAttributableToNonredeemableNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLossAttributableToNonredeemableNoncontrollingInterest"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NumeratorAbstract" xlink:to="us-gaap_NetIncomeLossAttributableToNonredeemableNoncontrollingInterest" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="DenominatorAbstract" xlink:href="arbe-20231231.xsd#arbe_DenominatorAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfSetsForthTheComputationOfBasicAndDilutedNetLossPerShareAttributableAbstract" xlink:to="DenominatorAbstract" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DenominatorAbstract" xlink:to="us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EarningsPerShareBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareBasic"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DenominatorAbstract" xlink:to="us-gaap_EarningsPerShareBasic" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="NumeratorAbstract0" xlink:href="arbe-20231231.xsd#arbe_NumeratorAbstract0"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfSetsForthTheComputationOfBasicAndDilutedNetLossPerShareAttributableAbstract" xlink:to="NumeratorAbstract0" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_TemporaryEquityAccretionToRedemptionValueAdjustment" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TemporaryEquityAccretionToRedemptionValueAdjustment"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NumeratorAbstract0" xlink:to="us-gaap_TemporaryEquityAccretionToRedemptionValueAdjustment" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="DenominatorAbstract0" xlink:href="arbe-20231231.xsd#arbe_DenominatorAbstract0"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfSetsForthTheComputationOfBasicAndDilutedNetLossPerShareAttributableAbstract" xlink:to="DenominatorAbstract0" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DenominatorAbstract0" xlink:to="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EarningsPerShareDiluted" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareDiluted"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DenominatorAbstract0" xlink:to="us-gaap_EarningsPerShareDiluted" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceOfWarrants" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromIssuanceOfWarrants"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfSetsForthTheComputationOfBasicAndDilutedNetLossPerShareAttributableAbstract" xlink:to="us-gaap_ProceedsFromIssuanceOfWarrants" order="4.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.arberobotics.com/role/ScheduleofOrdinarySharesthatwereExcludedfromtheComputationofDilutedNetLossPerShareTable">
    <loc xlink:type="locator" xlink:label="ScheduleOfOrdinarySharesThatWereExcludedFromTheComputationOfDilutedNetLossPerShareAbstract" xlink:href="arbe-20231231.xsd#arbe_ScheduleOfOrdinarySharesThatWereExcludedFromTheComputationOfDilutedNetLossPerShareAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfOrdinarySharesThatWereExcludedFromTheComputationOfDilutedNetLossPerShareAbstract" xlink:to="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="us-gaap_AntidilutiveSecuritiesNameDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConvertiblePreferredStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConvertiblePreferredStockMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="us-gaap_ConvertiblePreferredStockMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="OutstandingShareOptionsMember" xlink:href="arbe-20231231.xsd#arbe_OutstandingShareOptionsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="OutstandingShareOptionsMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.arberobotics.com/role/ScheduleofCompanysLossBeforeIncomeTaxesTable">
    <loc xlink:type="locator" xlink:label="ScheduleOfCompanysLossBeforeIncomeTaxesAbstract" xlink:href="arbe-20231231.xsd#arbe_ScheduleOfCompanysLossBeforeIncomeTaxesAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfCompanysLossBeforeIncomeTaxesAbstract" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" order="0.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfCompanysLossBeforeIncomeTaxesAbstract" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfCompanysLossBeforeIncomeTaxesAbstract" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" order="2.0" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.arberobotics.com/role/ScheduleofReconciliationIncomeTaxBenefitTable">
    <loc xlink:type="locator" xlink:label="ScheduleOfReconciliationIncomeTaxBenefitAbstract" xlink:href="arbe-20231231.xsd#arbe_ScheduleOfReconciliationIncomeTaxBenefitAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfReconciliationIncomeTaxBenefitAbstract" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfReconciliationIncomeTaxBenefitAbstract" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfReconciliationIncomeTaxBenefitAbstract" xlink:to="us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxReconciliationNondeductibleExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxReconciliationNondeductibleExpense"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfReconciliationIncomeTaxBenefitAbstract" xlink:to="us-gaap_IncomeTaxReconciliationNondeductibleExpense" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfReconciliationIncomeTaxBenefitAbstract" xlink:to="us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfReconciliationIncomeTaxBenefitAbstract" xlink:to="us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxReconciliationOtherAdjustments" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxReconciliationOtherAdjustments"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfReconciliationIncomeTaxBenefitAbstract" xlink:to="us-gaap_IncomeTaxReconciliationOtherAdjustments" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfReconciliationIncomeTaxBenefitAbstract" xlink:to="us-gaap_IncomeTaxExpenseBenefit" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.arberobotics.com/role/ScheduleofDeferredTaxAssetsTable">
    <loc xlink:type="locator" xlink:label="ScheduleOfDeferredTaxAssetsAbstract" xlink:href="arbe-20231231.xsd#arbe_ScheduleOfDeferredTaxAssetsAbstract"/>
    <loc xlink:type="locator" xlink:label="DeferredTaxAssetsAbstract" xlink:href="arbe-20231231.xsd#arbe_DeferredTaxAssetsAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfDeferredTaxAssetsAbstract" xlink:to="DeferredTaxAssetsAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DeferredTaxAssetsAbstract" xlink:to="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DeferredTaxAssetsAbstract" xlink:to="us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DeferredTaxAssetsAbstract" xlink:to="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DeferredTaxAssetsAbstract" xlink:to="us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsGross" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DeferredTaxAssetsAbstract" xlink:to="us-gaap_DeferredTaxAssetsGross" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfDeferredTaxAssetsAbstract" xlink:to="us-gaap_DeferredTaxAssetsValuationAllowance" order="1.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfDeferredTaxAssetsAbstract" xlink:to="us-gaap_DeferredTaxAssetsLiabilitiesNet" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.arberobotics.com/role/ScheduleofPropertyandEquipmentNetofDepreciationbyGeographicRegionTable">
    <loc xlink:type="locator" xlink:label="ScheduleOfPropertyAndEquipmentNetOfDepreciationByGeographicRegionAbstract" xlink:href="arbe-20231231.xsd#arbe_ScheduleOfPropertyAndEquipmentNetOfDepreciationByGeographicRegionAbstract"/>
    <loc xlink:type="locator" xlink:label="SegmentInformationDetailsScheduleofPropertyandEquipmentNetofDepreciationbyGeographicRegionTable" xlink:href="arbe-20231231.xsd#arbe_SegmentInformationDetailsScheduleofPropertyandEquipmentNetofDepreciationbyGeographicRegionTable"/>
    <loc xlink:type="locator" xlink:label="SegmentInformationDetailsScheduleofPropertyandEquipmentNetofDepreciationbyGeographicRegionLineItems" xlink:href="arbe-20231231.xsd#arbe_SegmentInformationDetailsScheduleofPropertyandEquipmentNetofDepreciationbyGeographicRegionLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfPropertyAndEquipmentNetOfDepreciationByGeographicRegionAbstract" xlink:to="SegmentInformationDetailsScheduleofPropertyandEquipmentNetofDepreciationbyGeographicRegionTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="srt_StatementGeographicalAxis" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_StatementGeographicalAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SegmentInformationDetailsScheduleofPropertyandEquipmentNetofDepreciationbyGeographicRegionTable" xlink:to="srt_StatementGeographicalAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="srt_SegmentGeographicalDomain" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_SegmentGeographicalDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_StatementGeographicalAxis" xlink:to="srt_SegmentGeographicalDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="country_IL" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_IL"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_StatementGeographicalAxis" xlink:to="country_IL" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="country_US" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_US"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_StatementGeographicalAxis" xlink:to="country_US" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SegmentInformationDetailsScheduleofPropertyandEquipmentNetofDepreciationbyGeographicRegionTable" xlink:to="SegmentInformationDetailsScheduleofPropertyandEquipmentNetofDepreciationbyGeographicRegionLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentNet" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SegmentInformationDetailsScheduleofPropertyandEquipmentNetofDepreciationbyGeographicRegionLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentNet" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.arberobotics.com/role/GeneralDetails">
    <loc xlink:type="locator" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <loc xlink:type="locator" xlink:label="GeneralDetailsTable" xlink:href="arbe-20231231.xsd#arbe_GeneralDetailsTable"/>
    <loc xlink:type="locator" xlink:label="GeneralDetailsLineItems" xlink:href="arbe-20231231.xsd#arbe_GeneralDetailsLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="GeneralDetailsTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesAxis" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidatedEntitiesAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="GeneralDetailsTable" xlink:to="srt_ConsolidatedEntitiesAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesDomain" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidatedEntitiesDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="srt_ConsolidatedEntitiesDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="ArbeRoboticsLtdMember" xlink:href="arbe-20231231.xsd#arbe_ArbeRoboticsLtdMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="ArbeRoboticsLtdMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementClassOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementClassOfStockAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="GeneralDetailsTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_CommonStockMember" order="1.0" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <loc xlink:type="locator" xlink:label="srt_RangeAxis" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="GeneralDetailsTable" xlink:to="srt_RangeAxis" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="srt_RangeMember" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" order="0.0"/>
    <loc xlink:type="locator" xlink:label="srt_MinimumMember" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MinimumMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis" xlink:to="srt_MinimumMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="srt_MaximumMember" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis" xlink:to="srt_MaximumMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsidiarySaleOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="GeneralDetailsTable" xlink:to="us-gaap_SubsidiarySaleOfStockAxis" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="PublicWarrantsMember" xlink:href="arbe-20231231.xsd#arbe_PublicWarrantsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="PublicWarrantsMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="PrivateWarrantsMember" xlink:href="arbe-20231231.xsd#arbe_PrivateWarrantsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="PrivateWarrantsMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="PIPEMember" xlink:href="arbe-20231231.xsd#arbe_PIPEMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="PIPEMember" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="GeneralDetailsTable" xlink:to="GeneralDetailsLineItems" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockOtherSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockOtherSharesOutstanding"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="GeneralDetailsLineItems" xlink:to="us-gaap_CommonStockOtherSharesOutstanding" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharesIssuedPricePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharesIssuedPricePerShare"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="GeneralDetailsLineItems" xlink:to="us-gaap_SharesIssuedPricePerShare" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PaymentsOfOrdinaryDividends" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsOfOrdinaryDividends"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="GeneralDetailsLineItems" xlink:to="us-gaap_PaymentsOfOrdinaryDividends" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightOutstanding"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="GeneralDetailsLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightOutstanding" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceInitialPublicOffering" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromIssuanceInitialPublicOffering"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="GeneralDetailsLineItems" xlink:to="us-gaap_ProceedsFromIssuanceInitialPublicOffering" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SaleOfStockConsiderationReceivedOnTransaction"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="GeneralDetailsLineItems" xlink:to="us-gaap_SaleOfStockConsiderationReceivedOnTransaction" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="GeneralDetailsLineItems" xlink:to="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.arberobotics.com/role/SignificantAccountingPoliciesDetails">
    <loc xlink:type="locator" xlink:label="us-gaap_AccountingPoliciesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <loc xlink:type="locator" xlink:label="SignificantAccountingPoliciesDetailsTable" xlink:href="arbe-20231231.xsd#arbe_SignificantAccountingPoliciesDetailsTable"/>
    <loc xlink:type="locator" xlink:label="SignificantAccountingPoliciesDetailsLineItems" xlink:href="arbe-20231231.xsd#arbe_SignificantAccountingPoliciesDetailsLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="SignificantAccountingPoliciesDetailsTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="srt_RangeAxis" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SignificantAccountingPoliciesDetailsTable" xlink:to="srt_RangeAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="srt_RangeMember" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" order="0.0"/>
    <loc xlink:type="locator" xlink:label="srt_MinimumMember" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MinimumMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis" xlink:to="srt_MinimumMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="srt_MaximumMember" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis" xlink:to="srt_MaximumMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SignificantAccountingPoliciesDetailsTable" xlink:to="SignificantAccountingPoliciesDetailsLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="srt_DemandDepositLiabilitiesInterestBearingAverageRatePaid" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_DemandDepositLiabilitiesInterestBearingAverageRatePaid"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SignificantAccountingPoliciesDetailsLineItems" xlink:to="srt_DemandDepositLiabilitiesInterestBearingAverageRatePaid" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="SeverancePercentageOfMonthlySalary" xlink:href="arbe-20231231.xsd#arbe_SeverancePercentageOfMonthlySalary"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SignificantAccountingPoliciesDetailsLineItems" xlink:to="SeverancePercentageOfMonthlySalary" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SeveranceCosts1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SeveranceCosts1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SignificantAccountingPoliciesDetailsLineItems" xlink:to="us-gaap_SeveranceCosts1" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SignificantAccountingPoliciesDetailsLineItems" xlink:to="us-gaap_EffectiveIncomeTaxRateContinuingOperations" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.arberobotics.com/role/RevenueDetails">
    <loc xlink:type="locator" xlink:label="us-gaap_RevenuesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenuesAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredRevenue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredRevenue"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RevenuesAbstract" xlink:to="us-gaap_DeferredRevenue" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RevenueRemainingPerformanceObligation" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueRemainingPerformanceObligation"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RevenuesAbstract" xlink:to="us-gaap_RevenueRemainingPerformanceObligation" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.arberobotics.com/role/PropertyandEquipmentDetails">
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Depreciation" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Depreciation"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentAbstract" xlink:to="us-gaap_Depreciation" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.arberobotics.com/role/CommitmentsandContingentLiabilitiesDetails">
    <loc xlink:type="locator" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_GrantsReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GrantsReceivable"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_GrantsReceivable" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="RoyaltyPercentage" xlink:href="arbe-20231231.xsd#arbe_RoyaltyPercentage"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="RoyaltyPercentage" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="GrantsReceived" xlink:href="arbe-20231231.xsd#arbe_GrantsReceived"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="GrantsReceived" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.arberobotics.com/role/WarrantsLiabilitiesDetails">
    <loc xlink:type="locator" xlink:label="us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <loc xlink:type="locator" xlink:label="WarrantsLiabilitiesDetailsTable" xlink:href="arbe-20231231.xsd#arbe_WarrantsLiabilitiesDetailsTable"/>
    <loc xlink:type="locator" xlink:label="WarrantsLiabilitiesDetailsLineItems" xlink:href="arbe-20231231.xsd#arbe_WarrantsLiabilitiesDetailsLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:to="WarrantsLiabilitiesDetailsTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsidiarySaleOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="WarrantsLiabilitiesDetailsTable" xlink:to="us-gaap_SubsidiarySaleOfStockAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PrivatePlacementMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PrivatePlacementMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_PrivatePlacementMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="WarrantsLiabilitiesDetailsTable" xlink:to="WarrantsLiabilitiesDetailsLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AdditionalCollateralAggregateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdditionalCollateralAggregateFairValue"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="WarrantsLiabilitiesDetailsLineItems" xlink:to="us-gaap_AdditionalCollateralAggregateFairValue" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="DerivativeWarrantLiabilityShares" xlink:href="arbe-20231231.xsd#arbe_DerivativeWarrantLiabilityShares"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="WarrantsLiabilitiesDetailsLineItems" xlink:to="DerivativeWarrantLiabilityShares" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="WarrantsLiabilitiesDetailsLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueAdjustmentOfWarrants" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAdjustmentOfWarrants"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="WarrantsLiabilitiesDetailsLineItems" xlink:to="us-gaap_FairValueAdjustmentOfWarrants" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceOfWarrants" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromIssuanceOfWarrants"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="WarrantsLiabilitiesDetailsLineItems" xlink:to="us-gaap_ProceedsFromIssuanceOfWarrants" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.arberobotics.com/role/ShareholdersEquityDetails">
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquityNoteAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityNoteAbstract"/>
    <loc xlink:type="locator" xlink:label="ShareholdersEquityDetailsTable" xlink:href="arbe-20231231.xsd#arbe_ShareholdersEquityDetailsTable"/>
    <loc xlink:type="locator" xlink:label="ShareholdersEquityDetailsLineItems" xlink:href="arbe-20231231.xsd#arbe_ShareholdersEquityDetailsLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityNoteAbstract" xlink:to="ShareholdersEquityDetailsTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="srt_TitleOfIndividualAxis" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_TitleOfIndividualAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareholdersEquityDetailsTable" xlink:to="srt_TitleOfIndividualAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_TitleOfIndividualAxis" xlink:to="srt_TitleOfIndividualWithRelationshipToEntityDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="PlanOneMember" xlink:href="arbe-20231231.xsd#arbe_PlanOneMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_TitleOfIndividualAxis" xlink:to="PlanOneMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PlanNameAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PlanNameAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareholdersEquityDetailsTable" xlink:to="us-gaap_PlanNameAxis" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PlanNameDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PlanNameAxis" xlink:to="us-gaap_PlanNameDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="TwoThousandSixteenIncentivePlanMember" xlink:href="arbe-20231231.xsd#arbe_TwoThousandSixteenIncentivePlanMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PlanNameAxis" xlink:to="TwoThousandSixteenIncentivePlanMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="TwoThousandTwentyOneEquityIncentivePlanMember" xlink:href="arbe-20231231.xsd#arbe_TwoThousandTwentyOneEquityIncentivePlanMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PlanNameAxis" xlink:to="TwoThousandTwentyOneEquityIncentivePlanMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementEquityComponentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareholdersEquityDetailsTable" xlink:to="us-gaap_StatementEquityComponentsAxis" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EquityComponentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_CommonStockMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareholdersEquityDetailsTable" xlink:to="ShareholdersEquityDetailsLineItems" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareholdersEquityDetailsLineItems" xlink:to="us-gaap_CommonStockSharesAuthorized" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareholdersEquityDetailsLineItems" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquityReverseStockSplit" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityReverseStockSplit"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareholdersEquityDetailsLineItems" xlink:to="us-gaap_StockholdersEquityReverseStockSplit" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonUnitIssuanceValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonUnitIssuanceValue"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareholdersEquityDetailsLineItems" xlink:to="us-gaap_CommonUnitIssuanceValue" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonUnitIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonUnitIssued"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareholdersEquityDetailsLineItems" xlink:to="us-gaap_CommonUnitIssued" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharePrice"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareholdersEquityDetailsLineItems" xlink:to="us-gaap_SharePrice" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareholdersEquityDetailsLineItems" xlink:to="us-gaap_ProceedsFromIssuanceOfCommonStock" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareholdersEquityDetailsLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareholdersEquityDetailsLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareholdersEquityDetailsLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardTermsOfAward" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardTermsOfAward"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareholdersEquityDetailsLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardTermsOfAward" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRights" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRights"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareholdersEquityDetailsLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRights" order="11.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodExpectedDividendRate" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodExpectedDividendRate"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareholdersEquityDetailsLineItems" xlink:to="us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodExpectedDividendRate" order="12.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareholdersEquityDetailsLineItems" xlink:to="us-gaap_AllocatedShareBasedCompensationExpense" order="13.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.arberobotics.com/role/TaxesonIncomeDetails">
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <loc xlink:type="locator" xlink:label="TaxesonIncomeDetailsTable" xlink:href="arbe-20231231.xsd#arbe_TaxesonIncomeDetailsTable"/>
    <loc xlink:type="locator" xlink:label="TaxesonIncomeDetailsLineItems" xlink:href="arbe-20231231.xsd#arbe_TaxesonIncomeDetailsLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="TaxesonIncomeDetailsTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="srt_StatementGeographicalAxis" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_StatementGeographicalAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="TaxesonIncomeDetailsTable" xlink:to="srt_StatementGeographicalAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="srt_SegmentGeographicalDomain" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_SegmentGeographicalDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_StatementGeographicalAxis" xlink:to="srt_SegmentGeographicalDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="country_IL" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_IL"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_StatementGeographicalAxis" xlink:to="country_IL" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="country_US" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_US"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_StatementGeographicalAxis" xlink:to="country_US" order="2.0" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="TaxesonIncomeDetailsTable" xlink:to="TaxesonIncomeDetailsLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="TaxesonIncomeDetailsLineItems" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLossCarryforwards" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLossCarryforwards"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="TaxesonIncomeDetailsLineItems" xlink:to="us-gaap_OperatingLossCarryforwards" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.arberobotics.com/role/SegmentInformationDetails">
    <loc xlink:type="locator" xlink:label="us-gaap_SegmentReportingInformationRevenueAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentReportingInformationRevenueAbstract"/>
    <loc xlink:type="locator" xlink:label="SegmentInformationDetailsTable" xlink:href="arbe-20231231.xsd#arbe_SegmentInformationDetailsTable"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SegmentReportingInformationLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SegmentReportingInformationRevenueAbstract" xlink:to="SegmentInformationDetailsTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SegmentInformationDetailsTable" xlink:to="us-gaap_ConcentrationRiskByBenchmarkAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SalesRevenueNetMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SalesRevenueNetMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:to="us-gaap_SalesRevenueNetMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConcentrationRiskByTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SegmentInformationDetailsTable" xlink:to="us-gaap_ConcentrationRiskByTypeAxis" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CustomerConcentrationRiskMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CustomerConcentrationRiskMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ConcentrationRiskByTypeAxis" xlink:to="us-gaap_CustomerConcentrationRiskMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="srt_MajorCustomersAxis" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MajorCustomersAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SegmentInformationDetailsTable" xlink:to="srt_MajorCustomersAxis" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="Customer1Member" xlink:href="arbe-20231231.xsd#arbe_Customer1Member"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_MajorCustomersAxis" xlink:to="Customer1Member" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="Customer2Member" xlink:href="arbe-20231231.xsd#arbe_Customer2Member"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_MajorCustomersAxis" xlink:to="Customer2Member" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="Customer3Member" xlink:href="arbe-20231231.xsd#arbe_Customer3Member"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_MajorCustomersAxis" xlink:to="Customer3Member" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SegmentInformationDetailsTable" xlink:to="us-gaap_SegmentReportingInformationLineItems" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConcentrationRiskPercentage1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SegmentReportingInformationLineItems" xlink:to="us-gaap_ConcentrationRiskPercentage1" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/dei/role/document/Cover">
    <loc xlink:type="locator" xlink:label="us-gaap_StatementClassOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementClassOfStockAxis"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentInformationTable" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentInformationTable"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="10.0"/>
    <loc xlink:type="locator" xlink:label="dei_EntitiesTable" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntitiesTable"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_EntitiesTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="11.0"/>
    <loc xlink:type="locator" xlink:label="dei_EntityAddressesTable" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressesTable"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_EntityAddressesTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="12.0"/>
    <loc xlink:type="locator" xlink:label="dei_EntityListingsTable" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityListingsTable"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_EntityListingsTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="13.0"/>
    <loc xlink:type="locator" xlink:label="dei_NameChangeEventTable" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_NameChangeEventTable"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_NameChangeEventTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="14.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="OrdinarySharesParValueNIS0000216PerShareMember" xlink:href="arbe-20231231.xsd#arbe_OrdinarySharesParValueNIS0000216PerShareMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="OrdinarySharesParValueNIS0000216PerShareMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="WarrantsMember" xlink:href="arbe-20231231.xsd#arbe_WarrantsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="WarrantsMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_AddressTypeDomain" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AddressTypeDomain"/>
  </presentationLink>
</linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1</span><table class="report" border="0" cellspacing="2" id="idm140068083402704">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cover - shares<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Mar. 01, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">20-F<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentRegistrationStatement', window );">Document Registration Statement</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentAnnualReport', window );">Document Annual Report</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFinStmtErrorCorrectionFlag', window );">Document Financial Statement Error Correction [Flag]</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentShellCompanyReport', window );">Document Shell Company Report</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentAccountingStandard', window );">Document Accounting Standard</a></td>
<td class="text">U.S. GAAP<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_IcfrAuditorAttestationFlag', window );">ICFR Auditor Attestation Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Dec. 31,  2023<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2023<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">FY<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInformationLineItems', window );"><strong>Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">Arbe Robotics Ltd.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001861841<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-40884<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">L3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityWellKnownSeasonedIssuer', window );">Entity Well-known Seasoned Issuer</a></td>
<td class="text">No<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityVoluntaryFilers', window );">Entity Voluntary Filers</a></td>
<td class="text">No<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Non-accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityExTransitionPeriod', window );">Entity Ex Transition Period</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityContactPersonnelLineItems', window );"><strong>Entity Contact Personnel [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">107 HaHashmonaim St<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Tel Aviv-Yafo<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCountry', window );">Entity Address, Country</a></td>
<td class="text">IL<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">6329302<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityListingsLineItems', window );"><strong>Entity Listings [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">78,221,557<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=arbe_OrdinarySharesParValueNIS0000216PerShareMember', window );">Ordinary shares, par value NIS 0.000216 per share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityListingsLineItems', window );"><strong>Entity Listings [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Ordinary shares, par value NIS 0.000216 per share<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">ARBE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=arbe_WarrantsMember', window );">Warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityListingsLineItems', window );"><strong>Entity Listings [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Warrants<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">ARBEW<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressesAddressTypeAxis=dei_BusinessContactMember', window );">Business Contact [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityContactPersonnelLineItems', window );"><strong>Entity Contact Personnel [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_ContactPersonnelName', window );">Contact Personnel Name</a></td>
<td class="text">Kobi Marenko<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_ContactPersonnelEmailAddress', window );">Contact Personnel Email Address</a></td>
<td class="text">kobi.m@arberobotics.com<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">107 HaHashmonaim St<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Tel Aviv-Yafo<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCountry', window );">Entity Address, Country</a></td>
<td class="text">IL<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">6329302<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityPhoneFaxNumbersLineItems', window );"><strong>Entity Phone Fax Numbers [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">972<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">73-7969804<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_ContactPersonnelEmailAddress">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Email address of contact personnel.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_ContactPersonnelEmailAddress</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_ContactPersonnelName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of contact personnel</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_ContactPersonnelName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentAccountingStandard">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentAccountingStandard</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:accountingStandardItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentAnnualReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an annual report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentAnnualReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFinStmtErrorCorrectionFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates whether any of the financial statement period in the filing include a restatement due to error correction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection w<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFinStmtErrorCorrectionFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentRegistrationStatement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a registration statement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentRegistrationStatement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentShellCompanyReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentShellCompanyReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCountry">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>ISO 3166-1 alpha-2 country code.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCountry</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:countryCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityContactPersonnelLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityContactPersonnelLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityExTransitionPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 7A<br> -Section B<br> -Subsection 2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityExTransitionPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityListingsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityListingsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityPhoneFaxNumbersLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityPhoneFaxNumbersLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityVoluntaryFilers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityVoluntaryFilers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityWellKnownSeasonedIssuer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityWellKnownSeasonedIssuer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_IcfrAuditorAttestationFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_IcfrAuditorAttestationFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=arbe_OrdinarySharesParValueNIS0000216PerShareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=arbe_OrdinarySharesParValueNIS0000216PerShareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=arbe_WarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=arbe_WarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressesAddressTypeAxis=dei_BusinessContactMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressesAddressTypeAxis=dei_BusinessContactMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1</span><table class="report" border="0" cellspacing="2" id="idm140068078287712">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Audit Information<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AuditorTable', window );"><strong>Auditor [Table]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AuditorName', window );">Auditor Name</a></td>
<td class="text">Somekh
Chaikin<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AuditorFirmId', window );">Auditor Firm ID</a></td>
<td class="text">1057<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AuditorLocation', window );">Auditor Location</a></td>
<td class="text">Tel
Aviv, Israel<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorFirmId">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>PCAOB issued Audit Firm Identifier</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorFirmId</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:nonemptySequenceNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorLocation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorLocation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:internationalNameItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:internationalNameItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorTable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorTable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1</span><table class="report" border="0" cellspacing="2" id="idm140068079786672">
<tr>
<th class="tl" colspan="2" rowspan="1"><div style="width: 200px;"><strong>Consolidated Balance Sheets - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>CURRENT ASSETS:</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 28,587<span></span>
</td>
<td class="nump">$ 54,171<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestrictedCashCurrent', window );">Restricted cash</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">163<span></span>
</td>
<td class="nump">144<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermInvestments', window );">Short term bank deposits</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">15,402<span></span>
</td>
<td class="nump">400<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Trade receivable</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1,258<span></span>
</td>
<td class="nump">2,202<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Prepaid expenses and other receivables</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">2,026<span></span>
</td>
<td class="nump">1,839<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">47,436<span></span>
</td>
<td class="nump">58,756<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsNoncurrentAbstract', window );"><strong>NON-CURRENT ASSETS:</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease right-of-use assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1,740<span></span>
</td>
<td class="nump">465<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment, net</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1,309<span></span>
</td>
<td class="nump">1,609<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsNoncurrent', window );">Total non-current assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">3,049<span></span>
</td>
<td class="nump">2,074<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">50,485<span></span>
</td>
<td class="nump">60,830<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>CURRENT LIABILITIES:</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableTradeCurrent', window );">Trade payables</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1,149<span></span>
</td>
<td class="nump">1,244<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Operating lease liabilities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">436<span></span>
</td>
<td class="nump">364<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeRelatedLiabilitiesCurrent', window );">Employees and payroll accruals</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">2,916<span></span>
</td>
<td class="nump">2,861<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredRevenueCurrent', window );">Deferred revenue</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="nump">351<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent', window );">Accrued expenses and other payables</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1,710<span></span>
</td>
<td class="nump">5,609<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">6,211<span></span>
</td>
<td class="nump">10,429<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesNoncurrentAbstract', window );"><strong>LONG-TERM LIABILITIES:</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Operating lease liabilities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1,306<span></span>
</td>
<td class="nump">17<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstanding', window );">Warrant liabilities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">875<span></span>
</td>
<td class="nump">1,631<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesNoncurrent', window );">Total long-term liabilities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">2,181<span></span>
</td>
<td class="nump">1,648<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>SHAREHOLDERS&#8217; EQUITY:</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Ordinary Shares, NIS 0.000216 par value; 130,000,000 authorized shares as of December 31, 2023 and 2022; 77,925,095 and 64,160,890 outstanding shares at December 31, 2023 and 2022, respectively</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapitalCommonStock', window );">Additional paid-in capital</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">245,733<span></span>
</td>
<td class="nump">208,893<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(203,640)<span></span>
</td>
<td class="num">(160,140)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total shareholders&#8217; equity</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">42,093<span></span>
</td>
<td class="nump">48,753<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities and shareholders&#8217; equity</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 50,485<span></span>
</td>
<td class="nump">$ 60,830<span></span>
</td>
</tr>
<tr><td colspan="3"></td></tr>
<tr><td colspan="3"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top"><span style="font-family: Times New Roman, Times, Serif">Represents less than $1.</span></td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities incurred to vendors for goods and services received, and accrued liabilities classified as other, payable within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableTradeCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483467/210-10-45-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableTradeCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481990/310-10-45-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481990/310-10-45-9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapitalCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapitalCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-12<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 23: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 26: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483467/210-10-45-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold or consumed after one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsNoncurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsNoncurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483467/210-10-45-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredRevenueCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredRevenueCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeRelatedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeRelatedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483467/210-10-45-5<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br><br>Reference 21: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation due after one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-25<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br><br>Reference 19: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br><br>Reference 20: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 21: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 201.5-02(24))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 22: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 201.5-02(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 23: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 201.5-02(26))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesNoncurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesNoncurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 360<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480842/942-360-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCashCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash restricted as to withdrawal or usage, classified as current. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCashCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated undistributed earnings (deficit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480990/946-20-50-11<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investments including trading securities, available-for-sale securities, held-to-maturity securities, and short-term investments classified as other and current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-12<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-2<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 14: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480418/310-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WarrantsAndRightsOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of outstanding derivative securities that permit the holder the right to purchase securities (usually equity) from the issuer at a specified price.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WarrantsAndRightsOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1</span><table class="report" border="0" cellspacing="2" id="idm140068079773488">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Balance Sheets (Parentheticals) - &#8362; / shares<br></strong></div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementOfFinancialPositionAbstract', window );"><strong>Statement of Financial Position [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Ordinary shares, par value (in New Shekels per share)</a></td>
<td class="nump">&#8362; 0.000216<span></span>
</td>
<td class="nump">&#8362; 0.000216<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Ordinary Shares, shares authorized</a></td>
<td class="nump">130,000,000<span></span>
</td>
<td class="nump">130,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Ordinary Shares, shares outstanding</a></td>
<td class="nump">77,925,095<span></span>
</td>
<td class="nump">64,160,890<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfFinancialPositionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfFinancialPositionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1</span><table class="report" border="0" cellspacing="2" id="idm140068172764064">
<tr>
<th class="tl" colspan="2" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Operations - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementAbstract', window );"><strong>Income Statement [Abstract]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 1,470<span></span>
</td>
<td class="nump">$ 3,517<span></span>
</td>
<td class="nump">$ 2,249<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostOfRevenue', window );">Costs of revenues</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1,508<span></span>
</td>
<td class="nump">1,283<span></span>
</td>
<td class="nump">1,440<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GrossProfit', window );">Gross profit (loss)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(38)<span></span>
</td>
<td class="nump">2,234<span></span>
</td>
<td class="nump">809<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingExpensesAbstract', window );"><strong>Operating expenses:</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development, net</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">34,082<span></span>
</td>
<td class="nump">36,731<span></span>
</td>
<td class="nump">28,564<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SellingAndMarketingExpense', window );">Sales and marketing</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">5,194<span></span>
</td>
<td class="nump">4,621<span></span>
</td>
<td class="nump">1,814<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GeneralAndAdministrativeExpense', window );">General and administrative</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">7,571<span></span>
</td>
<td class="nump">8,613<span></span>
</td>
<td class="nump">3,709<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingExpenses', window );">Total operating expenses</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">46,847<span></span>
</td>
<td class="nump">49,965<span></span>
</td>
<td class="nump">34,087<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating loss</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(46,885)<span></span>
</td>
<td class="num">(47,731)<span></span>
</td>
<td class="num">(33,278)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpense', window );">Financial expense (income), net</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(3,385)<span></span>
</td>
<td class="num">(7,237)<span></span>
</td>
<td class="nump">24,814<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">$ (43,500)<span></span>
</td>
<td class="num">$ (40,494)<span></span>
</td>
<td class="num">$ (58,092)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic loss per share attributable to Ordinary Shareholders (in Dollars per share)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">$ (0.6)<span></span>
</td>
<td class="num">$ (0.64)<span></span>
</td>
<td class="num">$ (2.64)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted-average number of shares used in computing basic loss per share attributable to Ordinary Shareholders (in Shares)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">72,021,520<span></span>
</td>
<td class="nump">68,489,983<span></span>
</td>
<td class="nump">22,027,292<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted loss per share attributable to Ordinary Shareholders (in Dollars per share)</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="num">$ (0.71)<span></span>
</td>
<td class="num">$ (0.8)<span></span>
</td>
<td class="num">$ (2.64)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Weighted-average number of shares used in computing diluted loss per share attributable to Ordinary Shareholders (in Shares)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">62,390,302<span></span>
</td>
<td class="nump">60,960,641<span></span>
</td>
<td class="nump">22,027,292<span></span>
</td>
</tr>
<tr><td colspan="4"></td></tr>
<tr><td colspan="4"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top"><span style="font-family: Times New Roman, Times, Serif; font-weight: normal">Loss per share attributable to ordinary shareholders, diluted, was adjusted and take into consideration warrants liabilities revaluations as part of our net loss for 2023 and 2022.</span></td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate cost of goods produced and sold and services rendered during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 14: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482635/260-10-55-15<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-7<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-10<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482635/260-10-55-52<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482635/260-10-55-15<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-7<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482635/260-10-55-52<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GrossProfit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 17: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 19: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1,2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GrossProfit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-6<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-8<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-9<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4<br><br>Reference 13: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-10<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483581/946-220-45-7<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-7<br><br>Reference 35: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1A<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1B<br><br>Reference 38: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 39: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 730<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482916/730-10-50-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 912<br> -SubTopic 730<br> -Name Accounting Standards Codification<br> -Section 25<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482517/912-730-25-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481283/985-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-42<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-40<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-41<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479557/942-235-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingAndMarketingExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate total amount of expenses directly related to the marketing or selling of products or services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingAndMarketingExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 16<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-16<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1</span><table class="report" border="0" cellspacing="2" id="idm140068084965520">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Statements of Changes in Redeemable Convertible Preferred Shares and Shareholders&#8217; Equity (Deficiency) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th">
<div>Seed </div>
<div>Redeemable convertible preferred Shares</div>
</th>
<th class="th">
<div>Series A </div>
<div>Redeemable convertible preferred Shares</div>
</th>
<th class="th">
<div>Series A-1 </div>
<div>Redeemable convertible preferred Shares</div>
</th>
<th class="th">
<div>Series B </div>
<div>Redeemable convertible preferred Shares</div>
</th>
<th class="th">
<div>Series B-1 </div>
<div>Redeemable convertible preferred Shares</div>
</th>
<th class="th">
<div>Series B-2 </div>
<div>Redeemable convertible preferred Shares</div>
</th>
<th class="th"><div>Redeemable convertible preferred Shares</div></th>
<th class="th" colspan="2"><div>Ordinary shares</div></th>
<th class="th"><div>Additional paid-in capital</div></th>
<th class="th"><div>Accumulated deficit</div></th>
<th class="th"><div>Total</div></th>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Dec. 31, 2020</a></td>
<td class="nump">$ 650<span></span>
</td>
<td class="nump">$ 9,394<span></span>
</td>
<td class="nump">$ 2,500<span></span>
</td>
<td class="nump">$ 32,159<span></span>
</td>
<td class="nump">$ 10,447<span></span>
</td>
<td class="nump">$ 290<span></span>
</td>
<td class="nump">$ 55,440<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">$ 1,397<span></span>
</td>
<td class="num">$ (61,554)<span></span>
</td>
<td class="num">$ (60,157)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance (in Shares) at Dec. 31, 2020</a></td>
<td class="nump">5,540,254<span></span>
</td>
<td class="nump">7,780,937<span></span>
</td>
<td class="nump">5,460,043<span></span>
</td>
<td class="nump">10,863,143<span></span>
</td>
<td class="nump">4,144,887<span></span>
</td>
<td class="nump">71,977<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,272,428<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants', window );">Exercise of warrants</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 8,027<span></span>
</td>
<td class="nump">8,027<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">9,222<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">9,222<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_arbe_StockIssuedDuringPeriodSharesExerciseOfWarrants', window );">Exercise of warrants (in Shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,194,886<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">872,614<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities', window );">Conversion of preferred shares into ordinary shares</a></td>
<td class="num">$ (650)<span></span>
</td>
<td class="num">$ (9,394)<span></span>
</td>
<td class="num">$ (2,500)<span></span>
</td>
<td class="num">$ (32,159)<span></span>
</td>
<td class="num">$ (10,447)<span></span>
</td>
<td class="num">$ (8,317)<span></span>
</td>
<td class="num">(63,467)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">63,467<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">63,467<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities', window );">Conversion of preferred shares into ordinary shares (in Shares)</a></td>
<td class="num">(5,540,254)<span></span>
</td>
<td class="num">(7,780,937)<span></span>
</td>
<td class="num">(5,460,043)<span></span>
</td>
<td class="num">(10,863,143)<span></span>
</td>
<td class="num">(4,144,887)<span></span>
</td>
<td class="num">(1,266,863)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">35,056,127<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueConversionOfUnits', window );">Conversion of convertible loan to ordinary shares</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">30,844<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">30,844<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits', window );">Conversion of convertible loan to ordinary shares (in Shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,205,020<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Issuance of ordinary shares, net of issuance costs</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">91,990<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">91,990<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issuance of ordinary shares, net of issuance costs (in Shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13,866,887<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition', window );">Stock-based compensation</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">2,211<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">2,211<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueIssuedForServices', window );">Stock-based compensation to service providers</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">115<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">115<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Exercise of options and vested RSUs</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">223<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">223<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercise of options and vested RSUs (in Shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">743,780<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="num">(58,092)<span></span>
</td>
<td class="num">(58,092)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Dec. 31, 2021</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">199,469<span></span>
</td>
<td class="num">(119,646)<span></span>
</td>
<td class="nump">79,823<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance (in Shares) at Dec. 31, 2021</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">63,016,856<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition', window );">Stock-based compensation</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">8,793<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">8,793<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueIssuedForServices', window );">Stock-based compensation to service providers</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">354<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">354<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Exercise of options and vested RSUs</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">277<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">277<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercise of options and vested RSUs (in Shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,144,034<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="num">(40,494)<span></span>
</td>
<td class="num">(40,494)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Dec. 31, 2022</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">208,893<span></span>
</td>
<td class="num">(160,140)<span></span>
</td>
<td class="nump">48,753<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance (in Shares) at Dec. 31, 2022</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">64,160,890<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Issuance of ordinary shares, net of issuance costs</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">22,496<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">22,496<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issuance of ordinary shares, net of issuance costs (in Shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,794,873<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition', window );">Stock-based compensation</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">13,012<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">13,012<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueIssuedForServices', window );">Stock-based compensation to service providers</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">629<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">629<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Exercise of options and vested RSUs</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">703<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">703<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercise of options and vested RSUs (in Shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,969,332<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="num">(43,500)<span></span>
</td>
<td class="num">(43,500)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Dec. 31, 2023</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">$ 245,733<span></span>
</td>
<td class="num">$ (203,640)<span></span>
</td>
<td class="nump">$ 42,093<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance (in Shares) at Dec. 31, 2023</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">77,925,095<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr><td colspan="13"></td></tr>
<tr><td colspan="13"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top"><span style="font-family: Times New Roman, Times, Serif">Represents less than $1.</span></td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_arbe_StockIssuedDuringPeriodSharesExerciseOfWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The represent the shares of exercise of warrants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">arbe_StockIssuedDuringPeriodSharesExerciseOfWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>arbe_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase to additional paid-in capital (APIC) for recognition of cost for option under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-6<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-8<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-9<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4<br><br>Reference 13: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-10<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483581/946-220-45-7<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-7<br><br>Reference 35: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1A<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1B<br><br>Reference 38: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 39: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued which are neither cancelled nor held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of preferred stock and warrants for common stock issued.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued during the period as a result of the conversion of convertible securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1E<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-3<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-30)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares issued during the period upon the conversion of units. An example of a convertible unit is an umbrella partnership real estate investment trust unit (UPREIT unit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481004/946-505-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479886/946-10-S99-3<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The gross value of stock issued during the period upon the conversion of convertible securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-31)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueConversionOfUnits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued during the period upon the conversion of units. An example of a convertible unit is an umbrella partnership real estate investment trust unit (UPREIT unit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-31)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueConversionOfUnits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueIssuedForServices">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued in lieu of cash for services contributed to the entity. Value of the stock issued includes, but is not limited to, services contributed by vendors and founders.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueIssuedForServices</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-11<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480767/946-205-45-4<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481004/946-505-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued as a result of the exercise of stock options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-31)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-12<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-2<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 14: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480418/310-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1</span><table class="report" border="0" cellspacing="2" id="idm140068084757552">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Cash Flows - USD ($)<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Cash flows from operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">$ (43,500,000)<span></span>
</td>
<td class="num">$ (40,494,000)<span></span>
</td>
<td class="num">$ (58,092,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net loss to net cash used in operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Depreciation', window );">Depreciation</a></td>
<td class="nump">557,000<span></span>
</td>
<td class="nump">481,000<span></span>
</td>
<td class="nump">342,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock-based compensation</a></td>
<td class="nump">13,012,000<span></span>
</td>
<td class="nump">8,793,000<span></span>
</td>
<td class="nump">2,211,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims', window );">Stock-based compensation to service providers</a></td>
<td class="nump">629,000<span></span>
</td>
<td class="nump">354,000<span></span>
</td>
<td class="nump">115,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentOfWarrantsGrantedForServices', window );">Revaluation of warrants and accretion</a></td>
<td class="num">(756,000)<span></span>
</td>
<td class="num">(8,122,000)<span></span>
</td>
<td class="nump">6,599,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_arbe_RevaluationOfConvertibleLoan', window );">Revaluation of convertible loan</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">17,866,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Change in operating assets and liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsReceivable', window );">Trade receivable</a></td>
<td class="nump">694,000<span></span>
</td>
<td class="num">(2,015,000)<span></span>
</td>
<td class="num">(50,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets', window );">Prepaid expenses and other receivables</a></td>
<td class="num">(187,000)<span></span>
</td>
<td class="nump">1,219,000<span></span>
</td>
<td class="num">(2,228,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingLeaseLiability', window );">Operating lease ROU assets and liabilities, net</a></td>
<td class="nump">86,000<span></span>
</td>
<td class="num">(84,000)<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayableTrade', window );">Trade payables</a></td>
<td class="num">(103,000)<span></span>
</td>
<td class="num">(769,000)<span></span>
</td>
<td class="nump">458,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities', window );">Employees and payroll accruals</a></td>
<td class="nump">55,000<span></span>
</td>
<td class="num">(234,000)<span></span>
</td>
<td class="nump">1,557,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInDeferredRevenue', window );">Deferred revenue</a></td>
<td class="num">(101,000)<span></span>
</td>
<td class="num">(375,000)<span></span>
</td>
<td class="nump">445,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities', window );">Accrued expenses and other payables</a></td>
<td class="num">(3,899,000)<span></span>
</td>
<td class="nump">884,000<span></span>
</td>
<td class="nump">4,361,000<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash used in operating activities</a></td>
<td class="num">(33,513,000)<span></span>
</td>
<td class="num">(40,362,000)<span></span>
</td>
<td class="num">(26,416,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>Cash flows from investing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForProceedsFromInvestments', window );">Change in bank deposits</a></td>
<td class="num">(15,002,000)<span></span>
</td>
<td class="num">(400,000)<span></span>
</td>
<td class="nump">100,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Purchase of property and equipment</a></td>
<td class="num">(249,000)<span></span>
</td>
<td class="num">(918,000)<span></span>
</td>
<td class="num">(784,000)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash used in investing activities</a></td>
<td class="num">(15,251,000)<span></span>
</td>
<td class="num">(1,318,000)<span></span>
</td>
<td class="num">(684,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Cash flows from financing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromShortTermDebt', window );">Proceeds from short-term loan</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">4,715,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RepaymentsOfLongTermDebt', window );">Repayment of long-term loan</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(2,639,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceInitialPublicOffering', window );">Proceeds from recapitalization and PIPE offering, net of issuance costs</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">98,587,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RepaymentsOfShortTermDebt', window );">Repayment of short-term loan</a></td>
<td class="text"> <span></span>
</td>
<td class="num">(5,218,000)<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Proceeds from issuance of ordinary shares, net of issuance costs</a></td>
<td class="nump">22,496,000<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromWarrantExercises', window );">Proceeds from exercise of warrants</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">12,859,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromStockOptionsExercised', window );">Proceeds from exercise of options</a></td>
<td class="nump">703,000<span></span>
</td>
<td class="nump">277,000<span></span>
</td>
<td class="nump">223,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromConvertibleDebt', window );">Proceeds from convertible loan</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">11,337,000<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash provided by (used in) financing activities</a></td>
<td class="nump">23,199,000<span></span>
</td>
<td class="num">(4,941,000)<span></span>
</td>
<td class="nump">125,082,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Effect of exchange rate fluctuations on cash and cash equivalent</a></td>
<td class="nump">47,000<span></span>
</td>
<td class="num">(1,189,000)<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">Increase (decrease) in cash, cash equivalents and restricted cash</a></td>
<td class="num">(25,612,000)<span></span>
</td>
<td class="num">(45,432,000)<span></span>
</td>
<td class="nump">97,982,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash, cash equivalents and restricted cash at the beginning of the year</a></td>
<td class="nump">54,315,000<span></span>
</td>
<td class="nump">100,936,000<span></span>
</td>
<td class="nump">2,954,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash, cash equivalents and restricted cash at the end of the year</a></td>
<td class="nump">28,750,000<span></span>
</td>
<td class="nump">54,315,000<span></span>
</td>
<td class="nump">100,936,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract', window );"><strong>Supplemental non-cash disclosure:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConversionOfStockAmountConverted1', window );">Exercise of warrants into convertible preferred shares</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">4,389,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssued1', window );">Issuance of private warrants</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">6,598,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_arbe_ConversionOfConvertibleLoanIntoOrdinarySharesUponTheRecapitalization', window );">Conversion of convertible loan into ordinary shares upon the recapitalization</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">30,844,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_arbe_ConversionOfPreferredSharesIntoOrdinarySharesUponTheRecapitalization', window );">Conversion of preferred shares into ordinary shares upon the recapitalization</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">63,467,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability', window );">Lease liabilities arising from obtaining right-of-use assets</a></td>
<td class="nump">1,713,000<span></span>
</td>
<td class="nump">797,000<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1', window );">Purchase of property and equipment</a></td>
<td class="nump">8,000<span></span>
</td>
<td class="nump">7,000<span></span>
</td>
<td class="nump">340,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowInformationAbstract', window );"><strong>Supplemental disclosure of cash flows activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestPaidNet', window );">Interest paid</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 250,000<span></span>
</td>
<td class="nump">$ 209,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_arbe_ConversionOfConvertibleLoanIntoOrdinarySharesUponTheRecapitalization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Conversion of convertible loan into ordinary shares upon the recapitalization.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">arbe_ConversionOfConvertibleLoanIntoOrdinarySharesUponTheRecapitalization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>arbe_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_arbe_ConversionOfPreferredSharesIntoOrdinarySharesUponTheRecapitalization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Conversion of preferred shares into ordinary shares upon the recapitalization.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">arbe_ConversionOfPreferredSharesIntoOrdinarySharesUponTheRecapitalization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>arbe_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_arbe_RevaluationOfConvertibleLoan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the issuance of a long-term debt instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">arbe_RevaluationOfConvertibleLoan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>arbe_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentOfWarrantsGrantedForServices">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Adjustment for noncash service expenses paid for by granting of warrants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentOfWarrantsGrantedForServices</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-8<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-24<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-24<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -SubTopic 230<br> -Topic 830<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481877/830-230-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConversionOfStockAmountConverted1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The value of the stock converted in a noncash (or part noncash) transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-4<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-3<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConversionOfStockAmountConverted1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Depreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Depreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 230<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481877/830-230-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayableTrade">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Change in recurring obligations of a business that arise from the acquisition of merchandise, materials, supplies and services used in the production and sale of goods and services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayableTrade</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInDeferredRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInDeferredRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in obligation for operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -SubTopic 20<br> -Topic 842<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in other obligations or expenses incurred but not yet paid.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in prepaid expenses, and assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-17<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of share-based compensation granted to nonemployees as payment for services rendered or acknowledged claims.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-24<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-25<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-6<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-8<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-9<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4<br><br>Reference 13: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-10<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483581/946-220-45-7<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-7<br><br>Reference 35: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1A<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1B<br><br>Reference 38: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 39: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of fixed assets that an Entity acquires in a noncash (or part noncash) acquisition. Noncash is defined as information about all investing and financing activities of an enterprise during a period that affect recognized assets or liabilities but that do not result in cash receipts or cash payments in the period. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-4<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-3<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForProceedsFromInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net cash paid (received) associated with the acquisition or disposal of all investments, including securities and other assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForProceedsFromInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromConvertibleDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the issuance of a long-term debt instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromConvertibleDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceInitialPublicOffering">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received from entity's first offering of stock to the public.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceInitialPublicOffering</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the additional capital contribution to the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromShortTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from a borrowing having initial term of repayment within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromShortTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from exercise of option under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-14<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2A<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 718<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromWarrantExercises">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received from holders exercising their stock warrants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromWarrantExercises</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for debt initially having maturity due after one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479886/946-10-S99-3<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfShortTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for a borrowing having initial term of repayment within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfShortTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in right-of-use asset obtained in exchange for operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssued1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The fair value of stock issued in noncash financing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-4<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-3<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssued1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalCashFlowInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalCashFlowInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1</span><table class="report" border="0" cellspacing="2" id="idm140068076248320">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>General<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>General [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NatureOfOperations', window );">GENERAL</a></td>
<td class="text"><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-transform: uppercase; text-align: justify; text-indent: -56.7pt"><span style="font-family: Times New Roman, Times, Serif">Note
1:- General</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 84.45pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">a.</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Arbe
                                            Robotics Ltd. (the &#8220;Company&#8221;) was founded and registered on November 4, 2015 and
                                            commenced its activities in January 2016. The Company, a global leader in Perception Radar
                                            solutions, is spearheading a radar revolution, enabling truly safe driver-assist systems
                                            today while paving the way to full autonomous-driving. The Company&#8217;s radar technology
                                            is a critical sensor for L2+ and higher autonomy. The Company is empowering automakers, Tier
                                            1 suppliers, autonomous ground vehicles, commercial and industrial vehicles, and a wide array
                                            of safety applications with advanced sensing and paradigm changing perception. The Company&#8217;s
                                            Ordinary Shares and Warrants are listed on the Nasdaq Capital Market under the symbols &#8220;ARBE&#8221;
                                            and &#8220;ARBEW,&#8221; respectively.</span></td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 84.45pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">b.</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">On
                                            October 26, 2017, the Company established a Delaware subsidiary, Arbe Robotics US Inc. Arbe
                                            Robotics US Inc is engaged mainly in the Company&#8217;s sales and will operate as the Company&#8217;s
                                            distributor in the U.S.</span></td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">On
February 5, 2024, the Company established a Chinese subsidiary, Shanghai Arbe Technologies Co., Ltd (&#8220;Arbe China&#8221;). Arbe
China was formed to assist mainly in providing customer support in the China region.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 84.45pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">c.</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">On
                                            October 7, 2021, the Company consummated the merger (the &#8220;Merger&#8221;) pursuant to
                                            which the Company&#8217;s wholly-owned subsidiary, Autobot MergerSub, Inc. (&#8220;Merger
                                            Sub&#8221;) was merged with an into Industrial Tech Acquisitions Inc. (&#8220;ITAC&#8221;)
                                            pursuant to which ITAC became a wholly-owned&#160;subsidiary of the Company, and the Company
                                            issued ordinary shares and warrants to the holders of ITAC common stock and warrants, respectively.
                                            In connection with the Merger, the name of ITAC was changed to Autobot HoldCo, Inc.</span></td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 84.45pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">In
connection with the Merger, and immediately prior to the closing of the Merger, the Company effected a recapitalization (the &#8220;Recapitalization&#8221;),
which was approved by the Company&#8217;s directors and shareholders. As part of the Recapitalization, (i) all warrants (other than certain
outstanding warrants) were exercised, (ii) all outstanding preferred shares, including preferred shares issued upon exercise of warrants,
were converted into ordinary shares and (iii) the ordinary shares that were outstanding after the exercise and conversion pursuant to
clauses (i) and (ii) became and were converted into a total of 48,268,611 ordinary shares. The Recapitalization resulted in a 46.25783-for-one
stock split and a change in the par value of the ordinary shares from NIS 0.01 per share to NIS 0.000216 per share. The stock split was
based on a valuation of the Ordinary Shares of $525,000 after the Recapitalization, with each Ordinary Share being valued at $10.00.
As part of the Recapitalization, the number of Ordinary Shares issuable upon exercise of outstanding options and warrants was multiplied
by the stock split ratio, which is the conversion ratio, and the exercise price of such options and warrants was divided by the conversion
ratio. Fractional shares were rounded to the closest integral number of Ordinary Shares, with a half-share being rounded to the next
higher number of Ordinary Shares. As a result, all Ordinary Shares, preferred shares, options to purchase ordinary shares, warrants to
purchase preferred shares, exercise price and net loss per share amounts in these financial statements were adjusted retroactively for
the year ended December 31, 2021, as if the stock split and change in par value had been in effect at January 1, 2021.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 84.45pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">Pursuant
to the Merger, Arbe issued to ITAC securityholders (a) 3,866,842 Ordinary Shares to the holders of ITAC common stock and (b) 10,735,680
Arbe warrants to the holders of ITAC warrants, of which 7,623,600 warrants are public warrants and 3,112,080 warrants are private warrants.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 84.45pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">Total
gross proceeds resulted from the Merger and the related PIPE financing were approximately $118,288, of which total transaction costs
amounted to approximately $16,707. The total gross proceeds include the $100,000 from the sale of 10,000,000 Ordinary Shares to the PIPE
investors at $10.00 per share.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 84.45pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">d.</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">The
                                            Company depends on one supplier for the development and productization of its products. If
                                            this supplier fails to deliver or delays the delivery of the necessary products, the Company
                                            will be required to seek alternative sources of supply. A change in supplier could result
                                            in manufacturing delays and increased costs, which could result in a possible loss of sales
                                            which would adversely affect the Company&#8217;s business, prospects, results of operations
                                            and financial position.</span></td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 84.45pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">e.</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">As
                                            the Company operates internationally and substantially all of its revenue is derived from
                                            sales outside of Israel, the business is affected by inflation, supply chain issues and economic
                                            conditions in countries in which the Company is seeking to conduct business, security and
                                            cybersecurity issues, fiscal and monetary policies, interest rates and regulations affection
                                            the automobile industry, the timing by the automobile and other industries on the introduction
                                            of unmanned automobiles and other unmanned devices, safety concerns and well as the effect
                                            of regional conflicts and steps taken by governments with respect to parties to such conflicts.&#160;
                                            As an Israeli company, the Company is also subject to the effect on Israel and the Israeli
                                            economy of the present war with Hamas as well as any other regional conflicts which may develop
                                            and the relationship between Israel and other countries, including the United States, China
                                            and the European Union.</span></td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 84.45pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.5in; text-align: justify; font-size: 10pt">&#160;</td>
    <td style="width: 0.25in; text-align: justify; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">f.</span></td>
    <td style="text-align: justify; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company has incurred losses from operations since its inception and has negative cash flow from operating activities. Management's plans with regard to these matters include continued development and marketing of its products as well as seeking additional financing arrangements.</span></td></tr>
  </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NatureOfOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the nature of an entity's business, major products or services, principal markets including location, and the relative importance of its operations in each business and the basis for the determination, including but not limited to, assets, revenues, or earnings. For an entity that has not commenced principal operations, disclosures about the risks and uncertainties related to the activities in which the entity is currently engaged and an understanding of what those activities are being directed toward.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org//275/tableOfContent<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NatureOfOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1</span><table class="report" border="0" cellspacing="2" id="idm140068076363392">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Significant Accounting Policies<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Significant Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SignificantAccountingPoliciesTextBlock', window );">SIGNIFICANT ACCOUNTING POLICIES</a></td>
<td class="text"><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-transform: uppercase; text-align: justify; text-indent: -56.7pt"><span style="font-family: Times New Roman, Times, Serif">Note
2:-&#160;&#160; Significant Accounting Policies</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"><tr style="vertical-align: top">
<td style="width: 57.9pt"></td><td style="width: 27.15pt"><span style="font-family: Times New Roman, Times, Serif">a.</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Basis of presentation:</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 84.45pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">The
consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States
of America (US GAAP). The significant accounting policies followed in the preparation of the financial statements applied on a consistent
basis for all years presented in these financial statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 84.45pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">The
consolidated financial statements include the accounts of the Company&#8217;s wholly owned subsidiaries. All intercompany balances and
transactions have been eliminated in consolidation.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">b.</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Use of estimates:</span></td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">The
preparation of consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect
the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial
statements and the reported amounts of revenues and expenses during the reporting periods. Significant items subject to such estimates
and assumptions including fair value of warrants, share-based compensation and the underlying fair value of the Company&#8217;s Ordinary
Shares issued prior to the Merger.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">The
Company bases these estimates on historical and anticipated results, trends and various other assumptions that it believes are reasonable
under the circumstances, including assumptions as to future events. Actual results could differ from those estimates.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">c.</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Consolidated financial statements in U.S. dollars:</span></td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">A
substantial portion the Company&#8217;s activity including transactions with customers, as well as equity transactions and cash investments,
are incurred in U.S. dollars. The Company&#8217;s management believes that the U.S. dollar is the currency of the primary economic environment
in which the Company operates. Thus, the functional and reporting currency of the Company is the U.S. dollar.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">A
subsidiary&#8217;s functional currency is the currency of the primary economic environment in which the subsidiary operates; normally,
that is the currency of the environment in which a subsidiary primarily generates and expends cash. In making the determination of the
appropriate functional currency for a subsidiary, the Company considers cash flow indicators, local market indicators, financing indicators
and the subsidiary&#8217;s relationship with both the parent company and other subsidiaries. The Company has determined the functional
currency of its U.S. subsidiaries to be the U.S. Dollar.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">Monetary
accounts maintained in currencies other than the U.S. dollar are remeasured into U.S. dollars in accordance with Statement of the Accounting
Standard Codification (&#8220;ASC&#8221;) No. 830 &#8220;Foreign Currency Matters&#8221; (&#8220;ASC No. 830&#8221;). All transaction
gains and losses of the remeasured monetary balance sheet items are reflected in the statements of operations as financial income or
expenses as appropriate.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">Transactions
in foreign currency are translated into dollars in accordance with the principles set forth in ASC Subtopic 830-20, <i>Foreign Currency
Transaction</i>. Monetary assets and liabilities denominated in foreign currencies of the reporting date are translated to the functional
currency at the closing rate at the end of the reporting period. Non-monetary assets and liabilities denominated in foreign currency
are translated using the exchange rate at the date of the transaction. Gains and losses from remeasurement of assets and liabilities
denominated in currencies other than the respective functional currencies are included in the consolidated statements of operations.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">d.</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Concentration of credit risk:</span></td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">Most
of the Company&#8217;s cash and cash equivalents, restricted cash and short-term deposits were deposited with Israeli banks and were
comprised mainly of cash deposits and short-term deposits.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">The
Company&#8217;s trade receivables are derived from customers located globally. The Company mitigates its credit risks by performing credit
evaluations of its customers&#8217; financial conditions and requires customer advance payments in certain circumstances. The Company
generally does not require collateral.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">e.</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Cash and cash equivalents and restricted cash:</span></td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">The
Company considers all highly liquid short-term deposits with original maturities of three months or less from the purchase date to be
cash equivalents. Cash equivalents consist primarily of amounts invested in short-term deposits.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">Restricted
cash consists of deposits at a financial institution that serves as collateral for a credit card agreement and lease agreements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">f.</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Short term deposits:</span></td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: -28.35pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">Short-term
deposits are bank deposits with an original maturity of more than three months and less than one year from the date of acquisition. The
deposits are presented according to their terms of deposit. As of December 31, 2023, these bank deposit bearing annual interest rates
in the range of&#160;4%-6%,</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: -28.35pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">g.</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Fair value of financial instruments:</span></td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">The
estimated fair value of financial instruments has been determined by the Company using available market information and valuation methodologies.
Considerable judgment is required in estimating fair values. Accordingly, the estimates may not be indicative of the amounts the Company
could realize in a current market exchange. The following methods and assumptions were used by the Company in estimating the fair value
of their financial instruments:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">The
carrying values of cash and cash equivalents, short-term deposits, restricted cash, trade receivables, other current assets, trade payables,
employees and payroll accruals, accrued expenses and other current liabilities approximate their fair values due to the short-term maturities
of these instruments.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">The
Company applies ASC No. 820, &#8220;Fair Value Measurements and Disclosures&#8221; (&#8220;ASC No. 820&#8221;), with respect to fair
value measurements of all financial assets and liabilities. In accordance with ASC No.&#160;820, the Company measures its short-term
deposits and warrant liability at fair value. Short-term deposits are classified within Level&#160;1 because these assets are valued
using quoted market prices. Fair value represents the amount that would be received to sell an asset or paid to transfer a liability
in an orderly transaction between market participants. As such, fair value is a market-based measurement that should be determined based
on assumptions that market participants would use in pricing an asset or a liability. A three-tier fair value hierarchy is established
as a basis for considering such assumptions and for inputs used in the valuation methodologies in measuring fair value:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 103.05pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.75in"></td><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Level
                                            1&#8212;Observable inputs that reflect quoted prices (unadjusted) for identical assets or
                                            liabilities in active markets.</span></td>
</tr></table>

<p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.75in"></td><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Level
                                            2&#8212;Include other inputs that are directly or indirectly observable in the marketplace.</span></td>
</tr></table>

<p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.75in"></td><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Level
                                            3&#8212;Unobservable inputs which are supported by little or no market activity.</span></td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 103.05pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">The
fair value hierarchy also requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when
measuring fair value.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">Pursuant
to the Merger, the Company (i) assumed a derivative warrant liability related to Company&#8217;s warrants that were issued to the holders of
private placement warrants that had been issued by ITAC in connection with its initial public offering, and (ii) issued equity instrument
in connection with warrants that had been issued as part of ITAC&#8217;s initial public offering and pursuant to the Merger became warrants
to purchase the Company&#8217;s Ordinary Shares. The fair value of the Company&#8217;s public warrants is measured based on the market
price of such warrants and are considered a Level 1 fair value measurement. The Company utilizes a Black-Scholes option pricing model
to estimate the fair value of the private placement warrants which are considered a Level 3 fair value measurement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">The
Company&#8217;s private warrants are measured at each reporting period, with changes in fair value recognized in the statement of operations.
See Note 8.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">h.</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Trade Receivables</span></td>
</tr></table>

<p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">Trade
receivables are recorded at the invoiced amount and do not bear interest. Trade receivables are periodically assessed for allowance for
doubtful accounts, which is the Company&#8217;s best estimate of the amount of credit losses with respect to its existing trade receivable.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">The
Company&#8217;s accounts receivables accounting policy from January 1, 2023, following the adoption of the new current expected credit
losses (&#8220;CECL&#8221;) standard:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">The
Company estimates CECL on trade receivables at inception for estimated losses resulting from the inability of the Company&#8217;s customers
to make required payments, based on estimated current expected credit losses. The allowance represents the current estimate of lifetime
expected credit losses over the remaining duration of existing accounts receivable considering historical information, current market
conditions and reasonable and supportable forecasts when appropriate. The estimate is a result of the Company&#8217;s ongoing evaluation
of collectability, customer creditworthiness, historical levels of credit losses, and future expectations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">The
allowance for credit losses was not material for the years ended December 31, 2023, 2022 and 2021.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">i.</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Property and equipment:</span></td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">Property
and equipment are recorded at cost and depreciated over their estimated useful lives using the straight-line method. Upon retirement
or sale, the cost of assets disposed of and the related accumulated depreciation are removed from the accounts and any resulting gain
or loss is included in income. Repair and maintenance costs are expensed as incurred.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">Depreciation
is calculated using the straight-line method over the estimated useful lives of the assets, at the following annual rates:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Computers and peripheral equipment</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">15-33</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Office furniture and equipment</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">7-15</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 88%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Vehicles</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 9%; text-align: center"><span style="font-family: Times New Roman, Times, Serif">15</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Leasehold improvement</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: center"><span style="-sec-ix-hidden: hidden-fact-214; font-family: Times New Roman, Times, Serif">(*)</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 113.4pt; text-align: justify; text-indent: -28.35pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.75in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">(*)</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Leasehold improvements are amortized using the straight-line method over the shorter of the lease term or the estimated useful life of the improvements.</span></td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">j.</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Impairment of long-lived assets:</span></td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">Long-lived
assets are reviewed for impairment in accordance with ASC 360, &#8220;Property, Plant and Equipment&#8221; a (&#8220;ASC 360&#8221;),
whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Impairment exists when
the carrying value of the asset exceeds the aggregate undiscounted cash flows expected to be generated by the asset. The impairment to
be recognized is measured by the amount by which the carrying amount of the assets exceeds their fair value. During the years ended December
31, 2023, 2022 and 2021, no impairment losses were identified.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">k.</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Accrued post-employment benefit:</span></td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in">The employees of Arbe Ltd. are included under section 14 of the Israeli
Severance Compensation Act, 1963 (&#8220;Section 14&#8221;). Pursuant to Section 14, the Company&#8217;s Israeli employees are entitled
to monthly deposits, at a rate of&#160;8.33% of their monthly salary, deposited on their behalf to their chosen insurance funds. By making
the payments in accordance with Section 14, the Company is released from any future severance payments in respect of those employees.
The obligation to make the monthly deposits is expensed as incurred. The deposits pursuant to Section 14 are not recorded as an asset
in the consolidated balance sheet, and there is no liability recorded as the Company does not have a future obligation to make any additional
payments. Severance costs amounted to approximately $1,166, $1,240 and $826 for the years ended December 31, 2023, 2022 and 2021, respectively.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">One
of the Company&#8217;s U.S. Subsidiaries has a 401(k) defined contribution plan covering one employee in the U.S. The expenses recorded
by the U.S. subsidiaries for matching contributions for the years ended December 31, 2023, 2022 and 2021 were immaterial.</span></p><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-transform: uppercase; text-align: justify; text-indent: -56.7pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">l.</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Stock-based compensation:</span></td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">The
Company accounts for stock-based compensation in accordance with ASC 718, &#8220;Compensation - Stock Compensation&#8221;, which requires
the measurement and recognition of compensation expense based on estimated fair values for all share-based payment awards made to employees,
nonemployees and directors. ASC 718 requires companies to estimate the fair value of equity-based payment awards on the date of grant
using an option-pricing model. The value of the portion of the award that is ultimately expected to vest is recognized as an expense
in the Company&#8217;s statements of operations over the applicable service periods.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">The
Company measures its share-based payment awards made to employees, directors, and non-employee service providers based on estimated fair
values. The fair value of each option award is estimated on the grant date using the Black-Scholes option pricing model which requires
several assumptions, of which the most significant are the expected share price volatility and the expected option term. The Company
recognizes forfeitures of equity-based awards as they occur. For graded vesting awards, the Company recognizes compensation expenses
based on the straight-line method over the applicable service period.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">m.</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Net loss per share attributable to ordinary shareholders:</span></td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">The
Company computes net loss per share using the two-class method required for participating securities. The two-class method requires income
available to ordinary shareholders for the period to be allocated between ordinary shares and participating securities based upon their
respective rights to receive dividends as if all income for the period had been distributed. The Company considered its convertible preferred
shares, which were outstanding through October 7, 2021, the date of the closing of the Merger, to be participating securities as the
holders of the convertible preferred shares would be entitled to dividends that would be distributed to the holders of ordinary shares,
equal to the higher of their original issue price pro-rata basis assuming conversion of all convertible preferred shares into ordinary
shares and that there are no preferences to any holders of any shares. These participating securities do not contractually require the
holders of such shares to participate in the Company&#8217;s losses. As such, net loss for the periods presented was not allocated to
the Company&#8217;s participating securities.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">The
Company&#8217;s basic net loss per share is calculated by dividing net loss attributable to ordinary shareholders by the weighted-average
number of ordinary shares outstanding for the period, without consideration of potentially dilutive securities. The diluted net loss
per share is calculated by giving effect to all potentially dilutive securities outstanding for the period using the treasury share method
or the if-converted method based on the nature of such securities. Diluted net loss per share is the same as basic net loss per share
in periods when the effects of potentially dilutive shares of ordinary shares are anti-dilutive. See Note 10.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">n.</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Other Comprehensive loss:</span></td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">The
Company has no components of comprehensive loss other than net loss. Thus, comprehensive loss is the same as net loss for the periods
presented.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 74.7pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">p.</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Revenue recognition:</span></td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">The
Company follows the provisions of ASC Topic 606, Revenue from Contracts with Customers (&#8220;ASC 606&#8221;), which apply to all contracts
with customers. Under Topic 606, revenues are recognized when control of the promised goods or services is transferred to the customers,
in an amount that reflects the consideration that the Company expects to receive in exchange for those goods or services. To determine
the appropriate revenue recognition for arrangements that an entity determines are within the scope of Topic 606, the entity performs
the following five steps:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.75in"></td><td style="width: 0.25in; text-align: left"></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Identify
                                            the contract(s) with a customer;</span></td>
</tr></table>

<p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.75in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Identify
                                            the performance obligations in the contract;</span></td>
</tr></table>

<p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.75in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Determine
                                            the transaction price;</span></td>
</tr></table>

<p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.75in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Allocate
                                            the transaction price to the performance obligations in the contract; and</span></td>
</tr></table>

<p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.75in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Recognize
                                            revenue when (or as) the entity satisfies a performance obligation.</span></td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">At
contract inception, once the contract is determined to be within the scope of Topic 606, the Company assesses the goods or services promised
within the contract and determines the performance obligations and assesses whether each promised good or service is distinct. The Company
evaluates each performance obligation to determine if it is satisfied at a point in time or over time. See Note 3.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif"><i>Nature
of Products and Services</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">The
Company derives its revenues mainly from sales of chipsets and prototype radar systems to be installed onto automotive vehicles and professional
services. Revenue from chipsets and prototype radar systems is recognized at the point in time when the control of the goods is transferred
to the customer, generally upon delivery, and the Company has no remaining performance obligations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif"><i>Right
of Return</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">The
Company&#8217;s general terms and conditions for its contracts do not contain a right of return that allows the customer to return products
and receive a credit. Therefore, the Company does not estimate returns and generally recognizes revenue at contract price upon product
delivery.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif"><i>Deferred
Revenue</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">Deferred
revenues, which represent a contract liability, where the Company has an obligation to transfer goods or services to the customer for
which it received consideration from the customer.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">q.</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Cost of revenues:</span></td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">Cost
of revenue includes the manufacturing cost of radar sensors and chipsets, which primarily consists of components cost, assembly costs
and personnel-related costs directly associated with our customer support personnel.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">r.</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Research and development expenses, net:</span></td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">Research
and development costs, net of grants received, are charged to the consolidated statement of operations as incurred.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">s.</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Income taxes:</span></td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">The
Company accounts for income taxes in accordance with ASC 740, &#8220;Income Taxes&#8221;. This standard prescribes the use of the asset
and liability method whereby deferred tax asset and liability account balances are determined based on differences between the financial
statement carrying amount and the tax bases of assets and liabilities and are measured using the enacted tax rates and laws that will
be in effect when the differences are expected to reverse. The Company provides a valuation allowance, if necessary, to reduce deferred
tax assets to the amount that is more likely than not to be realized.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">The
Company recognizes the tax benefit from a tax position only if it is more likely than not that the tax position will be sustained on
examination by the taxing authorities, based on the technical merits of the position. A tax position that meets the more-likely-than-not
recognition threshold is measured at the largest amount that is greater than 50 percent likely of being realized upon settlement with
the taxing authority using the facts, circumstances, and information available at the reporting date.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">t.</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Contingent Liabilities</span></td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 84.45pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">The
Company accounts for its contingent liabilities in accordance with ASC No.&#160;450, &#8220;Contingencies.&#8221; A provision is recorded
when it is both probable that a liability has been incurred and the amount of the loss can be reasonably estimated. With respect to legal
matters, provisions are reviewed and adjusted to reflect the impact of negotiations, estimated settlements, legal rulings, advice of
legal counsel and other information and events pertaining to a particular matter. As of December&#160;31, 2023 and 2022, the Company
is not a party to any litigation that could have a material adverse effect on the Company&#8217;s business, financial position, results
of operations or cash flows.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">u.</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Leases:</span></td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">On
January 1, 2022, the Company adopted Accounting Standards Update No. 2016-02, Leases (Topic 842) (ASU 2016-02) relating to the accounting
treatment of lease obligations, using the modified retrospective method.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">The
Company elected the package of practical expedients permitted under the transition guidance. The Company also elected not to recognize
a lease liability and a right-of-use (&#8220;ROU&#8221;) asset on the balance sheet for leases with a term of twelve months or less.
The Company recognizes the associated lease payments in the consolidated statements of income on a straight-line basis over the lease
term.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">Under
Topic 842, the Company determines if an arrangement is a lease at inception. ROU assets and liabilities are recognized at the commencement
date based on the present value of remaining lease payments over the lease term. For this purpose, the Company considers fixed and determinable
payments at the time of commencement. As most of the Company leases do not provide an implicit rate, the Company uses its incremental
borrowing rate based on the information available at the commencement date in determining the present value of lease payments. The incremental
borrowing rate is estimated to approximate the interest rate on a collateralized basis with similar terms and payments. The ROU asset
is recorded net of any lease incentives received. The lease terms may include options to extend or terminate the lease when it is reasonably
certain that the Company will exercise such options.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">Payments
under the Company&#8217;s lease agreements are primarily fixed, however, certain lease agreements contain variable costs such as common
area maintenance, real estate taxes, and insurance are not included in the lease liability and are recognized as they are incurred. See
Note 6.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">v.</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Impact of recently issued accounting standard:</span></td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">In
June 2016, the FASB issued ASU No. 2016-13, Financial Instruments&#8212;Credit Losses (&#8220;ASC 326&#8221;): Measurement of Credit
Losses on Financial Instruments to introduce a new model for recognizing credit losses on financial instruments based on estimated current
expected credit losses, or CECL. Under the new standard, an entity is required to estimate CECL on trade receivables at inception, based
on historical information, current conditions, and reasonable and supportable forecasts. The guidance is effective for the Company for
annual periods beginning after December 15, 2022, including interim periods within those fiscal years. Early application is permitted.
The Company adopted ASC 326 on January 1, 2023, and there was no material impact on the Company&#8217;s consolidated balance sheet and
the consolidated statements of operations upon adoption.</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for all significant accounting policies of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483426/235-10-50-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 235<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//235/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1</span><table class="report" border="0" cellspacing="2" id="idm140068079732928">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Revenue [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerTextBlock', window );">REVENUE</a></td>
<td class="text"><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">NOTE
3:- &#160;&#160;REVENUE</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif"><i>Disaggregation
of Revenues</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">Revenue
disaggregated by geography for the years ended December 31, 2023, 2022 and 2021, based on the billing address of the Company&#8217;s
customers, consists of the following:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="22" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><b>Year
                                            ended</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><b>December
                                            31,</b></span></p></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2023</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2022</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2021</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Revenue</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">%
    of Revenue</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Revenue</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">%
    of Revenue</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Revenue</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">%
    of Revenue</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Revenue by geography:</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 28%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">China</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">639</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">43.5</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,476</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">42.0</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">702</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">31.2</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Hong Kong</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">266</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">18.1</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-215; font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-216; font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">35</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">1.6</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Sweden</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">247</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">16.8</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,276</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">36.3</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">928</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">41.2</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">USA</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">148</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">10.1</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">135</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">3.8</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">63</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">2.8</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Germany</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">81</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">5.5</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">284</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">8.1</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">351</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">15.6</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Israel</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">50</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">3.4</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">25</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">0.7</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">34</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">1.5</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Italy</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-217; font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-218; font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">124</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">3.5</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-219; font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-220; font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Switzerland</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-221; font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-222; font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">197</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">5.6</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">53</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">2.4</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Other</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">39</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">2.6</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-223; font-family: Times New Roman, Times, Serif">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-224; font-family: Times New Roman, Times, Serif">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">83</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">3.7</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">Total revenue</span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,470</span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">100</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">3,517</span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">100</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">2,249</span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">100</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td></tr>
  </table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif"><i>Contract
Liabilities</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 85.05pt 0pt 0; text-align: justify; text-indent: -28.35pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">Contract
liabilities consist of deferred revenue and customer advanced payments. Deferred revenue includes billings in excess of revenue recognized
related to product sales and is recognized as revenue when the Company performs under the contract. Customer advanced payments represent
required customer payments in advance of product shipments according to customer&#8217;s payment term. Customer advance payments are
recognized as revenue when control of the performance obligation is transferred to the customer.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">Contract
liabilities presented as deferred revenue amounted to $0 and $351 as of December 31, 2023 and 2022, respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif"><i>Remaining
Performance Obligation</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">The
Company&#8217;s remaining performance obligations are comprised of product and services revenue not yet performed. As of December&#160;31,
2023 and 2022 the aggregate amount of the transaction price allocated to remaining performance obligations was $977 and $232, respectively.
The Company expects to recognize 2023 remaining performance obligations as revenue during 2024.</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-9<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-10<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-15<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-12<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-12<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-12<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-12<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-12<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-13<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Topic 606<br> -Publisher FASB<br> -URI https://asc.fasb.org//606/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenuesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenuesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1</span><table class="report" border="0" cellspacing="2" id="idm140068076181840">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Prepaid Expenses and Other Receivables<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssetsAbstract', window );"><strong>Prepaid Expenses and Other Receivables [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherCurrentAssetsTextBlock', window );">PREPAID EXPENSES AND OTHER RECEIVABLES</a></td>
<td class="text"><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-align: justify; text-indent: -56.7pt"><span style="font-family: Times New Roman, Times, Serif">NOTE
4:-&#160;&#160; PREPAID EXPENSES AND OTHER RECEIVABLES</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-align: justify; text-indent: -56.7pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">December
    31,</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2023</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2022</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Government authorities</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">385</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">280</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Deposits</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">69</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">85</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Grants receivable</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">310</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">319</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Prepaid expenses
    and other</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,262</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,155</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify; padding-bottom: 4pt; padding-left: 0.5in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">2,026</span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,839</span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherCurrentAssetsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for other current assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherCurrentAssetsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1</span><table class="report" border="0" cellspacing="2" id="idm140068079066208">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property and Equipment<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock', window );">PROPERTY AND EQUIPMENT</a></td>
<td class="text"><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-transform: uppercase; text-align: justify; text-indent: -56.7pt"><span style="font-family: Times New Roman, Times, Serif">Note
5:- Property and Equipment</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-transform: uppercase; text-align: justify; text-indent: -56.7pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">December
    31,</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2023</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2022</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Cost:</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.25in; width: 76%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Computers
    and peripheral equipment</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">2,448</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">2,350</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Leasehold
    improvement</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">582</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">438</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Office
    furniture and equipment</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">133</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">128</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Vehicles</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">149</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">139</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">3,312</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">3,055</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Accumulated
    depreciation</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">2,003</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,446</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">Property
    and equipment, net</span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,309</span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,609</span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: -28.35pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">Depreciation
expense for the years ended December 31, 2023, 2022 and 2021 was $557, $481 and $342, respectively.</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//360/tableOfContent<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -SubTopic 360<br> -Topic 958<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480321/958-360-50-6<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -SubTopic 360<br> -Topic 958<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480321/958-360-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -SubTopic 360<br> -Topic 958<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480321/958-360-50-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1</span><table class="report" border="0" cellspacing="2" id="idm140068078093152">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasesOperatingAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeasesTextBlock', window );">LEASES</a></td>
<td class="text"><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-transform: uppercase; text-align: justify; text-indent: -56.7pt"><span style="font-family: Times New Roman, Times, Serif">Note
6:-&#160;&#160; LEASES</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-transform: uppercase; text-align: justify; text-indent: -56.7pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-weight: normal; text-transform: none">The
Company has five non-cancelable operating lease agreements for certain office spaces in Israel. The leases have original lease periods
expiring until 2027, some of which may include options to extend the leases for up to three additional years. The Company does not assume
renewals in its determination of the lease term unless the renewals are considered as reasonably certain to exercise.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-transform: uppercase; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-weight: normal; text-transform: none">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-weight: normal; text-transform: none">Supplemental
cash flow information related to leases was as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-transform: uppercase; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-weight: normal; text-transform: none">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-align: justify"><span style="text-decoration: none; font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><b>Year
                                            ended</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2.85pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><b>December
                                            31,</b></span></p></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: justify"><span style="text-decoration: none; font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2023</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2022</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-decoration: none; width: 76%; text-align: justify"><span style="text-decoration: none; font-family: Times New Roman, Times, Serif">Cash
    payments and expenses related to operating leases</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(451</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(370</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-decoration: none; text-align: justify"><span style="text-decoration: none; font-family: Times New Roman, Times, Serif">Operating
    lease right-of-use assets and liabilities, net</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">2</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(84</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  </table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-transform: uppercase; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-weight: normal; text-transform: none">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-weight: normal; text-transform: none">Maturities
of lease liabilities as of December 31, 2023, were as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-transform: uppercase; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-weight: normal; text-transform: none">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 88%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">2024</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">443</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">2025</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">393</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">2026</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">356</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">2027 and after</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,033</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Total lease payments</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">2,225</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Less imputed interest</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">483</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Total lease liabilities</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,742</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-transform: uppercase; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-weight: normal; text-transform: none">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-weight: normal; text-transform: none">Supplemental
balance sheet information related to operating leases were as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-transform: uppercase; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-weight: normal; text-transform: none">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="white-space: nowrap; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">December&#160;31,</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">December&#160;31,</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2023</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><b>202<span style="font-size: 10pt">2</span></b></span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Operating lease right-of-use assets</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="white-space: nowrap; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="white-space: nowrap; width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,740</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">465</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Current maturities of operating leases</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="white-space: nowrap; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="white-space: nowrap; text-align: right"><span style="font-family: Times New Roman, Times, Serif">436</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">364</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Long-term operating lease liabilities</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="white-space: nowrap; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="white-space: nowrap; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,306</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">17</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Weighted average remaining lease term (in years)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="white-space: nowrap; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="white-space: nowrap; text-align: right"><span style="font-family: Times New Roman, Times, Serif">5.5</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">1.1</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Weighted average discount rate</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="white-space: nowrap; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="white-space: nowrap; text-align: right"><span style="font-family: Times New Roman, Times, Serif">9.4</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">5.8</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td></tr>
  </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesOperatingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesOperatingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeasesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//842-20/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeasesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1</span><table class="report" border="0" cellspacing="2" id="idm140068083439024">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingent Liabilities<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingent Liabilities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">COMMITMENTS AND CONTINGENT LIABILITIES</a></td>
<td class="text"><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-transform: uppercase; text-align: justify; text-indent: -56.7pt"><span style="font-family: Times New Roman, Times, Serif">Note
7:- &#160;&#160;COMMITMENTS AND CONTINGENT LIABILITIES</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">The
Company participated in programs sponsored mainly by the Israeli Innovation Authority (&#8220;IIA&#8221;), an Israeli government agency,
for the support of its research and development activities. Through December 31, 2023, the Company had obtained grants aggregating to
$3,846 for certain of its research and development projects. The Company is obligated to pay royalties to the IIA, amounting to 4% of
the sales of the products and other related revenues generated from such projects. The maximum aggregate royalties paid generally cannot
exceed 100% of the grants received, plus annual interest generally equal to 12-months SOFR applicable to dollar deposits, as published
on the first business day of each calendar year. The obligation to pay these royalties is contingent on sales of the products and in
the absence of such sales, no payment is required.&#160;</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for commitments and contingencies.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 440<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482648/440-10-50-4<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 450<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//450/tableOfContent<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 954<br> -SubTopic 440<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480327/954-440-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 440<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482648/440-10-50-4<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 440<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//440/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1</span><table class="report" border="0" cellspacing="2" id="idm140068076343168">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Warrants Liabilities<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract', window );"><strong>Warrants Liabilities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock', window );">WARRANTS LIABILITIES</a></td>
<td class="text"><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-transform: uppercase; text-align: justify; text-indent: -56.7pt"><span style="font-family: Times New Roman, Times, Serif">Note
8:- &#160;&#160;warrants liabilities</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">The
Company issued in 2019 warrants to purchase a number of convertible Series B-1 convertible preferred shares, for an aggregate exercise
price of $550. As a result of the Merger and the related Recapitalization, the warrants became convertible into the Company&#8217;s ordinary
shares. The Company classified the warrants as freestanding and treated as liability pursuant to ASC 480 and remeasured every reporting
period with any change to fair value recorded within financial expenses in the statements of operations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">As
a result of the Merger, the Company assumed a derivative warrant liability related to 3,112,080 private placement warrants assumed by
the Company pursuant to the terms of the Merger.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">The
Company utilizes a Black-Scholes option pricing model to estimate the fair value of the private placement warrants and the convertible
warrants (hereinafter: the &#8220;warrants&#8221;) and are considered a Level 3 fair value measurement. Black-Scholes option pricing
model takes into consideration certain parameters in computation of the fair value of the warrants which the significant parameter is
expected volatility. The Company computed a sensitivity analysis of the fair value to changes of the expected volatility. The volatility
impact of +/-5% on the warrants&#8217; fair value is approximately $180.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">The
warrants are measured at each reporting period, with changes in fair value recognized in the statement of operations. During 2023, 2022
and 2021, the Company recognized ($756), ($8,425) and $3,083, respectively, with respect with those warrants as a finance expenses (income).</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for derivative instruments and hedging activities including, but not limited to, risk management strategies, non-hedging derivative instruments, assets, liabilities, revenue and expenses, and methodologies and assumptions used in determining the amounts.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480237/815-40-50-5<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480434/815-10-50-5C<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 815<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//815/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1</span><table class="report" border="0" cellspacing="2" id="idm140068078336544">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Shareholders&#8217; Equity<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteAbstract', window );"><strong>Shareholders&#8217; Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock', window );">SHAREHOLDERS&#8217; EQUITY</a></td>
<td class="text"><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-transform: uppercase; text-align: justify; text-indent: -56.7pt"><span style="font-family: Times New Roman, Times, Serif">Note
9:- &#160;&#160;Shareholders&#8217; equity</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">a.</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">In connection with the Merger, the Company adopted its restated articles, pursuant to which the Company&#8217;s authorized capital consisted of 130,000,000 Ordinary Shares, with a par value of NIS 0.000216 per share and the Company effected a 1:46.25783 stock split.</span></td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: -28.35pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.75in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">b.</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">During June 2023, the Company raised $23,000 with Special Situations Funds, pursuant to which the Company issued a total of 11,794,873 Ordinary Shares with a purchase price of $1.95 per share. Existing investors, including two affiliates of Arbe&#8217;s directors also participated in this offering. The aggregate net proceeds received by the Company from the offering were $22,496&#160;net of issuance costs.</span></td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.75in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">c.</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Share
                                            option and RSU&#8217;s:</span></td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: -28.35pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">During
2016, the Company adopted the 2016 Share Incentive Plan (the &#8220;2016 Plan&#8221;) which provides the Company with the ability to grant
its employees, directors and service providers options to purchase Ordinary Shares of the Company, at a purchase price as determined
by the Board of Directors at the date of grant. Pursuant to the 2016 Plan, 3,384,454 Ordinary Shares were reserved for issuance. Each
option granted under the Plan expires no later than seven years from the date of grant or 60 days after termination of engagement. The
vesting period of the share options is generally four years.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">In
August 2021, the Board of the Company approved and in September 2021 the shareholders approved, the Arbe Robotics Ltd. 2021 Equity Incentive
Plan (the &#8220;2021 Plan&#8221;) which became effective on October 7, 2021. The 2021 Plan covers (a) 4,079,427 ordinary shares plus
(b) and without the need to further amend the Plan on January 1 of each calendar year beginning on January 1, 2022 and ending on and
including January 1, 2031, a number of Shares equal to the lesser of: (i) 5% of the total number of ordinary shares outstanding on December
31 of the immediately preceding calendar year, and (ii) an amount determined by the Board, if so determined prior to the January 1 of
the calendar year in which the increase will occur.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">Upon
the adoption of the 2021 Plan, the Company will no longer grant any awards under the 2016 Plan, although previously granted options under
the 2016 Plan will remain outstanding and governed by the 2016 Plan and awards available for grant under the 2016 Plan which had not
been issued or which expired unexercised may be issued pursuant to the 2021 Plan. The vesting period of the awards is generally four
years. Generally, under the terms of the Plans, unless determined otherwise,&#160;25% of an award granted becomes exercisable on the
first anniversary of the date of grant and&#160;6.25% becomes exercisable once every quarter during the subsequent&#160;three years.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">Share
option and RSU&#8217;s plans:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: -28.35pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">A
summary of the stock option activity under the Company&#8217;s equity plans during the years ended December 31, 2023, 2022 and 2021 is
as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><b>Outstanding</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2.85pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><b>share
                                            options</b></span></p></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Weighted-average
    exercise<br/>
 price ($)</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Weighted
    average remaining contractual<br/>
 life (years)</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Aggregate
    intrinsic value ($ in thousands)</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Options:</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 52%; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Outstanding
    as of December&#160;31, 2020</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">3,768,034</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">0.767</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">4.626</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">119,146</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Granted</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,966,916</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">7.250</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Forfeited</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(117,863</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">0.972</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Exercised</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(155,750</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif">0.602</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Outstanding
    as of December&#160;31, 2021</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif">5,461,337</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif">3.102</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif">5.363</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif">16,713,971</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Granted</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,630,142</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif">6.833</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Forfeited</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(468,814</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif">5.557</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Exercised</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(570,451</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif">0.482</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Outstanding as of December&#160;31,
    2022</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">6,052,214</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">4.166</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">5.570</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">7,761,705</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Granted</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">430,874</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">2.728</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Forfeited</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(351,671</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">7.767</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Exercised</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(1,074,162</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">0.654</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 4pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 11.35pt; text-align: left; text-indent: -8.5pt"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif"><b>Outstanding
                                            as of December&#160;31, 2023 </b></span></p></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">5,057,255</span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">4.543</span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">5.662</span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">2,352,517</span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">Exercisable as of December&#160;31,
    2023</span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">3,210,191</span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">3.643</span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">4.403</span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">2,277,303</span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">Options available for
    future grants</span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">611,246</span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: -28.35pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">A
summary of the Company&#8217;s RSUs activity during the years ended December 31, 2023, 2022 and 2021 is as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 84.95pt; text-align: left; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-transform: uppercase; text-align: justify; text-indent: -56.7pt"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Numbers
    of RSUs</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">RSUs:</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; text-align: left">&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"><b>Outstanding as of January 1, 2021</b></span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-225; font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 88%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Granted</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,968,794</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Forfeited</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-226; font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Vested</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-227; font-family: Times New Roman, Times, Serif">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Outstanding as of December&#160;31,
    2021</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,968,794</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Granted</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,619,898</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Forfeited</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(417,025</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Vested</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(573,583</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Outstanding as of December&#160;31,
    2022</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">2,598,084</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Granted</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">2,908,983</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Forfeited</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(370,067</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Vested</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(895,170</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 4pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Outstanding as of December&#160;31,
    2023</span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">4,241,830</span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>
<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-transform: uppercase; text-align: justify; text-indent: -56.7pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">Fair
value factors:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: -28.35pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">The
following table sets forth the parameters used in computation of the options compensation to employees and service providers:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="10" style="border-bottom: Black 1.5pt solid; white-space: nowrap; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><b>Year
                                            ended </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><b>December
                                            31</b></span></p></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2023</span></td><td style="white-space: nowrap; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2022</span></td><td style="white-space: nowrap; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2021</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="white-space: nowrap; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="white-space: nowrap; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="white-space: nowrap; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Expected term, in years</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="white-space: nowrap; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="white-space: nowrap; width: 9%; text-align: center"><span style="font-family: Times New Roman, Times, Serif">5.82</span></td><td style="white-space: nowrap; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="white-space: nowrap; width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="white-space: nowrap; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="white-space: nowrap; width: 9%; text-align: center"><span style="font-family: Times New Roman, Times, Serif">4.41-6.11</span></td><td style="white-space: nowrap; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="white-space: nowrap; width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="white-space: nowrap; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="white-space: nowrap; width: 9%; text-align: center"><span style="font-family: Times New Roman, Times, Serif">4.61-6.11</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Expected volatility</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="white-space: nowrap; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="white-space: nowrap; text-align: center"><span style="font-family: Times New Roman, Times, Serif">47%-51.75%</span></td><td style="white-space: nowrap; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="white-space: nowrap; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="white-space: nowrap; text-align: center"><span style="font-family: Times New Roman, Times, Serif">47%-48%</span></td><td style="white-space: nowrap; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="white-space: nowrap; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="white-space: nowrap; text-align: center"><span style="font-family: Times New Roman, Times, Serif">42%-46%</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Risk-free interest rate</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="white-space: nowrap; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="white-space: nowrap; text-align: center"><span style="font-family: Times New Roman, Times, Serif">4.15%-4.55%</span></td><td style="white-space: nowrap; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="white-space: nowrap; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="white-space: nowrap; text-align: center"><span style="font-family: Times New Roman, Times, Serif">1.74%-3.96%</span></td><td style="white-space: nowrap; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="white-space: nowrap; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="white-space: nowrap; text-align: center"><span style="font-family: Times New Roman, Times, Serif">0.49%-1.28%</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Expected dividend yield</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="white-space: nowrap; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="white-space: nowrap; text-align: center"><span style="font-family: Times New Roman, Times, Serif">0</span>%</td><td style="white-space: nowrap; text-align: left"></td><td style="white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="white-space: nowrap; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="white-space: nowrap; text-align: center"><span style="font-family: Times New Roman, Times, Serif">0</span>%</td><td style="white-space: nowrap; text-align: left"></td><td style="white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="white-space: nowrap; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="white-space: nowrap; text-align: center"><span style="font-family: Times New Roman, Times, Serif">0</span>%</td><td style="text-align: left"></td></tr>
  </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 84.45pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif"><i>&#160;</i></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif"><i>Fair
value:</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 84.45pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">Prior
to the Merger, which resulted in the Company becoming a public entity, in determining the fair value for share options granted, the board
of directors considered the fair value of the ordinary shares as of each grant date. The fair value of the ordinary shares underlying
the share options was determined by the board of directors at each award grant date based upon a variety of factors, including the results
obtained from independent third-party valuations, the Company&#8217;s financial position and historical financial performance, the status
of technological developments within the Company&#8217;s products, the composition and ability of the current management team, an evaluation
or benchmark of the Company&#8217;s competition, the current business climate in the marketplace, the illiquid nature of the ordinary
shares, arm&#8217;s length sales of the Company&#8217;s capital stock, the effect of the rights and preferences of the Company&#8217;s preferred
shareholders, and the prospects of a liquidity event, among others. Subsequent to the Company becoming a public entity, the fair value
of the Ordinary Shares is the market price of the Ordinary Shares on the date of grant.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 84.45pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif"><i>Expected
volatility:</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 84.45pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">As
the Company was privately owned until October 2021, there is not sufficient historical volatility for the expected term of the stock
options. Therefore, the Company uses an average historical share price volatility based on an analysis of reported data for a peer group
of comparable publicly traded companies which were selected based upon industry similarities.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 84.45pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif"><i>Expected
term (years):</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 84.45pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">Expected
term represents the period that the Company&#8217;s option grants are expected to be outstanding. There is not sufficient historical
share exercise data to calculate the expected term of the stock options. Therefore, the Company elected to utilize the simplified method
to value option grants. Under this approach, the weighted-average expected life is presumed to be the average of the shortest vesting
term and the contractual term of the option.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 84.45pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif"><i>Risk-free
interest rate:</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 84.45pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">The
Company determined the risk-free interest rate by using a weighted-average equivalent to the expected term based on the U.S. Treasury
yield curve in effect as of the date of grant.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 84.45pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif"><i>Expected
dividend yield:</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 84.45pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">The
Company does not anticipate paying any dividends in the foreseeable future. Thus, the Company used 0% as its expected dividend yield.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 84.45pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; background-color: white">The
following table presents stock-based compensation expense to employees included in the Company&#8217;s consolidated statements of operations:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: -28.35pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="10" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><b>Year
                                            ended </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><b>December
                                            31,</b></span></p></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2023</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2022</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2021</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Research and development</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">8,721</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">5,726</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,518</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Sales and marketing</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">2,229</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,403</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">217</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">General and administrative</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,786</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,537</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">419</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Cost of revenues</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">276</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">127</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">57</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">Total stock-based compensation
    expense</span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">13,012</span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">8,793</span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">2,211</span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 84.45pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; background-color: white">Share
based compensation expenses are not deductible for income tax purposes, and therefore the Company did not recognize any tax benefits
related to the share-based compensation for the years ended December&#160;31, 2023, 2022 and 2021.</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-transform: uppercase; text-align: justify; text-indent: -56.7pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-weight: normal">The
Company adopted ASU 2018-07 and accordingly measured at the grant dates of each of the above stock-based compensation issued to service
providers their fair value using Black and Scholes model, which requires inputs such as exercise price, estimated ordinary share price,
expected dividend yield, estimated ordinary share price volatility and risk-free interest rate. During 2023, 2022 and 2021, the Company
recognized the total fair value of the stock-based compensation of development related service providers in the amounts of $629, $354
and $115, respectively.</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-13<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-13<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-14<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481062/946-235-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481062/946-235-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481004/946-505-50-6<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480237/815-40-50-6<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(e)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//505/tableOfContent<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-13<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-13<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-13<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-14<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-14<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 16<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-16<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-18<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-18<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-18<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1</span><table class="report" border="0" cellspacing="2" id="idm140068076334304">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Loss Per Share Attributible to Ordinary Sharholders<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Net Loss Per Share Attributible to Ordinary Sharholders [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareTextBlock', window );">NET LOSS PER SHARE ATTRIBUTIBLE TO ORDINARY SHARHOLDERS</a></td>
<td class="text"><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">NOTE
10:- &#160;&#160;NET LOSS PER SHARE ATTRIBUTIBLE TO ORDINARY SHARHOLDERS</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-align: justify; text-indent: -56.7pt"><span style="font-family: Times New Roman, Times, Serif; font-weight: normal">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-weight: normal; background-color: white">The
following table sets forth the computation of basic and diluted net loss per share attributable to ordinary shareholders for the periods
presented: </span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-align: justify; text-indent: -56.7pt"><span style="font-family: Times New Roman, Times, Serif; font-weight: normal">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="10" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><b>Year
                                            ended </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><b>December
                                            31,</b></span></p></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2023</span></td><td style="padding-bottom: 2.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2022</span></td><td style="padding-bottom: 2.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2021</span></td><td style="padding-bottom: 2.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"><b><span style="text-decoration:underline">Basic</span></b></span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="padding-bottom: 1.5pt; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="padding-bottom: 1.5pt; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="padding-bottom: 1.5pt; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: left"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: left"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: left; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif"><b>Numerator:</b></span></p></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Net loss</span></td><td style="width: 1%; padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 4pt double; width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(43,500</span></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="width: 1%; padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 4pt double; width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(40,494</span></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="width: 1%; padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 4pt double; width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(58,092</span></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: left; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: left; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif"><b>Denominator:</b></span></p></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Weighted-average
    shares used in computing loss per share attributable to ordinary shareholders, basic</span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">72,021,520</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">63,489,983</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">22,027,292</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Loss per share attributable to ordinary shareholders,
    basic</span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(0.60</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(0.64</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(2.64</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"><b><span style="text-decoration:underline">Diluted</span></b></span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>

<tr style="vertical-align: bottom">
    <td style="text-align: left"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 11.35pt; text-align: left; text-indent: -8.5pt"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif"><b>Numerator:</b></span></p></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Adjusted Net loss*</span></td><td style="width: 1%; padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 4pt double; width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(44,256</span></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="width: 1%; padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 4pt double; width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(48,919</span></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="width: 1%; padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 4pt double; width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(58,092</span></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 11.35pt; text-align: left; text-indent: -8.5pt"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif"><b>Denominator:</b></span></p></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Weighted-average
    shares used in computing loss per share attributable to ordinary shareholders, diluted</span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">62,390,302</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">60,960,641</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">22,027,292</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Loss per share attributable to ordinary shareholders,
    diluted*</span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(0.71</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(0.80</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(2.64</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-align: justify; text-indent: -56.7pt"><span style="font-family: Times New Roman, Times, Serif; font-weight: normal">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">*</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-weight: normal">Loss per share attributable to ordinary shareholders, diluted, was adjusted and take into consideration warrants liabilities revaluations as part of our net loss for 2023 and 2022.</span></td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-align: justify; text-indent: -56.7pt"><span style="font-family: Times New Roman, Times, Serif; font-weight: normal">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><b>Year
                                            ended </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2.85pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><b>December
                                            31,</b></span></p></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2023</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2022</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Net loss</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(43,500</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(40,494</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Revaluation of warrants</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(756</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(8,425</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">Adjusted Net loss</span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(44,256</span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(48,919</span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  </table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-align: justify; text-indent: -56.7pt"><span style="font-family: Times New Roman, Times, Serif; font-weight: normal">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-weight: normal">The
potential Ordinary Shares that were excluded from the computation of diluted net loss per share attributable to ordinary shareholders
for the years ended December 31, 2023, 2022 and 2021 because including them would have been anti-dilutive are as follows:</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-align: justify; text-indent: -56.7pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="10" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><b>Year
                                            ended </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><b>December
                                            31,</b></span></p></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2023</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2022</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2021</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Convertible preferred shares</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 9%; text-align: right"><span style="-sec-ix-hidden: hidden-fact-228; font-family: Times New Roman, Times, Serif">-</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 9%; text-align: right"><span style="-sec-ix-hidden: hidden-fact-229; font-family: Times New Roman, Times, Serif">-</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">26,499,069</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Outstanding share options</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">9,299,085</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">8,650,298</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,362,786</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">Total</span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">9,299,085</span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">8,650,298</span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">27,861,855</span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for earnings per share.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//260/tableOfContent<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1</span><table class="report" border="0" cellspacing="2" id="idm140068079289088">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Taxes on Income<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Taxes on Income [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">TAXES ON INCOME</a></td>
<td class="text"><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">NOTE
11:- &#160;&#160;TAXES ON INCOME</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 84.45pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">a.</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">General:</span></td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 84.45pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif"><i>Israeli
tax rate:</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: -28.35pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">The
Corporate tax rate in Israel relevant to the Company in 2021, 2022 and 2023 - 23%.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif"><i>United
States:</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">The
Company&#8217;s subsidiaries are separately taxed under the U.S. tax laws at a corporate rate of 21%.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 84.45pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">b.</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Loss
                                            before income taxes:</span></td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: -28.35pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">The
following are the domestic (i.e. Israeli) and foreign components of the Company&#8217;s loss before income taxes:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: -28.35pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="10" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2.85pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><b>Year
                                            ended </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2.85pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><b>December
                                            31,</b></span></p></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2023</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2022</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2021</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Domestic</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(43,500</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(40,494</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(58,092</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Foreign</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-230; font-family: Times New Roman, Times, Serif">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-231; font-family: Times New Roman, Times, Serif">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-232; font-family: Times New Roman, Times, Serif">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">Total</span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(43,500</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(40,494</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(58,092</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  </table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 84.45pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">c.</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Taxes
                                            on income:</span></td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: -28.35pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">The
reconciliation of the income tax benefit that would result from applying the Israeli statutory tax rate to the Company&#8217;s reported
income tax (benefit) is as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: -28.35pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="10" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2.85pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><b>Year
                                            ended </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2.85pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><b>December
                                            31,</b></span></p></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2023</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2022</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2021</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; width: 64%; text-align: left; padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">Loss
    before income taxes, as reported in the consolidated statements of operations</span></td><td style="width: 1%; padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 4pt double; width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">43,500</span></td><td style="width: 1%; padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 1%; padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 4pt double; width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">40,494</span></td><td style="width: 1%; padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 1%; padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 4pt double; width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">58,092</span></td><td style="width: 1%; padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">Statutory
    tax rate</span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">23</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">23</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">23</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Income
    tax benefit at statutory tax rate</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(10,005</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(9,314</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(13,361</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Effect
    of Non-deductible expenses</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">3,063</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">475</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">6,129</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Remeasurement
    of deferred taxes from currency exchange*</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-233; font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">3,517</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">209</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Change
    in valuation allowance</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">7,508</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">5,322</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">7,023</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Other</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(566</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-234; font-family: Times New Roman, Times, Serif">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-235; font-family: Times New Roman, Times, Serif">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">Reported
    income taxes benefit</span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="-sec-ix-hidden: hidden-fact-236; font-family: Times New Roman, Times, Serif">-</span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="-sec-ix-hidden: hidden-fact-237; font-family: Times New Roman, Times, Serif">-</span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="-sec-ix-hidden: hidden-fact-238; font-family: Times New Roman, Times, Serif">-</span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif"><b>*</b></span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">The
income Tax Regulations (rules regarding ledger management of foreign invested companies and certain partnerships and the determination
of their taxable income), 1986 allow Foreign Invested Companies (i.e., foreign holding percentage of more than 25%) to report for tax
purposes in US dollars. The Company implemented these regulations on January 1, 2023.</span></td>
</tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">d.</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Net
                                            operating loss carryforward:</span></td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; background-color: white">As
of December&#160;31, 2023, the Company had a net operating loss carryforward for Israeli tax purposes of approximately $121,880. These
net operating loss carryforwards can be carried forward and offset against taxable income indefinitely.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">e.</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Deferred
                                            tax assets and liabilities:</span></td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 84.45pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">Deferred
tax assets and liabilities are recognized for the tax effects of temporary differences between the carrying amounts of assets and liabilities
for financial reporting purposes and the amounts used for income tax purposes and for carryforwards.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 84.45pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">The
principal components of the Company&#8217;s deferred tax assets are as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 84.45pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">December
    31</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2023</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2022</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Deferred tax assets:</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; width: 76%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Net operating loss carry forwards</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">28,032</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">21,991</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Research and development</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">6,252</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">4,834</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Employees and payroll accrual</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">299</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">272</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Property and equipment</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">79</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">57</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Total deferred tax assets</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">34,662</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">27,154</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Valuation allowance</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(34,662</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(27,154</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">Deferred
    tax assets, net of valuation allowance</span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="-sec-ix-hidden: hidden-fact-239; font-family: Times New Roman, Times, Serif">-</span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="-sec-ix-hidden: hidden-fact-240; font-family: Times New Roman, Times, Serif">-</span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 84.45pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">Based
on the available evidence, management believes that it is more likely than not that certain of its deferred tax assets relating to net
operating loss carryforwards and other temporary differences in Israel will not be realized and accordingly, a valuation allowance has
been provided.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: -28.35pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">f.</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Tax
                                            assessments:</span></td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: -28.35pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">The
Israeli entity&#8217;s&#8217; income tax assessments are considered final through 2018<span style="font-size: 10pt; background-color: white">.</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">g.</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Unrecognized
                                            Tax Benefits:</span></td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: -28.35pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; background-color: white">As
of December&#160;31, 2023, 2022 and 2021, the Company did not have any unrecognized tax benefits and does not expect that the amount
of unrecognized tax benefits will change significantly within the next 12 months. The Company&#8217;s accounting policy is to accrue
interest and penalties related to an underpayment of income taxes as a component of income tax expense.</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480990/946-20-50-13<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//740/tableOfContent<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-14<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 21<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-21<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 270<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482526/740-270-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-17<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.5.Q1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 11.C)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-2<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482603/740-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1</span><table class="report" border="0" cellspacing="2" id="idm140068076318880">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Information<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Segment Information [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingDisclosureTextBlock', window );">SEGMENT INFORMATION</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif"><b>NOTE
12:- &#160;&#160;SEGMENT INFORMATION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; background-color: white">The
Company operates in one operating and reportable segment. Operating segments are defined as components of an enterprise about which separate
financial information is evaluated regularly by the chief operating decision maker, who is the Company&#8217;s chief executive officer
(&#8220;<b>CEO</b>&#8221;), in deciding how to allocate resources and assessing performance. The Company&#8217;s chief operating decision
maker allocates resources and assesses performance based upon discrete financial information at the consolidated level. </span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 28.35pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; background-color: white">Revenue
by geographical region can be found in the revenue recognition disclosures in Note 3 The following table presents the Company&#8217;s
property and equipment, net of depreciation, by geographic region:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 28.35pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">December
    31,</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><b>202<span style="font-size: 10pt">3</span></b></span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><b>202<span style="font-size: 10pt">2</span></b></span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Israel</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,309</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,609</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">United States</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-241; font-family: Times New Roman, Times, Serif">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-242; font-family: Times New Roman, Times, Serif">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">Total property and equipment,
    net:</span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,309</span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,609</span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 28.35pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; background-color: white">*)</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; background-color: white">Represents
less than $1</span></td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 28.35pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif"><b>Major
Customers:</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">During
the year ended December 31, 2023, the Company had three customers that accounted for 38.9%, 18.1% and 12.7%, respectively, of revenues.
During the year ended December 31, 2022, the Company had three customers that accounted for 33.4%, 19.4% and 18.9%, respectively, of
revenues. During the year ended December 31, 2021, the Company had three customers that accounted for 41.1%, 31.2% and 15.6%, respectively,
of revenues.</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-15<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-42<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-40<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//280/tableOfContent<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 26<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-26<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 34<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-34<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-41<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-21<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-21<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingInformationRevenueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingInformationRevenueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1</span><table class="report" border="0" cellspacing="2" id="idm140068076390944">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Pay vs Performance Disclosure - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net Income (Loss)</a></td>
<td class="num">$ (43,500)<span></span>
</td>
<td class="num">$ (40,494)<span></span>
</td>
<td class="num">$ (58,092)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_PvpTable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_PvpTable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-6<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-8<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-9<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4<br><br>Reference 13: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-10<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483581/946-220-45-7<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-7<br><br>Reference 35: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1A<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1B<br><br>Reference 38: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 39: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1</span><table class="report" border="0" cellspacing="2" id="idm140068079842848">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Insider Trading Arrangements<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_TradingArrByIndTable', window );"><strong>Trading Arrangements, by Individual</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_Rule10b51ArrAdoptedFlag', window );">Rule 10b5-1 Arrangement Adopted</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_NonRule10b51ArrAdoptedFlag', window );">Non-Rule 10b5-1 Arrangement Adopted</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_Rule10b51ArrTrmntdFlag', window );">Rule 10b5-1 Arrangement Terminated</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_NonRule10b51ArrTrmntdFlag', window );">Non-Rule 10b5-1 Arrangement Terminated</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_NonRule10b51ArrAdoptedFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_NonRule10b51ArrAdoptedFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_NonRule10b51ArrTrmntdFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_NonRule10b51ArrTrmntdFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_Rule10b51ArrAdoptedFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_Rule10b51ArrAdoptedFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_Rule10b51ArrTrmntdFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_Rule10b51ArrTrmntdFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_TradingArrByIndTable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 2<br> -Subparagraph A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_TradingArrByIndTable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1</span><table class="report" border="0" cellspacing="2" id="idm140068084999856">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accounting Policies, by Policy (Policies)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Significant Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock', window );">Basis of presentation</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"><tr style="vertical-align: top">
<td style="width: 57.9pt"></td><td style="width: 27.15pt"><span style="font-family: Times New Roman, Times, Serif">a.</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Basis of presentation:</span></td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 84.45pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">The
consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States
of America (US GAAP). The significant accounting policies followed in the preparation of the financial statements applied on a consistent
basis for all years presented in these financial statements.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">The
consolidated financial statements include the accounts of the Company&#8217;s wholly owned subsidiaries. All intercompany balances and
transactions have been eliminated in consolidation.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UseOfEstimates', window );">Use of estimates</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">b.</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Use of estimates:</span></td>
</tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">The
preparation of consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect
the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial
statements and the reported amounts of revenues and expenses during the reporting periods. Significant items subject to such estimates
and assumptions including fair value of warrants, share-based compensation and the underlying fair value of the Company&#8217;s Ordinary
Shares issued prior to the Merger.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">The
Company bases these estimates on historical and anticipated results, trends and various other assumptions that it believes are reasonable
under the circumstances, including assumptions as to future events. Actual results could differ from those estimates.</span></p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock', window );">Consolidated financial statements in U.S. dollars</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">c.</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Consolidated financial statements in U.S. dollars:</span></td>
</tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">A
substantial portion the Company&#8217;s activity including transactions with customers, as well as equity transactions and cash investments,
are incurred in U.S. dollars. The Company&#8217;s management believes that the U.S. dollar is the currency of the primary economic environment
in which the Company operates. Thus, the functional and reporting currency of the Company is the U.S. dollar.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">A
subsidiary&#8217;s functional currency is the currency of the primary economic environment in which the subsidiary operates; normally,
that is the currency of the environment in which a subsidiary primarily generates and expends cash. In making the determination of the
appropriate functional currency for a subsidiary, the Company considers cash flow indicators, local market indicators, financing indicators
and the subsidiary&#8217;s relationship with both the parent company and other subsidiaries. The Company has determined the functional
currency of its U.S. subsidiaries to be the U.S. Dollar.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">Monetary
accounts maintained in currencies other than the U.S. dollar are remeasured into U.S. dollars in accordance with Statement of the Accounting
Standard Codification (&#8220;ASC&#8221;) No. 830 &#8220;Foreign Currency Matters&#8221; (&#8220;ASC No. 830&#8221;). All transaction
gains and losses of the remeasured monetary balance sheet items are reflected in the statements of operations as financial income or
expenses as appropriate.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">Transactions
in foreign currency are translated into dollars in accordance with the principles set forth in ASC Subtopic 830-20, <i>Foreign Currency
Transaction</i>. Monetary assets and liabilities denominated in foreign currencies of the reporting date are translated to the functional
currency at the closing rate at the end of the reporting period. Non-monetary assets and liabilities denominated in foreign currency
are translated using the exchange rate at the date of the transaction. Gains and losses from remeasurement of assets and liabilities
denominated in currencies other than the respective functional currencies are included in the consolidated statements of operations.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskCreditRisk', window );">Concentration of credit risk</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">d.</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Concentration of credit risk:</span></td>
</tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">Most
of the Company&#8217;s cash and cash equivalents, restricted cash and short-term deposits were deposited with Israeli banks and were
comprised mainly of cash deposits and short-term deposits.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">The
Company&#8217;s trade receivables are derived from customers located globally. The Company mitigates its credit risks by performing credit
evaluations of its customers&#8217; financial conditions and requires customer advance payments in certain circumstances. The Company
generally does not require collateral.</span></p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy', window );">Cash and cash equivalents and restricted cash</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">e.</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Cash and cash equivalents and restricted cash:</span></td>
</tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">The
Company considers all highly liquid short-term deposits with original maturities of three months or less from the purchase date to be
cash equivalents. Cash equivalents consist primarily of amounts invested in short-term deposits.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">Restricted
cash consists of deposits at a financial institution that serves as collateral for a credit card agreement and lease agreements.</span></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_arbe_ShortTermDepositsPolicyPolicyTextBlock', window );">Short term deposits</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">f.</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Short term deposits:</span></td>
</tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">Short-term
deposits are bank deposits with an original maturity of more than three months and less than one year from the date of acquisition. The
deposits are presented according to their terms of deposit. As of December 31, 2023, these bank deposit bearing annual interest rates
in the range of&#160;4%-6%,</span></p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueOfFinancialInstrumentsPolicy', window );">Fair value of financial instruments</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">g.</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Fair value of financial instruments:</span></td>
</tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">The
estimated fair value of financial instruments has been determined by the Company using available market information and valuation methodologies.
Considerable judgment is required in estimating fair values. Accordingly, the estimates may not be indicative of the amounts the Company
could realize in a current market exchange. The following methods and assumptions were used by the Company in estimating the fair value
of their financial instruments:</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">The
carrying values of cash and cash equivalents, short-term deposits, restricted cash, trade receivables, other current assets, trade payables,
employees and payroll accruals, accrued expenses and other current liabilities approximate their fair values due to the short-term maturities
of these instruments.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">The
Company applies ASC No. 820, &#8220;Fair Value Measurements and Disclosures&#8221; (&#8220;ASC No. 820&#8221;), with respect to fair
value measurements of all financial assets and liabilities. In accordance with ASC No.&#160;820, the Company measures its short-term
deposits and warrant liability at fair value. Short-term deposits are classified within Level&#160;1 because these assets are valued
using quoted market prices. Fair value represents the amount that would be received to sell an asset or paid to transfer a liability
in an orderly transaction between market participants. As such, fair value is a market-based measurement that should be determined based
on assumptions that market participants would use in pricing an asset or a liability. A three-tier fair value hierarchy is established
as a basis for considering such assumptions and for inputs used in the valuation methodologies in measuring fair value:</span></p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.75in"></td><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Level
                                            1&#8212;Observable inputs that reflect quoted prices (unadjusted) for identical assets or
                                            liabilities in active markets.</span></td>
</tr></table><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.75in"></td><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Level
                                            2&#8212;Include other inputs that are directly or indirectly observable in the marketplace.</span></td>
</tr></table><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.75in"></td><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Level
                                            3&#8212;Unobservable inputs which are supported by little or no market activity.</span></td>
</tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">The
fair value hierarchy also requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when
measuring fair value.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">Pursuant
to the Merger, the Company (i) assumed a derivative warrant liability related to Company&#8217;s warrants that were issued to the holders of
private placement warrants that had been issued by ITAC in connection with its initial public offering, and (ii) issued equity instrument
in connection with warrants that had been issued as part of ITAC&#8217;s initial public offering and pursuant to the Merger became warrants
to purchase the Company&#8217;s Ordinary Shares. The fair value of the Company&#8217;s public warrants is measured based on the market
price of such warrants and are considered a Level 1 fair value measurement. The Company utilizes a Black-Scholes option pricing model
to estimate the fair value of the private placement warrants which are considered a Level 3 fair value measurement.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">The
Company&#8217;s private warrants are measured at each reporting period, with changes in fair value recognized in the statement of operations.
See Note 8.</span></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy', window );">Trade Receivables</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">h.</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Trade Receivables</span></td>
</tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">Trade
receivables are recorded at the invoiced amount and do not bear interest. Trade receivables are periodically assessed for allowance for
doubtful accounts, which is the Company&#8217;s best estimate of the amount of credit losses with respect to its existing trade receivable.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">The
Company&#8217;s accounts receivables accounting policy from January 1, 2023, following the adoption of the new current expected credit
losses (&#8220;CECL&#8221;) standard:</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">The
Company estimates CECL on trade receivables at inception for estimated losses resulting from the inability of the Company&#8217;s customers
to make required payments, based on estimated current expected credit losses. The allowance represents the current estimate of lifetime
expected credit losses over the remaining duration of existing accounts receivable considering historical information, current market
conditions and reasonable and supportable forecasts when appropriate. The estimate is a result of the Company&#8217;s ongoing evaluation
of collectability, customer creditworthiness, historical levels of credit losses, and future expectations.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">The
allowance for credit losses was not material for the years ended December 31, 2023, 2022 and 2021.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock', window );">Property and equipment</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">i.</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Property and equipment:</span></td>
</tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">Property
and equipment are recorded at cost and depreciated over their estimated useful lives using the straight-line method. Upon retirement
or sale, the cost of assets disposed of and the related accumulated depreciation are removed from the accounts and any resulting gain
or loss is included in income. Repair and maintenance costs are expensed as incurred.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">Depreciation
is calculated using the straight-line method over the estimated useful lives of the assets, at the following annual rates:</span></p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Computers and peripheral equipment</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">15-33</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Office furniture and equipment</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">7-15</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 88%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Vehicles</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 9%; text-align: center"><span style="font-family: Times New Roman, Times, Serif">15</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Leasehold improvement</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: center"><span style="-sec-ix-hidden: hidden-fact-214; font-family: Times New Roman, Times, Serif">(*)</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.75in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">(*)</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Leasehold improvements are amortized using the straight-line method over the shorter of the lease term or the estimated useful life of the improvements.</span></td>
</tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock', window );">Impairment of long-lived assets</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">j.</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Impairment of long-lived assets:</span></td>
</tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">Long-lived
assets are reviewed for impairment in accordance with ASC 360, &#8220;Property, Plant and Equipment&#8221; a (&#8220;ASC 360&#8221;),
whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Impairment exists when
the carrying value of the asset exceeds the aggregate undiscounted cash flows expected to be generated by the asset. The impairment to
be recognized is measured by the amount by which the carrying amount of the assets exceeds their fair value. During the years ended December
31, 2023, 2022 and 2021, no impairment losses were identified.</span></p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PostemploymentBenefitPlansPolicy', window );">Accrued post-employment benefit</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">k.</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Accrued post-employment benefit:</span></td>
</tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in">The employees of Arbe Ltd. are included under section 14 of the Israeli
Severance Compensation Act, 1963 (&#8220;Section 14&#8221;). Pursuant to Section 14, the Company&#8217;s Israeli employees are entitled
to monthly deposits, at a rate of&#160;8.33% of their monthly salary, deposited on their behalf to their chosen insurance funds. By making
the payments in accordance with Section 14, the Company is released from any future severance payments in respect of those employees.
The obligation to make the monthly deposits is expensed as incurred. The deposits pursuant to Section 14 are not recorded as an asset
in the consolidated balance sheet, and there is no liability recorded as the Company does not have a future obligation to make any additional
payments. Severance costs amounted to approximately $1,166, $1,240 and $826 for the years ended December 31, 2023, 2022 and 2021, respectively.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">One
of the Company&#8217;s U.S. Subsidiaries has a 401(k) defined contribution plan covering one employee in the U.S. The expenses recorded
by the U.S. subsidiaries for matching contributions for the years ended December 31, 2023, 2022 and 2021 were immaterial.</span></p><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-transform: uppercase; text-align: justify; text-indent: -56.7pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy', window );">Stock-based compensation</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">l.</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Stock-based compensation:</span></td>
</tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">The
Company accounts for stock-based compensation in accordance with ASC 718, &#8220;Compensation - Stock Compensation&#8221;, which requires
the measurement and recognition of compensation expense based on estimated fair values for all share-based payment awards made to employees,
nonemployees and directors. ASC 718 requires companies to estimate the fair value of equity-based payment awards on the date of grant
using an option-pricing model. The value of the portion of the award that is ultimately expected to vest is recognized as an expense
in the Company&#8217;s statements of operations over the applicable service periods.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">The
Company measures its share-based payment awards made to employees, directors, and non-employee service providers based on estimated fair
values. The fair value of each option award is estimated on the grant date using the Black-Scholes option pricing model which requires
several assumptions, of which the most significant are the expected share price volatility and the expected option term. The Company
recognizes forfeitures of equity-based awards as they occur. For graded vesting awards, the Company recognizes compensation expenses
based on the straight-line method over the applicable service period.</span></p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerSharePolicyTextBlock', window );">Net loss per share attributable to ordinary shareholders</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">m.</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Net loss per share attributable to ordinary shareholders:</span></td>
</tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">The
Company computes net loss per share using the two-class method required for participating securities. The two-class method requires income
available to ordinary shareholders for the period to be allocated between ordinary shares and participating securities based upon their
respective rights to receive dividends as if all income for the period had been distributed. The Company considered its convertible preferred
shares, which were outstanding through October 7, 2021, the date of the closing of the Merger, to be participating securities as the
holders of the convertible preferred shares would be entitled to dividends that would be distributed to the holders of ordinary shares,
equal to the higher of their original issue price pro-rata basis assuming conversion of all convertible preferred shares into ordinary
shares and that there are no preferences to any holders of any shares. These participating securities do not contractually require the
holders of such shares to participate in the Company&#8217;s losses. As such, net loss for the periods presented was not allocated to
the Company&#8217;s participating securities.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">The
Company&#8217;s basic net loss per share is calculated by dividing net loss attributable to ordinary shareholders by the weighted-average
number of ordinary shares outstanding for the period, without consideration of potentially dilutive securities. The diluted net loss
per share is calculated by giving effect to all potentially dilutive securities outstanding for the period using the treasury share method
or the if-converted method based on the nature of such securities. Diluted net loss per share is the same as basic net loss per share
in periods when the effects of potentially dilutive shares of ordinary shares are anti-dilutive. See Note 10.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock', window );">Other Comprehensive loss</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">n.</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Other Comprehensive loss:</span></td>
</tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">The
Company has no components of comprehensive loss other than net loss. Thus, comprehensive loss is the same as net loss for the periods
presented.</span></p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRecognitionPolicyTextBlock', window );">Revenue recognition</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">p.</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Revenue recognition:</span></td>
</tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">The
Company follows the provisions of ASC Topic 606, Revenue from Contracts with Customers (&#8220;ASC 606&#8221;), which apply to all contracts
with customers. Under Topic 606, revenues are recognized when control of the promised goods or services is transferred to the customers,
in an amount that reflects the consideration that the Company expects to receive in exchange for those goods or services. To determine
the appropriate revenue recognition for arrangements that an entity determines are within the scope of Topic 606, the entity performs
the following five steps:</span></p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.75in"></td><td style="width: 0.25in; text-align: left"></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Identify
                                            the contract(s) with a customer;</span></td>
</tr></table><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.75in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Identify
                                            the performance obligations in the contract;</span></td>
</tr></table><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.75in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Determine
                                            the transaction price;</span></td>
</tr></table><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.75in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Allocate
                                            the transaction price to the performance obligations in the contract; and</span></td>
</tr></table><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.75in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Recognize
                                            revenue when (or as) the entity satisfies a performance obligation.</span></td>
</tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">At
contract inception, once the contract is determined to be within the scope of Topic 606, the Company assesses the goods or services promised
within the contract and determines the performance obligations and assesses whether each promised good or service is distinct. The Company
evaluates each performance obligation to determine if it is satisfied at a point in time or over time. See Note 3.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif"><i>Nature
of Products and Services</i></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">The
Company derives its revenues mainly from sales of chipsets and prototype radar systems to be installed onto automotive vehicles and professional
services. Revenue from chipsets and prototype radar systems is recognized at the point in time when the control of the goods is transferred
to the customer, generally upon delivery, and the Company has no remaining performance obligations.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif"><i>Right
of Return</i></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">The
Company&#8217;s general terms and conditions for its contracts do not contain a right of return that allows the customer to return products
and receive a credit. Therefore, the Company does not estimate returns and generally recognizes revenue at contract price upon product
delivery.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif"><i>Deferred
Revenue</i></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">Deferred
revenues, which represent a contract liability, where the Company has an obligation to transfer goods or services to the customer for
which it received consideration from the customer.</span></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostOfSalesPolicyTextBlock', window );">Cost of revenues</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">q.</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Cost of revenues:</span></td>
</tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">Cost
of revenue includes the manufacturing cost of radar sensors and chipsets, which primarily consists of components cost, assembly costs
and personnel-related costs directly associated with our customer support personnel.</span></p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpensePolicy', window );">Research and development expenses, net</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">r.</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Research and development expenses, net:</span></td>
</tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">Research
and development costs, net of grants received, are charged to the consolidated statement of operations as incurred.</span></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxPolicyTextBlock', window );">Income taxes</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">s.</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Income taxes:</span></td>
</tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">The
Company accounts for income taxes in accordance with ASC 740, &#8220;Income Taxes&#8221;. This standard prescribes the use of the asset
and liability method whereby deferred tax asset and liability account balances are determined based on differences between the financial
statement carrying amount and the tax bases of assets and liabilities and are measured using the enacted tax rates and laws that will
be in effect when the differences are expected to reverse. The Company provides a valuation allowance, if necessary, to reduce deferred
tax assets to the amount that is more likely than not to be realized.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">The
Company recognizes the tax benefit from a tax position only if it is more likely than not that the tax position will be sustained on
examination by the taxing authorities, based on the technical merits of the position. A tax position that meets the more-likely-than-not
recognition threshold is measured at the largest amount that is greater than 50 percent likely of being realized upon settlement with
the taxing authority using the facts, circumstances, and information available at the reporting date.</span></p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContingentLiabilityReserveEstimatePolicy', window );">Contingent Liabilities</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">t.</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Contingent Liabilities</span></td>
</tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">The
Company accounts for its contingent liabilities in accordance with ASC No.&#160;450, &#8220;Contingencies.&#8221; A provision is recorded
when it is both probable that a liability has been incurred and the amount of the loss can be reasonably estimated. With respect to legal
matters, provisions are reviewed and adjusted to reflect the impact of negotiations, estimated settlements, legal rulings, advice of
legal counsel and other information and events pertaining to a particular matter. As of December&#160;31, 2023 and 2022, the Company
is not a party to any litigation that could have a material adverse effect on the Company&#8217;s business, financial position, results
of operations or cash flows.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeLeasesPolicyTextBlock', window );">Leases</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">u.</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Leases:</span></td>
</tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">On
January 1, 2022, the Company adopted Accounting Standards Update No. 2016-02, Leases (Topic 842) (ASU 2016-02) relating to the accounting
treatment of lease obligations, using the modified retrospective method.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">The
Company elected the package of practical expedients permitted under the transition guidance. The Company also elected not to recognize
a lease liability and a right-of-use (&#8220;ROU&#8221;) asset on the balance sheet for leases with a term of twelve months or less.
The Company recognizes the associated lease payments in the consolidated statements of income on a straight-line basis over the lease
term.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">Under
Topic 842, the Company determines if an arrangement is a lease at inception. ROU assets and liabilities are recognized at the commencement
date based on the present value of remaining lease payments over the lease term. For this purpose, the Company considers fixed and determinable
payments at the time of commencement. As most of the Company leases do not provide an implicit rate, the Company uses its incremental
borrowing rate based on the information available at the commencement date in determining the present value of lease payments. The incremental
borrowing rate is estimated to approximate the interest rate on a collateralized basis with similar terms and payments. The ROU asset
is recorded net of any lease incentives received. The lease terms may include options to extend or terminate the lease when it is reasonably
certain that the Company will exercise such options.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">Payments
under the Company&#8217;s lease agreements are primarily fixed, however, certain lease agreements contain variable costs such as common
area maintenance, real estate taxes, and insurance are not included in the lease liability and are recognized as they are incurred. See
Note 6.</span></p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">Impact of recently issued accounting standard</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">v.</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Impact of recently issued accounting standard:</span></td>
</tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">In
June 2016, the FASB issued ASU No. 2016-13, Financial Instruments&#8212;Credit Losses (&#8220;ASC 326&#8221;): Measurement of Credit
Losses on Financial Instruments to introduce a new model for recognizing credit losses on financial instruments based on estimated current
expected credit losses, or CECL. Under the new standard, an entity is required to estimate CECL on trade receivables at inception, based
on historical information, current conditions, and reasonable and supportable forecasts. The guidance is effective for the Company for
annual periods beginning after December 15, 2022, including interim periods within those fiscal years. Early application is permitted.
The Company adopted ASC 326 on January 1, 2023, and there was no material impact on the Company&#8217;s consolidated balance sheet and
the consolidated statements of operations upon adoption.</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_arbe_ShortTermDepositsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Policy disclosure of short term deposits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">arbe_ShortTermDepositsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>arbe_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BasisOfAccountingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Entity's cash and cash equivalents accounting policy with respect to restricted balances. Restrictions may include legally restricted deposits held as compensating balances against short-term borrowing arrangements, contracts entered into with others, or company statements of intention with regard to particular deposits; however, time deposits and short-term certificates of deposit are not generally included in legally restricted deposits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(1)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomePolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskCreditRisk">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for credit risk.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 825<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480981/942-825-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskCreditRisk</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContingentLiabilityReserveEstimatePolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the claims loss reserve for insurance contracts with a life contingency (permanent life, some term life, accident and health, some annuities), describing the loss exposures and bases and methodologies for making the relevant accounting estimates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(13)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContingentLiabilityReserveEstimatePolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfSalesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for cost of product sold and service rendered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Accounting Standards Codification<br> -Topic 705<br> -Publisher FASB<br> -URI https://asc.fasb.org//705/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfSalesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerSharePolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerSharePolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueOfFinancialInstrumentsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for determining the fair value of financial instruments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 60<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 820<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482053/820-10-60-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 825<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueOfFinancialInstrumentsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for (1) transactions denominated in a currency other than the reporting enterprise's functional currency, (2) translating foreign currency financial statements that are incorporated into the financial statements of the reporting enterprise by consolidation, combination, or the equity method of accounting, and (3) remeasurement of the financial statements of a foreign reporting enterprise in a hyperinflationary economy.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//830/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for recognizing and measuring the impairment of long-lived assets. An entity also may disclose its accounting policy for long-lived assets to be sold. This policy excludes goodwill and intangible assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.CC)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480091/360-10-S99-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 05<br> -Paragraph 4<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482338/360-10-05-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(h)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479886/946-10-S99-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-17<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-9<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482525/740-10-45-25<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482525/740-10-45-28<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-19<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 20<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-20<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeLeasesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for leasing arrangement entered into by lessee.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeLeasesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PostemploymentBenefitPlansPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for postemployment benefits. Postemployment benefits are benefits provided to former or inactive employees, their beneficiaries, and covered dependents after employment but before retirement, except for: a) benefits provided through a pension or postretirement benefit plan, b) individual deferred compensation arrangements, c) special or contractual termination benefits, and d) stock compensation plans.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 712<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//712/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PostemploymentBenefitPlansPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -SubTopic 360<br> -Topic 958<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480321/958-360-50-6<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -SubTopic 360<br> -Topic 958<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480321/958-360-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for determining the allowance for doubtful accounts for trade and other accounts receivable balances, and when impairments, charge-offs or recoveries are recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481962/310-10-50-9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpensePolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for costs it has incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 730<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 05<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483044/730-10-05-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpensePolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRecognitionPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for revenue. Includes revenue from contract with customer and from other sources.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483426/235-10-50-4<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (e)<br> -SubTopic 10<br> -Topic 235<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483426/235-10-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRecognitionPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(v)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.C.Q3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479830/718-10-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.D.1.Q5)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479830/718-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.D.3.Q2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479830/718-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.D.2.Q6)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479830/718-10-S99-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//718/tableOfContent<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UseOfEstimates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-9<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-4<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-11<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-12<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UseOfEstimates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1</span><table class="report" border="0" cellspacing="2" id="idm140068078356736">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Significant Accounting Policies (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Significant Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_arbe_PropertyPlantAndEquipmentUsefulLifeTableTextBlock', window );">Schedule of the Straight-Line Method Over the Estimated Useful Lives of the Assets</a></td>
<td class="text"><span style="font-family: Times New Roman, Times, Serif">Depreciation
is calculated using the straight-line method over the estimated useful lives of the assets, at the following annual rates:</span><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Computers and peripheral equipment</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">15-33</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Office furniture and equipment</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">7-15</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 88%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Vehicles</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 9%; text-align: center"><span style="font-family: Times New Roman, Times, Serif">15</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Leasehold improvement</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: center"><span style="-sec-ix-hidden: hidden-fact-214; font-family: Times New Roman, Times, Serif">(*)</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.75in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">(*)</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Leasehold improvements are amortized using the straight-line method over the shorter of the lease term or the estimated useful life of the improvements.</span></td>
</tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_arbe_PropertyPlantAndEquipmentUsefulLifeTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the useful lives of property, plant and equipment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">arbe_PropertyPlantAndEquipmentUsefulLifeTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>arbe_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1</span><table class="report" border="0" cellspacing="2" id="idm140068076286032">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Revenue [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueTableTextBlock', window );">Schedule of Revenue Disaggregated by Geography</a></td>
<td class="text"><span style="font-family: Times New Roman, Times, Serif">Revenue
disaggregated by geography for the years ended December 31, 2023, 2022 and 2021, based on the billing address of the Company&#8217;s
customers, consists of the following:</span><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="22" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><b>Year
                                            ended</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><b>December
                                            31,</b></span></p></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2023</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2022</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2021</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Revenue</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">%
    of Revenue</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Revenue</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">%
    of Revenue</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Revenue</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">%
    of Revenue</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Revenue by geography:</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 28%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">China</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">639</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">43.5</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,476</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">42.0</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">702</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">31.2</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Hong Kong</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">266</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">18.1</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-215; font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-216; font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">35</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">1.6</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Sweden</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">247</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">16.8</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,276</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">36.3</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">928</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">41.2</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">USA</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">148</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">10.1</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">135</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">3.8</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">63</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">2.8</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Germany</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">81</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">5.5</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">284</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">8.1</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">351</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">15.6</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Israel</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">50</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">3.4</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">25</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">0.7</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">34</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">1.5</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Italy</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-217; font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-218; font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">124</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">3.5</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-219; font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-220; font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Switzerland</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-221; font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-222; font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">197</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">5.6</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">53</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">2.4</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Other</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">39</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">2.6</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-223; font-family: Times New Roman, Times, Serif">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-224; font-family: Times New Roman, Times, Serif">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">83</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">3.7</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">Total revenue</span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,470</span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">100</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">3,517</span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">100</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">2,249</span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">100</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td></tr>
  </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenuesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenuesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1</span><table class="report" border="0" cellspacing="2" id="idm140068076462896">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Prepaid Expenses and Other Receivables (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssetsAbstract', window );"><strong>Prepaid Expenses and Other Receivables [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock', window );">Schedule of Prepaid Expenses and Other Receivables</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">December
    31,</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2023</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2022</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Government authorities</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">385</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">280</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Deposits</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">69</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">85</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Grants receivable</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">310</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">319</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Prepaid expenses
    and other</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,262</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,155</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify; padding-bottom: 4pt; padding-left: 0.5in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">2,026</span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,839</span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the amounts paid in advance for capitalized costs that will be expensed with the passage of time or the occurrence of a triggering event, and will be charged against earnings within one year or the normal operating cycle, if longer; the aggregate carrying amount of current assets, not separately presented elsewhere in the balance sheet; and other deferred costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1</span><table class="report" border="0" cellspacing="2" id="idm140068078327712">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property and Equipment (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentTextBlock', window );">Schedule of Property and Equipment</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">December
    31,</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2023</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2022</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Cost:</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.25in; width: 76%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Computers
    and peripheral equipment</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">2,448</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">2,350</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Leasehold
    improvement</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">582</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">438</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Office
    furniture and equipment</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">133</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">128</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Vehicles</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">149</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">139</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">3,312</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">3,055</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Accumulated
    depreciation</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">2,003</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,446</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">Property
    and equipment, net</span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,309</span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,609</span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1</span><table class="report" border="0" cellspacing="2" id="idm140068076301120">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasesOperatingAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLeaseIncomeTableTextBlock', window );">Schedule of Supplemental Cash Flow Information Related to Leases</a></td>
<td class="text"><span style="font-family: Times New Roman, Times, Serif; font-weight: normal; text-transform: none">Supplemental
cash flow information related to leases was as follows:</span><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-align: justify"><span style="text-decoration: none; font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><b>Year
                                            ended</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2.85pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><b>December
                                            31,</b></span></p></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: justify"><span style="text-decoration: none; font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2023</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2022</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-decoration: none; width: 76%; text-align: justify"><span style="text-decoration: none; font-family: Times New Roman, Times, Serif">Cash
    payments and expenses related to operating leases</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(451</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(370</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-decoration: none; text-align: justify"><span style="text-decoration: none; font-family: Times New Roman, Times, Serif">Operating
    lease right-of-use assets and liabilities, net</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">2</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(84</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  </table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock', window );">Schedule of Maturities of Lease Liabilities</a></td>
<td class="text"><span style="font-family: Times New Roman, Times, Serif; font-weight: normal; text-transform: none">Maturities
of lease liabilities as of December 31, 2023, were as follows:</span><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 88%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">2024</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">443</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">2025</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">393</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">2026</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">356</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">2027 and after</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,033</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Total lease payments</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">2,225</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Less imputed interest</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">483</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Total lease liabilities</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,742</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeaseCostTableTextBlock', window );">Schedule of Supplemental Balance Sheet Information Related to Operating Leases</a></td>
<td class="text"><span style="font-family: Times New Roman, Times, Serif; font-weight: normal; text-transform: none">Supplemental
balance sheet information related to operating leases were as follows:</span><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="white-space: nowrap; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">December&#160;31,</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">December&#160;31,</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2023</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><b>202<span style="font-size: 10pt">2</span></b></span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Operating lease right-of-use assets</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="white-space: nowrap; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="white-space: nowrap; width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,740</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">465</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Current maturities of operating leases</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="white-space: nowrap; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="white-space: nowrap; text-align: right"><span style="font-family: Times New Roman, Times, Serif">436</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">364</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Long-term operating lease liabilities</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="white-space: nowrap; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="white-space: nowrap; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,306</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">17</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Weighted average remaining lease term (in years)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="white-space: nowrap; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="white-space: nowrap; text-align: right"><span style="font-family: Times New Roman, Times, Serif">5.5</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">1.1</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Weighted average discount rate</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="white-space: nowrap; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="white-space: nowrap; text-align: right"><span style="font-family: Times New Roman, Times, Serif">9.4</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">5.8</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td></tr>
  </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseCostTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseCostTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesOperatingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesOperatingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLeaseIncomeTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of components of income from operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479773/842-30-50-5<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6A<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482964/270-10-50-6A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLeaseIncomeTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1</span><table class="report" border="0" cellspacing="2" id="idm140068076154144">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Shareholders&#8217; Equity (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteAbstract', window );"><strong>Shareholders&#8217; Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock', window );">Schedule of Stock Option Activity</a></td>
<td class="text"><span style="font-family: Times New Roman, Times, Serif">A
summary of the stock option activity under the Company&#8217;s equity plans during the years ended December 31, 2023, 2022 and 2021 is
as follows:</span><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><b>Outstanding</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2.85pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><b>share
                                            options</b></span></p></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Weighted-average
    exercise<br/>
 price ($)</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Weighted
    average remaining contractual<br/>
 life (years)</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Aggregate
    intrinsic value ($ in thousands)</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Options:</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 52%; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Outstanding
    as of December&#160;31, 2020</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">3,768,034</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">0.767</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">4.626</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">119,146</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Granted</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,966,916</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">7.250</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Forfeited</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(117,863</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">0.972</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Exercised</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(155,750</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif">0.602</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Outstanding
    as of December&#160;31, 2021</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif">5,461,337</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif">3.102</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif">5.363</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif">16,713,971</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Granted</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,630,142</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif">6.833</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Forfeited</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(468,814</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif">5.557</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Exercised</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(570,451</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif">0.482</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Outstanding as of December&#160;31,
    2022</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">6,052,214</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">4.166</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">5.570</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">7,761,705</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Granted</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">430,874</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">2.728</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Forfeited</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(351,671</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">7.767</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Exercised</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(1,074,162</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">0.654</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 4pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 11.35pt; text-align: left; text-indent: -8.5pt"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif"><b>Outstanding
                                            as of December&#160;31, 2023 </b></span></p></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">5,057,255</span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">4.543</span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">5.662</span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">2,352,517</span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">Exercisable as of December&#160;31,
    2023</span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">3,210,191</span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">3.643</span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">4.403</span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">2,277,303</span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">Options available for
    future grants</span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">611,246</span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: -28.35pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock', window );">Schedule of RSUs Activity</a></td>
<td class="text"><span style="font-family: Times New Roman, Times, Serif">A
summary of the Company&#8217;s RSUs activity during the years ended December 31, 2023, 2022 and 2021 is as follows:</span><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Numbers
    of RSUs</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">RSUs:</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; text-align: left">&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"><b>Outstanding as of January 1, 2021</b></span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-225; font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 88%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Granted</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,968,794</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Forfeited</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-226; font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Vested</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-227; font-family: Times New Roman, Times, Serif">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Outstanding as of December&#160;31,
    2021</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,968,794</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Granted</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,619,898</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Forfeited</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(417,025</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Vested</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(573,583</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Outstanding as of December&#160;31,
    2022</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">2,598,084</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Granted</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">2,908,983</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Forfeited</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(370,067</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Vested</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(895,170</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 4pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Outstanding as of December&#160;31,
    2023</span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">4,241,830</span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock', window );">Schedule of Compensation to Employees</a></td>
<td class="text"><span style="font-family: Times New Roman, Times, Serif">The
following table sets forth the parameters used in computation of the options compensation to employees and service providers:</span><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="10" style="border-bottom: Black 1.5pt solid; white-space: nowrap; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><b>Year
                                            ended </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><b>December
                                            31</b></span></p></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2023</span></td><td style="white-space: nowrap; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2022</span></td><td style="white-space: nowrap; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2021</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="white-space: nowrap; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="white-space: nowrap; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="white-space: nowrap; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Expected term, in years</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="white-space: nowrap; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="white-space: nowrap; width: 9%; text-align: center"><span style="font-family: Times New Roman, Times, Serif">5.82</span></td><td style="white-space: nowrap; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="white-space: nowrap; width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="white-space: nowrap; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="white-space: nowrap; width: 9%; text-align: center"><span style="font-family: Times New Roman, Times, Serif">4.41-6.11</span></td><td style="white-space: nowrap; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="white-space: nowrap; width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="white-space: nowrap; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="white-space: nowrap; width: 9%; text-align: center"><span style="font-family: Times New Roman, Times, Serif">4.61-6.11</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Expected volatility</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="white-space: nowrap; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="white-space: nowrap; text-align: center"><span style="font-family: Times New Roman, Times, Serif">47%-51.75%</span></td><td style="white-space: nowrap; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="white-space: nowrap; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="white-space: nowrap; text-align: center"><span style="font-family: Times New Roman, Times, Serif">47%-48%</span></td><td style="white-space: nowrap; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="white-space: nowrap; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="white-space: nowrap; text-align: center"><span style="font-family: Times New Roman, Times, Serif">42%-46%</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Risk-free interest rate</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="white-space: nowrap; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="white-space: nowrap; text-align: center"><span style="font-family: Times New Roman, Times, Serif">4.15%-4.55%</span></td><td style="white-space: nowrap; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="white-space: nowrap; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="white-space: nowrap; text-align: center"><span style="font-family: Times New Roman, Times, Serif">1.74%-3.96%</span></td><td style="white-space: nowrap; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="white-space: nowrap; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="white-space: nowrap; text-align: center"><span style="font-family: Times New Roman, Times, Serif">0.49%-1.28%</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Expected dividend yield</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="white-space: nowrap; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="white-space: nowrap; text-align: center"><span style="font-family: Times New Roman, Times, Serif">0</span>%</td><td style="white-space: nowrap; text-align: left"></td><td style="white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="white-space: nowrap; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="white-space: nowrap; text-align: center"><span style="font-family: Times New Roman, Times, Serif">0</span>%</td><td style="white-space: nowrap; text-align: left"></td><td style="white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="white-space: nowrap; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="white-space: nowrap; text-align: center"><span style="font-family: Times New Roman, Times, Serif">0</span>%</td><td style="text-align: left"></td></tr>
  </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 84.45pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif"><i>&#160;</i></span></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock', window );">Schedule of Share Based Compensation Expense</a></td>
<td class="text"><span style="font-family: Times New Roman, Times, Serif; background-color: white">The
following table presents stock-based compensation expense to employees included in the Company&#8217;s consolidated statements of operations:</span><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="10" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><b>Year
                                            ended </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><b>December
                                            31,</b></span></p></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2023</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2022</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2021</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Research and development</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">8,721</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">5,726</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,518</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Sales and marketing</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">2,229</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,403</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">217</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">General and administrative</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,786</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,537</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">419</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Cost of revenues</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">276</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">127</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">57</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">Total stock-based compensation
    expense</span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">13,012</span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">8,793</span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">2,211</span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of activity for award under share-based payment arrangement. Includes, but is not limited to, outstanding award at beginning and end of year, granted, exercised, forfeited, and weighted-average grant date fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -SubTopic 10<br> -Topic 718<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -SubTopic 10<br> -Topic 718<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the number and weighted-average grant date fair value for restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock units that were granted, vested, or forfeited during the year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -SubTopic 10<br> -Topic 718<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -SubTopic 10<br> -Topic 718<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 718<br> -SubTopic 10<br> -Subparagraph (f)(2)<br> -Name Accounting Standards Codification<br> -Paragraph 2<br> -Section 50<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1</span><table class="report" border="0" cellspacing="2" id="idm140068076161728">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Loss Per Share Attributible to Ordinary Sharholders (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Net Loss Per Share Attributible to Ordinary Sharholders [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock', window );">Schedule of Sets Forth the Computation of Basic and Diluted Net Loss Per Share Attributable</a></td>
<td class="text">The
following table sets forth the computation of basic and diluted net loss per share attributable to ordinary shareholders for the periods
presented:<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="10" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><b>Year
                                            ended </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><b>December
                                            31,</b></span></p></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2023</span></td><td style="padding-bottom: 2.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2022</span></td><td style="padding-bottom: 2.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2021</span></td><td style="padding-bottom: 2.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"><b><span style="text-decoration:underline">Basic</span></b></span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="padding-bottom: 1.5pt; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="padding-bottom: 1.5pt; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="padding-bottom: 1.5pt; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: left"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: left"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: left; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif"><b>Numerator:</b></span></p></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Net loss</span></td><td style="width: 1%; padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 4pt double; width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(43,500</span></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="width: 1%; padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 4pt double; width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(40,494</span></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="width: 1%; padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 4pt double; width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(58,092</span></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: left; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: left; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif"><b>Denominator:</b></span></p></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Weighted-average
    shares used in computing loss per share attributable to ordinary shareholders, basic</span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">72,021,520</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">63,489,983</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">22,027,292</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Loss per share attributable to ordinary shareholders,
    basic</span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(0.60</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(0.64</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(2.64</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"><b><span style="text-decoration:underline">Diluted</span></b></span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>

<tr style="vertical-align: bottom">
    <td style="text-align: left"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 11.35pt; text-align: left; text-indent: -8.5pt"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif"><b>Numerator:</b></span></p></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Adjusted Net loss*</span></td><td style="width: 1%; padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 4pt double; width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(44,256</span></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="width: 1%; padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 4pt double; width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(48,919</span></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="width: 1%; padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 4pt double; width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(58,092</span></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 11.35pt; text-align: left; text-indent: -8.5pt"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif"><b>Denominator:</b></span></p></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Weighted-average
    shares used in computing loss per share attributable to ordinary shareholders, diluted</span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">62,390,302</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">60,960,641</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">22,027,292</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Loss per share attributable to ordinary shareholders,
    diluted*</span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(0.71</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(0.80</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(2.64</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  </table><table cellpadding="0" cellspacing="0" style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">*</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-weight: normal">Loss per share attributable to ordinary shareholders, diluted, was adjusted and take into consideration warrants liabilities revaluations as part of our net loss for 2023 and 2022.</span></td>
</tr></table><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><b>Year
                                            ended </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2.85pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><b>December
                                            31,</b></span></p></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2023</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2022</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Net loss</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(43,500</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(40,494</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Revaluation of warrants</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(756</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(8,425</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">Adjusted Net loss</span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(44,256</span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(48,919</span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  </table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock', window );">Schedule of Ordinary Shares that were Excluded from the Computation of Diluted Net Loss Per Share</a></td>
<td class="text"><span style="font-family: Times New Roman, Times, Serif; font-weight: normal">The
potential Ordinary Shares that were excluded from the computation of diluted net loss per share attributable to ordinary shareholders
for the years ended December 31, 2023, 2022 and 2021 because including them would have been anti-dilutive are as follows:</span><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="10" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><b>Year
                                            ended </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><b>December
                                            31,</b></span></p></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2023</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2022</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2021</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Convertible preferred shares</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 9%; text-align: right"><span style="-sec-ix-hidden: hidden-fact-228; font-family: Times New Roman, Times, Serif">-</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 9%; text-align: right"><span style="-sec-ix-hidden: hidden-fact-229; font-family: Times New Roman, Times, Serif">-</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">26,499,069</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Outstanding share options</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">9,299,085</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">8,650,298</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,362,786</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">Total</span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">9,299,085</span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">8,650,298</span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">27,861,855</span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1</span><table class="report" border="0" cellspacing="2" id="idm140068078304992">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Taxes on Income (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Taxes on Income [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock', window );">Schedule of Company&#8217;s Loss Before Income Taxes</a></td>
<td class="text"><span style="font-family: Times New Roman, Times, Serif">The
following are the domestic (i.e. Israeli) and foreign components of the Company&#8217;s loss before income taxes:</span><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="10" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2.85pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><b>Year
                                            ended </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2.85pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><b>December
                                            31,</b></span></p></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2023</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2022</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2021</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Domestic</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(43,500</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(40,494</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(58,092</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Foreign</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-230; font-family: Times New Roman, Times, Serif">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-231; font-family: Times New Roman, Times, Serif">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-232; font-family: Times New Roman, Times, Serif">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">Total</span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(43,500</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(40,494</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(58,092</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  </table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock', window );">Schedule of Reconciliation Income Tax Benefit</a></td>
<td class="text"><span style="font-family: Times New Roman, Times, Serif">The
reconciliation of the income tax benefit that would result from applying the Israeli statutory tax rate to the Company&#8217;s reported
income tax (benefit) is as follows:</span><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="10" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2.85pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><b>Year
                                            ended </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2.85pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><b>December
                                            31,</b></span></p></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2023</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2022</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2021</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; width: 64%; text-align: left; padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">Loss
    before income taxes, as reported in the consolidated statements of operations</span></td><td style="width: 1%; padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 4pt double; width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">43,500</span></td><td style="width: 1%; padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 1%; padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 4pt double; width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">40,494</span></td><td style="width: 1%; padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 1%; padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 4pt double; width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">58,092</span></td><td style="width: 1%; padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">Statutory
    tax rate</span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">23</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">23</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">23</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Income
    tax benefit at statutory tax rate</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(10,005</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(9,314</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(13,361</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Effect
    of Non-deductible expenses</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">3,063</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">475</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">6,129</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Remeasurement
    of deferred taxes from currency exchange*</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-233; font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">3,517</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">209</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Change
    in valuation allowance</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">7,508</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">5,322</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">7,023</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Other</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(566</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-234; font-family: Times New Roman, Times, Serif">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-235; font-family: Times New Roman, Times, Serif">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">Reported
    income taxes benefit</span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="-sec-ix-hidden: hidden-fact-236; font-family: Times New Roman, Times, Serif">-</span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="-sec-ix-hidden: hidden-fact-237; font-family: Times New Roman, Times, Serif">-</span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="-sec-ix-hidden: hidden-fact-238; font-family: Times New Roman, Times, Serif">-</span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif"><b>*</b></span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">The
income Tax Regulations (rules regarding ledger management of foreign invested companies and certain partnerships and the determination
of their taxable income), 1986 allow Foreign Invested Companies (i.e., foreign holding percentage of more than 25%) to report for tax
purposes in US dollars. The Company implemented these regulations on January 1, 2023.</span></td>
</tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock', window );">Schedule of Deferred Tax Assets</a></td>
<td class="text"><span style="font-family: Times New Roman, Times, Serif">The
principal components of the Company&#8217;s deferred tax assets are as follows:</span><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">December
    31</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2023</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2022</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Deferred tax assets:</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; width: 76%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Net operating loss carry forwards</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">28,032</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">21,991</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Research and development</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">6,252</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">4,834</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Employees and payroll accrual</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">299</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">272</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Property and equipment</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">79</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">57</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Total deferred tax assets</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">34,662</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">27,154</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Valuation allowance</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(34,662</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(27,154</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">Deferred
    tax assets, net of valuation allowance</span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="-sec-ix-hidden: hidden-fact-239; font-family: Times New Roman, Times, Serif">-</span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="-sec-ix-hidden: hidden-fact-240; font-family: Times New Roman, Times, Serif">-</span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Paragraph 2<br> -Section 50<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Paragraph 12<br> -Section 50<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of income before income tax between domestic and foreign jurisdictions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1</span><table class="report" border="0" cellspacing="2" id="idm140068076389440">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Information (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Segment Information [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock', window );">Schedule of Property and Equipment, Net of Depreciation, by Geographic Region</a></td>
<td class="text"><span style="font-family: Times New Roman, Times, Serif; background-color: white">Revenue
by geographical region can be found in the revenue recognition disclosures in Note 3 The following table presents the Company&#8217;s
property and equipment, net of depreciation, by geographic region:</span><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">December
    31,</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><b>202<span style="font-size: 10pt">3</span></b></span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><b>202<span style="font-size: 10pt">2</span></b></span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Israel</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,309</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,609</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">United States</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-241; font-family: Times New Roman, Times, Serif">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-242; font-family: Times New Roman, Times, Serif">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">Total property and equipment,
    net:</span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,309</span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,609</span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of long-lived assets, excluding financial instruments, long-term customer relationships of a financial institution, mortgage rights, deferred policy acquisition costs, and deferred tax assets, by geographic areas located in the entity's country of domicile and foreign countries in which the entity holds assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Subparagraph b<br> -SubTopic 10<br> -Topic 280<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-41<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingInformationRevenueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingInformationRevenueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1</span><table class="report" border="0" cellspacing="2" id="idm140068084401264">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>General (Details)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="2"></th>
</tr>
<tr>
<th class="th">
<div>Dec. 31, 2023 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2023 </div>
<div>&#8362; / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2023 </div>
<div>$ / shares </div>
<div>shares</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_arbe_GeneralDetailsLineItems', window );"><strong>General [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockOtherSharesOutstanding', window );">Ordinary shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">48,268,611<span></span>
</td>
<td class="nump">48,268,611<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesIssuedPricePerShare', window );">Ordinary shares par value | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsOfOrdinaryDividends', window );">Ordinary shares amount (in Dollars) | $</a></td>
<td class="nump">$ 525,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Warrants shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,735,680<span></span>
</td>
<td class="nump">10,735,680<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceInitialPublicOffering', window );">Total gross proceeds (in Dollars) | $</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 98,587<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockConsiderationReceivedOnTransaction', window );">Transaction costs (in Dollars) | $</a></td>
<td class="nump">16,707<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=arbe_PublicWarrantsMember', window );">Public Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_arbe_GeneralDetailsLineItems', window );"><strong>General [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Warrants shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,623,600<span></span>
</td>
<td class="nump">7,623,600<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=arbe_PrivateWarrantsMember', window );">Private Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_arbe_GeneralDetailsLineItems', window );"><strong>General [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Warrants shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,112,080<span></span>
</td>
<td class="nump">3,112,080<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=arbe_PIPEMember', window );">PIPE [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_arbe_GeneralDetailsLineItems', window );"><strong>General [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesIssuedPricePerShare', window );">Ordinary shares par value | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceInitialPublicOffering', window );">Total gross proceeds (in Dollars) | $</a></td>
<td class="nump">$ 118,288<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Sale of ordinary shares</a></td>
<td class="nump">10,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_arbe_GeneralDetailsLineItems', window );"><strong>General [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesIssuedPricePerShare', window );">Ordinary shares par value | &#8362; / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8362; 0.01<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_arbe_GeneralDetailsLineItems', window );"><strong>General [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesIssuedPricePerShare', window );">Ordinary shares par value | &#8362; / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8362; 0.000216<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember', window );">Common Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_arbe_GeneralDetailsLineItems', window );"><strong>General [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceInitialPublicOffering', window );">Total gross proceeds (in Dollars) | $</a></td>
<td class="nump">$ 100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=arbe_ArbeRoboticsLtdMember', window );">Arbe Robotics Ltd. [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_arbe_GeneralDetailsLineItems', window );"><strong>General [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockOtherSharesOutstanding', window );">Ordinary shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,866,842<span></span>
</td>
<td class="nump">3,866,842<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_arbe_GeneralDetailsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">arbe_GeneralDetailsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>arbe_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockOtherSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of shares of other common stock instruments held by shareholders, such as exchangeable shares. May be all or portion of the number of common shares authorized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockOtherSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfOrdinaryDividends">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cash outflow in the form of ordinary dividends to common shareholders, preferred shareholders and noncontrolling interests, generally out of earnings.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfOrdinaryDividends</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceInitialPublicOffering">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received from entity's first offering of stock to the public.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceInitialPublicOffering</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockConsiderationReceivedOnTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cash received on stock transaction after deduction of issuance costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockConsiderationReceivedOnTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares issued or sold by the subsidiary or equity method investee per stock transaction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesIssuedPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per share or per unit amount of equity securities issued.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesIssuedPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=arbe_PublicWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=arbe_PublicWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=arbe_PrivateWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=arbe_PrivateWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=arbe_PIPEMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=arbe_PIPEMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=arbe_ArbeRoboticsLtdMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=arbe_ArbeRoboticsLtdMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1</span><table class="report" border="0" cellspacing="2" id="idm140068171694464">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Significant Accounting Policies (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_arbe_SignificantAccountingPoliciesDetailsLineItems', window );"><strong>Significant Accounting Policies (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_arbe_SeverancePercentageOfMonthlySalary', window );">Deposits rate</a></td>
<td class="nump">8.33%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SeveranceCosts1', window );">Severance Costs (in Dollars)</a></td>
<td class="nump">$ 1,166<span></span>
</td>
<td class="nump">$ 1,240<span></span>
</td>
<td class="nump">$ 826<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations', window );">Tax percentage</a></td>
<td class="nump">50.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_arbe_SignificantAccountingPoliciesDetailsLineItems', window );"><strong>Significant Accounting Policies (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_DemandDepositLiabilitiesInterestBearingAverageRatePaid', window );">Bank deposit bearing annual interest rate</a></td>
<td class="nump">4.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_arbe_SignificantAccountingPoliciesDetailsLineItems', window );"><strong>Significant Accounting Policies (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_DemandDepositLiabilitiesInterestBearingAverageRatePaid', window );">Bank deposit bearing annual interest rate</a></td>
<td class="nump">6.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_arbe_SeverancePercentageOfMonthlySalary">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of monthly salary monthly severance rate.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">arbe_SeverancePercentageOfMonthlySalary</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>arbe_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_arbe_SignificantAccountingPoliciesDetailsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">arbe_SignificantAccountingPoliciesDetailsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>arbe_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_DemandDepositLiabilitiesInterestBearingAverageRatePaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Average rate paid on interest-bearing demand deposits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Regulation S-K (SK)<br> -Number 229<br> -Section 1406<br> -Paragraph (a)<br> -Subparagraph (2)<br> -Publisher SEC<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_DemandDepositLiabilitiesInterestBearingAverageRatePaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>srt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SeveranceCosts1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses for special or contractual termination benefits provided to current employees involuntarily terminated under a benefit arrangement associated exit or disposal activities pursuant to an authorized plan. Excludes expenses related to one-time termination benefits, a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SeveranceCosts1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1</span><table class="report" border="0" cellspacing="2" id="idm140068085442320">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Significant Accounting Policies (Details) - Schedule of the Straight-Line Method Over the Estimated Useful Lives of the Assets<br></strong></div></th>
<th class="th" colspan="2"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerEquipmentMember', window );">Computers and peripheral equipment [Member] | Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_arbe_SignificantAccountingPoliciesDetailsScheduleoftheStraightLineMethodOvertheEstimatedUsefulLivesoftheAssetsLineItems', window );"><strong>Significant Accounting Policies (Details) - Schedule of the Straight-Line Method Over the Estimated Useful Lives of the Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentSalvageValuePercentage', window );">Property and equipment</a></td>
<td class="nump">15.00%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerEquipmentMember', window );">Computers and peripheral equipment [Member] | Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_arbe_SignificantAccountingPoliciesDetailsScheduleoftheStraightLineMethodOvertheEstimatedUsefulLivesoftheAssetsLineItems', window );"><strong>Significant Accounting Policies (Details) - Schedule of the Straight-Line Method Over the Estimated Useful Lives of the Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentSalvageValuePercentage', window );">Property and equipment</a></td>
<td class="nump">33.00%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_OfficeEquipmentMember', window );">Office furniture and equipment [Member] | Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_arbe_SignificantAccountingPoliciesDetailsScheduleoftheStraightLineMethodOvertheEstimatedUsefulLivesoftheAssetsLineItems', window );"><strong>Significant Accounting Policies (Details) - Schedule of the Straight-Line Method Over the Estimated Useful Lives of the Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentSalvageValuePercentage', window );">Property and equipment</a></td>
<td class="nump">7.00%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_OfficeEquipmentMember', window );">Office furniture and equipment [Member] | Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_arbe_SignificantAccountingPoliciesDetailsScheduleoftheStraightLineMethodOvertheEstimatedUsefulLivesoftheAssetsLineItems', window );"><strong>Significant Accounting Policies (Details) - Schedule of the Straight-Line Method Over the Estimated Useful Lives of the Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentSalvageValuePercentage', window );">Property and equipment</a></td>
<td class="nump">15.00%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_VehiclesMember', window );">Vehicles [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_arbe_SignificantAccountingPoliciesDetailsScheduleoftheStraightLineMethodOvertheEstimatedUsefulLivesoftheAssetsLineItems', window );"><strong>Significant Accounting Policies (Details) - Schedule of the Straight-Line Method Over the Estimated Useful Lives of the Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentSalvageValuePercentage', window );">Property and equipment</a></td>
<td class="nump">15.00%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember', window );">Leasehold improvement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_arbe_SignificantAccountingPoliciesDetailsScheduleoftheStraightLineMethodOvertheEstimatedUsefulLivesoftheAssetsLineItems', window );"><strong>Significant Accounting Policies (Details) - Schedule of the Straight-Line Method Over the Estimated Useful Lives of the Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentSalvageValuePercentage', window );">Property and equipment</a></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr><td colspan="3"></td></tr>
<tr><td colspan="3"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top"><span style="font-family: Times New Roman, Times, Serif">Leasehold improvements are amortized using the straight-line method over the shorter of the lease term or the estimated useful life of the improvements.</span></td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_arbe_SignificantAccountingPoliciesDetailsScheduleoftheStraightLineMethodOvertheEstimatedUsefulLivesoftheAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">arbe_SignificantAccountingPoliciesDetailsScheduleoftheStraightLineMethodOvertheEstimatedUsefulLivesoftheAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>arbe_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentSalvageValuePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Stated as a percentage, the estimated or actual value of the asset at the end of its useful life or when it is no longer serviceable (cannot be used for its original purpose) divided by its [historical] capitalized cost.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentSalvageValuePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_OfficeEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_OfficeEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_VehiclesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_VehiclesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1</span><table class="report" border="0" cellspacing="2" id="idm140068076293328">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Revenue (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Revenue [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredRevenue', window );">Deferred revenue</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 351<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligation', window );">Remaining performance obligation</a></td>
<td class="nump">$ 977<span></span>
</td>
<td class="nump">$ 232<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(26)(c))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of transaction price allocated to performance obligation that has not been recognized as revenue.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 606<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenuesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenuesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1</span><table class="report" border="0" cellspacing="2" id="idm140068085219744">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue (Details) - Schedule of Revenue Disaggregated by Geography - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_arbe_RevenueByGeographyAbstract', window );"><strong>Revenue by geography:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax', window );">Revenue</a></td>
<td class="nump">$ 1,470<span></span>
</td>
<td class="nump">$ 3,517<span></span>
</td>
<td class="nump">$ 2,249<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationPercentage', window );">% of Revenue</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_CN', window );">China [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_arbe_RevenueByGeographyAbstract', window );"><strong>Revenue by geography:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax', window );">Revenue</a></td>
<td class="nump">$ 639<span></span>
</td>
<td class="nump">$ 1,476<span></span>
</td>
<td class="nump">$ 702<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationPercentage', window );">% of Revenue</a></td>
<td class="nump">43.50%<span></span>
</td>
<td class="nump">42.00%<span></span>
</td>
<td class="nump">31.20%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_HK', window );">Hong Kong [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_arbe_RevenueByGeographyAbstract', window );"><strong>Revenue by geography:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax', window );">Revenue</a></td>
<td class="nump">$ 266<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 35<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationPercentage', window );">% of Revenue</a></td>
<td class="nump">18.10%<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">1.60%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_SE', window );">Sweden [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_arbe_RevenueByGeographyAbstract', window );"><strong>Revenue by geography:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax', window );">Revenue</a></td>
<td class="nump">$ 247<span></span>
</td>
<td class="nump">$ 1,276<span></span>
</td>
<td class="nump">$ 928<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationPercentage', window );">% of Revenue</a></td>
<td class="nump">16.80%<span></span>
</td>
<td class="nump">36.30%<span></span>
</td>
<td class="nump">41.20%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_US', window );">USA [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_arbe_RevenueByGeographyAbstract', window );"><strong>Revenue by geography:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax', window );">Revenue</a></td>
<td class="nump">$ 148<span></span>
</td>
<td class="nump">$ 135<span></span>
</td>
<td class="nump">$ 63<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationPercentage', window );">% of Revenue</a></td>
<td class="nump">10.10%<span></span>
</td>
<td class="nump">3.80%<span></span>
</td>
<td class="nump">2.80%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_DE', window );">Germany [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_arbe_RevenueByGeographyAbstract', window );"><strong>Revenue by geography:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax', window );">Revenue</a></td>
<td class="nump">$ 81<span></span>
</td>
<td class="nump">$ 284<span></span>
</td>
<td class="nump">$ 351<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationPercentage', window );">% of Revenue</a></td>
<td class="nump">5.50%<span></span>
</td>
<td class="nump">8.10%<span></span>
</td>
<td class="nump">15.60%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_IL', window );">Israel [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_arbe_RevenueByGeographyAbstract', window );"><strong>Revenue by geography:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax', window );">Revenue</a></td>
<td class="nump">$ 50<span></span>
</td>
<td class="nump">$ 25<span></span>
</td>
<td class="nump">$ 34<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationPercentage', window );">% of Revenue</a></td>
<td class="nump">3.40%<span></span>
</td>
<td class="nump">0.70%<span></span>
</td>
<td class="nump">1.50%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_IT', window );">Italy [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_arbe_RevenueByGeographyAbstract', window );"><strong>Revenue by geography:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax', window );">Revenue</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 124<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationPercentage', window );">% of Revenue</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">3.50%<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_CH', window );">Switzerland [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_arbe_RevenueByGeographyAbstract', window );"><strong>Revenue by geography:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax', window );">Revenue</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 197<span></span>
</td>
<td class="nump">$ 53<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationPercentage', window );">% of Revenue</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">5.60%<span></span>
</td>
<td class="nump">2.40%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=arbe_OtherGeographicalMember', window );">Other [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_arbe_RevenueByGeographyAbstract', window );"><strong>Revenue by geography:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax', window );">Revenue</a></td>
<td class="nump">$ 39<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 83<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationPercentage', window );">% of Revenue</a></td>
<td class="nump">2.60%<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">3.70%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_arbe_RevenueByGeographyAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">arbe_RevenueByGeographyAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>arbe_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, including tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value-added and excise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 924<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479941/924-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-5<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-42<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-40<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-41<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligationPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of remaining performance obligation to total remaining performance obligation not recognized as revenue.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)(1)<br> -SubTopic 10<br> -Topic 606<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligationPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_CN">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_CN</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_HK">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_HK</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_SE">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_SE</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_DE">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_DE</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_IL">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_IL</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_IT">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_IT</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_CH">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_CH</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=arbe_OtherGeographicalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=arbe_OtherGeographicalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1</span><table class="report" border="0" cellspacing="2" id="idm140068172715232">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Prepaid Expenses and Other Receivables (Details) - Schedule of Prepaid Expenses and Other Receivables - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_arbe_ScheduleOfPrepaidExpensesAndOtherReceivablesAbstract', window );"><strong>Schedule of Prepaid Expenses and Other Receivables [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_arbe_GovernmentAuthorities', window );">Government authorities</a></td>
<td class="nump">$ 385<span></span>
</td>
<td class="nump">$ 280<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepositAssets', window );">Deposits</a></td>
<td class="nump">69<span></span>
</td>
<td class="nump">85<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GrantsReceivableCurrent', window );">Grants receivable</a></td>
<td class="nump">310<span></span>
</td>
<td class="nump">319<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssets', window );">Prepaid expenses and other</a></td>
<td class="nump">1,262<span></span>
</td>
<td class="nump">1,155<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsNoncurrent', window );">Total</a></td>
<td class="nump">$ 2,026<span></span>
</td>
<td class="nump">$ 1,839<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_arbe_GovernmentAuthorities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Government Authorities means any national, provincial, municipal or local government, administrative or regulatory body or department, court, tribunal, arbitrator or any body that exercises the function of a regulator.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">arbe_GovernmentAuthorities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>arbe_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_arbe_ScheduleOfPrepaidExpensesAndOtherReceivablesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">arbe_ScheduleOfPrepaidExpensesAndOtherReceivablesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>arbe_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepositAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The carrying amount of the asset transferred to a third party to serve as a deposit, which typically serves as security against failure by the transferor to perform under terms of an agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepositAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GrantsReceivableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date of amounts due under the terms of governmental, corporate, or foundation grants. For classified balance sheets, represents the current amount receivable, that is amounts expected to be collected within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3)(a)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GrantsReceivableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1</span><table class="report" border="0" cellspacing="2" id="idm140068079735648">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property and Equipment (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Depreciation', window );">Depreciation expense</a></td>
<td class="nump">$ 557<span></span>
</td>
<td class="nump">$ 481<span></span>
</td>
<td class="nump">$ 342<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Depreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Depreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1</span><table class="report" border="0" cellspacing="2" id="idm140068076441072">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Property and Equipment (Details) - Schedule of Property and Equipment - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_arbe_CostAbstract', window );"><strong>Cost:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment, gross</a></td>
<td class="nump">$ 3,312<span></span>
</td>
<td class="nump">$ 3,055<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment', window );">Accumulated depreciation</a></td>
<td class="nump">2,003<span></span>
</td>
<td class="nump">1,446<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment, net</a></td>
<td class="nump">1,309<span></span>
</td>
<td class="nump">1,609<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerEquipmentMember', window );">Computers and peripheral equipment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_arbe_CostAbstract', window );"><strong>Cost:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment, gross</a></td>
<td class="nump">2,448<span></span>
</td>
<td class="nump">2,350<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember', window );">Leasehold improvement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_arbe_CostAbstract', window );"><strong>Cost:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment, gross</a></td>
<td class="nump">582<span></span>
</td>
<td class="nump">438<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_OfficeEquipmentMember', window );">Office furniture and equipment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_arbe_CostAbstract', window );"><strong>Cost:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment, gross</a></td>
<td class="nump">133<span></span>
</td>
<td class="nump">128<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_VehiclesMember', window );">Vehicles [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_arbe_CostAbstract', window );"><strong>Cost:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment, gross</a></td>
<td class="nump">$ 149<span></span>
</td>
<td class="nump">$ 139<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_arbe_CostAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">arbe_CostAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>arbe_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 360<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480842/942-360-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_OfficeEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_OfficeEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_VehiclesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_VehiclesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1</span><table class="report" border="0" cellspacing="2" id="idm140068172703280">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases (Details) - Schedule of Supplemental Cash Flow Information Related to Leases - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_arbe_ScheduleOfSupplementalCashFlowInformationRelatedToLeasesAbstract', window );"><strong>Schedule of Supplemental Cash Flow Information Related to Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeasePayments', window );">Cash payments and expenses related to operating leases</a></td>
<td class="num">$ (451)<span></span>
</td>
<td class="num">$ (370)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_arbe_OperatingLeaseRightofuseAssetsAndLiabilitiesNet', window );">Operating lease right-of-use assets and liabilities, net</a></td>
<td class="nump">$ 2<span></span>
</td>
<td class="num">$ (84)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_arbe_OperatingLeaseRightofuseAssetsAndLiabilitiesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Operating lease right-of-use assets and liabilities net.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">arbe_OperatingLeaseRightofuseAssetsAndLiabilitiesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>arbe_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_arbe_ScheduleOfSupplementalCashFlowInformationRelatedToLeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">arbe_ScheduleOfSupplementalCashFlowInformationRelatedToLeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>arbe_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasePayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-5<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasePayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1</span><table class="report" border="0" cellspacing="2" id="idm140068179187792">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Leases (Details) - Schedule of Maturities of Lease Liabilities<br> $ in Thousands</strong></div></th>
<th class="th">
<div>Dec. 31, 2023 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_arbe_ScheduleOfMaturitiesOfLeaseLiabilitiesAbstract', window );"><strong>Schedule of Maturities of Lease Liabilities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths', window );">2024</a></td>
<td class="nump">$ 443<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo', window );">2025</a></td>
<td class="nump">393<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree', window );">2026</a></td>
<td class="nump">356<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour', window );">2027 and after</a></td>
<td class="nump">1,033<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue', window );">Total lease payments</a></td>
<td class="nump">2,225<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount', window );">Less imputed interest</a></td>
<td class="nump">483<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Total lease liabilities</a></td>
<td class="nump">$ 1,742<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_arbe_ScheduleOfMaturitiesOfLeaseLiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">arbe_ScheduleOfMaturitiesOfLeaseLiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>arbe_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1</span><table class="report" border="0" cellspacing="2" id="idm140068077521232">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Leases (Details) - Schedule of Supplemental Balance Sheet Information Related to Operating Leases - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_arbe_ScheduleOfSupplementalBalanceSheetInformationRelatedToOperatingLeasesAbstract', window );"><strong>Schedule of Supplemental Balance Sheet Information Related to Operating Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease right-of-use assets</a></td>
<td class="nump">$ 1,740<span></span>
</td>
<td class="nump">$ 465<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Current maturities of operating leases</a></td>
<td class="nump">436<span></span>
</td>
<td class="nump">364<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Long-term operating lease liabilities</a></td>
<td class="nump">$ 1,306<span></span>
</td>
<td class="nump">$ 17<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1', window );">Weighted average remaining lease term (in years)</a></td>
<td class="text">5 years 6 months<span></span>
</td>
<td class="text">1 year 1 month 6 days<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent', window );">Weighted average discount rate</a></td>
<td class="nump">9.40%<span></span>
</td>
<td class="nump">5.80%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_arbe_ScheduleOfSupplementalBalanceSheetInformationRelatedToOperatingLeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">arbe_ScheduleOfSupplementalBalanceSheetInformationRelatedToOperatingLeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>arbe_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average discount rate for operating lease calculated at point in time.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>64
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1</span><table class="report" border="0" cellspacing="2" id="idm140068076325744">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingent Liabilities (Details)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2023 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingent Liabilities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GrantsReceivable', window );">Grants value (in Dollars)</a></td>
<td class="nump">$ 3,846<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_arbe_RoyaltyPercentage', window );">Royalty percentage</a></td>
<td class="nump">4.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_arbe_GrantsReceived', window );">Maximum aggregate royalties paid</a></td>
<td class="nump">100.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_arbe_GrantsReceived">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Grants received for maximum aggregate royalties.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">arbe_GrantsReceived</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>arbe_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_arbe_RoyaltyPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of sales that royalties are paid.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">arbe_RoyaltyPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>arbe_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GrantsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date of amounts due under the terms of governmental, corporate, or foundation grants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3)(a)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GrantsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>65
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1</span><table class="report" border="0" cellspacing="2" id="idm140068085061536">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Warrants Liabilities (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_arbe_WarrantsLiabilitiesDetailsLineItems', window );"><strong>Warrants Liabilities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdditionalCollateralAggregateFairValue', window );">Aggregate exercise price</a></td>
<td class="nump">$ 550<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate', window );">Volatility impact rate</a></td>
<td class="nump">5.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAdjustmentOfWarrants', window );">Fair value of warrants</a></td>
<td class="nump">$ 180<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfWarrants', window );">Warrants</a></td>
<td class="nump">$ 756<span></span>
</td>
<td class="nump">$ 8,425<span></span>
</td>
<td class="nump">$ 3,083<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember', window );">Private Placement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_arbe_WarrantsLiabilitiesDetailsLineItems', window );"><strong>Warrants Liabilities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_arbe_DerivativeWarrantLiabilityShares', window );">Derivative warrant liability shares (in Shares)</a></td>
<td class="nump">3,112,080<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_arbe_DerivativeWarrantLiabilityShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Derivative warrant liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">arbe_DerivativeWarrantLiabilityShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>arbe_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_arbe_WarrantsLiabilitiesDetailsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">arbe_WarrantsLiabilitiesDetailsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>arbe_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalCollateralAggregateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate fair value of additional assets that would be required to be posted as collateral for derivative instruments with credit-risk-related contingent features if the credit-risk-related contingent features were triggered at the end of the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4H<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480434/815-10-50-4H<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalCollateralAggregateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAdjustmentOfWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense (income) related to adjustment to fair value of warrant liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 25<br> -Paragraph 13<br> -SubTopic 10<br> -Topic 480<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481766/480-10-25-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAdjustmentOfWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from issuance of rights to purchase common shares at predetermined price (usually issued together with corporate debt).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Rate of weighted-average expected volatility for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>66
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1</span><table class="report" border="0" cellspacing="2" id="idm140068085445264">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Shareholders&#8217; Equity (Details)<br></strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Jun. 30, 2023 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2023 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2023 </div>
<div>&#8362; / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>&#8362; / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2016 </div>
<div>shares</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_arbe_ShareholdersEquityDetailsLineItems', window );"><strong>Shareholders&#8217; Equity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Ordinary shares, authorized (in Shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">130,000,000<span></span>
</td>
<td class="nump">130,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Ordinary shares, par value (in New Shekels per share) | &#8362; / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8362; 0.000216<span></span>
</td>
<td class="nump">&#8362; 0.000216<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityReverseStockSplit', window );">Stock split</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">the Company effected a 1:46.25783 stock split<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonUnitIssuanceValue', window );">Ordinary shares issue value | $</a></td>
<td class="nump">$ 23,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonUnitIssued', window );">Ordinary shares issue (in Shares)</a></td>
<td class="nump">11,794,873<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharePrice', window );">Share Price (in Dollars per share) | $ / shares</a></td>
<td class="nump">$ 1.95<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Net of issuance costs | $</a></td>
<td class="nump">$ 22,496<span></span>
</td>
<td class="nump">$ 22,496,000<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod', window );">Plan expiration period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">7 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodExpectedDividendRate', window );">Expected dividend yield</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Stock-based compensation | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 629,000<span></span>
</td>
<td class="nump">$ 354,000<span></span>
</td>
<td class="nump">$ 115,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=arbe_TwoThousandSixteenIncentivePlanMember', window );">2016 Share Incentive Plan [Member] | Ordinary Shares [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_arbe_ShareholdersEquityDetailsLineItems', window );"><strong>Shareholders&#8217; Equity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized', window );">Ordinary shares were reserved for issuance (in Shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,384,454<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=arbe_TwoThousandTwentyOneEquityIncentivePlanMember', window );">2021 Plan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_arbe_ShareholdersEquityDetailsLineItems', window );"><strong>Shareholders&#8217; Equity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized', window );">Ordinary shares were reserved for issuance (in Shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,079,427<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Options vested period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">4 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardTermsOfAward', window );">Share option , description</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">(i) 5% of the total number of ordinary shares outstanding on December
31 of the immediately preceding calendar year, and (ii) an amount determined by the Board, if so determined prior to the January 1 of
the calendar year in which the increase will occur<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRights', window );">Vesting period, description</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">The vesting period of the awards is generally four
years. Generally, under the terms of the Plans, unless determined otherwise,&#160;25% of an award granted becomes exercisable on the
first anniversary of the date of grant and&#160;6.25% becomes exercisable once every quarter during the subsequent&#160;three years.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_TitleOfIndividualAxis=arbe_PlanOneMember', window );">2016 Plan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_arbe_ShareholdersEquityDetailsLineItems', window );"><strong>Shareholders&#8217; Equity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Options vested period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">4 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_arbe_ShareholdersEquityDetailsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">arbe_ShareholdersEquityDetailsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>arbe_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.F)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479830/718-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonUnitIssuanceValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Stated value of common units of ownership issued by a limited liability company (LLC).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonUnitIssuanceValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonUnitIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of common units issued of limited liability company (LLC).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonUnitIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the additional capital contribution to the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Description of service or performance condition required to be met for earning right to award under share-based payment arrangement. Includes, but is not limited to, combination of market, performance or service condition.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares authorized for issuance under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardTermsOfAward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Description of terms of award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardTermsOfAward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodExpectedDividendRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the expected term of a nonvested share or option award issued to other than an employee.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodExpectedDividendRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Price of a single share of a number of saleable stocks of a company.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period from grant date that an equity-based award expires, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityReverseStockSplit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Description of the reverse stock split arrangement. Also provide the retroactive effect given by the reverse split that occurs after the balance sheet date but before the release of financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SAB Topic 4.C)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityReverseStockSplit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=arbe_TwoThousandSixteenIncentivePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=arbe_TwoThousandSixteenIncentivePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=arbe_TwoThousandTwentyOneEquityIncentivePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=arbe_TwoThousandTwentyOneEquityIncentivePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=arbe_PlanOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=arbe_PlanOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>67
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1</span><table class="report" border="0" cellspacing="2" id="idm140068083880528">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Shareholders&#8217; Equity (Details) - Schedule of Stock Option Activity - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_arbe_OptionsAbstract', window );"><strong>Options:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Outstanding share options ending balance</a></td>
<td class="nump">3,768,034<span></span>
</td>
<td class="nump">5,057,255<span></span>
</td>
<td class="nump">6,052,214<span></span>
</td>
<td class="nump">5,461,337<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Weighted-average exercise price ending balance (in Dollars per share)</a></td>
<td class="nump">$ 0.767<span></span>
</td>
<td class="nump">$ 4.543<span></span>
</td>
<td class="nump">$ 4.166<span></span>
</td>
<td class="nump">$ 3.102<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2', window );">Weighted average remaining contractual life (years), ending balance</a></td>
<td class="text">4 years 7 months 15 days<span></span>
</td>
<td class="text">5 years 7 months 28 days<span></span>
</td>
<td class="text">5 years 6 months 25 days<span></span>
</td>
<td class="text">5 years 4 months 10 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue', window );">Aggregate intrinsic value ending balance (in Dollars)</a></td>
<td class="nump">$ 119,146<span></span>
</td>
<td class="nump">$ 2,352,517<span></span>
</td>
<td class="nump">$ 7,761,705<span></span>
</td>
<td class="nump">$ 16,713,971<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Granted, Outstanding share options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">430,874<span></span>
</td>
<td class="nump">1,630,142<span></span>
</td>
<td class="nump">1,966,916<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Granted, Weighted-average exercise price (in Dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2.728<span></span>
</td>
<td class="nump">$ 6.833<span></span>
</td>
<td class="nump">$ 7.25<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber', window );">Exercisable, Outstanding share options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,210,191<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice', window );">Exercisable, Weighted-average exercise price (in Dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3.643<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1', window );">Exercisable, Weighted average remaining contractual life (years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">4 years 4 months 25 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1', window );">Exercisable, Aggregate intrinsic value (in Dollars)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,277,303<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant', window );">Options available for future grants, Outstanding share options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">611,246<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod', window );">Forfeited, Outstanding share options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(351,671)<span></span>
</td>
<td class="num">(468,814)<span></span>
</td>
<td class="num">(117,863)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice', window );">Forfeited, Weighted-average exercise price (in Dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7.767<span></span>
</td>
<td class="nump">$ 5.557<span></span>
</td>
<td class="nump">$ 0.972<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised', window );">Exercised, Outstanding share options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,074,162)<span></span>
</td>
<td class="num">(570,451)<span></span>
</td>
<td class="num">(155,750)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice', window );">Exercised, Weighted-average exercise price (in Dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.654<span></span>
</td>
<td class="nump">$ 0.482<span></span>
</td>
<td class="nump">$ 0.602<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_arbe_OptionsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">arbe_OptionsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>arbe_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of non-option equity instruments exercised by participants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(2)<br> -SubTopic 10<br> -Topic 718<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For presentations that combine terminations, the number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan or that expired.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which option holders acquired shares when converting their stock options into shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 718<br> -SubTopic 10<br> -Subparagraph (e)(1)<br> -Name Accounting Standards Codification<br> -Paragraph 2<br> -Section 50<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>68
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1</span><table class="report" border="0" cellspacing="2" id="idm140068083526096">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Shareholders&#8217; Equity (Details) - Schedule of RSUs Activity - RSUs [Member] - shares<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_arbe_RsusAbstract', window );"><strong>RSUs:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber', window );">Outstanding, Numbers of RSUs, beginning balance</a></td>
<td class="nump">2,598,084<span></span>
</td>
<td class="nump">1,968,794<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted', window );">Granted, Numbers of RSUs</a></td>
<td class="nump">2,908,983<span></span>
</td>
<td class="nump">1,619,898<span></span>
</td>
<td class="nump">1,968,794<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures', window );">Forfeited, Numbers of RSUs</a></td>
<td class="num">(370,067)<span></span>
</td>
<td class="num">(417,025)<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsPeriodIncreaseDecrease', window );">Vested, Numbers of RSUs</a></td>
<td class="num">(895,170)<span></span>
</td>
<td class="num">(573,583)<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber', window );">Outstanding, Numbers of RSUs, ending balance</a></td>
<td class="nump">4,241,830<span></span>
</td>
<td class="nump">2,598,084<span></span>
</td>
<td class="nump">1,968,794<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_arbe_RsusAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">arbe_RsusAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>arbe_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares under non-option equity instrument agreements that were cancelled as a result of occurrence of a terminating event.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(3)<br> -SubTopic 10<br> -Topic 718<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Net number of non-option equity instruments granted to participants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(1)<br> -SubTopic 10<br> -Topic 718<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of equity instruments other than options outstanding, including both vested and non-vested instruments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -SubTopic 10<br> -Topic 718<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -SubTopic 10<br> -Topic 718<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsPeriodIncreaseDecrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Increase (decrease) in the number of shares under non-option equity instrument agreements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsPeriodIncreaseDecrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>69
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1</span><table class="report" border="0" cellspacing="2" id="idm140068085520160">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Shareholders&#8217; Equity (Details) - Schedule of Compensation to Employees<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_arbe_ShareholdersEquityDetailsScheduleofCompensationtoEmployeesLineItems', window );"><strong>Schedule of Compensation to Employees [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected term, in years</a></td>
<td class="text">5 years 9 months 25 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate', window );">Expected dividend yield</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_arbe_ShareholdersEquityDetailsScheduleofCompensationtoEmployeesLineItems', window );"><strong>Schedule of Compensation to Employees [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected term, in years</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">4 years 4 months 28 days<span></span>
</td>
<td class="text">4 years 7 months 9 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate', window );">Expected volatility</a></td>
<td class="nump">47.00%<span></span>
</td>
<td class="nump">47.00%<span></span>
</td>
<td class="nump">42.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Risk-free interest rate</a></td>
<td class="nump">4.15%<span></span>
</td>
<td class="nump">1.74%<span></span>
</td>
<td class="nump">0.49%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_arbe_ShareholdersEquityDetailsScheduleofCompensationtoEmployeesLineItems', window );"><strong>Schedule of Compensation to Employees [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected term, in years</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">6 years 1 month 9 days<span></span>
</td>
<td class="text">6 years 1 month 9 days<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate', window );">Expected volatility</a></td>
<td class="nump">51.75%<span></span>
</td>
<td class="nump">48.00%<span></span>
</td>
<td class="nump">46.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Risk-free interest rate</a></td>
<td class="nump">4.55%<span></span>
</td>
<td class="nump">3.96%<span></span>
</td>
<td class="nump">1.28%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_arbe_ShareholdersEquityDetailsScheduleofCompensationtoEmployeesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">arbe_ShareholdersEquityDetailsScheduleofCompensationtoEmployeesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>arbe_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>70
<FILENAME>R49.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1</span><table class="report" border="0" cellspacing="2" id="idm140068172731008">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Shareholders&#8217; Equity (Details) - Schedule of Share Based Compensation Expense - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_arbe_ShareholdersEquityDetailsScheduleofShareBasedCompensationExpenseLineItems', window );"><strong>Schedule of Share Based Compensation Expense [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Total stock-based compensation expense</a></td>
<td class="nump">$ 13,012<span></span>
</td>
<td class="nump">$ 8,793<span></span>
</td>
<td class="nump">$ 2,211<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember', window );">Research and development [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_arbe_ShareholdersEquityDetailsScheduleofShareBasedCompensationExpenseLineItems', window );"><strong>Schedule of Share Based Compensation Expense [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Total stock-based compensation expense</a></td>
<td class="nump">8,721<span></span>
</td>
<td class="nump">5,726<span></span>
</td>
<td class="nump">1,518<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_SellingAndMarketingExpenseMember', window );">Sales and marketing [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_arbe_ShareholdersEquityDetailsScheduleofShareBasedCompensationExpenseLineItems', window );"><strong>Schedule of Share Based Compensation Expense [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Total stock-based compensation expense</a></td>
<td class="nump">2,229<span></span>
</td>
<td class="nump">1,403<span></span>
</td>
<td class="nump">217<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember', window );">General and administrative [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_arbe_ShareholdersEquityDetailsScheduleofShareBasedCompensationExpenseLineItems', window );"><strong>Schedule of Share Based Compensation Expense [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Total stock-based compensation expense</a></td>
<td class="nump">1,786<span></span>
</td>
<td class="nump">1,537<span></span>
</td>
<td class="nump">419<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember', window );">Cost of revenues [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_arbe_ShareholdersEquityDetailsScheduleofShareBasedCompensationExpenseLineItems', window );"><strong>Schedule of Share Based Compensation Expense [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Total stock-based compensation expense</a></td>
<td class="nump">$ 276<span></span>
</td>
<td class="nump">$ 127<span></span>
</td>
<td class="nump">$ 57<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_arbe_ShareholdersEquityDetailsScheduleofShareBasedCompensationExpenseLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">arbe_ShareholdersEquityDetailsScheduleofShareBasedCompensationExpenseLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>arbe_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_SellingAndMarketingExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_SellingAndMarketingExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>71
<FILENAME>R50.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1</span><table class="report" border="0" cellspacing="2" id="idm140068084897280">
<tr>
<th class="tl" colspan="2" rowspan="2"><div style="width: 200px;"><strong>Net Loss Per Share Attributible to Ordinary Sharholders (Details) - Schedule of Sets Forth the Computation of Basic and Diluted Net Loss Per Share Attributable - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_arbe_NumeratorAbstract', window );"><strong>Numerator:</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToNonredeemableNoncontrollingInterest', window );">Net loss</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">$ (43,500)<span></span>
</td>
<td class="num">$ (40,494)<span></span>
</td>
<td class="num">$ (58,092)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_arbe_DenominatorAbstract', window );"><strong>Denominator:</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment', window );">Weighted-average shares used in computing loss per share attributable to ordinary shareholders, basic (in Shares)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">72,021,520<span></span>
</td>
<td class="nump">63,489,983<span></span>
</td>
<td class="nump">22,027,292<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Loss per share attributable to ordinary shareholders, basic (in Dollars per share)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">$ (0.6)<span></span>
</td>
<td class="num">$ (0.64)<span></span>
</td>
<td class="num">$ (2.64)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_arbe_NumeratorAbstract0', window );"><strong>Numerator:</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityAccretionToRedemptionValueAdjustment', window );">Adjusted Net loss</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="num">$ (44,256)<span></span>
</td>
<td class="num">$ (48,919)<span></span>
</td>
<td class="num">$ (58,092)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_arbe_DenominatorAbstract0', window );"><strong>Denominator:</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Weighted-average shares used in computing loss per share attributable to ordinary shareholders, diluted (in Shares)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">62,390,302<span></span>
</td>
<td class="nump">60,960,641<span></span>
</td>
<td class="nump">22,027,292<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Loss per share attributable to ordinary shareholders, diluted (in Dollars per share)</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="num">$ (0.71)<span></span>
</td>
<td class="num">$ (0.8)<span></span>
</td>
<td class="num">$ (2.64)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfWarrants', window );">Revaluation of warrants</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">$ (756)<span></span>
</td>
<td class="num">$ (8,425)<span></span>
</td>
<td class="num">$ (3,083)<span></span>
</td>
</tr>
<tr><td colspan="4"></td></tr>
<tr><td colspan="4"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top"><span style="font-family: Times New Roman, Times, Serif; font-weight: normal">Loss per share attributable to ordinary shareholders, diluted, was adjusted and take into consideration warrants liabilities revaluations as part of our net loss for 2023 and 2022.</span></td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_arbe_DenominatorAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">arbe_DenominatorAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>arbe_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_arbe_DenominatorAbstract0">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">arbe_DenominatorAbstract0</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>arbe_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_arbe_NumeratorAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">arbe_NumeratorAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>arbe_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_arbe_NumeratorAbstract0">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">arbe_NumeratorAbstract0</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>arbe_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482635/260-10-55-15<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-7<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-10<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482635/260-10-55-52<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482635/260-10-55-15<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-7<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482635/260-10-55-52<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAttributableToNonredeemableNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Portion of net income (loss) attributable to nonredeemable noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.19)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAttributableToNonredeemableNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from issuance of rights to purchase common shares at predetermined price (usually issued together with corporate debt).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityAccretionToRedemptionValueAdjustment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease to net income for accretion of temporary equity to its redemption value to derive net income apportioned to common stockholders.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityAccretionToRedemptionValueAdjustment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The sum of dilutive potential common shares or units used in the calculation of the diluted per-share or per-unit computation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 16<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-16<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>72
<FILENAME>R51.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1</span><table class="report" border="0" cellspacing="2" id="idm140068083886032">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Loss Per Share Attributible to Ordinary Sharholders (Details) - Schedule of Ordinary Shares that were Excluded from the Computation of Diluted Net Loss Per Share - shares<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Anti-dilutive shares</a></td>
<td class="nump">9,299,085<span></span>
</td>
<td class="nump">8,650,298<span></span>
</td>
<td class="nump">27,861,855<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_ConvertiblePreferredStockMember', window );">Convertible preferred shares [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Anti-dilutive shares</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">26,499,069<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=arbe_OutstandingShareOptionsMember', window );">Outstanding share options [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Anti-dilutive shares</a></td>
<td class="nump">9,299,085<span></span>
</td>
<td class="nump">8,650,298<span></span>
</td>
<td class="nump">1,362,786<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_ConvertiblePreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_ConvertiblePreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=arbe_OutstandingShareOptionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=arbe_OutstandingShareOptionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>73
<FILENAME>R52.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1</span><table class="report" border="0" cellspacing="2" id="idm140068084945776">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Taxes on Income (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_arbe_TaxesonIncomeDetailsLineItems', window );"><strong>Taxes on Income [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential', window );">Foreign holding percentage</a></td>
<td class="nump">25.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Net operating loss carryforward (in Dollars)</a></td>
<td class="nump">$ 121,880<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_IL', window );">Israel [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_arbe_TaxesonIncomeDetailsLineItems', window );"><strong>Taxes on Income [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential', window );">Foreign holding percentage</a></td>
<td class="nump">23.00%<span></span>
</td>
<td class="nump">23.00%<span></span>
</td>
<td class="nump">23.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_US', window );">United States [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_arbe_TaxesonIncomeDetailsLineItems', window );"><strong>Taxes on Income [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential', window );">Foreign holding percentage</a></td>
<td class="nump">21.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_arbe_TaxesonIncomeDetailsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">arbe_TaxesonIncomeDetailsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>arbe_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to statutory income tax expense (benefit) outside of the country of domicile.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-12<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLossCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLossCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_IL">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_IL</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>74
<FILENAME>R53.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1</span><table class="report" border="0" cellspacing="2" id="idm140068079618448">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Taxes on Income  (Details) - Schedule of Company&#8217;s Loss Before Income Taxes - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_arbe_ScheduleOfCompanysLossBeforeIncomeTaxesAbstract', window );"><strong>Schedule of Company&#8217;s Loss Before Income Taxes [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic', window );">Domestic</a></td>
<td class="num">$ (43,500)<span></span>
</td>
<td class="num">$ (40,494)<span></span>
</td>
<td class="num">$ (58,092)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign', window );">Foreign</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Total</a></td>
<td class="num">$ (43,500)<span></span>
</td>
<td class="num">$ (40,494)<span></span>
</td>
<td class="num">$ (58,092)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_arbe_ScheduleOfCompanysLossBeforeIncomeTaxesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">arbe_ScheduleOfCompanysLossBeforeIncomeTaxesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>arbe_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of earnings or loss from continuing operations before income taxes that is attributable to domestic operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(11))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479557/942-235-S99-1<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 25<br> -Paragraph 1<br> -SubTopic 20<br> -Topic 940<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481913/940-20-25-1<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of earnings or loss from continuing operations before income taxes that is attributable to foreign operations, which is defined as Income or Loss generated from operations located outside the entity's country of domicile.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>75
<FILENAME>R54.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1</span><table class="report" border="0" cellspacing="2" id="idm140068085202192">
<tr>
<th class="tl" colspan="2" rowspan="2"><div style="width: 200px;"><strong>Taxes on Income  (Details) - Schedule of Reconciliation Income Tax Benefit - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_arbe_ScheduleOfReconciliationIncomeTaxBenefitAbstract', window );"><strong>Schedule of Reconciliation Income Tax Benefit [Abstract]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Loss before income taxes, as reported in the consolidated statements of operations</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 43,500<span></span>
</td>
<td class="nump">$ 40,494<span></span>
</td>
<td class="nump">$ 58,092<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate', window );">Statutory tax rate</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">23.00%<span></span>
</td>
<td class="nump">23.00%<span></span>
</td>
<td class="nump">23.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate', window );">Income tax benefit at statutory tax rate</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">$ (10,005)<span></span>
</td>
<td class="num">$ (9,314)<span></span>
</td>
<td class="num">$ (13,361)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationNondeductibleExpense', window );">Effect of Non-deductible expenses</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">3,063<span></span>
</td>
<td class="nump">475<span></span>
</td>
<td class="nump">6,129<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential', window );">Remeasurement of deferred taxes from currency exchange</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text"> <span></span>
</td>
<td class="nump">3,517<span></span>
</td>
<td class="nump">209<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance', window );">Change in valuation allowance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">7,508<span></span>
</td>
<td class="nump">5,322<span></span>
</td>
<td class="nump">7,023<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationOtherAdjustments', window );">Other</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(566)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Reported income taxes benefit</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr><td colspan="4"></td></tr>
<tr><td colspan="4"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top"><span style="font-family: Times New Roman, Times, Serif">The
income Tax Regulations (rules regarding ledger management of foreign invested companies and certain partnerships and the determination
of their taxable income), 1986 allow Foreign Invested Companies (i.e., foreign holding percentage of more than 25%) to report for tax
purposes in US dollars. The Company implemented these regulations on January 1, 2023.</span></td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_arbe_ScheduleOfReconciliationIncomeTaxBenefitAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">arbe_ScheduleOfReconciliationIncomeTaxBenefitAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>arbe_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of domestic federal statutory tax rate applicable to pretax income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-12<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(11))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479557/942-235-S99-1<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 25<br> -Paragraph 1<br> -SubTopic 20<br> -Topic 940<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481913/940-20-25-1<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-8<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-10<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -SubTopic 20<br> -Topic 740<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482659/740-20-45-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -SubTopic 10<br> -Topic 235<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to increase (decrease) in the valuation allowance for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to foreign income tax expense (benefit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of income tax expense or benefit for the period computed by applying the domestic federal statutory tax rates to pretax income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationNondeductibleExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to nondeductible expenses.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationNondeductibleExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationOtherAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other adjustments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationOtherAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>76
<FILENAME>R55.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1</span><table class="report" border="0" cellspacing="2" id="idm140068083887488">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Taxes on Income  (Details) - Schedule of Deferred Tax Assets - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_arbe_DeferredTaxAssetsAbstract', window );"><strong>Deferred tax assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards', window );">Net operating loss carry forwards</a></td>
<td class="nump">$ 28,032<span></span>
</td>
<td class="nump">$ 21,991<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment', window );">Research and development</a></td>
<td class="nump">6,252<span></span>
</td>
<td class="nump">4,834<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost', window );">Employees and payroll accrual</a></td>
<td class="nump">299<span></span>
</td>
<td class="nump">272<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment', window );">Property and equipment</a></td>
<td class="nump">79<span></span>
</td>
<td class="nump">57<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsGross', window );">Total deferred tax assets</a></td>
<td class="nump">34,662<span></span>
</td>
<td class="nump">27,154<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsValuationAllowance', window );">Valuation allowance</a></td>
<td class="num">(34,662)<span></span>
</td>
<td class="num">(27,154)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsLiabilitiesNet', window );">Deferred tax assets, net of valuation allowance</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_arbe_DeferredTaxAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">arbe_DeferredTaxAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>arbe_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from in-process research and development costs expensed in connection with a business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-6<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsLiabilitiesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, without jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsLiabilitiesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-6<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOperatingLossCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from property, plant, and equipment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from share-based compensation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-6<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>77
<FILENAME>R56.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1</span><table class="report" border="0" cellspacing="2" id="idm140068172762816">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Information (Details) - Revenue Benchmark [Member] - Customer Concentration Risk [Member]<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember', window );">Customer1 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Percentage of revenue of customers</a></td>
<td class="nump">38.90%<span></span>
</td>
<td class="nump">33.40%<span></span>
</td>
<td class="nump">41.10%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember', window );">Customer2 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Percentage of revenue of customers</a></td>
<td class="nump">18.10%<span></span>
</td>
<td class="nump">19.40%<span></span>
</td>
<td class="nump">31.20%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember', window );">Customer3 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Percentage of revenue of customers</a></td>
<td class="nump">12.70%<span></span>
</td>
<td class="nump">18.90%<span></span>
</td>
<td class="nump">15.60%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskPercentage1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the "benchmark" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-42<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-21<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-20<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-18<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-20<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskPercentage1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=arbe_Customer1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=arbe_Customer1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=arbe_Customer2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=arbe_Customer2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=arbe_Customer3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=arbe_Customer3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>78
<FILENAME>R57.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1</span><table class="report" border="0" cellspacing="2" id="idm140068084458160">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Segment Information (Details) - Schedule of Property and Equipment, Net of Depreciation, by Geographic Region - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_arbe_SegmentInformationDetailsScheduleofPropertyandEquipmentNetofDepreciationbyGeographicRegionLineItems', window );"><strong>Segment Information (Details) - Schedule of Property and Equipment, Net of Depreciation, by Geographic Region [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Total property and equipment, net:</a></td>
<td class="nump">$ 1,309<span></span>
</td>
<td class="nump">$ 1,609<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_IL', window );">Israel [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_arbe_SegmentInformationDetailsScheduleofPropertyandEquipmentNetofDepreciationbyGeographicRegionLineItems', window );"><strong>Segment Information (Details) - Schedule of Property and Equipment, Net of Depreciation, by Geographic Region [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Total property and equipment, net:</a></td>
<td class="nump">1,309<span></span>
</td>
<td class="nump">1,609<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_US', window );">UNITED STATES [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_arbe_SegmentInformationDetailsScheduleofPropertyandEquipmentNetofDepreciationbyGeographicRegionLineItems', window );"><strong>Segment Information (Details) - Schedule of Property and Equipment, Net of Depreciation, by Geographic Region [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Total property and equipment, net:</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_arbe_SegmentInformationDetailsScheduleofPropertyandEquipmentNetofDepreciationbyGeographicRegionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">arbe_SegmentInformationDetailsScheduleofPropertyandEquipmentNetofDepreciationbyGeographicRegionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>arbe_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 360<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480842/942-360-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_IL">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_IL</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>79
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M=]W3CHG&K=!X#;[Q3X?#KHG&J]!TZVDF)_VN:Z3I%FA"1N/K>A(5M>5 TR
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M!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y'C[E>G@*-Y;&O%"N@GL!_]':-\*K^(+
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MU4#E/]O4#6CV#30<D05>,9FV-J/D3@H\W/[O#;#"Q([A[8N_ 5!+ P04
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M)>+\XYJS@,OL OC^40BU.\A^8/\6VNS_4$L#!!0    ( *)*?%A*>^L8,@(
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M^;"QN9&LK([Z[YF4+*\N5U3MR[@64.^7C,F7&SU _7EI\C]02P,$%     @
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MIA2,K*PNY*H7+?;EC=-*:"VR\G''**3- .#[1@C]^&(Z:*Y%9_\"4$L#!!0
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M5MO_DY^['7%00#=Z"M!= <H6<'H*:+L"&E/ (#T%]%T!_=@,QJZ <6P&<U?
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M *6%4%I$>/N%I6N6S4YW0K-.H;081>OJM+5@$/E2_K_22EGDI;@K!"W5WZ!
M+@KDH4 ^"A2@0"$*%*% $Q1H2@0N&,-6'<9;& _'==72ND.(W![2<\< $:KG
MC!5_L7I (!<%\E @'P4*4* 0!8I0H-N!)MDWAN0M,\1Q=--AAY$B0P]Q3-UD
M-<4'6H[=.U!LK2E$OO!_Q%T38GFA_"@HD(L">2B0CP(%*%!X#D@R_N,-&Z:F
M$M,V3'8$B,P[A=)B%*TKP-:>0N3^E).FZ\]8GA>+#@1R42 /!?)1H  %"E&@
M" 6:$-ZH8EL.-\4!2A</I>O>/=JZ1:A\ ?[5T_5R_@ER0H%<%,A#@7P4*$"!
M0A0H0H$FE+=@:*R]?(K*%@]DZXJIM7M0N=WCS.EZ.?44"8% +@KDG0/JGQ6$
MT@+41H8H4(0"W0ZTT[[;TWGG"&5O?9ZBZA@/9.M*L#5N4+EQ S!G+\]PZIP]
ME.9":1Z4YD-I 9060FD1Y:T3A.BZJK'W3$+33J&T&$7K"K7UB5"Y3T0V:2\O
M>DJ'B+* H$ >"N2C0 $*%*) $0HT08&FE'=W7.BJSMY[&P_'==72&D&H?)6]
M9]*>"M6#<G^@0"X*Y*% /@H4H$ A"A2A0+<#3;)O$"FP8JBVS4V,".(NZLZ%
ML$]LB@6!NFT9?3,?K;N#RMT=1TS:B^5UQF*W6%X@D(L">2B0CP(%*%!X#D@R
M .1-&Z9>!]OL+2H3:-XIE!:C:%T!MK8-*K=M8&Y4DR<Y18XH@P<*Y)T#DER>
MH5P>*% (W;X(5:T)Y9T7E.J.R79@J(> #.;KZJLU>E#YJCK^YC-YPI-G1I T
M%TKSH#0?2@N@M!!*BZC LD$LIQZP:6S'"'W,"906HVA=X;9V$BJWDYRRFBU'
MG=+]H2PD*)!W#DBB020M0&UDB )%*-"$\H84HJF$??8A*E\\F*^KHM830L_S
MA!R_LHTRBJ! +@KDG0.22 OZ9!+41H8H4(0"32COX3 IZV9$98L'LG6?#]T:
M1C2Y8>3,-6XY]00QH4 N"N2A0#X*%*! (0H4H4"W ZVS9U)2X^T>ELK.2*+J
M& ]DZPJO-9=HKS:7#%V_R3.<>OT&I;E0F@>E^5!: *6%4%JD"1X>XIB.IC'#
MOPDT[11*BU&TKE!;"XHFMZ#(5K;E14_I!E'/"D&!/!3(1X$"%"A$@2(4:(("
M337>RG*A:]SSHN/AN*Y:#EXX<MP;1YBE-TVH'I0O! 5R42 /!?)1H  %"E&@
M" 6Z'6B2?8/(;:G.6XATP]*X<20?=T%5S>16M@6!.E7[//U::Q;1CC.+2%:V
MQ?)"&4=0(!<%\E @'P4*4*#P')!D ,B[+2S+H8;J&.P($)EW"J7%*%I7@(VU
MI/M+N]:M#;YM0/F2;I(U[V%9I&6I5 _)2GE#WHM2C@]>2[E,B^^;][.6RBQ_
M7%7;MWGM?]V^ S8B'VXW+\]D?O^H&1]BS1#^Q7QY;>RX3;%]Z6R<%-^S55//
M^SJ=^MZJVT.Q?8_K]DN5KS<OQOR65U6^W'Q\2)-Y6C0!]=_O\[QZ^=(DV+]-
M]_H?4$L#!!0    ( *)*?%@>(%:C,@D  -(R   8    >&PO=V]R:W-H965T
M<R]S:&5E=#<N>&ULK9MM;^.X$8#_BN 6Q2ZP7HLO>G&:&-BU<FB WEV0=-O/
MC$3'ZLJBCZ*=I+^^I*185CAB[)SVPT:VAR/-<&;X\$673T+^K-:<*^]Y4Y35
MU62MU/9B-JO2-=^PZJO8\E+_LA)RPY3^*!]GU59REM6--L4,^WXXV["\G"PN
MZ^]NY>)2[%21E_Q6>M5NLV'RY3LOQ-/5!$U>O[C+']?*?#%;7&[9([_GZL?V
M5NI/LX.6+-_PLLI%Z4F^NII\0Q<)#4V#6N+?.7^JCJX]8\J#$#_-AYOL:N*;
M)^(%3Y51P?2?/5_RHC":]'/\T2J='.YI&AY?OVK_I39>&_/ *KX4Q7_R3*VO
M)O'$R_B*[0IU)Y[^P5N# J,O%455_^\]-;*1%DYWE1*;MK%^@DU>-G_9<^N(
MHP8H'&B VP;X;0,ZT("T#<BI#6C;@-:>:4RI_9 PQ1:74CQYTDAK;>:B=F;=
M6IN?EZ;?[Y74O^:ZG5HL15F)(L^8XIEWK_0?W:FJ\L3*6[)J[?VB Z/RIMZ/
M^\3[]-?/ES.E;VJ:SM+V!M^;&^"!&R#L_2I*M:Z\ZS+C65_!3#_MX9'QZR-_
MQTZ-"4^_>@1]\;"/"?! R].;8Z!Y<GISY+"&'#J U/K(4 <8+Z]J+Z^DV'@Z
MHR53>?G8I$2N<EY=0&YOU%)8K2D7%]66I?QJHNM!Q>6>3Q9_^PL*_;]#+AM3
M63*2LIX[Z<&=U*5]\9LNE86H*LAC3<NP;FGJX7XQI23PS;_+V?[8'9"D3^?4
MDDP R2#VY_A8LF=(<# D<,;%M^R_.ON;9%1"E]A4E&E><*]L+33?FNO4!-"N
MTNF;EZ='3S!F](RI+!E)6<_IX<'IH3-Z$JZ5ICDS0Q+DM:9U<-3;01#9X6.+
MT1C9L6.+$3H<.-'!ALAIP[T2Z<^I&0LS+Q4;#0C5H#V1]02(^ C;%MF"<30G
MMDFV',8(#=H4'VR*/V23R0$3 WG*O:T4^SSC$DS]V'JN$,]M,VTQ$@!);XLA
M% P:.3\8.7<:><?WK-@U=NGA]XE)R4SVLS+3V9Q*/M2+<^MQIE$0VM8!<C'"
M=F\GMF 8S.>#!B*_@PW_'!-U2=MSJ?('7=8*P4#CW!KA>N!!16HL14FKJ-?]
M41R&P_XY@C'DAH$U*Q_YFT)>5;R-@B)G#WDQ7-1;[2-5]5&U)6-IZWL6=Y[%
MSLC[EV09-Z,HS_=,QQOH/FS'/3#F+P&Y*?;[%: U&I ,_.% Z: 1.2%J<2OY
MEN69QY]-+>1-> BUYO+(1K 2MHI[CX1B8! #!!%&=M%,((T8XWC8S [FD)OF
M?C]D0<%U\??N?O\QD ]?# N!]E)[Z )J(R VC8'2[W[@DZI(WQ<=#R(G^;01
MO&4OPUT; %WKVZ/T$A*,0JAK;4$:.#JVXRSD!JWKS;80+[P-7&V4%$51CW([
M5L#&0>P%F&:+33&!.M(61&]@KF];QU_(#6 )7W$I-:E(ON?E#BXU-BCIKK(9
M<0D)D@@J-;8@I<-0@CKT0F[V^F8ZA8.EQAF,-B1-23P'H N0C,'4L^4H"8?A
M$G7@A=SD]=LITRC02 "I" D0E'. */5)". 7)(I#BH8) W<$AOVSEAMR36#5
M*1-&_ %\&F:+4;4E8VGK^[2C-NQDER-J>V#E3R_C6U'E"@R85E,_[W66 E,N
M2)0"BQ4)((C\8<C '3-A-S/=[F2Z-L.N1G4]N](YH5[J[.=_[/*M69H 383H
MB )Y#PG.40P8" A&_0K1M[##*.S&*"OQH70 C80H*L !4,%!40+:"4B&+CL[
MCL+TK*Q?Y24KTU.R_@.XX\CZ,;4E8VGK^[3C,>SFL5LI4LZSUJ/56D@U55QN
M!F>R;GUGS&3'4I1@ .\BQTH&[O@.N_GN3D]/7DR%,+6C$.7C.ZYQ:CO'-2,I
M2C#$D2$97@3!'1]B-Q_V T=/U]@V5ZS(_]>LBY@">WMS>ZT]ISE2YV@]M3%^
MS*MJI].6>ZFH!H87YYW/\>-(BA)L8^D\#N)ASL8=F&(WF/9B[)3\<ZH[QSD
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MHRPA4U'I+ZI^ $ %,"#GT*#,@;AVQ:JS6]C>I@@N%/C$RV]1H9O%]:*HP0"
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M!!'%&0]D58WYMR8_)AZO]SCIKZ"O0'JV2ERR09 8H_V$GUS%X/9IEF-$$5?
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M0@NS!9V\98_[Z+\>*_BOF/R5*08>"9S[O_\#4E#^#W\+[ER)I:S>'J35*GC
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M9+4H[R#OQ+Y=31V>H.$SU0*'LQX3EULM3N@)QLF0 =%0!I,>J-EP\6T:!JE
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MUU<,U+1/KJR;;VEB($FSVV*W39!+%XO%/M#2V"(JB2I)QW&_?H>DI#@W;Q'
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MC=R^"RFNV"8W<[F[P7T]7<N7R%Q7*^QJWZ[O0K+11A9[,&50<%&_V<O^'HX
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M08%KWE7F7F[?X"Z>S/+ELM)NA&WOFZ0>Y)TVLMZ!24$MFG[FC[L\' !&X3\
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M7 P"9LIG5CEP.O=/F[EV^%#RGRF^3,'0!EQ?:+P!JP$9J-^ZXW\!4$L#!!0
M   ( *)*?%@.N/Q?D@X  *XD   9    >&PO=V]R:W-H965T<R]S:&5E=#$V
M+GAM;)U::W/;-A;]SE^!<>T=>X:6^9(HN8EGG"9MTVF;K-VTT]G9#Q )29A0
M!$N05MQ?O^<"($7*<I+N]&&))"[N\]QS0;W8J?JCW@C1L$_;HM0O3S9-4UU?
M7>EL([9<3U0E2MQ9J7K+&WRMUU>ZJ@7/S:)M<14%P>QJRV5Y<O/"7'M?W[Q0
M;5/(4KROF6ZW6UX_OA*%VKT\"4^Z"W=RO6GHPM7-BXJOQ;UH/E3O:WR[ZJ7D
M<BM*+57):K%Z>7(;7K]*Z'GSP.]2[/3@,R-+EDI]I"]O\Y<G 2DD"I$U)('C
MSX/X3A0%"8(:?SF9)_V6M'#XN9/^O;$=MBRY%M^IX@^9-YN7)_,3EHL5;XOF
M3NU^%,Z>*<G+5*'-_]G./AM')RQK=:.V;C$TV,K2_N6?G!\&"^;!,PLBMR R
M>MN-C):O><-O7M1JQVIZ&M+H@S'5K(9RLJ2@W#<U[DJL:V[N-[P6&U7DHM;_
M^F8>A>FW[,U?K6P>7UPUD$]/765.UBLK*WI&5ABQ7U39;#1[4^8B'PNX@F*]
M=E&GW:OHLQ)?BVS"XM!G41#%GY$7]];&1E[\CZUE_[E=ZJ9&DOSWF.%6;')<
M+!7.M:YX)EZ>H#*TJ!_$R<V_O@EGP;>?43KIE4X^)_WF_L?;NS<_OOOY]9N[
M^U[I?W]X^]N?QS3]O*Q?52.\Q?4E.^8)83SA\0E[6[),E:6KG)UL-JS9"/:+
MJ->B]LWG[]2VXN4CX[FJ&I$SV6@4J6XX?>%U([-":)]5;:U;7C:L46RWD=EF
MN-AMK!EOFXVJY=]8FO%*-KR@_;74)$RM6!@'?A"8_]B[.I<E\,.:@"V,>IQ5
MO&8/O&@%+?CU[3T+)G@\"F>L$D A>ICQ,A\I+U8KV$@*L_ ZF4VB:3J/&8HN
M^\AT5<AFXBTG['5;RW+-?FI+81)Q[(":2PT)I[A.ZAEM[BN121AQ+YN6DP\U
M^[XM\R_Y@TFM6Z--H\@'9'GHIXO$GZ?QH>&]W6V=;8!+K*IE9HP_#2>+Z=[J
M"7OS"9XD$V3Y@!"I&HK(,BO:G"XV.\7X:B4+B=AI$G!;+T4?FUS6\!'6,%YH
M16Y&;&5EXBQ+J"]IS4J0CR;L-UC#U^M:K/$ *]%5JEIE0N24'9D  N=L^3@R
M>E6KK;G026$[@5B=1I&?+&9&!G0BU_ 2!F9*HPUY  ;C!P_I9^ =H;V[_]"I
M?>VBYD5!.#N>L72-[EHYR/E,E-0BV/N"E^R<;I.T*/C6/$57S??PVPL7.ICV
M('/X;"B^KQ:^A$N!+(CTND;(/2H1L:T*]2@H;P>.A>Z$&A0_)Q-7K6&:UO<Q
M/LP!.&:PM\]X\S0C.&(H&E&C>XC<<\Y_I7AM2NOU7HO&W,DI<+AA=)ZP]X.$
M[3U&OO!9[,?SQ$^FR=/4I  Z),P9J$,?/B0CSS9=T,P>> *U@6PE\<;WXE,E
M24RI6 %MZ ZN:O$@2O8H.'3M<V:D+<-&LP#7'F'-RBPT9IL2I*=$N0;3 *=H
M3*9Z5 V4<*@5J?+.FQ8K.O<CO=>B%#4O"N2J:FNK H&D=]NNT:()%$)_[-91
MPE445*KKTI3,O4#^;9=0CQ;NMW1PW#]O15(QLCNU5"@[S7YN\HE=YOI6G[;>
MD;3%8T?2=BDROA4._"CAX9QWR '2*#6]-K2%W M T3V09N?\@B5^D"[\)$KA
M;1=U;:->%:WVSI<7QDXJ Y! 8T(IJ-P46[4UOM8,NSL@-L*Q_4^\;$E2:**$
M#$$?*/ 0M]Z&RFM9EA2JX<-&U\ALAV?=77SS]N V>I:8!&=E:WR/C5RVHN\!
M;%U^HVMI<_>:G<L+-CWKHFDA>;_XT'H8B^[7JP'J8F+LQ6$G06ZW(B>012)5
MA(;FV9&AOC'F7$IR(ORD6F3UOGK9L'J!X2L&1![<1L&C!)PE0Y]Z=&'L4B3B
MO@'!8:#T@(R=+-!WLJRM)^Q#I4JST""F*Z%FF!?^ ?)A+=6L*D$37$F: MA!
M73VH\@&(\(+R9$U@*AZD:C6<T\%"5X)FH3=::#>K!<T=(]>3_]:4K0-W[5?1
M7:<-?^"RX,M"&'RRRA[1T#EIPW.8UGA+ 0QR;1K+[$V+5P1CXI.H,\,'MOP1
M6=L]6CU!4>=!6VC'<<@I^@2 / = /W17_8'BE M]7Z =--VEK!XFBJ(ZW$%1
ME(5-<7(.[=<['RBAME0=UB3C*47]7G@K66N*;"D)%2C'W'YC-"9G$Z<Z>T86
M>A,@':M1?S6A=6Z)E@'$=JE1EX)<MJF%Z$#W<ST?  1SK]FMYT;,'M -H>L6
M$>81<NY]=DA'+1&VXH9*V=XC:+CIZ[L?3P9@9*(KM8?.NU(%YEY][;T;Y*@>
M&*'9'V9R%/DEAS/0GKPNB?H[GKOC\MV@!@8MFE8(N6X[O@7<:Z"LEIECPN>G
MEJ*AK+"UOO#>V3U'ZI":1 0.# K0W]/9W _B!%0ZG:4LF<RB&1CIP@^3F?>#
MRY/07\QF_@+EDB+6@8=A>24DW3D/P]2?SV)V 0&+-/+>]-5Q'DZG?CH-S*U9
M$'V%/B&;^LDL].,X9?$D#"(VG<00#GJ7AK&_2,.!2C,,#&$2(?WF<3Q4*8%%
M\S#!OM/)=)H.59JF <A,:%1*YB.5V%.5/!/MF1],(S^"P&02SF8D- W01%,H
MF@;37J,$^LS3A$63-)H/]8FG4#:E35/R\<A%:+2)'\XBZZ1I\A5.BN&D8)KZ
MT70*C:8)OD]FD!#Y,?2<AOT&I@2/6Q4C\%$(_RU".'H&&<DD"6+(B-+4CX.X
MRZ(QA'JKMFG!FTSM:S;#Y!(ELZ?%>%AL*&"]+\K_O]K8L-I^-6U:>]B3Y'OT
MO^LC$1U3B9!=CM)Z3K/7(%J7WN]"VP]?3HYP(&*0F*B>^6*4 @FJ)(BF[**3
MCDR,_2D&T8NORD'$=8$RG>^WB?Q%,/<7\U'FQTCO %6\WV:^F/HATO5KMD$2
M()RA/X\#]CV7M6<!9L7-['!MV+3UO@F?20HM&@I)[>8A3(X@?@WQR%;;X1%=
MH6H;/N06'2K2+5%J>P]=LQ^<CD]+U]Z?2!=OG"W@7E9WZR?$!.E?V8F?6B%-
MP2[-II-Y1'D>7LXF84A09S_M%SPHS")VHDO2L\MI.$G1V>AC,L??"']G9]Z=
MU!\O5]2P@,6"#D1834T1\##%$\"<,X:5R=EE/%G,S@AJ%F>7X22:G^VWRB49
M!3,?I2AR%IA_]EZ_9N^)YWF.2W2G,I:+8,NVZ&?S/3DS+=C$%V1D6:!%T-C0
M/!H?=,R@*[T5]G(MA,C1>"!R!,%ROR4Q42JS_31K3FX0$S=B#V1U(3Y@SC;C
M#.NWQ(%HA"5&7UYLNGCQ2)#X=';;C6;?C@XNNR$M'\Z^9O\!!;)DADY\0>PJ
M(@Y0I):B,4CF$G]TCK(1SOO G67#S99F4)70L:+4-&Q&UODEG:(\&L/L\9!_
M%!I7L+0T!TF5TK*G/!M)9S@2='[XA*C-$3U8E>](#V]:@X"-R#:E*M3:+,G!
MN0I5T1!LSY#&B;(G4[7*VZQQJE$Y#G7H#C=<5# OU&0=]G<#-G;E6QIGP/$Z
M,SU%DUR9;= //C[7#TSA-V8G?R1[V6JX%#PV*^268N,4)V&B 5GK+,=D(,'@
M0-BYZ4@'F>-I=W#(ZVV_*R:C-7!*8T0Z/%79:^:.)@V=M%O9&;I;4!-=LP"%
M:6:%$D TGA5G'T&9>,/IW^\/*1$ 38!@!'!F;2*?TSE(X]-T2*,F,7DBQ@/"
MK+ZR\L?EZ3D]#P]SI!ZX>7_*>.Q1.Q\<'B%UN.;M(10D77NCV9&30^2#G8[5
MKC3C%![N3R;Z0Y::IBH:QC DK%8RDV3SH"8&0$W@9<(T1/W15-"Q< ,W"(BJ
MQ7BH1:O29CAR%'RPD<4:ZY#!IA8R3)W@7UX\:G-""FRHT L)WGG#C6H(B#"#
MLFHK\CZE/IHD]4X;*;@"+)]:FKE52CI;,S!O3MCLRRT"MCU* 6M:W1 ^RBW(
M68U"$GH0 ^.!<]/T+JX/+D-#.K0C8# ):*?19N-.!@\3>'B(!Q_50S\K&GX'
M<[GS[V<C9^N ]>./\1,DX5;6TD'@%V+)OA3+SEV0V5*P_K82X:FJD"M)4[O
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M965T,3<N>&ULQ59M;^)&$/[N7S%RJRH7.<$V8 PE2!"H$BD'$7 ]G:I^6/"
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M;!2%+![&HW?DC3H71T[>Z/M<9/^Y7!JKD0[_/>2MES4^+(M*Y-14/!'G/=2
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MM2/EHLH= ,+Y802!U.&&</V=ES4F,-;TV'Z0]MF]0$+X)"<LB<<2KO46BC<
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MI"[4(]]\@W:>H>%+>2'M+]HTN<.A@]):*EZV8-U!25GS)"^M#CL ;W0 X+<
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M_/T+YM81L!=F!Q;BCL')X_]XHN!_Q>BO+#'PCX"#_OTG1$&I$OA;YLY9?4J
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MZ%"QR&Q+5P-8%#06+>NVX181Z0<_8"[4!"'&Y.7P*/.PZ1-#16ZQ!*WM#4H
M5GBM$9<JGH+WA@0H[-!3SIU7I;/#9EN\!S.'2.3%3-!7ZBT(EL*B$E1:YR5>
M$N%)X? &5K$JZR'N,:=>V*$1Q(<J.$846]XLDLCFN )\N(XS!1H#!M _"(L3
M4D)@E4,O)!5AQ<B!=3\#S^/[*,AV"KB#*3CQAKB*DY.B_GS/CDK4RB<S<-=1
M<"#O:LIY(,+&XR%Q2OC1Q<JLFY"]E+<(AI9T)JYY"+W1!ZM"55AA"RO$@6:
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M;4;7G6SHEB#&W/N-='A?RO!(AF=E#"JL N]<K9?>1>G^=^<8?EF*N7=7U9V
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M<"6)AO4\O$PN%F/G[QV^<MB9@S5Q2E9*/3KC8SD/8Y<0""BL0V X;>$*A'!
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M&IU]Q+&@^L'1"T:VKEG7TF#KNV.-LQ:4-<#[2DJS%VR 87KG_P!02P,$%
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M,&?!Q\X:"YT.R[C5"WH^!GWSF2?+D5A*#84DD#^D+BHC-SW!J@>JB*M3#J(
M?;I%[D2-+F<S+6?"RJ""CQ44G (M1=U)]/H$52U05YT!T^8TZ .^2\?1A$ ]
M=RA",>9IAJ,X05'(4XZ2,*4I(B3')$F#]UJTP T1G*<ISDF*>$A9%$"QF<K*
M];PFA.,LC=$I .2<!M<KQUP78YBSR'>E$3V"#T$,)RG!<<Q1')*((A;& $Y2
MS$F,<TZV**5Q!"0I2L,LCK<I)>!11A*PRT+&^#8EQB.<,.(I)=D.)?1/2H%?
M[11'C&(*@$E(TM2!\@AQ"!S!/&(;1@GPR7B":,AIMLTG9D"6.Z/<Q7@G1#CB
M"28I[8/$DB."%$.0(L8Q90P8L03>PQ00*(Z!)R,; ZXTON!5# M/"<0O)Q#H
M%#"2,(EBP*"<XSB*URI"8BFJVB/![AI,.]MIB6;.98-20C!-4G2@;K!-W6!'
MUXV;VR_F8+TX"'5DO7A>#[S13=WX_P4!;1>$WSLWV@0KIP+W=[9'=+^)MG/<
MUEDPVLF\#/,\V1+4*/@J3=_X=_V2+8BMW($$S_(=E2:0R!%EZ'2-#LD28Y9!
M:A^5)B"]'"I)]F2&XCS*<)[M)&<,&1A!H7DRD^4,$\BH8\R 3D%Q!&=Q=$AU
MZ49UZ=&J<X* @YSP&XA5Z+I9U.I12K-/@0=A]ROP\UP&O3"\LGQ*&6F=6K2=
M>ZDMA!:-M* 8U+GR '6] %:=[4FME+O>4XIGA.6:L)>CLUH5@*G5LG)'B+/@
M#U!RL"OD("9]6/LE!+E \5C :13& (\&.PY]!K PHZY*D%$:$N(VBK[U-&&I
M:B!3N_Q)^'#$2,C9T#>3#)X4GNDPN*G,_6BJI01H, $B0!KV-5=<&8R BCU$
M,#,9CN(P3X>N4.?#$0EI-GPR55;.*7#SL9)UB2+_.R (OA$$/_[XXG9P="7<
M2NR(P[%HC=RGBX/HQ^O"][H*ZT\UHSO/86>]9<]A=]VKMJB[LA?.OAH'!PJC
MZJH4+H20:58VW@HX"S<H+5;GAOTZP<^%<@,<A2[F7FZE7,+E:>'PT F"<@.%
MYP0V*@ZGB1,H.(QDP:VH5^*$0GPOK?,7-AR:0[_??&#K>B];(%+[4:*$RT3E
M#KKN5@2#>)8Z*#@<)"0/WBJ0#E#78+KM )ERZ*8<P9;_65D >2EZP3IZP"S&
M$5P%/.4\AJ?;Z<E>*8VW;C"-U#-_3W-![5K;7V8V7S=7P<O^!O0TO+]'?A!Z
M!F<X5,LI3(63%^QHNK^;]2]6+?Q]Z$Y9N%WYYARNLU*[ = _5<JN7YR!S05Y
M\C=02P,$%     @ HDI\6,E=A8^,!   -@P  !D   !X;"]W;W)K<VAE971S
M+W-H965T,CDN>&ULQ5=M;]LV$/ZN7W'0AB$)E%B2+47*; -YZ; !;1HDV8IA
MV =:.EM<)5$EJ3C]]SM2LN*LKA>D X8@-B7RCL\]?.YXGJZ%_*@*1 V/55FK
MF5MHW9R-1BHKL&+J1#18T\Q2R(II>I2KD6HDLMP:5>4H]/UX5#%>N_.I?7<C
MYU/1ZI+7>"-!M57%Y.<++,5ZY@;NYL4M7Q7:O!C-IPU;X1WJ7YL;24^CP4O.
M*ZP5%S5(7,[<\^#L(C+K[8+?.*[5UAA,) LA/IJ'7_*9ZQM 6&*FC0=&7P]X
MB65I'!&,3[U/=]C2&&Z/-]Y_LK%3+ NF\%*4'WBNBYF;N)#CDK6EOA7KG[&/
MQP+,1*GL)ZS[M;X+6:NTJ'IC0E#QNOMFCST/+S$(>X/0XNXVLBBOF&;SJ11K
MD&8U>3,#&ZJU)G"\-H=RIR7-<K+3\VLZ][="*;A!"7<%DPCG6DN^:#5?E A:
MP'N9\YH.S$X7HLQ1*CBX9S2M#J<C32B,KU'6[WC1[1A^9<<@A'>BUH6"-W6.
M^7,'(X(_Q!!N8K@(]WJ\PNP$QH$'H1^.]_@;#YR,K;_Q?\S)'^<+I27I[,]=
MK'1[3G;O:7+O3#4LPYE+R:50/J [_^&[(/9_W!/19(AHLL_[_(YR.6\)NE@"
MY9D"4K0N0!<(EZ)J6LULBM#L!5,\ U;G<,7+5F,.>]@P$M@5ZGXP]P4Z2U%2
M.>#U"JP34 ;4<@"5/0>U&$#E/:B:0)4&5$.@E 7%MD"9(Q*;([+3FS.B/>P.
M9,=%KAQ+=DTNSYS?D4D'C2:!%(75 J5#JG*,JHRT0O,1.)8AY[JM4#(MY)ES
MO<'R/1Q,QE[D^W!HQ[XW22?=.$H\/PWAT+G"6E :=Y8?;,W _)@]D+,5.A:J
M@E81!E[W-!B67A.KU_-V&GJ$VXM"'^*Q-TE2+TTH(//VU O3T'G[&N=.YYQB
M\T_B/F(:]?&&=N3T&MIFZSS_BZI:KRL3UI'E:N*%4=SSEGAID/Z?O&U4%H?>
M./6]L1]"['LI_<>3X-N9Z]T?=92=!AOR$O\9>4?P*O<;]!ZLF0*VH=MDCV8?
MD?@ATTS0M9J;,S$IMF92LIHRL.1LP4NN.9$I\8&5K5U ;@@'D]HDHVCE4_J9
M=++Y8=R;'#GY]S1Z2IBG=!F2Q;E]VM;L-D [.+7Z.$B\21C1NB]TM"6B04)[
M2F<TE,[HQ:7S6=4GBG3!-*R1CN;-8U:V)N2E%-6NNOKU:KJK@.Z%M/NN,%6U
M$9IJ&6?E'J3X!=)_%-MO+;'.IL1^)B$H>*Z$X9KVNHK:RR: !6:,TI?4:>#9
MBX':3VKIVC*'@O*<5B U<13>L45(O1Q83$:$YC)1+Z[@EZ*FNM'=Y43@$J4D
MB[Z&'--?&),84\^/4^=]JY4FE 911X)HNI1(J0+0FB2"Q(LCGYX2"+PQU8S3
M)';NA:9CV+6&2D<2!UX21;!+GJ.M7HZ*YLIVK(H.J:UUU]8-;X>F^+SK!9^6
M=QWU.R97G)"6N"13JC0D*]EUJ=V#%HWM#!="4Y]IAP4U]BC- II?"A)4_V V
M&'XJS/\&4$L#!!0    ( *)*?%B7LWK&9P4  +8,   9    >&PO=V]R:W-H
M965T<R]S:&5E=#,P+GAM;(U766_;.!!^UZ\@W -VH=HZ;-E.$P,Y6C2+;3=(
MTBX6BWU@I+%-5")5DHKC?[\SU&%WZWJ#(#9%<6:^F6\.^G2C]#>S!K#LJ<BE
M.>NMK2U/1B.3KJ'@9JA*D/AFJ73!+3[JU<B4&GCFA(I\% 5!,BJXD+W%J=N[
MT8M35=E<2+C1S%1%P?7V G*U.>N%O7;C5JS6EC9&B].2K^ .[)?R1N/3J-.2
MB0*D$4HR#<NSWGEX<I'0>7?@JX"-V5LS\N1!J6_T<)V=]0("!#FDEC1P_'J$
M2\AS4H0POC<Z>YU)$MQ?M]H_.-_1EP=NX%+E?XK,KL]ZLQ[+8,FKW-ZJS4=H
M_)F0OE3EQGVR37UV/.VQM#)6%8TP(BB$K+_Y4Q.'/8%9\ N!J!&('.[:D$-Y
MQ2U?G&JU89I.HS9:.%>=-((3DDBYLQK?"I2SBWO^!(9A>*YEJ@I@_7O^D(,9
MG(XL:J<SH[31=%%KBGZA*8S8)R7MVK#W,H/L1P4CA-5ABUIL%]%1C5>0#ED<
M^BP*HOB(OKCS-7;ZXF?Z^O?Y@[$:\^*?0][6NL:'=5&MG)B2IW#6PV(PH!^A
MMWC](DR"=T>0CCNDXV/:%W=8>UF5 U-+=JF*DLOMZQ>S*)R^,^QW90R[ *Q'
M:!UQCAWRX;B5^S5X2Y5C70JY8ASUV36P##4:*U+6%T,8LFNC.>1BP+C,&!D5
M*\G0:JDD2&L((4G]%V5.*!]JE*)&:0GEB?<7<.T!I0A#@J%X .TAR1Z13$Q'
M]!%Z5RV,EZP_COU)$+"!6P?^>#ZNUY.9'\PC-O ^-+C>TI]WKRS/GR-WA*E)
MQ]3DV4S=0JID*G+!7</9D8-T25@*>XBBH^H/IQGQIG^TU;"PBS3&WIG$;6ZQ
M,U9YACW48*]B2ZT*QLLRWQ+M)-9PS(SEMK)*;YT&S2VJ4@?IU5 J;2'S]BSV
M&Y,#)@SCAM6I]7S&*;&] RGCD[+6(+YQ@-![HW*1<=HCW%"TZ8@#2[NH&.2Z
M20%<U/R_9#7YWEWKJ]?YBFA>[3Z\FC]O/Y@8R@,QPHP* S\()G5VS?TX;!(M
MC/TX"3%!WR^7.(8\1/=9R;<8B0JG$39:!D\X7@VVI=@/DIB-IQ.6^&$T]V[1
M(6XJ[?PB01PUH#5ZZX)2LYA6N"/3+:I)UURNX T6 'H<3C&D<^_2[2%'[)'G
M59TIG$CA,@4VQ<C,V,2/D8"ICUQX?V!D-99'DB!\JJ3;GVD&TT7C)9YI_KTW
MC+)2[%+^%E95WM#0UU@AQ.&*ZXR2+H=LA98*+G'PDX/$6]M<A'S$RD='4Y=T
M B6I]Z2@+5XR6,FUE:#-6I3U"]>TP(+&\>@,>G4U"$UX:9PUZ33P63B?)74(
M6-LSKEMSEYTYU_G\#M!:Y0XUYE6*6!$RP2V4:YA<LFCR:D"%4N<HB9%AKZQT
MJ8A:!/WE#OMJGG-MAA2HMIZ8*,K<!0"<'P8H2%W<D*[?N*SPLL2:*3AD1WI6
MTO6LY-D]ZZK-*N+LW!BP!P?)486_[E*EQLB+$KOQ_T^,_?S&BB<D;B;M=Y*]
M]K'K'M[5SY(GWF>\T#:=@!*.QE'*-482Z=E@&E)SB+ 5Q!$M0G\^#S'=#;:J
M=.W2*H-'O+*6+CL3/YI$;.S/XK'W'BE36VBRLN1;C>CP=IGJ"OV,YG,632/O
M1I-QNW6'X'LE:D73.9M,FP%UR.%X["<)]L.I'T[&WM<#5=MOC@Q8OSZ%W:4-
M@+?3Y#,)KJH.57Y;N(=R:;1WERQ K]R-&6.G*FGK:V6WVUW*S^N[Z.YX?:/_
MQ/5*8!KGL$318#C%6:?K6W+]8%7I;J8/RN(]URW7^,,"-!W ]TNE;/M !KJ?
M*HM_ 5!+ P04    " "B2GQ8/VY=;M,"   Q!@  &0   'AL+W=O<FMS:&5E
M=',O<VAE970S,2YX;6R55=MNVS ,??=7$.Y0;$!:.TYZ2Y, O6WK0XL@:;>'
M80^*S=A"9<F3Y*;Y^U%RZF9%&F OUHT\/(<2Z>%2Z2=3(%IX*84TH["PMAI$
MD4D++)DY5!5*.EDH73)+2YU'IM+(,N]4BBB)X^.H9%R&XZ'?F^CQ4-56<(D3
M#:8N2Z97ERC4<A1VP]>-*<\+ZS:B\;!B.<[0/E833:NH1<EXB=)P)4'C8A1>
M= >7?6?O#7YP7)J-.3@E<Z6>W.(V&X6Q(X0"4^L0& W/>(5".""B\6>-&;8A
MG>/F_!7]J]=.6N;,X)42/WEFBU%X&D*&"U8+.U7+[[C6<^3P4B6,_\*RL3TA
MX[0V5I5K9V)0<MF,[&6=APV'T_@#AV3MD'C>32#/\II9-AYJM03MK G-3;Q4
M[TWDN'27,K.:3CGYV?$,<TJQA5O97+#+U.<'-A=HO@PC2Q&<792NT2X;M.0#
MM&X"=TK:PL"-S##[%R B:BV_Y)7?9;(3\1K30^AU.Y#$26\'7J_5V_-XO?_0
M^^MB;JRF]_%[F^(&K[\=S]7,P%0LQ5%(16%0/V,XWM_K'L?G.]CV6[;]7>CC
M&=5@5@L$M8")IDK4=@5,9G#SI^:5$]*!>ZI<.KY&BI]RKZ@#\Q5\0Y5K5A4\
MA2GFM+M-W,[PV\5-\1EEC0&%R-L03%"%NB"0,@ESA(6JB2:78 ND(^]"8ZIR
MR7W2,VY2H4Q-N,[L7EF$'CP4SE50J^ R!^O>(?C0TAH/=:7*BLG5_MYITCTY
M-T&UF15\RXILLI*]S\H;Y37A04!/#,LYZH">64#/C&BX;Q+<&LU0P"?H=GKQ
MF1^/X[/@D11@!C/++'$_@(/@05E*P =4 J(R> \"VQY'M%'&)>K<-RL#*:72
M-A7=[K;]\*)I V_F33.]8SKGTH# !;G&AR='(>BF034+JRK?%.;*4HOQTX)Z
M.FIG0.<+11>R7K@ [5]B_!=02P,$%     @ HDI\6!CVA8=+!@  0SL  !D
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MD<4FUS)M@HL6I'%6?T8_F@NQ%4"/]P30)H#N!M ] 5X3X!T:,&D")CL!WKZ
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MG,7REFT_0Q%07_.%+!;F$VWSO?ZYA<),2)848.5!0FC^C7>%$'L UW\!X!4
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M 6D7F/E4"+WI6 7-'=OL!U!+ P04    " "B2GQ82'?OK#<"  "*!0  &0
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M+%%S,NN9'B4BL5-D/;U/3*W[1# S>[#&T8":75CC_%Y-H>0<=NNY+[=OW7N
M,WWPYQ<2C4&AZ=0I28GG0'N 4YL.YA 2C4&AZ0Z2DK3$+6D=(]1DZK\5S/FQ
M!9FJG5F"3@9,KUQI2>+464_N $VZN0-XIE*PQWET9C9AC^O;RH@2=,0MZ-Z)
M/.'IHW,7<$,,_02#HC$H-)T^I1@)D&](0(U#4#0&A:9SJ+0H.=L\)%W/KR.V
M+3%DYIOS8W48>X9'Z4#R,O>P23>G=F(:"SUQ9JO,'H<G/3\'B!)CQ"W&/A0Y
M%[%[$P U%$'1&!2:SIZ2@P3(5"2@KB(H&H-"TSE42I2<[2R2KB,X,6\@6&)(
M1PAT8ZC?,SE*!I*768O$:@=ZU#<;L,=YYDV0GCC<XWU0I<6H6XM]D#QVRP W
MP.![7Z#6(A2:3IZ2@Q3(6J2@UB(H&H-"TSE42I2>;2VZ,Y_OI]W0KFN(B:D5
M %;3*3BY"?TR_]&=/H0'NZ_8^>T$L*!.A1*%]"F#,I+_B3SF:>C>E$!=2E T
M!H6F4ZC4*05R*2FH2PF*QJ#0= Z5,*9GNY3NS"'#:'$RY^;WOB5HTN-B4"5<
MZ<M\3'?ZD!:M!J8W,>W:GCC2(].HDI?4+2]_EQN1NS<24*L3%(U!H>GD*8U+
M@:Q."FIU@J(Q*#3]?)22U_[95J??-2@[)R?<Z /N*%H6F_7L([Z2O_[+W%"_
MQ[TT[PZ[EQG298^M.C4Z'9\<[TQ$OJZ/R19HE>U2>3@*V3[;'L5]6Q] -9Z_
MQI?L<*!6P1S.]W[D^3I*"Q2+^Q+2NYB67VCYX<CLX4)FV_H0Z5TF99;4#S>"
MAR*O LK7[[-,'B^J!=J#R\O_ 5!+ P04    " "B2GQ8$"-) Z\"  #,!P
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M&Q#7JB0I#CV3  KE$KWD_;ON(/BPSYG_!+;E4Z_UJ7<,/7%VE.3%NJ/ O$R
MSR;(K /RU1.3;=(8Q1? G#O[+*GW&;A];,0MDTZOWXW]Y:;4/4719= 6;4GH
MMQ+Z1R5\W28'T@9,1\P[E9D0I; 1QBB9448U174.'/4^$?TW_,(=!6\K.E>]
M'0'^1FP4*!<N316DHN*Z_J+:U3:P;UQ.[:R/3)#7N?L*4_\%[HA<4*Z,Y+F!
M#"XN#2]9)VL]T:)TX303VD2=&^;F9X32%ICG<R'T>F(W:']OR1]02P,$%
M  @ HDI\6*X9E:Z1 @  !@<  !D   !X;"]W;W)K<VAE971S+W-H965T-#$N
M>&ULE95M;YLP$,>_BL6JJ9.V0GA*TA&DMM&T2:U4->WV8MH+!XY@U6!FFZ3]
M]CN;E&4+2;<WX+/O[G=_L,_)1LA'50)H\E3Q6LV<4NOFW'555D)%U9EHH,:5
M0LB*:C3ERE6-!)K;H(J[ON?%;D59[:2)G;N5:2):S5D-MY*HMJJH?+X$+C8S
M9^2\3-RQ5:G-A)LF#5W! O1#<RO1<OLL.:N@5DS41$(Q<RY&YY=3XV\=OC+8
MJ)TQ,4J60CP:XTL^<SQ3$'#(M,E \;6&*^#<),(R?FYS.CW2!.Z.7[)_LMI1
MRY(JN!+\&\MU.7,F#LFAH"W7=V+S&;9Z(I,O$US9)]ETOF-TSEJE1;4-Q@HJ
M5G=O^K3]#CL!OG\@P-\&^+;N#F2KG%--TT2*#9'&&[.9@95JH[$X5IN?LM 2
M5QG&Z?0:4)(BIW/0E''UCGP@"_SQ><N!B(+<4-U*IAFZH&6=R36C2\:[R1/"
M:G)?BE;1.E>)J[$DD]C-MOC+#N\?P,\A.R/!Z#WQ/3\@#XLY.3UY]V<:%Q7U
MLOQ>EF_S!@?R_H^&[Q=+I25NCQ]#]7><<)ACCLRY:F@&,P?/A *Y!B=]^V84
M>Q^/J AZ%<&Q["E^E'"HIBXJME'FU*W3, P2=SV "GM4^!HJ&D)U4=$.*I@>
M0$4]*GH-%0^AHGU4% ^CXAX5OX8:$]R9A!8:Y! TWH..O." P'%/'1^EW@M-
M.>%VHS7T&5N8'CP:XSVV[YN_,,2>].S)4?8U*$58U;0:<CR;J!J4'H)/]N#A
MY(#N:<^>_K-N_ON #=&G>SMX- []O_#N3ELS-\0-E2M6*R04&.:=C;%ZV77=
MSM"BL9UN*33V33LL\:(":1QPO1!"OQBF>?977_H+4$L#!!0    ( *)*?%@2
MCK/I! ,  )@(   9    >&PO=V]R:W-H965T<R]S:&5E=#0R+GAM;*U676^;
M,!3]*Q:KIE9:PE<@79<@K8FF5>JTJEG7AVD/#MPD5@UFMDG:?[]K0VF2DFB3
M^@*VN>=PSKTVE]%&R >U M#D,>>%&CLKK<L+UU7I"G*J^J*$ I\LA,RIQJE<
MNJJ40#,+RKD;>%[LYI053C*R:S<R&8E*<U; C22JRG,JGRZ!B\W8\9WGA5NV
M7&FSX":CDBYA!OJNO)$X<UN6C.50*"8*(F$Q=C[[%Y.AB;<!/QELU-:8&"=S
M(1[,Y"H;.YX1!!Q2;1@HWM8P <X-$<KXTW Z[2L-<'O\S/[%>D<O<ZI@(O@]
MR_1J[)P[)(,%K;B^%9NOT/B)#%\JN+)7LFEB/8>DE=(B;\"H(&=%?:>/31ZV
M /[P "!H ,$>( @. ,(&$%JCM3)K:THU3492;(@TT<AF!C8W%HUN6&&J.-,2
MGS+$Z>0:, >*G$Y!4\;5&>F1&>Z4K.) Q(+,JK+D@%73E)-+RFF1 IG9[755
MU'O(%.,6.-60$2W(]Q(D+A9+TE#WR-UL2DY/SL@)807YL1*5HD6F1JY&_4:%
MFS9:+VNMP0&M4TC[)/0_D, +P@[XY-_AP2[<Q:RUJ0O:U 66+SS ]\9Y^O5Y
MKK3$;?V[*S.UE$&W%'/4+U1)4Q@[>)85R#4XR?MW?NQ]ZLK3&Y'M9"ULLQ8>
M8T]>?'/CFTASSGIBT:MP0I4"W;DS:M+8DIHOTSKQAP-OY*ZW?;T.&L11&[,C
M=]#*'1R5.ZFDQ*KBD=.59)IAH;#<8M=$I^*:-]H6$\9[@E_'A/&@6W#4"HZ.
M"KX6Q;*G0>;[(@EG=,ZX]="E-WJ=X=#;%]P1-.S6&[=ZXZ-Z[^V'%L\$7:/<
M)6X(,,WG1;;U<HI?CB>@4IUU23_^AJA&DICDHM"K+O.3XPR^92!^38!$&7U2
M1\["L/4^_#_O&5.IJ'"[8>&@RVG-Y_M;!?#ZWL?!7IFZPZ+SO5*Y6WW#].QO
M5"Y9H3#Q"\1Y_2&66]9]L)YH4=I6,A<:&Y,=KO#7 :0)P.<+(?3SQ'2G]F<D
M^0M02P,$%     @ HDI\6 G9$ZU] @  U 4  !D   !X;"]W;W)K<VAE971S
M+W-H965T-#,N>&ULI51M;],P$/XK5IC0)J'FI5V81AII;8$A,:GJ&'Q ?'"3
M:V+-+\%VVNW?<W;:4"#K%[[$/OON>9X[YR[;*?UH:@!+G@279AK4UC;786B*
M&@0U(]6 Q)N-TH):-'45FD8#+7V0X&$216DH*)-!GOFSI<XSU5K.)"PU,:T0
M5#_/@*O=-(B#P\&*5;5U!V&>-;2">[ /S5*C%?8H)1,@#5.2:-A,@YOX>I8Z
M?^_PE<'.'.V)RV2MU*,S/I73('*"@$-A'0+%90MSX-P!H8R?>\R@IW2!Q_L#
M^@>?.^:RI@;FBG]CI:VGP55 2MC0EMN5VMW"/I]+AU<H;OR7[#K?=!*0HC56
MB7TP*A!,=BM]VM?A*"!)7@A(]@&)U]T1>94+:FF>:;4CVGDCFMOX5'TTBF/2
M/<J]U7C+,,[F<R4$LUAE:PB5)9DK:9FLT":?&5TSSBP#0\X78"GCYH*<$2;)
MEUJU!MU-%EH4X:#"8D\XZPB3%PCCA-PA1VW(>UE"^2= B.K[%))#"K/D).("
MBA$9QV]($B5C\G"_(.=G%R=PQWUIQAYW_'^E^7ZS-E;CW_5CJ!@=Q628PG7<
MM6EH =, 6\J WD*0OWX5I]&[$PE,^@0FI]#SCYHZ[5O*6R#G^&P+Q3G5YF)(
M: >5>BC7R=M\?#5)LW [(."R%W!Y4L!*/5-NGTD#NL"R89,/,7<8<7)$'8VB
MR3!UVE.G)ZGOZ!,3K2"TJC14U +17HQ[L8:R<DA(^J^0^"\5X5&G"="5GR>&
M%*J5MFNZ_K0?63==I_YV[^;='=45DX9PV&!H-'J+==#=#.D,JQK?MVME<0KX
M;8UC%[1SP/N-4O9@.()^D.>_ %!+ P04    " "B2GQ8$ML4 5(#  "/#0
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M5"(L!4VQB6#IU+=.YHQ<QU'DC=SU+IC6:*>"Z<AL#TQ4@XE:P?SBC"BSMYZ
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MKG1U;9N9OC&A,!/T\SGG:MLQ >H[6/P?4$L#!!0    ( *)*?%@*E\:H$P@
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M5QKT<F6*4'(= BRQ/^9LB[B>K6BZD8N96ZOP$ZKW?2ZY>ILH.^D_X!<02&W
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M;EY47$5'LBRO019,JHHF;\:J2@6N)ZCW2\;DKJ,=5'6O_P]02P,$%     @
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MP0E,&<CY#:7BU%$?J$K8X#]02P,$%     @ HDI\6$J><0[4 @  Z@L  !D
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MDB"((CL"F%U!$& ([$8<P12 !@P)@O(]N/,^\C;O*:_Y+77\%U!+ P04
M" "B2GQ8EXJ[',     3 @  "P   %]R96QS+RYR96QSG9*Y;L,P#$!_Q=">
M, ?0(8@S9?$6!/D!5J(/V!(%BD6=OZ_:I7&0"QEY/3P2W!YI0.TXI+:+J1C]
M$%)I6M6X 4BV)8]ISI%"KM0L'C6'TD!$VV-#L%HL/D N&6:WO606IW.D5XA<
MUYVE/=LO3T%O@*\Z3'%":4A+,P[PS=)_,O?S##5%Y4HCE5L:>-/E_G;@2=&A
M(E@6FD7)TZ(=I7\=Q_:0T^FO8R*T>EOH^7%H5 J.W&,EC'%BM/XU@LD/['X
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M&^IM!'H;ZFT$>AOJ;01Z&^IM!'H[ZNT$>COJ[01Z.^KM!'H[ZNT$>OMHLYM
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M<' N>&UL4$L! A0#%     @ HDI\6$/CT,/O    *P(  !$
M ( !KP   &1O8U!R;W!S+V-O<F4N>&UL4$L! A0#%     @ HDI\6)E<G",0
M!@  G"<  !,              ( !S0$  'AL+W1H96UE+W1H96UE,2YX;6Q0
M2P$"% ,4    " "B2GQ8OT<&%RT(  "1-@  &               @($."
M>&PO=V]R:W-H965T<R]S:&5E=#$N>&UL4$L! A0#%     @ HDI\6$I[ZQ@R
M @  I@4  !@              ("!<1   'AL+W=O<FMS:&5E=',O<VAE970R
M+GAM;%!+ 0(4 Q0    ( *)*?%A;',MN9 8  &H:   8              "
M@=D2  !X;"]W;W)K<VAE971S+W-H965T,RYX;6Q02P$"% ,4    " "B2GQ8
M[&;UOI0"  "N!@  &               @(%S&0  >&PO=V]R:W-H965T<R]S
M:&5E=#0N>&UL4$L! A0#%     @ HDI\6/ANP%-T!0  (A4  !@
M     ("!/1P  'AL+W=O<FMS:&5E=',O<VAE970U+GAM;%!+ 0(4 Q0    (
M *)*?%C>3GAS0 L  %EW   8              " @><A  !X;"]W;W)K<VAE
M971S+W-H965T-BYX;6Q02P$"% ,4    " "B2GQ8'B!6HS()  #2,@  &
M            @(%=+0  >&PO=V]R:W-H965T<R]S:&5E=#<N>&UL4$L! A0#
M%     @ HDI\6,_YNO5C"P  EQL  !@              ("!Q38  'AL+W=O
M<FMS:&5E=',O<VAE970X+GAM;%!+ 0(4 Q0    ( *)*?%A??<D]8AX   E;
M   8              " @5Y"  !X;"]W;W)K<VAE971S+W-H965T.2YX;6Q0
M2P$"% ,4    " "B2GQ8* *W%^,$  !G"P  &0              @('V8
M>&PO=V]R:W-H965T<R]S:&5E=#$P+GAM;%!+ 0(4 Q0    ( *)*?%A_? YG
MEP(  *L%   9              " @1!F  !X;"]W;W)K<VAE971S+W-H965T
M,3$N>&UL4$L! A0#%     @ HDI\6#SH =[O @  +P8  !D
M ("!WF@  'AL+W=O<FMS:&5E=',O<VAE970Q,BYX;6Q02P$"% ,4    " "B
M2GQ87Z;6;#0$   ]"0  &0              @($$;   >&PO=V]R:W-H965T
M<R]S:&5E=#$S+GAM;%!+ 0(4 Q0    ( *)*?%@,8U^I\ ,  '((   9
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M970Q."YX;6Q02P$"% ,4    " "B2GQ8:=C"WO #  #T"   &0
M    @($.E0  >&PO=V]R:W-H965T<R]S:&5E=#$Y+GAM;%!+ 0(4 Q0    (
M *)*?%@=$_%;9 (  (@&   9              " @369  !X;"]W;W)K<VAE
M971S+W-H965T,C N>&UL4$L! A0#%     @ HDI\6&0ZHFM# @  B@8  !D
M             ("!T)L  'AL+W=O<FMS:&5E=',O<VAE970R,2YX;6Q02P$"
M% ,4    " "B2GQ8#I^J.MD?  #-9@  &0              @(%*G@  >&PO
M=V]R:W-H965T<R]S:&5E=#(R+GAM;%!+ 0(4 Q0    ( *)*?%CS/I=3Y0(
M (P&   9              " @5J^  !X;"]W;W)K<VAE971S+W-H965T,C,N
M>&UL4$L! A0#%     @ HDI\6$X8_T!I P  00<  !D              ("!
M=L$  'AL+W=O<FMS:&5E=',O<VAE970R-"YX;6Q02P$"% ,4    " "B2GQ8
M -<X>7D"  "0!0  &0              @($6Q0  >&PO=V]R:W-H965T<R]S
M:&5E=#(U+GAM;%!+ 0(4 Q0    ( *)*?%CZ/R@MJ0(  ,D%   9
M      " @<;'  !X;"]W;W)K<VAE971S+W-H965T,C8N>&UL4$L! A0#%
M  @ HDI\6!F-+J"P P  7 D  !D              ("!ILH  'AL+W=O<FMS
M:&5E=',O<VAE970R-RYX;6Q02P$"% ,4    " "B2GQ8Y!O)LQT&   L#P
M&0              @(&-S@  >&PO=V]R:W-H965T<R]S:&5E=#(X+GAM;%!+
M 0(4 Q0    ( *)*?%C)786/C 0  #8,   9              " @>'4  !X
M;"]W;W)K<VAE971S+W-H965T,CDN>&UL4$L! A0#%     @ HDI\6)>S>L9G
M!0  M@P  !D              ("!I-D  'AL+W=O<FMS:&5E=',O<VAE970S
M,"YX;6Q02P$"% ,4    " "B2GQ8/VY=;M,"   Q!@  &0
M@(%"WP  >&PO=V]R:W-H965T<R]S:&5E=#,Q+GAM;%!+ 0(4 Q0    ( *)*
M?%@8]H6'2P8  $,[   9              " @4SB  !X;"]W;W)K<VAE971S
M+W-H965T,S(N>&UL4$L! A0#%     @ HDI\6$D(I>]U P  ;Q   !D
M         ("!SN@  'AL+W=O<FMS:&5E=',O<VAE970S,RYX;6Q02P$"% ,4
M    " "B2GQ8N?>(<]<#  !O$P  &0              @(%Z[   >&PO=V]R
M:W-H965T<R]S:&5E=#,T+GAM;%!+ 0(4 Q0    ( *)*?%A(=^^L-P(  (H%
M   9              " @8CP  !X;"]W;W)K<VAE971S+W-H965T,S4N>&UL
M4$L! A0#%     @ HDI\6*M\T*'[!0  Q"P  !D              ("!]O(
M 'AL+W=O<FMS:&5E=',O<VAE970S-BYX;6Q02P$"% ,4    " "B2GQ8$"-)
M Z\"  #,!P  &0              @($H^0  >&PO=V]R:W-H965T<R]S:&5E
M=#,W+GAM;%!+ 0(4 Q0    ( *)*?%C< [R[:P(  (D&   9
M  " @0[\  !X;"]W;W)K<VAE971S+W-H965T,S@N>&UL4$L! A0#%     @
MHDI\6#Q=75&( P  I!   !D              ("!L/X  'AL+W=O<FMS:&5E
M=',O<VAE970S.2YX;6Q02P$"% ,4    " "B2GQ8JOZ13+8"  #J!@  &0
M            @(%O @$ >&PO=V]R:W-H965T<R]S:&5E=#0P+GAM;%!+ 0(4
M Q0    ( *)*?%BN&96ND0(   8'   9              " @5P% 0!X;"]W
M;W)K<VAE971S+W-H965T-#$N>&UL4$L! A0#%     @ HDI\6!*.L^D$ P
MF @  !D              ("!) @! 'AL+W=O<FMS:&5E=',O<VAE970T,BYX
M;6Q02P$"% ,4    " "B2GQ8"=D3K7T"  #4!0  &0              @(%?
M"P$ >&PO=V]R:W-H965T<R]S:&5E=#0S+GAM;%!+ 0(4 Q0    ( *)*?%@2
MVQ0!4@,  (\-   9              " @1,. 0!X;"]W;W)K<VAE971S+W-H
M965T-#0N>&UL4$L! A0#%     @ HDI\6 J7QJ@3"   @T   !D
M     ("!G!$! 'AL+W=O<FMS:&5E=',O<VAE970T-2YX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( *)*?%CGG>ZJG 0  )D2   9              "
M@24K 0!X;"]W;W)K<VAE971S+W-H965T-3 N>&UL4$L! A0#%     @ HDI\
M6#I#</=W P  N@X  !D              ("!^"\! 'AL+W=O<FMS:&5E=',O
M<VAE970U,2YX;6Q02P$"% ,4    " "B2GQ8<HY023L#   ##P  &0
M        @(&F,P$ >&PO=V]R:W-H965T<R]S:&5E=#4R+GAM;%!+ 0(4 Q0
M   ( *)*?%B@6DD"P0(  +0(   9              " @1@W 0!X;"]W;W)K
M<VAE971S+W-H965T-3,N>&UL4$L! A0#%     @ HDI\6&!P\,#D!   ^@\
M !D              ("!$#H! 'AL+W=O<FMS:&5E=',O<VAE970U-"YX;6Q0
M2P$"% ,4    " "B2GQ8!4&Z> P#  !="0  &0              @($K/P$
M>&PO=V]R:W-H965T<R]S:&5E=#4U+GAM;%!+ 0(4 Q0    ( *)*?%@5^RA9
M)0,  ,X.   9              " @6Y" 0!X;"]W;W)K<VAE971S+W-H965T
M-38N>&UL4$L! A0#%     @ HDI\6$J><0[4 @  Z@L  !D
M ("!RD4! 'AL+W=O<FMS:&5E=',O<VAE970U-RYX;6Q02P$"% ,4    " "B
M2GQ8R,63-%\#  !8%0  #0              @ '52 $ >&PO<W1Y;&5S+GAM
M;%!+ 0(4 Q0    ( *)*?%B7BKL<P    !,"   +              "  5],
M 0!?<F5L<R\N<F5L<U!+ 0(4 Q0    ( *)*?%C(.S[V:P0  *XE   /
M          "  4A- 0!X;"]W;W)K8F]O:RYX;6Q02P$"% ,4    " "B2GQ8
M\R"+>>D!   2(@  &@              @ '@40$ >&PO7W)E;',O=V]R:V)O
M;VLN>&UL+G)E;'-02P$"% ,4    " "B2GQ8LFA)V-4!  "_(0  $P
M        @ $!5 $ 6T-O;G1E;G1?5'EP97-=+GAM;%!+!08     00!! +X1
(   '5@$    !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>80
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>81
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>83
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.24.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>204</ContextCount>
  <ElementCount>282</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>true</FootnotesReported>
  <SegmentCount>49</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>5</UnitCount>
  <MyReports>
    <Report instance="ea0202461-20f_arberobo.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>995100 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/dei/role/document/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="ea0202461-20f_arberobo.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>995300 - Document - Audit Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/dei/role/document/AuditInformation</Role>
      <ShortName>Audit Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="ea0202461-20f_arberobo.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>995301 - Statement - Consolidated Balance Sheets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.arberobotics.com/role/ConsolidatedBalanceSheet</Role>
      <ShortName>Consolidated Balance Sheets</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="ea0202461-20f_arberobo.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>995302 - Statement - Consolidated Balance Sheets (Parentheticals)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.arberobotics.com/role/ConsolidatedBalanceSheet_Parentheticals</Role>
      <ShortName>Consolidated Balance Sheets (Parentheticals)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="ea0202461-20f_arberobo.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>995303 - Statement - Consolidated Statements of Operations</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.arberobotics.com/role/ConsolidatedIncomeStatement</Role>
      <ShortName>Consolidated Statements of Operations</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="ea0202461-20f_arberobo.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>995304 - Statement - Consolidated Statements of Changes in Redeemable Convertible Preferred Shares and Shareholders??? Equity (Deficiency)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.arberobotics.com/role/ShareholdersEquityType2or3</Role>
      <ShortName>Consolidated Statements of Changes in Redeemable Convertible Preferred Shares and Shareholders??? Equity (Deficiency)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="ea0202461-20f_arberobo.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>995305 - Statement - Consolidated Statements of Cash Flows</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.arberobotics.com/role/ConsolidatedCashFlow</Role>
      <ShortName>Consolidated Statements of Cash Flows</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="ea0202461-20f_arberobo.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>995306 - Disclosure - General</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.arberobotics.com/role/General</Role>
      <ShortName>General</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="ea0202461-20f_arberobo.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>995307 - Disclosure - Significant Accounting Policies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.arberobotics.com/role/SignificantAccountingPolicies</Role>
      <ShortName>Significant Accounting Policies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="ea0202461-20f_arberobo.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>995308 - Disclosure - Revenue</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.arberobotics.com/role/Revenue</Role>
      <ShortName>Revenue</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="ea0202461-20f_arberobo.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>995309 - Disclosure - Prepaid Expenses and Other Receivables</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.arberobotics.com/role/PrepaidExpensesandOtherReceivables</Role>
      <ShortName>Prepaid Expenses and Other Receivables</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="ea0202461-20f_arberobo.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>995310 - Disclosure - Property and Equipment</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.arberobotics.com/role/PropertyandEquipment</Role>
      <ShortName>Property and Equipment</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="ea0202461-20f_arberobo.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>995311 - Disclosure - Leases</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.arberobotics.com/role/Leases</Role>
      <ShortName>Leases</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="ea0202461-20f_arberobo.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>995312 - Disclosure - Commitments and Contingent Liabilities</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.arberobotics.com/role/CommitmentsandContingentLiabilities</Role>
      <ShortName>Commitments and Contingent Liabilities</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="ea0202461-20f_arberobo.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>995313 - Disclosure - Warrants Liabilities</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.arberobotics.com/role/WarrantsLiabilities</Role>
      <ShortName>Warrants Liabilities</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="ea0202461-20f_arberobo.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>995314 - Disclosure - Shareholders??? Equity</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.arberobotics.com/role/ShareholdersEquity</Role>
      <ShortName>Shareholders??? Equity</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="ea0202461-20f_arberobo.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>995315 - Disclosure - Net Loss Per Share Attributible to Ordinary Sharholders</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.arberobotics.com/role/NetLossPerShareAttributibletoOrdinarySharholders</Role>
      <ShortName>Net Loss Per Share Attributible to Ordinary Sharholders</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="ea0202461-20f_arberobo.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>995316 - Disclosure - Taxes on Income</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.arberobotics.com/role/TaxesonIncome</Role>
      <ShortName>Taxes on Income</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="ea0202461-20f_arberobo.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>995317 - Disclosure - Segment Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.arberobotics.com/role/SegmentInformation</Role>
      <ShortName>Segment Information</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="ea0202461-20f_arberobo.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>995410 - Disclosure - Pay vs Performance Disclosure</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ecd/role/PvpDisclosure</Role>
      <ShortName>Pay vs Performance Disclosure</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>20</Position>
    </Report>
    <Report instance="ea0202461-20f_arberobo.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>995445 - Disclosure - Insider Trading Arrangements</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements</Role>
      <ShortName>Insider Trading Arrangements</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>21</Position>
    </Report>
    <Report instance="ea0202461-20f_arberobo.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>996000 - Disclosure - Accounting Policies, by Policy (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.arberobotics.com/role/AccountingPoliciesByPolicy</Role>
      <ShortName>Accounting Policies, by Policy (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <ParentRole>http://www.arberobotics.com/role/SignificantAccountingPolicies</ParentRole>
      <Position>22</Position>
    </Report>
    <Report instance="ea0202461-20f_arberobo.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>996001 - Disclosure - Significant Accounting Policies (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.arberobotics.com/role/SignificantAccountingPoliciesTables</Role>
      <ShortName>Significant Accounting Policies (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.arberobotics.com/role/SignificantAccountingPolicies</ParentRole>
      <Position>23</Position>
    </Report>
    <Report instance="ea0202461-20f_arberobo.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>996002 - Disclosure - Revenue (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.arberobotics.com/role/RevenueTables</Role>
      <ShortName>Revenue (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.arberobotics.com/role/Revenue</ParentRole>
      <Position>24</Position>
    </Report>
    <Report instance="ea0202461-20f_arberobo.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>996003 - Disclosure - Prepaid Expenses and Other Receivables (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.arberobotics.com/role/PrepaidExpensesandOtherReceivablesTables</Role>
      <ShortName>Prepaid Expenses and Other Receivables (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.arberobotics.com/role/PrepaidExpensesandOtherReceivables</ParentRole>
      <Position>25</Position>
    </Report>
    <Report instance="ea0202461-20f_arberobo.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>996004 - Disclosure - Property and Equipment (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.arberobotics.com/role/PropertyandEquipmentTables</Role>
      <ShortName>Property and Equipment (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.arberobotics.com/role/PropertyandEquipment</ParentRole>
      <Position>26</Position>
    </Report>
    <Report instance="ea0202461-20f_arberobo.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>996005 - Disclosure - Leases (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.arberobotics.com/role/LeasesTables</Role>
      <ShortName>Leases (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.arberobotics.com/role/Leases</ParentRole>
      <Position>27</Position>
    </Report>
    <Report instance="ea0202461-20f_arberobo.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>996006 - Disclosure - Shareholders??? Equity (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.arberobotics.com/role/ShareholdersEquityTables</Role>
      <ShortName>Shareholders??? Equity (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.arberobotics.com/role/ShareholdersEquity</ParentRole>
      <Position>28</Position>
    </Report>
    <Report instance="ea0202461-20f_arberobo.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>996007 - Disclosure - Net Loss Per Share Attributible to Ordinary Sharholders (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.arberobotics.com/role/NetLossPerShareAttributibletoOrdinarySharholdersTables</Role>
      <ShortName>Net Loss Per Share Attributible to Ordinary Sharholders (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.arberobotics.com/role/NetLossPerShareAttributibletoOrdinarySharholders</ParentRole>
      <Position>29</Position>
    </Report>
    <Report instance="ea0202461-20f_arberobo.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>996008 - Disclosure - Taxes on Income (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.arberobotics.com/role/TaxesonIncomeTables</Role>
      <ShortName>Taxes on Income (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.arberobotics.com/role/TaxesonIncome</ParentRole>
      <Position>30</Position>
    </Report>
    <Report instance="ea0202461-20f_arberobo.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>996009 - Disclosure - Segment Information (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.arberobotics.com/role/SegmentInformationTables</Role>
      <ShortName>Segment Information (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.arberobotics.com/role/SegmentInformation</ParentRole>
      <Position>31</Position>
    </Report>
    <Report instance="ea0202461-20f_arberobo.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>996010 - Disclosure - General (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.arberobotics.com/role/GeneralDetails</Role>
      <ShortName>General (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.arberobotics.com/role/General</ParentRole>
      <Position>32</Position>
    </Report>
    <Report instance="ea0202461-20f_arberobo.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>996011 - Disclosure - Significant Accounting Policies (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.arberobotics.com/role/SignificantAccountingPoliciesDetails</Role>
      <ShortName>Significant Accounting Policies (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.arberobotics.com/role/SignificantAccountingPoliciesTables</ParentRole>
      <Position>33</Position>
    </Report>
    <Report instance="ea0202461-20f_arberobo.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>996012 - Disclosure - Significant Accounting Policies (Details) - Schedule of the Straight-Line Method Over the Estimated Useful Lives of the Assets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.arberobotics.com/role/ScheduleoftheStraightLineMethodOvertheEstimatedUsefulLivesoftheAssetsTable</Role>
      <ShortName>Significant Accounting Policies (Details) - Schedule of the Straight-Line Method Over the Estimated Useful Lives of the Assets</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.arberobotics.com/role/SignificantAccountingPoliciesTables</ParentRole>
      <Position>34</Position>
    </Report>
    <Report instance="ea0202461-20f_arberobo.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>996013 - Disclosure - Revenue (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.arberobotics.com/role/RevenueDetails</Role>
      <ShortName>Revenue (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.arberobotics.com/role/RevenueTables</ParentRole>
      <Position>35</Position>
    </Report>
    <Report instance="ea0202461-20f_arberobo.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>996014 - Disclosure - Revenue (Details) - Schedule of Revenue Disaggregated by Geography</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.arberobotics.com/role/ScheduleofRevenueDisaggregatedbyGeographyTable</Role>
      <ShortName>Revenue (Details) - Schedule of Revenue Disaggregated by Geography</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.arberobotics.com/role/RevenueTables</ParentRole>
      <Position>36</Position>
    </Report>
    <Report instance="ea0202461-20f_arberobo.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>996015 - Disclosure - Prepaid Expenses and Other Receivables (Details) - Schedule of Prepaid Expenses and Other Receivables</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.arberobotics.com/role/ScheduleofPrepaidExpensesandOtherReceivablesTable</Role>
      <ShortName>Prepaid Expenses and Other Receivables (Details) - Schedule of Prepaid Expenses and Other Receivables</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.arberobotics.com/role/PrepaidExpensesandOtherReceivablesTables</ParentRole>
      <Position>37</Position>
    </Report>
    <Report instance="ea0202461-20f_arberobo.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>996016 - Disclosure - Property and Equipment (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.arberobotics.com/role/PropertyandEquipmentDetails</Role>
      <ShortName>Property and Equipment (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.arberobotics.com/role/PropertyandEquipmentTables</ParentRole>
      <Position>38</Position>
    </Report>
    <Report instance="ea0202461-20f_arberobo.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>996017 - Disclosure - Property and Equipment (Details) - Schedule of Property and Equipment</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.arberobotics.com/role/ScheduleofPropertyandEquipmentTable</Role>
      <ShortName>Property and Equipment (Details) - Schedule of Property and Equipment</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.arberobotics.com/role/PropertyandEquipmentTables</ParentRole>
      <Position>39</Position>
    </Report>
    <Report instance="ea0202461-20f_arberobo.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>996018 - Disclosure - Leases (Details) - Schedule of Supplemental Cash Flow Information Related to Leases</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.arberobotics.com/role/ScheduleofSupplementalCashFlowInformationRelatedtoLeasesTable</Role>
      <ShortName>Leases (Details) - Schedule of Supplemental Cash Flow Information Related to Leases</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.arberobotics.com/role/LeasesTables</ParentRole>
      <Position>40</Position>
    </Report>
    <Report instance="ea0202461-20f_arberobo.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>996019 - Disclosure - Leases (Details) - Schedule of Maturities of Lease Liabilities</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.arberobotics.com/role/ScheduleofMaturitiesofLeaseLiabilitiesTable</Role>
      <ShortName>Leases (Details) - Schedule of Maturities of Lease Liabilities</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.arberobotics.com/role/LeasesTables</ParentRole>
      <Position>41</Position>
    </Report>
    <Report instance="ea0202461-20f_arberobo.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>996020 - Disclosure - Leases (Details) - Schedule of Supplemental Balance Sheet Information Related to Operating Leases</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.arberobotics.com/role/ScheduleofSupplementalBalanceSheetInformationRelatedtoOperatingLeasesTable</Role>
      <ShortName>Leases (Details) - Schedule of Supplemental Balance Sheet Information Related to Operating Leases</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.arberobotics.com/role/LeasesTables</ParentRole>
      <Position>42</Position>
    </Report>
    <Report instance="ea0202461-20f_arberobo.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>996021 - Disclosure - Commitments and Contingent Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.arberobotics.com/role/CommitmentsandContingentLiabilitiesDetails</Role>
      <ShortName>Commitments and Contingent Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.arberobotics.com/role/CommitmentsandContingentLiabilities</ParentRole>
      <Position>43</Position>
    </Report>
    <Report instance="ea0202461-20f_arberobo.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>996022 - Disclosure - Warrants Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.arberobotics.com/role/WarrantsLiabilitiesDetails</Role>
      <ShortName>Warrants Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.arberobotics.com/role/WarrantsLiabilities</ParentRole>
      <Position>44</Position>
    </Report>
    <Report instance="ea0202461-20f_arberobo.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>996023 - Disclosure - Shareholders??? Equity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.arberobotics.com/role/ShareholdersEquityDetails</Role>
      <ShortName>Shareholders??? Equity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.arberobotics.com/role/ShareholdersEquityTables</ParentRole>
      <Position>45</Position>
    </Report>
    <Report instance="ea0202461-20f_arberobo.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>996024 - Disclosure - Shareholders??? Equity (Details) - Schedule of Stock Option Activity</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.arberobotics.com/role/ScheduleofStockOptionActivityTable</Role>
      <ShortName>Shareholders??? Equity (Details) - Schedule of Stock Option Activity</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.arberobotics.com/role/ShareholdersEquityTables</ParentRole>
      <Position>46</Position>
    </Report>
    <Report instance="ea0202461-20f_arberobo.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>996025 - Disclosure - Shareholders??? Equity (Details) - Schedule of RSUs Activity</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.arberobotics.com/role/ScheduleofRSUsActivityTable</Role>
      <ShortName>Shareholders??? Equity (Details) - Schedule of RSUs Activity</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.arberobotics.com/role/ShareholdersEquityTables</ParentRole>
      <Position>47</Position>
    </Report>
    <Report instance="ea0202461-20f_arberobo.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>996026 - Disclosure - Shareholders??? Equity (Details) - Schedule of Compensation to Employees</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.arberobotics.com/role/ScheduleofCompensationtoEmployeesTable</Role>
      <ShortName>Shareholders??? Equity (Details) - Schedule of Compensation to Employees</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.arberobotics.com/role/ShareholdersEquityTables</ParentRole>
      <Position>48</Position>
    </Report>
    <Report instance="ea0202461-20f_arberobo.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R49.htm</HtmlFileName>
      <LongName>996027 - Disclosure - Shareholders??? Equity (Details) - Schedule of Share Based Compensation Expense</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.arberobotics.com/role/ScheduleofShareBasedCompensationExpenseTable</Role>
      <ShortName>Shareholders??? Equity (Details) - Schedule of Share Based Compensation Expense</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.arberobotics.com/role/ShareholdersEquityTables</ParentRole>
      <Position>49</Position>
    </Report>
    <Report instance="ea0202461-20f_arberobo.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R50.htm</HtmlFileName>
      <LongName>996028 - Disclosure - Net Loss Per Share Attributible to Ordinary Sharholders (Details) - Schedule of Sets Forth the Computation of Basic and Diluted Net Loss Per Share Attributable</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.arberobotics.com/role/ScheduleofSetsForththeComputationofBasicandDilutedNetLossPerShareAttributableTable</Role>
      <ShortName>Net Loss Per Share Attributible to Ordinary Sharholders (Details) - Schedule of Sets Forth the Computation of Basic and Diluted Net Loss Per Share Attributable</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.arberobotics.com/role/NetLossPerShareAttributibletoOrdinarySharholdersTables</ParentRole>
      <Position>50</Position>
    </Report>
    <Report instance="ea0202461-20f_arberobo.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R51.htm</HtmlFileName>
      <LongName>996029 - Disclosure - Net Loss Per Share Attributible to Ordinary Sharholders (Details) - Schedule of Ordinary Shares that were Excluded from the Computation of Diluted Net Loss Per Share</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.arberobotics.com/role/ScheduleofOrdinarySharesthatwereExcludedfromtheComputationofDilutedNetLossPerShareTable</Role>
      <ShortName>Net Loss Per Share Attributible to Ordinary Sharholders (Details) - Schedule of Ordinary Shares that were Excluded from the Computation of Diluted Net Loss Per Share</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.arberobotics.com/role/NetLossPerShareAttributibletoOrdinarySharholdersTables</ParentRole>
      <Position>51</Position>
    </Report>
    <Report instance="ea0202461-20f_arberobo.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R52.htm</HtmlFileName>
      <LongName>996030 - Disclosure - Taxes on Income (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.arberobotics.com/role/TaxesonIncomeDetails</Role>
      <ShortName>Taxes on Income (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.arberobotics.com/role/TaxesonIncomeTables</ParentRole>
      <Position>52</Position>
    </Report>
    <Report instance="ea0202461-20f_arberobo.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R53.htm</HtmlFileName>
      <LongName>996031 - Disclosure - Taxes on Income  (Details) - Schedule of Company???s Loss Before Income Taxes</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.arberobotics.com/role/ScheduleofCompanysLossBeforeIncomeTaxesTable</Role>
      <ShortName>Taxes on Income  (Details) - Schedule of Company???s Loss Before Income Taxes</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.arberobotics.com/role/TaxesonIncomeTables</ParentRole>
      <Position>53</Position>
    </Report>
    <Report instance="ea0202461-20f_arberobo.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R54.htm</HtmlFileName>
      <LongName>996032 - Disclosure - Taxes on Income  (Details) - Schedule of Reconciliation Income Tax Benefit</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.arberobotics.com/role/ScheduleofReconciliationIncomeTaxBenefitTable</Role>
      <ShortName>Taxes on Income  (Details) - Schedule of Reconciliation Income Tax Benefit</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.arberobotics.com/role/TaxesonIncomeTables</ParentRole>
      <Position>54</Position>
    </Report>
    <Report instance="ea0202461-20f_arberobo.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R55.htm</HtmlFileName>
      <LongName>996033 - Disclosure - Taxes on Income  (Details) - Schedule of Deferred Tax Assets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.arberobotics.com/role/ScheduleofDeferredTaxAssetsTable</Role>
      <ShortName>Taxes on Income  (Details) - Schedule of Deferred Tax Assets</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.arberobotics.com/role/TaxesonIncomeTables</ParentRole>
      <Position>55</Position>
    </Report>
    <Report instance="ea0202461-20f_arberobo.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R56.htm</HtmlFileName>
      <LongName>996034 - Disclosure - Segment Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.arberobotics.com/role/SegmentInformationDetails</Role>
      <ShortName>Segment Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.arberobotics.com/role/SegmentInformationTables</ParentRole>
      <Position>56</Position>
    </Report>
    <Report instance="ea0202461-20f_arberobo.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R57.htm</HtmlFileName>
      <LongName>996035 - Disclosure - Segment Information (Details) - Schedule of Property and Equipment, Net of Depreciation, by Geographic Region</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.arberobotics.com/role/ScheduleofPropertyandEquipmentNetofDepreciationbyGeographicRegionTable</Role>
      <ShortName>Segment Information (Details) - Schedule of Property and Equipment, Net of Depreciation, by Geographic Region</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.arberobotics.com/role/SegmentInformationTables</ParentRole>
      <Position>57</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <Logs>
    <Log type="Warning">[dq-0542-Deprecated-Concept] Concept ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy in us-gaap/2023 used in 1 facts was deprecated in us-gaap/2024 as of 2024 and should not be used. ea0202461-20f_arberobo.htm 14569</Log>
    <Log type="Warning">[dq-0542-Deprecated-Concept] Concept ShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodExpectedDividendRate in us-gaap/2023 used in 1 facts was deprecated in us-gaap/2024 as of 2024 and should not be used. ea0202461-20f_arberobo.htm 16211</Log>
    <Log type="Warning">[ix-0514-Hidden-Fact-Eligible-For-Transform] WARN: 2 fact(s) appearing in ix:hidden were eligible for transformation: dei:EntityAddressPostalZipCode -  ea0202461-20f_arberobo.htm 17214, 17215</Log>
  </Logs>
  <InputFiles>
    <File>arbe-20231231.xsd</File>
    <File>arbe-20231231_cal.xml</File>
    <File>arbe-20231231_def.xml</File>
    <File>arbe-20231231_lab.xml</File>
    <File>arbe-20231231_pre.xml</File>
    <File doctype="20-F" isDefinitelyFs="true" isUsgaap="true" original="ea0202461-20f_arberobo.htm">ea0202461-20f_arberobo.htm</File>
  </InputFiles>
  <SupplementalFiles>
    <File>fin_001.jpg</File>
    <File>image_002.jpg</File>
    <File>image_003.jpg</File>
    <File>image_004.jpg</File>
    <File>image_005.jpg</File>
    <File>image_006.jpg</File>
    <File>image_007.jpg</File>
    <File>image_008.jpg</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy items="2">http://fasb.org/srt/2023</BaseTaxonomy>
    <BaseTaxonomy items="859">http://fasb.org/us-gaap/2023</BaseTaxonomy>
    <BaseTaxonomy items="47">http://xbrl.sec.gov/dei/2023</BaseTaxonomy>
    <BaseTaxonomy items="4">http://xbrl.sec.gov/ecd/2023</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>86
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "ea0202461-20f_arberobo.htm": {
   "nsprefix": "arbe",
   "nsuri": "http://www.arberobotics.com/20231231",
   "dts": {
    "schema": {
     "local": [
      "arbe-20231231.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd",
      "https://xbrl.sec.gov/country/2023/country-2023.xsd",
      "https://xbrl.sec.gov/dei/2023/dei-2023.xsd",
      "https://xbrl.sec.gov/dei/2023/dei-2023_def.xsd",
      "https://xbrl.sec.gov/dei/2023/dei-2023_lab.xsd",
      "https://xbrl.sec.gov/dei/2023/dei-2023_pre.xsd",
      "https://xbrl.sec.gov/dei/2023/dei-sub-2023.xsd",
      "https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd",
      "https://xbrl.sec.gov/ecd/2023/ecd-sub-2023.xsd",
      "https://xbrl.sec.gov/sic/2023/sic-2023.xsd"
     ]
    },
    "calculationLink": {
     "local": [
      "arbe-20231231_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "arbe-20231231_def.xml"
     ]
    },
    "labelLink": {
     "local": [
      "arbe-20231231_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "arbe-20231231_pre.xml"
     ]
    },
    "inline": {
     "local": [
      "ea0202461-20f_arberobo.htm"
     ]
    }
   },
   "keyStandard": 270,
   "keyCustom": 12,
   "axisStandard": 17,
   "axisCustom": 0,
   "memberStandard": 30,
   "memberCustom": 18,
   "hidden": {
    "total": 248,
    "http://fasb.org/us-gaap/2023": 237,
    "http://www.arberobotics.com/20231231": 6,
    "http://xbrl.sec.gov/dei/2023": 5
   },
   "contextCount": 204,
   "entityCount": 1,
   "segmentCount": 49,
   "elementCount": 645,
   "unitCount": 5,
   "baseTaxonomies": {
    "http://fasb.org/us-gaap/2023": 859,
    "http://xbrl.sec.gov/dei/2023": 47,
    "http://xbrl.sec.gov/ecd/2023": 4,
    "http://fasb.org/srt/2023": 2
   },
   "report": {
    "R1": {
     "role": "http://xbrl.sec.gov/dei/role/document/Cover",
     "longName": "995100 - Document - Cover",
     "shortName": "Cover",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "b",
       "p",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0202461-20f_arberobo.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "b",
       "p",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0202461-20f_arberobo.htm",
      "first": true,
      "unique": true
     }
    },
    "R2": {
     "role": "http://xbrl.sec.gov/dei/role/document/AuditInformation",
     "longName": "995300 - Document - Audit Information",
     "shortName": "Audit Information",
     "isDefault": "false",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "2",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "dei:AuditorName",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "p",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0202461-20f_arberobo.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "dei:AuditorName",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "p",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0202461-20f_arberobo.htm",
      "first": true,
      "unique": true
     }
    },
    "R3": {
     "role": "http://www.arberobotics.com/role/ConsolidatedBalanceSheet",
     "longName": "995301 - Statement - Consolidated Balance Sheets",
     "shortName": "Consolidated Balance Sheets",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "3",
     "firstAnchor": {
      "contextRef": "c5",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0202461-20f_arberobo.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c5",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0202461-20f_arberobo.htm",
      "first": true,
      "unique": true
     }
    },
    "R4": {
     "role": "http://www.arberobotics.com/role/ConsolidatedBalanceSheet_Parentheticals",
     "longName": "995302 - Statement - Consolidated Balance Sheets (Parentheticals)",
     "shortName": "Consolidated Balance Sheets (Parentheticals)",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "parenthetical",
     "menuCat": "Statements",
     "order": "4",
     "firstAnchor": {
      "contextRef": "c5",
      "name": "us-gaap:CommonStockParOrStatedValuePerShare",
      "unitRef": "ilsPershares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0202461-20f_arberobo.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c5",
      "name": "us-gaap:CommonStockSharesOutstanding",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0202461-20f_arberobo.htm",
      "unique": true
     }
    },
    "R5": {
     "role": "http://www.arberobotics.com/role/ConsolidatedIncomeStatement",
     "longName": "995303 - Statement - Consolidated Statements of Operations",
     "shortName": "Consolidated Statements of Operations",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "5",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:Revenues",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0202461-20f_arberobo.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:Revenues",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0202461-20f_arberobo.htm",
      "first": true,
      "unique": true
     }
    },
    "R6": {
     "role": "http://www.arberobotics.com/role/ShareholdersEquityType2or3",
     "longName": "995304 - Statement - Consolidated Statements of Changes in Redeemable Convertible Preferred Shares and Shareholders\u2019 Equity (Deficiency)",
     "shortName": "Consolidated Statements of Changes in Redeemable Convertible Preferred Shares and Shareholders\u2019 Equity (Deficiency)",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "6",
     "firstAnchor": {
      "contextRef": "c9",
      "name": "us-gaap:StockholdersEquity",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0202461-20f_arberobo.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c9",
      "name": "us-gaap:StockholdersEquity",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0202461-20f_arberobo.htm",
      "first": true,
      "unique": true
     }
    },
    "R7": {
     "role": "http://www.arberobotics.com/role/ConsolidatedCashFlow",
     "longName": "995305 - Statement - Consolidated Statements of Cash Flows",
     "shortName": "Consolidated Statements of Cash Flows",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "7",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:NetIncomeLoss",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0202461-20f_arberobo.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:IssuanceOfStockAndWarrantsForServicesOrClaims",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0202461-20f_arberobo.htm",
      "unique": true
     }
    },
    "R8": {
     "role": "http://www.arberobotics.com/role/General",
     "longName": "995306 - Disclosure - General",
     "shortName": "General",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "8",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:NatureOfOperations",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0202461-20f_arberobo.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:NatureOfOperations",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0202461-20f_arberobo.htm",
      "first": true,
      "unique": true
     }
    },
    "R9": {
     "role": "http://www.arberobotics.com/role/SignificantAccountingPolicies",
     "longName": "995307 - Disclosure - Significant Accounting Policies",
     "shortName": "Significant Accounting Policies",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "9",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0202461-20f_arberobo.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0202461-20f_arberobo.htm",
      "first": true,
      "unique": true
     }
    },
    "R10": {
     "role": "http://www.arberobotics.com/role/Revenue",
     "longName": "995308 - Disclosure - Revenue",
     "shortName": "Revenue",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "10",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:RevenueFromContractWithCustomerTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0202461-20f_arberobo.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:RevenueFromContractWithCustomerTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0202461-20f_arberobo.htm",
      "first": true,
      "unique": true
     }
    },
    "R11": {
     "role": "http://www.arberobotics.com/role/PrepaidExpensesandOtherReceivables",
     "longName": "995309 - Disclosure - Prepaid Expenses and Other Receivables",
     "shortName": "Prepaid Expenses and Other Receivables",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "11",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:OtherCurrentAssetsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0202461-20f_arberobo.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:OtherCurrentAssetsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0202461-20f_arberobo.htm",
      "first": true,
      "unique": true
     }
    },
    "R12": {
     "role": "http://www.arberobotics.com/role/PropertyandEquipment",
     "longName": "995310 - Disclosure - Property and Equipment",
     "shortName": "Property and Equipment",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "12",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0202461-20f_arberobo.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0202461-20f_arberobo.htm",
      "first": true,
      "unique": true
     }
    },
    "R13": {
     "role": "http://www.arberobotics.com/role/Leases",
     "longName": "995311 - Disclosure - Leases",
     "shortName": "Leases",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "13",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:LesseeOperatingLeasesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0202461-20f_arberobo.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:LesseeOperatingLeasesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0202461-20f_arberobo.htm",
      "first": true,
      "unique": true
     }
    },
    "R14": {
     "role": "http://www.arberobotics.com/role/CommitmentsandContingentLiabilities",
     "longName": "995312 - Disclosure - Commitments and Contingent Liabilities",
     "shortName": "Commitments and Contingent Liabilities",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "14",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0202461-20f_arberobo.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0202461-20f_arberobo.htm",
      "first": true,
      "unique": true
     }
    },
    "R15": {
     "role": "http://www.arberobotics.com/role/WarrantsLiabilities",
     "longName": "995313 - Disclosure - Warrants Liabilities",
     "shortName": "Warrants Liabilities",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "15",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0202461-20f_arberobo.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0202461-20f_arberobo.htm",
      "first": true,
      "unique": true
     }
    },
    "R16": {
     "role": "http://www.arberobotics.com/role/ShareholdersEquity",
     "longName": "995314 - Disclosure - Shareholders\u2019 Equity",
     "shortName": "Shareholders\u2019 Equity",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "16",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0202461-20f_arberobo.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0202461-20f_arberobo.htm",
      "first": true,
      "unique": true
     }
    },
    "R17": {
     "role": "http://www.arberobotics.com/role/NetLossPerShareAttributibletoOrdinarySharholders",
     "longName": "995315 - Disclosure - Net Loss Per Share Attributible to Ordinary Sharholders",
     "shortName": "Net Loss Per Share Attributible to Ordinary Sharholders",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "17",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0202461-20f_arberobo.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0202461-20f_arberobo.htm",
      "first": true,
      "unique": true
     }
    },
    "R18": {
     "role": "http://www.arberobotics.com/role/TaxesonIncome",
     "longName": "995316 - Disclosure - Taxes on Income",
     "shortName": "Taxes on Income",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "18",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0202461-20f_arberobo.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0202461-20f_arberobo.htm",
      "first": true,
      "unique": true
     }
    },
    "R19": {
     "role": "http://www.arberobotics.com/role/SegmentInformation",
     "longName": "995317 - Disclosure - Segment Information",
     "shortName": "Segment Information",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "19",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0202461-20f_arberobo.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0202461-20f_arberobo.htm",
      "first": true,
      "unique": true
     }
    },
    "R20": {
     "role": "http://xbrl.sec.gov/ecd/role/PvpDisclosure",
     "longName": "995410 - Disclosure - Pay vs Performance Disclosure",
     "shortName": "Pay vs Performance Disclosure",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "20",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:NetIncomeLoss",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0202461-20f_arberobo.htm",
      "first": true
     },
     "uniqueAnchor": null
    },
    "R21": {
     "role": "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements",
     "longName": "995445 - Disclosure - Insider Trading Arrangements",
     "shortName": "Insider Trading Arrangements",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "21",
     "firstAnchor": {
      "contextRef": "c81",
      "name": "ecd:Rule10b51ArrAdoptedFlag",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ecd:NonRule10b51ArrAdoptedFlag",
       "ecd:Rule10b51ArrTrmntdFlag",
       "ecd:NonRule10b51ArrTrmntdFlag",
       "p",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0202461-20f_arberobo.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c81",
      "name": "ecd:Rule10b51ArrAdoptedFlag",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ecd:NonRule10b51ArrAdoptedFlag",
       "ecd:Rule10b51ArrTrmntdFlag",
       "ecd:NonRule10b51ArrTrmntdFlag",
       "p",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0202461-20f_arberobo.htm",
      "first": true,
      "unique": true
     }
    },
    "R22": {
     "role": "http://www.arberobotics.com/role/AccountingPoliciesByPolicy",
     "longName": "996000 - Disclosure - Accounting Policies, by Policy (Policies)",
     "shortName": "Accounting Policies, by Policy (Policies)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "policies",
     "menuCat": "Policies",
     "order": "22",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0202461-20f_arberobo.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0202461-20f_arberobo.htm",
      "first": true,
      "unique": true
     }
    },
    "R23": {
     "role": "http://www.arberobotics.com/role/SignificantAccountingPoliciesTables",
     "longName": "996001 - Disclosure - Significant Accounting Policies (Tables)",
     "shortName": "Significant Accounting Policies (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "23",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "arbe:PropertyPlantAndEquipmentUsefulLifeTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "p",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0202461-20f_arberobo.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "arbe:PropertyPlantAndEquipmentUsefulLifeTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "p",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0202461-20f_arberobo.htm",
      "first": true,
      "unique": true
     }
    },
    "R24": {
     "role": "http://www.arberobotics.com/role/RevenueTables",
     "longName": "996002 - Disclosure - Revenue (Tables)",
     "shortName": "Revenue (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "24",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:DisaggregationOfRevenueTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "p",
       "us-gaap:RevenueFromContractWithCustomerTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0202461-20f_arberobo.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:DisaggregationOfRevenueTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "p",
       "us-gaap:RevenueFromContractWithCustomerTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0202461-20f_arberobo.htm",
      "first": true,
      "unique": true
     }
    },
    "R25": {
     "role": "http://www.arberobotics.com/role/PrepaidExpensesandOtherReceivablesTables",
     "longName": "996003 - Disclosure - Prepaid Expenses and Other Receivables (Tables)",
     "shortName": "Prepaid Expenses and Other Receivables (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "25",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:OtherCurrentAssetsTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0202461-20f_arberobo.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:OtherCurrentAssetsTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0202461-20f_arberobo.htm",
      "first": true,
      "unique": true
     }
    },
    "R26": {
     "role": "http://www.arberobotics.com/role/PropertyandEquipmentTables",
     "longName": "996004 - Disclosure - Property and Equipment (Tables)",
     "shortName": "Property and Equipment (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "26",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:PropertyPlantAndEquipmentTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0202461-20f_arberobo.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:PropertyPlantAndEquipmentTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0202461-20f_arberobo.htm",
      "first": true,
      "unique": true
     }
    },
    "R27": {
     "role": "http://www.arberobotics.com/role/LeasesTables",
     "longName": "996005 - Disclosure - Leases (Tables)",
     "shortName": "Leases (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "27",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:OperatingLeaseLeaseIncomeTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "p",
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0202461-20f_arberobo.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:OperatingLeaseLeaseIncomeTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "p",
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0202461-20f_arberobo.htm",
      "first": true,
      "unique": true
     }
    },
    "R28": {
     "role": "http://www.arberobotics.com/role/ShareholdersEquityTables",
     "longName": "996006 - Disclosure - Shareholders\u2019 Equity (Tables)",
     "shortName": "Shareholders\u2019 Equity (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "28",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "p",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0202461-20f_arberobo.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "p",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0202461-20f_arberobo.htm",
      "first": true,
      "unique": true
     }
    },
    "R29": {
     "role": "http://www.arberobotics.com/role/NetLossPerShareAttributibletoOrdinarySharholdersTables",
     "longName": "996007 - Disclosure - Net Loss Per Share Attributible to Ordinary Sharholders (Tables)",
     "shortName": "Net Loss Per Share Attributible to Ordinary Sharholders (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "29",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "us-gaap:EarningsPerShareTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0202461-20f_arberobo.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "us-gaap:EarningsPerShareTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0202461-20f_arberobo.htm",
      "first": true,
      "unique": true
     }
    },
    "R30": {
     "role": "http://www.arberobotics.com/role/TaxesonIncomeTables",
     "longName": "996008 - Disclosure - Taxes on Income (Tables)",
     "shortName": "Taxes on Income (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "30",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "p",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0202461-20f_arberobo.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "p",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0202461-20f_arberobo.htm",
      "first": true,
      "unique": true
     }
    },
    "R31": {
     "role": "http://www.arberobotics.com/role/SegmentInformationTables",
     "longName": "996009 - Disclosure - Segment Information (Tables)",
     "shortName": "Segment Information (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "31",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:LongLivedAssetsByGeographicAreasTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "p",
       "us-gaap:SegmentReportingDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0202461-20f_arberobo.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:LongLivedAssetsByGeographicAreasTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "p",
       "us-gaap:SegmentReportingDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0202461-20f_arberobo.htm",
      "first": true,
      "unique": true
     }
    },
    "R32": {
     "role": "http://www.arberobotics.com/role/GeneralDetails",
     "longName": "996010 - Disclosure - General (Details)",
     "shortName": "General (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "32",
     "firstAnchor": {
      "contextRef": "c5",
      "name": "us-gaap:CommonStockOtherSharesOutstanding",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "p",
       "us-gaap:NatureOfOperations",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0202461-20f_arberobo.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c5",
      "name": "us-gaap:SharesIssuedPricePerShare",
      "unitRef": "usdPershares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "2",
      "ancestors": [
       "span",
       "p",
       "us-gaap:NatureOfOperations",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0202461-20f_arberobo.htm",
      "unique": true
     }
    },
    "R33": {
     "role": "http://www.arberobotics.com/role/SignificantAccountingPoliciesDetails",
     "longName": "996011 - Disclosure - Significant Accounting Policies (Details)",
     "shortName": "Significant Accounting Policies (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "33",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "arbe:SeverancePercentageOfMonthlySalary",
      "unitRef": "pure",
      "xsiNil": "false",
      "lang": null,
      "decimals": "4",
      "ancestors": [
       "p",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0202461-20f_arberobo.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "arbe:SeverancePercentageOfMonthlySalary",
      "unitRef": "pure",
      "xsiNil": "false",
      "lang": null,
      "decimals": "4",
      "ancestors": [
       "p",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0202461-20f_arberobo.htm",
      "first": true,
      "unique": true
     }
    },
    "R34": {
     "role": "http://www.arberobotics.com/role/ScheduleoftheStraightLineMethodOvertheEstimatedUsefulLivesoftheAssetsTable",
     "longName": "996012 - Disclosure - Significant Accounting Policies (Details) - Schedule of the Straight-Line Method Over the Estimated Useful Lives of the Assets",
     "shortName": "Significant Accounting Policies (Details) - Schedule of the Straight-Line Method Over the Estimated Useful Lives of the Assets",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "34",
     "firstAnchor": {
      "contextRef": "c92",
      "name": "us-gaap:PropertyPlantAndEquipmentSalvageValuePercentage",
      "unitRef": "pure",
      "xsiNil": "false",
      "lang": null,
      "decimals": "2",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0202461-20f_arberobo.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c92",
      "name": "us-gaap:PropertyPlantAndEquipmentSalvageValuePercentage",
      "unitRef": "pure",
      "xsiNil": "false",
      "lang": null,
      "decimals": "2",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0202461-20f_arberobo.htm",
      "first": true,
      "unique": true
     }
    },
    "R35": {
     "role": "http://www.arberobotics.com/role/RevenueDetails",
     "longName": "996013 - Disclosure - Revenue (Details)",
     "shortName": "Revenue (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "35",
     "firstAnchor": {
      "contextRef": "c5",
      "name": "us-gaap:DeferredRevenue",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "us-gaap:RevenueFromContractWithCustomerTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0202461-20f_arberobo.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c5",
      "name": "us-gaap:DeferredRevenue",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "us-gaap:RevenueFromContractWithCustomerTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0202461-20f_arberobo.htm",
      "first": true,
      "unique": true
     }
    },
    "R36": {
     "role": "http://www.arberobotics.com/role/ScheduleofRevenueDisaggregatedbyGeographyTable",
     "longName": "996014 - Disclosure - Revenue (Details) - Schedule of Revenue Disaggregated by Geography",
     "shortName": "Revenue (Details) - Schedule of Revenue Disaggregated by Geography",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "36",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "us-gaap:RevenueFromContractWithCustomerTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0202461-20f_arberobo.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "us-gaap:RevenueFromContractWithCustomerTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0202461-20f_arberobo.htm",
      "first": true,
      "unique": true
     }
    },
    "R37": {
     "role": "http://www.arberobotics.com/role/ScheduleofPrepaidExpensesandOtherReceivablesTable",
     "longName": "996015 - Disclosure - Prepaid Expenses and Other Receivables (Details) - Schedule of Prepaid Expenses and Other Receivables",
     "shortName": "Prepaid Expenses and Other Receivables (Details) - Schedule of Prepaid Expenses and Other Receivables",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "37",
     "firstAnchor": {
      "contextRef": "c5",
      "name": "arbe:GovernmentAuthorities",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock",
       "us-gaap:OtherCurrentAssetsTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0202461-20f_arberobo.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c5",
      "name": "arbe:GovernmentAuthorities",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock",
       "us-gaap:OtherCurrentAssetsTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0202461-20f_arberobo.htm",
      "first": true,
      "unique": true
     }
    },
    "R38": {
     "role": "http://www.arberobotics.com/role/PropertyandEquipmentDetails",
     "longName": "996016 - Disclosure - Property and Equipment (Details)",
     "shortName": "Property and Equipment (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "38",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:Depreciation",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0202461-20f_arberobo.htm",
      "first": true
     },
     "uniqueAnchor": null
    },
    "R39": {
     "role": "http://www.arberobotics.com/role/ScheduleofPropertyandEquipmentTable",
     "longName": "996017 - Disclosure - Property and Equipment (Details) - Schedule of Property and Equipment",
     "shortName": "Property and Equipment (Details) - Schedule of Property and Equipment",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "39",
     "firstAnchor": {
      "contextRef": "c5",
      "name": "us-gaap:PropertyPlantAndEquipmentGross",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0202461-20f_arberobo.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c5",
      "name": "us-gaap:PropertyPlantAndEquipmentGross",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0202461-20f_arberobo.htm",
      "first": true,
      "unique": true
     }
    },
    "R40": {
     "role": "http://www.arberobotics.com/role/ScheduleofSupplementalCashFlowInformationRelatedtoLeasesTable",
     "longName": "996018 - Disclosure - Leases (Details) - Schedule of Supplemental Cash Flow Information Related to Leases",
     "shortName": "Leases (Details) - Schedule of Supplemental Cash Flow Information Related to Leases",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "40",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:OperatingLeasePayments",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0202461-20f_arberobo.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:OperatingLeasePayments",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0202461-20f_arberobo.htm",
      "first": true,
      "unique": true
     }
    },
    "R41": {
     "role": "http://www.arberobotics.com/role/ScheduleofMaturitiesofLeaseLiabilitiesTable",
     "longName": "996019 - Disclosure - Leases (Details) - Schedule of Maturities of Lease Liabilities",
     "shortName": "Leases (Details) - Schedule of Maturities of Lease Liabilities",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "41",
     "firstAnchor": {
      "contextRef": "c5",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0202461-20f_arberobo.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c5",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0202461-20f_arberobo.htm",
      "first": true,
      "unique": true
     }
    },
    "R42": {
     "role": "http://www.arberobotics.com/role/ScheduleofSupplementalBalanceSheetInformationRelatedtoOperatingLeasesTable",
     "longName": "996020 - Disclosure - Leases (Details) - Schedule of Supplemental Balance Sheet Information Related to Operating Leases",
     "shortName": "Leases (Details) - Schedule of Supplemental Balance Sheet Information Related to Operating Leases",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "42",
     "firstAnchor": {
      "contextRef": "c5",
      "name": "us-gaap:OperatingLeaseRightOfUseAsset",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0202461-20f_arberobo.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c5",
      "name": "us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "td",
       "tr",
       "table",
       "ix:continuation",
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0202461-20f_arberobo.htm",
      "unique": true
     }
    },
    "R43": {
     "role": "http://www.arberobotics.com/role/CommitmentsandContingentLiabilitiesDetails",
     "longName": "996021 - Disclosure - Commitments and Contingent Liabilities (Details)",
     "shortName": "Commitments and Contingent Liabilities (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "43",
     "firstAnchor": {
      "contextRef": "c5",
      "name": "us-gaap:GrantsReceivable",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0202461-20f_arberobo.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c5",
      "name": "us-gaap:GrantsReceivable",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0202461-20f_arberobo.htm",
      "first": true,
      "unique": true
     }
    },
    "R44": {
     "role": "http://www.arberobotics.com/role/WarrantsLiabilitiesDetails",
     "longName": "996022 - Disclosure - Warrants Liabilities (Details)",
     "shortName": "Warrants Liabilities (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "44",
     "firstAnchor": {
      "contextRef": "c5",
      "name": "us-gaap:AdditionalCollateralAggregateFairValue",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0202461-20f_arberobo.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c5",
      "name": "us-gaap:AdditionalCollateralAggregateFairValue",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0202461-20f_arberobo.htm",
      "first": true,
      "unique": true
     }
    },
    "R45": {
     "role": "http://www.arberobotics.com/role/ShareholdersEquityDetails",
     "longName": "996023 - Disclosure - Shareholders\u2019 Equity (Details)",
     "shortName": "Shareholders\u2019 Equity (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "45",
     "firstAnchor": {
      "contextRef": "c5",
      "name": "us-gaap:CommonStockSharesAuthorized",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0202461-20f_arberobo.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:StockholdersEquityReverseStockSplit",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0202461-20f_arberobo.htm",
      "unique": true
     }
    },
    "R46": {
     "role": "http://www.arberobotics.com/role/ScheduleofStockOptionActivityTable",
     "longName": "996024 - Disclosure - Shareholders\u2019 Equity (Details) - Schedule of Stock Option Activity",
     "shortName": "Shareholders\u2019 Equity (Details) - Schedule of Stock Option Activity",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "46",
     "firstAnchor": {
      "contextRef": "c19",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0202461-20f_arberobo.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c19",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0202461-20f_arberobo.htm",
      "first": true,
      "unique": true
     }
    },
    "R47": {
     "role": "http://www.arberobotics.com/role/ScheduleofRSUsActivityTable",
     "longName": "996025 - Disclosure - Shareholders\u2019 Equity (Details) - Schedule of RSUs Activity",
     "shortName": "Shareholders\u2019 Equity (Details) - Schedule of RSUs Activity",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "47",
     "firstAnchor": {
      "contextRef": "c170",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0202461-20f_arberobo.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c171",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0202461-20f_arberobo.htm",
      "unique": true
     }
    },
    "R48": {
     "role": "http://www.arberobotics.com/role/ScheduleofCompensationtoEmployeesTable",
     "longName": "996026 - Disclosure - Shareholders\u2019 Equity (Details) - Schedule of Compensation to Employees",
     "shortName": "Shareholders\u2019 Equity (Details) - Schedule of Compensation to Employees",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "48",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0202461-20f_arberobo.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0202461-20f_arberobo.htm",
      "first": true,
      "unique": true
     }
    },
    "R49": {
     "role": "http://www.arberobotics.com/role/ScheduleofShareBasedCompensationExpenseTable",
     "longName": "996027 - Disclosure - Shareholders\u2019 Equity (Details) - Schedule of Share Based Compensation Expense",
     "shortName": "Shareholders\u2019 Equity (Details) - Schedule of Share Based Compensation Expense",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "49",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:ShareBasedCompensation",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0202461-20f_arberobo.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c177",
      "name": "us-gaap:ShareBasedCompensation",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0202461-20f_arberobo.htm",
      "unique": true
     }
    },
    "R50": {
     "role": "http://www.arberobotics.com/role/ScheduleofSetsForththeComputationofBasicandDilutedNetLossPerShareAttributableTable",
     "longName": "996028 - Disclosure - Net Loss Per Share Attributible to Ordinary Sharholders (Details) - Schedule of Sets Forth the Computation of Basic and Diluted Net Loss Per Share Attributable",
     "shortName": "Net Loss Per Share Attributible to Ordinary Sharholders (Details) - Schedule of Sets Forth the Computation of Basic and Diluted Net Loss Per Share Attributable",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "50",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:NetIncomeLossAttributableToNonredeemableNoncontrollingInterest",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "us-gaap:EarningsPerShareTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0202461-20f_arberobo.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:NetIncomeLossAttributableToNonredeemableNoncontrollingInterest",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "us-gaap:EarningsPerShareTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0202461-20f_arberobo.htm",
      "first": true,
      "unique": true
     }
    },
    "R51": {
     "role": "http://www.arberobotics.com/role/ScheduleofOrdinarySharesthatwereExcludedfromtheComputationofDilutedNetLossPerShareTable",
     "longName": "996029 - Disclosure - Net Loss Per Share Attributible to Ordinary Sharholders (Details) - Schedule of Ordinary Shares that were Excluded from the Computation of Diluted Net Loss Per Share",
     "shortName": "Net Loss Per Share Attributible to Ordinary Sharholders (Details) - Schedule of Ordinary Shares that were Excluded from the Computation of Diluted Net Loss Per Share",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "51",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "us-gaap:EarningsPerShareTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0202461-20f_arberobo.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "us-gaap:EarningsPerShareTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0202461-20f_arberobo.htm",
      "first": true,
      "unique": true
     }
    },
    "R52": {
     "role": "http://www.arberobotics.com/role/TaxesonIncomeDetails",
     "longName": "996030 - Disclosure - Taxes on Income (Details)",
     "shortName": "Taxes on Income (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "52",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential",
      "unitRef": "pure",
      "xsiNil": "false",
      "lang": null,
      "decimals": "2",
      "ancestors": [
       "span",
       "link:footnote",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0202461-20f_arberobo.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential",
      "unitRef": "pure",
      "xsiNil": "false",
      "lang": null,
      "decimals": "2",
      "ancestors": [
       "span",
       "link:footnote",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0202461-20f_arberobo.htm",
      "first": true,
      "unique": true
     }
    },
    "R53": {
     "role": "http://www.arberobotics.com/role/ScheduleofCompanysLossBeforeIncomeTaxesTable",
     "longName": "996031 - Disclosure - Taxes on Income  (Details) - Schedule of Company\u2019s Loss Before Income Taxes",
     "shortName": "Taxes on Income  (Details) - Schedule of Company\u2019s Loss Before Income Taxes",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "53",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0202461-20f_arberobo.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0202461-20f_arberobo.htm",
      "first": true,
      "unique": true
     }
    },
    "R54": {
     "role": "http://www.arberobotics.com/role/ScheduleofReconciliationIncomeTaxBenefitTable",
     "longName": "996032 - Disclosure - Taxes on Income  (Details) - Schedule of Reconciliation Income Tax Benefit",
     "shortName": "Taxes on Income  (Details) - Schedule of Reconciliation Income Tax Benefit",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "54",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0202461-20f_arberobo.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate",
      "unitRef": "pure",
      "xsiNil": "false",
      "lang": null,
      "decimals": "2",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0202461-20f_arberobo.htm",
      "unique": true
     }
    },
    "R55": {
     "role": "http://www.arberobotics.com/role/ScheduleofDeferredTaxAssetsTable",
     "longName": "996033 - Disclosure - Taxes on Income  (Details) - Schedule of Deferred Tax Assets",
     "shortName": "Taxes on Income  (Details) - Schedule of Deferred Tax Assets",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "55",
     "firstAnchor": {
      "contextRef": "c5",
      "name": "us-gaap:DeferredTaxAssetsOperatingLossCarryforwards",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0202461-20f_arberobo.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c5",
      "name": "us-gaap:DeferredTaxAssetsOperatingLossCarryforwards",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0202461-20f_arberobo.htm",
      "first": true,
      "unique": true
     }
    },
    "R56": {
     "role": "http://www.arberobotics.com/role/SegmentInformationDetails",
     "longName": "996034 - Disclosure - Segment Information (Details)",
     "shortName": "Segment Information (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "56",
     "firstAnchor": {
      "contextRef": "c195",
      "name": "us-gaap:ConcentrationRiskPercentage1",
      "unitRef": "pure",
      "xsiNil": "false",
      "lang": null,
      "decimals": "3",
      "ancestors": [
       "span",
       "p",
       "us-gaap:SegmentReportingDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0202461-20f_arberobo.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c195",
      "name": "us-gaap:ConcentrationRiskPercentage1",
      "unitRef": "pure",
      "xsiNil": "false",
      "lang": null,
      "decimals": "3",
      "ancestors": [
       "span",
       "p",
       "us-gaap:SegmentReportingDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0202461-20f_arberobo.htm",
      "first": true,
      "unique": true
     }
    },
    "R57": {
     "role": "http://www.arberobotics.com/role/ScheduleofPropertyandEquipmentNetofDepreciationbyGeographicRegionTable",
     "longName": "996035 - Disclosure - Segment Information (Details) - Schedule of Property and Equipment, Net of Depreciation, by Geographic Region",
     "shortName": "Segment Information (Details) - Schedule of Property and Equipment, Net of Depreciation, by Geographic Region",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "57",
     "firstAnchor": {
      "contextRef": "c5",
      "name": "us-gaap:PropertyPlantAndEquipmentNet",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0202461-20f_arberobo.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c129",
      "name": "us-gaap:PropertyPlantAndEquipmentNet",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "us-gaap:SegmentReportingDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0202461-20f_arberobo.htm",
      "unique": true
     }
    }
   },
   "tag": {
    "us-gaap_AccountingPoliciesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AccountingPoliciesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Significant Accounting Policies [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AccountsPayableAndOtherAccruedLiabilitiesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.arberobotics.com/role/ConsolidatedBalanceSheet": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.arberobotics.com/role/ConsolidatedBalanceSheet"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accrued expenses and other payables",
        "label": "Accounts Payable and Other Accrued Liabilities, Current",
        "documentation": "Amount of liabilities incurred to vendors for goods and services received, and accrued liabilities classified as other, payable within one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AccountsPayableTradeCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AccountsPayableTradeCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.arberobotics.com/role/ConsolidatedBalanceSheet": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.arberobotics.com/role/ConsolidatedBalanceSheet"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Trade payables",
        "label": "Accounts Payable, Trade, Current",
        "documentation": "Carrying value as of the balance sheet date of obligations incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)."
       }
      }
     },
     "auth_ref": [
      "r21",
      "r22"
     ]
    },
    "us-gaap_AccountsReceivableNetCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AccountsReceivableNetCurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.arberobotics.com/role/ConsolidatedBalanceSheet": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.arberobotics.com/role/ConsolidatedBalanceSheet"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Trade receivable",
        "label": "Accounts Receivable, after Allowance for Credit Loss, Current",
        "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current."
       }
      }
     },
     "auth_ref": [
      "r220",
      "r221"
     ]
    },
    "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment",
     "crdr": "credit",
     "calculation": {
      "http://www.arberobotics.com/role/ScheduleofPropertyandEquipmentTable": {
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.arberobotics.com/role/ScheduleofPropertyandEquipmentTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accumulated depreciation",
        "label": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment",
        "documentation": "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services."
       }
      }
     },
     "auth_ref": [
      "r45",
      "r140",
      "r384"
     ]
    },
    "ecd_Additional402vDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "Additional402vDisclosureTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additional 402(v) Disclosure [Text Block]",
        "terseLabel": "Additional 402(v) Disclosure"
       }
      }
     },
     "auth_ref": [
      "r602"
     ]
    },
    "us-gaap_AdditionalCollateralAggregateFairValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AdditionalCollateralAggregateFairValue",
     "crdr": "debit",
     "presentation": [
      "http://www.arberobotics.com/role/WarrantsLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Aggregate exercise price",
        "label": "Additional Collateral, Aggregate Fair Value",
        "documentation": "The aggregate fair value of additional assets that would be required to be posted as collateral for derivative instruments with credit-risk-related contingent features if the credit-risk-related contingent features were triggered at the end of the reporting period."
       }
      }
     },
     "auth_ref": [
      "r54"
     ]
    },
    "us-gaap_AdditionalPaidInCapitalCommonStock": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AdditionalPaidInCapitalCommonStock",
     "crdr": "credit",
     "calculation": {
      "http://www.arberobotics.com/role/ConsolidatedBalanceSheet": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.arberobotics.com/role/ConsolidatedBalanceSheet"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Additional paid-in capital",
        "label": "Additional Paid in Capital, Common Stock",
        "documentation": "Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital."
       }
      }
     },
     "auth_ref": [
      "r65"
     ]
    },
    "us-gaap_AdditionalPaidInCapitalMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AdditionalPaidInCapitalMember",
     "presentation": [
      "http://www.arberobotics.com/role/ShareholdersEquityType2or3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Additional paid-in capital",
        "label": "Additional Paid-in Capital [Member]",
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders."
       }
      }
     },
     "auth_ref": [
      "r303",
      "r304",
      "r305",
      "r411",
      "r680",
      "r681",
      "r682",
      "r729",
      "r746"
     ]
    },
    "dei_AdditionalSecurities462b": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AdditionalSecurities462b",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additional Securities. 462(b)"
       }
      }
     },
     "auth_ref": [
      "r646"
     ]
    },
    "dei_AdditionalSecurities462bFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AdditionalSecurities462bFileNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additional Securities, 462(b), File Number"
       }
      }
     },
     "auth_ref": [
      "r646"
     ]
    },
    "dei_AdditionalSecuritiesEffective413b": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AdditionalSecuritiesEffective413b",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additional Securities Effective, 413(b)"
       }
      }
     },
     "auth_ref": [
      "r644"
     ]
    },
    "dei_AddressTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AddressTypeDomain",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Address Type [Domain]",
        "documentation": "An entity may have several addresses for different purposes and this domain represents all such types."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_AdjToCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AdjToCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustment to Compensation Amount",
        "terseLabel": "Adjustment to Compensation, Amount"
       }
      }
     },
     "auth_ref": [
      "r608"
     ]
    },
    "ecd_AdjToCompAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AdjToCompAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustment to Compensation [Axis]",
        "terseLabel": "Adjustment to Compensation:"
       }
      }
     },
     "auth_ref": [
      "r608"
     ]
    },
    "ecd_AdjToNonPeoNeoCompFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AdjToNonPeoNeoCompFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustment to Non-PEO NEO Compensation Footnote [Text Block]",
        "terseLabel": "Adjustment to Non-PEO NEO Compensation Footnote"
       }
      }
     },
     "auth_ref": [
      "r608"
     ]
    },
    "ecd_AdjToPeoCompFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AdjToPeoCompFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustment To PEO Compensation, Footnote [Text Block]",
        "terseLabel": "Adjustment To PEO Compensation, Footnote"
       }
      }
     },
     "auth_ref": [
      "r608"
     ]
    },
    "us-gaap_AdjustmentOfWarrantsGrantedForServices": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AdjustmentOfWarrantsGrantedForServices",
     "crdr": "debit",
     "calculation": {
      "http://www.arberobotics.com/role/ConsolidatedCashFlow": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.arberobotics.com/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Revaluation of warrants and accretion",
        "label": "Adjustment of Warrants Granted for Services",
        "documentation": "Adjustment for noncash service expenses paid for by granting of warrants."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition",
     "crdr": "credit",
     "presentation": [
      "http://www.arberobotics.com/role/ShareholdersEquityType2or3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock-based compensation",
        "label": "APIC, Share-Based Payment Arrangement, Option, Increase for Cost Recognition",
        "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for option under share-based payment arrangement."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "presentation": [
      "http://www.arberobotics.com/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Adjustments to reconcile net loss to net cash used in operating activities:",
        "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_AggtErrCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AggtErrCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Erroneous Compensation Amount",
        "terseLabel": "Aggregate Erroneous Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r564",
      "r576",
      "r592",
      "r620"
     ]
    },
    "ecd_AggtErrCompNotYetDeterminedTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AggtErrCompNotYetDeterminedTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Erroneous Compensation Not Yet Determined [Text Block]",
        "terseLabel": "Aggregate Erroneous Compensation Not Yet Determined"
       }
      }
     },
     "auth_ref": [
      "r567",
      "r579",
      "r595",
      "r623"
     ]
    },
    "ecd_AllAdjToCompMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AllAdjToCompMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "All Adjustments to Compensation [Member]",
        "terseLabel": "All Adjustments to Compensation"
       }
      }
     },
     "auth_ref": [
      "r608"
     ]
    },
    "ecd_AllExecutiveCategoriesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AllExecutiveCategoriesMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "All Executive Categories [Member]",
        "terseLabel": "All Executive Categories"
       }
      }
     },
     "auth_ref": [
      "r615"
     ]
    },
    "ecd_AllIndividualsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AllIndividualsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure",
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure",
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements",
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "All Individuals [Member]",
        "terseLabel": "All Individuals"
       }
      }
     },
     "auth_ref": [
      "r571",
      "r580",
      "r596",
      "r615",
      "r624",
      "r628",
      "r636"
     ]
    },
    "ecd_AllTradingArrangementsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AllTradingArrangementsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "All Trading Arrangements [Member]",
        "terseLabel": "All Trading Arrangements"
       }
      }
     },
     "auth_ref": [
      "r634"
     ]
    },
    "us-gaap_AllocatedShareBasedCompensationExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AllocatedShareBasedCompensationExpense",
     "crdr": "debit",
     "presentation": [
      "http://www.arberobotics.com/role/ShareholdersEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock-based compensation",
        "label": "Share-Based Payment Arrangement, Expense",
        "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized."
       }
      }
     },
     "auth_ref": [
      "r302",
      "r310"
     ]
    },
    "dei_AmendmentDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AmendmentDescription",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Description",
        "documentation": "Description of changes contained within amended document."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AnnualInformationForm": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AnnualInformationForm",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Annual Information Form",
        "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form."
       }
      }
     },
     "auth_ref": [
      "r572"
     ]
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
     "presentation": [
      "http://www.arberobotics.com/role/ScheduleofOrdinarySharesthatwereExcludedfromtheComputationofDilutedNetLossPerShareTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Anti-dilutive shares",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount",
        "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented."
       }
      }
     },
     "auth_ref": [
      "r187"
     ]
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis",
     "presentation": [
      "http://www.arberobotics.com/role/ScheduleofOrdinarySharesthatwereExcludedfromtheComputationofDilutedNetLossPerShareTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Antidilutive Securities [Axis]",
        "documentation": "Information by type of antidilutive security."
       }
      }
     },
     "auth_ref": [
      "r35"
     ]
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems",
     "presentation": [
      "http://www.arberobotics.com/role/ScheduleofOrdinarySharesthatwereExcludedfromtheComputationofDilutedNetLossPerShareTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AntidilutiveSecuritiesNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AntidilutiveSecuritiesNameDomain",
     "presentation": [
      "http://www.arberobotics.com/role/ScheduleofOrdinarySharesthatwereExcludedfromtheComputationofDilutedNetLossPerShareTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Antidilutive Securities, Name [Domain]",
        "documentation": "Incremental common shares attributable to securities that were not included in diluted earnings per share (EPS) because to do so would increase EPS amounts or decrease loss per share amounts for the period presented."
       }
      }
     },
     "auth_ref": [
      "r35"
     ]
    },
    "dei_ApproximateDateOfCommencementOfProposedSaleToThePublic": {
     "xbrltype": "dateOrAsapItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "ApproximateDateOfCommencementOfProposedSaleToThePublic",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Approximate Date of Commencement of Proposed Sale to Public",
        "documentation": "The approximate date of a commencement of a proposed sale of securities to the public. This element is disclosed in S-1, S-3, S-4, S-11, F-1, F-3 and F-10 filings."
       }
      }
     },
     "auth_ref": []
    },
    "arbe_ArbeRoboticsLtdMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.arberobotics.com/20231231",
     "localname": "ArbeRoboticsLtdMember",
     "presentation": [
      "http://www.arberobotics.com/role/GeneralDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Arbe Robotics Ltd. [Member]",
        "label": "Arbe Robotics Ltd Member"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_Assets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "Assets",
     "crdr": "debit",
     "calculation": {
      "http://www.arberobotics.com/role/ConsolidatedBalanceSheet": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.arberobotics.com/role/ConsolidatedBalanceSheet"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total assets",
        "label": "Assets",
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events."
       }
      }
     },
     "auth_ref": [
      "r100",
      "r141",
      "r161",
      "r199",
      "r206",
      "r211",
      "r222",
      "r233",
      "r234",
      "r235",
      "r236",
      "r237",
      "r238",
      "r239",
      "r240",
      "r241",
      "r335",
      "r337",
      "r351",
      "r379",
      "r446",
      "r530",
      "r543",
      "r692",
      "r693",
      "r734"
     ]
    },
    "us-gaap_AssetsCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AssetsCurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.arberobotics.com/role/ConsolidatedBalanceSheet": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.arberobotics.com/role/ConsolidatedBalanceSheet"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total current assets",
        "label": "Assets, Current",
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events."
       }
      }
     },
     "auth_ref": [
      "r136",
      "r145",
      "r161",
      "r222",
      "r233",
      "r234",
      "r235",
      "r236",
      "r237",
      "r238",
      "r239",
      "r240",
      "r241",
      "r335",
      "r337",
      "r351",
      "r530",
      "r692",
      "r693",
      "r734"
     ]
    },
    "us-gaap_AssetsCurrentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AssetsCurrentAbstract",
     "presentation": [
      "http://www.arberobotics.com/role/ConsolidatedBalanceSheet"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "CURRENT ASSETS:",
        "label": "Assets, Current [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AssetsNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AssetsNoncurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.arberobotics.com/role/ConsolidatedBalanceSheet": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.arberobotics.com/role/ConsolidatedBalanceSheet"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total non-current assets",
        "label": "Assets, Noncurrent",
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold or consumed after one year or beyond the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r161",
      "r222",
      "r233",
      "r234",
      "r235",
      "r236",
      "r237",
      "r238",
      "r239",
      "r240",
      "r241",
      "r335",
      "r337",
      "r351",
      "r692",
      "r693",
      "r734"
     ]
    },
    "us-gaap_AssetsNoncurrentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AssetsNoncurrentAbstract",
     "presentation": [
      "http://www.arberobotics.com/role/ConsolidatedBalanceSheet"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "NON-CURRENT ASSETS:",
        "label": "Assets, Noncurrent [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_AuditedAnnualFinancialStatements": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AuditedAnnualFinancialStatements",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Audited Annual Financial Statements",
        "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements."
       }
      }
     },
     "auth_ref": [
      "r572"
     ]
    },
    "dei_AuditorFirmId": {
     "xbrltype": "nonemptySequenceNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AuditorFirmId",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/AuditInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Firm ID",
        "documentation": "PCAOB issued Audit Firm Identifier"
       }
      }
     },
     "auth_ref": [
      "r556",
      "r559",
      "r572"
     ]
    },
    "dei_AuditorLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AuditorLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor [Line Items]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_AuditorLocation": {
     "xbrltype": "internationalNameItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AuditorLocation",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/AuditInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Location"
       }
      }
     },
     "auth_ref": [
      "r556",
      "r559",
      "r572"
     ]
    },
    "dei_AuditorName": {
     "xbrltype": "internationalNameItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AuditorName",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/AuditInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Name"
       }
      }
     },
     "auth_ref": [
      "r556",
      "r559",
      "r572"
     ]
    },
    "dei_AuditorTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AuditorTable",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/AuditInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_AwardExrcPrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AwardExrcPrice",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Exercise Price",
        "terseLabel": "Exercise Price"
       }
      }
     },
     "auth_ref": [
      "r631"
     ]
    },
    "ecd_AwardGrantDateFairValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AwardGrantDateFairValue",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Grant Date Fair Value",
        "terseLabel": "Fair Value as of Grant Date"
       }
      }
     },
     "auth_ref": [
      "r632"
     ]
    },
    "ecd_AwardTmgDiscLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AwardTmgDiscLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing Disclosures [Line Items]",
        "terseLabel": "Award Timing Disclosures"
       }
      }
     },
     "auth_ref": [
      "r627"
     ]
    },
    "ecd_AwardTmgHowMnpiCnsdrdTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AwardTmgHowMnpiCnsdrdTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing, How MNPI Considered [Text Block]",
        "terseLabel": "Award Timing, How MNPI Considered"
       }
      }
     },
     "auth_ref": [
      "r627"
     ]
    },
    "ecd_AwardTmgMethodTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AwardTmgMethodTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing Method [Text Block]",
        "terseLabel": "Award Timing Method"
       }
      }
     },
     "auth_ref": [
      "r627"
     ]
    },
    "ecd_AwardTmgMnpiCnsdrdFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AwardTmgMnpiCnsdrdFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing MNPI Considered [Flag]",
        "terseLabel": "Award Timing MNPI Considered"
       }
      }
     },
     "auth_ref": [
      "r627"
     ]
    },
    "ecd_AwardTmgMnpiDiscTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AwardTmgMnpiDiscTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing MNPI Disclosure [Text Block]",
        "terseLabel": "Award Timing MNPI Disclosure"
       }
      }
     },
     "auth_ref": [
      "r627"
     ]
    },
    "ecd_AwardTmgPredtrmndFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AwardTmgPredtrmndFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing Predetermined [Flag]",
        "terseLabel": "Award Timing Predetermined"
       }
      }
     },
     "auth_ref": [
      "r627"
     ]
    },
    "us-gaap_AwardTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AwardTypeAxis",
     "presentation": [
      "http://www.arberobotics.com/role/ScheduleofRSUsActivityTable",
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Type [Axis]",
        "terseLabel": "Award Type",
        "documentation": "Information by type of award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r273",
      "r274",
      "r275",
      "r277",
      "r278",
      "r279",
      "r280",
      "r281",
      "r282",
      "r283",
      "r284",
      "r285",
      "r286",
      "r287",
      "r288",
      "r289",
      "r290",
      "r291",
      "r292",
      "r293",
      "r294",
      "r297",
      "r298",
      "r299",
      "r300",
      "r301"
     ]
    },
    "ecd_AwardUndrlygSecuritiesAmt": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AwardUndrlygSecuritiesAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Underlying Securities Amount",
        "terseLabel": "Underlying Securities"
       }
      }
     },
     "auth_ref": [
      "r630"
     ]
    },
    "ecd_AwardsCloseToMnpiDiscIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AwardsCloseToMnpiDiscIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Awards Close in Time to MNPI Disclosures, Individual Name",
        "terseLabel": "Name"
       }
      }
     },
     "auth_ref": [
      "r629"
     ]
    },
    "ecd_AwardsCloseToMnpiDiscTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AwardsCloseToMnpiDiscTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Awards Close in Time to MNPI Disclosures [Table]",
        "terseLabel": "Awards Close in Time to MNPI Disclosures"
       }
      }
     },
     "auth_ref": [
      "r628"
     ]
    },
    "ecd_AwardsCloseToMnpiDiscTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AwardsCloseToMnpiDiscTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Awards Close in Time to MNPI Disclosures [Table Text Block]",
        "terseLabel": "Awards Close in Time to MNPI Disclosures, Table"
       }
      }
     },
     "auth_ref": [
      "r628"
     ]
    },
    "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BasisOfAccountingPolicyPolicyTextBlock",
     "presentation": [
      "http://www.arberobotics.com/role/AccountingPoliciesByPolicy"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Basis of presentation",
        "label": "Basis of Accounting, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS)."
       }
      }
     },
     "auth_ref": []
    },
    "dei_BusinessContactMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "BusinessContactMember",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Business Contact",
        "label": "Business Contact [Member]",
        "documentation": "Business contact for the entity"
       }
      }
     },
     "auth_ref": [
      "r559",
      "r572"
     ]
    },
    "country_CH": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/country/2023",
     "localname": "CH",
     "presentation": [
      "http://www.arberobotics.com/role/ScheduleofRevenueDisaggregatedbyGeographyTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Switzerland [Member]",
        "label": "SWITZERLAND"
       }
      }
     },
     "auth_ref": []
    },
    "country_CN": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/country/2023",
     "localname": "CN",
     "presentation": [
      "http://www.arberobotics.com/role/ScheduleofRevenueDisaggregatedbyGeographyTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "China [Member]",
        "label": "CHINA"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CashAndCashEquivalentsAtCarryingValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CashAndCashEquivalentsAtCarryingValue",
     "crdr": "debit",
     "calculation": {
      "http://www.arberobotics.com/role/ConsolidatedBalanceSheet": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.arberobotics.com/role/ConsolidatedBalanceSheet"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash and cash equivalents",
        "label": "Cash and Cash Equivalents, at Carrying Value",
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation."
       }
      }
     },
     "auth_ref": [
      "r30",
      "r138",
      "r512"
     ]
    },
    "us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy",
     "presentation": [
      "http://www.arberobotics.com/role/AccountingPoliciesByPolicy"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash and cash equivalents and restricted cash",
        "label": "Cash and Cash Equivalents, Restricted Cash and Cash Equivalents, Policy [Policy Text Block]",
        "documentation": "Entity's cash and cash equivalents accounting policy with respect to restricted balances. Restrictions may include legally restricted deposits held as compensating balances against short-term borrowing arrangements, contracts entered into with others, or company statements of intention with regard to particular deposits; however, time deposits and short-term certificates of deposit are not generally included in legally restricted deposits."
       }
      }
     },
     "auth_ref": [
      "r31",
      "r98"
     ]
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "crdr": "debit",
     "presentation": [
      "http://www.arberobotics.com/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Cash, cash equivalents and restricted cash at the beginning of the year",
        "periodEndLabel": "Cash, cash equivalents and restricted cash at the end of the year",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents",
        "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates."
       }
      }
     },
     "auth_ref": [
      "r30",
      "r79",
      "r158"
     ]
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
     "crdr": "debit",
     "calculation": {
      "http://www.arberobotics.com/role/ConsolidatedCashFlow": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.arberobotics.com/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Increase (decrease) in cash, cash equivalents and restricted cash",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect",
        "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates."
       }
      }
     },
     "auth_ref": [
      "r3",
      "r79"
     ]
    },
    "us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract",
     "presentation": [
      "http://www.arberobotics.com/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Supplemental non-cash disclosure:",
        "label": "Cash Flow, Noncash Investing and Financing Activities Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_ChangedPeerGroupFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "ChangedPeerGroupFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Changed Peer Group, Footnote [Text Block]",
        "terseLabel": "Changed Peer Group, Footnote"
       }
      }
     },
     "auth_ref": [
      "r606"
     ]
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CityAreaCode",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ClassOfStockDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ClassOfStockDomain",
     "presentation": [
      "http://www.arberobotics.com/role/GeneralDetails",
      "http://www.arberobotics.com/role/ShareholdersEquityType2or3",
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Stock [Domain]",
        "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock."
       }
      }
     },
     "auth_ref": [
      "r121",
      "r142",
      "r143",
      "r144",
      "r161",
      "r181",
      "r182",
      "r184",
      "r186",
      "r193",
      "r194",
      "r222",
      "r233",
      "r235",
      "r236",
      "r237",
      "r240",
      "r241",
      "r244",
      "r245",
      "r247",
      "r250",
      "r256",
      "r351",
      "r405",
      "r406",
      "r407",
      "r408",
      "r411",
      "r412",
      "r413",
      "r414",
      "r415",
      "r416",
      "r417",
      "r418",
      "r419",
      "r420",
      "r421",
      "r422",
      "r434",
      "r455",
      "r473",
      "r487",
      "r488",
      "r489",
      "r490",
      "r491",
      "r654",
      "r677",
      "r683"
     ]
    },
    "us-gaap_ClassOfWarrantOrRightOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ClassOfWarrantOrRightOutstanding",
     "presentation": [
      "http://www.arberobotics.com/role/GeneralDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Warrants shares",
        "label": "Class of Warrant or Right, Outstanding",
        "documentation": "Number of warrants or rights outstanding."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_CoSelectedMeasureAmt": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "CoSelectedMeasureAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Company Selected Measure Amount",
        "terseLabel": "Company Selected Measure Amount"
       }
      }
     },
     "auth_ref": [
      "r607"
     ]
    },
    "ecd_CoSelectedMeasureName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "CoSelectedMeasureName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Company Selected Measure Name",
        "terseLabel": "Company Selected Measure Name"
       }
      }
     },
     "auth_ref": [
      "r607"
     ]
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommitmentsAndContingenciesDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments and Contingent Liabilities [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommitmentsAndContingenciesDisclosureTextBlock",
     "presentation": [
      "http://www.arberobotics.com/role/CommitmentsandContingentLiabilities"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "COMMITMENTS AND CONTINGENT LIABILITIES",
        "label": "Commitments and Contingencies Disclosure [Text Block]",
        "documentation": "The entire disclosure for commitments and contingencies."
       }
      }
     },
     "auth_ref": [
      "r87",
      "r227",
      "r228",
      "r495",
      "r688"
     ]
    },
    "us-gaap_CommonStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommonStockMember",
     "presentation": [
      "http://www.arberobotics.com/role/GeneralDetails",
      "http://www.arberobotics.com/role/ShareholdersEquityDetails",
      "http://www.arberobotics.com/role/ShareholdersEquityType2or3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Ordinary Shares",
        "verboseLabel": "Ordinary shares",
        "netLabel": "Common Stock [Member]",
        "label": "Ordinary Shares [Member]",
        "documentation": "Stock that is subordinate to all other stock of the issuer."
       }
      }
     },
     "auth_ref": [
      "r533",
      "r534",
      "r535",
      "r537",
      "r538",
      "r539",
      "r540",
      "r680",
      "r681",
      "r729",
      "r745",
      "r746"
     ]
    },
    "us-gaap_CommonStockOtherSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommonStockOtherSharesOutstanding",
     "presentation": [
      "http://www.arberobotics.com/role/GeneralDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Ordinary shares",
        "label": "Common Stock, Other Shares, Outstanding",
        "documentation": "Total number of shares of other common stock instruments held by shareholders, such as exchangeable shares. May be all or portion of the number of common shares authorized."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CommonStockParOrStatedValuePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommonStockParOrStatedValuePerShare",
     "presentation": [
      "http://www.arberobotics.com/role/ConsolidatedBalanceSheet_Parentheticals",
      "http://www.arberobotics.com/role/ShareholdersEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Ordinary shares, par value (in New Shekels per share)",
        "label": "Common Stock, Par or Stated Value Per Share",
        "documentation": "Face amount or stated value per share of common stock."
       }
      }
     },
     "auth_ref": [
      "r64"
     ]
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommonStockSharesAuthorized",
     "presentation": [
      "http://www.arberobotics.com/role/ConsolidatedBalanceSheet_Parentheticals",
      "http://www.arberobotics.com/role/ShareholdersEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Ordinary Shares, shares authorized",
        "verboseLabel": "Ordinary shares, authorized (in Shares)",
        "label": "Common Stock, Shares Authorized",
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws."
       }
      }
     },
     "auth_ref": [
      "r64",
      "r434"
     ]
    },
    "us-gaap_CommonStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommonStockSharesOutstanding",
     "presentation": [
      "http://www.arberobotics.com/role/ConsolidatedBalanceSheet_Parentheticals"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Ordinary Shares, shares outstanding",
        "label": "Common Stock, Shares, Outstanding",
        "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation."
       }
      }
     },
     "auth_ref": [
      "r9",
      "r64",
      "r434",
      "r452",
      "r746",
      "r747"
     ]
    },
    "us-gaap_CommonStockValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommonStockValue",
     "crdr": "credit",
     "calculation": {
      "http://www.arberobotics.com/role/ConsolidatedBalanceSheet": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.arberobotics.com/role/ConsolidatedBalanceSheet"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Ordinary Shares, NIS 0.000216 par value; 130,000,000 authorized shares as of December 31, 2023 and 2022; 77,925,095 and 64,160,890 outstanding shares at December 31, 2023 and 2022, respectively",
        "label": "Common Stock, Value, Issued",
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity."
       }
      }
     },
     "auth_ref": [
      "r64",
      "r380",
      "r530"
     ]
    },
    "us-gaap_CommonUnitIssuanceValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommonUnitIssuanceValue",
     "crdr": "credit",
     "presentation": [
      "http://www.arberobotics.com/role/ShareholdersEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Ordinary shares issue value",
        "label": "Common Unit, Issuance Value",
        "documentation": "Stated value of common units of ownership issued by a limited liability company (LLC)."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CommonUnitIssued": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommonUnitIssued",
     "presentation": [
      "http://www.arberobotics.com/role/ShareholdersEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Ordinary shares issue (in Shares)",
        "label": "Common Unit, Issued",
        "documentation": "Number of common units issued of limited liability company (LLC)."
       }
      }
     },
     "auth_ref": [
      "r89"
     ]
    },
    "ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "CompActuallyPaidVsCoSelectedMeasureTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Compensation Actually Paid vs. Company Selected Measure [Text Block]",
        "terseLabel": "Compensation Actually Paid vs. Company Selected Measure"
       }
      }
     },
     "auth_ref": [
      "r612"
     ]
    },
    "ecd_CompActuallyPaidVsNetIncomeTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "CompActuallyPaidVsNetIncomeTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Compensation Actually Paid vs. Net Income [Text Block]",
        "terseLabel": "Compensation Actually Paid vs. Net Income"
       }
      }
     },
     "auth_ref": [
      "r611"
     ]
    },
    "ecd_CompActuallyPaidVsOtherMeasureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "CompActuallyPaidVsOtherMeasureTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Compensation Actually Paid vs. Other Measure [Text Block]",
        "terseLabel": "Compensation Actually Paid vs. Other Measure"
       }
      }
     },
     "auth_ref": [
      "r613"
     ]
    },
    "ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "CompActuallyPaidVsTotalShareholderRtnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Compensation Actually Paid vs. Total Shareholder Return [Text Block]",
        "terseLabel": "Compensation Actually Paid vs. Total Shareholder Return"
       }
      }
     },
     "auth_ref": [
      "r610"
     ]
    },
    "us-gaap_ComprehensiveIncomePolicyPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ComprehensiveIncomePolicyPolicyTextBlock",
     "presentation": [
      "http://www.arberobotics.com/role/AccountingPoliciesByPolicy"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other Comprehensive loss",
        "label": "Comprehensive Income, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for comprehensive income."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ComputerEquipmentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ComputerEquipmentMember",
     "presentation": [
      "http://www.arberobotics.com/role/ScheduleofPropertyandEquipmentTable",
      "http://www.arberobotics.com/role/ScheduleoftheStraightLineMethodOvertheEstimatedUsefulLivesoftheAssetsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Computers and peripheral equipment [Member]",
        "label": "Computer Equipment [Member]",
        "documentation": "Long lived, depreciable assets that are used in the creation, maintenance and utilization of information systems."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ConcentrationRiskByBenchmarkAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ConcentrationRiskByBenchmarkAxis",
     "presentation": [
      "http://www.arberobotics.com/role/SegmentInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Concentration Risk Benchmark [Axis]",
        "documentation": "Information by benchmark of concentration risk."
       }
      }
     },
     "auth_ref": [
      "r37",
      "r39",
      "r55",
      "r56",
      "r219",
      "r402",
      "r494"
     ]
    },
    "us-gaap_ConcentrationRiskByTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ConcentrationRiskByTypeAxis",
     "presentation": [
      "http://www.arberobotics.com/role/SegmentInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Concentration Risk Type [Axis]",
        "documentation": "Information by type of concentration risk, for example, but not limited to, asset, liability, net assets, geographic, customer, employees, supplier, lender."
       }
      }
     },
     "auth_ref": [
      "r37",
      "r39",
      "r55",
      "r56",
      "r219",
      "r494",
      "r657"
     ]
    },
    "us-gaap_ConcentrationRiskCreditRisk": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ConcentrationRiskCreditRisk",
     "presentation": [
      "http://www.arberobotics.com/role/AccountingPoliciesByPolicy"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Concentration of credit risk",
        "label": "Concentration Risk, Credit Risk, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for credit risk."
       }
      }
     },
     "auth_ref": [
      "r57",
      "r111"
     ]
    },
    "us-gaap_ConcentrationRiskPercentage1": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ConcentrationRiskPercentage1",
     "presentation": [
      "http://www.arberobotics.com/role/SegmentInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Percentage of revenue of customers",
        "label": "Concentration Risk, Percentage",
        "documentation": "For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the \"benchmark\" (or denominator) in the equation, this concept represents the concentration percentage derived from the division."
       }
      }
     },
     "auth_ref": [
      "r37",
      "r39",
      "r55",
      "r56",
      "r219"
     ]
    },
    "srt_ConsolidatedEntitiesAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "ConsolidatedEntitiesAxis",
     "presentation": [
      "http://www.arberobotics.com/role/GeneralDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Consolidated Entities [Axis]",
        "documentation": "Information by consolidated entity or group of entities."
       }
      }
     },
     "auth_ref": [
      "r124",
      "r164",
      "r335",
      "r336",
      "r337",
      "r338",
      "r372",
      "r505",
      "r661",
      "r662",
      "r663",
      "r691",
      "r694",
      "r695"
     ]
    },
    "srt_ConsolidatedEntitiesDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "ConsolidatedEntitiesDomain",
     "presentation": [
      "http://www.arberobotics.com/role/GeneralDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Consolidated Entities [Domain]",
        "documentation": "Entity or group of entities consolidated into reporting entity."
       }
      }
     },
     "auth_ref": [
      "r124",
      "r164",
      "r335",
      "r336",
      "r337",
      "r338",
      "r372",
      "r505",
      "r661",
      "r662",
      "r663",
      "r691",
      "r694",
      "r695"
     ]
    },
    "dei_ContactPersonnelEmailAddress": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "ContactPersonnelEmailAddress",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contact Personnel Email Address",
        "documentation": "Email address of contact personnel."
       }
      }
     },
     "auth_ref": []
    },
    "dei_ContactPersonnelFaxNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "ContactPersonnelFaxNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contact Personnel Fax Number",
        "documentation": "Fax Number of contact personnel."
       }
      }
     },
     "auth_ref": [
      "r559"
     ]
    },
    "dei_ContactPersonnelName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "ContactPersonnelName",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contact Personnel Name",
        "documentation": "Name of contact personnel"
       }
      }
     },
     "auth_ref": []
    },
    "dei_ContainedFileInformationFileDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "ContainedFileInformationFileDescription",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contained File Information, File Description",
        "documentation": "The description of the contained file."
       }
      }
     },
     "auth_ref": []
    },
    "dei_ContainedFileInformationFileName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "ContainedFileInformationFileName",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contained File Information, File Name",
        "documentation": "The name of the contained file."
       }
      }
     },
     "auth_ref": []
    },
    "dei_ContainedFileInformationFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "ContainedFileInformationFileNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contained File Information, File Number",
        "documentation": "The SEC Document Number of the contained file."
       }
      }
     },
     "auth_ref": []
    },
    "dei_ContainedFileInformationFileType": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "ContainedFileInformationFileType",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contained File Information, File Type",
        "documentation": "The type or format of the contained file (usually XBRL but may be used for other types such as HTML, Word, PDF, GIF/JPG, etc.)."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ContingentLiabilityReserveEstimatePolicy": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ContingentLiabilityReserveEstimatePolicy",
     "presentation": [
      "http://www.arberobotics.com/role/AccountingPoliciesByPolicy"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Contingent Liabilities",
        "label": "Contingent Liability Reserve Estimate, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for the claims loss reserve for insurance contracts with a life contingency (permanent life, some term life, accident and health, some annuities), describing the loss exposures and bases and methodologies for making the relevant accounting estimates."
       }
      }
     },
     "auth_ref": [
      "r96",
      "r97"
     ]
    },
    "arbe_ConversionOfConvertibleLoanIntoOrdinarySharesUponTheRecapitalization": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.arberobotics.com/20231231",
     "localname": "ConversionOfConvertibleLoanIntoOrdinarySharesUponTheRecapitalization",
     "crdr": "debit",
     "presentation": [
      "http://www.arberobotics.com/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Conversion of convertible loan into ordinary shares upon the recapitalization",
        "documentation": "Conversion of convertible loan into ordinary shares upon the recapitalization.",
        "label": "Conversion Of Convertible Loan Into Ordinary Shares Upon The Recapitalization"
       }
      }
     },
     "auth_ref": []
    },
    "arbe_ConversionOfPreferredSharesIntoOrdinarySharesUponTheRecapitalization": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.arberobotics.com/20231231",
     "localname": "ConversionOfPreferredSharesIntoOrdinarySharesUponTheRecapitalization",
     "crdr": "debit",
     "presentation": [
      "http://www.arberobotics.com/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Conversion of preferred shares into ordinary shares upon the recapitalization",
        "documentation": "Conversion of preferred shares into ordinary shares upon the recapitalization.",
        "label": "Conversion Of Preferred Shares Into Ordinary Shares Upon The Recapitalization"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ConversionOfStockAmountConverted1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ConversionOfStockAmountConverted1",
     "crdr": "debit",
     "presentation": [
      "http://www.arberobotics.com/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Exercise of warrants into convertible preferred shares",
        "label": "Conversion of Stock, Amount Converted",
        "documentation": "The value of the stock converted in a noncash (or part noncash) transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period."
       }
      }
     },
     "auth_ref": [
      "r32",
      "r33",
      "r34"
     ]
    },
    "us-gaap_ConvertiblePreferredStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ConvertiblePreferredStockMember",
     "presentation": [
      "http://www.arberobotics.com/role/ScheduleofOrdinarySharesthatwereExcludedfromtheComputationofDilutedNetLossPerShareTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Convertible preferred shares [Member]",
        "label": "Convertible Preferred Stock [Member]",
        "documentation": "Preferred stock that may be exchanged into common shares or other types of securities at the owner's option."
       }
      }
     },
     "auth_ref": [
      "r244",
      "r245",
      "r247",
      "r537",
      "r538",
      "r539",
      "r540"
     ]
    },
    "arbe_CostAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.arberobotics.com/20231231",
     "localname": "CostAbstract",
     "presentation": [
      "http://www.arberobotics.com/role/ScheduleofPropertyandEquipmentTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cost:",
        "label": "Cost Abstract"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CostOfRevenue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CostOfRevenue",
     "crdr": "debit",
     "calculation": {
      "http://www.arberobotics.com/role/ConsolidatedIncomeStatement": {
       "parentTag": "us-gaap_GrossProfit",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.arberobotics.com/role/ConsolidatedIncomeStatement"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Costs of revenues",
        "label": "Cost of Revenue",
        "documentation": "The aggregate cost of goods produced and sold and services rendered during the reporting period."
       }
      }
     },
     "auth_ref": [
      "r75",
      "r161",
      "r222",
      "r233",
      "r234",
      "r235",
      "r236",
      "r237",
      "r238",
      "r239",
      "r240",
      "r241",
      "r351",
      "r692"
     ]
    },
    "us-gaap_CostOfSalesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CostOfSalesMember",
     "presentation": [
      "http://www.arberobotics.com/role/ScheduleofShareBasedCompensationExpenseTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cost of revenues [Member]",
        "label": "Cost of Sales [Member]",
        "documentation": "Primary financial statement caption encompassing cost of sales."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CostOfSalesPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CostOfSalesPolicyTextBlock",
     "presentation": [
      "http://www.arberobotics.com/role/AccountingPoliciesByPolicy"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cost of revenues",
        "label": "Cost of Goods and Service [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for cost of product sold and service rendered."
       }
      }
     },
     "auth_ref": [
      "r660"
     ]
    },
    "dei_CountryRegion": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CountryRegion",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Country Region",
        "documentation": "Region code of country"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CurrentFiscalYearEndDate": {
     "xbrltype": "gMonthDayItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CurrentFiscalYearEndDate",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current Fiscal Year End Date",
        "documentation": "End date of current fiscal year in the format --MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "arbe_Customer1Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.arberobotics.com/20231231",
     "localname": "Customer1Member",
     "presentation": [
      "http://www.arberobotics.com/role/SegmentInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Customer1 [Member]",
        "label": "Customer1 Member"
       }
      }
     },
     "auth_ref": []
    },
    "arbe_Customer2Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.arberobotics.com/20231231",
     "localname": "Customer2Member",
     "presentation": [
      "http://www.arberobotics.com/role/SegmentInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Customer2 [Member]",
        "label": "Customer2 Member"
       }
      }
     },
     "auth_ref": []
    },
    "arbe_Customer3Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.arberobotics.com/20231231",
     "localname": "Customer3Member",
     "presentation": [
      "http://www.arberobotics.com/role/SegmentInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Customer3 [Member]",
        "label": "Customer3 Member"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CustomerConcentrationRiskMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CustomerConcentrationRiskMember",
     "presentation": [
      "http://www.arberobotics.com/role/SegmentInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Customer Concentration Risk [Member]",
        "label": "Customer Concentration Risk [Member]",
        "documentation": "Reflects the percentage that revenues in the period from one or more significant customers is to net revenues, as defined by the entity, such as total net revenues, product line revenues, segment revenues. The risk is the materially adverse effects of loss of a significant customer."
       }
      }
     },
     "auth_ref": [
      "r38",
      "r219"
     ]
    },
    "country_DE": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/country/2023",
     "localname": "DE",
     "presentation": [
      "http://www.arberobotics.com/role/ScheduleofRevenueDisaggregatedbyGeographyTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Germany [Member]",
        "label": "GERMANY"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock",
     "presentation": [
      "http://www.arberobotics.com/role/PrepaidExpensesandOtherReceivablesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Prepaid Expenses and Other Receivables",
        "label": "Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Table Text Block]",
        "documentation": "Tabular disclosure of the amounts paid in advance for capitalized costs that will be expensed with the passage of time or the occurrence of a triggering event, and will be charged against earnings within one year or the normal operating cycle, if longer; the aggregate carrying amount of current assets, not separately presented elsewhere in the balance sheet; and other deferred costs."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DeferredRevenue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredRevenue",
     "crdr": "credit",
     "presentation": [
      "http://www.arberobotics.com/role/RevenueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Deferred revenue",
        "label": "Deferred Revenue",
        "documentation": "Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable."
       }
      }
     },
     "auth_ref": [
      "r668"
     ]
    },
    "us-gaap_DeferredRevenueCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredRevenueCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.arberobotics.com/role/ConsolidatedBalanceSheet": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.arberobotics.com/role/ConsolidatedBalanceSheet"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Deferred revenue",
        "label": "Deferred Revenue, Current",
        "documentation": "Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable, classified as current."
       }
      }
     },
     "auth_ref": [
      "r667"
     ]
    },
    "arbe_DeferredTaxAssetsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.arberobotics.com/20231231",
     "localname": "DeferredTaxAssetsAbstract",
     "presentation": [
      "http://www.arberobotics.com/role/ScheduleofDeferredTaxAssetsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Deferred tax assets:",
        "label": "Deferred Tax Assets Abstract"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DeferredTaxAssetsGross": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredTaxAssetsGross",
     "crdr": "debit",
     "calculation": {
      "http://www.arberobotics.com/role/ScheduleofDeferredTaxAssetsTable": {
       "parentTag": "us-gaap_DeferredTaxAssetsLiabilitiesNet",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.arberobotics.com/role/ScheduleofDeferredTaxAssetsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total deferred tax assets",
        "label": "Deferred Tax Assets, Gross",
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards."
       }
      }
     },
     "auth_ref": [
      "r321"
     ]
    },
    "us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredTaxAssetsInProcessResearchAndDevelopment",
     "crdr": "debit",
     "calculation": {
      "http://www.arberobotics.com/role/ScheduleofDeferredTaxAssetsTable": {
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.arberobotics.com/role/ScheduleofDeferredTaxAssetsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Research and development",
        "label": "Deferred Tax Assets, in Process Research and Development",
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from in-process research and development costs expensed in connection with a business combination."
       }
      }
     },
     "auth_ref": [
      "r53",
      "r727"
     ]
    },
    "us-gaap_DeferredTaxAssetsLiabilitiesNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredTaxAssetsLiabilitiesNet",
     "crdr": "debit",
     "calculation": {
      "http://www.arberobotics.com/role/ScheduleofDeferredTaxAssetsTable": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.arberobotics.com/role/ScheduleofDeferredTaxAssetsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Deferred tax assets, net of valuation allowance",
        "label": "Deferred Tax Assets, Net",
        "documentation": "Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, without jurisdictional netting."
       }
      }
     },
     "auth_ref": [
      "r726"
     ]
    },
    "us-gaap_DeferredTaxAssetsOperatingLossCarryforwards": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredTaxAssetsOperatingLossCarryforwards",
     "crdr": "debit",
     "calculation": {
      "http://www.arberobotics.com/role/ScheduleofDeferredTaxAssetsTable": {
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.arberobotics.com/role/ScheduleofDeferredTaxAssetsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Net operating loss carry forwards",
        "label": "Deferred Tax Assets, Operating Loss Carryforwards",
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards."
       }
      }
     },
     "auth_ref": [
      "r53",
      "r727"
     ]
    },
    "us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredTaxAssetsPropertyPlantAndEquipment",
     "crdr": "debit",
     "calculation": {
      "http://www.arberobotics.com/role/ScheduleofDeferredTaxAssetsTable": {
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.arberobotics.com/role/ScheduleofDeferredTaxAssetsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Property and equipment",
        "label": "Deferred Tax Assets, Property, Plant and Equipment",
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from property, plant, and equipment."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost",
     "crdr": "debit",
     "calculation": {
      "http://www.arberobotics.com/role/ScheduleofDeferredTaxAssetsTable": {
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.arberobotics.com/role/ScheduleofDeferredTaxAssetsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Employees and payroll accrual",
        "label": "Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-Based Compensation Cost",
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from share-based compensation."
       }
      }
     },
     "auth_ref": [
      "r53",
      "r727"
     ]
    },
    "us-gaap_DeferredTaxAssetsValuationAllowance": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredTaxAssetsValuationAllowance",
     "crdr": "credit",
     "calculation": {
      "http://www.arberobotics.com/role/ScheduleofDeferredTaxAssetsTable": {
       "parentTag": "us-gaap_DeferredTaxAssetsLiabilitiesNet",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.arberobotics.com/role/ScheduleofDeferredTaxAssetsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Valuation allowance",
        "label": "Deferred Tax Assets, Valuation Allowance",
        "documentation": "Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized."
       }
      }
     },
     "auth_ref": [
      "r322"
     ]
    },
    "dei_DelayedOrContinuousOffering": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DelayedOrContinuousOffering",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Delayed or Continuous Offering"
       }
      }
     },
     "auth_ref": [
      "r584",
      "r585",
      "r599"
     ]
    },
    "srt_DemandDepositLiabilitiesInterestBearingAverageRatePaid": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "DemandDepositLiabilitiesInterestBearingAverageRatePaid",
     "presentation": [
      "http://www.arberobotics.com/role/SignificantAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Bank deposit bearing annual interest rate",
        "label": "Demand Deposit Liabilities, Interest-Bearing, Average Rate Paid",
        "documentation": "Average rate paid on interest-bearing demand deposits."
       }
      }
     },
     "auth_ref": [
      "r122"
     ]
    },
    "arbe_DenominatorAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.arberobotics.com/20231231",
     "localname": "DenominatorAbstract",
     "presentation": [
      "http://www.arberobotics.com/role/ScheduleofSetsForththeComputationofBasicandDilutedNetLossPerShareAttributableTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Denominator:",
        "label": "Denominator Abstract"
       }
      }
     },
     "auth_ref": []
    },
    "arbe_DenominatorAbstract0": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.arberobotics.com/20231231",
     "localname": "DenominatorAbstract0",
     "presentation": [
      "http://www.arberobotics.com/role/ScheduleofSetsForththeComputationofBasicandDilutedNetLossPerShareAttributableTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Denominator:",
        "label": "Denominator Abstract0"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DepositAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DepositAssets",
     "crdr": "debit",
     "calculation": {
      "http://www.arberobotics.com/role/ScheduleofPrepaidExpensesandOtherReceivablesTable": {
       "parentTag": "us-gaap_PrepaidExpenseAndOtherAssetsNoncurrent",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.arberobotics.com/role/ScheduleofPrepaidExpensesandOtherReceivablesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Deposits",
        "label": "Deposit Assets",
        "documentation": "The carrying amount of the asset transferred to a third party to serve as a deposit, which typically serves as security against failure by the transferor to perform under terms of an agreement."
       }
      }
     },
     "auth_ref": [
      "r665"
     ]
    },
    "us-gaap_Depreciation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "Depreciation",
     "crdr": "debit",
     "calculation": {
      "http://www.arberobotics.com/role/ConsolidatedCashFlow": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.arberobotics.com/role/ConsolidatedCashFlow",
      "http://www.arberobotics.com/role/PropertyandEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Depreciation",
        "verboseLabel": "Depreciation expense",
        "label": "Depreciation",
        "documentation": "The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation."
       }
      }
     },
     "auth_ref": [
      "r6",
      "r44"
     ]
    },
    "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrants Liabilities [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock",
     "presentation": [
      "http://www.arberobotics.com/role/WarrantsLiabilities"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "WARRANTS LIABILITIES",
        "label": "Derivative Instruments and Hedging Activities Disclosure [Text Block]",
        "documentation": "The entire disclosure for derivative instruments and hedging activities including, but not limited to, risk management strategies, non-hedging derivative instruments, assets, liabilities, revenue and expenses, and methodologies and assumptions used in determining the amounts."
       }
      }
     },
     "auth_ref": [
      "r95",
      "r339",
      "r346"
     ]
    },
    "arbe_DerivativeWarrantLiabilityShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.arberobotics.com/20231231",
     "localname": "DerivativeWarrantLiabilityShares",
     "presentation": [
      "http://www.arberobotics.com/role/WarrantsLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Derivative warrant liability shares (in Shares)",
        "documentation": "Derivative warrant liability.",
        "label": "Derivative Warrant Liability Shares"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DisaggregationOfRevenueLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DisaggregationOfRevenueLineItems",
     "presentation": [
      "http://www.arberobotics.com/role/ScheduleofRevenueDisaggregatedbyGeographyTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disaggregation of Revenue [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r267",
      "r518",
      "r519",
      "r520",
      "r521",
      "r522",
      "r523",
      "r524"
     ]
    },
    "us-gaap_DisaggregationOfRevenueTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DisaggregationOfRevenueTable",
     "presentation": [
      "http://www.arberobotics.com/role/ScheduleofRevenueDisaggregatedbyGeographyTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disaggregation of Revenue [Table]",
        "documentation": "Disclosure of information about disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor."
       }
      }
     },
     "auth_ref": [
      "r267",
      "r518",
      "r519",
      "r520",
      "r521",
      "r522",
      "r523",
      "r524"
     ]
    },
    "us-gaap_DisaggregationOfRevenueTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DisaggregationOfRevenueTableTextBlock",
     "presentation": [
      "http://www.arberobotics.com/role/RevenueTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Revenue Disaggregated by Geography",
        "label": "Disaggregation of Revenue [Table Text Block]",
        "documentation": "Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor."
       }
      }
     },
     "auth_ref": [
      "r698"
     ]
    },
    "dei_DividendOrInterestReinvestmentPlanOnly": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DividendOrInterestReinvestmentPlanOnly",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Dividend or Interest Reinvestment Plan Only"
       }
      }
     },
     "auth_ref": [
      "r584",
      "r585",
      "r599"
     ]
    },
    "dei_DocumentAccountingStandard": {
     "xbrltype": "accountingStandardItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentAccountingStandard",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Accounting Standard",
        "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'."
       }
      }
     },
     "auth_ref": [
      "r559"
     ]
    },
    "dei_DocumentAnnualReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentAnnualReport",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Annual Report",
        "documentation": "Boolean flag that is true only for a form used as an annual report."
       }
      }
     },
     "auth_ref": [
      "r556",
      "r559",
      "r572"
     ]
    },
    "dei_DocumentCopyrightInformation": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentCopyrightInformation",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Copyright Information",
        "documentation": "The copyright information for the document."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentCreationDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentCreationDate",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Creation Date",
        "documentation": "The date the document was made available and submitted, in YYYY-MM-DD format. The date of submission, date of acceptance by the recipient, and the document effective date are all potentially different."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentDescription",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Description",
        "documentation": "The description of the document."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentDomain",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document [Domain]",
        "documentation": "Type of the document as assigned by the filer, corresponding to SEC document naming convention standards."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentEffectiveDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentEffectiveDate",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Effective Date",
        "documentation": "The date when a document, upon receipt and acceptance, becomes officially effective, in YYYY-MM-DD format. Usually it is a system-assigned date time value, but it may be declared by the submitter in some cases."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentFinStmtErrorCorrectionFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentFinStmtErrorCorrectionFlag",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Financial Statement Error Correction [Flag]",
        "documentation": "Indicates whether any of the financial statement period in the filing include a restatement due to error correction."
       }
      }
     },
     "auth_ref": [
      "r556",
      "r559",
      "r572",
      "r616"
     ]
    },
    "dei_DocumentFinStmtRestatementRecoveryAnalysisFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentFinStmtRestatementRecoveryAnalysisFlag",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Financial Statement Restatement Recovery Analysis [Flag]",
        "documentation": "Indicates whether any of the financial statement periods include restatements that required a recovery analysis of incentive-based compensation received by any of the registrant's executive officers during the relevant recovery period pursuant to \u00a7240.10D-1(b)."
       }
      }
     },
     "auth_ref": [
      "r556",
      "r559",
      "r572",
      "r616"
     ]
    },
    "dei_DocumentFiscalPeriodFocus": {
     "xbrltype": "fiscalPeriodItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentFiscalPeriodFocus",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Period Focus",
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentFiscalYearFocus": {
     "xbrltype": "gYearItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentFiscalYearFocus",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Year Focus",
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentInformationDocumentAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentInformationDocumentAxis",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Information, Document [Axis]",
        "documentation": "The axis of a table defines the relationship between the domain members or categories in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentInformationLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentInformationLineItems",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Information [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentInformationTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentInformationTable",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Information [Table]",
        "documentation": "Container to support the formal attachment of each official or unofficial, public or private document as part of a submission package."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentInformationTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentInformationTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Information [Text Block]",
        "documentation": "Container to support the formal attachment of each official or unofficial, public or private document as part of a submission package."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentName",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Name",
        "documentation": "Name of the document as assigned by the filer, corresponding to SEC document naming convention standards. Examples appear in the &lt;FILENAME> field of EDGAR filings, such as 'htm_25911.htm', 'exhibit1.htm', 'v105727_8k.txt'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodStartDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentPeriodStartDate",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period Start Date",
        "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentQuarterlyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentQuarterlyReport",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Quarterly Report",
        "documentation": "Boolean flag that is true only for a form used as an quarterly report."
       }
      }
     },
     "auth_ref": [
      "r557"
     ]
    },
    "dei_DocumentRegistrationStatement": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentRegistrationStatement",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Registration Statement",
        "documentation": "Boolean flag that is true only for a form used as a registration statement."
       }
      }
     },
     "auth_ref": [
      "r545"
     ]
    },
    "dei_DocumentShellCompanyEventDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentShellCompanyEventDate",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Event Date",
        "documentation": "Date of event requiring a shell company report."
       }
      }
     },
     "auth_ref": [
      "r559"
     ]
    },
    "dei_DocumentShellCompanyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentShellCompanyReport",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Report",
        "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r559"
     ]
    },
    "dei_DocumentSubtitle": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentSubtitle",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Subtitle",
        "documentation": "The subtitle given to the document resource by the creator or publisher. An example is 'A New Period of Growth'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentSynopsis": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentSynopsis",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Synopsis",
        "documentation": "A synopsis or description of the document provided by the creator or publisher. Examples are 'This is the 2006 annual report for Company. During this period we saw revenue grow by 10% and earnings per share grow by 15% over the prior period'"
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentTitle": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentTitle",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Title",
        "documentation": "The name or title given to the document resource by the creator or publisher. An example is '2002 Annual Report'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentTransitionReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentTransitionReport",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Transition Report",
        "documentation": "Boolean flag that is true only for a form used as a transition report."
       }
      }
     },
     "auth_ref": [
      "r600"
     ]
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentType",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentVersion": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentVersion",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Version",
        "documentation": "The version identifier of the document."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Documents Incorporated by Reference [Text Block]",
        "documentation": "Documents incorporated by reference."
       }
      }
     },
     "auth_ref": [
      "r548"
     ]
    },
    "us-gaap_EarningsPerShareAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EarningsPerShareAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Loss Per Share Attributible to Ordinary Sharholders [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EarningsPerShareBasic": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EarningsPerShareBasic",
     "presentation": [
      "http://www.arberobotics.com/role/ConsolidatedIncomeStatement",
      "http://www.arberobotics.com/role/ScheduleofSetsForththeComputationofBasicandDilutedNetLossPerShareAttributableTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Basic loss per share attributable to Ordinary Shareholders (in Dollars per share)",
        "verboseLabel": "Loss per share attributable to ordinary shareholders, basic (in Dollars per share)",
        "label": "Earnings Per Share, Basic",
        "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period."
       }
      }
     },
     "auth_ref": [
      "r153",
      "r170",
      "r171",
      "r172",
      "r173",
      "r174",
      "r179",
      "r181",
      "r184",
      "r185",
      "r186",
      "r190",
      "r349",
      "r350",
      "r376",
      "r388",
      "r514"
     ]
    },
    "us-gaap_EarningsPerShareDiluted": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EarningsPerShareDiluted",
     "presentation": [
      "http://www.arberobotics.com/role/ConsolidatedIncomeStatement",
      "http://www.arberobotics.com/role/ScheduleofSetsForththeComputationofBasicandDilutedNetLossPerShareAttributableTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Diluted loss per share attributable to Ordinary Shareholders (in Dollars per share)",
        "verboseLabel": "Loss per share attributable to ordinary shareholders, diluted (in Dollars per share)",
        "label": "Earnings Per Share, Diluted",
        "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period."
       }
      }
     },
     "auth_ref": [
      "r153",
      "r170",
      "r171",
      "r172",
      "r173",
      "r174",
      "r181",
      "r184",
      "r185",
      "r186",
      "r190",
      "r349",
      "r350",
      "r376",
      "r388",
      "r514"
     ]
    },
    "us-gaap_EarningsPerSharePolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EarningsPerSharePolicyTextBlock",
     "presentation": [
      "http://www.arberobotics.com/role/AccountingPoliciesByPolicy"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Net loss per share attributable to ordinary shareholders",
        "label": "Earnings Per Share, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements."
       }
      }
     },
     "auth_ref": [
      "r35",
      "r36"
     ]
    },
    "us-gaap_EarningsPerShareTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EarningsPerShareTextBlock",
     "presentation": [
      "http://www.arberobotics.com/role/NetLossPerShareAttributibletoOrdinarySharholders"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "NET LOSS PER SHARE ATTRIBUTIBLE TO ORDINARY SHARHOLDERS",
        "label": "Earnings Per Share [Text Block]",
        "documentation": "The entire disclosure for earnings per share."
       }
      }
     },
     "auth_ref": [
      "r178",
      "r187",
      "r188",
      "r189"
     ]
    },
    "us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "crdr": "debit",
     "calculation": {
      "http://www.arberobotics.com/role/ConsolidatedCashFlow": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.arberobotics.com/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Effect of exchange rate fluctuations on cash and cash equivalent",
        "label": "Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Continuing Operations",
        "documentation": "Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates."
       }
      }
     },
     "auth_ref": [
      "r353"
     ]
    },
    "dei_EffectiveAfter60Days486a": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EffectiveAfter60Days486a",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective after 60 Days, 486(a)"
       }
      }
     },
     "auth_ref": [
      "r650"
     ]
    },
    "us-gaap_EffectiveIncomeTaxRateContinuingOperations": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EffectiveIncomeTaxRateContinuingOperations",
     "presentation": [
      "http://www.arberobotics.com/role/SignificantAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Tax percentage",
        "label": "Effective Income Tax Rate Reconciliation, Percent",
        "documentation": "Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations."
       }
      }
     },
     "auth_ref": [
      "r317"
     ]
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate",
     "presentation": [
      "http://www.arberobotics.com/role/ScheduleofReconciliationIncomeTaxBenefitTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Statutory tax rate",
        "label": "Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent",
        "documentation": "Percentage of domestic federal statutory tax rate applicable to pretax income (loss)."
       }
      }
     },
     "auth_ref": [
      "r163",
      "r317",
      "r331"
     ]
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential",
     "presentation": [
      "http://www.arberobotics.com/role/TaxesonIncomeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Foreign holding percentage",
        "label": "Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Percent",
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to statutory income tax expense (benefit) outside of the country of domicile."
       }
      }
     },
     "auth_ref": [
      "r725",
      "r728"
     ]
    },
    "dei_EffectiveOnDate486a": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EffectiveOnDate486a",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective on Date, 486(a)"
       }
      }
     },
     "auth_ref": [
      "r650"
     ]
    },
    "dei_EffectiveOnDate486b": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EffectiveOnDate486b",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective on Date, 486(b)"
       }
      }
     },
     "auth_ref": [
      "r651"
     ]
    },
    "dei_EffectiveOnSetDate486a": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EffectiveOnSetDate486a",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective on Set Date, 486(a)"
       }
      }
     },
     "auth_ref": [
      "r650"
     ]
    },
    "dei_EffectiveOnSetDate486b": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EffectiveOnSetDate486b",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective on Set Date, 486(b)"
       }
      }
     },
     "auth_ref": [
      "r651"
     ]
    },
    "dei_EffectiveUponFiling462e": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EffectiveUponFiling462e",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective Upon Filing, 462(e)"
       }
      }
     },
     "auth_ref": [
      "r649"
     ]
    },
    "dei_EffectiveUponFiling486b": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EffectiveUponFiling486b",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective upon Filing, 486(b)"
       }
      }
     },
     "auth_ref": [
      "r651"
     ]
    },
    "dei_EffectiveWhenDeclaredSection8c": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EffectiveWhenDeclaredSection8c",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective when Declared, Section 8(c)"
       }
      }
     },
     "auth_ref": [
      "r653"
     ]
    },
    "us-gaap_EmployeeRelatedLiabilitiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EmployeeRelatedLiabilitiesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.arberobotics.com/role/ConsolidatedBalanceSheet": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.arberobotics.com/role/ConsolidatedBalanceSheet"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Employees and payroll accruals",
        "label": "Employee-related Liabilities, Current",
        "documentation": "Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)."
       }
      }
     },
     "auth_ref": [
      "r23"
     ]
    },
    "us-gaap_EmployeeStockOptionMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EmployeeStockOptionMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Employee Stock Option [Member]",
        "terseLabel": "Employee Stock Option",
        "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntitiesTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntitiesTable",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entities [Table]",
        "documentation": "Container to assemble all relevant information about each entity associated with the document instance"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAccountingStandard": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAccountingStandard",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Accounting Standard",
        "documentation": "The standardized abbreviation of the accounting standard used by the entity. This can either be US GAAP as promulgated by the FASB or IFRS as promulgated by the IASB. Example: 'US GAAP', 'IFRS'.  This is distinct from the Document Accounting Standard element."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressDescription",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Description",
        "documentation": "Description of the kind of address for the entity, if needed to distinguish more finely among mailing, principal, legal, accounting, contact or other addresses."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine2": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine2",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Two",
        "documentation": "Address Line 2 such as Street or Suite number"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine3": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine3",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Three",
        "documentation": "Address Line 3 such as an Office Park"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCountry": {
     "xbrltype": "countryCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressCountry",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Country",
        "documentation": "ISO 3166-1 alpha-2 country code."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressesAddressTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressesAddressTypeAxis",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Addresses, Address Type [Axis]",
        "documentation": "The axis of a table defines the relationship between the domain members or categories in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressesLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressesLineItems",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Addresses [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressesTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressesTable",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Addresses [Table]",
        "documentation": "Container of address information for the entity"
       }
      }
     },
     "auth_ref": [
      "r547"
     ]
    },
    "dei_EntityBankruptcyProceedingsReportingCurrent": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityBankruptcyProceedingsReportingCurrent",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Bankruptcy Proceedings, Reporting Current",
        "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not.  Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element."
       }
      }
     },
     "auth_ref": [
      "r551"
     ]
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r547"
     ]
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityCommonStockSharesOutstanding",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Common Stock, Shares Outstanding",
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityContactPersonnelLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityContactPersonnelLineItems",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Contact Personnel [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCurrentReportingStatus": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityCurrentReportingStatus",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Current Reporting Status",
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityDomain",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/AuditInformation",
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity [Domain]",
        "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r547"
     ]
    },
    "dei_EntityExTransitionPeriod": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityExTransitionPeriod",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Ex Transition Period",
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards."
       }
      }
     },
     "auth_ref": [
      "r652"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityFilerCategory": {
     "xbrltype": "filerCategoryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityFilerCategory",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Filer Category",
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": [
      "r547"
     ]
    },
    "dei_EntityHomeCountryISOCode": {
     "xbrltype": "countryCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityHomeCountryISOCode",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Home Country ISO Code",
        "documentation": "ISO 3166-1 alpha-2 country code for the Entity's home country. If home country is different from country of legal incorporation, then also provide country of legal incorporation in the 'Entity Incorporation, State Country Code' element."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityIncorporationDateOfIncorporation": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityIncorporationDateOfIncorporation",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation, Date of Incorporation",
        "documentation": "Date when an entity was incorporated"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityInformationFormerLegalOrRegisteredName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityInformationFormerLegalOrRegisteredName",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Information, Former Legal or Registered Name",
        "documentation": "Former Legal or Registered Name of an entity"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityInformationLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityInformationLineItems",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Information [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityInteractiveDataCurrent": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityInteractiveDataCurrent",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Interactive Data Current",
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)."
       }
      }
     },
     "auth_ref": [
      "r642"
     ]
    },
    "dei_EntityInvCompanyType": {
     "xbrltype": "invCompanyType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityInvCompanyType",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Inv Company Type",
        "documentation": "One of: N-1A (Mutual Fund), N-1 (Open-End Separate Account with No Variable Annuities), N-2 (Closed-End Investment Company), N-3 (Separate Account Registered as Open-End Management Investment Company), N-4 (Variable Annuity UIT Separate Account), N-5 (Small Business Investment Company), N-6 (Variable Life UIT Separate Account), S-1 or S-3 (Face Amount Certificate Company), S-6 (UIT, Non-Insurance Product)."
       }
      }
     },
     "auth_ref": [
      "r641"
     ]
    },
    "dei_EntityLegalForm": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityLegalForm",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Legal Form",
        "documentation": "The details of the entity's legal form. Examples are partnership, limited liability company, trust, etc."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityListingDepositoryReceiptRatio": {
     "xbrltype": "pureItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityListingDepositoryReceiptRatio",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Listing, Depository Receipt Ratio",
        "documentation": "The number of underlying shares represented by one American Depository Receipt (ADR) or Global Depository Receipt (GDR). A value of '3' means that one ADR represents 3 underlying shares. If one underlying share represents 2 ADR's then the value would be represented as '0.5'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityListingDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityListingDescription",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Listing, Description",
        "documentation": "Description of the kind of listing the entity has on the exchange, if necessary to further describe different instruments that are already distinguished by Entity, Exchange and Security."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityListingForeign": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityListingForeign",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Listing, Foreign",
        "documentation": "Yes or No value indicating whether this is a listing that is a foreign listing or depository receipt."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityListingParValuePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityListingParValuePerShare",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Listing, Par Value Per Share",
        "documentation": "The par value per share of security quoted in same currency as Trading currency. Example: '0.01'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityListingPrimary": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityListingPrimary",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Listing, Primary",
        "documentation": "Yes or No value indicating whether a listing of an instrument on an exchange is primary for the entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityListingSecurityTradingCurrency": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityListingSecurityTradingCurrency",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Listing, Security Trading Currency",
        "documentation": "The three character ISO 4217 code for the currency in which the security is quoted. Example: 'USD'"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityListingsExchangeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityListingsExchangeAxis",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Listings, Exchange [Axis]",
        "documentation": "The axis of a table defines the relationship between the domain members or categories in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityListingsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityListingsLineItems",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Listings [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityListingsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityListingsTable",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Listings [Table]",
        "documentation": "Container for exchange listing information for an entity"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityNumberOfEmployees": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityNumberOfEmployees",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Number of Employees",
        "documentation": "Number of persons employed by the Entity"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityPhoneFaxNumbersLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityPhoneFaxNumbersLineItems",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Phone Fax Numbers [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityPrimarySicNumber": {
     "xbrltype": "sicNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityPrimarySicNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Primary SIC Number",
        "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity."
       }
      }
     },
     "auth_ref": [
      "r572"
     ]
    },
    "dei_EntityPublicFloat": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityPublicFloat",
     "crdr": "credit",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Public Float",
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r547"
     ]
    },
    "dei_EntityReportingCurrencyISOCode": {
     "xbrltype": "currencyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityReportingCurrencyISOCode",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Reporting Currency ISO Code",
        "documentation": "The three character ISO 4217 code for the currency used for reporting purposes. Example: 'USD'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityShellCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityShellCompany",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Shell Company",
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r547"
     ]
    },
    "dei_EntitySmallBusiness": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntitySmallBusiness",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Small Business",
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)."
       }
      }
     },
     "auth_ref": [
      "r547"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r547"
     ]
    },
    "dei_EntityTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity [Text Block]",
        "documentation": "Container to serve as parent of six Entity related Table concepts."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityVoluntaryFilers": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityVoluntaryFilers",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Voluntary Filers",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityWellKnownSeasonedIssuer",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Well-known Seasoned Issuer",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A."
       }
      }
     },
     "auth_ref": [
      "r643"
     ]
    },
    "us-gaap_EquityComponentDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EquityComponentDomain",
     "presentation": [
      "http://www.arberobotics.com/role/ShareholdersEquityDetails",
      "http://www.arberobotics.com/role/ShareholdersEquityType2or3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Component [Domain]",
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc."
       }
      }
     },
     "auth_ref": [
      "r9",
      "r134",
      "r149",
      "r150",
      "r151",
      "r165",
      "r166",
      "r167",
      "r169",
      "r175",
      "r177",
      "r192",
      "r223",
      "r224",
      "r257",
      "r303",
      "r304",
      "r305",
      "r326",
      "r327",
      "r340",
      "r341",
      "r342",
      "r343",
      "r344",
      "r345",
      "r348",
      "r354",
      "r355",
      "r356",
      "r357",
      "r358",
      "r359",
      "r371",
      "r397",
      "r398",
      "r399",
      "r411",
      "r473"
     ]
    },
    "ecd_EquityValuationAssumptionDifferenceFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "EquityValuationAssumptionDifferenceFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Valuation Assumption Difference, Footnote [Text Block]",
        "terseLabel": "Equity Valuation Assumption Difference, Footnote"
       }
      }
     },
     "auth_ref": [
      "r609"
     ]
    },
    "ecd_ErrCompAnalysisTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "ErrCompAnalysisTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Erroneous Compensation Analysis [Text Block]",
        "terseLabel": "Erroneous Compensation Analysis"
       }
      }
     },
     "auth_ref": [
      "r564",
      "r576",
      "r592",
      "r620"
     ]
    },
    "ecd_ErrCompRecoveryTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "ErrCompRecoveryTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Erroneously Awarded Compensation Recovery [Table]",
        "terseLabel": "Erroneously Awarded Compensation Recovery"
       }
      }
     },
     "auth_ref": [
      "r561",
      "r573",
      "r589",
      "r617"
     ]
    },
    "dei_ExchangeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "ExchangeDomain",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exchange [Domain]",
        "documentation": "The set of all exchanges. MIC exchange codes are drawn from ISO 10383."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_ExecutiveCategoryAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "ExecutiveCategoryAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Executive Category [Axis]",
        "terseLabel": "Executive Category:"
       }
      }
     },
     "auth_ref": [
      "r615"
     ]
    },
    "dei_ExhibitsOnly462d": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "ExhibitsOnly462d",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exhibits Only, 462(d)"
       }
      }
     },
     "auth_ref": [
      "r648"
     ]
    },
    "dei_ExhibitsOnly462dFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "ExhibitsOnly462dFileNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exhibits Only, 462(d), File Number"
       }
      }
     },
     "auth_ref": [
      "r648"
     ]
    },
    "dei_Extension": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "Extension",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Extension",
        "documentation": "Extension number for local phone number."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FairValueAdjustmentOfWarrants": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueAdjustmentOfWarrants",
     "crdr": "debit",
     "presentation": [
      "http://www.arberobotics.com/role/WarrantsLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair value of warrants",
        "label": "Fair Value Adjustment of Warrants",
        "documentation": "Amount of expense (income) related to adjustment to fair value of warrant liability."
       }
      }
     },
     "auth_ref": [
      "r2",
      "r6"
     ]
    },
    "us-gaap_FairValueOfFinancialInstrumentsPolicy": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueOfFinancialInstrumentsPolicy",
     "presentation": [
      "http://www.arberobotics.com/role/AccountingPoliciesByPolicy"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair value of financial instruments",
        "label": "Fair Value of Financial Instruments, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for determining the fair value of financial instruments."
       }
      }
     },
     "auth_ref": [
      "r8",
      "r19"
     ]
    },
    "us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock",
     "presentation": [
      "http://www.arberobotics.com/role/AccountingPoliciesByPolicy"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Consolidated financial statements in U.S. dollars",
        "label": "Foreign Currency Transactions and Translations Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for (1) transactions denominated in a currency other than the reporting enterprise's functional currency, (2) translating foreign currency financial statements that are incorporated into the financial statements of the reporting enterprise by consolidation, combination, or the equity method of accounting, and (3) remeasurement of the financial statements of a foreign reporting enterprise in a hyperinflationary economy."
       }
      }
     },
     "auth_ref": [
      "r352"
     ]
    },
    "ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery due to Disqualification of Tax Benefits, Amount",
        "terseLabel": "Forgone Recovery due to Disqualification of Tax Benefits, Amount"
       }
      }
     },
     "auth_ref": [
      "r568",
      "r580",
      "r596",
      "r624"
     ]
    },
    "ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "ForgoneRecoveryDueToExpenseOfEnforcementAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery due to Expense of Enforcement, Amount",
        "terseLabel": "Forgone Recovery due to Expense of Enforcement, Amount"
       }
      }
     },
     "auth_ref": [
      "r568",
      "r580",
      "r596",
      "r624"
     ]
    },
    "ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "ForgoneRecoveryDueToViolationOfHomeCountryLawAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery due to Violation of Home Country Law, Amount",
        "terseLabel": "Forgone Recovery due to Violation of Home Country Law, Amount"
       }
      }
     },
     "auth_ref": [
      "r568",
      "r580",
      "r596",
      "r624"
     ]
    },
    "ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "ForgoneRecoveryExplanationOfImpracticabilityTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery, Explanation of Impracticability [Text Block]",
        "terseLabel": "Forgone Recovery, Explanation of Impracticability"
       }
      }
     },
     "auth_ref": [
      "r568",
      "r580",
      "r596",
      "r624"
     ]
    },
    "ecd_ForgoneRecoveryIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "ForgoneRecoveryIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery, Individual Name",
        "terseLabel": "Name"
       }
      }
     },
     "auth_ref": [
      "r568",
      "r580",
      "r596",
      "r624"
     ]
    },
    "dei_FormerAddressMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "FormerAddressMember",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Former Address [Member]",
        "documentation": "Former address for entity"
       }
      }
     },
     "auth_ref": [
      "r558",
      "r583"
     ]
    },
    "dei_FormerFiscalYearEndDate": {
     "xbrltype": "gMonthDayItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "FormerFiscalYearEndDate",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Former Fiscal Year End Date",
        "documentation": "Former end date of previous fiscal years"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_GeneralAndAdministrativeExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "GeneralAndAdministrativeExpense",
     "crdr": "debit",
     "calculation": {
      "http://www.arberobotics.com/role/ConsolidatedIncomeStatement": {
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.arberobotics.com/role/ConsolidatedIncomeStatement"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "General and administrative",
        "label": "General and Administrative Expense",
        "documentation": "The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line."
       }
      }
     },
     "auth_ref": [
      "r76",
      "r457"
     ]
    },
    "us-gaap_GeneralAndAdministrativeExpenseMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "GeneralAndAdministrativeExpenseMember",
     "presentation": [
      "http://www.arberobotics.com/role/ScheduleofShareBasedCompensationExpenseTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "General and administrative [Member]",
        "label": "General and Administrative Expense [Member]",
        "documentation": "Primary financial statement caption encompassing general and administrative expense."
       }
      }
     },
     "auth_ref": [
      "r72"
     ]
    },
    "arbe_GeneralDetailsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.arberobotics.com/20231231",
     "localname": "GeneralDetailsLineItems",
     "presentation": [
      "http://www.arberobotics.com/role/GeneralDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "General [Line Items]"
       }
      }
     },
     "auth_ref": []
    },
    "arbe_GeneralDetailsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.arberobotics.com/20231231",
     "localname": "GeneralDetailsTable",
     "presentation": [
      "http://www.arberobotics.com/role/GeneralDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "General (Details) [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "arbe_GovernmentAuthorities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.arberobotics.com/20231231",
     "localname": "GovernmentAuthorities",
     "crdr": "debit",
     "calculation": {
      "http://www.arberobotics.com/role/ScheduleofPrepaidExpensesandOtherReceivablesTable": {
       "parentTag": "us-gaap_PrepaidExpenseAndOtherAssetsNoncurrent",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.arberobotics.com/role/ScheduleofPrepaidExpensesandOtherReceivablesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Government authorities",
        "documentation": "Government Authorities means any national, provincial, municipal or local government, administrative or regulatory body or department, court, tribunal, arbitrator or any body that exercises the function of a regulator.",
        "label": "Government Authorities"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_GrantsReceivable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "GrantsReceivable",
     "crdr": "debit",
     "presentation": [
      "http://www.arberobotics.com/role/CommitmentsandContingentLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Grants value (in Dollars)",
        "label": "Grants Receivable",
        "documentation": "Carrying amount as of the balance sheet date of amounts due under the terms of governmental, corporate, or foundation grants."
       }
      }
     },
     "auth_ref": [
      "r671"
     ]
    },
    "us-gaap_GrantsReceivableCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "GrantsReceivableCurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.arberobotics.com/role/ScheduleofPrepaidExpensesandOtherReceivablesTable": {
       "parentTag": "us-gaap_PrepaidExpenseAndOtherAssetsNoncurrent",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.arberobotics.com/role/ScheduleofPrepaidExpensesandOtherReceivablesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Grants receivable",
        "label": "Grants Receivable, Current",
        "documentation": "Carrying amount as of the balance sheet date of amounts due under the terms of governmental, corporate, or foundation grants. For classified balance sheets, represents the current amount receivable, that is amounts expected to be collected within one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r671"
     ]
    },
    "arbe_GrantsReceived": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.arberobotics.com/20231231",
     "localname": "GrantsReceived",
     "presentation": [
      "http://www.arberobotics.com/role/CommitmentsandContingentLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Maximum aggregate royalties paid",
        "documentation": "Grants received for maximum aggregate royalties.",
        "label": "Grants Received"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_GrossProfit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "GrossProfit",
     "crdr": "credit",
     "calculation": {
      "http://www.arberobotics.com/role/ConsolidatedIncomeStatement": {
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.arberobotics.com/role/ConsolidatedIncomeStatement"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Gross profit (loss)",
        "label": "Gross Profit",
        "documentation": "Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity."
       }
      }
     },
     "auth_ref": [
      "r73",
      "r161",
      "r199",
      "r205",
      "r210",
      "r213",
      "r222",
      "r233",
      "r234",
      "r235",
      "r236",
      "r237",
      "r238",
      "r239",
      "r240",
      "r241",
      "r351",
      "r515",
      "r692"
     ]
    },
    "country_HK": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/country/2023",
     "localname": "HK",
     "presentation": [
      "http://www.arberobotics.com/role/ScheduleofRevenueDisaggregatedbyGeographyTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Hong Kong [Member]",
        "label": "HONG KONG"
       }
      }
     },
     "auth_ref": []
    },
    "country_IL": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/country/2023",
     "localname": "IL",
     "presentation": [
      "http://www.arberobotics.com/role/ScheduleofPropertyandEquipmentNetofDepreciationbyGeographicRegionTable",
      "http://www.arberobotics.com/role/ScheduleofRevenueDisaggregatedbyGeographyTable",
      "http://www.arberobotics.com/role/TaxesonIncomeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Israel [Member]",
        "label": "ISRAEL"
       }
      }
     },
     "auth_ref": []
    },
    "country_IT": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/country/2023",
     "localname": "IT",
     "presentation": [
      "http://www.arberobotics.com/role/ScheduleofRevenueDisaggregatedbyGeographyTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Italy [Member]",
        "label": "ITALY"
       }
      }
     },
     "auth_ref": []
    },
    "dei_IcfrAuditorAttestationFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "IcfrAuditorAttestationFlag",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "ICFR Auditor Attestation Flag"
       }
      }
     },
     "auth_ref": [
      "r556",
      "r559",
      "r572"
     ]
    },
    "us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock",
     "presentation": [
      "http://www.arberobotics.com/role/AccountingPoliciesByPolicy"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Impairment of long-lived assets",
        "label": "Impairment or Disposal of Long-Lived Assets, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for recognizing and measuring the impairment of long-lived assets. An entity also may disclose its accounting policy for long-lived assets to be sold. This policy excludes goodwill and intangible assets."
       }
      }
     },
     "auth_ref": [
      "r0",
      "r86"
     ]
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic",
     "crdr": "credit",
     "calculation": {
      "http://www.arberobotics.com/role/ScheduleofCompanysLossBeforeIncomeTaxesTable": {
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.arberobotics.com/role/ScheduleofCompanysLossBeforeIncomeTaxesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Domestic",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Domestic",
        "documentation": "The portion of earnings or loss from continuing operations before income taxes that is attributable to domestic operations."
       }
      }
     },
     "auth_ref": [
      "r162",
      "r330"
     ]
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
     "crdr": "credit",
     "calculation": {
      "http://www.arberobotics.com/role/ScheduleofCompanysLossBeforeIncomeTaxesTable": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.arberobotics.com/role/ScheduleofCompanysLossBeforeIncomeTaxesTable",
      "http://www.arberobotics.com/role/ScheduleofReconciliationIncomeTaxBenefitTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTotalLabel": "Total",
        "terseLabel": "Loss before income taxes, as reported in the consolidated statements of operations",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest",
        "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest."
       }
      }
     },
     "auth_ref": [
      "r1",
      "r70",
      "r104",
      "r199",
      "r205",
      "r210",
      "r213",
      "r377",
      "r386",
      "r515"
     ]
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign",
     "crdr": "credit",
     "calculation": {
      "http://www.arberobotics.com/role/ScheduleofCompanysLossBeforeIncomeTaxesTable": {
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.arberobotics.com/role/ScheduleofCompanysLossBeforeIncomeTaxesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Foreign",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Foreign",
        "documentation": "The portion of earnings or loss from continuing operations before income taxes that is attributable to foreign operations, which is defined as Income or Loss generated from operations located outside the entity's country of domicile."
       }
      }
     },
     "auth_ref": [
      "r162",
      "r330"
     ]
    },
    "us-gaap_IncomeStatementAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeStatementAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Statement [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncomeStatementLocationAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeStatementLocationAxis",
     "presentation": [
      "http://www.arberobotics.com/role/ScheduleofShareBasedCompensationExpenseTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Statement Location [Axis]",
        "documentation": "Information by location in the income statement."
       }
      }
     },
     "auth_ref": [
      "r225",
      "r226",
      "r458"
     ]
    },
    "us-gaap_IncomeStatementLocationDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeStatementLocationDomain",
     "presentation": [
      "http://www.arberobotics.com/role/ScheduleofShareBasedCompensationExpenseTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Statement Location [Domain]",
        "documentation": "Location in the income statement."
       }
      }
     },
     "auth_ref": [
      "r226",
      "r458"
     ]
    },
    "us-gaap_IncomeTaxDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeTaxDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Taxes on Income [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncomeTaxDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeTaxDisclosureTextBlock",
     "presentation": [
      "http://www.arberobotics.com/role/TaxesonIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "TAXES ON INCOME",
        "label": "Income Tax Disclosure [Text Block]",
        "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information."
       }
      }
     },
     "auth_ref": [
      "r163",
      "r313",
      "r318",
      "r319",
      "r324",
      "r328",
      "r332",
      "r333",
      "r334",
      "r410"
     ]
    },
    "us-gaap_IncomeTaxExpenseBenefit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeTaxExpenseBenefit",
     "crdr": "debit",
     "calculation": {
      "http://www.arberobotics.com/role/ScheduleofReconciliationIncomeTaxBenefitTable": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.arberobotics.com/role/ScheduleofReconciliationIncomeTaxBenefitTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Reported income taxes benefit",
        "label": "Income Tax Expense (Benefit)",
        "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations."
       }
      }
     },
     "auth_ref": [
      "r107",
      "r118",
      "r176",
      "r177",
      "r202",
      "r316",
      "r329",
      "r389"
     ]
    },
    "us-gaap_IncomeTaxPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeTaxPolicyTextBlock",
     "presentation": [
      "http://www.arberobotics.com/role/AccountingPoliciesByPolicy"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income taxes",
        "label": "Income Tax, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements."
       }
      }
     },
     "auth_ref": [
      "r148",
      "r314",
      "r315",
      "r319",
      "r320",
      "r323",
      "r325",
      "r404"
     ]
    },
    "us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance",
     "crdr": "debit",
     "calculation": {
      "http://www.arberobotics.com/role/ScheduleofReconciliationIncomeTaxBenefitTable": {
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.arberobotics.com/role/ScheduleofReconciliationIncomeTaxBenefitTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Change in valuation allowance",
        "label": "Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount",
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to increase (decrease) in the valuation allowance for deferred tax assets."
       }
      }
     },
     "auth_ref": [
      "r725"
     ]
    },
    "us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeTaxReconciliationForeignIncomeTaxRateDifferential",
     "crdr": "debit",
     "calculation": {
      "http://www.arberobotics.com/role/ScheduleofReconciliationIncomeTaxBenefitTable": {
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.arberobotics.com/role/ScheduleofReconciliationIncomeTaxBenefitTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Remeasurement of deferred taxes from currency exchange",
        "label": "Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Amount",
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to foreign income tax expense (benefit)."
       }
      }
     },
     "auth_ref": [
      "r725"
     ]
    },
    "us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate",
     "crdr": "debit",
     "calculation": {
      "http://www.arberobotics.com/role/ScheduleofReconciliationIncomeTaxBenefitTable": {
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.arberobotics.com/role/ScheduleofReconciliationIncomeTaxBenefitTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income tax benefit at statutory tax rate",
        "label": "Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount",
        "documentation": "The amount of income tax expense or benefit for the period computed by applying the domestic federal statutory tax rates to pretax income from continuing operations."
       }
      }
     },
     "auth_ref": [
      "r317"
     ]
    },
    "us-gaap_IncomeTaxReconciliationNondeductibleExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeTaxReconciliationNondeductibleExpense",
     "crdr": "debit",
     "calculation": {
      "http://www.arberobotics.com/role/ScheduleofReconciliationIncomeTaxBenefitTable": {
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.arberobotics.com/role/ScheduleofReconciliationIncomeTaxBenefitTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Effect of Non-deductible expenses",
        "label": "Effective Income Tax Rate Reconciliation, Nondeductible Expense, Amount",
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to nondeductible expenses."
       }
      }
     },
     "auth_ref": [
      "r725"
     ]
    },
    "us-gaap_IncomeTaxReconciliationOtherAdjustments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeTaxReconciliationOtherAdjustments",
     "crdr": "debit",
     "calculation": {
      "http://www.arberobotics.com/role/ScheduleofReconciliationIncomeTaxBenefitTable": {
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.arberobotics.com/role/ScheduleofReconciliationIncomeTaxBenefitTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other",
        "label": "Effective Income Tax Rate Reconciliation, Other Adjustments, Amount",
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other adjustments."
       }
      }
     },
     "auth_ref": [
      "r725"
     ]
    },
    "us-gaap_IncreaseDecreaseInAccountsPayableTrade": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncreaseDecreaseInAccountsPayableTrade",
     "crdr": "debit",
     "calculation": {
      "http://www.arberobotics.com/role/ConsolidatedCashFlow": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 8.0
      }
     },
     "presentation": [
      "http://www.arberobotics.com/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Trade payables",
        "label": "Increase (Decrease) in Accounts Payable, Trade",
        "documentation": "Change in recurring obligations of a business that arise from the acquisition of merchandise, materials, supplies and services used in the production and sale of goods and services."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "us-gaap_IncreaseDecreaseInAccountsReceivable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncreaseDecreaseInAccountsReceivable",
     "crdr": "credit",
     "calculation": {
      "http://www.arberobotics.com/role/ConsolidatedCashFlow": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 12.0
      }
     },
     "presentation": [
      "http://www.arberobotics.com/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Trade receivable",
        "label": "Increase (Decrease) in Accounts Receivable",
        "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "us-gaap_IncreaseDecreaseInDeferredRevenue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncreaseDecreaseInDeferredRevenue",
     "crdr": "debit",
     "calculation": {
      "http://www.arberobotics.com/role/ConsolidatedCashFlow": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://www.arberobotics.com/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Deferred revenue",
        "label": "Increase (Decrease) in Deferred Revenue",
        "documentation": "Amount of increase (decrease) in deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable."
       }
      }
     },
     "auth_ref": [
      "r508"
     ]
    },
    "us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncreaseDecreaseInEmployeeRelatedLiabilities",
     "crdr": "debit",
     "calculation": {
      "http://www.arberobotics.com/role/ConsolidatedCashFlow": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 9.0
      }
     },
     "presentation": [
      "http://www.arberobotics.com/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Employees and payroll accruals",
        "label": "Increase (Decrease) in Employee Related Liabilities",
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncreaseDecreaseInOperatingCapitalAbstract",
     "presentation": [
      "http://www.arberobotics.com/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Change in operating assets and liabilities:",
        "label": "Increase (Decrease) in Operating Capital [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncreaseDecreaseInOperatingLeaseLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncreaseDecreaseInOperatingLeaseLiability",
     "crdr": "debit",
     "calculation": {
      "http://www.arberobotics.com/role/ConsolidatedCashFlow": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://www.arberobotics.com/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating lease ROU assets and liabilities, net",
        "label": "Increase (Decrease) in Operating Lease Liability",
        "documentation": "Amount of increase (decrease) in obligation for operating lease."
       }
      }
     },
     "auth_ref": [
      "r658",
      "r675"
     ]
    },
    "us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities",
     "crdr": "debit",
     "calculation": {
      "http://www.arberobotics.com/role/ConsolidatedCashFlow": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 11.0
      }
     },
     "presentation": [
      "http://www.arberobotics.com/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accrued expenses and other payables",
        "label": "Increase (Decrease) in Other Accounts Payable and Accrued Liabilities",
        "documentation": "The increase (decrease) during the reporting period in other obligations or expenses incurred but not yet paid."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets",
     "crdr": "credit",
     "calculation": {
      "http://www.arberobotics.com/role/ConsolidatedCashFlow": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 13.0
      }
     },
     "presentation": [
      "http://www.arberobotics.com/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Prepaid expenses and other receivables",
        "label": "Increase (Decrease) in Prepaid Expense and Other Assets",
        "documentation": "Amount of increase (decrease) in prepaid expenses, and assets classified as other."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "ecd_IndividualAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "IndividualAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure",
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure",
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements",
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Individual [Axis]",
        "terseLabel": "Individual:"
       }
      }
     },
     "auth_ref": [
      "r571",
      "r580",
      "r596",
      "r615",
      "r624",
      "r628",
      "r636"
     ]
    },
    "ecd_InsiderTradingArrLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "InsiderTradingArrLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Insider Trading Arrangements [Line Items]",
        "terseLabel": "Insider Trading Arrangements:"
       }
      }
     },
     "auth_ref": [
      "r634"
     ]
    },
    "ecd_InsiderTradingPoliciesProcLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "InsiderTradingPoliciesProcLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Insider Trading Policies and Procedures [Line Items]",
        "terseLabel": "Insider Trading Policies and Procedures:"
       }
      }
     },
     "auth_ref": [
      "r560",
      "r640"
     ]
    },
    "ecd_InsiderTrdPoliciesProcAdoptedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "InsiderTrdPoliciesProcAdoptedFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Insider Trading Policies and Procedures Adopted [Flag]",
        "terseLabel": "Insider Trading Policies and Procedures Adopted"
       }
      }
     },
     "auth_ref": [
      "r560",
      "r640"
     ]
    },
    "ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "InsiderTrdPoliciesProcNotAdoptedTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Insider Trading Policies and Procedures Not Adopted [Text Block]",
        "terseLabel": "Insider Trading Policies and Procedures Not Adopted"
       }
      }
     },
     "auth_ref": [
      "r560",
      "r640"
     ]
    },
    "us-gaap_InterestPaidNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InterestPaidNet",
     "crdr": "credit",
     "presentation": [
      "http://www.arberobotics.com/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Interest paid",
        "label": "Interest Paid, Excluding Capitalized Interest, Operating Activities",
        "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount."
       }
      }
     },
     "auth_ref": [
      "r154",
      "r156",
      "r157"
     ]
    },
    "dei_InvestmentCompanyActFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "InvestmentCompanyActFileNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment Company Act File Number"
       }
      }
     },
     "auth_ref": [
      "r585",
      "r586",
      "r587",
      "r588"
     ]
    },
    "dei_InvestmentCompanyActRegistration": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "InvestmentCompanyActRegistration",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment Company Act Registration"
       }
      }
     },
     "auth_ref": [
      "r601"
     ]
    },
    "dei_InvestmentCompanyRegistrationAmendment": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "InvestmentCompanyRegistrationAmendment",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment Company Registration Amendment"
       }
      }
     },
     "auth_ref": [
      "r601"
     ]
    },
    "dei_InvestmentCompanyRegistrationAmendmentNumber": {
     "xbrltype": "sequenceNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "InvestmentCompanyRegistrationAmendmentNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment Company Registration Amendment Number"
       }
      }
     },
     "auth_ref": [
      "r601"
     ]
    },
    "us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IssuanceOfStockAndWarrantsForServicesOrClaims",
     "crdr": "debit",
     "calculation": {
      "http://www.arberobotics.com/role/ConsolidatedCashFlow": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.arberobotics.com/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock-based compensation to service providers",
        "label": "Issuance of Stock and Warrants for Services or Claims",
        "documentation": "Fair value of share-based compensation granted to nonemployees as payment for services rendered or acknowledged claims."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "us-gaap_LeaseCostTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LeaseCostTableTextBlock",
     "presentation": [
      "http://www.arberobotics.com/role/LeasesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Supplemental Balance Sheet Information Related to Operating Leases",
        "label": "Lease, Cost [Table Text Block]",
        "documentation": "Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income."
       }
      }
     },
     "auth_ref": [
      "r731"
     ]
    },
    "us-gaap_LeaseholdImprovementsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LeaseholdImprovementsMember",
     "presentation": [
      "http://www.arberobotics.com/role/ScheduleofPropertyandEquipmentTable",
      "http://www.arberobotics.com/role/ScheduleoftheStraightLineMethodOvertheEstimatedUsefulLivesoftheAssetsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Leasehold improvement\t[Member]",
        "verboseLabel": "Leasehold improvement [Member]",
        "label": "Leasehold Improvements [Member]",
        "documentation": "Additions or improvements to assets held under a lease arrangement."
       }
      }
     },
     "auth_ref": [
      "r85"
     ]
    },
    "us-gaap_LeasesOperatingAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LeasesOperatingAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Leases [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_LegalEntityAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "LegalEntityAxis",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/AuditInformation",
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Legal Entity [Axis]",
        "documentation": "The set of legal entities associated with a report."
       }
      }
     },
     "auth_ref": []
    },
    "dei_LegalEntityIdentifier": {
     "xbrltype": "legalEntityIdentifierItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "LegalEntityIdentifier",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Legal Entity Identifier",
        "documentation": "A globally unique ISO 17442 value to identify entities, commonly abbreviated as LEI."
       }
      }
     },
     "auth_ref": [
      "r544"
     ]
    },
    "us-gaap_LesseeLeasesPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LesseeLeasesPolicyTextBlock",
     "presentation": [
      "http://www.arberobotics.com/role/AccountingPoliciesByPolicy"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Leases",
        "label": "Lessee, Leases [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for leasing arrangement entered into by lessee."
       }
      }
     },
     "auth_ref": [
      "r364"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
     "presentation": [
      "http://www.arberobotics.com/role/LeasesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Maturities of Lease Liabilities",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Maturity [Table Text Block]",
        "documentation": "Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position."
       }
      }
     },
     "auth_ref": [
      "r732"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDue",
     "crdr": "credit",
     "calculation": {
      "http://www.arberobotics.com/role/ScheduleofMaturitiesofLeaseLiabilitiesTable": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.arberobotics.com/role/ScheduleofMaturitiesofLeaseLiabilitiesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total lease payments",
        "label": "Lessee, Operating Lease, Liability, to be Paid",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease."
       }
      }
     },
     "auth_ref": [
      "r369"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
     "crdr": "credit",
     "calculation": {
      "http://www.arberobotics.com/role/ScheduleofMaturitiesofLeaseLiabilitiesTable": {
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.arberobotics.com/role/ScheduleofMaturitiesofLeaseLiabilitiesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2024",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year One",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r369"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFour",
     "crdr": "credit",
     "calculation": {
      "http://www.arberobotics.com/role/ScheduleofMaturitiesofLeaseLiabilitiesTable": {
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.arberobotics.com/role/ScheduleofMaturitiesofLeaseLiabilitiesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2027 and after",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Four",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r369"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearThree",
     "crdr": "credit",
     "calculation": {
      "http://www.arberobotics.com/role/ScheduleofMaturitiesofLeaseLiabilitiesTable": {
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.arberobotics.com/role/ScheduleofMaturitiesofLeaseLiabilitiesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2026",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Three",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r369"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearTwo",
     "crdr": "credit",
     "calculation": {
      "http://www.arberobotics.com/role/ScheduleofMaturitiesofLeaseLiabilitiesTable": {
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.arberobotics.com/role/ScheduleofMaturitiesofLeaseLiabilitiesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2025",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Two",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r369"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LesseeOperatingLeaseLiabilityUndiscountedExcessAmount",
     "crdr": "credit",
     "presentation": [
      "http://www.arberobotics.com/role/ScheduleofMaturitiesofLeaseLiabilitiesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Less imputed interest",
        "label": "Lessee, Operating Lease, Liability, Undiscounted Excess Amount",
        "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease."
       }
      }
     },
     "auth_ref": [
      "r369"
     ]
    },
    "us-gaap_LesseeOperatingLeasesTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LesseeOperatingLeasesTextBlock",
     "presentation": [
      "http://www.arberobotics.com/role/Leases"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "LEASES",
        "label": "Lessee, Operating Leases [Text Block]",
        "documentation": "The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability."
       }
      }
     },
     "auth_ref": [
      "r360"
     ]
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LiabilitiesAndStockholdersEquity",
     "crdr": "credit",
     "calculation": {
      "http://www.arberobotics.com/role/ConsolidatedBalanceSheet": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.arberobotics.com/role/ConsolidatedBalanceSheet"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total liabilities and shareholders\u2019 equity",
        "label": "Liabilities and Equity",
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any."
       }
      }
     },
     "auth_ref": [
      "r69",
      "r101",
      "r382",
      "r530",
      "r678",
      "r686",
      "r730"
     ]
    },
    "us-gaap_LiabilitiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LiabilitiesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.arberobotics.com/role/ConsolidatedBalanceSheet": {
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.arberobotics.com/role/ConsolidatedBalanceSheet"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total current liabilities",
        "label": "Liabilities, Current",
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r24",
      "r137",
      "r161",
      "r222",
      "r233",
      "r234",
      "r235",
      "r236",
      "r237",
      "r238",
      "r239",
      "r240",
      "r241",
      "r336",
      "r337",
      "r338",
      "r351",
      "r530",
      "r692",
      "r734",
      "r735"
     ]
    },
    "us-gaap_LiabilitiesCurrentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LiabilitiesCurrentAbstract",
     "presentation": [
      "http://www.arberobotics.com/role/ConsolidatedBalanceSheet"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "CURRENT LIABILITIES:",
        "label": "Liabilities, Current [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LiabilitiesNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LiabilitiesNoncurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.arberobotics.com/role/ConsolidatedBalanceSheet": {
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.arberobotics.com/role/ConsolidatedBalanceSheet"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total long-term liabilities",
        "label": "Liabilities, Noncurrent",
        "documentation": "Amount of obligation due after one year or beyond the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r20",
      "r59",
      "r60",
      "r61",
      "r62",
      "r161",
      "r222",
      "r233",
      "r234",
      "r235",
      "r236",
      "r237",
      "r238",
      "r239",
      "r240",
      "r241",
      "r336",
      "r337",
      "r338",
      "r351",
      "r692",
      "r734",
      "r735"
     ]
    },
    "us-gaap_LiabilitiesNoncurrentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LiabilitiesNoncurrentAbstract",
     "presentation": [
      "http://www.arberobotics.com/role/ConsolidatedBalanceSheet"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "LONG-TERM LIABILITIES:",
        "label": "Liabilities, Noncurrent [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LongLivedAssetsByGeographicAreasTableTextBlock",
     "presentation": [
      "http://www.arberobotics.com/role/SegmentInformationTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Property and Equipment, Net of Depreciation, by Geographic Region",
        "label": "Long-Lived Assets by Geographic Areas [Table Text Block]",
        "documentation": "Tabular disclosure of long-lived assets, excluding financial instruments, long-term customer relationships of a financial institution, mortgage rights, deferred policy acquisition costs, and deferred tax assets, by geographic areas located in the entity's country of domicile and foreign countries in which the entity holds assets."
       }
      }
     },
     "auth_ref": [
      "r18"
     ]
    },
    "srt_MajorCustomersAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "MajorCustomersAxis",
     "presentation": [
      "http://www.arberobotics.com/role/SegmentInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Customer [Axis]",
        "documentation": "Information by name or description of a single external customer or a group of external customers."
       }
      }
     },
     "auth_ref": [
      "r219",
      "r520",
      "r698",
      "r743",
      "r744"
     ]
    },
    "srt_MaximumMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "MaximumMember",
     "presentation": [
      "http://www.arberobotics.com/role/GeneralDetails",
      "http://www.arberobotics.com/role/ScheduleofCompensationtoEmployeesTable",
      "http://www.arberobotics.com/role/ScheduleoftheStraightLineMethodOvertheEstimatedUsefulLivesoftheAssetsTable",
      "http://www.arberobotics.com/role/SignificantAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Maximum [Member]",
        "label": "Maximum [Member]",
        "documentation": "Upper limit of the provided range."
       }
      }
     },
     "auth_ref": [
      "r229",
      "r230",
      "r231",
      "r232",
      "r271",
      "r374",
      "r396",
      "r426",
      "r427",
      "r478",
      "r480",
      "r482",
      "r483",
      "r485",
      "r506",
      "r507",
      "r516",
      "r517",
      "r525",
      "r532",
      "r696",
      "r736",
      "r737",
      "r738",
      "r739",
      "r740",
      "r741"
     ]
    },
    "ecd_MeasureAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "MeasureAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Measure [Axis]",
        "terseLabel": "Measure:"
       }
      }
     },
     "auth_ref": [
      "r607"
     ]
    },
    "ecd_MeasureName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "MeasureName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Measure Name",
        "terseLabel": "Name"
       }
      }
     },
     "auth_ref": [
      "r607"
     ]
    },
    "srt_MinimumMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "MinimumMember",
     "presentation": [
      "http://www.arberobotics.com/role/GeneralDetails",
      "http://www.arberobotics.com/role/ScheduleofCompensationtoEmployeesTable",
      "http://www.arberobotics.com/role/ScheduleoftheStraightLineMethodOvertheEstimatedUsefulLivesoftheAssetsTable",
      "http://www.arberobotics.com/role/SignificantAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Minimum [Member]",
        "label": "Minimum [Member]",
        "documentation": "Lower limit of the provided range."
       }
      }
     },
     "auth_ref": [
      "r229",
      "r230",
      "r231",
      "r232",
      "r271",
      "r374",
      "r396",
      "r426",
      "r427",
      "r478",
      "r480",
      "r482",
      "r483",
      "r485",
      "r506",
      "r507",
      "r516",
      "r517",
      "r525",
      "r532",
      "r696",
      "r736",
      "r737",
      "r738",
      "r739",
      "r740",
      "r741"
     ]
    },
    "ecd_MnpiDiscTimedForCompValFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "MnpiDiscTimedForCompValFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "MNPI Disclosure Timed for Compensation Value [Flag]",
        "terseLabel": "MNPI Disclosure Timed for Compensation Value"
       }
      }
     },
     "auth_ref": [
      "r627"
     ]
    },
    "ecd_MtrlTermsOfTrdArrTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "MtrlTermsOfTrdArrTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Material Terms of Trading Arrangement [Text Block]",
        "terseLabel": "Material Terms of Trading Arrangement"
       }
      }
     },
     "auth_ref": [
      "r635"
     ]
    },
    "dei_NameChangeEventDateAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "NameChangeEventDateAxis",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Name Change Event Date [Axis]",
        "documentation": "For a sequence of name change event related facts, use this typed dimension to distinguish them.  The axis members are restricted to be a valid for xml schema 'date' or 'datetime' data type."
       }
      }
     },
     "auth_ref": []
    },
    "dei_NameChangeEventLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "NameChangeEventLineItems",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Name Change Event [Line Items]",
        "documentation": "Line items represent concepts included in a table. Name change event line item concepts are used for information qualified by domain members of axes in the Name Change Event table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_NameChangeEventTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "NameChangeEventTable",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Name Change Event [Table]",
        "documentation": "For a set of related facts in a sequence of name change events, use this table when the events occurred within a single reporting period."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_NamedExecutiveOfficersFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "NamedExecutiveOfficersFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Named Executive Officers, Footnote [Text Block]",
        "terseLabel": "Named Executive Officers, Footnote"
       }
      }
     },
     "auth_ref": [
      "r608"
     ]
    },
    "us-gaap_NatureOfOperations": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NatureOfOperations",
     "presentation": [
      "http://www.arberobotics.com/role/General"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "GENERAL",
        "label": "Nature of Operations [Text Block]",
        "documentation": "The entire disclosure for the nature of an entity's business, major products or services, principal markets including location, and the relative importance of its operations in each business and the basis for the determination, including but not limited to, assets, revenues, or earnings. For an entity that has not commenced principal operations, disclosures about the risks and uncertainties related to the activities in which the entity is currently engaged and an understanding of what those activities are being directed toward."
       }
      }
     },
     "auth_ref": [
      "r108",
      "r119"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "crdr": "debit",
     "calculation": {
      "http://www.arberobotics.com/role/ConsolidatedCashFlow": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.arberobotics.com/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net cash provided by (used in) financing activities",
        "label": "Net Cash Provided by (Used in) Financing Activities",
        "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit."
       }
      }
     },
     "auth_ref": [
      "r155"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
     "presentation": [
      "http://www.arberobotics.com/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash flows from financing activities:",
        "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "crdr": "debit",
     "calculation": {
      "http://www.arberobotics.com/role/ConsolidatedCashFlow": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.arberobotics.com/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net cash used in investing activities",
        "label": "Net Cash Provided by (Used in) Investing Activities",
        "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets."
       }
      }
     },
     "auth_ref": [
      "r155"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract",
     "presentation": [
      "http://www.arberobotics.com/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash flows from investing activities:",
        "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "calculation": {
      "http://www.arberobotics.com/role/ConsolidatedCashFlow": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.arberobotics.com/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net cash used in operating activities",
        "label": "Net Cash Provided by (Used in) Operating Activities",
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities."
       }
      }
     },
     "auth_ref": [
      "r79",
      "r80",
      "r81"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
     "presentation": [
      "http://www.arberobotics.com/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash flows from operating activities:",
        "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NetIncomeLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NetIncomeLoss",
     "crdr": "credit",
     "calculation": {
      "http://www.arberobotics.com/role/ConsolidatedCashFlow": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 1.0
      },
      "http://www.arberobotics.com/role/ConsolidatedIncomeStatement": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.arberobotics.com/role/ConsolidatedCashFlow",
      "http://www.arberobotics.com/role/ConsolidatedIncomeStatement",
      "http://www.arberobotics.com/role/ShareholdersEquityType2or3",
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net loss",
        "verboseLabel": "Net loss",
        "label": "Net Income (Loss)",
        "terseLabel": "Net Income (Loss)",
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent."
       }
      }
     },
     "auth_ref": [
      "r71",
      "r81",
      "r105",
      "r135",
      "r146",
      "r147",
      "r151",
      "r161",
      "r168",
      "r170",
      "r171",
      "r172",
      "r173",
      "r176",
      "r177",
      "r183",
      "r199",
      "r205",
      "r210",
      "r213",
      "r222",
      "r233",
      "r234",
      "r235",
      "r236",
      "r237",
      "r238",
      "r239",
      "r240",
      "r241",
      "r350",
      "r351",
      "r387",
      "r454",
      "r471",
      "r472",
      "r515",
      "r541",
      "r692"
     ]
    },
    "us-gaap_NetIncomeLossAttributableToNonredeemableNoncontrollingInterest": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NetIncomeLossAttributableToNonredeemableNoncontrollingInterest",
     "crdr": "debit",
     "presentation": [
      "http://www.arberobotics.com/role/ScheduleofSetsForththeComputationofBasicandDilutedNetLossPerShareAttributableTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Net loss",
        "label": "Net Income (Loss) Attributable to Nonredeemable Noncontrolling Interest",
        "documentation": "Portion of net income (loss) attributable to nonredeemable noncontrolling interest."
       }
      }
     },
     "auth_ref": [
      "r74"
     ]
    },
    "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock",
     "presentation": [
      "http://www.arberobotics.com/role/AccountingPoliciesByPolicy"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Impact of recently issued accounting standard",
        "label": "New Accounting Pronouncements, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact."
       }
      }
     },
     "auth_ref": []
    },
    "dei_NewEffectiveDateForPreviousFiling": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "NewEffectiveDateForPreviousFiling",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "New Effective Date for Previous Filing"
       }
      }
     },
     "auth_ref": [
      "r585",
      "r586",
      "r587",
      "r588"
     ]
    },
    "dei_NoSubstantiveChanges462c": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "NoSubstantiveChanges462c",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "No Substantive Changes, 462(c)"
       }
      }
     },
     "auth_ref": [
      "r647"
     ]
    },
    "dei_NoSubstantiveChanges462cFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "NoSubstantiveChanges462cFileNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "No Substantive Changes, 462(c), File Number"
       }
      }
     },
     "auth_ref": [
      "r647"
     ]
    },
    "dei_NoTradingSymbolFlag": {
     "xbrltype": "trueItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "NoTradingSymbolFlag",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "No Trading Symbol Flag",
        "documentation": "Boolean flag that is true only for a security having no trading symbol."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_NonGaapMeasureDescriptionTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "NonGaapMeasureDescriptionTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-GAAP Measure Description [Text Block]",
        "terseLabel": "Non-GAAP Measure Description"
       }
      }
     },
     "auth_ref": [
      "r607"
     ]
    },
    "ecd_NonNeosMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "NonNeosMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-NEOs [Member]",
        "terseLabel": "Non-NEOs"
       }
      }
     },
     "auth_ref": [
      "r568",
      "r580",
      "r596",
      "r615",
      "r624"
     ]
    },
    "ecd_NonPeoNeoAvgCompActuallyPaidAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "NonPeoNeoAvgCompActuallyPaidAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-PEO NEO Average Compensation Actually Paid Amount",
        "terseLabel": "Non-PEO NEO Average Compensation Actually Paid Amount"
       }
      }
     },
     "auth_ref": [
      "r605"
     ]
    },
    "ecd_NonPeoNeoAvgTotalCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "NonPeoNeoAvgTotalCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-PEO NEO Average Total Compensation Amount",
        "terseLabel": "Non-PEO NEO Average Total Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r604"
     ]
    },
    "ecd_NonPeoNeoMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "NonPeoNeoMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-PEO NEO [Member]",
        "terseLabel": "Non-PEO NEO"
       }
      }
     },
     "auth_ref": [
      "r615"
     ]
    },
    "ecd_NonRule10b51ArrAdoptedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "NonRule10b51ArrAdoptedFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-Rule 10b5-1 Arrangement Adopted [Flag]",
        "terseLabel": "Non-Rule 10b5-1 Arrangement Adopted"
       }
      }
     },
     "auth_ref": [
      "r635"
     ]
    },
    "ecd_NonRule10b51ArrTrmntdFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "NonRule10b51ArrTrmntdFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-Rule 10b5-1 Arrangement Terminated [Flag]",
        "terseLabel": "Non-Rule 10b5-1 Arrangement Terminated"
       }
      }
     },
     "auth_ref": [
      "r635"
     ]
    },
    "us-gaap_NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1",
     "crdr": "debit",
     "presentation": [
      "http://www.arberobotics.com/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Purchase of property and equipment",
        "label": "Noncash or Part Noncash Acquisition, Fixed Assets Acquired",
        "documentation": "The amount of fixed assets that an Entity acquires in a noncash (or part noncash) acquisition. Noncash is defined as information about all investing and financing activities of an enterprise during a period that affect recognized assets or liabilities but that do not result in cash receipts or cash payments in the period. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period."
       }
      }
     },
     "auth_ref": [
      "r32",
      "r33",
      "r34"
     ]
    },
    "us-gaap_NonoperatingIncomeExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NonoperatingIncomeExpense",
     "crdr": "credit",
     "calculation": {
      "http://www.arberobotics.com/role/ConsolidatedIncomeStatement": {
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.arberobotics.com/role/ConsolidatedIncomeStatement"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Financial expense (income), net",
        "label": "Nonoperating Income (Expense)",
        "documentation": "The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business)."
       }
      }
     },
     "auth_ref": [
      "r77"
     ]
    },
    "arbe_NumeratorAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.arberobotics.com/20231231",
     "localname": "NumeratorAbstract",
     "presentation": [
      "http://www.arberobotics.com/role/ScheduleofSetsForththeComputationofBasicandDilutedNetLossPerShareAttributableTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Numerator:",
        "label": "Numerator Abstract"
       }
      }
     },
     "auth_ref": []
    },
    "arbe_NumeratorAbstract0": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.arberobotics.com/20231231",
     "localname": "NumeratorAbstract0",
     "presentation": [
      "http://www.arberobotics.com/role/ScheduleofSetsForththeComputationofBasicandDilutedNetLossPerShareAttributableTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Numerator:",
        "label": "Numerator Abstract0"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OfficeEquipmentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OfficeEquipmentMember",
     "presentation": [
      "http://www.arberobotics.com/role/ScheduleofPropertyandEquipmentTable",
      "http://www.arberobotics.com/role/ScheduleoftheStraightLineMethodOvertheEstimatedUsefulLivesoftheAssetsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Office furniture and equipment [Member]",
        "label": "Office Equipment [Member]",
        "documentation": "Tangible personal property used in an office setting. Examples include, but are not limited to, computers, copiers and fax machine."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OperatingExpenses": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingExpenses",
     "crdr": "debit",
     "calculation": {
      "http://www.arberobotics.com/role/ConsolidatedIncomeStatement": {
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.arberobotics.com/role/ConsolidatedIncomeStatement"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total operating expenses",
        "label": "Operating Expenses",
        "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OperatingExpensesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingExpensesAbstract",
     "presentation": [
      "http://www.arberobotics.com/role/ConsolidatedIncomeStatement"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating expenses:",
        "label": "Operating Expenses [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OperatingIncomeLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingIncomeLoss",
     "crdr": "credit",
     "calculation": {
      "http://www.arberobotics.com/role/ConsolidatedIncomeStatement": {
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.arberobotics.com/role/ConsolidatedIncomeStatement"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Operating loss",
        "label": "Operating Income (Loss)",
        "documentation": "The net result for the period of deducting operating expenses from operating revenues."
       }
      }
     },
     "auth_ref": [
      "r199",
      "r205",
      "r210",
      "r213",
      "r515"
     ]
    },
    "us-gaap_OperatingLeaseLeaseIncomeTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingLeaseLeaseIncomeTableTextBlock",
     "presentation": [
      "http://www.arberobotics.com/role/LeasesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Supplemental Cash Flow Information Related to Leases",
        "label": "Operating Lease, Lease Income [Table Text Block]",
        "documentation": "Tabular disclosure of components of income from operating lease."
       }
      }
     },
     "auth_ref": [
      "r191",
      "r370"
     ]
    },
    "us-gaap_OperatingLeaseLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingLeaseLiability",
     "crdr": "credit",
     "presentation": [
      "http://www.arberobotics.com/role/ScheduleofMaturitiesofLeaseLiabilitiesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Total lease liabilities",
        "label": "Operating Lease, Liability",
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease."
       }
      }
     },
     "auth_ref": [
      "r362"
     ]
    },
    "us-gaap_OperatingLeaseLiabilityCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingLeaseLiabilityCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.arberobotics.com/role/ConsolidatedBalanceSheet": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.arberobotics.com/role/ConsolidatedBalanceSheet",
      "http://www.arberobotics.com/role/ScheduleofSupplementalBalanceSheetInformationRelatedtoOperatingLeasesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating lease liabilities",
        "verboseLabel": "Current maturities of operating leases",
        "label": "Operating Lease, Liability, Current",
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current."
       }
      }
     },
     "auth_ref": [
      "r362"
     ]
    },
    "us-gaap_OperatingLeaseLiabilityNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingLeaseLiabilityNoncurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.arberobotics.com/role/ConsolidatedBalanceSheet": {
       "parentTag": "us-gaap_LiabilitiesNoncurrent",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.arberobotics.com/role/ConsolidatedBalanceSheet",
      "http://www.arberobotics.com/role/ScheduleofSupplementalBalanceSheetInformationRelatedtoOperatingLeasesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating lease liabilities",
        "verboseLabel": "Long-term operating lease liabilities",
        "label": "Operating Lease, Liability, Noncurrent",
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent."
       }
      }
     },
     "auth_ref": [
      "r362"
     ]
    },
    "us-gaap_OperatingLeasePayments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingLeasePayments",
     "crdr": "credit",
     "presentation": [
      "http://www.arberobotics.com/role/ScheduleofSupplementalCashFlowInformationRelatedtoLeasesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Cash payments and expenses related to operating leases",
        "label": "Operating Lease, Payments",
        "documentation": "Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use."
       }
      }
     },
     "auth_ref": [
      "r363",
      "r365"
     ]
    },
    "us-gaap_OperatingLeaseRightOfUseAsset": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingLeaseRightOfUseAsset",
     "crdr": "debit",
     "calculation": {
      "http://www.arberobotics.com/role/ConsolidatedBalanceSheet": {
       "parentTag": "us-gaap_AssetsNoncurrent",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.arberobotics.com/role/ConsolidatedBalanceSheet",
      "http://www.arberobotics.com/role/ScheduleofSupplementalBalanceSheetInformationRelatedtoOperatingLeasesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating lease right-of-use assets",
        "label": "Operating Lease, Right-of-Use Asset",
        "documentation": "Amount of lessee's right to use underlying asset under operating lease."
       }
      }
     },
     "auth_ref": [
      "r361"
     ]
    },
    "arbe_OperatingLeaseRightofuseAssetsAndLiabilitiesNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.arberobotics.com/20231231",
     "localname": "OperatingLeaseRightofuseAssetsAndLiabilitiesNet",
     "crdr": "debit",
     "presentation": [
      "http://www.arberobotics.com/role/ScheduleofSupplementalCashFlowInformationRelatedtoLeasesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Operating lease right-of-use assets and liabilities, net",
        "documentation": "Operating lease right-of-use assets and liabilities net.",
        "label": "Operating Lease Rightofuse Assets And Liabilities Net"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingLeaseWeightedAverageDiscountRatePercent",
     "presentation": [
      "http://www.arberobotics.com/role/ScheduleofSupplementalBalanceSheetInformationRelatedtoOperatingLeasesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted average discount rate",
        "label": "Operating Lease, Weighted Average Discount Rate, Percent",
        "documentation": "Weighted average discount rate for operating lease calculated at point in time."
       }
      }
     },
     "auth_ref": [
      "r368",
      "r529"
     ]
    },
    "us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingLeaseWeightedAverageRemainingLeaseTerm1",
     "presentation": [
      "http://www.arberobotics.com/role/ScheduleofSupplementalBalanceSheetInformationRelatedtoOperatingLeasesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted average remaining lease term (in years)",
        "label": "Operating Lease, Weighted Average Remaining Lease Term",
        "documentation": "Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r367",
      "r529"
     ]
    },
    "us-gaap_OperatingLossCarryforwards": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingLossCarryforwards",
     "crdr": "debit",
     "presentation": [
      "http://www.arberobotics.com/role/TaxesonIncomeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Net operating loss carryforward (in Dollars)",
        "label": "Operating Loss Carryforwards",
        "documentation": "Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws."
       }
      }
     },
     "auth_ref": [
      "r52"
     ]
    },
    "arbe_OptionsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.arberobotics.com/20231231",
     "localname": "OptionsAbstract",
     "presentation": [
      "http://www.arberobotics.com/role/ScheduleofStockOptionActivityTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Options:",
        "label": "Options Abstract"
       }
      }
     },
     "auth_ref": []
    },
    "arbe_OrdinarySharesParValueNIS0000216PerShareMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.arberobotics.com/20231231",
     "localname": "OrdinarySharesParValueNIS0000216PerShareMember",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Ordinary shares, par value NIS 0.000216 per share",
        "label": "Ordinary Shares Par Value NIS0000216 Per Share Member"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "General [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_OtherAddressMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "OtherAddressMember",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Address [Member]",
        "documentation": "Other address for entity"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OtherAssetsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherAssetsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Prepaid Expenses and Other Receivables [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OtherCurrentAssetsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherCurrentAssetsTextBlock",
     "presentation": [
      "http://www.arberobotics.com/role/PrepaidExpensesandOtherReceivables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "PREPAID EXPENSES AND OTHER RECEIVABLES",
        "label": "Other Current Assets [Text Block]",
        "documentation": "The entire disclosure for other current assets."
       }
      }
     },
     "auth_ref": []
    },
    "arbe_OtherGeographicalMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.arberobotics.com/20231231",
     "localname": "OtherGeographicalMember",
     "presentation": [
      "http://www.arberobotics.com/role/ScheduleofRevenueDisaggregatedbyGeographyTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other [Member]",
        "label": "Other Geographical Member"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_OtherPerfMeasureAmt": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "OtherPerfMeasureAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Performance Measure, Amount",
        "terseLabel": "Other Performance Measure, Amount"
       }
      }
     },
     "auth_ref": [
      "r607"
     ]
    },
    "dei_OtherReportingStandardItemNumber": {
     "xbrltype": "otherReportingStandardItemNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "OtherReportingStandardItemNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Reporting Standard Item Number",
        "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS."
       }
      }
     },
     "auth_ref": [
      "r559"
     ]
    },
    "ecd_OutstandingAggtErrCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "OutstandingAggtErrCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Outstanding Aggregate Erroneous Compensation Amount",
        "terseLabel": "Outstanding Aggregate Erroneous Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r566",
      "r578",
      "r594",
      "r622"
     ]
    },
    "ecd_OutstandingRecoveryCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "OutstandingRecoveryCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Outstanding Recovery Compensation Amount",
        "terseLabel": "Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r569",
      "r581",
      "r597",
      "r625"
     ]
    },
    "ecd_OutstandingRecoveryIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "OutstandingRecoveryIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Outstanding Recovery, Individual Name",
        "terseLabel": "Name"
       }
      }
     },
     "auth_ref": [
      "r569",
      "r581",
      "r597",
      "r625"
     ]
    },
    "arbe_OutstandingShareOptionsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.arberobotics.com/20231231",
     "localname": "OutstandingShareOptionsMember",
     "presentation": [
      "http://www.arberobotics.com/role/ScheduleofOrdinarySharesthatwereExcludedfromtheComputationofDilutedNetLossPerShareTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Outstanding share options [Member]",
        "label": "Outstanding Share Options Member"
       }
      }
     },
     "auth_ref": []
    },
    "arbe_PIPEMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.arberobotics.com/20231231",
     "localname": "PIPEMember",
     "presentation": [
      "http://www.arberobotics.com/role/GeneralDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "PIPE [Member]",
        "label": "PIPEMember"
       }
      }
     },
     "auth_ref": []
    },
    "dei_ParentEntityLegalName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "ParentEntityLegalName",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Parent Entity Legal Name",
        "documentation": "If the entity which the financial information concerns is a subsidiary of another company, then provide to full legal name of the parent entity"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_PayVsPerformanceDisclosureLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "PayVsPerformanceDisclosureLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Pay vs Performance Disclosure [Line Items]",
        "terseLabel": "Pay vs Performance Disclosure"
       }
      }
     },
     "auth_ref": [
      "r603"
     ]
    },
    "us-gaap_PaymentsForProceedsFromInvestments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PaymentsForProceedsFromInvestments",
     "crdr": "credit",
     "calculation": {
      "http://www.arberobotics.com/role/ConsolidatedCashFlow": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.arberobotics.com/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Change in bank deposits",
        "label": "Payments for (Proceeds from) Investments",
        "documentation": "The net cash paid (received) associated with the acquisition or disposal of all investments, including securities and other assets."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PaymentsOfOrdinaryDividends": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PaymentsOfOrdinaryDividends",
     "crdr": "credit",
     "presentation": [
      "http://www.arberobotics.com/role/GeneralDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Ordinary shares amount (in Dollars)",
        "label": "Payments of Ordinary Dividends",
        "documentation": "Cash outflow in the form of ordinary dividends to common shareholders, preferred shareholders and noncontrolling interests, generally out of earnings."
       }
      }
     },
     "auth_ref": [
      "r28"
     ]
    },
    "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PaymentsToAcquirePropertyPlantAndEquipment",
     "crdr": "credit",
     "calculation": {
      "http://www.arberobotics.com/role/ConsolidatedCashFlow": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.arberobotics.com/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Purchase of property and equipment",
        "label": "Payments to Acquire Property, Plant, and Equipment",
        "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets."
       }
      }
     },
     "auth_ref": [
      "r78"
     ]
    },
    "ecd_PeerGroupIssuersFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "PeerGroupIssuersFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Peer Group Issuers, Footnote [Text Block]",
        "terseLabel": "Peer Group Issuers, Footnote"
       }
      }
     },
     "auth_ref": [
      "r606"
     ]
    },
    "ecd_PeerGroupTotalShareholderRtnAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "PeerGroupTotalShareholderRtnAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Peer Group Total Shareholder Return Amount",
        "terseLabel": "Peer Group Total Shareholder Return Amount"
       }
      }
     },
     "auth_ref": [
      "r606"
     ]
    },
    "ecd_PeoActuallyPaidCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "PeoActuallyPaidCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "PEO Actually Paid Compensation Amount",
        "terseLabel": "PEO Actually Paid Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r605"
     ]
    },
    "ecd_PeoMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "PeoMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "PEO [Member]",
        "terseLabel": "PEO"
       }
      }
     },
     "auth_ref": [
      "r615"
     ]
    },
    "ecd_PeoName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "PeoName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "PEO Name",
        "terseLabel": "PEO Name"
       }
      }
     },
     "auth_ref": [
      "r608"
     ]
    },
    "ecd_PeoTotalCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "PeoTotalCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "PEO Total Compensation Amount",
        "terseLabel": "PEO Total Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r604"
     ]
    },
    "dei_PhoneFaxNumberDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "PhoneFaxNumberDescription",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Phone Fax Number Description",
        "documentation": "Description of Phone or Fax Number"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PlanNameAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PlanNameAxis",
     "presentation": [
      "http://www.arberobotics.com/role/ShareholdersEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Plan Name [Axis]",
        "documentation": "Information by plan name for share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r699",
      "r700",
      "r701",
      "r702",
      "r703",
      "r704",
      "r705",
      "r706",
      "r707",
      "r708",
      "r709",
      "r710",
      "r711",
      "r712",
      "r713",
      "r714",
      "r715",
      "r716",
      "r717",
      "r718",
      "r719",
      "r720",
      "r721",
      "r722",
      "r723",
      "r724"
     ]
    },
    "us-gaap_PlanNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PlanNameDomain",
     "presentation": [
      "http://www.arberobotics.com/role/ShareholdersEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Plan Name [Domain]",
        "documentation": "Plan name for share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r699",
      "r700",
      "r701",
      "r702",
      "r703",
      "r704",
      "r705",
      "r706",
      "r707",
      "r708",
      "r709",
      "r710",
      "r711",
      "r712",
      "r713",
      "r714",
      "r715",
      "r716",
      "r717",
      "r718",
      "r719",
      "r720",
      "r721",
      "r722",
      "r723",
      "r724"
     ]
    },
    "arbe_PlanOneMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.arberobotics.com/20231231",
     "localname": "PlanOneMember",
     "presentation": [
      "http://www.arberobotics.com/role/ShareholdersEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2016 Plan [Member]",
        "label": "Plan One Member"
       }
      }
     },
     "auth_ref": []
    },
    "dei_PostEffectiveAmendment": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "PostEffectiveAmendment",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Post-Effective Amendment"
       }
      }
     },
     "auth_ref": [
      "r545"
     ]
    },
    "dei_PostEffectiveAmendmentNumber": {
     "xbrltype": "sequenceNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "PostEffectiveAmendmentNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Post-Effective Amendment Number",
        "documentation": "Amendment number to registration statement under the Securities Act of 1933 after the registration becomes effective."
       }
      }
     },
     "auth_ref": [
      "r545"
     ]
    },
    "us-gaap_PostemploymentBenefitPlansPolicy": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PostemploymentBenefitPlansPolicy",
     "presentation": [
      "http://www.arberobotics.com/role/AccountingPoliciesByPolicy"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accrued post-employment benefit",
        "label": "Postemployment Benefit Plans, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for postemployment benefits. Postemployment benefits are benefits provided to former or inactive employees, their beneficiaries, and covered dependents after employment but before retirement, except for: a) benefits provided through a pension or postretirement benefit plan, b) individual deferred compensation arrangements, c) special or contractual termination benefits, and d) stock compensation plans."
       }
      }
     },
     "auth_ref": [
      "r269"
     ]
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r552"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r553"
     ]
    },
    "dei_PreEffectiveAmendment": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "PreEffectiveAmendment",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-Effective Amendment"
       }
      }
     },
     "auth_ref": [
      "r545"
     ]
    },
    "dei_PreEffectiveAmendmentNumber": {
     "xbrltype": "sequenceNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "PreEffectiveAmendmentNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-Effective Amendment Number",
        "documentation": "Amendment number to registration statement under the Securities Act of 1933 before the registration becomes effective."
       }
      }
     },
     "auth_ref": [
      "r545"
     ]
    },
    "us-gaap_PreferredStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PreferredStockMember",
     "presentation": [
      "http://www.arberobotics.com/role/ShareholdersEquityType2or3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Redeemable convertible preferred Shares",
        "label": "Preferred Stock [Member]",
        "documentation": "Preferred shares may provide a preferential dividend to the dividend on common stock and may take precedence over common stock in the event of a liquidation. Preferred shares typically represent an ownership interest in the company."
       }
      }
     },
     "auth_ref": [
      "r533",
      "r534",
      "r537",
      "r538",
      "r539",
      "r540",
      "r745",
      "r746"
     ]
    },
    "us-gaap_PrepaidExpenseAndOtherAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PrepaidExpenseAndOtherAssets",
     "crdr": "debit",
     "calculation": {
      "http://www.arberobotics.com/role/ScheduleofPrepaidExpensesandOtherReceivablesTable": {
       "parentTag": "us-gaap_PrepaidExpenseAndOtherAssetsNoncurrent",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.arberobotics.com/role/ScheduleofPrepaidExpensesandOtherReceivablesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Prepaid expenses and other",
        "label": "Prepaid Expense and Other Assets",
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PrepaidExpenseAndOtherAssetsCurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.arberobotics.com/role/ConsolidatedBalanceSheet": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.arberobotics.com/role/ConsolidatedBalanceSheet"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Prepaid expenses and other receivables",
        "label": "Prepaid Expense and Other Assets, Current",
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r673"
     ]
    },
    "us-gaap_PrepaidExpenseAndOtherAssetsNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PrepaidExpenseAndOtherAssetsNoncurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.arberobotics.com/role/ScheduleofPrepaidExpensesandOtherReceivablesTable": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.arberobotics.com/role/ScheduleofPrepaidExpensesandOtherReceivablesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total",
        "label": "Prepaid Expense and Other Assets, Noncurrent",
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed after one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r99",
      "r666"
     ]
    },
    "us-gaap_PrivatePlacementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PrivatePlacementMember",
     "presentation": [
      "http://www.arberobotics.com/role/WarrantsLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Private Placement [Member]",
        "label": "Private Placement [Member]",
        "documentation": "A private placement is a direct offering of securities to a limited number of sophisticated investors such as insurance companies, pension funds, mezzanine funds, stock funds and trusts."
       }
      }
     },
     "auth_ref": []
    },
    "arbe_PrivateWarrantsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.arberobotics.com/20231231",
     "localname": "PrivateWarrantsMember",
     "presentation": [
      "http://www.arberobotics.com/role/GeneralDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Private Warrants [Member]",
        "label": "Private Warrants Member"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ProceedsFromConvertibleDebt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ProceedsFromConvertibleDebt",
     "crdr": "debit",
     "calculation": {
      "http://www.arberobotics.com/role/ConsolidatedCashFlow": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.arberobotics.com/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Proceeds from convertible loan",
        "label": "Proceeds from Convertible Debt",
        "documentation": "The cash inflow from the issuance of a long-term debt instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder."
       }
      }
     },
     "auth_ref": [
      "r27"
     ]
    },
    "us-gaap_ProceedsFromIssuanceInitialPublicOffering": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ProceedsFromIssuanceInitialPublicOffering",
     "crdr": "debit",
     "calculation": {
      "http://www.arberobotics.com/role/ConsolidatedCashFlow": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.arberobotics.com/role/ConsolidatedCashFlow",
      "http://www.arberobotics.com/role/GeneralDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Proceeds from recapitalization and PIPE offering, net of issuance costs",
        "verboseLabel": "Total gross proceeds (in Dollars)",
        "label": "Proceeds from Issuance Initial Public Offering",
        "documentation": "The cash inflow associated with the amount received from entity's first offering of stock to the public."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "us-gaap_ProceedsFromIssuanceOfCommonStock": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ProceedsFromIssuanceOfCommonStock",
     "crdr": "debit",
     "calculation": {
      "http://www.arberobotics.com/role/ConsolidatedCashFlow": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.arberobotics.com/role/ConsolidatedCashFlow",
      "http://www.arberobotics.com/role/ShareholdersEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Proceeds from issuance of ordinary shares, net of issuance costs",
        "verboseLabel": "Net of issuance costs",
        "label": "Proceeds from Issuance of Common Stock",
        "documentation": "The cash inflow from the additional capital contribution to the entity."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "us-gaap_ProceedsFromIssuanceOfWarrants": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ProceedsFromIssuanceOfWarrants",
     "crdr": "debit",
     "presentation": [
      "http://www.arberobotics.com/role/ScheduleofSetsForththeComputationofBasicandDilutedNetLossPerShareAttributableTable",
      "http://www.arberobotics.com/role/WarrantsLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Revaluation of warrants",
        "terseLabel": "Warrants",
        "label": "Proceeds from Issuance of Warrants",
        "documentation": "The cash inflow from issuance of rights to purchase common shares at predetermined price (usually issued together with corporate debt)."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "us-gaap_ProceedsFromShortTermDebt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ProceedsFromShortTermDebt",
     "crdr": "debit",
     "calculation": {
      "http://www.arberobotics.com/role/ConsolidatedCashFlow": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.arberobotics.com/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Proceeds from short-term loan",
        "label": "Proceeds from Short-Term Debt",
        "documentation": "The cash inflow from a borrowing having initial term of repayment within one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r27"
     ]
    },
    "us-gaap_ProceedsFromStockOptionsExercised": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ProceedsFromStockOptionsExercised",
     "crdr": "debit",
     "calculation": {
      "http://www.arberobotics.com/role/ConsolidatedCashFlow": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.arberobotics.com/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Proceeds from exercise of options",
        "label": "Proceeds from Stock Options Exercised",
        "documentation": "Amount of cash inflow from exercise of option under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r4",
      "r17"
     ]
    },
    "us-gaap_ProceedsFromWarrantExercises": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ProceedsFromWarrantExercises",
     "crdr": "debit",
     "calculation": {
      "http://www.arberobotics.com/role/ConsolidatedCashFlow": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.arberobotics.com/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Proceeds from exercise of warrants",
        "label": "Proceeds from Warrant Exercises",
        "documentation": "The cash inflow associated with the amount received from holders exercising their stock warrants."
       }
      }
     },
     "auth_ref": [
      "r674"
     ]
    },
    "srt_ProductOrServiceAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "ProductOrServiceAxis",
     "presentation": [
      "http://www.arberobotics.com/role/ScheduleofRevenueDisaggregatedbyGeographyTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Product and Service [Axis]",
        "documentation": "Information by product and service, or group of similar products and similar services."
       }
      }
     },
     "auth_ref": [
      "r215",
      "r375",
      "r390",
      "r391",
      "r392",
      "r393",
      "r394",
      "r395",
      "r510",
      "r518",
      "r531",
      "r659",
      "r689",
      "r690",
      "r698",
      "r743"
     ]
    },
    "srt_ProductsAndServicesDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "ProductsAndServicesDomain",
     "presentation": [
      "http://www.arberobotics.com/role/ScheduleofRevenueDisaggregatedbyGeographyTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Product and Service [Domain]",
        "documentation": "Product or service, or a group of similar products or similar services."
       }
      }
     },
     "auth_ref": [
      "r215",
      "r375",
      "r390",
      "r391",
      "r392",
      "r393",
      "r394",
      "r395",
      "r510",
      "r518",
      "r531",
      "r659",
      "r689",
      "r690",
      "r698",
      "r743"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PropertyPlantAndEquipmentAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Property and Equipment [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PropertyPlantAndEquipmentByTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PropertyPlantAndEquipmentByTypeAxis",
     "presentation": [
      "http://www.arberobotics.com/role/ScheduleofPropertyandEquipmentTable",
      "http://www.arberobotics.com/role/ScheduleoftheStraightLineMethodOvertheEstimatedUsefulLivesoftheAssetsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Long-Lived Tangible Asset [Axis]",
        "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale."
       }
      }
     },
     "auth_ref": [
      "r7"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PropertyPlantAndEquipmentDisclosureTextBlock",
     "presentation": [
      "http://www.arberobotics.com/role/PropertyandEquipment"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "PROPERTY AND EQUIPMENT",
        "label": "Property, Plant and Equipment Disclosure [Text Block]",
        "documentation": "The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections."
       }
      }
     },
     "auth_ref": [
      "r84",
      "r112",
      "r116",
      "r117"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentGross": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PropertyPlantAndEquipmentGross",
     "crdr": "debit",
     "calculation": {
      "http://www.arberobotics.com/role/ScheduleofPropertyandEquipmentTable": {
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.arberobotics.com/role/ScheduleofPropertyandEquipmentTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Property and equipment, gross",
        "label": "Property, Plant and Equipment, Gross",
        "documentation": "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures."
       }
      }
     },
     "auth_ref": [
      "r85",
      "r139",
      "r385"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PropertyPlantAndEquipmentLineItems",
     "presentation": [
      "http://www.arberobotics.com/role/ScheduleofPropertyandEquipmentTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Property, Plant and Equipment [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PropertyPlantAndEquipmentNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PropertyPlantAndEquipmentNet",
     "crdr": "debit",
     "calculation": {
      "http://www.arberobotics.com/role/ConsolidatedBalanceSheet": {
       "parentTag": "us-gaap_AssetsNoncurrent",
       "weight": 1.0,
       "order": 2.0
      },
      "http://www.arberobotics.com/role/ScheduleofPropertyandEquipmentTable": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.arberobotics.com/role/ConsolidatedBalanceSheet",
      "http://www.arberobotics.com/role/ScheduleofPropertyandEquipmentNetofDepreciationbyGeographicRegionTable",
      "http://www.arberobotics.com/role/ScheduleofPropertyandEquipmentTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Property and equipment, net",
        "terseLabel": "Property and equipment, net",
        "verboseLabel": "Total property and equipment, net:",
        "label": "Property, Plant and Equipment, Net",
        "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures."
       }
      }
     },
     "auth_ref": [
      "r7",
      "r378",
      "r385",
      "r530"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PropertyPlantAndEquipmentPolicyTextBlock",
     "presentation": [
      "http://www.arberobotics.com/role/AccountingPoliciesByPolicy"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Property and equipment",
        "label": "Property, Plant and Equipment, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections."
       }
      }
     },
     "auth_ref": [
      "r7",
      "r112",
      "r116",
      "r383"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentSalvageValuePercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PropertyPlantAndEquipmentSalvageValuePercentage",
     "presentation": [
      "http://www.arberobotics.com/role/ScheduleoftheStraightLineMethodOvertheEstimatedUsefulLivesoftheAssetsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Property and equipment",
        "label": "Property, Plant and Equipment, Salvage Value, Percentage",
        "documentation": "Stated as a percentage, the estimated or actual value of the asset at the end of its useful life or when it is no longer serviceable (cannot be used for its original purpose) divided by its [historical] capitalized cost."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PropertyPlantAndEquipmentTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PropertyPlantAndEquipmentTextBlock",
     "presentation": [
      "http://www.arberobotics.com/role/PropertyandEquipmentTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Property and Equipment",
        "label": "Property, Plant and Equipment [Table Text Block]",
        "documentation": "Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation."
       }
      }
     },
     "auth_ref": [
      "r7"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PropertyPlantAndEquipmentTypeDomain",
     "presentation": [
      "http://www.arberobotics.com/role/ScheduleofPropertyandEquipmentTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Long-Lived Tangible Asset [Domain]",
        "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software."
       }
      }
     },
     "auth_ref": [
      "r85"
     ]
    },
    "arbe_PropertyPlantAndEquipmentUsefulLifeTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.arberobotics.com/20231231",
     "localname": "PropertyPlantAndEquipmentUsefulLifeTableTextBlock",
     "presentation": [
      "http://www.arberobotics.com/role/SignificantAccountingPoliciesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of the Straight-Line Method Over the Estimated Useful Lives of the Assets",
        "documentation": "Tabular disclosure of the useful lives of property, plant and equipment.",
        "label": "Property Plant And Equipment Useful Life Table Text Block"
       }
      }
     },
     "auth_ref": []
    },
    "arbe_PublicWarrantsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.arberobotics.com/20231231",
     "localname": "PublicWarrantsMember",
     "presentation": [
      "http://www.arberobotics.com/role/GeneralDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Public Warrants [Member]",
        "label": "Public Warrants Member"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_PvpTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "PvpTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pay vs Performance Disclosure [Table]",
        "terseLabel": "Pay vs Performance Disclosure"
       }
      }
     },
     "auth_ref": [
      "r603"
     ]
    },
    "ecd_PvpTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "PvpTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pay vs Performance [Table Text Block]",
        "terseLabel": "Pay vs Performance Disclosure, Table"
       }
      }
     },
     "auth_ref": [
      "r603"
     ]
    },
    "srt_RangeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "RangeAxis",
     "presentation": [
      "http://www.arberobotics.com/role/GeneralDetails",
      "http://www.arberobotics.com/role/ScheduleofCompensationtoEmployeesTable",
      "http://www.arberobotics.com/role/ScheduleoftheStraightLineMethodOvertheEstimatedUsefulLivesoftheAssetsTable",
      "http://www.arberobotics.com/role/SignificantAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Axis]",
        "documentation": "Information by statistical measurement. Includes, but is not limited to, minimum, maximum, weighted average, arithmetic average, and median."
       }
      }
     },
     "auth_ref": [
      "r229",
      "r230",
      "r231",
      "r232",
      "r270",
      "r271",
      "r298",
      "r299",
      "r300",
      "r373",
      "r374",
      "r396",
      "r426",
      "r427",
      "r478",
      "r480",
      "r482",
      "r483",
      "r485",
      "r506",
      "r507",
      "r516",
      "r517",
      "r525",
      "r532",
      "r535",
      "r687",
      "r696",
      "r737",
      "r738",
      "r739",
      "r740",
      "r741"
     ]
    },
    "srt_RangeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "RangeMember",
     "presentation": [
      "http://www.arberobotics.com/role/GeneralDetails",
      "http://www.arberobotics.com/role/ScheduleofCompensationtoEmployeesTable",
      "http://www.arberobotics.com/role/ScheduleoftheStraightLineMethodOvertheEstimatedUsefulLivesoftheAssetsTable",
      "http://www.arberobotics.com/role/SignificantAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Domain]",
        "documentation": "Statistical measurement. Includes, but is not limited to, minimum, maximum, weighted average, arithmetic average, and median."
       }
      }
     },
     "auth_ref": [
      "r229",
      "r230",
      "r231",
      "r232",
      "r270",
      "r271",
      "r298",
      "r299",
      "r300",
      "r373",
      "r374",
      "r396",
      "r426",
      "r427",
      "r478",
      "r480",
      "r482",
      "r483",
      "r485",
      "r506",
      "r507",
      "r516",
      "r517",
      "r525",
      "r532",
      "r535",
      "r687",
      "r696",
      "r737",
      "r738",
      "r739",
      "r740",
      "r741"
     ]
    },
    "us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy",
     "presentation": [
      "http://www.arberobotics.com/role/AccountingPoliciesByPolicy"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Trade Receivables",
        "label": "Receivables, Trade and Other Accounts Receivable, Allowance for Doubtful Accounts, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for determining the allowance for doubtful accounts for trade and other accounts receivable balances, and when impairments, charge-offs or recoveries are recognized."
       }
      }
     },
     "auth_ref": [
      "r43"
     ]
    },
    "ecd_RecoveryOfErrCompDisclosureLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "RecoveryOfErrCompDisclosureLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Recovery of Erroneously Awarded Compensation Disclosure [Line Items]",
        "terseLabel": "Recovery of Erroneously Awarded Compensation Disclosure"
       }
      }
     },
     "auth_ref": [
      "r561",
      "r573",
      "r589",
      "r617"
     ]
    },
    "dei_RegistrationStatementAmendmentNumber": {
     "xbrltype": "sequenceNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "RegistrationStatementAmendmentNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Registration Statement Amendment Number",
        "documentation": "Amendment number to registration statement under the Investment Company Act of 1940."
       }
      }
     },
     "auth_ref": [
      "r545"
     ]
    },
    "us-gaap_RepaymentsOfLongTermDebt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RepaymentsOfLongTermDebt",
     "crdr": "credit",
     "calculation": {
      "http://www.arberobotics.com/role/ConsolidatedCashFlow": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://www.arberobotics.com/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Repayment of long-term loan",
        "label": "Repayments of Long-Term Debt",
        "documentation": "The cash outflow for debt initially having maturity due after one year or beyond the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r29",
      "r408"
     ]
    },
    "us-gaap_RepaymentsOfShortTermDebt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RepaymentsOfShortTermDebt",
     "crdr": "credit",
     "calculation": {
      "http://www.arberobotics.com/role/ConsolidatedCashFlow": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0,
       "order": 8.0
      }
     },
     "presentation": [
      "http://www.arberobotics.com/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Repayment of short-term loan",
        "label": "Repayments of Short-Term Debt",
        "documentation": "The cash outflow for a borrowing having initial term of repayment within one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r29"
     ]
    },
    "us-gaap_ResearchAndDevelopmentExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ResearchAndDevelopmentExpense",
     "crdr": "debit",
     "calculation": {
      "http://www.arberobotics.com/role/ConsolidatedIncomeStatement": {
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.arberobotics.com/role/ConsolidatedIncomeStatement"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Research and development, net",
        "label": "Research and Development Expense",
        "documentation": "The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use."
       }
      }
     },
     "auth_ref": [
      "r58",
      "r312",
      "r742"
     ]
    },
    "us-gaap_ResearchAndDevelopmentExpenseMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ResearchAndDevelopmentExpenseMember",
     "presentation": [
      "http://www.arberobotics.com/role/ScheduleofShareBasedCompensationExpenseTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Research and development [Member]",
        "label": "Research and Development Expense [Member]",
        "documentation": "Primary financial statement caption in which the reported facts about research and development expense have been included."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ResearchAndDevelopmentExpensePolicy": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ResearchAndDevelopmentExpensePolicy",
     "presentation": [
      "http://www.arberobotics.com/role/AccountingPoliciesByPolicy"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Research and development expenses, net",
        "label": "Research and Development Expense, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for costs it has incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process."
       }
      }
     },
     "auth_ref": [
      "r311"
     ]
    },
    "ecd_RestatementDateAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "RestatementDateAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restatement Determination Date [Axis]",
        "terseLabel": "Restatement Determination Date:"
       }
      }
     },
     "auth_ref": [
      "r562",
      "r574",
      "r590",
      "r618"
     ]
    },
    "ecd_RestatementDeterminationDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "RestatementDeterminationDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restatement Determination Date",
        "terseLabel": "Restatement Determination Date"
       }
      }
     },
     "auth_ref": [
      "r563",
      "r575",
      "r591",
      "r619"
     ]
    },
    "ecd_RestatementDoesNotRequireRecoveryTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "RestatementDoesNotRequireRecoveryTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restatement Does Not Require Recovery [Text Block]",
        "terseLabel": "Restatement does not require Recovery"
       }
      }
     },
     "auth_ref": [
      "r570",
      "r582",
      "r598",
      "r626"
     ]
    },
    "us-gaap_RestrictedCashCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RestrictedCashCurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.arberobotics.com/role/ConsolidatedBalanceSheet": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.arberobotics.com/role/ConsolidatedBalanceSheet"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Restricted cash",
        "label": "Restricted Cash, Current",
        "documentation": "Amount of cash restricted as to withdrawal or usage, classified as current. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits."
       }
      }
     },
     "auth_ref": [
      "r664",
      "r676"
     ]
    },
    "us-gaap_RestrictedStockUnitsRSUMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RestrictedStockUnitsRSUMember",
     "presentation": [
      "http://www.arberobotics.com/role/ScheduleofRSUsActivityTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "RSUs [Member]",
        "label": "Restricted Stock Units (RSUs) [Member]",
        "documentation": "Share instrument which is convertible to stock or an equivalent amount of cash, after a specified period of time or when specified performance conditions are met."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RetainedEarningsAccumulatedDeficit",
     "crdr": "credit",
     "calculation": {
      "http://www.arberobotics.com/role/ConsolidatedBalanceSheet": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.arberobotics.com/role/ConsolidatedBalanceSheet"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accumulated deficit",
        "label": "Retained Earnings (Accumulated Deficit)",
        "documentation": "Amount of accumulated undistributed earnings (deficit)."
       }
      }
     },
     "auth_ref": [
      "r66",
      "r89",
      "r381",
      "r400",
      "r401",
      "r409",
      "r435",
      "r530"
     ]
    },
    "us-gaap_RetainedEarningsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RetainedEarningsMember",
     "presentation": [
      "http://www.arberobotics.com/role/ShareholdersEquityType2or3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accumulated deficit",
        "label": "Retained Earnings [Member]",
        "documentation": "Accumulated undistributed earnings (deficit)."
       }
      }
     },
     "auth_ref": [
      "r134",
      "r165",
      "r166",
      "r167",
      "r169",
      "r175",
      "r177",
      "r223",
      "r224",
      "r303",
      "r304",
      "r305",
      "r326",
      "r327",
      "r340",
      "r342",
      "r343",
      "r345",
      "r348",
      "r397",
      "r399",
      "r411",
      "r746"
     ]
    },
    "arbe_RevaluationOfConvertibleLoan": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.arberobotics.com/20231231",
     "localname": "RevaluationOfConvertibleLoan",
     "crdr": "debit",
     "calculation": {
      "http://www.arberobotics.com/role/ConsolidatedCashFlow": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.arberobotics.com/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Revaluation of convertible loan",
        "documentation": "The cash inflow from the issuance of a long-term debt instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder.",
        "label": "Revaluation Of Convertible Loan"
       }
      }
     },
     "auth_ref": []
    },
    "arbe_RevenueByGeographyAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.arberobotics.com/20231231",
     "localname": "RevenueByGeographyAbstract",
     "presentation": [
      "http://www.arberobotics.com/role/ScheduleofRevenueDisaggregatedbyGeographyTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Revenue by geography:",
        "label": "Revenue By Geography Abstract"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RevenueFromContractWithCustomerIncludingAssessedTax",
     "crdr": "credit",
     "presentation": [
      "http://www.arberobotics.com/role/ScheduleofRevenueDisaggregatedbyGeographyTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Revenue",
        "label": "Revenue from Contract with Customer, Including Assessed Tax",
        "documentation": "Amount, including tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value-added and excise."
       }
      }
     },
     "auth_ref": [
      "r200",
      "r201",
      "r204",
      "r208",
      "r209",
      "r215",
      "r217",
      "r219",
      "r266",
      "r267",
      "r375"
     ]
    },
    "us-gaap_RevenueFromContractWithCustomerTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RevenueFromContractWithCustomerTextBlock",
     "presentation": [
      "http://www.arberobotics.com/role/Revenue"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "REVENUE",
        "label": "Revenue from Contract with Customer [Text Block]",
        "documentation": "The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts."
       }
      }
     },
     "auth_ref": [
      "r120",
      "r258",
      "r259",
      "r260",
      "r261",
      "r262",
      "r263",
      "r264",
      "r265",
      "r268"
     ]
    },
    "us-gaap_RevenueRecognitionPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RevenueRecognitionPolicyTextBlock",
     "presentation": [
      "http://www.arberobotics.com/role/AccountingPoliciesByPolicy"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Revenue recognition",
        "label": "Revenue [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for revenue. Includes revenue from contract with customer and from other sources."
       }
      }
     },
     "auth_ref": [
      "r456",
      "r509",
      "r513"
     ]
    },
    "us-gaap_RevenueRemainingPerformanceObligation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RevenueRemainingPerformanceObligation",
     "crdr": "credit",
     "presentation": [
      "http://www.arberobotics.com/role/RevenueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Remaining performance obligation",
        "label": "Revenue, Remaining Performance Obligation, Amount",
        "documentation": "Amount of transaction price allocated to performance obligation that has not been recognized as revenue."
       }
      }
     },
     "auth_ref": [
      "r115"
     ]
    },
    "us-gaap_RevenueRemainingPerformanceObligationPercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RevenueRemainingPerformanceObligationPercentage",
     "presentation": [
      "http://www.arberobotics.com/role/ScheduleofRevenueDisaggregatedbyGeographyTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "% of Revenue",
        "label": "Revenue, Remaining Performance Obligation, Percentage",
        "documentation": "Percentage of remaining performance obligation to total remaining performance obligation not recognized as revenue."
       }
      }
     },
     "auth_ref": [
      "r655"
     ]
    },
    "us-gaap_Revenues": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "Revenues",
     "crdr": "credit",
     "calculation": {
      "http://www.arberobotics.com/role/ConsolidatedIncomeStatement": {
       "parentTag": "us-gaap_GrossProfit",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.arberobotics.com/role/ConsolidatedIncomeStatement"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Revenues",
        "label": "Revenues",
        "documentation": "Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss)."
       }
      }
     },
     "auth_ref": [
      "r152",
      "r161",
      "r200",
      "r201",
      "r204",
      "r208",
      "r209",
      "r215",
      "r217",
      "r219",
      "r222",
      "r233",
      "r234",
      "r235",
      "r236",
      "r237",
      "r238",
      "r239",
      "r240",
      "r241",
      "r351",
      "r377",
      "r692"
     ]
    },
    "us-gaap_RevenuesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RevenuesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenue [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability",
     "crdr": "debit",
     "presentation": [
      "http://www.arberobotics.com/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Lease liabilities arising from obtaining right-of-use assets",
        "label": "Right-of-Use Asset Obtained in Exchange for Operating Lease Liability",
        "documentation": "Amount of increase in right-of-use asset obtained in exchange for operating lease liability."
       }
      }
     },
     "auth_ref": [
      "r366",
      "r529"
     ]
    },
    "arbe_RoyaltyPercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.arberobotics.com/20231231",
     "localname": "RoyaltyPercentage",
     "presentation": [
      "http://www.arberobotics.com/role/CommitmentsandContingentLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Royalty percentage",
        "documentation": "Percentage of sales that royalties are paid.",
        "label": "Royalty Percentage"
       }
      }
     },
     "auth_ref": []
    },
    "arbe_RsusAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.arberobotics.com/20231231",
     "localname": "RsusAbstract",
     "presentation": [
      "http://www.arberobotics.com/role/ScheduleofRSUsActivityTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "RSUs:",
        "label": "Rsus Abstract"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_Rule10b51ArrAdoptedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "Rule10b51ArrAdoptedFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 10b5-1 Arrangement Adopted [Flag]",
        "terseLabel": "Rule 10b5-1 Arrangement Adopted"
       }
      }
     },
     "auth_ref": [
      "r635"
     ]
    },
    "ecd_Rule10b51ArrTrmntdFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "Rule10b51ArrTrmntdFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 10b5-1 Arrangement Terminated [Flag]",
        "terseLabel": "Rule 10b5-1 Arrangement Terminated"
       }
      }
     },
     "auth_ref": [
      "r635"
     ]
    },
    "country_SE": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/country/2023",
     "localname": "SE",
     "presentation": [
      "http://www.arberobotics.com/role/ScheduleofRevenueDisaggregatedbyGeographyTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Sweden [Member]",
        "label": "SWEDEN"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SaleOfStockConsiderationReceivedOnTransaction": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SaleOfStockConsiderationReceivedOnTransaction",
     "crdr": "debit",
     "presentation": [
      "http://www.arberobotics.com/role/GeneralDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Transaction costs (in Dollars)",
        "label": "Sale of Stock, Consideration Received on Transaction",
        "documentation": "Cash received on stock transaction after deduction of issuance costs."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SaleOfStockNameOfTransactionDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SaleOfStockNameOfTransactionDomain",
     "presentation": [
      "http://www.arberobotics.com/role/GeneralDetails",
      "http://www.arberobotics.com/role/WarrantsLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Sale of Stock [Domain]",
        "documentation": "Sale of the entity's stock, including, but not limited to, initial public offering (IPO) and private placement."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SaleOfStockNumberOfSharesIssuedInTransaction",
     "presentation": [
      "http://www.arberobotics.com/role/GeneralDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Sale of ordinary shares",
        "label": "Sale of Stock, Number of Shares Issued in Transaction",
        "documentation": "The number of shares issued or sold by the subsidiary or equity method investee per stock transaction."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SalesRevenueNetMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SalesRevenueNetMember",
     "presentation": [
      "http://www.arberobotics.com/role/SegmentInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Revenue Benchmark [Member]",
        "label": "Revenue Benchmark [Member]",
        "documentation": "Revenue from sale of product and rendering of service and other sources of income, when it serves as benchmark in concentration of risk calculation."
       }
      }
     },
     "auth_ref": [
      "r219",
      "r656"
     ]
    },
    "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable",
     "presentation": [
      "http://www.arberobotics.com/role/ScheduleofOrdinarySharesthatwereExcludedfromtheComputationofDilutedNetLossPerShareTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]",
        "documentation": "Schedule for securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by Antidilutive Securities."
       }
      }
     },
     "auth_ref": [
      "r35"
     ]
    },
    "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
     "presentation": [
      "http://www.arberobotics.com/role/NetLossPerShareAttributibletoOrdinarySharholdersTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Ordinary Shares that were Excluded from the Computation of Diluted Net Loss Per Share",
        "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]",
        "documentation": "Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities."
       }
      }
     },
     "auth_ref": [
      "r35"
     ]
    },
    "arbe_ScheduleOfCompanysLossBeforeIncomeTaxesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.arberobotics.com/20231231",
     "localname": "ScheduleOfCompanysLossBeforeIncomeTaxesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Company\u2019s Loss Before Income Taxes [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "arbe_ScheduleOfCompensationToEmployeesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.arberobotics.com/20231231",
     "localname": "ScheduleOfCompensationToEmployeesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Compensation To Employees Abstract"
       }
      }
     },
     "auth_ref": []
    },
    "arbe_ScheduleOfDeferredTaxAssetsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.arberobotics.com/20231231",
     "localname": "ScheduleOfDeferredTaxAssetsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Deferred Tax Assets Abstract"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
     "presentation": [
      "http://www.arberobotics.com/role/TaxesonIncomeTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Deferred Tax Assets",
        "label": "Schedule of Deferred Tax Assets and Liabilities [Table Text Block]",
        "documentation": "Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets."
       }
      }
     },
     "auth_ref": [
      "r94"
     ]
    },
    "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
     "presentation": [
      "http://www.arberobotics.com/role/NetLossPerShareAttributibletoOrdinarySharholdersTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Sets Forth the Computation of Basic and Diluted Net Loss Per Share Attributable",
        "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]",
        "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations."
       }
      }
     },
     "auth_ref": [
      "r684"
     ]
    },
    "us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
     "presentation": [
      "http://www.arberobotics.com/role/TaxesonIncomeTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Reconciliation Income Tax Benefit",
        "label": "Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]",
        "documentation": "Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations."
       }
      }
     },
     "auth_ref": [
      "r93"
     ]
    },
    "us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
     "presentation": [
      "http://www.arberobotics.com/role/TaxesonIncomeTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Company\u2019s Loss Before Income Taxes",
        "label": "Schedule of Income before Income Tax, Domestic and Foreign [Table Text Block]",
        "documentation": "Tabular disclosure of income before income tax between domestic and foreign jurisdictions."
       }
      }
     },
     "auth_ref": [
      "r679"
     ]
    },
    "arbe_ScheduleOfMaturitiesOfLeaseLiabilitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.arberobotics.com/20231231",
     "localname": "ScheduleOfMaturitiesOfLeaseLiabilitiesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Maturities of Lease Liabilities [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "arbe_ScheduleOfOrdinarySharesThatWereExcludedFromTheComputationOfDilutedNetLossPerShareAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.arberobotics.com/20231231",
     "localname": "ScheduleOfOrdinarySharesThatWereExcludedFromTheComputationOfDilutedNetLossPerShareAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Ordinary Shares That Were Excluded From the Computation of Diluted Net Loss Per Share [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "arbe_ScheduleOfPrepaidExpensesAndOtherReceivablesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.arberobotics.com/20231231",
     "localname": "ScheduleOfPrepaidExpensesAndOtherReceivablesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Prepaid Expenses and Other Receivables [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "arbe_ScheduleOfPropertyAndEquipmentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.arberobotics.com/20231231",
     "localname": "ScheduleOfPropertyAndEquipmentAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Property And Equipment Abstract"
       }
      }
     },
     "auth_ref": []
    },
    "arbe_ScheduleOfPropertyAndEquipmentNetOfDepreciationByGeographicRegionAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.arberobotics.com/20231231",
     "localname": "ScheduleOfPropertyAndEquipmentNetOfDepreciationByGeographicRegionAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Property And Equipment Net Of Depreciation By Geographic Region Abstract"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfPropertyPlantAndEquipmentTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfPropertyPlantAndEquipmentTable",
     "presentation": [
      "http://www.arberobotics.com/role/ScheduleofPropertyandEquipmentTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Property, Plant and Equipment [Table]",
        "documentation": "Disclosure of information about physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation."
       }
      }
     },
     "auth_ref": [
      "r7"
     ]
    },
    "arbe_ScheduleOfReconciliationIncomeTaxBenefitAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.arberobotics.com/20231231",
     "localname": "ScheduleOfReconciliationIncomeTaxBenefitAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Reconciliation Income Tax Benefit [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "arbe_ScheduleOfRevenueDisaggregatedByGeographyAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.arberobotics.com/20231231",
     "localname": "ScheduleOfRevenueDisaggregatedByGeographyAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Revenue Disaggregated By Geography Abstract"
       }
      }
     },
     "auth_ref": []
    },
    "arbe_ScheduleOfRsusActivityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.arberobotics.com/20231231",
     "localname": "ScheduleOfRsusActivityAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Rsus Activity Abstract"
       }
      }
     },
     "auth_ref": []
    },
    "arbe_ScheduleOfSetsForthTheComputationOfBasicAndDilutedNetLossPerShareAttributableAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.arberobotics.com/20231231",
     "localname": "ScheduleOfSetsForthTheComputationOfBasicAndDilutedNetLossPerShareAttributableAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Sets Forth The Computation Of Basic And Diluted Net Loss Per Share Attributable Abstract"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfShareBasedCompensationActivityTableTextBlock",
     "presentation": [
      "http://www.arberobotics.com/role/ShareholdersEquityTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Share Based Compensation Expense",
        "label": "Share-Based Payment Arrangement, Activity [Table Text Block]",
        "documentation": "Tabular disclosure of activity for award under share-based payment arrangement. Includes, but is not limited to, outstanding award at beginning and end of year, granted, exercised, forfeited, and weighted-average grant date fair value."
       }
      }
     },
     "auth_ref": [
      "r15",
      "r16",
      "r51"
     ]
    },
    "arbe_ScheduleOfShareBasedCompensationExpenseAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.arberobotics.com/20231231",
     "localname": "ScheduleOfShareBasedCompensationExpenseAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Share Based Compensation Expense Abstract"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock",
     "presentation": [
      "http://www.arberobotics.com/role/ShareholdersEquityTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of RSUs Activity",
        "label": "Share-Based Payment Arrangement, Restricted Stock Unit, Activity [Table Text Block]",
        "documentation": "Tabular disclosure of the number and weighted-average grant date fair value for restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock units that were granted, vested, or forfeited during the year."
       }
      }
     },
     "auth_ref": [
      "r50"
     ]
    },
    "us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
     "presentation": [
      "http://www.arberobotics.com/role/ShareholdersEquityTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Stock Option Activity",
        "label": "Share-Based Payment Arrangement, Option, Activity [Table Text Block]",
        "documentation": "Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value."
       }
      }
     },
     "auth_ref": [
      "r15",
      "r16",
      "r50"
     ]
    },
    "us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
     "presentation": [
      "http://www.arberobotics.com/role/ShareholdersEquityTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Compensation to Employees",
        "label": "Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]",
        "documentation": "Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions."
       }
      }
     },
     "auth_ref": [
      "r92"
     ]
    },
    "arbe_ScheduleOfStockOptionActivityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.arberobotics.com/20231231",
     "localname": "ScheduleOfStockOptionActivityAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Stock Option Activity Abstract"
       }
      }
     },
     "auth_ref": []
    },
    "arbe_ScheduleOfSupplementalBalanceSheetInformationRelatedToOperatingLeasesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.arberobotics.com/20231231",
     "localname": "ScheduleOfSupplementalBalanceSheetInformationRelatedToOperatingLeasesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Supplemental Balance Sheet Information Related to Operating Leases [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "arbe_ScheduleOfSupplementalCashFlowInformationRelatedToLeasesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.arberobotics.com/20231231",
     "localname": "ScheduleOfSupplementalCashFlowInformationRelatedToLeasesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Supplemental Cash Flow Information Related to Leases [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "arbe_ScheduleOfTheStraightLineMethodOverTheEstimatedUsefulLivesOfTheAssetsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.arberobotics.com/20231231",
     "localname": "ScheduleOfTheStraightLineMethodOverTheEstimatedUsefulLivesOfTheAssetsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of The Straight Line Method Over The Estimated Useful Lives Of The Assets Abstract"
       }
      }
     },
     "auth_ref": []
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "Security12bTitle",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r546"
     ]
    },
    "dei_Security12gTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "Security12gTitle",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(g) Security",
        "documentation": "Title of a 12(g) registered security."
       }
      }
     },
     "auth_ref": [
      "r550"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r549"
     ]
    },
    "dei_SecurityReportingObligation": {
     "xbrltype": "securityReportingObligationItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "SecurityReportingObligation",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Reporting Obligation",
        "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r554"
     ]
    },
    "arbe_SeedMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.arberobotics.com/20231231",
     "localname": "SeedMember",
     "presentation": [
      "http://www.arberobotics.com/role/ShareholdersEquityType2or3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Seed",
        "label": "Seed Member"
       }
      }
     },
     "auth_ref": []
    },
    "srt_SegmentGeographicalDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "SegmentGeographicalDomain",
     "presentation": [
      "http://www.arberobotics.com/role/ScheduleofPropertyandEquipmentNetofDepreciationbyGeographicRegionTable",
      "http://www.arberobotics.com/role/ScheduleofRevenueDisaggregatedbyGeographyTable",
      "http://www.arberobotics.com/role/TaxesonIncomeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Geographical [Domain]",
        "documentation": "Geographical area."
       }
      }
     },
     "auth_ref": [
      "r123",
      "r125",
      "r126",
      "r127",
      "r128",
      "r129",
      "r130",
      "r131",
      "r132",
      "r217",
      "r218",
      "r423",
      "r424",
      "r425",
      "r479",
      "r481",
      "r484",
      "r486",
      "r496",
      "r497",
      "r498",
      "r499",
      "r500",
      "r501",
      "r502",
      "r503",
      "r504",
      "r511",
      "r519",
      "r535",
      "r698",
      "r743"
     ]
    },
    "arbe_SegmentInformationDetailsScheduleofPropertyandEquipmentNetofDepreciationbyGeographicRegionLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.arberobotics.com/20231231",
     "localname": "SegmentInformationDetailsScheduleofPropertyandEquipmentNetofDepreciationbyGeographicRegionLineItems",
     "presentation": [
      "http://www.arberobotics.com/role/ScheduleofPropertyandEquipmentNetofDepreciationbyGeographicRegionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Segment Information (Details) - Schedule of Property and Equipment, Net of Depreciation, by Geographic Region [Line Items]"
       }
      }
     },
     "auth_ref": []
    },
    "arbe_SegmentInformationDetailsScheduleofPropertyandEquipmentNetofDepreciationbyGeographicRegionTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.arberobotics.com/20231231",
     "localname": "SegmentInformationDetailsScheduleofPropertyandEquipmentNetofDepreciationbyGeographicRegionTable",
     "presentation": [
      "http://www.arberobotics.com/role/ScheduleofPropertyandEquipmentNetofDepreciationbyGeographicRegionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Segment Information (Details) - Schedule of Property and Equipment, Net of Depreciation, by Geographic Region [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "arbe_SegmentInformationDetailsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.arberobotics.com/20231231",
     "localname": "SegmentInformationDetailsTable",
     "presentation": [
      "http://www.arberobotics.com/role/SegmentInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Segment Information (Details) [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SegmentReportingDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SegmentReportingDisclosureTextBlock",
     "presentation": [
      "http://www.arberobotics.com/role/SegmentInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "SEGMENT INFORMATION",
        "label": "Segment Reporting Disclosure [Text Block]",
        "documentation": "The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments."
       }
      }
     },
     "auth_ref": [
      "r195",
      "r196",
      "r197",
      "r198",
      "r199",
      "r203",
      "r207",
      "r211",
      "r212",
      "r213",
      "r214",
      "r215",
      "r216",
      "r219"
     ]
    },
    "us-gaap_SegmentReportingInformationLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SegmentReportingInformationLineItems",
     "presentation": [
      "http://www.arberobotics.com/role/SegmentInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Segment Information [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SegmentReportingInformationRevenueAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SegmentReportingInformationRevenueAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Segment Information [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SellingAndMarketingExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SellingAndMarketingExpense",
     "crdr": "debit",
     "calculation": {
      "http://www.arberobotics.com/role/ConsolidatedIncomeStatement": {
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.arberobotics.com/role/ConsolidatedIncomeStatement"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Sales and marketing",
        "label": "Selling and Marketing Expense",
        "documentation": "The aggregate total amount of expenses directly related to the marketing or selling of products or services."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SellingAndMarketingExpenseMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SellingAndMarketingExpenseMember",
     "presentation": [
      "http://www.arberobotics.com/role/ScheduleofShareBasedCompensationExpenseTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Sales and marketing [Member]",
        "label": "Selling and Marketing Expense [Member]",
        "documentation": "Primary financial statement caption encompassing selling and marketing expense."
       }
      }
     },
     "auth_ref": [
      "r72"
     ]
    },
    "arbe_SeriesA1PreferredStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.arberobotics.com/20231231",
     "localname": "SeriesA1PreferredStockMember",
     "presentation": [
      "http://www.arberobotics.com/role/ShareholdersEquityType2or3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Series A-1",
        "label": "Series A1 Preferred Stock Member"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SeriesAPreferredStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SeriesAPreferredStockMember",
     "presentation": [
      "http://www.arberobotics.com/role/ShareholdersEquityType2or3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Series A",
        "label": "Series A Preferred Stock [Member]",
        "documentation": "Series A preferred stock."
       }
      }
     },
     "auth_ref": [
      "r669",
      "r670",
      "r697"
     ]
    },
    "arbe_SeriesB1PreferredStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.arberobotics.com/20231231",
     "localname": "SeriesB1PreferredStockMember",
     "presentation": [
      "http://www.arberobotics.com/role/ShareholdersEquityType2or3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Series B-1",
        "label": "Series B1 Preferred Stock Member"
       }
      }
     },
     "auth_ref": []
    },
    "arbe_SeriesB2PreferredStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.arberobotics.com/20231231",
     "localname": "SeriesB2PreferredStockMember",
     "presentation": [
      "http://www.arberobotics.com/role/ShareholdersEquityType2or3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Series B-2",
        "label": "Series B2 Preferred Stock Member"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SeriesBPreferredStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SeriesBPreferredStockMember",
     "presentation": [
      "http://www.arberobotics.com/role/ShareholdersEquityType2or3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Series B",
        "label": "Series B Preferred Stock [Member]",
        "documentation": "Series B preferred stock."
       }
      }
     },
     "auth_ref": [
      "r669",
      "r670",
      "r697"
     ]
    },
    "us-gaap_SeveranceCosts1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SeveranceCosts1",
     "crdr": "debit",
     "presentation": [
      "http://www.arberobotics.com/role/SignificantAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Severance Costs (in Dollars)",
        "label": "Severance Costs",
        "documentation": "Amount of expenses for special or contractual termination benefits provided to current employees involuntarily terminated under a benefit arrangement associated exit or disposal activities pursuant to an authorized plan. Excludes expenses related to one-time termination benefits, a discontinued operation or an asset retirement obligation."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "arbe_SeverancePercentageOfMonthlySalary": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.arberobotics.com/20231231",
     "localname": "SeverancePercentageOfMonthlySalary",
     "presentation": [
      "http://www.arberobotics.com/role/SignificantAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Deposits rate",
        "documentation": "Percentage of monthly salary monthly severance rate.",
        "label": "Severance Percentage Of Monthly Salary"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensation",
     "crdr": "debit",
     "calculation": {
      "http://www.arberobotics.com/role/ConsolidatedCashFlow": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.arberobotics.com/role/ConsolidatedCashFlow",
      "http://www.arberobotics.com/role/ScheduleofShareBasedCompensationExpenseTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock-based compensation",
        "verboseLabel": "Total stock-based compensation expense",
        "label": "Share-Based Payment Arrangement, Noncash Expense",
        "documentation": "Amount of noncash expense for share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1",
     "presentation": [
      "http://www.arberobotics.com/role/ShareholdersEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Options vested period",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period",
        "documentation": "Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition."
       }
      }
     },
     "auth_ref": [
      "r526"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRights": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRights",
     "presentation": [
      "http://www.arberobotics.com/role/ShareholdersEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Vesting period, description",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Rights",
        "documentation": "Description of service or performance condition required to be met for earning right to award under share-based payment arrangement. Includes, but is not limited to, combination of market, performance or service condition."
       }
      }
     },
     "auth_ref": [
      "r49"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate",
     "presentation": [
      "http://www.arberobotics.com/role/ScheduleofCompensationtoEmployeesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Expected dividend yield",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate",
        "documentation": "The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term."
       }
      }
     },
     "auth_ref": [
      "r299"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate",
     "presentation": [
      "http://www.arberobotics.com/role/ScheduleofCompensationtoEmployeesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Expected volatility",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate",
        "documentation": "The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period."
       }
      }
     },
     "auth_ref": [
      "r298"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate",
     "presentation": [
      "http://www.arberobotics.com/role/ScheduleofCompensationtoEmployeesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Risk-free interest rate",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate",
        "documentation": "The risk-free interest rate assumption that is used in valuing an option on its own shares."
       }
      }
     },
     "auth_ref": [
      "r300"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate",
     "presentation": [
      "http://www.arberobotics.com/role/WarrantsLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Volatility impact rate",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Weighted Average Volatility Rate",
        "documentation": "Rate of weighted-average expected volatility for award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r298"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised",
     "presentation": [
      "http://www.arberobotics.com/role/ScheduleofStockOptionActivityTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Exercised, Outstanding share options",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Exercised",
        "documentation": "Number of non-option equity instruments exercised by participants."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures",
     "presentation": [
      "http://www.arberobotics.com/role/ScheduleofRSUsActivityTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Forfeited, Numbers of RSUs",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Forfeitures",
        "documentation": "Number of shares under non-option equity instrument agreements that were cancelled as a result of occurrence of a terminating event."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted",
     "presentation": [
      "http://www.arberobotics.com/role/ScheduleofRSUsActivityTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Granted, Numbers of RSUs",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Granted",
        "documentation": "Net number of non-option equity instruments granted to participants."
       }
      }
     },
     "auth_ref": [
      "r12"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber",
     "presentation": [
      "http://www.arberobotics.com/role/ScheduleofRSUsActivityTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Outstanding, Numbers of RSUs, beginning balance",
        "periodEndLabel": "Outstanding, Numbers of RSUs, ending balance",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Outstanding, Number",
        "documentation": "Number of equity instruments other than options outstanding, including both vested and non-vested instruments."
       }
      }
     },
     "auth_ref": [
      "r10",
      "r11"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsPeriodIncreaseDecrease": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsPeriodIncreaseDecrease",
     "presentation": [
      "http://www.arberobotics.com/role/ScheduleofRSUsActivityTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Vested, Numbers of RSUs",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Period Increase (Decrease)",
        "documentation": "Increase (decrease) in the number of shares under non-option equity instrument agreements."
       }
      }
     },
     "auth_ref": [
      "r50"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized",
     "presentation": [
      "http://www.arberobotics.com/role/ShareholdersEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Ordinary shares were reserved for issuance (in Shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Authorized",
        "documentation": "Number of shares authorized for issuance under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r528"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant",
     "presentation": [
      "http://www.arberobotics.com/role/ScheduleofStockOptionActivityTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Options available for future grants, Outstanding share options",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Available for Grant",
        "documentation": "The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable."
       }
      }
     },
     "auth_ref": [
      "r47"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber",
     "presentation": [
      "http://www.arberobotics.com/role/ScheduleofStockOptionActivityTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Exercisable, Outstanding share options",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number",
        "documentation": "The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan."
       }
      }
     },
     "auth_ref": [
      "r279"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice",
     "presentation": [
      "http://www.arberobotics.com/role/ScheduleofStockOptionActivityTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Exercisable, Weighted-average exercise price (in Dollars per share)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price",
        "documentation": "The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan."
       }
      }
     },
     "auth_ref": [
      "r279"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod",
     "presentation": [
      "http://www.arberobotics.com/role/ScheduleofStockOptionActivityTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Forfeited, Outstanding share options",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures and Expirations in Period",
        "documentation": "For presentations that combine terminations, the number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan or that expired."
       }
      }
     },
     "auth_ref": [
      "r705"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross",
     "presentation": [
      "http://www.arberobotics.com/role/ScheduleofStockOptionActivityTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Granted, Outstanding share options",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross",
        "documentation": "Gross number of share options (or share units) granted during the period."
       }
      }
     },
     "auth_ref": [
      "r281"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue",
     "crdr": "debit",
     "presentation": [
      "http://www.arberobotics.com/role/ScheduleofStockOptionActivityTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodEndLabel": "Aggregate intrinsic value ending balance (in Dollars)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value",
        "documentation": "Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding."
       }
      }
     },
     "auth_ref": [
      "r47"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
     "presentation": [
      "http://www.arberobotics.com/role/ScheduleofStockOptionActivityTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodEndLabel": "Outstanding share options ending balance",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number",
        "documentation": "Number of options outstanding, including both vested and non-vested options."
       }
      }
     },
     "auth_ref": [
      "r277",
      "r278"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice",
     "presentation": [
      "http://www.arberobotics.com/role/ScheduleofStockOptionActivityTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodEndLabel": "Weighted-average exercise price ending balance (in Dollars per share)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price",
        "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan."
       }
      }
     },
     "auth_ref": [
      "r277",
      "r278"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardTermsOfAward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardTermsOfAward",
     "presentation": [
      "http://www.arberobotics.com/role/ShareholdersEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Share option , description",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Terms of Award",
        "documentation": "Description of terms of award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r48"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "All Award Types",
        "terseLabel": "All Award Types",
        "documentation": "Award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r273",
      "r274",
      "r275",
      "r277",
      "r278",
      "r279",
      "r280",
      "r281",
      "r282",
      "r283",
      "r284",
      "r285",
      "r286",
      "r287",
      "r288",
      "r289",
      "r290",
      "r291",
      "r292",
      "r293",
      "r294",
      "r297",
      "r298",
      "r299",
      "r300",
      "r301"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice",
     "presentation": [
      "http://www.arberobotics.com/role/ScheduleofStockOptionActivityTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Exercised, Weighted-average exercise price (in Dollars per share)",
        "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price",
        "documentation": "Weighted average price at which option holders acquired shares when converting their stock options into shares."
       }
      }
     },
     "auth_ref": [
      "r282"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice",
     "presentation": [
      "http://www.arberobotics.com/role/ScheduleofStockOptionActivityTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Forfeited, Weighted-average exercise price (in Dollars per share)",
        "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price",
        "documentation": "Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated."
       }
      }
     },
     "auth_ref": [
      "r283"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice",
     "presentation": [
      "http://www.arberobotics.com/role/ScheduleofStockOptionActivityTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Granted, Weighted-average exercise price (in Dollars per share)",
        "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price",
        "documentation": "Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options."
       }
      }
     },
     "auth_ref": [
      "r281"
     ]
    },
    "us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationOptionAndIncentivePlansPolicy",
     "presentation": [
      "http://www.arberobotics.com/role/AccountingPoliciesByPolicy"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock-based compensation",
        "label": "Share-Based Payment Arrangement [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost."
       }
      }
     },
     "auth_ref": [
      "r272",
      "r276",
      "r295",
      "r296",
      "r297",
      "r298",
      "r301",
      "r306",
      "r307",
      "r308",
      "r309"
     ]
    },
    "us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodExpectedDividendRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodExpectedDividendRate",
     "presentation": [
      "http://www.arberobotics.com/role/ShareholdersEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Expected dividend yield",
        "label": "Share-Based Goods and Nonemployee Services Transaction, Valuation Method, Expected Dividend Rate",
        "documentation": "The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the expected term of a nonvested share or option award issued to other than an employee."
       }
      }
     },
     "auth_ref": [
      "r106"
     ]
    },
    "us-gaap_SharePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SharePrice",
     "presentation": [
      "http://www.arberobotics.com/role/ShareholdersEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Share Price (in Dollars per share)",
        "label": "Share Price",
        "documentation": "Price of a single share of a number of saleable stocks of a company."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod",
     "presentation": [
      "http://www.arberobotics.com/role/ShareholdersEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Plan expiration period",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Expiration Period",
        "documentation": "Period from grant date that an equity-based award expires, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r527"
     ]
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1",
     "presentation": [
      "http://www.arberobotics.com/role/ScheduleofCompensationtoEmployeesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Expected term, in years",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term",
        "documentation": "Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r297"
     ]
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1",
     "crdr": "debit",
     "presentation": [
      "http://www.arberobotics.com/role/ScheduleofStockOptionActivityTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Exercisable, Aggregate intrinsic value (in Dollars)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Intrinsic Value",
        "documentation": "Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable."
       }
      }
     },
     "auth_ref": [
      "r47"
     ]
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1",
     "presentation": [
      "http://www.arberobotics.com/role/ScheduleofStockOptionActivityTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Exercisable, Weighted average remaining contractual life (years)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term",
        "documentation": "Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r47"
     ]
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2",
     "presentation": [
      "http://www.arberobotics.com/role/ScheduleofStockOptionActivityTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted average remaining contractual life (years), ending balance",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term",
        "documentation": "Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r91"
     ]
    },
    "arbe_ShareholdersEquityDetailsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.arberobotics.com/20231231",
     "localname": "ShareholdersEquityDetailsLineItems",
     "presentation": [
      "http://www.arberobotics.com/role/ShareholdersEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Shareholders\u2019 Equity [Line Items]"
       }
      }
     },
     "auth_ref": []
    },
    "arbe_ShareholdersEquityDetailsScheduleofCompensationtoEmployeesLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.arberobotics.com/20231231",
     "localname": "ShareholdersEquityDetailsScheduleofCompensationtoEmployeesLineItems",
     "presentation": [
      "http://www.arberobotics.com/role/ScheduleofCompensationtoEmployeesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Compensation to Employees [Line Items]"
       }
      }
     },
     "auth_ref": []
    },
    "arbe_ShareholdersEquityDetailsScheduleofCompensationtoEmployeesTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.arberobotics.com/20231231",
     "localname": "ShareholdersEquityDetailsScheduleofCompensationtoEmployeesTable",
     "presentation": [
      "http://www.arberobotics.com/role/ScheduleofCompensationtoEmployeesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Shareholders\u2019 Equity (Details) - Schedule of Compensation to Employees [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "arbe_ShareholdersEquityDetailsScheduleofRSUsActivityLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.arberobotics.com/20231231",
     "localname": "ShareholdersEquityDetailsScheduleofRSUsActivityLineItems",
     "presentation": [
      "http://www.arberobotics.com/role/ScheduleofRSUsActivityTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Shareholders\u2019 Equity (Details) - Schedule of RSUs Activity [Line Items]"
       }
      }
     },
     "auth_ref": []
    },
    "arbe_ShareholdersEquityDetailsScheduleofRSUsActivityTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.arberobotics.com/20231231",
     "localname": "ShareholdersEquityDetailsScheduleofRSUsActivityTable",
     "presentation": [
      "http://www.arberobotics.com/role/ScheduleofRSUsActivityTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Shareholders\u2019 Equity (Details) - Schedule of RSUs Activity [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "arbe_ShareholdersEquityDetailsScheduleofShareBasedCompensationExpenseLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.arberobotics.com/20231231",
     "localname": "ShareholdersEquityDetailsScheduleofShareBasedCompensationExpenseLineItems",
     "presentation": [
      "http://www.arberobotics.com/role/ScheduleofShareBasedCompensationExpenseTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Share Based Compensation Expense [Line Items]"
       }
      }
     },
     "auth_ref": []
    },
    "arbe_ShareholdersEquityDetailsScheduleofShareBasedCompensationExpenseTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.arberobotics.com/20231231",
     "localname": "ShareholdersEquityDetailsScheduleofShareBasedCompensationExpenseTable",
     "presentation": [
      "http://www.arberobotics.com/role/ScheduleofShareBasedCompensationExpenseTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Shareholders\u2019 Equity (Details) - Schedule of Share Based Compensation Expense [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "arbe_ShareholdersEquityDetailsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.arberobotics.com/20231231",
     "localname": "ShareholdersEquityDetailsTable",
     "presentation": [
      "http://www.arberobotics.com/role/ShareholdersEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Shareholders\u2019 Equity (Details) [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SharesIssuedPricePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SharesIssuedPricePerShare",
     "presentation": [
      "http://www.arberobotics.com/role/GeneralDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Ordinary shares par value",
        "label": "Shares Issued, Price Per Share",
        "documentation": "Per share or per unit amount of equity securities issued."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SharesOutstanding",
     "presentation": [
      "http://www.arberobotics.com/role/ShareholdersEquityType2or3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Balance (in Shares)",
        "periodEndLabel": "Balance (in Shares)",
        "label": "Shares, Outstanding",
        "documentation": "Number of shares issued which are neither cancelled nor held in the treasury."
       }
      }
     },
     "auth_ref": []
    },
    "arbe_ShortTermDepositsPolicyPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.arberobotics.com/20231231",
     "localname": "ShortTermDepositsPolicyPolicyTextBlock",
     "presentation": [
      "http://www.arberobotics.com/role/AccountingPoliciesByPolicy"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Short term deposits",
        "documentation": "Policy disclosure of short term deposits.",
        "label": "Short Term Deposits Policy Policy Text Block"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShortTermInvestments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShortTermInvestments",
     "crdr": "debit",
     "calculation": {
      "http://www.arberobotics.com/role/ConsolidatedBalanceSheet": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.arberobotics.com/role/ConsolidatedBalanceSheet"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Short term bank deposits",
        "label": "Short-Term Investments",
        "documentation": "Amount of investments including trading securities, available-for-sale securities, held-to-maturity securities, and short-term investments classified as other and current."
       }
      }
     },
     "auth_ref": [
      "r102",
      "r103",
      "r672"
     ]
    },
    "arbe_SignificantAccountingPoliciesDetailsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.arberobotics.com/20231231",
     "localname": "SignificantAccountingPoliciesDetailsLineItems",
     "presentation": [
      "http://www.arberobotics.com/role/SignificantAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Significant Accounting Policies (Details) [Line Items]"
       }
      }
     },
     "auth_ref": []
    },
    "arbe_SignificantAccountingPoliciesDetailsScheduleoftheStraightLineMethodOvertheEstimatedUsefulLivesoftheAssetsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.arberobotics.com/20231231",
     "localname": "SignificantAccountingPoliciesDetailsScheduleoftheStraightLineMethodOvertheEstimatedUsefulLivesoftheAssetsLineItems",
     "presentation": [
      "http://www.arberobotics.com/role/ScheduleoftheStraightLineMethodOvertheEstimatedUsefulLivesoftheAssetsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Significant Accounting Policies (Details) - Schedule of the Straight-Line Method Over the Estimated Useful Lives of the Assets [Line Items]"
       }
      }
     },
     "auth_ref": []
    },
    "arbe_SignificantAccountingPoliciesDetailsScheduleoftheStraightLineMethodOvertheEstimatedUsefulLivesoftheAssetsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.arberobotics.com/20231231",
     "localname": "SignificantAccountingPoliciesDetailsScheduleoftheStraightLineMethodOvertheEstimatedUsefulLivesoftheAssetsTable",
     "presentation": [
      "http://www.arberobotics.com/role/ScheduleoftheStraightLineMethodOvertheEstimatedUsefulLivesoftheAssetsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Significant Accounting Policies (Details) - Schedule of the Straight-Line Method Over the Estimated Useful Lives of the Assets [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "arbe_SignificantAccountingPoliciesDetailsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.arberobotics.com/20231231",
     "localname": "SignificantAccountingPoliciesDetailsTable",
     "presentation": [
      "http://www.arberobotics.com/role/SignificantAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Significant Accounting Policies (Details) [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SignificantAccountingPoliciesTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SignificantAccountingPoliciesTextBlock",
     "presentation": [
      "http://www.arberobotics.com/role/SignificantAccountingPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "SIGNIFICANT ACCOUNTING POLICIES",
        "label": "Significant Accounting Policies [Text Block]",
        "documentation": "The entire disclosure for all significant accounting policies of the reporting entity."
       }
      }
     },
     "auth_ref": [
      "r82",
      "r159"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r555"
     ]
    },
    "us-gaap_StatementClassOfStockAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StatementClassOfStockAxis",
     "presentation": [
      "http://www.arberobotics.com/role/GeneralDetails",
      "http://www.arberobotics.com/role/ShareholdersEquityType2or3",
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Stock [Axis]",
        "documentation": "Information by the different classes of stock of the entity."
       }
      }
     },
     "auth_ref": [
      "r121",
      "r142",
      "r143",
      "r144",
      "r161",
      "r181",
      "r182",
      "r184",
      "r186",
      "r193",
      "r194",
      "r222",
      "r233",
      "r235",
      "r236",
      "r237",
      "r240",
      "r241",
      "r244",
      "r245",
      "r247",
      "r250",
      "r256",
      "r351",
      "r405",
      "r406",
      "r407",
      "r408",
      "r411",
      "r412",
      "r413",
      "r414",
      "r415",
      "r416",
      "r417",
      "r418",
      "r419",
      "r420",
      "r421",
      "r422",
      "r434",
      "r455",
      "r473",
      "r487",
      "r488",
      "r489",
      "r490",
      "r491",
      "r654",
      "r677",
      "r683"
     ]
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StatementEquityComponentsAxis",
     "presentation": [
      "http://www.arberobotics.com/role/ShareholdersEquityDetails",
      "http://www.arberobotics.com/role/ShareholdersEquityType2or3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Components [Axis]",
        "documentation": "Information by component of equity."
       }
      }
     },
     "auth_ref": [
      "r9",
      "r26",
      "r134",
      "r149",
      "r150",
      "r151",
      "r165",
      "r166",
      "r167",
      "r169",
      "r175",
      "r177",
      "r192",
      "r223",
      "r224",
      "r257",
      "r303",
      "r304",
      "r305",
      "r326",
      "r327",
      "r340",
      "r341",
      "r342",
      "r343",
      "r344",
      "r345",
      "r348",
      "r354",
      "r355",
      "r356",
      "r357",
      "r358",
      "r359",
      "r371",
      "r397",
      "r398",
      "r399",
      "r411",
      "r473"
     ]
    },
    "srt_StatementGeographicalAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "StatementGeographicalAxis",
     "presentation": [
      "http://www.arberobotics.com/role/ScheduleofPropertyandEquipmentNetofDepreciationbyGeographicRegionTable",
      "http://www.arberobotics.com/role/ScheduleofRevenueDisaggregatedbyGeographyTable",
      "http://www.arberobotics.com/role/TaxesonIncomeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Geographical [Axis]",
        "documentation": "Information by geographical components."
       }
      }
     },
     "auth_ref": [
      "r123",
      "r133",
      "r217",
      "r218",
      "r423",
      "r424",
      "r425",
      "r479",
      "r481",
      "r484",
      "r486",
      "r493",
      "r496",
      "r497",
      "r498",
      "r499",
      "r500",
      "r501",
      "r502",
      "r503",
      "r504",
      "r511",
      "r519",
      "r535",
      "r698",
      "r743"
     ]
    },
    "us-gaap_StatementLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StatementLineItems",
     "presentation": [
      "http://www.arberobotics.com/role/ShareholdersEquityType2or3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r165",
      "r166",
      "r167",
      "r192",
      "r375",
      "r403",
      "r422",
      "r428",
      "r429",
      "r430",
      "r431",
      "r432",
      "r433",
      "r434",
      "r437",
      "r438",
      "r439",
      "r440",
      "r441",
      "r442",
      "r443",
      "r444",
      "r445",
      "r447",
      "r448",
      "r449",
      "r450",
      "r451",
      "r453",
      "r456",
      "r457",
      "r459",
      "r460",
      "r461",
      "r462",
      "r463",
      "r464",
      "r465",
      "r466",
      "r467",
      "r468",
      "r469",
      "r470",
      "r473",
      "r536"
     ]
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StatementOfCashFlowsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Cash Flows [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StatementOfFinancialPositionAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Financial Position [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StatementOfStockholdersEquityAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Stockholders' Equity [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StatementTable",
     "presentation": [
      "http://www.arberobotics.com/role/ShareholdersEquityType2or3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement [Table]",
        "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed."
       }
      }
     },
     "auth_ref": [
      "r165",
      "r166",
      "r167",
      "r192",
      "r375",
      "r403",
      "r422",
      "r428",
      "r429",
      "r430",
      "r431",
      "r432",
      "r433",
      "r434",
      "r437",
      "r438",
      "r439",
      "r440",
      "r441",
      "r442",
      "r443",
      "r444",
      "r445",
      "r447",
      "r448",
      "r449",
      "r450",
      "r451",
      "r453",
      "r456",
      "r457",
      "r459",
      "r460",
      "r461",
      "r462",
      "r463",
      "r464",
      "r465",
      "r466",
      "r467",
      "r468",
      "r469",
      "r470",
      "r473",
      "r536"
     ]
    },
    "ecd_StkPrcOrTsrEstimationMethodTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "StkPrcOrTsrEstimationMethodTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock Price or TSR Estimation Method [Text Block]",
        "terseLabel": "Stock Price or TSR Estimation Method"
       }
      }
     },
     "auth_ref": [
      "r565",
      "r577",
      "r593",
      "r621"
     ]
    },
    "us-gaap_StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants",
     "crdr": "credit",
     "presentation": [
      "http://www.arberobotics.com/role/ShareholdersEquityType2or3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Exercise of warrants",
        "label": "Stock and Warrants Issued During Period, Value, Preferred Stock and Warrants",
        "documentation": "Value of preferred stock and warrants for common stock issued."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockAppreciationRightsSARSMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockAppreciationRightsSARSMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock Appreciation Rights (SARs) [Member]",
        "terseLabel": "Stock Appreciation Rights (SARs)",
        "documentation": "Right to receive cash or shares equal to appreciation of predetermined number of grantor's shares during predetermined time period."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockIssued1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockIssued1",
     "crdr": "credit",
     "presentation": [
      "http://www.arberobotics.com/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Issuance of private warrants",
        "label": "Stock Issued",
        "documentation": "The fair value of stock issued in noncash financing activities."
       }
      }
     },
     "auth_ref": [
      "r32",
      "r33",
      "r34"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities",
     "presentation": [
      "http://www.arberobotics.com/role/ShareholdersEquityType2or3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Conversion of preferred shares into ordinary shares (in Shares)",
        "label": "Stock Issued During Period, Shares, Conversion of Convertible Securities",
        "documentation": "Number of shares issued during the period as a result of the conversion of convertible securities."
       }
      }
     },
     "auth_ref": [
      "r9",
      "r25",
      "r46",
      "r89",
      "r242"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockIssuedDuringPeriodSharesConversionOfUnits",
     "presentation": [
      "http://www.arberobotics.com/role/ShareholdersEquityType2or3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Conversion of convertible loan to ordinary shares (in Shares)",
        "label": "Stock Issued During Period, Shares, Conversion of Units",
        "documentation": "The number of shares issued during the period upon the conversion of units. An example of a convertible unit is an umbrella partnership real estate investment trust unit (UPREIT unit)."
       }
      }
     },
     "auth_ref": [
      "r9",
      "r46",
      "r63",
      "r64",
      "r89"
     ]
    },
    "arbe_StockIssuedDuringPeriodSharesExerciseOfWarrants": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.arberobotics.com/20231231",
     "localname": "StockIssuedDuringPeriodSharesExerciseOfWarrants",
     "presentation": [
      "http://www.arberobotics.com/role/ShareholdersEquityType2or3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Exercise of warrants (in Shares)",
        "documentation": "The represent the shares of exercise of warrants.",
        "label": "Stock Issued During Period Shares Exercise Of Warrants"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockIssuedDuringPeriodSharesNewIssues": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockIssuedDuringPeriodSharesNewIssues",
     "presentation": [
      "http://www.arberobotics.com/role/ShareholdersEquityType2or3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Issuance of ordinary shares, net of issuance costs (in Shares)",
        "label": "Stock Issued During Period, Shares, New Issues",
        "documentation": "Number of new stock issued during the period."
       }
      }
     },
     "auth_ref": [
      "r9",
      "r63",
      "r64",
      "r89",
      "r405",
      "r473",
      "r488"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised",
     "presentation": [
      "http://www.arberobotics.com/role/ShareholdersEquityType2or3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Exercise of options and vested RSUs (in Shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period",
        "documentation": "Number of share options (or share units) exercised during the current period."
       }
      }
     },
     "auth_ref": [
      "r9",
      "r63",
      "r64",
      "r89",
      "r282"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockIssuedDuringPeriodValueConversionOfConvertibleSecurities",
     "crdr": "credit",
     "presentation": [
      "http://www.arberobotics.com/role/ShareholdersEquityType2or3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Conversion of preferred shares into ordinary shares",
        "label": "Stock Issued During Period, Value, Conversion of Convertible Securities",
        "documentation": "The gross value of stock issued during the period upon the conversion of convertible securities."
       }
      }
     },
     "auth_ref": [
      "r9",
      "r26",
      "r89"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodValueConversionOfUnits": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockIssuedDuringPeriodValueConversionOfUnits",
     "crdr": "credit",
     "presentation": [
      "http://www.arberobotics.com/role/ShareholdersEquityType2or3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Conversion of convertible loan to ordinary shares",
        "label": "Stock Issued During Period, Value, Conversion of Units",
        "documentation": "Value of stock issued during the period upon the conversion of units. An example of a convertible unit is an umbrella partnership real estate investment trust unit (UPREIT unit)."
       }
      }
     },
     "auth_ref": [
      "r9",
      "r26",
      "r89"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodValueIssuedForServices": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockIssuedDuringPeriodValueIssuedForServices",
     "crdr": "credit",
     "presentation": [
      "http://www.arberobotics.com/role/ShareholdersEquityType2or3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock-based compensation to service providers",
        "label": "Stock Issued During Period, Value, Issued for Services",
        "documentation": "Value of stock issued in lieu of cash for services contributed to the entity. Value of the stock issued includes, but is not limited to, services contributed by vendors and founders."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockIssuedDuringPeriodValueNewIssues": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockIssuedDuringPeriodValueNewIssues",
     "crdr": "credit",
     "presentation": [
      "http://www.arberobotics.com/role/ShareholdersEquityType2or3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Issuance of ordinary shares, net of issuance costs",
        "label": "Stock Issued During Period, Value, New Issues",
        "documentation": "Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering."
       }
      }
     },
     "auth_ref": [
      "r9",
      "r63",
      "r64",
      "r89",
      "r411",
      "r473",
      "r488",
      "r542"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockIssuedDuringPeriodValueStockOptionsExercised",
     "crdr": "credit",
     "presentation": [
      "http://www.arberobotics.com/role/ShareholdersEquityType2or3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Exercise of options and vested RSUs",
        "label": "Stock Issued During Period, Value, Stock Options Exercised",
        "documentation": "Value of stock issued as a result of the exercise of stock options."
       }
      }
     },
     "auth_ref": [
      "r9",
      "r26",
      "r89"
     ]
    },
    "us-gaap_StockholdersEquity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockholdersEquity",
     "crdr": "credit",
     "calculation": {
      "http://www.arberobotics.com/role/ConsolidatedBalanceSheet": {
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.arberobotics.com/role/ConsolidatedBalanceSheet",
      "http://www.arberobotics.com/role/ShareholdersEquityType2or3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total shareholders\u2019 equity",
        "periodStartLabel": "Balance",
        "periodEndLabel": "Balance",
        "label": "Equity, Attributable to Parent",
        "documentation": "Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest."
       }
      }
     },
     "auth_ref": [
      "r64",
      "r67",
      "r68",
      "r83",
      "r436",
      "r452",
      "r474",
      "r475",
      "r530",
      "r543",
      "r678",
      "r686",
      "r730",
      "r746"
     ]
    },
    "us-gaap_StockholdersEquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockholdersEquityAbstract",
     "presentation": [
      "http://www.arberobotics.com/role/ConsolidatedBalanceSheet"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "SHAREHOLDERS\u2019 EQUITY:",
        "label": "Equity, Attributable to Parent [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockholdersEquityNoteAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockholdersEquityNoteAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Shareholders\u2019 Equity [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockholdersEquityNoteDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockholdersEquityNoteDisclosureTextBlock",
     "presentation": [
      "http://www.arberobotics.com/role/ShareholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "SHAREHOLDERS\u2019 EQUITY",
        "label": "Equity [Text Block]",
        "documentation": "The entire disclosure for equity."
       }
      }
     },
     "auth_ref": [
      "r88",
      "r160",
      "r243",
      "r245",
      "r246",
      "r247",
      "r248",
      "r249",
      "r250",
      "r251",
      "r252",
      "r253",
      "r254",
      "r255",
      "r257",
      "r347",
      "r476",
      "r477",
      "r492"
     ]
    },
    "us-gaap_StockholdersEquityReverseStockSplit": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockholdersEquityReverseStockSplit",
     "presentation": [
      "http://www.arberobotics.com/role/ShareholdersEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock split",
        "label": "Stockholders' Equity, Reverse Stock Split",
        "documentation": "Description of the reverse stock split arrangement. Also provide the retroactive effect given by the reverse split that occurs after the balance sheet date but before the release of financial statements."
       }
      }
     },
     "auth_ref": [
      "r90"
     ]
    },
    "us-gaap_SubsidiarySaleOfStockAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SubsidiarySaleOfStockAxis",
     "presentation": [
      "http://www.arberobotics.com/role/GeneralDetails",
      "http://www.arberobotics.com/role/WarrantsLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Sale of Stock [Axis]",
        "documentation": "Information by type of sale of the entity's stock."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SupplementalCashFlowInformationAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SupplementalCashFlowInformationAbstract",
     "presentation": [
      "http://www.arberobotics.com/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Supplemental disclosure of cash flows activities:",
        "label": "Supplemental Cash Flow Information [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_TabularListTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "TabularListTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Tabular List [Table Text Block]",
        "terseLabel": "Tabular List, Table"
       }
      }
     },
     "auth_ref": [
      "r614"
     ]
    },
    "arbe_TaxesonIncomeDetailsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.arberobotics.com/20231231",
     "localname": "TaxesonIncomeDetailsLineItems",
     "presentation": [
      "http://www.arberobotics.com/role/TaxesonIncomeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Taxes on Income [Line Items]"
       }
      }
     },
     "auth_ref": []
    },
    "arbe_TaxesonIncomeDetailsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.arberobotics.com/20231231",
     "localname": "TaxesonIncomeDetailsTable",
     "presentation": [
      "http://www.arberobotics.com/role/TaxesonIncomeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Taxes on Income (Details) [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_TemporaryEquityAccretionToRedemptionValueAdjustment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "TemporaryEquityAccretionToRedemptionValueAdjustment",
     "crdr": "debit",
     "presentation": [
      "http://www.arberobotics.com/role/ScheduleofSetsForththeComputationofBasicandDilutedNetLossPerShareAttributableTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Adjusted Net loss",
        "label": "Temporary Equity, Accretion to Redemption Value, Adjustment",
        "documentation": "Amount of decrease to net income for accretion of temporary equity to its redemption value to derive net income apportioned to common stockholders."
       }
      }
     },
     "auth_ref": []
    },
    "srt_TitleOfIndividualAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "TitleOfIndividualAxis",
     "presentation": [
      "http://www.arberobotics.com/role/ShareholdersEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of Individual [Axis]",
        "documentation": "Information by title of individual or nature of relationship to individual or group of individuals."
       }
      }
     },
     "auth_ref": [
      "r685",
      "r733"
     ]
    },
    "srt_TitleOfIndividualWithRelationshipToEntityDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "TitleOfIndividualWithRelationshipToEntityDomain",
     "presentation": [
      "http://www.arberobotics.com/role/ShareholdersEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of Individual [Domain]",
        "documentation": "Title of individual, or nature of relationship to individual or group of individuals."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_TotalShareholderRtnAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "TotalShareholderRtnAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Shareholder Return Amount",
        "terseLabel": "Total Shareholder Return Amount"
       }
      }
     },
     "auth_ref": [
      "r606"
     ]
    },
    "ecd_TotalShareholderRtnVsPeerGroupTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "TotalShareholderRtnVsPeerGroupTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Shareholder Return Vs Peer Group [Text Block]",
        "terseLabel": "Total Shareholder Return Vs Peer Group"
       }
      }
     },
     "auth_ref": [
      "r613"
     ]
    },
    "ecd_TradingArrAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "TradingArrAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement [Axis]",
        "terseLabel": "Trading Arrangement:"
       }
      }
     },
     "auth_ref": [
      "r634"
     ]
    },
    "ecd_TradingArrByIndTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "TradingArrByIndTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangements, by Individual [Table]",
        "terseLabel": "Trading Arrangements, by Individual"
       }
      }
     },
     "auth_ref": [
      "r636"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "TradingSymbol",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_TrdArrAdoptionDate": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "TrdArrAdoptionDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement Adoption Date",
        "terseLabel": "Adoption Date"
       }
      }
     },
     "auth_ref": [
      "r637"
     ]
    },
    "ecd_TrdArrDuration": {
     "xbrltype": "durationItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "TrdArrDuration",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement Duration",
        "terseLabel": "Arrangement Duration"
       }
      }
     },
     "auth_ref": [
      "r638"
     ]
    },
    "ecd_TrdArrIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "TrdArrIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement, Individual Name",
        "terseLabel": "Name"
       }
      }
     },
     "auth_ref": [
      "r636"
     ]
    },
    "ecd_TrdArrIndTitle": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "TrdArrIndTitle",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement, Individual Title",
        "terseLabel": "Title"
       }
      }
     },
     "auth_ref": [
      "r636"
     ]
    },
    "ecd_TrdArrSecuritiesAggAvailAmt": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "TrdArrSecuritiesAggAvailAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement, Securities Aggregate Available Amount",
        "terseLabel": "Aggregate Available"
       }
      }
     },
     "auth_ref": [
      "r639"
     ]
    },
    "ecd_TrdArrTerminationDate": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "TrdArrTerminationDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement Termination Date",
        "terseLabel": "Termination Date"
       }
      }
     },
     "auth_ref": [
      "r637"
     ]
    },
    "arbe_TwoThousandSixteenIncentivePlanMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.arberobotics.com/20231231",
     "localname": "TwoThousandSixteenIncentivePlanMember",
     "presentation": [
      "http://www.arberobotics.com/role/ShareholdersEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2016 Share Incentive Plan [Member]",
        "label": "Two Thousand Sixteen Incentive Plan Member"
       }
      }
     },
     "auth_ref": []
    },
    "arbe_TwoThousandTwentyOneEquityIncentivePlanMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.arberobotics.com/20231231",
     "localname": "TwoThousandTwentyOneEquityIncentivePlanMember",
     "presentation": [
      "http://www.arberobotics.com/role/ShareholdersEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2021 Plan [Member]",
        "label": "Two Thousand Twenty One Equity Incentive Plan Member"
       }
      }
     },
     "auth_ref": []
    },
    "country_US": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/country/2023",
     "localname": "US",
     "presentation": [
      "http://www.arberobotics.com/role/ScheduleofPropertyandEquipmentNetofDepreciationbyGeographicRegionTable",
      "http://www.arberobotics.com/role/ScheduleofRevenueDisaggregatedbyGeographyTable",
      "http://www.arberobotics.com/role/TaxesonIncomeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "USA [Member]",
        "verboseLabel": "UNITED STATES [Member]",
        "netLabel": "United States [Member]",
        "label": "UNITED STATES"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_UndrlygSecurityMktPriceChngPct": {
     "xbrltype": "pureItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "UndrlygSecurityMktPriceChngPct",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Underlying Security Market Price Change, Percent",
        "terseLabel": "Underlying Security Market Price Change"
       }
      }
     },
     "auth_ref": [
      "r633"
     ]
    },
    "us-gaap_UseOfEstimates": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "UseOfEstimates",
     "presentation": [
      "http://www.arberobotics.com/role/AccountingPoliciesByPolicy"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Use of estimates",
        "label": "Use of Estimates, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles."
       }
      }
     },
     "auth_ref": [
      "r40",
      "r41",
      "r42",
      "r109",
      "r110",
      "r113",
      "r114"
     ]
    },
    "us-gaap_VehiclesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "VehiclesMember",
     "presentation": [
      "http://www.arberobotics.com/role/ScheduleofPropertyandEquipmentTable",
      "http://www.arberobotics.com/role/ScheduleoftheStraightLineMethodOvertheEstimatedUsefulLivesoftheAssetsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Vehicles [Member]",
        "label": "Vehicles [Member]",
        "documentation": "Equipment used primarily for road transportation."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_WarrantsAndRightsOutstanding": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "WarrantsAndRightsOutstanding",
     "crdr": "credit",
     "calculation": {
      "http://www.arberobotics.com/role/ConsolidatedBalanceSheet": {
       "parentTag": "us-gaap_LiabilitiesNoncurrent",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.arberobotics.com/role/ConsolidatedBalanceSheet"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Warrant liabilities",
        "label": "Warrants and Rights Outstanding",
        "documentation": "Value of outstanding derivative securities that permit the holder the right to purchase securities (usually equity) from the issuer at a specified price."
       }
      }
     },
     "auth_ref": []
    },
    "arbe_WarrantsLiabilitiesDetailsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.arberobotics.com/20231231",
     "localname": "WarrantsLiabilitiesDetailsLineItems",
     "presentation": [
      "http://www.arberobotics.com/role/WarrantsLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrants Liabilities [Line Items]"
       }
      }
     },
     "auth_ref": []
    },
    "arbe_WarrantsLiabilitiesDetailsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.arberobotics.com/20231231",
     "localname": "WarrantsLiabilitiesDetailsTable",
     "presentation": [
      "http://www.arberobotics.com/role/WarrantsLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrants Liabilities (Details) [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "arbe_WarrantsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.arberobotics.com/20231231",
     "localname": "WarrantsMember",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Warrants",
        "label": "Warrants Member"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "WeightedAverageNumberDilutedSharesOutstandingAdjustment",
     "presentation": [
      "http://www.arberobotics.com/role/ScheduleofSetsForththeComputationofBasicandDilutedNetLossPerShareAttributableTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted-average shares used in computing loss per share attributable to ordinary shareholders, basic (in Shares)",
        "label": "Weighted Average Number of Shares Outstanding, Diluted, Adjustment",
        "documentation": "The sum of dilutive potential common shares or units used in the calculation of the diluted per-share or per-unit computation."
       }
      }
     },
     "auth_ref": [
      "r684"
     ]
    },
    "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "WeightedAverageNumberOfDilutedSharesOutstanding",
     "presentation": [
      "http://www.arberobotics.com/role/ConsolidatedIncomeStatement",
      "http://www.arberobotics.com/role/ScheduleofSetsForththeComputationofBasicandDilutedNetLossPerShareAttributableTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted-average number of shares used in computing diluted loss per share attributable to Ordinary Shareholders (in Shares)",
        "verboseLabel": "Weighted-average shares used in computing loss per share attributable to ordinary shareholders, diluted (in Shares)",
        "label": "Weighted Average Number of Shares Outstanding, Diluted",
        "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period."
       }
      }
     },
     "auth_ref": [
      "r180",
      "r186"
     ]
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "WeightedAverageNumberOfSharesOutstandingBasic",
     "presentation": [
      "http://www.arberobotics.com/role/ConsolidatedIncomeStatement"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted-average number of shares used in computing basic loss per share attributable to Ordinary Shareholders (in Shares)",
        "label": "Weighted Average Number of Shares Outstanding, Basic",
        "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period."
       }
      }
     },
     "auth_ref": [
      "r179",
      "r186"
     ]
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r645"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "05",
   "Paragraph": "4",
   "SubTopic": "10",
   "Topic": "360",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482338/360-10-05-4"
  },
  "r1": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "25",
   "Paragraph": "1",
   "SubTopic": "20",
   "Topic": "940",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481913/940-20-25-1"
  },
  "r2": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "25",
   "Paragraph": "13",
   "SubTopic": "10",
   "Topic": "480",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481766/480-10-25-13"
  },
  "r3": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "SubTopic": "230",
   "Topic": "830",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481877/830-230-45-1"
  },
  "r4": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "14",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-14"
  },
  "r5": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28"
  },
  "r6": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(b)",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28"
  },
  "r7": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "SubTopic": "10",
   "Topic": "360",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1"
  },
  "r8": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "SubTopic": "10",
   "Topic": "825",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-1"
  },
  "r9": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "SubTopic": "10",
   "Topic": "505",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-2"
  },
  "r10": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(i)",
   "SubTopic": "10",
   "Topic": "718",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r11": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(ii)",
   "SubTopic": "10",
   "Topic": "718",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r12": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(1)",
   "SubTopic": "10",
   "Topic": "718",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r13": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(2)",
   "SubTopic": "10",
   "Topic": "718",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r14": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(3)",
   "SubTopic": "10",
   "Topic": "718",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r15": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "SubTopic": "10",
   "Topic": "718",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r16": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)",
   "SubTopic": "10",
   "Topic": "718",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r17": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2A",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "718",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2A"
  },
  "r18": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "41",
   "Subparagraph": "b",
   "SubTopic": "10",
   "Topic": "280",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-41"
  },
  "r19": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "60",
   "Paragraph": "1",
   "SubTopic": "10",
   "Topic": "820",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482053/820-10-60-1"
  },
  "r20": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(22))",
   "SubTopic": "10",
   "Topic": "210",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r21": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-8"
  },
  "r22": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.19(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r23": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.20)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r24": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.21)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r25": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.29-30)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r26": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.29-31)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r27": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "14",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-14"
  },
  "r28": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "15",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-15"
  },
  "r29": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "15",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-15"
  },
  "r30": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-4"
  },
  "r31": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-1"
  },
  "r32": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-3"
  },
  "r33": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-4"
  },
  "r34": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-5"
  },
  "r35": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "260",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1"
  },
  "r36": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "260",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-2"
  },
  "r37": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "18",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-18"
  },
  "r38": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-18"
  },
  "r39": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "20",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-20"
  },
  "r40": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-4"
  },
  "r41": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-8"
  },
  "r42": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-9"
  },
  "r43": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "310",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481962/310-10-50-9"
  },
  "r44": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "360",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1"
  },
  "r45": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "360",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1"
  },
  "r46": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-3"
  },
  "r47": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r48": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r49": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r50": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r51": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r52": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "740",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-3"
  },
  "r53": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "740",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-8"
  },
  "r54": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4H",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4H"
  },
  "r55": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "825",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "20",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-20"
  },
  "r56": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "825",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-21"
  },
  "r57": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "942",
   "SubTopic": "825",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480981/942-825-50-1"
  },
  "r58": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "985",
   "SubTopic": "20",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481283/985-20-50-1"
  },
  "r59": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 201.5-02(24))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r60": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 201.5-02(25))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r61": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 201.5-02(26))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r62": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(23))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r63": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(28))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r64": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(29))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r65": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r66": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r67": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r68": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(31))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r69": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(32))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r70": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(10))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r71": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(20))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r72": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r73": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03.1,2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r74": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03.19)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r75": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03.2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r76": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03.4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r77": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03.7)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r78": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "13",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-13"
  },
  "r79": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-24"
  },
  "r80": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-25"
  },
  "r81": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28"
  },
  "r82": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "235",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//235/tableOfContent"
  },
  "r83": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 4.E)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480418/310-10-S99-2"
  },
  "r84": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "360",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//360/tableOfContent"
  },
  "r85": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1"
  },
  "r86": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 5.CC)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480091/360-10-S99-2"
  },
  "r87": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "440",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//440/tableOfContent"
  },
  "r88": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "505",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//505/tableOfContent"
  },
  "r89": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.3-04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480008/505-10-S99-1"
  },
  "r90": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "4",
   "Subparagraph": "(SAB Topic 4.C)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480008/505-10-S99-4"
  },
  "r91": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "718",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Section": "50",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r92": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "718",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Section": "50",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r93": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Section": "50",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-12"
  },
  "r94": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Section": "50",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-2"
  },
  "r95": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "815",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//815/tableOfContent"
  },
  "r96": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(13)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1"
  },
  "r97": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1"
  },
  "r98": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(1)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1"
  },
  "r99": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(10))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1"
  },
  "r100": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(11))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1"
  },
  "r101": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(23))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1"
  },
  "r102": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1"
  },
  "r103": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1"
  },
  "r104": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(15))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1"
  },
  "r105": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(22))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1"
  },
  "r106": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r107": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "SubTopic": "20",
   "Topic": "740",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482659/740-20-45-2"
  },
  "r108": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-1"
  },
  "r109": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-1"
  },
  "r110": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-1"
  },
  "r111": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-1"
  },
  "r112": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "SubTopic": "360",
   "Topic": "958",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480321/958-360-50-1"
  },
  "r113": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-11"
  },
  "r114": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-12"
  },
  "r115": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "606",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-13"
  },
  "r116": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "SubTopic": "360",
   "Topic": "958",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480321/958-360-50-6"
  },
  "r117": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "SubTopic": "360",
   "Topic": "958",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480321/958-360-50-7"
  },
  "r118": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(h))",
   "SubTopic": "10",
   "Topic": "235",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1"
  },
  "r119": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//275/tableOfContent"
  },
  "r120": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Topic": "606",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//606/tableOfContent"
  },
  "r121": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "(a)",
   "Publisher": "SEC"
  },
  "r122": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1406",
   "Paragraph": "(a)",
   "Subparagraph": "(2)",
   "Publisher": "SEC"
  },
  "r123": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "28",
   "Footnote": "2",
   "Publisher": "SEC"
  },
  "r124": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "28",
   "Footnote": "4",
   "Publisher": "SEC"
  },
  "r125": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "28",
   "Paragraph": "Column B",
   "Publisher": "SEC"
  },
  "r126": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "28",
   "Paragraph": "Column C",
   "Publisher": "SEC"
  },
  "r127": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "28",
   "Paragraph": "Column D",
   "Publisher": "SEC"
  },
  "r128": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "28",
   "Paragraph": "Column E",
   "Publisher": "SEC"
  },
  "r129": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "28",
   "Paragraph": "Column F",
   "Publisher": "SEC"
  },
  "r130": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "28",
   "Paragraph": "Column G",
   "Publisher": "SEC"
  },
  "r131": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "28",
   "Paragraph": "Column H",
   "Publisher": "SEC"
  },
  "r132": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "28",
   "Paragraph": "Column I",
   "Publisher": "SEC"
  },
  "r133": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "29",
   "Footnote": "4",
   "Publisher": "SEC"
  },
  "r134": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "105",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479343/105-10-65-6"
  },
  "r135": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-7"
  },
  "r136": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1"
  },
  "r137": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-5"
  },
  "r138": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r139": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(13))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r140": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(14))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r141": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(18))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r142": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(27)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r143": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(28))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r144": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(29))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r145": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r146": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1A"
  },
  "r147": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1B"
  },
  "r148": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-1"
  },
  "r149": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-4"
  },
  "r150": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-5"
  },
  "r151": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-6"
  },
  "r152": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r153": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(25))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r154": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "17",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-17"
  },
  "r155": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-24"
  },
  "r156": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-25"
  },
  "r157": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-2"
  },
  "r158": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-8"
  },
  "r159": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483426/235-10-50-1"
  },
  "r160": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(e)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1"
  },
  "r161": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1"
  },
  "r162": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(h)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1"
  },
  "r163": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(h)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1"
  },
  "r164": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-04(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-3"
  },
  "r165": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "23",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-23"
  },
  "r166": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-24"
  },
  "r167": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-5"
  },
  "r168": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1"
  },
  "r169": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1"
  },
  "r170": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-11"
  },
  "r171": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-11"
  },
  "r172": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-3"
  },
  "r173": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-4"
  },
  "r174": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-7"
  },
  "r175": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-7"
  },
  "r176": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-8"
  },
  "r177": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-9"
  },
  "r178": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//260/tableOfContent"
  },
  "r179": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-10"
  },
  "r180": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "16",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-16"
  },
  "r181": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-2"
  },
  "r182": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-3"
  },
  "r183": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "60B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-60B"
  },
  "r184": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "60B",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-60B"
  },
  "r185": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-7"
  },
  "r186": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1"
  },
  "r187": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1"
  },
  "r188": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-2"
  },
  "r189": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-3"
  },
  "r190": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "15",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482635/260-10-55-15"
  },
  "r191": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "270",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482964/270-10-50-6A"
  },
  "r192": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "272",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483014/272-10-45-1"
  },
  "r193": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "272",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482987/272-10-50-1"
  },
  "r194": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "272",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482987/272-10-50-3"
  },
  "r195": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//280/tableOfContent"
  },
  "r196": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-15"
  },
  "r197": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-21"
  },
  "r198": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-21"
  },
  "r199": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22"
  },
  "r200": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22"
  },
  "r201": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22"
  },
  "r202": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22"
  },
  "r203": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "26",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-26"
  },
  "r204": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30"
  },
  "r205": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30"
  },
  "r206": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30"
  },
  "r207": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-31"
  },
  "r208": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32"
  },
  "r209": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32"
  },
  "r210": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32"
  },
  "r211": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32"
  },
  "r212": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32"
  },
  "r213": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32"
  },
  "r214": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "34",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-34"
  },
  "r215": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "40",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-40"
  },
  "r216": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "41",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-41"
  },
  "r217": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "41",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-41"
  },
  "r218": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "41",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-41"
  },
  "r219": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "42",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-42"
  },
  "r220": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481990/310-10-45-2"
  },
  "r221": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481990/310-10-45-9"
  },
  "r222": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3"
  },
  "r223": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "4",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-4"
  },
  "r224": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "5",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-5"
  },
  "r225": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-3"
  },
  "r226": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482017/420-10-50-1"
  },
  "r227": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "440",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482648/440-10-50-4"
  },
  "r228": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "440",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482648/440-10-50-4"
  },
  "r229": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-4"
  },
  "r230": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-9"
  },
  "r231": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 5.Y.Q2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480102/450-20-S99-1"
  },
  "r232": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 5.Y.Q4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480102/450-20-S99-1"
  },
  "r233": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A"
  },
  "r234": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A"
  },
  "r235": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A"
  },
  "r236": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A"
  },
  "r237": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B"
  },
  "r238": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B"
  },
  "r239": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B"
  },
  "r240": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B"
  },
  "r241": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B"
  },
  "r242": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1E",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1E"
  },
  "r243": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13"
  },
  "r244": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13"
  },
  "r245": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13"
  },
  "r246": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13"
  },
  "r247": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13"
  },
  "r248": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13"
  },
  "r249": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-14"
  },
  "r250": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-14"
  },
  "r251": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-14"
  },
  "r252": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "16",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-16"
  },
  "r253": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-18"
  },
  "r254": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-18"
  },
  "r255": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-18"
  },
  "r256": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-2"
  },
  "r257": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.3-04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480008/505-10-S99-1"
  },
  "r258": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-10"
  },
  "r259": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-12"
  },
  "r260": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-12"
  },
  "r261": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-12"
  },
  "r262": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-12"
  },
  "r263": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-12"
  },
  "r264": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-13"
  },
  "r265": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-15"
  },
  "r266": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-4"
  },
  "r267": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-5"
  },
  "r268": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-9"
  },
  "r269": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "712",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//712/tableOfContent"
  },
  "r270": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r271": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-5"
  },
  "r272": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//718/tableOfContent"
  },
  "r273": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r274": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r275": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r276": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r277": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r278": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r279": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r280": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r281": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r282": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r283": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r284": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r285": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r286": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r287": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r288": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r289": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r290": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r291": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r292": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r293": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r294": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r295": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r296": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r297": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r298": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r299": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r300": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r301": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(v)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r302": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r303": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "15",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15"
  },
  "r304": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "15",
   "Subparagraph": "(f)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15"
  },
  "r305": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "15",
   "Subparagraph": "(f)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15"
  },
  "r306": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 14.C.Q3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479830/718-10-S99-1"
  },
  "r307": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 14.D.1.Q5)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479830/718-10-S99-1"
  },
  "r308": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 14.D.2.Q6)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479830/718-10-S99-1"
  },
  "r309": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 14.D.3.Q2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479830/718-10-S99-1"
  },
  "r310": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 14.F)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479830/718-10-S99-1"
  },
  "r311": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "730",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "05",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483044/730-10-05-1"
  },
  "r312": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "730",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482916/730-10-50-1"
  },
  "r313": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//740/tableOfContent"
  },
  "r314": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482525/740-10-45-25"
  },
  "r315": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482525/740-10-45-28"
  },
  "r316": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-10"
  },
  "r317": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-12"
  },
  "r318": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-14"
  },
  "r319": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "17",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-17"
  },
  "r320": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "19",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-19"
  },
  "r321": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-2"
  },
  "r322": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-2"
  },
  "r323": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "20",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-20"
  },
  "r324": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-21"
  },
  "r325": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-9"
  },
  "r326": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "8",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482615/740-10-65-8"
  },
  "r327": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "8",
   "Subparagraph": "(d)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482615/740-10-65-8"
  },
  "r328": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB TOPIC 6.I.5.Q1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1"
  },
  "r329": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB TOPIC 6.I.7)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1"
  },
  "r330": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 6.I.Fact.3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1"
  },
  "r331": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 6.I.Fact.4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1"
  },
  "r332": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 11.C)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-2"
  },
  "r333": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "270",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482526/740-270-50-1"
  },
  "r334": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482603/740-30-50-2"
  },
  "r335": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-25"
  },
  "r336": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-25"
  },
  "r337": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(bb)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-3"
  },
  "r338": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-3"
  },
  "r339": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5C",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-5C"
  },
  "r340": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6"
  },
  "r341": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6"
  },
  "r342": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6"
  },
  "r343": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6"
  },
  "r344": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6"
  },
  "r345": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(i)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6"
  },
  "r346": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480237/815-40-50-5"
  },
  "r347": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480237/815-40-50-6"
  },
  "r348": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(e)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1"
  },
  "r349": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(e)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1"
  },
  "r350": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1"
  },
  "r351": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "28",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-28"
  },
  "r352": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//830/tableOfContent"
  },
  "r353": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "230",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481877/830-230-45-1"
  },
  "r354": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "17",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-17"
  },
  "r355": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20"
  },
  "r356": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20"
  },
  "r357": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20"
  },
  "r358": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20"
  },
  "r359": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481674/830-30-50-1"
  },
  "r360": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//842-20/tableOfContent"
  },
  "r361": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479041/842-20-45-1"
  },
  "r362": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479041/842-20-45-1"
  },
  "r363": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479041/842-20-45-5"
  },
  "r364": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-1"
  },
  "r365": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(g)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4"
  },
  "r366": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(g)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4"
  },
  "r367": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(g)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4"
  },
  "r368": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(g)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4"
  },
  "r369": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-6"
  },
  "r370": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479773/842-30-50-5"
  },
  "r371": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "848",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)(iii)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483550/848-10-65-2"
  },
  "r372": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "852",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "14",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481435/852-10-45-14"
  },
  "r373": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3"
  },
  "r374": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "910",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482546/910-10-50-6"
  },
  "r375": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "924",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 11.L)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479941/924-10-S99-1"
  },
  "r376": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(27))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1"
  },
  "r377": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-05(b)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479557/942-235-S99-1"
  },
  "r378": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480842/942-360-50-1"
  },
  "r379": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r380": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(22))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r381": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r382": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r383": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(8)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r384": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(8)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r385": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(8))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r386": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(11))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1"
  },
  "r387": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(18))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1"
  },
  "r388": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(23))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1"
  },
  "r389": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1"
  },
  "r390": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-17(Column A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2"
  },
  "r391": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-17(Column B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2"
  },
  "r392": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-17(Column C))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2"
  },
  "r393": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-17(Column D))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2"
  },
  "r394": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-17(Column E))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2"
  },
  "r395": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-17(Column F))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2"
  },
  "r396": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480081/944-40-50-7A"
  },
  "r397": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2"
  },
  "r398": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(f)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2"
  },
  "r399": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2"
  },
  "r400": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2"
  },
  "r401": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(h)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2"
  },
  "r402": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "825",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479383/944-825-50-1B"
  },
  "r403": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3"
  },
  "r404": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(h)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3"
  },
  "r405": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3"
  },
  "r406": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(2)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3"
  },
  "r407": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(2)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3"
  },
  "r408": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3"
  },
  "r409": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-11"
  },
  "r410": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-13"
  },
  "r411": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-4"
  },
  "r412": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-2"
  },
  "r413": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "27",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-27"
  },
  "r414": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7"
  },
  "r415": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7"
  },
  "r416": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7"
  },
  "r417": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7"
  },
  "r418": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7"
  },
  "r419": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7"
  },
  "r420": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7"
  },
  "r421": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7"
  },
  "r422": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480555/946-210-45-4"
  },
  "r423": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1"
  },
  "r424": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-2"
  },
  "r425": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6"
  },
  "r426": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6"
  },
  "r427": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6"
  },
  "r428": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r429": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(12)(b)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r430": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(12)(b)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r431": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(12)(b)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r432": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(13)(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r433": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(13)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r434": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(16)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r435": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r436": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r437": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(2)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r438": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(2)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r439": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(3)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r440": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(3)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r441": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(3)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r442": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r443": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r444": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r445": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(e))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r446": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(8))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r447": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r448": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r449": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r450": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(e))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r451": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.6-05(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-2"
  },
  "r452": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.6-05(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-2"
  },
  "r453": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-3"
  },
  "r454": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-7"
  },
  "r455": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483580/946-220-50-3"
  },
  "r456": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r457": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r458": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(g)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r459": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r460": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r461": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r462": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r463": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r464": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r465": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r466": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r467": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r468": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r469": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r470": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r471": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r472": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(1)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3"
  },
  "r473": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(4)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3"
  },
  "r474": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3"
  },
  "r475": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3"
  },
  "r476": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481062/946-235-50-2"
  },
  "r477": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481062/946-235-50-2"
  },
  "r478": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1"
  },
  "r479": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column C)(Footnote 5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1"
  },
  "r480": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2"
  },
  "r481": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-12A(Column C)(Footnote 4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2"
  },
  "r482": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3"
  },
  "r483": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3"
  },
  "r484": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3"
  },
  "r485": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6"
  },
  "r486": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column F)(Footnote 7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6"
  },
  "r487": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-1"
  },
  "r488": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2"
  },
  "r489": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2"
  },
  "r490": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2"
  },
  "r491": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2"
  },
  "r492": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-6"
  },
  "r493": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "948",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-29(Footnote 4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479851/948-310-S99-1"
  },
  "r494": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "954",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481027/954-310-50-2"
  },
  "r495": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "954",
   "SubTopic": "440",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480327/954-440-50-1"
  },
  "r496": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1"
  },
  "r497": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column C))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1"
  },
  "r498": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column D))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1"
  },
  "r499": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column E))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1"
  },
  "r500": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column F))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1"
  },
  "r501": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column G))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1"
  },
  "r502": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column H))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1"
  },
  "r503": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column I))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1"
  },
  "r504": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1"
  },
  "r505": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Footnote 4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1"
  },
  "r506": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "976",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482856/976-310-50-1"
  },
  "r507": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "978",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482707/978-310-50-1"
  },
  "r508": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28"
  },
  "r509": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(e)",
   "SubTopic": "10",
   "Topic": "235",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483426/235-10-50-4"
  },
  "r510": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "13H",
   "Subparagraph": "(a)",
   "SubTopic": "40",
   "Topic": "944",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480046/944-40-55-13H"
  },
  "r511": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "13H",
   "Subparagraph": "(b)",
   "SubTopic": "40",
   "Topic": "944",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480046/944-40-55-13H"
  },
  "r512": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1"
  },
  "r513": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483426/235-10-50-4"
  },
  "r514": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "52",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482635/260-10-55-52"
  },
  "r515": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-31"
  },
  "r516": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "12A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481933/310-10-55-12A"
  },
  "r517": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13"
  },
  "r518": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "91",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91"
  },
  "r519": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "91",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91"
  },
  "r520": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "91",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91"
  },
  "r521": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "91",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91"
  },
  "r522": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "91",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91"
  },
  "r523": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "91",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91"
  },
  "r524": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "91",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91"
  },
  "r525": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480547/715-80-55-8"
  },
  "r526": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r527": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r528": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r529": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "53",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479589/842-20-55-53"
  },
  "r530": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "852",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481372/852-10-55-10"
  },
  "r531": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479401/944-30-55-2"
  },
  "r532": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "29F",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480046/944-40-55-29F"
  },
  "r533": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1"
  },
  "r534": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6"
  },
  "r535": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480493/946-210-55-1"
  },
  "r536": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480833/946-310-45-1"
  },
  "r537": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1"
  },
  "r538": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2"
  },
  "r539": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 1)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3"
  },
  "r540": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6"
  },
  "r541": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "830",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-10"
  },
  "r542": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "830",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-11"
  },
  "r543": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "830",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-12"
  },
  "r544": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "Global LEI Foundation",
   "URI": "www.leiroc.org",
   "URIDate": "2013-08-21"
  },
  "r545": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12"
  },
  "r546": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r547": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r548": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-23"
  },
  "r549": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r550": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "g"
  },
  "r551": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12, 13, 15d"
  },
  "r552": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r553": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r554": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "15",
   "Subsection": "d"
  },
  "r555": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Section": "14a",
   "Number": "240",
   "Subsection": "12"
  },
  "r556": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-K",
   "Number": "249",
   "Section": "310"
  },
  "r557": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-Q",
   "Number": "240",
   "Section": "308",
   "Subsection": "a"
  },
  "r558": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-Q",
   "Number": "249",
   "Section": "308",
   "Subsection": "a"
  },
  "r559": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Number": "249",
   "Section": "220",
   "Subsection": "f"
  },
  "r560": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16",
   "Subsection": "J",
   "Paragraph": "a"
  },
  "r561": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1"
  },
  "r562": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i"
  },
  "r563": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "A"
  },
  "r564": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "B"
  },
  "r565": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "C"
  },
  "r566": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "D"
  },
  "r567": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "E"
  },
  "r568": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "ii"
  },
  "r569": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "iii"
  },
  "r570": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "2"
  },
  "r571": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "ii",
   "Section": "6"
  },
  "r572": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Number": "249",
   "Section": "240",
   "Subsection": "f"
  },
  "r573": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a"
  },
  "r574": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1"
  },
  "r575": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "i"
  },
  "r576": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "ii"
  },
  "r577": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iii"
  },
  "r578": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iv"
  },
  "r579": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "v"
  },
  "r580": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "2"
  },
  "r581": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "3"
  },
  "r582": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "b"
  },
  "r583": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 8-K",
   "Number": "249",
   "Section": "308"
  },
  "r584": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form F-3"
  },
  "r585": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2"
  },
  "r586": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-3"
  },
  "r587": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-4"
  },
  "r588": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-6"
  },
  "r589": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a"
  },
  "r590": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1"
  },
  "r591": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "i"
  },
  "r592": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "ii"
  },
  "r593": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iii"
  },
  "r594": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iv"
  },
  "r595": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "v"
  },
  "r596": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "2"
  },
  "r597": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "3"
  },
  "r598": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "b"
  },
  "r599": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form S-3"
  },
  "r600": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r601": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Investment Company Act",
   "Number": "270"
  },
  "r602": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v"
  },
  "r603": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "1"
  },
  "r604": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "ii"
  },
  "r605": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii"
  },
  "r606": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iv"
  },
  "r607": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "vi"
  },
  "r608": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "3"
  },
  "r609": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "4"
  },
  "r610": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "i"
  },
  "r611": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "ii"
  },
  "r612": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "iii"
  },
  "r613": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "iv"
  },
  "r614": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "6"
  },
  "r615": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "6",
   "Subparagraph": "i"
  },
  "r616": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w"
  },
  "r617": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1"
  },
  "r618": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i"
  },
  "r619": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "A"
  },
  "r620": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "B"
  },
  "r621": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "C"
  },
  "r622": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "D"
  },
  "r623": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "E"
  },
  "r624": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "ii"
  },
  "r625": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "iii"
  },
  "r626": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "2"
  },
  "r627": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "1"
  },
  "r628": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2"
  },
  "r629": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "A"
  },
  "r630": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "C"
  },
  "r631": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "D"
  },
  "r632": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "E"
  },
  "r633": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "F"
  },
  "r634": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a"
  },
  "r635": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "1"
  },
  "r636": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "A"
  },
  "r637": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "B"
  },
  "r638": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "C"
  },
  "r639": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "D"
  },
  "r640": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "b",
   "Paragraph": "1"
  },
  "r641": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-T",
   "Number": "232",
   "Section": "313"
  },
  "r642": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-T",
   "Number": "232",
   "Section": "405"
  },
  "r643": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "405"
  },
  "r644": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "413",
   "Subsection": "b"
  },
  "r645": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  },
  "r646": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "462",
   "Subsection": "b"
  },
  "r647": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "462",
   "Subsection": "c"
  },
  "r648": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "462",
   "Subsection": "d"
  },
  "r649": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "462",
   "Subsection": "e"
  },
  "r650": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "486",
   "Subsection": "a"
  },
  "r651": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "486",
   "Subsection": "b"
  },
  "r652": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "7A",
   "Section": "B",
   "Subsection": "2"
  },
  "r653": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Section": "8",
   "Subsection": "c"
  },
  "r654": {
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef",
   "Topic": "272",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483014/272-10-45-3"
  },
  "r655": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(b)(1)",
   "SubTopic": "10",
   "Topic": "606",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-13"
  },
  "r656": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-18"
  },
  "r657": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "SubTopic": "825",
   "Topic": "944",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479383/944-825-50-1B"
  },
  "r658": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(g)(1)",
   "SubTopic": "20",
   "Topic": "842",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4"
  },
  "r659": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4H",
   "SubTopic": "40",
   "Topic": "944",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480081/944-40-50-4H"
  },
  "r660": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Topic": "705",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//705/tableOfContent"
  },
  "r661": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "13",
   "Subsection": "01",
   "Paragraph": "(a)",
   "Subparagraph": "(4)(i)",
   "Publisher": "SEC"
  },
  "r662": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "13",
   "Subsection": "01",
   "Paragraph": "(a)",
   "Subparagraph": "(4)(iv)",
   "Publisher": "SEC"
  },
  "r663": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "13",
   "Subsection": "02",
   "Paragraph": "(a)",
   "Subparagraph": "(4)(iv)",
   "Publisher": "SEC"
  },
  "r664": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r665": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r666": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(18))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r667": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(20))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r668": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(26)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r669": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(27)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r670": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(28))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r671": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(3)(a)(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r672": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(8))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r673": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r674": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "14",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-14"
  },
  "r675": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28"
  },
  "r676": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-8"
  },
  "r677": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1"
  },
  "r678": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1"
  },
  "r679": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(h)(1)(Note 1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1"
  },
  "r680": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "23",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-23"
  },
  "r681": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-24"
  },
  "r682": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-5"
  },
  "r683": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "55",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-55"
  },
  "r684": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1"
  },
  "r685": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481990/310-10-45-13"
  },
  "r686": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3"
  },
  "r687": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "410",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "10",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481931/410-30-50-10"
  },
  "r688": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "450",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//450/tableOfContent"
  },
  "r689": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-9"
  },
  "r690": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 5.Y.Q2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480102/450-20-S99-1"
  },
  "r691": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A"
  },
  "r692": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A"
  },
  "r693": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A"
  },
  "r694": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A"
  },
  "r695": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B"
  },
  "r696": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B"
  },
  "r697": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-2"
  },
  "r698": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-5"
  },
  "r699": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r700": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r701": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r702": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r703": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r704": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r705": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r706": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r707": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r708": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r709": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r710": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r711": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r712": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r713": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r714": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r715": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r716": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r717": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r718": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r719": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r720": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r721": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r722": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r723": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r724": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(v)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r725": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-12"
  },
  "r726": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-2"
  },
  "r727": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-6"
  },
  "r728": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 6.I.Fact.4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1"
  },
  "r729": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(e)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1"
  },
  "r730": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "28",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-28"
  },
  "r731": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4"
  },
  "r732": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-6"
  },
  "r733": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-2"
  },
  "r734": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "852",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481404/852-10-50-7"
  },
  "r735": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "852",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481404/852-10-50-7"
  },
  "r736": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3"
  },
  "r737": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3"
  },
  "r738": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3"
  },
  "r739": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4"
  },
  "r740": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4"
  },
  "r741": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4"
  },
  "r742": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "912",
   "SubTopic": "730",
   "Name": "Accounting Standards Codification",
   "Section": "25",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482517/912-730-25-1"
  },
  "r743": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479432/944-30-50-2B"
  },
  "r744": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "13H",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480046/944-40-55-13H"
  },
  "r745": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-4"
  },
  "r746": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(4)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3"
  },
  "r747": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>87
<FILENAME>0001213900-24-026942-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001213900-24-026942-xbrl.zip
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M7#3+Y5Y512M#:(H@W+R(0# %@R5Q*G'-9DP*D1O-L:;/ \_!#OOU'[&+UH2
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MZ_/E9?OQ<*X-\-<K?*R9T^?OQ\</9O/VZM61_>JQ9SU__]%H7G;TI?7Y56<
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M 9F6YK^FE-6D#OU J,[ED[.QI%Q/OH,&N'7#*;]D G-OY;#CFOY3?Q*=':J
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M[7J0P@FX%C33?<+P7;=FA';>0L#LQ864Z;<-O].IZT^%X\&F0C.GJ4P% 4[
MK6\*MG#<=RH("$QD*HB&+U.2J07W^[YP-Q.8"MR"X7>F3[T4CRL5A'5<$0E+
MD,'C#]@7TN.Z<I;$7Z?F3G\&S'PG;_=T$88Q<4YCRA_D91,RR&IK2W.R\'F,
M^=)'G#'TM.N>6KT EUCI==9ZSJ<N3&J)9T^$VFY(YLMFO8O6(T6:XYV8>A"A
M]7D22))8SDG@/S"WS9";+].?(_?>(PMBLT_R%A,84U9;EN'3)?M8>VTBZ^L
M*ZS0-K"1F(:L,";< ;)U2.L!;;<E:;5W#&U3GB+E;21&.+1SR&#&J=F5ML$!
ME2UB_NS6 2'*2#V*VRSNBCPF_S+DA#[P?(9NO(HJUCN)K2,86*M5IF;B&(/,
MVKIFX:OV9L[O<?:&[6T@N$K-:W.(P^_]B!]:_$.)Z/,M_S&\(?^.W="-V-Z!
M/K@V24=Q0^Q@E:H#_-9Z&*FG;5R#Z;:S:A%CFYC^^3R@F5Q#KBIUWL]VF]@
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M*V\]79E9>B\]4'8<B=P'<N$SS.(<E[\39S5LDET?270/)QH\L29@+U&,+FD
M)E1^+Z./3D87[DI2,-:!Q\0*^88UVKWJ\6A@B=!5$&%-Q@YF/1]5KA'&GU[R
M?$TF;\MHN);\)X?F")>Q*Q+QOO[7A":39!9%U+V/D_2V<@I3-D+-B7-F49\Y
MC@,?G"DC9*.[.%4)8DT-,1^CRTJ7VDI56&*H1K<@W%I/) S\]%T+39-.O\PH
MH>_*VCCU:0A;)8IEW*VLC+?S[5)BI8UK"VARO8L&W?B0%=^Z%?)A=#<^*:$;
ML@TH/ZL5*&8W1%B;('G&^EEO%1X#[(0D.)K-JE+6=VE+) /H&&/#]5O\XUWR
MTTX_7CSA/)%C*W3#^;)".$,$:VY(,IU2GH@LCCBM9>_X.]]G8>2R^0O>>:)"
MW.!UEII*JJ!(%&WI8'\>4.*N_/1*F>F:6G[().*I<C/?27[UTLPYW$FE+X?1
MAT655-H#:Y2';TX"WR8\9299-=WPZPDECAOQG\ O#L2<IJ._5KPZRZ1T2]SY
M_4-'\7VU5T.Z(0!681]1S#[_JJ;D7I!#OW*3U/$5FB9N@]#-N;4Z9$&9I"2I
M*>Q=E*"1*$?26SXMEWZVO)@44M,+-Q(H,U&.YW3<JB2&*.WL"IF6R6MD^]<$
M:V]+SCPO>.0M+]DJ?AK$]]$R]O:OXV"H&50T<_<5:K8 JP^T/GK")#/<3;(T
MVPFMM_)08C4\N]ALF0=*:B?IJ1NR=<3RTA[BE^Y#7MJ*JU@M$:;CX?401ND?
M=AV$$4F>*>3B'!.?(1=QV\-QXIWLIJ/$;N0D&GUI1;_Y9=VQQ0B=!!M>*)'6
M FZS L&+Y%#&[ A/BSH23&7%U4(7IWM7]8(6U^=V<9N* CM1PZG@Y]9"R9H9
M3)*$Q:\=APB^2[.=T!9('LI<E6T/)O0JEV3[ZV"50H6KQVY^4XA!**"7JZXM
M-*0W#\-HOEQ8[,2$/?.$C*;B*MNPRO4#^_C!#0D)&PZ/&)XR&_&"Y&B3U7LB
MA0VZ.4[(-TH!F.NN]0'B?DE(R.<_$9O)7%>*@<J5TQJ%T;R^JA0/[;BUT >2
M7YOB7(3(LIW0+).',M=F:Q2F1_5?6L"&.]O:.$WG/-Z*5ZXF<?!$KS41>2P(
M20.?_6B30I@>5W'*[*>TAU3'-D\*&%,^9VO#F7U'BS]+GEIR1RF,<-^%9!E[
ME^Z2),BHW>2J4QW]7D(7K3$F:F8GPKW)/^,61J=N:*U6E*RR'FW%H:,50DKQ
M-+F8R_0NDD1N;#7\W5V+>GKZ:34O.LTZ:_/H0GB2=\\F3@;3_@H[X39$C7!/
M<0RN$Y)=D/HC/KXI5>^35)A$+^V2A,0'S[48Q42!;8TT\KU4UM2F,!W^7'V1
M*BWWLX?7DG ;XA9+EJO!6:#0)TD:0[2WBYHZ->VC;9]XHV+V7U2-ZDA@[FJG
M9Q.L3FB["VJTG0S?ER!KLIF+V7B7DL8$,'6_032"YBRWO5JS/I,>+?::.+%'
MYLOF#*+BH^19.QY<[P8@T*2ZN@#@+]GN!=PV#M4TB91W#.IP]FA19Q2&HBJ=
MT5=?H,U&634XRVB3F-=6DGF:2%.T;EX[DKX6$8;Q)OW;X ;40SC3;YE#F% ?
MW:#4MG;9^2@\S9_!H73XC?9G!<?<:*S?)G"J_<8.ZJZ2YCTD;)ZFY7HQ6SX&
MFEAJ4DRF5YDVS#@=.@[BS/S(=3AK]X$LB,U/UBX)SYYL+V93+GV%8[.-\_>:
MAFI/AR"@R<M#/5.!TXWD"]'&.N+U\[T3;XQW4'A*_I@L TH.K-A_PBCQ$5G#
MD8%<L9XTDVJOUQMZN0Y\?5;EY9+8T;Z.A EU8T5)88)ONYZ;3/VAEF9U48RN
MS]JVH(.YC(?M:0KY+3F3)[M2]YU",_B!K$!-BFD:@"+2,C%N\XTX>P:YGW,_
MSDKE^O'N(PE6U-JNF>NGQ,*=6HK,#<:T>[7H5,5X;!D]N7<(EM&:+-@PW=4Z
M8L3))Q*M V?^0"C[A[R\PLFS6Q_8)I=_(WO<C0]2=0JFC9':$K%/262Y7@@B
M(O_\140VE;Z-HOY3PXNE>N8=5LY4PZ."+A4);R6V/*_L, P;[*&9V,!*K[NL
MP(^8NSE+GXO_^568>E#@PX(P#>QX=\N^/GMRH7NPRG#$L[<U^R:U8S:IV%]Y
MD7W@F[2_THR72L\KZD5FF0-,KF1?/DU6^L&R*P\<$<\"N1V\=DJ#D\RQK,\3
MN2S+ IBFU/C;6S.*1-8B65JQ%PVM1@ZF9*146I<AC7Z[L?R5M!MF7RCHB?UV
MT%&9%I(6QNY=*X!VZDM+69]*QZ"^ZLJH849&6QU@HPV6L,S'"QS.K-"7<U:*
MB!KP1+)X2OD353P_L7%NX@V8A9;I&8G7":9=CFAEQ-!);@D+ZPD6U!*]48):
M'C'TLI>ONND%):'[U58>8H5-BXB+V;LHA5UXM7M8(V0H>\SYDJWB!%<]S3S,
M!3(U%2. "FOJ?"9KU_9(B**2"O$Q5KZU*Z.*3O<=C';U!\\/N]AL:?"0=N]
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M?[20YZ=9GHP_4<DRAA#)X 9?>B,%JP/8#I&Y;%G;>']U&83AB47I;AE0'IJ
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M&)(P^T'BGJ=[9>D@;:R3JJRWDH$'O.,M9UK@TNFJNM50IV:D0ZJ\L>78-\
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MQ^-BB!"7@/ 4++X=F<[>B'J*^!QX,3L-T-VYZQ$*H8$JQ0E-@!H8W9T%=2=
MPN&$K>JK@$*XG3*]*2VJ%22Z>_+I0OZ%>-XO?O#H+X@5!CYQDJ[/_4( [92G
MI 8A.C+][W1/5&DG1H@]?S/%2?@> 1CPO>.*S ZGBW/V%YCLBBK-*2RZ0CPD
MFJSUPSY5-S3Z1:H3B(^U0"+3&$US)3C;$+IB>ZN/-'B,UKPMF^5#+,+-=,<?
MZ&E%)=>#^%RKIX3%FJTX<-B7R$W!\S2AD&/=\@Z"IL4_)4TF$QPZ.YE+FWN=
MZ)1V/$V8Y IH._*J:N#"7M)9[+CL7V=11,(H[0_3-Z330G82VYXV6'(UP+T$
M4)0NOX[A_/:)0"!K<#/E:4R*#G1RE;2=A745,O/]V/+2D >('DH$)[0-*@.1
M7V2!91*4+G7VO@\0]QK1:9E^'9-<!1B'W^+2#ZB#!K*36 _:8,G5 'L6/L2?
MTB=I@,)P&;%)@%Z'((<:]IXWKPZQ \HT>EA;3M)VB2>! Y$?TDY_ NN %$RY
MAA .QED*4?8?+F9;S99BVG&)ZF24T0A)KH+6AP)[J>"$_3BGM\%COX1C$<WI
M') ;\,C1!S\EY[S2V08(?$9P:D:_!R)''/0F.$M#9$?O,/!]XO5.$FPD. ',
MFX'(,6\] RMCSI5+B=5[P2T1&G^$LSSN'%KQ6585U\N AZ_7@0^QE:P1F\16
ML@Y!GC$(6R)2G2UG; 1>YK! W4>)\!06S'9D<FT IM0OB!U3-K/>O;^_=:.>
MQ<\U8I.P^CH$.<ZP9]6<S]F3O>8OD?5>+!L)3F"Q; 8B!QWL>?OB:2PBU$K:
MO9]:D97E9X&<5AL)3\'3M".3*P,P3_EP3\P.Q)OHC-* G@2,GPURER)!?EJ1
MS#:<<O6T'5ZU(_EV\@!&FK?H.^T/F2K$\^MD)[$ZM,&2JZ'US7OUE/'T1NW<
MI9N+?MB7*4W!*U7&G@,,]"Q]@4/OQ;=(9Q*&7!IX#BSL[6S&@A\CHD*?@#[X
M[FE-8%]3&WZ.,D+R<78FN ["R/+^Y6Z!PN^-9"=AWFVPY$57G:=80>.MO[WA
MK/@S]MP(_S]02P,$%     @ I4I\6"KC%%^2C   (BX' !4   !A<F)E+3(P
M,C,Q,C,Q7VQA8BYX;6SLO?MSY#:2(/SS=W\%;B:^"3M6<G=52=UNS^.B].AV
M[:A5FE+)'J]C8H(B41)M%EE+LM22__K#@\\B0 (@"%#>N[@=MR0"2&0F$HE\
M_N7_/&\#\ 3CQ(_"O_YA\LW;/P 8NI'GAP]__</=[?'\]GRQ^,/_^1L _^LO
M__OX&'R"(8R=%'K@_@6<1]O=K>N#=>R$R2:*M^"K=/LU. :/:;K[[LV;+U^^
M?..B;Q+7CV$2[6,7)O@7X/@839A/>1Y#/.%W8/VX!Y^=&$R_!9/I=].3[V8G
MX&Y]#J9OIR=TR/_Z2^"'O]X["00([C#YZQ\J*SW?Q\$W4?SP9OKV[>Q-_N$?
MZ)??/>-?U+[_,B-?3SY\^/"&_+7X-/%9'Z)I)V_^^?GJUGV$6^?8#Y/4"5V\
M0.)_EY!?7D6NDQ),=L(%N%_@GX[SSX[QKXXGT^/9Y)OGQ/L#Q1L ?XFC *[@
M!A#(OTM?=O"O?TC\[2[  )'?/<9PPP8DB.,W>/R;$#Y@U.-%/N!%)N_P(G_,
M?GWEW,/@#P!_>;=:</?TH387'?1&-YQI$\94%KZTA,T0!M=1Z@1*:*R,+'$9
MX)^O$&0UF.%S"D,/>CG4>)H6!B2K$';/Y\4S1VYMS@ S<A3G4Y*%__J'?7+\
MX#B[?]^F",0M#-/SP$F2Y>8VC=Q?Y\]^TD1<@F @ZV^<Y)X D4V"@)G.WL @
M3?+?'./?$.QUK_.F"CL&K@9]+FRD,$*I)+???P?W 9$:: 06F# \OKO]P]_(
M9R#: /(A^!E_^J^_T"7^5H5Z'M?1[L1N#@+Z9P?8V1=OW A)H5UZ7-O!)HZV
M$@1+(]'=9J='FF?F20+3Y'P?QVAFS7Q2GYORAE;F2"OGN'MW'*X@1QJX]!O@
MD!$%4P ;;,&D2945FMMZ\S=%F4&GND9 #<@"E>G?_,T&!Y0 M#)!&(7'7$:P
MR I-\C2YX6"+;Y1O$3K=('Q@B?JM-!_/@>?3MB=%KWSGW@_\U(<#"7K& C:D
M?1,,(9$?E,/LL@&?3E66X.Q2^0:HS#?8-<!>P[0T8$+1RB)!%#X<IQ"]H,?(
M).W7 G^WZI*$Z)R/4>#!.+G\[[V?OFA_6C06L"%)FF"TLDGRZ,0P^_Q/?_QV
M.GG_9P#),-OZ Y]@]:<%<[MO_J89[SL8^Y&''C)Q*H_]MPSTGSD!MO646'YE
M*'X[P(N9(ODR].11/!%!\>MCY(D>W6D>>H/+O\[EM)])F5N3"5+[!5H.!D[H
MC5A2BA*:<\7R45-J.5*,]RF.DN0FCC:^;F6L.K-I%:RR-H=OR!=@1SX!7P7H
MAZ]MLP:#%%4N.-R3NK!9[K 3QP\?+I]W,$R@[E=X<W[SXJ0!0ZO\B/*O <P^
MMVFOY=*GR@[L#2I*@6*R1>A&6WB%.&THGJBL\.9OMIBB!(+#%L67 (L&NT^Q
M%N(P&>)@<_6'C11;7,-T,(:HSVWC]56#@,,'Z)LZ!UB@/Y,*5<HW-Z)=WC[!
M^#Y*H!0Z62^I!C[M'"EYE+[M8\[ VFBRW*<X9 #'5NBV9C3FM_:D/H2$<ZRR
MUQ[XR@\!'?.UW<<UCT*U5Q]S<YI56[%G-0N2%L,%$\^O"LUOE3W/A3^;OI5P
MT%(4HA^3(2,6F&OI5G>$8A98D' .)?T4E-\>ABY8LL@(T(\9P,#=>C^-Z-Q)
M'M$S[,GWH'?V<I= ;Q$6NM?<3?TG\E+7KRZ)+FS^L24.7(N:Y:(9P!X-!$A8
ME0\RIQAK7V>0)/V!0B&#(L5W'&>51?@$$QOLR5IX-.S) $Z4/?U\Z.C9LX7T
M NS)0Y%>]OSHATA+L<">K(5'PYX,X+K8<Y=-@:.SO\IX]6NPR2=B,^MX>+6%
M#P1XE8<O15[%2^#_PUK$DQ-@!6*%SD+LNRGT\!_FH5?_1>7+&Z+%HQ=D#)T$
M7D#Z7_1SL/>(R<Y]1 2$*Z2I7&XVT-5M>S<,O'[O8N>A,;M#SL'+9P!?>=D<
M7^/; 9_%(WHB8;DH<4S%!4CD[[9=#G:8O'J8+=!1]279"]0Q'?!A;!:=QJ%>
M,/-B[86/&G!2D#Y"< \?_##$MV&T(;]X@4YL]SK4PEC:#E73N6C.L-4;<)81
M3)Y'(/H3BSO^'V]4+.%JCL;XP0G]WTB:W'D4)E'@>^0'M.H-H@9:A/RXW&3J
MG!,4]IQD?H_ <K0K2WI@,FG=TP(Q+S""I'@&X.?\NW]9M<QK99B:NU0;#GL<
MA[GK1OL0/[!OT/HN#O 9AL=;%M*L#+3Q+1\*#C/>^@^AO_%=)TQ!.1CDHYE,
M:B6SHI..M6R+=C2H.QK1DQA=L^G+#4)BBO@82^X=9MBSES4:/H#'0V1%L]F:
M A!QF.T*1^%?^4](&5BCW_OW 00D,:;A![' 81*DK;*:*#9DWT1)G/Y[A=]6
MHCR%!E3X"?U4\E)]+@/BJ+8@3_)@Z9^D2/0$X#-Z5>YC(OF;+C&CW,!$.Z9W
M<TNJK]P5?(+A?K"+J#&]P>OG<&T.Z;//V)>+C;//(TGUH#/W)G^38#XJU)Q/
M,'J(G=TC/@2:SCE_;NUV=][)YX+ 58C+ST9P_#NIDXN#]GVJL0:Z3KR]FR[C
M6Q@_^:XNZ<^<UAA#L%;G\$+V*;$=9%_;5 ZZ2)*S G>'/6+(TT<8T[3AH9[E
MC!6,/K*;ZW.Y NX<WP-Y)#9A#S(<K* +_2<'J9+C>:RTD*[V0.;L7^&YZ\3W
M\-^X<)*W#^!RD^$K1Q=22\E:%5RQ60I/0_AD,J7UD/ZH/K$1Z:(,'D\IS:;"
MQLD^3&>4[7H3'S-E/TSVL-#45\H7&KB<B>"B-H+FQ4!K2[:Q*_SDZ%E_2@OO
M7+E( O>Y/M =V[W> #RF9+WIO(+I."(%BT$LZ3<FVTW;]2N&"?V<=@V-,1E>
MRHX,XP,DPE\P__X(A#"U'<,A0DDAQLIWKS\"#L;MJ4-=(+&\NB(4^1U08XC2
M#0+)7%U@L4HXT%3:'9\NW_W>CDJOB@\X5"DIX[^'N>!YJQB^UCE@\!PQY.L1
M/%T$:56KU="R4^G+^N#5<[O?[0)BTG,"')CQ,8B^+$)<>9EXJE<PH+5C*0R*
M;VC%14Q89K1 *O"TKDX,\,P 3PTJ<X-L<I!&@,^M]A[9_3B%\>#N@6MY$7FP
M]F<GW<<DGGNY(?-7ZZ&H,;G0E 8\4PI@"?!O.0W^B4P$*C/9#NWI05X&9PKC
M3+UR(41O?%B(]-HB+S?."XD(NM@SZH;WO+H%E[40?2\*6WO1)L*8N^QK^W>\
M')7KE[X$.F0=\RV2.$OOOGV$N%Q!4QK7(=*A$:BN:,/<K@%N664AS[<GZ_ 4
MAK*V3)NB.P[EH2>'=6@2?:C2PZ9_'FVW?DH#.4/O/"*A>##$@7@7?N(&$8[V
M&>A!)K>VV= Y*=AX"1GE',0"4,R2=JH@=G(O5'BA%D\OC335R*P+&/M/Z#@\
MP46(IMOG:WX/O8=:VN/@3-P'$I,N_!YP<MC[1R>.'<S;W<QL@YLUL$B5M_OB
MKX>,;E:YO([2H?BY8S'3[6;:@.%I)(R"IUD]EY$D<H@1M+W*;@,1RD6!,+K.
MD$[AX?(P,$QHY@<^VP^0AD>7GV0*_/R+$WO+'?ZP6IWH>K^]A[%NAM0.G[4R
M53IWP2O66'Y'*_^"B$Z $_GP+^]'4EQZ**YKE,_2CO2>Q>_TP/,C]!\>T<-@
M_H2>!0_P\AG&KI_ F]AW=1M?3$$]@!_&]-%LVQ]/B\J&'#MT#(#9(+##HPZ.
M+:E>=Q$%@1,G .V.GG'[A>S,,?5 Y[N3<LHF4XU +L(T]L/$=W]P NTVUN'@
MU/W,,7VJZ]OAG./YPT-,&E8"/_\</.'O6T[P[^7<LOERH)/*H$:?MY4J8-=1
M2&&CZGCE43A:A5@&Y*&*7HB5S1UX=]VZ\Q&@7Q*OX>KV+CFJ%$MIJM"OZ?@J
M,*Z6DRQ+G]=U:TCNCA7%U\Y^_.?;_V.^ <BCK.[14NE%PF'>!WV >@-M*QGQ
M,0H PB\6AT: 8@C(QS"22BVPMP -JUS9M7_%JHN73HRO&US9C3#U0 9?[C(F
MO1,\(%JJ?.)N! !]3XNY@WF*U,+[?4I*56#/<HR.M!._D#]GEM,1>2>ZB%OE
MKU;D]$]!S#%%B\VO'YWT1QBC%S"N' B]CPCL]2/$\G:?5P&Z\(,]>BLC*F B
MM/-G9TB%]N7-N"@&WH5 M$6-PV$"\*( KPKR90%>EY1NJZR,AV9K \8YLG]$
M#+$G(QYC$"(J2O]YF/H>GMU_@K?0S>+ZJK#4 #F4$6<O[ D&T$.&A-1D0:[A
MML$S&54&@'+$H0YDHX;7\,Q7*P(V,.K5/394M5L[SX/'D;2M9$&;9P+""V%U
MGG%X=0@RM=YV#)\$\9IJ/'_CDH+\X&[!'.R$+PF^)\[@)HIAL9YR-*K8G#;B
M384@$]!QLGFR,(Z$*BMTPIS;*/>-*XY?BM@,140<?3U,WV53-RIA<;3>'LG5
M+-(T"IM+7SZCE:-,2UJ@YR[)]D<C$7X":IN'N([P(+)Q&$AU:1@?Z-D(B0_(
M6W=E#0RXI?$6G## <4V!/AR.!T@VZ<H.'WA+++,T$;GW5.3Z5.2F>-XCX"0@
MAKLH3FDC(/S.=(OJP>AW25$C&(ORJ !Q%-:]WPL7*I4@/[AN5A"CS0]\ D\!
MR!D,X<;GU%OI5$X$)S64?:T$G(""4I^HHI. ;*YQ)</*49JAF4@@3C4@M9@T
M*R^4S3W4>^M@%1M%6#BP<&NR%C*WE,9(0I,Q5N.:.RC'?&PQMJSL>[N &QC'
M2/MRGFDMJD^Q_F;=G$7,]TIC ]*:9NIE0S#/H.L;#[+*,.T$JZ=?<#>K:&!M
MS%A)8]%?^*EK-<V&3GGFJ</#X:*+)O^0:C;X)L3!;O02=((@^F(_0D:0P*U<
MQL!*C_!O^("U82J_B1I72?,D):N'RND17]BHJ5$<+IXF1B>H91>/)<='FMBU
M0!<YS*CZF(:L63QPN>+.I[)0N>+Y[>WE^M9V,$!W 6*-M8?O0O(3]*3>=<U1
MYDKCL0'@4-22<:$=M<5#BKV+/EV3"&.<TX*K@Y[DPS5T:RQBY_D "E[F_=UJ
M=7F]!O1X?V?5E=I&H.819^U/7>/(>M@==*Z;I^=.'+^@:V6(/!*Q-<T7UA2"
MJZ6U)BGA<-@YT:J*(47=P[Z'8JA05"SJ31//!RD,SE[#M%1B0L$UW"0IJ^&Q
ME38Z+02J]]+A[:]/&BQ2:M<PWB[")S0]\1#H?O&PEK#@KV'!P2U;@#X%:,8M
MN'?"7X&'=/_$3VU[2]J(50_-Y^Q4U0R<=09,RD8&N-G](**D=:DA#,*=NDX+
M0#P#7^QX$,3% ,ML(T(]1A](_HY[5'?G]RH8AIU$5K0@BP3 ZFCJ ZO]52+2
M7Z5DN,2NM4^"S**=+ [9K_]3^ZW:6_O0QVOCN?U6X+UM_\']MDKCMHWHH>=$
MC9Z3$=!S\BKH.>FFYZ2?EG'0LV90$PIC&4MFT28DO$RKY?4QSYIBT5;*)UC3
MI,+9JS;[Z51-"$Q'( 2FKT((3+N%P+27$*C75EWA2C#+S1U2!S#_:)8$[6L9
M%P>MX/#J)!1%>VG9ZAB/.HXVQWOTPV%4@9VVCB($K35X[$2#-G$Q4Q,7LQ&(
MB]FK$!>S;G$QTZ@#GJC1\V0$]#QY%?0\Z:;G22_Q7^V2$'K-4IM#]2,27=:"
MK4 4-E[7HL7\;'&U6"\N;\'\^@+<?C]?77Z_O+JX7-T6)5G_<;=8_V35@2)+
M^%J? QD,Z9$TIVJ2YG0$DN;T54B:TVY)<ZI+T@SKLF]9R+2'C ]*A_.^(D2L
M>O"[B<:1"WI]^;F%_,9YP>968N\?UAW"6LF\W[X%FE97R(Y^GU@-_NBF&<L)
MPMNJHC>>TXQG&.;I6,R"+M,.D> ;-RB/M56518R6_*<M<_NZK0X"356[H6+E
M(F9_!MM:5[>H3BNK)WX(^O2H1G>YW071"X19&Z'FY:3Y]'>O9\.=W@D51PCD
MXZC#$UTH./\2.*X;[YW LK]3F+*U2F)"B.B=?Y6%J _#8IQ%S"LF;$"Z,F=B
M^O4X4F/8A&)EQ# VJ9IT4%=R"I<[/E4&))3T\C;C?T2!Y&4WT.]9<1L-[=AJ
ME) L+[0HS6*X4FL_W; &O%.SR+P;@47FW:NPR+RK4KQM(WHL;._5Z/E^!/1\
M_RKH^;Z;GN]U6=@&#^IH7\NX*[<5')ZA?GG]Z7A]N?H\1FN;6)!'][9[I%=Q
M'F?E0F:L)Y7U;*@CG5#U,:+8T3R$"2OP5#_ @_:7B+HYI0X9N[I3^'!,D@XB
M(6+]KDCUMH<Y/N]^BO1-$BY2;22@62BT+F5#'K0!U-XL=C1V5!'R5?FI<\N:
M7A3?JFF@WXY  _WV56B@WU:IV[81/2^*#VKT_# ">GYX%?3\T$W/#_WZXYJ*
M!VJ/ #*;MB@;\,,/\+$<+BX7U",0QJ.8B!]MMU%(IA\DY_YP>M,,<P@ [T%0
M;UEQ!*X7M^#M-V_?OIU.WH&=$].6B7\&D]G;(_1;_'_ V:>/4>S_ABN*TDX7
M#G'[74 7XH9-8#8Y A@EQ+R)_C'],WC__NC#]/3H[8=3\LMW)T>3=V^/OOWP
M%D2'#9+1=&G+7$< ?;*#N+T[#%XLQS7SV*B6W,\BA1;.O7'B94S:''EDYKS^
M_G#,S%W10AB! %A=7)]D7%\P.FD&>@V_H/, ?X4!LZ6O;4;KHCJ']UIQI'H7
M5^:G$F1>R(;AF+"QDH7:)7QH1"5M+NN*@3:-? )TY+ 5<_N:;SL!>TL'1,SV
MCH=2H'*O83% Y_EZ/#>,!LJ\U7?2AS.OM"YEP[S2!I#D<:]H.Z.Y4+CT;&6L
MWO:6PE_L>3ZNH^@$-X[O+<)S9^>G3E!94'?$0?>"YK. .V'BA104 P&NFW",
M!)=+Q]JVZ(O3M18]((:('BZD%4P=/X1>WK5J[KK[[9[$7UW C>]JKVPNL*!Q
M?NN&B1_"DG^(JU?C+^T*,G%RULMH">U?6Y+I1+'2R.2M.=[@0=!E=K1N<IP(
M5!F9O%5\=W.F4ZTT,K%.S\Y"(_;I*5)E9-+3CI(%4.HN=%=,:T-1S1?GUCND
M?[9;Z+".]KI0KH"OK$^>1TF*^Z*0N;0_3:ISVWF+5"#@)>RA;XA%-CXDN+5'
M+(,D]=?%X:XTN6\GBL5@)E/K<KJS%HQ].2U0"&8RU7OO*E;KF,RLT[.S6(=]
M>@I4ZIC,>MZ[12!05N)OJ'8'_'5LICP> M,9J)>G"GQGV0[9239FL!=SNZHF
MR!5,(((85\J^0#=%$.UP4=ML">UJ7-M:%I[K+>#PJUN3,<1SZI6C2(,@VV]V
M 4H>5+WNV'\/@] M)$T<T=R?G?A76.%;W0$E_(6,!Y1P0>$%E#A!EJ^TS0?8
MUBJ[Z5;OX-.Z8_4+[1,,D;0+T,1S;^N'/I9T.#AA&![J6LTT(W7 P^&F;!3A
M)Z<VSFH0JB IJVPELG]MRJ]B:;/)B77EM[.RF7WE5Z"LV>1$+ST5"TA-3JW3
ML[-^E'UZ"A2/FISJI:=B^NGDG75Z=F:?VJ>G0.KIY)U>>BJFGT[>6Z=G9_:I
M?7H*I)Y.WNNEIV(RQ^1;Z_3LS.6P3T^!1([)MSUU[=Q=FP<OGCF)[]:)VK]D
M#G,-TWHU$PH.$Y"_@2!**O&JP$G3V+_?I[@& T@C4(](RF+J2:#;110$3LR.
M=;512*>-QK7B.5P4Z;?P"80@<L%AIWFV$BNJQ29FQ#H"]X30'31[E20[[*C2
M1\HKIGA-/EB7\IT97O:EO$!ZU^1#3RG_(\09G6A"=.J<!WB]QYD@RTTC[G (
MZ2^WM@57@A2 O.3?;(YCATX"0C(+=AEG<:K[!'H QQ)&V]V>."+N^UTRC6AJ
M&SG&*GQ52SJ6QKV>I-6I8O38U'KTV'3\T6-3@>BQJ6KT&._BN_"#?:H]28:W
MBI4:CVQ8>.7XZ%\'46)'H! =D+M-):KBR4;EDA9X]"FR7D;NKN>''<>2'NJI
M%#/A2!_%8-.I]6#3Z?B#3:<"P:;3OL&F',4AXY:A$ZID5S>?3RD)H4:UUNM[
M\1PJMN/1:[NX2T"S;26 ^2Q/!2A9=U:#3[C<T<$5 K<;(XOT?PZ+R*>;<N2O
M:DM'ZU&\T_%'\4X%HGBGJE&\M4(N\]#+RW8MDF0/O8M]C#@%Z4Y^E!4EB+/R
MUH??:[X1>X-C/ *P+\2\BOK/,';]!.([\DOVJ>5(4UVLTJ@CU!=[JA9J,EES
M12HQ<P(L-VQ6YX@ZV3G-J70JX$DPIVV=JP]%"_FJ@IX^ :[LY0C+GT<ANL\3
M/PJ7&_KOU$?:S2UTLX8N0TA>95BLU%U3A9:;G96/PWR]RT5.KH3Z84.QM%N9
M4POW-(1Q+Z3VU$-X)V\D9T$4&///]'X ZSL/8WI9Z>$H@?,A@V7%5C"B)_,N
M](=1R877MN!XE0)0B-?=DGX@B)RP:5(8A2XNRQ JLKY$6J^RL"*GQB#S\A8?
MB1K# 4\7[X[&[Z_&&DHBN<['^M7U:_B%_,6D]"W7'(W&48>+P[#XCPYB#M*2
M\K#87PA3_'L__\;%-1/&R*5LLHO*V#J.]*H%E/L-<^3AHC9"&\1 T\:5KT;;
M5>%2%M)ZE!+\99^D.#4X64><2G)YW"GTSJ,MSM%S\$<$NN4._S-9P?_>^XF?
M(J4Z?O)=2 %=03=Z",F,FCG=%-16&B>:V1LO:1G/<7R/IR9.O7QNJW+>,)/6
MBRN:HX;R(6Z[SNBO/T9QMK1)-:BY]L@>H0T )4\%5N$3.A3LXNC)Q][LD5XX
M[=P@JAVQ,:;Y!4I6JIZ?W,"O._I3?GT[7DP9$ 4\0Q$=0FH)/,$$!UZL;N_&
M;#EI9091WN6C2[^GB"II%GFX#8#Q2.$6*-7Y^'584?JR=!?J-,41*5:/FUJO
M'C<=?_6XJ4#UN*EJ]3C.=(H%4:;6"Z),QU\092I0$&6JMR#*5+$@RM1Z093I
M^ NB3 4*HDQ5"Z+DXOT:IN=.\GA#GP_>V<L=DN"+L"@(.,=]NXB?<J"RCPH
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M6\E5LX+RMVK^'/*!89W(=90Z 4AX/L3F&7VEA% _M7F$SW)SF$96\30NX_/
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M"21_Q$T5)X-*+8'E[8NS;B!YK9:R@<"A(T&<#\V$'VF^^94?@A>D025?CT<
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M.GZH6_0W%QC@G1FT"?L&!#PNP!]B!R5MT/HS_=B*FZ&;/#4ASMZA>FED\MC
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M@KJ"3S#<PX]H\TA3)JSVHY\^GN^3%+UR8G0)!'ML4<3AG^C_XXQW?L\7,A7
MB 3Y9. +F@WDTV';338AR&?$+T.;*J@"!EC$5D:D85?!%5X=<@J,Y%ZDBSW\
M"3KQ&EVL7!< G>CHL&S+45FWY0B[WNXAB>D\ GA"0&:T^]:71@"+VHI8-"C
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M9)FG)'?/X@TE!)HM@]5:9*_SJ210HA ]CYAQLR,L3=CZ%I)#E5D7%[[Z'J/
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MKRKA<KTN4]"1=\5MNDEE/$N&M[QH_\U4ZLA:L&8V<(VV\^D@ P+S'T&.(SB
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MED*(&<^31FNRLR%R%_N3,.#%ZWB5/V#AUI(:G%SK@<-TS99.I8N=&-6Y)"W
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M2<]N64UG.!9I#5:)"'^4$.&[6(1.W$>B[;*[Y57D-2VX_-@#NI4?@9((Z2W
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MLRX,S]LM7(\7:H8^DF0HX^4'"<A6"4I GQZ(V*^=*,'%]\N+..J6?1/Y82I
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MOD.'GS'=4HLXX.F^=91P/',2 JR%";.T5>),3(R&B3?EC2<U[JA-Y'HOR6;
M8"V"]@T=KQW*"R'%EOF$5T:"EZLX77Q3IWZAB@.H?N\O!!^UO/OS)T]J)85"
MI\0D=$NLB9.YSNIS PC0'L#Y*H<E8 FHMEZ?I#-PUD"X[D;PS:11/$%J4A?
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M0N@[BU-39.CLH%X!K0JJ<X3U> -V<2X]0G)1A'0]'&.DQI@C:5E*ZU"V<J2
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M\4'%8"ELOK!52/!!4R'&*:;N9?BT]_3CJ8#/'7?\TC!+&4;CLD+*@&<N6+O
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MHR4(8EC1'MCH917)\.R1Q1D<-6*/>)PV,+S'1#NO]B[B'%CX?>(/:*7VEE+
M%.ORY]-HA1;IQXGRA6V^7D_%@O%F<9V<4A0[!*?W57U=86&)ABU=UZ+W[.2J
MRH\S&_)U.C]RT4M;]]-U%+U?([!MB7,S7=>*4EHTKEH1J^.>5=(TZ+15T(@C
M&;&$66T;]CE;O]OS>),9U3M@$>R)^:1IZ$!O2^F!4_TE*8%XDI=#V))FA 53
M0K/CR>BT81989;4URWKQR>R;JWE_4(;!D8[14 V<@!W8'8.60=+E,(H\O E&
M*!R/Q6)D!3ZDCN";V9I,6:A5"#P]:^F6<3/^Q6L0S.#Q%NN3"G)V8$#,-!3
M-<KMY/94VZUY+\+!ZP,%56*+Z7KB=?*JW5 4A?#ZR3+@6E*<N15X$5(\PHE$
M56>JROW&AOS0VB;Y!>ZL4_JIRG$(E@N+?5!E<.FS,,@([YAGD>&7H*J$E _O
M<6L$W%?^'?[&%*=95194A6JY\0;Q! ]@]V&!*0TV*LD#%?ST1134G# L$%;?
MX+J<EA@XXP+LP'"9!\LLFM2R-2C1#.I=+?A*'SV+RW9)W=,<9H$Q5X1\A7K>
ME@5"(<$OXJ4W"20%3(@B*!UTFH97B3U3'Y",[/8(#>+$GW>V E0.:W^>J.D9
M,N!':+)K;>?BM)=P1Z^ 47_'$X$[ZT2@) )?KQ.!=RX1>"LU1[_V\)N,74.$
MI1>E+IY.J[4X3M9"56A-%$>3/V>8@^@C(M)M0!HG^,*,D2]C>/ 1&@G/!IVT
MI.EMVU%?;Q*>95ATRNT!8FM11:OMR8X5[]HYT(<#!UVM+! '#.U 0K&XIX0]
MGGS-N%F!+XCH0RR-]3]&3Q*SD\FDHDP%4=UEQ;A*K),I?3=5,B:4;!6G'L)]
MS:GB"5('>H!YWBE+1*,L$E#7>+D^&&T=G&R5AM6-)ZHJ*JQ"=W'FVM'KD.M-
M;*^PT&F<V/XS=;\H$=Q!ANW?C ^P+LE?8+E&T>;&%4>,<\[?"B8O0T(G%,?L
M%,_K(F+N)P(+I5/<2U9&8HOB'VPYY1Y/A?@6M0DG02Q&C/]OL-V+%J"-9>1A
MVY^G:0B+OX6[3V'0M0WF,%UPH%0A-4*[0$\J9 ,;<(=$[K2E'4=;4.JB<"NN
M^J#\-MZ,/RJJZJ"%+* 9\PWV-*C58_8T8M2_%"F-X0G-\-;&A[ 44X--H70Z
M.;M<3K64.8;Q+$_+/<0^: [^D:P&1Y,K4RESX0/C!7:M5M@!Z"9,O^ 9DUCI
M9)=$4@:N$PV,]15M(I&ZTPJ(O2Y]8H'^%#EM2S[C&\?OR3'CH)="=R)@_@W\
MQES!*T94(][6RK61-^)W]ZD/:B 8!(\:@I,[SAHIT"2O1(NTU?>=LE6L&T:)
M\/"C,!MG)IM,R280#Y'A)+_:-!YN+QH")P%A7O+2EB0$R(U2&4J&0YFB*G9R
M&+0CN@(%JESM\G@-(ON>-#74BL(Y"8TZ@5M_AEW*PEO)T[\DS5P B\3S*J7'
M[[$DS3)$:1;GQJ>>)A@[.ML>7.E@_XJ9Q]%^,09.'IP?;@M=V5)%6TWVC5(G
M^B!3013M[-HH_C1Q#!P4O%5OX)J:T;UNF7>2"=>DY\Y/BZ?P#'9,/[:N _^T
M&]9G;)#I@MZ[5IF]%026_5[J*B<UZBEIO64>M3L05_W--5:KM$8G80>F&O<"
M)6#?N2R#SJBJ2AT=D/<]'SKWTQ?(?M@&O:-H]YVR2W:M1VE-P%Y<$DK<@6X=
M/-,2\KE3AHI4Y!!)S%V)"T<IZ\;9R4'\TN=:\V185E:=$\P%;ZM(#KW*C*BP
M0DE!K*2 R49MA:%H%6P*LK0^' *D>]13K/.25H':S#*!:Z:(V4DH=?CHLZ1"
M(_ZPKA*3<UOSYQ8LO 1MI-.DEB/[UR]50EU(DG?\"@JD&G(A"I[:.;QIJ@Z8
M_E?1W3;=\;N!#Z*.O*O4TT6";GH!?MU@8/*IR_F\>0SF+/*CLDDC)FGS:\L<
M;1(/5P1 *COO<I2NF2$(3Y^7CIXGJ/"+B+P3>E(P#&F@=.'(\_"-?0.$W-0*
MY%*2SZJKH"T;3"ZP."*OD?J*"J0/+15*JK#7"HX*.OJ=/;M<?=B_J(X9G'WV
M&''/(Q64!6/%:$,WX=3PHFQ=IK$V+CU"UJ20OO8\WB52$QF!7[Z@I._Q'&"<
M;K9XVQ820BO49EJA\HT43?R@(]!A#;<-#I!YZ'\D_I&X8XV92,M,6.5KN7<"
MS^K1%!>]1VDD'P#-"/A?-]/4NM4@9JV:4FJR3M)TN=T_Y*RV0/"P2ZDEG=A[
M\3>2#)IB-5_.H""Z?RJ $N%KD:,.B\DSP5M'4L)!9$_0(B@1%6X*KJQ6HXY=
MXY]( 1]#,LJTZP2@V5_B !]LY.6$O&R*%F@>A=X>!#@L]%:TY93*-AG$V'R(
M6]/V C0E'_Z.]6&-5/S@<=U^TZ:$%BN+Z&5=][(#F*6JHYTFF@9J1YLT0VU[
M<%QP)J5NP4]*1Q?N63?N%^;@95*EN^M4J:1*M[?6N=(KH,&M-=Z?UWALRKK4
M%*:4>DS6,4;'=%4S>P =^ ))!:C".+[.!\:&[8*)G,T7:5<C1H&.WKMG.FXM
MC=],&D]Z#%SP\_69N-K1L4>KQ]'C5*:K#29/V#;OR%-8^-PM-(^8 YC!WY5%
MWCFWK5<>_-X'&-F@5';!TL$O9@1#TSDP6&4]=&! >E]Z#6#]F/?*%\KO8[K+
M4#FXD\K4ZU0B6.N3;Q_1[=J=*DHQ3>;S16SY%S"[V]8N7%517@_=)/@P-U1,
M'^X'W*UEVW2$W+8M,%:9WR-KQ?]8A?F 2A#&H?!D6EZEI<$4&:&PFE%+";X2
M=;WMUBF,S0 O.6A+7IG>%CJME!)8-R.OSMA^X6";1=%U"AVA $XI([R6V\<J
MMX<=D779:FL=)+7.) >I"DPH4<"=FZJGU'[FR&H"@%B2VIIX:ZSPKF7NL<J<
M!*D<@@;9NEB'Q#C$]@SVQ^T_VH1R.1;'Q/6"+ML'-I'1#\&\%KE'*G(].50;
M*:A,:KDIK-*3DAI,?7H;DY**J[-A/2BF-M>I>D$\ _,Z9+ 63;KK+U4)DRB
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M\)=) S/>SCU5J$6ZI8OPJ9Y1,<! 76"4S^1CQ$#+/;4L1[X<F9&+7X7^,]J
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M:0G.P@YZ%,ERMQYS(MZ##<P]L-JUV8U:\](VPP[F]1+"$NI_9&H)V_2Y"&_
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MU?F(QZ"*5[DM:L%(E5U\FGZW+8GW$GTQ.80EW(TI1<00$!S;A[=? 46F=),
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M)2^,% _!"=D"2](*;2=MBC%'&5DL7/7K(5AAA.T4'*43WPCUP<ZL"$64L,:
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MO1*GB&U@[*B4\Q<[@TTK--/-,CSGOH1,+[!#'%JFP:)B.[4X^3K<62%LP0X
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MA)07(,['97A<AOM3*,&H#9N][<&&AP9[ Q1><EQ4QT5UHVU3Y"W*5]6=H9C
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M*4H"U%@7?PEM.4U7JKO7=5 ?N"B!,\>U)8F\I2_T"5STP>/Q\#QY^&<Q@="
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MD6@AKB9%T,R1G/1,Z[/X*1 TQ@!,D\PPW3BU@;C@IP$RZ/+@*Q_M2^@@483
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MP%EE_-FZMR236:T6YVZ^W=;0)<(N0P#HW-'39+*[GQ0/CT\)0F/VW&\O;ND
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ML3Z#K]NF:S7^N[<U?JOQ'VQSC?]-J^:-R^YWOHM-"_2F$L7AFTL4G\-C''V
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M#(_:D#RD91?BV%X>YNT2<2._N&^DZ0JT60H'O%:.K-$&CJQ1TB>_(AF0^^2
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M7_%:GNXOU[+"]2WC7?H"V\T)@%$:4$>YZ'?TN,9&'JYNE:(U**9<7.F?X@<
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MKQWH[N=B@PLE5UKD[MZ*B-#3/^G%5U;B\1E=Q0M>YKX,!G?!&=.R#- 49+X
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M[K2@3*#YX!#T%/\YMP\F;GXG37$N:P%%/T#&))&I#:HW3?U@%;W%KMWF6 _
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MT4)QSA<^\TRHAX*ZHDH11BCY6&$@E%<MO])#Q2=2/M7:'](2.56C*U\@;#5
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MHJ\BZ\U4>I9>D%>DT2^(N>3H]](7-81C\]& 1E]X6KQY-?HLFF]Q,- B;<G
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M.]F<84'".&_>><_>>4R"="]3.* L *6%="7O$_72281< FSJ0G+(6UB*#>P
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M6,ZU^@WLQ*T2J:?>ZW<.YJAWY(5IG?R/>YT=72MUYY6P3V;?D>W."%PTF5"
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M4@S8Q;!D8/Q^-^BM3..@_D&PT[MC X7EWL_6$SH:#LMIR1[<D1I'PZA8\L;
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M5\&-$[5%A]JN0V^G!L 1N#JE4TDXMF5S1)1NR6BMZ--KT1A[=<.-P/KT& S
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M+@#3I(<3]IM3?](P24K3IUE7!W +TM[.KC_0,&B93Z%HP0&B.^Y^8(,P:T;
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MK+%V.S=WA"J&#%IRFG[2Z.7G(*LI5OUQHN X?_%_5]<(7?T[?$IW_>)*H5P
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MXR^54Q]((^N\1T^NCR0VM@ "2XEZRTVL!-\:%>J_@WKPNLRJ>-&/9AD^C;"
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MZA8B_*23,]%# >MFMPN%1<RAW^ZZF3E^6(IS<%>&D8? %8R5U-R-$>?O888
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MLV)6YJ3'NQ^N.M9NW1BGJEY"M<W5NM2V9O1VMX!8_SD@I@-BW>> V%.3-!F
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MSY)U'2_N77@P^]S^29,H"=GU]K^_DYO:ZVSO+_VJ&J_DD[/D?\(HD^C6=W/
MCW!Q;RG <*ZU#BZ[(>9[P!8_A"I],BE'%-U\IH0UHX2O8!#G0QB5P]S/9+'"
M9%&M6_X6_/#KF7SXOV^BG$HV"P>8TK$.0(_B,#/53#JIMB4BZ7U%1++SV[P\
MP?4*'OZM_##.4]N;DZ)7\V-V%.BEKJ&F\Z=?SC#ZASD$)IAQ2'D-)V668HX
M):JW='?%X!FU@Z&F'!'V\D@N,(+&@6HY"K<Q*$>'/:D+T_T^'R^TN_3&'3>D
MM^E0]_'']_X1$RUAXE.8\?%3[IYD)TX3W[+\':+52AS;AK YY$H=;9RNZ[EM
M7M,6(S=9/SJ1QA]GX511G9M.@\!^R5P]A TQJ:A"FN(X*5P2B*^B@WOO==I]
M+<'+>;@)YQOX'"#'>C254=Y_,M3]:Z<JQ#(Z$B89*+%9%-*-HBD!+U<))H-P
M:T:]=N^&=K+<BS9-J-]MX,-MCN+;6M#N^ALV*<VE2"<7C2HIX BPZ].(R=;#
MAS"'"%-4:&"J<.1NHR#BI7>7R9##5L$Q_":^]HDJI.(APD[-64XE6VJ88JOX
M(0V)C5*=>CR[==P*":F&NY5Z2!QJF7V 5H'1G]42;.Q!!5*;GEVH@BG;JV<_
MH*[@AU@L<FF:2#LO7:1XLR*=0+JQLXG)]P5VEZ,RXTAQU0U0*1(GYG&X@[EG
M@Q_KX<>2D4=I.X%3)I-1D3 (>06+BP8R7+4O*?:ZVNC6)H"9*MBD &F&TD@W
M^LTI=OSW<Y-GO ICH&E@YW"IEN+*K@SH3=)/]/[0K<$>N'@?>27N8GG[\CDW
M5F^9\X:GW]#:#F;-@,6A*!UF'_:MC2'@W%E&[\ 3\&"2)ELM#ZXM[=^M_F'O
MN?Y!US_L/-<_K"A)@R*$19U8VEA-E=Q0G8L.M@^\P'K,-+OVAI,PN<#A<Y2:
MV$(/*P/XESK/;: !S%5R&65I@GP9U1_WE32[")/H2RB,ED<(@.-D%[I@<,@U
M\<@Z279@IG7F<0IQ'DVC&)4(^H.OBF%G\Z9\1;_)<J?A)TS^Q4U@O "192GE
M\6'F,*M6NC&][)!7V2$"EYBF(]C&VLL:_H&UBDQA/>NEDF;GN2\IKM;($2TP
MO,8&ZOX&EU&@/!@1A$"._R2L"%U""A_^HK(4EMW2,U+45)WI+(-3KN/-/A!;
M@;F>W/LH-QH[-JN<@"*+%2DCQ3F9(/NN54%]+.F\@5J]%N$6U+0>RI#&<9P]
M;RFLAM-IZ,CK*R?9SFRII;BA5ZKW)KSZ3JQ/^&KE*M)#(VQ23)OU"^T2*)GJ
MAQ<?,+D9\2F,Y6EN:?2BXY^:1O?![7UH0W]6#N 82-M#.I^B <PIVS7@-.F@
MJ@M4I,A\H&N^G )N*B;B@@LTDI%MZE(JK=)B^^7I%!52=K&)4EOYXE"S:UJ3
MS4-OGQA-?.!4T(0%U?(".T7M%K%GKMF(X-/E1.VYJP #=4;UP>X\\0E$:6F?
MIBZ. ?.0MB"P3D&QCB\1G4 7[FN_ DPAK,JIM^%_4L2G65MF<.K:@*;2J;(K
MXS BEYP<I]?L6L['CMUYP5:B9N,)C <'7W.WZC-NW>)@'A&C3I @T<#?8]1>
MT++,@(0]FB_<S(A1C0S*GUE'.W5HXDCF?1&'1'PJJ2J2ZIDQ"B/8"X4E3&$N
M<!D>W[%QF9'^DZG+",ZC[1+-3#5%6-3IL7U#+<"B%+>[3R.+&*E\!H*/*!J/
M"3N<RR.5([2GQ]8IC;^^-#T6QH1;Q+L]2F>(4=*VS>@&"4>7VB^!3"5*@+_!
MV0A#3L=C9I<;!,K!6!MAC@ACH+=EQM>BM6L@[X%4D6PRHH;4C>3.[N- ^"TX
M%<)M*=GK3AJM_F"@J30L6@E$^P=&2DT1* $V8H2.,UPM%ZG4VV7/E3\T3QS/
MRQ3"+^#+"J8QE*HOJ:L9$\2<9=KC+)W2H(C$8EN)X\8/D%^CNEV3:RT.&*>4
ML^%&S2N%7Z" X]>L)[)E'-<E27>(KBQ6RL&2/D^B023NL082S+-BHQ6;]\9<
MJB@T']LYE4<2'P,^"O?9\DPJSA7^3 AJ<*")]:5IV!X#7<LPF>Q[1-W\ FQ[
M[8ED>O#_T$6ZUA!S6L0'GD&<"QKMY,F+>&T10PP@8@;F(>R542ST'ZIHLO,F
MU]P6SU6$R,)42'&P^ *OUC@4O<8N01B0ZW65ZV)#H([Y:PQY"D[@!8G3Y&*+
M;FE>P'&JB^N M3V-<@>CD@@ EH73T2YXQ8=4W5S0\@J>/$4-M<88H%4,D]7%
MPABU"UKG2J""#(9(/@8/+5FCE/G &T52(0=,9U+7FZ^M1)K#\31(%;!*+&%C
M?HN\+P)%=X3GA-R<] O>9:#MZ=2<)_[N+?EE N1S(&7@JQQA@8.>HH:;*0RA
MXO.X]_"KZ-*\[I@)\+<F6@'>)1NGR4OR4J  A)V*1B6AFV$N@Z++1DNF*>FP
MC &CONU#-GYCJ=AUAQ,2(^MV($UJM 6K36.X@BF+29500 _9N:;ZI/G).A#U
M\!,Z$3&T09YWWD/!;!-M"@;TJA>-XB$!,KPKV 7-^!K?,I?"V3AG=2 .>=OX
M5DU"$RELD9 :PT-<'^3N,W"=4[I,/!A7T,/J;2!3(O$WE./2$-H*Y''H8@)]
M%E=*Z9$9&8YT7XH.8<BENJ'S=IUH$)2K:3G5A;OB^Y+HR+RY/4MF(YDK9#%6
MQ$F;0MI]RA/B(5X.MCL\C\2 --:\BQJYUB'6(5@2(+$4YKQ%0P<A5GM024)6
MT&(<A%N@T"%P> 2!P"=1E!".;"3TZ$+S:DTZ+%!.:F&(9$UW;;.I7%3!#9$T
MF=F1G,(7FRNL.$%RR['0VTW;G1MZKQ-U^X!UT#P#)6M!OWTW+EN_W)Y;9E_Y
M)'$T"892>A0SIM:[Y0 K_T*Y!"8F*CJNRP0$?LWA#9XY50D'H+5.;E2*HTL0
M0H]1!YPT;EG,NK(Q7T0ZGL]N*DB[(*A@!_$E#L*V%N+[899A.(+" L\\P?"$
M5YBU/J5>1,SYZUY("E+"07D:P5,)GN<LIP@W7"4X4(D2S86 T+[XB@(RKG^;
M5&7WU$-*,]'9> @B@\R Z#GP.3\#UT0&J\ZST=*!?/3R)1HG$).6C(@4?U"S
MPH#&A$;5P:<PKP4E#'(OS$3[U<]92Z#EP%[,C 7MA >$!YFUF$_C"AJ36WLJ
MO%-0??\YJ*Z#ZOWGH/K74O;2\[;OHG8YLK+"78\,J)85IY[(;&(;++-;U :*
M:C34'=Z)6::V@#'+#Z0BHR.R$L1V=33)&!(L8YJ/Y^0PSE$DVE5 %PR,I$0[
MK+#-Q6Y)7'2F2O(\Q 8"0Q3R:8*N%V6YM;#8^783)9+%%:-)!Q+F38UT%L;]
MH3P MCD\C#GEZ!.'C7K%#OLI7*_@)O1DLTRTA(M8FX82BYJSYD!F ,)BSJ8X
M@J<2Q+LA2P*>P'DVXQ5821S7++U,L3DG&B,<_F<RNR2O 8CZDQIYI@''O+UW
M%,E:Z,^:?L8BK$=;9MC*&W,F7 VT881Z[FN;'.U)"_(MP.0/=BF7C>3N_&FV
MV*#:J&]352L)>(3&[36QQN8F8(MO>>TE_^+,\<RA<>V9:)BD-EO#:[\3IG?9
M+1?120EAPHJO]=V8<WLVR*D2H04J\?K!M1=CT'WNG=HT 1%M51'%<Y:0H)"&
MN76X$8&ZZ:ZB3&OF91D>W%:?PIA.UI7G^*MNX&N&WIM9ZL+<#2^^G>'>\@WO
M!K9[2RI72T35S.N_: 63ETF X^ 7L?[Y\5-45_YJS>TY4;]?\W'VG+2>>5$W
MO /5$$#%H4R1?03U5%D#-!"'Y?E>4RL">YWA+7U5=<C'$2>&6AJTW$$XL2D^
M4AF,+Z%*)A@TTHU<<&/INKDN2D/37M.KI5W3Y 6I>)RK?]-E">3SJ1:?H&0O
M,I5<8'#69M&XCG;\C76VH[G;HF8)A\ 9D+]C?F!4G-_B)+W9F2VCXI4U^2VZ
M?,[#HV;75-- MZYDW(4LHFXE3E^+^F_AU+$-4UN4V>R9#3-)&0WL&,;;X0?T
M?+_6T(\!=:&H3,H)4#D::VOP@,6"H^_5?<N1]8#HR(AG#]X>G6OMJ[9(1<>?
MWP-&ST//ED/C")F+6A;^+[>O<M3V^-JK"+.1^73%R5$K*'"<JZA4F>IFG8Y@
MLWRQK"_B\ RQ61T)A5/+TM@P;,^4UC0\M/.4\[6-U-V!-1LP6A>;>'%/?.52
M5]V^?.13RD<U:E&+5%417>:-:)-W:4["ATY,UOE1GN/HXP20#YQ'3I&?#>Q3
M3+]R&LY4N!*2S8DN"^58S\EG\:#K39$9[>[O;6_U".097<M33K=E-<*;]WT5
MHV:"VW+&F2/VP8]9*(U\SHMT^ F^RPGJP#H+=.CC=#B_I74"Q.$RYV.@-GFH
MR<G$&G>6&N!M1 MNL'.9Y_M2U_;JW!+D%JQJ;>UZ%*ULIVM3NF<0V>L1<NL\
MP6I!I%+A5&U)6%(NT)H)Y#UU)E 5U?1Q4\#!!$+Q(5D\3]3/XXF:B<S3M3 >
M&49)/5G00Y</)2X3%\U)XG.',0)]QM88K&?K+!\8:"2],\1CA,#6VD%#W0HQ
MQ^[S$*EU5"I=76\#%ZAQ23^SM64:IT[E!0/2S^&Q[\)\%/[7$PM>"H/0K7FE
MJ%\4[3F<696FQ?.I%'?FHTY\=H!@3J\4DT'9'(].D0R=5M\I^8/%E]1J6B-0
M?93?W*X-^V!1>RO2Z!*$3(B=;#GG.?FCYQ"--@HH5W7,.?#XQ40:K3<?U8'G
MI "E,%89-36Y]C'@NF6F0K5,$_0RD\2OE(S9>1C5$VV#P$<]EU.S4\R03K@.
MRD2:<^S("A\;H85(:6OF65JLDIFPR6+<0)-4:\.47$KGLC4-/U'9KWPD\"39
MC]]E!;?ZJJY4:Q^ U;)2/.HM9D<23EG,<Q^_SA&',L.LT I;TPPUZ=RS,IN)
M?<DRK$)D:WO9/S;7*NF1R"--NIEJ31=@;DN2^KHE32(R=F* ./^H@\%F2[]+
M'@^.'WV%G,1-)Z6U"*^:<1(ZMXT5 B0-\6Q*NF<;7\A-00U)"O0>W+ DUC;#
MQ&M:]"FVOXL:I1E7W%;>>#')G%4S_-U<R:%%"UD4(;G78BP-QYG$D62]$S=K
M6[/#+1TWTI\)!1:HVV:N>SBC>@Z;4DUK3:[M;.?,#[,2T@PY+ZEE62;G@Y44
M:9GC1N1Y.:=+JCE[LS1M+R_T>L#EGMA ."UC\G&4<:']73+B% 8PLXW$(*9I
M7B%OE<D[75*E+9?N8)$1%!)LWRU/=KS_4Z+C@@I+2&D00:)G$A776H1H9P,V
M;K_%*TNJ"#D3M)]").H1G%%A'UQ;KG.W%(:#YQ0&G<*P^YS"L*(D_7&B;A8M
MCC-4BR,OTLF.-[PGO;E&+N8)P[V0O%#<K3H? EOD B W4QWQ=91Q&8TXRZPI
MMKR%Q%:EW8Y@Q#0+_$2QH](3:]DWT@&X<)P<.W9AE3"D,.MF'MB-VQ5A0(MY
M=EOU84U'X&YL)-OQ.]<B3&[4>U"VF4-AI!C83ET5'(=YSOF15@1'I/%@KR^R
MF-:6K:,!7]]AU XO0U#K\0!3KM2[4H,<U)4G<.D\C6/GQ)8I'5UD2O2DIVV'
MNG1T0[H0)!!-&JG=AM!N RH_GD9RFV?"_ZD57;#0[+N!?_-[2'R2\<UXAV6B
M,W!$O_/_5A2GUUFTRG,F25& L,2J4H==!33CM"Q,B6J2%M3PL!IVX/YGVO44
M#HOYH1L;YPNI4#L:<HP2+.%8A?C:11G%Q37G#8U5G";7NG0.V/$46>)E&E^2
M291B=7<!UFQ4E%@QG:@+.!PID1M%^21-$*"-)B0)9R-5X"CHW8!G0+E&1UF)
M)7:9%_JZBKDPECH? 4JD@N"[9!,IAF)VLI7OFW0)9YOU=M)6L_T7VOK?JPQ5
MX<33FSPFH#&T$:Y21A++*0V*"UU#L>"=I&A0Q4M$05.LH>NJI1S+UUG.<&FA
M ;5I$584N,,BC?C:<Q)67-D$;$^?[W^ \>>C2"!FR-O3/FXD61AS/!JTJ1E%
M_"ORDFX,E4"A [ZV44*-C\5;Y9=8UXF#[NS5E,+'8#8GK9EHA%<CA HGBW&+
M  &H)Y[H&Q3<-95\E3SZS.U("*>*T0CXI:T@J3(Q#2LT1K^<X!QBPAQ\EK@'
M>I1G!<?QA7BBQ*O%D&O?X;LU#Z^H6OCJ]O"LDJ1XZR2+2V9(A?110A_6C*;
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M4K]#::=Q1VA;Q+J!_>A>C/VC7;;!C)]XN\FM0ME%#D5GNF&'&6ZEBOM"_&G
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MOA\ VA6UPOL.%$2S'I0"X_5MUH-:&=W6@]YB/6@+*]]5#RH\6%^E&O3Z6E"
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M>#!SO M3B'1XT[;T+^*@_+S T!Z$*X(W&5N5"(PW>IF,))9U;QH3LZS"B*#
M*#$+<J5'5;K!Q4\P+932K/JF!?2"0%*5@Z0&4&N+Y6L 51EQP4E32F/[GHW-
M,</]S.31E1$78@]'(O='4DV2_Q"C/\6?6[!9?A\_]MKL.;_C>P)N=.-K-AV_
M0>U;6(!<X^YSAQABJ;I"X5=^)3#T9")VY[ZF,HP$82/+.!:91FC!5=$I^=Q+
MK ?IU$BF*YM,C]9,ICMG#LT%FS(!H(7M8!)\2<N$H]WE"'N4UW/F"JM$05%J
MP0%ZJ,'0.PML4R]R'K[>GEI8T4L'Y,+K^<J?J^R'Q?Y7N>/4=61L-DK!T0J1
MOI#58YY()E*FK$6]_A8MI8T^#'H$L66V4J<#HC$*-P(&NA)$6T"1/%2!>[D1
M(=E :W:#.UFLWM1H('H[6[63__>:Z3\X&IRL6\-Q,GA\M T$/+! P)KI_E8D
MCP R1IU2\X%6H(Y]18]XC6#?T>_-5BI44=!HI](28O4*>I\1*0,@B(1Q9:9!
M'8>M7=I'#!U-N)DHV@[L3,7,.X/\+C!9*MR"[W4.O1M?6P][]TZCX]O=]8WO
MKM^D5-H<<6 O I/;,O)X;1%"&JM>ZRM?(D @IX ,;[P.4V,KEENQ_)S,#6&3
M.<J$ J56:/..*%+_Z1'UGQZ8GX';+ 9[,9](+J;Y<@46]U:^M_)]$_FNB@P5
M:),4JU"2=TO*$L+-SCUMFC<VS\BU?*%S"S^$%LTV;[Z5SO5R;Y^,&"$>GAET
M.VE^8U?RXD'7,50D=K<0A3=*8X6 E M^XS"IC**.*00LR[2VLF)3&-/(\7>5
M?KL9LN]HB^P39-]PB^Q[H"*](JKD*MY=1EGU9I3#8%X[@+S$P"\W>#$**:TK
MG4VI?8 QXP@=X[JZ=%8%,MGS4C6Z6=M6V)#WD4;M=#8G'R5N#J;D6"**-1S0
MB5=[WLA=;W04L9&U[ TJ*D?G_OTF+_LJQDNM&E0C<4?"$"33XRP)LY?7S7]?
M;O.[*@5W1?DXF5U5^)N>7H3R\#6FH2>W)^A)<RNE\+;%?%M7H_E +\>)@<5*
M,LY09LW4C'DC]QO$='*03TW 0(];I_+SM0Z_+N>W[WDG\HS6(QQS@.I7BENO
M>BOJ:XDZ5:5+3#.LD$<@4,, 0.G?8J:W$O9YF&G"2A+&!Y#]KJUI)U"H42'!
M%,N>[HQM3[(L-><^ VHF^E)GQ;Q3-0?A=NB)BOP#G6\_7Z30#16Z(GA\"=+Z
M]#N*]/ANDB I>DTPU8WX_(Z=IG6F"I+H#7;=!L/C*G;=3D]J32/9)U)R2 *&
M[R&9V!TW []_+^M9BMPD]7+3?:D/#:2O[2N")5O(I26%883N -PVWS S#Z&Z
M>2S'Q](68[Y"+"N:%+IR1%,!2-/;&X +[$A[.L-X)]UU-P-AUP071EN$#3.G
M9N995%B:,BFZGD%?#Q![Z/O2^9"H]9!'X4/,F8;[H=1S:'&&W(QF1U%$SUC?
MKW[[]</__K^#Z$6!6E&;J:5N;^8;&+S#KQ+4#J%NR&2'%G3 T-GS<J0G"WL0
M6>S:3_Q]<41#B!5U@6F-UGL-U9N8U:,H(3#^F.,T9>:?/!W'>/6YS@MH]#)>
M9-B%"$A[C,RD!36-A-JF!?A"8YYPK&W@W/,BK\NEGP?WRWCG)=1 S!$.'L*,
M*II!<Q2;;\J0<%2(I_@AS,:JH3U;>_7&"39;#*>D;T9D_0;1G]KU /, R"BP
M(*<L0AZI:VEW!_1C!X&7$*T1^BMS:4%]U);1,SU&*5<'^S%R3F^J_@@XF )%
MPG,*&&,SJ](1*>']/A$%"XP;9?I)A AS=WYG6WJF(-BN+'#Z>[$F"$LOL+X,
MP'SI-(ZXDU>=SJBK6A@2L$RRD+'H\M^BQ.MLELPP%VK>P^V]/!8O[1#FI.]'
M]CX*I-&-@^A]BC1C&O>/66;>/<X@*:2I!<+^(;Q;39=,6BNRX"=L%\T/_ZX,
MD*<7QN[C5M0!W>VF&R3(_<E-5$)CI"8?Q)L6Y>0YD'K.[W<*?F!H6"9E/'''
M[3FG>^J+LEB<8\<[C\P3X;=)I=S>LTVZ"4>C)UZW2!Y3>Q"#Z!_6Y@Z@Y[$M
M,0T!!X*]C7:8@Q/K_@&)4%.[3>FOR#E$;8LQ=NV!EQ?2X;DNA$NZZICAGC$+
M'UE:V2>ZGJUF0CP8A4-=8$T/((6@)&R25LC.09WI9LF_R:@">O4[W>?WT3OI
M1JB)XRUJ0E 3!UO4Q .7[)&Q!YERYXPH=>[WJ%)W8YWU5@_%?64A:+(QKZGX
MUVA>\2%&+F*#O<AZ<(1MXY!FXA-'-FIPJ?2Q++(6W:V2AZ:5, B'B5%L3YI
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M[XTY\=Z<V6!R/8\%C(W?3'W2,,#*AFRT0(+GE[6>1<<8<?,:9RIJ5 GM7!'
M1R8'3]SM=5T,!?Z._;*[EO1?;TG2W^DLD:#[,OI0)GF5H$S<K<3?>7_=#U U
M5['XEWH*F0 CPR5-QZ,Y3D?M38=J@O:#GMKD)#0QK97 [&%/+?)%M6!' Y#Q
M7/5G W9C\T#RBZSUS-:R\#Y@9V0!UG/G6'1ZM!DE?@B9XGJ6IU-L6TO>5(NI
MV:.)0(>B )\I&1FO!$;U<_H+[?/!KP-\MSS^YQ_37VYA.W\#K;SO=+?O#[[R
M-O=[V\4HMT^?OXG15TV,+.6/O(Q-4)7Z(5DF#MV,\ \K.$DT2W,":WOJ_H[]
MIZW4V$4>?FVI0=X5R"1RNM 5"X3R-%^48R-*YJ>CO7C_N%U?903IC5&2$$48
M[@V':#W\[6AO/SX^V0/.>-"UT@[^[<NWST%[F@G,SX,: @@KR*NBJP3 4%#_
MQ:73T/85NH-CTVP*=5#0!70S:]K@V5:2\\LBN]03?DR&"G@?*S<ZJS>2.OK;
M_M[ _#+7;.A@PE// 'B1ZV)194M7J_1:E^?25OWEA[.GV_UQ7_OCX&OOCS\I
MGFF.^3I)<RMN@?$;U#F"YR@7-5V+ "D!&P+B7M!XW7LPUKL8"3PO-9_BH,!G
M4%,W$7$^I[H>%S]LO,L.M]3G:54S5(B?W%&6F);-'6!-&AF&ZV&/C=:3$EK%
M7NH<!T+1S] BF9?%)49ZJX$9)(4B+S%,?&%VUQ5TF:\NX/UXX009]E*XTQA/
M'<..X1:NR"PU]JG'W&8QP@]%BKXY/"JQ!8<R&>:?KN)H&IICC01#_XR".C,+
M 26I<-4R]OI@8'_[.LT7&JM$S1T<5)6W8HD6*-A,B[66L-(81._A4COVE.P^
M^XDI#=C\.D?[S3-6\7S&^[0=O/^AH&F]>DS/C-T9+TJCUVLH>TU:]XP*6%WS
M#\_N+77WHW8A$IQ6_>)KECG+W/R I%2+\A+,9YQ24+!I@:^;FC^2;EKJ!%XZ
MK3E^#K8K6"V\>C1S<814C&66FJMPAAF64BUF,VL5PY$&?X.XH;6>9Z2O&X8W
M;@RTK6%+FI_2DF!(2UAK(_KC,AV9J28G&25.OK)#X:]%P]-)N//@<HU?"\XZ
MW.NAR%VI@0\'7Z]*X=D"K(+HOQ>Y!BOE +5*F6 VZ6_#@\&>FAEQ!2F9EL6L
M#\-8P:XA\B>46_B3D>;Q AXS+U,SH?A3#NKA"H4JU0C&J&:)V0WSQ2A+QVQQ
MP1& D@<F6 Z!:=)[B@6Z=GA V#Q9.C46S#B%:#)LN\D"B*%@>8W99#Q/RL.1
M\O:%FR$F1JR+FE3D_GY\<GH8/SXY<(WEN:4\CT<,,<!WC=%D^MO^X/3(V42#
MZ/DGHZC)H1 [#,\U0(/51"!2@W[H-?:2<[.'S@&Y"=R'1IF-M3:S:=2+3CV]
MQI^A<%E0@_,#S0(:W?2WX7!P%/':T</A<9!CA#)9B+R/BZJNPM=?%:("6E;D
MU,Q'/L;,'H#>A(N$G/6K0K&JM'HP>' '7**B!&,W;4/,[P<A/!H<R'?@'7\;
M'I&9*D>VF95LV:R[51YZQIQ&%^9?@-V%!WA,M)@\?30M2(%1)6ZCU !+)_I&
M#S@B;N4I% WVX0 Z5DGD43+0*3<C.@+B@[@A>X6\<UU:!)> 56./%H$/1C>.
M^R\INJ5PUPL\4>FDFLL)Z)M&E3,L4 BX=B6-LN0*S^/^R%@L0:0%$3%02M<G
MN(+E\N\@->)''7RC.8XJK7D40G(*\2CC=OTZX!SPTR*?&DV)&_DEOV; 1O2=
M3>HWMX9!K! Y "@>2'R#'+-DE :K+UH,?QD@+/B(U5D0>YQ&SX)PZ',)AZHW
M_.CV"FW4 AD'[T4Z69".>[9 'VZ-6;G5K. ]3PG"=5@*GUJKYI611W;NR'^:
MRK2I"4T;NH(T0=+G+"JNT(NR :E!=)839_/QD^!2_-O)$PQOFS,G#RSS[M&0
MR\98*6)C+V-%5!4V'"]_-T^=+XP2;%X?7<(86G_%V!F&I+CH+C&6QRPE=Q$/
M;\"U(>J5)0;OF#*CH/'N4LI @#E43C+.#* C24_D#S;3EM:9]@]?.NCM 'A,
M#KM3+4;D\=9:8$&-\3,VB8>>I6",*+:%R ]Q<ROYE#-4RY0K-#/;[A1)=$V-
M];UFC0;FPBM]"3.*&"2POY2$,[P0@2"* !D,)AHXS31L,>$HTT&#AZL@>##3
M&BD326)2YR3R*$L>)E+*^8^&\U",OLZ6F"*"YN5P35&>FT_Z*^'1&AM],8;X
M^NWE2>];*]X(*+2_!0H)4.CQ%BCT0$7ZK*&[K/ZUYUC$Y]B8(,L*/9[)@D)I
M8_0<R0/C/V6 0:T9/1E<QR9=E\*$PU"(T1)S80)F-RBU#!H8!&]BI9XME7V>
M#9'^]%VF=.\WV-59O/UY4;#_^G].CT].GWR]4)B'[)'\&GH8\Q("'3G3"1AS
MR1BQ><019V-(H%M-K(\8V#'_ \$$&WM'^P<>3<&;R[2L%UH(C/EJ,7:>@-3>
M)4??5EB_36&%J"GG>R$#6R>8D'+0M#D9B&AM"T<W1R'N*MCS,,XL_V#ATZ;_
M;%%\M!B;];PHS)Y.\(S)K0D](H0(!5[(9[$X@>"\<=E!POUG67$%BT'GX_;H
MV>YF_X&EGI;@SF$PGQ-T-LXGXJ9&NK[2F@21CQ2,%8='"5M@J63_G' 287YP
M'U_<S( G.3ON?"Q%]FQ3SI\'3-_4[)"R>K(]L;8R?F,9A^/H$K+L$/127,>F
MZQ21I!9)U 2%LD!O16XK<C<3.?UIGA4IUR8NK5RI8@[V$W0/6C9D#$-7Y83J
M13G_2O@,TG[G^&Q4C;-*9U/6P/*?Q-&^M>BWPKJ6L HB7>+1[N1>!I8]L"L4
MXP7EKS [Z8Q\N<D&9OB ]N /C5B*A15@)L"8 (NL[O%-X9+P[GOV)*ZI];J]
MMWHX.,YW;7(NZZT'H^G-4D#RQ4MF*P+9H^.URJ<RWI-YC1E9";T5\AQU[16@
M[9K&*QFD <@4T^N@F7W# O7Z>6"M8NEY5^\)2PA%SAK"HY,9 !JE:MS\";IL
MY+:JO?;S95K;4G?S@S>V:)PED#BC"]HU-*%/:#:VL?"W3N'V0 A#/#FAG(5*
M(FEJ=X6XLHQSIU55C%,\(K:V\5:ZUI$NH_4@>:*#,)83KD5]493FCHF4>R3S
MM$ZRK71MI>MZZ6)$^1-S"&_E92LOU^?>*,:II;X@@$UB@(B#]H&9)4FV[RNE
M\=+A?AIF-]>VBH$*YK=J6LC@9Y;I#+!/:+Q"% .:6+3LZXU%YISU07")R]5S
M7:"6P?C/&"=J^R6#Z 5W^FN IP2=U_,:X98 A"EALHSW(!A3NM?\RMA305%&
M+VVUT5@+H%3UXPQMP3SAL BGMAA!K=J8,>" $VQ\9>PU_S27 CH.$(D$V)OI
M"3S=Y;B2RR3-8)<IK#9*(H#>>&Q7/BID275/.,-FVV*&S*N!PVD+;V^.[=N7
M1PP>/!U8Y#8:[L\_0:Z6O-FGQ2*O=':'T80;<8K<TG3_8:041,*<;D:6[G^9
M\?]8)J7]O5MB4GIL],?+/\[^>/KR[%7T\H\7;]Z]/@.ZI(?#EO15OO4,R#2D
MW% #_YSY'XI>@LB_P7/G!547F3/KI0MU?F?;X,VB] HS 5%D)Z5R<S;2YY"6
MR!4 &Z,7C_;OFVCHJPC)*WT.9)U4[ 8ALSO<!'>\S.]=74GSJT/2*2:I4K_"
M*>%7HAP._%TB6+6GSG^_NV*@]29T'0#T< N %@#TZ28!H+^JFKCUP^I9"L4Y
M^>0N$SH/02G]J8GE-H="$Z DSI#+%["K24J5-!.>&CA[J*"CP1!C?KHR5GN!
M7D>22\FS><)2DN[R#*A:C;H>(L7&"RP-B<RP+#$#XJ DXP/81@482+H26 \
MZXCH;CHV-3T?>W=C$(&S1?K3'--)0.O $("[.D'O0H"-"GEOEA991X!!^0)J
M';\W:7Y./FSBT[SIK-)76#\E%?A)GB^06@7P']RP)B\4!T*\21S3) KYG3/+
MC+5&81C:/,48A75B;@;Y0Q\VJ6W!-;^OTZJ#2$&"Y5)$,WW[(OGHI*G:5_E
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MNIP^)3&&CJ#F-*_+@IHS>\KVB>_M,)D9T68:\ZI8BN*DLAZ=GX<16M7SU$8
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MN-(E54P2$GBF6X=P>PK<R"$T(J?G=4/'?(9SF/CNX2BITHJJ*;-47S:\0W0
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M;!#7US?L2'$!E/W$W#<F=.6%YD_!!6)6>VA_\?=U1F9G>-T!6@,AF!L85VM
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MJULF*E&&OJEBR;G.;BD&T?)KNQ;9+?%\3$_#D,PEJSOO1)F.0-O1=["715?
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M>- '!+D,B'JTK=5&IJV-R)]J9#R$;0&1%_=^YK!=W!&M"I/E:);L8%6PFMD
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MCG5+Q$7-E$:!GO$+6% W'T&E7*KV5U>CC@9FKZ,?+M-4!7^%98D2=$FV7R-
MB01=BP5_R)0 P#:489/)-CA"]QRRWVH"F*MSO_0)41NKN68,7!$V%Z$T$V;=
M]E;CTGG14GIIC1B=LF=H8;$?3HZ8K<6UX K<)0#KPWJC?<>3G0PB3K2N% >
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MWNZ'7=[.Y>V^W^7M_C6V.+Z<5-"VAUB'88CIGG)3(QT(=>Q5 %V=!4[P(S;
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M)=?Y^ JX;L%8&D.]UZ@4J/VML""[ O6JJ#\1MI^X"I"#] K) (*'CH!WOL*
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M'F]@D[ ]A7*V0B(=^"O.=:,16Y"T)SW,,"VO"^4:F (0[ $(7*F-K74E'HC
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MRGCJB]&TI!@+!@E#\ID+^]@TS%IR)M/:0\2!;X=QYX],PZ>PJWGT].B9\-R
M4*-%E?<8>D] . 3SK-G,E_,ZG\*^LO-3(_V4/0W%G/@8&L0R2W*S,":XI%WK
M!A"\F!X.;]_>K.,'5S#C$X[BTB*JS],S&5ZPC"J1:(,1]*P=Z[D#(=1=-TI*
ML]&!U;YJ4<PIY1\312W>!EUFA,@>59NR(F OYI$=EL6^%$*WHQR%+KU&OBJ
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MEF\V,3W:4*!A0@P*ATLLR;5'AMV%K4TI]A2HSV]T#KQ /&%)OC_DGJWB#I+
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MWGJ5?7S1@E\<K5^:+RE=HOBW%Y"8%Y7< ,?\?@NK\P^-9'R/M9(R#5-W@T2
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MV+/D$W)7EWX"=,I5"70K7 KG1[?ALQ=$7:":UF@D>+LS,O58<MH\W+2R%9F
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M"N'K[GT^T[_6K5%8_N3>M/\<0N$=$0AP<WN7Y0K<D+%IFUE/.Q4'[KM?\^'
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M8)&A KH"&$9/J&"+T,4!<2[&ID4<=^]7S/DK#,Z(8S%PW+I?,>>O,#@CCL7
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M+]V0$9D,B2M555G2%$U#8;1G;FE&53$++Y'.$FTMHR)H:&.(!G1&I:00:-&
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M8R,)MAUC_2+EC\OY%<]G$^'3&%4[V9YV+AMH>/!PGU])21^-G G]_CO=;!)
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MX3?B+?G"6&Y26+8B& @&@G%99TR+M8*'NOTG];VFCF?Z>#?G5#'%1_T=VO%
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M,+&*BVX0VMZKX_H5G[@3R7)T^P))N;T)4_L<FC A4&I;0:!$ 4J,=-)8#ND
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ML+%(5O_ZFYE5A84$*7 'J.HXQV-+)%!+9E96YI-/@L]O<J0I)UC4^3:* NV
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M);F-GS=5Y.B'?UZP(</V9GJS7M8;M4:S+$HSX[,"]\>@HF/#M@/#FNOKH E
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MX?27C($G+<0F))LU44AI&JZRAUL4%M2MZ@.E\SY0 NWU:OLH,:)P6J:GASS
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MB%N+%M*T^2*0"0M;[X@%=QDUE(2'X/7@%"W.&A%U2AS"@G^5YR->PMPG=BG
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MC0007S-% RUZW(OL#X:B(//C$P+<8WNTB4'0?IRC:V(OV1'=2.0MQDGOZ_6
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MZZKZ0TGM&E)[; <)6]"7:R=<_['D.I,O8).ZZF_X(K49)[T9;\O+/!L.@VE
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M13XP<D..N<6))T/46E08I@[RG&S/F:?%517/*U"P)] ?"VSK,YX@ 2BKI=_
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M]:5N_V'8O^_==)YN;Z2[WD/GH=OKW$O#)_C&I]N'I]W3C6SWP=0"Y]$MOZY
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MAA<GH><45'MUIAYT9J'O"68Z0'(QTJ!_B?Q;2&[XRM!\[1O^U.5',P]IY_L
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MB&X_.QXJ8=\[]NL]%#<C"/>[GO\ G%=7F\"MT($'OY0%L),]=<V(-*HTE,L
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MKM@J+5%SG\'5 +Q!=QLCG6L=-.X=;3^:N6?FI-$;>8U.7/:87H,.@PLT#]R
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MN;1.WV'3]]?%!]GTW?8_4$L#!!0    ( *5*?%A+,HL"!00  ,,3   >
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M","4+L6=7:&8E\!$^54X1TLX"_W/J>@NZ)(E2A*NSF0V< 'H;R1D5.2Q,H)
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M8GQY'$4?X#!Q8(?Z89Q^")<_E=,/[_X!4$L#!!0    ( *5*?%B"#/;TZ0$
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MSP/K!*?/LY/&4/>-W05$W5-^ 5!+ P04    " "E2GQ8\L>(Q?@/  #_20
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M'C'RDT &EVI 69U5##>;);$%VTC8A76F\P;[#X[Z-EV / RUXSGYP+A,C5&
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MJOA:5P#N:8;#S%:\?KD-Z&5C^]4F1NC7V_B;7_(>9#?IVJAKU]BS?#.5V=G
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MKUU]_0.#0[3/7X;IC*GIF=FYK]_F5U;7UC<VMUC;.S]=$  *^4?^U(78=W'
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MPU"XZF3HU%F:SL";;UBHA&"?L.]YB&TRX=MI &WGHSCNM".^+;WC;JW=6\Z
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M169&UH>SB(/"C+5@@8=_NU?.HY$Z+*8^..PD[R]O80?6=4QZ$/"]>WQ#TU&
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MM]H0O@>453S&^$J.^N2><O(J$3YUS;+3&B,WVO9J2ESJU"-E[XG1ZFH(:EU
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M[JJ)NF[:6.ZI)'A>O?Z&*9DE&-H.D@^O4;\7+C$/O\TMGH56*F"_F/7U_0=
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M5HR+L\CRN8A_ZKR$1)&^VLN ZVHCA9Y,Q%71&BK01C\RH:H'F[N<P*6<S@[
MQ+]MB\5IS>VZQ8C]/%Q*G(P<^L7\\!OKM =@X%W??"ZJ#M#OB<A^URR@J1(Q
M)D$XPK W5"-#/#H\@@S9P]X(KZ6'"@0_/NW^7P&8!V?X)(PN*Y*R*22P*XV^
MGH>*N:;=++F*0!X91MD)[CI_G%5%)#&=/E)3J:%VP2H02IQSA<X].G2GL[B>
MJL8&I6$FFZA+;.#\I^4^H[&JH-=9KMF]]I8N-H\^U^\=V2Z>M<D"*\JO2]G.
MRV.FG/FB.J0?=Z].U1].].R I^E1%E,I,?G)]Z.O%(1R:GM(Q)."<87GGO7.
MDV[%MV1=""&)8R,<9--)W'OUZ=Z5CSD__7IN17=MHC$4D]13>",FG<8SUS2>
M]4,:>:U=+92-V3N7DC'^<_\ UJRSS[5JV652,R,L:J00V.:J'Q"EL7/G41@*
M5<9P1_$/Q^M2"3:R?-C V@=,'MQ0DC X*9]^Q/3-1L0!D!E89)<D8//0UUF1
M-&?D*DEARP<GC([?6D&R-55CA5P"<9QWZ_UIB8#9=@2P!8$@@XZX[4(#LDR6
MY.XJ1G@T7$6,@^8L?*CTZ'C_ /541#>8N0V ,;>IS3$X5FR$!);([G\.M*LC
M9RQR0N2<\$>PI7"Q4U5?M&E.5 W1G=M&<Y[G^=<S'&9)!&G); %=:"5;:[
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M=2:290YUR@!<@= "*C9<*"H!%*<*GWN>1SVIK,!Y>XY Z@4-H"Y;*)2PDC'
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MAL?PDT@Z&A?]=^5)B9M6ZA-JE=YB^8C&2 >,9%2QF.99(RCC<!CG:R^GU_\
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M77E&H;.CY(0O7 14WA9B;*S-!H;";X9EQ\8D14EF5:>\ATL2Q)#:?9T:CR[
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MY9Q>QKPK8L69<*(U'LY4OS*^ME:>;L$RB7DU:Q6@.?1[]K\D581X>P\RM8@
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M@3E!7I(L9[K279->9NR0Y[29XM\;O(@^T??2M;%L4/E /E@(";':D7Q<LO2
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MJ&N4NL_]6-,)_$<Y[8RYH[NO]GB",J>BKP&^16R[-R.FBDA75NP;)AI/PR2
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M%7L\@<OZT+)DQN(WHJ2L>6=+1,2)NKHW76_SMFR'?YP8O96_)O7@0_&F1KX
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M%_T^KL@[+S["E@$06J_RA).,FU/\USJ/ WW7;.W@)$K@1^R:HOR(QJ;=T:U
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M>F/5NR4<8/9985;!KK.[[P[FYSV_85(F)+XA;#:!]D(OI-9>FEJ>=UG3RGM
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M'+3,N;0L-E-BK\\P4 !C'W(6EN?EYXU6//'F:! R'FYL;FQL0!I!(M*1;BB
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M7[MG;,Q,[U5KY9&O31SE;4VS!O/)MKZB@ (H8@A>W*^<QT'4G;C%O\%_!-(
M]2;J%CY^\X/='EU/M7#"V%:B!<^HA5_(D^%W*^MO&;#\<J*/6I@.P\7V<";Z
MPC8LHK 9JW_PNLYE]$8[P\C3N?-<,=\G3R9=Y9F(%T%^W8"7P$H-;?%8V_*V
MVI><!U 06=*;(S)#A8B%L10QZE]YU4?8B:WISS5-_ U.CE-.>Y?@_,5V3F]L
M)XPMX[EJ?HKJ!QMVN)BR*92,?-AT>_VU\O"7XY>2S_C,V;4#*_^&R&Q-GS62
M6!_SQG;N57F98YV6+%1,HQ&]$GS14I[;MI*#KPKEZ+Z$:\D+56VH*K%5GYO
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M!![*^J4*'4<-"]?;UM& ^SQAU[G9Y=8&C<4F6]1GA"_LH.:D;+ 5=DR0@6P
MK?[Y62:.MDL>I/LC9"<*UE\<6K:A@,Z$9RA@@A+R^14N@1 ^D0*NA,26..T
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MRQW;M<U3+YE!4VYR;^Q6WY(:O^9^1-#![/8($*AI4QWCS!3D;L^AC,?FO.A
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MJI0X-:L:DH*FD][+I_LK,R+UM;?%9!7EUQ@K*'VMPF.,D'<Z/AS?.-4Z?7^
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MQ0HAA.-H>@Q7;P@B>6V=G-5;;A!DQPJ-'=(EE"$#(QB(;FJ]P&:=4*3)KR/
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MSG#VW$S)UMN']VS0)=6Z;7X,?%\XR7)THKB9T,#D@V-K.S ?.F1J90<D8T1
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M\M_'&2561+$QZ4KSA.EHRIC Y,P;B+E1"SIU^<#,<?WB::M?%B8\LG>_:;?
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M$!H<ODJ(N&R#O6*4#1(6;^:'%MM 5Q=7Y=[86'E_6N 9!X#_ O2?HMC^/YP
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MYF764,UJN4.%[9!@BY>A*]5(R?E^)". *FWNKWHRU6]*5GJQ<[?F";%QZOF
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M$F@#^.".TV3R'A-+8N^)W&7CW-!=/TG8)!MA9JE-$=9+''@3GTEDR:;=:@[
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M>PV",I#I49XMNMP'P)*,>S#!+(?P_=.S!\#="]!QSMM]-/%; Y$'0%ISZ@/
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MVLC-HYN?A[Z65NCQA>&<CQ[#-;D;!LS=^ZV>SCTWTU9;%.P>?,ZV'OB\HUR
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MPNJP)C/2+BEE4HF.F^3AZE[))KX"';KDV,\;BJ NAU-WP24G<<.UCGBJ1"*
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ME@YGUF+? 3?!3T.:9/V8H-BB"ZZ+ON<BM L8BR,B$CG66/G,S-V5A2(%3S*
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MV33+(^'.+SH)<X+?QB-BNSTTVL:,J8?K5?=;083A&=W]K:[$MH,$G:9.CO[
MVH:1T9F)7$8/92HKDT__5HA>P'BA-/]UP>-6AS@37%Y;[GFEOJ>%)9O19UMS
M6_R%5-C%GM1FPI7^Y2T/0%1$(@H%>J R ZM1(G[^L2T4-X<7(LU7 FHU]BDR
M&$A$''Q9)B+U]TVNG;.ERN[AA.9.K]^Y2)4NA]N:#?E<;W2WV;]Q'CYBH)(_
MR+\.AP**/Q^N*%2(6PUQ"4V>T.^74/Z.'#!3-W3@!Z^1^&C.HC8S8I&_N'$P
MI:=@9L_;_-&3_+W43=1'$DF'U%19#T!"O%]\V5?78O3736RB%;IJ+% 3Q#P>
MWTR>(#8>WPHPRNK&<K5EQ>X-I8EE([-]F/+EB#<Q<VTRB0A7+"\W-%OJ6YKN
MF.D6%(*S[='W<#+!"Z-(2? O_ED:OO_8=8CY =SR[69 9-D/D- 4!-)^O"MO
M1U-39:Z7@7IG,5A=6N)@+;6((;G@@=]VE\#*"G@W_Y5GT2-YMYH<7:&<8-8*
MA=?+-4')&62:A8E.-;UD$5(&W-;36Q'M:6U&%WM3%W.C+_L*+#ZUFT4EU[C#
M !N2Q8N^<^_))/*UKH0;98<TA4PCD?2R,YX9]]#K<X_V4NT"QS5CXQZ-B@<+
MXS3,G)E#O,P.,_<KDIN/W<B<N/<;O2+M%:&QJ2R\M3>^@A>R*A^[E+^RM(?(
MS?UFI-D6V1E#ML;:D(5:O])\JF<48.LD68K,!A9YO5[_:0+A@!!QI^H7/E'L
M^ N]S@\=TS+9GB5\_><2BP4ESZN\[ HRT5WHN.! S'(RBKJW34_\>8K 2HGU
MP><'+ZZ*&:-16P:<:"#?A@%JPX\S]?SZ[(\D6._X;_I,A+[$,'3@3'E*_N4@
M7]_^!4--/;A"#D2.M*P:BIW6%V?@O[+$@!6-:E0W4,+N6GV(.N+6?OT*BWNE
MCB[<)I'H.(U43 G,DG4!T=6&3:_?F-:78E$BJ'O;88K^T2_S6CORH4"&! $/
MFY^1]C+OR\E3YX\K+:4%!8P=BVPM@2GR!^*&0\4E.1$0G3K-.*N#*5?9H@R&
MXXBNAM<1Y[;(0PFE%ND513V%,<8-+6Z.Y=JY9EBERFC=,K,"@%N6K]@7:YTM
M_!**A@.L6MUQM& M,@F2C=CVA<8#JZN*8C3#*L_(U)&54RT&91I)2*(&,M$]
MU@NYA X+L!:8(FI9P?V=_+:/;0/Y4_*O^C1/$:\0KWJMA+#5LT$#7 EZUJ*]
M\VC=XP3N8=.EF)XW=/9BB \6AJ.VK&8?\\EYV!-2T=G/ZE9BK60OKB4Y)FGT
M\]*\'RG>2>B8D<34LS:5>MK231>)*3OM=4/S9ML=7^OM()%]4"*[8:=H_7L#
MN5M0KC!-_F'_:SKE_9.?K"P@FO%W)EB#>X?3BS]]""/<\9<E:4/:T3[P%GSL
M,APQ'UML[I[@U"#2;MH3^3#)#S_9OTF*0-[(4OZ),\ID5I@SVK=N>X> *L=O
M7Y)6HMH;;L5;Y2,;#F*_;..U0:;[0JRSQ?0&28!,VK/S(!L&V*_6O0%7\FQ]
M7N"CLE8,%O_DN?%Q<=*?QRH?MWAUKXM.I4"7+HIO J]8%5^P#;T/343K/,Q2
MQ+4'P-?R-M@0WH*;$'55U=]ZJ3IC34 ' B(:&NKOHL$TPALZB<(^%6\4+(=(
M-NX2ROS_>B,P<*=J7N'7OSSX;6T5_?+J8W9'JZ89"0.)*%J#(Y3R)/*M1Z)>
M]>!!5VA\=9#>QP3J/*Z\TQ"JO5;2 .^6%*$!$<9!]MQC0.;&YRU\^A%D3BV4
MLV@<M+>W<^?.E7>/WN3XUJZYHB_P8SU&JA ."R=^"7"GUC;O"13;+_B]\5U(
M)3BQEPA4K+=ELHOSE=YB>]V^^O8=L8#1G-)P"L=@B8C,GF7SZ#/Y.B5DA=O+
MW@&/9S6C ^I(D*]]HH&:9F]:&CDO7E".&9.2?<SERSHRJ2"^,5[&;,O6BXN&
MG%-"@-UTPT><8C39ZA.D;]A6;,+NR?12:["@R-ZGF#[K_2(6N9$*#N(-,;H1
M'E]KEG!)M6 R!4>[U6NUU6S+I52LWEK<&T\$"W=N@/QNC]9++ESXC=T?,74-
M8.7I:,U@\M![(J@JHQ1030[=WY :IYR;;\(#-3(/F(ZXO$DQT*'G6M4*Q$&G
M'E;S*%%,;1TZ,>46MG:07)$5R2C5  +K<H2#&((>+PZ($&5_>(R:&F-=Q%O/
MF?2LS003@RXF9GK?D/^)>#DKPYY[6(4MF;J1-'2GJZJ,KV3Y];-IP$Q@Z8JW
M;39M];"/2<::'\-0O; S:].DOG\W9Z9WL""DO4K2H&*1TP.L'[/8&.7K;N;(
MEI7):M$D2X<G4EC<ODR+'(<<<14HT1LIP4G--C)ZGF)"0W*;,V?6-U]Y8-OJ
MKM&J32O;P99X2Q/5M:Q\Z3.W9_CQ-Y."]^W(O[Y.67'./1I'L][P(_587VF;
M]+UH;7WJ%@GBNOWP$1--I<?*2;#@6<CJ0LWN5EB5DX2]#<J /-ORMR*^CM[F
M6W>QXCI6PI830QL"N#MX$I,9?63VT)XOZDJ_^'(AO%FI\%+" E43>3IN_XZO
M;&XCN?Z$9%8H#+@^K<<C%)E<:/CI+O=-K"MA<].1PL]%S-]1L(QSSWL4:L6U
M=774F(KD;CKU:A2;8265"'8L9-4\DZ@<6!Z.42Z-F_AB<NBVZO-UT?1@Z685
M\II";%!?8I&AC5KS[6PWCM##]$?17"+C\^$02W^L)O%MS#,9H^$MD5M?('73
M3P-5REN8>XY#BO$\U^4^Y(:W!68;ZNK-3*X=Q>=@1[6C3R&_V_SH4$,+["5I
M%=1MD7YSSIE%MR.6JS)_1W*S&UG82<+H9&LT]$[-@O)9SM-&E/'&%#U>E9O&
MVPD+8IB%;SYTK,K[BW^1;C"3V)T-LD[@+:<TK$JA?-I&>@==CTY1T"Q"]YMC
MTGZ,3JK6[L8:X?Q3W)S/00O/]<L8-44J>YH8-:8# K6W[!X$JAKQD7D\?"+K
M-_!XU_^&1&IJ0)NT)B10AM&P_W<;"7$!5/$??!0%_^2C^!'6SZ?YEWAD^I]B
MG@F(7Y&O6R'N_/TZ[%\TXH?XC<7?37G2C1K'),JW9Z2?!L_)TJPF8]O2<D!N
MHU4Z)#<Z*3=?*LL"28P,N01-4H!VHEIY5<.37E"+<V_A7AX:-KY%39L ^6'^
MKLVD18MZ)\7"\X7(GD=1>E?[=JY]L/!MD](>+3^UKU!B1-=7<"7"XD1#DFS1
M-#_J%"A,9'1%_VI0,*6P4?WXL?ZMQT>K1;06#OG<S\099K^XY)C3YKP?MG4E
M<+9A K,]J7W/Q17-Q56(1$(^0KAWK5 [/KY*\599L'8P$P9]-DORE":NZMVS
MFXJ[&THB\?%C<55\Q^XXX30]A*U:R)BA%YO.,=,)S=6![D^O-4UL9]8.+:<P
MV-P3Z=#=:;85]]33-??BLWI'P66C;T.F2105XWQ3 0M[RU4M3K@T0GAI^;GK
M#)?'UR@.?#JUTUYS;469B_EJ[)+JA7?L;+S>=4K,,J5Z#!'"</W"4UX=EVF0
M^!2W2.U^NP &/#*>;KX3P$L6'B?[9O@ZK;T>07WY6E*0X#H748*;A'-ZHDDE
MJ<O8Z$0*BZ5)>?&H3#BN]N0'2J2^ZA[0^V?(J0Z?:A(GEKQMO=7C!FT\MFW5
M1]$MC4I87SN(F3A3JQWP#DRV].M+8)&7.^;?7+][)08I;E15_W8'303=M(FY
M8S[[XO 7G(H^X[6Q#+7A$M-@APUWE-%O]PD2KU"$W4NM%Z2.P,URY5'7QUXR
ML]51'$J1/8#4A6Y,Y1FJ?*45?7_];1FCR,WRAS*57EI3$(NJ77,Y>Y0-BK?!
M)LQJD)ZHVC)SG!-UF[3TY%:SJ-'%.J$#H@2EHN9.H0+6SDH%S[:Y4RO<F0_0
M6^-[*;%.<H_J]LCYOH'XWXWK3WOF,;?4,;P*A'R2F)=6J1$Y6DG3TE3-3=/$
M!JX"6>GS9A%#;*[7*-$M8A2KDU-&K; =;5DC'KD;38@2\QN/+Y=,&-0+Q3U[
MT,(SZ1I(]J0^B#4_A'M;DNKDFHMF@";W'54L5VHGOW)#UA^7'UQ_W)Y_^>E?
M>@QU_EB-(7ZT* @D(3P&:=XO< TT6^BBD-3APY-T(GBV74Q*0_LJ? )N]7Y0
MQM@(#,ER%";U1A!F>"$"I*Z)-@N)!@7CZ08&F94IVL&S6\.>ZK4KU,Y1Q\H8
M +FC03E??UR6T@8B[MV "+E629$WEVI<UG6Q1T1DBP9D[NCF79;QEQP_6]%>
MS7C-JCE[&0V_%,A%K9N0>0=!FA"6AF]'(6K]%=\9-23Q)R'L0@2?M/ZYD8^F
MV8>(H.XE(X/TB ?_;J/4%K-S=[9FB]7^';$NF84C&AZI95S&(K@DE48TO,;+
MIMTL4TDD%#ZM_8X0G5+[P[079JCB6'FR>?60*YE-MD2<;B9*P+H4D>F0J>T?
MHOL>+NF[!K5N0LY?TW*)M;(Z7%4&-I3+:B/./F-5NWMJ4$?Q,VD\X>+"E6?G
M8D-4&^0NUEFF\/7-_S\=%8;_;^^N[.YMG%%SI-3BY:R=((-F[7HK;_#RM1]8
M.@IDE.^>[;=W)^=:MQ44U+KJ@>QY=9<Z;EHF66Y^QNK7[R!P,EAX;>L,$V_]
M+3Z33KWQ.LKCO7-)PM(-]@R>M@VKNA]U9Y:\CIZAJ_=TUC-GD;)%MIOR&::Q
MES$P\#RW6+YBBTDY/()>J_S8QA:=F+\\WM_F64"":\!'B1/AO-.8F]R=LHZ>
M[[ [MVUCK]&WZ-,MF:R+6#X+ADOJ3KMEU??G6:_3B[V((/*[_'[!E3>*>[>I
M'#9Z%WN8I5KP1M_4M*G'20_GL)YFK0?-/=]7FP1Z]@"K+P?1@R^EZE;F/N;D
MW3;?;'Y>A/32S\ZW/>;O>6I\(LEK#D_RL_/[*UU-WJBM*YQFE;9"Z5))YAHI
MBY+7^RW?<Z_T%"S/O<5X=_+$.8U]V9L7=4GO4$T 976BSEY#PX_W*7DD7=Y2
M*28^9]G:/!?/WO,G'Z3WS*_JD\Y^&W_T5]D:$\^2V=42RX0\+1U5GEYG-&CY
MLWB=Y[KFF(OAT7U'I<K:WVR?>)=)W+I+^-/O=-OL@)Z5<HM6_1(\75:YKUUO
MVW\&OO<VKI7K8GT+;M7\<TEF3#Z88_E8]5_<UCKKN]YQ5TSFBMEZ55NT397]
M>O>(A="9LPTBAC(\3R9I9UT^]#+SP;0/%W:G.>>KR&=H,/[<?,[XMJGH]5;I
MM-G%RU\%1;ZRJMVP+7JB1.DT [;0"Q_<W*H^9*UK34^:^V77\>8MNEF_8AU>
ME4UP4MG\V]]8^<NM(PR218[GX[:>]5P;'WGC>'WJZHJFWV&^ZU6W7./_5OGS
MYP2]@UN2+12^K3MW_E#'ARSUB'VS@^<'=I^:.:<R8^/C5A<9_9CGZ[+6U(E<
ME57:L/NC[9-;.:H>G4F"IU[Q<UU:>5*FN(%SH8G:S*LN_U(TU2[MGB*[?,7Y
MK%I9-HTU9YVPM6]P8+[J8V']Y0NMELVYOILS=^/)31[_PA@O+_-07U;)\O5E
MB*[:1]W^UF2/-<MV[IGDM.'GN=8'[<P\?QK.6#Y^.?G:;BZM]4L[MVVW6+S8
M9=NLXO,/3\^^LOUS2[?-BC2])\**L;>E"\_7]!EHEORU#[TH=>CW;ZOH-=&^
M>=\N^BQ]&*SWXUA$@T/\E,\W2M==ZK)LGG+JP].>7V7-N;DEHND_Y[D&3UAS
M)J+G^['"'V%K14*F;$&?;[3_?Q, 4$L#!!0    ( *5*?%AN#4_A:K@  $/%
M   -    :6UA9V5?,# W+FIP9Z2[=UA3V_<W& LB($2D@Y"KB$@7Z0CD*@H"
M M*;D(M(EZ* ! CD*M+;59K2<NG-$"D!J:$$N(* 0 0)4I((2),3Q7"$D$SN
ME/>=^7W?F>>=F9-G_W&R=]:SUMYK?=;G\YP<]B?V,N2TN8F9">3(D2.0/S@?
M"'L>8OSOW?^OZU\C_W]M'&'W0@1/0C:/8(X=.0\Y*GCDF. 1-A$"@T".</UO
M"R#_^W7DZ+'C7">X3_+P\G$6X$]#CAXY=NSH\6-<7,>/<V9C.?.0XX)<9\ZI
M7SLA9./)??ZA\)4GSTM/REYO[!.QG00N:-Q[])2'5U1,7$)2[J+\)05%32UM
M'5T]?>,;-TU,;YF9V]D[.#HYN[AZW??V\?7S#P@+CW@<B8R*CG^6D)B4G)+Z
M(CLG-R__Y:N"LO**RJKJFMJZIN86?&O;V_:._@'BX-#P/^]&IJ9)'V=F/\V1
M*53:EY75M:_K&_3O/W9_,O; 7_O_QG4$<NR_A?X_C$N0$]?1X\>/'>?^-ZXC
M1R/_72!XG.N<^HDSUVRX/1\*G;_RY*3P]>>EC7T\LAJV@,B]1Y.\HA<T*7+T
M?T/[7R/[GPOLZ?^GR/Y;8/\]+C+DU+$CG,,[)@B!0U@,E!,U ]HG(T872^^R
MKC&N1(;U%\C44PUC[-J#WOCO&Z5Y&977+)JCVT/\0Y0K3C4'D?]NA+#B7-B0
M/N-M/.'/DM,@CL*&/#'21R27*(/T9<+<.NLX<M1MTD"$!CL%TJ@B*YV@"4(X
MH.TY8IWLD5N/#+0'V)!46ON!P?N.8+Q(NW%D8(1DK/^!,8K_ \&/#4GH(/0M
MB06ZSN0NHT4#XJ1E#-Y\J$R=V1PRXI_"S_-[>0!<W_ZV7U@GBV4$/8!38'21
MF6R5JM=DD6^E_EXQ_G*3Q49Z=&NFD!CEO>MX-98I A;2H<LY^YCT'G[4G8(1
MODH06TT8#'FR/UX:0U&#W<6DY1NI? S&\Q7S?I_MEQPJ(#?Y1^H+9)1CN_'8
MA=*WV7.C>99;!,KU",=S5%E=<G%D4@9O:)&[XE2IEDW73?._"G-US<,IB2NV
M::\G!U.0BV@&<GBN+EAML:I._X5_;9]]6M:W<C$I<S.SC]T%3PWUX$&=4 '0
MB?:,#1'M$40N49*(.T^,I %"2D16PJS.OGS*&GV\F"ZPY_"!)?$9I4YW3+KJ
M+Z,8/RQS>1*O=OQ3RF_3:EL&UMYA7C7^;X;^FH!S4>'@I:HT_^6EN5E[@-#?
M??W',*9%I2WC)N9)W'GDC_ZEDRULR!%D&N59:T$($9/4<X4^FS*U=KT5?$[9
M$70WHRSH](L"9I%4J06X74=KR;QE4P'@.H->+I81!G-K^2,9?X)]= V:!QX+
M$OH\+H()*DPR^L_="?%U!.\6RE*^'W[TTSH!FOU[?I\,%$33X"(!""$5%902
MVKLV,.ZJ4MUF1^66_%:\FC,;\C34CQR29! %'%#$AJQ/,PU ,[K0X'Y;1L3.
MLQXU0.Q/(TXT@247)\,SX(,="4VHH&D#!+:G$K>I?[M$-?L.22MM/0AU$PLF
M4C5C8FVVR[:>4CJ'2QRD36TU:OUHCORFGPXDIJH5].YY<[EW>:OY6YJ'9GVL
M=BWR%CM[X<=5(P<1&2?QS6LS(9@2C1=FMM9S."\C,RW1P]?^8U68]KAI-@2?
M]^I A<D/[ TA))'&H[%HH@P4:"%?Q%,/H0/1\@D_,:)N[G>/47>D-:-[TBK7
M]5&M=OX8<NMC\NOHS,:P2G_&Y7\B="LS=P9QY+;KH/&!^CJZ!9>,@E([ RT1
MYN##,-B3B&Q/2G?8[S-&%S<D3V17K'L8D'Z:)3Y?3C/DMJ7SOX[3F(U(Z>FC
M=%JX;7;FYO2^,5O%"+$A?X1P@SO+LUML"!!O2F<0RLEQXP4WC&2 O$H:' JZ
M45F%5'>1KC.LHZ1S]+UX9JQG+&5):$/CZ_CT>@'IC=N&D0QI;D<S"LM\)QM<
M2(G<>E+#E#I\.<T( 72&LY*Q*GF5]4OK:&$#WRK0:7A1+28HS"'?B;2+$'8!
MZRU(F@B)KWNV[AN2#_+("_6CA_&&K7_E\PA@'M *U-^)POCD;<.(IE=J?[XT
M%Z^SP>9W-&=<-3>:LPFMY(V0&ZF;R<8JHD4D1JJPM&+S^ER3PO[A.2U%NU!B
MS<U1TW_6HD9LG+X\_6)+?F@S1!_>+J]E:AP6A2]E+*J"\MA &74Z-$V%*;^\
M%+_$PXRB0%/WJ[,J(]M)(5HA7,C.WV."H$Y3X02N=1EY^E"Y,N"_YUB@EO#3
M^9O*^?;3%W(,(@Y"W,E,.\!WP#H>P1>.20L%)Y81\6R('Q],;&-)O.L<4&^<
MWU>B3]?&4@@"QA7#U&*C[SMNI&!"TP62=^+<N0-#_%B%[;VHI[,%2"D6CPW@
M9DK2=-M)[E&CYQ,##>7=P11:#E#R%QTE#JA4$Y=2',D""0U(VH"'&*BE$^\)
MY#P'-7[/ZF\$T2:=EKS;$5EG-CN*L=^Z<4L(> B0S^(I/S#@5+M54D/ _LW\
MP6ZQWD5(/B6KG\"+<@,P\5T1W@"A+Q1E2T<,0J'K<:(?\8>B;(B["U,]C-H&
M++ZJ<]\0"GCT5=\HM6TO,K+5(GR!'UC0LC6;)=IGS?B*UXFL?ZC=]K+2#;AC
M-ZB@5C<B(J] *A+QFXW;[2[6#]0ZK)87_JC_,.Z=64?.BNYW/?WF?)6+F%;;
M=-O4[/CJIM6<(J-3A^TH7[H2%4/<2?2 @"*4,9]-"HYH#6->>1F :8'_J0D5
M#>SY#8P*XMN8=44/'&#/TXBGOT;J/'H9I&7VSMA;*N#1C58V1,X;Z<9@TO,9
M7N \=7;K8QU3 32M0(7,&AWA?'$'Q%*L)>9 #BB(96A!$V?UUY+#8]5N37_[
M X QY?,>[PLO*AW8SL]=JYT+F&W]\.D56>8'I7H+@44I@#2:=9J,*$@:H^S(
MH%SIA$%L9.\^I@_W;*^@MX=^P!.Q!/W$=)"\ #^MTG)-%^9E5S,:$>+/AISY
M89#WQ"96'SWGU3>+.18'1W&3(HJ=;('9;>[7K ^2L\FXG:V6F/H%4329VY6N
MW?EZL((\=F__ 1V\]X,X#8.VE@=&G-/6?K2D1>Q;*,/>3M6P23AI7ZZ[+%0K
MEID1?7<FT5-KS,8NPE]!GV1?2ZK6L[/_2+MZLU\O/NU1[:5QM=,DU[_7QQ<9
M$OYBJF8NUX/,KYC?)>LN '$7#_&[TF(,-Q![X.R/AO[<1O?*<,]$I,&/](GB
M*M=_,#V U6)JK%I?1TBFP=7(T!=NZS+B="-"5*Q\4O!/S4@2RM KD*H[O>7:
M72#@,\OXT32I"<]ZS(:(&$%!3"]:V.@8J-87I]T!^I<C,0/PT_-4_NI!OOI#
M(4I<QC),&(R^%;ZY<P9<&GJLM%S(#W5LGE*[-QO2\KWQ\Z>[:7C&1#J\B8/J
M/>IQH_O#6[4U 9))20;<KY'R_:RC@4M0E_7'LZW18@G?-/6"_FYLBC&N=),C
M2I[5?G1-I,R8J^4[MNSZ.S[Y,0T.I5!A0:0#[:9W-]D083_T"8-K='@?&R)A
M8 $8W^C)-Y^,P"5[' =R=Q(---#R65NJ*CT*\W[1[KMD=/H62@/*\2-\2=R/
M$5V2+Y)^98%LK>L?RJQU<*YQJH9CQ\/;1:*S]XMU$AGAGVF.EQEXRJGK!>'8
M;74!\U89S4M#Y77-(KHQ\E8/&>KIW]8'8Z(4NZ960A]]J5HQJ[>F5 >;9U9\
M?MSE>1 &#@U3H/VP#)@ &^(K[37,D@3S&\"KO9*,W!K4;8#PI,L26*(NI1M=
MX*05CQ!E(KFEV.XVR>AC)(<IP98L2L$LIY:W%A9'O,(BA<7NO$S[OB1$6*Y:
M%  E1*:9/J E#<Y+2(+[62<0FM>(H@"CTI.6AC@>@#C#XG-'!10.[=GY,?[Z
M'%#"!_AD!#'@0DO.<VF%R(2A9NEF9[)Y]4<#C0,NE"8 3V#:<*A6GX<2O2<>
M6+M[^#=+-&Z2K!/?H&5,=4;)TN!)<5< =%;$J+22!]TNT.ABSY21++*\__3&
MXD7W$"=2P]:WG^Z.E@)KUBYEMUI0%@>"H.P@7 1GI+AAI$;7<%]B3?:</"P/
M,3"8B>8:2@JK!^675:N!HVK<G^7&BY5_@%[.P+?ZA_4;3UVD[L3>YD,VV%GY
MXH/.V24YF$KF!%@]\_9XF".CFG>^0DYW%&H2]!%K+E3-0ZK8,"DJ6S')-?NA
M,&9FKI>O0M,=*K>GTM2\]&W\M6P?MGCJF=BF^Y1]*7"0$Y\;4ODCD-"6E5@^
MB[)91A]!Z=.AQ)UD.M.[$50'!OKC)&:[KDI7#_)?7UM>2XS364(N0H7=[_)+
M#2 $6F!<R(S@GUEG/+I_(9J&-.=5S&--1N8.@_=H;$@*\]S!5:8]2*.[+7]K
M!WZX@3<I<!ED/1$MD#^X*$Q_L%^,>](%?TB5#Q% 5@_L75G?>^SZL4+&"O.P
M[I-?QS.-7YB@R>4$SSS:*N(DNN^RD2A38<K F+L/E@(3[!%!)L*S]G';W$ V
ML2/P:]QOZ*?[#=W+_+*4AC: -A!MFKR[>7C5'32M0=I9M4_#*;ST\XN#WOYQ
M>>2@[:)HC[R@;MP H8F_FU._9+'EM;0>163;$'EG6TN'&,AQ'BT4K!G"]]5U
MF-%&1)QP!L]\^S'0(S6Y^Y6I4W&MW$_?L5 F_X\@56I@FN_;[IC\M_EZLRYG
M& C'HA4KW2(U?(3_/5IJK2F9DB<W:%+QAE0;B]CD']1_F91B:U]1TW%&6N=E
M#&M*P6RJ_MT[?=5TWW=.<^YOZYHQ>(;YMDE!I:_FVK8@17*-*1SB O@DX/IH
M2W,#1!EIL#"( GOF<14(>?(@[A(21G15R^ TO&PJ)I$#17'KJ(AJD]82R>XI
MIB>U6]LP>-1]\IR@/S5FVXAV)U5!.SR>Q<NC'-V !4K6EJ'I2XR*9CHC'S@P
M!Z&5R.$^U^ZJ3DX.2J)3;,".)2I*[#GRT6AOM.G3[24[NG8CNGJ@_FN^W?J^
M%_+QMQV[1J$(F7,<V'H8]SXZOZ_8>AF79"#BN1PK1"S(Z@_$26QV<%78@H5#
MKHA^A#@8,Z0?DOASS-<^<.':KK3'VK5 I7FIP$[DUM\?U;Z%/_>.F_Q<K57-
M*38=(PFD'/XJQS!+EQ[9MR3(P0 Q'$L+I42')KUNX??9HV2EHBR6-Q''03;D
M^@)5B?]ZB QX;-C5H<ZHEJ)V]NY&HW^S2H>?3H<W/N.9Z'Q=D8:NQ9[6NCTC
M.]36&>.S/2H97%Z=C-7U7%&+QIY4?)EI%64LPO-],I16<+%[_U&6XFISY1CV
M<XY][?4K=7E_U<I+HC[7V5=*C;DBYM<_+#)U.T >6@T;$M )3]8/&8@X+%+I
M,J,H=1:.&3L!L7M$*35),M/,[6V7"AO"6P-JW"9%I&$D/KOUQ02&^:JFR">R
M(:T>4@J1*/<#=Y03D('K(T 1<:/1+6AQEAJX-RQSH@D,B:&G4;8;LJN@1T =
M>_IX*?42ZS<WU?+*)7_)DI3*?S1C8L:4;LY4=SW_K6-J:_9^DQ=NB_M!_][P
M'DS&Z(+%@<T"\_JTD9S\MIIHQG)AR&F7C0[X,UP<[!/2:K;7YJMO[R;0"\)L
M"1]"NOBTGLWL/VO+WHR4C ^\G=^X3.:<@D:/6. /OXZL(8P4LI[FV&2D"1[0
MVC+E9Q]PJF(]3H]>G1DGSH;TUSEC3(%P27/0]Q;P+5XD=S4K\._%:U<W6I^N
MLC:V??(T="A?2"6-61JU7-8P/1)VJPJ;M(HS*0KEK;Y06_?#>>[=(X=B_<<O
MMU]ISCIYBXTEI7L)(#M)>+UWU+O!%12Q:RJ>$N9?\3B.2V9Q,D@T16Q@*=6.
M>07,B(JEXE)Z-,&'-+6C_I-^^YG=0/\2192 YO2(S#C#V9V6S<TQ,4< UA_5
M\BOD9U#DC>[V-(?I!F6?Z?SQC@.#N';8-AYX-,_(!Y\?7 $S?S%5J- D-H2K
M2XM.A4D$BCD^1,H362<^4NE<,YT7LU]'I?%NR A.M\AB-V:"OYM=?!).)D&<
MY]QO]4A1T* <8FLSL!J)'L (XKK\Z4Y])4=![WJ4-.BU?&A!E,0\T<1PH0SI
M8BGXB=-@O7F!=<+>(G\W/98-25ON^:!I+1K 4GG[,1AUS7/Y4))F:X;7^VDQ
MO\ /9?%D %9!1OPZ5$P**H2>: BW KDKO^Z5R'4U348$2JG-T5AG#N \9/<
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MI&5V"",:-X(Y00CHUJ&B!SMC-9SRG<"H/_8'_/=;LRF7MF%.TUWPA@#6R2;
M-(,"V$LFU!"F4'I8\.G:0.@XE;7XR?3A"BO>?^D$ZFJ55GXV%EGE_#I$^>?)
M;5^2)J/EQ;=^MRB5Z@*RX47=@ENTULR/[@[2*A8WA<X)-J'E8,"MD+E(!N$0
M U^ND!&?1HD=*#$]#HL)WL>G6/!-&(S)1\?=!<WH,12=/UGG SM,4K@34 X'
M,DROUCSKE,N$04N/D[B>\TCCVVZ!*D=)8Y6!!'+>*-?':H:_QW3/YY]!8Q.^
MR42MB?OM6W15@QFS,)?1_(75E;O59YM/N:T>KJA%RXQ;;[C<RTXH^+*::5]1
M6H]J+,C2"&LJ7.,%T2S>:P<.@;!&ZRT'.HV1 RP^":(BA)@&P& YTLN,L'3X
MDB5+%VVK!!$FW1^?/7AA5KD>N4_4S_W9]>BFW!?M#.^SC8;]_Q!"G0J9?X!F
MG$JD30Q SZ+.@K64>6L1I@&80N&0S%,@[O?NS^=[IM5HY"$%+R45[/;K4?YO
MF-AC<F,9A]WXE<X*P&3SZY>?;\0?S"L1?=[ZTQYU2&2>:/6*?];NF]H[-7BG
M-FV@[\?U*6Q2@JN_7I]%X?-QWN"'WQ^VT$5"D1W.^HVE:;6)N%-:_DI#F>?#
MZTPRS)0,S]GT6YL&>DSD3?R2.,00'DS,6]\%)X%"RL+.M@4=QB@#$^AGP0!.
M*RT#8[R]*?"C*/'#DA98<JNK6@H*&H3&KN^+)3$1%&D^HJ1):62UW])IE'1]
M@.VZ:T^NWL?P,825RS,"'BUE="%N9E]L^Q-*O3P0(]0RD6!1CKH,/[X;P@V&
M4<8K 35BI(XK(OD+B(=OWZ1)1V&&>T[CI[5N?""\J03BA^LMRJ_<]=N/JXU1
M7K^+V_K!*3PKT!T0&IS)%XJ;1)QER:'DI\2L6R=9?& /-"EO_P99]4G=V&ND
M7?^B&GTUA2(%3?'0 ?(30WSS@JX.2"ZE2MV46TETN]CXMKVI< =#UF!8-AZ6
M;G4Y',=(]AB@E#KIID]WV1 NK8E^0K).CUCKU&_33(M J@UN75M[D@M/MQR=
M1]^_&VBF^VK7I>J-PDIW#&C07R66#"9611"[] :C''U?K351/L?"H##^&<JB
MY%@]Y:&$C]E+[SG?CT![WM4D-^(*:!#,Q\4S(5MJ#<T:UU#>N3SD*QYR$6DV
MH=([P)>_ZN*CQ&]ZE$Z2)UJH9WJ^I/A_3%02,Q5*860/?!@F^'I4*N)=G=\=
MN#HK&PE!+7B<@.HA-$<X+N-%C:Z V(IU]:^S^UP[F6A_0^O>Z+5G*BBI"%_*
MH=1U8#6["HGH=[WMH?CF#<;C0W!51SL=T;N =GZQ^,-]5CE"6FCPRF*\O[]\
M+(Y%@@-W#(6<0"%XWR&,44A?ZE]*V&?5T]0R)/.'8<=08L $$9?6PT</20UB
MRE:!1K'R U=,92V75<X$>0WKHSRDIW:S1!&&><]%N_F<K5\17#27/CT>ZF>Q
M(39H,HSQO+-D<VCQ(AW;=89I0;J9D ;F][8M<J,%AN\Y4/,'),V7WE$MI<S^
M^N5H))<X;9?RK'5R%A[&28##Z?Q^',4=QL@_K E/YDBJTP#\6>D,C%J%K=M\
MCHMG6K]&5ATX9]N2TJ<GZL#^39=\*[K<_)MVS$W\FRGLM]]:6A*U]I=^=B9N
MZ*O7YP O,BXIVC+NJA7=*7=PZ%,6>7 S.ISN$##>K>B@2!KHB%@?*E$$:VSK
MW6UJH4H'4II95Q,U]()#BL-6/TEF)\E%>@C7CMA[G9PN*N>RL2KZ_)6<7GTR
M;,C#CN-J/6(^S X,HZI)Q<UA1,OICZMI?N'=QOTP_I_U:@+#M)VD=UZU@8SH
M2DZ;]@&6.,W0M\H-+)@_D'2_.G!BUBE(1;ED:S/;K,8L"+KQ$W4 \"W_!D+%
MB(5(UD64"?@\A ZE&G73S\B!&3A+J@13AOPKI0JH3OCVS66M"2B.OUYM/F7Q
M\H%(L2>O=/.N2%P4T7G?I20B:_A.XM'BLS>=QS,,FM6B''ESX5XW37+/"A<6
MJWE%V11MZ-@)VJ8W:J )J5G3WB^C*)=U489F]^1LBR2+&ITQV-F<]K6H\8X]
MWPEOW2$%DZ( 11N6U /<&@?BV)!M:QKZ"1N"W]L>BZ@(\(#3<<E;+2&?JI=]
M^Y9.F-%%T?Q,76 X&>VW?3TF)M:59B[Y&%NY+E9PL3LPJB$@3B'+K)LN_2VM
MSKKT=9CKX/U[AQ\X)/NI9E:*S"DZ[(G69G?TL G=Y)5V=LT"B"!*$A(,C$."
M]&R_^\O(?@C>BBB6H9M#5?>LNMHZTC"J#N]P^;M+H/S:%K82J8#B#P(8&]0A
M=*H,+SB&W2034KMLJ% IL(UJ.C#Z-0)V$LP>9.G,XMTMB"S90M.W3]4#_6L#
M'GTR/HD\AT_5N^ 4I6(DE'D^4R?EC>[KJ2IN$6/!/,]+!@Z\R <WSAY6&;7*
M0PO^<#Q_9L"\P=U)"6LL8BQB*N&(M?96-I+!*@U:J'\I5N9R#9=U+:J=K87[
MZN@_6L&+]R.C&_BMU+%G;\A;A:^8*ZK4CFLPJ3/P8$0FG/??MW&630>#A.[0
M8=L:%%@J[)@1'TJW"8 -2@7"GB$$?^+(2@,=^<D&,"I,")E/[#G2-&/  WT6
MU%)\G4:$],DNO=S>"D_&?:NZ!?6D1](PVUY X1#AN!$$'!A:$F :TG_0NCP,
MZ"I9R0TLM86OB",H06"3\CB[]%V=^T;'4C)'2O4[U"/9$,1,1&>,E*',D%2L
M#/)&V_-N0LX'V&26%&MPJ3F2B/6BJ;9Q$EK42+$;W!,;: %?1%ALWVXH#0/*
M9@(12?L-&7+X!?QLHA;AU.L=U4(L,F[-FK3\EK@>?D$J2Z*<#>DS)'AW2OM2
MOG538<<W,,(1U@DS/7I-@/OP$$8$3**),8*JB=9;:/#6]BHBN8UU7FQ2J-1_
MV-QB0M?O?;9V(>-Q>Q%A=GKBK=P![_0[7ZNZ@8^U&:6G>G*CD>DC+I;BGM5/
MBA_,%)\2=4D<ETW&)H\J334TMM1-U322_&V1(JM=,OY1-^_EE(Z)3Q7B+ID7
MBW@$E]65)N74.]4FA:8K#=UAV*;G-^54;EN_CX'/CU*[V9#>0SCM-ES<B(^I
M\S$<(<*\!SZDHI-@HG$J@05$@I#11:;0#'G 'O&$C'G:Q155BXSOW3]LN?PN
MZ!'Y;%NC4;7OV<G?&[+DM]6V*'0G5Y &P"CP039$$.1S Q$-J)N 21(5:]<K
M(^OD[MN_%XVMF[A8&+4Z$*)P['R,;\%)GQ=3@9%YE[[X7%O!\+$AGFIS2<M+
MF5T:=#'*[$",-3^8W]?$=,GOW_:/B3K,+T7W;\^&+PDRKR?=GGR/F9MY3*[B
M\&[#RN[NKM!U1^ PV\HBQM<O:_8C]:&V_P#RT_5,XQQ2?V5J?<K^ M)NP+$R
MJ59B2,^U- F7G*B8J_>6ZJ@C8K>IGIUY)MT(:TJ>W>RET$F%)1J"DAG3Z=*Z
M.KKF#_T/XOS[!8J*G.2;JF5,L69&4:YR<4'HOEL&<)HU68BA0@]^<F"XV2-+
M=\>E<G1T%#4E[@38=CV>"DTV.G.S/H?>@5+[J*KF-:D5(FCF*X3V7<^7S,#V
MM#$"QU07MQ#6(5*L).33?]\-F=G>Y:MWDWX<*VN;=+.[.V6UN?GC2O,KS?GZ
MMU[G5O!M77[>;U-.1ITWO?G;<\3X#(X#SS[@K\CE>ARW'[I%"_>,K,+M CPN
MI!KRLB'$R4!R]9.NF!K__;U,IBR-1R:BA:3<I87U\X E+6=\RQ#(C5RVE+_U
M;#&68--!:@B!P\>^CTC,.+U<$2]X6R>LH2PJS^78<Z)CP"N43K3-U4KNOR=]
M]O8EZIL?X8WB ;F7WW;8$#V_=GRZ[0X-22#N[RIVB-0ZIL;G*CZO*;=5M5]=
MWGFG.W0G^UDN3=6E_VY3OC)%U678BW6R&N"CK?7#!#FIED_/-I[N.852^FB@
M1,$]0W"CA&HV6@M"TN/DD3&4P6GM+'HY32<I;N:#,^IN]N^YX=V/U^Z[IC=N
MZ-@$% [B:Y+V9=K>MG4^52ITH;2W%HO>"E99,?N[0%O"Y7R>MM\7D[/UY2*R
M?UFB]3"2'&Z1R89(L;3\2LYFV].YM[:7<8)?XY1 A<<=T(&0H]UM_5^9<([2
MDRQ$3CBU33)=J@,EMTKTP8R*31\V9%C#,JX#GH49V#=Y0IUHFQ-I;SL</"R*
MXUJ'-6/Z,Z0HP6D-".33Z=LDINGK=^A(SRJ_O)0H:D;,'3K7_\+:=T<UM7WK
MYAP+@B+2FQ"5WBT@4G,4 0'IO>8@4@)"I 0"!'(4 :DY4A4$I-<0Z9U(%Q"0
M#D$("5(%201"A)"\>'[WC7'?N_>/WWWC_;$89.^,M=:<:\[O^^;>.VNOQL;2
M;N3?]7D'U^\^\NU_1W$1)94\\_$MW'!PXJ/<OE[E__6G$[!'P(6=L(V-O6[7
M[J'*FBF[%?T$IF][:>5EKW6?54):Q0S$B/-EWR,)7NN>;W>^P RMWL/#YIXT
MR6U](O_X5)-^([58[\56A7^Z+.=J*:_A6X@.C%\F0(\SP-_"O]3 T%I*< 8S
M!1^FZYM&@RFB9!9Z 2XGS#TT+Q'[-8C*K 1==R\AMQ3*9TMLIZ>HTLCGR*,P
M3RTP@8#]-FUZ C*3+HC_^('Y!_"_FPSFT)1 ZU-GUF!!=. GLU-E_^GDOUI[
M6R\#P%L/9J-6X[MG*4(O4F['JK[$J CD?G2PVPPF;P5\>?AY,"ASUO2"@_5P
M^^W@N@<Z]SF=7T>/%CL$/2JV\>8,2.0.:5+&#-6;AH/$4WV+DA$F2NQ1I4+-
M%9_S3:QEQA/71X:VK /,4&V"CMDI?CO2Q:R&%O$)C['\FOQEU&]=(4(N<8%0
M"%'AELUG34M""\;%;AOH1&JL<Z^VF_?FNI<R?#&O(EMJ NKG]IQH9.2SZ4=H
M;,XZ1XBT44K:6Y!N)+-T Q./]&K8"O!S<W"AW;[@2Z-6M\XK7:*Z^%KJ3BLD
M!XKTH6>(1?(D1Q/QYUHY^BO(O^H7'_D"1JK!6R2]JAD'TY@#M(E>KIV\HH+\
MM=N- >*M232'1':WQXF>K3^^M]>#W%^7N)0?WT6 )F!H#OU<9^/)WD[!B7;S
M?.]!#_X'4PH-SBY:D@HJ?IX94E%.?^R6(=T7==A[*3:S>>[<3K@1/[2'G737
M9*5%TH/)LHF3_?*A',,DW;XASA1OB^=.M2[;$_4%JQ!W>LW7M/*A#"GA9^5L
M*M,:)WY6Q7H=H14F::6&.0_H/] JHO:;0N5*$!85H5B:DK,J/2YO $A3[I1C
M +XZ@ AAF]C]A_0[3*%:3 8S ->F?<&4OTCKL9H2KBMY7!MA,]&$B& &0+>)
MU)D?&D+HS^QU"*Z[?+CB4%\;ZQA>Z:@!Y,!]H<9_7S!/GK50#Y(4]M%(TEVI
M]8OMQO/7@_C@"XXDW8P<I,@22K(UROS8!!7AQI3)YPZ^9[HC)@9*O$.:<'\T
M1[A,^%Z%M1FK'20\;F^>G/':KF8[?WVX^(ZE.:H^^_D+[1IG@^,'0U9XN7=9
MUF*"AEP0/?/ZU/J"KX1>39!%QV5E3P/BC8O/"^\2R?Z5H*K)<D=V)4_YRYX"
MCV0L<AQ4I 3NH;7MN_UX989*0/^&#V:;QYU=)F)/3H%H,I4,P!#*$4= ;K S
MS[LCZ1;PD'^O"_WZ? ;@CS$&@(U9J?YX1VD&'YU"4NV99]/R%.'K1-&DE211
MA6O(TY&?'=3[RNR]?__VD*I;;7 KV^!^S(S=@<*U(YR13_2G0+&[;9 A]?=G
MVXD_E"XL]ELQ"6&Q_I5RK'%S(Q4D'K@QY!9]5<B( >B6ULU>J'](-HQ_?-;&
M>0'@<%P1K[:!_/SK_DH6EE:F5<U/_PM/Y[-E %:E1K2!U%0"Z.+\_%T(*7-%
M;!&7?W-K8#FW 5H.=C$X'7P8EOYUQL&ZMC,?>=F LO#BOL_S&Y)6 '4PU:45
M>L(-2@91(0AF3Q\;OBN;[T@C/]_Z[T:)178?3"(WWM#\&8 >(R*6KEM(YZ_.
M9@#NCZV@Z$)@7J9G%,*3>,(-@?L7& !2"9/X9#E\HAF =ZH,0'0Z _#3@( G
M=03ACR21EY&D"2KS"Z]^W?3Z5L( C-^B,B5]3&8?DI;@LJ(K^I^6+.I_O&+3
M2N?HXY'GR#;9L$H#W\J-8+/J#F7V,AUHH,HT-N8)3,3(X;5.T1=P!W;^2=#@
M=SXYE*)!C_C3RD\/W7SN4?=(Z[UAZ(Q7Q7CO'Z;(\L97O+U+HC/H>NIN;OBQ
ML[9&]N;VQ!).RWO78'HGR* D*,$JSQ";/#^W\):LHS+D+>O'73 -)4@E5O)K
M6=G*N^L:V4H7X>(/"W8]WNS?2>8;>UK7UXT][_$W_/Q)@"%LR[('QRL+@MBD
M>1JHL%D[FI>;8SPM-*O-_&7^'8<'JGONZ"\G!5J+7AX/ G.[4*N-VA;5\3T6
M7260HQ>XI-*7#<9GSP>G, "6ST?/1YB(\%O,["^:A+^85*QOL[=R3M(5ZH7
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MGH4-\-EZ).M&AO;O,VB$"+G':+:=O\1'5)7<]+*=OP(>_&.2:%)<LI6!YU9
MG"KR:CITX9EH5W(OV9II.IK)AQ([_B@2.HN">L[_FB;2E>/H*G,:L7(K+ R
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MY$,I^L5_T*$*<@O9H_?2/21>#=55I2M>L[,GEJQ#S$&)AT]^TGTTV*'Z6TL
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M]IIB20^18-PMIA[YS "LE:#^;W5&JL^K*=V)X=6)'$+6AU^WOH G%7=>#?@
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M;;X],+..,>JFO%*_>;79P3@NQ;Z)DT]F*LB931*)]A:!>F2TE&-T_[O@X<4
M_$>,=/[_ 8W^ZQ"N^)\0'/C_&8!_8 !(5I7('*H$=CWSJ%%)B\FR[?'D.Y/=
MX3"=NJ,0MN*);['PT(=Q#R&/UY:QL%-#ZWD<F."% :4 ^IG7"&?1PXN!XDP&
M9&H8!B",\RA9(T&F3T2>.>ZZOM=^^71>/]#R M$$WZUA=(0\')9Z_1#1F0QY
MC?B0C3W4#Q[.OCKL;<+FE[_  '0/7:!ZVE4GF4S4L"&(1?%*07S6%1^*4WO,
M1S9W^V-D#O4-BA-Q*Q>=@O)?"IT]M*:?,6=B&<M1'N(1 X"[V0$GN>J06;K
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MUK0+!V9Q"F&:*@;#/4+7:[!"S4ZBNN<NE5WK_C9@)I62_CCJM-YXNJG%]5/
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M#3QGMS-$@2Q]X7.M)(L@0W\0667G=U0UA+PTO-$+1?0K;\ 'NLR>3J"I^3(
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M,S*^5LRC6)\FBXI%AA79DE$<+YOS;WF->_CRZ 2/7%_TC,N2)#4$)+[PD&,
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M,U'-=Y=M4%4S$,T:;?STD*GM39;ZZ70H=ZO./J2_:XQ$!U!?-$&/SS)&Y,B
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MO#EU0MU8HCT;8O0XO2-P$"YM24IA[U*3&F8I/N+6%"*,#_.)#H@)762;I)H
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M*6GN;)UC'_S*:?!S0ZVA:]=,+/27Z+SV7P>:DL5__I/Z"M\B9]/^:-<_B68
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MI&4>T1!\(';>-!#%+'96,RU)M+)[R#PR7__\3T.%U=4,5X*U5/=XTJ9E5-5
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MV#=]NG*0>'+'<3RLTH3KM\Y!RD<;LT+2OM1W(>L+ 03$:S,9PEG#9B%C2'-
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M!G2BV[1Y=(A>^8FM^ZTA? ,Y^[P/>#1#-J<=DT#4/ZD\=,"C4!8Z8$L!T\V
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M<OFR_6@F!^N/WV^SZDH6%N8PEX\__0J;D[?P=) .MM/NT@*,S^4K4H1(Z//
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M;IPTA+QO"[=S?#/YB(?MRZ,Z0\3+:L%4&WL[>[M!@?N*/YAAABLI(VD;U(.
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M @  [MQ631';H2W_5WU18.2_O:A^? W@#O$3>SP3;-?N9X(R3'!R>9_BI'7
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MTKG37]%$VF4?E(B,09CX@P-G6H+3A8:#CQ@CZNR+_9XN7KZ*GPW2E!S";0]
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M-*M<U,I3QR9$2$O>P:R*0[[BB/%E W1=V'1PYXU[&X9#;M1LT*RJU%1QK/6
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MG^);-R@NN)?W26]?5]?:,T3"%P7YG,VV.8?-4;4V:S-Y=,I)I"FK&@QU9#@
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M'GUPLK;J4!WE^,V0.D*\,LAEC][8S (WL'39='"X#SFY9+[U PD>QL[CSH,
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M LH%5+;;A=;P2S#2=8^&].CNHRF26*@)!%Q%[?5,*0HA'%D2+/\2<V/=%NM
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MNIV0@=:6A(PT1/1- ]F ESMJ>0O^@T@W1?RT?.-D9/O&CLE?YG';TFFE4])
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MTPD6JBVXE:_L%O]*WU,CWP]8JNZ+0^G2&D4;ZTR0B#8R_(M\K>=7+Q$)S(9
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M:)G2KMA?#1CG:8!:]52$ZF3'0^79Q'C-R-6::8J*5;6=#@2*OR&ON<DR?22
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MHG&[#8[6:-F7)3Q1YC;^:OL6I!)!Q+T>)&O"$-*,+-UYRLE!_4/UF[1[UVF
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M5,64\#[7Z0.6V& H_:5><3+3*JB?JJ@!:N9_Z#]MQ'^KH.MQ\P'+LTTHP';
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MSQVX:(X#8<5QF)1"$/>CD0P1+P1=76>Y_OR-1Y+F"7_@(N()[I*[IPUBW(%
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M#9+-^^X")KU3[V)WT.WH/ ]IXT25BU@;P7MXZ[XWAM*1Z5$46F0,W,H\H-!
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M,#(S,3(S,2YX<V102P$"% ,4    " "E2GQ8LY>T0*H-  "PHP  %0
M        @ $!$P  87)B92TR,#(S,3(S,5]C86PN>&UL4$L! A0#%     @
MI4I\6$YSL#-</0  H+L# !4              ( !WB   &%R8F4M,C R,S$R
M,S%?9&5F+GAM;%!+ 0(4 Q0    ( *5*?%@JXQ1?DHP  "(N!P 5
M      "  6U>  !A<F)E+3(P,C,Q,C,Q7VQA8BYX;6Q02P$"% ,4    " "E
M2GQ8C G;T' Y  #2H@, %0              @ $RZP  87)B92TR,#(S,3(S
M,5]P<F4N>&UL4$L! A0#%     @ I4I\6*8:+_Y"T , 094C !H
M     ( !U20! &5A,#(P,C0V,2TR,&9?87)B97)O8F\N:'1M4$L! A0#%
M  @ I4I\6/T=16Y*!P  ."T  !X              ( !3_4$ &5A,#(P,C0V
M,3 Q97@Q,BTQ7V%R8F5R;V)O+FAT;5!+ 0(4 Q0    ( *5*?%B$P1;S0 <
M +XM   >              "  =7\! !E83 R,#(T-C$P,65X,3(M,E]A<F)E
M<F]B;RYH=&U02P$"% ,4    " "E2GQ82S*+ @4$  ##$P  '@
M    @ %1! 4 96$P,C R-#8Q,#%E>#$S+3%?87)B97)O8F\N:'1M4$L! A0#
M%     @ I4I\6((,]O3I 0  VP<  !X              ( !D@@% &5A,#(P
M,C0V,3 Q97@R,RTQ7V%R8F5R;V)O+FAT;5!+ 0(4 Q0    ( *5*?%B.(S51
M+0(  *X(   =              "  ;<*!0!E83 R,#(T-C$P,65X."TQ7V%R
M8F5R;V)O+FAT;5!+ 0(4 Q0    ( *5*?%CRQXC%^ \  /])   >
M      "  1\-!0!E83 R,#(T-C$P,65X.3<M,5]A<F)E<F]B;RYH=&U02P$"
M% ,4    " "E2GQ8QMZ/&@X)  "^"0  "P              @ %3'04 9FEN
M7S P,2YJ<&=02P$"% ,4    " "E2GQ8UOC#\1!(  "E2   #0
M    @ &*)@4 :6UA9V5?,# R+FIP9U!+ 0(4 Q0    ( *5*?%@0H?-B<I8
M #:;   -              "  <5N!0!I;6%G95\P,#,N:G!G4$L! A0#%
M  @ I4I\6"U5I;[N4P  FF8   T              ( !8@4& &EM86=E7S P
M-"YJ<&=02P$"% ,4    " "E2GQ8G _<M[EO  "C@0  #0
M@ %[608 :6UA9V5?,# U+FIP9U!+ 0(4 Q0    ( *5*?%A(F!:,KT<  'Y<
M   -              "  5_)!@!I;6%G95\P,#8N:G!G4$L! A0#%     @
MI4I\6&X-3^%JN   0\4   T              ( !.1$' &EM86=E7S P-RYJ
M<&=02P$"% ,4    " "E2GQ874"LJ7 U 0#?40$ #0              @ '.
FR0< :6UA9V5?,# X+FIP9U!+!08     %  4 # %  !I_P@    !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>89
<FILENAME>ea0202461-20f_arberobo_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:arbe="http://www.arberobotics.com/20231231"
  xmlns:country="http://xbrl.sec.gov/country/2023"
  xmlns:dei="http://xbrl.sec.gov/dei/2023"
  xmlns:ecd="http://xbrl.sec.gov/ecd/2023"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:srt="http://fasb.org/srt/2023"
  xmlns:us-gaap="http://fasb.org/us-gaap/2023"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xhtml="http://www.w3.org/1999/xhtml"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="arbe-20231231.xsd" xlink:type="simple"/>
    <context id="c0">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:EntityAddressesAddressTypeAxis">dei:BusinessContactMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c2">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">arbe:OrdinarySharesParValueNIS0000216PerShareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c3">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">arbe:WarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c4">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
        </entity>
        <period>
            <instant>2024-03-01</instant>
        </period>
    </context>
    <context id="c5">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c6">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c7">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c8">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c9">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">arbe:SeedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="c10">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="c11">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">arbe:SeriesA1PreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="c12">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="c13">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">arbe:SeriesB1PreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="c14">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">arbe:SeriesB2PreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="c15">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="c16">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="c17">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="c18">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="c19">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="c20">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">arbe:SeedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c21">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c22">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">arbe:SeriesA1PreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c23">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c24">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">arbe:SeriesB1PreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c25">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">arbe:SeriesB2PreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c26">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c27">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c28">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c29">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">arbe:SeedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c32">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">arbe:SeriesA1PreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c33">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c34">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">arbe:SeriesB1PreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c35">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">arbe:SeriesB2PreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c36">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c37">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c38">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c39">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c40">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c41">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">arbe:SeedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c42">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c43">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">arbe:SeriesA1PreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c44">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c45">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">arbe:SeriesB1PreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c46">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">arbe:SeriesB2PreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c47">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c48">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c49">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c50">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c51">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">arbe:SeedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c52">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c53">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">arbe:SeriesA1PreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c54">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c55">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">arbe:SeriesB1PreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c56">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">arbe:SeriesB2PreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c57">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c58">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c59">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c60">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c61">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">arbe:SeedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c62">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c63">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">arbe:SeriesA1PreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c64">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">arbe:SeriesB1PreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c65">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">arbe:SeriesB2PreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c66">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c67">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c68">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c69">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c70">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c71">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">arbe:SeedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c72">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c73">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">arbe:SeriesA1PreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c74">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c75">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">arbe:SeriesB1PreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c76">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">arbe:SeriesB2PreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c77">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c78">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c79">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c80">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c81">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
        </entity>
        <period>
            <startDate>2023-10-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c82">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c83">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c84">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">arbe:ArbeRoboticsLtdMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c85">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">arbe:PublicWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c86">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">arbe:PrivateWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c87">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">arbe:PIPEMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c88">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c89">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">arbe:PIPEMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c90">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c91">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c92">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c93">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c94">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:OfficeEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c95">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:OfficeEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c96">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:VehiclesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c97">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c98">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CN</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c99">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CN</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c100">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CN</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c101">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CN</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c102">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CN</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c103">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CN</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c104">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:HK</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c105">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:HK</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c106">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:HK</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c107">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:HK</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c108">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:HK</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c109">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:HK</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c110">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:SE</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c111">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:SE</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c112">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:SE</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c113">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:SE</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c114">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:SE</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c115">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:SE</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c116">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c117">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c118">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c119">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c120">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c121">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c122">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:DE</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c123">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:DE</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c124">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:DE</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c125">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:DE</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c126">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:DE</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c127">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:DE</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c128">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:IL</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c129">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:IL</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c130">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:IL</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:IL</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c132">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:IL</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c133">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:IL</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c134">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:IT</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c135">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:IT</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c136">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:IT</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c137">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:IT</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c138">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:IT</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c139">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:IT</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c140">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CH</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c141">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CH</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c142">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CH</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c143">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CH</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c144">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CH</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c145">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CH</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c146">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">arbe:OtherGeographicalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c147">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">arbe:OtherGeographicalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c148">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">arbe:OtherGeographicalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c149">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">arbe:OtherGeographicalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c150">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">arbe:OtherGeographicalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c151">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">arbe:OtherGeographicalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c152">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c153">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c154">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c155">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:OfficeEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c156">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:OfficeEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c157">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:VehiclesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c158">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c159">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c160">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
        </entity>
        <period>
            <startDate>2023-06-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c161">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">arbe:TwoThousandSixteenIncentivePlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2016-12-31</instant>
        </period>
    </context>
    <context id="c162">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">arbe:PlanOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c163">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">arbe:TwoThousandTwentyOneEquityIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c164">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">arbe:TwoThousandTwentyOneEquityIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c165">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
        </entity>
        <period>
            <startDate>2020-12-31</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="c166">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="c167">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c168">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c169">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c170">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c171">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c172">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c173">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c174">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c175">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c176">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c177">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c178">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c179">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c180">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingAndMarketingExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c181">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingAndMarketingExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c182">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingAndMarketingExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c183">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c184">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c185">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c186">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c187">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c188">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c189">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:ConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c190">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:ConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c191">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:ConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c192">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">arbe:OutstandingShareOptionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c193">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">arbe:OutstandingShareOptionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c194">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">arbe:OutstandingShareOptionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c195">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">arbe:Customer1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c196">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">arbe:Customer2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c197">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">arbe:Customer3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c198">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">arbe:Customer1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c199">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">arbe:Customer2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c200">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">arbe:Customer3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c201">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">arbe:Customer1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c202">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">arbe:Customer2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c203">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">arbe:Customer3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <unit id="shares">
        <measure>shares</measure>
    </unit>
    <unit id="usd">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="ilsPershares">
        <divide>
            <unitNumerator>
                <measure>iso4217:ILS</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="usdPershares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="pure">
        <measure>pure</measure>
    </unit>
    <dei:DocumentType contextRef="c0" id="ixv-26117">20-F</dei:DocumentType>
    <dei:DocumentRegistrationStatement contextRef="c0" id="ixv-32">false</dei:DocumentRegistrationStatement>
    <dei:DocumentAnnualReport contextRef="c0" id="ixv-45">true</dei:DocumentAnnualReport>
    <dei:DocumentPeriodEndDate contextRef="c0" id="ixv-26118">2023-12-31</dei:DocumentPeriodEndDate>
    <dei:CurrentFiscalYearEndDate contextRef="c0" id="ixv-26119">--12-31</dei:CurrentFiscalYearEndDate>
    <dei:DocumentFiscalYearFocus contextRef="c0" id="ixv-26120">2023</dei:DocumentFiscalYearFocus>
    <dei:DocumentTransitionReport contextRef="c0" id="ixv-62">false</dei:DocumentTransitionReport>
    <dei:DocumentShellCompanyReport contextRef="c0" id="ixv-79">false</dei:DocumentShellCompanyReport>
    <dei:EntityFileNumber contextRef="c0" id="ixv-26121">001-40884</dei:EntityFileNumber>
    <dei:EntityRegistrantName contextRef="c0" id="ixv-26122">Arbe Robotics Ltd.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="c0" id="ixv-101">L3</dei:EntityIncorporationStateCountryCode>
    <dei:EntityAddressAddressLine1 contextRef="c0" id="ixv-26123">107 HaHashmonaim St</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown contextRef="c0" id="ixv-26124">Tel Aviv-Yafo</dei:EntityAddressCityOrTown>
    <dei:EntityAddressCountry contextRef="c0" id="ixv-26125">IL</dei:EntityAddressCountry>
    <dei:ContactPersonnelName contextRef="c1" id="ixv-26126">Kobi Marenko</dei:ContactPersonnelName>
    <dei:EntityAddressAddressLine1 contextRef="c1" id="ixv-26127">107 HaHashmonaim St</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown contextRef="c1" id="ixv-26128">Tel Aviv-Yafo</dei:EntityAddressCityOrTown>
    <dei:EntityAddressCountry contextRef="c1" id="ixv-26129">IL</dei:EntityAddressCountry>
    <dei:CityAreaCode contextRef="c1" id="ixv-26130">972</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="c1" id="ixv-26131">73-7969804</dei:LocalPhoneNumber>
    <dei:ContactPersonnelEmailAddress contextRef="c1" id="ixv-26132">kobi.m@arberobotics.com</dei:ContactPersonnelEmailAddress>
    <dei:Security12bTitle contextRef="c2" id="ixv-150">Ordinary shares, par value NIS 0.000216 per share</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="c2" id="ixv-156">ARBE</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="c2" id="ixv-26133">NASDAQ</dei:SecurityExchangeName>
    <dei:Security12bTitle contextRef="c3" id="ixv-166">Warrants</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="c3" id="ixv-171">ARBEW</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="c3" id="ixv-26134">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="c4"
      decimals="INF"
      id="ixv-26135"
      unitRef="shares">78221557</dei:EntityCommonStockSharesOutstanding>
    <dei:EntityWellKnownSeasonedIssuer contextRef="c0" id="ixv-26136">No</dei:EntityWellKnownSeasonedIssuer>
    <dei:EntityVoluntaryFilers contextRef="c0" id="ixv-26137">No</dei:EntityVoluntaryFilers>
    <dei:EntityCurrentReportingStatus contextRef="c0" id="ixv-26138">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent contextRef="c0" id="ixv-26139">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory contextRef="c0" id="ixv-26140">Non-accelerated Filer</dei:EntityFilerCategory>
    <dei:EntityEmergingGrowthCompany contextRef="c0" id="ixv-268">true</dei:EntityEmergingGrowthCompany>
    <dei:EntityExTransitionPeriod contextRef="c0" id="ixv-274">false</dei:EntityExTransitionPeriod>
    <dei:IcfrAuditorAttestationFlag contextRef="c0" id="ixv-289">false</dei:IcfrAuditorAttestationFlag>
    <dei:DocumentFinStmtErrorCorrectionFlag contextRef="c0" id="ixv-299">false</dei:DocumentFinStmtErrorCorrectionFlag>
    <dei:DocumentAccountingStandard contextRef="c0" id="ixv-26141">U.S. GAAP</dei:DocumentAccountingStandard>
    <dei:EntityShellCompany contextRef="c0" id="ixv-332">false</dei:EntityShellCompany>
    <dei:AuditorFirmId contextRef="c0" id="ixv-26142">1057</dei:AuditorFirmId>
    <ecd:NonRule10b51ArrTrmntdFlag contextRef="c81" id="ixv-26143">false</ecd:NonRule10b51ArrTrmntdFlag>
    <ecd:Rule10b51ArrTrmntdFlag contextRef="c81" id="ixv-26144">false</ecd:Rule10b51ArrTrmntdFlag>
    <ecd:NonRule10b51ArrAdoptedFlag contextRef="c81" id="ixv-26145">false</ecd:NonRule10b51ArrAdoptedFlag>
    <ecd:Rule10b51ArrAdoptedFlag contextRef="c81" id="ixv-26146">false</ecd:Rule10b51ArrAdoptedFlag>
    <dei:AuditorName contextRef="c0" id="ixv-12309">Somekh Chaikin</dei:AuditorName>
    <dei:AuditorLocation contextRef="c0" id="ixv-12319">Tel Aviv, Israel</dei:AuditorLocation>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="c5" decimals="-3" id="ixv-26147" unitRef="usd">28587000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="c6" decimals="-3" id="ixv-26148" unitRef="usd">54171000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:RestrictedCashCurrent contextRef="c5" decimals="-3" id="ixv-26149" unitRef="usd">163000</us-gaap:RestrictedCashCurrent>
    <us-gaap:RestrictedCashCurrent contextRef="c6" decimals="-3" id="ixv-26150" unitRef="usd">144000</us-gaap:RestrictedCashCurrent>
    <us-gaap:ShortTermInvestments contextRef="c5" decimals="-3" id="ixv-26151" unitRef="usd">15402000</us-gaap:ShortTermInvestments>
    <us-gaap:ShortTermInvestments contextRef="c6" decimals="-3" id="ixv-26152" unitRef="usd">400000</us-gaap:ShortTermInvestments>
    <us-gaap:AccountsReceivableNetCurrent contextRef="c5" decimals="-3" id="ixv-26153" unitRef="usd">1258000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent contextRef="c6" decimals="-3" id="ixv-26154" unitRef="usd">2202000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent contextRef="c5" decimals="-3" id="ixv-26155" unitRef="usd">2026000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent contextRef="c6" decimals="-3" id="ixv-26156" unitRef="usd">1839000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:AssetsCurrent contextRef="c5" decimals="-3" id="ixv-26157" unitRef="usd">47436000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent contextRef="c6" decimals="-3" id="ixv-26158" unitRef="usd">58756000</us-gaap:AssetsCurrent>
    <us-gaap:OperatingLeaseRightOfUseAsset contextRef="c5" decimals="-3" id="ixv-26159" unitRef="usd">1740000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset contextRef="c6" decimals="-3" id="ixv-26160" unitRef="usd">465000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="c5" decimals="-3" id="ixv-26161" unitRef="usd">1309000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="c6" decimals="-3" id="ixv-26162" unitRef="usd">1609000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:AssetsNoncurrent contextRef="c5" decimals="-3" id="ixv-26163" unitRef="usd">3049000</us-gaap:AssetsNoncurrent>
    <us-gaap:AssetsNoncurrent contextRef="c6" decimals="-3" id="ixv-26164" unitRef="usd">2074000</us-gaap:AssetsNoncurrent>
    <us-gaap:Assets contextRef="c5" decimals="-3" id="ixv-26165" unitRef="usd">50485000</us-gaap:Assets>
    <us-gaap:Assets contextRef="c6" decimals="-3" id="ixv-26166" unitRef="usd">60830000</us-gaap:Assets>
    <us-gaap:AccountsPayableTradeCurrent contextRef="c5" decimals="-3" id="ixv-26167" unitRef="usd">1149000</us-gaap:AccountsPayableTradeCurrent>
    <us-gaap:AccountsPayableTradeCurrent contextRef="c6" decimals="-3" id="ixv-26168" unitRef="usd">1244000</us-gaap:AccountsPayableTradeCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent contextRef="c5" decimals="-3" id="ixv-26169" unitRef="usd">436000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent contextRef="c6" decimals="-3" id="ixv-26170" unitRef="usd">364000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent contextRef="c5" decimals="-3" id="ixv-26171" unitRef="usd">2916000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent contextRef="c6" decimals="-3" id="ixv-26172" unitRef="usd">2861000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:DeferredRevenueCurrent contextRef="c6" decimals="-3" id="ixv-26173" unitRef="usd">351000</us-gaap:DeferredRevenueCurrent>
    <us-gaap:AccountsPayableAndOtherAccruedLiabilitiesCurrent contextRef="c5" decimals="-3" id="ixv-26174" unitRef="usd">1710000</us-gaap:AccountsPayableAndOtherAccruedLiabilitiesCurrent>
    <us-gaap:AccountsPayableAndOtherAccruedLiabilitiesCurrent contextRef="c6" decimals="-3" id="ixv-26175" unitRef="usd">5609000</us-gaap:AccountsPayableAndOtherAccruedLiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent contextRef="c5" decimals="-3" id="ixv-26176" unitRef="usd">6211000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent contextRef="c6" decimals="-3" id="ixv-26177" unitRef="usd">10429000</us-gaap:LiabilitiesCurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent contextRef="c5" decimals="-3" id="ixv-26178" unitRef="usd">1306000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent contextRef="c6" decimals="-3" id="ixv-26179" unitRef="usd">17000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:WarrantsAndRightsOutstanding contextRef="c5" decimals="-3" id="ixv-26180" unitRef="usd">875000</us-gaap:WarrantsAndRightsOutstanding>
    <us-gaap:WarrantsAndRightsOutstanding contextRef="c6" decimals="-3" id="ixv-26181" unitRef="usd">1631000</us-gaap:WarrantsAndRightsOutstanding>
    <us-gaap:LiabilitiesNoncurrent contextRef="c5" decimals="-3" id="ixv-26182" unitRef="usd">2181000</us-gaap:LiabilitiesNoncurrent>
    <us-gaap:LiabilitiesNoncurrent contextRef="c6" decimals="-3" id="ixv-26183" unitRef="usd">1648000</us-gaap:LiabilitiesNoncurrent>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="c5"
      decimals="6"
      id="ixv-26184"
      unitRef="ilsPershares">0.000216</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="c6"
      decimals="6"
      id="ixv-26185"
      unitRef="ilsPershares">0.000216</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="c5"
      decimals="INF"
      id="ixv-26186"
      unitRef="shares">130000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="c6"
      decimals="INF"
      id="ixv-26187"
      unitRef="shares">130000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="c5"
      decimals="INF"
      id="ixv-26188"
      unitRef="shares">77925095</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="c6"
      decimals="INF"
      id="ixv-26189"
      unitRef="shares">64160890</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:AdditionalPaidInCapitalCommonStock contextRef="c5" decimals="-3" id="ixv-26190" unitRef="usd">245733000</us-gaap:AdditionalPaidInCapitalCommonStock>
    <us-gaap:AdditionalPaidInCapitalCommonStock contextRef="c6" decimals="-3" id="ixv-26191" unitRef="usd">208893000</us-gaap:AdditionalPaidInCapitalCommonStock>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="c5" decimals="-3" id="ixv-26192" unitRef="usd">-203640000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="c6" decimals="-3" id="ixv-26193" unitRef="usd">-160140000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:StockholdersEquity contextRef="c5" decimals="-3" id="ixv-26194" unitRef="usd">42093000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c6" decimals="-3" id="ixv-26195" unitRef="usd">48753000</us-gaap:StockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity contextRef="c5" decimals="-3" id="ixv-26196" unitRef="usd">50485000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity contextRef="c6" decimals="-3" id="ixv-26197" unitRef="usd">60830000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:Revenues contextRef="c0" decimals="-3" id="ixv-26198" unitRef="usd">1470000</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="c7" decimals="-3" id="ixv-26199" unitRef="usd">3517000</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="c8" decimals="-3" id="ixv-26200" unitRef="usd">2249000</us-gaap:Revenues>
    <us-gaap:CostOfRevenue contextRef="c0" decimals="-3" id="ixv-26201" unitRef="usd">1508000</us-gaap:CostOfRevenue>
    <us-gaap:CostOfRevenue contextRef="c7" decimals="-3" id="ixv-26202" unitRef="usd">1283000</us-gaap:CostOfRevenue>
    <us-gaap:CostOfRevenue contextRef="c8" decimals="-3" id="ixv-26203" unitRef="usd">1440000</us-gaap:CostOfRevenue>
    <us-gaap:GrossProfit contextRef="c0" decimals="-3" id="ixv-26204" unitRef="usd">-38000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit contextRef="c7" decimals="-3" id="ixv-26205" unitRef="usd">2234000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit contextRef="c8" decimals="-3" id="ixv-26206" unitRef="usd">809000</us-gaap:GrossProfit>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="c0" decimals="-3" id="ixv-26207" unitRef="usd">34082000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="c7" decimals="-3" id="ixv-26208" unitRef="usd">36731000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="c8" decimals="-3" id="ixv-26209" unitRef="usd">28564000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:SellingAndMarketingExpense contextRef="c0" decimals="-3" id="ixv-26210" unitRef="usd">5194000</us-gaap:SellingAndMarketingExpense>
    <us-gaap:SellingAndMarketingExpense contextRef="c7" decimals="-3" id="ixv-26211" unitRef="usd">4621000</us-gaap:SellingAndMarketingExpense>
    <us-gaap:SellingAndMarketingExpense contextRef="c8" decimals="-3" id="ixv-26212" unitRef="usd">1814000</us-gaap:SellingAndMarketingExpense>
    <us-gaap:GeneralAndAdministrativeExpense contextRef="c0" decimals="-3" id="ixv-26213" unitRef="usd">7571000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense contextRef="c7" decimals="-3" id="ixv-26214" unitRef="usd">8613000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense contextRef="c8" decimals="-3" id="ixv-26215" unitRef="usd">3709000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:OperatingExpenses contextRef="c0" decimals="-3" id="ixv-26216" unitRef="usd">46847000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses contextRef="c7" decimals="-3" id="ixv-26217" unitRef="usd">49965000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses contextRef="c8" decimals="-3" id="ixv-26218" unitRef="usd">34087000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingIncomeLoss contextRef="c0" decimals="-3" id="ixv-26219" unitRef="usd">-46885000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="c7" decimals="-3" id="ixv-26220" unitRef="usd">-47731000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="c8" decimals="-3" id="ixv-26221" unitRef="usd">-33278000</us-gaap:OperatingIncomeLoss>
    <us-gaap:NonoperatingIncomeExpense contextRef="c0" decimals="-3" id="ixv-26222" unitRef="usd">3385000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense contextRef="c7" decimals="-3" id="ixv-26223" unitRef="usd">7237000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense contextRef="c8" decimals="-3" id="ixv-26224" unitRef="usd">-24814000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NetIncomeLoss contextRef="c0" decimals="-3" id="ixv-26225" unitRef="usd">-43500000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c7" decimals="-3" id="ixv-26226" unitRef="usd">-40494000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c8" decimals="-3" id="ixv-26227" unitRef="usd">-58092000</us-gaap:NetIncomeLoss>
    <us-gaap:EarningsPerShareBasic
      contextRef="c0"
      decimals="2"
      id="ixv-26228"
      unitRef="usdPershares">-0.6</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="c7"
      decimals="2"
      id="ixv-26229"
      unitRef="usdPershares">-0.64</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="c8"
      decimals="2"
      id="ixv-26230"
      unitRef="usdPershares">-2.64</us-gaap:EarningsPerShareBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="c0"
      decimals="0"
      id="ixv-26231"
      unitRef="shares">72021520</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="c7"
      decimals="0"
      id="ixv-26232"
      unitRef="shares">68489983</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="c8"
      decimals="0"
      id="ixv-26233"
      unitRef="shares">22027292</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c0"
      decimals="2"
      id="ixv-26234"
      unitRef="usdPershares">-0.71</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c7"
      decimals="2"
      id="ixv-26235"
      unitRef="usdPershares">-0.8</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c8"
      decimals="2"
      id="ixv-26236"
      unitRef="usdPershares">-2.64</us-gaap:EarningsPerShareDiluted>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="c0"
      decimals="0"
      id="ixv-26237"
      unitRef="shares">62390302</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="c7"
      decimals="0"
      id="ixv-26238"
      unitRef="shares">60960641</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="c8"
      decimals="0"
      id="ixv-26239"
      unitRef="shares">22027292</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:SharesOutstanding
      contextRef="c9"
      decimals="INF"
      id="ixv-26240"
      unitRef="shares">5540254</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity contextRef="c9" decimals="-3" id="ixv-26241" unitRef="usd">650000</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="c10"
      decimals="INF"
      id="ixv-26242"
      unitRef="shares">7780937</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity contextRef="c10" decimals="-3" id="ixv-26243" unitRef="usd">9394000</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="c11"
      decimals="INF"
      id="ixv-26244"
      unitRef="shares">5460043</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity contextRef="c11" decimals="-3" id="ixv-26245" unitRef="usd">2500000</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="c12"
      decimals="INF"
      id="ixv-26246"
      unitRef="shares">10863143</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity contextRef="c12" decimals="-3" id="ixv-26247" unitRef="usd">32159000</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="c13"
      decimals="INF"
      id="ixv-26248"
      unitRef="shares">4144887</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity contextRef="c13" decimals="-3" id="ixv-26249" unitRef="usd">10447000</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="c14"
      decimals="INF"
      id="ixv-26250"
      unitRef="shares">71977</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity contextRef="c14" decimals="-3" id="ixv-26251" unitRef="usd">290000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c15" decimals="-3" id="ixv-26252" unitRef="usd">55440000</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="c16"
      decimals="INF"
      id="ixv-26253"
      unitRef="shares">9272428</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity contextRef="c17" decimals="-3" id="ixv-26254" unitRef="usd">1397000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c18" decimals="-3" id="ixv-26255" unitRef="usd">-61554000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c19" decimals="-3" id="ixv-26256" unitRef="usd">-60157000</us-gaap:StockholdersEquity>
    <arbe:StockIssuedDuringPeriodSharesExerciseOfWarrants
      contextRef="c25"
      decimals="INF"
      id="ixv-26257"
      unitRef="shares">1194886</arbe:StockIssuedDuringPeriodSharesExerciseOfWarrants>
    <us-gaap:StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants contextRef="c25" decimals="-3" id="ixv-26258" unitRef="usd">8027000</us-gaap:StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants>
    <us-gaap:StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants contextRef="c26" decimals="-3" id="ixv-26259" unitRef="usd">8027000</us-gaap:StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants>
    <us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
      contextRef="c20"
      decimals="INF"
      id="ixv-26260"
      unitRef="shares">-5540254</us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities contextRef="c20" decimals="-3" id="ixv-26261" unitRef="usd">-650000</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
      contextRef="c21"
      decimals="INF"
      id="ixv-26262"
      unitRef="shares">-7780937</us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities contextRef="c21" decimals="-3" id="ixv-26263" unitRef="usd">-9394000</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
      contextRef="c22"
      decimals="INF"
      id="ixv-26264"
      unitRef="shares">-5460043</us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities contextRef="c22" decimals="-3" id="ixv-26265" unitRef="usd">-2500000</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
      contextRef="c23"
      decimals="INF"
      id="ixv-26266"
      unitRef="shares">-10863143</us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities contextRef="c23" decimals="-3" id="ixv-26267" unitRef="usd">-32159000</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
      contextRef="c24"
      decimals="INF"
      id="ixv-26268"
      unitRef="shares">-4144887</us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities contextRef="c24" decimals="-3" id="ixv-26269" unitRef="usd">-10447000</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
      contextRef="c25"
      decimals="INF"
      id="ixv-26270"
      unitRef="shares">-1266863</us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities contextRef="c25" decimals="-3" id="ixv-26271" unitRef="usd">-8317000</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities contextRef="c26" decimals="-3" id="ixv-26272" unitRef="usd">-63467000</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
      contextRef="c27"
      decimals="INF"
      id="ixv-26273"
      unitRef="shares">35056127</us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities contextRef="c29" decimals="-3" id="ixv-26274" unitRef="usd">63467000</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities contextRef="c8" decimals="-3" id="ixv-26275" unitRef="usd">63467000</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodSharesConversionOfUnits
      contextRef="c27"
      decimals="INF"
      id="ixv-26276"
      unitRef="shares">3205020</us-gaap:StockIssuedDuringPeriodSharesConversionOfUnits>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfUnits contextRef="c29" decimals="-3" id="ixv-26277" unitRef="usd">30844000</us-gaap:StockIssuedDuringPeriodValueConversionOfUnits>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfUnits contextRef="c8" decimals="-3" id="ixv-26278" unitRef="usd">30844000</us-gaap:StockIssuedDuringPeriodValueConversionOfUnits>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="c27"
      decimals="INF"
      id="ixv-26279"
      unitRef="shares">13866887</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="c29" decimals="-3" id="ixv-26280" unitRef="usd">91990000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="c8" decimals="-3" id="ixv-26281" unitRef="usd">91990000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <arbe:StockIssuedDuringPeriodSharesExerciseOfWarrants
      contextRef="c27"
      decimals="INF"
      id="ixv-26282"
      unitRef="shares">872614</arbe:StockIssuedDuringPeriodSharesExerciseOfWarrants>
    <us-gaap:StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants contextRef="c29" decimals="-3" id="ixv-26283" unitRef="usd">9222000</us-gaap:StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants>
    <us-gaap:StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants contextRef="c8" decimals="-3" id="ixv-26284" unitRef="usd">9222000</us-gaap:StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition contextRef="c29" decimals="-3" id="ixv-26285" unitRef="usd">2211000</us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition contextRef="c8" decimals="-3" id="ixv-26286" unitRef="usd">2211000</us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices contextRef="c29" decimals="-3" id="ixv-26287" unitRef="usd">115000</us-gaap:StockIssuedDuringPeriodValueIssuedForServices>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices contextRef="c8" decimals="-3" id="ixv-26288" unitRef="usd">115000</us-gaap:StockIssuedDuringPeriodValueIssuedForServices>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="c27"
      decimals="INF"
      id="ixv-26289"
      unitRef="shares">743780</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="c29" decimals="-3" id="ixv-26290" unitRef="usd">223000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="c8" decimals="-3" id="ixv-26291" unitRef="usd">223000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:NetIncomeLoss contextRef="c28" decimals="-3" id="ixv-26292" unitRef="usd">-58092000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c8" decimals="-3" id="ixv-26293" unitRef="usd">-58092000</us-gaap:NetIncomeLoss>
    <us-gaap:SharesOutstanding
      contextRef="c37"
      decimals="INF"
      id="ixv-26294"
      unitRef="shares">63016856</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity contextRef="c38" decimals="-3" id="ixv-26295" unitRef="usd">199469000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c39" decimals="-3" id="ixv-26296" unitRef="usd">-119646000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c40" decimals="-3" id="ixv-26297" unitRef="usd">79823000</us-gaap:StockholdersEquity>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition contextRef="c49" decimals="-3" id="ixv-26298" unitRef="usd">8793000</us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition contextRef="c7" decimals="-3" id="ixv-26299" unitRef="usd">8793000</us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices contextRef="c49" decimals="-3" id="ixv-26300" unitRef="usd">354000</us-gaap:StockIssuedDuringPeriodValueIssuedForServices>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices contextRef="c7" decimals="-3" id="ixv-26301" unitRef="usd">354000</us-gaap:StockIssuedDuringPeriodValueIssuedForServices>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="c48"
      decimals="INF"
      id="ixv-26302"
      unitRef="shares">1144034</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="c49" decimals="-3" id="ixv-26303" unitRef="usd">277000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="c7" decimals="-3" id="ixv-26304" unitRef="usd">277000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:NetIncomeLoss contextRef="c50" decimals="-3" id="ixv-26305" unitRef="usd">-40494000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c7" decimals="-3" id="ixv-26306" unitRef="usd">-40494000</us-gaap:NetIncomeLoss>
    <us-gaap:SharesOutstanding
      contextRef="c58"
      decimals="INF"
      id="ixv-26307"
      unitRef="shares">64160890</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity contextRef="c59" decimals="-3" id="ixv-26308" unitRef="usd">208893000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c60" decimals="-3" id="ixv-26309" unitRef="usd">-160140000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c6" decimals="-3" id="ixv-26310" unitRef="usd">48753000</us-gaap:StockholdersEquity>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="c66"
      decimals="INF"
      id="ixv-26311"
      unitRef="shares">11794873</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="c67" decimals="-3" id="ixv-26312" unitRef="usd">22496000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="c0" decimals="-3" id="ixv-26313" unitRef="usd">22496000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition contextRef="c67" decimals="-3" id="ixv-26314" unitRef="usd">13012000</us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition contextRef="c0" decimals="-3" id="ixv-26315" unitRef="usd">13012000</us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices contextRef="c67" decimals="-3" id="ixv-26316" unitRef="usd">629000</us-gaap:StockIssuedDuringPeriodValueIssuedForServices>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices contextRef="c0" decimals="-3" id="ixv-26317" unitRef="usd">629000</us-gaap:StockIssuedDuringPeriodValueIssuedForServices>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="c66"
      decimals="INF"
      id="ixv-26318"
      unitRef="shares">1969332</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="c67" decimals="-3" id="ixv-26319" unitRef="usd">703000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="c0" decimals="-3" id="ixv-26320" unitRef="usd">703000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:NetIncomeLoss contextRef="c68" decimals="-3" id="ixv-26321" unitRef="usd">-43500000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c0" decimals="-3" id="ixv-26322" unitRef="usd">-43500000</us-gaap:NetIncomeLoss>
    <us-gaap:SharesOutstanding
      contextRef="c78"
      decimals="INF"
      id="ixv-26323"
      unitRef="shares">77925095</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity contextRef="c79" decimals="-3" id="ixv-26324" unitRef="usd">245733000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c80" decimals="-3" id="ixv-26325" unitRef="usd">-203640000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c5" decimals="-3" id="ixv-26326" unitRef="usd">42093000</us-gaap:StockholdersEquity>
    <us-gaap:NetIncomeLoss contextRef="c0" decimals="-3" id="ixv-26327" unitRef="usd">-43500000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c7" decimals="-3" id="ixv-26328" unitRef="usd">-40494000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c8" decimals="-3" id="ixv-26329" unitRef="usd">-58092000</us-gaap:NetIncomeLoss>
    <us-gaap:Depreciation contextRef="c0" decimals="-3" id="ixv-26330" unitRef="usd">557000</us-gaap:Depreciation>
    <us-gaap:Depreciation contextRef="c7" decimals="-3" id="ixv-26331" unitRef="usd">481000</us-gaap:Depreciation>
    <us-gaap:Depreciation contextRef="c8" decimals="-3" id="ixv-26332" unitRef="usd">342000</us-gaap:Depreciation>
    <us-gaap:ShareBasedCompensation contextRef="c0" decimals="-3" id="ixv-26333" unitRef="usd">13012000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation contextRef="c7" decimals="-3" id="ixv-26334" unitRef="usd">8793000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation contextRef="c8" decimals="-3" id="ixv-26335" unitRef="usd">2211000</us-gaap:ShareBasedCompensation>
    <us-gaap:IssuanceOfStockAndWarrantsForServicesOrClaims contextRef="c0" decimals="-3" id="ixv-26336" unitRef="usd">629000</us-gaap:IssuanceOfStockAndWarrantsForServicesOrClaims>
    <us-gaap:IssuanceOfStockAndWarrantsForServicesOrClaims contextRef="c7" decimals="-3" id="ixv-26337" unitRef="usd">354000</us-gaap:IssuanceOfStockAndWarrantsForServicesOrClaims>
    <us-gaap:IssuanceOfStockAndWarrantsForServicesOrClaims contextRef="c8" decimals="-3" id="ixv-26338" unitRef="usd">115000</us-gaap:IssuanceOfStockAndWarrantsForServicesOrClaims>
    <us-gaap:AdjustmentOfWarrantsGrantedForServices contextRef="c0" decimals="-3" id="ixv-26339" unitRef="usd">-756000</us-gaap:AdjustmentOfWarrantsGrantedForServices>
    <us-gaap:AdjustmentOfWarrantsGrantedForServices contextRef="c7" decimals="-3" id="ixv-26340" unitRef="usd">-8122000</us-gaap:AdjustmentOfWarrantsGrantedForServices>
    <us-gaap:AdjustmentOfWarrantsGrantedForServices contextRef="c8" decimals="-3" id="ixv-26341" unitRef="usd">6599000</us-gaap:AdjustmentOfWarrantsGrantedForServices>
    <arbe:RevaluationOfConvertibleLoan contextRef="c8" decimals="-3" id="ixv-26342" unitRef="usd">17866000</arbe:RevaluationOfConvertibleLoan>
    <us-gaap:IncreaseDecreaseInAccountsReceivable contextRef="c0" decimals="-3" id="ixv-26343" unitRef="usd">-694000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable contextRef="c7" decimals="-3" id="ixv-26344" unitRef="usd">2015000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable contextRef="c8" decimals="-3" id="ixv-26345" unitRef="usd">50000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets contextRef="c0" decimals="-3" id="ixv-26346" unitRef="usd">187000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets contextRef="c7" decimals="-3" id="ixv-26347" unitRef="usd">-1219000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets contextRef="c8" decimals="-3" id="ixv-26348" unitRef="usd">2228000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInOperatingLeaseLiability contextRef="c0" decimals="-3" id="ixv-26349" unitRef="usd">86000</us-gaap:IncreaseDecreaseInOperatingLeaseLiability>
    <us-gaap:IncreaseDecreaseInOperatingLeaseLiability contextRef="c7" decimals="-3" id="ixv-26350" unitRef="usd">-84000</us-gaap:IncreaseDecreaseInOperatingLeaseLiability>
    <us-gaap:IncreaseDecreaseInAccountsPayableTrade contextRef="c0" decimals="-3" id="ixv-26351" unitRef="usd">-103000</us-gaap:IncreaseDecreaseInAccountsPayableTrade>
    <us-gaap:IncreaseDecreaseInAccountsPayableTrade contextRef="c7" decimals="-3" id="ixv-26352" unitRef="usd">-769000</us-gaap:IncreaseDecreaseInAccountsPayableTrade>
    <us-gaap:IncreaseDecreaseInAccountsPayableTrade contextRef="c8" decimals="-3" id="ixv-26353" unitRef="usd">458000</us-gaap:IncreaseDecreaseInAccountsPayableTrade>
    <us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities contextRef="c0" decimals="-3" id="ixv-26354" unitRef="usd">55000</us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities>
    <us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities contextRef="c7" decimals="-3" id="ixv-26355" unitRef="usd">-234000</us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities>
    <us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities contextRef="c8" decimals="-3" id="ixv-26356" unitRef="usd">1557000</us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities>
    <us-gaap:IncreaseDecreaseInDeferredRevenue contextRef="c0" decimals="-3" id="ixv-26357" unitRef="usd">-101000</us-gaap:IncreaseDecreaseInDeferredRevenue>
    <us-gaap:IncreaseDecreaseInDeferredRevenue contextRef="c7" decimals="-3" id="ixv-26358" unitRef="usd">-375000</us-gaap:IncreaseDecreaseInDeferredRevenue>
    <us-gaap:IncreaseDecreaseInDeferredRevenue contextRef="c8" decimals="-3" id="ixv-26359" unitRef="usd">445000</us-gaap:IncreaseDecreaseInDeferredRevenue>
    <us-gaap:IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities contextRef="c0" decimals="-3" id="ixv-26360" unitRef="usd">-3899000</us-gaap:IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities contextRef="c7" decimals="-3" id="ixv-26361" unitRef="usd">884000</us-gaap:IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities contextRef="c8" decimals="-3" id="ixv-26362" unitRef="usd">4361000</us-gaap:IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="c0" decimals="-3" id="ixv-26363" unitRef="usd">-33513000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="c7" decimals="-3" id="ixv-26364" unitRef="usd">-40362000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="c8" decimals="-3" id="ixv-26365" unitRef="usd">-26416000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:PaymentsForProceedsFromInvestments contextRef="c0" decimals="-3" id="ixv-26366" unitRef="usd">15002000</us-gaap:PaymentsForProceedsFromInvestments>
    <us-gaap:PaymentsForProceedsFromInvestments contextRef="c7" decimals="-3" id="ixv-26367" unitRef="usd">400000</us-gaap:PaymentsForProceedsFromInvestments>
    <us-gaap:PaymentsForProceedsFromInvestments contextRef="c8" decimals="-3" id="ixv-26368" unitRef="usd">-100000</us-gaap:PaymentsForProceedsFromInvestments>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment contextRef="c0" decimals="-3" id="ixv-26369" unitRef="usd">249000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment contextRef="c7" decimals="-3" id="ixv-26370" unitRef="usd">918000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment contextRef="c8" decimals="-3" id="ixv-26371" unitRef="usd">784000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities contextRef="c0" decimals="-3" id="ixv-26372" unitRef="usd">-15251000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities contextRef="c7" decimals="-3" id="ixv-26373" unitRef="usd">-1318000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities contextRef="c8" decimals="-3" id="ixv-26374" unitRef="usd">-684000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:ProceedsFromShortTermDebt contextRef="c8" decimals="-3" id="ixv-26375" unitRef="usd">4715000</us-gaap:ProceedsFromShortTermDebt>
    <us-gaap:RepaymentsOfLongTermDebt contextRef="c8" decimals="-3" id="ixv-26376" unitRef="usd">2639000</us-gaap:RepaymentsOfLongTermDebt>
    <us-gaap:ProceedsFromIssuanceInitialPublicOffering contextRef="c8" decimals="-3" id="ixv-26377" unitRef="usd">98587000</us-gaap:ProceedsFromIssuanceInitialPublicOffering>
    <us-gaap:RepaymentsOfShortTermDebt contextRef="c7" decimals="-3" id="ixv-26378" unitRef="usd">5218000</us-gaap:RepaymentsOfShortTermDebt>
    <us-gaap:ProceedsFromIssuanceOfCommonStock contextRef="c0" decimals="-3" id="ixv-26379" unitRef="usd">22496000</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:ProceedsFromWarrantExercises contextRef="c8" decimals="-3" id="ixv-26380" unitRef="usd">12859000</us-gaap:ProceedsFromWarrantExercises>
    <us-gaap:ProceedsFromStockOptionsExercised contextRef="c0" decimals="-3" id="ixv-26381" unitRef="usd">703000</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:ProceedsFromStockOptionsExercised contextRef="c7" decimals="-3" id="ixv-26382" unitRef="usd">277000</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:ProceedsFromStockOptionsExercised contextRef="c8" decimals="-3" id="ixv-26383" unitRef="usd">223000</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:ProceedsFromConvertibleDebt contextRef="c8" decimals="-3" id="ixv-26384" unitRef="usd">11337000</us-gaap:ProceedsFromConvertibleDebt>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities contextRef="c0" decimals="-3" id="ixv-26385" unitRef="usd">23199000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities contextRef="c7" decimals="-3" id="ixv-26386" unitRef="usd">-4941000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities contextRef="c8" decimals="-3" id="ixv-26387" unitRef="usd">125082000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c0" decimals="-3" id="ixv-26388" unitRef="usd">-47000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c7" decimals="-3" id="ixv-26389" unitRef="usd">1189000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect contextRef="c0" decimals="-3" id="ixv-26390" unitRef="usd">-25612000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect contextRef="c7" decimals="-3" id="ixv-26391" unitRef="usd">-45432000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect contextRef="c8" decimals="-3" id="ixv-26392" unitRef="usd">97982000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c6" decimals="-3" id="ixv-26393" unitRef="usd">54315000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c40" decimals="-3" id="ixv-26394" unitRef="usd">100936000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c19" decimals="-3" id="ixv-26395" unitRef="usd">2954000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c5" decimals="-3" id="ixv-26396" unitRef="usd">28750000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c6" decimals="-3" id="ixv-26397" unitRef="usd">54315000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c40" decimals="-3" id="ixv-26398" unitRef="usd">100936000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:ConversionOfStockAmountConverted1 contextRef="c8" decimals="-3" id="ixv-26399" unitRef="usd">4389000</us-gaap:ConversionOfStockAmountConverted1>
    <us-gaap:StockIssued1 contextRef="c8" decimals="-3" id="ixv-26400" unitRef="usd">6598000</us-gaap:StockIssued1>
    <arbe:ConversionOfConvertibleLoanIntoOrdinarySharesUponTheRecapitalization contextRef="c8" decimals="-3" id="ixv-26401" unitRef="usd">30844000</arbe:ConversionOfConvertibleLoanIntoOrdinarySharesUponTheRecapitalization>
    <arbe:ConversionOfPreferredSharesIntoOrdinarySharesUponTheRecapitalization contextRef="c8" decimals="-3" id="ixv-26402" unitRef="usd">63467000</arbe:ConversionOfPreferredSharesIntoOrdinarySharesUponTheRecapitalization>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability contextRef="c0" decimals="-3" id="ixv-26403" unitRef="usd">1713000</us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability contextRef="c7" decimals="-3" id="ixv-26404" unitRef="usd">797000</us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability>
    <us-gaap:NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1 contextRef="c0" decimals="-3" id="ixv-26405" unitRef="usd">8000</us-gaap:NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1>
    <us-gaap:NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1 contextRef="c7" decimals="-3" id="ixv-26406" unitRef="usd">7000</us-gaap:NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1>
    <us-gaap:NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1 contextRef="c8" decimals="-3" id="ixv-26407" unitRef="usd">340000</us-gaap:NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1>
    <us-gaap:InterestPaidNet contextRef="c7" decimals="-3" id="ixv-26408" unitRef="usd">250000</us-gaap:InterestPaidNet>
    <us-gaap:InterestPaidNet contextRef="c8" decimals="-3" id="ixv-26409" unitRef="usd">209000</us-gaap:InterestPaidNet>
    <us-gaap:NatureOfOperations contextRef="c0" id="ixv-20056">&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-transform: uppercase; text-align: justify; text-indent: -56.7pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Note
1:- General&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 84.45pt; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.5in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;a.&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Arbe
                                            Robotics Ltd. (the &#x201c;Company&#x201d;) was founded and registered on November 4, 2015 and
                                            commenced its activities in January 2016. The Company, a global leader in Perception Radar
                                            solutions, is spearheading a radar revolution, enabling truly safe driver-assist systems
                                            today while paving the way to full autonomous-driving. The Company&#x2019;s radar technology
                                            is a critical sensor for L2+ and higher autonomy. The Company is empowering automakers, Tier
                                            1 suppliers, autonomous ground vehicles, commercial and industrial vehicles, and a wide array
                                            of safety applications with advanced sensing and paradigm changing perception. The Company&#x2019;s
                                            Ordinary Shares and Warrants are listed on the Nasdaq Capital Market under the symbols &#x201c;ARBE&#x201d;
                                            and &#x201c;ARBEW,&#x201d; respectively.&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 84.45pt; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.5in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;b.&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;On
                                            October 26, 2017, the Company established a Delaware subsidiary, Arbe Robotics US Inc. Arbe
                                            Robotics US Inc is engaged mainly in the Company&#x2019;s sales and will operate as the Company&#x2019;s
                                            distributor in the U.S.&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;On
February 5, 2024, the Company established a Chinese subsidiary, Shanghai Arbe Technologies Co., Ltd (&#x201c;Arbe China&#x201d;). Arbe
China was formed to assist mainly in providing customer support in the China region.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 84.45pt; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.5in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;c.&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;On
                                            October 7, 2021, the Company consummated the merger (the &#x201c;Merger&#x201d;) pursuant to
                                            which the Company&#x2019;s wholly-owned subsidiary, Autobot MergerSub, Inc. (&#x201c;Merger
                                            Sub&#x201d;) was merged with an into Industrial Tech Acquisitions Inc. (&#x201c;ITAC&#x201d;)
                                            pursuant to which ITAC became a wholly-owned&#160;subsidiary of the Company, and the Company
                                            issued ordinary shares and warrants to the holders of ITAC common stock and warrants, respectively.
                                            In connection with the Merger, the name of ITAC was changed to Autobot HoldCo, Inc.&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 84.45pt; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;In
connection with the Merger, and immediately prior to the closing of the Merger, the Company effected a recapitalization (the &#x201c;Recapitalization&#x201d;),
which was approved by the Company&#x2019;s directors and shareholders. As part of the Recapitalization, (i) all warrants (other than certain
outstanding warrants) were exercised, (ii) all outstanding preferred shares, including preferred shares issued upon exercise of warrants,
were converted into ordinary shares and (iii) the ordinary shares that were outstanding after the exercise and conversion pursuant to
clauses (i) and (ii) became and were converted into a total of 48,268,611 ordinary shares. The Recapitalization resulted in a 46.25783-for-one
stock split and a change in the par value of the ordinary shares from NIS 0.01 per share to NIS 0.000216 per share. The stock split was
based on a valuation of the Ordinary Shares of $525,000 after the Recapitalization, with each Ordinary Share being valued at $10.00.
As part of the Recapitalization, the number of Ordinary Shares issuable upon exercise of outstanding options and warrants was multiplied
by the stock split ratio, which is the conversion ratio, and the exercise price of such options and warrants was divided by the conversion
ratio. Fractional shares were rounded to the closest integral number of Ordinary Shares, with a half-share being rounded to the next
higher number of Ordinary Shares. As a result, all Ordinary Shares, preferred shares, options to purchase ordinary shares, warrants to
purchase preferred shares, exercise price and net loss per share amounts in these financial statements were adjusted retroactively for
the year ended December 31, 2021, as if the stock split and change in par value had been in effect at January 1, 2021.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 84.45pt; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Pursuant
to the Merger, Arbe issued to ITAC securityholders (a) 3,866,842 Ordinary Shares to the holders of ITAC common stock and (b) 10,735,680
Arbe warrants to the holders of ITAC warrants, of which 7,623,600 warrants are public warrants and 3,112,080 warrants are private warrants.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 84.45pt; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Total
gross proceeds resulted from the Merger and the related PIPE financing were approximately $118,288, of which total transaction costs
amounted to approximately $16,707. The total gross proceeds include the $100,000 from the sale of 10,000,000 Ordinary Shares to the PIPE
investors at $10.00 per share.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 84.45pt; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.5in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;d.&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The
                                            Company depends on one supplier for the development and productization of its products. If
                                            this supplier fails to deliver or delays the delivery of the necessary products, the Company
                                            will be required to seek alternative sources of supply. A change in supplier could result
                                            in manufacturing delays and increased costs, which could result in a possible loss of sales
                                            which would adversely affect the Company&#x2019;s business, prospects, results of operations
                                            and financial position.&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 84.45pt; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.5in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;e.&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;As
                                            the Company operates internationally and substantially all of its revenue is derived from
                                            sales outside of Israel, the business is affected by inflation, supply chain issues and economic
                                            conditions in countries in which the Company is seeking to conduct business, security and
                                            cybersecurity issues, fiscal and monetary policies, interest rates and regulations affection
                                            the automobile industry, the timing by the automobile and other industries on the introduction
                                            of unmanned automobiles and other unmanned devices, safety concerns and well as the effect
                                            of regional conflicts and steps taken by governments with respect to parties to such conflicts.&#160;
                                            As an Israeli company, the Company is also subject to the effect on Israel and the Israeli
                                            economy of the present war with Hamas as well as any other regional conflicts which may develop
                                            and the relationship between Israel and other countries, including the United States, China
                                            and the European Union.&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 84.45pt; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 0.5in; text-align: justify; font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 0.25in; text-align: justify; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;f.&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The Company has incurred losses from operations since its inception and has negative cash flow from operating activities. Management's plans with regard to these matters include continued development and marketing of its products as well as seeking additional financing arrangements.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</us-gaap:NatureOfOperations>
    <us-gaap:CommonStockOtherSharesOutstanding
      contextRef="c5"
      decimals="0"
      id="ixv-26410"
      unitRef="shares">48268611</us-gaap:CommonStockOtherSharesOutstanding>
    <us-gaap:SharesIssuedPricePerShare
      contextRef="c82"
      decimals="2"
      id="ixv-26411"
      unitRef="ilsPershares">0.01</us-gaap:SharesIssuedPricePerShare>
    <us-gaap:SharesIssuedPricePerShare
      contextRef="c83"
      decimals="6"
      id="ixv-26412"
      unitRef="ilsPershares">0.000216</us-gaap:SharesIssuedPricePerShare>
    <us-gaap:PaymentsOfOrdinaryDividends contextRef="c0" decimals="-3" id="ixv-26413" unitRef="usd">525000000</us-gaap:PaymentsOfOrdinaryDividends>
    <us-gaap:SharesIssuedPricePerShare
      contextRef="c5"
      decimals="2"
      id="ixv-26414"
      unitRef="usdPershares">10</us-gaap:SharesIssuedPricePerShare>
    <us-gaap:CommonStockOtherSharesOutstanding
      contextRef="c84"
      decimals="0"
      id="ixv-26415"
      unitRef="shares">3866842</us-gaap:CommonStockOtherSharesOutstanding>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="c5"
      decimals="0"
      id="ixv-26416"
      unitRef="shares">10735680</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="c85"
      decimals="0"
      id="ixv-26417"
      unitRef="shares">7623600</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="c86"
      decimals="0"
      id="ixv-26418"
      unitRef="shares">3112080</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ProceedsFromIssuanceInitialPublicOffering contextRef="c87" decimals="-3" id="ixv-26419" unitRef="usd">118288000</us-gaap:ProceedsFromIssuanceInitialPublicOffering>
    <us-gaap:SaleOfStockConsiderationReceivedOnTransaction contextRef="c0" decimals="-3" id="ixv-26420" unitRef="usd">16707000</us-gaap:SaleOfStockConsiderationReceivedOnTransaction>
    <us-gaap:ProceedsFromIssuanceInitialPublicOffering contextRef="c88" decimals="-3" id="ixv-26421" unitRef="usd">100000000</us-gaap:ProceedsFromIssuanceInitialPublicOffering>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="c87"
      decimals="0"
      id="ixv-26422"
      unitRef="shares">10000000</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:SharesIssuedPricePerShare
      contextRef="c89"
      decimals="2"
      id="ixv-26423"
      unitRef="usdPershares">10</us-gaap:SharesIssuedPricePerShare>
    <us-gaap:SignificantAccountingPoliciesTextBlock contextRef="c0" id="ixv-20178">&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-transform: uppercase; text-align: justify; text-indent: -56.7pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Note
2:-&#160;&#160; Significant Accounting Policies&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 57.9pt"&gt;&lt;/td&gt;&lt;td style="width: 27.15pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;a.&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Basis of presentation:&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 84.45pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The
consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States
of America (US GAAP). The significant accounting policies followed in the preparation of the financial statements applied on a consistent
basis for all years presented in these financial statements.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 84.45pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The
consolidated financial statements include the accounts of the Company&#x2019;s wholly owned subsidiaries. All intercompany balances and
transactions have been eliminated in consolidation.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.5in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;b.&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Use of estimates:&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The
preparation of consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect
the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial
statements and the reported amounts of revenues and expenses during the reporting periods. Significant items subject to such estimates
and assumptions including fair value of warrants, share-based compensation and the underlying fair value of the Company&#x2019;s Ordinary
Shares issued prior to the Merger.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The
Company bases these estimates on historical and anticipated results, trends and various other assumptions that it believes are reasonable
under the circumstances, including assumptions as to future events. Actual results could differ from those estimates.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.5in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;c.&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Consolidated financial statements in U.S. dollars:&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;A
substantial portion the Company&#x2019;s activity including transactions with customers, as well as equity transactions and cash investments,
are incurred in U.S. dollars. The Company&#x2019;s management believes that the U.S. dollar is the currency of the primary economic environment
in which the Company operates. Thus, the functional and reporting currency of the Company is the U.S. dollar.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;A
subsidiary&#x2019;s functional currency is the currency of the primary economic environment in which the subsidiary operates; normally,
that is the currency of the environment in which a subsidiary primarily generates and expends cash. In making the determination of the
appropriate functional currency for a subsidiary, the Company considers cash flow indicators, local market indicators, financing indicators
and the subsidiary&#x2019;s relationship with both the parent company and other subsidiaries. The Company has determined the functional
currency of its U.S. subsidiaries to be the U.S. Dollar.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Monetary
accounts maintained in currencies other than the U.S. dollar are remeasured into U.S. dollars in accordance with Statement of the Accounting
Standard Codification (&#x201c;ASC&#x201d;) No. 830 &#x201c;Foreign Currency Matters&#x201d; (&#x201c;ASC No. 830&#x201d;). All transaction
gains and losses of the remeasured monetary balance sheet items are reflected in the statements of operations as financial income or
expenses as appropriate.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Transactions
in foreign currency are translated into dollars in accordance with the principles set forth in ASC Subtopic 830-20, &lt;i&gt;Foreign Currency
Transaction&lt;/i&gt;. Monetary assets and liabilities denominated in foreign currencies of the reporting date are translated to the functional
currency at the closing rate at the end of the reporting period. Non-monetary assets and liabilities denominated in foreign currency
are translated using the exchange rate at the date of the transaction. Gains and losses from remeasurement of assets and liabilities
denominated in currencies other than the respective functional currencies are included in the consolidated statements of operations.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.5in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;d.&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Concentration of credit risk:&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Most
of the Company&#x2019;s cash and cash equivalents, restricted cash and short-term deposits were deposited with Israeli banks and were
comprised mainly of cash deposits and short-term deposits.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The
Company&#x2019;s trade receivables are derived from customers located globally. The Company mitigates its credit risks by performing credit
evaluations of its customers&#x2019; financial conditions and requires customer advance payments in certain circumstances. The Company
generally does not require collateral.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.5in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;e.&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Cash and cash equivalents and restricted cash:&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The
Company considers all highly liquid short-term deposits with original maturities of three months or less from the purchase date to be
cash equivalents. Cash equivalents consist primarily of amounts invested in short-term deposits.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Restricted
cash consists of deposits at a financial institution that serves as collateral for a credit card agreement and lease agreements.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.5in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;f.&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Short term deposits:&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: -28.35pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Short-term
deposits are bank deposits with an original maturity of more than three months and less than one year from the date of acquisition. The
deposits are presented according to their terms of deposit. As of December 31, 2023, these bank deposit bearing annual interest rates
in the range of&#160;4%-6%,&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: -28.35pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.5in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;g.&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Fair value of financial instruments:&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The
estimated fair value of financial instruments has been determined by the Company using available market information and valuation methodologies.
Considerable judgment is required in estimating fair values. Accordingly, the estimates may not be indicative of the amounts the Company
could realize in a current market exchange. The following methods and assumptions were used by the Company in estimating the fair value
of their financial instruments:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The
carrying values of cash and cash equivalents, short-term deposits, restricted cash, trade receivables, other current assets, trade payables,
employees and payroll accruals, accrued expenses and other current liabilities approximate their fair values due to the short-term maturities
of these instruments.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The
Company applies ASC No. 820, &#x201c;Fair Value Measurements and Disclosures&#x201d; (&#x201c;ASC No. 820&#x201d;), with respect to fair
value measurements of all financial assets and liabilities. In accordance with ASC No.&#160;820, the Company measures its short-term
deposits and warrant liability at fair value. Short-term deposits are classified within Level&#160;1 because these assets are valued
using quoted market prices. Fair value represents the amount that would be received to sell an asset or paid to transfer a liability
in an orderly transaction between market participants. As such, fair value is a market-based measurement that should be determined based
on assumptions that market participants would use in pricing an asset or a liability. A three-tier fair value hierarchy is established
as a basis for considering such assumptions and for inputs used in the valuation methodologies in measuring fair value:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 103.05pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.75in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&#x25cf;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Level
                                            1&#x2014;Observable inputs that reflect quoted prices (unadjusted) for identical assets or
                                            liabilities in active markets.&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.75in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&#x25cf;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Level
                                            2&#x2014;Include other inputs that are directly or indirectly observable in the marketplace.&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.75in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&#x25cf;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Level
                                            3&#x2014;Unobservable inputs which are supported by little or no market activity.&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 103.05pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The
fair value hierarchy also requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when
measuring fair value.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Pursuant
to the Merger, the Company (i) assumed a derivative warrant liability related to Company&#x2019;s warrants that were issued to the holders of
private placement warrants that had been issued by ITAC in connection with its initial public offering, and (ii) issued equity instrument
in connection with warrants that had been issued as part of ITAC&#x2019;s initial public offering and pursuant to the Merger became warrants
to purchase the Company&#x2019;s Ordinary Shares. The fair value of the Company&#x2019;s public warrants is measured based on the market
price of such warrants and are considered a Level 1 fair value measurement. The Company utilizes a Black-Scholes option pricing model
to estimate the fair value of the private placement warrants which are considered a Level 3 fair value measurement.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The
Company&#x2019;s private warrants are measured at each reporting period, with changes in fair value recognized in the statement of operations.
See Note 8.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.5in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;h.&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Trade Receivables&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Trade
receivables are recorded at the invoiced amount and do not bear interest. Trade receivables are periodically assessed for allowance for
doubtful accounts, which is the Company&#x2019;s best estimate of the amount of credit losses with respect to its existing trade receivable.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The
Company&#x2019;s accounts receivables accounting policy from January 1, 2023, following the adoption of the new current expected credit
losses (&#x201c;CECL&#x201d;) standard:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The
Company estimates CECL on trade receivables at inception for estimated losses resulting from the inability of the Company&#x2019;s customers
to make required payments, based on estimated current expected credit losses. The allowance represents the current estimate of lifetime
expected credit losses over the remaining duration of existing accounts receivable considering historical information, current market
conditions and reasonable and supportable forecasts when appropriate. The estimate is a result of the Company&#x2019;s ongoing evaluation
of collectability, customer creditworthiness, historical levels of credit losses, and future expectations.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The
allowance for credit losses was not material for the years ended December 31, 2023, 2022 and 2021.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.5in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;i.&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Property and equipment:&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Property
and equipment are recorded at cost and depreciated over their estimated useful lives using the straight-line method. Upon retirement
or sale, the cost of assets disposed of and the related accumulated depreciation are removed from the accounts and any resulting gain
or loss is included in income. Repair and maintenance costs are expensed as incurred.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Depreciation
is calculated using the straight-line method over the estimated useful lives of the assets, at the following annual rates:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Computers and peripheral equipment&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;15-33&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Office furniture and equipment&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;7-15&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 88%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Vehicles&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;15&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Leasehold improvement&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-214; font-family: Times New Roman, Times, Serif"&gt;(*)&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 113.4pt; text-align: justify; text-indent: -28.35pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.75in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(*)&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Leasehold improvements are amortized using the straight-line method over the shorter of the lease term or the estimated useful life of the improvements.&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.5in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;j.&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Impairment of long-lived assets:&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Long-lived
assets are reviewed for impairment in accordance with ASC 360, &#x201c;Property, Plant and Equipment&#x201d; a (&#x201c;ASC 360&#x201d;),
whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Impairment exists when
the carrying value of the asset exceeds the aggregate undiscounted cash flows expected to be generated by the asset. The impairment to
be recognized is measured by the amount by which the carrying amount of the assets exceeds their fair value. During the years ended December
31, 2023, 2022 and 2021, no impairment losses were identified.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.5in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;k.&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Accrued post-employment benefit:&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"&gt;The employees of Arbe Ltd. are included under section 14 of the Israeli
Severance Compensation Act, 1963 (&#x201c;Section 14&#x201d;). Pursuant to Section 14, the Company&#x2019;s Israeli employees are entitled
to monthly deposits, at a rate of&#160;8.33% of their monthly salary, deposited on their behalf to their chosen insurance funds. By making
the payments in accordance with Section 14, the Company is released from any future severance payments in respect of those employees.
The obligation to make the monthly deposits is expensed as incurred. The deposits pursuant to Section 14 are not recorded as an asset
in the consolidated balance sheet, and there is no liability recorded as the Company does not have a future obligation to make any additional
payments. Severance costs amounted to approximately $1,166, $1,240 and $826 for the years ended December 31, 2023, 2022 and 2021, respectively.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;One
of the Company&#x2019;s U.S. Subsidiaries has a 401(k) defined contribution plan covering one employee in the U.S. The expenses recorded
by the U.S. subsidiaries for matching contributions for the years ended December 31, 2023, 2022 and 2021 were immaterial.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-transform: uppercase; text-align: justify; text-indent: -56.7pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.5in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;l.&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Stock-based compensation:&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The
Company accounts for stock-based compensation in accordance with ASC 718, &#x201c;Compensation - Stock Compensation&#x201d;, which requires
the measurement and recognition of compensation expense based on estimated fair values for all share-based payment awards made to employees,
nonemployees and directors. ASC 718 requires companies to estimate the fair value of equity-based payment awards on the date of grant
using an option-pricing model. The value of the portion of the award that is ultimately expected to vest is recognized as an expense
in the Company&#x2019;s statements of operations over the applicable service periods.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The
Company measures its share-based payment awards made to employees, directors, and non-employee service providers based on estimated fair
values. The fair value of each option award is estimated on the grant date using the Black-Scholes option pricing model which requires
several assumptions, of which the most significant are the expected share price volatility and the expected option term. The Company
recognizes forfeitures of equity-based awards as they occur. For graded vesting awards, the Company recognizes compensation expenses
based on the straight-line method over the applicable service period.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.5in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;m.&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Net loss per share attributable to ordinary shareholders:&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The
Company computes net loss per share using the two-class method required for participating securities. The two-class method requires income
available to ordinary shareholders for the period to be allocated between ordinary shares and participating securities based upon their
respective rights to receive dividends as if all income for the period had been distributed. The Company considered its convertible preferred
shares, which were outstanding through October 7, 2021, the date of the closing of the Merger, to be participating securities as the
holders of the convertible preferred shares would be entitled to dividends that would be distributed to the holders of ordinary shares,
equal to the higher of their original issue price pro-rata basis assuming conversion of all convertible preferred shares into ordinary
shares and that there are no preferences to any holders of any shares. These participating securities do not contractually require the
holders of such shares to participate in the Company&#x2019;s losses. As such, net loss for the periods presented was not allocated to
the Company&#x2019;s participating securities.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The
Company&#x2019;s basic net loss per share is calculated by dividing net loss attributable to ordinary shareholders by the weighted-average
number of ordinary shares outstanding for the period, without consideration of potentially dilutive securities. The diluted net loss
per share is calculated by giving effect to all potentially dilutive securities outstanding for the period using the treasury share method
or the if-converted method based on the nature of such securities. Diluted net loss per share is the same as basic net loss per share
in periods when the effects of potentially dilutive shares of ordinary shares are anti-dilutive. See Note 10.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.5in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;n.&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Other Comprehensive loss:&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The
Company has no components of comprehensive loss other than net loss. Thus, comprehensive loss is the same as net loss for the periods
presented.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 74.7pt; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.5in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;p.&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Revenue recognition:&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The
Company follows the provisions of ASC Topic 606, Revenue from Contracts with Customers (&#x201c;ASC 606&#x201d;), which apply to all contracts
with customers. Under Topic 606, revenues are recognized when control of the promised goods or services is transferred to the customers,
in an amount that reflects the consideration that the Company expects to receive in exchange for those goods or services. To determine
the appropriate revenue recognition for arrangements that an entity determines are within the scope of Topic 606, the entity performs
the following five steps:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.75in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Identify
                                            the contract(s) with a customer;&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.75in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Identify
                                            the performance obligations in the contract;&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.75in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Determine
                                            the transaction price;&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.75in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Allocate
                                            the transaction price to the performance obligations in the contract; and&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.75in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Recognize
                                            revenue when (or as) the entity satisfies a performance obligation.&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;At
contract inception, once the contract is determined to be within the scope of Topic 606, the Company assesses the goods or services promised
within the contract and determines the performance obligations and assesses whether each promised good or service is distinct. The Company
evaluates each performance obligation to determine if it is satisfied at a point in time or over time. See Note 3.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;i&gt;Nature
of Products and Services&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The
Company derives its revenues mainly from sales of chipsets and prototype radar systems to be installed onto automotive vehicles and professional
services. Revenue from chipsets and prototype radar systems is recognized at the point in time when the control of the goods is transferred
to the customer, generally upon delivery, and the Company has no remaining performance obligations.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;i&gt;Right
of Return&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The
Company&#x2019;s general terms and conditions for its contracts do not contain a right of return that allows the customer to return products
and receive a credit. Therefore, the Company does not estimate returns and generally recognizes revenue at contract price upon product
delivery.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;i&gt;Deferred
Revenue&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Deferred
revenues, which represent a contract liability, where the Company has an obligation to transfer goods or services to the customer for
which it received consideration from the customer.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.5in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;q.&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Cost of revenues:&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Cost
of revenue includes the manufacturing cost of radar sensors and chipsets, which primarily consists of components cost, assembly costs
and personnel-related costs directly associated with our customer support personnel.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.5in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;r.&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Research and development expenses, net:&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Research
and development costs, net of grants received, are charged to the consolidated statement of operations as incurred.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.5in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;s.&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Income taxes:&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The
Company accounts for income taxes in accordance with ASC 740, &#x201c;Income Taxes&#x201d;. This standard prescribes the use of the asset
and liability method whereby deferred tax asset and liability account balances are determined based on differences between the financial
statement carrying amount and the tax bases of assets and liabilities and are measured using the enacted tax rates and laws that will
be in effect when the differences are expected to reverse. The Company provides a valuation allowance, if necessary, to reduce deferred
tax assets to the amount that is more likely than not to be realized.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The
Company recognizes the tax benefit from a tax position only if it is more likely than not that the tax position will be sustained on
examination by the taxing authorities, based on the technical merits of the position. A tax position that meets the more-likely-than-not
recognition threshold is measured at the largest amount that is greater than 50 percent likely of being realized upon settlement with
the taxing authority using the facts, circumstances, and information available at the reporting date.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.5in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;t.&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Contingent Liabilities&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 84.45pt; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The
Company accounts for its contingent liabilities in accordance with ASC No.&#160;450, &#x201c;Contingencies.&#x201d; A provision is recorded
when it is both probable that a liability has been incurred and the amount of the loss can be reasonably estimated. With respect to legal
matters, provisions are reviewed and adjusted to reflect the impact of negotiations, estimated settlements, legal rulings, advice of
legal counsel and other information and events pertaining to a particular matter. As of December&#160;31, 2023 and 2022, the Company
is not a party to any litigation that could have a material adverse effect on the Company&#x2019;s business, financial position, results
of operations or cash flows.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.5in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;u.&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Leases:&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;On
January 1, 2022, the Company adopted Accounting Standards Update No. 2016-02, Leases (Topic 842) (ASU 2016-02) relating to the accounting
treatment of lease obligations, using the modified retrospective method.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The
Company elected the package of practical expedients permitted under the transition guidance. The Company also elected not to recognize
a lease liability and a right-of-use (&#x201c;ROU&#x201d;) asset on the balance sheet for leases with a term of twelve months or less.
The Company recognizes the associated lease payments in the consolidated statements of income on a straight-line basis over the lease
term.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Under
Topic 842, the Company determines if an arrangement is a lease at inception. ROU assets and liabilities are recognized at the commencement
date based on the present value of remaining lease payments over the lease term. For this purpose, the Company considers fixed and determinable
payments at the time of commencement. As most of the Company leases do not provide an implicit rate, the Company uses its incremental
borrowing rate based on the information available at the commencement date in determining the present value of lease payments. The incremental
borrowing rate is estimated to approximate the interest rate on a collateralized basis with similar terms and payments. The ROU asset
is recorded net of any lease incentives received. The lease terms may include options to extend or terminate the lease when it is reasonably
certain that the Company will exercise such options.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Payments
under the Company&#x2019;s lease agreements are primarily fixed, however, certain lease agreements contain variable costs such as common
area maintenance, real estate taxes, and insurance are not included in the lease liability and are recognized as they are incurred. See
Note 6.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.5in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;v.&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Impact of recently issued accounting standard:&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;In
June 2016, the FASB issued ASU No. 2016-13, Financial Instruments&#x2014;Credit Losses (&#x201c;ASC 326&#x201d;): Measurement of Credit
Losses on Financial Instruments to introduce a new model for recognizing credit losses on financial instruments based on estimated current
expected credit losses, or CECL. Under the new standard, an entity is required to estimate CECL on trade receivables at inception, based
on historical information, current conditions, and reasonable and supportable forecasts. The guidance is effective for the Company for
annual periods beginning after December 15, 2022, including interim periods within those fiscal years. Early application is permitted.
The Company adopted ASC 326 on January 1, 2023, and there was no material impact on the Company&#x2019;s consolidated balance sheet and
the consolidated statements of operations upon adoption.&lt;/span&gt;&lt;/p&gt;</us-gaap:SignificantAccountingPoliciesTextBlock>
    <us-gaap:BasisOfAccountingPolicyPolicyTextBlock contextRef="c0" id="ixv-20183">&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 57.9pt"&gt;&lt;/td&gt;&lt;td style="width: 27.15pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;a.&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Basis of presentation:&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 84.45pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The
consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States
of America (US GAAP). The significant accounting policies followed in the preparation of the financial statements applied on a consistent
basis for all years presented in these financial statements.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The
consolidated financial statements include the accounts of the Company&#x2019;s wholly owned subsidiaries. All intercompany balances and
transactions have been eliminated in consolidation.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;</us-gaap:BasisOfAccountingPolicyPolicyTextBlock>
    <us-gaap:UseOfEstimates contextRef="c0" id="ixv-20248">&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.5in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;b.&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Use of estimates:&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The
preparation of consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect
the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial
statements and the reported amounts of revenues and expenses during the reporting periods. Significant items subject to such estimates
and assumptions including fair value of warrants, share-based compensation and the underlying fair value of the Company&#x2019;s Ordinary
Shares issued prior to the Merger.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The
Company bases these estimates on historical and anticipated results, trends and various other assumptions that it believes are reasonable
under the circumstances, including assumptions as to future events. Actual results could differ from those estimates.&lt;/span&gt;&lt;/p&gt;</us-gaap:UseOfEstimates>
    <us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock contextRef="c0" id="ixv-20268">&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.5in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;c.&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Consolidated financial statements in U.S. dollars:&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;A
substantial portion the Company&#x2019;s activity including transactions with customers, as well as equity transactions and cash investments,
are incurred in U.S. dollars. The Company&#x2019;s management believes that the U.S. dollar is the currency of the primary economic environment
in which the Company operates. Thus, the functional and reporting currency of the Company is the U.S. dollar.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;A
subsidiary&#x2019;s functional currency is the currency of the primary economic environment in which the subsidiary operates; normally,
that is the currency of the environment in which a subsidiary primarily generates and expends cash. In making the determination of the
appropriate functional currency for a subsidiary, the Company considers cash flow indicators, local market indicators, financing indicators
and the subsidiary&#x2019;s relationship with both the parent company and other subsidiaries. The Company has determined the functional
currency of its U.S. subsidiaries to be the U.S. Dollar.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Monetary
accounts maintained in currencies other than the U.S. dollar are remeasured into U.S. dollars in accordance with Statement of the Accounting
Standard Codification (&#x201c;ASC&#x201d;) No. 830 &#x201c;Foreign Currency Matters&#x201d; (&#x201c;ASC No. 830&#x201d;). All transaction
gains and losses of the remeasured monetary balance sheet items are reflected in the statements of operations as financial income or
expenses as appropriate.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Transactions
in foreign currency are translated into dollars in accordance with the principles set forth in ASC Subtopic 830-20, &lt;i&gt;Foreign Currency
Transaction&lt;/i&gt;. Monetary assets and liabilities denominated in foreign currencies of the reporting date are translated to the functional
currency at the closing rate at the end of the reporting period. Non-monetary assets and liabilities denominated in foreign currency
are translated using the exchange rate at the date of the transaction. Gains and losses from remeasurement of assets and liabilities
denominated in currencies other than the respective functional currencies are included in the consolidated statements of operations.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;</us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock>
    <us-gaap:ConcentrationRiskCreditRisk contextRef="c0" id="ixv-20344">&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.5in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;d.&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Concentration of credit risk:&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Most
of the Company&#x2019;s cash and cash equivalents, restricted cash and short-term deposits were deposited with Israeli banks and were
comprised mainly of cash deposits and short-term deposits.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The
Company&#x2019;s trade receivables are derived from customers located globally. The Company mitigates its credit risks by performing credit
evaluations of its customers&#x2019; financial conditions and requires customer advance payments in certain circumstances. The Company
generally does not require collateral.&lt;/span&gt;&lt;/p&gt;</us-gaap:ConcentrationRiskCreditRisk>
    <us-gaap:CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy contextRef="c0" id="ixv-20364">&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.5in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;e.&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Cash and cash equivalents and restricted cash:&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The
Company considers all highly liquid short-term deposits with original maturities of three months or less from the purchase date to be
cash equivalents. Cash equivalents consist primarily of amounts invested in short-term deposits.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Restricted
cash consists of deposits at a financial institution that serves as collateral for a credit card agreement and lease agreements.&lt;/span&gt;&lt;/p&gt;</us-gaap:CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy>
    <arbe:ShortTermDepositsPolicyPolicyTextBlock contextRef="c0" id="ixv-20384">&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.5in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;f.&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Short term deposits:&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Short-term
deposits are bank deposits with an original maturity of more than three months and less than one year from the date of acquisition. The
deposits are presented according to their terms of deposit. As of December 31, 2023, these bank deposit bearing annual interest rates
in the range of&#160;4%-6%,&lt;/span&gt;&lt;/p&gt;</arbe:ShortTermDepositsPolicyPolicyTextBlock>
    <srt:DemandDepositLiabilitiesInterestBearingAverageRatePaid contextRef="c90" decimals="2" id="ixv-26424" unitRef="pure">0.04</srt:DemandDepositLiabilitiesInterestBearingAverageRatePaid>
    <srt:DemandDepositLiabilitiesInterestBearingAverageRatePaid contextRef="c91" decimals="2" id="ixv-26425" unitRef="pure">0.06</srt:DemandDepositLiabilitiesInterestBearingAverageRatePaid>
    <us-gaap:FairValueOfFinancialInstrumentsPolicy contextRef="c0" id="ixv-20399">&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.5in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;g.&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Fair value of financial instruments:&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The
estimated fair value of financial instruments has been determined by the Company using available market information and valuation methodologies.
Considerable judgment is required in estimating fair values. Accordingly, the estimates may not be indicative of the amounts the Company
could realize in a current market exchange. The following methods and assumptions were used by the Company in estimating the fair value
of their financial instruments:&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The
carrying values of cash and cash equivalents, short-term deposits, restricted cash, trade receivables, other current assets, trade payables,
employees and payroll accruals, accrued expenses and other current liabilities approximate their fair values due to the short-term maturities
of these instruments.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The
Company applies ASC No. 820, &#x201c;Fair Value Measurements and Disclosures&#x201d; (&#x201c;ASC No. 820&#x201d;), with respect to fair
value measurements of all financial assets and liabilities. In accordance with ASC No.&#160;820, the Company measures its short-term
deposits and warrant liability at fair value. Short-term deposits are classified within Level&#160;1 because these assets are valued
using quoted market prices. Fair value represents the amount that would be received to sell an asset or paid to transfer a liability
in an orderly transaction between market participants. As such, fair value is a market-based measurement that should be determined based
on assumptions that market participants would use in pricing an asset or a liability. A three-tier fair value hierarchy is established
as a basis for considering such assumptions and for inputs used in the valuation methodologies in measuring fair value:&lt;/span&gt;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.75in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&#x25cf;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Level
                                            1&#x2014;Observable inputs that reflect quoted prices (unadjusted) for identical assets or
                                            liabilities in active markets.&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.75in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&#x25cf;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Level
                                            2&#x2014;Include other inputs that are directly or indirectly observable in the marketplace.&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.75in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&#x25cf;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Level
                                            3&#x2014;Unobservable inputs which are supported by little or no market activity.&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The
fair value hierarchy also requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when
measuring fair value.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Pursuant
to the Merger, the Company (i) assumed a derivative warrant liability related to Company&#x2019;s warrants that were issued to the holders of
private placement warrants that had been issued by ITAC in connection with its initial public offering, and (ii) issued equity instrument
in connection with warrants that had been issued as part of ITAC&#x2019;s initial public offering and pursuant to the Merger became warrants
to purchase the Company&#x2019;s Ordinary Shares. The fair value of the Company&#x2019;s public warrants is measured based on the market
price of such warrants and are considered a Level 1 fair value measurement. The Company utilizes a Black-Scholes option pricing model
to estimate the fair value of the private placement warrants which are considered a Level 3 fair value measurement.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The
Company&#x2019;s private warrants are measured at each reporting period, with changes in fair value recognized in the statement of operations.
See Note 8.&lt;/span&gt;&lt;/p&gt;</us-gaap:FairValueOfFinancialInstrumentsPolicy>
    <us-gaap:ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy contextRef="c0" id="ixv-20512">&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.5in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;h.&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Trade Receivables&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Trade
receivables are recorded at the invoiced amount and do not bear interest. Trade receivables are periodically assessed for allowance for
doubtful accounts, which is the Company&#x2019;s best estimate of the amount of credit losses with respect to its existing trade receivable.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The
Company&#x2019;s accounts receivables accounting policy from January 1, 2023, following the adoption of the new current expected credit
losses (&#x201c;CECL&#x201d;) standard:&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The
Company estimates CECL on trade receivables at inception for estimated losses resulting from the inability of the Company&#x2019;s customers
to make required payments, based on estimated current expected credit losses. The allowance represents the current estimate of lifetime
expected credit losses over the remaining duration of existing accounts receivable considering historical information, current market
conditions and reasonable and supportable forecasts when appropriate. The estimate is a result of the Company&#x2019;s ongoing evaluation
of collectability, customer creditworthiness, historical levels of credit losses, and future expectations.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The
allowance for credit losses was not material for the years ended December 31, 2023, 2022 and 2021.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;</us-gaap:ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy>
    <us-gaap:PropertyPlantAndEquipmentPolicyTextBlock contextRef="c0" id="ixv-20587">&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.5in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;i.&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Property and equipment:&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Property
and equipment are recorded at cost and depreciated over their estimated useful lives using the straight-line method. Upon retirement
or sale, the cost of assets disposed of and the related accumulated depreciation are removed from the accounts and any resulting gain
or loss is included in income. Repair and maintenance costs are expensed as incurred.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Depreciation
is calculated using the straight-line method over the estimated useful lives of the assets, at the following annual rates:&lt;/span&gt;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Computers and peripheral equipment&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;15-33&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Office furniture and equipment&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;7-15&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 88%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Vehicles&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;15&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Leasehold improvement&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-214; font-family: Times New Roman, Times, Serif"&gt;(*)&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.75in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(*)&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Leasehold improvements are amortized using the straight-line method over the shorter of the lease term or the estimated useful life of the improvements.&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;</us-gaap:PropertyPlantAndEquipmentPolicyTextBlock>
    <arbe:PropertyPlantAndEquipmentUsefulLifeTableTextBlock contextRef="c0" id="ixv-20604">&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Depreciation
is calculated using the straight-line method over the estimated useful lives of the assets, at the following annual rates:&lt;/span&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Computers and peripheral equipment&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;15-33&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Office furniture and equipment&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;7-15&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 88%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Vehicles&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;15&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Leasehold improvement&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-214; font-family: Times New Roman, Times, Serif"&gt;(*)&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.75in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(*)&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Leasehold improvements are amortized using the straight-line method over the shorter of the lease term or the estimated useful life of the improvements.&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;</arbe:PropertyPlantAndEquipmentUsefulLifeTableTextBlock>
    <us-gaap:PropertyPlantAndEquipmentSalvageValuePercentage contextRef="c92" decimals="2" id="ixv-26426" unitRef="pure">0.15</us-gaap:PropertyPlantAndEquipmentSalvageValuePercentage>
    <us-gaap:PropertyPlantAndEquipmentSalvageValuePercentage contextRef="c93" decimals="2" id="ixv-26427" unitRef="pure">0.33</us-gaap:PropertyPlantAndEquipmentSalvageValuePercentage>
    <us-gaap:PropertyPlantAndEquipmentSalvageValuePercentage contextRef="c94" decimals="2" id="ixv-26428" unitRef="pure">0.07</us-gaap:PropertyPlantAndEquipmentSalvageValuePercentage>
    <us-gaap:PropertyPlantAndEquipmentSalvageValuePercentage contextRef="c95" decimals="2" id="ixv-26429" unitRef="pure">0.15</us-gaap:PropertyPlantAndEquipmentSalvageValuePercentage>
    <us-gaap:PropertyPlantAndEquipmentSalvageValuePercentage contextRef="c96" decimals="2" id="ixv-26430" unitRef="pure">0.15</us-gaap:PropertyPlantAndEquipmentSalvageValuePercentage>
    <us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock contextRef="c0" id="ixv-20678">&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.5in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;j.&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Impairment of long-lived assets:&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Long-lived
assets are reviewed for impairment in accordance with ASC 360, &#x201c;Property, Plant and Equipment&#x201d; a (&#x201c;ASC 360&#x201d;),
whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Impairment exists when
the carrying value of the asset exceeds the aggregate undiscounted cash flows expected to be generated by the asset. The impairment to
be recognized is measured by the amount by which the carrying amount of the assets exceeds their fair value. During the years ended December
31, 2023, 2022 and 2021, no impairment losses were identified.&lt;/span&gt;&lt;/p&gt;</us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock>
    <us-gaap:PostemploymentBenefitPlansPolicy contextRef="c0" id="ixv-20693">&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.5in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;k.&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Accrued post-employment benefit:&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"&gt;The employees of Arbe Ltd. are included under section 14 of the Israeli
Severance Compensation Act, 1963 (&#x201c;Section 14&#x201d;). Pursuant to Section 14, the Company&#x2019;s Israeli employees are entitled
to monthly deposits, at a rate of&#160;8.33% of their monthly salary, deposited on their behalf to their chosen insurance funds. By making
the payments in accordance with Section 14, the Company is released from any future severance payments in respect of those employees.
The obligation to make the monthly deposits is expensed as incurred. The deposits pursuant to Section 14 are not recorded as an asset
in the consolidated balance sheet, and there is no liability recorded as the Company does not have a future obligation to make any additional
payments. Severance costs amounted to approximately $1,166, $1,240 and $826 for the years ended December 31, 2023, 2022 and 2021, respectively.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;One
of the Company&#x2019;s U.S. Subsidiaries has a 401(k) defined contribution plan covering one employee in the U.S. The expenses recorded
by the U.S. subsidiaries for matching contributions for the years ended December 31, 2023, 2022 and 2021 were immaterial.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-transform: uppercase; text-align: justify; text-indent: -56.7pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;</us-gaap:PostemploymentBenefitPlansPolicy>
    <arbe:SeverancePercentageOfMonthlySalary contextRef="c0" decimals="4" id="ixv-26431" unitRef="pure">0.0833</arbe:SeverancePercentageOfMonthlySalary>
    <us-gaap:SeveranceCosts1 contextRef="c0" decimals="-3" id="ixv-26432" unitRef="usd">1166000</us-gaap:SeveranceCosts1>
    <us-gaap:SeveranceCosts1 contextRef="c7" decimals="-3" id="ixv-26433" unitRef="usd">1240000</us-gaap:SeveranceCosts1>
    <us-gaap:SeveranceCosts1 contextRef="c8" decimals="-3" id="ixv-26434" unitRef="usd">826000</us-gaap:SeveranceCosts1>
    <us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy contextRef="c0" id="ixv-20757">&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.5in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;l.&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Stock-based compensation:&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The
Company accounts for stock-based compensation in accordance with ASC 718, &#x201c;Compensation - Stock Compensation&#x201d;, which requires
the measurement and recognition of compensation expense based on estimated fair values for all share-based payment awards made to employees,
nonemployees and directors. ASC 718 requires companies to estimate the fair value of equity-based payment awards on the date of grant
using an option-pricing model. The value of the portion of the award that is ultimately expected to vest is recognized as an expense
in the Company&#x2019;s statements of operations over the applicable service periods.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The
Company measures its share-based payment awards made to employees, directors, and non-employee service providers based on estimated fair
values. The fair value of each option award is estimated on the grant date using the Black-Scholes option pricing model which requires
several assumptions, of which the most significant are the expected share price volatility and the expected option term. The Company
recognizes forfeitures of equity-based awards as they occur. For graded vesting awards, the Company recognizes compensation expenses
based on the straight-line method over the applicable service period.&lt;/span&gt;&lt;/p&gt;</us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy>
    <us-gaap:EarningsPerSharePolicyTextBlock contextRef="c0" id="ixv-20777">&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.5in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;m.&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Net loss per share attributable to ordinary shareholders:&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The
Company computes net loss per share using the two-class method required for participating securities. The two-class method requires income
available to ordinary shareholders for the period to be allocated between ordinary shares and participating securities based upon their
respective rights to receive dividends as if all income for the period had been distributed. The Company considered its convertible preferred
shares, which were outstanding through October 7, 2021, the date of the closing of the Merger, to be participating securities as the
holders of the convertible preferred shares would be entitled to dividends that would be distributed to the holders of ordinary shares,
equal to the higher of their original issue price pro-rata basis assuming conversion of all convertible preferred shares into ordinary
shares and that there are no preferences to any holders of any shares. These participating securities do not contractually require the
holders of such shares to participate in the Company&#x2019;s losses. As such, net loss for the periods presented was not allocated to
the Company&#x2019;s participating securities.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The
Company&#x2019;s basic net loss per share is calculated by dividing net loss attributable to ordinary shareholders by the weighted-average
number of ordinary shares outstanding for the period, without consideration of potentially dilutive securities. The diluted net loss
per share is calculated by giving effect to all potentially dilutive securities outstanding for the period using the treasury share method
or the if-converted method based on the nature of such securities. Diluted net loss per share is the same as basic net loss per share
in periods when the effects of potentially dilutive shares of ordinary shares are anti-dilutive. See Note 10.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;</us-gaap:EarningsPerSharePolicyTextBlock>
    <us-gaap:ComprehensiveIncomePolicyPolicyTextBlock contextRef="c0" id="ixv-20842">&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.5in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;n.&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Other Comprehensive loss:&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The
Company has no components of comprehensive loss other than net loss. Thus, comprehensive loss is the same as net loss for the periods
presented.&lt;/span&gt;&lt;/p&gt;</us-gaap:ComprehensiveIncomePolicyPolicyTextBlock>
    <us-gaap:RevenueRecognitionPolicyTextBlock contextRef="c0" id="ixv-20858">&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.5in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;p.&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Revenue recognition:&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The
Company follows the provisions of ASC Topic 606, Revenue from Contracts with Customers (&#x201c;ASC 606&#x201d;), which apply to all contracts
with customers. Under Topic 606, revenues are recognized when control of the promised goods or services is transferred to the customers,
in an amount that reflects the consideration that the Company expects to receive in exchange for those goods or services. To determine
the appropriate revenue recognition for arrangements that an entity determines are within the scope of Topic 606, the entity performs
the following five steps:&lt;/span&gt;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.75in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Identify
                                            the contract(s) with a customer;&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.75in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Identify
                                            the performance obligations in the contract;&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.75in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Determine
                                            the transaction price;&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.75in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Allocate
                                            the transaction price to the performance obligations in the contract; and&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.75in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Recognize
                                            revenue when (or as) the entity satisfies a performance obligation.&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;At
contract inception, once the contract is determined to be within the scope of Topic 606, the Company assesses the goods or services promised
within the contract and determines the performance obligations and assesses whether each promised good or service is distinct. The Company
evaluates each performance obligation to determine if it is satisfied at a point in time or over time. See Note 3.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;i&gt;Nature
of Products and Services&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The
Company derives its revenues mainly from sales of chipsets and prototype radar systems to be installed onto automotive vehicles and professional
services. Revenue from chipsets and prototype radar systems is recognized at the point in time when the control of the goods is transferred
to the customer, generally upon delivery, and the Company has no remaining performance obligations.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;i&gt;Right
of Return&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The
Company&#x2019;s general terms and conditions for its contracts do not contain a right of return that allows the customer to return products
and receive a credit. Therefore, the Company does not estimate returns and generally recognizes revenue at contract price upon product
delivery.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;i&gt;Deferred
Revenue&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Deferred
revenues, which represent a contract liability, where the Company has an obligation to transfer goods or services to the customer for
which it received consideration from the customer.&lt;/span&gt;&lt;/p&gt;</us-gaap:RevenueRecognitionPolicyTextBlock>
    <us-gaap:CostOfSalesPolicyTextBlock contextRef="c0" id="ixv-21009">&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.5in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;q.&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Cost of revenues:&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Cost
of revenue includes the manufacturing cost of radar sensors and chipsets, which primarily consists of components cost, assembly costs
and personnel-related costs directly associated with our customer support personnel.&lt;/span&gt;&lt;/p&gt;</us-gaap:CostOfSalesPolicyTextBlock>
    <us-gaap:ResearchAndDevelopmentExpensePolicy contextRef="c0" id="ixv-21024">&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.5in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;r.&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Research and development expenses, net:&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Research
and development costs, net of grants received, are charged to the consolidated statement of operations as incurred.&lt;/span&gt;&lt;/p&gt;</us-gaap:ResearchAndDevelopmentExpensePolicy>
    <us-gaap:IncomeTaxPolicyTextBlock contextRef="c0" id="ixv-21039">&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.5in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;s.&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Income taxes:&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The
Company accounts for income taxes in accordance with ASC 740, &#x201c;Income Taxes&#x201d;. This standard prescribes the use of the asset
and liability method whereby deferred tax asset and liability account balances are determined based on differences between the financial
statement carrying amount and the tax bases of assets and liabilities and are measured using the enacted tax rates and laws that will
be in effect when the differences are expected to reverse. The Company provides a valuation allowance, if necessary, to reduce deferred
tax assets to the amount that is more likely than not to be realized.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The
Company recognizes the tax benefit from a tax position only if it is more likely than not that the tax position will be sustained on
examination by the taxing authorities, based on the technical merits of the position. A tax position that meets the more-likely-than-not
recognition threshold is measured at the largest amount that is greater than 50 percent likely of being realized upon settlement with
the taxing authority using the facts, circumstances, and information available at the reporting date.&lt;/span&gt;&lt;/p&gt;</us-gaap:IncomeTaxPolicyTextBlock>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations contextRef="c0" decimals="2" id="ixv-26435" unitRef="pure">0.50</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:ContingentLiabilityReserveEstimatePolicy contextRef="c0" id="ixv-21059">&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.5in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;t.&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Contingent Liabilities&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The
Company accounts for its contingent liabilities in accordance with ASC No.&#160;450, &#x201c;Contingencies.&#x201d; A provision is recorded
when it is both probable that a liability has been incurred and the amount of the loss can be reasonably estimated. With respect to legal
matters, provisions are reviewed and adjusted to reflect the impact of negotiations, estimated settlements, legal rulings, advice of
legal counsel and other information and events pertaining to a particular matter. As of December&#160;31, 2023 and 2022, the Company
is not a party to any litigation that could have a material adverse effect on the Company&#x2019;s business, financial position, results
of operations or cash flows.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;</us-gaap:ContingentLiabilityReserveEstimatePolicy>
    <us-gaap:LesseeLeasesPolicyTextBlock contextRef="c0" id="ixv-21119">&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.5in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;u.&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Leases:&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;On
January 1, 2022, the Company adopted Accounting Standards Update No. 2016-02, Leases (Topic 842) (ASU 2016-02) relating to the accounting
treatment of lease obligations, using the modified retrospective method.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The
Company elected the package of practical expedients permitted under the transition guidance. The Company also elected not to recognize
a lease liability and a right-of-use (&#x201c;ROU&#x201d;) asset on the balance sheet for leases with a term of twelve months or less.
The Company recognizes the associated lease payments in the consolidated statements of income on a straight-line basis over the lease
term.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Under
Topic 842, the Company determines if an arrangement is a lease at inception. ROU assets and liabilities are recognized at the commencement
date based on the present value of remaining lease payments over the lease term. For this purpose, the Company considers fixed and determinable
payments at the time of commencement. As most of the Company leases do not provide an implicit rate, the Company uses its incremental
borrowing rate based on the information available at the commencement date in determining the present value of lease payments. The incremental
borrowing rate is estimated to approximate the interest rate on a collateralized basis with similar terms and payments. The ROU asset
is recorded net of any lease incentives received. The lease terms may include options to extend or terminate the lease when it is reasonably
certain that the Company will exercise such options.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Payments
under the Company&#x2019;s lease agreements are primarily fixed, however, certain lease agreements contain variable costs such as common
area maintenance, real estate taxes, and insurance are not included in the lease liability and are recognized as they are incurred. See
Note 6.&lt;/span&gt;&lt;/p&gt;</us-gaap:LesseeLeasesPolicyTextBlock>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock contextRef="c0" id="ixv-21149">&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.5in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;v.&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Impact of recently issued accounting standard:&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;In
June 2016, the FASB issued ASU No. 2016-13, Financial Instruments&#x2014;Credit Losses (&#x201c;ASC 326&#x201d;): Measurement of Credit
Losses on Financial Instruments to introduce a new model for recognizing credit losses on financial instruments based on estimated current
expected credit losses, or CECL. Under the new standard, an entity is required to estimate CECL on trade receivables at inception, based
on historical information, current conditions, and reasonable and supportable forecasts. The guidance is effective for the Company for
annual periods beginning after December 15, 2022, including interim periods within those fiscal years. Early application is permitted.
The Company adopted ASC 326 on January 1, 2023, and there was no material impact on the Company&#x2019;s consolidated balance sheet and
the consolidated statements of operations upon adoption.&lt;/span&gt;&lt;/p&gt;</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <us-gaap:RevenueFromContractWithCustomerTextBlock contextRef="c0" id="ixv-21205">&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;NOTE
3:- &#160;&#160;REVENUE&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;i&gt;Disaggregation
of Revenues&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Revenue
disaggregated by geography for the years ended December 31, 2023, 2022 and 2021, based on the billing address of the Company&#x2019;s
customers, consists of the following:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="22" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Year
                                            ended&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;December
                                            31,&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;%
    of Revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;%
    of Revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;%
    of Revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Revenue by geography:&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 28%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;China&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;639&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;43.5&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,476&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;42.0&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;702&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;31.2&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Hong Kong&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;266&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;18.1&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-215; font-family: Times New Roman, Times, Serif"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-216; font-family: Times New Roman, Times, Serif"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;35&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1.6&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Sweden&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;247&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;16.8&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,276&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;36.3&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;928&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;41.2&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;USA&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;148&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;10.1&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;135&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;3.8&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;63&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2.8&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Germany&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;81&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;5.5&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;284&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;8.1&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;351&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;15.6&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Israel&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;50&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;3.4&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;25&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;0.7&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;34&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1.5&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Italy&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-217; font-family: Times New Roman, Times, Serif"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-218; font-family: Times New Roman, Times, Serif"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;124&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;3.5&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-219; font-family: Times New Roman, Times, Serif"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-220; font-family: Times New Roman, Times, Serif"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Switzerland&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-221; font-family: Times New Roman, Times, Serif"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-222; font-family: Times New Roman, Times, Serif"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;197&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;5.6&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;53&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2.4&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;39&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2.6&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-223; font-family: Times New Roman, Times, Serif"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-224; font-family: Times New Roman, Times, Serif"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;83&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;3.7&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Total revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,470&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;100&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;3,517&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;100&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2,249&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;100&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;


&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;i&gt;Contract
Liabilities&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 85.05pt 0pt 0; text-align: justify; text-indent: -28.35pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Contract
liabilities consist of deferred revenue and customer advanced payments. Deferred revenue includes billings in excess of revenue recognized
related to product sales and is recognized as revenue when the Company performs under the contract. Customer advanced payments represent
required customer payments in advance of product shipments according to customer&#x2019;s payment term. Customer advance payments are
recognized as revenue when control of the performance obligation is transferred to the customer.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Contract
liabilities presented as deferred revenue amounted to $0 and $351 as of December 31, 2023 and 2022, respectively.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;i&gt;Remaining
Performance Obligation&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The
Company&#x2019;s remaining performance obligations are comprised of product and services revenue not yet performed. As of December&#160;31,
2023 and 2022 the aggregate amount of the transaction price allocated to remaining performance obligations was $977 and $232, respectively.
The Company expects to recognize 2023 remaining performance obligations as revenue during 2024.&lt;/span&gt;&lt;/p&gt;</us-gaap:RevenueFromContractWithCustomerTextBlock>
    <us-gaap:DisaggregationOfRevenueTableTextBlock contextRef="c0" id="ixv-21216">&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Revenue
disaggregated by geography for the years ended December 31, 2023, 2022 and 2021, based on the billing address of the Company&#x2019;s
customers, consists of the following:&lt;/span&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="22" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Year
                                            ended&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;December
                                            31,&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;%
    of Revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;%
    of Revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;%
    of Revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Revenue by geography:&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 28%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;China&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;639&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;43.5&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,476&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;42.0&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;702&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;31.2&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Hong Kong&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;266&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;18.1&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-215; font-family: Times New Roman, Times, Serif"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-216; font-family: Times New Roman, Times, Serif"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;35&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1.6&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Sweden&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;247&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;16.8&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,276&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;36.3&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;928&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;41.2&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;USA&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;148&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;10.1&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;135&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;3.8&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;63&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2.8&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Germany&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;81&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;5.5&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;284&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;8.1&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;351&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;15.6&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Israel&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;50&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;3.4&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;25&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;0.7&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;34&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1.5&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Italy&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-217; font-family: Times New Roman, Times, Serif"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-218; font-family: Times New Roman, Times, Serif"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;124&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;3.5&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-219; font-family: Times New Roman, Times, Serif"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-220; font-family: Times New Roman, Times, Serif"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Switzerland&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-221; font-family: Times New Roman, Times, Serif"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-222; font-family: Times New Roman, Times, Serif"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;197&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;5.6&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;53&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2.4&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;39&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2.6&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-223; font-family: Times New Roman, Times, Serif"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-224; font-family: Times New Roman, Times, Serif"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;83&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;3.7&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Total revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,470&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;100&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;3,517&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;100&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2,249&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;100&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</us-gaap:DisaggregationOfRevenueTableTextBlock>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax contextRef="c98" decimals="-3" id="ixv-26436" unitRef="usd">639000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueRemainingPerformanceObligationPercentage contextRef="c99" decimals="3" id="ixv-26437" unitRef="pure">0.435</us-gaap:RevenueRemainingPerformanceObligationPercentage>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="c100"
      decimals="-3"
      id="ixv-26438"
      unitRef="usd">1476000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueRemainingPerformanceObligationPercentage
      contextRef="c101"
      decimals="3"
      id="ixv-26439"
      unitRef="pure">0.42</us-gaap:RevenueRemainingPerformanceObligationPercentage>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="c102"
      decimals="-3"
      id="ixv-26440"
      unitRef="usd">702000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueRemainingPerformanceObligationPercentage
      contextRef="c103"
      decimals="3"
      id="ixv-26441"
      unitRef="pure">0.312</us-gaap:RevenueRemainingPerformanceObligationPercentage>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="c104"
      decimals="-3"
      id="ixv-26442"
      unitRef="usd">266000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueRemainingPerformanceObligationPercentage
      contextRef="c105"
      decimals="3"
      id="ixv-26443"
      unitRef="pure">0.181</us-gaap:RevenueRemainingPerformanceObligationPercentage>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="c108"
      decimals="-3"
      id="ixv-26444"
      unitRef="usd">35000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueRemainingPerformanceObligationPercentage
      contextRef="c109"
      decimals="3"
      id="ixv-26445"
      unitRef="pure">0.016</us-gaap:RevenueRemainingPerformanceObligationPercentage>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="c110"
      decimals="-3"
      id="ixv-26446"
      unitRef="usd">247000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueRemainingPerformanceObligationPercentage
      contextRef="c111"
      decimals="3"
      id="ixv-26447"
      unitRef="pure">0.168</us-gaap:RevenueRemainingPerformanceObligationPercentage>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="c112"
      decimals="-3"
      id="ixv-26448"
      unitRef="usd">1276000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueRemainingPerformanceObligationPercentage
      contextRef="c113"
      decimals="3"
      id="ixv-26449"
      unitRef="pure">0.363</us-gaap:RevenueRemainingPerformanceObligationPercentage>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="c114"
      decimals="-3"
      id="ixv-26450"
      unitRef="usd">928000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueRemainingPerformanceObligationPercentage
      contextRef="c115"
      decimals="3"
      id="ixv-26451"
      unitRef="pure">0.412</us-gaap:RevenueRemainingPerformanceObligationPercentage>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="c116"
      decimals="-3"
      id="ixv-26452"
      unitRef="usd">148000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueRemainingPerformanceObligationPercentage
      contextRef="c117"
      decimals="3"
      id="ixv-26453"
      unitRef="pure">0.101</us-gaap:RevenueRemainingPerformanceObligationPercentage>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="c118"
      decimals="-3"
      id="ixv-26454"
      unitRef="usd">135000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueRemainingPerformanceObligationPercentage
      contextRef="c119"
      decimals="3"
      id="ixv-26455"
      unitRef="pure">0.038</us-gaap:RevenueRemainingPerformanceObligationPercentage>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="c120"
      decimals="-3"
      id="ixv-26456"
      unitRef="usd">63000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueRemainingPerformanceObligationPercentage
      contextRef="c121"
      decimals="3"
      id="ixv-26457"
      unitRef="pure">0.028</us-gaap:RevenueRemainingPerformanceObligationPercentage>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="c122"
      decimals="-3"
      id="ixv-26458"
      unitRef="usd">81000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueRemainingPerformanceObligationPercentage
      contextRef="c123"
      decimals="3"
      id="ixv-26459"
      unitRef="pure">0.055</us-gaap:RevenueRemainingPerformanceObligationPercentage>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="c124"
      decimals="-3"
      id="ixv-26460"
      unitRef="usd">284000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueRemainingPerformanceObligationPercentage
      contextRef="c125"
      decimals="3"
      id="ixv-26461"
      unitRef="pure">0.081</us-gaap:RevenueRemainingPerformanceObligationPercentage>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="c126"
      decimals="-3"
      id="ixv-26462"
      unitRef="usd">351000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueRemainingPerformanceObligationPercentage
      contextRef="c127"
      decimals="3"
      id="ixv-26463"
      unitRef="pure">0.156</us-gaap:RevenueRemainingPerformanceObligationPercentage>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="c128"
      decimals="-3"
      id="ixv-26464"
      unitRef="usd">50000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueRemainingPerformanceObligationPercentage
      contextRef="c129"
      decimals="3"
      id="ixv-26465"
      unitRef="pure">0.034</us-gaap:RevenueRemainingPerformanceObligationPercentage>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="c130"
      decimals="-3"
      id="ixv-26466"
      unitRef="usd">25000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueRemainingPerformanceObligationPercentage
      contextRef="c131"
      decimals="3"
      id="ixv-26467"
      unitRef="pure">0.007</us-gaap:RevenueRemainingPerformanceObligationPercentage>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="c132"
      decimals="-3"
      id="ixv-26468"
      unitRef="usd">34000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueRemainingPerformanceObligationPercentage
      contextRef="c133"
      decimals="3"
      id="ixv-26469"
      unitRef="pure">0.015</us-gaap:RevenueRemainingPerformanceObligationPercentage>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="c136"
      decimals="-3"
      id="ixv-26470"
      unitRef="usd">124000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueRemainingPerformanceObligationPercentage
      contextRef="c137"
      decimals="3"
      id="ixv-26471"
      unitRef="pure">0.035</us-gaap:RevenueRemainingPerformanceObligationPercentage>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="c142"
      decimals="-3"
      id="ixv-26472"
      unitRef="usd">197000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueRemainingPerformanceObligationPercentage
      contextRef="c143"
      decimals="3"
      id="ixv-26473"
      unitRef="pure">0.056</us-gaap:RevenueRemainingPerformanceObligationPercentage>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="c144"
      decimals="-3"
      id="ixv-26474"
      unitRef="usd">53000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueRemainingPerformanceObligationPercentage
      contextRef="c145"
      decimals="3"
      id="ixv-26475"
      unitRef="pure">0.024</us-gaap:RevenueRemainingPerformanceObligationPercentage>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="c146"
      decimals="-3"
      id="ixv-26476"
      unitRef="usd">39000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueRemainingPerformanceObligationPercentage
      contextRef="c147"
      decimals="3"
      id="ixv-26477"
      unitRef="pure">0.026</us-gaap:RevenueRemainingPerformanceObligationPercentage>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="c150"
      decimals="-3"
      id="ixv-26478"
      unitRef="usd">83000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueRemainingPerformanceObligationPercentage
      contextRef="c151"
      decimals="3"
      id="ixv-26479"
      unitRef="pure">0.037</us-gaap:RevenueRemainingPerformanceObligationPercentage>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax contextRef="c0" decimals="-3" id="ixv-26480" unitRef="usd">1470000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueRemainingPerformanceObligationPercentage contextRef="c5" decimals="2" id="ixv-26481" unitRef="pure">1</us-gaap:RevenueRemainingPerformanceObligationPercentage>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax contextRef="c7" decimals="-3" id="ixv-26482" unitRef="usd">3517000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueRemainingPerformanceObligationPercentage contextRef="c6" decimals="2" id="ixv-26483" unitRef="pure">1</us-gaap:RevenueRemainingPerformanceObligationPercentage>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax contextRef="c8" decimals="-3" id="ixv-26484" unitRef="usd">2249000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueRemainingPerformanceObligationPercentage contextRef="c40" decimals="2" id="ixv-26485" unitRef="pure">1</us-gaap:RevenueRemainingPerformanceObligationPercentage>
    <us-gaap:DeferredRevenue contextRef="c5" decimals="-3" id="ixv-26486" unitRef="usd">0</us-gaap:DeferredRevenue>
    <us-gaap:DeferredRevenue contextRef="c6" decimals="-3" id="ixv-26487" unitRef="usd">351000</us-gaap:DeferredRevenue>
    <us-gaap:RevenueRemainingPerformanceObligation contextRef="c5" decimals="-3" id="ixv-26488" unitRef="usd">977000</us-gaap:RevenueRemainingPerformanceObligation>
    <us-gaap:RevenueRemainingPerformanceObligation contextRef="c6" decimals="-3" id="ixv-26489" unitRef="usd">232000</us-gaap:RevenueRemainingPerformanceObligation>
    <us-gaap:OtherCurrentAssetsTextBlock contextRef="c0" id="ixv-21906">&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-align: justify; text-indent: -56.7pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;NOTE
4:-&#160;&#160; PREPAID EXPENSES AND OTHER RECEIVABLES&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-align: justify; text-indent: -56.7pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;December
    31,&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 76%; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Government authorities&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;385&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;280&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Deposits&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;69&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;85&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Grants receivable&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;310&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;319&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Prepaid expenses
    and other&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,262&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,155&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify; padding-bottom: 4pt; padding-left: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2,026&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,839&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</us-gaap:OtherCurrentAssetsTextBlock>
    <us-gaap:DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock contextRef="c0" id="ixv-21911">&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;December
    31,&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 76%; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Government authorities&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;385&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;280&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Deposits&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;69&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;85&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Grants receivable&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;310&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;319&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Prepaid expenses
    and other&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,262&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,155&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify; padding-bottom: 4pt; padding-left: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2,026&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,839&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</us-gaap:DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock>
    <arbe:GovernmentAuthorities contextRef="c5" decimals="-3" id="ixv-26490" unitRef="usd">385000</arbe:GovernmentAuthorities>
    <arbe:GovernmentAuthorities contextRef="c6" decimals="-3" id="ixv-26491" unitRef="usd">280000</arbe:GovernmentAuthorities>
    <us-gaap:DepositAssets contextRef="c5" decimals="-3" id="ixv-26492" unitRef="usd">69000</us-gaap:DepositAssets>
    <us-gaap:DepositAssets contextRef="c6" decimals="-3" id="ixv-26493" unitRef="usd">85000</us-gaap:DepositAssets>
    <us-gaap:GrantsReceivableCurrent contextRef="c5" decimals="-3" id="ixv-26494" unitRef="usd">310000</us-gaap:GrantsReceivableCurrent>
    <us-gaap:GrantsReceivableCurrent contextRef="c6" decimals="-3" id="ixv-26495" unitRef="usd">319000</us-gaap:GrantsReceivableCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssets contextRef="c5" decimals="-3" id="ixv-26496" unitRef="usd">1262000</us-gaap:PrepaidExpenseAndOtherAssets>
    <us-gaap:PrepaidExpenseAndOtherAssets contextRef="c6" decimals="-3" id="ixv-26497" unitRef="usd">1155000</us-gaap:PrepaidExpenseAndOtherAssets>
    <us-gaap:PrepaidExpenseAndOtherAssetsNoncurrent contextRef="c5" decimals="-3" id="ixv-26498" unitRef="usd">2026000</us-gaap:PrepaidExpenseAndOtherAssetsNoncurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsNoncurrent contextRef="c6" decimals="-3" id="ixv-26499" unitRef="usd">1839000</us-gaap:PrepaidExpenseAndOtherAssetsNoncurrent>
    <us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock contextRef="c0" id="ixv-22051">&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-transform: uppercase; text-align: justify; text-indent: -56.7pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Note
5:- Property and Equipment&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-transform: uppercase; text-align: justify; text-indent: -56.7pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;December
    31,&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Cost:&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.25in; width: 76%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Computers
    and peripheral equipment&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2,448&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2,350&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Leasehold
    improvement&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;582&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;438&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Office
    furniture and equipment&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;133&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;128&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Vehicles&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;149&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;139&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;3,312&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;3,055&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Accumulated
    depreciation&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2,003&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,446&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; padding-bottom: 4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Property
    and equipment, net&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,309&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,609&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: -28.35pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Depreciation
expense for the years ended December 31, 2023, 2022 and 2021 was $557, $481 and $342, respectively.&lt;/span&gt;&lt;/p&gt;</us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock>
    <us-gaap:PropertyPlantAndEquipmentTextBlock contextRef="c0" id="ixv-22056">&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;December
    31,&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Cost:&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.25in; width: 76%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Computers
    and peripheral equipment&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2,448&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2,350&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Leasehold
    improvement&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;582&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;438&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Office
    furniture and equipment&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;133&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;128&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Vehicles&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;149&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;139&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;3,312&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;3,055&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Accumulated
    depreciation&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2,003&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,446&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; padding-bottom: 4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Property
    and equipment, net&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,309&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,609&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</us-gaap:PropertyPlantAndEquipmentTextBlock>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="c152"
      decimals="-3"
      id="ixv-26500"
      unitRef="usd">2448000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="c153"
      decimals="-3"
      id="ixv-26501"
      unitRef="usd">2350000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c97" decimals="-3" id="ixv-26502" unitRef="usd">582000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="c154"
      decimals="-3"
      id="ixv-26503"
      unitRef="usd">438000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="c155"
      decimals="-3"
      id="ixv-26504"
      unitRef="usd">133000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="c156"
      decimals="-3"
      id="ixv-26505"
      unitRef="usd">128000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c96" decimals="-3" id="ixv-26506" unitRef="usd">149000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="c157"
      decimals="-3"
      id="ixv-26507"
      unitRef="usd">139000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c5" decimals="-3" id="ixv-26508" unitRef="usd">3312000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c6" decimals="-3" id="ixv-26509" unitRef="usd">3055000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment contextRef="c5" decimals="-3" id="ixv-26510" unitRef="usd">2003000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment contextRef="c6" decimals="-3" id="ixv-26511" unitRef="usd">1446000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="c5" decimals="-3" id="ixv-26512" unitRef="usd">1309000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="c6" decimals="-3" id="ixv-26513" unitRef="usd">1609000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:Depreciation contextRef="c0" decimals="-3" id="ixv-26514" unitRef="usd">557000</us-gaap:Depreciation>
    <us-gaap:Depreciation contextRef="c7" decimals="-3" id="ixv-26515" unitRef="usd">481000</us-gaap:Depreciation>
    <us-gaap:Depreciation contextRef="c8" decimals="-3" id="ixv-26516" unitRef="usd">342000</us-gaap:Depreciation>
    <us-gaap:LesseeOperatingLeasesTextBlock contextRef="c0" id="ixv-22311">&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-transform: uppercase; text-align: justify; text-indent: -56.7pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Note
6:-&#160;&#160; LEASES&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-transform: uppercase; text-align: justify; text-indent: -56.7pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-weight: normal; text-transform: none"&gt;The
Company has five non-cancelable operating lease agreements for certain office spaces in Israel. The leases have original lease periods
expiring until 2027, some of which may include options to extend the leases for up to three additional years. The Company does not assume
renewals in its determination of the lease term unless the renewals are considered as reasonably certain to exercise.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-transform: uppercase; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-weight: normal; text-transform: none"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-weight: normal; text-transform: none"&gt;Supplemental
cash flow information related to leases was as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-transform: uppercase; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-weight: normal; text-transform: none"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="text-decoration: none; font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Year
                                            ended&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2.85pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;December
                                            31,&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="text-decoration: none; font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-decoration: none; width: 76%; text-align: justify"&gt;&lt;span style="text-decoration: none; font-family: Times New Roman, Times, Serif"&gt;Cash
    payments and expenses related to operating leases&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(451&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(370&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-decoration: none; text-align: justify"&gt;&lt;span style="text-decoration: none; font-family: Times New Roman, Times, Serif"&gt;Operating
    lease right-of-use assets and liabilities, net&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(84&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;


&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-transform: uppercase; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-weight: normal; text-transform: none"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-weight: normal; text-transform: none"&gt;Maturities
of lease liabilities as of December 31, 2023, were as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-transform: uppercase; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-weight: normal; text-transform: none"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 88%; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;443&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;393&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;356&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2027 and after&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,033&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Total lease payments&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2,225&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Less imputed interest&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;483&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Total lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,742&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;


&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-transform: uppercase; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-weight: normal; text-transform: none"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-weight: normal; text-transform: none"&gt;Supplemental
balance sheet information related to operating leases were as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-transform: uppercase; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-weight: normal; text-transform: none"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="white-space: nowrap; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;December&#160;31,&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;December&#160;31,&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;202&lt;span style="font-size: 10pt"&gt;2&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 76%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Operating lease right-of-use assets&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,740&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;465&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Current maturities of operating leases&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;436&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;364&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Long-term operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,306&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;17&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Weighted average remaining lease term (in years)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;5.5&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1.1&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Weighted average discount rate&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;9.4&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;5.8&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</us-gaap:LesseeOperatingLeasesTextBlock>
    <us-gaap:OperatingLeaseLeaseIncomeTableTextBlock contextRef="c0" id="ixv-22321">&lt;span style="font-family: Times New Roman, Times, Serif; font-weight: normal; text-transform: none"&gt;Supplemental
cash flow information related to leases was as follows:&lt;/span&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="text-decoration: none; font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Year
                                            ended&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2.85pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;December
                                            31,&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="text-decoration: none; font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-decoration: none; width: 76%; text-align: justify"&gt;&lt;span style="text-decoration: none; font-family: Times New Roman, Times, Serif"&gt;Cash
    payments and expenses related to operating leases&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(451&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(370&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-decoration: none; text-align: justify"&gt;&lt;span style="text-decoration: none; font-family: Times New Roman, Times, Serif"&gt;Operating
    lease right-of-use assets and liabilities, net&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(84&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</us-gaap:OperatingLeaseLeaseIncomeTableTextBlock>
    <us-gaap:OperatingLeasePayments contextRef="c0" decimals="-3" id="ixv-26517" unitRef="usd">451000</us-gaap:OperatingLeasePayments>
    <us-gaap:OperatingLeasePayments contextRef="c7" decimals="-3" id="ixv-26518" unitRef="usd">370000</us-gaap:OperatingLeasePayments>
    <arbe:OperatingLeaseRightofuseAssetsAndLiabilitiesNet contextRef="c0" decimals="-3" id="ixv-26519" unitRef="usd">-2000</arbe:OperatingLeaseRightofuseAssetsAndLiabilitiesNet>
    <arbe:OperatingLeaseRightofuseAssetsAndLiabilitiesNet contextRef="c7" decimals="-3" id="ixv-26520" unitRef="usd">84000</arbe:OperatingLeaseRightofuseAssetsAndLiabilitiesNet>
    <us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock contextRef="c0" id="ixv-22397">&lt;span style="font-family: Times New Roman, Times, Serif; font-weight: normal; text-transform: none"&gt;Maturities
of lease liabilities as of December 31, 2023, were as follows:&lt;/span&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 88%; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;443&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;393&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;356&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2027 and after&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,033&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Total lease payments&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2,225&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Less imputed interest&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;483&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Total lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,742&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths contextRef="c5" decimals="-3" id="ixv-26521" unitRef="usd">443000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo contextRef="c5" decimals="-3" id="ixv-26522" unitRef="usd">393000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree contextRef="c5" decimals="-3" id="ixv-26523" unitRef="usd">356000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour contextRef="c5" decimals="-3" id="ixv-26524" unitRef="usd">1033000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue contextRef="c5" decimals="-3" id="ixv-26525" unitRef="usd">2225000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue>
    <us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount contextRef="c5" decimals="-3" id="ixv-26526" unitRef="usd">483000</us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount>
    <us-gaap:OperatingLeaseLiability contextRef="c5" decimals="-3" id="ixv-26527" unitRef="usd">1742000</us-gaap:OperatingLeaseLiability>
    <us-gaap:LeaseCostTableTextBlock contextRef="c0" id="ixv-22483">&lt;span style="font-family: Times New Roman, Times, Serif; font-weight: normal; text-transform: none"&gt;Supplemental
balance sheet information related to operating leases were as follows:&lt;/span&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="white-space: nowrap; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;December&#160;31,&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;December&#160;31,&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;202&lt;span style="font-size: 10pt"&gt;2&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 76%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Operating lease right-of-use assets&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,740&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;465&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Current maturities of operating leases&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;436&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;364&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Long-term operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,306&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;17&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Weighted average remaining lease term (in years)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;5.5&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1.1&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Weighted average discount rate&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;9.4&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;5.8&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</us-gaap:LeaseCostTableTextBlock>
    <us-gaap:OperatingLeaseRightOfUseAsset contextRef="c5" decimals="-3" id="ixv-26528" unitRef="usd">1740000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset contextRef="c6" decimals="-3" id="ixv-26529" unitRef="usd">465000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseLiabilityCurrent contextRef="c5" decimals="-3" id="ixv-26530" unitRef="usd">436000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent contextRef="c6" decimals="-3" id="ixv-26531" unitRef="usd">364000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent contextRef="c5" decimals="-3" id="ixv-26532" unitRef="usd">1306000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent contextRef="c6" decimals="-3" id="ixv-26533" unitRef="usd">17000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1 contextRef="c5" id="ixv-22586">P5Y6M</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1 contextRef="c6" id="ixv-22595">P1Y1M6D</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent contextRef="c5" decimals="3" id="ixv-26534" unitRef="pure">0.094</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent contextRef="c6" decimals="3" id="ixv-26535" unitRef="pure">0.058</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock contextRef="c0" id="ixv-22657">&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-transform: uppercase; text-align: justify; text-indent: -56.7pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Note
7:- &#160;&#160;COMMITMENTS AND CONTINGENT LIABILITIES&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The
Company participated in programs sponsored mainly by the Israeli Innovation Authority (&#x201c;IIA&#x201d;), an Israeli government agency,
for the support of its research and development activities. Through December 31, 2023, the Company had obtained grants aggregating to
$3,846 for certain of its research and development projects. The Company is obligated to pay royalties to the IIA, amounting to 4% of
the sales of the products and other related revenues generated from such projects. The maximum aggregate royalties paid generally cannot
exceed 100% of the grants received, plus annual interest generally equal to 12-months SOFR applicable to dollar deposits, as published
on the first business day of each calendar year. The obligation to pay these royalties is contingent on sales of the products and in
the absence of such sales, no payment is required.&#160;&lt;/span&gt;&lt;/p&gt;</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <us-gaap:GrantsReceivable contextRef="c5" decimals="-3" id="ixv-26536" unitRef="usd">3846000</us-gaap:GrantsReceivable>
    <arbe:RoyaltyPercentage contextRef="c0" decimals="2" id="ixv-26537" unitRef="pure">0.04</arbe:RoyaltyPercentage>
    <arbe:GrantsReceived contextRef="c0" decimals="2" id="ixv-26538" unitRef="pure">1</arbe:GrantsReceived>
    <us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock contextRef="c0" id="ixv-22668">&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-transform: uppercase; text-align: justify; text-indent: -56.7pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Note
8:- &#160;&#160;warrants liabilities&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The
Company issued in 2019 warrants to purchase a number of convertible Series B-1 convertible preferred shares, for an aggregate exercise
price of $550. As a result of the Merger and the related Recapitalization, the warrants became convertible into the Company&#x2019;s ordinary
shares. The Company classified the warrants as freestanding and treated as liability pursuant to ASC 480 and remeasured every reporting
period with any change to fair value recorded within financial expenses in the statements of operations.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;As
a result of the Merger, the Company assumed a derivative warrant liability related to 3,112,080 private placement warrants assumed by
the Company pursuant to the terms of the Merger.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The
Company utilizes a Black-Scholes option pricing model to estimate the fair value of the private placement warrants and the convertible
warrants (hereinafter: the &#x201c;warrants&#x201d;) and are considered a Level 3 fair value measurement. Black-Scholes option pricing
model takes into consideration certain parameters in computation of the fair value of the warrants which the significant parameter is
expected volatility. The Company computed a sensitivity analysis of the fair value to changes of the expected volatility. The volatility
impact of +/-5% on the warrants&#x2019; fair value is approximately $180.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The
warrants are measured at each reporting period, with changes in fair value recognized in the statement of operations. During 2023, 2022
and 2021, the Company recognized ($756), ($8,425) and $3,083, respectively, with respect with those warrants as a finance expenses (income).&lt;/span&gt;&lt;/p&gt;</us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock>
    <us-gaap:AdditionalCollateralAggregateFairValue contextRef="c5" decimals="-3" id="ixv-26539" unitRef="usd">550000</us-gaap:AdditionalCollateralAggregateFairValue>
    <arbe:DerivativeWarrantLiabilityShares
      contextRef="c158"
      decimals="0"
      id="ixv-26540"
      unitRef="shares">3112080</arbe:DerivativeWarrantLiabilityShares>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate contextRef="c0" decimals="2" id="ixv-26541" unitRef="pure">0.05</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate>
    <us-gaap:FairValueAdjustmentOfWarrants contextRef="c0" decimals="-3" id="ixv-26542" unitRef="usd">180000</us-gaap:FairValueAdjustmentOfWarrants>
    <us-gaap:ProceedsFromIssuanceOfWarrants contextRef="c0" decimals="-3" id="ixv-26543" unitRef="usd">756000</us-gaap:ProceedsFromIssuanceOfWarrants>
    <us-gaap:ProceedsFromIssuanceOfWarrants contextRef="c7" decimals="-3" id="ixv-26544" unitRef="usd">8425000</us-gaap:ProceedsFromIssuanceOfWarrants>
    <us-gaap:ProceedsFromIssuanceOfWarrants contextRef="c8" decimals="-3" id="ixv-26545" unitRef="usd">3083000</us-gaap:ProceedsFromIssuanceOfWarrants>
    <us-gaap:StockholdersEquityNoteDisclosureTextBlock contextRef="c0" id="ixv-22726">&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-transform: uppercase; text-align: justify; text-indent: -56.7pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Note
9:- &#160;&#160;Shareholders&#x2019; equity&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;a.&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;In connection with the Merger, the Company adopted its restated articles, pursuant to which the Company&#x2019;s authorized capital consisted of 130,000,000 Ordinary Shares, with a par value of NIS 0.000216 per share and the Company effected a 1:46.25783 stock split.&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: -28.35pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.75in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;b.&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;During June 2023, the Company raised $23,000 with Special Situations Funds, pursuant to which the Company issued a total of 11,794,873 Ordinary Shares with a purchase price of $1.95 per share. Existing investors, including two affiliates of Arbe&#x2019;s directors also participated in this offering. The aggregate net proceeds received by the Company from the offering were $22,496&#160;net of issuance costs.&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.75in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;c.&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Share
                                            option and RSU&#x2019;s:&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: -28.35pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;During
2016, the Company adopted the 2016 Share Incentive Plan (the &#x201c;2016 Plan&#x201d;) which provides the Company with the ability to grant
its employees, directors and service providers options to purchase Ordinary Shares of the Company, at a purchase price as determined
by the Board of Directors at the date of grant. Pursuant to the 2016 Plan, 3,384,454 Ordinary Shares were reserved for issuance. Each
option granted under the Plan expires no later than seven years from the date of grant or 60 days after termination of engagement. The
vesting period of the share options is generally four years.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;In
August 2021, the Board of the Company approved and in September 2021 the shareholders approved, the Arbe Robotics Ltd. 2021 Equity Incentive
Plan (the &#x201c;2021 Plan&#x201d;) which became effective on October 7, 2021. The 2021 Plan covers (a) 4,079,427 ordinary shares plus
(b) and without the need to further amend the Plan on January 1 of each calendar year beginning on January 1, 2022 and ending on and
including January 1, 2031, a number of Shares equal to the lesser of: (i) 5% of the total number of ordinary shares outstanding on December
31 of the immediately preceding calendar year, and (ii) an amount determined by the Board, if so determined prior to the January 1 of
the calendar year in which the increase will occur.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Upon
the adoption of the 2021 Plan, the Company will no longer grant any awards under the 2016 Plan, although previously granted options under
the 2016 Plan will remain outstanding and governed by the 2016 Plan and awards available for grant under the 2016 Plan which had not
been issued or which expired unexercised may be issued pursuant to the 2021 Plan. The vesting period of the awards is generally four
years. Generally, under the terms of the Plans, unless determined otherwise,&#160;25% of an award granted becomes exercisable on the
first anniversary of the date of grant and&#160;6.25% becomes exercisable once every quarter during the subsequent&#160;three years.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Share
option and RSU&#x2019;s plans:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: -28.35pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;A
summary of the stock option activity under the Company&#x2019;s equity plans during the years ended December 31, 2023, 2022 and 2021 is
as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Outstanding&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2.85pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;share
                                            options&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Weighted-average
    exercise&lt;br/&gt;
 price ($)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Weighted
    average remaining contractual&lt;br/&gt;
 life (years)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Aggregate
    intrinsic value ($ in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Options:&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 52%; font-weight: bold; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Outstanding
    as of December&#160;31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;3,768,034&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;0.767&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;4.626&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;119,146&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,966,916&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;7.250&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(117,863&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;0.972&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Exercised&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(155,750&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;0.602&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Outstanding
    as of December&#160;31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;5,461,337&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;3.102&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;5.363&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;16,713,971&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,630,142&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;6.833&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(468,814&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;5.557&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Exercised&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(570,451&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;0.482&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Outstanding as of December&#160;31,
    2022&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;6,052,214&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;4.166&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;5.570&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;7,761,705&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;430,874&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2.728&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(351,671&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;7.767&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Exercised&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(1,074,162&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;0.654&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 4pt"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 11.35pt; text-align: left; text-indent: -8.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; text-indent: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Outstanding
                                            as of December&#160;31, 2023 &lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;5,057,255&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;4.543&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;5.662&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2,352,517&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Exercisable as of December&#160;31,
    2023&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;3,210,191&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;3.643&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;4.403&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2,277,303&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Options available for
    future grants&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;611,246&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: -28.35pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;A
summary of the Company&#x2019;s RSUs activity during the years ended December 31, 2023, 2022 and 2021 is as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 84.95pt; text-align: left; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-transform: uppercase; text-align: justify; text-indent: -56.7pt"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Numbers
    of RSUs&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;RSUs:&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Outstanding as of January 1, 2021&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-225; font-family: Times New Roman, Times, Serif"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 88%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,968,794&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-226; font-family: Times New Roman, Times, Serif"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Vested&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-227; font-family: Times New Roman, Times, Serif"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Outstanding as of December&#160;31,
    2021&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,968,794&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,619,898&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(417,025&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Vested&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(573,583&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Outstanding as of December&#160;31,
    2022&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2,598,084&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2,908,983&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(370,067&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Vested&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(895,170&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 4pt; font-weight: bold; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Outstanding as of December&#160;31,
    2023&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;4,241,830&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-transform: uppercase; text-align: justify; text-indent: -56.7pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Fair
value factors:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: -28.35pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The
following table sets forth the parameters used in computation of the options compensation to employees and service providers:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="10" style="border-bottom: Black 1.5pt solid; white-space: nowrap; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Year
                                            ended &lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;December
                                            31&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="white-space: nowrap; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="white-space: nowrap; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="white-space: nowrap; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 64%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Expected term, in years&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; width: 9%; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;5.82&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; width: 9%; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;4.41-6.11&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; width: 9%; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;4.61-6.11&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Expected volatility&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;47%-51.75%&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;47%-48%&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;42%-46%&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Risk-free interest rate&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;4.15%-4.55%&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1.74%-3.96%&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;0.49%-1.28%&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Expected dividend yield&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;0&lt;/span&gt;%&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: left"&gt;&lt;/td&gt;&lt;td style="white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;0&lt;/span&gt;%&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: left"&gt;&lt;/td&gt;&lt;td style="white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;0&lt;/span&gt;%&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 84.45pt; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;i&gt;Fair
value:&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 84.45pt; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Prior
to the Merger, which resulted in the Company becoming a public entity, in determining the fair value for share options granted, the board
of directors considered the fair value of the ordinary shares as of each grant date. The fair value of the ordinary shares underlying
the share options was determined by the board of directors at each award grant date based upon a variety of factors, including the results
obtained from independent third-party valuations, the Company&#x2019;s financial position and historical financial performance, the status
of technological developments within the Company&#x2019;s products, the composition and ability of the current management team, an evaluation
or benchmark of the Company&#x2019;s competition, the current business climate in the marketplace, the illiquid nature of the ordinary
shares, arm&#x2019;s length sales of the Company&#x2019;s capital stock, the effect of the rights and preferences of the Company&#x2019;s preferred
shareholders, and the prospects of a liquidity event, among others. Subsequent to the Company becoming a public entity, the fair value
of the Ordinary Shares is the market price of the Ordinary Shares on the date of grant.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 84.45pt; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;i&gt;Expected
volatility:&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 84.45pt; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;As
the Company was privately owned until October 2021, there is not sufficient historical volatility for the expected term of the stock
options. Therefore, the Company uses an average historical share price volatility based on an analysis of reported data for a peer group
of comparable publicly traded companies which were selected based upon industry similarities.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 84.45pt; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;i&gt;Expected
term (years):&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 84.45pt; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Expected
term represents the period that the Company&#x2019;s option grants are expected to be outstanding. There is not sufficient historical
share exercise data to calculate the expected term of the stock options. Therefore, the Company elected to utilize the simplified method
to value option grants. Under this approach, the weighted-average expected life is presumed to be the average of the shortest vesting
term and the contractual term of the option.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 84.45pt; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;i&gt;Risk-free
interest rate:&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 84.45pt; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The
Company determined the risk-free interest rate by using a weighted-average equivalent to the expected term based on the U.S. Treasury
yield curve in effect as of the date of grant.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 84.45pt; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;i&gt;Expected
dividend yield:&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 84.45pt; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The
Company does not anticipate paying any dividends in the foreseeable future. Thus, the Company used 0% as its expected dividend yield.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 84.45pt; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; background-color: white"&gt;The
following table presents stock-based compensation expense to employees included in the Company&#x2019;s consolidated statements of operations:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: -28.35pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="10" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Year
                                            ended &lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;December
                                            31,&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 64%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Research and development&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;8,721&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;5,726&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,518&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Sales and marketing&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2,229&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,403&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;217&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;General and administrative&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,786&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,537&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;419&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Cost of revenues&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;276&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;127&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;57&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Total stock-based compensation
    expense&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;13,012&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;8,793&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2,211&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;


&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 84.45pt; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; background-color: white"&gt;Share
based compensation expenses are not deductible for income tax purposes, and therefore the Company did not recognize any tax benefits
related to the share-based compensation for the years ended December&#160;31, 2023, 2022 and 2021.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-transform: uppercase; text-align: justify; text-indent: -56.7pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;The
Company adopted ASU 2018-07 and accordingly measured at the grant dates of each of the above stock-based compensation issued to service
providers their fair value using Black and Scholes model, which requires inputs such as exercise price, estimated ordinary share price,
expected dividend yield, estimated ordinary share price volatility and risk-free interest rate. During 2023, 2022 and 2021, the Company
recognized the total fair value of the stock-based compensation of development related service providers in the amounts of $629, $354
and $115, respectively.&lt;/span&gt;&lt;/p&gt;</us-gaap:StockholdersEquityNoteDisclosureTextBlock>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="c5"
      decimals="0"
      id="ixv-26546"
      unitRef="shares">130000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="c5"
      decimals="6"
      id="ixv-26547"
      unitRef="ilsPershares">0.000216</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:StockholdersEquityReverseStockSplit contextRef="c0" id="ixv-26548">the Company effected a 1:46.25783 stock split</us-gaap:StockholdersEquityReverseStockSplit>
    <us-gaap:CommonUnitIssuanceValue contextRef="c159" decimals="0" id="ixv-26549" unitRef="usd">23000</us-gaap:CommonUnitIssuanceValue>
    <us-gaap:CommonUnitIssued
      contextRef="c159"
      decimals="0"
      id="ixv-26550"
      unitRef="shares">11794873</us-gaap:CommonUnitIssued>
    <us-gaap:SharePrice
      contextRef="c159"
      decimals="2"
      id="ixv-26551"
      unitRef="usdPershares">1.95</us-gaap:SharePrice>
    <us-gaap:ProceedsFromIssuanceOfCommonStock contextRef="c160" decimals="0" id="ixv-26552" unitRef="usd">22496</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
      contextRef="c161"
      decimals="0"
      id="ixv-26553"
      unitRef="shares">3384454</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod contextRef="c0" id="ixv-26554">P7Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1 contextRef="c162" id="ixv-26555">P4Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
      contextRef="c163"
      decimals="0"
      id="ixv-26556"
      unitRef="shares">4079427</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardTermsOfAward contextRef="c164" id="ixv-26557">(i) 5% of the total number of ordinary shares outstanding on December
31 of the immediately preceding calendar year, and (ii) an amount determined by the Board, if so determined prior to the January 1 of
the calendar year in which the increase will occur</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardTermsOfAward>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRights contextRef="c164" id="ixv-26558">The vesting period of the awards is generally four
years. Generally, under the terms of the Plans, unless determined otherwise,&#160;25% of an award granted becomes exercisable on the
first anniversary of the date of grant and&#160;6.25% becomes exercisable once every quarter during the subsequent&#160;three years.</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRights>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1 contextRef="c164" id="ixv-26559">P4Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock contextRef="c0" id="ixv-22820">&lt;span style="font-family: Times New Roman, Times, Serif"&gt;A
summary of the stock option activity under the Company&#x2019;s equity plans during the years ended December 31, 2023, 2022 and 2021 is
as follows:&lt;/span&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Outstanding&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2.85pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;share
                                            options&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Weighted-average
    exercise&lt;br/&gt;
 price ($)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Weighted
    average remaining contractual&lt;br/&gt;
 life (years)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Aggregate
    intrinsic value ($ in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Options:&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 52%; font-weight: bold; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Outstanding
    as of December&#160;31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;3,768,034&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;0.767&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;4.626&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;119,146&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,966,916&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;7.250&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(117,863&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;0.972&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Exercised&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(155,750&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;0.602&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Outstanding
    as of December&#160;31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;5,461,337&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;3.102&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;5.363&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;16,713,971&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,630,142&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;6.833&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(468,814&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;5.557&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Exercised&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(570,451&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;0.482&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Outstanding as of December&#160;31,
    2022&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;6,052,214&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;4.166&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;5.570&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;7,761,705&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;430,874&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2.728&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(351,671&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;7.767&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Exercised&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(1,074,162&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;0.654&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 4pt"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 11.35pt; text-align: left; text-indent: -8.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; text-indent: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Outstanding
                                            as of December&#160;31, 2023 &lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;5,057,255&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;4.543&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;5.662&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2,352,517&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Exercisable as of December&#160;31,
    2023&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;3,210,191&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;3.643&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;4.403&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2,277,303&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Options available for
    future grants&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;611,246&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: -28.35pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;</us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="c19"
      decimals="INF"
      id="ixv-26560"
      unitRef="shares">3768034</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="c19"
      decimals="3"
      id="ixv-26561"
      unitRef="usdPershares">0.767</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2 contextRef="c165" id="ixv-22925">P4Y7M15D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue contextRef="c19" decimals="-3" id="ixv-26562" unitRef="usd">119146000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="c8"
      decimals="INF"
      id="ixv-26563"
      unitRef="shares">1966916</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="c8"
      decimals="3"
      id="ixv-26564"
      unitRef="usdPershares">7.25</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
      contextRef="c8"
      decimals="INF"
      id="ixv-26565"
      unitRef="shares">117863</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
      contextRef="c8"
      decimals="3"
      id="ixv-26566"
      unitRef="usdPershares">0.972</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised
      contextRef="c8"
      decimals="INF"
      id="ixv-26567"
      unitRef="shares">155750</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
      contextRef="c8"
      decimals="3"
      id="ixv-26568"
      unitRef="usdPershares">0.602</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="c40"
      decimals="INF"
      id="ixv-26569"
      unitRef="shares">5461337</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="c40"
      decimals="3"
      id="ixv-26570"
      unitRef="usdPershares">3.102</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2 contextRef="c8" id="ixv-23102">P5Y4M10D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue contextRef="c40" decimals="-3" id="ixv-26571" unitRef="usd">16713971000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="c7"
      decimals="INF"
      id="ixv-26572"
      unitRef="shares">1630142</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="c7"
      decimals="3"
      id="ixv-26573"
      unitRef="usdPershares">6.833</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
      contextRef="c7"
      decimals="INF"
      id="ixv-26574"
      unitRef="shares">468814</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
      contextRef="c7"
      decimals="3"
      id="ixv-26575"
      unitRef="usdPershares">5.557</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised
      contextRef="c7"
      decimals="INF"
      id="ixv-26576"
      unitRef="shares">570451</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
      contextRef="c7"
      decimals="3"
      id="ixv-26577"
      unitRef="usdPershares">0.482</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="c6"
      decimals="INF"
      id="ixv-26578"
      unitRef="shares">6052214</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="c6"
      decimals="3"
      id="ixv-26579"
      unitRef="usdPershares">4.166</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2 contextRef="c7" id="ixv-23279">P5Y6M25D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue contextRef="c6" decimals="-3" id="ixv-26580" unitRef="usd">7761705000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="c0"
      decimals="INF"
      id="ixv-26581"
      unitRef="shares">430874</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="c0"
      decimals="3"
      id="ixv-26582"
      unitRef="usdPershares">2.728</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
      contextRef="c0"
      decimals="INF"
      id="ixv-26583"
      unitRef="shares">351671</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
      contextRef="c0"
      decimals="3"
      id="ixv-26584"
      unitRef="usdPershares">7.767</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised
      contextRef="c0"
      decimals="INF"
      id="ixv-26585"
      unitRef="shares">1074162</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
      contextRef="c0"
      decimals="3"
      id="ixv-26586"
      unitRef="usdPershares">0.654</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="c5"
      decimals="INF"
      id="ixv-26587"
      unitRef="shares">5057255</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="c5"
      decimals="3"
      id="ixv-26588"
      unitRef="usdPershares">4.543</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2 contextRef="c0" id="ixv-23460">P5Y7M28D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue contextRef="c5" decimals="-3" id="ixv-26589" unitRef="usd">2352517000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
      contextRef="c5"
      decimals="INF"
      id="ixv-26590"
      unitRef="shares">3210191</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
      contextRef="c5"
      decimals="3"
      id="ixv-26591"
      unitRef="usdPershares">3.643</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1 contextRef="c0" id="ixv-23531">P4Y4M25D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 contextRef="c5" decimals="-3" id="ixv-26592" unitRef="usd">2277303000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
      contextRef="c5"
      decimals="INF"
      id="ixv-26593"
      unitRef="shares">611246</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
    <us-gaap:ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock contextRef="c0" id="ixv-23660">&lt;span style="font-family: Times New Roman, Times, Serif"&gt;A
summary of the Company&#x2019;s RSUs activity during the years ended December 31, 2023, 2022 and 2021 is as follows:&lt;/span&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Numbers
    of RSUs&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;RSUs:&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Outstanding as of January 1, 2021&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-225; font-family: Times New Roman, Times, Serif"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 88%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,968,794&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-226; font-family: Times New Roman, Times, Serif"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Vested&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-227; font-family: Times New Roman, Times, Serif"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Outstanding as of December&#160;31,
    2021&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,968,794&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,619,898&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(417,025&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Vested&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(573,583&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Outstanding as of December&#160;31,
    2022&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2,598,084&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2,908,983&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(370,067&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Vested&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(895,170&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 4pt; font-weight: bold; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Outstanding as of December&#160;31,
    2023&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;4,241,830&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</us-gaap:ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted
      contextRef="c167"
      decimals="INF"
      id="ixv-26594"
      unitRef="shares">1968794</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber
      contextRef="c168"
      decimals="INF"
      id="ixv-26595"
      unitRef="shares">1968794</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted
      contextRef="c169"
      decimals="INF"
      id="ixv-26596"
      unitRef="shares">1619898</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures
      contextRef="c169"
      decimals="INF"
      id="ixv-26597"
      unitRef="shares">417025</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsPeriodIncreaseDecrease
      contextRef="c169"
      decimals="INF"
      id="ixv-26598"
      unitRef="shares">573583</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsPeriodIncreaseDecrease>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber
      contextRef="c170"
      decimals="INF"
      id="ixv-26599"
      unitRef="shares">2598084</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted
      contextRef="c171"
      decimals="INF"
      id="ixv-26600"
      unitRef="shares">2908983</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures
      contextRef="c171"
      decimals="INF"
      id="ixv-26601"
      unitRef="shares">370067</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsPeriodIncreaseDecrease
      contextRef="c171"
      decimals="INF"
      id="ixv-26602"
      unitRef="shares">895170</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsPeriodIncreaseDecrease>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber
      contextRef="c172"
      decimals="INF"
      id="ixv-26603"
      unitRef="shares">4241830</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber>
    <us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock contextRef="c0" id="ixv-23871">&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The
following table sets forth the parameters used in computation of the options compensation to employees and service providers:&lt;/span&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="10" style="border-bottom: Black 1.5pt solid; white-space: nowrap; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Year
                                            ended &lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;December
                                            31&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="white-space: nowrap; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="white-space: nowrap; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="white-space: nowrap; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 64%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Expected term, in years&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; width: 9%; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;5.82&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; width: 9%; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;4.41-6.11&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; width: 9%; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;4.61-6.11&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Expected volatility&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;47%-51.75%&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;47%-48%&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;42%-46%&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Risk-free interest rate&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;4.15%-4.55%&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1.74%-3.96%&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;0.49%-1.28%&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Expected dividend yield&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;0&lt;/span&gt;%&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: left"&gt;&lt;/td&gt;&lt;td style="white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;0&lt;/span&gt;%&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: left"&gt;&lt;/td&gt;&lt;td style="white-space: nowrap"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;0&lt;/span&gt;%&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 84.45pt; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;</us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 contextRef="c0" id="ixv-26604">P5Y9M25D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 contextRef="c173" id="ixv-26605">P4Y4M28D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 contextRef="c174" id="ixv-26606">P6Y1M9D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 contextRef="c175" id="ixv-26607">P4Y7M9D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 contextRef="c176" id="ixv-26608">P6Y1M9D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate contextRef="c90" decimals="2" id="ixv-26609" unitRef="pure">0.47</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate contextRef="c91" decimals="4" id="ixv-26610" unitRef="pure">0.5175</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="c173"
      decimals="2"
      id="ixv-26611"
      unitRef="pure">0.47</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="c174"
      decimals="2"
      id="ixv-26612"
      unitRef="pure">0.48</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="c175"
      decimals="2"
      id="ixv-26613"
      unitRef="pure">0.42</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="c176"
      decimals="2"
      id="ixv-26614"
      unitRef="pure">0.46</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate contextRef="c90" decimals="4" id="ixv-26615" unitRef="pure">0.0415</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate contextRef="c91" decimals="4" id="ixv-26616" unitRef="pure">0.0455</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="c173"
      decimals="4"
      id="ixv-26617"
      unitRef="pure">0.0174</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="c174"
      decimals="4"
      id="ixv-26618"
      unitRef="pure">0.0396</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="c175"
      decimals="4"
      id="ixv-26619"
      unitRef="pure">0.0049</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="c176"
      decimals="4"
      id="ixv-26620"
      unitRef="pure">0.0128</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate contextRef="c0" decimals="2" id="ixv-26621" unitRef="pure">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate contextRef="c7" decimals="2" id="ixv-26622" unitRef="pure">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate contextRef="c8" decimals="2" id="ixv-26623" unitRef="pure">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodExpectedDividendRate contextRef="c0" decimals="2" id="ixv-26624" unitRef="pure">0</us-gaap:ShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodExpectedDividendRate>
    <us-gaap:ScheduleOfShareBasedCompensationActivityTableTextBlock contextRef="c0" id="ixv-24186">&lt;span style="font-family: Times New Roman, Times, Serif; background-color: white"&gt;The
following table presents stock-based compensation expense to employees included in the Company&#x2019;s consolidated statements of operations:&lt;/span&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="10" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Year
                                            ended &lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;December
                                            31,&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 64%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Research and development&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;8,721&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;5,726&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,518&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Sales and marketing&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2,229&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,403&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;217&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;General and administrative&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,786&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,537&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;419&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Cost of revenues&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;276&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;127&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;57&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Total stock-based compensation
    expense&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;13,012&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;8,793&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2,211&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</us-gaap:ScheduleOfShareBasedCompensationActivityTableTextBlock>
    <us-gaap:ShareBasedCompensation
      contextRef="c177"
      decimals="-3"
      id="ixv-26625"
      unitRef="usd">8721000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="c178"
      decimals="-3"
      id="ixv-26626"
      unitRef="usd">5726000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="c179"
      decimals="-3"
      id="ixv-26627"
      unitRef="usd">1518000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="c180"
      decimals="-3"
      id="ixv-26628"
      unitRef="usd">2229000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="c181"
      decimals="-3"
      id="ixv-26629"
      unitRef="usd">1403000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="c182"
      decimals="-3"
      id="ixv-26630"
      unitRef="usd">217000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="c183"
      decimals="-3"
      id="ixv-26631"
      unitRef="usd">1786000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="c184"
      decimals="-3"
      id="ixv-26632"
      unitRef="usd">1537000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="c185"
      decimals="-3"
      id="ixv-26633"
      unitRef="usd">419000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="c186"
      decimals="-3"
      id="ixv-26634"
      unitRef="usd">276000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="c187"
      decimals="-3"
      id="ixv-26635"
      unitRef="usd">127000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="c188"
      decimals="-3"
      id="ixv-26636"
      unitRef="usd">57000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation contextRef="c0" decimals="-3" id="ixv-26637" unitRef="usd">13012000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation contextRef="c7" decimals="-3" id="ixv-26638" unitRef="usd">8793000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation contextRef="c8" decimals="-3" id="ixv-26639" unitRef="usd">2211000</us-gaap:ShareBasedCompensation>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c0" decimals="-3" id="ixv-26640" unitRef="usd">629000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c7" decimals="-3" id="ixv-26641" unitRef="usd">354000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c8" decimals="-3" id="ixv-26642" unitRef="usd">115000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:EarningsPerShareTextBlock contextRef="c0" id="ixv-24430">&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;NOTE
10:- &#160;&#160;NET LOSS PER SHARE ATTRIBUTIBLE TO ORDINARY SHARHOLDERS&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-align: justify; text-indent: -56.7pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-weight: normal; background-color: white"&gt;The
following table sets forth the computation of basic and diluted net loss per share attributable to ordinary shareholders for the periods
presented: &lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-align: justify; text-indent: -56.7pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="10" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Year
                                            ended &lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;December
                                            31,&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;span style="text-decoration:underline"&gt;Basic&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="padding-bottom: 1.5pt; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="padding-bottom: 1.5pt; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="padding-bottom: 1.5pt; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: left"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: left"&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: left; text-indent: -0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Numerator:&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 64%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Net loss&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(43,500&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(40,494&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(58,092&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: left; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: left; text-indent: -0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Denominator:&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Weighted-average
    shares used in computing loss per share attributable to ordinary shareholders, basic&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;72,021,520&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;63,489,983&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;22,027,292&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Loss per share attributable to ordinary shareholders,
    basic&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(0.60&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(0.64&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(2.64&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;span style="text-decoration:underline"&gt;Diluted&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;

&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: left"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 11.35pt; text-align: left; text-indent: -8.5pt"&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; text-indent: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Numerator:&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 64%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Adjusted Net loss*&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(44,256&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(48,919&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(58,092&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 11.35pt; text-align: left; text-indent: -8.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; text-indent: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Denominator:&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Weighted-average
    shares used in computing loss per share attributable to ordinary shareholders, diluted&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;62,390,302&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;60,960,641&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;22,027,292&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Loss per share attributable to ordinary shareholders,
    diluted*&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(0.71&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(0.80&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(2.64&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-align: justify; text-indent: -56.7pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;*&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;Loss per share attributable to ordinary shareholders, diluted, was adjusted and take into consideration warrants liabilities revaluations as part of our net loss for 2023 and 2022.&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-align: justify; text-indent: -56.7pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Year
                                            ended &lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2.85pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;December
                                            31,&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 76%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Net loss&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(43,500&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(40,494&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Revaluation of warrants&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(756&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(8,425&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Adjusted Net loss&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(44,256&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(48,919&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;


&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-align: justify; text-indent: -56.7pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;The
potential Ordinary Shares that were excluded from the computation of diluted net loss per share attributable to ordinary shareholders
for the years ended December 31, 2023, 2022 and 2021 because including them would have been anti-dilutive are as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-align: justify; text-indent: -56.7pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="10" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Year
                                            ended &lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;December
                                            31,&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 64%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Convertible preferred shares&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-228; font-family: Times New Roman, Times, Serif"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-229; font-family: Times New Roman, Times, Serif"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;26,499,069&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Outstanding share options&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;9,299,085&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;8,650,298&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,362,786&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;9,299,085&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;8,650,298&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;27,861,855&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</us-gaap:EarningsPerShareTextBlock>
    <us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock contextRef="c0" id="ixv-26643">The
following table sets forth the computation of basic and diluted net loss per share attributable to ordinary shareholders for the periods
presented:&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="10" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Year
                                            ended &lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;December
                                            31,&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;span style="text-decoration:underline"&gt;Basic&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="padding-bottom: 1.5pt; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="padding-bottom: 1.5pt; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="padding-bottom: 1.5pt; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: left"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: left"&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: left; text-indent: -0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Numerator:&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 64%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Net loss&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(43,500&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(40,494&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(58,092&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: left; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: left; text-indent: -0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Denominator:&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Weighted-average
    shares used in computing loss per share attributable to ordinary shareholders, basic&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;72,021,520&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;63,489,983&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;22,027,292&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Loss per share attributable to ordinary shareholders,
    basic&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(0.60&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(0.64&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(2.64&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;span style="text-decoration:underline"&gt;Diluted&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;

&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: left"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 11.35pt; text-align: left; text-indent: -8.5pt"&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; text-indent: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Numerator:&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 64%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Adjusted Net loss*&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(44,256&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(48,919&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(58,092&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 11.35pt; text-align: left; text-indent: -8.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; text-indent: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Denominator:&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Weighted-average
    shares used in computing loss per share attributable to ordinary shareholders, diluted&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;62,390,302&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;60,960,641&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;22,027,292&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Loss per share attributable to ordinary shareholders,
    diluted*&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(0.71&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(0.80&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(2.64&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;&lt;table cellpadding="0" cellspacing="0" style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;*&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;Loss per share attributable to ordinary shareholders, diluted, was adjusted and take into consideration warrants liabilities revaluations as part of our net loss for 2023 and 2022.&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Year
                                            ended &lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2.85pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;December
                                            31,&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 76%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Net loss&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(43,500&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(40,494&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Revaluation of warrants&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(756&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(8,425&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Adjusted Net loss&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(44,256&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(48,919&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock>
    <us-gaap:NetIncomeLossAttributableToNonredeemableNoncontrollingInterest contextRef="c0" decimals="-3" id="ixv-26644" unitRef="usd">-43500000</us-gaap:NetIncomeLossAttributableToNonredeemableNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNonredeemableNoncontrollingInterest contextRef="c7" decimals="-3" id="ixv-26645" unitRef="usd">-40494000</us-gaap:NetIncomeLossAttributableToNonredeemableNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNonredeemableNoncontrollingInterest contextRef="c8" decimals="-3" id="ixv-26646" unitRef="usd">-58092000</us-gaap:NetIncomeLossAttributableToNonredeemableNoncontrollingInterest>
    <us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment
      contextRef="c0"
      decimals="INF"
      id="ixv-26647"
      unitRef="shares">72021520</us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment>
    <us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment
      contextRef="c7"
      decimals="INF"
      id="ixv-26648"
      unitRef="shares">63489983</us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment>
    <us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment
      contextRef="c8"
      decimals="INF"
      id="ixv-26649"
      unitRef="shares">22027292</us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment>
    <us-gaap:EarningsPerShareBasic
      contextRef="c0"
      decimals="2"
      id="ixv-26650"
      unitRef="usdPershares">-0.6</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="c7"
      decimals="2"
      id="ixv-26651"
      unitRef="usdPershares">-0.64</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="c8"
      decimals="2"
      id="ixv-26652"
      unitRef="usdPershares">-2.64</us-gaap:EarningsPerShareBasic>
    <us-gaap:TemporaryEquityAccretionToRedemptionValueAdjustment contextRef="c0" decimals="-3" id="ix_0_fact" unitRef="usd">-44256000</us-gaap:TemporaryEquityAccretionToRedemptionValueAdjustment>
    <us-gaap:TemporaryEquityAccretionToRedemptionValueAdjustment contextRef="c7" decimals="-3" id="ix_1_fact" unitRef="usd">-48919000</us-gaap:TemporaryEquityAccretionToRedemptionValueAdjustment>
    <us-gaap:TemporaryEquityAccretionToRedemptionValueAdjustment contextRef="c8" decimals="-3" id="ix_2_fact" unitRef="usd">-58092000</us-gaap:TemporaryEquityAccretionToRedemptionValueAdjustment>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="c0"
      decimals="INF"
      id="ixv-26656"
      unitRef="shares">62390302</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="c7"
      decimals="INF"
      id="ixv-26657"
      unitRef="shares">60960641</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="c8"
      decimals="INF"
      id="ixv-26658"
      unitRef="shares">22027292</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c0"
      decimals="2"
      id="ix_3_fact"
      unitRef="usdPershares">-0.71</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c7"
      decimals="2"
      id="ix_4_fact"
      unitRef="usdPershares">-0.8</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c8"
      decimals="2"
      id="ix_5_fact"
      unitRef="usdPershares">-2.64</us-gaap:EarningsPerShareDiluted>
    <us-gaap:NetIncomeLossAttributableToNonredeemableNoncontrollingInterest contextRef="c0" decimals="-3" id="ixv-26662" unitRef="usd">-43500000</us-gaap:NetIncomeLossAttributableToNonredeemableNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNonredeemableNoncontrollingInterest contextRef="c7" decimals="-3" id="ixv-26663" unitRef="usd">-40494000</us-gaap:NetIncomeLossAttributableToNonredeemableNoncontrollingInterest>
    <us-gaap:ProceedsFromIssuanceOfWarrants contextRef="c0" decimals="-3" id="ixv-26664" unitRef="usd">756000</us-gaap:ProceedsFromIssuanceOfWarrants>
    <us-gaap:ProceedsFromIssuanceOfWarrants contextRef="c7" decimals="-3" id="ixv-26665" unitRef="usd">8425000</us-gaap:ProceedsFromIssuanceOfWarrants>
    <us-gaap:TemporaryEquityAccretionToRedemptionValueAdjustment contextRef="c0" decimals="-3" id="ixv-26666" unitRef="usd">-44256000</us-gaap:TemporaryEquityAccretionToRedemptionValueAdjustment>
    <us-gaap:TemporaryEquityAccretionToRedemptionValueAdjustment contextRef="c7" decimals="-3" id="ixv-26667" unitRef="usd">-48919000</us-gaap:TemporaryEquityAccretionToRedemptionValueAdjustment>
    <us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock contextRef="c0" id="ixv-24921">&lt;span style="font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;The
potential Ordinary Shares that were excluded from the computation of diluted net loss per share attributable to ordinary shareholders
for the years ended December 31, 2023, 2022 and 2021 because including them would have been anti-dilutive are as follows:&lt;/span&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="10" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Year
                                            ended &lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;December
                                            31,&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 64%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Convertible preferred shares&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-228; font-family: Times New Roman, Times, Serif"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-229; font-family: Times New Roman, Times, Serif"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;26,499,069&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Outstanding share options&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;9,299,085&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;8,650,298&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,362,786&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;9,299,085&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;8,650,298&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;27,861,855&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="c191"
      decimals="0"
      id="ixv-26668"
      unitRef="shares">26499069</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="c192"
      decimals="0"
      id="ixv-26669"
      unitRef="shares">9299085</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="c193"
      decimals="0"
      id="ixv-26670"
      unitRef="shares">8650298</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="c194"
      decimals="0"
      id="ixv-26671"
      unitRef="shares">1362786</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="c0"
      decimals="0"
      id="ixv-26672"
      unitRef="shares">9299085</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="c7"
      decimals="0"
      id="ixv-26673"
      unitRef="shares">8650298</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="c8"
      decimals="0"
      id="ixv-26674"
      unitRef="shares">27861855</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:IncomeTaxDisclosureTextBlock contextRef="c0" id="ixv-25104">&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;NOTE
11:- &#160;&#160;TAXES ON INCOME&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 84.45pt; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.5in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;a.&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;General:&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 84.45pt; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;i&gt;Israeli
tax rate:&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: -28.35pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The
Corporate tax rate in Israel relevant to the Company in 2021, 2022 and 2023 - 23%.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;i&gt;United
States:&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The
Company&#x2019;s subsidiaries are separately taxed under the U.S. tax laws at a corporate rate of 21%.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 84.45pt; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.5in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;b.&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Loss
                                            before income taxes:&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: -28.35pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The
following are the domestic (i.e. Israeli) and foreign components of the Company&#x2019;s loss before income taxes:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: -28.35pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="10" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2.85pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Year
                                            ended &lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2.85pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;December
                                            31,&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 64%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Domestic&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(43,500&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(40,494&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(58,092&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Foreign&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-230; font-family: Times New Roman, Times, Serif"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-231; font-family: Times New Roman, Times, Serif"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-232; font-family: Times New Roman, Times, Serif"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(43,500&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(40,494&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(58,092&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;


&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 84.45pt; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.5in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;c.&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Taxes
                                            on income:&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: -28.35pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The
reconciliation of the income tax benefit that would result from applying the Israeli statutory tax rate to the Company&#x2019;s reported
income tax (benefit) is as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: -28.35pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="10" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2.85pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Year
                                            ended &lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2.85pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;December
                                            31,&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; width: 64%; text-align: left; padding-bottom: 4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Loss
    before income taxes, as reported in the consolidated statements of operations&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;43,500&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 4pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;40,494&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 4pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;58,092&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 4pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; padding-bottom: 4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Statutory
    tax rate&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;23&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;23&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;23&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Income
    tax benefit at statutory tax rate&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(10,005&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(9,314&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(13,361&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Effect
    of Non-deductible expenses&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;3,063&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;475&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;6,129&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Remeasurement
    of deferred taxes from currency exchange*&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-233; font-family: Times New Roman, Times, Serif"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;3,517&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;209&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Change
    in valuation allowance&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;7,508&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;5,322&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;7,023&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(566&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-234; font-family: Times New Roman, Times, Serif"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-235; font-family: Times New Roman, Times, Serif"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; padding-bottom: 4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Reported
    income taxes benefit&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-236; font-family: Times New Roman, Times, Serif"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-237; font-family: Times New Roman, Times, Serif"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-238; font-family: Times New Roman, Times, Serif"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;


&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;*&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The
income Tax Regulations (rules regarding ledger management of foreign invested companies and certain partnerships and the determination
of their taxable income), 1986 allow Foreign Invested Companies (i.e., foreign holding percentage of more than 25%) to report for tax
purposes in US dollars. The Company implemented these regulations on January 1, 2023.&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.5in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;d.&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Net
                                            operating loss carryforward:&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; background-color: white"&gt;As
of December&#160;31, 2023, the Company had a net operating loss carryforward for Israeli tax purposes of approximately $121,880. These
net operating loss carryforwards can be carried forward and offset against taxable income indefinitely.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.5in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;e.&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Deferred
                                            tax assets and liabilities:&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 84.45pt; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Deferred
tax assets and liabilities are recognized for the tax effects of temporary differences between the carrying amounts of assets and liabilities
for financial reporting purposes and the amounts used for income tax purposes and for carryforwards.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 84.45pt; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The
principal components of the Company&#x2019;s deferred tax assets are as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 84.45pt; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;December
    31&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Deferred tax assets:&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; width: 76%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Net operating loss carry forwards&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;28,032&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;21,991&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 0.125in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Research and development&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;6,252&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;4,834&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Employees and payroll accrual&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;299&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;272&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 0.125in; text-align: left; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Property and equipment&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;79&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;57&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Total deferred tax assets&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;34,662&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;27,154&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Valuation allowance&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(34,662&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(27,154&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; text-align: left; padding-bottom: 4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Deferred
    tax assets, net of valuation allowance&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-239; font-family: Times New Roman, Times, Serif"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-240; font-family: Times New Roman, Times, Serif"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 84.45pt; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Based
on the available evidence, management believes that it is more likely than not that certain of its deferred tax assets relating to net
operating loss carryforwards and other temporary differences in Israel will not be realized and accordingly, a valuation allowance has
been provided.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: -28.35pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.5in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;f.&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Tax
                                            assessments:&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: -28.35pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The
Israeli entity&#x2019;s&#x2019; income tax assessments are considered final through 2018&lt;span style="font-size: 10pt; background-color: white"&gt;.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.5in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;g.&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Unrecognized
                                            Tax Benefits:&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: -28.35pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; background-color: white"&gt;As
of December&#160;31, 2023, 2022 and 2021, the Company did not have any unrecognized tax benefits and does not expect that the amount
of unrecognized tax benefits will change significantly within the next 12 months. The Company&#x2019;s accounting policy is to accrue
interest and penalties related to an underpayment of income taxes as a component of income tax expense.&lt;/span&gt;&lt;/p&gt;</us-gaap:IncomeTaxDisclosureTextBlock>
    <us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential
      contextRef="c128"
      decimals="2"
      id="ixv-26675"
      unitRef="pure">0.23</us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential>
    <us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential
      contextRef="c130"
      decimals="2"
      id="ixv-26676"
      unitRef="pure">0.23</us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential>
    <us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential
      contextRef="c132"
      decimals="2"
      id="ixv-26677"
      unitRef="pure">0.23</us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential>
    <us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential
      contextRef="c116"
      decimals="2"
      id="ixv-26678"
      unitRef="pure">0.21</us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential>
    <us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock contextRef="c0" id="ixv-25146">&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The
following are the domestic (i.e. Israeli) and foreign components of the Company&#x2019;s loss before income taxes:&lt;/span&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="10" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2.85pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Year
                                            ended &lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2.85pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;December
                                            31,&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 64%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Domestic&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(43,500&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(40,494&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(58,092&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Foreign&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-230; font-family: Times New Roman, Times, Serif"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-231; font-family: Times New Roman, Times, Serif"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-232; font-family: Times New Roman, Times, Serif"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(43,500&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(40,494&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(58,092&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic contextRef="c0" decimals="-3" id="ixv-26679" unitRef="usd">43500000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic contextRef="c7" decimals="-3" id="ixv-26680" unitRef="usd">40494000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic contextRef="c8" decimals="-3" id="ixv-26681" unitRef="usd">58092000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="c0" decimals="-3" id="ixv-26682" unitRef="usd">43500000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="c7" decimals="-3" id="ixv-26683" unitRef="usd">40494000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="c8" decimals="-3" id="ixv-26684" unitRef="usd">58092000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock contextRef="c0" id="ixv-25301">&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The
reconciliation of the income tax benefit that would result from applying the Israeli statutory tax rate to the Company&#x2019;s reported
income tax (benefit) is as follows:&lt;/span&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="10" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2.85pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Year
                                            ended &lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2.85pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;December
                                            31,&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; width: 64%; text-align: left; padding-bottom: 4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Loss
    before income taxes, as reported in the consolidated statements of operations&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;43,500&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 4pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;40,494&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 4pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;58,092&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 4pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; padding-bottom: 4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Statutory
    tax rate&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;23&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;23&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;23&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Income
    tax benefit at statutory tax rate&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(10,005&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(9,314&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(13,361&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Effect
    of Non-deductible expenses&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;3,063&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;475&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;6,129&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Remeasurement
    of deferred taxes from currency exchange*&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-233; font-family: Times New Roman, Times, Serif"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;3,517&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;209&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Change
    in valuation allowance&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;7,508&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;5,322&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;7,023&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(566&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-234; font-family: Times New Roman, Times, Serif"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-235; font-family: Times New Roman, Times, Serif"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; padding-bottom: 4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Reported
    income taxes benefit&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-236; font-family: Times New Roman, Times, Serif"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-237; font-family: Times New Roman, Times, Serif"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-238; font-family: Times New Roman, Times, Serif"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;*&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The
income Tax Regulations (rules regarding ledger management of foreign invested companies and certain partnerships and the determination
of their taxable income), 1986 allow Foreign Invested Companies (i.e., foreign holding percentage of more than 25%) to report for tax
purposes in US dollars. The Company implemented these regulations on January 1, 2023.&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;</us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="c0" decimals="-3" id="ixv-26685" unitRef="usd">43500000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="c7" decimals="-3" id="ixv-26686" unitRef="usd">40494000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="c8" decimals="-3" id="ixv-26687" unitRef="usd">58092000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate contextRef="c0" decimals="2" id="ixv-26688" unitRef="pure">0.23</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate contextRef="c7" decimals="2" id="ixv-26689" unitRef="pure">0.23</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate contextRef="c8" decimals="2" id="ixv-26690" unitRef="pure">0.23</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate contextRef="c0" decimals="-3" id="ixv-26691" unitRef="usd">-10005000</us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate>
    <us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate contextRef="c7" decimals="-3" id="ixv-26692" unitRef="usd">-9314000</us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate>
    <us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate contextRef="c8" decimals="-3" id="ixv-26693" unitRef="usd">-13361000</us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate>
    <us-gaap:IncomeTaxReconciliationNondeductibleExpense contextRef="c0" decimals="-3" id="ixv-26694" unitRef="usd">3063000</us-gaap:IncomeTaxReconciliationNondeductibleExpense>
    <us-gaap:IncomeTaxReconciliationNondeductibleExpense contextRef="c7" decimals="-3" id="ixv-26695" unitRef="usd">475000</us-gaap:IncomeTaxReconciliationNondeductibleExpense>
    <us-gaap:IncomeTaxReconciliationNondeductibleExpense contextRef="c8" decimals="-3" id="ixv-26696" unitRef="usd">6129000</us-gaap:IncomeTaxReconciliationNondeductibleExpense>
    <us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential contextRef="c7" decimals="-3" id="ix_6_fact" unitRef="usd">3517000</us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential>
    <us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential contextRef="c8" decimals="-3" id="ix_7_fact" unitRef="usd">209000</us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential>
    <us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance contextRef="c0" decimals="-3" id="ixv-26699" unitRef="usd">7508000</us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance contextRef="c7" decimals="-3" id="ixv-26700" unitRef="usd">5322000</us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance contextRef="c8" decimals="-3" id="ixv-26701" unitRef="usd">7023000</us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:IncomeTaxReconciliationOtherAdjustments contextRef="c0" decimals="-3" id="ixv-26702" unitRef="usd">-566000</us-gaap:IncomeTaxReconciliationOtherAdjustments>
    <us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential contextRef="c0" decimals="2" id="ixv-26703" unitRef="pure">0.25</us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential>
    <us-gaap:OperatingLossCarryforwards contextRef="c5" decimals="-3" id="ixv-26704" unitRef="usd">121880000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock contextRef="c0" id="ixv-25671">&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The
principal components of the Company&#x2019;s deferred tax assets are as follows:&lt;/span&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;December
    31&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Deferred tax assets:&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; width: 76%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Net operating loss carry forwards&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;28,032&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;21,991&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 0.125in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Research and development&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;6,252&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;4,834&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Employees and payroll accrual&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;299&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;272&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 0.125in; text-align: left; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Property and equipment&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;79&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;57&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Total deferred tax assets&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;34,662&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;27,154&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Valuation allowance&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(34,662&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(27,154&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; text-align: left; padding-bottom: 4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Deferred
    tax assets, net of valuation allowance&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-239; font-family: Times New Roman, Times, Serif"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-240; font-family: Times New Roman, Times, Serif"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwards contextRef="c5" decimals="-3" id="ixv-26705" unitRef="usd">28032000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwards>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwards contextRef="c6" decimals="-3" id="ixv-26706" unitRef="usd">21991000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwards>
    <us-gaap:DeferredTaxAssetsInProcessResearchAndDevelopment contextRef="c5" decimals="-3" id="ixv-26707" unitRef="usd">6252000</us-gaap:DeferredTaxAssetsInProcessResearchAndDevelopment>
    <us-gaap:DeferredTaxAssetsInProcessResearchAndDevelopment contextRef="c6" decimals="-3" id="ixv-26708" unitRef="usd">4834000</us-gaap:DeferredTaxAssetsInProcessResearchAndDevelopment>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost contextRef="c5" decimals="-3" id="ixv-26709" unitRef="usd">299000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost contextRef="c6" decimals="-3" id="ixv-26710" unitRef="usd">272000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost>
    <us-gaap:DeferredTaxAssetsPropertyPlantAndEquipment contextRef="c5" decimals="-3" id="ixv-26711" unitRef="usd">79000</us-gaap:DeferredTaxAssetsPropertyPlantAndEquipment>
    <us-gaap:DeferredTaxAssetsPropertyPlantAndEquipment contextRef="c6" decimals="-3" id="ixv-26712" unitRef="usd">57000</us-gaap:DeferredTaxAssetsPropertyPlantAndEquipment>
    <us-gaap:DeferredTaxAssetsGross contextRef="c5" decimals="-3" id="ixv-26713" unitRef="usd">34662000</us-gaap:DeferredTaxAssetsGross>
    <us-gaap:DeferredTaxAssetsGross contextRef="c6" decimals="-3" id="ixv-26714" unitRef="usd">27154000</us-gaap:DeferredTaxAssetsGross>
    <us-gaap:DeferredTaxAssetsValuationAllowance contextRef="c5" decimals="-3" id="ixv-26715" unitRef="usd">34662000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsValuationAllowance contextRef="c6" decimals="-3" id="ixv-26716" unitRef="usd">27154000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:SegmentReportingDisclosureTextBlock contextRef="c0" id="ixv-25960">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;NOTE
12:- &#160;&#160;SEGMENT INFORMATION&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; background-color: white"&gt;The
Company operates in one operating and reportable segment. Operating segments are defined as components of an enterprise about which separate
financial information is evaluated regularly by the chief operating decision maker, who is the Company&#x2019;s chief executive officer
(&#x201c;&lt;b&gt;CEO&lt;/b&gt;&#x201d;), in deciding how to allocate resources and assessing performance. The Company&#x2019;s chief operating decision
maker allocates resources and assesses performance based upon discrete financial information at the consolidated level. &lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 28.35pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; background-color: white"&gt;Revenue
by geographical region can be found in the revenue recognition disclosures in Note 3 The following table presents the Company&#x2019;s
property and equipment, net of depreciation, by geographic region:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 28.35pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;December
    31,&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;202&lt;span style="font-size: 10pt"&gt;3&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;202&lt;span style="font-size: 10pt"&gt;2&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 76%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Israel&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,309&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,609&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-241; font-family: Times New Roman, Times, Serif"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-242; font-family: Times New Roman, Times, Serif"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Total property and equipment,
    net:&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,309&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,609&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;


&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 28.35pt; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; background-color: white"&gt;*)&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; background-color: white"&gt;Represents
less than $1&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 28.35pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Major
Customers:&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;During
the year ended December 31, 2023, the Company had three customers that accounted for 38.9%, 18.1% and 12.7%, respectively, of revenues.
During the year ended December 31, 2022, the Company had three customers that accounted for 33.4%, 19.4% and 18.9%, respectively, of
revenues. During the year ended December 31, 2021, the Company had three customers that accounted for 41.1%, 31.2% and 15.6%, respectively,
of revenues.&lt;/span&gt;&lt;/p&gt;</us-gaap:SegmentReportingDisclosureTextBlock>
    <us-gaap:LongLivedAssetsByGeographicAreasTableTextBlock contextRef="c0" id="ixv-25973">&lt;span style="font-family: Times New Roman, Times, Serif; background-color: white"&gt;Revenue
by geographical region can be found in the revenue recognition disclosures in Note 3 The following table presents the Company&#x2019;s
property and equipment, net of depreciation, by geographic region:&lt;/span&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;December
    31,&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;202&lt;span style="font-size: 10pt"&gt;3&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;202&lt;span style="font-size: 10pt"&gt;2&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 76%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Israel&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,309&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,609&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-241; font-family: Times New Roman, Times, Serif"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-242; font-family: Times New Roman, Times, Serif"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Total property and equipment,
    net:&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,309&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,609&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</us-gaap:LongLivedAssetsByGeographicAreasTableTextBlock>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="c129"
      decimals="-3"
      id="ixv-26717"
      unitRef="usd">1309000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="c131"
      decimals="-3"
      id="ixv-26718"
      unitRef="usd">1609000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="c5" decimals="-3" id="ixv-26719" unitRef="usd">1309000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="c6" decimals="-3" id="ixv-26720" unitRef="usd">1609000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="c195"
      decimals="3"
      id="ixv-26721"
      unitRef="pure">0.389</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="c196"
      decimals="3"
      id="ixv-26722"
      unitRef="pure">0.181</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="c197"
      decimals="3"
      id="ixv-26723"
      unitRef="pure">0.127</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="c198"
      decimals="3"
      id="ixv-26724"
      unitRef="pure">0.334</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="c199"
      decimals="3"
      id="ixv-26725"
      unitRef="pure">0.194</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="c200"
      decimals="3"
      id="ixv-26726"
      unitRef="pure">0.189</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="c201"
      decimals="3"
      id="ixv-26727"
      unitRef="pure">0.411</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="c202"
      decimals="3"
      id="ixv-26728"
      unitRef="pure">0.312</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="c203"
      decimals="3"
      id="ixv-26729"
      unitRef="pure">0.156</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:DeferredRevenueCurrent
      contextRef="c5"
      id="hidden-fact-0"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:CommonStockValue
      contextRef="c5"
      id="hidden-fact-1"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:CommonStockValue
      contextRef="c6"
      id="hidden-fact-2"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="c16"
      id="hidden-fact-3"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants
      contextRef="c20"
      id="hidden-fact-4"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants
      contextRef="c21"
      id="hidden-fact-5"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants
      contextRef="c22"
      id="hidden-fact-6"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants
      contextRef="c23"
      id="hidden-fact-7"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants
      contextRef="c24"
      id="hidden-fact-8"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants
      contextRef="c27"
      id="hidden-fact-9"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants
      contextRef="c28"
      id="hidden-fact-10"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
      contextRef="c27"
      id="hidden-fact-11"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
      contextRef="c28"
      id="hidden-fact-12"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfUnits
      contextRef="c20"
      id="hidden-fact-13"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfUnits
      contextRef="c21"
      id="hidden-fact-14"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfUnits
      contextRef="c22"
      id="hidden-fact-15"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfUnits
      contextRef="c23"
      id="hidden-fact-16"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfUnits
      contextRef="c24"
      id="hidden-fact-17"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfUnits
      contextRef="c25"
      id="hidden-fact-18"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfUnits
      contextRef="c26"
      id="hidden-fact-19"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfUnits
      contextRef="c27"
      id="hidden-fact-20"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfUnits
      contextRef="c28"
      id="hidden-fact-21"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="c20"
      id="hidden-fact-22"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="c21"
      id="hidden-fact-23"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="c22"
      id="hidden-fact-24"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="c23"
      id="hidden-fact-25"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="c24"
      id="hidden-fact-26"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="c25"
      id="hidden-fact-27"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="c26"
      id="hidden-fact-28"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="c27"
      id="hidden-fact-29"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="c28"
      id="hidden-fact-30"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants
      contextRef="c20"
      id="hidden-fact-31"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants
      contextRef="c21"
      id="hidden-fact-32"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants
      contextRef="c22"
      id="hidden-fact-33"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants
      contextRef="c27"
      id="hidden-fact-34"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants
      contextRef="c28"
      id="hidden-fact-35"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
      contextRef="c20"
      id="hidden-fact-36"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
      contextRef="c21"
      id="hidden-fact-37"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
      contextRef="c22"
      id="hidden-fact-38"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
      contextRef="c23"
      id="hidden-fact-39"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
      contextRef="c24"
      id="hidden-fact-40"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
      contextRef="c25"
      id="hidden-fact-41"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
      contextRef="c26"
      id="hidden-fact-42"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
      contextRef="c27"
      id="hidden-fact-43"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
      contextRef="c28"
      id="hidden-fact-44"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices
      contextRef="c20"
      id="hidden-fact-45"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices
      contextRef="c21"
      id="hidden-fact-46"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices
      contextRef="c22"
      id="hidden-fact-47"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices
      contextRef="c23"
      id="hidden-fact-48"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices
      contextRef="c24"
      id="hidden-fact-49"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices
      contextRef="c25"
      id="hidden-fact-50"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices
      contextRef="c26"
      id="hidden-fact-51"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices
      contextRef="c27"
      id="hidden-fact-52"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices
      contextRef="c28"
      id="hidden-fact-53"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="c20"
      id="hidden-fact-54"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="c21"
      id="hidden-fact-55"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="c22"
      id="hidden-fact-56"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="c24"
      id="hidden-fact-57"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="c25"
      id="hidden-fact-58"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="c26"
      id="hidden-fact-59"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="c27"
      id="hidden-fact-60"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="c28"
      id="hidden-fact-61"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="c20"
      id="hidden-fact-62"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="c21"
      id="hidden-fact-63"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="c22"
      id="hidden-fact-64"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="c23"
      id="hidden-fact-65"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="c24"
      id="hidden-fact-66"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="c25"
      id="hidden-fact-67"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="c26"
      id="hidden-fact-68"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="c27"
      id="hidden-fact-69"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="c29"
      id="hidden-fact-70"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:SharesOutstanding
      contextRef="c30"
      id="hidden-fact-71"
      unitRef="shares"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="c30"
      id="hidden-fact-72"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:SharesOutstanding
      contextRef="c31"
      id="hidden-fact-73"
      unitRef="shares"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="c31"
      id="hidden-fact-74"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:SharesOutstanding
      contextRef="c32"
      id="hidden-fact-75"
      unitRef="shares"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="c32"
      id="hidden-fact-76"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:SharesOutstanding
      contextRef="c33"
      id="hidden-fact-77"
      unitRef="shares"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="c33"
      id="hidden-fact-78"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:SharesOutstanding
      contextRef="c34"
      id="hidden-fact-79"
      unitRef="shares"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="c34"
      id="hidden-fact-80"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:SharesOutstanding
      contextRef="c35"
      id="hidden-fact-81"
      unitRef="shares"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="c35"
      id="hidden-fact-82"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="c36"
      id="hidden-fact-83"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="c37"
      id="hidden-fact-84"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
      contextRef="c41"
      id="hidden-fact-85"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
      contextRef="c42"
      id="hidden-fact-86"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
      contextRef="c43"
      id="hidden-fact-87"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
      contextRef="c44"
      id="hidden-fact-88"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
      contextRef="c45"
      id="hidden-fact-89"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
      contextRef="c46"
      id="hidden-fact-90"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
      contextRef="c47"
      id="hidden-fact-91"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
      contextRef="c48"
      id="hidden-fact-92"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
      contextRef="c50"
      id="hidden-fact-93"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices
      contextRef="c41"
      id="hidden-fact-94"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices
      contextRef="c42"
      id="hidden-fact-95"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices
      contextRef="c43"
      id="hidden-fact-96"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices
      contextRef="c44"
      id="hidden-fact-97"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices
      contextRef="c45"
      id="hidden-fact-98"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices
      contextRef="c46"
      id="hidden-fact-99"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices
      contextRef="c47"
      id="hidden-fact-100"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices
      contextRef="c48"
      id="hidden-fact-101"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices
      contextRef="c50"
      id="hidden-fact-102"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="c41"
      id="hidden-fact-103"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="c42"
      id="hidden-fact-104"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="c43"
      id="hidden-fact-105"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="c46"
      id="hidden-fact-106"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="c47"
      id="hidden-fact-107"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="c48"
      id="hidden-fact-108"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="c50"
      id="hidden-fact-109"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="c41"
      id="hidden-fact-110"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="c42"
      id="hidden-fact-111"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="c43"
      id="hidden-fact-112"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="c44"
      id="hidden-fact-113"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="c45"
      id="hidden-fact-114"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="c46"
      id="hidden-fact-115"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="c47"
      id="hidden-fact-116"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="c48"
      id="hidden-fact-117"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="c49"
      id="hidden-fact-118"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:SharesOutstanding
      contextRef="c51"
      id="hidden-fact-119"
      unitRef="shares"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="c51"
      id="hidden-fact-120"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:SharesOutstanding
      contextRef="c52"
      id="hidden-fact-121"
      unitRef="shares"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="c52"
      id="hidden-fact-122"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:SharesOutstanding
      contextRef="c53"
      id="hidden-fact-123"
      unitRef="shares"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="c53"
      id="hidden-fact-124"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:SharesOutstanding
      contextRef="c54"
      id="hidden-fact-125"
      unitRef="shares"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="c54"
      id="hidden-fact-126"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:SharesOutstanding
      contextRef="c55"
      id="hidden-fact-127"
      unitRef="shares"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="c55"
      id="hidden-fact-128"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:SharesOutstanding
      contextRef="c56"
      id="hidden-fact-129"
      unitRef="shares"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="c56"
      id="hidden-fact-130"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="c57"
      id="hidden-fact-131"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="c58"
      id="hidden-fact-132"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="c61"
      id="hidden-fact-133"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="c62"
      id="hidden-fact-134"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="c63"
      id="hidden-fact-135"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="c64"
      id="hidden-fact-136"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="c65"
      id="hidden-fact-137"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="c66"
      id="hidden-fact-138"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="c68"
      id="hidden-fact-139"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
      contextRef="c61"
      id="hidden-fact-140"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
      contextRef="c62"
      id="hidden-fact-141"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
      contextRef="c63"
      id="hidden-fact-142"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
      contextRef="c65"
      id="hidden-fact-143"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
      contextRef="c69"
      id="hidden-fact-144"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
      contextRef="c66"
      id="hidden-fact-145"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
      contextRef="c68"
      id="hidden-fact-146"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices
      contextRef="c61"
      id="hidden-fact-147"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices
      contextRef="c62"
      id="hidden-fact-148"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices
      contextRef="c63"
      id="hidden-fact-149"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices
      contextRef="c65"
      id="hidden-fact-150"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices
      contextRef="c69"
      id="hidden-fact-151"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices
      contextRef="c66"
      id="hidden-fact-152"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices
      contextRef="c68"
      id="hidden-fact-153"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="c61"
      id="hidden-fact-154"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="c62"
      id="hidden-fact-155"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="c63"
      id="hidden-fact-156"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="c70"
      id="hidden-fact-157"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="c64"
      id="hidden-fact-158"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="c65"
      id="hidden-fact-159"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="c69"
      id="hidden-fact-160"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="c66"
      id="hidden-fact-161"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="c68"
      id="hidden-fact-162"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="c61"
      id="hidden-fact-163"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="c62"
      id="hidden-fact-164"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="c63"
      id="hidden-fact-165"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="c70"
      id="hidden-fact-166"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="c64"
      id="hidden-fact-167"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="c65"
      id="hidden-fact-168"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="c69"
      id="hidden-fact-169"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="c66"
      id="hidden-fact-170"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="c67"
      id="hidden-fact-171"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:SharesOutstanding
      contextRef="c71"
      id="hidden-fact-172"
      unitRef="shares"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="c71"
      id="hidden-fact-173"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:SharesOutstanding
      contextRef="c72"
      id="hidden-fact-174"
      unitRef="shares"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="c72"
      id="hidden-fact-175"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:SharesOutstanding
      contextRef="c73"
      id="hidden-fact-176"
      unitRef="shares"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="c73"
      id="hidden-fact-177"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:SharesOutstanding
      contextRef="c74"
      id="hidden-fact-178"
      unitRef="shares"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="c74"
      id="hidden-fact-179"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:SharesOutstanding
      contextRef="c75"
      id="hidden-fact-180"
      unitRef="shares"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="c75"
      id="hidden-fact-181"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:SharesOutstanding
      contextRef="c76"
      id="hidden-fact-182"
      unitRef="shares"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="c76"
      id="hidden-fact-183"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="c77"
      id="hidden-fact-184"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="c78"
      id="hidden-fact-185"
      unitRef="usd"
      xsi:nil="true"/>
    <arbe:RevaluationOfConvertibleLoan
      contextRef="c0"
      id="hidden-fact-186"
      unitRef="usd"
      xsi:nil="true"/>
    <arbe:RevaluationOfConvertibleLoan
      contextRef="c7"
      id="hidden-fact-187"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:IncreaseDecreaseInOperatingLeaseLiability
      contextRef="c8"
      id="hidden-fact-188"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:ProceedsFromShortTermDebt
      contextRef="c0"
      id="hidden-fact-189"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:ProceedsFromShortTermDebt
      contextRef="c7"
      id="hidden-fact-190"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:RepaymentsOfLongTermDebt
      contextRef="c0"
      id="hidden-fact-191"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:RepaymentsOfLongTermDebt
      contextRef="c7"
      id="hidden-fact-192"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:ProceedsFromIssuanceInitialPublicOffering
      contextRef="c0"
      id="hidden-fact-193"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:ProceedsFromIssuanceInitialPublicOffering
      contextRef="c7"
      id="hidden-fact-194"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:RepaymentsOfShortTermDebt
      contextRef="c0"
      id="hidden-fact-195"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:RepaymentsOfShortTermDebt
      contextRef="c8"
      id="hidden-fact-196"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="c7"
      id="hidden-fact-197"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="c8"
      id="hidden-fact-198"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:ProceedsFromWarrantExercises
      contextRef="c0"
      id="hidden-fact-199"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:ProceedsFromWarrantExercises
      contextRef="c7"
      id="hidden-fact-200"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:ProceedsFromConvertibleDebt
      contextRef="c0"
      id="hidden-fact-201"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:ProceedsFromConvertibleDebt
      contextRef="c7"
      id="hidden-fact-202"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="c8"
      id="hidden-fact-203"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:ConversionOfStockAmountConverted1
      contextRef="c0"
      id="hidden-fact-204"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:ConversionOfStockAmountConverted1
      contextRef="c7"
      id="hidden-fact-205"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:StockIssued1
      contextRef="c0"
      id="hidden-fact-206"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:StockIssued1
      contextRef="c7"
      id="hidden-fact-207"
      unitRef="usd"
      xsi:nil="true"/>
    <arbe:ConversionOfConvertibleLoanIntoOrdinarySharesUponTheRecapitalization
      contextRef="c0"
      id="hidden-fact-208"
      unitRef="usd"
      xsi:nil="true"/>
    <arbe:ConversionOfConvertibleLoanIntoOrdinarySharesUponTheRecapitalization
      contextRef="c7"
      id="hidden-fact-209"
      unitRef="usd"
      xsi:nil="true"/>
    <arbe:ConversionOfPreferredSharesIntoOrdinarySharesUponTheRecapitalization
      contextRef="c0"
      id="hidden-fact-210"
      unitRef="usd"
      xsi:nil="true"/>
    <arbe:ConversionOfPreferredSharesIntoOrdinarySharesUponTheRecapitalization
      contextRef="c7"
      id="hidden-fact-211"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
      contextRef="c8"
      id="hidden-fact-212"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:InterestPaidNet
      contextRef="c0"
      id="hidden-fact-213"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:PropertyPlantAndEquipmentSalvageValuePercentage
      contextRef="c97"
      id="hidden-fact-214"
      unitRef="pure"
      xsi:nil="true"/>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="c106"
      id="hidden-fact-215"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:RevenueRemainingPerformanceObligationPercentage
      contextRef="c107"
      id="hidden-fact-216"
      unitRef="pure"
      xsi:nil="true"/>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="c134"
      id="hidden-fact-217"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:RevenueRemainingPerformanceObligationPercentage
      contextRef="c135"
      id="hidden-fact-218"
      unitRef="pure"
      xsi:nil="true"/>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="c138"
      id="hidden-fact-219"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:RevenueRemainingPerformanceObligationPercentage
      contextRef="c139"
      id="hidden-fact-220"
      unitRef="pure"
      xsi:nil="true"/>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="c140"
      id="hidden-fact-221"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:RevenueRemainingPerformanceObligationPercentage
      contextRef="c141"
      id="hidden-fact-222"
      unitRef="pure"
      xsi:nil="true"/>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="c148"
      id="hidden-fact-223"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:RevenueRemainingPerformanceObligationPercentage
      contextRef="c149"
      id="hidden-fact-224"
      unitRef="pure"
      xsi:nil="true"/>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber
      contextRef="c166"
      id="hidden-fact-225"
      unitRef="shares"
      xsi:nil="true"/>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures
      contextRef="c167"
      id="hidden-fact-226"
      unitRef="shares"
      xsi:nil="true"/>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsPeriodIncreaseDecrease
      contextRef="c167"
      id="hidden-fact-227"
      unitRef="shares"
      xsi:nil="true"/>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="c189"
      id="hidden-fact-228"
      unitRef="shares"
      xsi:nil="true"/>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="c190"
      id="hidden-fact-229"
      unitRef="shares"
      xsi:nil="true"/>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
      contextRef="c0"
      id="hidden-fact-230"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
      contextRef="c7"
      id="hidden-fact-231"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
      contextRef="c8"
      id="hidden-fact-232"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential
      contextRef="c0"
      id="hidden-fact-233"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:IncomeTaxReconciliationOtherAdjustments
      contextRef="c7"
      id="hidden-fact-234"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:IncomeTaxReconciliationOtherAdjustments
      contextRef="c8"
      id="hidden-fact-235"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="c0"
      id="hidden-fact-236"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="c7"
      id="hidden-fact-237"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="c8"
      id="hidden-fact-238"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:DeferredTaxAssetsLiabilitiesNet
      contextRef="c5"
      id="hidden-fact-239"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:DeferredTaxAssetsLiabilitiesNet
      contextRef="c6"
      id="hidden-fact-240"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="c117"
      id="hidden-fact-241"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="c119"
      id="hidden-fact-242"
      unitRef="usd"
      xsi:nil="true"/>
    <dei:AmendmentFlag contextRef="c0" id="ixv-26975">false</dei:AmendmentFlag>
    <dei:DocumentFiscalPeriodFocus contextRef="c0" id="ixv-26976">FY</dei:DocumentFiscalPeriodFocus>
    <dei:EntityAddressPostalZipCode contextRef="c0" id="ixv-26977">6329302</dei:EntityAddressPostalZipCode>
    <dei:EntityAddressPostalZipCode contextRef="c1" id="ixv-26978">6329302</dei:EntityAddressPostalZipCode>
    <dei:EntityCentralIndexKey contextRef="c0" id="ixv-26979">0001861841</dei:EntityCentralIndexKey>
    <link:footnoteLink
      xlink:role="http://www.xbrl.org/2003/role/link"
      xlink:type="extended">
        <link:loc
          xlink:href="#hidden-fact-1"
          xlink:label="hidden-fact-1"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#hidden-fact-2"
          xlink:label="hidden-fact-2"
          xlink:type="locator"/>
        <link:footnote id="ix_0_footnote" xlink:label="ix_0_footnote" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US"><xhtml:span style="font-family: Times New Roman, Times, Serif">Represents less than $1.</xhtml:span></link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="hidden-fact-1"
          xlink:to="ix_0_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="hidden-fact-2"
          xlink:to="ix_0_footnote"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#hidden-fact-161"
          xlink:label="hidden-fact-161"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#hidden-fact-84"
          xlink:label="hidden-fact-84"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#hidden-fact-11"
          xlink:label="hidden-fact-11"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#hidden-fact-3"
          xlink:label="hidden-fact-3"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#hidden-fact-60"
          xlink:label="hidden-fact-60"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#hidden-fact-185"
          xlink:label="hidden-fact-185"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#hidden-fact-20"
          xlink:label="hidden-fact-20"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#hidden-fact-34"
          xlink:label="hidden-fact-34"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#hidden-fact-29"
          xlink:label="hidden-fact-29"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#hidden-fact-132"
          xlink:label="hidden-fact-132"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#hidden-fact-108"
          xlink:label="hidden-fact-108"
          xlink:type="locator"/>
        <link:footnote id="ix_1_footnote" xlink:label="ix_1_footnote" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US"><xhtml:span style="font-family: Times New Roman, Times, Serif">Represents less than $1.</xhtml:span></link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="hidden-fact-161"
          xlink:to="ix_1_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="hidden-fact-84"
          xlink:to="ix_1_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="hidden-fact-11"
          xlink:to="ix_1_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="hidden-fact-3"
          xlink:to="ix_1_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="hidden-fact-60"
          xlink:to="ix_1_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="hidden-fact-185"
          xlink:to="ix_1_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="hidden-fact-20"
          xlink:to="ix_1_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="hidden-fact-34"
          xlink:to="ix_1_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="hidden-fact-29"
          xlink:to="ix_1_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="hidden-fact-132"
          xlink:to="ix_1_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="hidden-fact-108"
          xlink:to="ix_1_footnote"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#hidden-fact-214"
          xlink:label="hidden-fact-214"
          xlink:type="locator"/>
        <link:footnote id="ix_2_footnote" xlink:label="ix_2_footnote" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US"><xhtml:span style="font-family: Times New Roman, Times, Serif">Leasehold improvements are amortized using the straight-line method over the shorter of the lease term or the estimated useful life of the improvements.</xhtml:span></link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="hidden-fact-214"
          xlink:to="ix_2_footnote"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#ix_5_fact"
          xlink:label="ix_5_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_4_fact"
          xlink:label="ix_4_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_3_fact"
          xlink:label="ix_3_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_0_fact"
          xlink:label="ix_0_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_1_fact"
          xlink:label="ix_1_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_2_fact"
          xlink:label="ix_2_fact"
          xlink:type="locator"/>
        <link:footnote id="ix_3_footnote" xlink:label="ix_3_footnote" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US"><xhtml:span style="font-family: Times New Roman, Times, Serif; font-weight: normal">Loss per share attributable to ordinary shareholders, diluted, was adjusted and take into consideration warrants liabilities revaluations as part of our net loss for 2023 and 2022.</xhtml:span></link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_5_fact"
          xlink:to="ix_3_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_4_fact"
          xlink:to="ix_3_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_3_fact"
          xlink:to="ix_3_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_0_fact"
          xlink:to="ix_3_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_1_fact"
          xlink:to="ix_3_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_2_fact"
          xlink:to="ix_3_footnote"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#hidden-fact-233"
          xlink:label="hidden-fact-233"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_7_fact"
          xlink:label="ix_7_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_6_fact"
          xlink:label="ix_6_fact"
          xlink:type="locator"/>
        <link:footnote id="ix_4_footnote" xlink:label="ix_4_footnote" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US"><xhtml:span style="font-family: Times New Roman, Times, Serif">The
income Tax Regulations (rules regarding ledger management of foreign invested companies and certain partnerships and the determination
of their taxable income), 1986 allow Foreign Invested Companies (i.e., foreign holding percentage of more than 25%) to report for tax
purposes in US dollars. The Company implemented these regulations on January 1, 2023.</xhtml:span></link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="hidden-fact-233"
          xlink:to="ix_4_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_7_fact"
          xlink:to="ix_4_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_6_fact"
          xlink:to="ix_4_footnote"
          xlink:type="arc"/>
    </link:footnoteLink>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
